Citrus Sinensis ID: 014202

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------43
Protein Sequence
METKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLNTGKQRCR
Secondary Structure (PSIPRED)
ccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcHHHHHHHHcccccccccccccccEEEEEEEccccccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEcccccccccccccEEEEEEEEccccccccHHHHHHHHHHHHHccccHEEEEEEEEccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccHcHEEEcccccccHcHccccccccccccccEEEEEccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcHccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
metkcgcwaflkrgvrgsckssasnhsantiprtslvydaatetrylnasnrelcapneahlssdnpdpaptdekspcqLLQFTFQELKsatgnfrpdsilgeggfgyvfkgwieengtapakpgsgiTVAVkslkpdglqghrEWVAEVDFlgqlhhpnLVKLIGYCIEDDQRLLVYEFMTrgslenhlfrrtiplpwsnrIKIALGAAKGLaflhggsepviyrdfktsnilldseynaklsdfglakagpqgdkthvstrvvgtygyaapeyvmtghltsksdvYSFGVVLLEILTgrrsmdkkrpsgeQNLVAWARQYLADKRKlyqivdprlelnyslkgvQKVSQLAYNclsrdpksrpsmdEVVKVLtplqdlndLAILSYHSRLsqqgrrkkkqdgTQQLASAHSksirdsplntgkqrcr
Flexible Loop (DISEMBL)
metkcgcwaflkrgvrgsckssasnhsantiprtslVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGtapakpgsgITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDfglakagpqgdkthvstRVVGTYGYAAPEYVMTGhltsksdvySFGVVLLEILtgrrsmdkkrpsgeqnlVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLsrdpksrpsMDEVVKVLTPLQDLNDLAILSYHSrlsqqgrrkkkqDGTQqlasahsksirdsplntgkqrcr
Low Complexity Region (SEG)
METKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLNTGKQRCR
Disordered region (IsUnstruct)
****CGCWAFLKRGVRG*****************SLVYDAATETRYL*******************************QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA*****SGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG*************NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCL************VVKVLTPLQDLNDLAILSY*****************************************
Disordered Region (DISOPRED)
**TKCGCWA************************************************************************QFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ***************************************************
Disordered Region (DISEMBL)
METKCGCWAFLKRGV*************NTIPRTSLVYDAATETRYLNASNRELCAPNEAHL************KSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSR**************************************
Disordered Region (DISPRO)
***KCGCWAFLKRG***************************************************************CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD**************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLNTGKQRCR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	429	2.2.26 [Sep-21-2011]
Q9SRH7	490	Receptor-like serine/thre	yes	no	0.913	0.8	0.632	1e-142
Q9LFP7	493	Probable receptor-like pr	no	no	0.773	0.673	0.720	1e-142
Q8GXZ3	410	Serine/threonine-protein	no	no	0.743	0.778	0.678	1e-124
P46573	412	Protein kinase APK1B, chl	no	no	0.736	0.766	0.662	1e-122
P43293	389	Probable serine/threonine	no	no	0.701	0.773	0.661	1e-121
Q06548	410	Protein kinase APK1A, chl	no	no	0.743	0.778	0.646	1e-121
O48814	395	Serine/threonine-protein	no	no	0.692	0.751	0.64	1e-114
O49840	426	Protein kinase 2B, chloro	no	no	0.722	0.727	0.643	1e-114
Q8H186	389	Probable receptor-like pr	no	no	0.776	0.856	0.586	1e-114
Q9FM85	408	Probable receptor-like pr	no	no	0.713	0.75	0.631	1e-111

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  505 bits (1300), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 256/405 (63%), Positives = 306/405 (75%), Gaps = 13/405 (3%)

Query: 2   ETKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAH 61
           E   GCW   +  V   C SS S+   +    TS V   +     +  SN +   P  + 
Sbjct: 43  EEANGCWVKFRYIV--CCASSTSDVETSLTLSTSTVGSQSA----IVQSNDQPVGPVSST 96

Query: 62  LSSDNPD-----PAPTDEKSP-CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIE 115
            ++ N +     P  ++E +    L +F+F +LK AT NFRP+S+LGEGGFG VFKGW+E
Sbjct: 97  TTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVE 156

Query: 116 ENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL 175
           ENGTAP KPG+G+TVAVK+L PDGLQGH+EW+AE+++LG L HPNLVKL+GYCIEDDQRL
Sbjct: 157 ENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRL 216

Query: 176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNIL 234
           LVYEFM RGSLENHLFRR++PLPWS R+KIALGAAKGL+FLH  + +PVIYRDFKTSNIL
Sbjct: 217 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNIL 276

Query: 235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 294
           LD EYNAKLSDFGLAK  P   KTHVSTRV+GTYGYAAPEYVMTGHLTSKSDVYSFGVVL
Sbjct: 277 LDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 336

Query: 295 LEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAY 354
           LE+LTGRRSMDK RP+GE NLV WAR +L DKR+ Y+++DPRLE ++S+KG QKV+QLA 
Sbjct: 337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAA 396

Query: 355 NCLSRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRK 399
            CLSRD K RP M EVV+VL PL  L D+A  SY+ +  Q  R K
Sbjct: 397 QCLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLK 441

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  504 bits (1298), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 240/333 (72%), Positives = 279/333 (83%), Gaps = 1/333 (0%)

Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD 138
            L +FTF +LK +T NFRP+S+LGEGGFG VFKGWIEENGTAP KPG+G+TVAVK+L PD
Sbjct: 126 HLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPD 185

Query: 139 GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP 198
           GLQGH+EW+AE++FLG L HPNLVKL+GYCIEDDQRLLVYEFM RGSLENHLFRR++PLP
Sbjct: 186 GLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP 245

Query: 199 WSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK 257
           WS R+KIALGAAKGL+FLH  + +PVIYRDFKTSNILLD++YNAKLSDFGLAK  P   K
Sbjct: 246 WSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGK 305

Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
           THVSTRV+GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE+LTGRRSMDK RP+GE NLV 
Sbjct: 306 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 365

Query: 318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           WAR +L DKR+ Y+++DPRLE ++S+KG QKV+QLA  CLSRDPK RP M +VV+ L PL
Sbjct: 366 WARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425

Query: 378 QDLNDLAILSYHSRLSQQGRRKKKQDGTQQLAS 410
             L D+A  SY+ +  Q  R K     +Q   S
Sbjct: 426 PHLKDMASSSYYFQTMQAERLKNGSGRSQGFGS 458

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  444 bits (1142), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 224/330 (67%), Positives = 258/330 (78%), Gaps = 11/330 (3%)

Query: 64  SDNPDPAP----TDEKSP---CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEE 116
           SD  DP+      D ++P    Q++ FT  EL++ T +FRPD ILGEGGFG V+KG+I++
Sbjct: 31  SDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDD 90

Query: 117 NGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLL 176
           N     K    + VAVK L  +GLQGHREW+ EV+FLGQL HPNLVKLIGYC EDD RLL
Sbjct: 91  NLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL 147

Query: 177 VYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL 235
           VYEFM RGSLENHLFR+T  PL WS R+ IALGAAKGLAFLH    PVIYRDFKTSNILL
Sbjct: 148 VYEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILL 207

Query: 236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 295
           DS+Y AKLSDFGLAKAGPQGD+THVSTRV+GTYGYAAPEYVMTGHLT++SDVYSFGVVLL
Sbjct: 208 DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLL 267

Query: 296 EILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN 355
           E+LTGR+S+DK RPS EQNLV WAR  L DKRKL QI+DPRLE  YS++  QK   LAY 
Sbjct: 268 EMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYY 327

Query: 356 CLSRDPKSRPSMDEVVKVLTPLQDLNDLAI 385
           CLS++PK+RP M +VV+ L PLQ   D  I
Sbjct: 328 CLSQNPKARPLMSDVVETLEPLQCTGDALI 357

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  439 bits (1130), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 212/320 (66%), Positives = 254/320 (79%), Gaps = 4/320 (1%)

Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           NP       +SP  L  FTF ELK+AT NFRPDS+LGEGGFG VFKGWI+E     +KPG
Sbjct: 41  NPRTEGEILQSP-NLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPG 99

Query: 126 SGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGS 185
           +G+ +AVK L  DG QGH+EW+AEV++LGQ  HPNLVKLIGYC+ED+ RLLVYEFM RGS
Sbjct: 100 TGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGS 159

Query: 186 LENHLFRRTI---PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK 242
           LENHLFRR     PL W+ R+K+ALGAAKGLAFLH     VIYRDFKTSNILLDSEYNAK
Sbjct: 160 LENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAK 219

Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
           LSDFGLAK GP GDK+HVSTR++GTYGYAAPEY+ TGHLT+KSDVYS+GVVLLE+L+GRR
Sbjct: 220 LSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRR 279

Query: 303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPK 362
           ++DK RP GEQ LV WAR  LA+KRKL++++D RL+  YS++   KV+ LA  CL+ + K
Sbjct: 280 AVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIK 339

Query: 363 SRPSMDEVVKVLTPLQDLND 382
            RP+M+EVV  L  +Q LN+
Sbjct: 340 LRPNMNEVVSHLEHIQTLNE 359

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  435 bits (1119), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 201/304 (66%), Positives = 246/304 (80%), Gaps = 3/304 (0%)

Query: 78  CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP 137
             L  F+  ELKSAT NFRPDS++GEGGFG VFKGWI+E+  AP+KPG+GI +AVK L  
Sbjct: 51  ANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQ 110

Query: 138 DGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-- 195
           +G QGHREW+AE+++LGQL HPNLVKLIGYC+E++ RLLVYEFMTRGSLENHLFRR    
Sbjct: 111 EGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFY 170

Query: 196 -PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
            PL W+ R+++ALGAA+GLAFLH     VIYRDFK SNILLDS YNAKLSDFGLA+ GP 
Sbjct: 171 QPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPM 230

Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN 314
           GD +HVSTRV+GT GYAAPEY+ TGHL+ KSDVYSFGVVLLE+L+GRR++DK +P GE N
Sbjct: 231 GDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHN 290

Query: 315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           LV WAR YL +KR+L +++DPRL+  YSL    K++ LA +C+S D KSRP+M+E+VK +
Sbjct: 291 LVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTM 350

Query: 375 TPLQ 378
             L 
Sbjct: 351 EELH 354

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  435 bits (1119), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 210/325 (64%), Positives = 256/325 (78%), Gaps = 6/325 (1%)

Query: 63  SSDNPDPAPTDEKSPCQ---LLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGT 119
           SS +  P+P  E    Q   L  F+F ELKSAT NFRPDS+LGEGGFG VFKGWI+E   
Sbjct: 33  SSVSVRPSPRTEGEILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSL 92

Query: 120 APAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYE 179
             ++PG+G+ +AVK L  DG QGH+EW+AEV++LGQ  H +LVKLIGYC+ED+ RLLVYE
Sbjct: 93  TASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYE 152

Query: 180 FMTRGSLENHLFRRTI---PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD 236
           FM RGSLENHLFRR +   PL W  R+K+ALGAAKGLAFLH     VIYRDFKTSNILLD
Sbjct: 153 FMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLD 212

Query: 237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 296
           SEYNAKLSDFGLAK GP GDK+HVSTRV+GT+GYAAPEY+ TGHLT+KSDVYSFGVVLLE
Sbjct: 213 SEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLE 272

Query: 297 ILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNC 356
           +L+GRR++DK RPSGE+NLV WA+ YL +KRK+++++D RL+  YS++   KV+ L+  C
Sbjct: 273 LLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRC 332

Query: 357 LSRDPKSRPSMDEVVKVLTPLQDLN 381
           L+ + K RP+M EVV  L  +Q LN
Sbjct: 333 LTTEIKLRPNMSEVVSHLEHIQSLN 357

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  413 bits (1062), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 192/300 (64%), Positives = 238/300 (79%), Gaps = 3/300 (1%)

Query: 83  FTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG 142
           FTF ELK AT NFRPDS++GEGGFG VFKGW++E+   P KPG+G+ +AVK L  +G QG
Sbjct: 55  FTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQG 114

Query: 143 HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---PLPW 199
           HREW+ E+++LGQL HPNLVKLIGYC+ED+ RLLVYEFM +GSLENHLFRR     PLPW
Sbjct: 115 HREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPW 174

Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
             R+ +AL AAKGLAFLH     VIYRD K SNILLD++YNAKLSDFGLA+ GP GD ++
Sbjct: 175 FLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSY 234

Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
           VSTRV+GTYGYAAPEY+ +GHL ++SDVYSFGV+LLEIL+G+R++D  RP+ E+NLV WA
Sbjct: 235 VSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWA 294

Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
           R YL  KRK+  IVD RL+  Y  +   +++ +A  CLS +PKSRP+MD+VV+ L  LQD
Sbjct: 295 RPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD 354

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  413 bits (1062), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 202/314 (64%), Positives = 240/314 (76%), Gaps = 4/314 (1%)

Query: 69  PAPTDEK---SPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           P P  E    S   L  FTF ELK+AT NFRPDS+LGEGGFGYVFKGWI+      +KPG
Sbjct: 54  PTPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPG 113

Query: 126 SGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGS 185
           SGI VAVK LK +G QGH+EW+ EV++LGQL HPNLVKL+GYC+E + RLLVYEFM +GS
Sbjct: 114 SGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGS 173

Query: 186 LENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS 244
           LENHLFRR   PL W+ R+K+A+GAAKGL FLH     VIYRDFK +NILLD+E+N+KLS
Sbjct: 174 LENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLS 233

Query: 245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSM 304
           DFGLAKAGP GDKTHVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GRR++
Sbjct: 234 DFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAV 293

Query: 305 DKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           DK +   EQ+LV WA  YL DKRKL++I+D RL   Y  KG    + LA  CL+ D K R
Sbjct: 294 DKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLR 353

Query: 365 PSMDEVVKVLTPLQ 378
           P M EV+  L  L+
Sbjct: 354 PKMSEVLAKLDQLE 367

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  412 bits (1058), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 203/346 (58%), Positives = 255/346 (73%), Gaps = 13/346 (3%)

Query: 44  TRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQ------FTFQELKSATGNFRP 97
           +R LN S+  L   ++ HLSS     + T  K+  ++L       F+F ELK AT NFR 
Sbjct: 7   SRVLNKSSSGL---DDLHLSSCKSSSSATAHKTEGEILSSTTVKSFSFNELKLATRNFRS 63

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           DS++GEGGFG VF+GW++E    P K  SG+ +AVK L PDG QGHREW+ E+++LGQL 
Sbjct: 64  DSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPDGFQGHREWLTEINYLGQLS 123

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF----RRTIPLPWSNRIKIALGAAKGL 213
           HPNLVKLIGYC+ED+QRLLVYEFM +GSLENHLF    +   PL W  RIK+AL AAKGL
Sbjct: 124 HPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPLSWILRIKVALDAAKGL 183

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
           AFLH     VIYRD K SNILLDS++NAKLSDFGLA+ GP G++++VSTRV+GT+GYAAP
Sbjct: 184 AFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQSYVSTRVMGTFGYAAP 243

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           EYV TGHL ++SDVYSFGVVLLE+L GR+++D  RP+ EQNLV WAR YL  +RK+  IV
Sbjct: 244 EYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNLVDWARPYLTSRRKVLLIV 303

Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
           D RL   Y  +G  +++ +A  CLS +PKSRP+MD+VV+ L  LQD
Sbjct: 304 DTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQD 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  402 bits (1034), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 195/309 (63%), Positives = 241/309 (77%), Gaps = 3/309 (0%)

Query: 80  LLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG 139
           L+ FT++ELK+ T NFR D +LG GGFG V+KG+I+E+      P   + VAVK    D 
Sbjct: 61  LIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVP-EPLPVAVKVHDGDN 119

Query: 140 -LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-PL 197
             QGHREW+AEV FLGQL HPNLVKLIGYC ED+ R+L+YE+M RGS+EN+LF R + PL
Sbjct: 120 SFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPL 179

Query: 198 PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK 257
            W+ R+KIA GAAKGLAFLH   +PVIYRDFKTSNILLD +YNAKLSDFGLAK GP GDK
Sbjct: 180 SWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDK 239

Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
           +HVSTR++GTYGYAAPEY+MTGHLT  SDVYSFGVVLLE+LTGR+S+DK RP+ EQNL+ 
Sbjct: 240 SHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLID 299

Query: 318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           WA   L +K+K+  IVDP++   Y +K VQK + LAY+CL+R+PK+RP M ++V  L PL
Sbjct: 300 WALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPL 359

Query: 378 QDLNDLAIL 386
           Q   + A+L
Sbjct: 360 QATEEEALL 368

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	429
118483460	427	unknown [Populus trichocarpa]	0.995	1.0	0.927	0.0
224087096	437	predicted protein [Populus trichocarpa]	0.995	0.977	0.906	0.0
255572467	441	Protein kinase APK1B, chloroplast precur	0.976	0.950	0.937	0.0
359484216	429	PREDICTED: receptor-like serine/threonin	1.0	1.0	0.916	0.0
356565172	473	PREDICTED: probable receptor-like protei	0.986	0.894	0.908	0.0
359484218	432	PREDICTED: receptor-like serine/threonin	1.0	0.993	0.907	0.0
357478207	444	Protein kinase 2B [Medicago truncatula]	0.979	0.945	0.888	0.0
351722224	421	protein kinase [Glycine max] gi|22345249	0.932	0.950	0.847	0.0
449464976	424	PREDICTED: probable receptor-like protei	0.988	1.0	0.827	0.0
449443053	433	PREDICTED: receptor-like serine/threonin	0.990	0.981	0.826	0.0

>gi|118483460|gb|ABK93629.1| unknown [Populus trichocarpa]

 Score =  822 bits (2122), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/429 (92%), Positives = 409/429 (95%), Gaps = 2/429 (0%)

Query: 1   METKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEA 60
           M++KCGCWA LKRGVRGSCKSSAS  SAN IPRTSLVYDAATETRYLNASNRELCA NEA
Sbjct: 1   MDSKCGCWAVLKRGVRGSCKSSASRDSANAIPRTSLVYDAATETRYLNASNRELCAHNEA 60

Query: 61  HLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA 120
            LSSDNPDP   D+KSPCQLLQFTFQELKS+TGNFRPDSILGEGGFGYVFKGWIEENGTA
Sbjct: 61  QLSSDNPDP--QDKKSPCQLLQFTFQELKSSTGNFRPDSILGEGGFGYVFKGWIEENGTA 118

Query: 121 PAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 180
           PAKPGSGITVAVKSLKP GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF
Sbjct: 119 PAKPGSGITVAVKSLKPGGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 178

Query: 181 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN 240
           MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG EPVIYRDFKTSNILLDSEYN
Sbjct: 179 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGPEPVIYRDFKTSNILLDSEYN 238

Query: 241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG
Sbjct: 239 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 298

Query: 301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD 360
           RRSMDKKRPSGEQNLVAWAR YLADKRK+YQ+VDPRLELNYSLK VQKVSQLAY+CLSRD
Sbjct: 299 RRSMDKKRPSGEQNLVAWARPYLADKRKMYQLVDPRLELNYSLKAVQKVSQLAYSCLSRD 358

Query: 361 PKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSP 420
            KSRP+MDEVVKVLTPLQDLNDLAILSYHSRLSQQG+RKKK +G QQ A+  SKSIRDSP
Sbjct: 359 SKSRPTMDEVVKVLTPLQDLNDLAILSYHSRLSQQGKRKKKSEGAQQHANVSSKSIRDSP 418

Query: 421 LNTGKQRCR 429
           LNTGKQR R
Sbjct: 419 LNTGKQRYR 427

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087096|ref|XP_002308064.1| predicted protein [Populus trichocarpa] gi|222854040|gb|EEE91587.1| predicted protein [Populus trichocarpa]

 Score =  815 bits (2105), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/439 (90%), Positives = 409/439 (93%), Gaps = 12/439 (2%)

Query: 1   METKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEA 60
           M++KCGCWA LKRGVRGSCKSSAS  SAN IPRTSLVYDAATETRYLNASNRELCA NEA
Sbjct: 1   MDSKCGCWAVLKRGVRGSCKSSASRDSANAIPRTSLVYDAATETRYLNASNRELCAHNEA 60

Query: 61  HLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA 120
            LSSDNPDP   D+KSPCQLLQFTFQELKS+TGNFRPDSILGEGGFGYVFKGWIEENGTA
Sbjct: 61  QLSSDNPDP--QDKKSPCQLLQFTFQELKSSTGNFRPDSILGEGGFGYVFKGWIEENGTA 118

Query: 121 PAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 180
           PAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF
Sbjct: 119 PAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 178

Query: 181 MTRGSLENHLFRR----------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKT 230
           MTRGSLENHLFR           TIPLPWSNRIKIALGAAKGLAFLHGG EPVIYRDFKT
Sbjct: 179 MTRGSLENHLFRTNSDADITFEGTIPLPWSNRIKIALGAAKGLAFLHGGPEPVIYRDFKT 238

Query: 231 SNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSF 290
           SNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSF
Sbjct: 239 SNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSF 298

Query: 291 GVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVS 350
           GVVLLEILTGRRSMDKKRPSGEQNLVAWAR YLADKRK+YQ+VDPRLELNYSLK VQKVS
Sbjct: 299 GVVLLEILTGRRSMDKKRPSGEQNLVAWARPYLADKRKMYQLVDPRLELNYSLKAVQKVS 358

Query: 351 QLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLAS 410
           QLAY+CLSRD KSRP+MDEVVKVLTPLQDLNDLAILSYHSRLSQQG+RKKK +G QQ A+
Sbjct: 359 QLAYSCLSRDSKSRPTMDEVVKVLTPLQDLNDLAILSYHSRLSQQGKRKKKSEGAQQHAN 418

Query: 411 AHSKSIRDSPLNTGKQRCR 429
             SKSIRDSPLNTGKQR R
Sbjct: 419 VSSKSIRDSPLNTGKQRYR 437

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572467|ref|XP_002527168.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223533433|gb|EEF35181.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  814 bits (2103), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/419 (93%), Positives = 401/419 (95%)

Query: 11  LKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPA 70
           +  GVRG+CK SAS  SANTIPRTSLVYDAATETRYLNASNRELC PNEA LSSDNPDP 
Sbjct: 23  IXXGVRGACKPSASKDSANTIPRTSLVYDAATETRYLNASNRELCPPNEAQLSSDNPDPP 82

Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           PTD KS CQLLQFTFQELKSATGNFRPDSILGEGGFG+VFKGWIEENGTAPAKPGSGITV
Sbjct: 83  PTDNKSLCQLLQFTFQELKSATGNFRPDSILGEGGFGFVFKGWIEENGTAPAKPGSGITV 142

Query: 131 AVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL 190
           AVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL
Sbjct: 143 AVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL 202

Query: 191 FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
           FRRTIPLPWSNRIKIALGAAKGLAFLHGG EPVIYRDFKTSNILLDSEYNAKLSDFGLAK
Sbjct: 203 FRRTIPLPWSNRIKIALGAAKGLAFLHGGPEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 262

Query: 251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS 310
           AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS
Sbjct: 263 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS 322

Query: 311 GEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           GEQNLVAWAR YLADKRKLYQ+VDPRLELNYSLKGVQKVSQLAYNCLSRDPK+RP+MDEV
Sbjct: 323 GEQNLVAWARPYLADKRKLYQLVDPRLELNYSLKGVQKVSQLAYNCLSRDPKTRPTMDEV 382

Query: 371 VKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLNTGKQRCR 429
           VKVLTPLQDLNDLAILSYHSRLSQQ RRKKK +GTQ   +A SKSIRDSPLNTGKQRCR
Sbjct: 383 VKVLTPLQDLNDLAILSYHSRLSQQARRKKKSEGTQLHMNASSKSIRDSPLNTGKQRCR 441

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484216|ref|XP_002285390.2| PREDICTED: receptor-like serine/threonine-protein kinase At3g01300-like isoform 1 [Vitis vinifera] gi|297738993|emb|CBI28238.3| unnamed protein product [Vitis vinifera]

 Score =  805 bits (2079), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/429 (91%), Positives = 398/429 (92%)

Query: 1   METKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEA 60
           ME  CGCWA LKRGVRGSCKSSAS  S NTIPRTSLVYDAATETRYLNASNREL APNEA
Sbjct: 1   MEKNCGCWAVLKRGVRGSCKSSASRDSVNTIPRTSLVYDAATETRYLNASNRELYAPNEA 60

Query: 61  HLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA 120
            LSSDNP+P+ T+ K  CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA
Sbjct: 61  QLSSDNPNPSATENKDVCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA 120

Query: 121 PAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 180
           PAKPGSGITVAVKSLKPDGLQGHREWVAEV FLGQLHHPNLVKLIGYCIEDDQRLLVYEF
Sbjct: 121 PAKPGSGITVAVKSLKPDGLQGHREWVAEVGFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 180

Query: 181 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN 240
           MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH G EPVIYRDFKTSNILLDSEYN
Sbjct: 181 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHEGPEPVIYRDFKTSNILLDSEYN 240

Query: 241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           AKLSDFGLAKAGPQ   THVSTRVVGTYGYAAPEYV TGHLTSKSDVYSFGVVLLEILTG
Sbjct: 241 AKLSDFGLAKAGPQEGDTHVSTRVVGTYGYAAPEYVRTGHLTSKSDVYSFGVVLLEILTG 300

Query: 301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD 360
           RRSMDKKRP GEQNLVAWAR YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLS D
Sbjct: 301 RRSMDKKRPRGEQNLVAWARPYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSAD 360

Query: 361 PKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSP 420
           PKSRP MDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKK DGT Q+    SKS+R SP
Sbjct: 361 PKSRPCMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKPDGTPQVTYNQSKSMRGSP 420

Query: 421 LNTGKQRCR 429
           LNTGKQ CR
Sbjct: 421 LNTGKQHCR 429

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356565172|ref|XP_003550818.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  801 bits (2069), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/425 (90%), Positives = 401/425 (94%), Gaps = 2/425 (0%)

Query: 4   KCGCWAFLKRGVRGSCK-SSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHL 62
           KCGCWA LKRGVRG+CK SSAS  S NTIPRTSLVYDAATETRYLNASNRELC PNEA L
Sbjct: 49  KCGCWAVLKRGVRGACKPSSASRDSPNTIPRTSLVYDAATETRYLNASNRELCPPNEARL 108

Query: 63  SSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPA 122
           SSDNPDP   + K PCQLLQFTFQELK+ATGNFRPDSILGEGGFGYVFKGWIEE+GTAPA
Sbjct: 109 SSDNPDPPSQENKVPCQLLQFTFQELKAATGNFRPDSILGEGGFGYVFKGWIEEDGTAPA 168

Query: 123 KPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMT 182
           KPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMT
Sbjct: 169 KPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMT 228

Query: 183 RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK 242
           RGSLENHLFRRT+PLPWSNRIKIALGAAKGLAFLH G EPVIYRDFKTSNILLD+EYNAK
Sbjct: 229 RGSLENHLFRRTVPLPWSNRIKIALGAAKGLAFLHNGPEPVIYRDFKTSNILLDTEYNAK 288

Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
           LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLEILTGRR
Sbjct: 289 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEILTGRR 348

Query: 303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPK 362
           SMDKKRPSGEQNLV+WAR YLADKRKL+Q+VDPRLELNYSLKGVQK+SQLAYNCL+RDPK
Sbjct: 349 SMDKKRPSGEQNLVSWARPYLADKRKLFQLVDPRLELNYSLKGVQKISQLAYNCLTRDPK 408

Query: 363 SRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLN 422
           SRP++DEVVK LTPLQDLNDLAILSYHSRLSQQGRRKKK DGT Q     SKS+R SPLN
Sbjct: 409 SRPNVDEVVKALTPLQDLNDLAILSYHSRLSQQGRRKKK-DGTPQFTYTQSKSMRASPLN 467

Query: 423 TGKQR 427
           TGKQR
Sbjct: 468 TGKQR 472

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484218|ref|XP_003633081.1| PREDICTED: receptor-like serine/threonine-protein kinase At3g01300-like isoform 2 [Vitis vinifera]

 Score =  797 bits (2058), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 392/432 (90%), Positives = 397/432 (91%), Gaps = 3/432 (0%)

Query: 1   METKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEA 60
           ME  CGCWA LKRGVRGSCKSSAS  S NTIPRTSLVYDAATETRYLNASNREL APNEA
Sbjct: 1   MEKNCGCWAVLKRGVRGSCKSSASRDSVNTIPRTSLVYDAATETRYLNASNRELYAPNEA 60

Query: 61  HLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA 120
            LSSDNP+P+ T+ K  CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA
Sbjct: 61  QLSSDNPNPSATENKDVCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA 120

Query: 121 PAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 180
           PAKPGSGITVAVKSLKPDGLQGHREWVAEV FLGQLHHPNLVKLIGYCIEDDQRLLVYEF
Sbjct: 121 PAKPGSGITVAVKSLKPDGLQGHREWVAEVGFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 180

Query: 181 MTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS 237
           MTRGSLENHLFR    TIPLPWSNRIKIALGAAKGLAFLH G EPVIYRDFKTSNILLDS
Sbjct: 181 MTRGSLENHLFRSDSGTIPLPWSNRIKIALGAAKGLAFLHEGPEPVIYRDFKTSNILLDS 240

Query: 238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEI 297
           EYNAKLSDFGLAKAGPQ   THVSTRVVGTYGYAAPEYV TGHLTSKSDVYSFGVVLLEI
Sbjct: 241 EYNAKLSDFGLAKAGPQEGDTHVSTRVVGTYGYAAPEYVRTGHLTSKSDVYSFGVVLLEI 300

Query: 298 LTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCL 357
           LTGRRSMDKKRP GEQNLVAWAR YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCL
Sbjct: 301 LTGRRSMDKKRPRGEQNLVAWARPYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCL 360

Query: 358 SRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIR 417
           S DPKSRP MDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKK DGT Q+    SKS+R
Sbjct: 361 SADPKSRPCMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKPDGTPQVTYNQSKSMR 420

Query: 418 DSPLNTGKQRCR 429
            SPLNTGKQ CR
Sbjct: 421 GSPLNTGKQHCR 432

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357478207|ref|XP_003609389.1| Protein kinase 2B [Medicago truncatula] gi|355510444|gb|AES91586.1| Protein kinase 2B [Medicago truncatula]

 Score =  791 bits (2044), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/423 (88%), Positives = 395/423 (93%), Gaps = 3/423 (0%)

Query: 4   KCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLS 63
           KCGCW+ LKRGV   CK SAS HS NTIPRTS+V+DAATETRYLNASNRELC PNEA +S
Sbjct: 23  KCGCWSVLKRGV---CKPSASRHSPNTIPRTSVVHDAATETRYLNASNRELCPPNEARIS 79

Query: 64  SDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAK 123
           SDNPDP P + K+PCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEE GTAPAK
Sbjct: 80  SDNPDPPPQENKAPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEEGGTAPAK 139

Query: 124 PGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTR 183
           PGSG+TVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTR
Sbjct: 140 PGSGVTVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTR 199

Query: 184 GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL 243
           GSLENHLFRRT+PLPWSNR+KIALGAAKGLAFLH G EPVIYRDFKTSNILLD+EY AKL
Sbjct: 200 GSLENHLFRRTVPLPWSNRVKIALGAAKGLAFLHNGPEPVIYRDFKTSNILLDTEYTAKL 259

Query: 244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS 303
           SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS
Sbjct: 260 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS 319

Query: 304 MDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKS 363
           MDKKRPSGEQNLV+WAR YLADKRKLYQ+VDPRLELNYSLK VQK++QLAY+CLSRDPKS
Sbjct: 320 MDKKRPSGEQNLVSWARPYLADKRKLYQLVDPRLELNYSLKAVQKIAQLAYSCLSRDPKS 379

Query: 364 RPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLNT 423
           RP+MDEVVK LTPLQDLND AILSYHSRLSQQGRRKKK DGT  +   HSKS+R SPLNT
Sbjct: 380 RPNMDEVVKALTPLQDLNDFAILSYHSRLSQQGRRKKKPDGTPHITYTHSKSMRASPLNT 439

Query: 424 GKQ 426
           G+ 
Sbjct: 440 GRH 442

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351722224|ref|NP_001235445.1| protein kinase [Glycine max] gi|223452498|gb|ACM89576.1| protein kinase [Glycine max]

 Score =  748 bits (1932), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/433 (84%), Positives = 381/433 (87%), Gaps = 33/433 (7%)

Query: 2   ETKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAH 61
           E KCGCWA LKRGVR                        ATETRYLNASNRELC PNEA 
Sbjct: 12  EKKCGCWAVLKRGVR------------------------ATETRYLNASNRELCPPNEAR 47

Query: 62  LSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAP 121
           LSSDNPDP P ++K PCQLLQFTFQELK+ATGNFRPDSILGEGGFGYVFKGWIEE+GTAP
Sbjct: 48  LSSDNPDPPPQEKKVPCQLLQFTFQELKAATGNFRPDSILGEGGFGYVFKGWIEEDGTAP 107

Query: 122 AKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFM 181
           AKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFM
Sbjct: 108 AKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFM 167

Query: 182 TRGSLENHLFRR--------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNI 233
           TRGSLENHLFR         T+PLPWSNRIKIALGAAKGLAFLH G EPVIYRDFKTSNI
Sbjct: 168 TRGSLENHLFRMLILPIFEGTVPLPWSNRIKIALGAAKGLAFLHNGPEPVIYRDFKTSNI 227

Query: 234 LLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVV 293
           LLD+EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLT+KSDVYSFGVV
Sbjct: 228 LLDTEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTAKSDVYSFGVV 287

Query: 294 LLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLA 353
           LLEILTGRRSMDKKRPSGEQNLV+WAR YLADKRKLYQ+VDPRLELNYSLKGVQK+SQLA
Sbjct: 288 LLEILTGRRSMDKKRPSGEQNLVSWARPYLADKRKLYQLVDPRLELNYSLKGVQKISQLA 347

Query: 354 YNCLSRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHS 413
           YNCLSRDPKSRP+MDEV+K LTPLQD NDLAILSYHSRLSQQGRRKKK DGT Q+    S
Sbjct: 348 YNCLSRDPKSRPNMDEVMKALTPLQDFNDLAILSYHSRLSQQGRRKKK-DGTPQITYTQS 406

Query: 414 KSIRDSPLNTGKQ 426
           KS+R SPLNTGKQ
Sbjct: 407 KSMRASPLNTGKQ 419

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449464976|ref|XP_004150205.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Cucumis sativus] gi|449529668|ref|XP_004171820.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Cucumis sativus]

 Score =  734 bits (1894), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/429 (82%), Positives = 378/429 (88%), Gaps = 5/429 (1%)

Query: 1   METKCGCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEA 60
           ME +CGCW  L R V G CKSS S  S NTIPRTSLVYD+ATETRYLNASNR+LC  NE 
Sbjct: 1   MEKRCGCWGVLTRTVSGVCKSSVSRDSPNTIPRTSLVYDSATETRYLNASNRDLCTLNEV 60

Query: 61  HLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA 120
            L SDN +P+ +D K   +LLQFTF ELK+ATGNFRPDSILGEGGFG+VFKGWIEENGTA
Sbjct: 61  ELVSDNANPSQSDNKKSSKLLQFTFYELKAATGNFRPDSILGEGGFGFVFKGWIEENGTA 120

Query: 121 PAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 180
           PAKPGSGITVAVKSLK DGLQGHREWVAEV FLGQLHHPNLVKLIGYC EDDQRLLVYEF
Sbjct: 121 PAKPGSGITVAVKSLKLDGLQGHREWVAEVAFLGQLHHPNLVKLIGYCNEDDQRLLVYEF 180

Query: 181 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN 240
           M+RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH G  PVIYRDFKTSNILLDS+YN
Sbjct: 181 MSRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHSGPVPVIYRDFKTSNILLDSDYN 240

Query: 241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           AKLSDFG AKAGPQGDKTHVSTRV+GTYGYAAPEYVMTGHLTSK+DVYSFGVVLLEI+TG
Sbjct: 241 AKLSDFGFAKAGPQGDKTHVSTRVIGTYGYAAPEYVMTGHLTSKNDVYSFGVVLLEIVTG 300

Query: 301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD 360
           RRSMDKKRPSGEQNLV WAR YLADKRKLYQIVDPRLE NYS+KGVQKVSQLA +CLSRD
Sbjct: 301 RRSMDKKRPSGEQNLVTWARPYLADKRKLYQIVDPRLEFNYSIKGVQKVSQLACSCLSRD 360

Query: 361 PKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSP 420
           PK RP+MDEVVK+LTPLQDLNDLAIL+ H R S QGRRKKK +G       +++S R SP
Sbjct: 361 PKLRPTMDEVVKILTPLQDLNDLAILTSHCRSSSQGRRKKKPEGL-----TYTQSFRASP 415

Query: 421 LNTGKQRCR 429
           LNTGKQ  R
Sbjct: 416 LNTGKQHVR 424

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449443053|ref|XP_004139295.1| PREDICTED: receptor-like serine/threonine-protein kinase At3g01300-like [Cucumis sativus]

 Score =  711 bits (1834), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/427 (82%), Positives = 379/427 (88%), Gaps = 2/427 (0%)

Query: 5   CGCWAFLKR-GVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLS 63
           CGCWA LKR     S  S +S HS N+IPR +L+ D+ATETRYLNAS+R+ CAP E  LS
Sbjct: 7   CGCWAVLKRTVSDVSKSSPSSKHSPNSIPRLTLLDDSATETRYLNASDRDFCAPAEPRLS 66

Query: 64  SDN-PDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPA 122
            DN P P   ++K   QLL+F+FQEL+SATGNFRPDSILGEGGFG+VFKGWIEENGTAPA
Sbjct: 67  FDNAPLPTRLEDKYKPQLLKFSFQELRSATGNFRPDSILGEGGFGFVFKGWIEENGTAPA 126

Query: 123 KPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMT 182
           KPGSGITVAVKSLKPDGLQGHREW AEV FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMT
Sbjct: 127 KPGSGITVAVKSLKPDGLQGHREWEAEVSFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMT 186

Query: 183 RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK 242
           RGSLENHLFRRTIPLPWSNRIKIAL AAKGLAFLH G EPVIYRDFKTSNILLD+EYNAK
Sbjct: 187 RGSLENHLFRRTIPLPWSNRIKIALAAAKGLAFLHNGPEPVIYRDFKTSNILLDTEYNAK 246

Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
           LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY+MTGHLTSKSDVYSFGVVLLEILTGRR
Sbjct: 247 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYLMTGHLTSKSDVYSFGVVLLEILTGRR 306

Query: 303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPK 362
           SMDKKRPSGEQNLV+WAR YL DKRKLY IVDPRLELNYS++GVQK+S+LA +C+SRDPK
Sbjct: 307 SMDKKRPSGEQNLVSWARPYLDDKRKLYHIVDPRLELNYSIQGVQKISRLASHCISRDPK 366

Query: 363 SRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLN 422
           SRP+MDEVVKVL PLQDLNDLAIL+YHSRLSQQGRRKKK DG  QL    S++IR SPLN
Sbjct: 367 SRPTMDEVVKVLVPLQDLNDLAILAYHSRLSQQGRRKKKSDGLHQLTYTQSRNIRTSPLN 426

Query: 423 TGKQRCR 429
            G  R R
Sbjct: 427 VGVHRRR 433

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	429
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.895	0.778	0.643	7.3e-130
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.916	0.802	0.628	1.9e-129
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.748	0.708	0.721	8.9e-125
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.743	0.778	0.681	1.2e-113
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.785	0.796	0.625	7.6e-112
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.694	0.766	0.671	1e-109
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.832	0.838	0.579	9.2e-107
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.692	0.751	0.64	9.5e-105
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.834	0.840	0.567	9.8e-103
TAIR|locus:2205714	412	AT1G26970 [Arabidopsis thalian	0.699	0.728	0.642	1.3e-102

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1274 (453.5 bits), Expect = 7.3e-130, P = 7.3e-130
 Identities = 251/390 (64%), Positives = 304/390 (77%)

Query:    21 SSASNHSAN-TIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKS-PC 78
             SS+S + +N T+  T++   +A E        +       ++  S +  P  ++E +   
Sbjct:    68 SSSSIYGSNCTV--TTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISS 125

Query:    79 QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD 138
              L +FTF +LK +T NFRP+S+LGEGGFG VFKGWIEENGTAP KPG+G+TVAVK+L PD
Sbjct:   126 HLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPD 185

Query:   139 GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP 198
             GLQGH+EW+AE++FLG L HPNLVKL+GYCIEDDQRLLVYEFM RGSLENHLFRR++PLP
Sbjct:   186 GLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP 245

Query:   199 WSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK 257
             WS R+KIALGAAKGL+FLH  + +PVIYRDFKTSNILLD++YNAKLSDFGLAK  P   K
Sbjct:   246 WSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGK 305

Query:   258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
             THVSTRV+GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE+LTGRRSMDK RP+GE NLV 
Sbjct:   306 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 365

Query:   318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
             WAR +L DKR+ Y+++DPRLE ++S+KG QKV+QLA  CLSRDPK RP M +VV+ L PL
Sbjct:   366 WARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425

Query:   378 QDLNDLAILSYHSRLSQQGRRKKKQDGTQQ 407
               L D+A  SY+ + + Q  R K   G  Q
Sbjct:   426 PHLKDMASSSYYFQ-TMQAERLKNGSGRSQ 454

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
 Identities = 256/407 (62%), Positives = 310/407 (76%)

Query:     6 GCWAFLKRGVRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSD 65
             GCW   +  V   C SS S+   +    TS V    +++  +  SN +   P  +  ++ 
Sbjct:    47 GCWVKFRYIV--CCASSTSDVETSLTLSTSTV---GSQSAIVQ-SNDQPVGPVSSTTTTS 100

Query:    66 NPD-----PAPTDEKSP-CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGT 119
             N +     P  ++E +    L +F+F +LK AT NFRP+S+LGEGGFG VFKGW+EENGT
Sbjct:   101 NAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 160

Query:   120 APAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYE 179
             AP KPG+G+TVAVK+L PDGLQGH+EW+AE+++LG L HPNLVKL+GYCIEDDQRLLVYE
Sbjct:   161 APVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYE 220

Query:   180 FMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSE 238
             FM RGSLENHLFRR++PLPWS R+KIALGAAKGL+FLH  + +PVIYRDFKTSNILLD E
Sbjct:   221 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGE 280

Query:   239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
             YNAKLSDFGLAK  P   KTHVSTRV+GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE+L
Sbjct:   281 YNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340

Query:   299 TGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLS 358
             TGRRSMDK RP+GE NLV WAR +L DKR+ Y+++DPRLE ++S+KG QKV+QLA  CLS
Sbjct:   341 TGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLS 400

Query:   359 RDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGT 405
             RD K RP M EVV+VL PL  L D+A  SY+ + + Q  R K   G+
Sbjct:   401 RDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQ-TMQAERLKAGSGS 446

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 1226 (436.6 bits), Expect = 8.9e-125, P = 8.9e-125
 Identities = 233/323 (72%), Positives = 272/323 (84%)

Query:    64 SDNPDPAPTDE-KSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPA 122
             S +  P  + E K   +L  F F +LK AT NFRP+S+LGEGGFG VFKGWIEENGTAP 
Sbjct:    71 SGSSTPLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 130

Query:   123 KPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMT 182
             KPG+G+TVAVK+L PDGLQGH+EW+AE++FLG L HP+LVKL+GYC+E+DQRLLVYEFM 
Sbjct:   131 KPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMP 190

Query:   183 RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNILLDSEYNA 241
             RGSLENHLFRRT+PLPWS R+KIALGAAKGLAFLH  +E PVIYRDFKTSNILLD EYNA
Sbjct:   191 RGSLENHLFRRTLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 250

Query:   242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
             KLSDFGLAK  P   K+HVSTRV+GTYGYAAPEYVMTGHLT+KSDVYSFGVVLLEILTGR
Sbjct:   251 KLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGR 310

Query:   302 RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDP 361
             RS+DK RP+GEQNLV W R +L DK++ Y+++DPRLE +YS+KG QK +Q+A  CL+RD 
Sbjct:   311 RSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDS 370

Query:   362 KSRPSMDEVVKVLTPLQDLNDLA 384
             K+RP M EVV+ L PL +L D A
Sbjct:   371 KARPKMSEVVEALKPLPNLKDFA 393

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1121 (399.7 bits), Expect = 1.2e-113, P = 1.2e-113
 Identities = 225/330 (68%), Positives = 259/330 (78%)

Query:    64 SDNPDPA-PT---DEKSP---CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEE 116
             SD  DP+ P    D ++P    Q++ FT  EL++ T +FRPD ILGEGGFG V+KG+I++
Sbjct:    31 SDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDD 90

Query:   117 NGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLL 176
             N     K    + VAVK L  +GLQGHREW+ EV+FLGQL HPNLVKLIGYC EDD RLL
Sbjct:    91 NLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL 147

Query:   177 VYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL 235
             VYEFM RGSLENHLFR+T  PL WS R+ IALGAAKGLAFLH    PVIYRDFKTSNILL
Sbjct:   148 VYEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILL 207

Query:   236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 295
             DS+Y AKLSDFGLAKAGPQGD+THVSTRV+GTYGYAAPEYVMTGHLT++SDVYSFGVVLL
Sbjct:   208 DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLL 267

Query:   296 EILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN 355
             E+LTGR+S+DK RPS EQNLV WAR  L DKRKL QI+DPRLE  YS++  QK   LAY 
Sbjct:   268 EMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYY 327

Query:   356 CLSRDPKSRPSMDEVVKVLTPLQDLNDLAI 385
             CLS++PK+RP M +VV+ L PLQ   D  I
Sbjct:   328 CLSQNPKARPLMSDVVETLEPLQCTGDALI 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1104 (393.7 bits), Expect = 7.6e-112, P = 7.6e-112
 Identities = 214/342 (62%), Positives = 263/342 (76%)

Query:    45 RYLNASNRELCAPNEAHLS-SDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGE 103
             +Y+++   +      + +S   NP       +SP  L  FTF ELK+AT NFRPDS+LGE
Sbjct:    30 KYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSP-NLKSFTFAELKAATRNFRPDSVLGE 88

Query:   104 GGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVK 163
             GGFG VFKGWI+E     +KPG+G+ +AVK L  DG QGH+EW+AEV++LGQ  HPNLVK
Sbjct:    89 GGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVK 148

Query:   164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---PLPWSNRIKIALGAAKGLAFLHGGS 220
             LIGYC+ED+ RLLVYEFM RGSLENHLFRR     PL W+ R+K+ALGAAKGLAFLH   
Sbjct:   149 LIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAE 208

Query:   221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
               VIYRDFKTSNILLDSEYNAKLSDFGLAK GP GDK+HVSTR++GTYGYAAPEY+ TGH
Sbjct:   209 TSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGH 268

Query:   281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
             LT+KSDVYS+GVVLLE+L+GRR++DK RP GEQ LV WAR  LA+KRKL++++D RL+  
Sbjct:   269 LTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQ 328

Query:   341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLND 382
             YS++   KV+ LA  CL+ + K RP+M+EVV  L  +Q LN+
Sbjct:   329 YSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNE 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 1084 (386.6 bits), Expect = 1.0e-109, P = 1.0e-109
 Identities = 202/301 (67%), Positives = 247/301 (82%)

Query:    80 LLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG 139
             L  F+  ELKSAT NFRPDS++GEGGFG VFKGWI+E+  AP+KPG+GI +AVK L  +G
Sbjct:    53 LKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEG 112

Query:   140 LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-TI--P 196
              QGHREW+AE+++LGQL HPNLVKLIGYC+E++ RLLVYEFMTRGSLENHLFRR T   P
Sbjct:   113 FQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQP 172

Query:   197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
             L W+ R+++ALGAA+GLAFLH     VIYRDFK SNILLDS YNAKLSDFGLA+ GP GD
Sbjct:   173 LSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGD 232

Query:   257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
              +HVSTRV+GT GYAAPEY+ TGHL+ KSDVYSFGVVLLE+L+GRR++DK +P GE NLV
Sbjct:   233 NSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLV 292

Query:   317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP 376
              WAR YL +KR+L +++DPRL+  YSL    K++ LA +C+S D KSRP+M+E+VK +  
Sbjct:   293 DWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEE 352

Query:   377 L 377
             L
Sbjct:   353 L 353

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1056 (376.8 bits), Expect = 9.2e-107, P = 9.2e-107
 Identities = 215/371 (57%), Positives = 266/371 (71%)

Query:    17 GSC-KSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDN-----PDPA 70
             G+C  SSA   S++  P  +    A+  +R  + ++R    P+   ++S +     P P 
Sbjct:     2 GNCLDSSAKVDSSSHSPHAN---SASLSSRVSSKTSRST-VPSSLSINSYSSVESLPTPR 57

Query:    71 PTDE--KSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGI 128
                E   SP  L  FTF ELK+AT NFRPDS+LGEGGFGYVFKGWI+      +KPGSGI
Sbjct:    58 TEGEILSSP-NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116

Query:   129 TVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN 188
              VAVK LK +G QGH+EW+ EV++LGQL HPNLVKL+GYC+E + RLLVYEFM +GSLEN
Sbjct:   117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176

Query:   189 HLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG 247
             HLFRR   PL W+ R+K+A+GAAKGL FLH     VIYRDFK +NILLD+E+N+KLSDFG
Sbjct:   177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFG 236

Query:   248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKK 307
             LAKAGP GDKTHVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GRR++DK 
Sbjct:   237 LAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKS 296

Query:   308 RPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM 367
             +   EQ+LV WA  YL DKRKL++I+D RL   Y  KG    + LA  CL+ D K RP M
Sbjct:   297 KVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKM 356

Query:   368 DEVVKVLTPLQ 378
              EV+  L  L+
Sbjct:   357 SEVLAKLDQLE 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
 Identities = 192/300 (64%), Positives = 238/300 (79%)

Query:    83 FTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG 142
             FTF ELK AT NFRPDS++GEGGFG VFKGW++E+   P KPG+G+ +AVK L  +G QG
Sbjct:    55 FTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQG 114

Query:   143 HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---PLPW 199
             HREW+ E+++LGQL HPNLVKLIGYC+ED+ RLLVYEFM +GSLENHLFRR     PLPW
Sbjct:   115 HREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPW 174

Query:   200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
               R+ +AL AAKGLAFLH     VIYRD K SNILLD++YNAKLSDFGLA+ GP GD ++
Sbjct:   175 FLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSY 234

Query:   260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
             VSTRV+GTYGYAAPEY+ +GHL ++SDVYSFGV+LLEIL+G+R++D  RP+ E+NLV WA
Sbjct:   235 VSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWA 294

Query:   320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
             R YL  KRK+  IVD RL+  Y  +   +++ +A  CLS +PKSRP+MD+VV+ L  LQD
Sbjct:   295 RPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
 Identities = 210/370 (56%), Positives = 257/370 (69%)

Query:    18 SCKSSASNHS--ANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDE- 74
             S K   SNHS  AN+    S V  ++  +R    S   L   + +  SS  P P    E 
Sbjct:     8 SAKVDNSNHSPHANSASSGSKV--SSKTSRSTGPSG--LSTTSYSTDSSFGPLPTLRTEG 63

Query:    75 ---KSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
                 SP  L  FTF ELK+AT NFR D++LGEGGFG VFKGWI++     ++PGSGI VA
Sbjct:    64 EILSSP-NLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122

Query:   132 VKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF 191
             VK LKP+G QGH+EW+ EV++LGQL HPNLV L+GYC E + RLLVYEFM +GSLENHLF
Sbjct:   123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182

Query:   192 RRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
             RR   PL W+ R+K+A+GAAKGL FLH     VIYRDFK +NILLD+++NAKLSDFGLAK
Sbjct:   183 RRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAK 242

Query:   251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS 310
             AGP GD THVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+++GRR+MD     
Sbjct:   243 AGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGG 302

Query:   311 GEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
              E +LV WA  YL DKRKL++I+D +L   Y  KG    + LA  CL+ D K RP M EV
Sbjct:   303 NEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEV 362

Query:   371 VKVLTPLQDL 380
             +  L  L+ +
Sbjct:   363 LVTLEQLESV 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)]

 Score = 1017 (363.1 bits), Expect = 1.3e-102, P = 1.3e-102
 Identities = 196/305 (64%), Positives = 239/305 (78%)

Query:    76 SPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL 135
             SP  L  FTF ELK+AT NFRPDS++GEGGFGYV+KGWI+E   +P+KPGSG+ VAVK L
Sbjct:    65 SPT-LKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSGMVVAVKKL 123

Query:   136 KPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ-RLLVYEFMTRGSLENHLFRRT 194
             K +G QGHR+W+AEVD LG+LHH NLVKLIGYC + D  RLLVYE+M +GSLENHLFRR 
Sbjct:   124 KEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENHLFRRG 183

Query:   195 I-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP 253
               P+PW  RIK+A+GAA+GLAFLH     VIYRDFK SNILLDSE+NAKLSDFGLAK GP
Sbjct:   184 AEPIPWRTRIKVAIGAARGLAFLHEAQ--VIYRDFKASNILLDSEFNAKLSDFGLAKVGP 241

Query:   254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
              GD+THVST+V+GT GYAAPEYV TG +T+KSDVYSFGVVLLE+L+GR ++DK +   E+
Sbjct:   242 TGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKVGVER 301

Query:   314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV 373
             NLV WA  YL DKRK+++I+D +L   Y  KG    +  A  CL+++PK RP M +V+  
Sbjct:   302 NLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSDVLST 361

Query:   374 LTPLQ 378
             L  L+
Sbjct:   362 LEELE 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SRH7	Y3130_ARATH	2, ., 7, ., 1, 1, ., 1	0.6320	0.9137	0.8	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00060537 SubName- Full=Putative uncharacterized protein; (438 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	429
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-58
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-58
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-55
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-53
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-51
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-36
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-34
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-30
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-30
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-29
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-29
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-29
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-25
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-24
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-23
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-22
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-20
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-20
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-19
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  191 bits (489), Expect = 1e-58
 Identities = 93/283 (32%), Positives = 138/283 (48%), Gaps = 34/283 (12%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL 156
              LGEG FG V+KG ++         G  + VAVK+LK D   Q   E++ E   + +L
Sbjct: 4   GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN+VKL+G C E++  ++V E+M  G L ++L   R   L  S+ +  AL  A+G+ +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           L   S+  I+RD    N L+      K+SDFGL++     D   V    +    + APE 
Sbjct: 119 LE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPES 175

Query: 276 VMTGHLTSKSDVYSFGVVLLEILT-GRR---SMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           +  G  TSKSDV+SFGV+L EI T G      M                +YL    +L +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE----------VLEYLKKGYRLPK 225

Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
             +   EL Y         +L   C + DP+ RP+  E+V++L
Sbjct: 226 PPNCPPEL-Y---------KLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  191 bits (489), Expect = 1e-58
 Identities = 90/279 (32%), Positives = 138/279 (49%), Gaps = 27/279 (9%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL 156
              LGEG FG V+KG ++            + VAVK+LK D   Q   E++ E   + +L
Sbjct: 4   GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HPN+VKL+G C E++   +V E+M  G L ++L +    L  S+ +  AL  A+G+ +L
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD-KTHVSTRVVGTYGYAAPEY 275
              S+  I+RD    N L+      K+SDFGL++     D       ++     + APE 
Sbjct: 119 E--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPES 174

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +  G  TSKSDV+SFGV+L EI T       ++P    +      +YL +  +L Q  + 
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNEE-VLEYLKNGYRLPQPPNC 228

Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
             EL Y          L   C + DP+ RP+  E+V++L
Sbjct: 229 PPEL-Y---------DLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  189 bits (482), Expect = 4e-58
 Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 65/277 (23%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           LGEGGFG V+    ++ G           VA+K +K +      E  + E++ L +L+HP
Sbjct: 1   LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N+VKL G   +++   LV E+   GSL++ L      L     ++I L   +GL +LH  
Sbjct: 52  NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109

Query: 220 SEPVIYRDFKTSNILLDS-EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM- 277
           S  +I+RD K  NILLDS     KL+DFGL+K             +VGT  Y APE ++ 
Sbjct: 110 SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLG 167

Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
            G+ + KSD++S GV+L E+                                        
Sbjct: 168 KGYYSEKSDIWSLGVILYEL---------------------------------------- 187

Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                     ++  L    L +DP+ RPS  E+++ L
Sbjct: 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  183 bits (467), Expect = 3e-55
 Identities = 88/282 (31%), Positives = 135/282 (47%), Gaps = 38/282 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHP 159
           LGEG FG V+KG ++         G+   VAVK+LK     +   E++ E   + +L HP
Sbjct: 7   LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N+V+L+G C + +   +V E+M  G L + L +    L   + +++AL  AKG+ +L   
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG---YAAPEYV 276
           S+  ++RD    N L+      K+SDFGL++   + D         G      + APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPESL 176

Query: 277 MTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
             G  TSKSDV+SFGV+L EI T G         S E+       + L D  +L +   P
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGE--QPYPGMSNEE-----VLELLEDGYRLPR---P 226

Query: 336 RL---ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                EL           +L   C + DP+ RP+  E+V+ L
Sbjct: 227 ENCPDELY----------ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  179 bits (456), Expect = 1e-53
 Identities = 93/285 (32%), Positives = 132/285 (46%), Gaps = 36/285 (12%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDF 152
           +     LG G FG V+K             G+G  VAVK LK      +  +    E+  
Sbjct: 1   YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L +L HPN+V+LI    + D   LV E+   G L ++L R   PL      KIAL   +G
Sbjct: 52  LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRG 110

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVGTYGY 270
           L +LH  S  +I+RD K  NILLD     K++DFGLAK         T      VGT  Y
Sbjct: 111 LEYLH--SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT----FVGTPWY 164

Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
            APE ++ G     K DV+S GV+L E+LTG+                     L   + +
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLI 211

Query: 330 YQIVDPRLELNYSLK--GVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            +I+ P LE +      G ++   L   CL++DP  RP+ +E+++
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  175 bits (446), Expect = 4e-52
 Identities = 90/294 (30%), Positives = 136/294 (46%), Gaps = 51/294 (17%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHH 158
            LGEG FG V+KG          K G    VAVK+LK D  +  R +++ E   + +L H
Sbjct: 2   KLGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH 55

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRI------KIALGAA 210
           PN+V+L+G C E++   LV E+M  G L ++L   R   P P  + +        A+  A
Sbjct: 56  PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST------RV 264
           KG+ +L   S+  ++RD    N L+  +   K+SDFGL++     D     T      R 
Sbjct: 116 KGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR- 172

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
                + APE +  G  TSKSDV+SFGV+L EI T   +     P             L+
Sbjct: 173 -----WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPG----------LS 212

Query: 325 DKRKLYQIVDP-RLE--LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           ++  L  +    RL            ++ +L  +C   DP+ RP+  E+V+ L 
Sbjct: 213 NEEVLEYLRKGYRLPKPEYCP----DELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  173 bits (440), Expect = 3e-51
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 34/281 (12%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFL 153
           +     LGEG FG V+               +G  VA+K +K   ++  RE  + E+  L
Sbjct: 1   YEILEKLGEGSFGKVYLAR---------DKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
            +L HPN+V+L     ++D+  LV E+   G L + L ++   L               L
Sbjct: 52  KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSAL 110

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH  S+ +++RD K  NILLD + + KL+DFGLA+   Q D     T  VGT  Y AP
Sbjct: 111 EYLH--SKGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAP 165

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADKRKLYQI 332
           E ++        D++S GV+L E+LTG+       P  G+  L+   +          +I
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFK----------KI 209

Query: 333 VDPRLELNYSLKGV-QKVSQLAYNCLSRDPKSRPSMDEVVK 372
             P+         +  +   L    L +DP+ R + +E ++
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  139 bits (352), Expect = 3e-38
 Identities = 88/287 (30%), Positives = 135/287 (47%), Gaps = 25/287 (8%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LGEG FG V     +  G       +G  VAVKSL   G + HR ++  E++ L  L H 
Sbjct: 12  LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 160 NLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           N+VK  G C +   R   L+ E++  GSL ++L R    +     +  +    KG+ +L 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL- 125

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST--RVVGTYGYAAPEY 275
            GS+  I+RD    NIL++SE   K+SDFGLAK  P+    +          + Y APE 
Sbjct: 126 -GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 276 VMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
           + T   +S SDV+SFGV L E+ T G  S   + P  E   +    Q    +  + ++++
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPS---QSPPAEFLRMIGIAQ---GQMIVTRLLE 237

Query: 335 PRLELNYSLKGVQK----VSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
             L+    L         V  L   C   +P+ RPS  +++ ++  L
Sbjct: 238 -LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  138 bits (349), Expect = 5e-38
 Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 14/207 (6%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG 154
           F     +G+GGFG V+K           K  +G  VA+K +K +  +   + + E+  L 
Sbjct: 2   FEILEKIGKGGFGEVYKAR--------HKR-TGKEVAIKVIKLESKEKKEKIINEIQILK 52

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           +  HPN+VK  G  ++ D+  +V EF + GSL++ L      L  S    +     KGL 
Sbjct: 53  KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LH  S  +I+RD K +NILL S+   KL DFGL+    Q   T     +VGT  + APE
Sbjct: 113 YLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPE 167

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGR 301
            +       K+D++S G+  +E+  G+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  134 bits (339), Expect = 2e-36
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 51/284 (17%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKS--LKPDGLQGHREWVAEVDFLGQLH 157
           +LG G FG V+    ++ G           +AVKS  L  D  +       E+  L  L 
Sbjct: 7   LLGRGSFGSVYLALDKDTGE---------LMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 158 HPNLVKLIGYCIEDDQR-LLVY-EFMTRGSLENHLFRRTIPLP------WSNRIKIALGA 209
           HPN+V+  G   ++++  L ++ E+++ GSL + L ++   LP      ++ +I      
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQI------ 110

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
            +GLA+LH  S  +++RD K +NIL+DS+   KL+DFG AK     +    +  V GT  
Sbjct: 111 LEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           + APE +        +D++S G  ++E+ TG      K P  E      A         L
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATG------KPPWSELGNPMAA---------L 213

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDE 369
           Y+I              + +S+ A +    CL RDPK RP+ DE
Sbjct: 214 YKIGSSGEPPEIP----EHLSEEAKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (320), Expect = 6e-34
 Identities = 82/283 (28%), Positives = 135/283 (47%), Gaps = 46/283 (16%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
           + +G+G FG V  G              G  VAVK LK D     + ++AE   +  L H
Sbjct: 12  ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRH 59

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLH 217
           PNLV+L+G  ++ +   +V E+M +GSL ++L  R    +  + ++  AL   +G+ +L 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
              +  ++RD    N+L+  +  AK+SDFGLAK   QG     S ++     + APE + 
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAPEALR 172

Query: 278 TGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
               ++KSDV+SFG++L EI + GR              V + R  L D       V P 
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKD-------VVPH 211

Query: 337 LELNYSLKGVQK----VSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           +E  Y ++  +     V ++  +C   DP  RP+  ++ + L 
Sbjct: 212 VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (320), Expect = 7e-34
 Identities = 83/283 (29%), Positives = 127/283 (44%), Gaps = 49/283 (17%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLH 157
           ++G G FG V+KG   E G           VA+K +  + +  +  +  + E+D L  L 
Sbjct: 7   LIGRGAFGVVYKGLNLETGD---------FVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
           HPN+VK IG  IE    L ++ E+   GSL   + ++  P P S          +GLA+L
Sbjct: 58  HPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYL 115

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPEY 275
           H   + VI+RD K +NIL   +   KL+DFG+A K             VVGT  + APE 
Sbjct: 116 HE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEV 170

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV-- 333
           +     ++ SD++S G  ++E+LTG        P  +          L     L++IV  
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTG------NPPYYD----------LNPMAALFRIVQD 214

Query: 334 -DPRLELNYSLKGVQKVSQLA---YNCLSRDPKSRPSMDEVVK 372
             P L    S        +L      C  +DP  RP+  +++K
Sbjct: 215 DHPPLPEGIS-------PELKDFLMQCFQKDPNLRPTAKQLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  124 bits (313), Expect = 9e-33
 Identities = 87/278 (31%), Positives = 139/278 (50%), Gaps = 15/278 (5%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           LGEG FG V     +     PA  G+G  VAVK+LK +  Q +   W  E++ L  L+H 
Sbjct: 12  LGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 160 NLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           N+VK  G C E   +   L+ E++  GSL ++L +  + L  +  +  A    +G+A+LH
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQICEGMAYLH 124

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH-VSTRVVGTYGYAAPEYV 276
             S+  I+RD    N+LLD++   K+ DFGLAKA P+G + + V         + A E +
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
                +  SDV+SFGV L E+LT      K+ P  +   +   +Q      +L ++++  
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT--HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240

Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           + L       Q+V  L  NC   + K RP+   ++ +L
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  126 bits (316), Expect = 2e-32
 Identities = 94/343 (27%), Positives = 146/343 (42%), Gaps = 43/343 (12%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV---AEV 150
           ++R    LGEG FG V+     +             VA+K L        +E      E+
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48

Query: 151 DFLGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRIKIAL 207
             L  L H PN+VKL  +  ++    LV E++  GSLE+ L    R  PL  S  + I  
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN-AKLSDFGLAK----AGPQGDKTHVST 262
                L +LH  S+ +I+RD K  NILLD +    KL DFGLAK     G       + +
Sbjct: 109 QILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166

Query: 263 RVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
             VGT GY APE ++     + +S SD++S G+ L E+LTG    + ++ S   +     
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT--- 223

Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVK--V 373
                  + + ++  P L    S    + +S+ A +     L++DPK+R S    +   +
Sbjct: 224 ------LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Query: 374 LTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSI 416
           L  L+              S   R          ++S +S +I
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAI 320

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 3e-31
 Identities = 77/280 (27%), Positives = 128/280 (45%), Gaps = 37/280 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +G+G FG V+KG ++ N            VAVK+ +       +  ++ E + L Q  HP
Sbjct: 3   IGKGNFGDVYKGVLKGNTE----------VAVKTCRSTLPPDLKRKFLQEAEILKQYDHP 52

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N+VKLIG C++     +V E +  GSL   L ++   L     ++++L AA G+ +L   
Sbjct: 53  NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE-- 110

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           S+  I+RD    N L+      K+SDFG+++    G  T           + APE +  G
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
             TS+SDV+S+G++L E  +           G+      + Q   +          R+E 
Sbjct: 171 RYTSESDVWSYGILLWETFSL----------GDTPYPGMSNQQTRE----------RIES 210

Query: 340 NYSLKGVQ----KVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
            Y +   Q    ++ +L   C + DP++RPS  E+   L 
Sbjct: 211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (301), Expect = 3e-31
 Identities = 77/295 (26%), Positives = 124/295 (42%), Gaps = 61/295 (20%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK--SLKPDGLQGHREWVAEVD 151
            +     +G+G FG V+    + +G             +K   L     +   + + EV 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMSEKEREDALNEVK 51

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLL-VYEFMTRGSLENHLFRRT---IPLP----WSNRI 203
            L +L+HPN++K      E+  +L  V E+   G L   + ++     P P        +
Sbjct: 52  ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
           ++ L     L +LH  S  +++RD K  NI L S    KL DFG++K         ++  
Sbjct: 111 QLCLA----LKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKT 162

Query: 264 VVGTYGYAAPE------YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
           VVGT  Y +PE      Y        KSD++S G VL E+ T       K P   +NL+ 
Sbjct: 163 VVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTL------KHPFEGENLLE 210

Query: 318 WARQYLADK--RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                LA K  +  Y    P +   YS     ++  L  + L +DP+ RPS+ ++
Sbjct: 211 -----LALKILKGQY----PPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  118 bits (298), Expect = 2e-30
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 22/213 (10%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHP 159
           LGEG FG V+KG +    T P +  S  +VA+K+LK +   +  +E+  E + +  L HP
Sbjct: 13  LGEGAFGKVYKGEL----TGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIK 204
           N+V L+G C ++    +++E++  G L   L R +                 L  S+ + 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           IA+  A G+ +L   S   ++RD    N L+      K+SDFGL++     D   V ++ 
Sbjct: 129 IAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEI 297
           +    +  PE ++ G  T++SD++SFGVVL EI
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 2e-30
 Identities = 87/295 (29%), Positives = 143/295 (48%), Gaps = 35/295 (11%)

Query: 101 LGEGGFGYVF----KGWIEENG-TAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLG 154
           LGEG FG V     +G  E  G  AP   G  + VAVK L+ D  +  R +++ E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRI 203
           +L +PN+++L+G C+ DD   ++ E+M  G L   L +R I            +  +N +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +A+  A G+ +L   S   ++RD  T N L+ + Y  K++DFG+++    GD   +  R
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP----SGEQNLVAWA 319
            V    + A E ++ G  T+ SDV++FGV L E+ T    + K++P    S EQ +    
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENTG 246

Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
             +    R++Y    P             V +L   C SRD K RP+ +++   L
Sbjct: 247 EFFRNQGRQIYLSQTPLCP--------SPVFKLMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 74/205 (36%), Positives = 111/205 (54%), Gaps = 20/205 (9%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHP 159
           LG G FG V KG          K G  + VAVK+LK + +  G +E++ E   + QL HP
Sbjct: 3   LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF-RRTIPLPWSNRIKIALGAAKGLAFLHG 218
            +V+LIG C  +   +LV E    G L  +L  RR IP+  S+  ++A   A G+A+L  
Sbjct: 57  CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYLE- 112

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV----VGTYGYAAPE 274
            S+  ++RD    N+LL + + AK+SDFG+++A   G   + +T      +  Y   APE
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APE 168

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +  G  +SKSDV+S+GV L E  +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 8e-30
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 47/289 (16%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQL 156
           + ++G G FG V +G ++  G         I VA+K+LK       R +++ E   +GQ 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKE------IDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62

Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HPN+++L G   +    +++ E+M  GSL+  L            + +  G A G+ +L
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 217 HGGSEPV-IYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG------ 269
              SE   ++RD    NIL++S    K+SDFGL++     + T+       T G      
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIR 173

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           + APE +     TS SDV+SFG+V+ E+++           GE+     + Q +      
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKA--- 220

Query: 330 YQIVDPRLELNYSLKG----VQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                  +E  Y L         + QL  +C  +D   RP+  ++V  L
Sbjct: 221 -------VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  116 bits (291), Expect = 1e-29
 Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 45/295 (15%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           ILGEG FG V +G + ++  +  K      VAVK++K D    + E   +++E   +   
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHT-YSEIEEFLSEAACMKDF 58

Query: 157 HHPNLVKLIGYCIEDDQR------LLVYEFMTRGSLENHLFRRTIP-----LPWSNRIKI 205
            HPN++KLIG C E          +++  FM  G L + L    +      LP    +K 
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD---KTHVST 262
            +  A G+ +L   +   I+RD    N +L  +    ++DFGL+K    GD   +  ++ 
Sbjct: 119 MVDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
             V    + A E +     TSKSDV++FGV + EI T      +    G +N       Y
Sbjct: 177 MPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYPGVEN--HEIYDY 227

Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           L    +L Q  D           + ++  L Y+C   DPK RP+  ++ +VL  +
Sbjct: 228 LRHGNRLKQPED----------CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-29
 Identities = 74/213 (34%), Positives = 107/213 (50%), Gaps = 36/213 (16%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           LG G FG V+ G W   NGT          VAVK+LKP G      ++ E   + +L H 
Sbjct: 14  LGAGQFGEVWMGTW---NGTTK--------VAVKTLKP-GTMSPEAFLQEAQIMKKLRHD 61

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFL 216
            LV+L   C E++   +V E+M++GSL + L     + + LP    + +A   A+G+A+L
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYL 119

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVSTRVVGTYG 269
              S   I+RD    NIL+      K++DFGLA+          +G K  +         
Sbjct: 120 E--SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK-------- 169

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GR 301
           + APE    G  T KSDV+SFG++L EI+T GR
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (287), Expect = 3e-29
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 35/275 (12%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG 154
           F  +  LG G FG V++G  +            + VA+K LK D L   +++  EV  L 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR----------VRVAIKILKSDDLLKQQDFQKEVQALK 57

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---LPWSNRIKIALGAAK 211
           +L H +L+ L   C   +   ++ E M +GSL    F R+     LP ++ I +A   A+
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAE 115

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+A+L    +  I+RD    NIL+  +   K++DFGLA+   +        ++   Y + 
Sbjct: 116 GMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWT 171

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE    G  ++KSDV+SFG++L E+ T  +       + E                +Y 
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----------------VYD 215

Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
            +     +    K  Q++ ++   C + +P+ RPS
Sbjct: 216 QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  115 bits (288), Expect = 5e-29
 Identities = 88/305 (28%), Positives = 144/305 (47%), Gaps = 44/305 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPA-------KPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           LGEG FG V    +      P        + G  + VAVK L+PD  +  R +++ EV  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------PL 197
           L +L  PN+++L+G C+++D   ++ E+M  G L   L    +                L
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 198 P---WSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
           P   +S+ + +AL  A G+ +L   S   ++RD  T N L+      K++DFG+++    
Sbjct: 133 PAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190

Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE-- 312
           GD   +  R V    + A E ++ G  T+ SDV++FGV L EIL     + K++P GE  
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGELT 246

Query: 313 -QNLVAWARQYLAD-KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
            + ++  A ++  D  R++Y    P           Q + +L   C SRD + RPS  ++
Sbjct: 247 DEQVIENAGEFFRDQGRQVYLFRPPPCP--------QGLYELMLQCWSRDCRERPSFSDI 298

Query: 371 VKVLT 375
              LT
Sbjct: 299 HAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  114 bits (288), Expect = 5e-29
 Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 46/297 (15%)

Query: 101 LGEGGFGYV-------FKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           LGEG FG V        + + E+         + + VAVK L+PD     R +++ EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP-----------LPWSN 201
           L +L  PN+ +L+G C  D    ++ E+M  G L N   ++ +            L +S 
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSLSFST 131

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            + +A   A G+ +L   S   ++RD  T N L+   Y  K++DFG+++     D   V 
Sbjct: 132 LLYMATQIASGMRYLE--SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE-------QN 314
            R      + A E V+ G  T+KSDV++FGV L EILT    + +++P          +N
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCREQPYEHLTDQQVIEN 245

Query: 315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQK-VSQLAYNCLSRDPKSRPSMDEV 370
                  +  D R   QI  PR           K + +L   C  RD + RP+  E+
Sbjct: 246 A---GHFFRDDGR---QIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  113 bits (283), Expect = 2e-28
 Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 28/293 (9%)

Query: 101 LGEGGFGYV-------FKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           LGEG FG V        + +++++ +        + VAVK L+ D  +  R +++ E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP----------WSNR 202
           + +L  PN+++L+  CI  D   ++ E+M  G L   L R                +S  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I +A   A G+ +L   S   ++RD  T N L+   Y  K++DFG+++    GD   +  
Sbjct: 133 IFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
           R V    + + E ++ G  T+ SDV++FGV L EILT  +     + S EQ +      +
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF 250

Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
               R++Y                  + +L  +C  R+ K RPS  E+   L 
Sbjct: 251 RDQGRQVYLPKPALCP--------DSLYKLMLSCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 2e-28
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 25/208 (12%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWV-AEVDFLGQLH 157
           LG+G FG V     ++ G            A+K LK   +      E    E + L +++
Sbjct: 1   LGKGSFGKVLLVRKKDTGK---------LYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRR-TIPLPWSNRI--KIALGAAKGL 213
           HP +VKL  Y  + +++L LV E+   G L +HL +        +     +I L     L
Sbjct: 52  HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----L 106

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH  S  +IYRD K  NILLD++ + KL+DFGLAK          +    GT  Y AP
Sbjct: 107 EYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAP 162

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           E ++        D +S GV+L E+LTG+
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  110 bits (278), Expect = 6e-28
 Identities = 84/280 (30%), Positives = 122/280 (43%), Gaps = 33/280 (11%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHH 158
           LG+G FG V +G W    G         I VAVK LK D L     +++ E   +  L H
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALGAAKGLAFLH 217
            NL++L G  +     ++V E    GSL + L +  +     S     A+  A G+ +L 
Sbjct: 56  ENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST--RVVGTYGYAAPEY 275
             S+  I+RD    NILL S+   K+ DFGL +A PQ +  +V      V  + + APE 
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPES 171

Query: 276 VMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
           + T   +  SDV+ FGV L E+ T G         SG Q L         DK        
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGE--EPWAGLSGSQIL------KKIDKEG------ 217

Query: 335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
            RLE   +    Q +  +   C + +P  RP+   + + L
Sbjct: 218 ERLERPEACP--QDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  110 bits (277), Expect = 9e-28
 Identities = 81/282 (28%), Positives = 121/282 (42%), Gaps = 50/282 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG G  G V K           +P +G  +AVK+++ +      ++ + E+D L + + P
Sbjct: 9   LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            +V   G    +    +  E+M  GSL+  L      +P     KIA+   KGL +LH  
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV--------GTYGYA 271
            + +I+RD K SNIL++S    KL DFG            VS ++V        GT  Y 
Sbjct: 120 HK-IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYM 166

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE +     + KSD++S G+ L+E+ TGR                           L  
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQY 215

Query: 332 IVD---PRLEL-NYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
           IV+   PRL    +S      V+     CL +DP+ RPS  E
Sbjct: 216 IVNEPPPRLPSGKFSPDFQDFVNL----CLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 28/209 (13%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           LG G FG V++G W   N T P        VAVK+LKP  +   ++++AE   + +L HP
Sbjct: 14  LGAGQFGEVWEGLW---NNTTP--------VAVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFL 216
            L++L   C  ++   +V E M  GSL  +L     R + LP    I +A   A G+A+L
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLP--QLIDMAAQVASGMAYL 119

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAP 273
              ++  I+RD    N+L+      K++DFGLA+      K  +     G      + AP
Sbjct: 120 E--AQNYIHRDLAARNVLVGENNICKVADFGLARV----IKEDIYEAREGAKFPIKWTAP 173

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT-GR 301
           E  +    + KSDV+SFG++L EI+T GR
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 38/289 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPG-SGITVAVKSLK-PDGLQGHREWVAEVDFLGQLHH 158
           LGEG FG VF G          +P      VAVK+LK        +++  E + L    H
Sbjct: 13  LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL------FRRTI-------PLPWSNRIKI 205
            N+VK  G C E D  ++V+E+M  G L   L                   L  S  ++I
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
           A+  A G+ +L   S+  ++RD  T N L+  +   K+ DFG+++     D   V    +
Sbjct: 128 AVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
               +  PE +M    T++SDV+SFGVVL EI T           G+Q    W   Y   
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT----------YGKQ---PW---YGLS 229

Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
             ++ + +     L        +V  +   C  RDP+ R ++ ++ + L
Sbjct: 230 NEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (270), Expect = 5e-27
 Identities = 74/266 (27%), Positives = 120/266 (45%), Gaps = 29/266 (10%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG VFK   + +    A     ++   +  +        E + E   L +L    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER-------EEAIDEARVLAKLDSSY 60

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           +++     ++  +  +V E+   G L   L  +R  PLP     +  +    GLA LH  
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           S+ +++RD K+ N+ LD+  N K+ D G+AK     D T+ +  +VGT  Y +PE     
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
               KSDV++ GVVL E  TG+   D        N  A          K+ + V P +  
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALI-------LKIIRGVFPPVSQ 223

Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRP 365
            YS    Q+++QL   CL++D + RP
Sbjct: 224 MYS----QQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  108 bits (273), Expect = 6e-27
 Identities = 78/284 (27%), Positives = 127/284 (44%), Gaps = 53/284 (18%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE--WVAEVDFLGQLHH 158
           +GEG  G V+K    +  T       G  VA+K ++   L+   +   + E+  +    H
Sbjct: 27  IGEGASGEVYKA--TDRAT-------GKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           PN+V      +  D+  +V E+M  GSL + + +  + +       +     +GL +LH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH- 133

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT 278
            S+ VI+RD K+ NILL  + + KL+DFG A    +      S  VVGT  + APE V+ 
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE-VIK 189

Query: 279 GHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK--RKLYQIVD- 334
                 K D++S G++ +E+  G        P            YL +   R L+ I   
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGE-------PP-----------YLREPPLRALFLITTK 231

Query: 335 --PRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVK 372
             P L      K  +K S    +    CL +DP+ RPS +E+++
Sbjct: 232 GIPPL------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  107 bits (269), Expect = 9e-27
 Identities = 79/276 (28%), Positives = 125/276 (45%), Gaps = 33/276 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH---REWVAEVDFLGQLH 157
           LG G FG V++G   ++G   A       V   SL  DG  G    ++   E+  L +L 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFA-------VKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN+V+ +G   E+D   +  E +  GSL   L ++    P             GL +LH
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH 119

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                 ++RD K +NIL+D+    KL+DFG+AK   Q  +   +    G+  + APE + 
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 278 -TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
             G     +D++S G  +LE+ TG      K P  +   VA A   +   ++L  I D  
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATG------KPPWSQLEGVA-AVFKIGRSKELPPIPD-- 225

Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
              + S +    + +    CL RDP  RP+  E+++
Sbjct: 226 ---HLSDEAKDFILK----CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 37/297 (12%)

Query: 95  FRPDSI-----LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVA 148
              + I     LG+G FG V++G          K      VA+K++  +     R E++ 
Sbjct: 3   LPREKITLIRELGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLN 58

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---------IPLPW 199
           E   + + +  ++V+L+G        L+V E M +G L+++L  R           P   
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
              I++A   A G+A+L   ++  ++RD    N ++  +   K+ DFG+ +   + D   
Sbjct: 119 QKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176

Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
              + +    + APE +  G  T+KSDV+SFGVVL E+ T               L    
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQP 221

Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP 376
            Q L+++  L  ++D    L+       K+ +L   C   +PK RP+  E+V  L  
Sbjct: 222 YQGLSNEEVLKFVIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 4e-26
 Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 46/283 (16%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           LG G FG V  G W              I VA+K ++ +G     +++ E   + +L HP
Sbjct: 12  LGSGQFGVVHLGKWR-----------GKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHP 59

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           NLV+L G C +     +V E+M  G L N+L  R   L     + +     + + +L   
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE-- 117

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVSTRVVGTYGYAA 272
           S   I+RD    N L+  +   K+SDFGLA+          QG K  V         +A 
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK--------WAP 169

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
           PE       +SKSDV+SFGV++ E+ +  + M  +R S  + + + +  Y     +LY+ 
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-MPYERFSNSEVVESVSAGY-----RLYR- 222

Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
             P+L          +V  + Y+C    P+ RP+  +++  LT
Sbjct: 223 --PKL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (265), Expect = 5e-26
 Identities = 76/277 (27%), Positives = 119/277 (42%), Gaps = 37/277 (13%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLH 157
            +LG+G  G V+K           KP +G   A+K +  DG +  R+ +  E+  L    
Sbjct: 7   KVLGQGSSGVVYK--------VRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
            P +VK  G   ++ +  +V E+M  GSL + L ++   +P      IA    KGL +LH
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH 116

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                +I+RD K SN+L++S+   K++DFG++K          +   VGT  Y +PE + 
Sbjct: 117 TKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPERIQ 173

Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD-PR 336
               +  +D++S G+ LLE   G+             L             +  I D P 
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-------------MQAICDGPP 220

Query: 337 LELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDE 369
             L          S    +    CL +DPK RPS  E
Sbjct: 221 PSLPAEEF-----SPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  104 bits (261), Expect = 1e-25
 Identities = 70/213 (32%), Positives = 114/213 (53%), Gaps = 29/213 (13%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            I+GEG FG V +G             +G  VAVK++K D     + ++ E   + +LHH
Sbjct: 12  EIIGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHH 58

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAF 215
            NLV+L+G  I  +   +V E M++G+L N L  R    + +     ++ +L  A+G+ +
Sbjct: 59  KNLVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEY 115

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG-DKTHVSTRVVGTYGYAAPE 274
           L   S+ +++RD    NIL+  +  AK+SDFGLA+ G  G D + +  +      + APE
Sbjct: 116 LE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPE 167

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDK 306
            +     +SKSDV+S+GV+L E+ + GR    K
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 1e-25
 Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 23/213 (10%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAEV 150
           +     LGEG +G V+K   ++ G           VA+K ++ D    G+      + E+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK-IALGA 209
             L +L HPN+VKL+     + +  LV+E+     L+ +L +R  PL   N IK I    
Sbjct: 50  SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS-PNLIKSIMYQL 107

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
            +GLA+ H  S  +++RD K  NIL++ +   KL+DFGLA+A     +T+  T  V T  
Sbjct: 108 LRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLW 163

Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     S + D++S G +  E++TG+
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 76/278 (27%), Positives = 118/278 (42%), Gaps = 35/278 (12%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
           S LGEG  G V K  ++  G   A      T+      PD     ++ + E++       
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALK----TITTDP-NPDL---QKQILRELEINKSCKS 58

Query: 159 PNLVKLIGYCIEDDQRLL--VYEFMTRGSLENHLFRRTIPLPWSNRI------KIALGAA 210
           P +VK  G  +++    +    E+   GSL++ ++++        RI      KIA    
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKV--KKRGGRIGEKVLGKIAESVL 115

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYG 269
           KGL++LH  S  +I+RD K SNILL  +   KL DFG++ +       T       GT  
Sbjct: 116 KGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSF 168

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA-RQYLADKRK 328
           Y APE +     +  SDV+S G+ LLE+   R       P GE  L       Y+ +   
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELLSYIVNMPN 225

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
                +P   + +S    ++       CL +DP  RP+
Sbjct: 226 PELKDEPGNGIKWS----EEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  104 bits (260), Expect = 3e-25
 Identities = 91/284 (32%), Positives = 134/284 (47%), Gaps = 29/284 (10%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
             LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H
Sbjct: 10  QQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64

Query: 159 PNLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            N+VK  G C    +R   LV E++  GSL ++L +    L     +  A    KG+ +L
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG---TYGYAAP 273
             GS+  ++RD  T NIL++SE   K+ DFGL K  PQ DK +   R  G    + Y AP
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-AP 180

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK---LY 330
           E +     +  SDV+SFGVVL E+ T   S     P  E     + R    DK+    +Y
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT--YSDKSCSPPAE-----FMRMMGNDKQGQMIVY 233

Query: 331 QIVDPRLELNYSLKGVQ----KVSQLAYNCLSRDPKSRPSMDEV 370
            +++  L+ N  L        ++  +   C + DP  RPS  E+
Sbjct: 234 HLIE-LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  108 bits (271), Expect = 3e-25
 Identities = 74/225 (32%), Positives = 113/225 (50%), Gaps = 16/225 (7%)

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           +G+L HPN+VKLIG C  +    L++E++   +L   L      L W  R KIA+G AK 
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKA 792

Query: 213 LAFLHGGSEP-VIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           L FLH    P V+  +     I++D +    L    L+  G         T+   +  Y 
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----LCTDTKCFISSAYV 845

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE   T  +T KSD+Y FG++L+E+LTG+   D +      ++V WAR Y      L  
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWAR-YCYSDCHLDM 903

Query: 332 IVDPRLELNYSLKGVQKVS--QLAYNCLSRDPKSRPSMDEVVKVL 374
            +DP +  + S+   + V    LA +C + DP +RP  ++V+K L
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (257), Expect = 4e-25
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 32/267 (11%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V+ G W+E+             VA+K+++ +G     +++ E   + +L HP
Sbjct: 12  IGSGQFGLVWLGYWLEKR-----------KVAIKTIR-EGAMSEEDFIEEAQVMMKLSHP 59

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            LV+L G C E     LV+EFM  G L ++L  +         + + L   +G+A+L   
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +  VI+RD    N L+      K+SDFG+ +     D+   ST       +++PE     
Sbjct: 120 N--VIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
             +SKSDV+SFGV++ E+ +  ++  + R + E        + +    +LY+   PRL  
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAGFRLYK---PRL-- 225

Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPS 366
                  Q V +L  +C    P+ RPS
Sbjct: 226 -----ASQSVYELMQHCWKERPEDRPS 247

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 4e-25
 Identities = 62/218 (28%), Positives = 111/218 (50%), Gaps = 24/218 (11%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLH 157
           +LG G FG V+KG WI      P      I VA+K L+ +   + ++E + E   +  + 
Sbjct: 14  VLGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIP----LPWSNRIKIALGAAK 211
           HP++V+L+G C+   Q  L+ + M  G L +++   +  I     L W  +I      AK
Sbjct: 68  HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AK 120

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+++L    + +++RD    N+L+ +  + K++DFGLAK     +K + +        + 
Sbjct: 121 GMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKR 308
           A E ++    T KSDV+S+GV + E++T G +  +   
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  102 bits (255), Expect = 6e-25
 Identities = 79/274 (28%), Positives = 125/274 (45%), Gaps = 48/274 (17%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
            +G+G FG V  G              G  VAVK +K D     + ++AE   + QL H 
Sbjct: 13  TIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 59

Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNR-IKIALGAAKGLAFLH 217
           NLV+L+G  +E+   L +V E+M +GSL ++L  R   +   +  +K +L   + + +L 
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYV 276
             +   ++RD    N+L+  +  AK+SDFGL K A    D   +  +      + APE +
Sbjct: 120 ANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEAL 171

Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
                ++KSDV+SFG++L EI +  R             V + R  L D       V PR
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD-------VVPR 211

Query: 337 LELNYSLKGVQKVSQLAYN----CLSRDPKSRPS 366
           +E  Y +        + Y+    C   D  +RPS
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPS 245

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  102 bits (255), Expect = 1e-24
 Identities = 74/204 (36%), Positives = 108/204 (52%), Gaps = 13/204 (6%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLHHP 159
           LGEG FG V     E     P    +G  VAVKSLKP+    H  +   E++ L  L+H 
Sbjct: 12  LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66

Query: 160 NLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           N+VK  G C ED      L+ EF+  GSL+ +L R    +    ++K A+   KG+ +L 
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL- 125

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYGYAAPEY 275
            GS   ++RD    N+L++SE+  K+ DFGL KA  + DK + + +  +     + APE 
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           ++       SDV+SFGV L E+LT
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  102 bits (255), Expect = 1e-24
 Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 41/294 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E    +P K    + VAVK+LK   L   +++  E + L  L H +
Sbjct: 13  LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP----------------LPWSNRIK 204
           +VK  G C + D  ++V+E+M  G L N   R   P                L  S  + 
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           IA   A G+ +L   S+  ++RD  T N L+ +    K+ DFG+++     D   V    
Sbjct: 128 IASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYL 323
           +    +  PE +M    T++SDV+SFGV+L EI T G++   +   +     +   R   
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR--- 242

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
                   +  PR+         ++V  +   C  R+P+ R ++ E+ K+L  L
Sbjct: 243 -------VLERPRV-------CPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  101 bits (252), Expect = 2e-24
 Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 34/281 (12%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP-DGLQGHREWVA---EVDFLGQ 155
           +LG+G +G V+ G   +        G  I V    L   + L   +E+     EVD L  
Sbjct: 7   VLGKGAYGTVYCGLTNQ--------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L H N+V+ +G C++D+   +  EF+  GS+ + L  R  PLP     K       G+A+
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAY 117

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK----AGPQGDKTHVSTRVVGTYGYA 271
           LH     V++RD K +N++L      KL DFG A+     G  G  +++   + GT  + 
Sbjct: 118 LHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE +       KSD++S G  + E+ TG      K P    + +A A  Y+   R L  
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG------KPPLASMDRLA-AMFYIGAHRGLM- 227

Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
              PRL  ++S   +  V+     CL+RD   RPS  ++++
Sbjct: 228 ---PRLPDSFSAAAIDFVTS----CLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  100 bits (251), Expect = 3e-24
 Identities = 90/288 (31%), Positives = 137/288 (47%), Gaps = 35/288 (12%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSG-ITVAVKSLKPDGL-QGHREWVAEVDFLGQLH 157
            LG G FG V++G      T    PGSG I VAVK+L+     Q  +E++ E   +   +
Sbjct: 2   FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL----FRRTIP--LPWSNRIKIALGAAK 211
           HPN+VKL+G C+ ++ + ++ E M  G L ++L      R  P  L     + I L  AK
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 212 GLAFLHGGSEPVIYRDFKTSNILL-----DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           G  +L       I+RD    N L+     D++   K+ DFGLA+   + D        + 
Sbjct: 118 GCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
              + APE ++ G  T++SDV+SFGV++ EILT           G+Q   A   Q     
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----------LGQQPYPALNNQ----- 220

Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
            ++ Q V     L        K+ QL  NC ++DP  RP+ D + ++L
Sbjct: 221 -EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 99.0 bits (247), Expect = 1e-23
 Identities = 76/279 (27%), Positives = 120/279 (43%), Gaps = 27/279 (9%)

Query: 97  PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQ 155
               +GEG FG V++G         +     I VAVK+ K       RE ++ E   + Q
Sbjct: 10  LGRCIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
             HP++VKLIG    ++   +V E    G L ++L      L  ++ I  +   +  LA+
Sbjct: 64  FDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           L   S+  ++RD    N+L+ S    KL DFGL++   + +  + +++      + APE 
Sbjct: 123 LE--SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPES 179

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +     TS SDV+ FGV + EIL     +  K   G +N     R    ++  +     P
Sbjct: 180 INFRRFTSASDVWMFGVCMWEIL----MLGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 235

Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
            L   YS         L   C + DP  RP   E+   L
Sbjct: 236 TL---YS---------LMTKCWAYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 81/277 (29%), Positives = 130/277 (46%), Gaps = 30/277 (10%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHH 158
           +LG+G FG VFKG +++             VAVK+ K D  Q  + ++++E   L Q  H
Sbjct: 2   LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           PN+VKLIG C +     +V E +  G   + L ++   L     +K AL AA G+A+L  
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT 278
            S+  I+RD    N L+      K+SDFG+++    G  +    + +    + APE +  
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNY 168

Query: 279 GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLE 338
           G  +S+SDV+S+G++L E      S+      G  N     +Q      K Y++  P+  
Sbjct: 169 GRYSSESDVWSYGILLWETF----SLGVCPYPGMTN-----QQAREQVEKGYRMSCPQ-- 217

Query: 339 LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
                K    V ++   C    P++RP   E+ K L 
Sbjct: 218 -----KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.9 bits (244), Expect = 3e-23
 Identities = 75/286 (26%), Positives = 128/286 (44%), Gaps = 33/286 (11%)

Query: 94  NFRPDSILGEGGFG-YVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           ++ P  +LG+G FG        E++     K      V +  L     +  R+ + E+  
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWK-----EVNLTRLSE---KERRDALNEIVI 52

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL--GAA 210
           L  L HPN++    + ++D+  L+  E+   G+L + + R+   L +   + +       
Sbjct: 53  LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIV 111

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             ++++H     +++RD KT NI L      KL DFG++K    G +  ++  VVGT  Y
Sbjct: 112 SAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYY 167

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            +PE         KSD+++ G VL E+LT +R+ D   P    NLV    Q        Y
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQ------GNY 218

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP 376
             V       YS     ++  L ++ L +DP+ RP+ DEV+     
Sbjct: 219 TPVVSV----YS----SELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 98.8 bits (246), Expect = 3e-23
 Identities = 77/296 (26%), Positives = 126/296 (42%), Gaps = 44/296 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           +G+G FG VF+      G  P +P +   VAVK LK +       ++  E   + +  HP
Sbjct: 13  IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---------------------IPLP 198
           N+VKL+G C       L++E+M  G L   L  R+                     +PL 
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 199 WSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT 258
            + ++ IA   A G+A+L       ++RD  T N L+      K++DFGL++     D  
Sbjct: 129 CTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 259 HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW 318
             S        +  PE +     T++SDV+++GVVL EI +           G Q     
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS----------YGMQPYYG- 235

Query: 319 ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
               +A +  +Y + D  + L+       ++  L   C S+ P  RPS   + ++L
Sbjct: 236 ----MAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.7 bits (244), Expect = 3e-23
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 15/207 (7%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG 154
           F     LGEG +G V+K   +E G           VA+K +  +     +E + E+  L 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           Q   P +VK  G   ++    +V E+   GS+ + +      L       I     KGL 
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LH  S   I+RD K  NILL+ E  AKL+DFG+  +G   D       V+GT  + APE
Sbjct: 114 YLH--SNKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPE 169

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGR 301
            +      +K+D++S G+  +E+  G+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 98.2 bits (244), Expect = 4e-23
 Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 36/290 (12%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E     P +    I VAVK+LK       +++  E + L  L H +
Sbjct: 13  LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP-------------LPWSNRIKIAL 207
           +VK  G C+E D  ++V+E+M  G L N   R   P             L  S  + IA 
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A G+ +L   S+  ++RD  T N L+      K+ DFG+++     D   V    +  
Sbjct: 128 QIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             +  PE +M    T++SDV+S GVVL EI T           G+Q    W +  L++  
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT----------YGKQ---PWYQ--LSNNE 230

Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            +  I   R+ L       ++V  L   C  R+P  R ++ E+  +L  L
Sbjct: 231 VIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 74/253 (29%), Positives = 115/253 (45%), Gaps = 26/253 (10%)

Query: 129 TVAVKSLKPDGLQGHREWVA-EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLE 187
            VA+K +  +  Q   + +  EV  + Q +HPN+VK     +  D+  LV  +++ GSL 
Sbjct: 28  KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87

Query: 188 NHLFRRTIPLPWSNRIKIAL---GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS 244
             + + + P    +   IA       KGL +LH  S   I+RD K  NILL  + + K++
Sbjct: 88  -DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIA 144

Query: 245 DFGLAK--AGPQGDKTHVSTRVVGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTG 300
           DFG++   A        V    VGT  + APE VM        K+D++SFG+  +E+ TG
Sbjct: 145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATG 203

Query: 301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKV-SQLAYNCLSR 359
                K  P   + L+              Q   P LE     K   K   ++   CL +
Sbjct: 204 AAPYSKYPPM--KVLM-----------LTLQNDPPSLETGADYKKYSKSFRKMISLCLQK 250

Query: 360 DPKSRPSMDEVVK 372
           DP  RP+ +E++K
Sbjct: 251 DPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 96.8 bits (241), Expect = 7e-23
 Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 32/276 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K  + I VA+K++  +G     +++ E   + +L HP 
Sbjct: 12  LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     +V EFM  G L N+L +R   L     + +     +G+ +L   S
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
              I+RD    N L+ S    K+SDFG+ +     D+   S+       ++ PE      
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 281 LTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
            +SKSDV+SFGV++ E+ T G+   +KK  S  + +   +R +     +LY+   P+L  
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRGF-----RLYR---PKLAS 227

Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
                    V ++ Y+C    P+ RP+  E+++ +T
Sbjct: 228 MT-------VYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.0 bits (241), Expect = 7e-23
 Identities = 72/282 (25%), Positives = 133/282 (47%), Gaps = 30/282 (10%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHH 158
           ++G G FG VF+G ++  G         + VA+K+LKP   +  R ++++E   +GQ  H
Sbjct: 12  VIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
            N+++L G   +    +++ E+M  G+L+ +L            + +  G A G+ +L  
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVSTRVVGTYGYAAPEY 275
            +   ++RD    NIL++S    K+SDFGL++     P+G  T    ++     + APE 
Sbjct: 126 MN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEA 181

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +     TS SDV+SFG+V+ E+++       +RP  + +             ++ + ++ 
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMS-----------NHEVMKAIND 225

Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
              L   +     V QL   C  +D   RP   ++V +L  L
Sbjct: 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.8 bits (241), Expect = 8e-23
 Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 42/277 (15%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           LG G +G V++G W + +          +TVAVK+LK D ++   E++ E   + ++ HP
Sbjct: 14  LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT--IPLPWSNRIKIALGAAKGLAFLH 217
           NLV+L+G C  +    ++ EFMT G+L ++L R      +     + +A   +  + +L 
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
              +  I+RD    N L+   +  K++DFGL++    GD             + APE + 
Sbjct: 122 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 178

Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               + KSDV++FGV+L EI T   S     P  +                L Q+ +  L
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMS---PYPGID----------------LSQVYE-LL 218

Query: 338 ELNYSLKGVQ----KVSQLAYNCLSRDPKSRPSMDEV 370
           E  Y ++  +    KV +L   C   +P  RPS  E+
Sbjct: 219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 33/212 (15%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G V+K   +  G           VA+K +K        E +      E+  L +
Sbjct: 7   IGEGTYGVVYKARDKLTGE---------IVAIKKIKLRFES---EGIPKTALREIKLLKE 54

Query: 156 LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK-IALGAAKGL 213
           L+HPN++KL+         L LV+EFM    L   +  R   LP S  IK       +GL
Sbjct: 55  LNHPNIIKLLD-VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPES-LIKSYLYQLLQGL 111

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTH-VSTRVVGTYGY 270
           AF H  S  +++RD K  N+L+++E   KL+DFGLA+    P    TH V TR      Y
Sbjct: 112 AFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WY 164

Query: 271 AAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR 301
            APE ++     ++  D++S G +  E+L+ R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 39/294 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWI----EENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVA 148
           N +  + LG G FG VF        EE G           V VK+L K        E+  
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETL--------VLVKALQKTKDENLQSEFRR 57

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--------FRRTIPLPWS 200
           E+D   +L H N+V+L+G C E +   ++ E+   G L+  L          +  PL   
Sbjct: 58  ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
            ++ +    A G+  L       ++RD    N L+ S+   K+S   L+K      + + 
Sbjct: 118 QKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYK 174

Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
               +    + APE V     ++KSDV+SFGV++ E+ T           GE        
Sbjct: 175 LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGELPFYG--- 221

Query: 321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
             L+D+  L ++   +LEL        ++ +L   C + +PK RPS  E+V  L
Sbjct: 222 --LSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 35/212 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   +            VA+KSLK  G      ++AE + + QL HP 
Sbjct: 14  LGAGQFGEVWMGYYNGH----------TKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPR 62

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGAAKGLAFLH 217
           LV+L    +  +   ++ E+M  GSL + L  +T   I L  +  I +A   A+G+AF+ 
Sbjct: 63  LVRLYA-VVTQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVSTRVVGTYGY 270
              +  I+RD + +NIL+      K++DFGLA+          +G K  +         +
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK--------W 169

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT-GR 301
            APE +  G  T KSDV+SFG++L EI+T GR
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 95.1 bits (236), Expect = 5e-22
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 24/216 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP-DGLQGHREWVAEVDFLGQLHHP 159
           LGE  FG ++KG +   G   A+      VA+K+LK  +  Q   E+  E   + +LHHP
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT----------------IPLPWSNRI 203
           N+V L+G   ++    +++E++ +G L   L  R+                  L   + +
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            IA+  A G+ +L   S   +++D    NIL+  + + K+SD GL++     D   V  +
Sbjct: 128 HIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +    +  PE +M G  +S SD++SFGVVL EI +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 68/235 (28%), Positives = 102/235 (43%), Gaps = 35/235 (14%)

Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLL--VYEFMTRGSLENHLFRRTI----PLPWS 200
           V+EV+ L +L HPN+V+     I+   + L  V E+   G L   L ++       +   
Sbjct: 47  VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEE 105

Query: 201 NRIKIALGAAKGLAFLHGGSEP---VIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD- 256
              +I       L   H  S+P   V++RD K +NI LD+  N KL DFGLAK       
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165

Query: 257 --KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN 314
             KT+     VGT  Y +PE +       KSD++S G ++ E+           P     
Sbjct: 166 FAKTY-----VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL-------SPPFT-- 211

Query: 315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
               AR  L    K+ +    R+   YS   + +V +   + L+ DP  RPS +E
Sbjct: 212 ----ARNQLQLASKIKEGKFRRIPYRYS-SELNEVIK---SMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 94.9 bits (237), Expect = 6e-22
 Identities = 57/220 (25%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW------VA 148
           +   + +GEG +G V+K       T       G  VA+K ++ +    + +       + 
Sbjct: 1   YEKIAQIGEGTYGQVYKA--RNKKT-------GELVALKKIRME----NEKEGFPITAIR 47

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQR--LLVYEFMT---RGSLENHLFRRTIPLPWSNRI 203
           E+  L +L HPN+V+L        +    +V+E+M     G L++   + T       +I
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES-----QI 102

Query: 204 K-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           K       +GL +LH     +++RD K SNIL++++   KL+DFGLA+   + +    + 
Sbjct: 103 KCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160

Query: 263 RVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           RV+ T  Y  PE ++       + D++S G +L E+  G+
Sbjct: 161 RVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.2 bits (235), Expect = 8e-22
 Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 46/280 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHHP 159
           +G+G FG V+K   +              VA+K +  +  +   E +  E+ FL Q   P
Sbjct: 9   IGKGSFGEVYKAIDKRTNQ---------VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSP 59

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            + K  G  ++  +  ++ E+   GS  + L  +   L  +    I      GL +LH  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLH-- 115

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
            E  I+RD K +NILL  E + KL+DFG++     G  T   ++    VGT  + APE +
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD-- 334
                  K+D++S G+  +E+  G   +    P                 R L+ I    
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----------------MRVLFLIPKNN 214

Query: 335 -PRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            P LE N +S      VS     CL++DPK RPS  E++K
Sbjct: 215 PPSLEGNKFSKPFKDFVSL----CLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 26/210 (12%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK-------PDGLQGHREWVAEVDFL 153
           LGEG +  V+K   +E G           VA+K +K        DG+  +   + E+  L
Sbjct: 8   LGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGI--NFTALREIKLL 56

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK-IALGAAKG 212
            +L HPN++ L+          LV+EFM    LE  +  ++I L  ++ IK   L   +G
Sbjct: 57  QELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPAD-IKSYMLMTLRG 114

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +LH  S  +++RD K +N+L+ S+   KL+DFGLA++        ++ +VV T  Y A
Sbjct: 115 LEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRA 170

Query: 273 PEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           PE +    H     D++S G +  E+L   
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 19/208 (9%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-H 157
            LG G FG V    +E      +K  + + VAVK LKP      RE  ++E+  +  L +
Sbjct: 42  TLGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGLAFL 216
           H N+V L+G C      L++ E+   G L N L R R   L   + +  +   AKG+AFL
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG-----TYGYA 271
              S+  I+RD    N+LL      K+ DFGLA+     D  + S  VV         + 
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWM 210

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           APE +     T +SDV+S+G++L EI +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 73/288 (25%), Positives = 133/288 (46%), Gaps = 30/288 (10%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
             + + ++G G FG V  G ++     P K    I VA+K+LK    +  R ++++E   
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLK----LPGK--REIPVAIKTLKAGYTEKQRRDFLSEASI 58

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           +GQ  HPN++ L G   +    ++V E+M  GSL+  L +          + +  G A G
Sbjct: 59  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVSTRVVGTYG 269
           + +L       ++RD    NIL++S    K+SDFGL++     P+   T    ++     
Sbjct: 119 MKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 174

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           + APE +     TS SDV+S+G+V+ E+++       +RP  E +            + +
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSY-----GERPYWEMS-----------NQDV 218

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            + ++    L   +     + QL  +C  +D   RP  +++V +L  L
Sbjct: 219 IKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 39/277 (14%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL---KPDGLQGHREWVAEV 150
           +F    ++G+G FG V    +++  T           A+K +   K       R  + E 
Sbjct: 1   HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWS-NRIKIALG 208
             L +L+HP LV L  Y  +D++ + LV + +  G L  HL ++     +S  ++K  + 
Sbjct: 52  RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWIC 107

Query: 209 A-AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
                L +LH  S+ +I+RD K  NILLD + +  ++DF +A        T   T   GT
Sbjct: 108 EIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGT 162

Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
            GY APE +     +   D +S GV   E L G+R       +    +    R       
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETAD 218

Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
            LY             + +  +++L    L RDP+ R
Sbjct: 219 VLYPATWS-------TEAIDAINKL----LERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 28/215 (13%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL------ 153
           LG G FG V++G +   +G A         VAVK+L     +       E DFL      
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQ-----VAVKTLPESCSEQ-----DESDFLMEALIM 63

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR------RTIPLPWSNRIKIAL 207
            + +H N+V+LIG   E   R ++ E M  G L++ L        R   L   + +  A 
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRV 264
             AKG  +L       I+RD    N LL  +     AK++DFG+A+   +        R 
Sbjct: 124 DVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           +    +  PE  + G  TSK+DV+SFGV+L EI +
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 93.1 bits (231), Expect = 3e-21
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 30/230 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDF 152
           N      LGEG FG V K           + G   TVAVK LK +      R+ ++E + 
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFR---LKGRAGY-TTVAVKMLKENASSSELRDLLSEFNL 56

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTI---------------- 195
           L Q++HP+++KL G C +D   LL+ E+   GSL + L   R +                
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 196 ------PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
                  L   + I  A   ++G+ +L      +++RD    N+L+      K+SDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           +   + D     ++      + A E +     T++SDV+SFGV+L EI+T
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 38/285 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E +   P +    + VAVK+LK       +++  E + L  L H +
Sbjct: 13  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRIKI 205
           +V+  G C E    L+V+E+M  G L N   R   P               L     + I
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
           A   A G+ +L   S   ++RD  T N L+      K+ DFG+++     D   V  R +
Sbjct: 128 ASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
               +  PE ++    T++SD++SFGVVL EI T           G+Q    W +  L++
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT----------YGKQ---PWYQ--LSN 230

Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
              +  I   R EL        +V  +   C  R+P+ R  + ++
Sbjct: 231 TEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 80/279 (28%), Positives = 125/279 (44%), Gaps = 34/279 (12%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQLHH 158
           ++G+G FG V+      +GT     G  I  AVKSL +   L+   +++ E   +    H
Sbjct: 2   VIGKGHFGCVY------HGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55

Query: 159 PNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           PN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +L 
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL- 114

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVGTYGYAAPEY 275
             S+  ++RD    N +LD  +  K++DFGLA+     +    H  T       + A E 
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ---I 332
           + T   T+KSDV+SFGV+L E++T  R           ++      YL   R+L Q    
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDIT----VYLLQGRRLLQPEYC 227

Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
            DP  E+  S             C    P+ RP+  E+V
Sbjct: 228 PDPLYEVMLS-------------CWHPKPEMRPTFSELV 253

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.5 bits (227), Expect = 5e-21
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 38/275 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VA+K +K +G     E++ E   + +L H  
Sbjct: 12  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEK 60

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     +V E+M+ G L N+L         S  +++     +G+A+L   S
Sbjct: 61  LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--S 118

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEYVM 277
           +  I+RD    N L+D +   K+SDFGL++     D  + S+  VG+     ++ PE ++
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLL 174

Query: 278 TGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
               +SKSDV++FGV++ E+ + G+  M  +R +  + +     + ++   +LY+   P 
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGK--MPYERFNNSETV-----EKVSQGLRLYR---PH 224

Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L         +KV  + Y+C     + RP+  +++
Sbjct: 225 L-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.5 bits (227), Expect = 7e-21
 Identities = 74/287 (25%), Positives = 134/287 (46%), Gaps = 34/287 (11%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL 156
           + ++G G FG V +G ++  G         I VA+K+LK     +  R++++E   +GQ 
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKRE------IFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HPN++ L G   +    +++ EFM  G+L++ L +          + +  G A G+ +L
Sbjct: 63  DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG---TYGYAAP 273
              +   ++RD    NIL++S    K+SDFGL++           T  +G      + AP
Sbjct: 123 SEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP---SGEQNLVAWARQYLADKRKLY 330
           E +     TS SDV+S+G+V+ E+++       +RP      Q+++    Q   D R   
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSY-----GERPYWDMSNQDVINAIEQ---DYR--- 229

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
             + P ++   +L       QL  +C  +D  +RP   ++V  L  +
Sbjct: 230 --LPPPMDCPTALH------QLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 90.8 bits (225), Expect = 9e-21
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 14/202 (6%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG G FG V KG  +            I VA+K LK +  +  R E + E + + QL +P
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            +V++IG C E +  +LV E  + G L   L  +   +  SN +++    + G+ +L G 
Sbjct: 56  YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEYVM 277
           +   ++RD    N+LL +++ AK+SDFGL+KA    D ++   R  G +   + APE + 
Sbjct: 115 N--FVHRDLAARNVLLVNQHYAKISDFGLSKA-LGADDSYYKARSAGKWPLKWYAPECIN 171

Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
               +S+SDV+S+G+ + E  +
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 64/206 (31%), Positives = 86/206 (41%), Gaps = 20/206 (9%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+GGFG V          A     +G   A K L    L   +G +  + E   L ++ 
Sbjct: 1   LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALGAAKGLAF 215
              +V L  Y  E    L LV   M  G L+ H++    P  P +  I  A     GL  
Sbjct: 52  SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           LH     ++YRD K  N+LLD   N ++SD GLA     G K        GT GY APE 
Sbjct: 111 LH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEV 165

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGR 301
           +         D ++ G  L E++ GR
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 52/279 (18%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           LG G FG V+ G W   NG           VAVK+LKP G      ++ E   + +L H 
Sbjct: 14  LGNGQFGEVWMGTW---NGNT--------KVAVKTLKP-GTMSPESFLEEAQIMKKLRHD 61

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFL 216
            LV+L    + ++   +V E+M++GSL + L     R + LP  N + +A   A G+A++
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAYI 118

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVSTRVVGTYG 269
              +   I+RD +++NIL+      K++DFGLA+          QG K  +         
Sbjct: 119 ERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-------- 168

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           + APE  + G  T KSDV+SFG++L E++T  R      P    N     R+ L    + 
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV-----PYPGMN----NREVLEQVERG 219

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           Y++  P+            + +L   C  +DP+ RP+ +
Sbjct: 220 YRMPCPQ-------DCPISLHELMLQCWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 44/235 (18%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   I+GEG F  V     +E              A+K L    L  +   ++V  E 
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNK---------EYAIKILDKRQLIKEKKVKYVKIEK 52

Query: 151 DFLGQL-HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL-FRRTIPLPWSNRIKIAL 207
           + L +L  HP ++KL  Y  +D++ L  V E+   G L  ++    ++    +       
Sbjct: 53  EVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY---- 107

Query: 208 GAA---KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK---------AGPQG 255
            AA     L +LH  S+ +I+RD K  NILLD + + K++DFG AK         +    
Sbjct: 108 -AAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164

Query: 256 DKTHVSTR---------VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
                S            VGT  Y +PE +        SD+++ G ++ ++LTG+
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 39/279 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK--PDGLQGHREWVAEVDFLGQLHH 158
           +G G FG V+     + G           +AVK ++   +  +  +E   E+  L  L H
Sbjct: 8   IGGGTFGKVYTAVNLDTGE---------LMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           PNLVK  G  +  ++  +  E+ + G+LE  L      L         L   +GLA+LH 
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLH- 116

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV---VGTYGYAAPEY 275
            S  +++RD K +NI LD     KL DFG A    + + T +   V    GT  Y APE 
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK-LKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 276 V----MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY-LADKRKLY 330
           +      GH  + +D++S G V+LE+ TG+R      P  E +   +   + +    K  
Sbjct: 175 ITGGKGKGHGRA-ADIWSLGCVVLEMATGKR------PWSELDNE-FQIMFHVGAGHKP- 225

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
            I D    L  S +G   + +    CL  DPK RP+  E
Sbjct: 226 PIPDS---LQLSPEGKDFLDR----CLESDPKKRPTASE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 84/282 (29%), Positives = 124/282 (43%), Gaps = 48/282 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLH 157
           +G G FG V+      N        +   VAVK +   G Q + +W   + EV FL QL 
Sbjct: 29  IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN ++  G  +++    LV E+   GS  + L     PL       I  GA +GLA+LH
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPEYV 276
             S  +I+RD K  NILL      KL+DFG A K+ P       +   VGT  + APE +
Sbjct: 139 --SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVI 189

Query: 277 MT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           +    G    K DV+S G+  +E+       ++K P    N ++           LY I 
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMS----------ALYHIA 233

Query: 334 ---DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
               P L+ N   +           CL + P+ RP+  E+++
Sbjct: 234 QNDSPTLQSN---EWTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 78/294 (26%), Positives = 115/294 (39%), Gaps = 42/294 (14%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK--PDGLQGHREWVAEVDFLGQL 156
            ++GEG +G V K   +          +G  VA+K  K   D     +  + EV  L QL
Sbjct: 7   GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57

Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            H N+V L        +  LV+E++ R  LE  L      LP            + +A+ 
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           H  S  +I+RD K  NIL+      KL DFG A+A      + ++  V  T  Y APE +
Sbjct: 117 H--SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELL 173

Query: 277 MTGHLTSKS-DVYSFGVVLLEILTGR------RSMDK---------KRPSGEQNLVAWAR 320
           +      K  DV++ G ++ E+L G         +D+           P   Q L     
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL----- 228

Query: 321 QYLADKR----KLYQIVDPR-LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
            + ++ R       +   P  LE  Y  K           CL  DPK R + DE
Sbjct: 229 -FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 89.2 bits (221), Expect = 5e-20
 Identities = 78/280 (27%), Positives = 120/280 (42%), Gaps = 37/280 (13%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEVDFLGQLH 157
           +LG+G FG V +  ++         GS   VAVK LK D        E++ E   + +  
Sbjct: 6   MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 158 HPNLVKLIGYCIED--DQRL----LVYEFMTRGSLENHLFRRTI-----PLPWSNRIKIA 206
           HPN++KLIG  +      RL    ++  FM  G L   L    I      LP    ++  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           +  A G+ +L   S+  I+RD    N +L+      ++DFGL+K    GD          
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
              + A E +     T+ SDV++FGV + EI+T      +   +G +N  +    YL   
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT----RGQTPYAGVEN--SEIYNYLIKG 231

Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
            +L Q  D           ++ V +L   C S +PK RPS
Sbjct: 232 NRLKQPPD----------CLEDVYELMCQCWSPEPKCRPS 261

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 89.1 bits (222), Expect = 5e-20
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 45/218 (20%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-----VAEVDFLGQ 155
           LG+G FG V+    +E G           VA+K +K    +    W     + EV  L +
Sbjct: 7   LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53

Query: 156 L-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF-----RRTIPLPWSNRIK-IALG 208
           L  HPN+VKL     E+D+   V+E+M     E +L+     R+  P    + I+ I   
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFS-ESVIRSIIYQ 107

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK----AGPQGDKTHVSTRV 264
             +GLA +H       +RD K  N+L+      K++DFGLA+      P  D  +VSTR 
Sbjct: 108 ILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR- 162

Query: 265 VGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
                Y APE ++ +   +S  D+++ G ++ E+ T R
Sbjct: 163 ----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 84/310 (27%), Positives = 131/310 (42%), Gaps = 64/310 (20%)

Query: 88  LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV 147
           L   TG F    ++GEG +G V+K   ++ G           VA+K +         E  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQ---------LVAIKIMDIIE-DEEEEIK 50

Query: 148 AEVDFLGQL-HHPNLVKLIG------YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWS 200
            E + L +  +HPN+    G          DDQ  LV E    GS+ + L +        
Sbjct: 51  EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKG-- 107

Query: 201 NRIK------IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
            R+K      I     +GLA+LH     VI+RD K  NILL      KL DFG++    Q
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---Q 162

Query: 255 GDKTHVSTR--VVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKK 307
            D T +  R   +GT  + APE +           ++SDV+S G+  +E+       D K
Sbjct: 163 LDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL------ADGK 215

Query: 308 RPSGEQNLVAWARQYLADKRKLYQIV---DPRLE--LNYSLKGVQKVSQLAYNCLSRDPK 362
            P  + + +          R L++I     P L+   N+S    +K +     CL ++ +
Sbjct: 216 PPLCDMHPM----------RALFKIPRNPPPTLKSPENWS----KKFNDFISECLIKNYE 261

Query: 363 SRPSMDEVVK 372
            RP M+E+++
Sbjct: 262 QRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 89.6 bits (222), Expect = 6e-20
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 21/216 (9%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HH 158
           LGEG FG V +   E  G   ++P   +TVAVK LK +   +   + ++E++ +  +  H
Sbjct: 20  LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP---------------WSNRI 203
            N++ L+G C ++    ++ E+  +G+L   L  R  P P               + + +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S   I+RD    N+L+  +   K++DFGLA+     D    ++ 
Sbjct: 138 SCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFG+++ EI T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 88.3 bits (219), Expect = 6e-20
 Identities = 67/285 (23%), Positives = 123/285 (43%), Gaps = 37/285 (12%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHRE-WVAEVD 151
           +F+    LG+G +G V+K     +             A+K +    + Q  RE  V E+ 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDLGSMSQKEREDAVNEIR 51

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---PLPWSNRIKIALG 208
            L  ++HPN++      ++ ++  +V E+   G L   + +R      +P     +I + 
Sbjct: 52  ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
             +GL  LH   + +++RD K++NILL +    K+ D G++K   +     ++   +GT 
Sbjct: 112 LLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTP 165

Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            Y APE       + KSD++S G +L E+ T     + +     +  V         +R 
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV---------QRG 216

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV 373
            Y    P +   YS    Q +     + L   PK RP+ D+++  
Sbjct: 217 KY----PPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 8e-20
 Identities = 81/307 (26%), Positives = 131/307 (42%), Gaps = 46/307 (14%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFL 153
           ++   ++G G +G V++G             +G  VA+K +  D        +  EV  L
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALL 53

Query: 154 GQLHH---PNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
            QL     PN+ K  G       RL ++ E+   GS+   +    I   + + I   +  
Sbjct: 54  SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV 112

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           A  L ++H     VI+RD K +NIL+ +  N KL DFG+A    Q   +   +  VGT  
Sbjct: 113 A--LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPY 166

Query: 270 YAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
           + APE +  G    +K+D++S G+ + E+ TG                  A   +   + 
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRAMMLIPKSKP 219

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV-------LTPLQDLN 381
                 PRLE N   K +++   +A  CL  +PK R S +E++K         TP+  L 
Sbjct: 220 ------PRLEDNGYSKLLREF--VAA-CLDEEPKERLSAEELLKSKWIKAHSKTPVSILK 270

Query: 382 DLAILSY 388
           +L I  Y
Sbjct: 271 EL-ISRY 276

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.6 bits (220), Expect = 9e-20
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 23/219 (10%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL 156
              LGEG FG V K   E  G     P    TVAVK LK D   +   + V+E++ +  +
Sbjct: 17  GKPLGEGAFGQVVKA--EAVGLD--NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72

Query: 157 -HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI------------ 203
             H N++ L+G C ++    +V E+   G+L + L  R  P  +++              
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 204 ---KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
                A   A+G+ FL   S+  I+RD    N+L+  ++  K++DFGLA+     D    
Sbjct: 133 DLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           +T       + APE +     T +SDV+SFGV+L EI T
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKP-DGLQGHREWVAEVDFLGQLH 157
           +LG G FG V KG WI E  +        I VA+K+++   G Q  +E    +  +G L 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIK------IPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H  +V+L+G C       LV +    GSL +H+ +    L     +   +  AKG+ +L 
Sbjct: 68  HAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                +++R+    NILL S+   +++DFG+A      DK +  +       + A E ++
Sbjct: 127 --EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
            G  T +SDV+S+GV + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 21/216 (9%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D   +   + V+E++ +  +  H
Sbjct: 20  LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L + + +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 66/252 (26%), Positives = 116/252 (46%), Gaps = 20/252 (7%)

Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG 184
           +G  +A K +         ++ + E+  + +   P +V   G  + ++   +  EFM  G
Sbjct: 29  TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88

Query: 185 SLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS 244
           SL+  ++++  P+P     KIA+   +GL +L+     +++RD K SNIL++S    KL 
Sbjct: 89  SLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLC 146

Query: 245 DFGLAKAGPQGDKTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS 303
           DFG++     G+  + ++   VGT  Y +PE +  G  T KSDV+S G+ ++E+  G+  
Sbjct: 147 DFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Query: 304 MDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PRLELNYSLKGVQKVSQLAYNCLSRD 360
                   +          L     L QIV    PRL    S    + +      CL +D
Sbjct: 202 FAFSNIDDDGQDDPMGILDL-----LQQIVQEPPPRLP---SSDFPEDLRDFVDACLLKD 253

Query: 361 PKSRPSMDEVVK 372
           P  RP+  ++  
Sbjct: 254 PTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 85/293 (29%), Positives = 135/293 (46%), Gaps = 54/293 (18%)

Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R D  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLKP-GTMMPEAFLQEAQI 54

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGA 209
           + +L H  LV L    + ++   +V EFM +GSL + L     + + LP    + +A   
Sbjct: 55  MKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP--QLVDMAAQI 111

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   I+RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 112 ADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQ 321
                  + APE  + G  T KSDV+SFG++L E++T  R      P  G  N     R+
Sbjct: 169 -------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV-----PYPGMVN-----RE 211

Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
            L    + Y++  P+          + + +L   C  +DP  RP+ + +   L
Sbjct: 212 VLEQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 23  LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 141 SCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 38/277 (13%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHH 158
           ILG G  G V+K +            +   +AVK +  D  ++  ++ ++E++ L +   
Sbjct: 8   ILGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS 58

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           P ++   G    +++  +  EFM  GSL+ +   R IP     RI +A+   KGL +L  
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSLDVY---RKIPEHVLGRIAVAV--VKGLTYLW- 112

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT 278
            S  +++RD K SN+L+++    KL DFG++          ++   VGT  Y APE +  
Sbjct: 113 -SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISG 167

Query: 279 GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---P 335
                 SDV+S G+  +E+  GR       P  ++N     +  L   + L  IVD   P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPY----PQIQKN-----QGSLMPLQLLQCIVDEDPP 218

Query: 336 RLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
            L +  +S K V  ++Q    C+ + PK RP+ + ++
Sbjct: 219 VLPVGQFSEKFVHFITQ----CMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 31/221 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 26  LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L + + +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D  H+   
Sbjct: 144 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 196

Query: 264 VVGTYG-----YAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
              T G     + APE +     T +SDV+SFGV+L EI T
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 85/283 (30%), Positives = 120/283 (42%), Gaps = 50/283 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLH 157
           +G G FG V+                   VA+K +   G Q + +W   + EV FL QL 
Sbjct: 23  IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN ++  G  + +    LV E+   GS  + L     PL       I  GA +GLA+LH
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYV 276
             S   I+RD K  NILL      KL+DFG A    P       +   VGT  + APE +
Sbjct: 133 --SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMAPEVI 183

Query: 277 MT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           +    G    K DV+S G+  +E+       ++K P    N ++           LY I 
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMS----------ALYHIA 227

Query: 334 D---PRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
               P L  N +S      V      CL + P+ RPS +E++K
Sbjct: 228 QNDSPTLSSNDWSDYFRNFVDS----CLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 86.7 bits (214), Expect = 6e-19
 Identities = 75/257 (29%), Positives = 116/257 (45%), Gaps = 33/257 (12%)

Query: 130 VAVKSLKPDGLQGHREW---VAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSL 186
           VA+K +   G Q + +W   + EV FL ++ HPN ++  G  + +    LV E+   GS 
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSA 111

Query: 187 ENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF 246
            + L     PL       I  GA +GLA+LH  S  +I+RD K  NILL      KL+DF
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADF 169

Query: 247 GLAK-AGPQGDKTHVSTRVVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRR 302
           G A  A P       +   VGT  + APE ++    G    K DV+S G+  +E+     
Sbjct: 170 GSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL----- 217

Query: 303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPK 362
             ++K P    N ++           LY I         S +          +CL + P+
Sbjct: 218 -AERKPPLFNMNAMS----------ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQ 266

Query: 363 SRPSMDEVVKVLTPLQD 379
            RP+ +E++K +  L++
Sbjct: 267 DRPTSEELLKHMFVLRE 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.9 bits (212), Expect = 7e-19
 Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 33/273 (12%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHHP 159
           +G+G FG VFKG   +N T          VA+K +  +  +   E +  E+  L Q   P
Sbjct: 12  IGKGSFGEVFKGI--DNRTQK-------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH  
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH-- 118

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           SE  I+RD K +N+LL      KL+DFG+  AG   D        VGT  + APE +   
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
              SK+D++S G+  +E+  G     +  P            +L  K        P LE 
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIPKNN-----PPTLEG 223

Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           NYS    + + +    CL+++P  RP+  E++K
Sbjct: 224 NYS----KPLKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 85.1 bits (210), Expect = 8e-19
 Identities = 74/277 (26%), Positives = 115/277 (41%), Gaps = 32/277 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK---PDGLQGHREWVAEVDFLGQLH 157
           +G G FG VF G +  + T          VAVKS +   P  L+   +++ E   L Q  
Sbjct: 3   IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKA--KFLQEARILKQYS 51

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN+V+LIG C +     +V E +  G     L      L     I++   AA G+ +L 
Sbjct: 52  HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE 111

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
             S+  I+RD    N L+  +   K+SDFG+++    G              + APE + 
Sbjct: 112 --SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
            G  +S+SDV+SFG++L E  +           G       + Q      +  + ++  +
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS----------LGAVPYANLSNQ------QTREAIEQGV 213

Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
            L         V +L   C   DP  RPS   V + L
Sbjct: 214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 78/211 (36%), Positives = 107/211 (50%), Gaps = 29/211 (13%)

Query: 100 ILGEGGFGYVF-----KGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV---AEVD 151
           +LG+G FG VF      G           P +G   A+K LK   L+  R+ V    E D
Sbjct: 3   VLGQGSFGKVFLVRKITG-----------PDAGQLYAMKVLKKATLK-VRDRVRTKMERD 50

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
            L +++HP +VKL  Y  + + +L L+ +F+  G L   L +    +     +K  L A 
Sbjct: 51  ILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYL-AE 106

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             LA  H  S  +IYRD K  NILLD E + KL+DFGL+K     +K   S    GT  Y
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 164

Query: 271 AAPEYV-MTGHLTSKSDVYSFGVVLLEILTG 300
            APE V   GH T  +D +SFGV++ E+LTG
Sbjct: 165 MAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 71/283 (25%), Positives = 134/283 (47%), Gaps = 36/283 (12%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G  +  G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 14  LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P      I++A  
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  +   ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 128 IADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q +++++ 
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSNEQV 230

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 231 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 54/287 (18%)

Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 54

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 55  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 111

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 112 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 168

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQ 321
                  + APE  + G  T KSDV+SFG++L E+ T  R      P  G  N     R+
Sbjct: 169 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----PYPGMVN-----RE 211

Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
            L    + Y++  P  E   SL        L   C  ++P+ RP+ +
Sbjct: 212 VLDQVERGYRMPCPP-ECPESLH------DLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 72/288 (25%), Positives = 119/288 (41%), Gaps = 47/288 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA--EVD 151
            +    ++G G FG V    +               V +K +  + +       A  E  
Sbjct: 1   KYEKIRVVGRGAFGIV---HLCRRKADQKL------VIIKQIPVEQMTKDERLAAQNECQ 51

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLE-------NHLFRRTIPLPWSNRIK 204
            L  L HPN+++     +ED   ++V E+   G+L        N L      L +  +I 
Sbjct: 52  VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN-AKLSDFGLAKAGPQGDKTHVSTR 263
           +AL         H  ++ +++RD KT NILLD      K+ DFG++K      K+   T 
Sbjct: 112 LALH--------HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT- 160

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
           VVGT  Y +PE         KSD+++ G VL E+ + +R+ +        NL A   + +
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------ANLPALVLKIM 214

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           +       I D      YS      + QL  + L+ DP  RP + +++
Sbjct: 215 SGTFA--PISD-----RYS----PDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL----KPDGLQGHREWVAEVDFLGQL 156
           +GEG  G VFK    E G          TVA+K +       G+    + + E+  L   
Sbjct: 8   IGEGAHGIVFKAKDRETGE---------TVALKKVALRRLEGGIP--NQALREIKALQAC 56

Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HP +VKL+         +LV E+M    L   L     PLP +          KG+A++
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           H     +++RD K +N+L+ ++   K++DFGLA+     ++  + +  V T  Y APE +
Sbjct: 116 HA--NGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPE-L 171

Query: 277 MTG--HLTSKSDVYSFGVVLLEILTGR 301
           + G        D+++ G +  E+L G 
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 41/291 (14%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAE 149
            NFR +  +G G F  V++     +G           VA+K ++   L   +   + + E
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKE 52

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN---HLFRRTIPLPWSNRIKIA 206
           +D L QL+HPN++K     IED++  +V E    G L     H  ++   +P     K  
Sbjct: 53  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           +     L  +H  S  V++RD K +N+ + +    KL D GL +      KT  +  +VG
Sbjct: 113 VQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
           T  Y +PE +       KSD++S G +L E                  + A    +  DK
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDK 210

Query: 327 RKLYQIVDPRLELNY----SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV 373
             LY +     + +Y    S    +++ QL   C++ DP+ RP +  V  V
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 38/283 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHH 158
           LGEG FG V +G + ++        S + VAVK++K          ++++E   + +  H
Sbjct: 7   LGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59

Query: 159 PNLVKLIGYCIEDDQR------LLVYEFMTRGSLENHLFRRTIP-----LPWSNRIKIAL 207
           PN+++LIG C++  +       +++  FM  G L + L    +      LP    +K   
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A G+ +L   S+  I+RD    N +L+   N  ++DFGL+K    GD           
Sbjct: 120 DIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             + A E +     T+KSDV+SFGV + EI T  ++     P  E + +     YL    
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEI---YDYLRQGN 231

Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +L Q  D        L G+     L  +C   +PK RPS + +
Sbjct: 232 RLKQPPD-------CLDGLY---SLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 23/204 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   N T          VAVK+LKP G    + ++ E + +  L H  
Sbjct: 14  LGAGQFGEVWMGYYN-NST---------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 62

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGAAKGLAFLH 217
           LV+L     +++   ++ E+M +GSL + L       + LP    I  +   A+G+A++ 
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL--IDFSAQIAEGMAYIE 120

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
              +  I+RD + +N+L+      K++DFGLA+     + T    R    +   + APE 
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT---AREGAKFPIKWTAPEA 175

Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +  G  T KSDV+SFG++L EI+T
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 72/210 (34%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 104 GGFGYVFKGWIEENGTAPAKPGS-GITVAVKSLKPDGLQGHR---EWVAEVDFLGQLHHP 159
           G +G VF           AK  S G   A+K +K   +       + + E D L Q   P
Sbjct: 4   GAYGRVFL----------AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP 53

Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN-RIKIALGAAKGLAFLH 217
            +VKL  Y  +  + L LV E++  G L   L      L     RI IA      L +LH
Sbjct: 54  YVVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIA-EIVLALEYLH 110

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS------TRVVGTYGYA 271
             S  +I+RD K  NIL+DS  + KL+DFGL+K G    + +++       R+VGT  Y 
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 272 APEYVMTGHLTSKS-DVYSFGVVLLEILTG 300
           APE V+ G   SK+ D +S G +L E L G
Sbjct: 169 APE-VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 79/311 (25%), Positives = 131/311 (42%), Gaps = 55/311 (17%)

Query: 101 LGEGGFGYVFKGWIEENGT-APAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           LG+G FG V+K   +E G  A AK      + ++S   + L+     + E+D L +  HP
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAK-----IIQIES--EEELEDF---MVEIDILSECKHP 62

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N+V L      +++  ++ EF   G+L++ +      L       +     + L FLH  
Sbjct: 63  NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH-- 120

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           S  VI+RD K  NILL  + + KL+DFG++       +   +   +GT  + APE V   
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178

Query: 280 HLTS-----KSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV- 333
                    K+D++S G+ L+E       + +  P   +         L   R L +I+ 
Sbjct: 179 TFKDNPYDYKADIWSLGITLIE-------LAQMEPPHHE---------LNPMRVLLKILK 222

Query: 334 -DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLAILSYHSRL 392
            +P      S K     +    +CL +DP  RP+  E++K                H  +
Sbjct: 223 SEPPTLDQPS-KWSSSFNDFLKSCLVKDPDDRPTAAELLK----------------HPFV 265

Query: 393 SQQGRRKKKQD 403
           S Q   K  +D
Sbjct: 266 SDQSDNKAIKD 276

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 37/266 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHH 158
           LG G FG V KG  +   +         TVAVK LK D        E + E + + QL +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           P +V++IG C E +  +LV E    G L N   ++   +   N  ++    + G+ +L  
Sbjct: 56  PYIVRMIGIC-EAESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLE- 112

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEYV 276
                ++RD    N+LL +++ AK+SDFGL+KA    D+ +   +  G +   + APE +
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAKTHGKWPVKWYAPECM 170

Query: 277 MTGHLTSKSDVYSFGVVLLE--------------------ILTGRRSMDKKRPSGEQ-NL 315
                +SKSDV+SFGV++ E                    I +G R    +R   E  +L
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDL 230

Query: 316 VAWARQYLADKRKLYQIVDPRLELNY 341
           +     Y  D+R  + +V+ RL   Y
Sbjct: 231 MKLCWTYGVDERPGFAVVELRLRNYY 256

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 84/294 (28%), Positives = 140/294 (47%), Gaps = 52/294 (17%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK--PDGLQGHREWVA--- 148
           N+R   +LG+G FG V+  +  + G           +AVK +   PD  +  +E  A   
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRE---------LAVKQVPFDPDSPETKKEVNALEC 53

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVY-EFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
           E+  L  L H  +V+  G C+ DD+ L ++ E+M  GS+++ L +    L  +   K   
Sbjct: 54  EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK------AGPQGDKTHVS 261
              +G+ +LH  S  +++RD K +NIL DS  N KL DFG +K      +   G K+   
Sbjct: 112 QILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--- 166

Query: 262 TRVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
             V GT  + +PE V++G     K+DV+S G  ++E+LT      +K P        WA 
Sbjct: 167 --VTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT------EKPP--------WAE 209

Query: 321 -QYLADKRKL-YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            + +A   K+  Q  +P+L  + S      + +        + K RPS +E+++
Sbjct: 210 FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR----TFVENAKKRPSAEELLR 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHH 158
           LGE  FG V+KG +   GTAP +      VA+K+LK D  +G    E+  E     +L H
Sbjct: 13  LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLREEFKHEAMMRSRLQH 67

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRI 203
           PN+V L+G   ++    +++ + +   L   L  R+                 L  ++ +
Sbjct: 68  PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            I    A G+ FL   S  V+++D  T N+L+  + N K+SD GL +     D   +   
Sbjct: 128 HIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +    + +PE +M G  +  SD++S+GVVL E+ +
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 86.4 bits (214), Expect = 6e-18
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 17/192 (8%)

Query: 126 SGITVAVKSLKPDGLQGHREWV---AEVDFLGQLHHPNLVKLI--GYCIEDDQRLLVYEF 180
           +G  VA+K L+ D  +   +      E     +L+HPN+V L+  G          V+E+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60

Query: 181 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DS 237
           +   +L   L      LP     ++ L     LA  H  ++ +++RD K  NI++     
Sbjct: 61  VPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAH--NQGIVHRDLKPQNIMVSQTGV 117

Query: 238 EYNAKLSDFGLAKAGP---QGDKTHVS--TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGV 292
             +AK+ DFG+    P     D   ++  T V+GT  Y APE +    +T  SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 293 VLLEILTGRRSM 304
           + LE LTG+R +
Sbjct: 178 IFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.6 bits (206), Expect = 7e-18
 Identities = 78/279 (27%), Positives = 117/279 (41%), Gaps = 42/279 (15%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLH 157
           +G G FG V+      N            VA+K +   G Q + +W   + EV FL +L 
Sbjct: 23  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN ++  G  + +    LV E+   GS  + L     PL       +  GA +GLA+LH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYV 276
             S  +I+RD K  NILL      KL DFG A    P       +   VGT  + APE +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVI 183

Query: 277 MT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           +    G    K DV+S G+  +E+       ++K P    N ++           LY I 
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMS----------ALYHIA 227

Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                   S    +       +CL + P+ RP+ + ++K
Sbjct: 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 82.6 bits (204), Expect = 8e-18
 Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 55/298 (18%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           +G G FG V  G     G + A+      V VK L+          ++ EV    +L+HP
Sbjct: 3   IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-----FRRTIPLPWSNRIKIALGAAKGLA 214
           N+++ +G CIE    LLV EF   G L+N+L         +        ++A   A GL 
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLL 114

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LH      I+ D    N  L ++ + K+ D+GLA      D             + APE
Sbjct: 115 WLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172

Query: 275 YV-------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY--LAD 325
            V       +    T KS+++S GV + E+ T                 A  + Y  L+D
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----------------AADQPYPDLSD 215

Query: 326 KRKLYQIV--------DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           ++ L Q+V         P+L+L YS +  + V Q  +     DP++RP+ +EV ++LT
Sbjct: 216 EQVLKQVVREQDIKLPKPQLDLKYSDRWYE-VMQFCW----LDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 68/287 (23%), Positives = 129/287 (44%), Gaps = 40/287 (13%)

Query: 100 ILGEGGFGYVFKGW------------IEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV 147
           ++G+G +G V+               +E   T   +  S     VK+L+           
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALR----------- 56

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
           +E++ L  L H N+V+ +G+   ++   +  E++  GS+ +   R               
Sbjct: 57  SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTE 115

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLA+LH  S+ +++RD K  N+L+D++   K+SDFG++K          +  + G+
Sbjct: 116 QVLEGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 268 YGYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
             + APE + +     ++K D++S G V+LE+  GR      RP  ++  +A A   L +
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFKLGN 226

Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           KR    I  P + +N S             C + +P +RP+  E+++
Sbjct: 227 KRSAPPI-PPDVSMNLS----PVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 86/296 (29%), Positives = 130/296 (43%), Gaps = 46/296 (15%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL--KPDGLQGHREWVAEVDFLGQLHH 158
           +GEG +G VFK    E G           VA+K      D     +  + E+  L QL H
Sbjct: 9   IGEGSYGVVFKCRNRETGQ---------IVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59

Query: 159 PNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           PNLV LI       ++L LV+E+    ++ N L +    +P     KI     + + F H
Sbjct: 60  PNLVNLI-EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKT-HVSTRVVGTYGYAAPE 274
                 I+RD K  NIL+  +   KL DFG A+   GP  D T +V+TR      Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170

Query: 275 YVMTGHLT--SKSDVYSFGVVLLEILT------GRRSMDK----KRPSGEQNLVAWARQY 322
            ++ G        DV++ G V  E+LT      G+  +D+    ++  G+  L+   +Q 
Sbjct: 171 -LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD--LIPRHQQI 227

Query: 323 LADKR--KLYQIVDPR----LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            +  +  K   I +P     LE  +       +S L   CL  DP  R S +E+++
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLK-GCLQMDPTERLSCEELLE 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 70/209 (33%), Positives = 96/209 (45%), Gaps = 24/209 (11%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWV-AEVDFLGQL 156
           +LG+G FG V     E  GT           AVK LK D +      E    E   L   
Sbjct: 2   VLGKGSFGKVL--LAELKGT-------DELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52

Query: 157 -HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGL 213
             HP L +L   C +   RL  V E++  G L  H+ R      P +     A     GL
Sbjct: 53  GKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA--RFYAAEIVLGL 109

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            FLH     +IYRD K  N+LLDSE + K++DFG+ K G  G  T  ++   GT  Y AP
Sbjct: 110 QFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAP 165

Query: 274 EYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           E +++      + D ++ GV+L E+L G+
Sbjct: 166 E-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 60/163 (36%), Positives = 90/163 (55%), Gaps = 18/163 (11%)

Query: 149 EVDFLGQL-HHPNLVKLIG-YCIEDDQRL-LVYEFMTRGSLENHL---FRRTIPLPWSNR 202
           E+ FL +L  HPN+VKL+     E+D+ + LV+E+M     E  L    R  I L   ++
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANI-LEDVHK 109

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTH 259
             I     K L ++H G+  VI+RD K SNILL+S+   KL+DFGLA++     +  +  
Sbjct: 110 RYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           V T  V T  Y APE ++     +K  D++S G +L E+L G+
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 47/284 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G +G V+K      G           VA+K +K +          E+  L +  HPN
Sbjct: 11  IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V   G  +  D+  +V E+   GSL++       PL       +     KGLA+LH   
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH--E 119

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYGYAAPEYV-- 276
              I+RD K +NILL  + + KL+DFG++    Q   T ++ R   +GT  + APE    
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTAT-IAKRKSFIGTPYWMAPEVAAV 175

Query: 277 -MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI--- 332
              G    K D+++ G+  +E+   +  M    P                 R L+ I   
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----------------MRALFLISKS 219

Query: 333 --VDPRLE--LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
               P+L+    +S      + +    CL++DPK RP+  ++++
Sbjct: 220 NFPPPKLKDKEKWSPVFHDFIKK----CLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 67/285 (23%), Positives = 128/285 (44%), Gaps = 38/285 (13%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQ 155
           + ILG G FG + +G ++     P+K    + VA+ +L+  G      R ++AE   LGQ
Sbjct: 10  ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTLR-AGCSDKQRRGFLAEALTLGQ 62

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
             H N+V+L G     +  ++V E+M+ G+L++ L +    L     + +  G A G+ +
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG--YAAP 273
           L       +++      +L++S+   K+S F       +     + T + G     +AAP
Sbjct: 123 L--SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAP 177

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP---SGEQNLVAWARQYLADKRKLY 330
           E +   H +S SDV+SFG+V+ E+++       +RP      Q+++              
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSY-----GERPYWDMSGQDVI-------------- 218

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           + V+    L         + QL  +C  ++   RP   ++  +L+
Sbjct: 219 KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 38/212 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQLH 157
           LG G FG V             K  SG   A+K L    +   ++    + E   L  + 
Sbjct: 9   LGTGSFGRVM--------LVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRI---KIALGAAKG 212
           HP LV L G   +DD  L LV E++  G L +HL +    P P + R    ++ L     
Sbjct: 60  HPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAAQVVLA---- 113

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYG 269
           L +LH  S  ++YRD K  N+LLDS+   K++DFG AK         V  R   + GT  
Sbjct: 114 LEYLH--SLDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPE 163

Query: 270 YAAPEYVM-TGHLTSKSDVYSFGVVLLEILTG 300
           Y APE ++  G+     D ++ G+++ E+L G
Sbjct: 164 YLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 81.3 bits (200), Expect = 4e-17
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 11/202 (5%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQLH 157
           +LG G FG V+KG W+ E  T        I VA+K L +  G + + E++ E   +  + 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVK------IPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HP+LV+L+G C+    +L V + M  G L +++      +     +   +  AKG+ +L 
Sbjct: 68  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                +++RD    N+L+ S  + K++DFGLA+     +K + +        + A E + 
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
               T +SDV+S+GV + E++T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 31/212 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G V+KG    N        +G  VA+K ++   L+   E V      E+  L +
Sbjct: 8   IGEGTYGVVYKG---RNKK------TGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP----LPWSNRIKIAL-GAA 210
           L HPN+V L    +++ +  L++EF++   L+ +L   ++P    +  +  +K  L    
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMD-AELVKSYLYQIL 111

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +G+ F H  S  V++RD K  N+L+D++   KL+DFGLA+A   G    V T  V T  Y
Sbjct: 112 QGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA--FGIPVRVYTHEVVTLWY 167

Query: 271 AAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
            APE ++     S   D++S G +  E+ T +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 33/221 (14%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL 156
           + ++GEG FG V +  I+       K G  +  A+K LK    +  HR++  E++ L +L
Sbjct: 7   EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59

Query: 157 -HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------PLPWS 200
            HHPN++ L+G C       +  E+   G+L + L +  +                L   
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
             ++ A   A G+ +L    +  I+RD    N+L+     +K++DFGL++    G++ +V
Sbjct: 120 QLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV 173

Query: 261 STRVVGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
             + +G     + A E +     T+KSDV+SFGV+L EI++
Sbjct: 174 K-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 69/209 (33%), Positives = 95/209 (45%), Gaps = 28/209 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-----GLQGHREWVAEVDFLGQ 155
           LG GGFG V    ++             T A+K +K       G Q H    +E + L +
Sbjct: 1   LGVGGFGRVEL--VKVKSK-------NRTFALKCVKKRHIVETGQQEH--IFSEKEILEE 49

Query: 156 LHHPNLVKLIGYCIEDDQRLLVY---EFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
            +HP +VKL  Y    D++  +Y   E+   G L   L  R +   ++ R  IA      
Sbjct: 50  CNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLA 105

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
             +LH  +  +IYRD K  N+LLDS    KL DFG AK    G KT       GT  Y A
Sbjct: 106 FEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVA 160

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE ++        D +S G++L E+LTGR
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 49/299 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEV 150
           NF+ +  +G G F  V++     +            VA+K ++   +   +  ++ V E+
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRK---------PVALKKVQIFEMMDAKARQDCVKEI 53

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF-----RRTIP--LPWSNRI 203
           D L QL+HPN++K +   IED++  +V E    G L   +      +R IP    W   +
Sbjct: 54  DLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
           ++        A  H  S  V++RD K +N+ + +    KL D GL +      KT  +  
Sbjct: 114 QLC------SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHS 165

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
           +VGT  Y +PE +       KSD++S G +L E                  + A    + 
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFY 207

Query: 324 ADKRKLYQIVDPRLELNY-SLKG---VQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
            DK  L+ +     + +Y  L      +K+ +L   C+  DP  RP +  V ++   + 
Sbjct: 208 GDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 46/232 (19%)

Query: 99  SILGEGGFGYVFKGWIEEN-GTAPAKPGSGITVAVKSLKPDGL------QGHREWVAEVD 151
            +LG+GG+G VF+  + +  G    K       A+K LK   +        H +  AE +
Sbjct: 2   KVLGKGGYGKVFQ--VRKVTGADTGK-----IFAMKVLKKATIVRNQKDTAHTK--AERN 52

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP-----WSNRIKI 205
            L  + HP +V LI Y  +   +L L+ E+++ G L  HL R  I +      + + I +
Sbjct: 53  ILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL 111

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRV 264
           AL         H   + +IYRD K  NILLD++ + KL+DFGL K     G  TH     
Sbjct: 112 ALE--------HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---F 160

Query: 265 VGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTG---------RRSMDK 306
            GT  Y APE +M +GH     D +S G ++ ++LTG         ++++DK
Sbjct: 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 75/300 (25%), Positives = 132/300 (44%), Gaps = 57/300 (19%)

Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVA 148
            GNF+ +  +G+G F  V+K     +G           VA+K ++   +   +  ++ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGR---------VVALKKVQIFEMMDAKARQDCLK 51

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FR---RTIPLP--WSN 201
           E+D L QL HPN++K +   IE+++  +V E    G L   +  F+   R IP    W  
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            +++       L  +H  S+ +++RD K +N+ + +    KL D GL +      KT  +
Sbjct: 112 FVQL----CSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAA 163

Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
             +VGT  Y +PE +       KSD++S G +L E                  + A    
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSP 205

Query: 322 YLADKRKLYQIVD--------PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV 373
           +  DK  LY +          P    +YS    +++  L   C++ DP+ RP +  V++V
Sbjct: 206 FYGDKMNLYSLCKKIEKCDYPPLPADHYS----EELRDLVSRCINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL---KPDGLQGHRE-------WVAEV 150
           LG G FG V+K           K      +A+K +    P   +  RE        V+EV
Sbjct: 8   LGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59

Query: 151 DFLG-QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF-------RRTIPLPWSNR 202
             +  QL HPN+V+     +E+D+  +V + +    L  H         R T    W+  
Sbjct: 60  TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +++ L     L +LH   + +++RD   +NI+L  +    ++DFGLAK   Q       T
Sbjct: 120 VQMVLA----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLT 171

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
            VVGT  Y+ PE V       K+DV++FG +L ++ T       + P    N+++ A + 
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKI 225

Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +          +P  E  YS    + V+ +  +CL+ D ++RP + +V
Sbjct: 226 VEAV------YEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 79/281 (28%), Positives = 123/281 (43%), Gaps = 48/281 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWV-AEVDFLGQLHH 158
           +GEG  G V                +G  VAVK  K D   Q  RE +  EV  +    H
Sbjct: 27  IGEGSTGIV---------CIATDKSTGRQVAVK--KMDLRKQQRRELLFNEVVIMRDYQH 75

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAF 215
           PN+V++    +  D+  +V EF+  G+L + +    +     N  +IA   L   K L+F
Sbjct: 76  PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIATVCLAVLKALSF 130

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG----LAKAGPQGDKTHVSTRVVGTYGYA 271
           LH  ++ VI+RD K+ +ILL S+   KLSDFG    ++K  P+         +VGT  + 
Sbjct: 131 LH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPYWM 182

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE +      ++ D++S G++++E++ G      + P      +   R  L  K K   
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI---RDNLPPKLKNLH 239

Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            V PRL                   L RDP  R +  E++ 
Sbjct: 240 KVSPRL------------RSFLDRMLVRDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 29/220 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----- 148
           NF+    +GEG +G V+K   +          +G  VA+K ++   L    E V      
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIR---LDTETEGVPSTAIR 48

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKI 205
           E+  L +L+HPN+VKL+     +++  LV+EF+ +  L+  +       IPLP       
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
            L   +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V
Sbjct: 108 QL--LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEV 161

Query: 266 GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSM 304
            T  Y APE ++   + ++  D++S G +  E++T RR++
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 44/238 (18%)

Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL----KPDGLQGHRE 145
           S   ++     LGEG FG V+K    + G           VA+K +    + DG      
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRV---------VALKKILMHNEKDGF--PIT 53

Query: 146 WVAEVDFLGQLHHPNLVKLIGYCIE-----DDQRLLVY---EFMTR---GSLENHLFRRT 194
            + E+  L +L HPN+V LI   +E       +R  VY    +M     G LEN   + T
Sbjct: 54  ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113

Query: 195 IPLPWSNRIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--- 250
                  +IK   L   +G+ +LH     +++RD K +NIL+D++   K++DFGLA+   
Sbjct: 114 ES-----QIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Query: 251 ------AGPQGDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
                  G  G  T   T +V T  Y  PE ++     T+  D++  G V  E+ T R
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 48/220 (21%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G V+K    +  T       G  VA+K ++   L+   E V      E+  L +
Sbjct: 7   IGEGTYGVVYKA--RDKLT-------GEIVALKKIR---LETEDEGVPSTAIREISLLKE 54

Query: 156 LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA---- 210
           L+HPN+V+L+   +  + +L LV+EF+    L+ ++   + P          L       
Sbjct: 55  LNHPNIVRLLD-VVHSENKLYLVFEFLDL-DLKKYM--DSSP-------LTGLDPPLIKS 103

Query: 211 ------KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-G-PQGDKTHVST 262
                 +G+A+ H  S  V++RD K  N+L+D E   KL+DFGLA+A G P    TH   
Sbjct: 104 YLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--- 158

Query: 263 RVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
            VV T  Y APE ++     S   D++S G +  E++  R
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 73/247 (29%), Positives = 104/247 (42%), Gaps = 60/247 (24%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVA--- 148
            +F    ++G G FG V+               +G   A+K L K D ++  R  +A   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIK--RNQIAHVR 49

Query: 149 -EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRR-TIPLPWSN---- 201
            E D L     P +VKL  Y  +D++ L LV E+M  G L N L R+   P   +     
Sbjct: 50  AERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA 108

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG------ 255
            + +AL +   L F+H        RD K  NIL+D++ + KL+DFGL K   +       
Sbjct: 109 ELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160

Query: 256 ----------DKTHVSTR-----------VVGTYGYAAPEYVMTGH-LTSKSDVYSFGVV 293
                     D   V  R            VGT  Y APE V+ G     + D +S GV+
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVI 219

Query: 294 LLEILTG 300
           L E+L G
Sbjct: 220 LYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 39/276 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHHP 159
           +G+G FG V+KG   +N T          VA+K +  +  +   E +  E+  L Q   P
Sbjct: 12  IGKGSFGEVYKGI--DNRTKE-------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            + +  G  ++  +  ++ E++  GS  + L  +  PL  +    I     KGL +LH  
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH-- 118

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           SE  I+RD K +N+LL  + + KL+DFG+  AG   D        VGT  + APE +   
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PR 336
               K+D++S G+  +E+  G        P                 R L+ I     P 
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHP----------------MRVLFLIPKNSPPT 220

Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           LE  YS    +   +    CL++DP+ RP+  E++K
Sbjct: 221 LEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 70/232 (30%), Positives = 99/232 (42%), Gaps = 60/232 (25%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD------------------GL 140
            +LG+G FG V             + G+    A+K LK D                   L
Sbjct: 6   MVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56

Query: 141 QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL-----FRRT 194
            G      +  FL QLH          C +   RL  V E++  G L  H+     F+  
Sbjct: 57  PG------KPPFLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP 101

Query: 195 IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
             + ++  I I      GL FLH  S+ +IYRD K  N++LD+E + K++DFG+ K    
Sbjct: 102 HAVFYAAEIAI------GLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153

Query: 255 GDKTHVSTRV-VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD 305
           G KT   TR   GT  Y APE +         D ++FGV+L E+L G+   D
Sbjct: 154 GGKT---TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.6 bits (193), Expect = 2e-16
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 39/276 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHHP 159
           +G+G FG VFKG   +N T          VA+K +  +  +   E +  E+  L Q   P
Sbjct: 12  IGKGSFGEVFKGI--DNRTQQ-------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            + K  G  ++  +  ++ E++  GS  + L  R  P        +     KGL +LH  
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLH-- 118

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           SE  I+RD K +N+LL  + + KL+DFG+  AG   D        VGT  + APE +   
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PR 336
              SK+D++S G+  +E+  G        P                 R L+ I     P 
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHP----------------MRVLFLIPKNNPPT 220

Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           L   +S    +   +    CL++DP  RP+  E++K
Sbjct: 221 LTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 82/291 (28%), Positives = 125/291 (42%), Gaps = 58/291 (19%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           +  LG G FG V   W+       A       VAVK++KP G      ++AE + +  L 
Sbjct: 11  EKKLGAGQFGEV---WM-------ATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQ 59

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLA 214
           H  LVKL    +  +   ++ EFM +GSL + L        PLP    I  +   A+G+A
Sbjct: 60  HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 116

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVSTRVVGT 267
           F+       I+RD + +NIL+ +    K++DFGLA+          +G K  +       
Sbjct: 117 FIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------ 168

Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             + APE +  G  T KSDV+SFG++L+EI+T  R       + E               
Sbjct: 169 --WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------------- 211

Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVKVL 374
                V   LE  Y +   +   +  YN    C    P+ RP+ + +  VL
Sbjct: 212 -----VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDF 152
           NF+    LGEG +  V+KG     G           VA+K +  D  +G     + E+  
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGE---------IVALKEIHLDAEEGTPSTAIREISL 51

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMT---RGSLENHLFRRTIPLPWSNRIKIALGA 209
           + +L H N+V+L      +++ +LV+E+M    +  ++ H  R  +           L  
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
            KG+AF H     V++RD K  N+L++     KL+DFGLA+A      T  S  VV T  
Sbjct: 110 LKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLW 165

Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y AP+ ++     S S D++S G ++ E++TGR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 33/219 (15%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-H 157
           ++GEG FG V K  I+++G         +  A+K +K    +  HR++  E++ L +L H
Sbjct: 2   VIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------PLPWSNR 202
           HPN++ L+G C       L  E+   G+L + L +  +                L     
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +  A   A+G+ +L    +  I+RD    NIL+   Y AK++DFGL++    G + +V  
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 167

Query: 263 RVVGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           + +G     + A E +     T+ SDV+S+GV+L EI++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL--KPDGLQGHREWVAEVDFLGQLH 157
           ++GEG +G V K   +E         +G  VA+K      D     +  + E+  L QL 
Sbjct: 8   LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H NLV LI       +  LV+EF+    L + L +    L  S   K      +G+ F H
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAPEY 275
             S  +I+RD K  NIL+      KL DFG A+  A P      V T  V T  Y APE 
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----EVYTDYVATRWYRAPEL 171

Query: 276 VMTGHLTSKS-DVYSFGVVLLEILTG 300
           ++      ++ D+++ G ++ E+LTG
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 33/219 (15%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-H 157
           ++GEG FG V K  I+++G         +  A+K +K    +  HR++  E++ L +L H
Sbjct: 14  VIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------PLPWSNR 202
           HPN++ L+G C       L  E+   G+L + L +  +                L     
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +  A   A+G+ +L    +  I+RD    NIL+   Y AK++DFGL++    G + +V  
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179

Query: 263 RVVGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           + +G     + A E +     T+ SDV+S+GV+L EI++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 36/286 (12%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 14  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI----------PLP-WSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++          P P     I++A  
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 128 IADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 230

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +PK RP+  E+V +L
Sbjct: 231 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 75/216 (34%), Positives = 106/216 (49%), Gaps = 32/216 (14%)

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLP----WSNRIKIALGAAK 211
           HP LV L   C + + RL  V EF++ G L  H+ R R +P      +S  I +AL    
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 110

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRVVGTYGY 270
              FLH     +IYRD K  N+LLD+E + KL+D+G+ K G + GD T  ST   GT  Y
Sbjct: 111 ---FLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--ST-FCGTPNY 162

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD--KKRPSGEQNLVAWARQYLADKRK 328
            APE +         D ++ GV++ E++ GR   D      + +QN   +  Q + +K  
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-- 220

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             QI  PR     SL    K S +    L++DPK R
Sbjct: 221 --QIRIPR-----SLS--VKASSVLKGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 42/221 (19%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP--DGLQGHREWVAEVDFLGQL 156
           S +GEG +G V         +A  KP +G+ VA+K + P        R  + E+  L + 
Sbjct: 11  SYIGEGAYGMVC--------SATHKP-TGVKVAIKKISPFEHQTFCQRT-LREIKILRRF 60

Query: 157 HHPNLVKLIGYCIEDDQR----------LLVYEFMTRGSLENHLFR--RTIPLPWSN-RI 203
            H N++      I D  R           +V E M     E  L++  +T  L  SN  I
Sbjct: 61  KHENIIG-----ILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHL--SNDHI 108

Query: 204 KIAL-GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVS 261
           +  L    +GL ++H  S  V++RD K SN+LL++  + K+ DFGLA+ A P+ D T   
Sbjct: 109 QYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 262 TRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           T  V T  Y APE ++     +K+ D++S G +L E+L+ R
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 7e-16
 Identities = 69/266 (25%), Positives = 121/266 (45%), Gaps = 53/266 (19%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGHREWVA----E 149
           +++G G FG V+ G             SG  +AVK     S+        R  +     E
Sbjct: 6   ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           +  L +L H N+V+ +G  ++ D   +  E++  GS+   L     F  T+     N ++
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV---RNFVR 113

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR- 263
             L   KGL +LH  +  +I+RD K +NIL+D++   K+SDFG++K   + +     T  
Sbjct: 114 QIL---KGLNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNG 167

Query: 264 ----VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR-------------RSMDK 306
               + G+  + APE V     T K+D++S G +++E+LTG+             +  + 
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN 227

Query: 307 KRPSGEQNLVAWARQYLADKRKLYQI 332
             P    N+ + A  +L    K ++I
Sbjct: 228 ASPEIPSNISSEAIDFL---EKTFEI 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V+K   +E         +G+  A K +     +   +++ E+D L    HPN
Sbjct: 13  LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +VKL+     ++   ++ EF   G+++  +     PL       +     + L +LH   
Sbjct: 64  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--E 121

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
             +I+RD K  NIL   + + KL+DFG++    +  +   S   +GT  + APE VM   
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE- 178

Query: 281 LTS-------KSDVYSFGVVLLEI 297
            TS       K+DV+S G+ L+E+
Sbjct: 179 -TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.8 bits (189), Expect = 9e-16
 Identities = 51/187 (27%), Positives = 95/187 (50%), Gaps = 14/187 (7%)

Query: 125 GSGITVAVKSLK------PDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVY 178
            +G  +AVK +        +  +       E+  + +L+HP++++++G   ED    L  
Sbjct: 23  KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82

Query: 179 EFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE 238
           E+M  GS+ +HL  +      +  I       +GL++LH     +I+RD K +N+L+DS 
Sbjct: 83  EWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDST 139

Query: 239 -YNAKLSDFGLA-KAGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVL 294
               +++DFG A +   +G        +++GT  + APE V+ G    +S DV+S G V+
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVI 198

Query: 295 LEILTGR 301
           +E+ T +
Sbjct: 199 IEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 18/205 (8%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+GGFG V    ++  G   A       +  K LK     G +  + E + L +++ P 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACK----KLDKKRLKKKS--GEKMALLEKEILEKVNSPF 54

Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLF---RRTIPLPWSNRIKIALGAAKGLAFL 216
           +V L  Y  E    L LV   M  G L+ H++    R + +    R+ I   A      L
Sbjct: 55  IVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM---ERV-IHYSAQITCGIL 109

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           H  S  ++YRD K  N+LLD + N +LSD GLA     G      T+  GT GY APE +
Sbjct: 110 HLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEIL 166

Query: 277 MTGHLTSKSDVYSFGVVLLEILTGR 301
                +   D ++ G  + E++ GR
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 32/217 (14%)

Query: 157 HHPNLVKLIGYCIEDDQRLL-VYEFMTRGSLENHLFR-RTIPLP----WSNRIKIALGAA 210
           +HP LV L   C + + RL  V E++  G L  H+ R R +P      +S  I +AL   
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN-- 110

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRVVGTYG 269
               +LH     +IYRD K  N+LLDSE + KL+D+G+ K G + GD T   +   GT  
Sbjct: 111 ----YLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPN 161

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG--EQNLVAWARQYLADKR 327
           Y APE +         D ++ GV++ E++ GR   D    S   +QN   +  Q + +K 
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK- 220

Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
              QI  PR   + S+K    +       L++DPK R
Sbjct: 221 ---QIRIPR---SLSVKAASVLKSF----LNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 70/219 (31%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL- 153
           FR  ++LG G FG V     E   T       G   A+K+LK   +   R+   EV+ L 
Sbjct: 1   FRCLAVLGRGHFGKVL--LAEYKKT-------GELYAIKALKKGDIIA-RD---EVESLM 47

Query: 154 ---------GQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRI 203
                        HP LV L   C + +  +  V E+   G L  H+       P   R 
Sbjct: 48  CEKRIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RA 103

Query: 204 KI-ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP-QGDKTHVS 261
              A     GL +LH     ++YRD K  N+LLD+E   K++DFGL K G   GD+T  S
Sbjct: 104 VFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159

Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           T   GT  + APE +     T   D +  GV++ E+L G
Sbjct: 160 T-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V+K   +E         +G   A K ++    +   +++ E++ L   +HP 
Sbjct: 20  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +VKL+G    D +  ++ EF   G+++  +      L       I     + L +LH  S
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH--S 128

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
             +I+RD K  N+LL  + + KL+DFG++    +  +   S   +GT  + APE VM   
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCET 186

Query: 281 LTS-----KSDVYSFGVVLLEI 297
           +       K+D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 68/207 (32%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           +LG+G FG V    ++E         SG   AVK LK D +    +    + E   L   
Sbjct: 2   VLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52

Query: 157 H-HPNLVKLIGYCIEDDQRLL-VYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGL 213
             HP L +L   C +   RL  V EF+  G L  H+ + R      +      + +A  L
Sbjct: 53  RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--L 109

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            FLH   + +IYRD K  N+LLD E + KL+DFG+ K G    KT  ++   GT  Y AP
Sbjct: 110 MFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAP 165

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTG 300
           E +         D ++ GV+L E+L G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.6 bits (187), Expect = 4e-15
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 30/220 (13%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP---DGLQGHREWVAEVD 151
           +     +G G +G V     +  G           VA+K +     D +   R    E+ 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGR---------KVAIKKISNVFDDLIDAKRIL-REIK 51

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRL------LVYEFMTRGSLENHLFRRTIPLPWSN-RIK 204
            L  L H N++ L+   +            +V E M   +  + + +   PL  ++  I+
Sbjct: 52  LLRHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPL--TDDHIQ 106

Query: 205 -IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-GPQGDKTHVST 262
                  +GL +LH  S  VI+RD K SNIL++S  + K+ DFGLA+   P  D+    T
Sbjct: 107 YFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 263 RVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
             V T  Y APE +++    +K+ D++S G +  E+LT +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 11/207 (5%)

Query: 95  FRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVDF 152
           F+   +LG G FG V+KG WI      P      I VA+K L+     + ++E + E   
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           +  + +P++ +L+G C+    +L + + M  G L +++      +     +   +  AKG
Sbjct: 63  MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           + +L      +++RD    N+L+ +  + K++DFGLAK     +K + +        + A
Sbjct: 122 MNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILT 299
            E ++    T +SDV+S+GV + E++T
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 28/211 (13%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLG-Q 155
           +LG+G FG VF   ++         G+    A+K+LK D +    +    + E   L   
Sbjct: 2   MLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52

Query: 156 LHHPNLVKLIGYCI--EDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGAA 210
             HP L  L  YC     +    V E++  G L  H+    +  +P       +I  G  
Sbjct: 53  WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             L FLH  S+ ++YRD K  NILLD++ + K++DFG+ K    GD    +    GT  Y
Sbjct: 109 --LQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
            APE ++     +  D +SFGV+L E+L G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 55/231 (23%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK----PDGL--QGHREWV 147
            F   + +GEG +G V++              SG  VA+K ++     DG+     RE  
Sbjct: 8   EFEKLNRIGEGTYGIVYRA---------RDTTSGEIVALKKVRMDNERDGIPISSLRE-- 56

Query: 148 AEVDFLGQLHHPNLVKL---------------IGYCIEDDQRLLVYEFMTRGSLENHLFR 192
             +  L  L HPN+V+L               + YC +D   LL  + M           
Sbjct: 57  --ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT--------- 103

Query: 193 RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG 252
              P   S    + L   +GL +LH     +I+RD K SN+LL  +   K++DFGLA+  
Sbjct: 104 ---PFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-- 156

Query: 253 PQGDKTHVSTRVVGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEILTGR 301
             G      T  V T  Y APE +   T + T+  D+++ G +L E+L  +
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 66/283 (23%), Positives = 111/283 (39%), Gaps = 54/283 (19%)

Query: 123 KPGSGITVAVK-SLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFM 181
           KPG    V +K   K   L        E   L  ++HP+++++        +  LV   +
Sbjct: 87  KPGQPDPVVLKIGQKGTTL-------IEAMLLQNVNHPSVIRM--------KDTLVSGAI 131

Query: 182 T-------RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL 234
           T          L  +L +R+ PLP    + I     +GL +LH   + +I+RD KT NI 
Sbjct: 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIF 189

Query: 235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 294
           ++      + D G A+  P      +   + GT    APE +      SK+D++S G+VL
Sbjct: 190 INDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVL 246

Query: 295 LEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI------VDP--RLELNY-SLKG 345
            E+L    ++ +  PS  +  V     +L       ++       DP  RL   +     
Sbjct: 247 FEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYAS 306

Query: 346 VQKVSQLAYNCLSR-----------------DPKSRPSMDEVV 371
           +++     Y C  R                 D   RPS +E++
Sbjct: 307 LERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349

Length = 357

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 58/180 (32%), Positives = 92/180 (51%), Gaps = 13/180 (7%)

Query: 125 GSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFM 181
           G+G   A+K LK   +   ++      E   L +L HP +V ++    ++++   + EF+
Sbjct: 41  GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100

Query: 182 TRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA 241
             G L  HL R+    P  N +     A   LAF +  S+ +IYRD K  N+LLD++ + 
Sbjct: 101 VGGELFTHL-RKAGRFP--NDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV 157

Query: 242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTG 300
           K++DFG AK  P  D+T     + GT  Y APE + + GH     D ++ GV+L E + G
Sbjct: 158 KVTDFGFAKKVP--DRTFT---LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 46/285 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDF-LGQLHH 158
           LG G +G V K              +G  +AVK ++     Q  +  + ++D  +  +  
Sbjct: 9   LGRGAYGVVDK---------MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLEN---HLFRRTIPLPWSNRIKIALGAAKGLAF 215
           P  V   G    +    +  E M   SL+     ++ + + +P     KIA+   K L +
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           LH     VI+RD K SN+L++     KL DFG+  +G   D     T   G   Y APE 
Sbjct: 119 LHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVDSV-AKTIDAGCKPYMAPER 174

Query: 276 V----MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           +           KSDV+S G+ ++E+ TGR   D  +   +Q               L Q
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ---------------LKQ 219

Query: 332 IVD---PRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           +V+   P+L    +S +    V++    CL ++ K RP+  E+++
Sbjct: 220 VVEEPSPQLPAEKFSPEFQDFVNK----CLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 79/275 (28%), Positives = 117/275 (42%), Gaps = 34/275 (12%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVD 151
           FR   +LG+GGFG V          A     +G   A K L+   ++   G    + E  
Sbjct: 2   FRQYRVLGKGGFGEV---------CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ 52

Query: 152 FLGQLHHPNLVKLIGYCIE-DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKI-ALGA 209
            L +++   +V L  Y  E  D   LV   M  G L+ H++    P     R    A   
Sbjct: 53  ILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI 111

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             GL  LH   E  +YRD K  NILLD   + ++SD GLA   P+G+   +  R VGT G
Sbjct: 112 LCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGR-VGTVG 166

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           Y APE +     T   D +  G ++ E++ G+     ++   ++  V        D+R L
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--------DRRVL 218

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
                   E  YS K  ++   +    L++DPK R
Sbjct: 219 ------ETEEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 72/208 (34%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVD-FLGQ 155
           ++G+G FG V             +   G   AVK L+   +   +E    +AE +  L  
Sbjct: 2   VIGKGSFGKVLLA---------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52

Query: 156 LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGL 213
           + HP LV L  Y  +  ++L  V +F+  G L  HL R R+ P P + R   A   A  L
Sbjct: 53  VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVSTRVVGTYGYAA 272
            +LH  S  ++YRD K  NILLDS+ +  L+DFGL K G  Q D T   T   GT  Y A
Sbjct: 110 GYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLA 164

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           PE +      +  D +  G VL E+L G
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 56/171 (32%), Positives = 87/171 (50%), Gaps = 24/171 (14%)

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLL--VYEFMTRGSLENHL-----FRRTIPLPWSN 201
           E   L ++ HP +++L  +  E DQR L  + E++  G L ++L     F  +  L +++
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            I  AL       +LH  S+ ++YRD K  NILLD E + KL+DFG AK     D+T   
Sbjct: 109 EIVCAL------EYLH--SKEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT- 157

Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG 311
             + GT  Y APE +   GH  +  D ++ G+++ E+L G        P G
Sbjct: 158 --LCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 24/213 (11%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL----KPDGLQGHREWVAE 149
           +F     LG G  G V K           +P SG+ +A K +    KP       + + E
Sbjct: 2   DFEKLGELGAGNGGVVTK--------VLHRP-SGLIMARKLIHLEIKPAIRN---QIIRE 49

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR-RTIPLPWSNRIKIALG 208
           +  L + + P +V   G    D +  +  E M  GSL+  L +   IP     +I IA+ 
Sbjct: 50  LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV- 108

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
             +GL +L      +++RD K SNIL++S    KL DFG++  G   D   ++   VGT 
Sbjct: 109 -LRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 162

Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
            Y +PE +   H T +SD++S G+ L+E+  GR
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 84/294 (28%), Positives = 142/294 (48%), Gaps = 50/294 (17%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQ 155
           +L EG FG +F G  I+E      KPG    V VK++K D    +Q     + E   L  
Sbjct: 13  LLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVK-DHASEIQVTL-LLQESCLLYG 64

Query: 156 LHHPNLVKLIGYCIED-DQRLLVYEFMTRGSLENHLFR-----RTIPLPWSNR--IKIAL 207
           L H N++ ++  CIED +   ++Y +M  G+L+  L +        P   S +  + +A+
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQ-----GDKTHVS 261
             A G+++LH     VI++D    N ++D E   K++D  L++   P      GD  +  
Sbjct: 125 QIACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
            +      + A E ++    +S SDV+SFGV+L E++T  ++     P  E +    A  
Sbjct: 183 VK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQT-----PYVEIDPFEMA-A 230

Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           YL D  +L Q ++   EL +++        +A  C + DP+ RPS  ++V+ LT
Sbjct: 231 YLKDGYRLAQPINCPDEL-FAV--------MAC-CWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 70/220 (31%), Positives = 98/220 (44%), Gaps = 29/220 (13%)

Query: 94  NFRPDSILGEGGFGYVF---KGWIEENGTAPA-KPGSGITVAVKSLKPDGLQGHR---EW 146
           NF    +LG G +G VF   K    + G   A K     T+  K+   +  +  R   E 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
           V    FL  LH         Y  + D +L L+ +++  G L  HL++R        R+ I
Sbjct: 61  VRRCPFLVTLH---------YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTR 263
           A      LA  H     +IYRD K  NILLDSE +  L+DFGL+K     + ++ +    
Sbjct: 112 A---EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---S 165

Query: 264 VVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTG 300
             GT  Y APE +     GH     D +S GV+  E+LTG
Sbjct: 166 FCGTIEYMAPEVIRGGSGGH-DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 77/288 (26%), Positives = 134/288 (46%), Gaps = 39/288 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK--PDGLQGHREWVA--- 148
           N+R   +LG+G FG V+  +  + G           +A K ++  P+  +  +E  A   
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRE---------LAAKQVQFDPESPETSKEVSALEC 53

Query: 149 EVDFLGQLHHPNLVKLIGYCIED--DQRLLVY-EFMTRGSLENHLFRRTIPLPWSNRIKI 205
           E+  L  L H  +V+  G C+ D  ++ L ++ E+M  GS+++ L +    L  S   K 
Sbjct: 54  EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKY 111

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR-V 264
                +G+++LH     +++RD K +NIL DS  N KL DFG +K       +    R V
Sbjct: 112 TRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  + +PE +       K+DV+S G  ++E+LT      +K P  E   +A      A
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT------EKPPWAEYEAMA------A 217

Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             +   Q  +P+L  + S      +      C+  + + RPS +E+++
Sbjct: 218 IFKIATQPTNPQLPSHISEHARDFL-----GCIFVEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 66/214 (30%), Positives = 94/214 (43%), Gaps = 34/214 (15%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLG-Q 155
           +LG+G FG V    ++         G G   AVK+LK D +    +    + E   L   
Sbjct: 2   VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH--------LFRRTIPLPWSNRIKIAL 207
             +P L  L       +    V EF+  G L  H        L+R T           A 
Sbjct: 53  WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF---------YAA 103

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
               GL FLH  S+ +IYRD K  N++LD + + K++DFG+ K    GD    ++   GT
Sbjct: 104 EIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGT 159

Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE +     T   D +SFGV+L E+L G+
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK----SLKPDGLQGHREWVAE 149
           +F   S LG G  G V K           KP SG+ +A K     +KP       + + E
Sbjct: 6   DFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKP---AIRNQIIRE 53

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
           +  L + + P +V   G    D +  +  E M  GSL+  + +    +P     K+++  
Sbjct: 54  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSIAV 112

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
            +GLA+L    + +++RD K SNIL++S    KL DFG++  G   D   ++   VGT  
Sbjct: 113 LRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRS 167

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLH 157
           +LG G FG V+KG WI      P      I VA+K L+ +   + ++E + E   +  + 
Sbjct: 14  VLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
            P + +L+G C+    +L V + M  G L +++      +   + +   +  AKG+++L 
Sbjct: 68  SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                +++RD    N+L+ S  + K++DFGLA+     +  + +        + A E ++
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
               T +SDV+S+GV + E++T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 77/275 (28%), Positives = 114/275 (41%), Gaps = 34/275 (12%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVD 151
           FR   +LG+GGFG V          A     +G   A K L+   ++   G    + E  
Sbjct: 2   FRQYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ 52

Query: 152 FLGQLHHPNLVKLIGYCIE-DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGA 209
            L +++   +V L  Y  E  D   LV   M  G L+ H++            +  A   
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             GL  LH   E ++YRD K  NILLD   + ++SD GLA   P+G    +  R VGT G
Sbjct: 112 CCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR-VGTVG 166

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           Y APE V     T   D ++ G +L E++ G+    +++                 KR+ 
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------------IKREE 212

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
            + +   ++  YS K       L    L +DPK R
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEV 150
           +F    +LG+G FG V             + G+    A+K LK D +    +    + E 
Sbjct: 1   DFNFLMVLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEK 51

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
             L     P  +  +  C +   RL  V E++  G L  H+ ++         +  A   
Sbjct: 52  RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEI 110

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV-VGTY 268
           + GL FLH     +IYRD K  N++LDSE + K++DFG+ K   +     V+TR   GT 
Sbjct: 111 SVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTP 165

Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD 305
            Y APE +         D +++GV+L E+L G+   D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK----SLKPDGLQGHREWVAE 149
           +F   S LG G  G VFK           KP SG+ +A K     +KP       + + E
Sbjct: 6   DFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKP---AIRNQIIRE 53

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
           +  L + + P +V   G    D +  +  E M  GSL+  + ++   +P     K+++  
Sbjct: 54  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIAV 112

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
            KGL +L      +++RD K SNIL++S    KL DFG++  G   D   ++   VGT  
Sbjct: 113 IKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRS 167

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 78/277 (28%), Positives = 120/277 (43%), Gaps = 40/277 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V    ++          SG  VAVK +     Q       EV  +    H N
Sbjct: 28  IGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLH 217
           +V++    +  D+  +V EF+  G+L + +    +     N  +IA   L   K L+ LH
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIAAVCLAVLKALSVLH 133

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYGYAAPEY 275
             ++ VI+RD K+ +ILL  +   KLSDFG      Q  K  V  R  +VGT  + APE 
Sbjct: 134 --AQGVIHRDIKSDSILLTHDGRVKLSDFGFCA---QVSK-EVPRRKSLVGTPYWMAPEL 187

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +       + D++S G++++E++ G      + P     ++   R  L  K K    V P
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHKVSP 244

Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                 SLKG           L RDP  R +  E++K
Sbjct: 245 ------SLKGFLD------RLLVRDPAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 70/208 (33%), Positives = 100/208 (48%), Gaps = 24/208 (11%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQ- 155
           ++G+G FG V     + +G            AVK L+   +   +E    +AE + L + 
Sbjct: 2   VIGKGSFGKVLLAKHKADGK---------FYAVKVLQKKAILKKKEQKHIMAERNVLLKN 52

Query: 156 LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRIKI-ALGAAKG 212
           + HP LV L  Y  +   +L  V +++  G L  HL R R+ P P   R +  A   A  
Sbjct: 53  VKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASA 108

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +LH  S  +IYRD K  NILLDS+ +  L+DFGL K G +  KT  ++   GT  Y A
Sbjct: 109 LGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           PE +         D +  G VL E+L G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 35/214 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G V+K    +  T         T+A+K ++   L+   E V      E+  L +
Sbjct: 10  IGEGTYGVVYKA--RDRVTNE-------TIALKKIR---LEQEDEGVPSTAIREISLLKE 57

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-----FRRTIPLPWSNRIKIAL-GA 209
           + H N+V+L      + +  LV+E++    L+ H+     F +   L     IK  L   
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRL-----IKTYLYQI 111

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            +G+A+ H  S  V++RD K  N+L+D   NA KL+DFGLA+A   G      T  V T 
Sbjct: 112 LRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTL 167

Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE ++ + H ++  D++S G +  E++  +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 9/155 (5%)

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           Q   P + KL       D   LV E++  G   + L +    LP     +       G+ 
Sbjct: 53  QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVE 111

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
            LH     +I+RD K  N+L+D   + KL+DFGL++ G        + + VGT  Y APE
Sbjct: 112 DLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPE 163

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP 309
            ++       SD +S G V+ E L G      + P
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
           +P LV L   C +   RL LV E++  G L  H+ +R   LP  +    A      L FL
Sbjct: 55  NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFL 112

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRVVGTYGYAAPEY 275
           H     +IYRD K  N+LLD++ + KL+D+G+ K G   GD T   +   GT  Y APE 
Sbjct: 113 H--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEI 167

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +         D ++ GV++ E++ GR   D    + + N   +  Q + +K     I  P
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----PIRIP 223

Query: 336 R---LELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           R   ++ ++ LKG           L++DPK R
Sbjct: 224 RFLSVKASHVLKGF----------LNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 45/223 (20%)

Query: 102 GEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWVAEVDFLGQLHH 158
           G G +G V+K               G   A+K  K D  Q     +    E+  L +L H
Sbjct: 9   GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 159 PNLVKLIGYCIEDDQRL--LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK----- 211
            N+V L+   +E   +   L++++      +   F R      + R+ I     K     
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQ 116

Query: 212 ---GLAFLHGGSEPVIYRDFKTSNILLDSEYNA----KLSDFGLA-------KAGPQGDK 257
              G+ +LH  S  V++RD K +NIL+  E       K+ D GLA       K     D 
Sbjct: 117 ILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174

Query: 258 THVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILT 299
                 VV T  Y APE ++   H T   D+++ G +  E+LT
Sbjct: 175 ------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           GL FLH   + +IYRD K  N+LLD + + K++DFG+ K    G+    ++   GT  Y 
Sbjct: 108 GLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYI 163

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           APE +         D +SFGV+L E+L G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 20/219 (9%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVA--EVD 151
           FR   +LG+GGFG V          A     +G   A K L+   ++    E +A  E  
Sbjct: 2   FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52

Query: 152 FLGQLHHPNLVKLIGYCIE-DDQRLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALGA 209
            L +++   +V L  Y  E  D   LV   M  G L+ H++    P       +  A   
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI 111

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             GL  LH   E ++YRD K  NILLD   + ++SD GLA   P+G+   +  R VGT G
Sbjct: 112 TCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR-VGTVG 166

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           Y APE V     T   D +  G ++ E++ G+    +++
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 69/227 (30%), Positives = 97/227 (42%), Gaps = 41/227 (18%)

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI--KIALGAAKGLAFL 216
           P +VK  GY I D    +  E M+   L+  L R   P+P    I  K+ +   K L +L
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIP--EDILGKMTVAIVKALHYL 130

Query: 217 ---HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD-KTHVSTRVVGTYGYAA 272
              HG    VI+RD K SNILLD+  N KL DFG+  +G   D K    TR  G   Y A
Sbjct: 131 KEKHG----VIHRDVKPSNILLDASGNVKLCDFGI--SGRLVDSKAK--TRSAGCAAYMA 182

Query: 273 PEYVMTGHLTSK----SDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
           PE +       K    +DV+S G+ L+E+ TG+       P               +   
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ------FPYKNCK---------TEFEV 227

Query: 329 LYQIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           L +I+    P L  N               CL++D + RP   E+++
Sbjct: 228 LTKILQEEPPSLPPNEGFS--PDFCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK-PDGLQGH-----REWVA 148
           + P + +G G +G V+K            P SG  VA+KS++      G      RE VA
Sbjct: 2   YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VA 51

Query: 149 EVDFLGQLHHPNLVKLIGYC--IEDDQRL---LVYEFMTRGSLENHLFRRTIP-LPWSNR 202
            +  L    HPN+V+L+  C     D+     LV+E + +  L  +L +   P LP    
Sbjct: 52  LLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETI 110

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS- 261
             +     +GL FLH  +  +++RD K  NIL+ S    KL+DFGLA+         ++ 
Sbjct: 111 KDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMAL 164

Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
           T VV T  Y APE ++     +  D++S G +  E+ 
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 16/159 (10%)

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           E++ L  ++HPN+VK       + +  ++ EFM  GSLE         L       +A  
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQ 176

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG-DKTHVSTRVVGT 267
              G+A+LH     +++RD K SN+L++S  N K++DFG+++   Q  D  + S   VGT
Sbjct: 177 ILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGT 231

Query: 268 YGYAAPEYVMTGHLTSK-----SDVYSFGVVLLEILTGR 301
             Y +PE + T            D++S GV +LE   GR
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 79/278 (28%), Positives = 118/278 (42%), Gaps = 40/278 (14%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVD 151
           FR   +LG+GGFG V          A     +G   A K L+   ++   G    + E  
Sbjct: 2   FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKR 52

Query: 152 FLGQLHHPNLVKLIGYCIE-DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR-IKIALGA 209
            L +++   +V L  Y  E  D   LV   M  G L+ H++    P     R I  A   
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL 111

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             GL  L    E ++YRD K  NILLD   + ++SD GLA   P+G+   V  R VGT G
Sbjct: 112 CCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGR-VGTVG 166

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           Y APE +     T   D +  G ++ E++ G+    K++                 +R  
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK-----------------ERVK 209

Query: 330 YQIVDPRL---ELNYSLKGVQKVSQLAYNCLSRDPKSR 364
            + VD R+   +  YS K  +    +    L+++PK R
Sbjct: 210 REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 41/279 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG FG       +E+G         I+     + P   +  R+   EV  L  + HPN
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINIS----KMSPKEREESRK---EVAVLSNMKHPN 60

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTIPLP------WSNRIKIALGAAKGL 213
           +V+      E+    +V ++   G L   +  +R +  P      W  +I +AL      
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
              H     +++RD K+ NI L  +   KL DFG+A+         ++   +GT  Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSP 170

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E        +KSD+++ G VL E+ T + + +       +NLV      L   R  Y   
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLV------LKIIRGSY--- 218

Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            P +  +YS      VSQL      R+P+ RPS++ +++
Sbjct: 219 -PPVSSHYSYDLRNLVSQL----FKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 68/249 (27%), Positives = 97/249 (38%), Gaps = 37/249 (14%)

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF---RRTIPLPWSNRIKI 205
           E+D L  + H  ++ LI        R      M     +  LF    R+ PLP    I I
Sbjct: 136 EIDILKTISHRAIINLI-----HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
                + LA+LHG    +I+RD KT NI LD   NA L DFG A        T       
Sbjct: 191 QRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSM-DKKRP-SGEQ---------- 313
           GT    +PE +      +K+D++S G+VL E+     ++  K+   S  Q          
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308

Query: 314 -----------NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPK 362
                      NL    +QY    R  Y I  P +   Y +     V  L    L+ D +
Sbjct: 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTI--PPVIRKYGMH--MDVEYLIAKMLTFDQE 364

Query: 363 SRPSMDEVV 371
            RPS  +++
Sbjct: 365 FRPSAQDIL 373

Length = 392

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 67/255 (26%), Positives = 116/255 (45%), Gaps = 37/255 (14%)

Query: 126 SGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGS 185
           +G  VAVK +     Q       EV  +   HH N+V +    +  D+  +V EF+  G+
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 186 LENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK 242
           L + +    +     N  +IA   L   + L++LH  ++ VI+RD K+ +ILL S+   K
Sbjct: 106 LTDIVTHTRM-----NEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIK 158

Query: 243 LSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           LSDFG  A+   +  K      +VGT  + APE +      ++ D++S G++++E++ G 
Sbjct: 159 LSDFGFCAQVSKEVPK---RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Query: 302 RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLS--- 358
                + P             L   R++   + PR      +K   KVS +    L    
Sbjct: 216 PPYFNEPP-------------LQAMRRIRDNLPPR------VKDSHKVSSVLRGFLDLML 256

Query: 359 -RDPKSRPSMDEVVK 372
            R+P  R +  E+++
Sbjct: 257 VREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK----PDG--LQGHREWVA 148
           +   + +GEG +G VFK    +NG        G  VA+K ++     +G  L   RE VA
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIRE-VA 53

Query: 149 EVDFLGQLHHPNLVKLIGYCI-----EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI 203
            +  L    HPN+V+L   C       + +  LV+E + +  L  +L +   P   +  I
Sbjct: 54  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETI 112

Query: 204 K-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           K +     +GL FLH  S  V++RD K  NIL+ S    KL+DFGLA+           T
Sbjct: 113 KDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALT 167

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
            VV T  Y APE ++     +  D++S G +  E+   +
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 77/290 (26%), Positives = 118/290 (40%), Gaps = 48/290 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-SLKPDGLQGHREWVAEVDF 152
            +     +GEG FG ++         A AK  S   V  +  L    ++       EV  
Sbjct: 1   RYEIIKKIGEGSFGKIY--------LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL 52

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH-------LFRRTIPLPWSNRIKI 205
           L ++ HPN+V       E+ +  +V E+   G L          LF     L W   ++I
Sbjct: 53  LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQI 110

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAKAGPQGDKTHVSTRV 264
           +LG    L  +H     +++RD K+ NI L      AKL DFG+A+     D   ++   
Sbjct: 111 SLG----LKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTC 162

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           VGT  Y +PE        +K+D++S G VL E+ T       K P    NL       L 
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT------LKHPFEGNNL-----HQLV 211

Query: 325 DK--RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            K  +  +  + P    N+S      +SQL        P+ RPS+  ++K
Sbjct: 212 LKICQGYFAPISP----NFSRDLRSLISQL----FKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 40/223 (17%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-----VAEVDFL 153
             +GEG +G V+K    +  T       G  VA+K ++   L   +E      + E+  L
Sbjct: 13  GQIGEGTYGQVYKA--RDKDT-------GELVALKKVR---LDNEKEGFPITAIREIKIL 60

Query: 154 GQLHHPNLVKLIGYCIEDDQRL----------LVYEFMTR---GSLENHLFRRTIPLPWS 200
            QL+H N+V L     +    L          LV+E+M     G LE+ L   +      
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS-----E 115

Query: 201 NRIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
           + IK       +GL + H   +  ++RD K SNILL+++   KL+DFGLA+     +   
Sbjct: 116 DHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
            + +V+ T  Y  PE ++       + DV+S G +L E+ T +
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 6e-13
 Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 43/294 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G  G VF               +G  VA+K +           + E+  + +L +PN
Sbjct: 27  IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V  +   +  D+  +V E++  GSL + +      +  +    +     + L FLH   
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHANQ 135

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
             VI+RD K+ N+LL  + + KL+DFG  A+  P+  K    + +VGT  + APE V   
Sbjct: 136 --VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRK 190

Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV---DPR 336
               K D++S G++ +E++ G      + P                 R LY I     P 
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENP----------------LRALYLIATNGTPE 234

Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV-----VKVLTPLQDLNDLAI 385
           L+    L  + +       CL  D + R S  E+     +K+  PL  L  L +
Sbjct: 235 LQNPEKLSPIFR--DFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLIL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK-PDGLQGH-----REWVAEVDF 152
           + +GEG +G V+K      G           VA+K ++ P   +G      RE +A +  
Sbjct: 5   AEIGEGAYGTVYKARDLNTGR---------FVALKKVRVPLSEEGIPLSTLRE-IALLKQ 54

Query: 153 LGQLHHPNLVKLIGYC--IEDDQRL---LVYEFMTRGSLENHLFRRTIP---LPWSNRIK 204
           L    HPN+V+L+  C     D+ L   LV+E + +   +   +    P   LP    IK
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLP-PETIK 110

Query: 205 -IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +     +G+ FLH  S  +++RD K  NIL+ S+   K++DFGLA+           T 
Sbjct: 111 DLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTS 165

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEI 297
           VV T  Y APE ++     +  D++S G +  E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 79/289 (27%), Positives = 117/289 (40%), Gaps = 51/289 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH-P 159
           +G G FG V K   + +GT  A      TV  K  K          + ++D + +    P
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQK--------RLLMDLDVVMRSSDCP 63

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI------KIALGAAKGL 213
            +VK  G    +    +  E M   SL+   F + +     + I      KIA+   K L
Sbjct: 64  YIVKFYGALFREGDCWICMELMDI-SLDK--FYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +L    + +I+RD K SNILLD   N KL DFG++    Q   +   TR  G   Y AP
Sbjct: 121 NYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAP 176

Query: 274 EYVMTGHLTS---KSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
           E +          +SDV+S G+ L E+ TG+    K     +Q               L 
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ---------------LT 221

Query: 331 QIVD---PRL----ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           Q+V    P L    E  +S   V  ++     CL +D   RP   E+++
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINL----CLIKDESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.5 bits (165), Expect = 9e-13
 Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 42/287 (14%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           LG+G F  ++KG    ++      PG  ++V +K L  D  +    +      + QL H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           +LVKL G C+  D+ ++V E++  G L+  L R    +    ++ +A   A  L +L   
Sbjct: 62  HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118

Query: 220 SEPVIYRDFKTSNILL-----DSEYN--AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
            + +++ +    NIL+     +  Y    KLSD G+        +     R+     + A
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----PWIA 172

Query: 273 PEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
           PE +  G   LT  +D +SFG  LLEI +           GE+ L   +     +K + Y
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSN----------GEEPLSTLSSS---EKERFY 219

Query: 331 QI--VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           Q     P  +         +++ L   C + DP  RPS   +++ L 
Sbjct: 220 QDQHRLPMPD-------CAELANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 28/215 (13%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           +LG+G FG V             + G+    A+K LK D +    +    + E   L   
Sbjct: 7   VLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL-----FRRTIPLPWSNRIKIALGAA 210
             P  +  +  C +   RL  V E++  G L   +     F+    + ++  I I     
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI----- 112

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            GL FLH  S+ +IYRD K  N++LDSE + K++DFG+ K       T  +    GT  Y
Sbjct: 113 -GLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDY 167

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD 305
            APE +         D ++FGV+L E+L G+   +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 35/212 (16%)

Query: 103 EGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-----WVAEVDFLGQLH 157
           EG +G V++    +  T       G  VA+K LK   ++  +E      + E++ L +L 
Sbjct: 15  EGTYGVVYRA--RDKKT-------GEIVALKKLK---MEKEKEGFPITSLREINILLKLQ 62

Query: 158 HPNLVKL----IGYCIEDDQRLLVYEFMT---RGSLENHLFRRTIPLPWSNRIKIALGAA 210
           HPN+V +    +G  +  D+  +V E++    +  +E        P   S    + L   
Sbjct: 63  HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM----KQPFLQSEVKCLMLQLL 116

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            G+A LH     +++RD KTSN+LL++    K+ DFGLA+    G      T++V T  Y
Sbjct: 117 SGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWY 172

Query: 271 AAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            APE ++     ++  D++S G +  E+LT +
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 20/206 (9%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVD-FLGQ 155
           ++G+G FG V     + +G+           AVK L+   +   +E    +AE +  L  
Sbjct: 2   VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52

Query: 156 LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           L HP LV L  Y  +  ++L  V +++  G L  HL R    L    R   A   A  + 
Sbjct: 53  LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LH  S  +IYRD K  NILLDS+ +  L+DFGL K G + ++T  ++   GT  Y APE
Sbjct: 111 YLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPE 166

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTG 300
            +         D +  G VL E+L G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 38/223 (17%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA---EV 150
           N+R   +LG G FG V+  +        A  G  + V      PD  +  +E  A   E+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCY-------DADTGRELAVKQVPFDPDSQETSKEVNALECEI 55

Query: 151 DFLGQLHHPNLVKLIGYCIED--DQRLLVY-EFMTRGSLENHL-----FRRTIPLPWSNR 202
             L  L H  +V+  G C+ D  +++L ++ E+M  GS+++ L         +   ++ +
Sbjct: 56  QLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ 114

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK------AGPQGD 256
           I       +G+++LH     +++RD K +NIL DS  N KL DFG +K          G 
Sbjct: 115 I------LQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           K+     V GT  + +PE +       K+DV+S    ++E+LT
Sbjct: 167 KS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 61/240 (25%), Positives = 99/240 (41%), Gaps = 41/240 (17%)

Query: 90  SATGNFRP-DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK----PDGLQGHR 144
           S +  +    + LGEG +G V K +    G           VA+K +K     + +   R
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGK---------IVAIKKVKIIEISNDVTKDR 55

Query: 145 EWVA----------EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT 194
           + V           E+  + ++ H N++ L+   +E D   LV + M    L+  +  R 
Sbjct: 56  QLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKK-VVDRK 113

Query: 195 IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK---- 250
           I L  S    I L    GL  LH      ++RD   +NI ++S+   K++DFGLA+    
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGY 171

Query: 251 ---AGPQGDKTHVSTRV-----VGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              +        +  R      V T  Y APE +M         D++S G +  E+LTG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 66/208 (31%), Positives = 91/208 (43%), Gaps = 22/208 (10%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLG-Q 155
           +LG+G FG V               G+    A+K LK D +    +    + E   L   
Sbjct: 2   VLGKGSFGKVMLA---------ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52

Query: 156 LHHPNLVKLIGYCIEDDQRLL-VYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGL 213
             HP L  L   C +   RL  V E++  G L   + R R    P S      +  A  L
Sbjct: 53  AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--L 109

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            FLH     VIYRD K  NILLD+E + KL+DFG+ K G     T  +T   GT  Y AP
Sbjct: 110 MFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAP 165

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           E +         D ++ GV++ E++ G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 75/274 (27%), Positives = 106/274 (38%), Gaps = 41/274 (14%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+GGFG V          A     +G   A K L    L   +G+   + E   L ++H
Sbjct: 1   LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH 51

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---GL 213
              +V L  Y  +    L LV   M  G L  H++      P     +     A+   GL
Sbjct: 52  SRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA---KAGPQGDKTHVSTRVVGTYGY 270
             LH     +IYRD K  N+LLD++ N ++SD GLA   K G    K +      GT G+
Sbjct: 111 EHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY-----AGTPGF 163

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            APE +         D ++ GV L E++  R      R  GE+            +R L 
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK-----VENKELKQRILN 215

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             V       Y  K            L++DP+ R
Sbjct: 216 DSV------TYPDKFSPASKSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 79/285 (27%), Positives = 120/285 (42%), Gaps = 45/285 (15%)

Query: 94  NFRPDSILGEGGFGYVF---KGWIEENGTAPA-KPGSGITVAVKSLKPDGLQGHR---EW 146
           NF    +LG G +G VF   K    ++G   A K     T+  K+   +  +  R   E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
           + +  FL  LH         Y  + D +L L+ +++  G L  HL +R         ++I
Sbjct: 61  IRQSPFLVTLH---------YAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQI 109

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
             G    LA  H     +IYRD K  NILLDS  +  L+DFGL+K   + D+   +    
Sbjct: 110 YSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFC 167

Query: 266 GTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG----------------RRSMDK 306
           GT  Y AP+ V     GH     D +S GV++ E+LTG                 R + K
Sbjct: 168 GTIEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK 226

Query: 307 KRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQ 351
             P   Q + A A+  +  +R L  + DP+  L        ++ +
Sbjct: 227 SEPPYPQEMSALAKDII--QRLL--MKDPKKRLGCGPSDADEIKK 267

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 66/208 (31%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           +LG+G FG V    + E  T       G   A+K L+ + +    E    V E   L   
Sbjct: 2   LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52

Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA--AKGL 213
            HP L  L  Y  +   RL  V E+   G L  HL R  +      R     GA     L
Sbjct: 53  RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSAL 108

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH  S  V+YRD K  N++LD + + K++DFGL K G     T  +    GT  Y AP
Sbjct: 109 EYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           E +         D +  GVV+ E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 74/299 (24%), Positives = 127/299 (42%), Gaps = 58/299 (19%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGIT-VAVKSLKPD-GLQGHREWVAEVDFLGQLHH 158
           +G G FG V    I           +G+  V VK LK +   +   E++ + D    L H
Sbjct: 3   IGNGWFGKVLLSEI--------YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR-------IKIALGAAK 211
           PN+++ +G C+E    LLV+E+   G L+++L +      W  R        ++A   A 
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQ----WHRRNSQLLLLQRMACEIAA 110

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  +H      ++ D    N  L S+   K+ D+G+  +  + D             + 
Sbjct: 111 GVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168

Query: 272 APEYV-------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           APE V       +T   T  S+V++ GV L E+       +  +P            +L+
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQPY----------SHLS 213

Query: 325 DKRKLYQIV--------DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           D+  L  ++         P+LEL YS +  + V Q  +  LS  P+ R + +EV ++LT
Sbjct: 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYE-VLQFCW--LS--PEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 36/224 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA---EV 150
           N+R   +LG+G FG V+  +        A  G  + V      P+  +  +E  A   E+
Sbjct: 3   NWRLGKLLGQGAFGRVYLCY-------DADTGRELAVKQVQFDPESPETSKEVNALECEI 55

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLL--VYEFMTRGSLENHL-----FRRTIPLPWSNRI 203
             L  L H  +V+  G   +  +R L    E M  GS+++ L         +   ++ +I
Sbjct: 56  QLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI 115

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA------GPQGDK 257
                  +G+++LH  S  +++RD K +NIL DS  N KL DFG +K          G K
Sbjct: 116 ------LEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167

Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           +     V GT  + +PE +       K+D++S G  ++E+LT +
Sbjct: 168 S-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 65/223 (29%), Positives = 95/223 (42%), Gaps = 36/223 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL------QGHR--- 144
           NF    +LG G +G VF   +    T       G   A+K L+   L        H    
Sbjct: 1   NFELLKVLGTGAYGKVF---LVRKVTGHDT---GKLYAMKVLQKAALVQKAKTVEHTRTE 54

Query: 145 ----EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPW 199
               E V +  FL  LH         Y  + + +L L+ ++++ G +  HL++R      
Sbjct: 55  RNVLEHVRQSPFLVTLH---------YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED 105

Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
             R          LA  H     ++YRD K  NILLDSE +  L+DFGL+K     +K  
Sbjct: 106 EVRF---YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162

Query: 260 VSTRVVGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEILTG 300
             +   GT  Y APE +    GH     D +S G+++ E+LTG
Sbjct: 163 TYS-FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.3 bits (161), Expect = 5e-12
 Identities = 65/208 (31%), Positives = 92/208 (44%), Gaps = 23/208 (11%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           +LG+G FG V    + E         SG   A+K LK + +    E    + E   L   
Sbjct: 2   LLGKGTFGKVI--LVREKA-------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52

Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA--AKGL 213
            HP L  L  Y  +   RL  V E++  G L  HL R  +   +S       GA     L
Sbjct: 53  RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERV---FSEDRTRFYGAEIVSAL 108

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH G   ++YRD K  N++LD + + K++DFGL K G     T  +    GT  Y AP
Sbjct: 109 DYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAP 164

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           E +         D +  GVV+ E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 79/279 (28%), Positives = 113/279 (40%), Gaps = 57/279 (20%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           +LG+G FG V    + E  T       G   A+K LK + +    E    + E   L   
Sbjct: 2   LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52

Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLP----WSNRIKIALGAA 210
            HP L  L  Y  +   RL  V E+   G L  HL R R         +   I  ALG  
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG-- 109

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVSTRVVGTYG 269
               +LH  S  V+YRD K  N++LD + + K++DFGL K G   G          GT  
Sbjct: 110 ----YLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPE 160

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           Y APE +         D +  GVV+ E++ GR                    Y  D  KL
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKL 203

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLS----RDPKSR 364
           ++++     L   ++  + +S  A + L+    +DPK R
Sbjct: 204 FELI-----LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 84/308 (27%), Positives = 125/308 (40%), Gaps = 55/308 (17%)

Query: 85  FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR 144
            + L   T  +     +G+G +G V+K           K GS    AVK L P       
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYK-------VTNKKDGS--LAAVKILDPIS-DVDE 63

Query: 145 EWVAEVDFLGQL-HHPNLVKLIGYCIEDD-----QRLLVYEFMTRGS---LENHLFRRTI 195
           E  AE + L  L +HPN+VK  G   + D     Q  LV E    GS   L   L     
Sbjct: 64  EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
            L  +    I  GA  GL  LH     +I+RD K +NILL +E   KL DFG++      
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVS------ 175

Query: 256 DKTHVSTRV-----VGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEILTGRRSMD 305
                STR+     VGT  + APE +           ++ DV+S G+  +E+  G   + 
Sbjct: 176 -AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234

Query: 306 KKRPSGEQNLVAWARQYLADKRKLYQIV-DPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
              P                 + L++I  +P   L +  K  +  +     CL +D ++R
Sbjct: 235 DMHPV----------------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEAR 278

Query: 365 PSMDEVVK 372
           PS+  +++
Sbjct: 279 PSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 43/218 (19%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G VFK    E         +   VA+K ++   L    E V      E+  L +
Sbjct: 8   IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 55

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFM----------TRGSLENHLFRRTIPLPWSNRIKI 205
           L H N+V+L      D +  LV+E+             G ++  + +             
Sbjct: 56  LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK-----------SF 104

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
                KGLAF H  S  V++RD K  N+L++     KL+DFGLA+A     + + S  VV
Sbjct: 105 MFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV 161

Query: 266 GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRR 302
            T  Y  P+ +    L S S D++S G +  E+    R
Sbjct: 162 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 65.7 bits (160), Expect = 7e-12
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G  G V+        TA     +G  VA+K +           + E+  + +  HPN
Sbjct: 27  IGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL---GAAKGLAFLH 217
           +V  +   +  D+  +V E++  GSL + +    +     +  +IA       + L FLH
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLH 132

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
             S  VI+RD K+ NILL  + + KL+DFG  A+  P+  K    + +VGT  + APE V
Sbjct: 133 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVV 187

Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
                  K D++S G++ +E++ G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 84/308 (27%), Positives = 129/308 (41%), Gaps = 63/308 (20%)

Query: 88  LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV 147
           L+   G F    ++G G +G V+KG             +G   A+K +   G +   E  
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTGDE-EEEIK 50

Query: 148 AEVDFLGQL-HHPNLVKLIGYCIE------DDQRLLVYEFMTRGSLENHLFRRTIPLPWS 200
            E++ L +  HH N+    G  I+      DDQ  LV EF   GS+ + L + T      
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTK----G 105

Query: 201 NRIK------IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
           N +K      I     +GL+ LH     VI+RD K  N+LL      KL DFG++    Q
Sbjct: 106 NTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---Q 160

Query: 255 GDKTHVSTR--VVGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEILTGRRSMDKK 307
            D+T V  R   +GT  + APE +            KSD++S G+  +E+  G   +   
Sbjct: 161 LDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Query: 308 RPSGEQNLVAWARQYLADKRKLYQIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
            P                 R L+ I     PRL+   S K  +K      +CL ++   R
Sbjct: 220 HP----------------MRALFLIPRNPAPRLK---SKKWSKKFQSFIESCLVKNHSQR 260

Query: 365 PSMDEVVK 372
           P+ ++++K
Sbjct: 261 PTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 61/206 (29%), Positives = 88/206 (42%), Gaps = 25/206 (12%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLH 157
           LG G FG V          A  K      VA+K  +   +   ++     +E   L  ++
Sbjct: 38  LGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HP  V L G   ++    LV EF+  G     L RR    P  N +     A   L F +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFP--NDVGCFYAAQIVLIFEY 146

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPE 274
             S  ++YRD K  N+LLD +   K++DFG AK         V TR   + GT  Y APE
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAPE 198

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTG 300
            ++       +D ++ G+ + EIL G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 78/274 (28%), Positives = 113/274 (41%), Gaps = 46/274 (16%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           +LG+G FG V    ++E  T       G   A+K LK + +    E    + E   L   
Sbjct: 2   LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52

Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA--AKGL 213
            HP L  L  Y  +   RL  V E+   G L  HL R  +   +S       GA     L
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 108

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH     V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y AP
Sbjct: 109 DYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 165

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +         D +  GVV+ E++ GR                    Y  D  KL++++
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFELI 208

Query: 334 ---DPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
              + R     S +    +S L    L +DPK R
Sbjct: 209 LMEEIRFPRTLSPEAKSLLSGL----LKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 56/154 (36%), Positives = 76/154 (49%), Gaps = 17/154 (11%)

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           LA  H  S+ +I+RD K++NILL S    KL DFG +K         V     GT  Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
           PE       + K+D++S GV+L E+LT +R  D     GE N+     + LA +      
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLAGR------ 261

Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
            DP L  + S +  + V+ L    LS DPK RPS
Sbjct: 262 YDP-LPPSISPEMQEIVTAL----LSSDPKRRPS 290

Length = 496

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 34/268 (12%)

Query: 125 GSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG 184
            +G  VA++ +           + E+  + +  +PN+V  +   +  D+  +V E++  G
Sbjct: 43  ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102

Query: 185 SLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS 244
           SL + +      +       +     + L FLH  S  VI+RD K+ NILL  + + KL+
Sbjct: 103 SLTDVVTETC--MDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLT 158

Query: 245 DFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS 303
           DFG  A+  P+  K    + +VGT  + APE V       K D++S G++ +E++ G   
Sbjct: 159 DFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Query: 304 MDKKRPSGEQNLVAWARQYLADKRKLYQIV---DPRLELNYSLKGVQKVSQLAYNCLSRD 360
              + P                 R LY I     P L+    L  + +       CL  D
Sbjct: 216 YLNENPL----------------RALYLIATNGTPELQNPEKLSAIFR--DFLNRCLDMD 257

Query: 361 PKSRPSMDEV-----VKVLTPLQDLNDL 383
            + R S  E+     +K+  PL  L  L
Sbjct: 258 VEKRGSAKELLQHQFLKIAKPLSSLTPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 85/308 (27%), Positives = 128/308 (41%), Gaps = 63/308 (20%)

Query: 88  LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV 147
           L+   G F    ++G G +G V+KG          K G    + V  +  D      E  
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTEDE---EEEIK 60

Query: 148 AEVDFLGQL-HHPNLVKLIGYCIE------DDQRLLVYEFMTRGSLENHLFRRTIPLPWS 200
            E++ L +  HH N+    G  I+      DDQ  LV EF   GS+ + L + T      
Sbjct: 61  LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTK----G 115

Query: 201 NRIK------IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
           N +K      I     +GLA LH  +  VI+RD K  N+LL      KL DFG++    Q
Sbjct: 116 NALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---Q 170

Query: 255 GDKTHVSTR--VVGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEILTGRRSMDKK 307
            D+T V  R   +GT  + APE +            +SD++S G+  +E+  G   +   
Sbjct: 171 LDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Query: 308 RPSGEQNLVAWARQYLADKRKLYQI---VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
            P                 R L+ I     P+L+   S K  +K       CL ++  SR
Sbjct: 230 HP----------------MRALFLIPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSR 270

Query: 365 PSMDEVVK 372
           PS ++++K
Sbjct: 271 PSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.4 bits (156), Expect = 2e-11
 Identities = 70/270 (25%), Positives = 113/270 (41%), Gaps = 34/270 (12%)

Query: 125 GSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG 184
            +G  VA+K +           + E+  + +  +PN+V  +   +  D+  +V E++  G
Sbjct: 42  ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101

Query: 185 SLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS 244
           SL + +      +       +     + L FLH  S  VI+RD K+ NILL  + + KL+
Sbjct: 102 SLTDVVTETC--MDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLT 157

Query: 245 DFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS 303
           DFG  A+  P+  K    + +VGT  + APE V       K D++S G++ +E++ G   
Sbjct: 158 DFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Query: 304 MDKKRPSGEQNLVAWARQYLADKRKLYQIV---DPRLELNYSLKGVQKVSQLAYNCLSRD 360
              + P                 R LY I     P L+    L  V +       CL  D
Sbjct: 215 YLNENP----------------LRALYLIATNGTPELQNPERLSAVFR--DFLNRCLEMD 256

Query: 361 PKSRPSMDEV-----VKVLTPLQDLNDLAI 385
              R S  E+     +K+  PL  L  L I
Sbjct: 257 VDRRGSAKELLQHPFLKLAKPLSSLTPLII 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL +LH  S  +++RD K  N+L++S    K+ DFGLA+     +  H++  VV  Y Y
Sbjct: 114 RGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170

Query: 271 AAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            APE +M + H TS  D++S G +  E+L  R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG+G +G V+                 + +A+K +     +  +    E+     L H 
Sbjct: 15  VLGKGTYGIVYAARDLSTQ---------VRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA--KGLAFLH 217
           N+V+ +G   E+    +  E +  GSL   L  +  PL  + +  I       +GL +LH
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 218 GGSEPVIYRDFKTSNILLDSEYNA--KLSDFG----LAKAGPQGDKTHVSTRVVGTYGYA 271
                +++RD K  N+L+++ Y+   K+SDFG    LA   P       +    GT  Y 
Sbjct: 126 --DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYM 176

Query: 272 APEYVMTGH--LTSKSDVYSFGVVLLEILTGR 301
           APE +  G     + +D++S G  ++E+ TG+
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 101 LGEGGFGYVFKGW--IEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLH 157
           LGEG +  VFKG   + EN            VA+K ++ +  +G     + EV  L  L 
Sbjct: 14  LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL-GAAKGLAFL 216
           H N+V L      D    LV+E++ +  L+ ++      +   N +KI L    +GLA+ 
Sbjct: 63  HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHN-VKIFLYQILRGLAYC 120

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           H     V++RD K  N+L++     KL+DFGLA+A     KT+ S  VV T  Y  P+ +
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVL 176

Query: 277 M-TGHLTSKSDVYSFGVVLLEILTGR 301
           + +   +++ D++  G +  E+ +GR
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 21/162 (12%)

Query: 149 EVDFLGQLHHPNLVKLIGYC-IEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN----R 202
           E D +   + P +V+L  +C  +DD+ L +V E+M  G L N +    +P  W+      
Sbjct: 93  ERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAE 150

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           + +AL A   +  +H        RD K  N+LLD   + KL+DFG      +       T
Sbjct: 151 VVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202

Query: 263 RVVGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEILTG 300
             VGT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 203 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 77/298 (25%), Positives = 131/298 (43%), Gaps = 67/298 (22%)

Query: 101 LGEGGFGYVFKGWI------EENGTAPAKPGSGITVAVKSLKPDGLQGHRE----WVAEV 150
           LG G    ++ G +      E++G +  K    I V +K L P     HR+    +    
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKE---IKVILKVLDP----SHRDISLAFFETA 55

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPL--PWSNRIKIALG 208
             + Q+ H ++V L G C+ D + ++V EF+  G L+  + R++  L  PW  + K+A  
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQ 113

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILL-----DSEYNA--KLSDFGLAKAGPQGDKTHVS 261
            A  L++L    + +++ +  T NILL     D E     KLSD G+           V 
Sbjct: 114 LASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVL 163

Query: 262 TR--VVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW 318
           +R   V    + APE V  + +L+  +D +SFG  L EI            +GE  L   
Sbjct: 164 SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPL--- 210

Query: 319 ARQYLADKRKLY----QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             + LA+K + Y     +V P           ++++ L  +C++ DP  RP    +++
Sbjct: 211 KDKTLAEKERFYEGQCMLVTP---------SCKELADLMTHCMNYDPNQRPFFRAIMR 259

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 67/254 (26%), Positives = 101/254 (39%), Gaps = 67/254 (26%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEV-- 150
           +F    ++G G FG V             K  +G   A+K L K + L+  +E VA V  
Sbjct: 2   DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50

Query: 151 --DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKI-- 205
             D L +  +P +VKL  Y  +D+  L L+ E++  G +   L ++        R  I  
Sbjct: 51  ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109

Query: 206 ---ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL-------------- 248
              A+ +   L ++H        RD K  N+LLD++ + KLSDFGL              
Sbjct: 110 TILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161

Query: 249 --AKAGP------------QGDKTHVSTR--------VVGTYGYAAPEYVMTGHLTSKSD 286
             + A P               K     R         VGT  Y APE  +      + D
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221

Query: 287 VYSFGVVLLEILTG 300
            +S GV++ E+L G
Sbjct: 222 WWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 19/161 (11%)

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN----RI 203
           E D +   +   +V+L  Y  +DD+ L +V E+M  G L N +    IP  W+      +
Sbjct: 93  ERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEV 151

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +AL A   + F+H        RD K  N+LLD   + KL+DFG              T 
Sbjct: 152 VLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT- 202

Query: 264 VVGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEILTG 300
            VGT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 61/214 (28%), Positives = 88/214 (41%), Gaps = 42/214 (19%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH---REWVAEVDFLGQLH 157
           +G+GG+G VF            K  +G  VA+K +K   L      R  + E D L    
Sbjct: 9   VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFM----------TRGSLENHLFRRTIPLPWSNRIKIA 206
              LVKL+ Y  +DD+ L L  E++            G L     R  +       +  A
Sbjct: 60  SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA-----EMFEA 113

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           + A   L ++H        RD K  N L+D+  + KL+DFGL+K          +  VVG
Sbjct: 114 VDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVG 160

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           +  Y APE +         D +S G +L E L G
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 31/230 (13%)

Query: 149 EVDFLGQLHHPNLVKLI-GYCIEDDQRLLVYEFMTRGSLENHLF-RRTIPLPWSNRIKIA 206
           E   L QL HPN+V     +  ED    +V  F   G L + L  ++   LP +  ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           +  A  L +LH   + +++RD KT N+ L      K+ D G+A+     ++  +++ ++G
Sbjct: 109 VQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIG 164

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
           T  Y +PE         KSDV++ G  + E+ T + + + K                 D 
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----------------DM 207

Query: 327 RKL-YQIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             L Y+I++   P +  +YS     ++ +L    LS+ P+ RPS+  +++
Sbjct: 208 NSLVYRIIEGKLPPMPKDYS----PELGELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 8/130 (6%)

Query: 172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTS 231
           D+   + + M  G L  HL +  +   +S        A   L   H  +  V+YRD K +
Sbjct: 70  DKLSFILDLMNGGDLHYHLSQHGV---FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPA 126

Query: 232 NILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSF 290
           NILLD   + ++SD GLA       K H S   VGT+GY APE +  G    S +D +S 
Sbjct: 127 NILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSL 182

Query: 291 GVVLLEILTG 300
           G +L ++L G
Sbjct: 183 GCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 51/149 (34%), Positives = 69/149 (46%), Gaps = 5/149 (3%)

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            L  + HP LV L       D+   V +++  G L  HL R    L    R   A   A 
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIAS 107

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
            L +LH  S  ++YRD K  NILLDS+ +  L+DFGL K   + + T  ++   GT  Y 
Sbjct: 108 ALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYL 163

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE +         D +  G VL E+L G
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.3 bits (152), Expect = 8e-11
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 39/213 (18%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL---- 156
           +GEG F  V K    + G            A+K +K      H + + +V+ L ++    
Sbjct: 7   IGEGTFSEVLKAQSRKTGK---------YYAIKCMK-----KHFKSLEQVNNLREIQALR 52

Query: 157 ---HHPNLVKLIGYCIEDDQ--RL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL-GA 209
               HPN+++LI   + D +  RL LV+E M   +L   +  R  PLP   R+K  +   
Sbjct: 53  RLSPHPNILRLIE-VLFDRKTGRLALVFELMD-MNLYELIKGRKRPLP-EKRVKSYMYQL 109

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVGT 267
            K L  +H     + +RD K  NIL+  +   KL+DFG  +          ++STR    
Sbjct: 110 LKSLDHMHRNG--IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR---- 162

Query: 268 YGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILT 299
             Y APE ++T G+   K D+++ G V  EIL+
Sbjct: 163 -WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 68/220 (30%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
           +AE   L Q++ P +V L  +  +  ++L LV  F+  G L +HL R         R   
Sbjct: 41  LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT 99

Query: 206 A-LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           A L  A  L  LH     VIYRD K  NILLD + +  L DFGL K   + D    +   
Sbjct: 100 AELLCA--LENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTF 153

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y APE ++    T   D ++ GV+L E+LTG        P  ++N+    R+ L 
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL------PPFYDENVNEMYRKILQ 207

Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           +  +     D            +    L    LSRDP  R
Sbjct: 208 EPLRFPDGFD------------RDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 101 LGEGGFGYVFKGW--IEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLH 157
           LGEG +  VFKG   + EN            VA+K ++ +  +G     + EV  L  L 
Sbjct: 13  LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKNLK 61

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H N+V L      +    LV+E++    L+ +L      +   N         +GL++ H
Sbjct: 62  HANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                +++RD K  N+L++ +   KL+DFGLA+A     KT+ S  VV T  Y  P+ ++
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLL 176

Query: 278 -TGHLTSKSDVYSFGVVLLEILTGR 301
            +   ++  D++  G +L E+ TGR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQL 156
           I+G GGFG V+            K  +G   A+K L    +   QG    + E   L  +
Sbjct: 1   IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51

Query: 157 HH---PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
                P +V +       D+   + + M  G L  HL +  +   +S +          L
Sbjct: 52  STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---FSEKEMRFYATEIIL 108

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
              H  +  V+YRD K +NILLD   + ++SD GLA       K H S   VGT+GY AP
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAP 164

Query: 274 EYVMTG-HLTSKSDVYSFGVVLLEILTG 300
           E +  G    S +D +S G +L ++L G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 33/287 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHP 159
           +G G FG V  G +  +G  PA+      V VK L+    +Q   +++ E      L H 
Sbjct: 3   IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRI--KIALGAAKGLAF 215
           NL++ +G C E    LLV EF   G L+ +L   R+   +        ++A   A GL  
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           LH  +   I+ D    N LL ++   K+ D+GL+    + D      ++     + APE 
Sbjct: 116 LHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 276 VMTGH-------LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
           V   H        T +S+V+S GV + E+     S   +  S EQ L      Y   +++
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFE-LGSQPYRHLSDEQVLT-----YTVREQQ 227

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           L ++  PRL+L  S +  + V Q  +      P+ RPS +EV  +L+
Sbjct: 228 L-KLPKPRLKLPLSDRWYE-VMQFCW----LQPEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 19/161 (11%)

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN----RI 203
           E D +   + P +V+L  Y  +DD+ L +V E+M  G L N +    +P  W+      +
Sbjct: 93  ERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 151

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +AL A   + F+H        RD K  N+LLD   + KL+DFG      +       T 
Sbjct: 152 VLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT- 202

Query: 264 VVGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEILTG 300
            VGT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 53/235 (22%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP--DGLQGHREWVAEVD 151
            ++P   +G G +G V    I+          SG  VA+K +    D     +  + E+ 
Sbjct: 6   RYKPIENIGSGAYGVVCSA-IDTR--------SGKKVAIKKIPHAFDVPTLAKRTLRELK 56

Query: 152 FLGQLHHPNLVKLIGYCIEDDQR---------LLVYEFM---------TRGSLENHLFRR 193
            L    H N++      I D  R          +V + M         +   L     R 
Sbjct: 57  ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111

Query: 194 TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--A 251
            +               +GL ++H  S  VI+RD K SN+L++ +   ++ DFG+A+  +
Sbjct: 112 FL-----------YQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158

Query: 252 GPQGDKTHVSTRVVGTYGYAAPE--YVMTGHLTSKSDVYSFGVVLLEILTGRRSM 304
               +  +  T  V T  Y APE    +  + T+  D++S G +  E+L GRR +
Sbjct: 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 21/159 (13%)

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-TIPLP----WSNRIKIALGAAKGL 213
           PN+V L  Y + +D   LV +    G L +H+ +   IP      W+  + +AL A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG-LAKAGPQGDKTHVSTRVVGTYGYAA 272
             LH   E ++ RD   +NILLD   + +L+ F   ++     D   V         Y A
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG 311
           PE       T   D +S G +L E+LTG +++ +  PSG
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 40/216 (18%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP--DGLQGHREWVAEVDFLGQLH 157
           +G G +G V          A     +G  VA+K L +P    +   R +  E+  L  + 
Sbjct: 23  VGSGAYGQVCS--------AFDT-KTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMD 72

Query: 158 HPNLVKLI-----GYCIED-DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK-IALGAA 210
           H N++ L+        +ED     LV   M    L N +  +   L   + I+ +     
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIV--KCQKLS-DDHIQFLVYQIL 128

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK---THVSTRVVGT 267
           +GL ++H  S  +I+RD K SNI ++ +   K+ DFGLA+     D     +V+TR    
Sbjct: 129 RGLKYIH--SAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVATR---- 179

Query: 268 YGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGR 301
             Y APE +M    H     D++S G ++ E+LTG+
Sbjct: 180 -WYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 49/281 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLHHP 159
           LG+G +G V+K           +P +G+T+A+K ++ +  +    + + E+D L +   P
Sbjct: 9   LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLEN----HLFRRTIPLPWSNRIKIALGAAKGLAF 215
            +V   G    +    +  E+M  GSL+      +    IP     RI  A+   KGL F
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV--VKGLKF 117

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD-KTHVSTRVVGTYGYAAPE 274
           L      +I+RD K +N+L++     KL DFG++     G+    ++   +G   Y APE
Sbjct: 118 LKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171

Query: 275 YVMTGHL------TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +G        T +SDV+S G+ +LE+  GR       P    N+ A          +
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFA----------Q 218

Query: 329 LYQIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
           L  IVD   P L   YS      V++    CL++ P  RP+
Sbjct: 219 LSAIVDGDPPTLPSGYSDDAQDFVAK----CLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 34/160 (21%)

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           LA  H     ++YRD K  NILLD+  +  L DFGL+KA    +KT  +    GT  Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLA 164

Query: 273 PEYVM--TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
           PE ++   G+ T   D +S GV++ E+  G                 W+  Y  D +++Y
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQMY 206

Query: 331 QIVD------PRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           + +       P+  L  S +G Q V  L    L+R+P+ R
Sbjct: 207 RNIAFGKVRFPKNVL--SDEGRQFVKGL----LNRNPQHR 240

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 14/180 (7%)

Query: 126 SGITVAVKSL-KPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMT 182
           +G  VA+K + KP       +    E+  L  L H N++ L    I   + +  V E + 
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92

Query: 183 RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK 242
               + H    + PL             +GL ++H  S  V++RD K SNIL++   + K
Sbjct: 93  --GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLK 148

Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGR 301
           + DFGLA+        +VSTR      Y APE ++T      + D++S G +  E+L G+
Sbjct: 149 ICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 48/179 (26%), Positives = 86/179 (48%), Gaps = 14/179 (7%)

Query: 126 SGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGS 185
           SG  VAVK +     Q       EV  +    H N+V++    +  ++  ++ EF+  G+
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 186 LENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD 245
           L + +      L       +     + L +LH  S+ VI+RD K+ +ILL  +   KLSD
Sbjct: 105 LTDIV--SQTRLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSD 160

Query: 246 FG----LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           FG    ++K  P+         +VGT  + APE +      ++ D++S G++++E++ G
Sbjct: 161 FGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 56/200 (28%), Positives = 80/200 (40%), Gaps = 48/200 (24%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPA---------KPGSGITVAVKSLKPDGLQGHREWVAE 149
           + +G+G FG VFK   ++     A         K G  IT    +L+            E
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT----ALR------------E 61

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQR--------LLVYEFMTR---GSLENHLFRRTIPLP 198
           +  L  L H N+V LI  C               LV+EF      G L N   + T+   
Sbjct: 62  IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS-- 119

Query: 199 WSNRIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ--- 254
               IK +      GL ++H     +++RD K +NIL+  +   KL+DFGLA+A      
Sbjct: 120 ---EIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174

Query: 255 GDKTHVSTRVVGTYGYAAPE 274
                 + RVV T  Y  PE
Sbjct: 175 SKPNRYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 33/231 (14%)

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL----LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
           E+  L ++   N++K+ G+ I+    L    L+ E+ TRG L   L  +   L +  ++ 
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLD 126

Query: 205 IALGAAKGLAFLHG-GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
           +A+   KGL  L+   ++P  Y++  + + L+   Y  K+   GL K        +V+  
Sbjct: 127 MAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184

Query: 264 VVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
           V     Y + + +       T K D+YS GVVL EI TG+   +                
Sbjct: 185 V-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN--------------- 224

Query: 322 YLADKRKLYQ-IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
                +++Y  I++    L   L    ++  +   C S D   RP++ E++
Sbjct: 225 --LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 20/205 (9%)

Query: 101 LGEGGFGYVFKGW--IEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLH 157
           LGEG +  V+KG   + +N            VA+K ++ +  +G     + EV  L  L 
Sbjct: 14  LGEGTYATVYKGRSKLTDN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H N+V L      +    LV+E++ +  L+ +L      +   N         +GL + H
Sbjct: 63  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                V++RD K  N+L++     KL+DFGLA+A     KT+ S  VV T  Y  P+ ++
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWYRPPDILL 177

Query: 278 -TGHLTSKSDVYSFGVVLLEILTGR 301
            +   +++ D++  G +  E+ TGR
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 20/226 (8%)

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIA 206
           +E+  L    H  +VK       DD+ LL+ E+ + G L   + +R    LP+       
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           L     LA     S  +++RD K++NI L      KL DFG +K         V++   G
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
           T  Y APE       + K+D++S GV+L E+LT  R    K PS  + +          +
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF--KGPSQREIM----------Q 281

Query: 327 RKLYQIVDP-RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           + LY   DP    ++  +K +          LS++P  RP+  +++
Sbjct: 282 QVLYGKYDPFPCPVSSGMKALLD------PLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.7 bits (142), Expect = 9e-10
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 49/293 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR----EWVAEVDFLGQL 156
           LG+G F  +FKG   E G       + + + V          HR     +      + QL
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS------HRNYSESFFEAASMMSQL 56

Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR--TIPLPWSNRIKIALGAAKGLA 214
            H +LV   G C+  D+ ++V E++  GSL+ +L +    I + W  ++++A   A  L 
Sbjct: 57  SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALH 114

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYGYAA 272
           FL      + + +    N+LL  E + K  +    K    G    V  +  ++    +  
Sbjct: 115 FLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVP 172

Query: 273 PEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           PE +    +L+  +D +SFG  L EI +G          G++ L A     L  ++KL Q
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG----------GDKPLSA-----LDSQKKL-Q 216

Query: 332 IVDPRLELNYSLKGVQKVSQLAY---NCLSRDPKSRPSMDEVVKVLTPLQDLN 381
             + R +L        K ++LA     C+  +P  RPS   +++      DLN
Sbjct: 217 FYEDRHQLP-----APKWTELANLINQCMDYEPDFRPSFRAIIR------DLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 28/179 (15%)

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK---AGPQGDKTHVSTRVVGTY 268
           GL ++H  S  V++RD K  N+L++++   K+ DFGLA+     P  +   + T  V T 
Sbjct: 117 GLKYIH--SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173

Query: 269 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ-NLVAWARQYLA-- 324
            Y APE +++    +K+ DV+S G +L E+L GR+ + K +   +Q N +    Q L   
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQIL---QVLGTP 229

Query: 325 DKRKLYQIVDPR-LELNYSLKGVQKV---------SQLAYNCLSR----DPKSRPSMDE 369
           D+  L +I  P+      SL  + K          + LA + L +    DP  R S++E
Sbjct: 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE 288

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 64/276 (23%), Positives = 118/276 (42%), Gaps = 32/276 (11%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G +G V+K              +G   A+K +K +  +       E+  +    H N
Sbjct: 17  IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V   G  +  D+  +  EF   GSL++ ++  T PL  S    ++    +GL +LH  S
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH--S 124

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR-VVGTYGYAAPEYVMT- 278
           +  ++RD K +NILL    + KL+DFG++    Q   T    +  +GT  + APE     
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 279 --GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
             G      D+++ G+  +E+   +  M    P          R      +  +Q   P+
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHP---------MRALFLMTKSNFQ--PPK 230

Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           L+    +K            L+++PK RP+ +++++
Sbjct: 231 LK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 73/320 (22%), Positives = 117/320 (36%), Gaps = 82/320 (25%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG----HREWVAEVDFLGQ 155
           ++G+GG G V+  +          P     VA+K ++ D L       + ++ E      
Sbjct: 9   LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFM--TRGSLENHLFRRTI---PLPWSNRIKIALGA- 209
           L HP +V +  Y I  D    VY  M    G     L +       L      K ++GA 
Sbjct: 59  LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 210 -------AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA------------- 249
                     + ++H  S+ V++RD K  NILL       + D+G A             
Sbjct: 116 LSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 250 KAGPQGDKTHVST---RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT------- 299
               +       T   ++VGT  Y APE ++    +  +D+Y+ GV+L ++LT       
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233

Query: 300 --GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCL 357
             GR+   +                          V P  E+   L      SQ+A   L
Sbjct: 234 KKGRKISYRDVILSPIE------------------VAPYREIPPFL------SQIAMKAL 269

Query: 358 SRDPKSR-PSMDEVVKVLTP 376
           + DP  R  S+ E+ + L P
Sbjct: 270 AVDPAERYSSVQELKQDLEP 289

Length = 932

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 16/220 (7%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHP 159
           LGEG +  V+KG    NG           VA+K +     +G     + E   L  L H 
Sbjct: 13  LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N+V L       +    V+E+M    L  ++ +    L   N         +GLA++HG 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG- 121

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-T 278
            + +++RD K  N+L+      KL+DFGLA+A     +T+ S+ VV T  Y  P+ ++  
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY-SSEVV-TLWYRPPDVLLGA 178

Query: 279 GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW 318
              +S  D++  G + +E+L G+ +        EQ    W
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 23/185 (12%)

Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
           PL   + I  +   A+G+ FL   S   I+RD    NILL      K+ DFGLA+     
Sbjct: 170 PLTMEDLICYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYK 226

Query: 256 DKTHV---STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE 312
           D  +V   S R+     + APE +     T++SDV+SFGV+L EI     S+      G 
Sbjct: 227 DPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF----SLGASPYPGV 280

Query: 313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           Q    +  Q L D  ++     P            ++ ++   C   DPK RP+   +V+
Sbjct: 281 QINEEFC-QRLKDGTRMRA---PEN-------ATPEIYRIMLACWQGDPKERPTFSALVE 329

Query: 373 VLTPL 377
           +L  L
Sbjct: 330 ILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 38/185 (20%)

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS-TRVVGTYG 269
           + L ++H  +  V +RD K  NIL +++   K+ DFGLA+       T +  T  V T  
Sbjct: 114 RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 270 YAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKK--------------RPSGEQ 313
           Y APE   +     T   D++S G +  E+LTG+     K               PS E 
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231

Query: 314 NLVAW-----ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR----DPKSR 364
             ++      AR+YL+  RK       +  + +S K       LA   L R    DPK R
Sbjct: 232 --ISRVRNEKARRYLSSMRK-------KQPVPFSQK-FPNADPLALRLLERLLAFDPKDR 281

Query: 365 PSMDE 369
           P+ +E
Sbjct: 282 PTAEE 286

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 78/287 (27%), Positives = 119/287 (41%), Gaps = 45/287 (15%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HP 159
           +G+G +G VFK   ++NG+           AVK L P       E  AE + L  L  HP
Sbjct: 26  IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIH-DIDEEIEAEYNILKALSDHP 75

Query: 160 NLVKLIG-YCIED----DQRLLVYEFMTRGS---LENHLFRRTIPLPWSNRIKIALGAAK 211
           N+VK  G Y  +D    DQ  LV E    GS   L     +R   +       I   A  
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           GL  LH      I+RD K +NILL +E   KL DFG+  +             VGT  + 
Sbjct: 136 GLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGV--SAQLTSTRLRRNTSVGTPFWM 191

Query: 272 APEYV-----MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
           APE +     +     ++ DV+S G+  +E+  G   +    P                 
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----------------M 235

Query: 327 RKLYQIV-DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           R L++I  +P   L+       + +     CL++D + RP++ ++++
Sbjct: 236 RALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-----VAEVDFLGQ 155
           LGEG +  V+KG  +  G           VA+K ++   L+ H E      + E   L  
Sbjct: 13  LGEGSYATVYKGRSKLTGQL---------VALKEIR---LE-HEEGAPFTAIREASLLKD 59

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL-GAAKGLA 214
           L H N+V L           LV+E++    L+ ++      L   N +++ L    +GLA
Sbjct: 60  LKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN-VRLFLFQLLRGLA 117

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           + H     V++RD K  N+L+      KL+DFGLA+A     KT+ S  VV T  Y  P+
Sbjct: 118 YCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYRPPD 173

Query: 275 YVM--TGHLTSKSDVYSFGVVLLEILTGR 301
            ++  T + TS  D++  G +  E+ TGR
Sbjct: 174 VLLGSTEYSTS-LDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 41/108 (37%), Positives = 57/108 (52%), Gaps = 10/108 (9%)

Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQ 254
           PL   + I  +   A+G+ FL   S   I+RD    NILL SE N  K+ DFGLA+    
Sbjct: 169 PLTLEDLISYSFQVARGMEFL--ASRKCIHRDLAARNILL-SENNVVKICDFGLAR-DIY 224

Query: 255 GDKTHV---STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            D  +V     R+     + APE +     T++SDV+SFGV+L EI +
Sbjct: 225 KDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 60/227 (26%), Positives = 88/227 (38%), Gaps = 38/227 (16%)

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSL-------ENHLFRRTIPLPWSN 201
           E   L ++ HPN+V        D    +V E+   G L          LF     L W  
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF- 106

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTH 259
            +++ LG        H   + V++RD K+ NI L      KL DFG A+    P      
Sbjct: 107 -VQMCLGVQ------HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---- 155

Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
            +   VGT  Y  PE        +KSD++S G +L E+ T +               +W 
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN---------SWK 206

Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
              L    K+ Q     L  +YS +    + Q+      R+P+SRPS
Sbjct: 207 NLIL----KVCQGSYKPLPSHYSYELRSLIKQM----FKRNPRSRPS 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 131 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183

Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 49/180 (27%), Positives = 86/180 (47%), Gaps = 27/180 (15%)

Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
           PL   + ++ +   A+G+ FL   S+  I+RD    N+LL     AK+ DFGLA+     
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR----- 260

Query: 256 DKTHVSTRVVGTYG-----YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS 310
           D  + S  VV         + APE +     T +SDV+S+G++L EI     S+ K   S
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGK---S 313

Query: 311 GEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
               ++  ++ Y   KR  YQ+  P    +++   +  + ++   C + +P  RP+  ++
Sbjct: 314 PYPGILVNSKFYKMVKRG-YQMSRP----DFAPPEIYSIMKM---CWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  V++RD K SN+LL++  + K+ DFGLA+     +K    T  V T  Y
Sbjct: 119 RGLKYIH--SANVLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDFMTEYVVTRWY 174

Query: 271 AAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR 301
            APE ++     T+  DV+S G +  E+L  +
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 38/227 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           + RP   LG G  G VF     +             VAVK +     Q  +  + E+  +
Sbjct: 9   DLRP---LGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKII 56

Query: 154 GQLHHPNLVKL--------------IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPW 199
            +L H N+VK+              +G   E +   +V E+M    L N L +  +    
Sbjct: 57  RRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLS--- 112

Query: 200 SNRIKI-ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAKAGPQ--G 255
               ++      +GL ++H  S  V++RD K +N+ +++E    K+ DFGLA+       
Sbjct: 113 EEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170

Query: 256 DKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR 301
            K ++S  +V  + Y +P  +++  + T   D+++ G +  E+LTG+
Sbjct: 171 HKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 30/216 (13%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH- 158
            +GEG +G V+K   +  G   A   + + +  + + P  L+       E+  L  L   
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-------EISLLQMLSES 60

Query: 159 PNLVKLIGYCIEDDQR-------LLVYEFMT---RGSLENHLFRRTIPLPWSNRIKIALG 208
             +V+L+   +E  +         LV+E++    +  ++++      PLP          
Sbjct: 61  IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAG--PQGDKTHVSTRVV 265
             KG+A  H     V++RD K  N+L+D +    K++D GL +A   P    TH    +V
Sbjct: 119 LLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV 173

Query: 266 GTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTG 300
            T  Y APE ++   H ++  D++S G +  E+   
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 63/247 (25%), Positives = 94/247 (38%), Gaps = 34/247 (13%)

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP--LPWSNRIKI 205
            E+    QL HPN++  +   I D +  +V   M  GS E+ L +   P  LP      I
Sbjct: 48  QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFI 106

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF----GLAKAGPQGDKTHVS 261
                  L ++H  S+  I+R  K S+ILL  +    LS       + K G +    H  
Sbjct: 107 LKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164

Query: 262 TR-VVGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
            +  V    + +PE +   + G+   KSD+YS G+   E+  G         +  Q L+ 
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPAT--QMLLE 221

Query: 318 WAR---QYLADKRKLYQIVDPRLEL-----------NYSLKGVQKVS----QLAYNCLSR 359
             R     L DK       D   +            +      +  S    Q    CL R
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281

Query: 360 DPKSRPS 366
           DP+SRPS
Sbjct: 282 DPESRPS 288

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 70/265 (26%), Positives = 108/265 (40%), Gaps = 43/265 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----E 149
           +F   S++G G FG V    + E  T       G   A+K +K   L   +E V+    E
Sbjct: 2   DFDVKSLVGRGHFGEV--QVVREKAT-------GDIYAMKVMKKSVL-LAQETVSFFEEE 51

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWS------NR 202
            D L   + P + +L  Y  +D   L LV E+   G L + L R                
Sbjct: 52  RDILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           + +A+ +   + ++H        RD K  N+L+D   + KL+DFG A A    +K   S 
Sbjct: 111 LVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSA-ARLTANKMVNSK 161

Query: 263 RVVGTYGYAAPEYVMTGHLTSKS------DVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
             VGT  Y APE + T +   K       D +S GV+  E++ GR       P  E    
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR------SPFHEGTSA 215

Query: 317 AWARQYLADKRKLYQIVDPRLELNY 341
                 +  +R L    DP++  ++
Sbjct: 216 KTYNNIMNFQRFLKFPEDPKVSSDF 240

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           KGL ++H     +I+RD K  N+ ++ +   K+ DFGLA+        +V TR      Y
Sbjct: 129 KGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WY 181

Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H T   D++S G ++ E+LTG+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 16/202 (7%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LGEG +  V+KG  + NG           VA+K ++    +G     + E   L  L H 
Sbjct: 13  LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N+V L       +   LV+E++    L  ++ +    L   N         +GL+++H  
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH-- 120

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-T 278
              +++RD K  N+L+      KL+DFGLA+A  +   +H  +  V T  Y  P+ ++ +
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGS 178

Query: 279 GHLTSKSDVYSFGVVLLEILTG 300
              ++  D++  G + +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 66/251 (26%), Positives = 99/251 (39%), Gaps = 64/251 (25%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVA---- 148
           +F    ++G G FG V             K  +G   A+K L K D L+  +E VA    
Sbjct: 2   DFESLKVIGRGAFGEV---------RLVQKKDTGHIYAMKILRKADMLE--KEQVAHIRA 50

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKI-- 205
           E D L +     +VK+  Y  +D + L L+ EF+  G +   L ++      + +  I  
Sbjct: 51  ERDILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAE 109

Query: 206 ---ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT---- 258
              A+ A   L F+H        RD K  N+LLD++ + KLSDFGL     +  +T    
Sbjct: 110 TVLAIDAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161

Query: 259 -----------------------------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYS 289
                                         ++   VGT  Y APE  M        D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221

Query: 290 FGVVLLEILTG 300
            GV++ E+L G
Sbjct: 222 LGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 66/251 (26%), Positives = 96/251 (38%), Gaps = 64/251 (25%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQ----GHREWVA 148
           +F    ++G G FG V             K  +G   A+K L K D L+    GH    A
Sbjct: 2   DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIR--A 50

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIA- 206
           E D L +     +VK+  Y  +D   L L+ EF+  G +   L ++        +  IA 
Sbjct: 51  ERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109

Query: 207 ----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT---- 258
               + +   L F+H        RD K  N+LLDS+ + KLSDFGL     +  +T    
Sbjct: 110 TVLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161

Query: 259 -----------------------------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYS 289
                                         ++   VGT  Y APE  M        D +S
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221

Query: 290 FGVVLLEILTG 300
            GV++ E+L G
Sbjct: 222 LGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 66/258 (25%), Positives = 105/258 (40%), Gaps = 33/258 (12%)

Query: 63  SSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVF----KGWIEE-- 116
           S  + D AP D   P  L Q   +       +FR    L  G FG +F    +   EE  
Sbjct: 118 SHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAE 177

Query: 117 -----NGTAPAKPGSGITVA--VKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKL----- 164
                N T   KP     +A  VK+     +Q   E +A    LG+L+H N++K+     
Sbjct: 178 ARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILA----LGRLNHENILKIEEILR 233

Query: 165 ---IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE 221
                Y I       +Y FM   + +     +  PL    R  I       + ++H   +
Sbjct: 234 SEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQTR-AIMKQLLCAVEYIH--DK 286

Query: 222 PVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL 281
            +I+RD K  NI L+ +    L DFG A    + ++       VGT    +PE +     
Sbjct: 287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGY 345

Query: 282 TSKSDVYSFGVVLLEILT 299
              +D++S G++LL++L+
Sbjct: 346 CEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 51/168 (30%), Positives = 72/168 (42%), Gaps = 33/168 (19%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL------KPDGLQGHREWV 147
           +F    ++G+G FG V             K  +G   A+K+L      K D L   +   
Sbjct: 2   DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVK--- 49

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL-----FRRTIPLPWSN 201
           AE D L +   P +V L  Y  +D Q L L+ EF+  G L   L     F   +   +  
Sbjct: 50  AERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
              +A+ A   L F+H        RD K  NIL+D   + KLSDFGL+
Sbjct: 109 ECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            GL ++H  S  +I+RD K  N+ ++ +   K+ DFGLA+        +V TR      Y
Sbjct: 128 CGLKYIH--SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180

Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTG+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 27/170 (15%)

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           AKG++FL   S+  I+RD    NILL      K+ DFGLA+     D  + S  VV    
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNA 276

Query: 270 -----YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
                + APE +     T +SDV+S+G++L EI +   S     P               
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------------- 322

Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
              K Y+++     +        ++  +  +C   DP  RP+  ++V+++
Sbjct: 323 -DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH  S  +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 130 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 184

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           APE ++        D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 47/190 (24%), Positives = 67/190 (35%), Gaps = 46/190 (24%)

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            E + L  L HP L  L      +    LV ++   G L      +  P      +    
Sbjct: 50  TEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQP---GKCLSEE- 103

Query: 208 GAAK--------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--------- 250
             A+         L +LH     ++YRD K  NILL    +  LSDF L+K         
Sbjct: 104 -VARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160

Query: 251 -----AGPQGDKTHVSTR-------------VVGTYGYAAPEYVM-TGHLTSKSDVYSFG 291
                 G +    +                  VGT  Y APE +   GH  S  D ++ G
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLG 219

Query: 292 VVLLEILTGR 301
           ++L E+L G 
Sbjct: 220 ILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 22/169 (13%)

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLL--VYEFMTRGSLENHLFRRTIPLPWS-NRIK 204
            E D L    +P +V +  +C  + +R L  V E++  G     L +    LP    R+ 
Sbjct: 50  VERDILTFAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMY 106

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV---- 260
            A      L +LH  +  +++RD K  N+L+ S  + KL+DFGL+K G     T++    
Sbjct: 107 FA-ETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163

Query: 261 ---STR------VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
               TR      V GT  Y APE ++        D ++ G++L E L G
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 68/288 (23%), Positives = 122/288 (42%), Gaps = 55/288 (19%)

Query: 101 LGEGGFGYVF----KGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV---AEVDFL 153
           LG+G FG V+    K  + E      K      + V  L P+      E V    E   L
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLK-----EIPVGELNPN------ETVQANQEAQLL 56

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR-----RTIPLP----WSNRIK 204
            +L HP +VK     +E D   ++ E+     L+  L       +T+       W   I+
Sbjct: 57  SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF--IQ 114

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           + LG    + ++H     +++RD K  NI L +    K+ DFG+++         ++T  
Sbjct: 115 LLLG----VHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTF 165

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y +PE +      SKSD++S G +L E+     + +              + +L+
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE-------------GQNFLS 212

Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
              ++ +   P L   YS    ++++ +  + L++DP  RPS  E+++
Sbjct: 213 VVLRIVEGPTPSLPETYS----RQLNSIMQSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 38/107 (35%), Positives = 52/107 (48%), Gaps = 8/107 (7%)

Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
            L   + I  +   AKG+ FL   S   I+RD    NILL      K+ DFGLA+     
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYK 231

Query: 256 DKTHV---STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           D  +V     R+     + APE +     T +SDV+SFGV+L EI +
Sbjct: 232 DPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 17/182 (9%)

Query: 127 GITVAVKSL-KPDGLQGH-REWVAEVDFLGQLHHPNLVKLIGY-----CIEDDQRL-LVY 178
           GI VAVK L +P   Q H +    E+  L  ++H N++ L+        +E+ Q + LV 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 179 EFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE 238
           E M      N      + L       +      G+  LH  S  +I+RD K SNI++ S+
Sbjct: 106 ELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSD 159

Query: 239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
              K+ DFGLA+         + T  V T  Y APE ++        D++S G ++ E++
Sbjct: 160 CTLKILDFGLART---ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216

Query: 299 TG 300
            G
Sbjct: 217 KG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 60/299 (20%), Positives = 117/299 (39%), Gaps = 70/299 (23%)

Query: 22  SASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLL 81
            A+   +              E    + +N       E  + +D                
Sbjct: 19  KANKGGSGKFEMND---KKLDEEERSHNNNAGEDEDEEKMIDNDIN-------------- 61

Query: 82  QFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ 141
                  +S   +++  +I+G G FG V++    +             VA+K +  D   
Sbjct: 62  -------RSPNKSYKLGNIIGNGSFGVVYEAICIDTSE---------KVAIKKVLQDPQY 105

Query: 142 GHREWVAEVDFLGQLHHPNLVKLIGY----CIEDDQRLL------------VYEFMTRGS 185
            +RE +     +  L+H N++ L  Y    C + +++ +            V+++M   +
Sbjct: 106 KNRELL----IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA 161

Query: 186 LENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-SEYNAKLS 244
             NH     +PL         L   + LA++H  S+ + +RD K  N+L+D + +  KL 
Sbjct: 162 RNNH----ALPLFLVKLYSYQL--CRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLC 213

Query: 245 DFGLAK--AGPQGDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTG 300
           DFG AK     Q   +++ +R      Y APE ++   + T+  D++S G ++ E++ G
Sbjct: 214 DFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 17/200 (8%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G +G V+K              +G   AVK +K +          E+  + +  H N
Sbjct: 17  VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V   G  +  ++  +  E+   GSL++ ++  T PL       +     +GLA+LH  S
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH--S 124

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM--- 277
           +  ++RD K +NILL    + KL+DFG+A           S   +GT  + APE      
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEK 182

Query: 278 TGHLTSKSDVYSFGVVLLEI 297
            G      D+++ G+  +E+
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 54/187 (28%), Positives = 81/187 (43%), Gaps = 33/187 (17%)

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH  S  +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 131 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 185

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L    L  DP  R 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQ-ARDLLSKMLVIDPAKRI 303

Query: 366 SMDEVVK 372
           S+DE ++
Sbjct: 304 SVDEALQ 310

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  +I+RD K SN+ ++ +   ++ DFGLA+        +V+TR      Y
Sbjct: 129 RGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181

Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+L G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 19/206 (9%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE----WVAEVDFLGQ 155
           ++GEG +G V K   +E             VA+K  K    + + E     + E+  L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKE---------IVAIKKFKDS--EENEEVKETTLRELKMLRT 56

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L   N+V+L        +  LV+E++ +  LE          P   R  I     K + +
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHW 115

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H     +++RD K  N+L+      KL DFG A+   +G   +  T  V T  Y +PE 
Sbjct: 116 CH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGR 301
           ++        D++S G +L E+  G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-H 157
            LG G FG V    +E       K  + +TVAVK LKP      RE  ++E+  L  L +
Sbjct: 42  TLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 97

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR 193
           H N+V L+G C      L++ E+   G L N L R+
Sbjct: 98  HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 62/264 (23%), Positives = 114/264 (43%), Gaps = 44/264 (16%)

Query: 125 GSGITVAVKSLKPDGLQGHRE----WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEF 180
           G  + V +K L P     HR+    +      + Q+ H +L  + G C+   + ++V EF
Sbjct: 42  GRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEF 97

Query: 181 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL----- 235
           +  G L+  L +    +P + +I +A   A  L++L   +  +++ +    NILL     
Sbjct: 98  VEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL 155

Query: 236 --DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGV 292
              +    KLSD G++      ++       V    + APE V  G  L++ +D +SFG 
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSREER------VERIPWIAPECVPGGNSLSTAADKWSFGT 209

Query: 293 VLLEI-LTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQ 351
            LLEI   G   + ++ PS              +K + Y+      +        ++++ 
Sbjct: 210 TLLEICFDGEVPLKERTPS--------------EKERFYE-----KKHRLPEPSCKELAT 250

Query: 352 LAYNCLSRDPKSRPSMDEVVKVLT 375
           L   CL+ +P  RPS   +++ LT
Sbjct: 251 LISQCLTYEPTQRPSFRTILRDLT 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH  S  +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           APE ++        D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)

Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
           V E   L +L HP ++ L+   +      LV     R  L  +L  R  PL  +    +A
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP-KYRSDLYTYLGARLRPLGLAQVTAVA 266

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
                 + ++HG  E +I+RD KT N+L++   +  L DFG A        T     + G
Sbjct: 267 RQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAG 324

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSM------DKKRPSGEQ 313
           T    APE +     T   D++S G+V+ E      S+      D++RP   Q
Sbjct: 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ 377

Length = 461

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 7/162 (4%)

Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF-RRTIPLPWSNRIKI 205
             E   L  ++HP++++L G    +    L+     +  L  +L  +R I +   + + I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNIAI--CDILAI 187

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
                + + +LH     +I+RD K  NI ++   +  L DFG A   P     +      
Sbjct: 188 ERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244

Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKK 307
           GT    APE +         D++S G+VL E+ T   S+ +K
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286

Length = 391

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV--GT 267
           A+G+ FL   S+  ++RD    N+LL      K+ DFGLA+     D  H S  V    T
Sbjct: 247 ARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGST 299

Query: 268 Y---GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           +    + APE +     T+ SDV+S+G++L EI +
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 64/236 (27%), Positives = 94/236 (39%), Gaps = 65/236 (27%)

Query: 131 AVKSL-KPDGLQ----GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRG 184
           A+K+L K D L      H +  AE D L +  +  +VKL  Y  +D   L  V +++  G
Sbjct: 30  AMKTLRKADVLMRNQAAHVK--AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGG 86

Query: 185 SLENHLFRRTIPLPWSNRIKIA-----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY 239
            + + L R  I      R  IA     + +   + F+H        RD K  NIL+D + 
Sbjct: 87  DMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIH--------RDIKPDNILIDRDG 138

Query: 240 NAKLSDFGL---------AKAGPQGDKTHVS---------------------------TR 263
           + KL+DFGL         +K   +GD                                 R
Sbjct: 139 HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQR 198

Query: 264 V-----VGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
                 VGT  Y APE ++ TG+ T   D +S GV+L E+L G+       P+  Q
Sbjct: 199 CLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQ 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 39/131 (29%), Positives = 61/131 (46%), Gaps = 12/131 (9%)

Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           L + + +  +   A G+ FL   S+  ++RD    N+L+      K+ DFGLA+     D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----D 288

Query: 257 KTHVSTRVV--GTY---GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG 311
               S  +    T+    + APE +     T+ SDV+SFG++L EI T   +   + P  
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348

Query: 312 EQNLVAWARQY 322
           EQ   A  R Y
Sbjct: 349 EQFYNAIKRGY 359

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 42/222 (18%)

Query: 101 LGEGGFGYVFK-----GWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ 155
           +G G +G+V+K     G  E+        G+GI+++                 E+  L +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--------------CREIALLRE 54

Query: 156 LHHPNLVKLIGYCIEDDQR--LLVYEF----------MTRGSLENHLFRRTIPLPWSNRI 203
           L HPN++ L    +    R   L++++            R S  N   ++ + LP S   
Sbjct: 55  LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVK 111

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NAKLSDFGLAKAGPQGDKTH 259
            +      G+ +LH  +  V++RD K +NIL+  E       K++D G A+      K  
Sbjct: 112 SLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 260 VSTR-VVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILT 299
                VV T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 6/96 (6%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-H 157
            LG G FG V    +E       K  + + VAVK LK       RE  ++E+  L  L  
Sbjct: 45  TLGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQ 100

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR 193
           H N+V L+G C      L++ E+   G L N L ++
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 42/222 (18%)

Query: 101 LGEGGFGYVFK-----GWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ 155
           +G G +G+V+K     G  + +       G+GI+++                 E+  L +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--------------CREIALLRE 54

Query: 156 LHHPNLVKLIGYCIE--DDQRLLVYEF----------MTRGSLENHLFRRTIPLPWSNRI 203
           L HPN++ L    +   D +  L++++            R S  N   ++ + LP     
Sbjct: 55  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVK 111

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NAKLSDFGLAKAGPQGDKTH 259
            +      G+ +LH  +  V++RD K +NIL+  E       K++D G A+      K  
Sbjct: 112 SLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 260 VSTR-VVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILT 299
                VV T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 21/151 (13%)

Query: 162 VKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP------WSNRIKIALGAAKGLA 214
           +  + Y  +D+  L LV ++   G L   L +    LP      +   + IA+ +   L 
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           ++H        RD K  NIL+D   + +L+DFG      + D T  S+  VGT  Y +PE
Sbjct: 123 YVH--------RDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPE 173

Query: 275 YVMT-----GHLTSKSDVYSFGVVLLEILTG 300
            +       G    + D +S GV + E+L G
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 38/172 (22%)

Query: 142 GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP-- 198
           G R W+        LH         Y  +D+  L LV ++   G L   L +    LP  
Sbjct: 58  GDRRWIT------NLH---------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED 102

Query: 199 ----WSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG-LAKAGP 253
               +   + +A+ +   L ++H        RD K  N+LLD   + +L+DFG   +   
Sbjct: 103 MARFYLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLA 154

Query: 254 QGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTG 300
            G  T  S   VGT  Y +PE +       G    + D +S GV + E+L G
Sbjct: 155 DG--TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 21/146 (14%)

Query: 167 YCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP------WSNRIKIALGAAKGLAFLHGG 219
           Y  +D+  L LV ++   G L   L +    LP      +   + +A+ +   L ++H  
Sbjct: 68  YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT- 278
                 RD K  N+LLD   + +L+DFG      Q D T  S+  VGT  Y +PE +   
Sbjct: 126 ------RDIKPDNVLLDMNGHIRLADFGSCLKMNQ-DGTVQSSVAVGTPDYISPEILQAM 178

Query: 279 ----GHLTSKSDVYSFGVVLLEILTG 300
               G    + D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 69/276 (25%), Positives = 108/276 (39%), Gaps = 79/276 (28%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEV----DFLGQ 155
           LG G FG V             K  +    A+K+L K D L  +R  VA V    D L +
Sbjct: 9   LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVL--NRNQVAHVKAERDILAE 57

Query: 156 LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP------WSNRIKIALG 208
             +  +VKL  Y  +D   L  V +++  G + + L R  +  P      +   + +A+ 
Sbjct: 58  ADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIE 115

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL---------AKAGPQGD--- 256
           +   + F+H        RD K  NIL+D + + KL+DFGL         +K   +G    
Sbjct: 116 SVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR 167

Query: 257 ------------------------------KTH---VSTRVVGTYGYAAPEYVMTGHLTS 283
                                         K H   ++  +VGT  Y APE ++    T 
Sbjct: 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227

Query: 284 KSDVYSFGVVLLEILTGRRSMDKKRPSGEQ-NLVAW 318
             D +S GV+L E+L G+       P+  Q  ++ W
Sbjct: 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQL-H 157
           LG G FG V    I+ +     K  S  TVAVK LK +G     ++  + E+  L  + H
Sbjct: 15  LGRGAFGKV----IQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTELKILIHIGH 69

Query: 158 HPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL 190
           H N+V L+G C +    L+V  E+   G+L N+L
Sbjct: 70  HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 7/93 (7%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HH 158
           LG G FG V    IE +     K  +  TVAVK LK       HR  ++E+  L  + HH
Sbjct: 15  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 70

Query: 159 PNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL 190
            N+V L+G C +    L+V  EF   G+L N+L
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 32/191 (16%)

Query: 145 EWVAEVDFLGQLHHPNLVKLIG-YCIEDDQRL-LVYEFMTRGSLENHL---FRRTIPLPW 199
           + V EV+ + +L H N+V+ I  +  + +Q+L ++ EF   G L  ++   ++    +  
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 200 SNRIKIALGAAKGLAFLHG-----GSEPVIYRDFKTSNILLDSEYN-------------- 240
              + I       LA+ H        E V++RD K  NI L +                 
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 241 ---AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLL 295
              AK+ DFGL+K        H     VGT  Y +PE ++  T     KSD+++ G ++ 
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 296 EILTGRRSMDK 306
           E+ +G+    K
Sbjct: 235 ELCSGKTPFHK 245

Length = 1021

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 35/107 (32%), Positives = 53/107 (49%), Gaps = 8/107 (7%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-H 157
           +LG G FG V    +E +     K  S  TVAVK LK       H+  ++E+  L  + +
Sbjct: 14  VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69

Query: 158 HPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-FRRTIPLPWSNR 202
           H N+V L+G C + +  L+V  EF   G+L N L  +R    P+  +
Sbjct: 70  HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 20/157 (12%)

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI--KIALGAAKGLAF 215
           HPN++             ++  FM  GS  N L +   P   S  +   I  GA +GL +
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNY 116

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSD----FGLAKAGPQG----DKTHVSTRVVGT 267
           LH      I+R+ K S+IL+  +    LS     + L + G +     D    ST V+  
Sbjct: 117 LHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP- 173

Query: 268 YGYAAPEYV---MTGHLTSKSDVYSFGVVLLEILTGR 301
             + +PE +   + G+   KSD+YS G+   E+ TGR
Sbjct: 174 --WLSPELLRQDLYGY-NVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 63/224 (28%)

Query: 148 AEVDFLGQLHHPNLVKLIGYCIED-DQRLLVYEFMTRGSLENHLFRRTIPLP------WS 200
           AE D L +  +  +V+L  Y  +D D    V +++  G + + L R  I  P      + 
Sbjct: 50  AERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYI 107

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL---------AKA 251
             +  A+ +   + F+H        RD K  NIL+D + + KL+DFGL         +K 
Sbjct: 108 AELTCAVESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 252 GPQGD---------------------------------KTH---VSTRVVGTYGYAAPEY 275
              GD                                 + H   ++  +VGT  Y APE 
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ-NLVAW 318
           ++    T   D +S GV+L E+L G+     + P   Q  ++ W
Sbjct: 220 LLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-H 157
           ILG G FG V +G     G + ++P   + VAVK LKP      ++  ++E+  +  L  
Sbjct: 44  ILGSGAFGKVVEG--TAYGLSRSQPV--MKVAVKMLKPTARSSEKQALMSELKIMTHLGP 99

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR 192
           H N+V L+G C +     ++ E+   G L N+L +
Sbjct: 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHK 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	429
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
smart00090	237	RIO RIO-like kinase.	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG1243	690	consensus Protein kinase [General function predict	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.42
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.88
PRK09902	216	hypothetical protein; Provisional	98.76
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.7
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.64
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.6
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.58
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.48
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.41
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.4
PF01636	239	APH: Phosphotransferase enzyme family This family	98.39
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.22
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.18
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.12
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.96
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.91
PRK10593	297	hypothetical protein; Provisional	97.87
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.85
PRK05231	319	homoserine kinase; Provisional	97.81
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.74
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.7
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.68
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.67
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.34
KOG2270	520	consensus Serine/threonine protein kinase involved	97.27
PLN02236	344	choline kinase	97.17
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.07
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.01
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.0
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.86
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.84
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.81
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.79
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.79
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.46
PRK12396	409	5-methylribose kinase; Reviewed	96.28
PLN02756	418	S-methyl-5-thioribose kinase	96.07
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.97
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.89
PRK06148	1013	hypothetical protein; Provisional	95.87
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.66
PTZ00384	383	choline kinase; Provisional	95.44
PTZ00296	442	choline kinase; Provisional	95.37
PRK11768	325	serine/threonine protein kinase; Provisional	95.27

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-53  Score=409.92  Aligned_cols=248  Identities=27%  Similarity=0.436  Sum_probs=213.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .+|...+.||+|||+.||.+++..+++         .||+|++.+..   ....+.+.+|++|.+.|+|||||+++++|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge---------~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE   88 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGE---------VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE   88 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCc---------EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence            469999999999999999999988766         99999998753   234567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +.+++|||+|+|..++|..++. +..+++|.++..+++||+.||.|||  +++|||||||..|+|++++.+|||+|||+|
T Consensus        89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIgDFGLA  165 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIGDFGLA  165 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEeccccee
Confidence            9999999999999999999886 5568999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........  .....||||.|+|||++.....+..+||||+||++|.||.|++||....-      .+          ..
T Consensus       166 t~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------ke----------ty  227 (592)
T KOG0575|consen  166 TQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------KE----------TY  227 (592)
T ss_pred             eeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------HH----------HH
Confidence            98764433  23458999999999999999999999999999999999999999975421      11          11


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..+....  ...+...+.+.++||.++|+.||.+|||+++|+.
T Consensus       228 ~~Ik~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  228 NKIKLNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHhcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111111  2223355688999999999999999999999996

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=389.84  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=213.1

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +.+.+..||+|..|+||+++|+.++.         .+|+|.+..+ .....+++.+|+++|+..+||+||.+|++|..+.
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~---------i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGK---------IYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCe---------EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            34557899999999999999998866         9999999654 3345688999999999999999999999999999


Q ss_pred             -eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 -QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 -~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                       .++|+||||+||+|++++... +.+++.....++.++++||.|||. .++||||||||+|||++..|.|||||||.+..
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence             499999999999999988665 469999999999999999999994 49999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      +...    ....++||..|||||-+.+..|+.++||||||++++|+++|+.||....+. .....+          .+..
T Consensus       229 lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~----------Ll~~  293 (364)
T KOG0581|consen  229 LVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFE----------LLCA  293 (364)
T ss_pred             hhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHH----------HHHH
Confidence            6443    445689999999999999999999999999999999999999999764111 111111          1223


Q ss_pred             hcCCccccCCCH-HHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          332 IVDPRLELNYSL-KGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       332 ~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +++...+ ..+. .++++++++|..||++||.+||++.|++.
T Consensus       294 Iv~~ppP-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 IVDEPPP-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HhcCCCC-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            3442222 1222 47899999999999999999999999997

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-54  Score=397.22  Aligned_cols=253  Identities=28%  Similarity=0.419  Sum_probs=210.2

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-------hHHHHHHHHHHhcCCCcceee
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-------HREWVAEVDFLGQLHHPNLVK  163 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~  163 (429)
                      ..+.|.+.+.||+|+||.|-+|..+.+++         .||||++++.....       ...+.+|+++|++|+|||||+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk---------~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~  240 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGK---------QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR  240 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCc---------EEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence            45679999999999999999999988765         99999998763322       234679999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CC
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---YN  240 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~  240 (429)
                      ++++|+..+..||||||++||+|.+++..++ .+.+.....++.|++.|+.|||  ++||+||||||+|||+..+   ..
T Consensus       241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             EeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccCCcceE
Confidence            9999999999999999999999999997775 4788888999999999999999  9999999999999999655   67


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCC---CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      +||+|||+|+...   ........||||.|.|||++.+..   +..++|||||||+||-+|+|.+||......  ..+.+
T Consensus       318 lKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~e  392 (475)
T KOG0615|consen  318 LKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKE  392 (475)
T ss_pred             EEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHH
Confidence            9999999999854   334455689999999999998654   345889999999999999999999764432  11111


Q ss_pred             HHHHHHHhhhhhhhhcCCcccc--CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          318 WARQYLADKRKLYQIVDPRLEL--NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                   ++....+..  ......+++..+||.+||..||++|||++|+|+.
T Consensus       393 -------------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  393 -------------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             -------------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                         222222221  2334667899999999999999999999999983

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-53  Score=389.00  Aligned_cols=251  Identities=29%  Similarity=0.497  Sum_probs=206.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||+|+||+||+|+++.++.         .||||.+.+..  ....+.+..|+.+|+.++|||||.+++++.
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~---------~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~   79 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGT---------EVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE   79 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCc---------eEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence            4689999999999999999999998765         99999998774  344566789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC------CCEEE
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE------YNAKL  243 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~------~~~kl  243 (429)
                      .++.+|||||||.||+|.+++.+++ .+++..+..++.||+.||++||  +++||||||||+||||+..      -.+||
T Consensus        80 ~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   80 DDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence            9999999999999999999998776 5899999999999999999999  9999999999999999764      45899


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      +|||+|+.+..+   ......||+|.|||||++....|+.|+|+||+|++||+|++|+.||....+..      ... +.
T Consensus       157 ADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e------L~~-~~  226 (429)
T KOG0595|consen  157 ADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE------LLL-YI  226 (429)
T ss_pred             cccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH------HHH-HH
Confidence            999999987643   23445899999999999999999999999999999999999999998654321      111 11


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...        .......+...+..+.+|+...|+.+|.+|.++.+.+.
T Consensus       227 ~k~--------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  227 KKG--------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             hcc--------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence            111        11111222233345667888888888888877766554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-53  Score=387.51  Aligned_cols=242  Identities=29%  Similarity=0.422  Sum_probs=205.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|+++++||+|+||+||.++.+++++         .||+|++++....   ..+....|..||.+++||+||+++..|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~k---------iYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ   95 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGK---------IYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ   95 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCc---------eeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence            579999999999999999999987755         9999999887543   3456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +.+.+|||+||+.||+|..+|.+++ .+++..+..++..|+.||.|||  +.|||||||||+|||+|.+|+++|+|||++
T Consensus        96 t~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~LtDFgL~  172 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLTDFGLC  172 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEeccccc
Confidence            9999999999999999999997665 5999999999999999999999  999999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +......  .....+|||+.|||||++.+..|+..+|+||||+++|||++|.+||.+...      ..+.......    
T Consensus       173 k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~----  240 (357)
T KOG0598|consen  173 KEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKG----  240 (357)
T ss_pred             hhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcC----
Confidence            9643332  233448999999999999999999999999999999999999999976432      2222221111    


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP  365 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  365 (429)
                            + ....+.-.+.+.+++++++|..||++|.
T Consensus       241 ------k-~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  241 ------K-LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ------c-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                  1 1112223457899999999999999995

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-51  Score=394.62  Aligned_cols=289  Identities=57%  Similarity=0.986  Sum_probs=249.9

Q ss_pred             ccccccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCC
Q 014202           79 QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH  158 (429)
Q Consensus        79 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  158 (429)
                      ....|++.++..++++|.....||+|+||.||+|...+.          ..||||.+.....+..++|.+|+.+|.+++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~----------~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H  130 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG----------TVVAVKRLSSNSGQGEREFLNEVEILSRLRH  130 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC----------CEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence            566799999999999999999999999999999998753          3899998876644314669999999999999


Q ss_pred             cceeeEEeEEEeCC-eEEEEEEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEE
Q 014202          159 PNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILL  235 (429)
Q Consensus       159 pnIv~~~~~~~~~~-~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill  235 (429)
                      ||+|+++|||.+.+ ..+||+||+++|+|.++|..... +++|..+++|+.++|.||+|||... ..|||||||++|||+
T Consensus       131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            99999999999999 59999999999999999988766 8999999999999999999999522 269999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      |++.++||+|||+|+..... .........||.+|+|||++..+..+.++|||||||+|.||++|+.|.+...+.....+
T Consensus       211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l  289 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL  289 (361)
T ss_pred             CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence            99999999999999765431 11111111899999999999999999999999999999999999999987776777779


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccc-cCCCH-HHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          316 VAWARQYLADKRKLYQIVDPRLE-LNYSL-KGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ..|....+... .+.+++|+.+. ..+.. .....+..+..+|++.+|.+||+|.+|++.|+.+..
T Consensus       290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99987766655 88899999987 55554 567789999999999999999999999998855543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-53  Score=373.14  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=207.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEe-EEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIG-YCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~  170 (429)
                      +|+++++||+|+||.||++.+..++.         .||.|.+.....  ...+.+..|+.+|++|+|||||++++ .|.+
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~---------l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGK---------LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcc---------hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            58899999999999999999998766         899999985533  44567899999999999999999998 4555


Q ss_pred             CCe-EEEEEEecCCCChHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeEEcCCCCEEEc
Q 014202          171 DDQ-RLLVYEFMTRGSLENHLF---RRTIPLPWSNRIKIALGAAKGLAFLHGGSEP--VIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       171 ~~~-~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      +.. ++||||||.+|+|...+.   +...-+++..+|.++.|++.||..+|..-..  |+||||||.||||+.+|.|||+
T Consensus        91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence            555 899999999999999884   3456799999999999999999999931145  9999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |||+++.+...  .......+|||+||+||.+.+.+|+.++|||||||++|||+.-.+||.+..      +.+...    
T Consensus       171 DfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~----  238 (375)
T KOG0591|consen  171 DFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCK----  238 (375)
T ss_pred             cchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHH----
Confidence            99999986543  334556899999999999999999999999999999999999999998752      222111    


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ++-+...+.-....++.++..||..|+..||+.||+...++.
T Consensus       239 ------KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  239 ------KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             ------HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence                  111222221122567889999999999999999999555444

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-51  Score=388.29  Aligned_cols=254  Identities=26%  Similarity=0.377  Sum_probs=214.6

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcC-CCcceeeE
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQL-HHPNLVKL  164 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~  164 (429)
                      +....+|..++.||+|+|++|++|+...++.         .||||++.+.-.   ...+.+..|-.+|.+| .||.|++|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~k---------eYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL  139 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGK---------EYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL  139 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCc---------eeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence            4455789999999999999999999988765         999999976532   2234567899999999 69999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      |..|+++..+|+|+||+++|+|.++|.+.+ .+++.....++.+|+.||+|||  +.|||||||||+|||+|.+++++|+
T Consensus       140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhikIT  216 (604)
T KOG0592|consen  140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHIKIT  216 (604)
T ss_pred             EEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcEEEe
Confidence            999999999999999999999999997775 6999999999999999999999  9999999999999999999999999


Q ss_pred             cccCcccCCCCCcc-----------ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 014202          245 DFGLAKAGPQGDKT-----------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ  313 (429)
Q Consensus       245 DFg~a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  313 (429)
                      |||.|+.+......           .....++||..|.+||++..+..++.+|||+|||+||.|+.|.+||.+..+.-. 
T Consensus       217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-  295 (604)
T KOG0592|consen  217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-  295 (604)
T ss_pred             eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-
Confidence            99999876543221           112458999999999999999999999999999999999999999986543110 


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                                     +.+++.  +...++...++.+.+||+++|..||.+|+|+++|..
T Consensus       296 ---------------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  296 ---------------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ---------------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                           111121  123344455588999999999999999999999976

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=386.43  Aligned_cols=254  Identities=36%  Similarity=0.569  Sum_probs=211.5

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcE-EEEEEeCCCCchh--hHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGIT-VAVKSLKPDGLQG--HREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ..+.+.||.|+||+||+|.+..+           . ||||++.......  .++|.+|+.+|.+|+|||||+++|++...
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~-----------~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGT-----------DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCc-----------eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34456699999999999998754           5 9999998654322  56899999999999999999999999988


Q ss_pred             C-eEEEEEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhCCCCC-eeeCCCCCCCeEEcCCC-CEEEcccc
Q 014202          172 D-QRLLVYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGLAFLHGGSEP-VIYRDFKTSNILLDSEY-NAKLSDFG  247 (429)
Q Consensus       172 ~-~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~-ivHrDlkp~Nill~~~~-~~kl~DFg  247 (429)
                      . .++|||||+++|+|.+++.. ....+++..++.++.||+.||.|||  +.+ ||||||||+|||++.++ ++||+|||
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--SEGPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence            8 79999999999999999988 4678999999999999999999999  788 99999999999999998 99999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhh--cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      +++......  ...+...||+.|||||++.  ...|+.|+||||||+++|||+||..||....+..              
T Consensus       190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--------------  253 (362)
T KOG0192|consen  190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--------------  253 (362)
T ss_pred             cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--------------
Confidence            998744321  2223368999999999999  5689999999999999999999999998755310              


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                        ..........+...+..+++.+..|+.+||..||..||++.+++..|+.+..
T Consensus       254 --~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  254 --VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             --HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence              0111111222233334467899999999999999999999999998887654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-51  Score=363.13  Aligned_cols=266  Identities=26%  Similarity=0.331  Sum_probs=212.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|+.+.++|+|+||.||++++++|++         .||||++.....  ...+-.++|+++|++|+|+|+|.++++|..
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~Tgq---------IVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr   72 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQ---------IVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR   72 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCccc---------EEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence            468888999999999999999998866         999999875532  223456899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ...++||+|||+. ++.+.|.+....++...+..++.|++.|+.|+|  ++++|||||||+||||+.+|.+||||||+|+
T Consensus        73 krklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFGFAR  149 (396)
T KOG0593|consen   73 KRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFGFAR  149 (396)
T ss_pred             cceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccchhhH
Confidence            9999999999976 666667777677999999999999999999999  9999999999999999999999999999999


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH--------HH
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA--------RQ  321 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~  321 (429)
                      .+..  .....+.++.|.+|.|||.+.| ..|+..+||||+||++.||++|.+.|.+.........+...        .+
T Consensus       150 ~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~  227 (396)
T KOG0593|consen  150 TLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS  227 (396)
T ss_pred             hhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence            8763  2234566899999999999987 68999999999999999999999999887654433222211        11


Q ss_pred             HHHhhhhhhhhcCCccccC-----CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLADKRKLYQIVDPRLELN-----YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .......+..+.-|..+..     .....+.-+.+|+++||..||++|++.++++.
T Consensus       228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111111111111111111     11233457889999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=352.05  Aligned_cols=237  Identities=27%  Similarity=0.369  Sum_probs=205.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|+.++.||.|+||+|.+++.+.++.         .+|+|++.+....   ..+...+|..+|+.+.||+++++++.+.
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~---------yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~  114 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGN---------YYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK  114 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCc---------eeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence            468889999999999999999998755         9999999877543   3455789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +.+.+||||||++||.|..++.+.+ .+++..+..++.||+.||+|||  +.+|++|||||+|||+|.+|.+||+|||+|
T Consensus       115 d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKitDFGFA  191 (355)
T KOG0616|consen  115 DNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKITDFGFA  191 (355)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEEeccce
Confidence            9999999999999999999996654 6999999999999999999999  999999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +.....     .-..||||.|+|||++....|+.++|+|||||++|||+.|.+||....+.      ..          .
T Consensus       192 K~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~i----------Y  250 (355)
T KOG0616|consen  192 KRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QI----------Y  250 (355)
T ss_pred             EEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HH----------H
Confidence            975332     33479999999999999999999999999999999999999999876541      11          1


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR  364 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  364 (429)
                      .+++...+  .++...+.++++||.++|+.|-.+|
T Consensus       251 ~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  251 EKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            12233322  2344455789999999999999999

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-50  Score=380.13  Aligned_cols=255  Identities=31%  Similarity=0.476  Sum_probs=221.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      .+++++.||+|.||.||+|+++.+.          .||+|.++... .....|.+|+++|++|+|+|||++++++..++.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~----------~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGST----------KVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCC----------cccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            4566789999999999999998653          59999998653 344678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          174 RLLVYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      +||||||++.|+|.++|.. .+..+...+.+.++.||++|++||+  ++++|||||...||||++++.+||+|||+|+..
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEccccccccc
Confidence            9999999999999999987 5667899999999999999999999  999999999999999999999999999999954


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      .+ +.......-.-...|.|||.+..+.++.+||||||||+||||+| |+.|+.+..                 ...+.+
T Consensus       354 ~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~  415 (468)
T KOG0197|consen  354 GD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLE  415 (468)
T ss_pred             CC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHH
Confidence            33 33333333345678999999999999999999999999999999 778876532                 234556


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      .++...+++.+..+++++.+|+..||..+|++|||++.+...|+.+..
T Consensus       416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            677788888899999999999999999999999999999988877654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-49  Score=378.83  Aligned_cols=251  Identities=27%  Similarity=0.394  Sum_probs=210.5

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC----Cc-hhhHHHHHHHHHHhcCC-Ccceee
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GL-QGHREWVAEVDFLGQLH-HPNLVK  163 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~  163 (429)
                      ...++|.+++.||+|+||+|++|++..++.         .||+|++...    .. ...+.+.+|+.+|++++ ||||++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~---------~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~   84 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGE---------KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIR   84 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCC---------eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeE
Confidence            345789999999999999999999988765         9999987764    11 22345678999999999 999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CCEE
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAK  242 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k  242 (429)
                      +++++.....+|+||||+.||+|.+++.+ ...+.+..+..++.|++.|++|||  ++||+||||||+|||++.+ +++|
T Consensus        85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   85 LLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             EEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCCCCEE
Confidence            99999999999999999999999999988 567999999999999999999999  8999999999999999999 9999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCC-CC-CccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LT-SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      |+|||++....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||....      ......
T Consensus       162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~  233 (370)
T KOG0583|consen  162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYR  233 (370)
T ss_pred             EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHH
Confidence            99999999763  1222344589999999999999877 75 89999999999999999999998622      111111


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHH-HHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKG-VQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                                .+....+  .++... +.++.+|+.+||..||.+|+++.+|+.
T Consensus       234 ----------ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  234 ----------KIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----------HHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                      1122212  222222 688999999999999999999999995

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=369.26  Aligned_cols=258  Identities=29%  Similarity=0.437  Sum_probs=209.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|..++.||+|+||.||++.+.+++.         .+|||.+........+.+.+|+.+|.+|+|||||++++......
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~---------~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~   87 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGE---------LMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE   87 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCc---------ceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence            458889999999999999999987644         89999998764444677899999999999999999999754444


Q ss_pred             --eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCCEEEccccCc
Q 014202          173 --QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNAKLSDFGLA  249 (429)
Q Consensus       173 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFg~a  249 (429)
                        .++++|||+++|+|.+++.+.+..+++..+..++.||++||.|||  ++|||||||||+|||++. ++.+||+|||++
T Consensus        88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEeccCccc
Confidence              689999999999999999887667999999999999999999999  999999999999999999 799999999999


Q ss_pred             ccCCC-CCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          250 KAGPQ-GDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       250 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +.... ...........||+.|||||++..+ ....++|||||||++.||+||++||...     .....          
T Consensus       166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~----------  230 (313)
T KOG0198|consen  166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAE----------  230 (313)
T ss_pred             cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHH----------
Confidence            87543 1112223347899999999999853 3446999999999999999999999753     01111          


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      .+..+........++...+.+..++|.+||..||++|||+.++|+....
T Consensus       231 ~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  231 ALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             HHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            1111111111114455567899999999999999999999999985433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-49  Score=372.99  Aligned_cols=265  Identities=26%  Similarity=0.345  Sum_probs=213.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .+.|+.+++||+|.||.||+|++..+++         .||+|++..+.  ........+||.||++|+||||+++.+...
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgk---------ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt  186 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGK---------IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVT  186 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCc---------EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence            3568889999999999999999998866         99999998775  334566789999999999999999999888


Q ss_pred             eC--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          170 ED--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       170 ~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +.  ..+|||+|||+. +|..++......|++.++..++.|++.||+|||  .+||+|||||.+|||||.+|.+||+|||
T Consensus       187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEecccc
Confidence            76  689999999976 999988887888999999999999999999999  9999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh-
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD-  325 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-  325 (429)
                      +|+.+...... ..+..+-|.+|.|||++.|. .|+.++|+||.||||.||+.|++.|.+.....+...+-   ..... 
T Consensus       264 LAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf---klcGSP  339 (560)
T KOG0600|consen  264 LARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF---KLCGSP  339 (560)
T ss_pred             ceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH---HHhCCC
Confidence            99977554332 34556889999999999875 69999999999999999999999999876543322211   11100 


Q ss_pred             ------hhhhh--hhcCCccccCC-----CHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          326 ------KRKLY--QIVDPRLELNY-----SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       326 ------~~~~~--~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ..++.  ..+.+......     ....+....+|+..||..||.+|.|+.++|+
T Consensus       340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                  00111  01111111000     1122456789999999999999999999997

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-49  Score=377.12  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=219.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ...|....+||+|+.|.||.|+...+++         .||||.+........+-+.+|+.+|+.++|+|||++++.|...
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~---------~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~  342 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQ---------EVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG  342 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCc---------eEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence            3678889999999999999999887765         8999999888766667789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +.+|+||||++||+|.|.+...  .+++.++..+++.++.||+|||  ..||+|||||.+|||++.+|.+||+|||++..
T Consensus       343 deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFcaq  418 (550)
T KOG0578|consen  343 DELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQ  418 (550)
T ss_pred             ceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeeec
Confidence            9999999999999999988554  3899999999999999999999  89999999999999999999999999999988


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      +.....  .....+|||+|||||++....|++++||||||++++||+-|.+||-...+....                +.
T Consensus       419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl----------------yL  480 (550)
T KOG0578|consen  419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------------YL  480 (550)
T ss_pred             cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH----------------HH
Confidence            655432  334579999999999999999999999999999999999999999765543221                22


Q ss_pred             hc-CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          332 IV-DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       332 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +. +.......+...+..+++++.+||+.|+++|+++.|+|+
T Consensus       481 Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  481 IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            22 233445566778899999999999999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.5e-49  Score=372.28  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=210.3

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEe
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~  166 (429)
                      ...++|.++++||+|+||.||+|+-+.|+.         .+|+|++++....   ....++.|-.+|....+|+||++|.
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~---------iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY  208 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGE---------IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY  208 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCc---------EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence            344899999999999999999999888765         9999999987543   3456789999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      .|++.+++||||||++||++..+|.+.+ .+++..+..++.+++.|++.||  ..|+|||||||+|+|||..|++||+||
T Consensus       209 sFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  209 SFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             EecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeeccc
Confidence            9999999999999999999999886654 6999999999999999999999  999999999999999999999999999


Q ss_pred             cCcccCCC----------------------CCcc----ce-------------------eeeccccccccChhhhhcCCC
Q 014202          247 GLAKAGPQ----------------------GDKT----HV-------------------STRVVGTYGYAAPEYVMTGHL  281 (429)
Q Consensus       247 g~a~~~~~----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~  281 (429)
                      ||+..+..                      .+..    ..                   ....+|||.|||||++.+..|
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            99853211                      0000    00                   012589999999999999999


Q ss_pred             CCccchhhhHHHHHHHHhCCCCCCCCCCCccc-cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCC
Q 014202          282 TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ-NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD  360 (429)
Q Consensus       282 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  360 (429)
                      +..+|+||||||+||||.|.+||....+...- +++.|-.               .+..+.....+.+..|||.+||. |
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~~~~~s~eA~DLI~rll~-d  429 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPEEVDLSDEAKDLITRLLC-D  429 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCCcCcccHHHHHHHHHHhc-C
Confidence            99999999999999999999999887653321 1222211               12222233445889999999998 9


Q ss_pred             CCCCC---CHhHHHH
Q 014202          361 PKSRP---SMDEVVK  372 (429)
Q Consensus       361 P~~Rp---t~~eil~  372 (429)
                      |++|.   .++||.+
T Consensus       430 ~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  430 PENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHhcCcccHHHHhc
Confidence            99995   5777765

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.7e-49  Score=372.97  Aligned_cols=247  Identities=28%  Similarity=0.416  Sum_probs=211.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|.+.+.||+|+||+||+|+.+.+.+         .||+|.+.+...  ...+.+.+|++|++.|+|||||.++++|+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~---------~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQ---------VVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET   72 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccccee---------EEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence            478999999999999999999888755         999999987643  335668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ..++++|.||+.| +|..+|...+ .++++.+..++.+++.||.|||  +.+|+|||+||.|||++.+|.+|+||||+|+
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar  148 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFGLAR  148 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhhhhh
Confidence            9999999999977 9999885554 6999999999999999999999  9999999999999999999999999999999


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ....  .+...+...|||.|||||++.+++|+..+|+|||||++|||++|++||....      +.+..+          
T Consensus       149 ~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~----------  210 (808)
T KOG0597|consen  149 AMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVK----------  210 (808)
T ss_pred             hccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHH----------
Confidence            8543  4556777899999999999999999999999999999999999999995321      111111          


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .+...  +...+...+..+..++.-+|.+||.+|.+..+++.
T Consensus       211 ~I~~d--~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  211 SILKD--PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHhcC--CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            11111  11223366788999999999999999999999985

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-48  Score=339.46  Aligned_cols=266  Identities=27%  Similarity=0.385  Sum_probs=213.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--hHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .+|...+.||+|.||.||+|++..+++         .||||+++..+..+  ....++|++.|+.++|+||+.++++|.+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~---------~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGK---------RVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCc---------EEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence            468889999999999999999988765         99999998764432  3467899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      .+.+.||+||++. +|+..+......++...+..++.+++.||+|||  .+.|+||||||.|+||+.+|.+||+|||+|+
T Consensus        73 ~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFGLAr  149 (318)
T KOG0659|consen   73 KSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFGLAR  149 (318)
T ss_pred             CCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeecccchh
Confidence            9999999999964 999999888888999999999999999999999  8999999999999999999999999999999


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH----------HH
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA----------WA  319 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~----------~~  319 (429)
                      .+...+...  +..+-|.+|.|||++.|. .|+..+||||.|||+.||+-|.+-|.+.....+...+-          |.
T Consensus       150 ~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP  227 (318)
T KOG0659|consen  150 FFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP  227 (318)
T ss_pred             ccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence            876654432  234789999999999875 69999999999999999999998888765433221110          10


Q ss_pred             HH-HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          320 RQ-YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       320 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .- .+.+-.++. ..........-...+.++.+|+..||..||.+|+++.|++++
T Consensus       228 ~~~~lpdY~~~~-~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  228 EMTSLPDYVKIQ-QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccccHHHHh-cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            00 000001111 111111111233456778999999999999999999999973

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-48  Score=375.56  Aligned_cols=247  Identities=27%  Similarity=0.414  Sum_probs=210.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      +-|++++.||.|+-|.|.+|++..||+         .+|||++.+...   .....+.+|+-||+.+.||||+++|++|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGq---------laaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe   82 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQ---------LAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE   82 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccc---------eeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence            559999999999999999999998866         999999976621   12345789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +..++|+|.||++||.|++++.+++ ++++.++..++.||+.|+.|||  ..+|+||||||+|+|+|..+++||+|||+|
T Consensus        83 ~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIADFGMA  159 (786)
T KOG0588|consen   83 NKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIADFGMA  159 (786)
T ss_pred             cCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeecccee
Confidence            9999999999999999999997776 6999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ..-..+   ......||+|.|.|||++.|.+| +.++||||.|||||.||+|+.||+..      ++.....        
T Consensus       160 sLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLl--------  222 (786)
T KOG0588|consen  160 SLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLL--------  222 (786)
T ss_pred             ecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHH--------
Confidence            874332   23445799999999999999988 57999999999999999999999743      2211111        


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                        +....  .+..+...+.++++||++||.+||.+|.|++||++
T Consensus       223 --KV~~G--~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  223 --KVQRG--VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             --HHHcC--cccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence              11111  12334456689999999999999999999999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-48  Score=358.49  Aligned_cols=248  Identities=24%  Similarity=0.394  Sum_probs=211.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhH---HHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR---EWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..+|++.+.||+|.||+|-+|+....         |+.||||.+.++...+.+   .+.+|++||..|+||||+.+|++|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~s---------gR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF  122 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKS---------GREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF  122 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccC---------CcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence            35799999999999999999987554         559999999988765544   467999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ++.+.+.|||||..+|+|++|+.+++ .+++.++..+++||+.|+.|+|  .++++|||||.+|||+|.++++||+|||+
T Consensus       123 ENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  123 ENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             cCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeeccch
Confidence            99999999999999999999997665 6999999999999999999999  99999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +..+....   ..+.+||+|.|.+||+++|.+| ++.+|.|||||+||.|+.|..||++...   .             .
T Consensus       200 SNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k-------------~  260 (668)
T KOG0611|consen  200 SNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---K-------------R  260 (668)
T ss_pred             hhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---H-------------H
Confidence            99875543   3456899999999999999988 6899999999999999999999987542   1             1


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .+.++.......+   .-+....-||++||.+||++|.|+.+|...
T Consensus       261 lvrQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  261 LVRQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            1222222222211   223567889999999999999999999753

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-49  Score=368.30  Aligned_cols=267  Identities=25%  Similarity=0.351  Sum_probs=213.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHH--HHHHHHHHhcCC-CcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE--WVAEVDFLGQLH-HPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-hpnIv~~~~~  167 (429)
                      .-++|.++++||.|.||.||+|+..+++.         .||||.++..-.. .++  =++|+.-|++|+ |||||+++++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~---------~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev   77 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGE---------LVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV   77 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCc---------eeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence            34689999999999999999999988766         8999999765322 222  269999999999 9999999999


Q ss_pred             EEeCC-eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          168 CIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       168 ~~~~~-~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      +.+.+ .+|+|||||+ .+|++++..++..+++..+..|+.||+.||+|+|  .+|+.||||||+|||+..+..|||+||
T Consensus        78 i~d~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   78 IRDNDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             hhccCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEeccc
Confidence            99888 9999999995 5999999999999999999999999999999999  999999999999999998889999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhh-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH-----H
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA-----R  320 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~-----~  320 (429)
                      |+|+.....   ...+.++.|.+|.|||++. .+.|+.+.||||+|||++|+.+-++.|.+....++...+..+     +
T Consensus       155 GLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  155 GLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             ccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence            999975433   3455689999999999986 467899999999999999999999999887654332211100     0


Q ss_pred             HHHHhhhhhhhhcCCccccC-------CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          321 QYLADKRKLYQIVDPRLELN-------YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..+.....+...++-.++..       .....+.++.+||.+||.-||++|||+.+++++
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            00011112222222222111       112256889999999999999999999999983

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-47  Score=352.13  Aligned_cols=268  Identities=24%  Similarity=0.351  Sum_probs=215.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-hHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +.|++.++||.|.-++||+|+...+++         .||||++..+.-.. ...+.+|+..|+.++||||++++..|..+
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e---------~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNE---------VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCC---------EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            579999999999999999999988766         99999998775443 47889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ..+|+||.||.+|++.+++... ...+++..+..|++++++||.|||  .+|.||||||+.||||+.+|.|||+|||.+-
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEcCceeee
Confidence            9999999999999999999764 345899999999999999999999  9999999999999999999999999999976


Q ss_pred             cCCCCC-cccee-eeccccccccChhhhhc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          251 AGPQGD-KTHVS-TRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       251 ~~~~~~-~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .+.... ..... ..++||++|||||++..  ..|+.|+||||||++..||.+|..||....|...      ....+.+ 
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLqn-  247 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQN-  247 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhcC-
Confidence            544432 22222 56799999999999653  4799999999999999999999999986554210      0000000 


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCcC
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQD  379 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~~  379 (429)
                       ..+......+........+..+++++..||+.||.+|||++++++  ++...+.
T Consensus       248 -~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  248 -DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             -CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence             000000011122222344568999999999999999999999997  4544443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-47  Score=354.54  Aligned_cols=264  Identities=28%  Similarity=0.382  Sum_probs=214.8

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--------------hhHHHHHHHHH
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--------------GHREWVAEVDF  152 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~  152 (429)
                      +-....++|++++.||+|.||.|-+|++..+++         .||||++.+....              ..+.+.+|+.+
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~---------l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai  161 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGK---------LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI  161 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCc---------EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHH
Confidence            334556889999999999999999999988766         9999999765321              12467899999


Q ss_pred             HhcCCCcceeeEEeEEEeC--CeEEEEEEecCCCChHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 014202          153 LGQLHHPNLVKLIGYCIED--DQRLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFK  229 (429)
Q Consensus       153 l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlk  229 (429)
                      |++|+|||||+++++..+.  +.+|||+|||..|.+...  ....+ +++.+++.++.+++.||+|||  .+||||||||
T Consensus       162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH--~QgiiHRDIK  237 (576)
T KOG0585|consen  162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLH--YQGIIHRDIK  237 (576)
T ss_pred             HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHH--hcCeeccccc
Confidence            9999999999999998764  578999999999988642  23334 899999999999999999999  9999999999


Q ss_pred             CCCeEEcCCCCEEEccccCcccCCCCC---ccceeeeccccccccChhhhhcCC----CCCccchhhhHHHHHHHHhCCC
Q 014202          230 TSNILLDSEYNAKLSDFGLAKAGPQGD---KTHVSTRVVGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEILTGRR  302 (429)
Q Consensus       230 p~Nill~~~~~~kl~DFg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~  302 (429)
                      |+|+||+.+|+|||+|||.+.....+.   ........+|||.|+|||++.++.    .+.+.|||||||+||.|+.|+.
T Consensus       238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            999999999999999999998653321   111223368999999999987632    3678999999999999999999


Q ss_pred             CCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       303 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ||-+...                .....++++..+..+...+..+.+.+||.+||.+||++|.++.+|..+.+-...
T Consensus       318 PF~~~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  318 PFFDDFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             CcccchH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            9965321                112334556666666555677899999999999999999999999887665554

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-47  Score=367.58  Aligned_cols=265  Identities=29%  Similarity=0.452  Sum_probs=206.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|.+...+.    ...+..||||++..... .....+.+|+.+|..+ +||||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDK----KSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCC----cccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            4679999999999999999998643221    12345799999975432 3345688999999999 8999999999887


Q ss_pred             eCC-eEEEEEEecCCCChHHHHhcCC------------------------------------------------------
Q 014202          170 EDD-QRLLVYEFMTRGSLENHLFRRT------------------------------------------------------  194 (429)
Q Consensus       170 ~~~-~~~lv~e~~~gg~L~~~l~~~~------------------------------------------------------  194 (429)
                      ..+ .+++||||+++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            644 5789999999999999986431                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeecccc
Q 014202          195 -------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT  267 (429)
Q Consensus       195 -------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt  267 (429)
                             .++++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||+++...............++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                   24777888999999999999999  899999999999999999999999999999865332222222234567


Q ss_pred             ccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHH
Q 014202          268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGV  346 (429)
Q Consensus       268 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      +.|+|||++.+..++.++|||||||++|||++ |..||.......  ..    ...+...          .....+...+
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~----------~~~~~~~~~~  303 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF----CQRLKDG----------TRMRAPENAT  303 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----HHHHhcC----------CCCCCCCCCC
Confidence            88999999999999999999999999999997 999997543211  00    0111110          0111122345


Q ss_pred             HHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          347 QKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       347 ~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            78999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-48  Score=359.72  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=213.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .|+..+.||+|.||.||+|.+..+++         .||+|++..+... ...++.+|+.+|.+++++||.++|+.|..+.
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k---------~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~   84 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKK---------VVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT   84 (467)
T ss_pred             ccccchhccccccceeeeeeeccccc---------eEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence            47778999999999999999998876         9999999877543 4577889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .++++||||.||++.+.+.... .+.+..+.-++++++.||.|||  ..+.+|||||+.|||+..+|.+||+|||++...
T Consensus        85 ~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             cHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEecceeeee
Confidence            9999999999999999885443 4588888899999999999999  899999999999999999999999999999876


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ......  ...++|||.|||||++.+..|+.++||||||++.|||++|.+||....|..-.                + +
T Consensus       162 ~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------f-l  222 (467)
T KOG0201|consen  162 TNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------F-L  222 (467)
T ss_pred             echhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------E-e
Confidence            554332  35689999999999999889999999999999999999999999877663211                1 1


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +....+..+...++..+++++..||.+||+.||++.++++
T Consensus       223 Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  223 IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1111122223356688999999999999999999999997

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-46  Score=345.05  Aligned_cols=260  Identities=27%  Similarity=0.338  Sum_probs=218.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh---HHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH---REWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||.|.-|+||++....++.         .+|+|++.+.....+   .++..|-+||+.++||.++.+|..|+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~---------~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe  147 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNC---------LFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE  147 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCc---------eEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence            458889999999999999999988765         899999988755443   45678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+...|||||||+||+|..+++++ +..+++..+..++..++-||+|||  -.|||+|||||+||||.++|+|.|+||.+
T Consensus       148 t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLsDFDL  225 (459)
T KOG0610|consen  148 TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLSDFDL  225 (459)
T ss_pred             ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEeeeccc
Confidence            999999999999999999988766 556999999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCC---------------------------------CCc---------------------cceeeeccccccccChh
Q 014202          249 AKAGPQ---------------------------------GDK---------------------THVSTRVVGTYGYAAPE  274 (429)
Q Consensus       249 a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE  274 (429)
                      +.....                                 ...                     ......++||-.|+|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            753210                                 000                     01123478999999999


Q ss_pred             hhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHH
Q 014202          275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAY  354 (429)
Q Consensus       275 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  354 (429)
                      ++.|...+.++|+|+|||++||||.|..||.+...                ...+..++-..+..+.....+..++|||+
T Consensus       306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr  369 (459)
T KOG0610|consen  306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIR  369 (459)
T ss_pred             eeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence            99999999999999999999999999999987643                23345555555555555567789999999


Q ss_pred             HcccCCCCCCCC----HhHHHH--HhcCCcC
Q 014202          355 NCLSRDPKSRPS----MDEVVK--VLTPLQD  379 (429)
Q Consensus       355 ~~l~~dP~~Rpt----~~eil~--~l~~~~~  379 (429)
                      ++|.+||.+|..    +.||.+  +++.++.
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW  400 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW  400 (459)
T ss_pred             HHhccChhhhhccccchHHhhcCccccCCCh
Confidence            999999999987    888876  4555543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-47  Score=327.42  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=211.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|-||.||+|+.+.+.-         .||+|++.+...   +...++.+|++|-..|+||||+++|++|.
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~---------IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh   92 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLF---------IVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH   92 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCc---------EEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence            579999999999999999999988755         899999977643   23467889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ++...||++||..+|+|...|... ...+++...+.++.|++.||.|+|  ..+||||||||+|+|++..|.+||+|||.
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiAdfGw  170 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIADFGW  170 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence            999999999999999999999744 445899999999999999999999  99999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +.....    ......|||..|.+||+..+..++..+|+|++|++.||++.|.+||.....   ...             
T Consensus       171 sV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~et-------------  230 (281)
T KOG0580|consen  171 SVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SET-------------  230 (281)
T ss_pred             eeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHH-------------
Confidence            987432    223457999999999999999999999999999999999999999975331   111             


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..++..  ....++...+..+++||.+||..+|.+|.+..|++..
T Consensus       231 YkrI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  231 YKRIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            111111  1122334556889999999999999999999999874

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=366.60  Aligned_cols=246  Identities=27%  Similarity=0.411  Sum_probs=207.7

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCC-CcceeeE
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLH-HPNLVKL  164 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~  164 (429)
                      ....++|+++++||+|.||+|++|..+.+++         .+|||.++++..-   +.+..+.|.+|+.... ||+++.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e---------~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L  434 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNE---------YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL  434 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCc---------EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence            3445789999999999999999999998876         9999999988553   3456788999998886 9999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      +..|+..+++|+||||+.||++..+  .+...+++..+..++..|+.||.|||  ++||||||||.+|||+|.+|.+||+
T Consensus       435 ~~~fQT~~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  435 FSCFQTKEHLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             ccccccCCeEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcEEec
Confidence            9999999999999999999995433  34456999999999999999999999  9999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |||+++......  ....++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+......            
T Consensus       511 DFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------  576 (694)
T KOG0694|consen  511 DFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------  576 (694)
T ss_pred             ccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------
Confidence            999999754322  244569999999999999999999999999999999999999999987543211            


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM  367 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  367 (429)
                          ...++.-  ...++...+.+...+++++|.+||++|.-+
T Consensus       577 ----FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 ----FDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----HHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                1112211  223455567889999999999999999755

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-47  Score=360.81  Aligned_cols=251  Identities=27%  Similarity=0.395  Sum_probs=216.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|..+++||+|+||.+++++++.++.         .|++|.+......  ..+....|+.++++++|||||.+++.|..
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~---------~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~   74 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDK---------LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE   74 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCc---------eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence            579999999999999999999988765         8999999876543  33467899999999999999999999999


Q ss_pred             CCe-EEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          171 DDQ-RLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       171 ~~~-~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ++. ++|||+||+||+|.+.+.+.. .-+++..+..|+.|++.|+.|||  +.+|+|||||+.|||++.++.|+|+|||+
T Consensus        75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecchhh
Confidence            988 899999999999999997765 67999999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      |+......  ......+|||.||+||++.+.+|+.|+|||||||++|||++-+++|......      ..          
T Consensus       153 aK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~L----------  214 (426)
T KOG0589|consen  153 AKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------EL----------  214 (426)
T ss_pred             hhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HH----------
Confidence            99875543  2344579999999999999999999999999999999999999999865421      11          


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +.++.. ..-.+.+..++.++..||..||+.+|..||++.++|..
T Consensus       215 i~ki~~-~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  215 ILKINR-GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHhh-ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            111111 11234455677899999999999999999999999874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-45  Score=349.68  Aligned_cols=271  Identities=30%  Similarity=0.511  Sum_probs=209.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCC-------CCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAP-------AKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~-------~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      ++|++.+.||+|+||.||+|.+.......       .....+..||+|.+..... ....++.+|+.+|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            57999999999999999999876543211       1223456899999976533 234678999999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRT------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYR  226 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHr  226 (429)
                      ++++...+..++||||+.+|+|.+++....                  ..+++..++.++.||+.||.|||  +.+|+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~ivH~  162 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVHR  162 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCcccc
Confidence            999999999999999999999999885431                  23677889999999999999999  8999999


Q ss_pred             CCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh--CCCCC
Q 014202          227 DFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT--GRRSM  304 (429)
Q Consensus       227 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf  304 (429)
                      ||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++  +..||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999999999986544333222333456889999999998899999999999999999987  55677


Q ss_pred             CCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          305 DKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .....   ...............       .......+..++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus       243 ~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         243 GELTD---EQVIENAGEFFRDQG-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CcCCH---HHHHHHHHHHhhhcc-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            64321   122221111111100       00111112234578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=358.35  Aligned_cols=268  Identities=25%  Similarity=0.418  Sum_probs=217.0

Q ss_pred             cHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcce
Q 014202           84 TFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNL  161 (429)
Q Consensus        84 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnI  161 (429)
                      ...++.+..+.+.++..||+|.||+||+|++..            .||||+++.+...  ..+.|++|+.+|++-+|.||
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NI  450 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENI  450 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhh
Confidence            345666667778889999999999999999864            6999999887553  45789999999999999999


Q ss_pred             eeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          162 VKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      +-+.|++..+.. .||+-+|+|.+|+.+|+.....|.....+.|+.||+.|+.|||  .++|||||||..|||+.++++|
T Consensus       451 lLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  451 LLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             eeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCcE
Confidence            999999988877 8999999999999999887778999999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW  318 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  318 (429)
                      ||+|||++..-..-..........|...|||||++.   ..+|++.+||||||+|+|||++|..||.....  ++-+.  
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIif--  603 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIF--  603 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEE--
Confidence            999999997533322222233356888999999986   35789999999999999999999999983221  11000  


Q ss_pred             HHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          319 ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                          +...+.+    . .........++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus       604 ----mVGrG~l----~-pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  604 ----MVGRGYL----M-PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ----Eeccccc----C-ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                0000000    0 00111223566799999999999999999999999997776654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-46  Score=337.69  Aligned_cols=279  Identities=25%  Similarity=0.326  Sum_probs=216.3

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeC--CCCchhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK--PDGLQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .....|...+.||+|+||.|..|.+..+++         .||||++.  .......++..+|+++|+.++|+||+.++++
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~---------~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di   89 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGE---------KVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI   89 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCC---------EeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence            344667778999999999999999998865         99999997  3455566788999999999999999999998


Q ss_pred             EEe-----CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          168 CIE-----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       168 ~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      +..     -..+|+|+|+| +.+|...+..+ ..++...+..+++|++.||.|+|  +.+|+||||||.|+|++.+..+|
T Consensus        90 ~~p~~~~~f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiH--SAnViHRDLKPsNll~n~~c~lK  165 (359)
T KOG0660|consen   90 FRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIH--SANVIHRDLKPSNLLLNADCDLK  165 (359)
T ss_pred             cccccccccceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhh--cccccccccchhheeeccCCCEE
Confidence            876     35789999999 56888877544 45999999999999999999999  99999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhh-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH--
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA--  319 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~--  319 (429)
                      |+|||+|+...........+..+-|.+|.|||++. ...|+.+.||||+|||+.||++|++.|.+........++...  
T Consensus       166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG  245 (359)
T KOG0660|consen  166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG  245 (359)
T ss_pred             eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence            99999999875432333446688999999999876 568999999999999999999999999987654433222100  


Q ss_pred             ------HHHHHh--hhhhhhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCcCcc
Q 014202          320 ------RQYLAD--KRKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQDLN  381 (429)
Q Consensus       320 ------~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~~~~  381 (429)
                            ...+..  .....+......+.+   .-....+...+|+.+||..||.+|+|++|.|.  .|..+++.+
T Consensus       246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence                  000000  000111111111111   11234578899999999999999999999997  556665544

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=370.52  Aligned_cols=265  Identities=23%  Similarity=0.313  Sum_probs=219.6

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeE-
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGY-  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~-  167 (429)
                      ...-+++|.+.|.+|||+.||+|.+...+         ..||+|++...+....+.+.+|+.+|++|+ |+|||.+++. 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~---------~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGG---------KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCC---------ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            33456888999999999999999988754         489999998887788889999999999998 9999999993 


Q ss_pred             EEe------CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          168 CIE------DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       168 ~~~------~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      ...      .-+++|+||||.||.|-|++..+ ...|++.++++|+.|+++|+++||.....|||||||-|||||+.+|.
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence            221      13568999999999999999765 23499999999999999999999966667999999999999999999


Q ss_pred             EEEccccCcccCCCCCccce-------eeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 014202          241 AKLSDFGLAKAGPQGDKTHV-------STRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS  310 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  310 (429)
                      +||||||.+.-.........       ......|+.|.|||++.   +..++.|+|||+|||+||-|+....||....  
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--  262 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--  262 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--
Confidence            99999999975333221110       01145799999999984   6789999999999999999999999997542  


Q ss_pred             ccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCccch
Q 014202          311 GEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDL  383 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~~~  383 (429)
                                        ...|++..+..+....++..+.+||+.||+.||++||++-+++..+..+......
T Consensus       263 ------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  263 ------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             ------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                              2345566666666678889999999999999999999999999988777664433

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.3e-46  Score=333.53  Aligned_cols=263  Identities=24%  Similarity=0.336  Sum_probs=210.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--hHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +.|+.+..|++|+||.||+|+++.+++         .||+|+++.+....  .-.-++||.+|.+.+|||||.+.++...
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~e---------IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDE---------IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcce---------eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            458889999999999999999999877         99999998764221  1235799999999999999999998765


Q ss_pred             C--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          171 D--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       171 ~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .  +.+|||||||+. +|...+.....++...++..++.|++.|++|||  .+.|+||||||+|+|++..|.+||+|||+
T Consensus       147 ~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  147 SNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             cccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEecccch
Confidence            4  579999999976 999999888889999999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh-h
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD-K  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~  326 (429)
                      |+.+....  ...+..+-|.+|.|||++.+. .|+.+.|+||+|||+.||+++++.|.+.....+.+.+   -+.+.. .
T Consensus       224 AR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I---f~llGtPt  298 (419)
T KOG0663|consen  224 AREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI---FKLLGTPS  298 (419)
T ss_pred             hhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH---HHHhCCCc
Confidence            99876642  334557889999999999875 6999999999999999999999999887654333221   111111 0


Q ss_pred             hhhhhhcC----------C-----ccccCCCHH-HHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          327 RKLYQIVD----------P-----RLELNYSLK-GVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~----------~-----~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +.+...+.          +     .++..+... .++.-.+|+..+|.+||.+|.|+++.|+
T Consensus       299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            00110000          0     000011111 3467789999999999999999999997

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=330.41  Aligned_cols=255  Identities=25%  Similarity=0.331  Sum_probs=210.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .+.|.+.+.||+|.|+.||++.+..++.         .+|+|++.....  .+.+++.+|+.|-+.|+|||||++++.+.
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~---------~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~   80 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGL---------EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   80 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchH---------HHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence            4678999999999999999998887755         899999875533  35578899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD---SEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~DF  246 (429)
                      .+...|||+|++.|++|..-+..+ .-+++..+..++.||+++|.|+|  .++|||||+||+|+|+.   ...-+||+||
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCceeeccc
Confidence            999999999999999998777655 34788899999999999999999  99999999999999993   4455999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |+|.....   .......+|||.|||||++...+|+..+|||+.||+||-||.|.+||.+....   .+   ..+.+.. 
T Consensus       158 GvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rl---ye~I~~g-  227 (355)
T KOG0033|consen  158 GLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL---YEQIKAG-  227 (355)
T ss_pred             ceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HH---HHHHhcc-
Confidence            99998652   23445579999999999999999999999999999999999999999763311   11   1111111 


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                             +...+.+.....+++.++|+++||..||.+|.|+.|.|+.-+
T Consensus       228 -------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  228 -------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             -------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence                   112223334456688999999999999999999999998543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-45  Score=351.33  Aligned_cols=251  Identities=27%  Similarity=0.336  Sum_probs=215.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh---hHHHHHHHHHHhcCC-CcceeeEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWVAEVDFLGQLH-HPNLVKLIG  166 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hpnIv~~~~  166 (429)
                      ....|.+.+.||+|.||.||+++.+.++.         .+|+|.+.+.....   ...+.+|+.+|++|. |||||.+++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~---------~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~  103 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGK---------EVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD  103 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCc---------eeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34679999999999999999999988755         99999998775543   458899999999999 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC----CCCEE
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS----EYNAK  242 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~~k  242 (429)
                      +|++...+++|||+|.||.|.+.+...  .+++..+..++.|++.++.|||  +.||+||||||+|+|+..    ++.+|
T Consensus       104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  104 AFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             EEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCCCCcEE
Confidence            999999999999999999999999877  3999999999999999999999  899999999999999943    35799


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      ++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+........        
T Consensus       180 ~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------  248 (382)
T KOG0032|consen  180 LIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------  248 (382)
T ss_pred             EeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------
Confidence            999999998654   334556899999999999999999999999999999999999999998755322111        


Q ss_pred             HHhhhhhhhhcC--CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          323 LADKRKLYQIVD--PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       323 ~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                              .+..  ..+........+..+.++|+.||..||.+|+|+.++|++
T Consensus       249 --------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 --------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                    1111  123333445567899999999999999999999999995

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-46  Score=350.57  Aligned_cols=246  Identities=24%  Similarity=0.309  Sum_probs=203.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|++.....   .....+.+|+.+|++++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEH---------YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH   71 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCC---------EEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence            368999999999999999999887655         899999865422   23456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||+.+|+|.+++.... .+++..+..++.|++.||+|||  +.||+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~  148 (291)
T cd05612          72 DQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDFGFA  148 (291)
T ss_pred             cCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEecCcc
Confidence            9999999999999999999986554 6899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......     ....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ......       
T Consensus       149 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i-------  210 (291)
T cd05612         149 KKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKI-------  210 (291)
T ss_pred             hhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-------
Confidence            8653321     2357999999999999888999999999999999999999999754321      111111       


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~~  373 (429)
                         .....  ..+...+..+.+||.+||+.||.+||+     ++++++.
T Consensus       211 ---~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         211 ---LAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---HhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               11111  122233578999999999999999995     8888864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3e-45  Score=345.69  Aligned_cols=250  Identities=28%  Similarity=0.407  Sum_probs=203.7

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      |++.+.||+|+||.||+|.+..++.         .||+|.+......   ....+.+|+.+|.+++|+||+++++++..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~   72 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCc---------eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence            7788999999999999999987755         8999998754322   234577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..++||||+++|+|.+++... ...+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.++|+|||++.
T Consensus        73 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  150 (285)
T cd05631          73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAV  150 (285)
T ss_pred             CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence            9999999999999999887543 346899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .......   .....||+.|+|||++.+..++.++|||||||++|||++|..||...........   .          .
T Consensus       151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~----------~  214 (285)
T cd05631         151 QIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---V----------D  214 (285)
T ss_pred             EcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---H----------H
Confidence            6533221   2235799999999999999999999999999999999999999986543211110   0          0


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~  372 (429)
                      ..+ ......++...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       215 ~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         215 RRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            000 00111223345578999999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-45  Score=359.44  Aligned_cols=263  Identities=26%  Similarity=0.440  Sum_probs=207.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|++...+..    .++..||+|.+..... .....+.+|+.+|+.+ +|+||+++++++..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKE----DNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcc----cccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            4799999999999999999987654331    1345799999976533 3345688999999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC--------------------------------------------------------
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT--------------------------------------------------------  194 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~--------------------------------------------------------  194 (429)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999885421                                                        


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCcccee
Q 014202          195 -------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS  261 (429)
Q Consensus       195 -------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~  261 (429)
                                   .++++..++.++.||+.||.|||  +.+|+||||||+|||+++++.+||+|||+++...........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                         24678889999999999999999  899999999999999999999999999999765433222222


Q ss_pred             eeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccC
Q 014202          262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN  340 (429)
Q Consensus       262 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (429)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||.......  ..              ...........
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~--------------~~~~~~~~~~~  335 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF--------------YKMVKRGYQMS  335 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH--------------HHHHHcccCcc
Confidence            22345678999999998899999999999999999997 999997543211  00              11111111111


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       341 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .+...+.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1222347899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-45  Score=355.43  Aligned_cols=246  Identities=26%  Similarity=0.391  Sum_probs=204.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||+|++..++.         .||+|++....   ......+.+|+.+|++++||||+++++++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   88 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGE---------YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ   88 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            469999999999999999999887654         89999987542   223456889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..|+||||+.||+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  165 (329)
T PTZ00263         89 DENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFA  165 (329)
T ss_pred             cCCEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEEEeeccCc
Confidence            9999999999999999999986654 5889999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......     ....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.      ....         
T Consensus       166 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~---------  225 (329)
T PTZ00263        166 KKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYE---------  225 (329)
T ss_pred             eEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHH---------
Confidence            8653321     2357999999999999999999999999999999999999999754321      1111         


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~~  373 (429)
                       .+....+  ..+...+..+.+||.+||+.||.+||+     +.+++.+
T Consensus       226 -~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        226 -KILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -HHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             1111111  112224467899999999999999986     6888764

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.2e-46  Score=371.87  Aligned_cols=264  Identities=31%  Similarity=0.476  Sum_probs=223.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+-...+.||+|+||+||+|....-....    ..+.||||.++..... .+.+|.+|+++|..|+|||||+++|+|..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~----~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQ----DEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCc----cceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            45666789999999999999865533211    2348999999987665 778999999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC---------CCC----CCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR---------TIP----LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE  238 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~---------~~~----~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~  238 (429)
                      +..|+|+|||..|||.++|..+         +.+    ++..+.+.|+.|||.|+.||-  ++.+|||||..+|+||.++
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhceeccc
Confidence            9999999999999999999653         223    788999999999999999999  8999999999999999999


Q ss_pred             CCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHH
Q 014202          239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~  317 (429)
                      ..|||+|||+++..-..+.......-.-..+|||||.+..+.|+.+|||||+||+|||+++ |..||.+...        
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence            9999999999998766666555444456789999999999999999999999999999999 8889876432        


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                              .+.+..+.+..+ +..+..++.+++.|+..||+.+|.+||+++||-..|.....
T Consensus       712 --------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  712 --------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             --------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                    122222333344 66778889999999999999999999999999988876554

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2e-45  Score=353.12  Aligned_cols=242  Identities=27%  Similarity=0.366  Sum_probs=199.0

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL  175 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  175 (429)
                      +.||+|+||.||+|++..++.         .||+|++....   ......+.+|+.+|++++||||+++++++..++..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGK---------YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence            469999999999999887654         99999987542   223356778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCC
Q 014202          176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG  255 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~  255 (429)
                      +||||+.||+|.+++... ..+++..+..++.||+.||+|||  +.||+||||||+|||++.++.+||+|||+++.....
T Consensus        72 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  148 (323)
T cd05571          72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence            999999999999988654 46899999999999999999999  899999999999999999999999999998753221


Q ss_pred             CccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCC
Q 014202          256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP  335 (429)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (429)
                      .  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......          +...
T Consensus       149 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~----------~~~~  210 (323)
T cd05571         149 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFEL----------ILME  210 (323)
T ss_pred             C--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHH----------HHcC
Confidence            1  112336799999999999999999999999999999999999999965321      111110          0111


Q ss_pred             ccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                      .  ..++...+.++.+||.+||+.||++||     ++.++++
T Consensus       211 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             C--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            1  112234457899999999999999999     8999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-45  Score=352.87  Aligned_cols=254  Identities=24%  Similarity=0.296  Sum_probs=206.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||++....   ......+..|+.+|..++||||+++++++.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~   71 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGE---------IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ   71 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            469999999999999999999987655         89999997542   223456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..||||||++||+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a  148 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDFGLS  148 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeCcCC
Confidence            9999999999999999999986543 5899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .....     ......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ..   .....    .
T Consensus       149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~---~~i~~----~  213 (333)
T cd05600         149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TW---ENLKY----W  213 (333)
T ss_pred             ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HH---HHHHh----c
Confidence            86433     2233679999999999999999999999999999999999999997543211   10   00000    0


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ................+.++.+||.+||..+|.+||++.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         214 KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00111111111112345789999999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.2e-45  Score=345.20  Aligned_cols=264  Identities=24%  Similarity=0.330  Sum_probs=204.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|.+.+.||.|+||.||+|++..++.         .||+|.+..... .....+.+|+.+|++++||||+++++++..+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTEN---------LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCC---------EEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            569999999999999999999887655         899999875432 2334677999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+.+ +|.+++......+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~  152 (288)
T cd07871          76 RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARA  152 (288)
T ss_pred             CeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence            999999999975 999988776666899999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH------
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA------  324 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------  324 (429)
                      ......  ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......   ......+.      
T Consensus       153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~  227 (288)
T cd07871         153 KSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRLLGTPTEET  227 (288)
T ss_pred             ccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHH
Confidence            432221  1223578999999998875 56899999999999999999999999765432111   11111000      


Q ss_pred             -----hhhhhhhhcCCccc----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          325 -----DKRKLYQIVDPRLE----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       325 -----~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                           ..........+...    .......+.++.+||.+||+.||.+|||++|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                 00000011111100    00111234678999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-45  Score=358.60  Aligned_cols=263  Identities=27%  Similarity=0.424  Sum_probs=205.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|++....    ...++..||||+++... ......+.+|+.+|..+ +||||+++++++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLF----KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccc----cCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            357999999999999999999753211    11234589999997543 23345688999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC-------------------------------------------------------
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT-------------------------------------------------------  194 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------------  194 (429)
                      ..+..++||||++||+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999885432                                                       


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCC
Q 014202          195 -------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG  255 (429)
Q Consensus       195 -------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~  255 (429)
                                         ..+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                               24678888999999999999999  899999999999999999999999999999865433


Q ss_pred             CccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ..........++..|+|||++.+..++.++|||||||++|||++ |..||......  .....+    +.          
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~----------  331 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IK----------  331 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HH----------
Confidence            22222222345678999999999999999999999999999998 88898653221  111111    11          


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      .......+...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            111111112234689999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-44  Score=341.28  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=199.1

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh---hHHHHHHHHHHhcCCCcceeeEEeEEEe----C
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWVAEVDFLGQLHHPNLVKLIGYCIE----D  171 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~  171 (429)
                      ..||+|++|.||+|.+.           |..||||.+.......   .+.+.+|+.+|.+++||||+++++++.+    .
T Consensus        26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            57999999999999873           3489999997654332   3567799999999999999999999877    3


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ...++||||++||+|.+++.+. ..+++.....++.|++.||.|||  . .+++||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHH--hcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence            4689999999999999998665 46899999999999999999999  5 589999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ......     ....|+..|+|||++.+  ..++.++|||||||++|||++|..||......      .....       
T Consensus       172 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~-------  233 (283)
T PHA02988        172 ILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDL-------  233 (283)
T ss_pred             hhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHH-------
Confidence            643321     12468899999999876  68999999999999999999999999754311      11111       


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                         +.........+...+..+.+|+.+||+.||++|||+.++++.|+.++
T Consensus       234 ---i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        234 ---IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ---HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence               11111112223345678999999999999999999999999887654

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-44  Score=338.47  Aligned_cols=259  Identities=24%  Similarity=0.423  Sum_probs=208.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+|++.+.||+|+||.||+|++...+.      .+..||+|.+..... .....+.+|+.+|.+++||||+++++++..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   78 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSK------RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG   78 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCC------ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence            468999999999999999998764322      245899999986533 3345688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++|+|.+++......+++..++.++.|++.||+|||  +.+++||||||+|||++.++.++|+|||.+..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            9999999999999999999776667899999999999999999999  89999999999999999999999999998765


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ...... .......++..|+|||.+.+..++.++|||||||++||+++ |..||......   ....   .         
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~---~---------  220 (266)
T cd05064         157 DKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIK---A---------  220 (266)
T ss_pred             ccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---H---------
Confidence            322111 11112345678999999999999999999999999999775 99999654321   1111   0         


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                        +........+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       221 --~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         221 --VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              001111122334567899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-44  Score=348.17  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=206.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|.+..... .....+.+|+.+|++++||||+++++++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGL---------IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCc---------EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            3689999999999999999999887654         899999876532 334678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++..++||||+++++|.+++.... .+++..+..++.|++.||.|||  +. +|+||||||+|||++.++.++|+|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  151 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh--hcCCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence            999999999999999999886544 5899999999999999999999  54 6999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH-Hh---
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL-AD---  325 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~---  325 (429)
                      .......    .....|++.|+|||++.+..++.++|||||||++|||++|+.||......   .+........ ..   
T Consensus       152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~  224 (331)
T cd06649         152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEG  224 (331)
T ss_pred             ccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccC
Confidence            7653321    22357999999999999889999999999999999999999999653321   0100000000 00   


Q ss_pred             -----------------------------hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 -----------------------------KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                                   ......+.....+.......+.++.+||.+||+.||++|||+.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                         000000000000111112345789999999999999999999999974

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.8e-45  Score=343.44  Aligned_cols=268  Identities=21%  Similarity=0.287  Sum_probs=204.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||+|++.....  .....+.+|+.+++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKE---------IVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCc---------EEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            469999999999999999999987655         899999875432  234567899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|+||||++++.+..+. .....+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||++.
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  148 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFAR  148 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence            99999999999987666543 44456899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH--------HH
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR--------QY  322 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~  322 (429)
                      ........ ......|++.|+|||++.+..++.++|||||||++|||++|..||................        ..
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07848         149 NLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL  227 (287)
T ss_pred             cccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence            75432211 1223578999999999998889999999999999999999999997643221110000000        00


Q ss_pred             HHhhhhhhhhcCCcccc------CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          323 LADKRKLYQIVDPRLEL------NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ............+....      ......+..+.+|+.+||+.||++|||++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000000000      0111245679999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.6e-44  Score=340.06  Aligned_cols=261  Identities=29%  Similarity=0.508  Sum_probs=211.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.....+.    ...+..||+|.+..... .....+.+|+.+|.+++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            368899999999999999999876542    11235799999875533 3345688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      ...+++|||+++++|.+++....               ..+++..++.++.|++.||.|||  ..+++|+||||+||+++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~  158 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVG  158 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEc
Confidence            99999999999999999986542               35788899999999999999999  89999999999999999


Q ss_pred             CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccH
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNL  315 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  315 (429)
                      +++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....   ..
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~  235 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV  235 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence            999999999999986543332222334567889999999988899999999999999999998 99999754321   11


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      .              ..+........+..++.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus       236 ~--------------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 I--------------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H--------------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1              1111111112234556889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.8e-44  Score=342.07  Aligned_cols=265  Identities=24%  Similarity=0.332  Sum_probs=201.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT   74 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCC---------EEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence            3679999999999999999999887654         899999875532 223456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..++||||+. ++|.+++......+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  151 (303)
T cd07869          75 KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLAR  151 (303)
T ss_pred             CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence            999999999995 6888888776667899999999999999999999  8999999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh-h
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR-K  328 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~  328 (429)
                      ......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....  .........+.... .
T Consensus       152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~  227 (303)
T cd07869         152 AKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNED  227 (303)
T ss_pred             eccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChh
Confidence            532221  11223578999999999875 457889999999999999999999997643211  11111100000000 0


Q ss_pred             -------hhhhcCCccccCCC---------HHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 -------LYQIVDPRLELNYS---------LKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 -------~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             .............+         ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                   00000000000000         012356889999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-44  Score=364.83  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=206.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      .|.+.+.||+|+||.||+|....+.        +..||+|.+..........+.+|+.+|+.++|||||++++++..++.
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~--------~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDP--------KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCC--------CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            4999999999999999999887652        23789998766655555667889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          174 RLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      .||||||++||+|.+++...   ..++++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            99999999999999887542   446889999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .......+       
T Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-------  284 (478)
T PTZ00267        218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-------  284 (478)
T ss_pred             ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-------
Confidence            75443322233446799999999999999999999999999999999999999965321      11111111       


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         .... ...+...+..+.+||.+||+.||++||++.+++.
T Consensus       285 ---~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        285 ---YGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---hCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               0000 0122234578999999999999999999999975

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=343.90  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=222.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh--HHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .+-|.+.+.||+|-|+.|-+|++.-+++         .||||++.+......  ..+..|++.|+.++|||||++|++..
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGe---------kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD   87 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGE---------KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID   87 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccc---------eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence            4679999999999999999999998866         999999988766543  56889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-cCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL-DSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill-~~~~~~kl~DFg~  248 (429)
                      ....+|||+|+=++|+|.+||.++...+.+..+.+++.||+.|+.|+|  ...+|||||||+||.+ ..-|-|||+|||+
T Consensus        88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeeeccc
Confidence            999999999999999999999999888999999999999999999999  8999999999999876 6678899999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +..+.++..   .+..||+..|.|||++.|..|+ +++||||||||||.|++|++||.....                .+
T Consensus       166 SNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SE  226 (864)
T KOG4717|consen  166 SNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SE  226 (864)
T ss_pred             cccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hh
Confidence            988766543   3457999999999999999886 689999999999999999999975432                23


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCc
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQ  378 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~  378 (429)
                      .+-.++|...  ..+...+.+.++||..||..||.+|.+.++|..  ||....
T Consensus       227 TLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  227 TLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             hhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            3445666544  356677899999999999999999999999975  554443

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-44  Score=353.93  Aligned_cols=265  Identities=25%  Similarity=0.410  Sum_probs=209.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCC-CcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLH-HPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  169 (429)
                      .++|.+++.||+|+||.||+|.+...+.    ...+..||||++..... ...+.+.+|+.+|.++. ||||+++++++.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSR----SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCC----CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            4689999999999999999998754322    11244799999975533 33457889999999996 999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC-------------------------------------------------------
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT-------------------------------------------------------  194 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------------  194 (429)
                      ..+..|||||||++|+|.+++....                                                       
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            9999999999999999999885421                                                       


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          195 ----------------------------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       195 ----------------------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                                                              ..+++..+..++.|++.||.|||  ..+|+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~Nil  269 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHhEE
Confidence                                                    23677888999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--  347 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--  347 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence            99999999999999986543222222223457788999999998899999999999999999997 999986532110  


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..              ...+........+...+..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus       348 ~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 TF--------------YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HH--------------HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            00              0011111111223345678999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=346.29  Aligned_cols=240  Identities=29%  Similarity=0.377  Sum_probs=196.7

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ||+|+||.||+|++..++.         .||+|++....   ......+.+|+.+|.+++||||+++++++..++..|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQR---------IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence            7999999999999987655         89999986532   23345678899999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+|||+++...... 
T Consensus        72 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-  147 (312)
T cd05585          72 LAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-  147 (312)
T ss_pred             EcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-
Confidence            99999999999986643 5899999999999999999999  8999999999999999999999999999998643221 


Q ss_pred             cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCcc
Q 014202          258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL  337 (429)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (429)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......          +.... 
T Consensus       148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~----------~~~~~-  209 (312)
T cd05585         148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRK----------ILQEP-  209 (312)
T ss_pred             -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHH----------HHcCC-
Confidence             122346799999999999999999999999999999999999999975321      111111          11111 


Q ss_pred             ccCCCHHHHHHHHHHHHHcccCCCCCCCC---HhHHHH
Q 014202          338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPS---MDEVVK  372 (429)
Q Consensus       338 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~eil~  372 (429)
                       ...+...+..+.+||.+||+.||.+||+   +.+++.
T Consensus       210 -~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         210 -LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             -CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence             1222344578999999999999999975   566665

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.8e-44  Score=352.89  Aligned_cols=254  Identities=24%  Similarity=0.304  Sum_probs=200.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .|.+++.||+|+||+||+|++..++.         .||||++.....   .....+.+|+.+|++++||||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHA---------LYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            58899999999999999999887655         899999975432   234567899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++.+|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFGl~~  149 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFGLCT  149 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence            999999999999999999986554 5899999999999999999999  8999999999999999999999999999975


Q ss_pred             cCCCCCc---------------------------------------------cceeeeccccccccChhhhhcCCCCCcc
Q 014202          251 AGPQGDK---------------------------------------------THVSTRVVGTYGYAAPEYVMTGHLTSKS  285 (429)
Q Consensus       251 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~  285 (429)
                      .......                                             .......+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (381)
T cd05626         150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC  229 (381)
T ss_pred             ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence            4211000                                             0011235799999999999988999999


Q ss_pred             chhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcc--cCCCCC
Q 014202          286 DVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCL--SRDPKS  363 (429)
Q Consensus       286 DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dP~~  363 (429)
                      |||||||++|||++|..||....+....      ..       +.. ....+..+.....+.++.+||.+|+  ..+|..
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~------~~-------i~~-~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~  295 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQ------LK-------VIN-WENTLHIPPQVKLSPEAVDLITKLCCSAEERLG  295 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHH------HH-------HHc-cccccCCCCCCCCCHHHHHHHHHHccCcccccC
Confidence            9999999999999999999764321100      00       000 0111111222234578899999855  455566


Q ss_pred             CCCHhHHHHH
Q 014202          364 RPSMDEVVKV  373 (429)
Q Consensus       364 Rpt~~eil~~  373 (429)
                      ||++.+++..
T Consensus       296 R~~~~~~l~h  305 (381)
T cd05626         296 RNGADDIKAH  305 (381)
T ss_pred             CCCHHHHhcC
Confidence            9999999973

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9e-45  Score=350.52  Aligned_cols=247  Identities=25%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||+|.+..++        +..||+|.+....   ......+.+|+.+|+.++||||+++++++.
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNED--------FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCC--------CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            46999999999999999999876543        2379999986432   223456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||+.||+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence            9999999999999999999986554 5899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ......     .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.      .....        
T Consensus       179 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~--------  239 (340)
T PTZ00426        179 KVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQK--------  239 (340)
T ss_pred             eecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHH--------
Confidence            864321     12357999999999999988999999999999999999999999754321      00011        


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                        +.....  .++...+..+.++|++||+.||.+|+     +++++++.
T Consensus       240 --i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        240 --ILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --HhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              111111  12223446789999999999999995     89999874

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.1e-44  Score=347.58  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=196.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|..++.||+|+||.||+|++..+++         .||||++..... .....+.+|+.+|+.++|+||+++++++..+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  144 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGR---------LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN  144 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCC---------EEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence            357778999999999999999877654         899999965433 2346688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +.+++||||+++|+|.+..     ...+..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||++..
T Consensus       145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999986532     3467788899999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ......  ......||..|+|||++..     ...+.++|||||||++|||++|+.||......   ........     
T Consensus       218 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~-----  287 (353)
T PLN00034        218 LAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCA-----  287 (353)
T ss_pred             cccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHH-----
Confidence            533211  1223579999999998743     23456899999999999999999999733221   11110000     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        ..    ...........+.++.+||.+||+.||++||++.|+++.
T Consensus       288 --~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        288 --IC----MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --Hh----ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00    000111223345789999999999999999999999984

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-44  Score=353.16  Aligned_cols=254  Identities=23%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||++....   ......+.+|+.+|..++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGH---------IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ   71 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            369999999999999999999987655         89999997542   123345778999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||++||+|.+++.... .+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.++|+|||++
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  148 (364)
T cd05599          72 DENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDFGLC  148 (364)
T ss_pred             cCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeecccc
Confidence            9999999999999999999986654 5899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccc------------------------------------eeeeccccccccChhhhhcCCCCCccchhhhHHH
Q 014202          250 KAGPQGDKTH------------------------------------VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVV  293 (429)
Q Consensus       250 ~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  293 (429)
                      ..........                                    .....+||+.|+|||++.+..++.++|||||||+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  228 (364)
T cd05599         149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI  228 (364)
T ss_pred             eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence            7542211000                                    0112469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC---HhHH
Q 014202          294 LLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS---MDEV  370 (429)
Q Consensus       294 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ei  370 (429)
                      +|||++|..||....+.      ......+.       . ...+..+.....++.+.+||.+||. +|.+|++   +.++
T Consensus       229 l~el~~G~~Pf~~~~~~------~~~~~i~~-------~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l  293 (364)
T cd05599         229 MYEMLVGYPPFCSDNPQ------ETYRKIIN-------W-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI  293 (364)
T ss_pred             HHHhhcCCCCCCCCCHH------HHHHHHHc-------C-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence            99999999999754321      11111100       0 0111111112345788999999996 9999997   9999


Q ss_pred             HHH
Q 014202          371 VKV  373 (429)
Q Consensus       371 l~~  373 (429)
                      +..
T Consensus       294 l~h  296 (364)
T cd05599         294 KSH  296 (364)
T ss_pred             hcC
Confidence            873

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-44  Score=347.16  Aligned_cols=243  Identities=26%  Similarity=0.370  Sum_probs=199.1

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL  175 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  175 (429)
                      +.||+|+||.||+|.+..++.         .||+|++....   ......+.+|+.+|+.++||||+++++++..++..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGK---------YYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence            469999999999999887655         99999997542   233456788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCC
Q 014202          176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG  255 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~  255 (429)
                      +||||+++|+|.+++... ..+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        72 lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~  148 (328)
T cd05593          72 FVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD  148 (328)
T ss_pred             EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence            999999999999888654 46899999999999999999999  899999999999999999999999999998753221


Q ss_pred             CccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCC
Q 014202          256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP  335 (429)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (429)
                      .  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......      .....          +...
T Consensus       149 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~----------~~~~  210 (328)
T cd05593         149 A--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFEL----------ILME  210 (328)
T ss_pred             c--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHH----------hccC
Confidence            1  1123367999999999999889999999999999999999999999653211      11111          0101


Q ss_pred             ccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                        ....+...+.++.+||.+||+.||++|+     ++.++++.
T Consensus       211 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 --DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              1112233457899999999999999997     89999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=331.72  Aligned_cols=249  Identities=26%  Similarity=0.393  Sum_probs=219.8

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeE
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      |.++.+||+|+||.||+|.+++++.         .+|||.+..+  .+.+++..|+.||++++.|+||++|+.|.....+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~---------v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGH---------VLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCc---------EEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            7778899999999999999998755         9999999766  5668899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      +||||||..|++.+++..++.++.+.++..++...+.||+|||  ...-||||||..|||++.+|..||+|||.|..+.+
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            9999999999999999999999999999999999999999999  88899999999999999999999999999987543


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                        .....+...|||.|||||++..-.|+.++||||||++..||..|++||....|.....+               --.+
T Consensus       182 --TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------IPT~  244 (502)
T KOG0574|consen  182 --TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------IPTK  244 (502)
T ss_pred             --hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------------ccCC
Confidence              22334457899999999999999999999999999999999999999987665322111               0123


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +......+..++.++.++++.||-++|++|.|+.+++++
T Consensus       245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            445566778889999999999999999999999999874

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.9e-44  Score=350.59  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=199.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||+||+|.+..++.         .||+|++.....   .....+..|+.++.+++||||+++++.+.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~   71 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGH---------VYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ   71 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCC---------EEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            468999999999999999999887654         899999975422   23356788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++..+|+||||++||+|.+++.+.. .+++..+..++.|++.||+|||  +.||+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DFGla  148 (363)
T cd05628          72 DKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDFGLC  148 (363)
T ss_pred             cCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeeccCc
Confidence            9999999999999999999986654 6899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCcc---------------------------------ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHH
Q 014202          250 KAGPQGDKT---------------------------------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE  296 (429)
Q Consensus       250 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  296 (429)
                      +........                                 ......+||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e  228 (363)
T cd05628         149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence            754321100                                 00123579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCC---CCCCHhHHHHH
Q 014202          297 ILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPK---SRPSMDEVVKV  373 (429)
Q Consensus       297 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rpt~~eil~~  373 (429)
                      |++|..||....+..      ......       .. ...+..+.....++++.++|.+|+. +|.   .||+++||++.
T Consensus       229 ll~G~~Pf~~~~~~~------~~~~i~-------~~-~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         229 MLIGYPPFCSETPQE------TYKKVM-------NW-KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHhCCCCCCCCCHHH------HHHHHH-------cC-cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            999999997543211      111100       00 0011111111234678899988764 444   45899999873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=353.80  Aligned_cols=269  Identities=30%  Similarity=0.480  Sum_probs=219.2

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC---CchhhHHHHHHHHHHhcCCCcceeeE
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD---GLQGHREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      +....++-.+.++||+|+||.||+|.....+....     ..||||..+..   ......++.+|+++|++++|||||++
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~-----~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKV-----VPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCcee-----eeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            33344566667999999999999999887543111     13899999853   24567889999999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ||+...+..++||||+|.||+|.++|.+....++..+...++.+.+.||+|||  .+++|||||..+|+|++.++.+||+
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEeC
Confidence            99999999999999999999999999888777999999999999999999999  9999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||+++....-  ........-...|+|||.+....|+.++|||||||++||+++ |..||.+....      +      
T Consensus       305 DFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~------  370 (474)
T KOG0194|consen  305 DFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------E------  370 (474)
T ss_pred             ccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------H------
Confidence            99999864311  111111235678999999999999999999999999999999 88898765421      1      


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                          ....+.....+...+...+..+..++.+||..||++||+|.++.+.|+.+....
T Consensus       371 ----v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  371 ----VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             ----HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                011121333444555566788999999999999999999999999887776544

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=348.00  Aligned_cols=241  Identities=29%  Similarity=0.461  Sum_probs=206.0

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ++-||.|+.|.||+|+...           ..||||+++.-.       ..+|+-|++|+||||+.|.++|.....+|||
T Consensus       129 LeWlGSGaQGAVF~Grl~n-----------etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHN-----------ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             hhhhccCcccceeeeeccC-----------ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            5679999999999999764           389999885322       3688899999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      ||||..|-|...|... .++.......|..+|+.|+.|||  .+.|||||||.-||||..+..|||+|||-++..... .
T Consensus       191 MEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH--~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-S  266 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLH--LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-S  266 (904)
T ss_pred             eeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHH--HhhHhhhccCCCceEeeccceEEeccccchHhhhhh-h
Confidence            9999999999998655 46888999999999999999999  899999999999999999999999999999865432 2


Q ss_pred             cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCcc
Q 014202          258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL  337 (429)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (429)
                        ..-.++||..|||||++.+.+.+.|+|||||||||||||||..||.......                -+...-...+
T Consensus       267 --TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----------------IIwGVGsNsL  328 (904)
T KOG4721|consen  267 --TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----------------IIWGVGSNSL  328 (904)
T ss_pred             --hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----------------eEEeccCCcc
Confidence              2334899999999999999999999999999999999999999997543211                1222234455


Q ss_pred             ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       338 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .++.+..+++.|.-|++.||+..|..||++.+|+.+|+-..
T Consensus       329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            66777888899999999999999999999999999876443

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-44  Score=350.54  Aligned_cols=261  Identities=19%  Similarity=0.252  Sum_probs=199.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|.+.+.||+|+||.||+|++..++.         .||+|....      ..+.+|+.+|++|+||||+++++++..+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~---------~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~  155 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCE---------HVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN  155 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCC---------EEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence            4679999999999999999999987755         899997542      3467899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++|||++. ++|..++... ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++..
T Consensus       156 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        156 KFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             CeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            99999999994 6888888654 35899999999999999999999  89999999999999999999999999999975


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc----cHHHHHHHHHH---
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ----NLVAWARQYLA---  324 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~---  324 (429)
                      ..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.........    .....+.....   
T Consensus       232 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p  310 (391)
T PHA03212        232 PVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP  310 (391)
T ss_pred             ccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence            32211 11223467999999999999989999999999999999999999887543321110    00000000000   


Q ss_pred             ---------hhhhhh----hhcCCccc----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 ---------DKRKLY----QIVDPRLE----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ---------~~~~~~----~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                               .....+    ........    .......+.++.+||.+||+.||.+|||+.|+++
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                     000000    00000000    0001134568999999999999999999999997

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-45  Score=352.70  Aligned_cols=254  Identities=26%  Similarity=0.347  Sum_probs=206.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||+|.+..++.         .||||++.....   .....+..|+.+|..++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ---------VYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ   71 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCC---------EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence            469999999999999999999987654         999999975422   33456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||++|++|.+++.+. ..+++..+..++.|++.||+|||  ..||+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~  148 (350)
T cd05573          72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADFGLC  148 (350)
T ss_pred             cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecCCCC
Confidence            999999999999999999999766 46899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCC---------------------------ccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCC
Q 014202          250 KAGPQGD---------------------------KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR  302 (429)
Q Consensus       250 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  302 (429)
                      .......                           .........||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence            8654322                           0011223579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-HhHHHHH
Q 014202          303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-MDEVVKV  373 (429)
Q Consensus       303 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~eil~~  373 (429)
                      ||......      .....       +... ......+.....+..+.+||.+||. ||.+||+ +.++++.
T Consensus       229 Pf~~~~~~------~~~~~-------i~~~-~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         229 PFYSDTLQ------ETYNK-------IINW-KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCHH------HHHHH-------Hhcc-CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            99764421      11111       1000 0111111112246789999999997 9999999 9999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-44  Score=346.31  Aligned_cols=243  Identities=27%  Similarity=0.371  Sum_probs=198.2

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL  175 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  175 (429)
                      +.||+|+||.||+|++..++.         .||+|++....   ......+.+|+.+|+.++||||+++++++..++..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGR---------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence            469999999999999877654         99999987542   223345678999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCC
Q 014202          176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG  255 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~  255 (429)
                      +||||+++|+|..++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||++......
T Consensus        72 lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  148 (323)
T cd05595          72 FVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence            9999999999998886543 6899999999999999999999  899999999999999999999999999998753222


Q ss_pred             CccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCC
Q 014202          256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP  335 (429)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (429)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|..||......      .....          +...
T Consensus       149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~----------~~~~  210 (323)
T cd05595         149 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFEL----------ILME  210 (323)
T ss_pred             CC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHH----------HhcC
Confidence            11  122357999999999999999999999999999999999999999754321      11111          1111


Q ss_pred             ccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                      ..  ..+...++.+.+||.+||+.||++||     ++.++++.
T Consensus       211 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         211 EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CC--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            11  12233457899999999999999998     88888863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-44  Score=331.76  Aligned_cols=260  Identities=27%  Similarity=0.476  Sum_probs=209.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+...+.      ....||||.+..... ....++.+|+.++++++||||+++++++...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS   77 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence            569999999999999999999875422      134799999876533 3345788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+|+||||+|||++.++.++|+|||++..
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            9999999999999999999776667899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ......          +.
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~----------~~  222 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKA----------VE  222 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHH----------HH
Confidence            642222222222345678999999998899999999999999999998 9999864321   111110          00


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .    ....+.+...+..+.+|+.+||+.+|++||++.+|++.|..+
T Consensus       223 ~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 D----GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             c----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0    011112233457899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-44  Score=352.30  Aligned_cols=254  Identities=22%  Similarity=0.282  Sum_probs=200.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||+|.+..++.         .||||++....   ......+.+|+.+|++++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   71 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGK---------IYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ   71 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCC---------EEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            368999999999999999999887655         89999986542   223456788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||++||+|.+++... ..+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~DfGla  148 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDFGLS  148 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999999998654 46899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCcc---------------------------------------------ceeeeccccccccChhhhhcCCCCCc
Q 014202          250 KAGPQGDKT---------------------------------------------HVSTRVVGTYGYAAPEYVMTGHLTSK  284 (429)
Q Consensus       250 ~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~  284 (429)
                      +........                                             ......+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  228 (377)
T cd05629         149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE  228 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence            632211000                                             00012469999999999999999999


Q ss_pred             cchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCC
Q 014202          285 SDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR  364 (429)
Q Consensus       285 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  364 (429)
                      +|||||||++|||++|..||.......      .......       . ...+..+.....+.++.+||.+||. +|.+|
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~-------~-~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r  293 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSENSHE------TYRKIIN-------W-RETLYFPDDIHLSVEAEDLIRRLIT-NAENR  293 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCCCHHH------HHHHHHc-------c-CCccCCCCCCCCCHHHHHHHHHHhc-CHhhc
Confidence            999999999999999999997543211      0011000       0 0011111112345789999999997 77765


Q ss_pred             ---CCHhHHHHH
Q 014202          365 ---PSMDEVVKV  373 (429)
Q Consensus       365 ---pt~~eil~~  373 (429)
                         +++.+++..
T Consensus       294 ~~r~~~~~~l~h  305 (377)
T cd05629         294 LGRGGAHEIKSH  305 (377)
T ss_pred             CCCCCHHHHhcC
Confidence               599999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-44  Score=348.46  Aligned_cols=253  Identities=24%  Similarity=0.255  Sum_probs=205.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||+|.+..++.         .||+|++.....   .....+.+|+.+++.++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~   71 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGD---------IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ   71 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            368999999999999999999887655         899999975432   23456788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||++||+|.+++.+....+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a  149 (330)
T cd05601          72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADFGSA  149 (330)
T ss_pred             cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccCCCC
Confidence            999999999999999999999877567999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhh------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVM------TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      ......... ......||+.|+|||++.      +..++.++|||||||++|||++|..||......      ......+
T Consensus       150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~  222 (330)
T cd05601         150 ARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIM  222 (330)
T ss_pred             eECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHH
Confidence            865432221 223357999999999986      456789999999999999999999999754321      1111111


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..        ......+.....+..+.+|+..||. ||.+||++.+++.
T Consensus       223 ~~--------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         223 NF--------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cC--------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            00        0111111122345789999999997 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.4e-44  Score=344.71  Aligned_cols=266  Identities=23%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||+|+||.||+|++..++.         .||||.+...  .......+.+|+.+|+.++||||+++++++...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   71 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGE---------KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP   71 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCC---------EEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence            58899999999999999999887655         8999998643  223345688999999999999999999987643


Q ss_pred             C-----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          172 D-----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       172 ~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      .     ..|+||||+ +++|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          72 SRREFKDIYVVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             CCCCCceEEEEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEccC
Confidence            2     479999999 468988886543 5899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCc-cceeeeccccccccChhhhhc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH------
Q 014202          247 GLAKAGPQGDK-THVSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA------  317 (429)
Q Consensus       247 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~------  317 (429)
                      |+++....... ........||+.|+|||++.+  ..++.++|||||||++|||++|++||.+.........+.      
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~  227 (338)
T cd07859         148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP  227 (338)
T ss_pred             ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99986432221 112234579999999999875  678999999999999999999999997643211100000      


Q ss_pred             ---HHHHHHH-hhhhhhhhcCCccccCC---CHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 ---WARQYLA-DKRKLYQIVDPRLELNY---SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 ---~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         ....... ........+........   ....+..+.+++.+||+.||++||+++++++
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence               0000000 00001111111111000   0123467889999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.3e-44  Score=342.22  Aligned_cols=262  Identities=24%  Similarity=0.406  Sum_probs=208.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+|++.+.||+|+||.||+|.+..++...     ...||+|.+.... ....+++.+|+.+++.++||||+++++++..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKV-----KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCcc-----ceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            46999999999999999999987654421     2359999987543 23456788999999999999999999998764


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                       ..++|+||+.+|+|.+++......+++..++.++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEcccccccc
Confidence             567999999999999999877667899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............++..|+|||++.+..++.++|||||||++|||++ |..||......   ..              .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~--------------~  221 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI--------------S  221 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH--------------H
Confidence            644332222222345678999999999999999999999999999998 99999753211   01              0


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ..+........+..++..+.+++.+||..||++||++.+++..|..+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            1111111111222344678999999999999999999999998766644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-43  Score=348.05  Aligned_cols=267  Identities=24%  Similarity=0.269  Sum_probs=204.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ...+|.+.+.||.|+||.||+|.......       +..||+|.+...     ....+|+.+|++++||||+++++++..
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~-------~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~  157 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQ-------RKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW  157 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCcc-------ceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence            45689999999999999999998654332       458999988643     234689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ....|+|||++. ++|.+++ .....+++..++.++.||+.||.|||  ..+|+||||||+|||++.++.++|+|||++.
T Consensus       158 ~~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        158 KSTVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             CCEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            999999999995 6888888 44456899999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh----
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK----  326 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  326 (429)
                      ...............||+.|+|||++.+..++.++|||||||++|||++|..||.+............+...+...    
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            6544333222334679999999999999999999999999999999999999997765433221111111100000    


Q ss_pred             ------------hhhhhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 ------------RKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                  ........+....+   .....+.++.++|.+||..||++||++.+++..
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                        00000000000000   001234578899999999999999999999984

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.7e-44  Score=361.80  Aligned_cols=256  Identities=26%  Similarity=0.317  Sum_probs=206.9

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ...++|.+.+.||+|+||+||+|++..++.         .||||.+.....  .....+.+|+.+|..++|+||+++++.
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~---------~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~   99 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGE---------PFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED   99 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCC---------EEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence            445789999999999999999999887655         999999876533  334567899999999999999999987


Q ss_pred             EEeCC--------eEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          168 CIEDD--------QRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       168 ~~~~~--------~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      +...+        .+++||||+.+|+|.+++...   ...+++..+..++.|++.||.|||  +.+|+||||||+|||++
T Consensus       100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NILl~  177 (496)
T PTZ00283        100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANILLC  177 (496)
T ss_pred             eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEe
Confidence            75432        368999999999999988653   346899999999999999999999  89999999999999999


Q ss_pred             CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  316 (429)
                      .++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~  251 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------E  251 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------H
Confidence            9999999999999865433222233446899999999999999999999999999999999999999975321      1


Q ss_pred             HHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ......+          ... ....+...++++.+|+.+||+.||.+||++.+++..
T Consensus       252 ~~~~~~~----------~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 EVMHKTL----------AGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHh----------cCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111111          100 011223445789999999999999999999999863

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.8e-44  Score=334.82  Aligned_cols=260  Identities=29%  Similarity=0.465  Sum_probs=208.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|.+.+.||+|+||.||+|.+.....    ...+..||+|.+...... ....+.+|+++|+.++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEP----ENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccC----cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            468899999999999999998754311    112458999999765443 456889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRT-------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE  238 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~  238 (429)
                      ...++||||+++++|.+++...+             ..+++..+..++.|++.||.|||  ..+++||||||+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~  158 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcCC
Confidence            99999999999999999996542             34788899999999999999999  8999999999999999999


Q ss_pred             CCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHH
Q 014202          239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~  317 (429)
                      +.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......   ....
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~  235 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIE  235 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH
Confidence            9999999999976433222222223456788999999999999999999999999999998 99998654321   1111


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .             +... .....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus       236 ~-------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 C-------------ITQG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             H-------------HHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            0             0011 111112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.6e-44  Score=352.38  Aligned_cols=252  Identities=25%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +|.+++.||+|+||.||+|++..++.         .||+|++.....   .....+.+|+.+|++++||||+++++.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKA---------LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCC---------EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            58899999999999999999887655         899999875422   234567899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|+||||++||+|.+++.+.+ .+++..+..++.||+.||+|||  +.+|+||||||+|||++.+|.+||+|||++.
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFGla~  149 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence            999999999999999999886653 5889999999999999999999  8999999999999999999999999999975


Q ss_pred             cCCCCC---------------------------------------------ccceeeeccccccccChhhhhcCCCCCcc
Q 014202          251 AGPQGD---------------------------------------------KTHVSTRVVGTYGYAAPEYVMTGHLTSKS  285 (429)
Q Consensus       251 ~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  285 (429)
                      ......                                             ........+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (382)
T cd05625         150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  229 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence            321000                                             00001235799999999999999999999


Q ss_pred             chhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014202          286 DVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP  365 (429)
Q Consensus       286 DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  365 (429)
                      |||||||++|||++|..||....+...      ...       +.. .......+.....++++.++|.+|+ .||.+|+
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~------~~~-------i~~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~  294 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLET------QMK-------VIN-WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRL  294 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHH------HHH-------HHc-cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcC
Confidence            999999999999999999976432110      000       000 0111112222334578889998876 5999998


Q ss_pred             C---HhHHHH
Q 014202          366 S---MDEVVK  372 (429)
Q Consensus       366 t---~~eil~  372 (429)
                      +   +.+++.
T Consensus       295 ~~~~~~ei~~  304 (382)
T cd05625         295 GKNGADEIKA  304 (382)
T ss_pred             CCCCHHHHhc
Confidence            7   888876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.3e-44  Score=343.20  Aligned_cols=266  Identities=25%  Similarity=0.348  Sum_probs=203.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||.|+||.||+|.+..++.         .+|+|.+..... .....+.+|+++|++++||||+++++++..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~---------~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGL---------IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCc---------EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            3689999999999999999999877654         899999876532 334568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..++||||+.+|+|.+++.... .+++..+..++.|++.||.|||. ..+|+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence            999999999999999999986543 58899999999999999999993 2479999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH-------------
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA-------------  317 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~-------------  317 (429)
                      .....    ......|+..|+|||++.+..++.++|||||||++|+|++|..||.............             
T Consensus       153 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (333)
T cd06650         153 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS  228 (333)
T ss_pred             hhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence            64322    1223578999999999998889999999999999999999999997543210000000             


Q ss_pred             --------HHHHHHH------hhhhhhh-hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 --------WARQYLA------DKRKLYQ-IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 --------~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                              ....+..      ....+.. +.....+.......+.++.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                    0000000      0000000 00000000001123467899999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6e-45  Score=318.39  Aligned_cols=253  Identities=27%  Similarity=0.406  Sum_probs=208.5

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----hhh----HHHHHHHHHHhcCC-Cc
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGH----REWVAEVDFLGQLH-HP  159 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~----~~~~~E~~~l~~l~-hp  159 (429)
                      +....+|...++||.|..+.|.++.++.++.         .+|+|++.....    +..    +.-..|+.||+++. ||
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~---------e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP   83 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGK---------EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHP   83 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhccccc---------ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCC
Confidence            3445678889999999999999988887755         899999865422    112    33468999999985 99


Q ss_pred             ceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 014202          160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY  239 (429)
Q Consensus       160 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~  239 (429)
                      +|+++.++|+.+...++|+|.|+.|.|.|+|... ..+++.....|+.|+++|+.|||  ..+||||||||+|||+|++.
T Consensus        84 ~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENILlddn~  160 (411)
T KOG0599|consen   84 YIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENILLDDNM  160 (411)
T ss_pred             cEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhheeecccc
Confidence            9999999999999999999999999999999654 46899999999999999999999  89999999999999999999


Q ss_pred             CEEEccccCcccCCCCCccceeeeccccccccChhhhhc------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 014202          240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ  313 (429)
Q Consensus       240 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  313 (429)
                      ++||+|||++.....+...   ...||||+|+|||.+..      ..|+..+|+||+||++|.||.|.+||....     
T Consensus       161 ~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----  232 (411)
T KOG0599|consen  161 NIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----  232 (411)
T ss_pred             ceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----
Confidence            9999999999988776543   35799999999998852      468889999999999999999999995321     


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccc--cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLE--LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                              .+.   .+.-++.....  .+...+.+....+||.+||+.||.+|.|++|+|.
T Consensus       233 --------Qml---MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 --------QML---MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             --------HHH---HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                    111   11122222222  2233456788999999999999999999999987

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.2e-44  Score=353.25  Aligned_cols=254  Identities=24%  Similarity=0.286  Sum_probs=201.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||.||+|++..++.         .||||++.....   .....+.+|+.+|++++||||+++++.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNA---------LYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ   71 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCC---------EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            369999999999999999999887654         899999865321   23356789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++.+|+||||++||+|.+++.+.+ .+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DFG~a  148 (376)
T cd05598          72 DKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLC  148 (376)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence            9999999999999999999986654 5889999999999999999999  899999999999999999999999999997


Q ss_pred             ccCCCCC-----------------------------------------ccceeeeccccccccChhhhhcCCCCCccchh
Q 014202          250 KAGPQGD-----------------------------------------KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVY  288 (429)
Q Consensus       250 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  288 (429)
                      .......                                         ........+||+.|+|||++.+..++.++|||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  228 (376)
T cd05598         149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  228 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence            5321000                                         00001235799999999999999999999999


Q ss_pred             hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC---
Q 014202          289 SFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP---  365 (429)
Q Consensus       289 SlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---  365 (429)
                      ||||++|||++|..||....+...      .....        ..............+..+.++|.+|+ .+|.+|+   
T Consensus       229 SlGvilyell~G~~Pf~~~~~~~~------~~~i~--------~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~  293 (376)
T cd05598         229 SVGVILYEMLVGQPPFLADTPAET------QLKVI--------NWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN  293 (376)
T ss_pred             eccceeeehhhCCCCCCCCCHHHH------HHHHh--------ccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence            999999999999999976542111      00000        00011111112234577889999976 5999999   


Q ss_pred             CHhHHHHH
Q 014202          366 SMDEVVKV  373 (429)
Q Consensus       366 t~~eil~~  373 (429)
                      ++.++++.
T Consensus       294 t~~ell~h  301 (376)
T cd05598         294 GADEIKAH  301 (376)
T ss_pred             CHHHHhCC
Confidence            89999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4e-44  Score=345.83  Aligned_cols=265  Identities=28%  Similarity=0.427  Sum_probs=206.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||.|+||.||+|....++.    ..+++.||+|++..... ...+.+..|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~----~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEK----SASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEecccccccc----ccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            3579999999999999999998654322    12356899999875432 2345678899999999 7999999999876


Q ss_pred             eC-CeEEEEEEecCCCChHHHHhcCC------------------------------------------------------
Q 014202          170 ED-DQRLLVYEFMTRGSLENHLFRRT------------------------------------------------------  194 (429)
Q Consensus       170 ~~-~~~~lv~e~~~gg~L~~~l~~~~------------------------------------------------------  194 (429)
                      .. ..++++|||+++++|.+++....                                                      
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            54 56789999999999999885421                                                      


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccc
Q 014202          195 ------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY  268 (429)
Q Consensus       195 ------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~  268 (429)
                            ..+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.++|+|||++................++.
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                  25788999999999999999999  8999999999999999999999999999998754332222222345677


Q ss_pred             cccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHH
Q 014202          269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQ  347 (429)
Q Consensus       269 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .|+|||++.+..++.++|||||||++|||++ |..||.......  ...    ..+.          .......+...+.
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~----------~~~~~~~~~~~~~  303 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLK----------EGTRMRAPEYATP  303 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHh----------ccCCCCCCccCCH
Confidence            8999999999999999999999999999998 999997533211  010    0010          0011111223447


Q ss_pred             HHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          348 KVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       348 ~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ++.+++.+||+.+|++||++.++++.|+.+.
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            8999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8e-44  Score=343.38  Aligned_cols=256  Identities=27%  Similarity=0.361  Sum_probs=202.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC----chhhHHHHHHHHHHhcCC-CcceeeEEeEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG----LQGHREWVAEVDFLGQLH-HPNLVKLIGYC  168 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  168 (429)
                      +|++.+.||+|+||.||+|+.....      .+|..||+|++....    ......+..|+.+|..++ ||||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGH------DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence            4889999999999999999875422      135689999986532    123355778999999995 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..++..++||||+.||+|.+++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~DfG~  151 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGL  151 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence            99999999999999999999986554 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ++........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||..........  ......     
T Consensus       152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~-----  223 (332)
T cd05614         152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRI-----  223 (332)
T ss_pred             CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHH-----
Confidence            9864332221 22246799999999998865 47889999999999999999999997543222111  111100     


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                        . ..++    ..+...+..+.+++.+||+.||++||     +++++++.
T Consensus       224 --~-~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         224 --L-KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --h-cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              0 0111    12223457789999999999999999     77788874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-43  Score=328.28  Aligned_cols=249  Identities=29%  Similarity=0.439  Sum_probs=199.6

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +.||+|+||.||+|.+..++.         .||+|.+..... .....+.+|+.+|++++||||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~---------~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNT---------PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV   71 (252)
T ss_pred             CccCcccCccEEEEEEecCCc---------eEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence            469999999999999877654         899998865432 3346688999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+.+++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++........
T Consensus        72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence            9999999999999766666899999999999999999999  89999999999999999999999999999876432211


Q ss_pred             cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCc
Q 014202          258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR  336 (429)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |..||......   ..              ...+...
T Consensus       150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~--------------~~~~~~~  212 (252)
T cd05084         150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT--------------REAIEQG  212 (252)
T ss_pred             cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH--------------HHHHHcC
Confidence            111111123457999999998889999999999999999998 88888643211   00              0011111


Q ss_pred             cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .....+...+..+.+|+.+||+.||++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            111223344578999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-44  Score=345.56  Aligned_cols=243  Identities=27%  Similarity=0.369  Sum_probs=197.7

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL  175 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  175 (429)
                      +.||+|+||.||+|.+..++.         .||+|++....   ......+..|+.++..++||||+++++++..++..|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGR---------YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence            469999999999999877654         99999997542   223356678999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      +||||+++|+|..++.... .+++..+..++.||+.||.|||  + .+|+||||||+|||++.++.+||+|||+++....
T Consensus        72 lv~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH--~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~  148 (325)
T cd05594          72 FVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  148 (325)
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence            9999999999998886543 6899999999999999999999  6 7999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||......      .....          +..
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~----------i~~  210 (325)
T cd05594         149 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFEL----------ILM  210 (325)
T ss_pred             CCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHH----------Hhc
Confidence            211  122357999999999999999999999999999999999999999754311      11000          001


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                      ..  ..++...+.++.+||.+||+.||++|+     ++.++++.
T Consensus       211 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         211 EE--IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            11  112223457899999999999999996     89999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5e-44  Score=343.59  Aligned_cols=246  Identities=27%  Similarity=0.412  Sum_probs=197.1

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHH---hcCCCcceeeEEeEE
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFL---GQLHHPNLVKLIGYC  168 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~  168 (429)
                      |++.+.||+|+||.||+|.+..++.         .||||++....   ......+..|+.++   +.++||||+++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~   71 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGE---------LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF   71 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence            6788999999999999999887655         89999997542   12234566666654   567899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ...+..|+||||++|++|..++..  ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05589          72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGL  147 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCcccC
Confidence            999999999999999999988754  35899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +.......  ......+|++.|+|||++.+..++.++|||||||++|||++|..||.+....      .....       
T Consensus       148 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~-------  212 (324)
T cd05589         148 CKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDS-------  212 (324)
T ss_pred             CccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHH-------
Confidence            87532221  1223467999999999999989999999999999999999999999754321      11111       


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                         +.....  ..+...+..+.++|.+||+.||.+||     ++.++++.
T Consensus       213 ---i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         213 ---IVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ---HHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence               111111  12223457789999999999999999     57777763

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.8e-44  Score=342.95  Aligned_cols=247  Identities=29%  Similarity=0.406  Sum_probs=198.6

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      ++.||+|+||.||+|+......      .|+.||+|++.....    .....+..|+.+|+.++||||+++++++..++.
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~   74 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGAD------TGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK   74 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCC------CCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence            3679999999999998754321      356899999875321    223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .|+||||+.|++|.+++...+ .+.+..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          75 LYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             EEEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            999999999999999886554 5788899999999999999999  8999999999999999999999999999987532


Q ss_pred             CCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|..||......      ....          .+.
T Consensus       152 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~----------~~~  213 (323)
T cd05584         152 HEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTID----------KIL  213 (323)
T ss_pred             cCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHH----------HHH
Confidence            221  1122357999999999999888999999999999999999999999754321      1111          111


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                      ....  ..+...+..+.+||.+||+.||++||     ++.+++..
T Consensus       214 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         214 KGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             cCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            1111  12233457899999999999999999     88888873

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=314.25  Aligned_cols=266  Identities=25%  Similarity=0.362  Sum_probs=213.1

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ....+|++.+.||+|||+.||++....++.         .||+|++.....++.+..++|++..++++||||++++++..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~---------~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l   88 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGH---------LYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL   88 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCccc---------chhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence            345789999999999999999999777654         89999999888788889999999999999999999998765


Q ss_pred             eCC-----eEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          170 EDD-----QRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       170 ~~~-----~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      .+.     ..||+++|...|+|.+.+...   +..+++.+++.|+.++++||.+||+....++||||||.|||+.+++.+
T Consensus        89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~  168 (302)
T KOG2345|consen   89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP  168 (302)
T ss_pred             HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence            443     489999999999999988653   446899999999999999999999433349999999999999999999


Q ss_pred             EEccccCcccCCCCCccc-------eeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 014202          242 KLSDFGLAKAGPQGDKTH-------VSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG  311 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  311 (429)
                      +|.|||.+....-.-...       ......-|..|.|||.+.   +...+.++|||||||+||+|+.|..||...-..+
T Consensus       169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G  248 (302)
T KOG2345|consen  169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG  248 (302)
T ss_pred             EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence            999999997643211110       011134688899999885   4567899999999999999999999997432211


Q ss_pred             cccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .              .-...+.++....+.....++.+.+||++||+.||.+||++.+++..+..+.
T Consensus       249 g--------------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 G--------------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             C--------------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1              1112223334444444457789999999999999999999999999876653

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-43  Score=335.07  Aligned_cols=264  Identities=30%  Similarity=0.466  Sum_probs=209.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|.+.+.||+|+||.||++.......    ...+..+|+|.+..........+.+|+.+|++++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCP----EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCC----CCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            468999999999999999998643211    1124479999987665555677899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      ..++||||+++++|.+++....            ..+++..++.++.|++.||+|||  ..+++||||||+|||++.++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCc
Confidence            9999999999999999986432            24899999999999999999999  899999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  319 (429)
                      ++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......   ....  
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~--  233 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE--  233 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence            99999999986533222222222446778999999998889999999999999999998 99998654321   1100  


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                       .          +.... ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       234 -~----------i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         234 -C----------ITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             -H----------HHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence             0          00000 001112234679999999999999999999999998876653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7e-44  Score=325.35  Aligned_cols=263  Identities=26%  Similarity=0.328  Sum_probs=205.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcc-eeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPN-LVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~  170 (429)
                      .|..+++||+|+||+||+|+...+++         .||+|++.....+  ......+|+.+|+.|+|+| ||.+++++..
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~---------~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGK---------FVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCC---------EEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            47777889999999999999998865         8999999876442  3456789999999999999 9999999998


Q ss_pred             CC------eEEEEEEecCCCChHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          171 DD------QRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       171 ~~------~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      .+      .+++|+||++ -+|..++....   ..++...+..++.||+.||+|||  +++|+||||||.||||+.+|.+
T Consensus        83 ~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G~l  159 (323)
T KOG0594|consen   83 SNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSGVL  159 (323)
T ss_pred             cccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCCcE
Confidence            87      7899999995 59999997765   35778899999999999999999  9999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+|+...-..  ...+..++|..|.|||++.+. .|+...||||+|||++||+++++.|.+......   ...+-
T Consensus       160 KlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q---l~~If  234 (323)
T KOG0594|consen  160 KLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ---LFRIF  234 (323)
T ss_pred             eeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH---HHHHH
Confidence            999999999654322  224457899999999999987 799999999999999999999999987654211   11111


Q ss_pred             HHHHhh--hhhhhhc---CCc--cccCC-C-------HHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          321 QYLADK--RKLYQIV---DPR--LELNY-S-------LKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       321 ~~~~~~--~~~~~~~---~~~--~~~~~-~-------~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..+...  .......   +..  ..... +       ........+++.+||+.+|.+|.|++.++.+
T Consensus       235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111100  0000000   000  00000 0       0111478899999999999999999999884

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-43  Score=347.02  Aligned_cols=255  Identities=23%  Similarity=0.279  Sum_probs=203.2

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEE
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLI  165 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~  165 (429)
                      ....++|++.+.||+|+||.||+|.+..++.         .||+|++....   ......+.+|+.+++.++||||++++
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQK---------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence            3345789999999999999999999987655         89999986432   12234577899999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          166 GYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      +++.+++..|+||||++||+|.+++...  .+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL~D  185 (370)
T cd05621         110 CAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKLAD  185 (370)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999999988554  4789999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||++........ ......+||+.|+|||++.+.    .++.++|||||||++|||++|..||.....      ..... 
T Consensus       186 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~-  257 (370)
T cd05621         186 FGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYS-  257 (370)
T ss_pred             cccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHH-
Confidence            999986533221 112346799999999998754    378899999999999999999999975432      11111 


Q ss_pred             HHHhhhhhhhhcCC--ccccCCCHHHHHHHHHHHHHcccCCCCC--CCCHhHHHHH
Q 014202          322 YLADKRKLYQIVDP--RLELNYSLKGVQKVSQLAYNCLSRDPKS--RPSMDEVVKV  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~eil~~  373 (429)
                               .+.+.  .+..+.....+..+.+++..||..++.+  |+++.+++++
T Consensus       258 ---------~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 ---------KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---------HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                     11111  1111222234578899999999865544  8999999984

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-45  Score=346.94  Aligned_cols=246  Identities=32%  Similarity=0.460  Sum_probs=211.3

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh---HHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH---REWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      |.-++.||.|+||.||-|++..+.+         .||||++...+.+..   ++++.|+.+|++|+|||+|.+.++|..+
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~e---------vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccc---------eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            5557889999999999999998877         899999987765543   5789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...|||||||- |+-.|++.-...++.+.++..|..+.+.||+|||  +++.||||||..|||+++.|.|||+|||.|..
T Consensus        99 ~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH--S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen   99 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNRIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             chHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH--HhhHHhhhccccceEecCCCeeeeccccchhh
Confidence            99999999994 5888888878889999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ..+.      +.++|||+|||||++.   .+.|+-++||||||++..||...++|+-.-      +          ....
T Consensus       176 ~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------N----------AMSA  233 (948)
T KOG0577|consen  176 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------N----------AMSA  233 (948)
T ss_pred             cCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------h----------HHHH
Confidence            5443      3489999999999985   578999999999999999999999987531      1          1223


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                      ++.+.....+.--..++++.++.++..||++-|.+|||.+++++.-
T Consensus       234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence            3443333333333567889999999999999999999999998743

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.6e-43  Score=332.06  Aligned_cols=260  Identities=29%  Similarity=0.482  Sum_probs=206.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+|++.+.||+|+||.||+|....++.     ..+..||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            358889999999999999998754332     1245899999975432 3346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR----------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      ...|+||||+.+++|.+++...                ...+++..+..++.|++.||.|||  +.+|+||||||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili  157 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILI  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEE
Confidence            9999999999999999998532                124788889999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQN  314 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  314 (429)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+..+   ..
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~  234 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QE  234 (283)
T ss_pred             cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence            9999999999999986543332222233456778999999988889999999999999999998 9999865331   11


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      ..+              .+........+...+..+.+++.+||+.||.+||++.+|++.|..
T Consensus       235 ~~~--------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIE--------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH--------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111              111111112223345789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-43  Score=332.36  Aligned_cols=262  Identities=25%  Similarity=0.417  Sum_probs=205.4

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..++|++.+.||+|+||.||+|.+.....    ...+..||+|.+..... ....++.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVK----DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCC----CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            45679999999999999999998754211    12355899999865432 33456889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT---------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      .+...++||||+++++|.+++.+..         ..+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCCC
Confidence            9999999999999999999986532         23567888999999999999999  899999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  319 (429)
                      ++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......   ....  
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~--  232 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR--  232 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--
Confidence            99999999876433222211222355788999999998899999999999999999999 78888654321   1111  


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                       .          ...... ...+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus       233 -~----------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 -F----------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -H----------HHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence             0          000000 1112234578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-43  Score=340.57  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=198.5

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  174 (429)
                      ++||+|+||.||+|++..++.         .||+|++....   ......+..|..++..+ +||||+++++++..++..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRR---------IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            469999999999999887655         89999997542   22335578899999998 699999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|.+++... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        72 ~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            9999999999999888654 46899999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc--cccHHHHHHHHHHhhhhhhhh
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG--EQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+..+..         
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------  217 (329)
T cd05588         149 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI---------  217 (329)
T ss_pred             CC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---------
Confidence            11  12234689999999999999999999999999999999999999997432221  111111111111         


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC------HhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS------MDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~eil~  372 (429)
                      .....  ..+...+..+.+||.+||+.||.+|++      +.++++
T Consensus       218 ~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         218 LEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            11111  122234577999999999999999997      677775

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-43  Score=332.13  Aligned_cols=262  Identities=26%  Similarity=0.393  Sum_probs=206.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++...     ...+++|.+..... ....++..|+.++.++.||||+++++++. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSI-----KIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCce-----eeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            46889999999999999999987665421     12588888864432 23456788899999999999999999875 4


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++++||+++|+|.+++......+++..+..++.|++.||.|||  +.+++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            5678999999999999999877667899999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............++..|+|||.+.+..++.++|||||||++|||++ |..||.+..+..   ...    .+       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~-------  224 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LL-------  224 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HH-------
Confidence            543322222223457788999999998899999999999999999998 999997543211   111    01       


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                         ........+..++..+.+++.+||..||++||++.|+++.|..+..
T Consensus       225 ---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 ---EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ---HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence               1001111111234678899999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.8e-44  Score=341.57  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=199.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCC-cceeeEEeEEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHH-PNLVKLIGYCI  169 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~  169 (429)
                      +|++.+.||+|+||.||+|.+..++.         .||||++....   ......+..|+.++..+.| ++|+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDE---------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            48889999999999999999887654         89999987542   2334567889999999975 56889999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ..+..|+||||++||+|.+++.... .+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMC  148 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence            9999999999999999999886544 5899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ..   ..         
T Consensus       149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~---~~---------  211 (324)
T cd05587         149 KENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL---FQ---------  211 (324)
T ss_pred             eecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HH---------
Confidence            75322211  223467999999999999999999999999999999999999999754311   11   11         


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH-----hHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM-----DEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~eil~  372 (429)
                       .+....  ..++...+..+.+++.+||..||.+|++.     .++++
T Consensus       212 -~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         212 -SIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             -HHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             111111  11223345789999999999999999986     56554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.2e-43  Score=354.21  Aligned_cols=266  Identities=22%  Similarity=0.366  Sum_probs=195.1

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCC------cce
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH------PNL  161 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnI  161 (429)
                      +....++|++.++||+|+||+||+|++..++.         .||||++.... ....++..|+.++..++|      ++|
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~---------~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i  193 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKE---------YCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPL  193 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCe---------EEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcce
Confidence            34456889999999999999999999887654         89999996432 223445667777776654      568


Q ss_pred             eeEEeEEEeC-CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCC
Q 014202          162 VKLIGYCIED-DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEY  239 (429)
Q Consensus       162 v~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~  239 (429)
                      +++++++..+ ..+|+|||++ |++|.+++.+. ..+++..+..++.||+.||.|||  . .|||||||||+|||++.++
T Consensus       194 ~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~~gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        194 MKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSD  269 (467)
T ss_pred             eeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hcCCeecCCCCHHHEEEecCC
Confidence            9999988765 4688999988 77899888665 36899999999999999999999  6 5999999999999998765


Q ss_pred             ----------------CEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCC
Q 014202          240 ----------------NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS  303 (429)
Q Consensus       240 ----------------~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p  303 (429)
                                      .+||+|||++.....     .....+||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                            499999998864221     12346899999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccHHH---------HHHHH-HHhhhhhhhhc---CCccc-----------cCCCHHHHHHHHHHHHHcccC
Q 014202          304 MDKKRPSGEQNLVA---------WARQY-LADKRKLYQIV---DPRLE-----------LNYSLKGVQKVSQLAYNCLSR  359 (429)
Q Consensus       304 f~~~~~~~~~~~~~---------~~~~~-~~~~~~~~~~~---~~~~~-----------~~~~~~~~~~l~~li~~~l~~  359 (429)
                      |.+.........+.         |.... ......+....   .+...           ..........+.+||.+||+.
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            97654321111111         00000 00000000000   00000           000001235688999999999


Q ss_pred             CCCCCCCHhHHHH
Q 014202          360 DPKSRPSMDEVVK  372 (429)
Q Consensus       360 dP~~Rpt~~eil~  372 (429)
                      ||++|||++|+++
T Consensus       425 dP~~R~ta~e~L~  437 (467)
T PTZ00284        425 DRQKRLNARQMTT  437 (467)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999998

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.8e-44  Score=348.06  Aligned_cols=252  Identities=23%  Similarity=0.271  Sum_probs=203.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||+|.+.....   .....+..|+.+|+.++||||+++++++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~  112 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQ---------VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF  112 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            4679999999999999999999987655         899999864321   2234567899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+++..|+||||++||+|.+++...  .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         113 QDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999999999999999988554  4788999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|||++|..||......      ....    
T Consensus       189 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~----  257 (370)
T cd05596         189 CMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYS----  257 (370)
T ss_pred             eeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHH----
Confidence            976533211 112235799999999998653    4789999999999999999999999764321      1111    


Q ss_pred             hhhhhhhhcCC--ccccCCCHHHHHHHHHHHHHcccCCCCC--CCCHhHHHHH
Q 014202          325 DKRKLYQIVDP--RLELNYSLKGVQKVSQLAYNCLSRDPKS--RPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~eil~~  373 (429)
                            .+...  .+..+.....+..+.+||.+||+.+|.+  |+++.++++.
T Consensus       258 ------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         258 ------KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ------HHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                  11111  1111112234678999999999999998  9999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.7e-43  Score=331.23  Aligned_cols=271  Identities=28%  Similarity=0.451  Sum_probs=211.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCC-------CCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAP-------AKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~-------~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      ++|++.+.||+|+||.||+|.+...+...       .....+..||+|.+..... .....+.+|+.+|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            57999999999999999999987655322       1223345799999886543 345678899999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRT----------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      ++++..++..++||||+.+++|.+++....          ..+++..++.++.|++.||.|||  +.+|+||||||+||+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~Nil  162 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhcee
Confidence            999999999999999999999999986543          25899999999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCCcc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT--GRRSMDKKRPSGE  312 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~  312 (429)
                      ++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++  |..||.....   
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---  239 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD---  239 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---
Confidence            99999999999999976543332222334567789999999988889999999999999999998  6777754321   


Q ss_pred             ccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .........       .............+...+.++.+|+.+||+.||.+|||+.+|++.|.
T Consensus       240 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGH-------FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHh-------ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            111111111       10101111111122234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.9e-43  Score=328.08  Aligned_cols=255  Identities=27%  Similarity=0.406  Sum_probs=207.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ..|.+.+.||+|+||.||+|.+..++.         .||+|.+..+. ....++.+|+.+|++++||||+++++++..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~---------~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   75 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCc---------eEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence            358888999999999999999887654         89999987543 34567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||+|||  ..+++||||||+|||+++++.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            999999999999999998654 345899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....      .....          
T Consensus       154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~----------  216 (263)
T cd05052         154 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYE----------  216 (263)
T ss_pred             cccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH----------
Confidence            5432211 1111234668999999998899999999999999999998 9999865421      11111          


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                       .+........+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         217 -LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             1111111222334557899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-43  Score=334.45  Aligned_cols=265  Identities=29%  Similarity=0.468  Sum_probs=212.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|.+.+.||+|+||.||+|.+.....    ...+..+++|.+........+.+.+|+.++++++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            458889999999999999998654321    1124479999987766666677899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      ..++||||+++++|.+++....               ..+++..++.++.|++.||+|||  ..+|+||||||+|||++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEcc
Confidence            9999999999999999986532               24788999999999999999999  899999999999999999


Q ss_pred             CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHH
Q 014202          238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~  316 (429)
                      ++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......   ...
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~  235 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVI  235 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence            99999999999976543322222233457889999999998899999999999999999998 99998654321   111


Q ss_pred             HHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                      +.             +.... ........+..+.+++.+||+.||++||++.++++.|+.+.+.
T Consensus       236 ~~-------------~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 EC-------------ITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HH-------------HhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            10             00100 1111223456799999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-42  Score=338.72  Aligned_cols=262  Identities=22%  Similarity=0.292  Sum_probs=197.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ...+|++.+.||+|+||.||+|++..++.         .||+|+....      ....|+.+|++++||||+++++++..
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~  128 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPD---------PVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS  128 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCc---------eEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence            34679999999999999999999877654         8999985433      23469999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ....++|||++. ++|.+++......+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||++.
T Consensus       129 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        129 GAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             CCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence            999999999994 6899988777778999999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHH----HHHHHHh-
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW----ARQYLAD-  325 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~----~~~~~~~-  325 (429)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||+++..|+....+.........    +...+.. 
T Consensus       206 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~  282 (357)
T PHA03209        206 FPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL  282 (357)
T ss_pred             ccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence            532211   12235799999999999999999999999999999999986655533322221111100    0000000 


Q ss_pred             ---hhhhh---------hhcCC--c--ccc-----CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 ---KRKLY---------QIVDP--R--LEL-----NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 ---~~~~~---------~~~~~--~--~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         ...+.         ..++.  .  .+.     ......+..+.+||.+||+.||.+|||+.|++++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence               00000         00000  0  000     0001223466789999999999999999999873

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.2e-43  Score=336.71  Aligned_cols=242  Identities=26%  Similarity=0.406  Sum_probs=193.6

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhc-CCCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQ-LHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|.+..++.         .||+|.+....   ......+..|..++.. ++||||+++++++..++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNE---------FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999999887655         89999987542   1223445667777765 4799999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        72 ~lv~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            99999999999999886544 6899999999999999999999  89999999999999999999999999999976433


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+...      ......          +..
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~----------i~~  210 (316)
T cd05592         149 GE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDS----------ILN  210 (316)
T ss_pred             CC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHH----------HHc
Confidence            22  222346799999999999998999999999999999999999999975431      111111          001


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHh-HHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD-EVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-eil~  372 (429)
                      .  ...++...+.++.+|+.+||+.||.+||++. ++++
T Consensus       211 ~--~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         211 D--RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            0  0112223457789999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-43  Score=330.12  Aligned_cols=254  Identities=30%  Similarity=0.495  Sum_probs=209.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|.+.+.||.|+||.||+|.+.. +.         .+|+|.+..........+..|+.+|+.++||||+++++++...+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~---------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RV---------RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE   75 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CC---------cEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence            468999999999999999999876 33         79999998776656678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||.|||  +.+|+|+||||+|||++.++.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~  153 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARL  153 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccchhh
Confidence            999999999999999999764 446899999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....   .         
T Consensus       154 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~---~---------  216 (261)
T cd05148         154 IKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYD---Q---------  216 (261)
T ss_pred             cCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHH---H---------
Confidence            533211  1123346778999999988889999999999999999998 8999965431   11111   0         


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                        +........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       217 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         217 --ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              101111222334557899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-43  Score=340.78  Aligned_cols=242  Identities=28%  Similarity=0.417  Sum_probs=195.8

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|++..++.         .||||++....   ......+..|..++..+ +||||+++++++...+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGR---------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCC---------EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            469999999999999887655         89999987542   22345567888888876 699999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|.+++... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             EEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            9999999999999988654 36899999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ..  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ......          +..
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~----------i~~  210 (320)
T cd05590         149 NG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEA----------ILN  210 (320)
T ss_pred             CC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHH----------Hhc
Confidence            11  122346799999999999988999999999999999999999999975432      111111          111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCH------hHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM------DEVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~eil~  372 (429)
                      ..  ...+...+.++.+||.+||+.||.+||++      +++++
T Consensus       211 ~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~  252 (320)
T cd05590         211 DE--VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR  252 (320)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence            11  11222345789999999999999999998      66665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.4e-43  Score=326.27  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=208.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||.+....   ......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRK---------PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI   72 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCC---------EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence            579999999999999999999887655         89999876432   233456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      ..+..++||||+++++|.+++..   ....+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+||
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence            99999999999999999988743   2345789999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |++........  ......|++.|+|||.+.+..++.++|+||||+++|||++|..||.....    +...+...     
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~-----  219 (267)
T cd08228         151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQK-----  219 (267)
T ss_pred             ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHH-----
Confidence            99886543221  11235688999999999988899999999999999999999999864321    11111110     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        +..   ...+.......+..+.+++.+||..+|++||++.++++.|+.++
T Consensus       220 --~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         220 --IEQ---CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --Hhc---CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence              000   01111112244578999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-43  Score=335.48  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=208.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCC-CcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLH-HPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  168 (429)
                      ...|+++++||+||.+.||++.....+          .||+|.+...  +.+...-+.+|+.+|.+|+ |.+||.+|+|-
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~----------iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE  429 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQ----------IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE  429 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCc----------chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence            456999999999999999999876543          5777776544  3344567899999999997 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..++.+|+||||= .-+|..+|.+.....+...+..+..||+.|+.++|  ..||||.||||.|+|+ -.|.+||+|||+
T Consensus       430 v~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLl-VkG~LKLIDFGI  505 (677)
T KOG0596|consen  430 VTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLL-VKGRLKLIDFGI  505 (677)
T ss_pred             ccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEE-EeeeEEeeeech
Confidence            9999999999964 55999999887766665688899999999999999  8999999999999998 567999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcC-----------CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-----------HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      |.........-.....+||+.||+||.+...           ..+.++||||||||||+|+.|+.||...          
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----------  575 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----------  575 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------
Confidence            9988776666666778999999999998532           2567999999999999999999999632          


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHH-HHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGV-QKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                           .....++..+.++....+++.--. .++.++++.||..||++||++.++|+
T Consensus       576 -----~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  576 -----INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -----HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                 122335666777766555543322 23999999999999999999999998

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-44  Score=368.68  Aligned_cols=265  Identities=31%  Similarity=0.462  Sum_probs=220.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+-.+.+.||+|.||.||.|..........    ...||||.+.+. ..+...+|++|..+|+.++|||||+++|++.+.
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~----~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVS----PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCcc----ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            456677899999999999999876543211    346999999876 446678899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      ...+|++|||+||+|..+|.+.      ...+...+.+.++.|||.|+.||+  ++++|||||..+|+|++....|||+|
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccCcEEEcc
Confidence            9999999999999999999876      667899999999999999999999  99999999999999999999999999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHH
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ||+|+.....+.......-.-...|||||.+..+.++.++|||||||+|||++| |..||......              
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--------------  911 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--------------  911 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--------------
Confidence            999996544444333222234568999999999999999999999999999999 88898754321              


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                         .+...+...-+++.+..+++.+.+++..||+.+|++||++..|++.+..+.+.
T Consensus       912 ---~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  912 ---EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ---HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence               11111111125666778889999999999999999999999999977666543

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-43  Score=331.17  Aligned_cols=271  Identities=28%  Similarity=0.481  Sum_probs=206.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCC-----CCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTA-----PAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~-----~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~  166 (429)
                      ++|++.+.||+|+||.||+|++..++..     .........||+|.+..... .....+.+|+++|++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5799999999999999999988654321     01112234699999976532 33456889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRT-----------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      ++..++..++||||+.+++|.+++....           ..+++..++.++.|++.||.|||  +.+++||||||+||++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nill  162 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhEEE
Confidence            9999999999999999999999885432           23678889999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCCccc
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT--GRRSMDKKRPSGEQ  313 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~  313 (429)
                      +.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||.....   .
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---~  239 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---E  239 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---H
Confidence            9999999999999976543322222223455778999999998889999999999999999998  6667754321   1


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      ............       .........+...+..+.+|+.+||+.||++||++++|++.|.
T Consensus       240 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            111111111110       0000001112224478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-43  Score=330.99  Aligned_cols=245  Identities=27%  Similarity=0.404  Sum_probs=197.4

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ||+|+||+||+|.+..++.         .||+|.+......   ....+..|+.+|+.++||||+++++++..+...|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMRATGK---------LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEccCCc---------EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence            7999999999999887655         8999998754322   234567899999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          178 YEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |||++||+|.+++..   ....+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            999999999987743   3446899999999999999999999  89999999999999999999999999999976543


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||.........  ...          ......
T Consensus       150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~----------~~~~~~  215 (280)
T cd05608         150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KEL----------KQRILN  215 (280)
T ss_pred             CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHH----------HHhhcc
Confidence            222  122357999999999999999999999999999999999999999754321110  000          001111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                      ..  ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       216 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         216 DS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            11  122334567899999999999999999     6677776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=332.47  Aligned_cols=252  Identities=28%  Similarity=0.409  Sum_probs=203.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +|++.+.||+|+||.||++.+..++.         .||+|.+......   ....+.+|+.+|+.++||||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCc---------eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            48889999999999999999876654         8999998754322   23456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+||++++++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999999999999888654 346899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........   .....|++.|+|||++.+..++.++|||||||++|||++|..||.+.......   ..          +
T Consensus       150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~----------~  213 (285)
T cd05605         150 VEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EE----------V  213 (285)
T ss_pred             eecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HH----------H
Confidence            86533221   12357899999999999888999999999999999999999999764321110   00          0


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                      ...+.. ....++...+..+.+|+.+||..||++||     +++++++.
T Consensus       214 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         214 ERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            000100 11122234557899999999999999999     88888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.4e-43  Score=326.25  Aligned_cols=252  Identities=28%  Similarity=0.463  Sum_probs=202.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||+|.+...          ..+|+|.+.... .....+.+|+.+|++++||||+++++++..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~----------~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQ----------IKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccC----------ceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            3588899999999999999987542          279999886543 23467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+++|+|.+++......+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||++...
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            999999999999999998765556899999999999999999999  899999999999999999999999999999864


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++ |..||......   .....   .         
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~---i---------  214 (256)
T cd05114         151 LDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEM---I---------  214 (256)
T ss_pred             CCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---H---------
Confidence            332211 1112345668999999988889999999999999999999 89999654321   11111   0         


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                       ... .....+...+..+.+++.+||+.||++||++.++++.|.
T Consensus       215 -~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         215 -SRG-FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -HCC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             000 001111223467999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-43  Score=339.84  Aligned_cols=243  Identities=26%  Similarity=0.386  Sum_probs=196.5

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  174 (429)
                      ++||+|+||.||+|.+..++.         .||+|++....   ......+..|..++..+ +||||+++++++..++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDE---------VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEECCCCC---------EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence            469999999999999877654         89999987542   22334567889998866 799999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||+++|+|..++... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        72 ~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999999888654 35899999999999999999999  89999999999999999999999999999875432


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......      .....          +..
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~----------i~~  210 (321)
T cd05591         149 NGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFES----------ILH  210 (321)
T ss_pred             CCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHH----------HHc
Confidence            221  123367999999999999889999999999999999999999999754321      11111          111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCC-------CHhHHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-------SMDEVVKV  373 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------t~~eil~~  373 (429)
                      ...  ..+...+.++.+|+.+||+.||++||       ++.++++.
T Consensus       211 ~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         211 DDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            111  11222347899999999999999999       78888764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-43  Score=327.04  Aligned_cols=258  Identities=29%  Similarity=0.488  Sum_probs=203.8

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      |.+.+.||+|+||.||+|....++.      .+..||+|.+.....  .....+.+|+.+|+.++||||+++++++....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            6788999999999999999876432      244899999876532  33457889999999999999999999876655


Q ss_pred             e------EEEEEEecCCCChHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          173 Q------RLLVYEFMTRGSLENHLFRR-----TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       173 ~------~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      .      .++||||+++|+|..++...     ...+++..+..++.|++.||.|||  +.+++||||||+||++++++.+
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~  152 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTV  152 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeE
Confidence            4      78999999999999988442     235889999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....   
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~---  226 (273)
T cd05035         153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYD---  226 (273)
T ss_pred             EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---
Confidence            9999999986544332222222345678999999988889999999999999999999 88998653321   1111   


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .           +........+...+..+.+++.+||+.||++||++.++++.|..+
T Consensus       227 ~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         227 Y-----------LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             H-----------HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0           000111122334557899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.1e-43  Score=337.84  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=197.0

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|++..++.         .||+|++....   ......+..|+.++.++ +||||+++++++..++..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTER---------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence            469999999999999887655         89999997542   23345577899988876 799999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||+++|+|..++... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        72 ~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~  148 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  148 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence            9999999999999888554 46899999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc--cccHHHHHHHHHHhhhhhhhh
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG--EQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......  ......+....         +
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------i  217 (329)
T cd05618         149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV---------I  217 (329)
T ss_pred             CCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---------H
Confidence            211  1233679999999999999999999999999999999999999996422211  11111111111         1


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC------HhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS------MDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~eil~  372 (429)
                      ....  ...+...+..+.+||.+||+.||++||+      +.++++
T Consensus       218 ~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         218 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             hcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            1111  1122334577899999999999999998      467665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-43  Score=339.59  Aligned_cols=242  Identities=26%  Similarity=0.377  Sum_probs=196.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      +|++.+.||+|+||.||+|.+..++.         .||+|++.....   .....+..|..++..+ +|++|+++++++.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDE---------LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            48889999999999999999887654         899999875422   2234567788888877 5899999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ..+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~DfG~~  148 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccCCCc
Confidence            9999999999999999999886554 5899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +......  .......||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......        
T Consensus       149 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~--------  212 (323)
T cd05616         149 KENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQS--------  212 (323)
T ss_pred             eecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHH--------
Confidence            7532211  122346799999999999999999999999999999999999999975432      111111        


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM  367 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  367 (429)
                        +....  ..++...+.++.+|+.+||+.||.+|++.
T Consensus       213 --i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         213 --IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --HHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              11111  11223345789999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.6e-44  Score=326.80  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=200.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC-
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD-  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  172 (429)
                      .|...+++|.|+||.||+|...++++         .||||++..+..    .-.+|+.+|+.+.|||||++..+|.... 
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~---------~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEE---------EVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCc---------eeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            47778999999999999999988755         899999876642    2237999999999999999998887543 


Q ss_pred             ----eEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CCEEEc
Q 014202          173 ----QRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLS  244 (429)
Q Consensus       173 ----~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~  244 (429)
                          ...|||||++. +|.+.+..   .+..++...+.-++.||++||+|||  ..||+||||||.|+|+|.+ |.+|||
T Consensus        92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LKic  168 (364)
T KOG0658|consen   92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLKIC  168 (364)
T ss_pred             CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEEec
Confidence                23589999965 99988864   3566888899999999999999999  8999999999999999876 889999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||.|+....+...   ....-|..|.|||.+.|. .|+.+.||||.|||+.||+-|++.|.+.....  .+.+.++-+-
T Consensus       169 DFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG  243 (364)
T KOG0658|consen  169 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLG  243 (364)
T ss_pred             cCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhC
Confidence            99999987665443   346778999999999875 69999999999999999999999999855322  2222211111


Q ss_pred             HhhhhhhhhcCCc-------------cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADKRKLYQIVDPR-------------LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .....-...+++.             .........++++.+|+.++|+.+|.+|.++.|++.
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1111111111111             111123345688999999999999999999999985

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.8e-43  Score=331.42  Aligned_cols=262  Identities=28%  Similarity=0.440  Sum_probs=207.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +|++.+.||+|+||.||+|........    .....+++|.+..... .....+.+|+.+|+.++||||+++++.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGR----AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCC----CcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            478899999999999999987643221    1234789998875543 33467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 014202          173 QRLLVYEFMTRGSLENHLFRR-----------------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFK  229 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlk  229 (429)
                      ..++||||+.+++|.+++...                       ...+++..++.++.|++.||.|||  +.+|+|||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dik  154 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLA  154 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhh
Confidence            999999999999999987542                       124788899999999999999999  8999999999


Q ss_pred             CCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 014202          230 TSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKR  308 (429)
Q Consensus       230 p~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  308 (429)
                      |+|||+++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999976433222111222356778999999988889999999999999999998 999996543


Q ss_pred             CCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      +.   .+..              ..........+...+..+.+++.+||+.||++||++.++++.|+.+.
T Consensus       235 ~~---~~~~--------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         235 PE---RLFN--------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HH---HHHH--------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            21   1111              11111112223344578999999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4e-43  Score=326.64  Aligned_cols=254  Identities=26%  Similarity=0.440  Sum_probs=205.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||+|.+...          ..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~----------~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNS----------TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE   74 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCC----------ceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            5799999999999999999986532          379999987543 33567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||+|||  ..+++||||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~  152 (261)
T cd05072          75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARV  152 (261)
T ss_pred             CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCcccee
Confidence            999999999999999998654 446888999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......   .....          +.
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----------~~  218 (261)
T cd05072         153 IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA----------LQ  218 (261)
T ss_pred             cCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH----------HH
Confidence            543221 11222346678999999988889999999999999999998 99999653211   11110          00


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      ..    ...+.....+..+.+++.+||..+|++||+++++++.|+.+
T Consensus       219 ~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         219 RG----YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             cC----CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            00    11112223457899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-43  Score=333.89  Aligned_cols=265  Identities=28%  Similarity=0.448  Sum_probs=209.7

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~  167 (429)
                      ...++|++.+.||+|+||.||+|.+.....    ......+|+|.+..... ....++.+|+.++.++ +||||++++++
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            344679999999999999999998875432    12245899999876432 3345688999999999 79999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN  232 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~N  232 (429)
                      +..++..++||||+++|+|.+++...               ...+++..++.++.|++.||.|||  +.+|+||||||+|
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~N  162 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARN  162 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceee
Confidence            99999999999999999999998542               345889999999999999999999  8999999999999


Q ss_pred             eEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCc
Q 014202          233 ILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSG  311 (429)
Q Consensus       233 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  311 (429)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-  241 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-  241 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-
Confidence            9999999999999999987544322221222345678999999988899999999999999999997 99998653311 


Q ss_pred             cccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                           +           +.+.+........+...+..+.+|+.+||..||++|||+.++++.|+.+
T Consensus       242 -----~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 -----E-----------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -----H-----------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                 1           0111111111122334457899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.7e-43  Score=329.03  Aligned_cols=261  Identities=23%  Similarity=0.401  Sum_probs=206.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+|++.+.||.|+||.||+|.+..++...     ...||+|.+..... ....++.+|+.++..++||||+++++++.. 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~-----~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENV-----KIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCcc-----ceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence            56889999999999999999987665421     22589999875533 334678899999999999999999998875 


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...+++|||+++|+|.+++......+++..++.++.|++.||+|||  +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence            4578999999999999999776667899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   .....             
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~-------------  222 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPD-------------  222 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-------------
Confidence            543222211122345678999999988899999999999999999998 8999864321   11111             


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                       .+........+...+..+.+++.+||..||++||++.++++.|..+.
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         223 -LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             -HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence             11111111112234578999999999999999999999998876554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.5e-43  Score=328.79  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=204.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|.+.+.||+|+||.||+|.+.....    ...+..||+|.+..... .....+..|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            3569999999999999999999876211    01244899998875533 234568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---CE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY---NA  241 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~  241 (429)
                      .+..++||||++|++|.+++....      ..+++..++.++.||+.||+|||  +.+++||||||+|||++.++   .+
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCCcce
Confidence            999999999999999999986543      24889999999999999999999  89999999999999998765   59


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   ....   
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~---  232 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME---  232 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---
Confidence            9999999986532221111112234568999999998899999999999999999997 99999754321   1111   


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                                 .+........+...+..+.+++.+||+.||++||++.++++.|.
T Consensus       233 -----------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 -----------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                       11111111222334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.6e-44  Score=331.04  Aligned_cols=254  Identities=36%  Similarity=0.573  Sum_probs=198.1

Q ss_pred             CCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEE
Q 014202           97 PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL  175 (429)
Q Consensus        97 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  175 (429)
                      +.+.||.|.||.||+|.+...     ....+..|+||.++.... .....+.+|++.|++++||||+++++++...+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence            457899999999999999831     112356899999966433 34678999999999999999999999999888899


Q ss_pred             EEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          176 LVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      +||||+++|+|.++|... ...+++..++.++.|++.||.|||  +.+++|+||+++|||++.++.+||+|||++.....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence            999999999999999887 567999999999999999999999  88999999999999999999999999999987633


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ...........+...|+|||.+.+..++.++||||||+++|||++ |..||.....   .   ......           
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~---~~~~~~-----------  218 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---E---EIIEKL-----------  218 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---H---HHHHHH-----------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---cccccc-----------
Confidence            222222233457788999999998889999999999999999999 7888864321   1   111111           


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                      ........+..++..+.+++..||..||++||++.++++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  219 KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11111222334457899999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-43  Score=343.61  Aligned_cols=260  Identities=23%  Similarity=0.265  Sum_probs=203.7

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceee
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVK  163 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~  163 (429)
                      ++....++|++.+.||+|+||.||+|.+..++.         .||+|++....   ......+.+|+.+++.++||||++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~  107 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK---------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ  107 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCc---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence            334445789999999999999999999987755         89999986432   122345678999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      +++++..++..|+||||++||+|.+++...  .+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999988654  4788999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      +|||++........ ......+||+.|+|||++.+.    .++.++|||||||++|||++|..||.....      ....
T Consensus       184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~  256 (371)
T cd05622         184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTY  256 (371)
T ss_pred             EeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHH
Confidence            99999986533211 122346799999999998754    378999999999999999999999975432      1111


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCC--CCCHhHHHHHh
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKS--RPSMDEVVKVL  374 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~eil~~l  374 (429)
                      ...+..        ...+..+.....+..+.+||.+||..++.+  |+++.++++..
T Consensus       257 ~~i~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         257 SKIMNH--------KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHHcC--------CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            111100        011111222245578999999999844433  78999998853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.8e-43  Score=335.79  Aligned_cols=266  Identities=26%  Similarity=0.411  Sum_probs=208.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      ++|.+.+.||+|+||.||+|.+...+..  ....+..+|+|.+.... .....++..|+.++..+ +||||+++++++..
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKE--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCc--ccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            5799999999999999999987543221  11224579999998653 23446688899999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      ++..|+||||+.+|+|.+++....               ..+++..++.++.|++.||+|||  +.+++||||||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nill  173 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheEE
Confidence            999999999999999999996542               24788999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQN  314 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  314 (429)
                      +.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....     
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            9999999999999976533221111112234578999999998889999999999999999998 8888864321     


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                       .....           .+........+...+.++.+|+.+||..+|++||++.++++.|..+..
T Consensus       249 -~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 -EELFK-----------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -HHHHH-----------HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence             11110           111111112233445789999999999999999999999998877644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.9e-43  Score=336.49  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=198.9

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcC-CCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|.+..++.         .||+|++.....   .....+..|+.++.++ +||||+.+++++...+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQ---------IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence            469999999999999887655         899999976432   2345578899999888 599999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|..++.... .+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  148 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG  148 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence            99999999999998886543 6899999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.............+.....         ..
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------~~  217 (327)
T cd05617         149 PG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------LE  217 (327)
T ss_pred             CC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------Hh
Confidence            11  12234679999999999999999999999999999999999999997544332222222211111         11


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCH------hHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM------DEVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~eil~  372 (429)
                      ..  ...+...+..+.+++.+||+.||.+|+++      .++++
T Consensus       218 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  259 (327)
T cd05617         218 KP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS  259 (327)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence            11  11222344678999999999999999985      46655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.3e-43  Score=334.86  Aligned_cols=266  Identities=24%  Similarity=0.349  Sum_probs=202.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|.+.+.||+|+||.||+|++..++.         .||+|.+...... ....+.+|+.++++++||||+++++++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTEN---------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD   76 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCC---------eEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            569999999999999999999877654         8999998755322 234577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+.+ +|.+++......+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++..
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          77 KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence            999999999965 888888776666899999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH--------HHH
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA--------RQY  322 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~  322 (429)
                      ......  ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...............        ...
T Consensus       154 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07872         154 KSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG  231 (309)
T ss_pred             cCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence            432221  1223468999999998865 46889999999999999999999999765432111110000        000


Q ss_pred             HHhhhhhhhhcCCccc----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADKRKLYQIVDPRLE----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ............+...    .......+.++.+||.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000000000000    0111224567899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.1e-43  Score=330.16  Aligned_cols=263  Identities=26%  Similarity=0.367  Sum_probs=196.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcC---CCcceeeEEeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQL---HHPNLVKLIGY  167 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~  167 (429)
                      .+|++.+.||+|+||.||+|.+..++        |..||+|.+......  ....+.+|+.+++.+   +||||++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCC--------CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            36999999999999999999885432        348999998754322  223456777777665   69999999998


Q ss_pred             EE-----eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          168 CI-----EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       168 ~~-----~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      +.     .....++||||+. ++|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCCCE
Confidence            85     2456899999996 5899888654 345899999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||+|||++......   .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.....   ....+..
T Consensus       150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~  223 (290)
T cd07862         150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILD  223 (290)
T ss_pred             EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHH
Confidence            99999999764332   12233578999999999998899999999999999999999999998654321   1111110


Q ss_pred             HHH--hhhhhhh-------hcCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLA--DKRKLYQ-------IVDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~--~~~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...  .......       .......   .......+..+.+|+.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000  0000000       0000000   0011123467889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-43  Score=326.10  Aligned_cols=255  Identities=28%  Similarity=0.460  Sum_probs=205.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..+          ..||+|.+.... ...+++.+|+.++++++||||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~----------~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNT----------TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE   73 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCC----------eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence            45799999999999999999986532          379999987654 3356788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||++.
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  151 (261)
T cd05068          74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGLAR  151 (261)
T ss_pred             CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence            99999999999999999986643 46899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......   ...             
T Consensus       152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~-------------  214 (261)
T cd05068         152 VIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVL-------------  214 (261)
T ss_pred             EccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH-------------
Confidence            75422111 1111223457999999988899999999999999999999 99999654211   000             


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                       ..+........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       215 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         215 -QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -HHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             00111111122233457899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.3e-44  Score=341.18  Aligned_cols=242  Identities=30%  Similarity=0.397  Sum_probs=195.4

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  176 (429)
                      +.||+|+||.||++++.....      +|..||+|++.....  .....+..|+.+|++++||||+++++++..++..|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPD------AGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence            679999999999998753221      356999999975432  233456789999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCC
Q 014202          177 VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~  256 (429)
                      ||||+++|+|.+++.+. ..+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          76 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            99999999999988654 36899999999999999999999  8999999999999999999999999999997643321


Q ss_pred             ccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCc
Q 014202          257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR  336 (429)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......          +....
T Consensus       153 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~----------i~~~~  214 (318)
T cd05582         153 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTM----------ILKAK  214 (318)
T ss_pred             --CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHH----------HHcCC
Confidence              122346799999999999988899999999999999999999999975431      111111          11111


Q ss_pred             cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhH
Q 014202          337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE  369 (429)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  369 (429)
                        ...+...+..+.+||.+||+.||++||++.+
T Consensus       215 --~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 --LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              1122234578999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-42  Score=331.68  Aligned_cols=242  Identities=28%  Similarity=0.407  Sum_probs=194.3

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|.+..++.         .||+|.+....   ......+..|..++..+ +||||+++++++..++..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGE---------YFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence            469999999999999887655         89999997542   12334566788888764 899999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||+.||+|..++... ..+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.++|+|||+++....
T Consensus        72 ~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF  148 (316)
T ss_pred             EEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence            9999999999999988654 45899999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....   .   .......        ...
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~---~~~~~~~--------~~~  212 (316)
T cd05620         149 GD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---D---ELFESIR--------VDT  212 (316)
T ss_pred             CC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---H---HHHHHHH--------hCC
Confidence            11  123346799999999999999999999999999999999999999975431   1   1111100        001


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHh-HHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD-EVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-eil~  372 (429)
                      +    ..+...+.++.+||.+||+.||++||++. ++++
T Consensus       213 ~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         213 P----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             C----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            1    11222446789999999999999999984 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.7e-43  Score=325.85  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=204.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|++..........+.+|+.++++++||||+++++++..++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGE---------LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCe---------EEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            579999999999999999999876654         89999997655445566789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||  +.+|+||||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence            999999999999999988654 36899999999999999999999  899999999999999999999999999999865


Q ss_pred             CCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .....  ......|++.|+|||.+.   ...++.++|||||||++|||++|..||....+......        ...   
T Consensus       157 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--------~~~---  223 (267)
T cd06646         157 TATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------MSK---  223 (267)
T ss_pred             ccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--------eec---
Confidence            32211  112356889999999874   34578899999999999999999999864332111000        000   


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                      .....+..  ......+..+.+++.+||..||++||+++++++.|
T Consensus       224 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         224 SNFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00000111  11123457899999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.1e-43  Score=329.97  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +|++.+.||+|+||.||+|.+..+..    ...+..||+|.+...... ....+..|+.++..++||||+++++++...+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            47888999999999999998765421    112458999999765432 2356889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          173 QRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      ..++++||+.+++|.+++...               ...+++..+..++.|++.||.|||  +.+|+||||||+|||+++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEecC
Confidence            999999999999999998532               124788889999999999999999  899999999999999999


Q ss_pred             CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHH
Q 014202          238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~  316 (429)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...   ... 
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~-  235 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDV-  235 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHH-
Confidence            99999999999886544332222233456789999999988889999999999999999998 8888865321   111 


Q ss_pred             HHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                        ...          +.+.. ....+...+..+.+|+..||+.+|++||++.+|+..|+.
T Consensus       236 --~~~----------i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 --IEM----------IRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHH----------HHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              111          11111 112233456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-42  Score=328.16  Aligned_cols=271  Identities=27%  Similarity=0.455  Sum_probs=206.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCC-------CCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAP-------AKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~-------~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      ++|++.+.||+|+||.||+|.+.......       .....+..||+|.+..... .....+.+|+.+|+.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46999999999999999998765432210       1122345799999976532 334678899999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRT----------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      ++++..++..++||||+.+++|.+++....          ..+++..+..++.|++.||+|||  +.+++|+||||+|||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~Nil  162 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChheEE
Confidence            999999999999999999999999986542          23677889999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCCcc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT--GRRSMDKKRPSGE  312 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~  312 (429)
                      ++.++.++|+|||++................+++.|+|||...++.++.++|||||||++|||++  |..||......  
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~--  240 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE--  240 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH--
Confidence            99999999999999986543322222222345678999999888889999999999999999998  77888643221  


Q ss_pred             ccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                       ........+...       .........+..++..+.+|+.+||+.||++||++.+|++.|+
T Consensus       241 -~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 -QVIENTGEFFRD-------QGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             -HHHHHHHHHHhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             111111111100       0000011112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.2e-43  Score=335.86  Aligned_cols=242  Identities=27%  Similarity=0.432  Sum_probs=194.3

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhc-CCCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQ-LHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|.+..++.         .||||.+....   .........|..++.. ++||||+++++++.+++.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQ---------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            469999999999999887655         89999987542   1223456678888876 4899999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|.+++... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        72 ~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            9999999999999988654 35889999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||.....      .......        ....
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i--------~~~~  212 (316)
T cd05619         149 GDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSI--------RMDN  212 (316)
T ss_pred             CCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHH--------HhCC
Confidence            221  22346799999999999998999999999999999999999999975431      1111110        0011


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHh-HHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD-EVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-eil~  372 (429)
                      +.    ++...+.++.+++.+||+.||++||++. +++.
T Consensus       213 ~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         213 PC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            11    1223446789999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-43  Score=344.04  Aligned_cols=253  Identities=25%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|++....   ......+..|+.+|..++||||+++++.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGH---------IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            368899999999999999999987655         89999986432   223456788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++.+|+||||++||+|.+++.+.. .+++..+..++.|++.||.|||  +.||+||||||+|||++.++.++|+|||++
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~DfG~~  148 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDFGLC  148 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeeccCC
Confidence            9999999999999999999986544 5899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCcc---------------------------------ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHH
Q 014202          250 KAGPQGDKT---------------------------------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE  296 (429)
Q Consensus       250 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  296 (429)
                      .........                                 ......+||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye  228 (360)
T cd05627         149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence            754221100                                 00113579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC---HhHHHH
Q 014202          297 ILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS---MDEVVK  372 (429)
Q Consensus       297 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~eil~  372 (429)
                      |++|..||....+..      .....+.       . ...+..+.....+.++.+||.+|+ .||.+|++   +.++++
T Consensus       229 l~tG~~Pf~~~~~~~------~~~~i~~-------~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         229 MLIGYPPFCSETPQE------TYRKVMN-------W-KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             cccCCCCCCCCCHHH------HHHHHHc-------C-CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            999999997644311      1111000       0 011111111124468899999977 59999985   677776

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.3e-43  Score=337.02  Aligned_cols=242  Identities=28%  Similarity=0.417  Sum_probs=197.0

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|.+..++.         .||||++....   ......+..|..++..+ +||||+++++++...+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDE---------LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999999887655         89999997542   22345567899999888 699999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|.+++.+.. .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            99999999999999886553 6899999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ...  .....+|++.|+|||++.+..++.++|||||||++|+|++|..||.....      ......          +..
T Consensus       149 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~----------i~~  210 (318)
T cd05570         149 GGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQS----------ILE  210 (318)
T ss_pred             CCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHH----------HHc
Confidence            211  12235799999999999999999999999999999999999999975431      111111          111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCH-----hHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM-----DEVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~eil~  372 (429)
                      ...  ..+...+..+.+||.+||+.||++||++     .++++
T Consensus       211 ~~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         211 DEV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            111  1222345789999999999999999999     88876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-43  Score=328.09  Aligned_cols=261  Identities=26%  Similarity=0.421  Sum_probs=207.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|.+.+.||+|+||.||+|.+.....    ...+..||+|.+..... .....+.+|+.+|..++||||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            3579999999999999999999875431    12345899999875532 334568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT---------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      ....++||||+++|+|.+++....         ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCCE
Confidence            999999999999999999986432         23678899999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....   
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~---  232 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLK---  232 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHH---
Confidence            9999999976543322222223456789999999988889999999999999999998 99998643321   1111   


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                       ...         . ......+...+..+.+++.+||+.+|++|||+.+++..|+
T Consensus       233 -~~~---------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 -FVI---------D-GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -HHh---------c-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             000         0 1111122334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-42  Score=325.72  Aligned_cols=257  Identities=28%  Similarity=0.446  Sum_probs=200.1

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC-
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED-  171 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  171 (429)
                      |.+.+.||+|+||.||+|.+..++.       ...||+|.++...  ......+..|+.+|+.++||||+++++++... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~-------~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDS-------ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV   73 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCC-------eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence            4577899999999999999876543       2268999987542  23456788999999999999999999976432 


Q ss_pred             -----CeEEEEEEecCCCChHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          172 -----DQRLLVYEFMTRGSLENHLFR-----RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       172 -----~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                           ...++||||+.+|+|.+++..     ....+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+
T Consensus        74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~  151 (272)
T cd05075          74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNV  151 (272)
T ss_pred             cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCE
Confidence                 246899999999999988742     2234789999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      +|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   .....   
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~---  225 (272)
T cd05075         152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD---  225 (272)
T ss_pred             EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---
Confidence            9999999987543322111122356778999999998899999999999999999999 8899865322   11111   


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                       ......          ........+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       226 -~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 -YLRQGN----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -HHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             111100          0111223456799999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-42  Score=326.02  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=195.7

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ||+|+||.||+++...++.         .||+|.+......   ....+..|+.+|++++||||+++++++..+...|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGK---------MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEccCCc---------EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence            7999999999999887655         8999998654221   233456799999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCC
Q 014202          178 YEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~  256 (429)
                      |||++|++|.+++... ...+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.++|+|||++.......
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~  149 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK  149 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence            9999999999887554 345889999999999999999999  8999999999999999999999999999997654322


Q ss_pred             ccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCc
Q 014202          257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR  336 (429)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                         ......|++.|+|||++.+..++.++|||||||++|||++|..||........  ......          ......
T Consensus       150 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~----------~~~~~~  214 (277)
T cd05607         150 ---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKR----------RTLEDE  214 (277)
T ss_pred             ---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHH----------Hhhccc
Confidence               12335789999999999988899999999999999999999999975432111  111111          111111


Q ss_pred             cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .... ....+.++.+|+.+||+.||++||++.|+++.
T Consensus       215 ~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         215 VKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            1110 11345779999999999999999999777643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-43  Score=333.52  Aligned_cols=267  Identities=25%  Similarity=0.410  Sum_probs=209.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||+|+||.||+|.+.....  .....+..||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4578999999999999999998643221  011134579999987543 23456788999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      .....|+||||+.+|+|.+++....               ..+++..+..++.|++.||.|||  +.||+||||||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccceEE
Confidence            9999999999999999999986532               24678889999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.....    
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  245 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence            99999999999999987543322222222356778999999988889999999999999999998 7888854321    


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                        ......           +........+..++..+.+|+.+||..+|++||++.++++.|..+..
T Consensus       246 --~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 --EELFKL-----------LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             --HHHHHH-----------HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence              111111           11111111223455789999999999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.4e-43  Score=334.92  Aligned_cols=238  Identities=29%  Similarity=0.414  Sum_probs=191.0

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHH-HHhcCCCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVD-FLGQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||+||+|++..++.         .||+|++.....   .....+..|.. +++.++||||+++++.+...+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGK---------FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence            469999999999999987655         999999875422   22234555554 56789999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|..++... ..+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||+|||++.....
T Consensus        72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence            9999999999999988654 46899999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .+....          +..
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~----------i~~  210 (323)
T cd05575         149 HS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDN----------ILN  210 (323)
T ss_pred             CC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHH----------HHc
Confidence            21  122346799999999999999999999999999999999999999975421      111111          111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHh
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD  368 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  368 (429)
                      ...  ......+..+.++|.+||+.||.+||++.
T Consensus       211 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         211 KPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            111  11223357899999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.8e-43  Score=331.62  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=207.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      ++|.+.+.||+|+||.||+|.+.....    ...+..||+|.+..... .....+.+|+.+++++ +||||+++++++..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSK----SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCC----CCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            469999999999999999998643211    12345899999876532 3345688999999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .+..|+||||+.+|+|.+++.... ..+++..+..++.|++.||.|||  +.+|+|+||||+|||++.++.++|+|||++
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            999999999999999999986543 33899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ................++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ..             
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~-------------  253 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KF-------------  253 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HH-------------
Confidence            86544322222222456788999999998889999999999999999998 999986543211  00             


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                       ............+...+..+.+++.+||..+|++||++.++++.|..+
T Consensus       254 -~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 -YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence             011111111111223347899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.1e-43  Score=349.98  Aligned_cols=260  Identities=23%  Similarity=0.345  Sum_probs=195.1

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..++|++++.||+|+||.||+|.+..++.         .||||.+....    ....+|+.+|+.++||||+++++++..
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~---------~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSE---------KVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCC---------EEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence            34679999999999999999999877654         89999886442    233579999999999999999988753


Q ss_pred             C--------CeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 014202          171 D--------DQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY  239 (429)
Q Consensus       171 ~--------~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~  239 (429)
                      .        ..+++||||+++ +|.+++..   ....+++..+..++.||+.||.|||  +.+|+||||||+|||++.++
T Consensus       131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~  207 (440)
T PTZ00036        131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNT  207 (440)
T ss_pred             cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCC
Confidence            2        246799999975 77666642   3456899999999999999999999  89999999999999998665


Q ss_pred             -CEEEccccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          240 -NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       240 -~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                       .+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+......  +..
T Consensus       208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~  282 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR  282 (440)
T ss_pred             CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH
Confidence             699999999986543221   2235789999999998764 689999999999999999999999976543211  111


Q ss_pred             HHHHHHHh-hhhhhhhcC-------------CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 WARQYLAD-KRKLYQIVD-------------PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 ~~~~~~~~-~~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      . .+.+.. .........             ..+...++...+.++.+||.+||+.||.+|||+.|+++
T Consensus       283 i-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        283 I-IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             H-HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            1 110000 000000000             01111122234578999999999999999999999986

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.6e-43  Score=323.40  Aligned_cols=252  Identities=27%  Similarity=0.433  Sum_probs=202.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||+|.+...          ..+|+|.+.... .....+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~----------~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQ----------YDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR   72 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCC----------CcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3588899999999999999976532          269999987543 33467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+.+|+|.+++......+++..++.++.|++.||.|||  +.+++|+||||+|||++.++.+||+|||+++..
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~  150 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV  150 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence            999999999999999999765557899999999999999999999  899999999999999999999999999998765


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ..... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......   ....   .       +..
T Consensus       151 ~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~-------~~~  216 (256)
T cd05113         151 LDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---K-------VSQ  216 (256)
T ss_pred             CCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---H-------Hhc
Confidence            33221 11112345678999999988889999999999999999998 99998643321   1111   0       000


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .    .....+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus       217 ~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         217 G----LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             C----CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0    001111223478999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.3e-43  Score=327.81  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=206.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|.+.++||+|+||.||+|......    ...++..+|+|.+..........+.+|+.+++.++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLL----PEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCC----CCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            46888999999999999999764321    11234589999987665555678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT--------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE  238 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~  238 (429)
                      ..++||||+++++|.+++....              ..+++..+..++.|++.||+|||  +.+++||||||+|||++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcCC
Confidence            9999999999999999986543              24788999999999999999999  8999999999999999999


Q ss_pred             CCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHH
Q 014202          239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~  317 (429)
                      +.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||......   ....
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~  235 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIE  235 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHH
Confidence            9999999999976433222111222345788999999998899999999999999999998 89998643221   1100


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                                   .... ......+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       236 -------------~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 -------------CITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -------------HHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                         0001 0111122234577999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=322.47  Aligned_cols=250  Identities=28%  Similarity=0.446  Sum_probs=201.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      +|++.+.||+|+||.||+|.+.. +         ..+|+|.+..... ....+.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~-~---------~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG-K---------IDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP   73 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC-C---------ccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            58889999999999999998753 2         2699999865432 33567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .|+||||++|++|.+++......+++..++.++.|++.||+|||  +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence            99999999999999999766557899999999999999999999  8999999999999999999999999999997643


Q ss_pred             CCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ....          .+.. 
T Consensus       152 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----------~~~~-  216 (256)
T cd05059         152 DDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE----------SVSA-  216 (256)
T ss_pred             ccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHH----------HHHc-
Confidence            22111 1111233457999999998899999999999999999999 89999754321   1110          0111 


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                         ......+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       217 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 ---GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               111112223457899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=335.87  Aligned_cols=256  Identities=20%  Similarity=0.231  Sum_probs=200.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||+|++....   ......+.+|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQ---------VYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ   71 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            469999999999999999999887655         89999986432   123355788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..|+||||+.||+|.+++.+....+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  149 (331)
T cd05597          72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADFGSC  149 (331)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEECCce
Confidence            999999999999999999999765667899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ........ .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.....      .+.....+.
T Consensus       150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~  222 (331)
T cd05597         150 LRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMN  222 (331)
T ss_pred             eecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHc
Confidence            76433221 11223469999999999863     4578899999999999999999999975422      111111111


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCC--CCCHhHHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKS--RPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~eil~~  373 (429)
                      ... .   .  .+. ......+..+.+++.+||..++++  |+++.++++.
T Consensus       223 ~~~-~---~--~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         223 HKE-H---F--QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCC-c---c--cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000 0   0  000 011124578899999988664444  7899999984

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.8e-43  Score=325.87  Aligned_cols=260  Identities=26%  Similarity=0.468  Sum_probs=207.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +.|++.+.||+|+||.||+|.+..++.      .+..||||.+.... .....++..|+.+++.++||||+++++++..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   77 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence            358889999999999999999877654      12369999987652 33456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++||||+++++|.+++......+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||++..
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCccccc
Confidence            9999999999999999999776667899999999999999999999  89999999999999999999999999999876


Q ss_pred             CCCCCccceeeecc---ccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          252 GPQGDKTHVSTRVV---GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       252 ~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ..............   ++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....++        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i--------  224 (269)
T cd05065         156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI--------  224 (269)
T ss_pred             cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH--------
Confidence            54322211111111   2457999999998899999999999999999886 99999653311   111110        


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                        .    .....+.+...+..+.+++.+||+.+|++||++.+++..|+.+
T Consensus       225 --~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 --E----QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --H----cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              0    0111122234457789999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=322.68  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=204.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-----hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-----QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ++|.+.+.||+|+||.||+|.+..++.         .||+|.+.....     .....+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~---------~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   72 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGR---------ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC   72 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCc---------EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence            469999999999999999999876654         899999865422     123467889999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +..++..++||||++|++|.+++.... .+++..+..++.|++.||.|||  +.+|+|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          73 LRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             EccCCeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999999999999999999886543 5889999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccce-eeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          248 LAKAGPQGDKTHV-STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       248 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ++........... .....|+..|+|||++.+..++.++||||||+++|||++|+.||......     ..         
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~---------  215 (263)
T cd06625         150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA---------  215 (263)
T ss_pred             cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH---------
Confidence            9976433211111 12356888999999999888999999999999999999999999653211     00         


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        .............+...+..+.+++.+||..+|++|||+.++++.
T Consensus       216 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         216 --IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              011111111122333455789999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-42  Score=323.70  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=209.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .||||.+.....   ....++.+|+.+++.++||||+++++++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~---------~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI   72 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCc---------eEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence            468899999999999999999877654         899998865422   23457889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      .++..+++|||+++++|.+++..   ....+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.++|+||
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcc
Confidence            99999999999999999998853   2345899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |++........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......    .......     
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-----  219 (267)
T cd08229         151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-----  219 (267)
T ss_pred             hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-----
Confidence            99876543221  122357899999999998888999999999999999999999999643211    1111110     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        +.....+.   ......+..+.+++.+||..||++|||+.+|++.+.+++
T Consensus       220 --~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         220 --IEQCDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --hhcCCCCC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              11111111   111235578999999999999999999999999887664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=347.33  Aligned_cols=252  Identities=24%  Similarity=0.412  Sum_probs=214.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +.|.|+..||.|+||.||+|..+.++.         ..|.|++.-...+...+++-|+.||..+.||+||++++.|..++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~---------lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en  102 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKL---------LAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN  102 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchh---------hhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence            458888999999999999999887654         67888887777777788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .++|+.|||.||-.+.++..-+..+.+.++..+++|++.||.|||  +.+|||||||..|||++-+|.|+|+|||.+-..
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeecccccccc
Confidence            999999999999999999988889999999999999999999999  999999999999999999999999999998653


Q ss_pred             CCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ..  .......+.|||+|||||++.     ..+|+.++||||||++|.||..+.+|.....+      +.          
T Consensus       181 ~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MR----------  242 (1187)
T KOG0579|consen  181 KS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MR----------  242 (1187)
T ss_pred             hh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HH----------
Confidence            22  222334589999999999875     46899999999999999999999999764332      11          


Q ss_pred             hhhhhcCC-ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 KLYQIVDP-RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .+.++... +..+--+..++..+.+++.+||..||..||++.+++++
T Consensus       243 VllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  243 VLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            12222221 12233455678899999999999999999999999984

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-42  Score=324.10  Aligned_cols=260  Identities=27%  Similarity=0.476  Sum_probs=208.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++.      .+..+|+|.+..... .....+.+|+.+|.+++||||+++++++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            578999999999999999998765433      133799999876432 2346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..|+||||+++++|.+++......+++..+..++.|++.||.|||  +.+++||||||+|||++.++.++|+|||++..
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            9999999999999999999777667899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccce-eeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          252 GPQGDKTHV-STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       252 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ......... .....++..|+|||.+.+..++.++|+|||||++||+++ |..||.......   ....    +      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~------  222 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKA----I------  222 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHH----H------
Confidence            543221111 111233568999999998889999999999999999886 999996543211   1110    0      


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .+.    .........+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       223 ~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         223 EEG----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             hCC----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            000    11112233457889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.9e-43  Score=344.44  Aligned_cols=263  Identities=24%  Similarity=0.401  Sum_probs=206.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCC-CcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLH-HPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  170 (429)
                      ++|.+.+.||+|+||.||+|++.....    ...+..||+|++...... ....+.+|+.+|.++. ||||+++++++..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSH----SQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCC----CCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            468889999999999999999764211    112458999999765332 2356889999999997 9999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC--------------------------------------------------------
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT--------------------------------------------------------  194 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~--------------------------------------------------------  194 (429)
                      .+..++||||+.+|+|.+++.+..                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999986432                                                        


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 014202          195 -----------------------------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNI  233 (429)
Q Consensus       195 -----------------------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Ni  233 (429)
                                                               ..+++..++.++.|++.||.|||  ..+|+||||||+||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~Ni  270 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAARNV  270 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcceE
Confidence                                                     12566778889999999999999  89999999999999


Q ss_pred             EEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcc
Q 014202          234 LLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGE  312 (429)
Q Consensus       234 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  312 (429)
                      |++.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||....... 
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-  349 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-  349 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence            999999999999999986433222112223467889999999998889999999999999999998 889986532111 


Q ss_pred             ccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                           ..          ...+........+...+..+.+|+.+||..+|.+||++.+|++.|+.+
T Consensus       350 -----~~----------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 -----QF----------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             -----HH----------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                 00          011111111122233457899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-42  Score=324.11  Aligned_cols=260  Identities=26%  Similarity=0.482  Sum_probs=208.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|+..+.||+|+||.||+|....++.      ....+|+|.+.... ......+..|+.++++++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF   78 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence            468888999999999999999876543      13379999987653 23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..|+||||+++++|.+++......+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence            9999999999999999999776667899999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCcccee-eeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          252 GPQGDKTHVS-TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       252 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......... .....+..|+|||++.+..++.++|||||||++|||++ |..||.....   ...   ...        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~---~~~--------  222 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEV---MKA--------  222 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHH---HHH--------
Confidence            5432221111 11223457999999988889999999999999999997 9999964321   111   110        


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                         +......+.....+..+.+++.+||+.||++||++.++++.|+.+
T Consensus       223 ---i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         223 ---INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               101111122234457899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=320.89  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=209.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .+++|.+..........+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCC---------EEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence            579999999999999999999877654         89999998766556678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|++|||+.+++|.+++......+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++...
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECccccchhh
Confidence            999999999999999998776567999999999999999999999  899999999999999999999999999999764


Q ss_pred             CCCCccceeeeccccccccChhhhhcC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ....  .......++..|+|||.+.+.   .++.++|||||||++|+|++|..||....+....  ..      ...   
T Consensus       152 ~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~------~~~---  218 (262)
T cd06613         152 TATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FL------ISK---  218 (262)
T ss_pred             hhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH------HHh---
Confidence            3321  112235788999999998776   7899999999999999999999999754321100  00      000   


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       .... ..........+.++.+++.+||..||.+|||+.+++.
T Consensus       219 -~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         219 -SNFP-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -ccCC-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0000 1111223345678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4e-43  Score=337.44  Aligned_cols=241  Identities=26%  Similarity=0.372  Sum_probs=191.7

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHH-HHhcCCCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVD-FLGQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|++..++.         .||+|++.....   .....+..|.. +++.++||||+++++++..++..
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEK---------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence            469999999999999887654         899999875421   22234444444 57889999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|.+++.... .+.+..+..++.||+.||.|||  +.||+||||||+|||++.++.+||+|||+++....
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          72 YFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            99999999999999886543 5788899999999999999999  89999999999999999999999999999975332


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .+.....          ..
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i----------~~  210 (325)
T cd05602         149 HNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNI----------LN  210 (325)
T ss_pred             CCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHH----------Hh
Confidence            211  22346799999999999999999999999999999999999999975432      1111111          11


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV  371 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil  371 (429)
                      ..  .......+..+.++|.+||+.||.+||++.+.+
T Consensus       211 ~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         211 KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            11  112223457899999999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.7e-42  Score=320.64  Aligned_cols=251  Identities=26%  Similarity=0.429  Sum_probs=199.2

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEEE
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVY  178 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  178 (429)
                      .||+|+||.||+|.+...+.       +..||+|++..... .....+.+|+.+|++++||||+++++++. .+..++||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~-------~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKK-------QIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecCCC-------ceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence            48999999999998764332       44799999876533 23456889999999999999999999875 45789999


Q ss_pred             EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCcc
Q 014202          179 EFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT  258 (429)
Q Consensus       179 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~  258 (429)
                      ||+++++|.+++......+++..++.++.|++.||.|||  ..+++||||||+|||++.++.+||+|||++.........
T Consensus        74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence            999999999999766667899999999999999999999  899999999999999999999999999999865433221


Q ss_pred             ce-eeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCc
Q 014202          259 HV-STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR  336 (429)
Q Consensus       259 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                      .. .....++..|+|||++.+..++.++|||||||++|||++ |..||......   ...              ..+...
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~--------------~~~~~~  214 (257)
T cd05115         152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVM--------------SFIEQG  214 (257)
T ss_pred             eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHH--------------HHHHCC
Confidence            11 111233578999999988889999999999999999996 99999754321   111              111111


Q ss_pred             cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .....+...+.++.+++.+||..||++||++.+|.+.|+.+
T Consensus       215 ~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11222334457899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-42  Score=320.18  Aligned_cols=252  Identities=33%  Similarity=0.533  Sum_probs=206.6

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-hHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +.||+|+||.||+|.+....      ..+..|++|.+....... ...+.+|+.++..++|+||+++++++..+...++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence            46999999999999987641      124489999998765443 57788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          178 YEFMTRGSLENHLFRR--------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      |||+++++|.+++...        ...+++..++.++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||.+
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEcccccc
Confidence            9999999999999776        467999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....   . ..    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~---~-~~----  221 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLE---Y-LR----  221 (262)
T ss_pred             cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHH---H-HH----
Confidence            87654332222334567889999999988889999999999999999999 6999976521   11111   0 00    


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                        .    ......+...+.++.+++.+||..||.+||++.++++.|+
T Consensus       222 --~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 --K----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --c----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              0    1112223344678999999999999999999999998774

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-42  Score=330.21  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=203.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|+...++.       ...+++|.++.. .....+.+.+|+.++.++ +||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGL-------KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCC-------cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence            478999999999999999999877654       225788888743 223446788999999999 69999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      .+..|+||||+++++|.+++....               ..+++..++.++.|++.||+|||  +.+|+||||||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill  152 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLV  152 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEE
Confidence            999999999999999999986532               24788999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQN  314 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  314 (429)
                      +.++.+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||......    
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----  225 (297)
T cd05089         153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----  225 (297)
T ss_pred             CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            999999999999986422110   0111223557999999988889999999999999999997 99999654321    


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                        ....           ..........+...+..+.+|+.+||+.||.+||++.++++.|..+..
T Consensus       226 --~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         226 --ELYE-----------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             --HHHH-----------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              1111           011111111223345789999999999999999999999988765544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-42  Score=332.57  Aligned_cols=266  Identities=25%  Similarity=0.430  Sum_probs=207.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||+|+||.||+|.+.....  .....+..||+|.+.... .....++..|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            3578999999999999999998754322  111234579999987543 23346788999999999 5999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      .++..|+||||+.+|+|.+++....               ..+++..+..++.|++.||.|||  +.||+||||||+|||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nil  166 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVL  166 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeEE
Confidence            9999999999999999999986532               34788899999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......   
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---  243 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---  243 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999986543222111112234567999999998889999999999999999999 88898654321   


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ....    ...          .......+...+..+.+++.+||..||++||++.++++.|..+.
T Consensus       244 ~~~~----~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         244 ELFK----LLR----------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHH----HHH----------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1111    000          11111222344568999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-42  Score=344.63  Aligned_cols=264  Identities=24%  Similarity=0.260  Sum_probs=200.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ...|.+.+.||+|+||.||+|.+..++.         .||||....      ..+.+|+.+|++|+|+|||++++++..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~---------~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQ---------RVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCC---------EEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            3579999999999999999999887654         899996432      2456899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++|||++. ++|.+++......+++..++.++.|++.||.|||  ..||+||||||+||||+.++.++|+|||+++.
T Consensus       233 ~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~  309 (461)
T PHA03211        233 GLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGAACF  309 (461)
T ss_pred             CEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence            99999999994 6899888776667999999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC-cc----ccHHHHHHHHHHhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS-GE----QNLVAWARQYLADK  326 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~----~~~~~~~~~~~~~~  326 (429)
                      ..............||+.|+|||++.+..++.++|||||||+||||++|..|+...... ..    ..+...+.......
T Consensus       310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence            54322222223467999999999999999999999999999999999988765432211 11    11111111100000


Q ss_pred             hhhhh----------------hcCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQ----------------IVDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~----------------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..+..                ...+...   ..........+.+||.+||+.||.+|||+.|+|+.
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000                0000000   00001223578899999999999999999999984

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-42  Score=326.25  Aligned_cols=275  Identities=31%  Similarity=0.449  Sum_probs=206.4

Q ss_pred             CCC-CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNF-RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y-~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++| ++.+.||+|+||+||++......     ...+..||+|.+..... .....+.+|+.+|+.++||||+++++++..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPAN-----DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE   77 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEcccc-----CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            345 88999999999999988754321     12356899999976533 334678899999999999999999998765


Q ss_pred             C--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          171 D--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       171 ~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .  ...++||||+.+++|.+++...  .+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.++|+|||+
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          78 QGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             CCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeeccc
Confidence            4  4578999999999999998654  4899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +.......... ......++..|+|||++.+..++.++||||||+++|||++|..||........ ........ .....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~-~~~~~  231 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQG-QMTVV  231 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccc-ccchh
Confidence            98654332211 11123456779999999888899999999999999999999999865332110 00000000 00000


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .+....+.......+...+..+.+++.+||+.||++|||+++++..|+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111112222223345678999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-42  Score=320.15  Aligned_cols=250  Identities=28%  Similarity=0.409  Sum_probs=198.0

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      .||+|+||.||+|.+...+.       +..+|+|++.....  ...+++..|+.+|+.++||||+++++++. .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKS-------EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecCCC-------ceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence            68999999999997654322       45899999875532  23467889999999999999999999875 4567899


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||.||+++.++.++|+|||++........
T Consensus        74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~  150 (257)
T cd05116          74 MELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN  150 (257)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence            99999999999986543 5899999999999999999999  89999999999999999999999999999986543322


Q ss_pred             cc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCC
Q 014202          258 TH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP  335 (429)
Q Consensus       258 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (429)
                      .. ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....              .+..
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~--------------~i~~  213 (257)
T cd05116         151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ--------------MIES  213 (257)
T ss_pred             eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--------------HHHC
Confidence            11 1112234678999999988889999999999999999998 99999754221   1111              1111


Q ss_pred             ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      ......+...+.++.++|.+||+.||++||++.+|.+.|+..
T Consensus       214 ~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         214 GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            111122334557899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-42  Score=326.40  Aligned_cols=274  Identities=27%  Similarity=0.368  Sum_probs=206.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe--
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE--  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--  170 (429)
                      .+|++.+.||+|+||.||+|.....+     ...+..||+|.+........+.+.+|+.+|++++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQ-----DNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCc-----CCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            47899999999999999999864211     12355899999987665666788999999999999999999997654  


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ....++||||+++++|.+++.+....+++..++.++.|++.||.|||  ..||+||||||+||+++.++.++|+|||++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence            34688999999999999999766556899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccce-eeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH---Hhh
Q 014202          251 AGPQGDKTHV-STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL---ADK  326 (429)
Q Consensus       251 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~  326 (429)
                      .......... .....++..|+|||++.+..++.++|||||||++|||++|..++......    .........   ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  232 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIV  232 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccch
Confidence            7544322111 11123445699999999888999999999999999999988776432211    000000000   000


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      ..+...+............+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            001111111111222334457899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.5e-42  Score=325.10  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+.|++++.||.|+||.||+|.+..++.         .|++|.+..........+.+|+.+++.++||||+++++.+..+
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGA---------LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD   81 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCc---------eEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence            3679999999999999999999887654         8999999877666667788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...|+||||+++++|..++.+....+++..+..++.|++.+|.|||  ..+++||||||+||+++.++.++|+|||++..
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  159 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK  159 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence            9999999999999999888766667899999999999999999999  89999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ....  ........+++.|+|||++.     ...++.++|||||||++|||++|..||....+.      .....     
T Consensus       160 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~-----  226 (292)
T cd06644         160 NVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-----  226 (292)
T ss_pred             cccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHH-----
Confidence            3221  11123356889999999884     345788999999999999999999999653321      10000     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                        +.....+  ....+...+.++.+++.+||..||++||++.++++
T Consensus       227 --~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         227 --IAKSEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             --HhcCCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              0010111  11122334567899999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-42  Score=340.70  Aligned_cols=266  Identities=26%  Similarity=0.379  Sum_probs=200.8

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||+|+||.||+|.+..++.         .||||.+...  .....+.+.+|+.+|+.++||||+++++++...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGK---------RVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCC---------EEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            47889999999999999999876654         8999998653  223446788999999999999999999999877


Q ss_pred             C-----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          172 D-----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       172 ~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      +     ..|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEeccc
Confidence            6     7899999996 5888877544 46899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHH-------
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW-------  318 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~-------  318 (429)
                      |++........ .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+..+......+..       
T Consensus       148 g~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~  226 (372)
T cd07853         148 GLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL  226 (372)
T ss_pred             cceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            99986433221 122235689999999998874 478999999999999999999999976543221111100       


Q ss_pred             --HHHHHHh-hhhhhhhc-CCc-cc--cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          319 --ARQYLAD-KRKLYQIV-DPR-LE--LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       319 --~~~~~~~-~~~~~~~~-~~~-~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        ....... ...+.... .+. ..  .......++++.+||.+||+.||++|||+.+++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence              0000000 00000000 000 00  01112235788999999999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-42  Score=324.52  Aligned_cols=262  Identities=24%  Similarity=0.414  Sum_probs=209.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++...     ...||+|.+..... ....++.+|+.+|++++||||+++++++.. 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~-----~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKV-----KIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCc-----ceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            56899999999999999999987665421     23699998876643 334678899999999999999999999887 


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++||||+.+|+|.+++......+++..+..++.|++.||+|||  +.+++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            7889999999999999999877667999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............++..|+|||.+....++.++||||||+++||+++ |..||......   .+.              
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~--------------  221 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP--------------  221 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH--------------
Confidence            543322211112234568999999988889999999999999999998 99999764321   111              


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      +.+........+...+..+.+++.+||..||++||++.++++.|..+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111111111222344678999999999999999999999998877644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.5e-42  Score=324.12  Aligned_cols=251  Identities=24%  Similarity=0.400  Sum_probs=204.4

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeE
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      |++.+.||.|+||.||+|.+..++.         .+++|.+..........+.+|+.+++.++||||+++++++..+...
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   77 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGV---------LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   77 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCe---------EEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence            6788999999999999999887654         8999999766555667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||+++++|..++.+...++++..+..++.|++.||.|||  +.+++||||||+|||++.++.++|+|||++.....
T Consensus        78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEccccccccccc
Confidence            9999999999999988766667999999999999999999999  89999999999999999999999999999876432


Q ss_pred             CCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ..  .......|++.|+|||++.     +..++.++|||||||++|||++|.+||....+..      ....       .
T Consensus       156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~-------~  220 (282)
T cd06643         156 TI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLK-------I  220 (282)
T ss_pred             cc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHH-------H
Confidence            21  1223357899999999874     3457889999999999999999999996543210      0000       0


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .....+  ....+...+..+.++|.+||+.||.+||++.++++.
T Consensus       221 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         221 AKSEPP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             hhcCCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000000  111222345789999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=340.93  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=210.0

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEEEE
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYE  179 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  179 (429)
                      +||+|.||+||.|++..++.         .+|||.+........+-+..|+.+.++|+|.|||+++|.+..++.+-|.||
T Consensus       582 VLGKGTYG~VYA~RD~~tqv---------rIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQV---------RIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeecccccee---------EEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            69999999999999999876         899999987776667778999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCCEEEccccCcccCCCCC
Q 014202          180 FMTRGSLENHLFRRTIPL--PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-SEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       180 ~~~gg~L~~~l~~~~~~~--~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~DFg~a~~~~~~~  256 (429)
                      ..+||+|.++|...-+++  .+..+-.+..||++||.|||  +..|||||||-+||||+ -.|.+||+|||-++.+..-+
T Consensus       653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            999999999998887777  78888999999999999999  89999999999999995 57899999999998865432


Q ss_pred             ccceeeeccccccccChhhhhcC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          257 KTHVSTRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                        .....+.||..|||||++..+  .|+.++|||||||++.||.||++||.......               ..+++.-.
T Consensus       731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------------AAMFkVGm  793 (1226)
T KOG4279|consen  731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------------AAMFKVGM  793 (1226)
T ss_pred             --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------------Hhhhhhcc
Confidence              344568999999999999765  58999999999999999999999996432111               11122222


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...-.+.+...+.+.+.+|.+|+..||.+||++.++|.
T Consensus       794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            22334567788899999999999999999999999987

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.1e-42  Score=319.42  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=209.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|.++...   ......+.+|+.++++++|+||+++++++.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~   72 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGR---------VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI   72 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCC---------EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            579999999999999999999886654         89999886432   233467889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      .++..++||||+++++|.+++..   ....+++..+..++.|++.||.|||  +.||+|+||+|+||+++.++.++|+||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecc
Confidence            99999999999999999998853   2445899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |++........  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.....    ........     
T Consensus       151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-----  219 (267)
T cd08224         151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-----  219 (267)
T ss_pred             ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-----
Confidence            99876433221  12235689999999999988899999999999999999999999964331    11111111     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        +..   ...........+..+.++|.+||..+|++||++.+|++.|+.++
T Consensus       220 --~~~---~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         220 --IEK---CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --hhc---CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence              000   00111111244568999999999999999999999999987764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.4e-42  Score=323.83  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=200.9

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +|++.+.||+|+||.||+|.+..++.         .||+|.+.... ......+.+|+.+|.+++||||+++++++..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   72 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRR---------ILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN   72 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCc---------EEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence            58889999999999999999877654         89999987552 233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+++++|..+.     .+++..+..++.|++.||.|||  +.+|+|+||||+|||++.++.++|+|||++...
T Consensus        73 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          73 RISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             EEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            999999999999997542     4688899999999999999999  899999999999999999999999999999764


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc-HHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN-LVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  331 (429)
                      ....    .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... .....          ..
T Consensus       146 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~  211 (279)
T cd06619         146 VNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL----------QC  211 (279)
T ss_pred             cccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------HH
Confidence            3221    223579999999999998889999999999999999999999997533221111 00100          00


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..+...........+.++.+++.+||+.||++||+++++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         212 IVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            011111111112234679999999999999999999999984

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-42  Score=336.28  Aligned_cols=264  Identities=23%  Similarity=0.299  Sum_probs=198.5

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||+|.+....  ......+.+|+.+++.++||||+++++++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   89 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGI---------NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF   89 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCc---------eeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            34789999999999999999999877654         89999997542  23345678999999999999999999998


Q ss_pred             EeCC------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IEDD------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~~~------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ...+      ..|+||||+.+ +|.+.+..   .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+|
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          90 TPQKSLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             ccCCCccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEE
Confidence            7543      47999999965 66665532   3788899999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc--------
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN--------  314 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--------  314 (429)
                      |+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........        
T Consensus       164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  240 (359)
T cd07876         164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT  240 (359)
T ss_pred             EecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999997643221   1233578999999999999999999999999999999999999997653211000        


Q ss_pred             -HHHHHHHHHHhhhhhhhhcCCccc----------------cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          315 -LVAWARQYLADKRKLYQIVDPRLE----------------LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       ...+............. ..+...                .......+..+.+||.+||+.||++|||+.|++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         241 PSAEFMNRLQPTVRNYVE-NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CcHHHHHHHHHHHHHHHh-hCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence             00000000000000000 000000                00111124678999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-42  Score=319.57  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=204.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +|++.+.||.|+||.||++.+..++.         .||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQ---------KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCc---------eEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence            48889999999999999999877654         89999986542 234467789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..|+||||+++++|.+++... ...+++..+..++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||++..
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~  149 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL  149 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCccee
Confidence            999999999999999988653 445889999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      .....  .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....      ......       +. 
T Consensus       150 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~-------~~-  213 (255)
T cd08219         150 LTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILK-------VC-  213 (255)
T ss_pred             ecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHH-------Hh-
Confidence            53321  122335789999999999888899999999999999999999999975321      111000       00 


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        ... ....+...+..+.+|+.+||+.||++||++.+++..
T Consensus       214 --~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         214 --QGS-YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --cCC-CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              000 011222345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-42  Score=319.21  Aligned_cols=250  Identities=28%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|.+.+.||+|+||.||+|.+..++.         .|++|.+....  ......+.+|+.+++.++||||+++++++..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKR---------VYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCc---------EEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence            47788999999999999999887655         89999986542  23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..|+||||++|++|.+++... ...+++..++.++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~~~  149 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK  149 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence            9999999999999999998764 456899999999999999999999  8999999999999999999999999999988


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .......  ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.....   ...   ...         
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~---------  212 (256)
T cd08529         150 LLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GAL---ILK---------  212 (256)
T ss_pred             eccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHH---HHH---------
Confidence            6543221  12235788999999999988899999999999999999999999975431   111   000         


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       ..... ........+..+.+++.+||+.+|++||++.++++.
T Consensus       213 -~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         213 -IIRGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -HHcCC-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             01100 111122345789999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-42  Score=326.89  Aligned_cols=265  Identities=25%  Similarity=0.387  Sum_probs=205.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..++|++.+.||+|+||.||+|.......    ...+..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIK----GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCC----CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            35689999999999999999998664211    11244799999875532 23346788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT---------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      ..+..|+||||+.+|+|.+++....         ...+...+..++.|++.||.|||  +.+|+||||||+|||++.++.
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~~  157 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCCc
Confidence            9999999999999999999996431         23466788899999999999999  899999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  319 (429)
                      ++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....      .+..
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~  231 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVL  231 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHH
Confidence            99999999986433222222222345778999999998899999999999999999998 7888865321      1111


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..          +.+.. ....+...+..+.+++.+||+.||++|||+.++++.|....
T Consensus       232 ~~----------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         232 KF----------VMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HH----------HHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            10          01110 01112233478999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-42  Score=334.89  Aligned_cols=255  Identities=20%  Similarity=0.238  Sum_probs=200.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||++++..++.         .||+|++....   ......+..|+.++..++|+||+++++++.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~   71 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTER---------IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ   71 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            479999999999999999999887654         89999986532   122345778999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..|+||||++||+|.+++.+....+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~DfG~a  149 (331)
T cd05624          72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADFGSC  149 (331)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEeccce
Confidence            999999999999999999999775567899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ........ .......||+.|+|||++.+     +.++.++|||||||++|+|++|..||.....      .........
T Consensus       150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~  222 (331)
T cd05624         150 LKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMN  222 (331)
T ss_pred             eeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHc
Confidence            76543222 11223579999999999875     4678899999999999999999999975432      111111111


Q ss_pred             hhhhhhhhcCCcccc-CCCHHHHHHHHHHHHHcccCCCCC--CCCHhHHHHH
Q 014202          325 DKRKLYQIVDPRLEL-NYSLKGVQKVSQLAYNCLSRDPKS--RPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~eil~~  373 (429)
                      .        ...... ......+..+.+|+.+||..++.+  |++++++++.
T Consensus       223 ~--------~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         223 H--------EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C--------CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0        000110 011224578999999999876654  4688888864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-42  Score=330.10  Aligned_cols=256  Identities=28%  Similarity=0.469  Sum_probs=201.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      ++|.+.+.||+|+||.||+|.+..++.       ...+|+|.+.... ......+.+|+.++.++ +||||+++++++..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~   79 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   79 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCc-------eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence            468999999999999999999876543       1246888776432 23345788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      ++..|+||||+++++|.+++....               ..+++..++.++.|++.||+|||  +.||+||||||+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nili  157 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILV  157 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEe
Confidence            999999999999999999986432               24789999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQN  314 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  314 (429)
                      +.++.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|||++ |..||......    
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  230 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----  230 (303)
T ss_pred             cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----
Confidence            999999999999986421111   1111234667999999988889999999999999999998 99999643321    


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                        +....       +    ........+...+..+.+|+.+||+.+|++||++.+++..|..+
T Consensus       231 --~~~~~-------~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         231 --ELYEK-------L----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             --HHHHH-------H----hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              11000       0    01111112223456789999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-42  Score=333.80  Aligned_cols=256  Identities=20%  Similarity=0.223  Sum_probs=201.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||++.+..++.         .||+|++....   ......+..|+.++..++|+||+++++.+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADK---------VFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ   71 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCC---------EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            368999999999999999999887654         89999986432   122344778999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||+++|+|.+++.+....+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~DfG~a  149 (332)
T cd05623          72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSC  149 (332)
T ss_pred             cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeecchh
Confidence            999999999999999999999776667899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ........ ......+||+.|+|||++.     ...++.++|||||||++|||++|..||.....      .........
T Consensus       150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~  222 (332)
T cd05623         150 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMN  222 (332)
T ss_pred             eecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhC
Confidence            76433221 1222357999999999986     34688999999999999999999999975431      111111111


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCC--CCCHhHHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKS--RPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~eil~~  373 (429)
                      ...      ....+ ......+..+.+|+.+||..++++  |+++.++++.
T Consensus       223 ~~~------~~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         223 HKE------RFQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCc------cccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000      00000 011234578999999999765554  6899999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.3e-43  Score=336.58  Aligned_cols=239  Identities=28%  Similarity=0.383  Sum_probs=191.2

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHH-HHhcCCCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVD-FLGQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||+|+||.||+|.+..++.         .||+|++....   ......+..|.. +++.++||||+++++++..++..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGK---------CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence            469999999999999887654         89999986542   123344555655 57789999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||+.||+|..++... ..+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||+|||++.....
T Consensus        72 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          72 YFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence            9999999999999888654 46899999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .......          ..
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~----------~~  210 (325)
T cd05604         149 QSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNI----------LH  210 (325)
T ss_pred             CCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHH----------Hc
Confidence            211  22346799999999999999999999999999999999999999975431      1111111          11


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE  369 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  369 (429)
                      ...  ......+..+.++|.+||+.||.+||++.+
T Consensus       211 ~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         211 KPL--VLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            111  111234467889999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.1e-42  Score=325.46  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=206.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|.+.+.||.|+||.||+|.+..++.         .||+|.+..........+.+|+.+++.++||||+++++.+..+.
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQ---------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCc---------EEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            579999999999999999999876644         89999998766566677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+||||++|++|.+++...  .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++|+|||++...
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             EEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            999999999999999988543  4789999999999999999999  899999999999999999999999999998764


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+...      ....         .
T Consensus       167 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~---------~  229 (296)
T cd06654         167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLI---------A  229 (296)
T ss_pred             ccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHH---------h
Confidence            33221  12235789999999999988899999999999999999999999975432110      0000         0


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .........+...+..+.+|+.+||..||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            0111111222344577999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.3e-42  Score=322.65  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=203.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|.+.+.||+|+||.||+|.+..++.         .||+|.+..........+.+|+.+++.++||||+++++.+..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGE---------LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCc---------EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            468889999999999999999877655         89999987665555566789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||  ..|++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            9999999999999999886544 6899999999999999999999  899999999999999999999999999998764


Q ss_pred             CCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ....  .......|++.|+|||++.   ...++.++|||||||++|+|++|..||....+.....  .      ....  
T Consensus       157 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~--~------~~~~--  224 (267)
T cd06645         157 TATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L------MTKS--  224 (267)
T ss_pred             cCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH--h------hhcc--
Confidence            3221  1223357999999999874   4568899999999999999999999986433211000  0      0000  


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       ....+...  .....+..+.+++.+||+.||++||+++++++.
T Consensus       225 -~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         225 -NFQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -CCCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence             00001110  111234678999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.9e-43  Score=334.48  Aligned_cols=238  Identities=28%  Similarity=0.400  Sum_probs=190.5

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHH-HHhcCCCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVD-FLGQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      ++||+|+||.||+|++..++.         .||+|++.....   .....+..|.. +++.++||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence            469999999999999887655         899999865422   22334555554 67889999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++||+|...+... ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||++.....
T Consensus        72 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  148 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE  148 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence            9999999999999888554 45889999999999999999999  89999999999999999999999999999875322


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|..||....      .......          +..
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~----------i~~  210 (321)
T cd05603         149 PE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDN----------ILH  210 (321)
T ss_pred             CC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHH----------Hhc
Confidence            21  12234679999999999998899999999999999999999999997542      1111111          111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHh
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD  368 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  368 (429)
                      ..  ...+...+..+.++|.+||+.||.+||++.
T Consensus       211 ~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 KP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11  122233457899999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=338.00  Aligned_cols=200  Identities=27%  Similarity=0.362  Sum_probs=175.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-C-----cceeeEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-H-----PNLVKLIG  166 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~  166 (429)
                      .+|.+.++||+|+||.|.+|++..|++         .||||+++... .-..+...|+.+|..|+ |     -|||++++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e---------~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGE---------IVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCc---------EEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            478999999999999999999999876         99999998664 33455678999999997 4     58999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC--CEEE
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY--NAKL  243 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--~~kl  243 (429)
                      +|...++.|||+|.+ ..+|++++..+. .+++...+..++.||+.||.+||  +.+|||+|||||||||.+-+  .|||
T Consensus       256 ~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  256 YFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             ccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCceeE
Confidence            999999999999988 569999997663 45899999999999999999999  99999999999999995543  6999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS  310 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  310 (429)
                      +|||.|........     ..+-+..|.|||++.|.+|+.+.||||||||++||++|.+.|.+....
T Consensus       333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             EecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence            99999987433222     467889999999999999999999999999999999999999886654

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.3e-42  Score=320.89  Aligned_cols=254  Identities=27%  Similarity=0.456  Sum_probs=203.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..+          ..||+|.+..... ....+.+|+.++++++||||+++++.+. +
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~----------~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT----------TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   72 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC----------ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence            35799999999999999999987543          2699999975432 3457889999999999999999999874 4


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ...++||||+.+|+|.+++.+. ...+++..+..++.|++.||+|||  +.+++||||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCcee
Confidence            5679999999999999999754 345789999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||......   ...   ..        
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~---~~--------  215 (262)
T cd05071         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL---DQ--------  215 (262)
T ss_pred             eccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH---HH--------
Confidence            65433221 1122346778999999988899999999999999999999 88888654311   000   00        


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                         .............+..+.+|+.+||+.||++||++.++++.|+..
T Consensus       216 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         216 ---VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               000111122234557899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-42  Score=319.99  Aligned_cols=254  Identities=29%  Similarity=0.472  Sum_probs=203.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.++||+|+||.||+|....          +..||+|.+..... ....+.+|+.++++++||||+++++++. .
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   72 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG----------HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-Q   72 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC----------CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence            4679999999999999999998643          34899999876543 3467889999999999999999999874 5


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..++||||+.+++|.+++... +..+++..+..++.|++.||+|||  +.+++||||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCccee
Confidence            6789999999999999988653 346889999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......   .....           
T Consensus       151 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~-----------  215 (260)
T cd05067         151 LIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN-----------  215 (260)
T ss_pred             ecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH-----------
Confidence            6542221 11122356778999999988889999999999999999999 99999754321   11110           


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                         +........+...+.++.+++.+||..+|++||++++++..|+.+
T Consensus       216 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         216 ---LERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             ---HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence               001111112223456899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-42  Score=333.53  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=195.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCC-CcceeeEEeEEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLH-HPNLVKLIGYCI  169 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  169 (429)
                      +|+..+.||+|+||.||+|.+..++.         .||+|++....   ......+..|+.++..+. |++|+++++++.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDE---------LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence            47788999999999999999887655         89999987542   223355778899998886 678889999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..|+||||++||+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Dfg~~  148 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeccccc
Confidence            9999999999999999999886543 5899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ...   ...        
T Consensus       149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~---~~~--------  212 (323)
T cd05615         149 KEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DEL---FQS--------  212 (323)
T ss_pred             cccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHH---HHH--------
Confidence            75322211  12335799999999999988999999999999999999999999975432   111   111        


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM  367 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  367 (429)
                        +....  ..++...+..+.+++.+||+.||.+|++.
T Consensus       213 --i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         213 --IMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --HHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              11111  11222345778999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-42  Score=317.82  Aligned_cols=253  Identities=31%  Similarity=0.493  Sum_probs=200.9

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ++||+|+||.||+|.+...+.      .+..||+|.+...... ....+.+|+.+|+++.||||+++++++. .+..++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG------KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCC------CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence            479999999999998765542      2348999999866543 4467889999999999999999999876 4567999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+.+|+|.+++.... .+++..+..++.|++.||.|||  ..+++|+||||+|||++.++.+||+|||+++.......
T Consensus        74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          74 MELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            99999999999997654 6899999999999999999999  89999999999999999999999999999986543322


Q ss_pred             cce-eeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCC
Q 014202          258 THV-STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP  335 (429)
Q Consensus       258 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (429)
                      ... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....   .....++.              .
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~--------------~  213 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE--------------S  213 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH--------------c
Confidence            111 111223567999999998899999999999999999998 9999965321   11111110              0


Q ss_pred             ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ......+...+..+.+++.+||..||++||++.++++.|+.+.
T Consensus       214 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            1111223344578999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=323.24  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=207.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .||+|.+..........+..|+.++++++||||+++++++..+.
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGL---------FAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN   75 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCc---------EEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence            569999999999999999999876544         89999998765556677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+||||+++++|.+++.+....+++..+..++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999999999999998776667999999999999999999999  899999999999999999999999999998764


Q ss_pred             CCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ....  .......|++.|+|||++.     +..++.++||||||+++|+|++|..||......      .....      
T Consensus       154 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~------  219 (280)
T cd06611         154 KSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLK------  219 (280)
T ss_pred             cccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHH------
Confidence            3321  1223357899999999875     345678999999999999999999999754321      10000      


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       +...  .......+...+..+.+++.+||+.||.+||++.++++.
T Consensus       220 -~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         220 -ILKS--EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -HhcC--CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             0000  001111223345789999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.9e-42  Score=325.31  Aligned_cols=252  Identities=29%  Similarity=0.432  Sum_probs=202.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .|++.+.||+|+||.||+|.+..++.         .||+|.+......   ....+..|+.+|++++|+||+.+++.+..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCc---------eEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence            37788899999999999999988755         9999998754322   23456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++..++||||+.|++|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence            99999999999999999988543 335899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........   .....|++.|+|||++.+..++.++|||||||++|+|++|..||...........   ......     
T Consensus       150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~-----  218 (285)
T cd05630         150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVK-----  218 (285)
T ss_pred             eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhh-----
Confidence            76433221   1234799999999999988999999999999999999999999975432111100   000000     


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~~  373 (429)
                        ..    ........+..+.+|+.+||+.||++|||     +.|+++.
T Consensus       219 --~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         219 --EV----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             --hh----hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence              00    01112234467899999999999999999     8888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-42  Score=315.68  Aligned_cols=248  Identities=29%  Similarity=0.482  Sum_probs=200.9

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ++||.|+||.||+|.+.. +.         .||+|.+...... ....+.+|+.++++++||||+++++++......++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~---------~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NT---------EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC-CC---------cEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence            479999999999998765 44         8999998766443 456789999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+.|++|.+++......+++..+..++.+++.||.|||  +.+++||||+|+|||++.++.++|+|||++........
T Consensus        71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY  148 (251)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence            9999999999999766567889999999999999999999  89999999999999999999999999999986432211


Q ss_pred             cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCc
Q 014202          258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR  336 (429)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                      ........++..|+|||.+.++.++.++|||||||++|+|++ |..||.......   ..              ..+...
T Consensus       149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~--------------~~~~~~  211 (251)
T cd05041         149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TR--------------ERIESG  211 (251)
T ss_pred             eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HH--------------HHHhcC
Confidence            111111234567999999988899999999999999999999 888886543211   00              001111


Q ss_pred             cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .....+...+..+.+++.+||..+|++||++.|+++.|.
T Consensus       212 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         212 YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            111223344578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-42  Score=333.31  Aligned_cols=269  Identities=26%  Similarity=0.410  Sum_probs=209.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      ..+|++++.||+|+||.||+|.+...++.  ....+..||+|.+.... .....++.+|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKD--KPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCc--cCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            35799999999999999999987543321  11223479999887543 23356788999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      .++..++||||+.+|+|.+++.+..               ..+++..+..++.|++.||.|||  ..+|+||||||+|||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil  166 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARNVL  166 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEE
Confidence            9999999999999999999986532               24678888999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....    
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  242 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  242 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence            99999999999999986543222211222334568999999999999999999999999999998 8888865321    


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                        ......           +........+...+..+.+|+.+||+.+|++||++.++++.|..+....
T Consensus       243 --~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 --EELFKL-----------LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             --HHHHHH-----------HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence              111111           1011111222334568999999999999999999999999998776433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.6e-42  Score=319.40  Aligned_cols=253  Identities=29%  Similarity=0.473  Sum_probs=202.5

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+...          ..||+|.+..... ....+.+|+.++++++|+||+++++++. .
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~----------~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGN----------TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E   72 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCC----------ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence            35799999999999999999976532          3699999876543 3456889999999999999999999875 4


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ...++||||+.+++|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+||++++++.++|+|||++.
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCceeee
Confidence            5689999999999999998654 345899999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ....   .        
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~--------  215 (260)
T cd05070         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLE---Q--------  215 (260)
T ss_pred             eccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---H--------
Confidence            65432211 1112345668999999988889999999999999999999 89999653211   1111   0        


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                         +........+...+..+.+|+.+||..||++|||+.+++++|+.
T Consensus       216 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         216 ---VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               11111112233445789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-42  Score=335.53  Aligned_cols=265  Identities=29%  Similarity=0.412  Sum_probs=203.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|++...+.    ..+++.||||++..... .....+.+|+.+|.++ +||||+++++++..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCc----cccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            579999999999999999998653221    12356899999976532 3345688999999999 68999999998765


Q ss_pred             C-CeEEEEEEecCCCChHHHHhcCC-------------------------------------------------------
Q 014202          171 D-DQRLLVYEFMTRGSLENHLFRRT-------------------------------------------------------  194 (429)
Q Consensus       171 ~-~~~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------------  194 (429)
                      . ...++||||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 46789999999999999885421                                                       


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeee
Q 014202          195 -----------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR  263 (429)
Q Consensus       195 -----------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~  263 (429)
                                 ..+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||++..............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                       13577788899999999999999  89999999999999999999999999999976433222111222


Q ss_pred             ccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCC
Q 014202          264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYS  342 (429)
Q Consensus       264 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...    ..+..          ......+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~----------~~~~~~~  304 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKE----------GTRMRAP  304 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhc----------cCCCCCC
Confidence            345678999999998899999999999999999997 999986532210  000    00100          0011111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          343 LKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       343 ~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ...+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1234678999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.1e-42  Score=317.39  Aligned_cols=252  Identities=29%  Similarity=0.455  Sum_probs=203.0

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +.||+|+||.||+|.+..++.      ....||||.+..... ...+.+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGG------KVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCCC------CceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence            468999999999999865322      133699999988766 556788999999999999999999999988 889999


Q ss_pred             EEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCC
Q 014202          178 YEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~  256 (429)
                      |||+++++|.+++.... ..+++..++.++.|++.||+|||  ..+++|+||||+||+++.++.+||+|||++.......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence            99999999999997654 56899999999999999999999  8999999999999999999999999999998764422


Q ss_pred             ccc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          257 KTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       257 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......   ..   ......          
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~---~~~~~~----------  215 (257)
T cd05040         152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QI---LKKIDK----------  215 (257)
T ss_pred             cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHHh----------
Confidence            211 1112457788999999998899999999999999999998 99999643211   11   111000          


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00111122234578999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.1e-42  Score=327.31  Aligned_cols=262  Identities=27%  Similarity=0.352  Sum_probs=203.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .+|+|.+..... .....+.+|++++++++||||+++++.+..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~---------~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGL---------IMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD   71 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCe---------EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            368999999999999999999877654         899999875532 2345688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..++||||++|++|.+++... ..+++..+..++.|++.||.|||  + .+++|+||||+|||++.++.++|+|||++.
T Consensus        72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (308)
T cd06615          72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  148 (308)
T ss_pred             CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hhCCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence            9999999999999999998655 46899999999999999999999  5 589999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh-----
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD-----  325 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  325 (429)
                      ......    .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......   ...+.......     
T Consensus       149 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  221 (308)
T cd06615         149 QLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKE  221 (308)
T ss_pred             cccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccC
Confidence            543221    223578999999999988889999999999999999999999996433211   11000000000     


Q ss_pred             ------------------hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 ------------------KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 ------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                        ............+.......+.++.+|+.+||..||++||++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                              000000000000000011245679999999999999999999999984

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.2e-42  Score=322.43  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=201.4

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++.|++.+.||+|+||.||+|.+..++.         .||+|.+.... .....+..|+.++.++ +||||+++++++.
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQ---------LAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   73 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCc---------EEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            45789999999999999999999877654         89999987553 3345778999999998 6999999999987


Q ss_pred             eC------CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          170 ED------DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       170 ~~------~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ..      ...|+||||+.+++|.+++... ...+++..+..++.|++.||+|||  +.+|+|+||||+||++++++.++
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~~~  151 (272)
T cd06637          74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVK  151 (272)
T ss_pred             ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCCEE
Confidence            53      4689999999999999998764 346899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      |+|||++........  ......|++.|+|||++.     +..++.++|||||||++|||++|..||....+..     .
T Consensus       152 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~  224 (272)
T cd06637         152 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----A  224 (272)
T ss_pred             EccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----H
Confidence            999999986433211  223367899999999986     3457889999999999999999999996433211     0


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..        ....   ...........+..+.+|+.+||..||.+|||+.++++.
T Consensus       225 ~~--------~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         225 LF--------LIPR---NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HH--------HHhc---CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            00        0000   001111122345689999999999999999999999873

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-42  Score=336.96  Aligned_cols=265  Identities=23%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||.+....  ......+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   85 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDR---------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCc---------eEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence            45789999999999999999999876654         89999997542  23345678999999999999999999988


Q ss_pred             EeCC------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IEDD------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~~~------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ....      ..|+||||+++ +|.+.+..   .+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~~~k  159 (355)
T cd07874          86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_pred             eccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCCCEE
Confidence            6543      46999999965 67666643   3788999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH------
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV------  316 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~------  316 (429)
                      |+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........      
T Consensus       160 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (355)
T cd07874         160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_pred             EeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999998643221   123357899999999999989999999999999999999999999764321110000      


Q ss_pred             ---H-------HHHHHHHhhhhhhhhcCCc------c--ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          317 ---A-------WARQYLADKRKLYQIVDPR------L--ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       317 ---~-------~~~~~~~~~~~~~~~~~~~------~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         +       ....+............+.      .  ........+..+.+||.+||+.||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               0       0000000000000000000      0  000111234678999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.5e-42  Score=323.71  Aligned_cols=264  Identities=27%  Similarity=0.431  Sum_probs=208.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..++|.+.+.||+|+||.||+|.+..++     +..+..|++|.+.... ......+.+|+.+|++++||||+++++++.
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            3467999999999999999999987643     1224589999987543 233566889999999999999999999876


Q ss_pred             e-CCeEEEEEEecCCCChHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          170 E-DDQRLLVYEFMTRGSLENHLFRRT-------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       170 ~-~~~~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      . +...++++||+.+++|.+++....       ..+++..++.++.|++.||+|||  +.+++||||||+||+++.++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCcE
Confidence            6 467899999999999999986532       45889999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |..||....+.   ....+  
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~--  231 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAY--  231 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHH--
Confidence            9999999986544332222222346778999999998889999999999999999999 99999654321   11111  


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        ...          .........++..+.+++.+||..||++|||+.++++.|..+.
T Consensus       232 --~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         232 --LKD----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             --HHc----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence              111          1111112234578999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-42  Score=327.35  Aligned_cols=263  Identities=30%  Similarity=0.515  Sum_probs=217.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-hHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .....+.++||+|.||.|.++....          +..||||+++...... .++|.+|+++|.+|+|||||+++++|..
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            4567888999999999999987653          3589999999875544 4889999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++.+++|+||+++|+|.+++.++.-+ +.......++.||+.|++||.  +.++|||||.+.|+|+|.++++||+|||++
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe--s~nfVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE--SLNFVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH--hhchhhccccccceeecCcccEEecCcccc
Confidence            99999999999999999999877433 355667789999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT--GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +.+-.++........+-..+|||+|.+.-+.++.++|+|+||+++||+++  ...||.....   ...++...       
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~-------  754 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAG-------  754 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhh-------
Confidence            98877788777777888899999999999999999999999999999765  6777754321   12222111       


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      .+...-....-...+.-++..+.+|+..||..|-.+||+++++...|..
T Consensus       755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            1111111122233455677899999999999999999999999887754

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.8e-42  Score=323.03  Aligned_cols=262  Identities=26%  Similarity=0.357  Sum_probs=195.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcC---CCcceeeEEeEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQL---HHPNLVKLIGYC  168 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~  168 (429)
                      +|++.+.||+|+||.||+|.+..++.         .||+|.+......  ....+.+|+.+++.+   +||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~   71 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGH---------FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC   71 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCc---------EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence            58899999999999999999987655         8999998754222  223456777777665   699999999987


Q ss_pred             Ee-----CCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IE-----DDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~-----~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ..     ....++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+|
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             ccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEE
Confidence            64     3457999999974 8888886543 35899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|.+||........  ... +...
T Consensus       149 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~  222 (288)
T cd07863         149 LADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDL  222 (288)
T ss_pred             ECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHH
Confidence            999999986533221   1235789999999999988999999999999999999999999975432111  101 0000


Q ss_pred             HHh--hhhhhhh-------cCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          323 LAD--KRKLYQI-------VDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       323 ~~~--~~~~~~~-------~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ...  .......       ..+...   .......+..+.+||.+||+.||++|||+.+++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000  0000000       000000   00112345678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-42  Score=320.55  Aligned_cols=254  Identities=33%  Similarity=0.525  Sum_probs=203.0

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhH--HHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR--EWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      |++++.||+|+||+||+|.+..++.         .||+|.+.........  ...+|+.++++++||||+++++++..+.
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~---------~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQ---------KVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTE---------EEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCe---------EEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence            6788999999999999999988755         8999999877544332  3456999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++|||++.+++|.+++. ....+++..+..++.|++.||.+||  +.+|+|+||||+||+++.++.++|+|||.+...
T Consensus        72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             ccccccccccccccccccc-ccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc
Confidence            9999999999999999997 3335899999999999999999999  899999999999999999999999999999753


Q ss_pred             CCCCccceeeeccccccccChhhhh-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      .  ..........++..|+|||++. +..++.++||||||+++|+|++|..||.....   .+...........  ....
T Consensus       149 ~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~--~~~~  221 (260)
T PF00069_consen  149 S--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKR--PLPS  221 (260)
T ss_dssp             T--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHT--HHHH
T ss_pred             c--ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhcccc--cccc
Confidence            1  1222333467899999999998 78899999999999999999999999976411   1111111111100  0000


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..      .........+.++|.+||+.||++||++.++++.
T Consensus       222 ~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  222 SS------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HT------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cc------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00      0000112789999999999999999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.7e-42  Score=323.72  Aligned_cols=262  Identities=27%  Similarity=0.426  Sum_probs=204.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+....    ...++..||+|.+..... ....++.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccC----CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            357999999999999999999875311    011245899999876532 334668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT---------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFK  229 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~---------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlk  229 (429)
                      ++..++||||+++|+|.+++....                     ..+++..++.++.|++.||.|||  ..+++|||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~  157 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLA  157 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeeccccc
Confidence            999999999999999999986431                     24678889999999999999999  8999999999


Q ss_pred             CCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 014202          230 TSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKR  308 (429)
Q Consensus       230 p~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  308 (429)
                      |+|||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999876433222211222345677999999998899999999999999999997 888885432


Q ss_pred             CCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      .      .+....          +.+... ...+...+.++.+|+.+||+.||.+|||+.|+++.|+.
T Consensus       238 ~------~~~~~~----------~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 H------EEVIYY----------VRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H------HHHHHH----------HhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1      111110          011110 11122345789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.2e-42  Score=327.09  Aligned_cols=262  Identities=25%  Similarity=0.406  Sum_probs=207.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|+..+.||+|+||.||+|.+..++...     ...||+|.+..... ....++.+|+.+++.++||||+++++++...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETV-----KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcc-----eeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            56888999999999999999987765422     12689998876533 2234678999999999999999999988754


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                       ..++++||+++|+|.+++......+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEcccccccc
Confidence             467999999999999999877667899999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............++..|+|||++.+..++.++|||||||++|||++ |..||.+...   .....    .+..     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~----~~~~-----  226 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPD----LLEK-----  226 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHC-----
Confidence            543322211222345778999999998899999999999999999997 8999865321   11111    1110     


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                           ......+...+..+.+++.+||..+|++||++.++++.|..+..
T Consensus       227 -----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         227 -----GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 11111122234678999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.3e-42  Score=320.74  Aligned_cols=249  Identities=26%  Similarity=0.432  Sum_probs=194.6

Q ss_pred             cccccCceeEEEEEEccCCCCCC---------------CCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeE
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPA---------------KPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~---------------~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      .||+|+||.||+|....++....               .......|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998754332111               222345699999876544445678899999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-----
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-----  239 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-----  239 (429)
                      ++++..+...++||||+++|+|..++.+....+++..+..++.|++.||+|||  +.+|+||||||+|||++..+     
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcccCc
Confidence            99999999999999999999999998766667899999999999999999999  89999999999999997643     


Q ss_pred             --CEEEccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHH-hCCCCCCCCCCCccccH
Q 014202          240 --NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEIL-TGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       240 --~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~  315 (429)
                        .++|+|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+...   
T Consensus       160 ~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---  230 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---  230 (274)
T ss_pred             cceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---
Confidence              3899999988653221      11357888999998865 56899999999999999985 69999875432111   


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      ..    ....        ....+    ......+.++|.+||+.+|++|||+.++++.|.
T Consensus       231 ~~----~~~~--------~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ER----FYEK--------KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH----HHHh--------ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            00    0000        00111    112357899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-42  Score=317.86  Aligned_cols=255  Identities=29%  Similarity=0.473  Sum_probs=206.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..++|.+.+.||+|+||.||+|.+...          ..||||.+.... ....++.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~----------~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGT----------TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE   72 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCC----------ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence            346899999999999999999987542          279999987654 334678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +...++||||+++++|.+++.... ..+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECccccc
Confidence            899999999999999999997653 46899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+...   .....   .       
T Consensus       151 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~---~-------  216 (261)
T cd05034         151 RLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLE---Q-------  216 (261)
T ss_pred             eeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---H-------
Confidence            86543211 11112234678999999998889999999999999999998 9999965321   11111   0       


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      +.    .......+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus       217 ~~----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         217 VE----RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HH----cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            00    011111222335789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.1e-42  Score=322.28  Aligned_cols=250  Identities=29%  Similarity=0.431  Sum_probs=200.5

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      |+..+.||.|+||+||+|.+..+++         .||+|.+......   ....+.+|+.+|++++|+||+.+++.+..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGK---------MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCc---------EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            6778899999999999999887655         8999998754322   234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..++||||+.+++|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~  150 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCcce
Confidence            9999999999999999888654 346899999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .......   .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.........  .....       .+.
T Consensus       151 ~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~-------~~~  218 (285)
T cd05632         151 KIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDR-------RVL  218 (285)
T ss_pred             ecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH-------hhh
Confidence            6432211   12357899999999999889999999999999999999999999754321110  00000       000


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~  372 (429)
                         ..  ...+....+..+.+|+..||+.||++||+     +.+++.
T Consensus       219 ---~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         219 ---ET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---cc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               00  01122234567899999999999999999     566665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-41  Score=317.59  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=194.8

Q ss_pred             CcccccCceeEEEEEEccCCCC---CCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTA---PAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL  175 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~---~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  175 (429)
                      +.||+|+||.||+|+.......   .........|++|.+..........+..|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999986533211   0111234578999987655444567788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC-------EEEccccC
Q 014202          176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN-------AKLSDFGL  248 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-------~kl~DFg~  248 (429)
                      +||||+++|+|..++......+++..++.++.||+.||+|||  +.+|+||||||+|||++.++.       ++++|||+
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            999999999999988766667899999999999999999999  899999999999999987664       89999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhh-cCCCCCccchhhhHHHHHHHH-hCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEIL-TGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +......      ....|+..|+|||.+. +..++.++|||||||++|||+ .|..||........       .      
T Consensus       159 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~------  219 (262)
T cd05077         159 PITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------E------  219 (262)
T ss_pred             CccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------H------
Confidence            8764321      1246788999999886 567899999999999999998 58888764321100       0      


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                       .+..   ....  .......++.+|+.+||+.||.+||++.+|++.|
T Consensus       220 -~~~~---~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 -RFYE---GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -HHHh---cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             0000   0000  1112236789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.9e-42  Score=333.27  Aligned_cols=264  Identities=23%  Similarity=0.282  Sum_probs=198.5

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||+|+||.||+|.+..++.         .||||++....  ......+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~   93 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILER---------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   93 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCc---------EEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence            4689999999999999999999877654         89999987542  233466789999999999999999999876


Q ss_pred             eC------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          170 ED------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       170 ~~------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      ..      ...|+||||+.+ +|.+.+..   .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL  167 (364)
T cd07875          94 PQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  167 (364)
T ss_pred             ccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCCcEEE
Confidence            43      357999999965 77776643   3788899999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH-------
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV-------  316 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~-------  316 (429)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+       
T Consensus       168 ~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  244 (364)
T cd07875         168 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  244 (364)
T ss_pred             EeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999998643221   123357899999999999999999999999999999999999999765422110000       


Q ss_pred             -----HHH----HHHHHhhhhhhh----hcCCcc----ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          317 -----AWA----RQYLADKRKLYQ----IVDPRL----ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       317 -----~~~----~~~~~~~~~~~~----~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                           ...    ..+.........    ...+..    ...........+.+||.+||+.||.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                 000    000000000000    000000    000111123578999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.1e-42  Score=322.45  Aligned_cols=266  Identities=30%  Similarity=0.437  Sum_probs=205.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC-
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED-  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  171 (429)
                      .|++.+.||+|+||.||+|.....+     ..++..||+|.+.... ......+.+|+.+|+.++||||+++++++... 
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   79 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCC-----CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            4788999999999999999864321     1235589999987553 23346788999999999999999999998875 


Q ss_pred             -CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 -DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                       ...++||||++|++|.+++.+....+++..+..++.|++.||+|||  +.|++||||||+||+++.++.++|+|||++.
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence             5689999999999999998766556899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC---------ccccHHHHHH
Q 014202          251 AGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS---------GEQNLVAWAR  320 (429)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~~~~~~  320 (429)
                      ........ .......|+..|+|||++.+..++.++|||||||++|||+++..|+......         ........  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL--  235 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH--
Confidence            65433221 1122345777899999998888999999999999999999987765321110         00000000  


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                               ...+............+..+.+|+.+||+.||++||+++++++.|+.+
T Consensus       236 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 ---------VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ---------HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                     000000111112233557899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.2e-41  Score=316.50  Aligned_cols=255  Identities=27%  Similarity=0.391  Sum_probs=193.3

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +.||+|+||.||+|.......       +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYT-------PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCCC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence            469999999999998754322       34799999876542 3345688899999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          178 YEFMTRGSLENHLFRRT----IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      |||+++|+|.+++....    ...++..+..++.|++.||+|||  +.+++||||||+||+++.++.++|+|||++....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999999986532    24567778889999999999999  8999999999999999999999999999997543


Q ss_pred             CCCccceeeeccccccccChhhhhcC-------CCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTG-------HLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ............|+..|+|||++.+.       .++.++||||||+++|||++ |..||.......   ....    . .
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~----~-~  223 (269)
T cd05087         152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY----T-V  223 (269)
T ss_pred             CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----H-h
Confidence            32221222235678899999988642       35789999999999999996 999996543211   1000    0 0


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .........+..    ....+..+.+++..|| .+|++|||+++|+..|+
T Consensus       224 ~~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         224 REQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hcccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            000011111111    1123467889999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-41  Score=316.09  Aligned_cols=248  Identities=29%  Similarity=0.434  Sum_probs=199.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE-eC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI-ED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~  171 (429)
                      .+|.+.+.||+|+||.||+|...           |..||+|.+....  ..+.+.+|+.++++++|+||+++++++. .+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   72 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence            46899999999999999999754           3479999986543  3457889999999999999999999754 45


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..++||||+++++|.+++..... .+++..++.++.|++.||+|||  ..+++||||||+||++++++.+||+|||++.
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCccce
Confidence            678999999999999999876543 4789999999999999999999  8999999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ......     ....++..|+|||++.+..++.++|||||||++|+|++ |..||.....      ......        
T Consensus       151 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~--------  211 (256)
T cd05082         151 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPR--------  211 (256)
T ss_pred             eccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH--------
Confidence            643221     12345668999999988889999999999999999997 9999864321      111110        


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                         +............+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       212 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         212 ---VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               101111122234457899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-41  Score=314.43  Aligned_cols=250  Identities=28%  Similarity=0.420  Sum_probs=207.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .|++|.+.....  ..++.+|+.++++++||||+++++.+..+.
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT   71 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCc---------EEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            579999999999999999999887544         899999875532  578899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+++||+.+++|.+++......+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence            999999999999999999776677899999999999999999999  899999999999999999999999999999875


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .....  ......|+..|+|||++.+..++.++||||||+++|+|++|..||....+.....             .... 
T Consensus       150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------------~~~~-  213 (256)
T cd06612         150 TDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------------MIPN-  213 (256)
T ss_pred             ccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------------hhcc-
Confidence            43321  1223568899999999998899999999999999999999999997543211000             0000 


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       ........+...+..+.+++.+||+.||++|||+.++++
T Consensus       214 -~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 -KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             011111122334578999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.8e-42  Score=326.37  Aligned_cols=263  Identities=24%  Similarity=0.336  Sum_probs=202.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|.+.+.||.|+||.||+|++..++.         .||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDN---------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCc---------EEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            569999999999999999999877654         899999875432 2234677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+. ++|.+++......+++..+..++.|++.||.|||  +.+|+|+||||+|||++.++.++|+|||++..
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            99999999996 5999988776667899999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh-hhh-
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD-KRK-  328 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-  328 (429)
                      ......  ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.......   ....+...+.. ... 
T Consensus       154 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~  228 (301)
T cd07873         154 KSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEET  228 (301)
T ss_pred             cCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhh
Confidence            432221  11224678999999988754 57889999999999999999999997653211   11111110000 000 


Q ss_pred             hhhhc---------CCccc----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIV---------DPRLE----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~---------~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .....         .+...    .......+..+.+||.+||+.||.+|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000         00000    0011223567899999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.5e-42  Score=323.75  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=206.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|.+.+.||.|+||.||+|.+..++.         .||+|.+..........+.+|+.+++.++||||+++++++..++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQ---------EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCC---------EEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            679999999999999999999876654         89999998765555667889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+||||+++++|.+++.+.  .+++..+..++.|++.||.|||  +.+++||||||+|||++.++.++|+|||++...
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            999999999999999988553  4788999999999999999999  899999999999999999999999999998764


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+......               ..
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------------~~  228 (297)
T cd06656         166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------------IA  228 (297)
T ss_pred             cCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---------------ec
Confidence            33221  12235789999999999988899999999999999999999999975433111000               00


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .........+...+..+.+|+.+||..||++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         229 TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011111122334577899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-41  Score=316.76  Aligned_cols=250  Identities=25%  Similarity=0.394  Sum_probs=202.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh---------hHHHHHHHHHHhcCCCcceeeE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---------HREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      +|.+.+.||.|+||.||+|.+..++.         .||+|.+.......         ...+.+|+.++++++||||+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   71 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGE---------LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY   71 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCc---------EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            47889999999999999999876544         89999886543221         2457889999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||  +.+++||||+|+||+++.++.++|+
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~~l~  148 (267)
T cd06628          72 LGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKIS  148 (267)
T ss_pred             EEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCEEec
Confidence            99999999999999999999999999655 46889999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCc----cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          245 DFGLAKAGPQGDK----THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       245 DFg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      |||+++.......    ........|+..|+|||.+.+..++.++|||||||++|+|++|..||......      ....
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~  222 (267)
T cd06628         149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIF  222 (267)
T ss_pred             ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHH
Confidence            9999986542111    11112346889999999998888999999999999999999999999753210      0000


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             .......+    ..+...+..+.++|.+||+.||.+||++.++++
T Consensus       223 -------~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         223 -------KIGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -------HHhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                   01111111    122334578999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=315.72  Aligned_cols=248  Identities=30%  Similarity=0.518  Sum_probs=204.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|++.+.||.|+||.||+|...           |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN   73 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence            46899999999999999999864           34899999986643 4567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEcccccccc
Confidence            9999999999999999986654 35899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ......     ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .+..             
T Consensus       152 ~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~-------------  210 (256)
T cd05039         152 ASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP-------------  210 (256)
T ss_pred             cccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH-------------
Confidence            532211     2345667999999988889999999999999999997 99998644211   1110             


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                       .+........+...++.+.+++.+||..+|++||++.++++.|+.
T Consensus       211 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         211 -HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -HHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             000111111223345789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.1e-42  Score=355.93  Aligned_cols=259  Identities=23%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.++||+|+||.||+|.+..++.         .||+|++.....   ...+++.+|+.++++++||||+++++++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~---------~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSR---------RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCc---------EEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            579999999999999999999877654         899999975422   23457889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRR----------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY  239 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~  239 (429)
                      +++..|+||||++||+|.+++...          ....++..++.++.||+.||+|||  +.||+||||||+|||++.++
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg  150 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFG  150 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCC
Confidence            999999999999999999988532          123456778899999999999999  89999999999999999999


Q ss_pred             CEEEccccCcccCCCCCc----------------cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCC
Q 014202          240 NAKLSDFGLAKAGPQGDK----------------THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS  303 (429)
Q Consensus       240 ~~kl~DFg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p  303 (429)
                      .++|+|||+++.......                .......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            999999999976521100                0111225799999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-CHhHHHHHhcCC
Q 014202          304 MDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-SMDEVVKVLTPL  377 (429)
Q Consensus       304 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~eil~~l~~~  377 (429)
                      |.......   ..        .    ................+..+.+++.+||+.||++|| +++++++.|+..
T Consensus       231 F~~~~~~k---i~--------~----~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        231 YRRKKGRK---IS--------Y----RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             CCCcchhh---hh--------h----hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            97532211   00        0    000000011111123457789999999999999996 566666665544

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-42  Score=334.23  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=211.3

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--hHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..+.|.+.+.||+|.|+.|.+|++..++.         .||||++.+.....  ...+.+|+++|+.|+|||||+++.+.
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~---------~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~  124 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGT---------EVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI  124 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCc---------eEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            34689999999999999999999998755         99999998775433  34578999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      +....+|+||||+.+|.+++++.+.+. ..+..+..++.|++.|++|||  .++|||||||++|||++.+.++||+|||+
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaDfgf  201 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIADFGF  201 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeecccc
Confidence            999999999999999999999988775 455899999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +..+..   ......++|++.|.|||++.+..| ++.+|+||||++||.|+.|..||++.....-..             
T Consensus       202 S~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-------------  265 (596)
T KOG0586|consen  202 STFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-------------  265 (596)
T ss_pred             ceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-------------
Confidence            988653   334556899999999999998876 689999999999999999999998754221110             


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         ..+...  ...+.-.+.+..+||+++|.++|.+|++++++.+
T Consensus       266 ---rvl~gk--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  266 ---RVLRGK--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ---hheeee--ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence               011111  1223334567889999999999999999999976

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=318.43  Aligned_cols=250  Identities=28%  Similarity=0.468  Sum_probs=197.0

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEEeCCeEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l  176 (429)
                      +.||+|+||.||+|.+..++.       ...+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCC-------eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            468999999999999877643       2257888887433 23446788999999999 79999999999999999999


Q ss_pred             EEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          177 VYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      ||||+++|+|.+++....               ..+++..+..++.|++.||+|||  +.+++||||||+|||++.++.+
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~  151 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA  151 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeE
Confidence            999999999999986532               24788999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||.....      .....
T Consensus       152 kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~  222 (270)
T cd05047         152 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE  222 (270)
T ss_pred             EECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHH
Confidence            99999998642211   11111234567999999988889999999999999999997 9999964321      11111


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                                 .+........+...+..+.+|+.+||..||.+|||+.+++..|..+
T Consensus       223 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         223 -----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -----------HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                       1111111112223446799999999999999999999999988755

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-41  Score=316.43  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=196.1

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcCCCcceeeEEeEEE-eCCeEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHPNLVKLIGYCI-EDDQRLL  176 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~l  176 (429)
                      +.||+|+||.||+|.+...+.      .+..||+|.+... .......+.+|+.+++.++||||+++++++. .++..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDG------QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecCCC------ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence            468999999999998765332      2347999998643 2334567889999999999999999999765 4556789


Q ss_pred             EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCC
Q 014202          177 VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~  256 (429)
                      ||||+.+|+|.+++.+.....++..+..++.|++.||.|||  ..+++||||||+|||++.++.+||+|||+++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            99999999999999766556778888999999999999999  8999999999999999999999999999997543221


Q ss_pred             cc--ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          257 KT--HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG-RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       257 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ..  .......++..|+|||.+.+..++.++|||||||++|||++| .+||.....      ......       +..  
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~-------~~~--  217 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVY-------LLQ--  217 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-------Hhc--
Confidence            11  111123567789999999888899999999999999999995 555643221      111110       000  


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        ......+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus       218 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         218 --GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              0011112223467999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-42  Score=331.81  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=197.7

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ...++|.+.+.||.|+||.||+|.+..++.         .||||.+.....  .....+.+|+.+|++++||||++++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQ---------KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV   82 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCC---------EEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence            345789999999999999999999877654         899999875422  233567789999999999999999998


Q ss_pred             EEeC------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          168 CIED------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       168 ~~~~------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      +...      ...|++|+++ +++|.+++..  ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          83 FTPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             hcccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECCCCCE
Confidence            7543      3468999988 7899887743  35899999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........  +..+..
T Consensus       158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~  230 (343)
T cd07878         158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIME  230 (343)
T ss_pred             EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHH
Confidence            99999999864332     223578999999999876 5689999999999999999999999975432110  000000


Q ss_pred             HHHHhhhhhh---------hhcC--Ccccc----CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          321 QYLADKRKLY---------QIVD--PRLEL----NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       321 ~~~~~~~~~~---------~~~~--~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..-.......         ....  +....    .......+.+.+||.+||+.||.+|||+.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000         0000  00000    0001123567899999999999999999999973

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=318.16  Aligned_cols=249  Identities=28%  Similarity=0.385  Sum_probs=205.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .||+|.+.... ......+.+|+.+++.++||||+++++++.++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQ---------VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG   71 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCe---------EEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence            468899999999999999999877654         89999987653 33445678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...|+|+||+++++|.+++...  .+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  147 (274)
T cd06609          72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVSGQ  147 (274)
T ss_pred             CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccccccee
Confidence            9999999999999999998654  6899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      .....  .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+..      ...       .+..
T Consensus       148 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~-------~~~~  212 (274)
T cd06609         148 LTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLF-------LIPK  212 (274)
T ss_pred             ecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHH-------Hhhh
Confidence            54322  12233578899999999998889999999999999999999999997543211      000       0011


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...+.+..   ...+..+.+++.+||..||++||++.++++
T Consensus       213 ~~~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         213 NNPPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cCCCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11111111   114567999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-41  Score=325.16  Aligned_cols=199  Identities=25%  Similarity=0.408  Sum_probs=161.7

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe--CCeEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE--DDQRL  175 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~  175 (429)
                      +++||+|+||.||+|++.....       +..||+|.+.....  ...+.+|+.+|++++||||+++++++..  +...|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~-------~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   76 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCC-------CceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence            4689999999999999764322       45899999875432  2456789999999999999999998854  45678


Q ss_pred             EEEEecCCCChHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCCEEE
Q 014202          176 LVYEFMTRGSLENHLFRR--------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL----DSEYNAKL  243 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl  243 (429)
                      +||||+. ++|.+++...        ...+++..+..++.|++.||.|||  +.+|+||||||+|||+    +.++.+||
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07868          77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence            9999985 5888776432        225889999999999999999999  8999999999999999    45678999


Q ss_pred             ccccCcccCCCCCcc-ceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014202          244 SDFGLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKR  308 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~  308 (429)
                      +|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            999999865432211 11234678999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-41  Score=312.04  Aligned_cols=247  Identities=31%  Similarity=0.474  Sum_probs=197.8

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ++||.|+||.||+|.... +         ..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~-~---------~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   70 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD-K---------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV   70 (250)
T ss_pred             CccCCCCCceEEEEEecC-C---------cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence            469999999999998643 2         37999998765432 234688999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+++++|.+++......+++..+..++.|++.+|.|||  ..+++|+||||+||+++.++.++|+|||++........
T Consensus        71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (250)
T cd05085          71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY  148 (250)
T ss_pred             EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence            9999999999998766666899999999999999999999  89999999999999999999999999999875332211


Q ss_pred             cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCc
Q 014202          258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR  336 (429)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                       .......++..|+|||++.+..++.++||||||+++|+|++ |..||......   ....          .+..    .
T Consensus       149 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~----------~~~~----~  210 (250)
T cd05085         149 -SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE----------QVEK----G  210 (250)
T ss_pred             -ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----------HHHc----C
Confidence             11111244667999999988889999999999999999998 99999654221   1000          0000    1


Q ss_pred             cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       211 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            111222334578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.1e-42  Score=320.30  Aligned_cols=248  Identities=25%  Similarity=0.374  Sum_probs=195.2

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVY  178 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  178 (429)
                      +.||.|+||.||+|.+...+..  .......||+|.+........+.+..|+.+|+.++||||+++++++..++..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            4699999999999998654431  01123368999887655445567889999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC--------EEEccccCcc
Q 014202          179 EFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN--------AKLSDFGLAK  250 (429)
Q Consensus       179 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--------~kl~DFg~a~  250 (429)
                      ||+.+|+|.+++......+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.        ++++|||++.
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999776667899999999999999999999  899999999999999987665        6999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCC-CCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR-RSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      .....      ....+++.|+|||++.+ ..++.++|||||||++|||++|. .||....+..      .. ....    
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~----  219 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYE----  219 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHH----
Confidence            54321      12468889999999876 45789999999999999999985 5554322110      00 0000    


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                            ..  ...+.....++.+|+.+||+.||++|||++++++.|+
T Consensus       220 ------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 ------DR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------cc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  00  1112223367899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-41  Score=315.26  Aligned_cols=252  Identities=28%  Similarity=0.443  Sum_probs=201.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||+|.+..+          ..+|+|.+.... .....+.+|+.++++++||||+++++++. .+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~----------~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT----------TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC----------ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence            5689999999999999999987543          268999886543 23456889999999999999999999875 45


Q ss_pred             eEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+.+++|.+++... ...+++..+..++.|++.||.|||  +.+++|+||||+||++++++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~  151 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARL  151 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence            678999999999999998654 335789999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ....+          +.
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----------~~  217 (260)
T cd05069         152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ----------VE  217 (260)
T ss_pred             ccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----------HH
Confidence            5332211 1122346678999999988889999999999999999999 89999753321   11110          00


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      .    ......+...+..+.+++.+||..||++||++++++++|+.
T Consensus       218 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         218 R----GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             c----CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0    11111223445789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.6e-41  Score=322.11  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=206.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|++.+.||.|+||.||+|.+..++.         .|++|.+..........+.+|+.+++.++||||+++++++..++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQ---------EVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCc---------EEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            469999999999999999999877654         89999997665555677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+|+||+++++|..++...  .+++..+..++.|++.||+|||  +.+++|+||||+||+++.++.++|+|||++...
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            999999999999999988543  4899999999999999999999  899999999999999999999999999998764


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+...      ...       +.. 
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~-------~~~-  229 (296)
T cd06655         166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYL-------IAT-  229 (296)
T ss_pred             ccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-------HHh-
Confidence            33221  12235788999999999888899999999999999999999999976442111      000       000 


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       ........+...+..+.++|.+||..||.+||++.++++
T Consensus       230 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         230 -NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             001111122334578999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-42  Score=358.42  Aligned_cols=254  Identities=25%  Similarity=0.378  Sum_probs=199.3

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ...++|.+++.||.|+||.||+|++..++.         .||+|.+.....  .....+..|+.+|.+|+|||||+++++
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~---------~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~   80 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQE---------FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR   80 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCe---------EEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            445689999999999999999999987654         899999876532  334668899999999999999999998


Q ss_pred             EEeC--CeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCC-----CCeeeCCCCCCCeEEcC
Q 014202          168 CIED--DQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGS-----EPVIYRDFKTSNILLDS  237 (429)
Q Consensus       168 ~~~~--~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-----~~ivHrDlkp~Nill~~  237 (429)
                      |...  ..+||||||+++|+|.++|...   ...+++..++.|+.||+.||.|||...     .+||||||||+||||+.
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            8654  5689999999999999988653   346899999999999999999999311     45999999999999954


Q ss_pred             -----------------CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhc--CCCCCccchhhhHHHHHHHH
Q 014202          238 -----------------EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEIL  298 (429)
Q Consensus       238 -----------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell  298 (429)
                                       .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||||+
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence                             2348999999998653321   1233579999999999864  45889999999999999999


Q ss_pred             hCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          299 TGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       299 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +|..||.....     ....... +.      .  .+.++   ....+..+.+||..||+.+|.+||++.++|.
T Consensus       238 TGk~PF~~~~~-----~~qli~~-lk------~--~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        238 SGKTPFHKANN-----FSQLISE-LK------R--GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HCCCCCCcCCc-----HHHHHHH-Hh------c--CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99999964321     1111110 00      0  01111   1123478999999999999999999999984

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-41  Score=317.41  Aligned_cols=260  Identities=27%  Similarity=0.426  Sum_probs=207.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+|++.+.||.|+||.||+|+...+..    ......|++|.+...... ...++.+|+.+|++++||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            468999999999999999999876533    122447999998765443 356789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRT--------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      +..++||||+++|+|.+++....        ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEEE
Confidence            99999999999999999986543        15899999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      +|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....     
T Consensus       159 ~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~-----  229 (275)
T cd05046         159 SLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN-----  229 (275)
T ss_pred             cccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH-----
Confidence            99999875432211 11222456788999999988888999999999999999998 7888854321   11111     


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                              ...............+..+.+++.+||+.||.+||++.+++..|.
T Consensus       230 --------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 --------RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --------HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                    011111111222334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.6e-41  Score=313.41  Aligned_cols=251  Identities=26%  Similarity=0.383  Sum_probs=206.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||.|+||.||.++...++.         .+++|.+....  ......+.+|+.+|++++|+||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDS---------LVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCc---------EEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence            58899999999999999999887654         89999986543  33446788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..+++|||+++++|.+++.+. ...+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.+||+|||++.
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~  149 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISK  149 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcceE
Confidence            9999999999999999999765 456899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .......  ......|++.|+|||++.+..++.++||||||+++|+|++|..||......      +.....        
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~--------  213 (256)
T cd08221         150 ILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI--------  213 (256)
T ss_pred             Ecccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH--------
Confidence            6543321  223357899999999998888999999999999999999999999653321      111111        


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                        ...... ......+.++.+++.+||..||.+||++.++++.+
T Consensus       214 --~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         214 --VQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --HcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              111111 11133457899999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-41  Score=317.53  Aligned_cols=255  Identities=31%  Similarity=0.504  Sum_probs=200.4

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +.||+|+||.||+|++.....   ....+..||+|.+.... ......+.+|+.+|+.++||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            369999999999998865431   11123579999886543 23456788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-----CEEEccc
Q 014202          178 YEFMTRGSLENHLFRR------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-----NAKLSDF  246 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-----~~kl~DF  246 (429)
                      |||+++++|.+++...      ...+++..+..++.|++.||.|||  +.+++|+||||+||+++.++     .++|+||
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence            9999999999998642      234788999999999999999999  89999999999999998877     8999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      |++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....   .....        
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~--------  224 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQ--------  224 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHH--------
Confidence            99976543322222222356788999999998899999999999999999998 9999864321   11111        


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                            .+........+...+..+.+++.+||+.+|.+||++++|++.|.
T Consensus       225 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         225 ------HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ------HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                  00111111222345678999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=333.03  Aligned_cols=241  Identities=25%  Similarity=0.337  Sum_probs=189.4

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcC---CCcceeeEEeEEEeCCeE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQL---HHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~  174 (429)
                      ||+|+||.||+|++..++.         .||||++......   ....+..|..++..+   +||||+++++++..++..
T Consensus         1 lG~G~~g~Vy~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRR---------IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEECCCCC---------EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence            7999999999999887655         9999998654221   223345677777665   699999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||+.+|+|.+++... ..+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.++|+|||++.....
T Consensus        72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~  148 (330)
T cd05586          72 YLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT  148 (330)
T ss_pred             EEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence            9999999999999988654 46899999999999999999999  89999999999999999999999999999875332


Q ss_pred             CCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ...  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.....      .......          .
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i----------~  210 (330)
T cd05586         149 DNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNI----------A  210 (330)
T ss_pred             CCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHH----------H
Confidence            221  12346799999999998754 589999999999999999999999975331      1111110          0


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCC----CHhHHHH
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP----SMDEVVK  372 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----t~~eil~  372 (429)
                      ....... ....+..+.+||.+||+.||.+||    ++.++++
T Consensus       211 ~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         211 FGKVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0001111 112346789999999999999998    5777766

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-41  Score=320.70  Aligned_cols=276  Identities=29%  Similarity=0.389  Sum_probs=210.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEe-
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIE-  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  170 (429)
                      +.|++.+.||+|+||.||+|.+...+.     .++..||||.+...... ....+.+|+.+++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCC-----CCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence            468888999999999999998764421     13568999999866543 45678999999999999999999999887 


Q ss_pred             -CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 -DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                       ....++||||+++++|.+++......+++..+..++.|++.||+|||  ..+++|+||||+||+++.++.++|+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence             55789999999999999999776656899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ......... .......++..|+|||.+.+..++.++||||||+++|||++|..||..............  ........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~  234 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--QGQMIVTR  234 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc--cccccHHH
Confidence            876532221 111123455679999999888899999999999999999999999865322110000000  00000001


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      +...+........+..++.++.+|+.+||+.||++||++.+|++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111112222334457899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2e-41  Score=319.23  Aligned_cols=264  Identities=24%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||+|+||.||+|.+..++.         .||+|.+.....  .....+.+|+.++++++||||+++++++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQ---------IVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCc---------EEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence            48889999999999999999877655         899999865432  2235678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR--TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +..|+||||+. ++|.+++...  +..+++..+..++.|++.||.|||  ..+|+|+||||+|||++.++.++|+|||++
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence            99999999997 5888887543  256899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH------
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY------  322 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------  322 (429)
                      .......  .......+++.|+|||++.+. .++.++|||||||++|+|++|..||........  ........      
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~  224 (285)
T cd07861         149 RAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTED  224 (285)
T ss_pred             eecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChh
Confidence            7543221  112234678999999988654 578899999999999999999999975432110  00000000      


Q ss_pred             ----HHhhhhhhhhcCC---ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          323 ----LADKRKLYQIVDP---RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       323 ----~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                          .............   ..........+.++.++|.+||+.||.+|||+.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                0000000000000   00000111245778999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-41  Score=313.02  Aligned_cols=255  Identities=33%  Similarity=0.529  Sum_probs=204.9

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      +.+.+.||.|+||.||+|.+...+.     ..+..||+|.+...... ....+..|+.+|..++|+||+++++++...+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence            4567899999999999999887542     12348999999766443 55778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .+++|||+++++|.+++...... +++..+..++.|++.||+|||  +.+++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence            99999999999999998765434 899999999999999999999  899999999999999999999999999999875


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ......... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....   .          
T Consensus       154 ~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~---~----------  216 (258)
T smart00219      154 YDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE---Y----------  216 (258)
T ss_pred             ccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---H----------
Confidence            443221111 2337789999999988889999999999999999998 7888865221   11111   0          


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                       +............+.++.+++.+||..||++|||+.++++.|
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 -LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             000011112223557899999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-41  Score=317.55  Aligned_cols=260  Identities=27%  Similarity=0.388  Sum_probs=206.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+|.+.+.||.|+||.||+|.+.....      ....||||...... ....+.+.+|+.++++++||||+++++++.+ 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   78 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPEN------EKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-   78 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCC------CCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence            468889999999999999998765421      12369999987654 3445678899999999999999999998875 


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...|+||||+++|+|.+++......+++..++.++.|++.||.|||  +.+++|+||||+|||++.++.++|+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCceeee
Confidence            5578999999999999999776656899999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......   .....          +.
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----------~~  222 (270)
T cd05056         157 LEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR----------IE  222 (270)
T ss_pred             cccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----------HH
Confidence            543211 11112334568999999988889999999999999999986 99999654321   11110          00


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      .    ......+...+..+.+++.+||..+|++|||+.++++.|..+.+
T Consensus       223 ~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         223 N----GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             c----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0    00111223445789999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.1e-41  Score=315.26  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=202.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++++.....||+|+||.||+|.+..++.         .||+|.+........+.+.+|+.++++++|+||+++++++..+
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQV---------RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN   77 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCc---------EEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence            3455556789999999999999876644         8999998877666667889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCCEEEccccC
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPL--PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNAKLSDFGL  248 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~--~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFg~  248 (429)
                      +..++||||+++++|.+++......+  ++..+..++.|++.||+|||  ..+|+||||||+||+++. ++.++|+|||+
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence            99999999999999999997654445  78888999999999999999  899999999999999976 67899999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +........  ......|++.|+|||++.+..  ++.++||||||+++|+|++|..||........   ..+..      
T Consensus       156 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~------  224 (268)
T cd06624         156 SKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKV------  224 (268)
T ss_pred             heecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhh------
Confidence            876433221  122246889999999986543  78899999999999999999999964321110   00000      


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       ...     ......+...++++.+++.+||+.+|.+|||+.+++..
T Consensus       225 -~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 -GMF-----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -hhh-----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence             000     00111223345789999999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=330.34  Aligned_cols=264  Identities=27%  Similarity=0.439  Sum_probs=223.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +....+.++||.|.||.||+|.+..-.+     +....||||.-+.+ .....+.|+.|+.+|+.++|||||+++|++.+
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~k-----ge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEK-----GERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEeccccc-----CcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            3445567889999999999999876532     23447999999875 34556779999999999999999999999875


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                       ...+||||+++.|.|..+|..+...++......++.||+.||+|||  +.++|||||...|||+.....|||+|||+++
T Consensus       463 -~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe--SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  463 -QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE--SKRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             -cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH--hhchhhhhhhhhheeecCcceeeecccchhh
Confidence             5679999999999999999999889999999999999999999999  9999999999999999999999999999999


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........... ...-...|||||.++-..++.++|||-|||++||++. |..||.+...                 .++
T Consensus       540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDV  601 (974)
T KOG4257|consen  540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDV  601 (974)
T ss_pred             hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cce
Confidence            87665544433 2344668999999999999999999999999999887 9999986543                 233


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                      ...++..-+.+.+..+++.+..|+.+||.+||.+||.+.++...|..+...+
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence            3444555567778889999999999999999999999999998887765533

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-41  Score=318.75  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=201.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|.+.... ......+.+|+.++++++||||+++++.+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~---------~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGV---------TMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE   71 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCc---------EEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence            368899999999999999999876654         89999987542 23346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR--TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +..|+||||++|++|..++...  ...+++..+..++.|++.||.|||. ..+|+|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            9999999999999999888653  2368999999999999999999993 359999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcC------CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      .......    .....|++.|+|||.+.+.      .++.++|||||||++|+|++|..||......   ....      
T Consensus       151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~------  217 (286)
T cd06622         151 GNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFA------  217 (286)
T ss_pred             ccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHH------
Confidence            7643221    1224688899999988543      3578999999999999999999999643211   1110      


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          .+..+.... ....+...+.++.++|.+||+.+|++||++.+++.
T Consensus       218 ----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         218 ----QLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----HHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                011111111 11222335678999999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=323.44  Aligned_cols=253  Identities=26%  Similarity=0.342  Sum_probs=205.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .+|++.+.||+|+||.||+|.+..++.         .||+|.+......   ....+..|+.+|+.++||||+++++.+.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGK---------LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ   71 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCc---------EEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence            368899999999999999999887654         8999999766433   3456889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .++..|+||||+.|++|.+++... ...+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeecch
Confidence            999999999999999999988654 356899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCcc---------------------------ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCC
Q 014202          249 AKAGPQGDKT---------------------------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR  301 (429)
Q Consensus       249 a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~  301 (429)
                      +.........                           .......|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            8754321110                           0111346899999999999888999999999999999999999


Q ss_pred             CCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC----HhHHHH
Q 014202          302 RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS----MDEVVK  372 (429)
Q Consensus       302 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~eil~  372 (429)
                      .||.......                .+..+.............+..+.+++.+||..||++||+    +++++.
T Consensus       230 ~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         230 TPFKGSNRDE----------------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCCchHH----------------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            9997543210                111112222222222225688999999999999999999    888876

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=311.97  Aligned_cols=249  Identities=28%  Similarity=0.405  Sum_probs=208.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHH---HHHHHHHHhcCCCcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .-++|..+++||+|.||+|.+++.+.+++         .||+|++++.......+   -+.|-++|+..+||.+..+.-.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k---------~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs  236 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGK---------LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS  236 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCc---------eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence            34789999999999999999999877655         99999999875544433   4689999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      |+..+.+|+||||..||.|.-+|.+. ..+++.....+...|+.||.|||  +.+||+||||.+|.|+|.+|++||+|||
T Consensus       237 FQt~drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLH--s~~ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  237 FQTQDRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLH--SRNIVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             hccCceEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhh--hCCeeeeechhhhheeccCCceEeeecc
Confidence            99999999999999999999988654 46899999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +++.....  ......+||||.|+|||++....|+.++|+|.+||++|||++|+.||.....                 .
T Consensus       314 LCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----------------~  374 (516)
T KOG0690|consen  314 LCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----------------E  374 (516)
T ss_pred             cchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----------------h
Confidence            99864332  2234458999999999999999999999999999999999999999976432                 1


Q ss_pred             hhhhhc-CCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          328 KLYQIV-DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       328 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                      +++.++ -.  ...++...+++...|+.-+|.+||.+|.     ++.||..
T Consensus       375 kLFeLIl~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  375 KLFELILME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             HHHHHHHhh--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            222221 11  1223445568899999999999999994     4556543

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.2e-41  Score=312.91  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=202.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe-
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE-  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  170 (429)
                      +|++.+.||.|+||.||+|.+..++.         .||+|.+.....  .....+.+|+.++++++|+||+++++.+.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGK---------QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCc---------EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence            48899999999999999999877654         899999875432  334567899999999999999999998764 


Q ss_pred             CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +...|+||||+++++|.+++... ...+++..+..++.|++.||++||  +.+|+|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEecccce
Confidence            44678999999999999988764 445899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......  .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....      ........      
T Consensus       150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~------  215 (257)
T cd08223         150 RVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII------  215 (257)
T ss_pred             EEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH------
Confidence            7653321  122345789999999999998999999999999999999999999964321      11111110      


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                          .... ...+...+..+.+++.+||+.||++||++.++++.
T Consensus       216 ----~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         216 ----EGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----hcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0001 11223455789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6e-41  Score=313.50  Aligned_cols=255  Identities=28%  Similarity=0.398  Sum_probs=190.6

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +.||+|+||.||+|......       ....+|+|.+..... .....+.+|+.+++.++||||+++++.+......|+|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv   73 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGM-------SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV   73 (269)
T ss_pred             CcCCccCCceEEEEEEecCC-------CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence            36999999999999754321       133789998765432 2345678999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          178 YEFMTRGSLENHLFRRT----IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      |||+++|+|.+++....    ...++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||++....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence            99999999999986643    22467788899999999999999  8999999999999999999999999999987543


Q ss_pred             CCCccceeeeccccccccChhhhhc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ............+++.|+|||++..       ..++.++|||||||++|||++ |..||....+.   ..   .......
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~---~~~~~~~  225 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV---LKQVVRE  225 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHHhhc
Confidence            3221111222356778999998753       356789999999999999999 78888643221   00   0000000


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                        .......+    ......+..+.+++..|| .||++||++++|++.|.
T Consensus       226 --~~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         226 --QDIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             --cCccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence              00001111    122334567888999998 69999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.1e-41  Score=314.46  Aligned_cols=249  Identities=26%  Similarity=0.384  Sum_probs=205.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ..|+..+.||.|+||.||+|.+..++.         .||+|.+.... ......+.+|+.+++++.||||+++++++.++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQ---------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG   74 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCE---------EEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            358888999999999999999887654         89999987553 23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...|+||||++|++|.+++..  .++++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~  150 (277)
T cd06640          75 TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEccccccee
Confidence            999999999999999998854  35889999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ......  ......++..|+|||++.+..++.++|+|||||++|||++|..||....+...                 ..
T Consensus       151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------------~~  211 (277)
T cd06640         151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----------------LF  211 (277)
T ss_pred             ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----------------hh
Confidence            543221  12235688899999999888899999999999999999999999975432110                 00


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..............+..+.+++.+||+.+|++||++.++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         212 LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            011111122334566789999999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.3e-41  Score=312.91  Aligned_cols=254  Identities=27%  Similarity=0.461  Sum_probs=203.2

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..++|++.+.||+|+||.||+|.+...          ..+|+|.+.... .....+.+|+.++++++|+||+++++.+..
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~----------~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKH----------TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCC----------ccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            356899999999999999999975432          269999887543 334678899999999999999999999887


Q ss_pred             CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                       ...+++|||+++++|.+++... ...+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCcce
Confidence             7789999999999999998664 345788899999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ........ .......++..|+|||++.+..++.++|+|||||++|++++ |..||......   .....          
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----------  215 (260)
T cd05073         150 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----------  215 (260)
T ss_pred             eeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----------
Confidence            76533221 11122345678999999988889999999999999999998 99999753211   11110          


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                          +............+..+.+++.+||+.||++||++.++++.|+.
T Consensus       216 ----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         216 ----LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----HhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                00111111223345789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-41  Score=318.53  Aligned_cols=259  Identities=28%  Similarity=0.401  Sum_probs=203.2

Q ss_pred             HHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceee
Q 014202           85 FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVK  163 (429)
Q Consensus        85 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  163 (429)
                      +.++....+.|++.+.||.|+||.||+|.+..++.         .||+|.+.... ....++..|+.++.++ +||||++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~   77 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQ---------LAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIAT   77 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCc---------EEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEE
Confidence            34444556789999999999999999999887654         89999986553 3345678899999998 6999999


Q ss_pred             EEeEEEe------CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          164 LIGYCIE------DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       164 ~~~~~~~------~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      +++++..      ....|++|||+.+|+|.+++... ...+++..+..++.|++.||.|||  +.+|+|+||+|+||+++
T Consensus        78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nili~  155 (282)
T cd06636          78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLT  155 (282)
T ss_pred             EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEC
Confidence            9998853      45789999999999999988653 345788889999999999999999  89999999999999999


Q ss_pred             CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG  311 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  311 (429)
                      .++.++|+|||++........  ......|++.|+|||.+.     +..++.++|||||||++|||++|..||....+..
T Consensus       156 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~  233 (282)
T cd06636         156 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR  233 (282)
T ss_pred             CCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence            999999999999875432111  122357899999999875     3467889999999999999999999996433211


Q ss_pred             cccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..                ................+..+.+||.+||+.||.+|||+.++++.
T Consensus       234 ~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         234 AL----------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hh----------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            00                00011111111112345789999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-41  Score=317.53  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~---------~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGT---------VMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCc---------EEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            468899999999999999999877654         89999886543 23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++||||+++++|.+++.+. ..+++..+..++.+++.||.|||. ..+++||||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            9999999999999999988654 468999999999999999999993 36899999999999999999999999999865


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc-----cHHHHHHHHHHhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ-----NLVAWARQYLADK  326 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~  326 (429)
                      .....    .....|+..|+|||++.+..++.++|||||||++|+|++|..||.........     ....+..      
T Consensus       154 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------  223 (284)
T cd06620         154 LINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ------  223 (284)
T ss_pred             hhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH------
Confidence            42211    12357899999999998888999999999999999999999999754432111     1111111      


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                          .+.............+..+.+|+.+||+.||++||++.|+++..
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         224 ----QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ----HHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                11111111001112456799999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.5e-41  Score=320.07  Aligned_cols=264  Identities=25%  Similarity=0.299  Sum_probs=200.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||.|+||.||+|++..++.         .||+|.+......  ....+.+|+.++++++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~---------~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCc---------EEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence            58889999999999999999987655         8999998754221  234577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++|+||+. ++|.+++......+++..++.++.||+.||.|||  ..+|+||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence            99999999996 5888888766667999999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh--h-
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK--R-  327 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~-  327 (429)
                      ......  ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.......  .....+...+...  . 
T Consensus       149 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  224 (284)
T cd07839         149 FGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEES  224 (284)
T ss_pred             cCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHH
Confidence            433221  11234678999999998764 47899999999999999999998864322211  1111000000000  0 


Q ss_pred             --hhhhhcCC----ccc-----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 --KLYQIVDP----RLE-----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 --~~~~~~~~----~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        .+....+.    ...     .......+.++.+||.+||+.||.+|||+.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence              00000000    000     00112345788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.9e-41  Score=323.27  Aligned_cols=263  Identities=20%  Similarity=0.267  Sum_probs=196.0

Q ss_pred             CCCccccc--CceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           97 PDSILGEG--GFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        97 ~~~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++++||+|  +|++||++.+..+++         .||+|.+.....  .....+.+|+.+++.++||||+++++++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGE---------YVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCc---------EEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence            46789999  789999999988765         999999976532  23356778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+++|+|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++++|||.+..
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~  150 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLS  150 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence            999999999999999998654 345899999999999999999999  89999999999999999999999999987544


Q ss_pred             CCCCCcc-----ceeeeccccccccChhhhhc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          252 GPQGDKT-----HVSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       252 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      .......     .......++..|+|||++.+  ..++.++|||||||++|||++|..||.......  ...........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~  228 (327)
T cd08227         151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVP  228 (327)
T ss_pred             cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcc
Confidence            3211110     01112356778999999876  468999999999999999999999997432110  00000000000


Q ss_pred             ---h-----hhhhh-----hhcC-----------------CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 ---D-----KRKLY-----QIVD-----------------PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ---~-----~~~~~-----~~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         +     ...+.     ...+                 ...........++.+.+|+.+||+.||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence               0     00000     0000                 00000112234568999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-40  Score=310.97  Aligned_cols=257  Identities=29%  Similarity=0.406  Sum_probs=206.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||.|+||.||+|....++.         .+|+|.+..... .....+.+|+.+|+.++|+||+++++.+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNE---------KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG   71 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCc---------EEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence            469999999999999999999876544         899999875432 3456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR--TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +..++|||++++++|.+++...  ...+++..+..++.|++.||+|||  +.+++|+||+|+||++++++.++|+|||++
T Consensus        72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            9999999999999999998654  246899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccc--eeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          250 KAGPQGDKTH--VSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       250 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ..........  ......|+..|+|||++... .++.++|+|||||++|+|++|..||....+..  ....    ..   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~---  220 (267)
T cd06610         150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TL---  220 (267)
T ss_pred             HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----Hh---
Confidence            7655432221  22335789999999998776 78999999999999999999999997543311  0100    00   


Q ss_pred             hhhhhhcCCccccCC-CHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQIVDPRLELNY-SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                          ....+...... ....+..+.+++.+||..||++||++.++++.
T Consensus       221 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         221 ----QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ----cCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                00011111111 12445789999999999999999999999873

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=329.99  Aligned_cols=269  Identities=26%  Similarity=0.411  Sum_probs=231.4

Q ss_pred             HHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEE
Q 014202           86 QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLI  165 (429)
Q Consensus        86 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~  165 (429)
                      .+++..+.+.....+||-|.||.||.|.++....         .||||.++.+. ....+|+.|+.+|+.++|||+|+++
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkysl---------TvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccce---------eeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHh
Confidence            4555555666777899999999999999987655         89999998765 4458899999999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          166 GYCIEDDQRLLVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ++|..+..+|||+|||..|+|.+||.+.+. .++....+.++.||..|++||.  .+++|||||...|+|+.++..||++
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvA  407 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVA  407 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEee
Confidence            999999999999999999999999987643 3666778899999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||+++.+.....+ ..........|.|||-+....++.|+|||+|||+|||+.| |-.||.+..               
T Consensus       408 DFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---------------  471 (1157)
T KOG4278|consen  408 DFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------  471 (1157)
T ss_pred             ccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---------------
Confidence            99999987553322 2222334678999999999999999999999999999998 777887642               


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCccchh
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLA  384 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~~~~  384 (429)
                        ..+++.+++..+++.-+..|++.+.+|++.||+-+|.+||++.|+-+.|+.+...+.+.
T Consensus       472 --lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis  530 (1157)
T KOG4278|consen  472 --LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS  530 (1157)
T ss_pred             --HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence              24567777888888889999999999999999999999999999999998887766543

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.2e-41  Score=311.42  Aligned_cols=251  Identities=27%  Similarity=0.471  Sum_probs=201.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|++.+.||.|+||.||+|.+.. +         ..+|+|.+..... ....+.+|+.++++++||||+++++++....
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~---------~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-K---------RKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-C---------CeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            368888999999999999998753 2         3799999875432 3356889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+.+++|.+++......+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||++...
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcceeec
Confidence            999999999999999999776667899999999999999999999  899999999999999999999999999998764


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....      ......       +..
T Consensus       151 ~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~-------~~~  216 (256)
T cd05112         151 LDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVET-------INA  216 (256)
T ss_pred             ccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHH-------HhC
Confidence            33211 11112345678999999988889999999999999999998 9999864321      111111       000


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                          ......+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus       217 ----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         217 ----GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                001011112347899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.8e-41  Score=312.25  Aligned_cols=255  Identities=24%  Similarity=0.400  Sum_probs=204.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc------hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL------QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      +|+..+.||+|+||.||+|.+..++.         .||+|.+.....      .....+.+|+.+|++++|+||++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   71 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGT---------LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA   71 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCc---------EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence            48888999999999999999876654         899999875431      124578899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CEEEccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDF  246 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DF  246 (429)
                      +.+.+..++||||++|++|.+++.+. .++++..+..++.|++.||.|||  +.+++|+||+|+||+++.++ .++|+||
T Consensus        72 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l~df  148 (268)
T cd06630          72 TCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADF  148 (268)
T ss_pred             eccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccc
Confidence            99999999999999999999988654 36899999999999999999999  89999999999999998776 5999999


Q ss_pred             cCcccCCCCCc--cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          247 GLAKAGPQGDK--THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       247 g~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |++........  ........|+..|+|||.+.+..++.++||||||+++|+|++|..||.........   ..      
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~------  219 (268)
T cd06630         149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---AL------  219 (268)
T ss_pred             ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HH------
Confidence            99876543211  11122356889999999998888999999999999999999999999654321111   10      


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                          .............+...+.++.+++.+||..||++||++.++++.
T Consensus       220 ----~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         220 ----IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ----HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                001111111122334456789999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.2e-40  Score=311.09  Aligned_cols=252  Identities=26%  Similarity=0.381  Sum_probs=198.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-----hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-----QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .+|.+.+.||+|+||.||+|.+..++.         .||+|.+.....     .....+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   72 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGR---------ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC   72 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCc---------EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence            368999999999999999999877654         899999864421     223567889999999999999999998


Q ss_pred             EEeC--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          168 CIED--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       168 ~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      +...  ...+++|||+++++|.+++.... .+++...+.++.|++.||+|||  +.+|+|+||+|+||+++.++.++|+|
T Consensus        73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             EEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence            8753  57789999999999999886544 5889999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCc-cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          246 FGLAKAGPQGDK-THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       246 Fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ||++........ ........++..|+|||++.+..++.++|||||||++|||++|..||......      ..      
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~------  217 (266)
T cd06651         150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AA------  217 (266)
T ss_pred             CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HH------
Confidence            999876432111 11112246889999999999888999999999999999999999999743211      00      


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                          +............+......+.+++ .||..+|++||+++||++.
T Consensus       218 ----~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         218 ----IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ----HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                0111111111122333456788888 6888999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.3e-41  Score=321.43  Aligned_cols=199  Identities=25%  Similarity=0.408  Sum_probs=161.4

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe--CCeEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE--DDQRL  175 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~  175 (429)
                      +.+||+|+||.||+|++.....       +..||+|.+.....  ...+.+|+.+|++++||||+++++++..  +...+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~-------~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKD-------EKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW   76 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCc-------cceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence            4689999999999999765332       45899999875432  2457789999999999999999998854  55789


Q ss_pred             EEEEecCCCChHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCCEEE
Q 014202          176 LVYEFMTRGSLENHLFRR--------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL----DSEYNAKL  243 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl  243 (429)
                      +||||+. ++|.+++...        ...+++..+..++.|++.||.|||  +.+|+||||||+|||+    +.++.+||
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence            9999986 4787776421        234788999999999999999999  8999999999999999    56678999


Q ss_pred             ccccCcccCCCCCcc-ceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014202          244 SDFGLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKR  308 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~  308 (429)
                      +|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||....
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            999999865432211 11233578999999999876 457999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-41  Score=341.91  Aligned_cols=279  Identities=20%  Similarity=0.250  Sum_probs=192.1

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCC------CCCCc----EEEEEEeCCCCchhhHHHHHHHHHHhcCCC
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAK------PGSGI----TVAVKSLKPDGLQGHREWVAEVDFLGQLHH  158 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~------~~~g~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  158 (429)
                      ....++|++++.||+|+||+||+|...........      ...+.    .++.|.+.. .......+.+|+.+|++++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCC
Confidence            34457899999999999999999876543221100      00001    112222211 11234567899999999999


Q ss_pred             cceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT----IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       159 pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      |||+++++++...+..|+|++++. ++|.+++....    .......+..++.||+.||.|||  +.+||||||||+|||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NIL  299 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIF  299 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEE
Confidence            999999999999999999999984 57777765432    12345667889999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCC-CCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSM-DKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~  313 (429)
                      ++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||++|..++ .........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999987543222 1222367999999999999999999999999999999999987644 322211111


Q ss_pred             cHHHHHHHHH-------HhhhhhhhhcCCc--------cc-cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          314 NLVAWARQYL-------ADKRKLYQIVDPR--------LE-LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       314 ~~~~~~~~~~-------~~~~~~~~~~~~~--------~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .+...+....       .....+...++..        +. .-.....+..+.++|.+||+.||.+|||+.|++.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1111111000       0000011111000        00 0000112356788999999999999999999997

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.9e-41  Score=313.11  Aligned_cols=256  Identities=23%  Similarity=0.396  Sum_probs=201.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch----------hhHHHHHHHHHHhcCCCcceee
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ----------GHREWVAEVDFLGQLHHPNLVK  163 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~  163 (429)
                      +|.+.+.||.|+||.||+|....++.         .||+|.+......          ..+.+..|+.+++.++||||++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   72 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGE---------MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ   72 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCc---------eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence            58889999999999999999876654         8999988543111          1235778999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      +++++...+..++||||+.+++|.+++.+. ..+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCeEEE
Confidence            999999999999999999999999998665 46899999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      +|||++................|+..|+|||.+....  ++.++|+||||+++|+|++|..||.....     ..... .
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-~  223 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMF-K  223 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHH-H
Confidence            9999997643322222223356889999999987654  78999999999999999999999953221     11100 0


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      . .     ................+..+.+++.+||..||++||++.+++..
T Consensus       224 ~-~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         224 L-G-----NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             h-h-----ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0 0     00011111111222345789999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.1e-41  Score=312.97  Aligned_cols=254  Identities=29%  Similarity=0.397  Sum_probs=206.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .||+|.+..... .....+.+|+.++++++||||+++++.+..+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGK---------IMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCc---------EEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            368888999999999999999987655         899999876643 3446788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ...++|+||+.+++|.+++......+++..+..++.|++.||+|||  + .+++|+||||+||+++.++.++|+|||.+.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~  149 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG  149 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc--CCCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence            9999999999999999999766567899999999999999999999  7 999999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .......    ....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... .........         
T Consensus       150 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~---------  215 (265)
T cd06605         150 QLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQY---------  215 (265)
T ss_pred             hhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHH---------
Confidence            6432211    11678899999999998899999999999999999999999996543211 111111111         


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       ..............+..+.++|.+||..||++|||+.+++.
T Consensus       216 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         216 -IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -HhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             11111111111115578999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=301.65  Aligned_cols=254  Identities=22%  Similarity=0.249  Sum_probs=203.3

Q ss_pred             HhhcCCCCCC-CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEe
Q 014202           89 KSATGNFRPD-SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIG  166 (429)
Q Consensus        89 ~~~~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~  166 (429)
                      ...+++|.+. ++||-|--|.|..+.++.+++         .+|+|++...     ....+|+++.-.. .|||||.+++
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~e---------kfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~Iid  122 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQE---------KFALKVLLDS-----PKARREVELHWMASGHPHIVSIID  122 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchh---------hhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeeh
Confidence            3456778775 579999999999999998866         8999998533     3445788876555 4999999999


Q ss_pred             EEEe----CCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---C
Q 014202          167 YCIE----DDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---E  238 (429)
Q Consensus       167 ~~~~----~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---~  238 (429)
                      +|++    ...+.+|||.++||+|+..+..++ ..+++.++..|+.||..|+.|||  +.+|.||||||+|+|...   |
T Consensus       123 VyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH--~~nIAHRDlKpENLLyt~t~~n  200 (400)
T KOG0604|consen  123 VYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH--SMNIAHRDLKPENLLYTTTSPN  200 (400)
T ss_pred             hhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH--hcchhhccCChhheeeecCCCC
Confidence            8765    346789999999999999997764 46999999999999999999999  999999999999999954   4


Q ss_pred             CCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHH
Q 014202          239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW  318 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  318 (429)
                      ..+||+|||+|+....   .......+-||+|.|||++....|+...|+||+||++|-||+|.+||..........    
T Consensus       201 a~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp----  273 (400)
T KOG0604|consen  201 APLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----  273 (400)
T ss_pred             cceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh----
Confidence            5699999999997432   223345789999999999998999999999999999999999999997654322110    


Q ss_pred             HHHHHHhhhhhhhhcCC--ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          319 ARQYLADKRKLYQIVDP--RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                              +.-.++...  .++.+.....++..+++|+.+|..+|.+|.|+.+++..
T Consensus       274 --------gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  274 --------GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             --------hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                    011112221  22223334567889999999999999999999999873

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.5e-41  Score=316.04  Aligned_cols=261  Identities=29%  Similarity=0.408  Sum_probs=203.0

Q ss_pred             HHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceee
Q 014202           85 FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVK  163 (429)
Q Consensus        85 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  163 (429)
                      +..+....++|++.+.||+|+||.||+|.+..++.         .+|+|++.... .....+.+|+.+++.+ +||||++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~---------~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~   79 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGS---------KAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK   79 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCc---------eeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeee
Confidence            34455567899999999999999999999877654         89999886532 2235677899999999 6999999


Q ss_pred             EEeEEE-----eCCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          164 LIGYCI-----EDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       164 ~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      +++++.     .++..++||||++|++|.+++..   ....+++..+..++.|++.||.|||  ..+|+||||||+||++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili  157 (286)
T cd06638          80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILL  157 (286)
T ss_pred             eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEE
Confidence            999874     34568999999999999988753   3346889999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS  310 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  310 (429)
                      +.++.++|+|||++........  ......|++.|+|||++..     ..++.++|||||||++|||++|..||....+.
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~  235 (286)
T cd06638         158 TTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM  235 (286)
T ss_pred             CCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence            9999999999999876533221  1223568999999998753     45788999999999999999999999654321


Q ss_pred             ccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          311 GEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                      ..  .    .       .......+  ....+...+..+.+|+.+||+.||++|||+.|+++.+
T Consensus       236 ~~--~----~-------~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         236 RA--L----F-------KIPRNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             HH--H----h-------hccccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            10  0    0       00000000  1111122346799999999999999999999999753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-40  Score=310.09  Aligned_cols=252  Identities=26%  Similarity=0.358  Sum_probs=199.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-----chhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-----LQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .+|++.+.||+|+||.||+|.+..++.         .||+|.+....     ......+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~---------~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   72 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGR---------ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC   72 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCc---------EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence            468999999999999999999887654         89999885432     1223567889999999999999999998


Q ss_pred             EEeC--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          168 CIED--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       168 ~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      +.+.  ..+++||||++|++|.+++.+.. .+++.....++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             eccCCCceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEEECc
Confidence            8764  46789999999999999986553 5788999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          246 FGLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       246 Fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ||++......... .......|+..|+|||++.+..++.++|||||||++|+|++|..||......      .       
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~-------  216 (265)
T cd06652         150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------A-------  216 (265)
T ss_pred             CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------H-------
Confidence            9999764321111 1122356889999999998888999999999999999999999999643211      0       


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         .+............+...+..+.+++.+|| .+|++||+++++++.
T Consensus       217 ---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~  261 (265)
T cd06652         217 ---AIFKIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH  261 (265)
T ss_pred             ---HHHHHhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence               001111111112233445578899999999 599999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.6e-41  Score=315.73  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=202.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .|...+.||.|+||.||+|.+..++.         .||+|.+..... .....+.+|+.++++++||||+++++.+..+.
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKE---------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCe---------EEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence            47778899999999999999876544         899999875532 33457889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+||||+++++|.+++..  ..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEccccccccc
Confidence            99999999999999998854  35889999999999999999999  899999999999999999999999999999765


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .....  ......|+..|+|||++.+..++.++|||||||++|||++|..||....+...   .              ..
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~--------------~~  212 (277)
T cd06642         152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L--------------FL  212 (277)
T ss_pred             cCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H--------------hh
Confidence            43221  11224688999999999988899999999999999999999999864332110   0              00


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +............+..+.+++.+||+.+|++||++.++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         213 IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            00011111222345779999999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.8e-41  Score=312.55  Aligned_cols=258  Identities=28%  Similarity=0.453  Sum_probs=200.5

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      |.+.+.||+|+||.||+|.+...+.      ++..||||.+....  ....+++.+|+.+|++++||||+++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDG------SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCC------CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            6778899999999999998765432      35689999987653  234566889999999999999999999886543


Q ss_pred             ------eEEEEEEecCCCChHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          173 ------QRLLVYEFMTRGSLENHLFRR-----TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       173 ------~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                            ..+++++|+.+|+|.+++...     ...+++..+..++.|++.||+|||  +.+|+||||||+||+++.++.+
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~  152 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTV  152 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCE
Confidence                  247889999999999887432     224788899999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |.+||.....   .....+  
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~--  227 (273)
T cd05074         153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY--  227 (273)
T ss_pred             EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH--
Confidence            9999999986543222111222456678999999998889999999999999999999 8888864321   111110  


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                        ....          .....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       228 --~~~~----------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 --LIKG----------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --HHcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              0000          00111123447899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-42  Score=299.15  Aligned_cols=251  Identities=27%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCC-CcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLH-HPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  171 (429)
                      +.+.+..||.|+-|.|++++...++.         .+|||.+.... .+..++++..+.++..-+ +|+||+++|+|..+
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~---------iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGH---------IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccce---------EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            34456789999999999999998765         89999998764 345577888888777665 99999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..+++.||.| +..++.++.+-..++++..+-.+...++.||.||-. .++|+|||+||+|||+|+.|++||||||++..
T Consensus       164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccce
Confidence            9999999988 456777777777889999999999999999999985 78999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +.+.   ...+...|.+.|||||-+.   ...|+.++||||||++|+||.||..||.+.....+               .
T Consensus       242 lvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe---------------~  303 (391)
T KOG0983|consen  242 LVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE---------------V  303 (391)
T ss_pred             eecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH---------------H
Confidence            5442   2334468999999999885   44688999999999999999999999987442111               1


Q ss_pred             hhhhcC-CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 LYQIVD-PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +-.+++ ....++.....++.+.+++..||++|+.+||.+.++++.
T Consensus       304 ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  304 LTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            112222 112223333467899999999999999999999999983

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-41  Score=313.31  Aligned_cols=253  Identities=28%  Similarity=0.420  Sum_probs=201.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      ..++|++.+.||.|+||.||+|.+..++.         .|++|.+..... ....+.+|+.+++++ .|+||+++++++.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQ---------LVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCc---------EEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            35789999999999999999999876544         899999876543 346788999999999 6999999999987


Q ss_pred             eCC------eEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          170 EDD------QRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       170 ~~~------~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      ...      ..++||||+++++|.+++...   ...+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~  151 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAE  151 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCe
Confidence            644      489999999999999988543   356899999999999999999999  899999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      ++|+|||++.......  .......|+..|+|||++..     ..++.++|||||||++|+|++|..||....+..  . 
T Consensus       152 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-  226 (275)
T cd06608         152 VKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A-  226 (275)
T ss_pred             EEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H-
Confidence            9999999987643321  12223568999999998753     346789999999999999999999996432110  0 


Q ss_pred             HHHHHHHHHhhhhhhhhcC-CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          316 VAWARQYLADKRKLYQIVD-PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                   +.++.. ...........+..+.+|+.+||..||++|||+.++++.
T Consensus       227 -------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         227 -------------LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -------------HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                         001111 111112223356789999999999999999999999873

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-40  Score=311.09  Aligned_cols=251  Identities=27%  Similarity=0.433  Sum_probs=200.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc------hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL------QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      +|++.+.||.|+||.||+|... +         |..+|+|.+.....      .....+.+|+.+|++++|+||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~---------~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-Q---------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT   70 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-C---------CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence            4888999999999999999753 2         34899999865421      123457889999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +.+.+..++||||++|++|.+++.+.. .+++..+..++.|++.||+|||  ..+|+|+||+|+||+++.++.++|+|||
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg  147 (265)
T cd06631          71 CLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFG  147 (265)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEeccch
Confidence            999999999999999999999986543 5889999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCC----ccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          248 LAKAGPQGD----KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       248 ~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      ++.......    .........|+..|+|||++.+..++.++|||||||++|+|++|..||.........      .. .
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~-~  220 (265)
T cd06631         148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FY-I  220 (265)
T ss_pred             hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HH-h
Confidence            987542211    111122356899999999999888999999999999999999999999653211100      00 0


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...    ....+    ..+...+..+.++|.+||..+|++||++.+++.
T Consensus       221 ~~~----~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         221 GAH----RGLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hhc----cCCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000    00011    122234578999999999999999999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.8e-41  Score=315.27  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=204.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||.|+||.||+|.+..++.         .||+|.+.....  .....+.+|+.++++++||||+++++++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGE---------TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCc---------eEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            58899999999999999999877654         899999876542  2346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++||||+ +++|.+++......+++..++.++.|++.||+|||  +.+++|+||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~  148 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARL  148 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence            9999999999 99999998776677999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh----
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK----  326 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  326 (429)
                      ...... .......|+..|+|||++.+. .++.++|||||||++|||++|.+||......   .............    
T Consensus       149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~  224 (286)
T cd07832         149 FSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEET  224 (286)
T ss_pred             ccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHH
Confidence            544321 112235789999999988654 4689999999999999999998888654321   1111111000000    


Q ss_pred             -------hhhhhhcCCcc---c-cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 -------RKLYQIVDPRL---E-LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 -------~~~~~~~~~~~---~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                             .....+..+..   . .......+..+.+||.+||+.||.+||++++++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   00000000000   0 00111234789999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.6e-41  Score=310.12  Aligned_cols=245  Identities=32%  Similarity=0.505  Sum_probs=197.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||++...           +..||+|.+....  ....+.+|+.++++++||||+++++++..+ 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   71 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYT-----------GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-   71 (254)
T ss_pred             HHceeeeeeccCCCCceEecccC-----------CCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence            45899999999999999988532           3479999987543  345788999999999999999999998764 


Q ss_pred             eEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~  149 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARV  149 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence            4799999999999999986553 35789999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .....     .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||......      .....         
T Consensus       150 ~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~---------  209 (254)
T cd05083         150 GSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC---------  209 (254)
T ss_pred             ccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH---------
Confidence            43221     11234568999999988899999999999999999998 99999654321      11110         


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                        +............+..+.+++.+||+.+|++||++++++..|+
T Consensus       210 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         210 --VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             --HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence              0111111122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.3e-41  Score=317.84  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=202.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      .|.....||.|+||.||++.+..++.         .||||.+..........+.+|+.+++.++||||+++++.+...+.
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~   93 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGK---------QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE   93 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCC---------EEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence            35556779999999999999876654         899999876655556678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .|+||||+++++|.+++...  .+++..+..++.||+.||.|||  +.+|+||||||+||+++.++.++|+|||++....
T Consensus        94 ~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658          94 LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             EEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            99999999999999987443  4789999999999999999999  8999999999999999999999999999987543


Q ss_pred             CCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ....  ......|+..|+|||++.+..++.++||||||+++|||++|..||....+..   .   ..       .+....
T Consensus       170 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~-------~~~~~~  234 (292)
T cd06658         170 KEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A---MR-------RIRDNL  234 (292)
T ss_pred             cccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HH-------HHHhcC
Confidence            2221  1223578999999999988889999999999999999999999997543211   0   00       011111


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .....  .....+..+.+++.+||..||.+|||+.++++.
T Consensus       235 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 PPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11111  112234678999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.6e-41  Score=309.63  Aligned_cols=250  Identities=22%  Similarity=0.356  Sum_probs=204.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||+|+||.||++....++.         .||+|.+....  .....++.+|+.++++++||||+++++++...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGK---------QYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCC---------EEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence            58889999999999999999877654         89999987542  23345788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..++||||+.+++|.+++... ...+++..+..++.|++.||.|||  +.+++|+||+|+|||++.++.++|+|||++.
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~  149 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR  149 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence            9999999999999999988654 345789999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .......  ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.....      .......        
T Consensus       150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~--------  213 (256)
T cd08218         150 VLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKI--------  213 (256)
T ss_pred             ecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHH--------
Confidence            6533221  11234688999999999888899999999999999999999999964321      1111111        


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        ..... ...+...+..+.++|.+||+.+|++||++.++++.
T Consensus       214 --~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         214 --IRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --hcCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              11000 11223345789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=341.63  Aligned_cols=261  Identities=27%  Similarity=0.485  Sum_probs=226.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ....|.++||.|.||.|++|+.+..++.      ...||||.++.... ..+.+|+.|+.||.+++||||++|.|+....
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkr------e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKR------EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCc------ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            4567789999999999999999887653      34899999987754 3457899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..+.||+|||++|+|+.+|..+...+...++..+++.|+.|+.||-  +.++|||||...|||++.+...|++|||+++.
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEeccccceee
Confidence            9999999999999999999998888999999999999999999999  89999999999999999999999999999997


Q ss_pred             CCCCCccceeeecc--ccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          252 GPQGDKTHVSTRVV--GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       252 ~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +.++... ..+..-  -..+|.|||.+....++.++||||+|+++||.++ |..||....                 +.+
T Consensus       781 ledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQd  842 (996)
T KOG0196|consen  781 LEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQD  842 (996)
T ss_pred             cccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hHH
Confidence            6554322 222222  2468999999999999999999999999999877 889986432                 234


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      +.+.++..++++.+.+++..|.+|+..||++|-.+||.+.+|+..|.++..
T Consensus       843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            455566677888888999999999999999999999999999999887753

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-40  Score=308.59  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-----hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-----QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      +|+..+.||+|+||.||+|....++.         .|++|.+.....     +..+.+.+|+.+++.++|+||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGD---------FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCc---------EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence            47888999999999999999876544         899999865431     2346788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..+...++||||+++++|.+++.+.. .+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.+||+|||+
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence            99999999999999999999986543 5889999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +.......   ......|++.|+|||.+.... ++.++|+|||||++|+|++|..||....+.      .....      
T Consensus       149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~------  213 (258)
T cd06632         149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFK------  213 (258)
T ss_pred             ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHH------
Confidence            87653322   123357899999999987766 899999999999999999999999654310      00000      


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       .....   .....+...+..+.+++.+||+.+|++||++.+++..
T Consensus       214 -~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         214 -IGRSK---ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -HHhcc---cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence             00000   0011122345788999999999999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-40  Score=309.28  Aligned_cols=248  Identities=28%  Similarity=0.455  Sum_probs=194.9

Q ss_pred             CcccccCceeEEEEEEccCCCCC-CCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAP-AKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~-~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +.||+|+||.||+|.+..++... ........+++|.+...... ...+.+|+.+|+.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999998765210 01112236888887655433 5778899999999999999999999888 778999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-------CEEEccccCcc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-------NAKLSDFGLAK  250 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-------~~kl~DFg~a~  250 (429)
                      |||+++|+|.+++......+++..+..++.|++.||.|||  +.+|+||||||+|||++.++       .++|+|||++.
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999999776657899999999999999999999  89999999999999998887       79999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcC--CCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.......   ...   .+     
T Consensus       157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~---~~-----  219 (259)
T cd05037         157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KER---FY-----  219 (259)
T ss_pred             cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHH---HH-----
Confidence            6433      1124577889999998876  78999999999999999999 577776543211   000   00     


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                         .. ......    .....+.+++.+||..+|.+||++.++++.|+
T Consensus       220 ---~~-~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 ---QD-QHRLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---hc-CCCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               00 000111    11168899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=315.61  Aligned_cols=264  Identities=25%  Similarity=0.350  Sum_probs=199.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .||+|.+...... ....+.+|+.++++++||||+++++++..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQ---------LVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK   75 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCc---------EEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence            579999999999999999999876644         8999998754322 234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+.+ +|.+++......+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+|||+++.
T Consensus        76 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          76 KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             CeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence            999999999975 999988776667899999999999999999999  89999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh-hhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK-RKL  329 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  329 (429)
                      ......  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||........  ........+... ...
T Consensus       153 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  228 (291)
T cd07844         153 KSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEET  228 (291)
T ss_pred             cCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhh
Confidence            322111  1122357889999998875 4588999999999999999999999965431110  000000000000 000


Q ss_pred             h-h------hcC--------CccccC-CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 Y-Q------IVD--------PRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~-~------~~~--------~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      . .      ...        ..+... ........+.+++.+||+.||++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0 0      000        000000 00111267889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-40  Score=313.84  Aligned_cols=246  Identities=27%  Similarity=0.400  Sum_probs=203.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||+|.+..++.         .||+|.+.....   .....+.+|+++|++++||||+++++++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGK---------YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ   71 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence            368899999999999999999887654         899999865432   23456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||+++++|.+++... ..+++..+..++.|++.||.|||  +.+|+|+||+|+|||++.++.+||+|||++
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~dfg~~  148 (290)
T cd05580          72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDFGFA  148 (290)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeCCCc
Confidence            999999999999999999998665 46899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ......     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.....      .....         
T Consensus       149 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~---------  208 (290)
T cd05580         149 KRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYE---------  208 (290)
T ss_pred             cccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHH---------
Confidence            875433     2235789999999999888889999999999999999999999975431      00000         


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                       .+.....  ..+...+..+.++|.+||..||.+|+     ++.++++.
T Consensus       209 -~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         209 -KILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -HHhcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence             0111111  12223357899999999999999999     78888763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-40  Score=313.27  Aligned_cols=264  Identities=28%  Similarity=0.361  Sum_probs=201.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+..+++         .||+|.+.....  ...+.+.+|+.++++++||||+++++++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQ---------IVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCc---------EEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            468999999999999999999876654         899999865422  223557899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +...++||||++++.|..++.. ...+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFAR  148 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccccce
Confidence            9999999999999888776644 346899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh----
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD----  325 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  325 (429)
                      .......  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+........   ........    
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~  223 (286)
T cd07847         149 ILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY---LIRKTLGDLIPR  223 (286)
T ss_pred             ecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCChH
Confidence            7544321  1223467889999999876 457899999999999999999999997654321110   00000000    


Q ss_pred             h------hhhh-hhcCCccccCC-----CHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 K------RKLY-QIVDPRLELNY-----SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 ~------~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .      .... ....+......     ....+..+.+|+.+||+.||++||++.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0      0000 00000000000     01235678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.6e-40  Score=308.18  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=191.6

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +.||+|+||.||+|.......       ...+++|.+..... .....+.+|+.+++.++||||+++++.+......|+|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv   73 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTG-------VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV   73 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCC-------cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence            369999999999997654332       23577888765432 3456789999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          178 YEFMTRGSLENHLFRRT---IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |||+++|+|.+++.+..   ...++..+..++.|++.||.|||  +.+++||||||+|||++.++.++|+|||++.....
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence            99999999999986542   34567778899999999999999  89999999999999999999999999999864322


Q ss_pred             CCccceeeeccccccccChhhhhc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ...........|+..|+|||++..       ..++.++|||||||++|||++ |..||....+      .+.....+.. 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-  224 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-  224 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-
Confidence            221122233578899999998743       245789999999999999997 5667754321      1111111111 


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                       ......++...    ...++.+.+++..|| .+|++||++++|++.|.
T Consensus       225 -~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 -QQVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -cccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             11111222222    224467889999999 78999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=319.71  Aligned_cols=258  Identities=29%  Similarity=0.432  Sum_probs=210.5

Q ss_pred             ccccHHHHHhhc-CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcC
Q 014202           81 LQFTFQELKSAT-GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQL  156 (429)
Q Consensus        81 ~~~~~~~~~~~~-~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l  156 (429)
                      .+|..-+....+ +.|+.-++||+||||.||-+....|++         .||.|.+.+....   ...-.++|..+|.++
T Consensus       172 lQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGK---------MYAcKkL~KKRiKkr~ge~maLnEk~iL~kV  242 (591)
T KOG0986|consen  172 LQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGK---------MYACKKLDKKRIKKRKGETMALNEKQILEKV  242 (591)
T ss_pred             HHHHHHHhhhccccceeeeEEEecccccceeEEEEecchh---------hHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh
Confidence            344444444333 568899999999999999998887655         9999998765433   224467999999999


Q ss_pred             CCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       157 ~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      +.++||.+--+|+..+.++|||..|.||+|.-+|.+.+ ..+++..++.++.+|+.||++||  ..+||+|||||+|||+
T Consensus       243 ~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILL  320 (591)
T KOG0986|consen  243 SSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILL  320 (591)
T ss_pred             ccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheee
Confidence            99999999999999999999999999999999887654 45999999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      |+.|+++|+|+|+|..+..+...   ..-+||.+|||||++.++.|+...|+|||||+||||+.|+.||.......... 
T Consensus       321 Dd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-  396 (591)
T KOG0986|consen  321 DDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-  396 (591)
T ss_pred             ccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-
Confidence            99999999999999987665432   22489999999999999999999999999999999999999997543221110 


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS  366 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  366 (429)
                                  .+.+.+ ...+..++...++++.+|.+.+|+.||.+|..
T Consensus       397 ------------Evdrr~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  397 ------------EVDRRT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             ------------HHHHHH-hcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence                        111111 11233455677789999999999999999963

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-41  Score=328.00  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=198.4

Q ss_pred             CCC-CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC----CchhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           93 GNF-RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        93 ~~y-~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ++| +...+||+|+|-+||+|.+..++.         .||--.++..    .....+.|..|+.+|+.|+|||||++|++
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~gi---------EVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~S  109 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGI---------EVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDS  109 (632)
T ss_pred             Cceeehhhhcccccceeeeeccccccch---------hhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeh
Confidence            444 456789999999999999977654         6664443322    22344778999999999999999999999


Q ss_pred             EEeCCe--EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCCEEEc
Q 014202          168 CIEDDQ--RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNAKLS  244 (429)
Q Consensus       168 ~~~~~~--~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~  244 (429)
                      |.+...  +.+|+|++..|+|..|+.+.+ ..+...+..|++||++||.|||.+...|||||||.+||||+. -|.|||+
T Consensus       110 W~d~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  110 WVDTDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             eecCCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence            988766  778999999999999997765 478899999999999999999988889999999999999965 4889999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |+|+|......    .....+|||.|||||++. ..|+..+||||||++++||+|+.+||..     ..+..+..+....
T Consensus       189 DLGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYKKV~S  258 (632)
T KOG0584|consen  189 DLGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYKKVTS  258 (632)
T ss_pred             chhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHHHHHc
Confidence            99999875332    223379999999999887 7899999999999999999999999963     3333333332222


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..          .+..+..-..++++++|.+||.. ..+|||+.|+|+
T Consensus       259 Gi----------KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  259 GI----------KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CC----------CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            11          01111111126899999999999 999999999997

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-40  Score=307.15  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=203.1

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||+|+||.||+|.+..++.         .+|+|.+....  ......+.+|+.+|++++||||+++++.+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQK---------LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCc---------EEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence            58889999999999999999887654         89999987653  23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CEEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFg~a  249 (429)
                      +..++||||+++++|.+++... ...+++..+..++.|++.+|.|||  +.+++|+||+|+||+++.++ .++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~  149 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGIS  149 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence            9999999999999999999764 345899999999999999999999  89999999999999997654 5899999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......      ......       
T Consensus       150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~-------  213 (256)
T cd08220         150 KILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKI-------  213 (256)
T ss_pred             eecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHH-------
Confidence            87543221   12356889999999998888899999999999999999999999654321      111110       


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         .... ....+...+..+.+++.+||..||++|||+.+++..
T Consensus       214 ---~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         214 ---MSGT-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---HhcC-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               0000 011222345789999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-40  Score=314.77  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=205.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|.+.+.||.|+||.||+|....++.         .||+|.+..........+.+|+.+++.++||||+++++.+...+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~   89 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQ---------EVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD   89 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCC---------EEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence            679999999999999999998776544         89999987655455567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+|+||+++++|.+++.+.  .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            999999999999999988654  4788999999999999999999  899999999999999999999999999998754


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+......             +  .
T Consensus       166 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-------------~--~  228 (293)
T cd06647         166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------I--A  228 (293)
T ss_pred             ccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-------------h--h
Confidence            33221  12235688999999999888899999999999999999999999975433211000             0  0


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .............+..+.+++.+||..+|++||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         229 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01111111222345679999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2e-40  Score=308.48  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=203.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe-
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE-  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  170 (429)
                      +|++.+.||.|+||.||+|.+..++.         .||+|.+.....  .....+..|+.++++++||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGK---------ILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR   71 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCC---------EEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence            48889999999999999999887654         899999875432  334568899999999999999999998764 


Q ss_pred             -CCeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCC---CCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          171 -DDQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGG---SEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       171 -~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                       +...+++|||+++++|.+++...   ...+++..++.++.|++.||.|||..   ..+++|+||+|+||+++.++.++|
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence             45679999999999999998653   45689999999999999999999943   578999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      +|||++........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....   .....   .  
T Consensus       152 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~---~--  221 (265)
T cd08217         152 GDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS---K--  221 (265)
T ss_pred             ecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH---H--
Confidence            99999987544321  12235789999999999888899999999999999999999999975431   11111   0  


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                               +........+...+..+.+++.+||+.+|++||++.+|++.
T Consensus       222 ---------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         222 ---------IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---------HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                     11111112233455789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.2e-40  Score=315.60  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=201.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||++.+..++.         .|++|.+.....   .....+.+|+.+++.++||||+++++.+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---------~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQ---------RFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCc---------EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            368899999999999999999887654         899999876532   22356779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..++||||++|++|.+++... ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~dfg~~  148 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLS  148 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeCCCc
Confidence            999999999999999999998655 46899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCc-------------cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH
Q 014202          250 KAGPQGDK-------------THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       250 ~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  316 (429)
                      +.......             ........|+..|+|||.+.+..++.++|||||||++|||++|..||.+..+      .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~  222 (305)
T cd05609         149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------E  222 (305)
T ss_pred             cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------H
Confidence            64211100             0011124678899999999888899999999999999999999999975432      1


Q ss_pred             HHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      +........     ....+.    .....+..+.++|.+||+.||++||+..++++.|+
T Consensus       223 ~~~~~~~~~-----~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         223 ELFGQVISD-----DIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHHHHhc-----ccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            111110000     000000    01134577999999999999999999655555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.6e-40  Score=312.83  Aligned_cols=261  Identities=29%  Similarity=0.394  Sum_probs=203.7

Q ss_pred             cHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCccee
Q 014202           84 TFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLV  162 (429)
Q Consensus        84 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  162 (429)
                      ++..+....++|.+.+.||+|+||.||+|....+++         .+|+|.+.... .....+.+|+.++.++ +||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~---------~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~   82 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGS---------LAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVV   82 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCC---------EEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeE
Confidence            334555567889999999999999999999877654         89999986543 2235677899999999 799999


Q ss_pred             eEEeEEEeC-----CeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          163 KLIGYCIED-----DQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       163 ~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      ++++++...     +..|+||||++|++|.+++..   ....+++..++.++.|++.||.|||  ..+++|+||||+||+
T Consensus        83 ~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nil  160 (291)
T cd06639          83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNIL  160 (291)
T ss_pred             EEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEE
Confidence            999998754     357999999999999998753   3456899999999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEILTGRRSMDKKRP  309 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~  309 (429)
                      ++.++.++|+|||++........  ......|+..|+|||++...     .++.++|||||||++|||++|..||....+
T Consensus       161 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         161 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             EcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            99999999999999886433221  11235688999999987643     368899999999999999999999975432


Q ss_pred             CccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..  .+.           .+...  .......+......+.+||.+||+.||++||++.++++.
T Consensus       239 ~~--~~~-----------~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         239 VK--TLF-----------KIPRN--PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HH--HHH-----------HHhcC--CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            10  000           00000  011111122344679999999999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.9e-40  Score=306.62  Aligned_cols=251  Identities=28%  Similarity=0.419  Sum_probs=207.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +|++.+.||.|++|.||+|.+..++.         .|++|++..... .....+.+|+..+.+++|+||+++++++..+.
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~---------~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGK---------IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG   72 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCc---------EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence            68899999999999999999987655         899999987654 34567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+++++|.+++... ..+++..++.++.|++.||.|||  + .+++|+||+|+||+++.++.++|+|||++..
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~  149 (264)
T cd06623          73 EISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV  149 (264)
T ss_pred             eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence            999999999999999998665 46899999999999999999999  8 9999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      .......  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............   ..          
T Consensus       150 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~----------  214 (264)
T cd06623         150 LENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QA----------  214 (264)
T ss_pred             cccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HH----------
Confidence            5432221  12356889999999999888999999999999999999999999765431111111   11          


Q ss_pred             hcCCccccCCCHH-HHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          332 IVDPRLELNYSLK-GVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       332 ~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +... .....+.. .+..+.++|.+||..+|++||++.++++
T Consensus       215 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         215 ICDG-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HhcC-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0111 11111222 4578999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.8e-41  Score=317.10  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      .|.....||.|+||.||+|.+..++.         .||+|.+..........+.+|+.++..++||||+++++.+..++.
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   92 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGR---------QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE   92 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCC---------EEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence            34556689999999999999876654         899999876554555678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .|+||||+++++|..++..  ..+++..++.++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++....
T Consensus        93 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659          93 LWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             EEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            9999999999999987744  35789999999999999999999  8999999999999999999999999999987543


Q ss_pred             CCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ....  ......|+..|+|||++.+..++.++|||||||++|||++|..||....+..   ..   ..       +....
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~---~~-------~~~~~  233 (297)
T cd06659         169 KDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM---KR-------LRDSP  233 (297)
T ss_pred             cccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HH-------HhccC
Confidence            3211  1223578999999999998889999999999999999999999997533211   00   00       00000


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..  ........+..+.++|.+||+.+|++||++.++++.
T Consensus       234 ~~--~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         234 PP--KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CC--CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00  011112334678999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.6e-40  Score=314.51  Aligned_cols=255  Identities=29%  Similarity=0.448  Sum_probs=204.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .|...+.||+|+||.||+|++..++.         .||+|.+.....   .....+.+|+.++++++||||+++++++..
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~---------~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR   96 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCc---------EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            47888999999999999999877654         899999875432   233568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..++||||+. |+|.+.+.....++++..+..++.|++.||.|||  ..+|+||||+|+||+++.++.++|+|||++.
T Consensus        97 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~  173 (317)
T cd06635          97 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSAS  173 (317)
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCCCcc
Confidence            999999999996 4888877666667999999999999999999999  8999999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .....      ....|++.|+|||++.   ++.++.++|||||||++|+|++|..||......      ..         
T Consensus       174 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~---------  232 (317)
T cd06635         174 IASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA---------  232 (317)
T ss_pred             ccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HH---------
Confidence            54321      2246889999999874   456889999999999999999999998653211      00         


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCccc
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLND  382 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~~  382 (429)
                       +..+.............+..+.+++.+||+.+|.+||++.++++.+..+.....
T Consensus       233 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         233 -LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             -HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence             011111111111122345679999999999999999999999986655554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-42  Score=347.67  Aligned_cols=258  Identities=25%  Similarity=0.278  Sum_probs=214.0

Q ss_pred             HHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcce
Q 014202           85 FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNL  161 (429)
Q Consensus        85 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI  161 (429)
                      +.+++...++|.++++||+|+||.|.+++++.+++         .||+|++++...   ....-|..|-.+|..-+.+-|
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~---------VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi  137 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEK---------VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI  137 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeecccc---------chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence            34555666899999999999999999999998876         899999987432   223457889999999999999


Q ss_pred             eeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          162 VKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      +.++-+|+++.++|+||||++||+|..++.+.. ++++..+..++..|+.||.-||  +.|+|||||||+|||||..|++
T Consensus       138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~GHi  214 (1317)
T KOG0612|consen  138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSGHI  214 (1317)
T ss_pred             HHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccCcE
Confidence            999999999999999999999999999997777 7999999999999999999999  9999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhh----c-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM----T-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  316 (429)
                      ||+|||.+-.+.. +..-.....+|||.|++||++.    + +.|+..+|+||+||++|||+.|..||....      ++
T Consensus       215 kLADFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lv  287 (1317)
T KOG0612|consen  215 KLADFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LV  287 (1317)
T ss_pred             eeccchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HH
Confidence            9999999877643 3334455579999999999985    3 579999999999999999999999996432      22


Q ss_pred             HHHHHHHHhhhhhhhhcCC--ccccCCCHHHHHHHHHHHHHcccCCCCCCCC---HhHHHH
Q 014202          317 AWARQYLADKRKLYQIVDP--RLELNYSLKGVQKVSQLAYNCLSRDPKSRPS---MDEVVK  372 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~eil~  372 (429)
                      +-.          .++++-  .+.++.....+.+..+||.+.+ -+|+.|..   ++++..
T Consensus       288 eTY----------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  288 ETY----------GKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             HHH----------HHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence            211          122222  2222222457789999999877 78999987   888876

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.2e-40  Score=311.86  Aligned_cols=250  Identities=28%  Similarity=0.411  Sum_probs=194.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHH-HhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDF-LGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|.+..... .....+..|+.+ ++.++||||+++++++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGT---------IMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCc---------EEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            368899999999999999999887654         999999876532 233455666665 666789999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      ++..|+||||++ |+|.+++..   ....+++..++.++.|++.||.|||  +. +++||||||+|||++.++.+||+||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999996 588777643   3346899999999999999999999  66 9999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhc----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |++.......   ......|+..|+|||++.+    ..++.++|+|||||++|+|++|..||......    . +.... 
T Consensus       149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~-  219 (283)
T cd06617         149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQ-  219 (283)
T ss_pred             cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHH-
Confidence            9998653221   1122468899999998864    45688999999999999999999999643211    0 00000 


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ......+..   .....+.++.++|.+||..+|++||++.++++
T Consensus       220 ------~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         220 ------VVEEPSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ------HHhcCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  001011111   11224578999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.7e-40  Score=313.60  Aligned_cols=248  Identities=31%  Similarity=0.438  Sum_probs=200.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..|.+.+.||+|+||.||+|.+..+++         .||+|.+.....   ....++.+|+.+++.++||||+++++++.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCc---------EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            469999999999999999999876654         899999865432   23356889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..|+||||+. |+|.+++......+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++
T Consensus        86 ~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          86 REHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             eCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEEeecCcc
Confidence            9999999999996 5777777655567899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ......      ....|++.|+|||++.   ...++.++||||||+++|||++|..||.......      .        
T Consensus       163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~--------  222 (307)
T cd06607         163 SLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A--------  222 (307)
T ss_pred             eecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------H--------
Confidence            764322      1246888999999874   4568899999999999999999999996532111      0        


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                        ...+.............+..+.+++.+||+.||++||++.+++...
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         223 --LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             --HHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence              0001100111111223557899999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.6e-40  Score=307.41  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=201.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC----------chhhHHHHHHHHHHhc-CCCccee
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG----------LQGHREWVAEVDFLGQ-LHHPNLV  162 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpnIv  162 (429)
                      .|.+.+.||+|+||.||+|.+..+.        +..+|+|.+....          .....++..|+.++.+ ++||||+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~--------~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~   72 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV   72 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCC--------CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence            4888999999999999999987621        3489999886432          1223456788888865 7899999


Q ss_pred             eEEeEEEeCCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 014202          163 KLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY  239 (429)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~  239 (429)
                      ++++++..++..++||||++|++|.+++..   ....+++..++.++.|++.||.|||. ..+++|+||+|+|||++.++
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~  151 (269)
T cd08528          73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDD  151 (269)
T ss_pred             eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCC
Confidence            999999999999999999999999988743   34568999999999999999999993 36899999999999999999


Q ss_pred             CEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       240 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      .++|+|||++.......   ......|+..|+|||++.+..++.++||||||+++|+|++|..||......      ...
T Consensus       152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~  222 (269)
T cd08528         152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLA  222 (269)
T ss_pred             cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHH
Confidence            99999999998754332   223457899999999999888999999999999999999999999643211      111


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      ..          ..+...........+..+.+++.+||+.||++||++.|+...+.
T Consensus       223 ~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 TK----------IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HH----------HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            10          01111110111133478999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.6e-41  Score=311.17  Aligned_cols=249  Identities=25%  Similarity=0.349  Sum_probs=205.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +|++.+.||.|+||.||+|.+..++.         .||+|.+.....   ...+.+.+|+.++++++||||+++++.+..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKK---------MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCc---------EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            48889999999999999999877655         899999975432   335678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +...++||||+.|++|.+++... .++++..+..++.|+++||.|||  ..+++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~  148 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIAT  148 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence            99999999999999999998665 56899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ......   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......    ..+...         
T Consensus       149 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~---------  212 (258)
T cd05578         149 KVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRA---------  212 (258)
T ss_pred             ccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHH---------
Confidence            754332   1223568899999999988889999999999999999999999997654321    111110         


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH--hHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM--DEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~--~eil~  372 (429)
                       .... .....+...+..+.++|.+||+.||.+||++  +|+++
T Consensus       213 -~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         213 -KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             0000 1112223345789999999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.7e-40  Score=313.72  Aligned_cols=262  Identities=26%  Similarity=0.345  Sum_probs=201.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-----hhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-----GHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      +|.+.+.||.|+||.||+|.+..++.         .||||.+......     ....+..|+.++++++|+||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF   71 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCc---------EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence            48888999999999999999877654         8999999765432     234567899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+++..++||||+ +++|.+++......+++..+..++.||++||.|||  ..+|+|+||+|+|||++.++.++|+|||+
T Consensus        72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEcccee
Confidence            9999999999999 89999998765547899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh--
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD--  325 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  325 (429)
                      +........  ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||........   ..........  
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~  223 (298)
T cd07841         149 ARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPT  223 (298)
T ss_pred             eeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCc
Confidence            987543321  1122456888999998865 4678999999999999999999888865433111   1000000000  


Q ss_pred             ------hhhhhhhcCCccc-----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          326 ------KRKLYQIVDPRLE-----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       326 ------~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ...+.........     .......+..+.++|.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                  0000000000000     0011223578899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.3e-41  Score=343.75  Aligned_cols=254  Identities=28%  Similarity=0.405  Sum_probs=195.7

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      +...+|+.++.||+||||.||+++++-++.         .||||++.... ......+.+|+.+|.+|+|||||++|..|
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr---------~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW  546 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGR---------EYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW  546 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccch---------hhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence            445678999999999999999999998765         99999998764 23346688999999999999999998644


Q ss_pred             EeC-----------------------------------------------------------------------------
Q 014202          169 IED-----------------------------------------------------------------------------  171 (429)
Q Consensus       169 ~~~-----------------------------------------------------------------------------  171 (429)
                      .+.                                                                             
T Consensus       547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded  626 (1351)
T KOG1035|consen  547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED  626 (1351)
T ss_pred             hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence            310                                                                             


Q ss_pred             ------------------------------------------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHH
Q 014202          172 ------------------------------------------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA  209 (429)
Q Consensus       172 ------------------------------------------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi  209 (429)
                                                                ..+||-||||+...|.+++.++...-.....|+++++|
T Consensus       627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreI  706 (1351)
T KOG1035|consen  627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREI  706 (1351)
T ss_pred             ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHH
Confidence                                                      12578999999877777775554322578899999999


Q ss_pred             HHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC----------------CCCccceeeeccccccccCh
Q 014202          210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP----------------QGDKTHVSTRVVGTYGYAAP  273 (429)
Q Consensus       210 ~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~----------------~~~~~~~~~~~~gt~~y~aP  273 (429)
                      ++||.|+|  +.|||||||||.|||+|.++.|||+|||+|....                .+......+..+||.-|+||
T Consensus       707 lEGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  707 LEGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            99999999  8999999999999999999999999999998621                01111134457999999999


Q ss_pred             hhhhcC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccC--CCHHHHHH
Q 014202          274 EYVMTG---HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN--YSLKGVQK  348 (429)
Q Consensus       274 E~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  348 (429)
                      |++.+.   .|+.|+|+|||||||+||+.   ||...               +.....+..+.+..++.+  +.....+.
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---------------MERa~iL~~LR~g~iP~~~~f~~~~~~~  846 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---------------MERASILTNLRKGSIPEPADFFDPEHPE  846 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc---cCCch---------------HHHHHHHHhcccCCCCCCcccccccchH
Confidence            998754   59999999999999999986   46432               111122223333333333  22233355


Q ss_pred             HHHHHHHcccCCCCCCCCHhHHHH
Q 014202          349 VSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       349 l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      -..+|++||+.||.+|||+.|+|+
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhh
Confidence            678999999999999999999997

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.7e-40  Score=311.79  Aligned_cols=265  Identities=25%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-hHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|.+....... ...+.+|+.+|+.++|+||+++++++..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   74 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT   74 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCc---------EEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence            3679999999999999999999887655         89999987553322 2456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|+||||+. ++|.+.+......+++..+..++.|++.||.|||  ..+|+|+||||+|||++.++.++|+|||+++
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEecccccc
Confidence            999999999995 6887777665556788889999999999999999  8899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH-----
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA-----  324 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----  324 (429)
                      .......  ......+++.|+|||++.+. .++.++|||||||++|+|++|..||........  ........+.     
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~  227 (291)
T cd07870         152 AKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTED  227 (291)
T ss_pred             ccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChh
Confidence            6432211  12234678999999988754 578899999999999999999999975432111  0000000000     


Q ss_pred             ---hhhhhhh----hcCCccccC-----CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 ---DKRKLYQ----IVDPRLELN-----YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ---~~~~~~~----~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         ....+..    .........     .....+..+.+++.+||..||.+|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               0000000    000000000     00112467889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=308.90  Aligned_cols=248  Identities=27%  Similarity=0.408  Sum_probs=201.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCC---CcceeeEEeEEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLH---HPNLVKLIGYCI  169 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~  169 (429)
                      .|++.+.||.|+||.||+|.+..++.         .||+|.+.... .....++.+|+.++++++   ||||+++++++.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~   72 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGR---------VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL   72 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCc---------EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence            47888999999999999999876654         89999987553 234456889999999997   999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .+...++||||++|++|.+++...  .+++..++.++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06917          73 KGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVA  148 (277)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccCCce
Confidence            999999999999999999988553  6899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ........  ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||..........             .
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------~  213 (277)
T cd06917         149 ALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------L  213 (277)
T ss_pred             eecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------------c
Confidence            87544321  1223578999999998865 457899999999999999999999997543211100             0


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +.....+.+.   ....+.++.+++.+||+.||++||++.++++
T Consensus       214 ~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         214 IPKSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cccCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            0000011111   1114568999999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=327.98  Aligned_cols=252  Identities=27%  Similarity=0.461  Sum_probs=215.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +..+.++||+|.||.|++|.+..-+.      +-..||||.+..+... ...+|++|+.+|.+|+|||++++||+..+ .
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psg------k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSG------KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCC------cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            34557899999999999999876432      2347999999887655 56789999999999999999999999887 7


Q ss_pred             eEEEEEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...+|||++++|+|.+.|.+ ....|-......++.||+.|+.||.  .+++|||||...|+|+-....|||+|||+.+.
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe--skrlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE--SKRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhhhheecccceeeeecccceec
Confidence            77899999999999999987 4556888899999999999999999  89999999999999998888999999999998


Q ss_pred             CCCCCccceee-eccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          252 GPQGDKTHVST-RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       252 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +..++...... ...-...|+|||.+....++.++|||+|||+||||++ |..||.+...                 ..+
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qI  324 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQI  324 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHH
Confidence            76654433221 2234567999999999999999999999999999999 7889987542                 234


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV  371 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil  371 (429)
                      .+.+|..-.+..+..++++++++++.||..+|.+|||+..|.
T Consensus       325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair  366 (1039)
T KOG0199|consen  325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR  366 (1039)
T ss_pred             HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence            555666667778888999999999999999999999999996

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=357.77  Aligned_cols=256  Identities=26%  Similarity=0.366  Sum_probs=207.8

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ..+-+|.-+..||.|.||.||-|.+.++++         -.|+|.+.....  .....+.+|..+|..|+|||||++|++
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGe---------llAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV 1302 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGE---------LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV 1302 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccc---------hhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce
Confidence            344677778899999999999999998866         789998865533  334567899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      -.+.+..+|.||||+||+|.+.+ +.+.-.++.....+..|++.|++|||  +.|||||||||+|||++.+|.+|++|||
T Consensus      1303 EvHRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1303 EVHREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             eecHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeeccc
Confidence            99999999999999999999987 44445677777888999999999999  9999999999999999999999999999


Q ss_pred             CcccCCCCCc--cceeeeccccccccChhhhhcC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          248 LAKAGPQGDK--THVSTRVVGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       248 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      .|........  ........||+.|||||++.+.   ....++||||||||+.||+||+.||.....       +|..  
T Consensus      1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aI-- 1450 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAI-- 1450 (1509)
T ss_pred             ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHH--
Confidence            9987654321  1223347899999999999754   456799999999999999999999975332       1111  


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                             .--+-..-...++...+.+-.++|.+||+.||++|.++.|+++.
T Consensus      1451 -------My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 -------MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                   11111111223445577889999999999999999999999874

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=314.09  Aligned_cols=265  Identities=27%  Similarity=0.365  Sum_probs=203.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+..+++         .||+|.+....  ......+.+|+.+|++++|+||+++++++..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---------~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGE---------IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR   71 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCc---------EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence            468999999999999999999887654         89999986542  2234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..++||||++++.+..++ .....+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~  148 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFAR  148 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence            99999999999886666554 44456899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh----
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD----  325 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  325 (429)
                      ....... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.......   ...........    
T Consensus       149 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~  224 (288)
T cd07833         149 ALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPS  224 (288)
T ss_pred             ccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence            7544322 122335788999999999887 78999999999999999999999997543211   11000000000    


Q ss_pred             -------hhhh-----hhhcCC-ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 -------KRKL-----YQIVDP-RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 -------~~~~-----~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                             ....     ....+. .....++...+.++.+||.+||..||++||+++++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                   0000     000000 00001122236789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-39  Score=300.64  Aligned_cols=251  Identities=29%  Similarity=0.466  Sum_probs=207.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      +|.+.+.||.|++|.||+|.+..++.         .+++|++..........+.+|+.++++++||||+++++++..+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGK---------EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCc---------EEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            47888999999999999999876544         899999987655566788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .++++||+++++|.+++......+++..+..++.|++.||.+||  ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence            99999999999999998776567899999999999999999999  8999999999999999999999999999998754


Q ss_pred             CCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ....   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......      ....       .....
T Consensus       150 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-------~~~~~  213 (253)
T cd05122         150 DTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFK-------IATNG  213 (253)
T ss_pred             cccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHH-------HHhcC
Confidence            4321   233578999999999988889999999999999999999999997543110      0000       00000


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .+  ........+..+.++|.+||+.||++|||+.++++.
T Consensus       214 ~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         214 PP--GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CC--CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  111111225789999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7e-40  Score=309.08  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      .|...+.||.|++|.||+|.+..++.         .+++|.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGR---------QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCC---------EEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            35556789999999999999876654         899999876555555678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .++|+||+.|++|.+++..  ..+++..+..++.|++.||+|||  +.+|+||||+|+||+++.++.++|+|||++....
T Consensus        91 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~  166 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS  166 (285)
T ss_pred             EEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence            9999999999999998866  35889999999999999999999  8999999999999999999999999999887543


Q ss_pred             CCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ...  .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+.      .....       +....
T Consensus       167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~-------~~~~~  231 (285)
T cd06648         167 KEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKR-------IRDNL  231 (285)
T ss_pred             cCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH-------HHhcC
Confidence            321  1122356899999999998888999999999999999999999999653321      11111       11110


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .+.  .......+..+.+++.+||+.||++||++.++++
T Consensus       232 ~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 PPK--LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCC--CcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            111  1111224578999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-39  Score=308.15  Aligned_cols=258  Identities=27%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|+..+.||.|++|.||+|.+..++.         .||+|.+..... .....+.+|++++++++||||+++++++...
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   71 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGM---------IFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE   71 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCe---------EEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence            368889999999999999999977654         899999875533 3446788999999999999999999988654


Q ss_pred             --CeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          172 --DQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       172 --~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                        ..+|+||||++|++|.+++..   ....+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~df  149 (287)
T cd06621          72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDF  149 (287)
T ss_pred             CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeec
Confidence              368999999999999887643   3456889999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |++........    ....++..|+|||.+.+..++.++|||||||++|+|++|..||....... ....+.... ... 
T Consensus       150 g~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~~-  222 (287)
T cd06621         150 GVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSY-IVN-  222 (287)
T ss_pred             ccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHH-Hhc-
Confidence            99875432211    23467889999999998899999999999999999999999997653311 111111111 111 


Q ss_pred             hhhhhhcCCcccc--CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQIVDPRLEL--NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                           ...+.+..  ......++.+.+++.+||..||.+|||+.|+++.
T Consensus       223 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         223 -----MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             -----CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                 00011111  1112345789999999999999999999999983

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-40  Score=314.36  Aligned_cols=267  Identities=27%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+..+++         .||+|.+......  ..+.+.+|+.+|+.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQ---------IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCC---------EEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            368899999999999999999876654         8999998654322  24567899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|+||||++++.|..+.... ..+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~  148 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFAR  148 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeeeeee
Confidence            99999999999998888766443 35899999999999999999999  8999999999999999999999999999988


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc-HHHHHHHHHHhh--
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN-LVAWARQYLADK--  326 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~--  326 (429)
                      ......  .......++..|+|||++.+ ..++.++||||||+++|||++|.+||.......... ...+........  
T Consensus       149 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07846         149 TLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE  226 (286)
T ss_pred             eccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence            653322  12223568899999999875 457889999999999999999999996543211000 000000000000  


Q ss_pred             ----hhhh-hhcCCcccc-----CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 ----RKLY-QIVDPRLEL-----NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ----~~~~-~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                          ..+. ....+....     ......+..+.+|+.+||+.||++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                0000 000000000     0011335779999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.3e-40  Score=307.22  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      -|++.+.||.|+||.||+|.+..++.         .||+|.+..... .....+.+|+.++.+++||||+++++++..++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   75 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQK---------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT   75 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCc---------EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence            37788999999999999998876654         899999865432 33456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|+||||+++++|.+++...  .+++..+..++.|++.++.|||  ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        76 ~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06641          76 KLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  151 (277)
T ss_pred             eEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence            999999999999999988543  5889999999999999999999  899999999999999999999999999998765


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .....  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....+.      .....       +.. 
T Consensus       152 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~-------~~~-  215 (277)
T cd06641         152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFL-------IPK-  215 (277)
T ss_pred             ccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHH-------Hhc-
Confidence            33221  122356888999999998888899999999999999999999999643211      00000       000 


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         ..........+..+.+++.+||+.+|.+||++.++++.
T Consensus       216 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         216 ---NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               00111222345779999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.6e-40  Score=308.51  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=207.7

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ...+.|.+.+.||.|+||.||+|.+..++.         .|++|.+..... ....+.+|+.+++.++|+||+++++.+.
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~   85 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGK---------EVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL   85 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCc---------EEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence            345678999999999999999999876544         899999976544 4567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .+...|+|+||++|++|.+++......+++..+..++.|++.||.|||  ..|++|+||+|+||+++.++.++|+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~  163 (286)
T cd06614          86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFGFA  163 (286)
T ss_pred             ECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccchh
Confidence            999999999999999999999776557899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........  ......+++.|+|||++.+..++.++|+|||||++|+|++|..||....+...      ...       .
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~-------~  228 (286)
T cd06614         164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFL-------I  228 (286)
T ss_pred             hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-------H
Confidence            75433221  11234688899999999888899999999999999999999999965332110      000       0


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..  ............+..+.++|.+||+.+|.+||++.+++.
T Consensus       229 ~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         229 TT--KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             Hh--cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            00  000111111224578999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4e-40  Score=311.89  Aligned_cols=264  Identities=25%  Similarity=0.337  Sum_probs=201.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--hHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .||+|.++......  ...+.+|+.++.+++||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   75 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGE---------IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG   75 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCc---------EEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence            468999999999999999999876654         89999997553221  2356789999999999999999999888


Q ss_pred             C--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          171 D--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       171 ~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      +  ...|+||||+. ++|.+++......+++..+..++.|++.||+|||  +.+++|+||||+|||++.++.++|+|||+
T Consensus        76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          76 SNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             cCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence            7  88999999997 4999988766657899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh--
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD--  325 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  325 (429)
                      +........  ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........   ..........  
T Consensus       153 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~  227 (293)
T cd07843         153 AREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPT  227 (293)
T ss_pred             eeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCc
Confidence            987544321  12234678899999988754 468999999999999999999999975442111   0000000000  


Q ss_pred             ------hhhhhh--------hcCCccccCCCHH-HHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 ------KRKLYQ--------IVDPRLELNYSLK-GVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 ------~~~~~~--------~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                            ...+..        .....+...++.. .++.+.++|.+||+.||++|||+.|++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  000000        0000001111111 35778999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8e-40  Score=304.61  Aligned_cols=253  Identities=29%  Similarity=0.421  Sum_probs=203.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|.+.+.||+|+||.||+|.+..++.         .|++|.+......  ....+..|+.++++++|+||+++++.+...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGE---------LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCc---------EEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence            58889999999999999999876644         8999999766543  567789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++|+||+++++|.+++... ..+++..+..++.|++.||.|||  +.+|+|+||+|+||+++.++.+||+|||++..
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~  148 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK  148 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEcccccccc
Confidence            9999999999999999988654 35789999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccce--eeeccccccccChhhhhcCC---CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          252 GPQGDKTHV--STRVVGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       252 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .........  .....+++.|+|||++.+..   ++.++||||||+++|+|++|..||......     ......     
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~-----  218 (264)
T cd06626         149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFH-----  218 (264)
T ss_pred             cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHH-----
Confidence            543322111  11256889999999988665   889999999999999999999999653211     000000     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                        +.  .......+.....+..+.++|.+||+.||.+||++.+++.
T Consensus       219 --~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         219 --VG--AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --Hh--cCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              00  0111111112223577899999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=300.30  Aligned_cols=257  Identities=26%  Similarity=0.369  Sum_probs=205.0

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  176 (429)
                      .+.||+|+|+.|--+....++.         .||||++.+...-.+.++.+|++++.+.+ |+||+.++++|++++..||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~---------EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGK---------EYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             HHHhcCccceeeeeeeeeccch---------hhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            3689999999999888877655         99999999886677788999999999997 9999999999999999999


Q ss_pred             EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC---EEEccccCcccCC
Q 014202          177 VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGP  253 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl~DFg~a~~~~  253 (429)
                      |||-+.||.|..+|.++. .+++.++..++.+|+.||.+||  .+||.||||||+|||......   ||||||.+.....
T Consensus       154 VfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             EEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            999999999999997775 5899999999999999999999  999999999999999965443   8999998875432


Q ss_pred             CCC-----ccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc----cHHHHH
Q 014202          254 QGD-----KTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ----NLVAWA  319 (429)
Q Consensus       254 ~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~----~~~~~~  319 (429)
                      ...     .+......+|+..|||||++.     ...|+.+.|.||||||||-||+|.+||.+.-.....    .....-
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C  310 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC  310 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence            211     122233478999999999874     235899999999999999999999999876543221    111111


Q ss_pred             HHHHHhhhhhhh-hcCCcccc--CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          320 RQYLADKRKLYQ-IVDPRLEL--NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       320 ~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +      ..++. +.+...+.  .-....+.+..+|+..+|..|+.+|.++.+++.
T Consensus       311 Q------~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  311 Q------NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             H------HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            1      12222 22222221  122346788999999999999999999999987

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1e-39  Score=302.21  Aligned_cols=250  Identities=25%  Similarity=0.413  Sum_probs=207.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|.+.+.||.|+||.||+|.+..++.         .|++|.+.....  .....+.+|+++++.++|||++++++.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCc---------EEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence            58889999999999999999876544         899999976643  4556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      +..++|+||+++++|.+++...   ...+++..+..++.+++.||.|||  ..+++|+||+|+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~  149 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGI  149 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccc
Confidence            9999999999999999998765   367999999999999999999999  88999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +.......  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      .......      
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~------  215 (258)
T cd08215         150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKI------  215 (258)
T ss_pred             eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHH------
Confidence            98754432  223335789999999999888899999999999999999999999965431      1111110      


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                          .... ....+...+..+.+++.+||..+|++||++.++++.
T Consensus       216 ----~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         216 ----LKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ----hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000 111222445789999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-39  Score=300.54  Aligned_cols=253  Identities=30%  Similarity=0.443  Sum_probs=208.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||+|++|.||+|.+..++.         .|++|.+.....  .....+.+|+.++++++||||+++++.+...
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGE---------LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE   71 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCc---------EEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence            47888999999999999999886654         899999876643  3456788999999999999999999999988


Q ss_pred             --CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 --DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                        ...++||||+.+++|.+++.... .+++..++.++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||.+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          72 EKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             CCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEcccccE
Confidence              88999999999999999987665 7899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ................++..|+|||.+.+..++.++||||||+++|+|++|..||.....     ....          .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~----------~  213 (260)
T cd06606         149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAA----------L  213 (260)
T ss_pred             EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHH----------H
Confidence            876543321112335788999999999888899999999999999999999999976441     1110          1


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ............+...+..+.+++.+||+.||++||++.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         214 YKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             HhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            11111111122333446889999999999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-39  Score=316.29  Aligned_cols=264  Identities=22%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||+|.+...  .......+.+|+.++++++||||+++++++
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQ---------NVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF   84 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCC---------EEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence            34789999999999999999999887655         8999998643  223345677899999999999999999988


Q ss_pred             EeC------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IED------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~~------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ...      ...|+||||+. ++|.+.+...   +++..+..++.|++.||+|||  ..||+||||||+||+++.++.+|
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             ccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEE
Confidence            644      35799999995 5888877543   788999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc--------
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN--------  314 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--------  314 (429)
                      |+|||++........   .....|++.|+|||++.+..++.++|||||||++|+|++|+.||..........        
T Consensus       159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  235 (353)
T cd07850         159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT  235 (353)
T ss_pred             EccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999986533211   223568899999999999999999999999999999999999997543211000        


Q ss_pred             ----HHHHHH----HHHHhhh-----hhhhhcCC----ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          315 ----LVAWAR----QYLADKR-----KLYQIVDP----RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       315 ----~~~~~~----~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          +.....    .+.....     .+.+....    ..........+..+.++|.+||+.||++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                000000    0000000     00000000    0000001123567899999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.8e-39  Score=307.66  Aligned_cols=265  Identities=16%  Similarity=0.187  Sum_probs=190.3

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh-----------HHHHHHHHHHhcCCCc
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-----------REWVAEVDFLGQLHHP  159 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hp  159 (429)
                      ..++|++.++||+|+||.||+|.+..++.      .+..+|+|+.........           .....++..+..+.|+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~   83 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL   83 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence            34689999999999999999999876522      122577776543322111           1123344556677899


Q ss_pred             ceeeEEeEEEeCC----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          160 NLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       160 nIv~~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      ||+++++.+....    ..+++|+++. .++.+.+... ...++..+..++.|++.||.|||  +.+|+||||||+|||+
T Consensus        84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiKp~Nill  159 (294)
T PHA02882         84 GIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIKPENIMV  159 (294)
T ss_pred             CCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence            9999998766543    3467888773 4666665433 34678889999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS  310 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  310 (429)
                      +.++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999999999765322111     1112346999999999999999999999999999999999999999765321


Q ss_pred             ccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          311 GEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .  ........     .-+.++.......   ...+..+.+++..||..+|++||++.++++.|+
T Consensus       240 ~--~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 G--NLIHAAKC-----DFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             h--HHHHHhHH-----HHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1  11110000     0011111111111   123478999999999999999999999998763

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=302.33  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=201.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-----CchhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-----GLQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .+|++.+.||+|+||.||+|.+..++.         .||+|.+...     .......+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   72 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGR---------ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC   72 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCC---------EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            479999999999999999999876654         8999987532     12334578899999999999999999998


Q ss_pred             EEeC--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          168 CIED--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       168 ~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      +.+.  ..+++||||+++++|.+++.... .+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             EEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEECc
Confidence            8764  45789999999999999986544 4889999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCc-cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          246 FGLAKAGPQGDK-THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       246 Fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ||++........ ........|+..|+|||++.+..++.++|+|||||++|+|++|..||......      .       
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-------  216 (264)
T cd06653         150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------A-------  216 (264)
T ss_pred             cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------H-------
Confidence            999986432111 11112356899999999998888999999999999999999999999643211      0       


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         .+.+..........+...++.+.+++.+||+ +|..||++.+++.+
T Consensus       217 ---~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         217 ---AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ---HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence               1111111111222344556789999999998 67999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-39  Score=306.06  Aligned_cols=243  Identities=26%  Similarity=0.380  Sum_probs=189.5

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHH---hcCCCcceeeEEeEEEeCCe
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFL---GQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~  173 (429)
                      .||+|+||.||+|.+..++.         .||+|.+......   ......+|..++   ...+||||+.+++++..++.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEECCCCc---------EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence            48999999999999877654         8999998654321   112234444433   34479999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .++||||+.|++|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+|||++....
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            999999999999999886554 5899999999999999999999  8999999999999999999999999999987543


Q ss_pred             CCCccceeeeccccccccChhhhh-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ...    .....|++.|+|||.+. +..++.++|||||||++|+|++|..||...........    ..       ... 
T Consensus       149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~-------~~~-  212 (279)
T cd05633         149 KKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DR-------MTL-  212 (279)
T ss_pred             ccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HH-------Hhh-
Confidence            221    12246899999999886 45689999999999999999999999975433211110    00       000 


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                         ......+...+.++.++|.+||..||.+||     +++++++.
T Consensus       213 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 ---TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ---cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence               011122334557899999999999999999     69999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=310.81  Aligned_cols=270  Identities=23%  Similarity=0.311  Sum_probs=198.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +|++.+.||+|+||.||+|.+...+       .+..||+|.+....   ......+.+|+.++..++||||+++++++..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~-------~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGK-------DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE   73 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCC-------CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence            4888999999999999999987621       14499999998743   2233567889999999999999999999998


Q ss_pred             C--CeEEEEEEecCCCChHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC----CCC
Q 014202          171 D--DQRLLVYEFMTRGSLENHLFRR----TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS----EYN  240 (429)
Q Consensus       171 ~--~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~  240 (429)
                      .  ...++||||+++ +|.+.+...    ...+++..++.++.|++.||.|||  +.+|+||||||+|||++.    ++.
T Consensus        74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~  150 (316)
T cd07842          74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGV  150 (316)
T ss_pred             CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccce
Confidence            8  889999999965 677666432    236889999999999999999999  899999999999999999    899


Q ss_pred             EEEccccCcccCCCCCc-cceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH---
Q 014202          241 AKLSDFGLAKAGPQGDK-THVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL---  315 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---  315 (429)
                      +||+|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|.+||...........   
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~  230 (316)
T cd07842         151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ  230 (316)
T ss_pred             EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence            99999999986543222 1112235688999999988764 578999999999999999999999986554321100   


Q ss_pred             ---HHHHHHHHH-----------hhhhhhhhcCCccccCCC---------H--HHHHHHHHHHHHcccCCCCCCCCHhHH
Q 014202          316 ---VAWARQYLA-----------DKRKLYQIVDPRLELNYS---------L--KGVQKVSQLAYNCLSRDPKSRPSMDEV  370 (429)
Q Consensus       316 ---~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~~l~~dP~~Rpt~~ei  370 (429)
                         .......+.           .........+.......+         .  ..+..+.+++.+||+.||++|||+.|+
T Consensus       231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei  310 (316)
T cd07842         231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA  310 (316)
T ss_pred             HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence               000000000           000000000000000000         0  234578999999999999999999999


Q ss_pred             HHH
Q 014202          371 VKV  373 (429)
Q Consensus       371 l~~  373 (429)
                      ++.
T Consensus       311 l~~  313 (316)
T cd07842         311 LEH  313 (316)
T ss_pred             hcC
Confidence            863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-39  Score=310.67  Aligned_cols=264  Identities=27%  Similarity=0.365  Sum_probs=199.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||.|+||.||+|.+..++.         .||+|.+......  ....+.+|+.+|++++|+||+++++++..
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGE---------IVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG   77 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCc---------EEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence            579999999999999999999887655         8999998754322  12345689999999999999999999876


Q ss_pred             C--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          171 D--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       171 ~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .  +..++||||+. ++|.+++......+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL~dfg~  154 (309)
T cd07845          78 KHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGL  154 (309)
T ss_pred             CCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECccce
Confidence            5  46899999996 4888888765567899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh-
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK-  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  326 (429)
                      +........  ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+...   ........... 
T Consensus       155 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~  229 (309)
T cd07845         155 ARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPN  229 (309)
T ss_pred             eeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCC
Confidence            987543221  1122346788999998875 4578999999999999999999999975433211   11111100000 


Q ss_pred             hhhhh---------hcC-CccccCC----CHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQ---------IVD-PRLELNY----SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~---------~~~-~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .....         ... .......    ....+..+.++|.+||+.||++|||+.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000         000 0000000    01135678899999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-39  Score=307.85  Aligned_cols=253  Identities=27%  Similarity=0.371  Sum_probs=196.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCC-CcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLH-HPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  171 (429)
                      +|...+.||+|+||.||++.+..++.         .||+|.+..... .....+.+|+.++.++. ||||+++++++..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~   75 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE   75 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCC---------EEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence            46667899999999999999887654         899999875532 34457889999999996 99999999999999


Q ss_pred             CeEEEEEEecCCCChHHHH---hc-CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          172 DQRLLVYEFMTRGSLENHL---FR-RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l---~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      ...+++|||+. ++|.++.   .. ....+++..+..++.|++.||+|||. ..+|+||||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecc
Confidence            99999999985 4555433   22 23568999999999999999999992 3599999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ++........   .....|+..|+|||++.+.   .++.++|||||||++|+|++|..||....     ........   
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~---  222 (288)
T cd06616         154 ISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQ---  222 (288)
T ss_pred             hhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhh---
Confidence            9976433211   1224688999999998765   68999999999999999999999997542     11111110   


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          ......+.+........+..+.+|+.+||+.||++|||+++|++
T Consensus       223 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         223 ----VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             ----hcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00011111121222345678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-39  Score=306.33  Aligned_cols=260  Identities=24%  Similarity=0.319  Sum_probs=197.2

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCC-CcceeeEEeEEEeC-
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLH-HPNLVKLIGYCIED-  171 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~-  171 (429)
                      |++.+.||+|+||.||+|.+..++.         .||+|.+..... .......+|+.++.++. |+||+++++++.++ 
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~---------~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK   71 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCc---------EEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence            6778899999999999999887655         899999875421 22234467999999986 99999999999988 


Q ss_pred             -CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 -DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                       +..++||||+. ++|.+.+......+++..+..++.|++.||.|||  ..+++||||+|+||+++. +.+||+|||++.
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEeccccc
Confidence             88999999996 5888888766567899999999999999999999  899999999999999999 999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh-hh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK-RK  328 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~  328 (429)
                      .......   .....++..|+|||++.. ..++.++|||||||++|||++|..||....+..   ............ ..
T Consensus       148 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~  221 (282)
T cd07831         148 GIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAE  221 (282)
T ss_pred             ccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence            6533221   122468899999997754 557889999999999999999999997654321   111111111000 00


Q ss_pred             hhhhc------CCcccc-------CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 LYQIV------DPRLEL-------NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~~~~~------~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +.+..      +...+.       ......+..+.+||.+||+.||++||++.+++..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00000      000000       0012346789999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9e-40  Score=311.66  Aligned_cols=269  Identities=24%  Similarity=0.342  Sum_probs=197.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||.+......  ....+.+|+.++++++||||+++++++..
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQ---------IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCc---------EEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            579999999999999999999887654         8999998654322  22345689999999999999999998876


Q ss_pred             CC--------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          171 DD--------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       171 ~~--------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ..        ..++||||+. ++|.+.+......+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILK  159 (310)
T ss_pred             ccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECCCCcEE
Confidence            54        4599999995 5888888766667899999999999999999999  88999999999999999999999


Q ss_pred             EccccCcccCCCCCcc--ceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          243 LSDFGLAKAGPQGDKT--HVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      |+|||++.........  .......++..|+|||++.+. .++.++||||||+++|+|++|..||....+..........
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~  239 (310)
T cd07865         160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL  239 (310)
T ss_pred             ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999765332211  111234678899999988764 4788999999999999999999999765432111111100


Q ss_pred             HHHH-----Hhhh--hhhhhcC-Cc-----cccC-CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          320 RQYL-----ADKR--KLYQIVD-PR-----LELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       320 ~~~~-----~~~~--~~~~~~~-~~-----~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ....     ....  ....... +.     .... ........+.+||.+||..||.+|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0000     0000  0000000 00     0000 000123567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-39  Score=308.01  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=196.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCC-CcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLH-HPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|.+......  ....+.+|+.+++.+. ||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGK---------LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCc---------EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            468999999999999999999887655         8999998654322  2356788999999995 699999999988


Q ss_pred             eCCe-----EEEEEEecCCCChHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CC
Q 014202          170 EDDQ-----RLLVYEFMTRGSLENHLFRR----TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EY  239 (429)
Q Consensus       170 ~~~~-----~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~  239 (429)
                      ..+.     .|+||||+++ +|.+++...    ...+++..++.++.||+.||.|||  ..+|+||||+|+||+++. ++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~  148 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKG  148 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCC
Confidence            7766     8999999975 888887543    235899999999999999999999  899999999999999998 88


Q ss_pred             CEEEccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHH
Q 014202          240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW  318 (429)
Q Consensus       240 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  318 (429)
                      .++|+|||++........  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+...  ....
T Consensus       149 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~  224 (295)
T cd07837         149 LLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHI  224 (295)
T ss_pred             eEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHH
Confidence            999999999876432211  1122357889999998865 4578999999999999999999999976432111  0000


Q ss_pred             HHHHHHh-hhhhh-hhcC-------Cc----cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          319 ARQYLAD-KRKLY-QIVD-------PR----LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       319 ~~~~~~~-~~~~~-~~~~-------~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .. .+.. ..... ....       +.    .........+..+.++|.+||..||.+||++.+++..
T Consensus       225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         225 FK-LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HH-HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00 0000 00000 0000       00    0000011245778999999999999999999999863

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.7e-40  Score=303.17  Aligned_cols=250  Identities=22%  Similarity=0.374  Sum_probs=202.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|.+.+.||.|+||.||+|.+..++.         .||+|.+.....  .....+.+|+.+++.++|+||+++++.+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSE---------HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCc---------eEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence            58889999999999999999987654         899999876422  2345678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC-EEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN-AKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-~kl~DFg~a  249 (429)
                      ...++|+||+++++|.+++.... ..+++..+..++.|++.||.|||  ..+++|+||||+||+++.++. ++|+|||.+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~  149 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIA  149 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccccc
Confidence            99999999999999999986643 35789999999999999999999  899999999999999988865 699999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......  .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....      ..+....       
T Consensus       150 ~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-------  214 (257)
T cd08225         150 RQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKI-------  214 (257)
T ss_pred             hhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-------
Confidence            7654322  122235689999999999888899999999999999999999999964321      1111111       


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         ...... ......+..+.+++.+||..+|++|||+.++++.
T Consensus       215 ---~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         215 ---CQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---hcccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               111110 1112334679999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-39  Score=301.11  Aligned_cols=243  Identities=27%  Similarity=0.378  Sum_probs=198.8

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ||.|+||.||+|++..++.         .||+|.+.....   ...+.+.+|+.+++.++||||+++++.+.++...|+|
T Consensus         1 lg~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNR---------TFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECCCCc---------EEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence            7999999999999876544         899999875432   2346788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+++++|.+++.+. ..+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-  147 (262)
T cd05572          72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-  147 (262)
T ss_pred             EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence            9999999999998654 35899999999999999999999  8999999999999999999999999999998754432 


Q ss_pred             cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCcc
Q 014202          258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL  337 (429)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (429)
                        ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......    ......          .+.....
T Consensus       148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----------~~~~~~~  211 (262)
T cd05572         148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYN----------DILKGNG  211 (262)
T ss_pred             --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHH----------HHhccCC
Confidence              122357899999999998888999999999999999999999999765421    111111          1111111


Q ss_pred             ccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHH
Q 014202          338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVK  372 (429)
Q Consensus       338 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~  372 (429)
                      ....+...+..+.++|.+||+.||++||+     +.|+++
T Consensus       212 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         212 KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            12223333678999999999999999999     888876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.9e-39  Score=305.69  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=200.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +|++.+.||.|++|.||+|.+..++.         .||||.+...... ....+.+|+.++++++||||+++++++...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   71 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGE---------IVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN   71 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCe---------EEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence            58889999999999999999877654         8999999765432 3456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT--IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ..++||||+.+ +|.+++....  ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++.
T Consensus        72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            99999999975 8888876543  46899999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH-------
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY-------  322 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------  322 (429)
                      .......  ......+++.|++||++.+. .++.++|||||||++|+|++|..||........  ........       
T Consensus       149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~  224 (284)
T cd07836         149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTEST  224 (284)
T ss_pred             hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhh
Confidence            5432211  11234678899999988654 578899999999999999999999976543211  00000000       


Q ss_pred             HHhhhhhhhhcCCccc-------cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          323 LADKRKLYQIVDPRLE-------LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +.......... ....       .......+..+.+++.+||+.||.+||++.++++.
T Consensus       225 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         225 WPGISQLPEYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HHHHhcCchhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000000000 0000       00111235678999999999999999999999863

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-39  Score=304.70  Aligned_cols=244  Identities=30%  Similarity=0.423  Sum_probs=195.1

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ||+|+||.||+|.+..++.         .||+|.+.....   .....+..|+.+|++++||||+++++++...+..|+|
T Consensus         1 lg~g~~g~vy~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKATGK---------MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcCCCc---------EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence            6999999999999887654         899999865422   2234567899999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCC
Q 014202          178 YEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~  256 (429)
                      |||+++++|.+++.... ..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~  149 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK  149 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence            99999999999886654 36899999999999999999999  8999999999999999999999999999987643311


Q ss_pred             ccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCc
Q 014202          257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR  336 (429)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                         ......++..|+|||++.+..++.++|||||||++|+|++|..||...........             +..... .
T Consensus       150 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~-~  212 (277)
T cd05577         150 ---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------------LKRRTL-E  212 (277)
T ss_pred             ---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------------HHhccc-c
Confidence               11234678899999999888899999999999999999999999975443211110             000000 0


Q ss_pred             cccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          337 LELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                      .....+...++.+.++|.+||+.||.+||     ++.+++.
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            11122233457899999999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.8e-40  Score=307.67  Aligned_cols=263  Identities=27%  Similarity=0.367  Sum_probs=198.8

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||.|+||.||+|.+..++.         .||||.+.....  .....+.+|++++++++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGE---------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCC---------EEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence            48889999999999999999877654         899999875432  2235678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..++||||+. ++|..++... ...+++..+..++.|++.||+|||  ..+++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~~~  148 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR  148 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence            99999999995 5888887553 356899999999999999999999  8999999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh----
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD----  325 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  325 (429)
                      .......  ......+++.|+|||++.+.. ++.++|||||||++|+|++|..||.......  .........-..    
T Consensus       149 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~  224 (284)
T cd07860         149 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVV  224 (284)
T ss_pred             hcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhh
Confidence            6433221  122245788999999887644 6889999999999999999999997543211  111100000000    


Q ss_pred             ----------hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 ----------KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                ............ .......+..+.++|.+||+.||.+||++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         225 WPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                      000000000000 00011234678899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=324.91  Aligned_cols=269  Identities=27%  Similarity=0.417  Sum_probs=202.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .|...+.||+||||.||+|+++.+|.         .||||.+.... ....+.+.+|+++|++|+|+|||+++++-+...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~---------~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~   84 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGR---------LVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF   84 (732)
T ss_pred             ceeehhhhcCCccceeeeeccccccc---------chhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence            46667899999999999999988755         99999998653 344567889999999999999999999765544


Q ss_pred             ------eEEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--cCCCC--
Q 014202          173 ------QRLLVYEFMTRGSLENHLFRR--TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL--DSEYN--  240 (429)
Q Consensus       173 ------~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~~--  240 (429)
                            ...+|||||.||+|+..|.+.  ...+++.+.+.++.++..||.|||  ++||+||||||.||++  ..+|+  
T Consensus        85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~I  162 (732)
T KOG4250|consen   85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSI  162 (732)
T ss_pred             cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceE
Confidence                  457999999999999999753  456999999999999999999999  9999999999999998  33344  


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      .||+|||.|+...++.   ....++||+.|++||++.. +.|+..+|.|||||++|+.+||..||..........-+.| 
T Consensus       163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~-  238 (732)
T KOG4250|consen  163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW-  238 (732)
T ss_pred             EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh-
Confidence            7999999999875543   5567899999999999985 7889999999999999999999999975443321111111 


Q ss_pred             HHHHHhhhh-hhhhc----CCcc--------ccCCCHHHHHHHHHHHHHcccCCCCCCC--CHhHHHHHhcCCc
Q 014202          320 RQYLADKRK-LYQIV----DPRL--------ELNYSLKGVQKVSQLAYNCLSRDPKSRP--SMDEVVKVLTPLQ  378 (429)
Q Consensus       320 ~~~~~~~~~-~~~~~----~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rp--t~~eil~~l~~~~  378 (429)
                       .....+.. +.-..    +.++        +..........+..++..+|.-+|.+|.  ...++...+..+.
T Consensus       239 -~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  239 -HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             -hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence             11111100 00000    0001        1112233345567788889999999998  6666555444443

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.1e-39  Score=300.31  Aligned_cols=250  Identities=22%  Similarity=0.269  Sum_probs=196.0

Q ss_pred             HHHHhhcCCCCCCCcc--cccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCccee
Q 014202           86 QELKSATGNFRPDSIL--GEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLV  162 (429)
Q Consensus        86 ~~~~~~~~~y~~~~~l--g~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  162 (429)
                      .+.....++|.+.+.+  |.|+||.||++....++.         .+|+|.+.......     .|+.+...+ +||||+
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv   72 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQK---------LFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFI   72 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCc---------EEEEEEEehhhcch-----hhHHHHHHhhcCCCEE
Confidence            3444445678887777  999999999999887655         89999987543221     123222222 699999


Q ss_pred             eEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CE
Q 014202          163 KLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NA  241 (429)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~  241 (429)
                      ++++.+..++..|+||||+++++|.+++.... .+++..+..++.|++.||.|||  +.+++||||||+||+++.++ .+
T Consensus        73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~  149 (267)
T PHA03390         73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKDRI  149 (267)
T ss_pred             EEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCCCCeE
Confidence            99999999999999999999999999986654 7899999999999999999999  89999999999999999988 99


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      +|+|||++......      ....|+..|+|||++.+..++.++||||||+++|+|++|..||...... ......+.  
T Consensus       150 ~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~--  220 (267)
T PHA03390        150 YLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLL--  220 (267)
T ss_pred             EEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHH--
Confidence            99999998764322      1246899999999999889999999999999999999999999743321 11111111  


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-HhHHHH
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-MDEVVK  372 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~eil~  372 (429)
                               ......  .......+..+.++|.+||+.||.+||+ ++++++
T Consensus       221 ---------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        221 ---------KRQQKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---------Hhhccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                     111111  1122245578999999999999999996 699986

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=315.35  Aligned_cols=271  Identities=24%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|.+.+.||+|+||.||+|.+..++.         .||+|.+.... ......+.+|+.+|++++||||+++++++..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGV---------KVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP   74 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCC---------eEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence            4689999999999999999999887655         89999986432 2334567889999999999999999998765


Q ss_pred             CC-----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          171 DD-----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       171 ~~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      ..     ..|+||||+. ++|.+++..  ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+|
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~kl~d  149 (336)
T cd07849          75 PSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLKICD  149 (336)
T ss_pred             ccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEECc
Confidence            43     5799999996 588887744  35899999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCcc-ceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          246 FGLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       246 Fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      ||++......... .......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......   .......+
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~  226 (336)
T cd07849         150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVL  226 (336)
T ss_pred             ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHc
Confidence            9999764332211 11223578999999998764 5688999999999999999999999975432110   00000000


Q ss_pred             Hh--hhhhh-----------hhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH--hcCCcC
Q 014202          324 AD--KRKLY-----------QIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV--LTPLQD  379 (429)
Q Consensus       324 ~~--~~~~~-----------~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~--l~~~~~  379 (429)
                      ..  ...+.           ..........   .....+.++.+++.+||+.||++|||+.++++.  +.....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            00  00000           0000000000   011234678999999999999999999999984  555543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-39  Score=297.40  Aligned_cols=248  Identities=31%  Similarity=0.500  Sum_probs=205.3

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|.+.+.||+|++|.||+|.+..++.         .|++|.+.....  .....+.+|++++.+++||||+++++++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGD---------FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCc---------EEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence            48889999999999999999876654         899999987754  3456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||.|||  +.||+|+||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  148 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK  148 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEecccccee
Confidence            9999999999999999988665 46899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      .......  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.....     .....        ....
T Consensus       149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~--------~~~~  213 (254)
T cd06627         149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALF--------RIVQ  213 (254)
T ss_pred             cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH--------HHhc
Confidence            5443221  2235689999999999887889999999999999999999999964331     00000        0000


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...    ...+...+..+.+++.+||..+|++||++.+++.
T Consensus       214 ~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 DDH----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             cCC----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            011    1122234578999999999999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.9e-39  Score=306.76  Aligned_cols=251  Identities=29%  Similarity=0.409  Sum_probs=200.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .|...+.||.|+||.||+|++..++.         .||+|.+....   .....++.+|+.+++.++|+||+++++++..
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   86 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCc---------EEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence            47778899999999999999877654         89999986432   2234567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +...++||||+. |+|.+.+.....++++..+..++.|++.||.|||  ..+++||||+|+||+++.++.++|+|||++.
T Consensus        87 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  163 (308)
T cd06634          87 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (308)
T ss_pred             CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECCcccce
Confidence            999999999996 5888877666667899999999999999999999  8999999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .....      ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||......      ....       
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~-------  224 (308)
T cd06634         164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALY-------  224 (308)
T ss_pred             eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHH-------
Confidence            64321      2256889999999875   346788999999999999999999998643211      0000       


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                         ...............+..+.+||.+||..+|++||++.++++...-..
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         225 ---HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             ---HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence               000001111112234577999999999999999999999998654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.3e-39  Score=312.94  Aligned_cols=268  Identities=26%  Similarity=0.341  Sum_probs=199.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcC-CCcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQL-HHPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~  167 (429)
                      ..++|.+.+.||+|+||.||+|.+..++.         .||+|.+...  .......+.+|+.++.++ +||||++++++
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~   75 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKE---------VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV   75 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCe---------EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence            34689999999999999999999876654         8999988543  223345677899999999 99999999998


Q ss_pred             EEeC--CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          168 CIED--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       168 ~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      +...  ...|+||||+. ++|..++...  .+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          76 IKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             eccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEee
Confidence            8654  36799999996 5999888654  6788999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCcc---ceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH--
Q 014202          246 FGLAKAGPQGDKT---HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA--  319 (429)
Q Consensus       246 Fg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~--  319 (429)
                      ||++.........   .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...............  
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~  230 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG  230 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999865433221   12234578999999998764 45789999999999999999999999754332110000000  


Q ss_pred             -------HHH-HHhhhhhhhhcC-Cc--cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          320 -------RQY-LADKRKLYQIVD-PR--LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       320 -------~~~-~~~~~~~~~~~~-~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             ... ......+..... ..  .........+.++.++|.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                   000 000000000000 00  000111124578999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.8e-39  Score=302.03  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=196.3

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ||.|+||.||+|.+..++.         .|++|.+.....   .....+.+|+.++++++||||+++++.+..+...|+|
T Consensus         1 lg~g~~~~vy~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGD---------IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECCCCC---------EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence            6899999999999877654         899999976543   3345688999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+.+++|.+++.+.. .+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++........
T Consensus        72 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~  148 (265)
T cd05579          72 MEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ  148 (265)
T ss_pred             EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence            99999999999987655 6899999999999999999999  89999999999999999999999999999876433211


Q ss_pred             ------cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          258 ------THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       258 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                            ........++..|+|||.+.+..++.++||||||+++|+|++|..||....+.      .....          
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~----------  212 (265)
T cd05579         149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQN----------  212 (265)
T ss_pred             cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHH----------
Confidence                  11223356888999999998888999999999999999999999999754321      11111          


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..............+..+.+++.+||+.+|++|||+.++.+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~  254 (265)
T cd05579         213 ILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI  254 (265)
T ss_pred             HhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence            011111111111135789999999999999999999444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3e-39  Score=299.22  Aligned_cols=248  Identities=23%  Similarity=0.372  Sum_probs=204.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||.|+||.||++.+..++.         .+|+|.+.....  .....+.+|+.+++.++|+||+++++++...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCC---------EEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence            48889999999999999998876654         899999876432  3345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ...|+||||+++++|.+++...   ...+++..++.++.|++.||.|||  +.|++|+||+|+||+++.++.+||+|||+
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~  149 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGI  149 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccc
Confidence            9999999999999999988652   345889999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +......    ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      .....       
T Consensus       150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~-------  212 (256)
T cd08530         150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYK-------  212 (256)
T ss_pred             hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-------
Confidence            9875443    122246889999999999888999999999999999999999999754321      10000       


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         ..... ....+...+.++.+++.+||+.+|++||++.++++.
T Consensus       213 ---~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         213 ---VQRGK-YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ---HhcCC-CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               00011 111223456789999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=305.91  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=198.9

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      |++.+.||.|++|.||+|.+..++.         .||+|++.....  .....+.+|+.+++.++||||+++++++..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGE---------IVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCC---------EEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence            6778999999999999999887654         899999875532  22356788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~  148 (283)
T cd07835          72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARA  148 (283)
T ss_pred             eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence            9999999995 68999886554 35899999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh----
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK----  326 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  326 (429)
                      ......  ......+++.|+|||++.+. .++.++||||||+++|+|++|..||........  ............    
T Consensus       149 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  224 (283)
T cd07835         149 FGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVW  224 (283)
T ss_pred             cCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHh
Confidence            432211  11223578899999987654 578899999999999999999999975432111  111000000000    


Q ss_pred             ------hhhhhhcC---CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 ------RKLYQIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ------~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                            ........   ...........+..+.++|.+||+.||.+|||++++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  00000000   000001112334678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.2e-39  Score=301.09  Aligned_cols=242  Identities=26%  Similarity=0.376  Sum_probs=189.7

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh---hHHHHHHH---HHHhcCCCcceeeEEeEEEeCCe
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWVAEV---DFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      +||+|+||.||+|.+..++.         .||+|.+.......   ...+..|.   .+++...||||+++++++..++.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   71 (278)
T ss_pred             CcccCCCeEEEEEEEecCCC---------EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence            48999999999999876644         89999987643221   11233343   44555679999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .++||||+.|++|.+++... ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++....
T Consensus        72 ~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            99999999999999888654 46899999999999999999999  8999999999999999999999999999987543


Q ss_pred             CCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ...    .....|+..|+|||++.++ .++.++|||||||++|+|++|..||............           .....
T Consensus       149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----------~~~~~  213 (278)
T cd05606         149 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMTLT  213 (278)
T ss_pred             ccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----------HHhhc
Confidence            221    1235799999999998754 6899999999999999999999999765322111100           00000


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                      ..    ...+...+..+.+++.+||..||.+||     ++.++++
T Consensus       214 ~~----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 MA----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cC----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            11    112223457899999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-39  Score=312.20  Aligned_cols=268  Identities=24%  Similarity=0.360  Sum_probs=201.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||+|+||.||+|.+..++.         .||||.+...  .......+.+|+.+|+.++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   74 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNE---------KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP   74 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCC---------eEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence            3579999999999999999999887655         9999998653  2233456778999999999999999999876


Q ss_pred             eC-----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          170 ED-----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       170 ~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ..     ...|+||||+. ++|.+++... ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEC
Confidence            54     34799999995 6898888654 46899999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+......   ...+....
T Consensus       151 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~  225 (337)
T cd07858         151 DFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELL  225 (337)
T ss_pred             cCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHh
Confidence            999998653321  12233568899999998865 4689999999999999999999999975432110   00000000


Q ss_pred             H-----------h--hhhhhhhc----CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH--hcCCc
Q 014202          324 A-----------D--KRKLYQIV----DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV--LTPLQ  378 (429)
Q Consensus       324 ~-----------~--~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~--l~~~~  378 (429)
                      .           .  .....+..    ..... ......+..+.+||.+||+.||++|||+.++++.  +..+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             CCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            0           0  00000000    00000 0112345778999999999999999999999974  54443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.3e-39  Score=304.10  Aligned_cols=245  Identities=26%  Similarity=0.377  Sum_probs=198.9

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ...||+|+||.||+|....++.         .||||.+..........+.+|+.+++.++|+||+++++.+..++..++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCe---------EEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            4679999999999999887654         8999998765545556788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+++++|.+++...  .+++..+..++.|++.||+|||  +.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-  170 (292)
T cd06657          96 MEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  170 (292)
T ss_pred             EecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-
Confidence            9999999999977443  4789999999999999999999  8999999999999999999999999999987643322 


Q ss_pred             cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCcc
Q 014202          258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL  337 (429)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (429)
                       .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......   .....          +........
T Consensus       171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~----------~~~~~~~~~  236 (292)
T cd06657         171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM----------IRDNLPPKL  236 (292)
T ss_pred             -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----------HHhhCCccc
Confidence             1122356899999999998888999999999999999999999999753321   11110          001111111


Q ss_pred             ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       338 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .  .....+..+.+++.+||+.||.+||++.+++.
T Consensus       237 ~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         237 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             C--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            1  11223467899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.9e-39  Score=305.63  Aligned_cols=245  Identities=30%  Similarity=0.443  Sum_probs=197.4

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      |...+.||+|+||.||+|.+..++.         .|++|.+.....   .....+.+|+.+++.++||||+++++++.+.
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   93 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNE---------VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE   93 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCc---------EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            6777889999999999999876654         899999875432   2335678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...|+||||+. |+|.+++.....++++..+..++.|++.||.|||  ..|++|+||+|+||+++.++.++|+|||++..
T Consensus        94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633          94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            99999999995 5888888766667999999999999999999999  89999999999999999999999999999865


Q ss_pred             CCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ...      .....|+..|+|||++.   +..++.++|||||||++|+|++|..||........      ...       
T Consensus       171 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~-------  231 (313)
T cd06633         171 SSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-------  231 (313)
T ss_pred             cCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHH-------
Confidence            322      12357899999999984   45688899999999999999999999865432110      000       


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         ..............+..+.+|+.+||+.+|.+||++.+++..
T Consensus       232 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         232 ---IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000001111112234678999999999999999999999973

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-39  Score=313.73  Aligned_cols=265  Identities=22%  Similarity=0.332  Sum_probs=200.5

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||.|+||.||+|.+..++.         .||+|.+....  ......+.+|+.+|++++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---------~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   74 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGK---------KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR   74 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCC---------EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence            3689999999999999999999887655         89999987642  233456778999999999999999999876


Q ss_pred             e----CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          170 E----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       170 ~----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      .    ....|+||||+. ++|.+++... ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+||+|
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          75 PPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             ccCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEecc
Confidence            3    346899999995 6898888554 45899999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCcc--ceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          246 FGLAKAGPQGDKT--HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       246 Fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      ||++.........  .......|+..|+|||++.+ ..++.++|||||||++|||++|..||..........   .+...
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~---~~~~~  227 (334)
T cd07855         151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK---LILSV  227 (334)
T ss_pred             cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH---HHHHH
Confidence            9999764332211  11223578999999998865 468899999999999999999999997643321110   00000


Q ss_pred             HHh----------hhh---hhhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LAD----------KRK---LYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~----------~~~---~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...          ...   ..+.........   .....+..+.++|.+||+.||.+||++.+++.
T Consensus       228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000          000   000000000000   01223578999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-39  Score=298.02  Aligned_cols=242  Identities=26%  Similarity=0.311  Sum_probs=189.2

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh---hHHHHHHHHHH-hcCCCcceeeEEeEEEeCCeE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWVAEVDFL-GQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      +.||.|+||.||+|.+..++.         .||+|.+.......   ...+..|..++ ..++|+||+++++++..++..
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGD---------YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCC---------eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence            579999999999999877654         89999987653222   22344555544 455899999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      |+||||++|++|.+++... ..+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        73 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            9999999999999988654 36899999999999999999999  89999999999999999999999999999876432


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                            .....|++.|+|||.+.+..++.++||||||+++|+|++|..||......      .........        .
T Consensus       150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~--------~  209 (260)
T cd05611         150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSR--------R  209 (260)
T ss_pred             ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhc--------c
Confidence                  12356889999999998888899999999999999999999999653321      111110000        0


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...........+..+.+++.+||+.||++||++.++.+
T Consensus       210 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            00111112234578999999999999999997754444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.1e-39  Score=303.47  Aligned_cols=264  Identities=22%  Similarity=0.299  Sum_probs=196.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||.|+||.||+|.+..+++         .||+|.+.....  .....+.+|+.++++++||||+++++++..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNE---------TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCc---------EEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            469999999999999999999877654         899999865432  223567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCCEEEccccC
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNAKLSDFGL  248 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFg~  248 (429)
                      +...|+||||+. ++|.+++.... ..+++..+..++.||+.||+|||  +.+++|+||+|+||+++. ++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~dfg~  149 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGL  149 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEccccc
Confidence            999999999995 58888775443 33678888899999999999999  899999999999999985 55799999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +.......  .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.........  .......-....
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~~~~~~~~~~~  225 (294)
T PLN00009        150 ARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FKIFRILGTPNE  225 (294)
T ss_pred             ccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCh
Confidence            97643221  11223467899999998876 45789999999999999999999999764322110  000000000000


Q ss_pred             hh-------hhhc--CCccc----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KL-------YQIV--DPRLE----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~-------~~~~--~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..       ....  .+...    .......++.+.+++.+||+.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00       0000  00000    0011223467899999999999999999999987

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.6e-39  Score=305.24  Aligned_cols=267  Identities=24%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..+++         .||+|.+.....  .....+.+|+.++++++||||+++++++
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~   75 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGE---------LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV   75 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCc---------EEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence            44689999999999999999999987654         899999975432  2234567899999999999999999988


Q ss_pred             EeCC----------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 014202          169 IEDD----------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE  238 (429)
Q Consensus       169 ~~~~----------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~  238 (429)
                      ....          ..++|+||+++ +|.+.+......+++..+..++.|++.||+|||  ..+|+|+||||+||+++.+
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~  152 (302)
T cd07864          76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNK  152 (302)
T ss_pred             cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence            7655          78999999976 777777666557899999999999999999999  8999999999999999999


Q ss_pred             CCEEEccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      +.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.......   ...
T Consensus       153 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~  228 (302)
T cd07864         153 GQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLE  228 (302)
T ss_pred             CcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHH
Confidence            9999999999986543321 11122356788999998865 357899999999999999999999997543211   111


Q ss_pred             HHHHHHHhh-hhhh-hhc--------CCccc-----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          318 WARQYLADK-RKLY-QIV--------DPRLE-----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       318 ~~~~~~~~~-~~~~-~~~--------~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .+....... .... ...        +....     .......+..+.+++..||+.||.+||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111100000 0000 000        00000     00011235789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=303.21  Aligned_cols=262  Identities=26%  Similarity=0.354  Sum_probs=202.6

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      |.+.+.||.|++|.||+|.+..+++         .+++|.+......  ....+.+|+.+|++++|+||+++++++..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGE---------IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCc---------EEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence            6778899999999999999876654         8999998765332  3456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+++ +|.+++......+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||.+...
T Consensus        72 ~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          72 DLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             CEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence            99999999965 898888776667899999999999999999999  899999999999999999999999999999775


Q ss_pred             CCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh-hhhh-
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD-KRKL-  329 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~-  329 (429)
                      ....  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.........   ......+.. .... 
T Consensus       149 ~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  223 (283)
T cd05118         149 GSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVW  223 (283)
T ss_pred             CCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhc
Confidence            4432  112234688899999998876 7899999999999999999999999754421110   000000000 0000 


Q ss_pred             hhhcC---------Cc----cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVD---------PR----LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~---------~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ....+         +.    .........+.++.++|.+||+.||.+||++.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000         00    0001112346789999999999999999999999873

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-39  Score=301.79  Aligned_cols=263  Identities=26%  Similarity=0.375  Sum_probs=200.7

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC-
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED-  171 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  171 (429)
                      |.+.+.||.|+||.||+|.+..++.         .+|+|.+....  ......+.+|+.++++++||||+++++++... 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~---------~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGE---------LVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCe---------EEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence            6778899999999999999887654         89999998663  23345678999999999999999999999988 


Q ss_pred             -CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 -DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                       +..++||||+++ +|.+++......+++..++.++.|++.||+|||  ..+++|+||+|+||++++++.++|+|||++.
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          72 KGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             CCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEcccccee
Confidence             889999999964 899888766567899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh--h
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK--R  327 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~  327 (429)
                      ....... .......++..|+|||.+.+ ..++.++||||||+++|||++|..||........   ...........  .
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~  224 (287)
T cd07840         149 PYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDE  224 (287)
T ss_pred             eccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchh
Confidence            7544321 11222457889999998765 4578999999999999999999999975443111   11110000000  0


Q ss_pred             ------hh--hhhcCC------ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 ------KL--YQIVDP------RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 ------~~--~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                            .+  ......      .+........+..+.+++.+||+.||.+||++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                  00  000000      00000011125788999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-38  Score=301.68  Aligned_cols=253  Identities=28%  Similarity=0.437  Sum_probs=197.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCC-CcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLH-HPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  169 (429)
                      .++|++.+.||.|+||.||+|.+..++.         .||||.+..... ....++..|+.++.++. ||||+++++++.
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGH---------VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCe---------EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            3578999999999999999999887654         899999975432 33455677887777775 999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+...|+||||+. ++|.+++......+++..+..++.|++.||+|||  . .+|+||||+|+||+++.++.++|+|||+
T Consensus        85 ~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          85 TDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK--EKHGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             cCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--hhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence            9999999999984 5787777665557899999999999999999999  5 5999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      +........   .....++..|+|||++.+..    ++.++||||||+++|+|++|+.||......     .+.....+.
T Consensus       162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~  233 (296)
T cd06618         162 SGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQ  233 (296)
T ss_pred             chhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhc
Confidence            876533221   12245788999999987543    788999999999999999999999642211     111111111


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .       ..+  ........+.++.+|+.+||..||.+||++.+++..
T Consensus       234 ~-------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         234 E-------EPP--SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C-------CCC--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0       001  111111245789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.6e-39  Score=302.03  Aligned_cols=251  Identities=26%  Similarity=0.377  Sum_probs=204.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCC-CcceeeEEeEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH-HPNLVKLIGYC  168 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  168 (429)
                      ++|.+.+.||.|+||.||+|....++.         .||+|++.....   .....+..|+.++++++ ||||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNK---------EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCC---------EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            368999999999999999999877654         899999876422   33456789999999999 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..++..++|||++++++|.+++.+.. .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||+
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~df~~  148 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITDFGT  148 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecCCcc
Confidence            99999999999999999999986654 6999999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCcc------------------ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 014202          249 AKAGPQGDKT------------------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS  310 (429)
Q Consensus       249 a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  310 (429)
                      +.........                  .......|+..|+|||.+.+..++.++||||||+++|++++|..||......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            8865432211                  1222356889999999998888999999999999999999999999754310


Q ss_pred             ccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH----hHHHHH
Q 014202          311 GEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM----DEVVKV  373 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~eil~~  373 (429)
                            .....          ...  .....+...+..+.++|.+||+.||.+||++    .++++.
T Consensus       229 ------~~~~~----------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 ------LTFQK----------ILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ------HHHHH----------HHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                  00000          000  1112223345789999999999999999999    887753

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.8e-39  Score=305.32  Aligned_cols=267  Identities=26%  Similarity=0.316  Sum_probs=197.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||.|+||.||+|.+..++.         .||+|.+......  ....+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGR---------VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV   77 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCc---------EEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence            4689999999999999999999887655         8999998654322  2245678999999999999999999875


Q ss_pred             eCC--------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          170 EDD--------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       170 ~~~--------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      ...        .+++||||+.+ +|...+......+++..+..++.|+++||.|||  +.+|+|+||||+||+++.++.+
T Consensus        78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             cccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCE
Confidence            433        46999999964 787777666667999999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCcc---------ceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 014202          242 KLSDFGLAKAGPQGDKT---------HVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG  311 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  311 (429)
                      +|+|||++.........         .......|++.|+|||.+.+. .++.++|||||||++|||++|.+||.+.....
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~  234 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID  234 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999764332111         111234678899999988654 57899999999999999999999997544321


Q ss_pred             cccHHHHHHHHHH--------hhhhhhhhc----CCcccc---CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          312 EQNLVAWARQYLA--------DKRKLYQIV----DPRLEL---NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       312 ~~~~~~~~~~~~~--------~~~~~~~~~----~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ....   ......        ....+....    ......   .........+.++|.+||+.||.+|||+.+++..
T Consensus       235 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         235 QLHL---IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHH---HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1110   000000        000000000    000000   0001123578899999999999999999999863

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.3e-39  Score=310.02  Aligned_cols=267  Identities=22%  Similarity=0.294  Sum_probs=197.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|.+.+.||.|+||.||+|.+..++.         .||+|.+........+.+.+|+.+|+.++||||+++++.+...
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~---------~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~   74 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDK---------RVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS   74 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCc---------EEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence            4689999999999999999999887655         8999999776656667788999999999999999999876544


Q ss_pred             --------------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-
Q 014202          172 --------------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-  236 (429)
Q Consensus       172 --------------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~-  236 (429)
                                    ...|+||||+. ++|.+++...  .+++..+..++.|++.||.|||  ..||+||||||+||+++ 
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nili~~  149 (342)
T cd07854          75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINT  149 (342)
T ss_pred             ccccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcC
Confidence                          35789999996 5898877543  5889999999999999999999  89999999999999997 


Q ss_pred             CCCCEEEccccCcccCCCCCcc-ceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN  314 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  314 (429)
                      .++.++|+|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||....+.....
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~  229 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ  229 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            4567899999999764321111 11122467889999998764 567889999999999999999999997654321111


Q ss_pred             HHHH---------HHHHHHhhhhhhh--hcCCccc-cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          315 LVAW---------ARQYLADKRKLYQ--IVDPRLE-LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       315 ~~~~---------~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ....         .............  ....... .......+.++.+|+.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0000         0000000000000  0000000 0001123467889999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=306.42  Aligned_cols=265  Identities=26%  Similarity=0.341  Sum_probs=197.5

Q ss_pred             cCCCC-CCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--------------hHHHHHHHHHHhcC
Q 014202           92 TGNFR-PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--------------HREWVAEVDFLGQL  156 (429)
Q Consensus        92 ~~~y~-~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l  156 (429)
                      .++|. +.+.||.|+||.||+|.+..+++         .||||.+.......              ...+.+|+.+|+.+
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   77 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGK---------IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI   77 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCC---------eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence            35676 45789999999999999876654         89999986543221              12477899999999


Q ss_pred             CCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       157 ~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      +||||+++++++..++..++||||+. |+|.+++... ..+++.....++.|++.||.|||  +.+|+|+||+|+||+++
T Consensus        78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~nill~  153 (335)
T PTZ00024         78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFIN  153 (335)
T ss_pred             CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHeEEC
Confidence            99999999999999999999999996 5899888554 35899999999999999999999  89999999999999999


Q ss_pred             CCCCEEEccccCcccCCCCC------------ccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCC
Q 014202          237 SEYNAKLSDFGLAKAGPQGD------------KTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRS  303 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~p  303 (429)
                      .++.++|+|||++.......            .........+++.|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999997643110            01111224568899999998764 468999999999999999999999


Q ss_pred             CCCCCCCccccHHHHHHHHHHhhhh--hhhh--------cCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHH
Q 014202          304 MDKKRPSGEQNLVAWARQYLADKRK--LYQI--------VDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV  370 (429)
Q Consensus       304 f~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ei  370 (429)
                      |.......   ....+.........  ....        ......   .......+..+.++|.+||+.||++||+++++
T Consensus       234 ~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        234 FPGENEID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             CCCCCHHH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            97654321   11111110000000  0000        000000   00011234678999999999999999999999


Q ss_pred             HH
Q 014202          371 VK  372 (429)
Q Consensus       371 l~  372 (429)
                      +.
T Consensus       311 l~  312 (335)
T PTZ00024        311 LK  312 (335)
T ss_pred             hc
Confidence            97

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.4e-38  Score=303.63  Aligned_cols=261  Identities=22%  Similarity=0.282  Sum_probs=192.8

Q ss_pred             Cccccc--CceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeE
Q 014202           99 SILGEG--GFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        99 ~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      ..||+|  +||+||+|++..++.         .||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGT---------LVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCc---------EEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence            456666  999999999877655         999999875532  2346678999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          175 LLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      ++||||+.+++|.+++.+. ...+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.++++||+.+....
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~  152 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLV  152 (328)
T ss_pred             EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence            9999999999999988654 335889999999999999999999  8999999999999999999999999998654322


Q ss_pred             CCCccc-e----eeeccccccccChhhhhcC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH------
Q 014202          254 QGDKTH-V----STRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR------  320 (429)
Q Consensus       254 ~~~~~~-~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~------  320 (429)
                      ...... .    .....++..|+|||++.+.  .++.++|||||||++|+|++|..||.......  .......      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~  230 (328)
T cd08226         153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSP  230 (328)
T ss_pred             ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCC
Confidence            211100 0    0112345679999998763  47899999999999999999999997543110  0000000      


Q ss_pred             ----------HHHHhh-hhh----h----------hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          321 ----------QYLADK-RKL----Y----------QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       321 ----------~~~~~~-~~~----~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                                ...... ...    .          ...............+..+.+|+.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                      000000 000    0          000011111223345678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-40  Score=308.19  Aligned_cols=245  Identities=27%  Similarity=0.335  Sum_probs=201.9

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL  175 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  175 (429)
                      .++||+|.||+||-|.++.++.         .||||++.+-...  ....+.+|+.||+.++||.||.+...|+..+.+|
T Consensus       569 devLGSGQFG~VYgg~hRktGr---------dVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGR---------DVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HhhccCCcceeeecceecccCc---------eeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            4789999999999999998755         9999999876443  3356889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CCEEEccccCcccC
Q 014202          176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAG  252 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~DFg~a~~~  252 (429)
                      +|||.+.|.=|+-+|......+++.....++.||+.||.|||  .++|+|+||||+|||+...   -.+||||||+|+..
T Consensus       640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence            999999665555556666778999999999999999999999  8999999999999999554   45999999999986


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ...   ......+|||.|+|||++.++.|...-|+||.|||+|--|+|..||.......++                .+.
T Consensus       718 gEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ----------------IQN  778 (888)
T KOG4236|consen  718 GEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ----------------IQN  778 (888)
T ss_pred             chh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH----------------hhc
Confidence            543   2334579999999999999999999999999999999999999999654321111                000


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...-.+.....+.+....+||..+|+..-.+|-+.+..+.
T Consensus       779 AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  779 AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            0111122223456678999999999999999999998876

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.4e-38  Score=298.93  Aligned_cols=259  Identities=27%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----hhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      +|++.+.||+|+||.||+|+......      .+..||||.+.....    .....+..|+.++.++ +||||+++++.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~   74 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHD------AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF   74 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecccc------CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence            47888999999999999998654322      245899999875422    2235678899999999 599999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..+...++||||+.+++|.+++... ..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||+
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~dfg~  151 (288)
T cd05583          75 QTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGL  151 (288)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEECcc
Confidence            9999999999999999999988654 35889999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +......... ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.......  .........    
T Consensus       152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~----  224 (288)
T cd05583         152 SKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRI----  224 (288)
T ss_pred             cccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHH----
Confidence            8765432211 122356899999999987654  7889999999999999999999996432211  111111110    


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                         .. ...    ..+...+..+.+++.+||+.||++|||+.++.+.|..
T Consensus       225 ---~~-~~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         225 ---LK-SKP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ---Hc-cCC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence               00 011    1122234678999999999999999998877665543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9.3e-40  Score=290.66  Aligned_cols=272  Identities=23%  Similarity=0.290  Sum_probs=200.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..|+++..||+|.||.||+|....++..-     ...+|||.++.....  --....+|+.+++.|+||||+.+..+|..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-----~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKR-----TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCccc-----chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            46999999999999999999766554311     237999999765221  12456799999999999999999999887


Q ss_pred             -CCeEEEEEEecCCCChHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC----CCE
Q 014202          171 -DDQRLLVYEFMTRGSLENHLFRR----TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE----YNA  241 (429)
Q Consensus       171 -~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~~~  241 (429)
                       +..+++++||.+. +|..+|.-.    ...++...+..|+.||+.|+.|||  +.=|+||||||.|||+..+    |.|
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--~NWvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--SNWVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--hhheeeccCCcceEEEeccCCccCee
Confidence             7889999999976 888887432    346889999999999999999999  8889999999999999776    899


Q ss_pred             EEccccCcccCCCCCccc-eeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc-----
Q 014202          242 KLSDFGLAKAGPQGDKTH-VSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN-----  314 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-----  314 (429)
                      ||+|||+++.+...-... .....+-|..|.|||++.|. .|+.+.||||.|||+.||++-.+.|.+........     
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            999999999875543322 22346789999999999875 68999999999999999999999997654322111     


Q ss_pred             -HHHHHHHHHHh--------hhhh------hhhcCCccccCC--------CHHHHHHHHHHHHHcccCCCCCCCCHhHHH
Q 014202          315 -LVAWARQYLAD--------KRKL------YQIVDPRLELNY--------SLKGVQKVSQLAYNCLSRDPKSRPSMDEVV  371 (429)
Q Consensus       315 -~~~~~~~~~~~--------~~~~------~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rpt~~eil  371 (429)
                       ....+-..+..        ..++      ...+......+.        ....++...+|+.+||++||.+|.|+++.+
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl  335 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL  335 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence             11111111100        0000      000000000000        000123478999999999999999999999


Q ss_pred             H
Q 014202          372 K  372 (429)
Q Consensus       372 ~  372 (429)
                      +
T Consensus       336 e  336 (438)
T KOG0666|consen  336 E  336 (438)
T ss_pred             c
Confidence            7

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-38  Score=307.19  Aligned_cols=260  Identities=25%  Similarity=0.334  Sum_probs=201.8

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|++.+.||.|+||.||+|.+..++.         .||||.+....  ....+.+.+|+.+++.++||||+++++++...
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGR---------KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP   71 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCc---------EEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence            58899999999999999999876644         89999987643  33446788999999999999999999998877


Q ss_pred             C-----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          172 D-----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       172 ~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      .     ..|+||||+. ++|.+++.+.. .+++..+..++.|++.||.|||  +.||+|+||||+|||++.++.++|+||
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          72 SPEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             CcccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEccc
Confidence            5     7899999996 58988886544 7899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCcc-ceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          247 GLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       247 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |++......... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.......      .......
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~  221 (330)
T cd07834         148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID------QLNLIVE  221 (330)
T ss_pred             CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH------HHHHHHH
Confidence            999875443210 112335688999999999877 78999999999999999999999997654211      0110000


Q ss_pred             hhh-------------hhhhh---cCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 DKR-------------KLYQI---VDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ~~~-------------~~~~~---~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...             .....   ......   .......+..+.++|.+||+.||.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             hcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            000             00000   000000   0001123567899999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.5e-38  Score=298.15  Aligned_cols=255  Identities=28%  Similarity=0.373  Sum_probs=198.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----hhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      +|++.+.||.|+||.||+|......      .+|..||+|.+.....    ...+.+.+|+.+|.++ +|+||+++++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~------~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH------DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   74 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC------CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence            4888999999999999999875321      1356899999875422    2335678899999999 599999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..+...|+||||+++++|.+++.... .+++..+..++.|++.||.|||  +.+++||||+|+|||++.++.++|+|||+
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~  151 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGL  151 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEeeCcc
Confidence            99999999999999999999986553 5889999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +........ .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.......  .........    
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~----  224 (290)
T cd05613         152 SKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRI----  224 (290)
T ss_pred             ceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHh----
Confidence            976533221 112235689999999998753  46789999999999999999999996432211  111111110    


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                            ....  ..++...+..+.+++.+||+.||++||     ++.+++.
T Consensus       225 ------~~~~--~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         225 ------LKSE--PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ------hccC--CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                  0000  112223457889999999999999997     6777766

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.2e-38  Score=304.34  Aligned_cols=265  Identities=24%  Similarity=0.299  Sum_probs=194.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCC-CcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLH-HPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  170 (429)
                      +|++.+.||+|+||.||+|++..+..       +..||+|.+....  ....+.+.+|+.+++++. ||||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSE-------EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCc-------CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            47888999999999999999876511       3489999986432  223456788999999994 9999999987543


Q ss_pred             C----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          171 D----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       171 ~----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      .    ...|+++||+. ++|.+.+... ..+++..+..++.|++.||.|||  ..||+||||||+|||++.++.++|+||
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEeCcC
Confidence            2    45788999885 6898888544 46899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCcc--ceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          247 GLAKAGPQGDKT--HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       247 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |++.........  .......|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.......   ........+
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~  226 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVL  226 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHh
Confidence            999865432211  11223578999999998765 468999999999999999999999997643211   100000000


Q ss_pred             ------------Hhhh-hhhhhcCC--cccc-CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ------------ADKR-KLYQIVDP--RLEL-NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ------------~~~~-~~~~~~~~--~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                                  .... ........  .... ......+..+.+++.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                        0000 00000000  0000 001112467999999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.2e-38  Score=300.38  Aligned_cols=262  Identities=23%  Similarity=0.276  Sum_probs=191.7

Q ss_pred             CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           96 RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        96 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      .+++.+|.|++  ||.++...++         ..||||++...  .......+.+|+.+|+.++||||+++++++..++.
T Consensus         5 ~i~~~~~~~~~--v~~~~~~~~~---------~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   73 (314)
T cd08216           5 LIGKCFEDLMI--VHLAKHKPTN---------TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE   73 (314)
T ss_pred             hhhHhhcCCce--EEEEEecCCC---------CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence            34444555555  4555544443         48999999765  23445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          174 RLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .+++|||+++|+|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||.+...
T Consensus        74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCccceee
Confidence            99999999999999998754 345889999999999999999999  899999999999999999999999999988754


Q ss_pred             CCCCcc-----ceeeeccccccccChhhhhc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH--
Q 014202          253 PQGDKT-----HVSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL--  323 (429)
Q Consensus       253 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--  323 (429)
                      ......     .......++..|+|||++.+  ..++.++|||||||++|||++|..||.......  ...+......  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~  229 (314)
T cd08216         152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPC  229 (314)
T ss_pred             ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCcc
Confidence            322111     11122457788999999875  358899999999999999999999997543211  1111000000  


Q ss_pred             --------Hhhhhhhh----hcC----CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 --------ADKRKLYQ----IVD----PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 --------~~~~~~~~----~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                              ........    ..+    ...........+.++.+|+.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                    00000000    000    00111122334578899999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=299.81  Aligned_cols=242  Identities=29%  Similarity=0.400  Sum_probs=202.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh---HHHHHHHHHHhcCC-CcceeeEEeE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH---REWVAEVDFLGQLH-HPNLVKLIGY  167 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~-hpnIv~~~~~  167 (429)
                      ..+|..+.+||+|+||+|.+|..+.+.+         .||||+++++.....   +--+.|.++|.... -|.++.++..
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdE---------LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDE---------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcch---------hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            4578999999999999999998887766         899999988754322   23357888887764 7899999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      |+.-+.+|+||||+.||+|--++.+-+ .+.+..+..++..|+-||-+||  ++|||+||||.+|||+|.+|++||+|||
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi~DFG  495 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFG  495 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEeeecc
Confidence            999999999999999999998886655 5889999999999999999999  9999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +++...-...+  ...++|||.|+|||++...+|+..+|+||+||+||||+.|++||++.....   +            
T Consensus       496 mcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---l------------  558 (683)
T KOG0696|consen  496 MCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L------------  558 (683)
T ss_pred             cccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---H------------
Confidence            99875443332  345899999999999999999999999999999999999999998754311   1            


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP  365 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  365 (429)
                       +..+.+..  ..++...+.+..++.+..|...|.+|.
T Consensus       559 -F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  559 -FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence             11122222  234555668899999999999999995

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-38  Score=304.57  Aligned_cols=269  Identities=23%  Similarity=0.318  Sum_probs=201.4

Q ss_pred             cHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcce
Q 014202           84 TFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNL  161 (429)
Q Consensus        84 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI  161 (429)
                      ...++....++|.+.+.||+|+||.||+|.+..++.         .||+|++....  ......+.+|+.++++++||||
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i   78 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL---------RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV   78 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCe---------EEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc
Confidence            345566778999999999999999999999876654         89999987542  2234567889999999999999


Q ss_pred             eeEEeEEEeC------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          162 VKLIGYCIED------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       162 v~~~~~~~~~------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      +++++++...      ...|++++++ |++|.+++...  .+++..+..++.|++.||.|||  +.+|+||||||+||++
T Consensus        79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll  153 (345)
T cd07877          79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAV  153 (345)
T ss_pred             cceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEE
Confidence            9999987643      3467888877 78998877543  4899999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN  314 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  314 (429)
                      +.++.++|+|||++......     .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..........
T Consensus       154 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  228 (345)
T cd07877         154 NEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK  228 (345)
T ss_pred             cCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999998764321     123578899999998876 568899999999999999999999996543211100


Q ss_pred             HHHHHHHHHHhh------------hhhhhhcCCccccCC---CHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          315 LVAWARQYLADK------------RKLYQIVDPRLELNY---SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       315 ~~~~~~~~~~~~------------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        ..........            ......+.......+   ....+..+.++|.+||+.||.+||++.+++..
T Consensus       229 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         229 --LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             --HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence              0000000000            000000000000000   01234678999999999999999999999873

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-38  Score=306.55  Aligned_cols=267  Identities=22%  Similarity=0.314  Sum_probs=196.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||+|+||.||+|.+..++.         .||||.+.....  .....+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGE---------KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCc---------EEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            4789999999999999999999876654         899999875421  22346789999999999999999999887


Q ss_pred             eCC------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          170 EDD------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       170 ~~~------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      ...      .+|+||||+. .+|..++   ...+++..+..++.|++.||+|||  ..+|+||||||+|||++.++.++|
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             ccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEE
Confidence            543      4689999985 4777654   235889999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH---
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA---  319 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~---  319 (429)
                      +|||+++......     ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.............   
T Consensus       159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  233 (342)
T cd07879         159 LDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  233 (342)
T ss_pred             eeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999997643211     23467889999999876 46889999999999999999999999764321110000000   


Q ss_pred             -----HHHHHh--hhhhhhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCc
Q 014202          320 -----RQYLAD--KRKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQ  378 (429)
Q Consensus       320 -----~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~  378 (429)
                           ......  ...............   .....+..+.+||.+||+.||.+||++.+++.  +++.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                 000000  000000000000000   00123467889999999999999999999995  354443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.4e-38  Score=342.59  Aligned_cols=261  Identities=31%  Similarity=0.528  Sum_probs=206.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ..|...++||+|+||.||+|.+..++.         .||||.+......    ...|+.+|++++|||||++++++.+++
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~  756 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGM---------QFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK  756 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCc---------EEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence            457788899999999999999876544         8999998654321    235688999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC-CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG-SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..|+||||+++|+|.+++.    .+++..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. ||....
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            9999999999999999984    378999999999999999999943 4699999999999999998888775 665543


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ....      ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......|....... .....
T Consensus       832 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~  903 (968)
T PLN00113        832 LCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDM  903 (968)
T ss_pred             cccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhh
Confidence            2111      123688999999999999999999999999999999999999954322 234455555433221 22333


Q ss_pred             hcCCcccc--CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          332 IVDPRLEL--NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       332 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      .+++.+..  ........++.+++.+||+.||++||++.|+++.|+.+..
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            44444422  2334555678899999999999999999999999987644

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-38  Score=305.19  Aligned_cols=264  Identities=22%  Similarity=0.294  Sum_probs=197.7

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ...++|.+.+.||+|+||.||+|.+..++.         .||||.+....  ......+.+|+.+|++++||||++++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGA---------KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV   82 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCc---------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeee
Confidence            356789999999999999999999877654         89999986532  2223567899999999999999999999


Q ss_pred             EEeCC------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          168 CIEDD------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       168 ~~~~~------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      +..+.      ..++||||+ |++|.+++..  ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07880          83 FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDCEL  157 (343)
T ss_pred             ecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCE
Confidence            87654      358999998 7799888754  35899999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH-----
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL-----  315 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~-----  315 (429)
                      +|+|||++......     .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........     
T Consensus       158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07880         158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT  232 (343)
T ss_pred             EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999864322     122467899999999876 4588999999999999999999999975432110000     


Q ss_pred             ----HHHHHHHHHh-hhhhhhhcCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          316 ----VAWARQYLAD-KRKLYQIVDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       316 ----~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          ..+....... .......+.....   .......+..+.++|.+||+.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                0000000000 0000000000000   0011123467899999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=293.68  Aligned_cols=258  Identities=25%  Similarity=0.330  Sum_probs=196.2

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcC---CCcceeeEEeEEE
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQL---HHPNLVKLIGYCI  169 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~  169 (429)
                      |++.+.||.|+||.||+|.+..++.         .||+|.+......  ....+.+|+.+++++   +||||+++++++.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGR---------FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCC---------EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            6778899999999999999876544         8999999754322  224566788777666   5999999999998


Q ss_pred             eCCe-----EEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          170 EDDQ-----RLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       170 ~~~~-----~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      ..+.     .+++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||  ..+++|+||+|+||+++.++.++|
T Consensus        72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~~l  148 (287)
T cd07838          72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKI  148 (287)
T ss_pred             eccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCEEE
Confidence            8877     8999999964 8988886543 35899999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      +|||++........   .....++..|+|||++.+..++.++|||||||++|+|++|.+||.......      ......
T Consensus       149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~------~~~~~~  219 (287)
T cd07838         149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD------QLDKIF  219 (287)
T ss_pred             eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH------HHHHHH
Confidence            99999977543221   122457889999999998899999999999999999999999997543211      111111


Q ss_pred             Hhhh---hh---------hhhcCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          324 ADKR---KL---------YQIVDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       324 ~~~~---~~---------~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ....   ..         .........   .......+..+.++|.+||+.||.+||++.+++..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         220 DVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             HHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            1000   00         000000000   01112345778899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.8e-38  Score=304.12  Aligned_cols=266  Identities=25%  Similarity=0.317  Sum_probs=199.3

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEe
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~  166 (429)
                      ...+++|.+.+.||.|+||.||+|.+..++.         .||+|.+....  ....+.+..|+.+++.++||||+++++
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   76 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQ---------NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD   76 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCC---------EEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence            3456789999999999999999999887655         89999886432  223456789999999999999999999


Q ss_pred             EEEe-CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          167 YCIE-DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       167 ~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      ++.. ....|+||||+ +++|..++...  ++++..+..++.|++.||.|||  ..+|+||||+|+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~~l~d  151 (328)
T cd07856          77 IFISPLEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICD  151 (328)
T ss_pred             eEecCCCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCEEeCc
Confidence            8876 55789999998 66898877543  4788888999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH--------
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV--------  316 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~--------  316 (429)
                      ||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||............        
T Consensus       152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  226 (328)
T cd07856         152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP  226 (328)
T ss_pred             cccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9998753221     122467889999998765 56899999999999999999999999754321110000        


Q ss_pred             -HHHHHHHHh-hhhhhhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          317 -AWARQYLAD-KRKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       317 -~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       ++....... ...+...........   .....+..+.++|.+||+.+|++||++.+++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             000000000 000000000000000   011234789999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=263.55  Aligned_cols=264  Identities=25%  Similarity=0.296  Sum_probs=202.5

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +|.-.++||+|.||+||+|++.++.+         .||+|.+..+..  ......++|+-+|+.|+|.|||+++++...+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~e---------ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHE---------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD   73 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccc---------eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence            46678899999999999999988766         899999976632  2345678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..+.+|+||| ..+|..+...-++.++...+..++.|++.||.++|  ++++.||||||.|.||+.+|.+||+|||+++.
T Consensus        74 kkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch--shnvlhrdlkpqnllin~ngelkladfglara  150 (292)
T KOG0662|consen   74 KKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH--SHNVLHRDLKPQNLLINRNGELKLADFGLARA  150 (292)
T ss_pred             ceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh--hhhhhhccCCcceEEeccCCcEEecccchhhh
Confidence            9999999999 45999999888888999999999999999999999  89999999999999999999999999999997


Q ss_pred             CCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHH-hhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLA-DKRK  328 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  328 (429)
                      +.-..  ......+-|..|.+|.++.+. -|+...|+||.||++.|+.. |.+.|.+......  +....+..-. ....
T Consensus       151 fgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~  226 (292)
T KOG0662|consen  151 FGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQ  226 (292)
T ss_pred             cCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCcccc
Confidence            54332  223345779999999999876 47899999999999999987 6666665432211  1111111000 0000


Q ss_pred             h---hhhcCCccccCC---------CHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 L---YQIVDPRLELNY---------SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~---~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .   .+.-|...-..+         -+.....-++|+.++|.-+|.+|.++++.++.
T Consensus       227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            0   011111000000         11222345799999999999999999998873

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.9e-38  Score=293.72  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=196.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCC---CC--chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP---DG--LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~---~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      +|.+.+.||+|+||.||+|.+..++.         .+++|.++.   ..  ......+..|+.+++.++||||+++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVA---------EERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF   71 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCC---------cceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence            58899999999999999998876543         445555432   21  12234566899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      ......++||||+++++|.+++..   ....+++..++.++.|++.||.|||  +.+++|+||+|+||+++. +.++|+|
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d  148 (260)
T cd08222          72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGD  148 (260)
T ss_pred             hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecc
Confidence            999999999999999999988854   3456899999999999999999999  899999999999999975 5799999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ||++........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ......    
T Consensus       149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~----  216 (260)
T cd08222         149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR----  216 (260)
T ss_pred             cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH----
Confidence            999876533221  22235688999999999888889999999999999999999999964321      111111    


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                            ..... ....+...+.++.++|.+||..||++||++.++++.
T Consensus       217 ------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         217 ------IVEGP-TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ------HHcCC-CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                  11111 111233456789999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=289.11  Aligned_cols=246  Identities=28%  Similarity=0.419  Sum_probs=195.6

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhc-CCCcceeeEEeEEEeCCeEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQ-LHHPNLVKLIGYCIEDDQRL  175 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~  175 (429)
                      +..||.|+||+|++-.++..++         .+|||.+..... ..+++++.|.+...+ -++||||++||+...++..|
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~---------~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGK---------LMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCc---------EEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            5689999999999999887655         999999987765 556778888886544 46999999999999999999


Q ss_pred             EEEEecCCCChHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          176 LVYEFMTRGSLENHLFR----RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      |.||+|. -+|+.+...    ....+++..+-.|....+.||.||-. ...|||||+||+|||+|..|.|||||||++..
T Consensus       140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            9999994 477654422    34568999999999999999999975 67899999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhh--cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +..   .-..+...|...|||||-+.  +..|+-++||||||++|||+.||+.|+.++..     +.+          ++
T Consensus       218 Lv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfe----------ql  279 (361)
T KOG1006|consen  218 LVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFE----------QL  279 (361)
T ss_pred             HHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHH----------HH
Confidence            432   22334468999999999986  34589999999999999999999999987542     111          11


Q ss_pred             hhhc--CCc-cccC-CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIV--DPR-LELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~--~~~-~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .+.+  +++ +... .....+..+..+|.-||.+|-.+||.+.++++
T Consensus       280 ~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  280 CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1111  111 1111 12345678999999999999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=310.74  Aligned_cols=242  Identities=25%  Similarity=0.292  Sum_probs=199.3

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .+..|.+...+|.|+|+.|-.+.+..+++         ..++|++.....    +..+|+.++... +||||+++++.+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~---------~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~  386 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQ---------EPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYE  386 (612)
T ss_pred             cchhhccccccCCCCccceeeeecccccc---------chhheecccccc----ccccccchhhhhcCCCcceeecceec
Confidence            35678888899999999999998887765         899999976622    223577666665 5999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-cCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL-DSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill-~~~~~~kl~DFg~  248 (429)
                      +..+.|+|||++.|+.|.+.+.....  ...++..|+.+|+.|+.|||  .+|||||||||+|||+ +..++++|+|||.
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             CCceeeeeehhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEEech
Confidence            99999999999999999888866543  23788889999999999999  8999999999999999 6899999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ++.....     ....+-|..|.|||++....|+.++||||||++||+||+|..||......     .           .
T Consensus       463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~-----------e  521 (612)
T KOG0603|consen  463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----I-----------E  521 (612)
T ss_pred             hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----H-----------H
Confidence            9875443     22357788999999999999999999999999999999999999765432     1           1


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +...+   ....+....++.+++||.+||+.||.+||++.+++..
T Consensus       522 i~~~i---~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  522 IHTRI---QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HHHhh---cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            11111   1112225567899999999999999999999999874

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=297.51  Aligned_cols=262  Identities=29%  Similarity=0.396  Sum_probs=201.3

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      |++.+.||+|+||.||+|.+..+++         .||+|.+....  ......+..|+.++++++|+||+++++++...+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCc---------EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence            5677899999999999999887655         89999998653  223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+. ++|.+++.+....+++..+..++.|++.||.|||  ..+|+|+||+|+||++++++.++|+|||++...
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence            9999999997 5999999776557899999999999999999999  899999999999999999999999999999865


Q ss_pred             CCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh--h---
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD--K---  326 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~---  326 (429)
                      .....  ......++..|+|||.+.+. .++.++|||||||++|||++|..||........   ...+...+..  .   
T Consensus       149 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  223 (282)
T cd07829         149 GIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESW  223 (282)
T ss_pred             CCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHH
Confidence            43221  12224567889999998766 789999999999999999999999976442111   1101000000  0   


Q ss_pred             ---hhh--hhhcCCcccc----CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 ---RKL--YQIVDPRLEL----NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ---~~~--~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         ..+  .....+....    ......+..+.++|.+||+.||++||++.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence               000  0000000000    0011125679999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=295.97  Aligned_cols=261  Identities=28%  Similarity=0.375  Sum_probs=197.9

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  172 (429)
                      |.+.+.||.|+||.||+|....++.         .|+||.+..... .......+|+..+.+++ ||||+++++++..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGE---------LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCc---------EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence            6778999999999999999877654         899999865432 22234467999999999 999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+ +|+|.+++.... ..+++..+..++.|++.+|.|||  +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~  148 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLARE  148 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeeccccee
Confidence            999999999 789999886654 46899999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhh-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH------
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA------  324 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------  324 (429)
                      ......   .....|+..|+|||++. +..++.++|+||||+++|+|++|.+||..........   .....+.      
T Consensus       149 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~  222 (283)
T cd07830         149 IRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY---KICSVLGTPTKQD  222 (283)
T ss_pred             ccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH---HHHHhcCCCChhh
Confidence            533221   12356889999999875 4457899999999999999999999997654321100   0000000      


Q ss_pred             --hhhhhhhhcCCcccc-------CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          325 --DKRKLYQIVDPRLEL-------NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       325 --~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        ....+....+.....       ......+..+.++|.+||+.||++||++.|++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence              000000000000000       0001124679999999999999999999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=293.18  Aligned_cols=273  Identities=24%  Similarity=0.334  Sum_probs=208.3

Q ss_pred             cccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-C-c
Q 014202           82 QFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-H-P  159 (429)
Q Consensus        82 ~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p  159 (429)
                      .+.++.....+.+|.+...+|+|.||.|-.+++..++.         .||||+++.-. .-.+..+-|+++|.++. + |
T Consensus        78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~---------~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP  147 (415)
T KOG0671|consen   78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKE---------HVALKIIKNVD-KYREAALIEIEVLQKINESDP  147 (415)
T ss_pred             eEEEEeccccccceehhhhhcCCcccceEEEeecCCCc---------eehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCC
Confidence            45555566668999999999999999999999988744         89999986331 22344578999999994 2 2


Q ss_pred             ----ceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          160 ----NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       160 ----nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                          -+|.+.+||...++.+||+|.+ |-++.++|.++ -.+++...+..++.|+++++++||  +.+++|-||||+|||
T Consensus       148 ~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENIL  224 (415)
T KOG0671|consen  148 NGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENIL  224 (415)
T ss_pred             CCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEE
Confidence                3788889999999999999988 77999999775 457999999999999999999999  999999999999999


Q ss_pred             EcC--------------------CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHH
Q 014202          235 LDS--------------------EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  294 (429)
Q Consensus       235 l~~--------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  294 (429)
                      +-.                    +..|+|+|||.|+......     ...+.|..|.|||++.+-.++.++||||+||||
T Consensus       225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL  299 (415)
T KOG0671|consen  225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL  299 (415)
T ss_pred             EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence            831                    3459999999998743322     346889999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCccccHHHHHHHH----HHhhh---hh-----------------hhhcCCcccc----CCCHHHH
Q 014202          295 LEILTGRRSMDKKRPSGEQNLVAWARQY----LADKR---KL-----------------YQIVDPRLEL----NYSLKGV  346 (429)
Q Consensus       295 ~ell~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~---~~-----------------~~~~~~~~~~----~~~~~~~  346 (429)
                      +|+.+|...|......+...+++.+...    +....   +.                 ....++..++    .......
T Consensus       300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~  379 (415)
T KOG0671|consen  300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH  379 (415)
T ss_pred             EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence            9999999999876643322222211100    00000   00                 0000000000    0112334


Q ss_pred             HHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          347 QKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       347 ~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .+|.+|+++||..||.+|+|+.|++.
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhc
Confidence            67999999999999999999999987

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=309.20  Aligned_cols=243  Identities=25%  Similarity=0.359  Sum_probs=205.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .+++++..||-||||.|=++..+....         .+|+|++++...   ...+.+..|-.||...+.|.||++|-.|.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~---------~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr  490 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKA---------TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR  490 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccch---------HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence            456677889999999999988776543         589999877643   33456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++.++|++||-|-||.|...|..++ .+++.....++.-+++|++|||  .+|||+|||||+|.++|.+|-+||.|||+|
T Consensus       491 d~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~KLVDFGFA  567 (732)
T KOG0614|consen  491 DSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLKLVDFGFA  567 (732)
T ss_pred             cchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceEEeehhhH
Confidence            9999999999999999999997665 5899999999999999999999  999999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +....+..+.   .+||||.|.|||++.+...+.++|.||||+++|||++|.+||.+..+....+++             
T Consensus       568 Kki~~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------------  631 (732)
T KOG0614|consen  568 KKIGSGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------------  631 (732)
T ss_pred             HHhccCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------------
Confidence            9876665443   489999999999999999999999999999999999999999987653322221             


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS  366 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  366 (429)
                      .+-++   ...++........+||+++...+|.+|..
T Consensus       632 LkGid---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  632 LKGID---KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             Hhhhh---hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            11111   12334455577889999999999999965

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-38  Score=306.41  Aligned_cols=260  Identities=23%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|.+.+.||+|+||.||+|++..++.         .||+|.+....  ......+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGR---------KVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCc---------EEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            45789999999999999999999987654         89999986542  22345677899999999999999999988


Q ss_pred             EeCCe------EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IEDDQ------RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~~~~------~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ...+.      .++|+||+ +++|.+++..  ..+++..+..++.|++.||.|||  +.||+||||||+||+++.++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEE
Confidence            76654      89999998 6799998864  35899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||........   ......
T Consensus       159 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~  230 (343)
T cd07851         159 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMN  230 (343)
T ss_pred             Ecccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHH
Confidence            9999999865332     223568889999998865 3678999999999999999999999975432111   110000


Q ss_pred             HHHh-h------------hhhhhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLAD-K------------RKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~-~------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .... .            ..+...+.......   .....+..+.++|.+||+.||++|||+.+|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000 0            00000000000000   00123578999999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-39  Score=307.00  Aligned_cols=245  Identities=26%  Similarity=0.323  Sum_probs=200.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..|..++.||-|+||.|.+++..+|..         .||.|.+.+.+.-   ....++.|-.||..-..+-||+||..|+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~---------lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ  699 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRA---------LYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ  699 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhh---------HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence            567778999999999999999888765         7999999776432   2345678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++.+|+||+|++||++-.+|.+.+. |++..+..++..+..|+++.|  ..|+|||||||+|||||.+|+|||+||||+
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeeecccc
Confidence            99999999999999999999988774 888889999999999999999  999999999999999999999999999998


Q ss_pred             ccCC---------CCCcc-------------------------------ceeeeccccccccChhhhhcCCCCCccchhh
Q 014202          250 KAGP---------QGDKT-------------------------------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYS  289 (429)
Q Consensus       250 ~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  289 (429)
                      .-+.         .++..                               ......+||+.|+|||++....|+.-+|+||
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws  856 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS  856 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence            6321         10000                               0011268999999999999999999999999


Q ss_pred             hHHHHHHHHhCCCCCCCCCCCccccHH-HHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014202          290 FGVVLLEILTGRRSMDKKRPSGEQNLV-AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP  365 (429)
Q Consensus       290 lG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  365 (429)
                      .|||||||+.|++||....+.+.+..+ .|-               ..+...+....+.+..+||.++. -+++.|.
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~---------------~~l~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGETQYKVINWR---------------NFLHIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCcceeeeeehh---------------hccccccccccCHHHHHHHHHHh-cChhhhh
Confidence            999999999999999988887655332 221               11223344455677888888754 5677774

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=312.13  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=215.1

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYC  168 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  168 (429)
                      ..++.|.+.+.||.|.+|.||++++..+++         .+|+|++..+. ....++..|..+|+.+. |||++.+|++|
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~---------~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQ---------LAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCc---------eeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            345679999999999999999999998866         88999987664 33467788999999985 99999999988


Q ss_pred             Ee-----CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IE-----DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~-----~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ..     ++.+|||||||.||+.-|++..- +..+.|..+..|++.++.||.+||  ...++|||||-.|||++.++.||
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEE
Confidence            64     56899999999999999988643 556899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      |+|||++.......  ......+|||.|||||++..     ..|+..+|+||||++..||.-|.+|+....|.       
T Consensus       164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------  234 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------  234 (953)
T ss_pred             Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------
Confidence            99999998764432  23445799999999999863     35778999999999999999999999764431       


Q ss_pred             HHHHHHHhhhhhhhhc-CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          318 WARQYLADKRKLYQIV-DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                               ..++.+. +|++.+..+...++++.++|..||.+|..+||++.+++++
T Consensus       235 ---------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  235 ---------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                     2233333 5666666788899999999999999999999999999983

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-37  Score=325.30  Aligned_cols=146  Identities=29%  Similarity=0.369  Sum_probs=131.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||+|++..++.         .||||++.....   .....+..|+.++..++||||+++++++.
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~---------~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   74 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSK---------LYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ   74 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCc---------EEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            579999999999999999999987654         899999975432   22356789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .....||||||+.|++|.+++.... .+++..++.++.||+.||.|||  ..+|+||||||+||||+.++.+||+|||++
T Consensus        75 ~~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          75 SANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             ECCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            9999999999999999999886543 5889999999999999999999  889999999999999999999999999998


Q ss_pred             c
Q 014202          250 K  250 (429)
Q Consensus       250 ~  250 (429)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-40  Score=285.67  Aligned_cols=266  Identities=26%  Similarity=0.383  Sum_probs=202.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +.|.-..+||+|.||.||+|+...+++         .||+|++..++.  .-....++|+.+|..|+|+|++.+++.|..
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~k---------kvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t   87 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGK---------KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   87 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccc---------hhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence            457778899999999999999988765         899988754321  122456899999999999999999987653


Q ss_pred             C--------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          171 D--------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       171 ~--------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      .        ..+|+||.+|+. +|..+|......++..++..++.+++.||.|+|  ...|+|||+|++|+||+.+|.+|
T Consensus        88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             ccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCCceEE
Confidence            2        357999999976 999999888788999999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCcc--ceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          243 LSDFGLAKAGPQGDKT--HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      |+|||+++.+...+..  ...+.-+-|..|.+||.+.| ..|+++.|||..||++.||++|.+.+.+........++   
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I---  241 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI---  241 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH---
Confidence            9999999765433221  12233466999999999886 47999999999999999999999999876543322222   


Q ss_pred             HHHHH----------hhhhhhhhcCCc-ccc-C--------CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          320 RQYLA----------DKRKLYQIVDPR-LEL-N--------YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       320 ~~~~~----------~~~~~~~~~~~~-~~~-~--------~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .....          +.-.+++.+... +.. .        .+....++..+|+.++|..||.+|+++++++..
T Consensus       242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            11111          011112222100 100 0        011113578899999999999999999999974

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=286.65  Aligned_cols=240  Identities=30%  Similarity=0.412  Sum_probs=196.2

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      ||.|+||.||++.+..+++         .||+|.+......   ....+..|+.++++++||||+++++.+..+...++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGK---------LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECCCCc---------EEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence            6999999999999876544         8999998765432   345788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK  257 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  257 (429)
                      |||+.+++|.+++.... .+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        72 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-  147 (250)
T cd05123          72 LEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-  147 (250)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-
Confidence            99999999999986554 5899999999999999999999  8999999999999999999999999999998754321 


Q ss_pred             cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCcc
Q 014202          258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL  337 (429)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (429)
                       .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      .....          .....  
T Consensus       148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~----------~~~~~--  208 (250)
T cd05123         148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYE----------KILKD--  208 (250)
T ss_pred             -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHH----------HHhcC--
Confidence             112335788999999999888889999999999999999999999965432      11111          11111  


Q ss_pred             ccCCCHHHHHHHHHHHHHcccCCCCCCCCH---hHHHH
Q 014202          338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSM---DEVVK  372 (429)
Q Consensus       338 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~eil~  372 (429)
                      ....+...+..+.+++.+||..||++||++   .++++
T Consensus       209 ~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         209 PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            112233335789999999999999999999   55554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=312.24  Aligned_cols=259  Identities=26%  Similarity=0.405  Sum_probs=217.1

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      .+..++||+|+||+||+|.+.-.++....     +||||++.... .+.-.+++.|+-+|.+|+|||++++++++.... 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKi-----pVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKI-----PVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecc-----eeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            34468999999999999998876654433     89999987653 345678999999999999999999999998776 


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      +.||++|+++|+|.+++..+...+.....+.|..||++||.|||  .+++|||||..+|||+..-..+||.|||+++...
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            77999999999999999998888999999999999999999999  8999999999999999999999999999999876


Q ss_pred             CCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ............-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....                 .+...
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dl  912 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDL  912 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHH
Confidence            6543332222334568999999999999999999999999999999 88998875432                 23333


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      +....++.-+..++.++..++.+||..|++.||+++++...+..+.
T Consensus       913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            3334445566677889999999999999999999999987655443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-37  Score=284.28  Aligned_cols=220  Identities=24%  Similarity=0.256  Sum_probs=178.8

Q ss_pred             cCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCC
Q 014202          104 GGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTR  183 (429)
Q Consensus       104 G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g  183 (429)
                      |.||.||+|++..+++         .||+|.+....     ....|...+....||||+++++++...+..++||||++|
T Consensus         4 g~~~~v~~~~~~~~~~---------~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMDTRTQQ---------TFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEEccCCc---------EEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence            8999999999988765         89999997653     223455555566799999999999999999999999999


Q ss_pred             CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeee
Q 014202          184 GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR  263 (429)
Q Consensus       184 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~  263 (429)
                      |+|.+++.+.. .+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||.+.......     ..
T Consensus        70 ~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~  141 (237)
T cd05576          70 GKLWSHISKFL-NIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DG  141 (237)
T ss_pred             CCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----cc
Confidence            99999886553 5899999999999999999999  8999999999999999999999999999886543321     22


Q ss_pred             ccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCH
Q 014202          264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSL  343 (429)
Q Consensus       264 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ..++..|+|||.+.+..++.++||||||+++|||++|..||.......                      ........+.
T Consensus       142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~~  199 (237)
T cd05576         142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIPE  199 (237)
T ss_pred             CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCcc
Confidence            456778999999988889999999999999999999998875321100                      0000111222


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH
Q 014202          344 KGVQKVSQLAYNCLSRDPKSRPSM  367 (429)
Q Consensus       344 ~~~~~l~~li~~~l~~dP~~Rpt~  367 (429)
                      ..+..+.++|.+||+.||++||++
T Consensus       200 ~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         200 WVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCHHHHHHHHHHccCCHHHhcCC
Confidence            345779999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=316.68  Aligned_cols=267  Identities=29%  Similarity=0.471  Sum_probs=215.2

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCC-CcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLH-HPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~  167 (429)
                      ....+..+.+.||+|.||.|++|.........  ......||||.++.... ...+.+..|+++|+.+. ||||+.++++
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             echhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            33445566779999999999999866433211  11245899999986643 45577899999999995 9999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN  232 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~N  232 (429)
                      +..++..++|+||+..|+|.+++....               ..++..+.+.++.||+.|++||+  +.++|||||..+|
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAARN  448 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhhh
Confidence            999999999999999999999997765               34889999999999999999999  8999999999999


Q ss_pred             eEEcCCCCEEEccccCcccCCCCCccceeeecc--ccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCC
Q 014202          233 ILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV--GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRP  309 (429)
Q Consensus       233 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  309 (429)
                      ||+..+..+||+|||+|+............ ..  -...|||||.+....|+.++|||||||+|||+++ |..||.+...
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999999654433332111 12  2346999999999999999999999999999999 8888875221


Q ss_pred             CccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .                ..+.+.+....+...+..+++++.++++.||+.+|++||++.++.+.|...
T Consensus       528 ~----------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 T----------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             H----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1                112223344445566667789999999999999999999999999988763

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=284.25  Aligned_cols=265  Identities=27%  Similarity=0.415  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhc--CCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ--LHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~  171 (429)
                      ...+.++||+|.||.||+|....           +.||||++..   +..+.|.+|..|...  ++|+||++++++-...
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~-----------~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN-----------RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC-----------ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            35567889999999999998764           3899999964   455677888887766  5799999999987766


Q ss_pred             C----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhC-------CCCCeeeCCCCCCCeEEcCCCC
Q 014202          172 D----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG-------GSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       172 ~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-------~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      +    .++||++|.+.|+|.++|..+.  ++|....+++..++.||+|||.       +...|+|||||..||||..+++
T Consensus       277 t~~~~eywLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  277 TADRMEYWLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             CccccceeEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence            6    7899999999999999997765  7999999999999999999993       3567999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCC-CC-----CccchhhhHHHHHHHHhCCCCCCC-CCCCccc
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LT-----SKSDVYSFGVVLLEILTGRRSMDK-KRPSGEQ  313 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~  313 (429)
                      .-|+|||+|..+..+.........+||.+|||||++.+.. +.     .+.||||+|.|||||++....+.. ..+.-..
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            9999999999887665554455589999999999997642 22     368999999999999996554431 1111110


Q ss_pred             cH---------HHHHHHHHHhhhhhhhhcCCccccC-CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          314 NL---------VAWARQYLADKRKLYQIVDPRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       314 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      -.         .+..+.+..     .+...|.++.. ........+.+.+..||..||+.|.|+.=+-+.+..+..
T Consensus       435 pfe~evG~hPt~e~mq~~VV-----~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVV-----RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHH-----hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            00         111111111     11111111110 111334678999999999999999999888877665544

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=277.34  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=202.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC---CchhhHHHHHHHHHHhcC-CCcceeeEEeE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD---GLQGHREWVAEVDFLGQL-HHPNLVKLIGY  167 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~  167 (429)
                      ..+|+++++||+|+|++|.+++++.+.+         .||+|++++.   ..++..-+..|..+..+- +||.+|-++..
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~q---------iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc  319 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQ---------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC  319 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccce---------eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence            3679999999999999999999998876         8999998765   234445567888888876 59999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      |+.+..+++|.||.+||+|--++.++. .++++.+..+...|+.||.|||  ++|||+||||.+|+|+|..|++||+|+|
T Consensus       320 fqtesrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  320 FQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             hcccceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceeecccc
Confidence            999999999999999999988886554 5999999999999999999999  9999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCC-CccccHHHHHHHHHHhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADK  326 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~  326 (429)
                      +++......  .....++|||.|+|||++.+..|+..+|+|+|||+++||+.|+.||+...- ..+.+...+.-+.+   
T Consensus       397 mcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi---  471 (593)
T KOG0695|consen  397 MCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI---  471 (593)
T ss_pred             hhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH---
Confidence            998643322  234458999999999999999999999999999999999999999974331 22333333322221   


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP  365 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  365 (429)
                            ++..++  ++...+-....+++..|++||.+|.
T Consensus       472 ------lekqir--iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  472 ------LEKQIR--IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ------hhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence                  122222  2223335567788999999999995

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=290.58  Aligned_cols=258  Identities=24%  Similarity=0.384  Sum_probs=202.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-------hhHHHHHHHHHHhcCCCcceeeEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-------GHREWVAEVDFLGQLHHPNLVKLI  165 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~  165 (429)
                      ++|.++.+||+|||+.||+|.+...+.         .||||+-..+...       -.+...+|..|.+.|.||.||++|
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqR---------YvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQR---------YVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhh---------eeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            678899999999999999999887655         8999997655321       124567899999999999999999


Q ss_pred             eEEEeC-CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCCE
Q 014202          166 GYCIED-DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD---SEYNA  241 (429)
Q Consensus       166 ~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~  241 (429)
                      ++|.-+ +.+|-|+|||+|.+|+-+|..+. .+++.++..|+.||+.||.||..-...|||-||||.|||+-   .-|.+
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence            998755 45678999999999998886554 58999999999999999999997678999999999999993   34779


Q ss_pred             EEccccCcccCCCCCcc-----ceeeeccccccccChhhhhcC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcc
Q 014202          242 KLSDFGLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE  312 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  312 (429)
                      ||+|||+++.+......     .......||.+|++||++.-+    ..+.++||||+|||+|..+.|+.||....  ..
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--sQ  690 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--SQ  690 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--hH
Confidence            99999999987554322     234447899999999998632    46889999999999999999999997532  22


Q ss_pred             ccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +++.+        ...+....+  +.++..+-.+.+..++|++||++--++|.+..++..
T Consensus       691 QdILq--------eNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 QDILQ--------ENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHHHh--------hhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            22211        111111111  122223345678999999999999999999888764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.8e-35  Score=301.38  Aligned_cols=264  Identities=21%  Similarity=0.262  Sum_probs=172.4

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeE---
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGY---  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~---  167 (429)
                      ..++|.+.+.||+|+||.||+|++..+..     ..+..||+|.+......  +.+..|  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            45789999999999999999999987622     11448999988643221  111111  1222223333322221   


Q ss_pred             ---EEeCCeEEEEEEecCCCChHHHHhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 014202          168 ---CIEDDQRLLVYEFMTRGSLENHLFRRTIPL-------------------PWSNRIKIALGAAKGLAFLHGGSEPVIY  225 (429)
Q Consensus       168 ---~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~-------------------~~~~~~~~~~qi~~~l~~lH~~~~~ivH  225 (429)
                         ...+...+|||||+.+++|.+++.....+.                   ....+..++.|++.||.|||  +.+|+|
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiH  278 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVH  278 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence               245667899999999999999886543221                   12345679999999999999  899999


Q ss_pred             CCCCCCCeEEcC-CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC----------------------CCC
Q 014202          226 RDFKTSNILLDS-EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG----------------------HLT  282 (429)
Q Consensus       226 rDlkp~Nill~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~  282 (429)
                      |||||+|||++. ++.+||+|||+++....... .......|++.|+|||.+...                      .++
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            999999999985 57899999999986433221 222346899999999976422                      234


Q ss_pred             CccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh---hhhhhcCCcccc------CCCHHHHHHHHHHH
Q 014202          283 SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR---KLYQIVDPRLEL------NYSLKGVQKVSQLA  353 (429)
Q Consensus       283 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~l~~li  353 (429)
                      .++|||||||+||||+++..++..       +...+.........   .......+....      ...........+||
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi  430 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELL  430 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHH
Confidence            567999999999999997766432       11111111110000   011111111000      00001123456899


Q ss_pred             HHcccCCCCCCCCHhHHHHH
Q 014202          354 YNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       354 ~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .+||+.||.+|||+.+++++
T Consensus       431 ~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        431 KSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHccCCcccCCCHHHHhCC
Confidence            99999999999999999983

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=254.65  Aligned_cols=213  Identities=26%  Similarity=0.362  Sum_probs=175.0

Q ss_pred             ccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcC-CCcc
Q 014202           83 FTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-HHPN  160 (429)
Q Consensus        83 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpn  160 (429)
                      +....+....+....+..||+|++|.|=+-++..++.         ..|+|.+... ..+..+.+++|+.+..+. .+|+
T Consensus        36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~---------imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf  106 (282)
T KOG0984|consen   36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGT---------IMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPF  106 (282)
T ss_pred             EecCccccchhhhhhhhhhcCCccchhhheeeccCCe---------EEEEeeehhhcChHHHHHHHHhhhhhccCCCCCe
Confidence            3333344444556667889999999998888887655         9999999765 335567788999976665 6999


Q ss_pred             eeeEEeEEEeCCeEEEEEEecCCCChHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       161 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l---~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      +|.+|+.+......++.||.|. .+|+.+.   .+.+..+++..+-+|+..+++||.|||+ ...+||||+||+||||+.
T Consensus       107 ~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~  184 (282)
T KOG0984|consen  107 TVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINY  184 (282)
T ss_pred             EEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEcc
Confidence            9999999999999999999994 4776554   3467789999999999999999999996 679999999999999999


Q ss_pred             CCCEEEccccCcccCCCCCccceeeeccccccccChhhhh----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 014202          238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP  309 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  309 (429)
                      +|+||+||||++-.+.+.-   ..+...|...|||||.+.    ...|+-++||||||++++||.+++.||+.+..
T Consensus       185 ~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  185 DGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             CCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            9999999999997653321   222256888999999885    34789999999999999999999999987653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=272.56  Aligned_cols=273  Identities=25%  Similarity=0.362  Sum_probs=222.8

Q ss_pred             ccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcce
Q 014202           83 FTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNL  161 (429)
Q Consensus        83 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI  161 (429)
                      -..+++.....+++...++-+|.||.||.|.+.+.+.    ....+.|-+|.++....+ ....++.|..+|..+.|||+
T Consensus       274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt----~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nl  349 (563)
T KOG1024|consen  274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDT----YNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNL  349 (563)
T ss_pred             hhHHhhhhhhhheechhhhhcCchhheeeeeecccCC----cchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCc
Confidence            3456777778899999999999999999998775433    223456788888765433 34567899999999999999


Q ss_pred             eeEEeEEEeC-CeEEEEEEecCCCChHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 014202          162 VKLIGYCIED-DQRLLVYEFMTRGSLENHLFR-------RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNI  233 (429)
Q Consensus       162 v~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Ni  233 (429)
                      ..+.++..++ +..+.++.+..-|+|..+|..       ..+.++..+...++.|++.|++|||  .++|||.||..+|+
T Consensus       350 l~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNC  427 (563)
T KOG1024|consen  350 LSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNC  427 (563)
T ss_pred             cceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcc
Confidence            9999987654 456888999999999999962       1234667788899999999999999  99999999999999


Q ss_pred             EEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcc
Q 014202          234 LLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGE  312 (429)
Q Consensus       234 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  312 (429)
                      +||+..++||+|-.+++.+.+.+.............||+||.+.+..|+.++|+|||||++|||+| |+.|+...+|.+ 
T Consensus       428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-  506 (563)
T KOG1024|consen  428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-  506 (563)
T ss_pred             eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence            999999999999999998887776655555667789999999999999999999999999999999 888987654422 


Q ss_pred             ccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                                      +...+....+..-+..+++++..++.-||..+|++||++++++..|..+.
T Consensus       507 ----------------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  507 ----------------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ----------------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                            12222223344455667899999999999999999999999999887653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=275.93  Aligned_cols=268  Identities=28%  Similarity=0.422  Sum_probs=201.5

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhc--CCCcceeeEEe
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ--LHHPNLVKLIG  166 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~  166 (429)
                      +....+..+.+.||+|.||.||+|++.           |..||||++...   +...+.+|.+|.+.  |+|+||+.+++
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIa  272 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIA  272 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-----------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhh
Confidence            344567888999999999999999987           568999999743   33567788888766  58999999998


Q ss_pred             EEEeCC----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhC------CCCCeeeCCCCCCCeEEc
Q 014202          167 YCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG------GSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       167 ~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~------~~~~ivHrDlkp~Nill~  236 (429)
                      .-..++    +++||.+|.+.|+|.|+|.+.  .++....+.++..++.||++||.      ....|.|||||..|||+.
T Consensus       273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             ccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            755443    679999999999999999775  48899999999999999999993      355799999999999999


Q ss_pred             CCCCEEEccccCcccCCCCCcc--ceeeeccccccccChhhhhcCC----C--CCccchhhhHHHHHHHHhC--------
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKT--HVSTRVVGTYGYAAPEYVMTGH----L--TSKSDVYSFGVVLLEILTG--------  300 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwSlG~il~ell~g--------  300 (429)
                      .+|..-|+|+|+|.........  ...+..+||.+|||||++...-    +  -..+||||||.|+||++..        
T Consensus       351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            9999999999999876543211  1223468999999999986431    2  2469999999999998762        


Q ss_pred             --CCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccc-cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          301 --RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLE-LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       301 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                        ++||...-+.+. ...+     +...-- .+.+.|.++ .-...+....+.+|++.||..||.-|-|+--|.+.|.++
T Consensus       431 ey~~Pyyd~Vp~DP-s~ee-----MrkVVC-v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  431 EYQLPYYDVVPSDP-SFEE-----MRKVVC-VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             hhcCCcccCCCCCC-CHHH-----Hhccee-ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence              467765544322 1111     000000 011112221 112344556788999999999999999999998888776


Q ss_pred             cC
Q 014202          378 QD  379 (429)
Q Consensus       378 ~~  379 (429)
                      .+
T Consensus       504 ~~  505 (513)
T KOG2052|consen  504 SN  505 (513)
T ss_pred             hc
Confidence            64

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.7e-35  Score=267.43  Aligned_cols=238  Identities=32%  Similarity=0.463  Sum_probs=193.9

Q ss_pred             CceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-hHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCC
Q 014202          105 GFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTR  183 (429)
Q Consensus       105 ~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g  183 (429)
                      +||.||+|.+..++.         .+|+|++....... ...+.+|+..+++++|+||+++++.+......+++|||+.+
T Consensus         1 ~~g~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKKTGK---------LVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECCCCc---------EEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence            589999999876544         89999998765544 67889999999999999999999999999999999999999


Q ss_pred             CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeee
Q 014202          184 GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR  263 (429)
Q Consensus       184 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~  263 (429)
                      ++|.+++..... +++..++.++.+++.++.|||  ..+++|+||+|+||+++.++.++|+|||.+.......   ....
T Consensus        72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~  145 (244)
T smart00220       72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT  145 (244)
T ss_pred             CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence            999998865543 889999999999999999999  8899999999999999999999999999998754432   2233


Q ss_pred             ccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCH
Q 014202          264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSL  343 (429)
Q Consensus       264 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ..++..|++||.+.+..++.++||||||+++|+|++|..||......  ......             ............
T Consensus       146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~-------------~~~~~~~~~~~~  210 (244)
T smart00220      146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKK-------------IGKPKPPFPPPE  210 (244)
T ss_pred             ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH-------------HhccCCCCcccc
Confidence            57889999999998888999999999999999999999999653110  111000             001111100000


Q ss_pred             -HHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          344 -KGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       344 -~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       ..+..+.+++.+||..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence             14478999999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-35  Score=290.27  Aligned_cols=275  Identities=19%  Similarity=0.259  Sum_probs=187.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCC-------CCCCCCcEEEEEEeCCCCchhhHH--------------HHHH
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAP-------AKPGSGITVAVKSLKPDGLQGHRE--------------WVAE  149 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~-------~~~~~g~~vavK~~~~~~~~~~~~--------------~~~E  149 (429)
                      ..++|++.++||+|+||.||+|.....+...       .....++.||||.+........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3578999999999999999999865433211       122345689999987654332222              2346


Q ss_pred             HHHHhcCCCcce-----eeEEeEEEe--------CCeEEEEEEecCCCChHHHHhcCC----------------------
Q 014202          150 VDFLGQLHHPNL-----VKLIGYCIE--------DDQRLLVYEFMTRGSLENHLFRRT----------------------  194 (429)
Q Consensus       150 ~~~l~~l~hpnI-----v~~~~~~~~--------~~~~~lv~e~~~gg~L~~~l~~~~----------------------  194 (429)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776554     667776653        356799999999999999886421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccCh
Q 014202          195 -IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP  273 (429)
Q Consensus       195 -~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP  273 (429)
                       ..+++..+..++.|++.+|.|||  ..+|+||||||+|||++.++.+||+|||++.......... .....+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeCh
Confidence             12356678889999999999999  8999999999999999999999999999997643322111 1113458899999


Q ss_pred             hhhhcCC--------------------CC--CccchhhhHHHHHHHHhCCC-CCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          274 EYVMTGH--------------------LT--SKSDVYSFGVVLLEILTGRR-SMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       274 E~~~~~~--------------------~~--~~~DiwSlG~il~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      |.+....                    ++  .+.||||+||++|+|++|.. ||........ ..    ..+........
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~----~~~~~~~~~~r  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-EL----RQYDNDLNRWR  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HH----hhccchHHHHH
Confidence            9875322                    12  24799999999999999875 6643221110 00    00000000001


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCC---CCCCCHhHHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDP---KSRPSMDEVVKV  373 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rpt~~eil~~  373 (429)
                      ...............++...+|+.+||..+|   .+|+|++|+|++
T Consensus       455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            1111112222233456789999999999866   689999999985

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=267.87  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=194.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-----C---cceeeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-----H---PNLVKL  164 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~~  164 (429)
                      ++|.+.++||.|-|++||+|++..+..         .||+|+.+-.. .-.+..+.||++|++++     |   ..||+|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r---------~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKR---------YVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCe---------EEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            889999999999999999999998766         99999987442 22355689999999984     2   469999


Q ss_pred             EeEEEe----CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-
Q 014202          165 IGYCIE----DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-  238 (429)
Q Consensus       165 ~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-  238 (429)
                      ++.|..    +.++++|+|++ |.+|..+|... -+.++...+..|++||+.||.|||. ..||||-||||+|||+..+ 
T Consensus       148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeeccc
Confidence            999875    45899999998 77888888654 4568999999999999999999996 7899999999999998300 


Q ss_pred             --------------------------------------------------------------------------------
Q 014202          239 --------------------------------------------------------------------------------  238 (429)
Q Consensus       239 --------------------------------------------------------------------------------  238 (429)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 014202          239 --------------------------------------------------------------------------------  238 (429)
Q Consensus       239 --------------------------------------------------------------------------------  238 (429)
                                                                                                      
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                                                                            


Q ss_pred             -----CCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC---
Q 014202          239 -----YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS---  310 (429)
Q Consensus       239 -----~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---  310 (429)
                           -++||+|||-|.....     ..+....|..|.|||++.+..|+..+||||++|++|||+||...|......   
T Consensus       386 ~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~  460 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS  460 (590)
T ss_pred             CCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence                 0134444444433211     112235688899999999999999999999999999999999999754322   


Q ss_pred             ccccHHHHHHHHH--------HhhhhhhhhcCCcc-------------------ccCCCHHHHHHHHHHHHHcccCCCCC
Q 014202          311 GEQNLVAWARQYL--------ADKRKLYQIVDPRL-------------------ELNYSLKGVQKVSQLAYNCLSRDPKS  363 (429)
Q Consensus       311 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP~~  363 (429)
                      .+.+-+..+...+        .....-..+++..-                   ...++.+...++.+++.-||+.+|++
T Consensus       461 rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeK  540 (590)
T KOG1290|consen  461 RDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEK  540 (590)
T ss_pred             ccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccc
Confidence            1111111111111        11111111222111                   11244566788999999999999999


Q ss_pred             CCCHhHHHH
Q 014202          364 RPSMDEVVK  372 (429)
Q Consensus       364 Rpt~~eil~  372 (429)
                      |||+.++++
T Consensus       541 R~tA~~cl~  549 (590)
T KOG1290|consen  541 RPTAAQCLK  549 (590)
T ss_pred             cccHHHHhc
Confidence            999999997

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=290.55  Aligned_cols=245  Identities=30%  Similarity=0.427  Sum_probs=187.6

Q ss_pred             CCCCCcccccCcee-EEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGY-VFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~-Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  172 (429)
                      |.-.+++|.|+-|+ ||+|...           |+.||||.+-...   ..-..+|+..|+.-+ |||||++|+.-.++.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q  576 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ  576 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence            44457889999885 7999876           5589999986432   234568999999885 999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCC--CC-CHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---C--CCEEEc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTI--PL-PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---E--YNAKLS  244 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~--~~-~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---~--~~~kl~  244 (429)
                      ..||..|.|. .+|.+++.....  .. .....+.++.|++.||++||  +.+||||||||.||||+.   +  .+++|+
T Consensus       577 F~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH--sl~iVHRDLkPQNILI~~~~~~~~~ra~iS  653 (903)
T KOG1027|consen  577 FLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH--SLKIVHRDLKPQNILISVPSADGTLRAKIS  653 (903)
T ss_pred             eEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH--hcccccccCCCceEEEEccCCCcceeEEec
Confidence            9999999995 599999976311  11 11455788999999999999  899999999999999965   3  469999


Q ss_pred             cccCcccCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCCccccHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG-RRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       245 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |||+++....+... .......||-+|+|||++....-+.++|||||||++|+.++| .+||...... +.+       .
T Consensus       654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N-------I  725 (903)
T KOG1027|consen  654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN-------I  725 (903)
T ss_pred             ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------h
Confidence            99999987654322 223457899999999999988888899999999999999996 8999643211 000       1


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +.....+.       .+....++  +..+||.+|+..||..||++.+|+.+
T Consensus       726 l~~~~~L~-------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  726 LTGNYTLV-------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             hcCcccee-------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            11111111       11111122  78999999999999999999999863

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=278.57  Aligned_cols=197  Identities=26%  Similarity=0.352  Sum_probs=171.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh--------HHHHHHHHHHhcCC---Ccce
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--------REWVAEVDFLGQLH---HPNL  161 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---hpnI  161 (429)
                      .+|..++.+|+|+||.|++|.++.+..         .|+||.+.+...-..        -.+-.|+.||..|+   |+||
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~---------eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNY---------EVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccce---------EEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            468999999999999999999998865         899999987643211        12456999999997   9999


Q ss_pred             eeEEeEEEeCCeEEEEEEec-CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          162 VKLIGYCIEDDQRLLVYEFM-TRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~-~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      ++++++|++++++||+||-. +|-+|.+++..+ ..+++.++..|+.|++.|+++||  +.||||||||-+|+.++.+|-
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEecCCe
Confidence            99999999999999999965 456899988554 46899999999999999999999  999999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCC
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMD  305 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~  305 (429)
                      +||+|||.+.....+    ....++||..|.|||++.|..| +..-|||+||++||.++....||.
T Consensus       709 ~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999999775443    2344899999999999998877 678999999999999999888875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.4e-35  Score=277.21  Aligned_cols=209  Identities=22%  Similarity=0.269  Sum_probs=176.2

Q ss_pred             cHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC------
Q 014202           84 TFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH------  157 (429)
Q Consensus        84 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------  157 (429)
                      .++-.+...++|.+....|+|-|++|.+|.+...+.         .||||++..+. .-++.=+.|++||++|+      
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~---------~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Ed  492 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQ---------EVAIKIIRNNE-VMHKTGLKELEILKKLNDADPED  492 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCC---------eeEEEEeecch-HHhhhhhHHHHHHHHhhccCchh
Confidence            333345566889999999999999999998876544         89999998664 23455678999999995      


Q ss_pred             CcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT--IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       158 hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      --|+++++..|...+++|||+|-+ ..+|.+.|.+.+  ..+....+..++.|+..||..|-  ..||+|.||||+|||+
T Consensus       493 k~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  493 KFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILV  569 (752)
T ss_pred             hhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEe
Confidence            358999999999999999999987 569999997754  45778899999999999999999  8999999999999999


Q ss_pred             cCCC-CEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 014202          236 DSEY-NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP  309 (429)
Q Consensus       236 ~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  309 (429)
                      ++.. .+||||||.|.......-+    .+.-+..|.|||++.|.+|+...|+||+||+||||.||+..|.+...
T Consensus       570 NE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             ccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            8764 4899999999875543322    24456789999999999999999999999999999999999988754

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.3e-34  Score=245.20  Aligned_cols=260  Identities=21%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  170 (429)
                      .++|++.+++|+|.|+.||.|....+++         .++||++++-   ..+.+.+|+.||..|. ||||++++++..+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~e---------K~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNE---------KCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCc---------eEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            4689999999999999999999887766         8999999743   3467789999999998 9999999999877


Q ss_pred             CC--eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CCEEEcccc
Q 014202          171 DD--QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFG  247 (429)
Q Consensus       171 ~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~DFg  247 (429)
                      ..  ...||+||+.+.+...+.    ..++...+..++.+++.||.|||  +.||+|||+||.|++||.. -.++|+|+|
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH--S~GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH--SMGIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH--hcCcccccCCcceeeechhhceeeeeecc
Confidence            54  457999999887776654    23677888999999999999999  9999999999999999865 459999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc-----------cH
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ-----------NL  315 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-----------~~  315 (429)
                      +|..+..+....   .-+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-......++           .+
T Consensus       179 LAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  179 LAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             hHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            999876654332   2467788999998864 56889999999999999999999999655443222           11


Q ss_pred             HHHHHHHHHhh-hhhhhhcCC---ccccC-----CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          316 VAWARQYLADK-RKLYQIVDP---RLELN-----YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       316 ~~~~~~~~~~~-~~~~~~~~~---~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..+...+-... .....++..   .....     ...-.++++.+|+.++|..|-.+|+|++|.+.
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            11111111100 001111100   00000     00112478999999999999999999999976

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=259.20  Aligned_cols=264  Identities=24%  Similarity=0.375  Sum_probs=197.1

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+..+.||.|+||.||.+++..+         |+.||+|++..-  +....+.+.+|+++|..++|.|++..+++.....
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRd---------grrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph  125 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRS---------GKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPAN  125 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCC---------ccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCC
Confidence            44567899999999999887765         459999988532  3344577889999999999999999998776543


Q ss_pred             -----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          173 -----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       173 -----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                           ++|+|+|++. .+|..++.. ..+++...+.-+++||+.||.|||  +.+|+||||||.|.|++.+..+||||||
T Consensus       126 ~dfFqEiYV~TELmQ-SDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLH--sA~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  126 PSFFQELYVLTELMQ-SDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLH--TANILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             chHHHHHHHHHHHHH-hhhhheecc-CCCCCcchhhhhHHHHHhhhHHHh--hcchhhccCCCccEEeccCceEEecccc
Confidence                 4678888884 478776644 456888899999999999999999  9999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH-------
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA-------  319 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~-------  319 (429)
                      +++.-...+ ....+..+-|.+|.|||+++|. .|+.+.||||.||++.||+..+..|....+....+++...       
T Consensus       202 LARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  202 LARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             cccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            999754433 3334456789999999999975 6899999999999999999999999877665443332110       


Q ss_pred             -HHHHHhhhhhhhhcC-----Cccc----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          320 -RQYLADKRKLYQIVD-----PRLE----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       320 -~~~~~~~~~~~~~~~-----~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       .+...+..+ ..++.     +.+.    ..-+.....+...++.++|..||++|.+..+.+..
T Consensus       281 aMr~ACEGAk-~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  281 AMKYACEGAK-NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHHHHhhhhH-HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence             000000000 00111     1111    01111223467788999999999999999988753

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=248.50  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=193.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEe-EEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIG-YCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~-~~~  169 (429)
                      .+.|.+.+.||+|.||.+-++.++.+++         .+++|.+.... ....+|.+|...--.|. |.||+.-|+ .|+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t---------~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq   92 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKT---------RIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ   92 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCce---------EEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence            3679999999999999999999998877         89999987653 55688999998777775 999999887 577


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--cCCCCEEEcccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL--DSEYNAKLSDFG  247 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~~~kl~DFg  247 (429)
                      ..+.+++++||++.|+|..-+...  .+.+.....++.|+++||.|+|  +.++||||||.+||||  .+..+|||||||
T Consensus        93 t~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH--sknlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   93 TSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH--SKNLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             cCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh--ccchhhcccccceEEEecCCccEEEeeecc
Confidence            888889999999999999877554  3788899999999999999999  9999999999999999  334579999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhc---C--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT---G--HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      +.+.......     ...-+..|.+||.+..   +  ...+.+|||.||+++|.+++|.+||. .....++...+|.+..
T Consensus       169 ~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~  242 (378)
T KOG1345|consen  169 LTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWL  242 (378)
T ss_pred             cccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHh
Confidence            9986332211     1234566999997753   2  34678999999999999999999998 3444555555554432


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV  371 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil  371 (429)
                      -.....+.+.+.         ..++.+..++++-|..+|++|--+.++.
T Consensus       243 ~rk~~~~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  243 KRKNPALPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             cccCccCchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            221111211111         2336788999999999999994444443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=280.12  Aligned_cols=254  Identities=25%  Similarity=0.378  Sum_probs=208.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|.++..+|.|.||.||+|++..+++         ..|+|+++.....+..-+..|+-+++..+|||||.+++.+...
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~e---------laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGE---------LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCc---------hhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence            3579999999999999999999998766         8999999888777777788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +.+++.||||.||+|.+..+ -..++++.++..+.+..+.||+|||  +.|=+|||||-.|||+++.|.+||+|||.+-.
T Consensus        85 dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylh--s~gk~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLH--SQGKIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             cCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhh--cCCcccccccccceeecccCceeecccCchhh
Confidence            99999999999999998664 4457999999999999999999999  89999999999999999999999999999876


Q ss_pred             CCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +...  ......+.||++|||||+..   .+.|...+|||++|+...|+-.-++|.-...+..        .-++..+..
T Consensus       162 itat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--------~l~LmTkS~  231 (829)
T KOG0576|consen  162 ITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--------ALFLMTKSG  231 (829)
T ss_pred             hhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--------HHHHhhccC
Confidence            4332  12233589999999999864   6789999999999999999988777754333211        111111111


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          .+ .....-.....+.+.++++-+|..+|++||+++.+|.
T Consensus       232 ----~q-pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 ----FQ-PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ----CC-CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                11 1122233456688999999999999999999988764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-34  Score=254.20  Aligned_cols=262  Identities=24%  Similarity=0.337  Sum_probs=196.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .+|.-++.+|.|.- .|-.|.+.-.+         +.||+|++...  .....+...+|..++..++|+||++++.+|.-
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~---------~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP   86 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLG---------RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP   86 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhcc---------CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence            46888889999998 66666666554         48999998654  22334667899999999999999999999875


Q ss_pred             CC------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          171 DD------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       171 ~~------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ..      ..|+|||++. .+|...+..   .++-..+..++.|++.|+.|||  +.||+||||||+||++..++.+||.
T Consensus        87 ~~~l~~~~e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   87 QKTLEEFQEVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             cccHHHHHhHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchhheeec
Confidence            54      5699999994 589888763   3677889999999999999999  9999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH--------
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV--------  316 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~--------  316 (429)
                      |||+|+....   .-..+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+......-..+        
T Consensus       161 dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd  237 (369)
T KOG0665|consen  161 DFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD  237 (369)
T ss_pred             cchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence            9999986322   23455688999999999999988999999999999999999999999865432111000        


Q ss_pred             --------HHHHHHHHhhhh-----hhhhc-CCcc--ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          317 --------AWARQYLADKRK-----LYQIV-DPRL--ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       317 --------~~~~~~~~~~~~-----~~~~~-~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                              ...+.+.....+     ..+.+ |...  ....+......+++|+.+||-.||++|.+++++|.+
T Consensus       238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                    000011110000     00000 0000  011111234568899999999999999999999973

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.2e-31  Score=239.57  Aligned_cols=212  Identities=38%  Similarity=0.608  Sum_probs=184.2

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEEEE
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYE  179 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  179 (429)
                      ||+|++|.||++....++.         .+++|++...... ....+.+|+..++.++|++|+++++++......+++||
T Consensus         1 l~~g~~~~v~~~~~~~~~~---------~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecCCCc---------EEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence            6899999999999876544         8999999866543 34678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCCEEEccccCcccCCCCCcc
Q 014202          180 FMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNAKLSDFGLAKAGPQGDKT  258 (429)
Q Consensus       180 ~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFg~a~~~~~~~~~  258 (429)
                      ++.|++|.+++......++...+..++.+++.++.+||  ..+++|+||+|.||+++. ++.++|+|||.+........ 
T Consensus        72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-  148 (215)
T cd00180          72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-  148 (215)
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence            99999999998765446899999999999999999999  889999999999999999 89999999999986543321 


Q ss_pred             ceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCcc
Q 014202          259 HVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL  337 (429)
Q Consensus       259 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (429)
                       ......+...|++||.+... .++.++|+|+||+++++|                                        
T Consensus       149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------  187 (215)
T cd00180         149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------  187 (215)
T ss_pred             -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence             12235678899999998877 788999999999999998                                        


Q ss_pred             ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       338 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                               ..+.+++..|++.||++||++.++++.+
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                     3477899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=9.2e-31  Score=237.12  Aligned_cols=200  Identities=33%  Similarity=0.439  Sum_probs=174.3

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      |.+.+.||.|++|.||+|.+..++.         .+|+|.+...... ....+.+|+..+.+++|+||+++++++.....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGE---------LVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCc---------EEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence            5678899999999999999886544         8999999876555 56788899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .++++|++.+++|.+++......+++..+..++.+++.++.+||  ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            99999999999999998765433789999999999999999999  7899999999999999999999999999998764


Q ss_pred             CCCccceeeeccccccccChhhh-hcCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEILTGRRSMDK  306 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~  306 (429)
                      .... .......++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus       150 ~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      150 RDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             Cccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4321 112235688899999998 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=6.2e-31  Score=243.90  Aligned_cols=271  Identities=25%  Similarity=0.333  Sum_probs=198.9

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEe
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIG  166 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~  166 (429)
                      +......|.++.+||+|.|++||+|.+...      ...+..||+|.+....  ....+.+|+++|..+. +.||+++.+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchh
Confidence            344456799999999999999999988762      1134589999997653  3456889999999996 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCCEEEcc
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNAKLSD  245 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~D  245 (429)
                      .+..++...+||||++.....+++..    ++...+..+++.++.||.++|  ..|||||||||.|+|.+. .+.-.|+|
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCceEEe
Confidence            99999999999999999888887743    568899999999999999999  999999999999999965 46689999


Q ss_pred             ccCcccCC-----------------C--CC--------------c---------cceeeeccccccccChhhhhc-CCCC
Q 014202          246 FGLAKAGP-----------------Q--GD--------------K---------THVSTRVVGTYGYAAPEYVMT-GHLT  282 (429)
Q Consensus       246 Fg~a~~~~-----------------~--~~--------------~---------~~~~~~~~gt~~y~aPE~~~~-~~~~  282 (429)
                      ||+|....                 .  +.              .         ........||++|.|||++.. ...+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99997210                 0  00              0         000012469999999999875 4578


Q ss_pred             CccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH----HHHHh----hhh--hh---------------hhc----
Q 014202          283 SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR----QYLAD----KRK--LY---------------QIV----  333 (429)
Q Consensus       283 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~~~~~----~~~--~~---------------~~~----  333 (429)
                      +++||||.|||+.-++++..||-......+ .+.+...    ..+..    .+.  +.               +.+    
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            999999999999999999999975443211 1111000    00000    000  00               000    


Q ss_pred             -CC-c---cc-cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          334 -DP-R---LE-LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       334 -~~-~---~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       .+ .   .. .......+..+.+|+.+||..||.+|.|+++.|+.
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence             00 0   00 00111123478899999999999999999999984

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=223.13  Aligned_cols=265  Identities=18%  Similarity=0.203  Sum_probs=211.9

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYC  168 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  168 (429)
                      ...++|++++.||.|+||.+|+|.....++         .||||+.....  .+..+..|..+.+.|+ ...|..+..++
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge---------~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGE---------EVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCc---------eEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc
Confidence            456899999999999999999999887755         99999987553  3356788999999998 57888889999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CCEEEcc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSD  245 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~D  245 (429)
                      .+..+-.+||+++ |.+|++++.-....++..+++.++-|++.-++|+|  .+++|||||||+|+|+.-+   ..+.|+|
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEEEe
Confidence            9999999999988 88999988777778999999999999999999999  8999999999999999543   4599999


Q ss_pred             ccCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          246 FGLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       246 Fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|+.+.+....     .......||..|.+-..+.+...+...|+-|+|.+|.++.-|..||.+..+.......+.+.
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~  237 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS  237 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence            9999987553322     12334789999999998888888999999999999999999999999877654433332221


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .          ..-...........+.++.-.+..|-..--++-|+..-+.+.+..+.
T Consensus       238 E----------kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  238 E----------KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             H----------hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            1          11111112233345678888999999999999999888776554443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-30  Score=230.30  Aligned_cols=267  Identities=18%  Similarity=0.186  Sum_probs=213.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  171 (429)
                      -+|+++++||+|.||.+|.|.+.-+++         .||||......  ...++..|.+..+.|. .++|...|-+...+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne---------~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNE---------PVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG   96 (449)
T ss_pred             ccceeccccccCcceeeecccccccCc---------eEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence            479999999999999999999988876         99999876542  3346778888888885 89999999999988


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-----CEEEccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-----NAKLSDF  246 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-----~~kl~DF  246 (429)
                      -+-.||||++ |-+|+|++.-.+..|+...+..++.|++.-++|+|  ++.+|.|||||+|+||...+     .|.|+||
T Consensus        97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEEEEec
Confidence            8889999988 88999988878888999999999999999999999  89999999999999996433     4999999


Q ss_pred             cCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          247 GLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       247 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |+|+.+.+....     .......||..||+.....|...+.+.|+-|||-+++++|-|..||.+..........+-   
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK---  250 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK---  250 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH---
Confidence            999987665432     123347899999999999999999999999999999999999999998765443322111   


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCccch
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDL  383 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~~~  383 (429)
                             +-+..............+.++...+.-.-..+-.+-|+.+-+...+..+.+....
T Consensus       251 -------IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  251 -------IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             -------hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence                   1111111111122334567888888888888899999999888777666654443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.3e-30  Score=275.12  Aligned_cols=197  Identities=20%  Similarity=0.252  Sum_probs=141.6

Q ss_pred             hcCCC-cceeeEEeEE-------EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 014202          154 GQLHH-PNLVKLIGYC-------IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIY  225 (429)
Q Consensus       154 ~~l~h-pnIv~~~~~~-------~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivH  225 (429)
                      +.++| +||++++++|       .....++++||++ +++|.++|......+++..+..++.||+.||.|||  +.||+|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~gIvH  103 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH--SQGIVV  103 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH--hCCeee
Confidence            34556 6888888877       3334567788987 66999999766667999999999999999999999  899999


Q ss_pred             CCCCCCCeEEcCC-------------------CCEEEccccCcccCCCCCc--------------cceeeeccccccccC
Q 014202          226 RDFKTSNILLDSE-------------------YNAKLSDFGLAKAGPQGDK--------------THVSTRVVGTYGYAA  272 (429)
Q Consensus       226 rDlkp~Nill~~~-------------------~~~kl~DFg~a~~~~~~~~--------------~~~~~~~~gt~~y~a  272 (429)
                      |||||+||||+..                   +.+||+|||+++.......              .......+||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999553                   4566666666653211000              000112468999999


Q ss_pred             hhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHH
Q 014202          273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQL  352 (429)
Q Consensus       273 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  352 (429)
                      ||++.+..|+.++|||||||+||||++|..|+....     ..   .... .     .....+..     ........++
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~---~~~~-~-----~~~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RT---MSSL-R-----HRVLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HH---HHHH-H-----HhhcChhh-----hhcCHHHHHH
Confidence            999999999999999999999999999888764211     00   0000 0     00111100     0112446688


Q ss_pred             HHHcccCCCCCCCCHhHHHH
Q 014202          353 AYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       353 i~~~l~~dP~~Rpt~~eil~  372 (429)
                      +.+||+.||.+||++.|+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            99999999999999999987

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-28  Score=233.76  Aligned_cols=264  Identities=22%  Similarity=0.255  Sum_probs=201.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCC----cceeeEEeEE-
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH----PNLVKLIGYC-  168 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~-  168 (429)
                      +|.+.+.||+|+||.||+|.+..++        ...+|+|............+..|..+|..+..    +++..+++.+ 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence            7999999999999999999987754        12789998876543333367889999999873    6899999999 


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-----CCEE
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-----YNAK  242 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-----~~~k  242 (429)
                      ..+...|+||+.+ |.+|.++..... ..++...+..++.|++.+|.+||  +.|++||||||.|+++...     ..+.
T Consensus        91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen   91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccceEE
Confidence            5778889999987 889999875554 67999999999999999999999  9999999999999999765     3599


Q ss_pred             EccccCcc--cCCCCCcc----ce--eeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 014202          243 LSDFGLAK--AGPQGDKT----HV--STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN  314 (429)
Q Consensus       243 l~DFg~a~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  314 (429)
                      |.|||+++  .+......    ..  ...+.||..|+++.+..+...+.+.|+||++.++.+++.|..||..........
T Consensus       168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~  247 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS  247 (322)
T ss_pred             EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence            99999998  43222211    11  123569999999999999999999999999999999999999996654322211


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                      ...   .   ....  .....     .....+..+.++...+-..+...+|++..+...|.......
T Consensus       248 ~~~---~---~~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  248 KFE---K---DPRK--LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHH---H---Hhhh--hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            110   0   0000  00000     11223356777777777799999999999998865554433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4e-28  Score=212.07  Aligned_cols=167  Identities=25%  Similarity=0.259  Sum_probs=126.5

Q ss_pred             CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeee
Q 014202          184 GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR  263 (429)
Q Consensus       184 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~  263 (429)
                      |+|.+++..++..+++..++.++.|++.||.|||  +.+      ||+|||++.++.+++  ||++.......       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccceEeecccc-------
Confidence            6899999876777999999999999999999999  665      999999999999999  99998643321       


Q ss_pred             ccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCH
Q 014202          264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSL  343 (429)
Q Consensus       264 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ..||+.|||||++.+..++.++|||||||++|||++|..||.......     .........   ... ..+. ......
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~---~~~-~~~~-~~~~~~  133 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNG---MPA-DDPR-DRSNLE  133 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHH---hcc-CCcc-ccccHH
Confidence            268999999999999999999999999999999999999996433211     111111100   000 0000 001112


Q ss_pred             HHHH--HHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          344 KGVQ--KVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       344 ~~~~--~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      ....  .+.+++.+||..||.+||++.++++.+..+
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            2233  699999999999999999999999876433

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2.8e-27  Score=226.40  Aligned_cols=177  Identities=18%  Similarity=0.152  Sum_probs=134.0

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-----chhhHHHHHHHHHHhcCCCcceee-
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-----LQGHREWVAEVDFLGQLHHPNLVK-  163 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~-  163 (429)
                      ...++|.+.+.||+|+||+||+|++..+.        |..||||++....     ......+.+|+.+|++|+|+||+. 
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~--------~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~   86 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDP--------GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ   86 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCC--------CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence            44578999999999999999999887532        3378999875331     123456889999999999999985 


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCeEEcCCCCEE
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDF-KTSNILLDSEYNAK  242 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDl-kp~Nill~~~~~~k  242 (429)
                      ++++    +..||||||++|++|.. +..    ..   ...++.|++.+|.|||  +.||+|||| ||+|||++.++.++
T Consensus        87 l~~~----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         87 LLAT----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             EEEc----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcCCCCEE
Confidence            4432    45799999999999973 211    11   1467889999999999  899999999 99999999999999


Q ss_pred             EccccCcccCCCCCccce------eeeccccccccChhhhhcC------CCCCccchh
Q 014202          243 LSDFGLAKAGPQGDKTHV------STRVVGTYGYAAPEYVMTG------HLTSKSDVY  288 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~Diw  288 (429)
                      |+|||+++..........      .....+++.|+|||.+...      ..+..+|-|
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999987544321111      1346788999999988532      233456777

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=5.8e-25  Score=209.57  Aligned_cols=258  Identities=33%  Similarity=0.448  Sum_probs=197.4

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCc-ceeeEEeEEEe
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHP-NLVKLIGYCIE  170 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~  170 (429)
                      |.+.+.||.|+||.||++.+.            ..+++|.+......   ....+.+|+.++..+.|+ +|+++++.+..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence            677889999999999999987            27899999766433   356789999999999988 79999999987


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CEEEcccc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT--IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDFG  247 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFg  247 (429)
                      ....+++++++.++++.+++....  ..+.......++.|++.++.|+|  ..+++||||||+||+++..+ .++++|||
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence            777899999999999997665543  26899999999999999999999  89999999999999999988 69999999


Q ss_pred             CcccCCCCCccc----eeeeccccccccChhhhhc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCC-ccccHHHHH
Q 014202          248 LAKAGPQGDKTH----VSTRVVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS-GEQNLVAWA  319 (429)
Q Consensus       248 ~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~  319 (429)
                      ++..........    ......|+..|+|||.+.+   ..+....|+||+|++++++++|..||...... ........ 
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~-  226 (384)
T COG0515         148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI-  226 (384)
T ss_pred             cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH-
Confidence            998544433221    2345789999999999987   57889999999999999999999997654431 00011000 


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                        .......   .................+.+++..++..+|..|.+..+...
T Consensus       227 --~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         227 --ILELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             --HHhcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence              0000000   00000000000122357889999999999999999887765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.4e-27  Score=243.00  Aligned_cols=259  Identities=21%  Similarity=0.239  Sum_probs=191.6

Q ss_pred             CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-Cchhh-HHHHHHHHHHhcCCCcceeeEEeEEEeCCe
Q 014202           96 RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGH-REWVAEVDFLGQLHHPNLVKLIGYCIEDDQ  173 (429)
Q Consensus        96 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  173 (429)
                      ....++|.|++|.|+.+......+....    ..+++| .... ..... ..+..|+.+=..|+|||++..+..+.+...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~----~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPE----KEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchh----hhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence            4567899999998888776655442111    122332 1111 11111 125678888888999999888887777666


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .+-+||||++ +|..++... ..+...++-.++.|++.|+.|+|  ..||.||||||+|+++..+|.+||+|||.+....
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             chhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence            6666999999 999988665 35788899999999999999999  9999999999999999999999999999998765


Q ss_pred             CCCcc--ceeeeccccccccChhhhhcCCCCC-ccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          254 QGDKT--HVSTRVVGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       254 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      -....  ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.............         ....
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~---------~~~~  542 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN---------NYSD  542 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh---------cccc
Confidence            44443  5566789999999999999999875 6899999999999999999998765443321000         0000


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +.....-........+...+.+|.+||+.||.+|.|+++|++
T Consensus       543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000000111122334567889999999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=5.5e-25  Score=196.22  Aligned_cols=174  Identities=11%  Similarity=0.099  Sum_probs=135.2

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHH---------HHHHHHHHhcCCCc
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---------WVAEVDFLGQLHHP  159 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hp  159 (429)
                      +...++|++.++||.|+||.||++..  +         +..+|||.+..........         +.+|+..+.++.||
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~---------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~   95 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--D---------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE   95 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--C---------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence            35578999999999999999999644  2         2279999997553332221         57899999999999


Q ss_pred             ceeeEEeEEEeC--------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 014202          160 NLVKLIGYCIED--------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTS  231 (429)
Q Consensus       160 nIv~~~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~  231 (429)
                      +|..+.+++...        ...+|||||++|.+|.+..     .+++    ....+++.+|..+|  ..|++|||++|+
T Consensus        96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH--~~gi~H~Dikp~  164 (232)
T PRK10359         96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLH--QHGMVSGDPHKG  164 (232)
T ss_pred             CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHH--HcCCccCCCChH
Confidence            999999886644        3578999999999998863     1232    24568999999999  899999999999


Q ss_pred             CeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh
Q 014202          232 NILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT  299 (429)
Q Consensus       232 Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~  299 (429)
                      ||+++.+| ++|+|||...........              ..++....|+.++|+|+||+++..+..
T Consensus       165 Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        165 NFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             HEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            99999988 999999988764221110              114555667789999999999876653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-25  Score=196.96  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=196.6

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--hHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ...+..+|.+...|..|+|++..+           .+++|++.......  -++|..|.-.|+-+.||||+.+++.+...
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp  259 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP  259 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence            345567788999999999999754           67888887654333  36788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc--cccC
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS--DFGL  248 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~--DFg~  248 (429)
                      .++.++..|++.|+|+..+.... ...+..++.+++.+++.|++|||..+.-|.---|....++||++.+.+|.  |--+
T Consensus       260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence            99999999999999999998764 34677899999999999999999644445556789999999999886664  4322


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCC---CccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      +...         ....-.|.||+||.+...+-+   .++|+|||++++|||.|...||....+....-.          
T Consensus       340 sfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----------  400 (448)
T KOG0195|consen  340 SFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----------  400 (448)
T ss_pred             eeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----------
Confidence            2220         012347889999999876543   579999999999999999999987766433221          


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                            +.-..++..+++..+..+..|+.-|+..||.+||.++.|+-.|++++
T Consensus       401 ------ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 ------IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ------hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                  12234455566677789999999999999999999999999887664

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.2e-25  Score=213.97  Aligned_cols=229  Identities=30%  Similarity=0.397  Sum_probs=183.4

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--hHHHHHHHHHHhcCC-CcceeeEEeEEEeCCeEEE
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  176 (429)
                      .+|.|.||.|++++.....      ..|.-+|+|.+++.....  ......|..++...+ ||.+|+++..++.+...++
T Consensus         1 vlg~g~~gkvfLvrk~~g~------da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGA------DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhccc------cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            4799999999987643322      235578999887653221  123456888888887 9999999999999999999


Q ss_pred             EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCC
Q 014202          177 VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~  256 (429)
                      ++++..||+|...+.... .+.+.....+...++-+++++|  ..+|+|||+|++||+++.+|++++.|||+++......
T Consensus        75 ~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             hhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            999999999998886554 4677777788888999999999  9999999999999999999999999999998754332


Q ss_pred             ccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCc
Q 014202          257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR  336 (429)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                      .      .|||..|||||++.  .....+|.||||++.+||++|..||..       +.             ...+..  
T Consensus       152 ~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~-------------~~~Il~--  201 (612)
T KOG0603|consen  152 I------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DT-------------MKRILK--  201 (612)
T ss_pred             h------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HH-------------HHHHhh--
Confidence            2      28999999999988  567899999999999999999999975       11             111111  


Q ss_pred             cccCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014202          337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSM  367 (429)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  367 (429)
                      .....+......+.+++..++..+|..|--.
T Consensus       202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            1234455667889999999999999999644

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.8e-23  Score=184.28  Aligned_cols=139  Identities=17%  Similarity=0.167  Sum_probs=107.9

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--h-------h-----------------HHHHHHHH
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--G-------H-----------------REWVAEVD  151 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~  151 (429)
                      ...||+|+||.||+|.+. ++         ..||||+++.....  .       .                 .....|+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g---------~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   71 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NG---------EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR   71 (190)
T ss_pred             CCccccccceEEEEEECC-CC---------CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence            568999999999999875 44         49999999754211  0       0                 11235999


Q ss_pred             HHhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCC
Q 014202          152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL-HGGSEPVIYRDFKT  230 (429)
Q Consensus       152 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l-H~~~~~ivHrDlkp  230 (429)
                      +|.++.+++|.....+...  ..+|||||++|+++...+... ..++...+..++.|++.+|.++ |  ..||+||||||
T Consensus        72 ~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP  146 (190)
T cd05147          72 NLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSE  146 (190)
T ss_pred             HHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCH
Confidence            9999988776443333222  238999999988776554333 4688999999999999999999 7  78999999999


Q ss_pred             CCeEEcCCCCEEEccccCcccC
Q 014202          231 SNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       231 ~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      +|||++ ++.++|+|||+|...
T Consensus       147 ~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         147 YNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HHEEEE-CCcEEEEEccccccC
Confidence            999998 478999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=1.8e-23  Score=191.96  Aligned_cols=231  Identities=21%  Similarity=0.294  Sum_probs=148.7

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCC----------cce
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHH----------PNL  161 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------pnI  161 (429)
                      +..++.||.|+|+.||.+++..+++         .+|+|+......   ...+.+.+|.-....+.+          -.+
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~---------~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~   84 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGE---------EFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF   84 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred             EEEccccccCCceEEEEEEEccCCc---------eEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence            4557899999999999999998866         999999754432   234556666654444322          223


Q ss_pred             eeEEeEEE---------eC---C-----eEEEEEEecCCCChHHHHh---cCCC---CCCHHHHHHHHHHHHHHHHHHhC
Q 014202          162 VKLIGYCI---------ED---D-----QRLLVYEFMTRGSLENHLF---RRTI---PLPWSNRIKIALGAAKGLAFLHG  218 (429)
Q Consensus       162 v~~~~~~~---------~~---~-----~~~lv~e~~~gg~L~~~l~---~~~~---~~~~~~~~~~~~qi~~~l~~lH~  218 (429)
                      +..++...         ..   .     ..+++|+-+ -++|.+++.   ....   .+.......+..|++..+++|| 
T Consensus        85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh-  162 (288)
T PF14531_consen   85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH-  162 (288)
T ss_dssp             ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh-
Confidence            33333222         11   1     236788877 458887753   2211   2334455667799999999999 


Q ss_pred             CCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhc--------CCCCCccchhhh
Q 014202          219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT--------GHLTSKSDVYSF  290 (429)
Q Consensus       219 ~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSl  290 (429)
                       ..|++|+||+|+|+|++.+|.+.|+||+.......    .... ...+..|.+||....        -.++.+.|.|+|
T Consensus       163 -~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L  236 (288)
T PF14531_consen  163 -SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL  236 (288)
T ss_dssp             -HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred             -hcceEecccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence             89999999999999999999999999998876322    1111 345678999997643        247888999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCC
Q 014202          291 GVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR  364 (429)
Q Consensus       291 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  364 (429)
                      |+++|.|++|..||....+......                      ......+.++.++.||..+|+.||.+|
T Consensus       237 G~~ly~lWC~~lPf~~~~~~~~~~~----------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  237 GITLYSLWCGRLPFGLSSPEADPEW----------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHSS-STCCCGGGSTSGG----------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHccCCCCCCCccccccc----------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999999999999986533221110                      111222567889999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-22  Score=187.50  Aligned_cols=257  Identities=21%  Similarity=0.280  Sum_probs=171.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCC--------------------------CCCCCcEEEEEEeCCCCchh-h--
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPA--------------------------KPGSGITVAVKSLKPDGLQG-H--  143 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~--------------------------~~~~g~~vavK~~~~~~~~~-~--  143 (429)
                      ++|++++.||+|.-+.||.|+...++..-.                          ......+.|||.+..-..+. .  
T Consensus       157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~  236 (598)
T KOG4158|consen  157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH  236 (598)
T ss_pred             hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence            569999999999999999998765332100                          01122456777764322211 1  


Q ss_pred             --HHHHHHH------------H-----HHh----c-CCCcceeeEEeEEEeC---------------------------C
Q 014202          144 --REWVAEV------------D-----FLG----Q-LHHPNLVKLIGYCIED---------------------------D  172 (429)
Q Consensus       144 --~~~~~E~------------~-----~l~----~-l~hpnIv~~~~~~~~~---------------------------~  172 (429)
                        +.+.+|.            .     .+.    + -+|||||++..+|.+.                           .
T Consensus       237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~  316 (598)
T KOG4158|consen  237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK  316 (598)
T ss_pred             HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence              1111121            1     111    1 2599999999877542                           3


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--cCCC--CEEEccccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL--DSEY--NAKLSDFGL  248 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~--~~kl~DFg~  248 (429)
                      .+|+||.-+. .+|..++-.+.  .+.....-++.|+++|+.|||  .+||.|||||.+|||+  |+++  .+.|+|||.
T Consensus       317 tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC  391 (598)
T KOG4158|consen  317 TLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQLLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGC  391 (598)
T ss_pred             eEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccce
Confidence            5789998874 49999986654  567778889999999999999  9999999999999999  4443  389999998


Q ss_pred             cccCCCC----CccceeeeccccccccChhhhhcCC------CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHH
Q 014202          249 AKAGPQG----DKTHVSTRVVGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW  318 (429)
Q Consensus       249 a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  318 (429)
                      +-.....    ..........|....||||+....+      --.++|.|+.|.+.||+++...||...... ..+.   
T Consensus       392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~---  467 (598)
T KOG4158|consen  392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDT---  467 (598)
T ss_pred             eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eech---
Confidence            7542221    1111122356888999999876322      134899999999999999999999763211 0000   


Q ss_pred             HHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHH
Q 014202          319 ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV  370 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ei  370 (429)
                              ....+.--+    ..+..+++.+++|+..+|+.||.+|++..=.
T Consensus       468 --------r~Yqe~qLP----alp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  468 --------RTYQESQLP----ALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             --------hhhhhhhCC----CCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence                    000111111    2334566789999999999999999875433

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2e-22  Score=178.18  Aligned_cols=141  Identities=17%  Similarity=0.140  Sum_probs=110.6

Q ss_pred             CCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--------------------------hHHHHHHH
Q 014202           97 PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--------------------------HREWVAEV  150 (429)
Q Consensus        97 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~E~  150 (429)
                      +.+.||+|+||.||+|.+. ++         ..||||++.......                          ...+..|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g---------~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   70 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DG---------EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF   70 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CC---------CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence            3578999999999999876 43         499999987652110                          11235789


Q ss_pred             HHHhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCC
Q 014202          151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFK  229 (429)
Q Consensus       151 ~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlk  229 (429)
                      ..+.++.|++|.....+....  .||||||++|+++....... ..++......++.|++.++.++|  . .||+|||||
T Consensus        71 ~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDlk  145 (190)
T cd05145          71 RNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDLS  145 (190)
T ss_pred             HHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCC
Confidence            999999999885554443332  48999999988654433232 35778899999999999999999  7 999999999


Q ss_pred             CCCeEEcCCCCEEEccccCcccCC
Q 014202          230 TSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       230 p~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      |+|||++ ++.++|+|||++....
T Consensus       146 P~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         146 EYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             hhhEEEE-CCCEEEEEcccceecC
Confidence            9999998 7899999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=3.4e-23  Score=211.32  Aligned_cols=210  Identities=26%  Similarity=0.367  Sum_probs=151.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ..+|..++.|..|+||.||+++++.+.+         .+|+| +++++..     ++-  +|.....|.+|         
T Consensus        82 e~df~~IklisngAygavylvrh~~trq---------rfa~k-iNkq~li-----lRn--ilt~a~npfvv---------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQ---------RFAMK-INKQNLI-----LRN--ILTFAGNPFVV---------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeecccccc---------chhhc-ccccchh-----hhc--cccccCCccee---------
Confidence            4679999999999999999999998866         88984 4433211     111  44444555555         


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                                  |+-...+..- ++++...        +.+++|||  +.||+|||+||+|.+|+.-|++|++|||+++.
T Consensus       136 ------------gDc~tllk~~-g~lPvdm--------vla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 ------------GDCATLLKNI-GPLPVDM--------VLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             ------------chhhhhcccC-CCCcchh--------hHHhHhhc--cCCeecCCCCCCcceeeecccccccchhhhhh
Confidence                        4555555332 2344332        67899999  99999999999999999999999999999875


Q ss_pred             CCCCCccc-------------eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHH
Q 014202          252 GPQGDKTH-------------VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW  318 (429)
Q Consensus       252 ~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  318 (429)
                      ........             .....+|||.|.|||++....|+..+|+|++|+|+||++-|..||.+..+..      .
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------l  266 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------L  266 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------H
Confidence            32111110             1122589999999999999999999999999999999999999998876532      1


Q ss_pred             HHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014202          319 ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP  365 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  365 (429)
                      +.+++.+.....         +.......+++++|.++|+.+|..|-
T Consensus       267 fg~visd~i~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  267 FGQVISDDIEWP---------EEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             Hhhhhhhhcccc---------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            222222211111         11334457899999999999999993

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5.7e-22  Score=173.21  Aligned_cols=188  Identities=17%  Similarity=0.100  Sum_probs=139.3

Q ss_pred             CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh----hHHHHHHHHHHhcCC-CcceeeEEeEEEe
Q 014202           96 RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG----HREWVAEVDFLGQLH-HPNLVKLIGYCIE  170 (429)
Q Consensus        96 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  170 (429)
                      .+...|++|+||+||++...           +.+++.+.+.....-.    ...+.+|+++|++|. |++|++++++   
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~-----------~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGG-----------ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---   70 (218)
T ss_pred             ccceeecCCCcceEEEeecC-----------CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence            45678999999999976542           3478877776553311    124689999999996 5889999886   


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDF-KTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDl-kp~Nill~~~~~~kl~DFg~a  249 (429)
                       +..+++|||+.|.+|...+..        ....++.|++.+|.++|  ..||+|||| ||+|||++.++.++|+|||++
T Consensus        71 -~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A  139 (218)
T PRK12274         71 -DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQLA  139 (218)
T ss_pred             -cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECCCc
Confidence             346999999999998754321        12357789999999999  899999999 799999999999999999999


Q ss_pred             ccCCCCCcc----ce-------eeeccccccccChhhhhcC-CCC-CccchhhhHHHHHHHHhCCCCCCCCC
Q 014202          250 KAGPQGDKT----HV-------STRVVGTYGYAAPEYVMTG-HLT-SKSDVYSFGVVLLEILTGRRSMDKKR  308 (429)
Q Consensus       250 ~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~ell~g~~pf~~~~  308 (429)
                      .........    ..       ......++.|+.|+...-- ..+ ...++++.|+-+|.++|+..++....
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            854332210    00       0112367888888854321 223 56799999999999999998875443

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=9.4e-22  Score=174.96  Aligned_cols=135  Identities=18%  Similarity=0.195  Sum_probs=106.8

Q ss_pred             CCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-----CCcceeeEEeEEEeC
Q 014202           97 PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-----HHPNLVKLIGYCIED  171 (429)
Q Consensus        97 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~  171 (429)
                      -.+.||+|+||.||.  +..+..         . +||++........+.+.+|+.+++.+     .||||++++++++++
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~---------k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~   73 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQ---------R-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD   73 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcC---------e-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence            357899999999995  544432         4 69998766555567789999999999     579999999999987


Q ss_pred             C---eEE-EEEEe--cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCCCeEEcC----CCC
Q 014202          172 D---QRL-LVYEF--MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL-AFLHGGSEPVIYRDFKTSNILLDS----EYN  240 (429)
Q Consensus       172 ~---~~~-lv~e~--~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l-~~lH~~~~~ivHrDlkp~Nill~~----~~~  240 (429)
                      .   ..+ +||||  +.+|+|.+++.+.  .+++.  ..++.|++.++ +|||  +.+|+||||||+|||++.    ++.
T Consensus        74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         74 CGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             CCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCCCCCc
Confidence            4   434 78999  5579999999553  35555  35678888788 9999  899999999999999964    347


Q ss_pred             EEEccccCc
Q 014202          241 AKLSDFGLA  249 (429)
Q Consensus       241 ~kl~DFg~a  249 (429)
                      ++|+||+-+
T Consensus       148 ~~LiDg~G~  156 (210)
T PRK10345        148 PVVCDNIGE  156 (210)
T ss_pred             EEEEECCCC
Confidence            999995444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=2.8e-22  Score=208.32  Aligned_cols=198  Identities=20%  Similarity=0.203  Sum_probs=161.0

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC---CcceeeEEe
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH---HPNLVKLIG  166 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~  166 (429)
                      .....|.|.+.||+|+||.||+|...+          |+.||+|+-+.....   +|.--.+++.+|+   -+-|..+..
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~  761 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISS  761 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHH
Confidence            445778899999999999999998876          348999998776543   2233344555555   355666777


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-------CCC
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-------SEY  239 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~-------~~~  239 (429)
                      .+...+..+||+||.+.|+|.+++. ....+++..++.++.|++..++.||  ..+|||+||||+|+||.       ++-
T Consensus       762 a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  762 AHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             HHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCCccc
Confidence            7777788899999999999999997 4456899999999999999999999  89999999999999993       233


Q ss_pred             CEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCC
Q 014202          240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS  303 (429)
Q Consensus       240 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p  303 (429)
                      -++|+|||.+..+..-.........++|-.+-.+|+..|..++..+|.|.|+.+++-||.|++.
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            4999999999765443333345567899999999999999999999999999999999999643

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-22  Score=207.89  Aligned_cols=247  Identities=24%  Similarity=0.293  Sum_probs=177.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      +|...+.||++.|=+|.+|++.+          | .|+||++-+...    ....+.+.|++ ...++|||.+.+.-+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e----------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE----------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC----------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence            57778899999999999998764          3 599999865542    23344455666 56678999999998888


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .+...|||-+|... +|+|++..+. -+...+..-|+.|++.||.-+|  ..||+|+|||.+||||+.=+-+.|+||...
T Consensus        92 t~kAAylvRqyvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDFAsF  167 (1431)
T KOG1240|consen   92 TDKAAYLVRQYVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDFASF  167 (1431)
T ss_pred             hhHHHHHHHHHHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhccccc
Confidence            88888999898854 9999885553 3666777778999999999999  999999999999999998888999999877


Q ss_pred             ccCCC-CCccceeeeccc----cccccChhhhhcC----------C-CCCccchhhhHHHHHHHHh-CCCCCCCCCCCcc
Q 014202          250 KAGPQ-GDKTHVSTRVVG----TYGYAAPEYVMTG----------H-LTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGE  312 (429)
Q Consensus       250 ~~~~~-~~~~~~~~~~~g----t~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  312 (429)
                      +..-- .+.....+-+.-    -..|+|||-+...          . .+++-||||+||+++||++ |.+||....    
T Consensus       168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----  243 (1431)
T KOG1240|consen  168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----  243 (1431)
T ss_pred             CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----
Confidence            64221 122111111222    2479999987531          1 5678999999999999998 688885211    


Q ss_pred             ccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        +..+-...-.+...+.+.++           ...++.||..|++.||.+|.++++.|+-
T Consensus       244 --L~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 --LLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             --HHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence              00000000000111111110           1358899999999999999999999874

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=2.5e-21  Score=188.84  Aligned_cols=220  Identities=27%  Similarity=0.405  Sum_probs=165.9

Q ss_pred             HhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 014202          153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN  232 (429)
Q Consensus       153 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~N  232 (429)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.|.+......+++.-...++++++.||+|||.... ..|+.|+..|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~n   79 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSN   79 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecccc
Confidence            467899999999999999999999999999999999998888889999999999999999999995333 3999999999


Q ss_pred             eEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC-------CCCCccchhhhHHHHHHHHhCCCCCC
Q 014202          233 ILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-------HLTSKSDVYSFGVVLLEILTGRRSMD  305 (429)
Q Consensus       233 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ell~g~~pf~  305 (429)
                      +++|....+||+|||+.................-..-|.|||.+.+.       ..+.+.||||||++++|+++...||.
T Consensus        80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            99999999999999998875431111111112345579999988653       14678999999999999999999998


Q ss_pred             CCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          306 KKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                      ........  .+.+.. +..  .-.....|.+..  ..+..+.+..++..||..+|.+||+++.+-..++.+...
T Consensus       160 ~~~~~~~~--~eii~~-~~~--~~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  160 LRNLVEDP--DEIILR-VKK--GGSNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccCCh--HHHHHH-HHh--cCCCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            64433322  111111 111  001111111111  113445799999999999999999999999888777764

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=2.3e-20  Score=170.04  Aligned_cols=144  Identities=17%  Similarity=0.142  Sum_probs=111.5

Q ss_pred             cCCCCCCCcccccCceeEEEEE-EccCCCCCCCCCCCcEEEEEEeCCCCch------------------------hhHHH
Q 014202           92 TGNFRPDSILGEGGFGYVFKGW-IEENGTAPAKPGSGITVAVKSLKPDGLQ------------------------GHREW  146 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------------~~~~~  146 (429)
                      ..-|.+.+.||+|+||.||+|. +..+         |+.||+|++......                        ....+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~---------g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   97 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGS---------GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA   97 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCC---------CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence            3458999999999999999998 4444         449999998754211                        01235


Q ss_pred             HHHHHHHhcCCCc--ceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC-e
Q 014202          147 VAEVDFLGQLHHP--NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP-V  223 (429)
Q Consensus       147 ~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~-i  223 (429)
                      ..|+.++.++.+.  .+.+++++    ...+|||||+.|++|...+... ..+.......++.|++.+|.+||  ..| |
T Consensus        98 ~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~g~i  170 (237)
T smart00090       98 EKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY--KEGEL  170 (237)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH--hcCCE
Confidence            6899999999753  34444442    2348999999998887654333 34566677899999999999999  899 9


Q ss_pred             eeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          224 IYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       224 vHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      +||||||+||+++ ++.++|+|||.+...
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999999999 889999999998753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=3.2e-21  Score=184.73  Aligned_cols=173  Identities=26%  Similarity=0.363  Sum_probs=129.1

Q ss_pred             CeEEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR--TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++||.|++|.-.+|.++|..+  ....++.....++.|++.|+.|     ++.+|||+||.||++..+..+||+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence            3578999999999999999643  3456788889999999999998     67999999999999999999999999998


Q ss_pred             ccCCCCC----ccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHH
Q 014202          250 KAGPQGD----KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       250 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      .......    .....+...||..||+||.+.+..|+.++||||||++|+||+. =..+|.                   
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-------------------  464 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-------------------  464 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-------------------
Confidence            8654433    1223345789999999999999999999999999999999998 222221                   


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE  369 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  369 (429)
                      ....+..+.+..++..+..+ .+.-.+|+.++|...|.+||++.+
T Consensus       465 r~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  465 RIATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             HHHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHH
Confidence            11111112222222111111 133458999999999999994443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2e-19  Score=161.85  Aligned_cols=134  Identities=19%  Similarity=0.303  Sum_probs=112.5

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--------hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--------GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +.||+|++|.||+|.+.           |..|++|........        ....+.+|+.++..+.|++|.....++..
T Consensus         2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   70 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD   70 (211)
T ss_pred             cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence            57999999999999872           337899986543221        12356789999999999999887777777


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      .+..++||||++|++|.+.+....    . ....++.+++.+|.++|  ..+++|+|++|.|||++ ++.++|+|||.+.
T Consensus        71 ~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~  142 (211)
T PRK14879         71 PENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFGLAE  142 (211)
T ss_pred             CCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence            888899999999999999885432    2 78889999999999999  89999999999999999 7899999999987


Q ss_pred             c
Q 014202          251 A  251 (429)
Q Consensus       251 ~  251 (429)
                      .
T Consensus       143 ~  143 (211)
T PRK14879        143 F  143 (211)
T ss_pred             C
Confidence            5

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=1.6e-19  Score=160.89  Aligned_cols=130  Identities=19%  Similarity=0.334  Sum_probs=105.9

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--------hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--------GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .||+|+||.||+|.+.           |..|++|........        ...++.+|+.++..+.|+++....-++...
T Consensus         1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   69 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP   69 (199)
T ss_pred             CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence            4899999999999842           347999986543211        124567899999999988766655556667


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||++|++|.+.+.....        .++.+++.+|.+||  ..+++|+|++|.||+++ ++.++++|||++..
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            778999999999999988744321        78899999999999  89999999999999999 78999999999876

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=7.5e-19  Score=179.55  Aligned_cols=139  Identities=21%  Similarity=0.291  Sum_probs=112.6

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--Cc------hhhHHHHHHHHHHhcCCCcce
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GL------QGHREWVAEVDFLGQLHHPNL  161 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~hpnI  161 (429)
                      .....|...+.||+|+||.||+|.+...           .+++|+....  ..      .....+.+|+.+|..++|++|
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i  398 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGV  398 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCC
Confidence            3345567789999999999999987543           2344432111  11      112457899999999999999


Q ss_pred             eeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          162 VKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      +..+.++......++||||++|++|.+++.         ....++.+++.+|.+||  ..+++||||||+|||+ .++.+
T Consensus       399 ~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        399 PTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             CeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECCcE
Confidence            988887777778899999999999999874         35678999999999999  8999999999999999 67799


Q ss_pred             EEccccCccc
Q 014202          242 KLSDFGLAKA  251 (429)
Q Consensus       242 kl~DFg~a~~  251 (429)
                      +|+|||+++.
T Consensus       467 ~liDFGla~~  476 (535)
T PRK09605        467 YLIDFGLGKY  476 (535)
T ss_pred             EEEeCccccc
Confidence            9999999976

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1e-18  Score=155.65  Aligned_cols=144  Identities=16%  Similarity=0.082  Sum_probs=110.3

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch----------------------hhH
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ----------------------GHR  144 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------------------~~~  144 (429)
                      ++......|.+.+.||.|+||.||+|... +         |..||||++......                      ...
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   78 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-D---------GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRL   78 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-C---------CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHH
Confidence            34444445889999999999999999864 3         448999987643210                      011


Q ss_pred             HHHHHHHHHhcCCCcc--eeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC
Q 014202          145 EWVAEVDFLGQLHHPN--LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP  222 (429)
Q Consensus       145 ~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~  222 (429)
                      ....|+.++..+.|++  ++..++    ....++||||++|++|......       .....++.+++.++.++|  ..+
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh--~~g  145 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY--KHG  145 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH--HCC
Confidence            3567899999998774  444443    2345899999999998765421       345678899999999999  899


Q ss_pred             eeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          223 VIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       223 ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      |+||||||+||+++.++.++|+|||.+....
T Consensus       146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         146 IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2.2e-20  Score=190.47  Aligned_cols=255  Identities=23%  Similarity=0.263  Sum_probs=196.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCC-CcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLH-HPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  170 (429)
                      .|.+.+.||+|+|+.|-++....+.+        ..+|+|.+....  .........|..+-..+. |+|++.+++...+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~--------~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~   92 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPE--------SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS   92 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCc--------ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence            47778889999999998776654432        267777776553  222334456888888887 9999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CEEEccccC
Q 014202          171 DDQRLLVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDFGL  248 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l-~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFg~  248 (429)
                      .+..+++++|..|+++.+.+ .......+......++.|+..++.|+|. ..++.||||||+|.+++..+ .++++|||+
T Consensus        93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCchh
Confidence            99999999999999999988 4443356778888999999999999995 57899999999999999999 999999999


Q ss_pred             cccCCC-CCccceeeeccc-cccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          249 AKAGPQ-GDKTHVSTRVVG-TYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       249 a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      |..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||........ ....        
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~--------  242 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSS--------  242 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-ccee--------
Confidence            998766 444444455788 9999999998874 557889999999999999999999976543221 1111        


Q ss_pred             hhhhhhhcCCc--cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          326 KRKLYQIVDPR--LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            .....  ..............+++.+++..+|..|.+.+++..
T Consensus       243 ------~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  243 ------WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ------ecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                  11111  011222334467889999999999999999988754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=3.1e-17  Score=144.63  Aligned_cols=137  Identities=19%  Similarity=0.161  Sum_probs=97.5

Q ss_pred             CCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh--hHH----------------------HHHHHHH
Q 014202           97 PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HRE----------------------WVAEVDF  152 (429)
Q Consensus        97 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~E~~~  152 (429)
                      +.+.||+|+||.||+|.+. +         |..||||++.......  ...                      ...|...
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~---------~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~   70 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-D---------GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRN   70 (187)
T ss_pred             CCcccccccceeEEEEECC-C---------CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHH
Confidence            3578999999999999875 3         3489999987542211  111                      1356666


Q ss_pred             HhcCCCc--ceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCC
Q 014202          153 LGQLHHP--NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFK  229 (429)
Q Consensus       153 l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlk  229 (429)
                      +.++.+.  .+.+.++.    ...++||||++|+.+......... .. .....++.+++.++.++|  . .+|+|+|||
T Consensus        71 l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh--~~~~ivH~Dl~  142 (187)
T cd05119          71 LKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLY--REAGLVHGDLS  142 (187)
T ss_pred             HHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHh--hccCcCcCCCC
Confidence            6666543  24445543    235899999998544322111110 11 567889999999999999  7 999999999


Q ss_pred             CCCeEEcCCCCEEEccccCcccC
Q 014202          230 TSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       230 p~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      |+||+++ ++.++|+|||.+...
T Consensus       143 p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         143 EYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             hhhEEEE-CCcEEEEECcccccc
Confidence            9999999 889999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=8.9e-17  Score=146.78  Aligned_cols=135  Identities=22%  Similarity=0.234  Sum_probs=102.7

Q ss_pred             Cccc-ccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-------------hhhHHHHHHHHHHhcCCCcce--e
Q 014202           99 SILG-EGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-------------QGHREWVAEVDFLGQLHHPNL--V  162 (429)
Q Consensus        99 ~~lg-~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnI--v  162 (429)
                      ..|| .||.|+||.+...           +..++||.+.....             .....+.+|+.++.+|.|++|  +
T Consensus        37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP  105 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP  105 (239)
T ss_pred             ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence            4676 7888888887664           23789998854221             122457889999999998775  6


Q ss_pred             eEEeEEEeCCe----EEEEEEecCC-CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          163 KLIGYCIEDDQ----RLLVYEFMTR-GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       163 ~~~~~~~~~~~----~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      ..+++...+..    .++|||+++| .+|.+++...  .+++.    .+.+++.+|.+||  ..||+||||||+|||++.
T Consensus       106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NILv~~  177 (239)
T PRK01723        106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNILLDP  177 (239)
T ss_pred             eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEEEcC
Confidence            67766443322    2599999997 6898887543  34443    3568999999999  899999999999999999


Q ss_pred             CCCEEEccccCcccC
Q 014202          238 EYNAKLSDFGLAKAG  252 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~  252 (429)
                      ++.++|+|||.+...
T Consensus       178 ~~~v~LIDfg~~~~~  192 (239)
T PRK01723        178 DGKFWLIDFDRGELR  192 (239)
T ss_pred             CCCEEEEECCCcccC
Confidence            899999999998763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=7.2e-17  Score=157.84  Aligned_cols=250  Identities=26%  Similarity=0.295  Sum_probs=190.8

Q ss_pred             CCCCCCCcccc--cCceeEEEEEE--ccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCC-CcceeeEE
Q 014202           93 GNFRPDSILGE--GGFGYVFKGWI--EENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLH-HPNLVKLI  165 (429)
Q Consensus        93 ~~y~~~~~lg~--G~fg~Vy~~~~--~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~  165 (429)
                      ..|.+.+.+|.  |.+|.||.+..  ..+         +..+|+|.-+..  .......-.+|+.-...++ |+|.++.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s---------~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~  184 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSES---------PHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDS  184 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccC---------CcccccccccCCCCCccccccccchhhcccccCccccccccC
Confidence            35777888999  99999999887  443         448899884332  2233334457888777886 99999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHhCCCCCeeeCCCCCCCeEEcCC-CC
Q 014202          166 GYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK----GLAFLHGGSEPVIYRDFKTSNILLDSE-YN  240 (429)
Q Consensus       166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~----~l~~lH~~~~~ivHrDlkp~Nill~~~-~~  240 (429)
                      ..+...+..|+-+|+| +.+|..+.......++...++..+.+...    ||.++|  ..+++|-|+||.||++..+ ..
T Consensus       185 ~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h--s~~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  185 PAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH--SNNIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             cccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC--CCcccccccchhheecccccce
Confidence            9999999999999999 57998888777766889999999999999    999999  9999999999999999988 88


Q ss_pred             EEEccccCcccCCCCCccc---eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTH---VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      .+++|||+........-..   ......|...|++||.. ++.++..+|||+||.++.+..+|..++.......      
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------  334 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------  334 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC------
Confidence            9999999998876654222   12223688899999954 5678999999999999999999877765431100      


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      |           .++-...++.++....+..+...+..|++.+|-.|++.+.+..
T Consensus       335 W-----------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 W-----------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c-----------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1           0111111223333334456667899999999999999888765

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=9.9e-17  Score=135.65  Aligned_cols=134  Identities=20%  Similarity=0.128  Sum_probs=112.4

Q ss_pred             CCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCC--cceeeEEeEEEeCCeE
Q 014202           97 PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH--PNLVKLIGYCIEDDQR  174 (429)
Q Consensus        97 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~  174 (429)
                      +.+.||.|.++.||++....           ..+++|.......  ...+..|+.++..++|  .++++++.++...+..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-----------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-----------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS   68 (155)
T ss_pred             cceecccccccceEEEEecC-----------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence            45789999999999998753           2799999865543  4568899999999986  5899999988888889


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +++|||+.|+.+..+        +......++.+++.+|+++|... .+++|+||+|+||+++..+.++++|||.+..
T Consensus        69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999999998877654        45666778899999999999321 4799999999999999989999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=2.1e-14  Score=142.28  Aligned_cols=139  Identities=19%  Similarity=0.190  Sum_probs=96.1

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh-----------------------------------
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-----------------------------------  143 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------------------------------  143 (429)
                      +.||.|++|.||+|+...          |+.||||+.........                                   
T Consensus       123 ~plasaSigQVh~A~l~~----------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~  192 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVD----------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK  192 (437)
T ss_pred             cceeeeehhheEEEEecC----------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence            679999999999998753          45899999866421110                                   


Q ss_pred             -----HHHHHHHHHHhcCC-----CcceeeEEeE-EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHH-
Q 014202          144 -----REWVAEVDFLGQLH-----HPNLVKLIGY-CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK-  211 (429)
Q Consensus       144 -----~~~~~E~~~l~~l~-----hpnIv~~~~~-~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~-  211 (429)
                           -++.+|+..+.++.     +++| .+-.+ ....+..+|||||++|++|.+..........   ...++.+++. 
T Consensus       193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~  268 (437)
T TIGR01982       193 TLRRELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARS  268 (437)
T ss_pred             HHHHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHH
Confidence                 01344555555542     3333 22222 2234456899999999999887643221222   3345555555 


Q ss_pred             HHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       212 ~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .+..+|  ..|++|+|++|.||+++.++.++|+|||++....
T Consensus       269 ~l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       269 FLNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            467888  8999999999999999999999999999998754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.51  E-value=4e-13  Score=133.07  Aligned_cols=163  Identities=18%  Similarity=0.181  Sum_probs=125.0

Q ss_pred             CcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHH
Q 014202          127 GITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA  206 (429)
Q Consensus       127 g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~  206 (429)
                      |.+|.|+..+...........+-++.|+.|+||||+++++.++.++..|||+|-+  ..|..++.+.+    .......+
T Consensus        37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~~Gl  110 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVCLGL  110 (690)
T ss_pred             CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHHHHH
Confidence            4588888887665533345678889999999999999999999999999999987  35777776544    56667788


Q ss_pred             HHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccc
Q 014202          207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSD  286 (429)
Q Consensus       207 ~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  286 (429)
                      .||+.||.+||+ +.+++|++|.-..|+++..|..||++|-++........  ......---.|..|+.+....  -..|
T Consensus       111 ~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  111 FQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchh
Confidence            999999999985 78999999999999999999999999988865332221  111112223455666443222  3469


Q ss_pred             hhhhHHHHHHHHhC
Q 014202          287 VYSFGVVLLEILTG  300 (429)
Q Consensus       287 iwSlG~il~ell~g  300 (429)
                      .|-|||++++++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=2.1e-14  Score=140.68  Aligned_cols=248  Identities=22%  Similarity=0.164  Sum_probs=178.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHH--HHHHHHHhcCC-CcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW--VAEVDFLGQLH-HPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-hpnIv~~~~~  167 (429)
                      ...+|..+..||.|.|+.|+.......+        +..|++|.+...-.....++  ..|+-+...+. |.+++.++..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~--------~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~  334 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEG--------DCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS  334 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCC--------CceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence            3478899999999999999987744121        34899998876543333332  46777777765 9999999988


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CCEEEccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDF  246 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~DF  246 (429)
                      |......|+-.|||+++++...+ .-...+.+...+.+..|++.++.++|  +..++|+|+||+||++..+ +.-++.||
T Consensus       335 W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  335 WSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             ccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhhhcccc
Confidence            88888889999999999888766 33345788889999999999999999  9999999999999999775 77899999


Q ss_pred             cCcccCCCCCccceeeecccccccc--ChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYA--APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |........     .....+.-++.  +++......+..+.|++|||..+.+.++|...-....                
T Consensus       412 ~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------------  470 (524)
T KOG0601|consen  412 GCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------------  470 (524)
T ss_pred             cccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------------
Confidence            998742111     11123333444  5555556778899999999999999999764322110                


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                         ....+....... .+ ....++..+.+.++..++..||.+.++....+
T Consensus       471 ---~~~~i~~~~~p~-~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  471 ---QSLTIRSGDTPN-LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ---cceeeecccccC-CC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence               011111111111 11 22267888999999999999999988866543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=4.1e-14  Score=128.40  Aligned_cols=202  Identities=22%  Similarity=0.302  Sum_probs=139.2

Q ss_pred             HHHhcCCCcceeeEEeEEEeCC-----eEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCC
Q 014202          151 DFLGQLHHPNLVKLIGYCIEDD-----QRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEP  222 (429)
Q Consensus       151 ~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~  222 (429)
                      .-|-++-|.|||+++.|+.+..     ...++.||+..|+|..+|.+.   ...+......+|+.||+.||.|||+....
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3455667999999999887654     467899999999999999653   34577788889999999999999998899


Q ss_pred             eeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCc--cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhC
Q 014202          223 VIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK--THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG  300 (429)
Q Consensus       223 ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  300 (429)
                      |+|+++..+.|++..+|-+|++----.........  ........+.++|.|||.=...+.+.++|||+||....||.-|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999999888753211111000000  0111123567899999976666677899999999999999887


Q ss_pred             CCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       301 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..--......  ....+.+       ......+..           ..-++++.+||+..|..||++.+++-
T Consensus       279 Eiq~tnseS~--~~~ee~i-------a~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSESK--VEVEENI-------ANVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCcce--eehhhhh-------hhheeeccC-----------ccccCcCcccccCCCCCCcchhhhhc
Confidence            5432111100  0000000       000000110           11246888999999999999999864

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=8.6e-14  Score=139.64  Aligned_cols=143  Identities=18%  Similarity=0.185  Sum_probs=93.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh------------------------------
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG------------------------------  142 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~------------------------------  142 (429)
                      ..|.. +.||+|++|.||+|+...+++         .||||+..+.-...                              
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~---------~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~  189 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGR---------EVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV  189 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCC---------EEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence            45776 789999999999999886544         99999997652110                              


Q ss_pred             ----hH------HHHHHHHHHhcCC----CcceeeEEeEEE-eCCeEEEEEEecCCCChHHH--HhcCCC---CCCHHHH
Q 014202          143 ----HR------EWVAEVDFLGQLH----HPNLVKLIGYCI-EDDQRLLVYEFMTRGSLENH--LFRRTI---PLPWSNR  202 (429)
Q Consensus       143 ----~~------~~~~E~~~l~~l~----hpnIv~~~~~~~-~~~~~~lv~e~~~gg~L~~~--l~~~~~---~~~~~~~  202 (429)
                          .+      ++.+|+..+.++.    +.+.+.+-.++. .....+|||||++|+.|.+.  +...+.   .+.+..+
T Consensus       190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v  269 (537)
T PRK04750        190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV  269 (537)
T ss_pred             HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence                01      1334444444442    333333333332 24456799999999999874  222221   1222223


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----CEEEccccCcccCCC
Q 014202          203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NAKLSDFGLAKAGPQ  254 (429)
Q Consensus       203 ~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~~kl~DFg~a~~~~~  254 (429)
                      ..++.|+       .  ..|++|+|++|.||+++.+|    .++++|||++.....
T Consensus       270 ~~~~~Qi-------f--~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        270 EVFFTQV-------F--RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHH-------H--hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3333333       3  57899999999999999888    999999999986543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.2e-13  Score=117.87  Aligned_cols=128  Identities=20%  Similarity=0.108  Sum_probs=94.8

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCccee-eEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLV-KLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~l  176 (429)
                      .+.|+.|.++.||++...           |..|++|....... ....+..|+.+++.+.+.+++ +++.+.  .+..++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL   68 (170)
T ss_pred             eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence            356899999999998764           33899999765432 123457899999998755543 455443  334589


Q ss_pred             EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC-----eeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          177 VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP-----VIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~-----ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ||||++|.++...    .  .   ....++.+++.+|+.||  ..+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        69 v~e~i~G~~l~~~----~--~---~~~~~~~~l~~~l~~LH--~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          69 ITEFIEGSELLTE----D--F---SDPENLEKIAKLLKKLH--SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEEecCCCccccc----c--c---cCHHHHHHHHHHHHHHh--CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9999999888643    0  1   11345678999999999  565     59999999999998 66899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.44  E-value=1.4e-12  Score=114.17  Aligned_cols=145  Identities=12%  Similarity=0.085  Sum_probs=100.8

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--h--------------------hhHHH----HHHHH
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--Q--------------------GHREW----VAEVD  151 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~--------------------~~~~~----~~E~~  151 (429)
                      ...||.|--+.||.|.......   ....+..+|||+.+....  .                    ....+    .+|+.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r   78 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH   78 (197)
T ss_pred             CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence            4579999999999997543210   011245899999753210  0                    01122    38999


Q ss_pred             HHhcCCC--cceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCC
Q 014202          152 FLGQLHH--PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL-HGGSEPVIYRDF  228 (429)
Q Consensus       152 ~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l-H~~~~~ivHrDl  228 (429)
                      .|.++..  -++.+++++    ..-+|||||+.+..+.....+. ..++......+..+++.+|..| |  ..||||+||
T Consensus        79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H--~~glVHGDL  151 (197)
T cd05146          79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYK--ECNLVHADL  151 (197)
T ss_pred             HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHH--hCCeecCCC
Confidence            9999863  456666654    3458999999765443222122 1345556677889999999998 8  889999999


Q ss_pred             CCCCeEEcCCCCEEEccccCcccCC
Q 014202          229 KTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       229 kp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      ++.|||++ ++.+.|+|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999996 4689999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.42  E-value=5.8e-14  Score=144.53  Aligned_cols=249  Identities=22%  Similarity=0.239  Sum_probs=178.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .+.+.+.+-+-+|.|+.++.+.-..++         ...++|......   ....+....+-.++-..++|.++...-.+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sg---------h~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~  873 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSG---------HTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF  873 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccc---------cccchhhhccchhhccccccccCCccCccccCCCCceecccCCC
Confidence            356777788899999999887654443         234444443321   12233444555555556678888777666


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ......+|+++|+.|++|...|..-+ ..+..-....+..+..+++|||  ...+.|||++|.|+|+..+|..+++|||.
T Consensus       874 ~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~--s~~r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  874 PCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH--SSLRKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             CCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc--cchhhcccccccchhhcccCCcccCcccc
Confidence            67788899999999999999886655 3555566667777889999999  77799999999999999999999999984


Q ss_pred             cccCCC---------------------C--------CccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh
Q 014202          249 AKAGPQ---------------------G--------DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT  299 (429)
Q Consensus       249 a~~~~~---------------------~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~  299 (429)
                      ......                     .        +.........||+.|.+||.+.+......+|+|++|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            321100                     0        00011223679999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCcccc-CCCHHHHHHHHHHHHHcccCCCCCCCCHh
Q 014202          300 GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL-NYSLKGVQKVSQLAYNCLSRDPKSRPSMD  368 (429)
Q Consensus       300 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  368 (429)
                      |.+||....+...                +..+....... .-+...+....+++...|..+|.+|..+.
T Consensus      1031 g~pp~na~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999986654221                11122221211 22344567889999999999999997766

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=1.8e-11  Score=103.69  Aligned_cols=131  Identities=21%  Similarity=0.313  Sum_probs=98.9

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--h------hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--Q------GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..+++|+-+.+|.+.+.           |..+++|.=.+...  .      ......+|+.+|.+++--.|...+=+..+
T Consensus         2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD   70 (204)
T ss_pred             chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence            46889999999998553           33566665332211  1      11345789999999876566555555667


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      .+...|+|||++|..|.+.+...        ...++..+-.-+.-||  ..||+|+||.++||++..+ .+.++|||++.
T Consensus        71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~-~i~~IDfGLg~  139 (204)
T COG3642          71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGG-RIYFIDFGLGE  139 (204)
T ss_pred             CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCC-cEEEEECCccc
Confidence            77788999999999999888654        2456667777888899  9999999999999999765 49999999998


Q ss_pred             c
Q 014202          251 A  251 (429)
Q Consensus       251 ~  251 (429)
                      .
T Consensus       140 ~  140 (204)
T COG3642         140 F  140 (204)
T ss_pred             c
Confidence            5

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=2.1e-11  Score=102.71  Aligned_cols=142  Identities=20%  Similarity=0.218  Sum_probs=106.3

Q ss_pred             CCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--------hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           97 PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--------QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        97 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .+..|-+|+-+.|+++.+.           |+.++||.-.....        -...+.++|+++|.++.--.|.-..=++
T Consensus        11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~   79 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF   79 (229)
T ss_pred             cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence            5678999999999998765           55777776433211        1235568899999998755655555556


Q ss_pred             EeCCeEEEEEEecCC-CChHHHHhcCCCCCCHH-HHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC---EEE
Q 014202          169 IEDDQRLLVYEFMTR-GSLENHLFRRTIPLPWS-NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKL  243 (429)
Q Consensus       169 ~~~~~~~lv~e~~~g-g~L~~~l~~~~~~~~~~-~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl  243 (429)
                      .+...-.|+|||++| .++.+++......-.+. ....++.+|-+.+.-||  ..+|||+||..+||++..++.   +.|
T Consensus        80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~~l  157 (229)
T KOG3087|consen   80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITPIL  157 (229)
T ss_pred             EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCceEE
Confidence            666677899999977 47888887654333333 33788999999999999  999999999999999965543   589


Q ss_pred             ccccCccc
Q 014202          244 SDFGLAKA  251 (429)
Q Consensus       244 ~DFg~a~~  251 (429)
                      +|||++..
T Consensus       158 Idfgls~~  165 (229)
T KOG3087|consen  158 IDFGLSSV  165 (229)
T ss_pred             Eeecchhc
Confidence            99999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=4.7e-11  Score=107.90  Aligned_cols=141  Identities=21%  Similarity=0.258  Sum_probs=106.4

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCC--cceeeEEeEEEeCC---
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHH--PNLVKLIGYCIEDD---  172 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~---  172 (429)
                      +.|+.|.++.||++....          |..+++|....... .....+..|+.++..+.+  .++.+++.+.....   
T Consensus         4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~   73 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG   73 (223)
T ss_pred             eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence            568999999999987643          23799999865432 134567899999999975  44677777766542   


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG---------------------------------  219 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---------------------------------  219 (429)
                      ..++||||++|.++.+.+..  ..++......++.+++.+|..||..                                 
T Consensus        74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            56899999999888775532  2466677777788888888888731                                 


Q ss_pred             ---------------------CCCeeeCCCCCCCeEEcC--CCCEEEccccCccc
Q 014202          220 ---------------------SEPVIYRDFKTSNILLDS--EYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ---------------------~~~ivHrDlkp~Nill~~--~~~~kl~DFg~a~~  251 (429)
                                           ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                 245799999999999988  56689999998875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.18  E-value=4.8e-10  Score=108.23  Aligned_cols=212  Identities=17%  Similarity=0.231  Sum_probs=149.7

Q ss_pred             eeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE----eCCeEEEEEEecC
Q 014202          107 GYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI----EDDQRLLVYEFMT  182 (429)
Q Consensus       107 g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~~lv~e~~~  182 (429)
                      .+.|+++...++.         .|++|++.-+..+.....-.-++.++++.|+|||++.++|.    .+..++||++|++
T Consensus       290 ~Ttyk~~s~~DG~---------~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  290 ITTYKATSNVDGN---------AYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             ceeEeeeeccCCc---------eeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            5679999888765         89999996554443333345678899999999999999887    3456789999987


Q ss_pred             C-CChHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          183 R-GSLENHLFRR--------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       183 g-g~L~~~l~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      + ++|.++....              +...++..+|.++.|+..||.++|  +.|+.-+-|.|.+||++.+.+++|...|
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH--ssGLAck~L~~~kIlv~G~~RIriS~C~  438 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH--SSGLACKTLDLKKILVTGKMRIRISGCG  438 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH--hcCceeecccHhHeEeeCcceEEEeccc
Confidence            5 4777765332              334788999999999999999999  8999999999999999998899998888


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +.........                |-+.+   -.+-|.=.||.+++.|.||..--...  ...+..            
T Consensus       439 i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~--d~~~~s------------  485 (655)
T KOG3741|consen  439 IMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRT--DSTQSS------------  485 (655)
T ss_pred             ceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccc--cchHHH------------
Confidence            7765433220                11211   23568889999999999985321000  000000            


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .+.         .....++.+++++|..+...++++ -++.+++.
T Consensus       486 ~~~---------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  486 HLT---------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             HHH---------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence            000         011234567888888888888886 56777764

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=3.3e-09  Score=100.16  Aligned_cols=263  Identities=15%  Similarity=0.146  Sum_probs=161.3

Q ss_pred             CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeE------E
Q 014202           96 RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGY------C  168 (429)
Q Consensus        96 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~------~  168 (429)
                      ..++.||+|+-+.+|-.-...            ..+.|++.........+..   ..|... .||-+-.-+.|      .
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~------------d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G   78 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVR------------DQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHG   78 (637)
T ss_pred             CCCccccCCccceeeecchhh------------chhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhC
Confidence            346789999999999642221            2456777655433333222   223333 45543331111      1


Q ss_pred             EeCC-eEEEEEEecCCCC-hHHHHh----c-CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          169 IEDD-QRLLVYEFMTRGS-LENHLF----R-RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       169 ~~~~-~~~lv~e~~~gg~-L~~~l~----~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      -+.. ..-++|..+.|.. +.+++.    + .-..+.|.-.++.++.++.+.+.||  ..|.+-+|+.++|+|+.+++.|
T Consensus        79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V  156 (637)
T COG4248          79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKV  156 (637)
T ss_pred             CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceE
Confidence            1222 3568888887753 222221    1 1234788999999999999999999  8899999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCCccc-c
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTG-RRSMDKKRPSGEQ-N  314 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~-~  314 (429)
                      .|.|=..-...   .........+|.+.|.+||...     +..-+...|.|.||++++++|.| .+||.+....... +
T Consensus       157 ~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~  233 (637)
T COG4248         157 VLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN  233 (637)
T ss_pred             EEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence            99986544332   1122223368999999999764     33456789999999999999987 9999875432211 0


Q ss_pred             HHH-HHHH--HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccC--CCCCCCCHhHHHHHhcCCcC
Q 014202          315 LVA-WARQ--YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR--DPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       315 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dP~~Rpt~~eil~~l~~~~~  379 (429)
                      -.+ .+..  +...... ..-..+..........++.+..|+.+|+..  ++.-|||++.++..|..+..
T Consensus       234 p~E~~Ia~g~f~ya~~~-~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         234 PLETDIAHGRFAYASDQ-RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             cchhhhhcceeeechhc-cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            000 0000  0000000 000111111111123457788899999864  46789999999877665543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=4.3e-11  Score=119.30  Aligned_cols=150  Identities=22%  Similarity=0.319  Sum_probs=106.0

Q ss_pred             HHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccce-------eeeccccccccChhhhhcCC
Q 014202          208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-------STRVVGTYGYAAPEYVMTGH  280 (429)
Q Consensus       208 qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~  280 (429)
                      +++.|+.|+|. +.++||++|.|++|.++.++.+||+.|+++...........       ..-..-...|.|||++.+..
T Consensus       107 ~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            44589999997 78999999999999999999999999999875433211100       00123456799999999988


Q ss_pred             CCCccchhhhHHHHHHHH-hCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccC
Q 014202          281 LTSKSDVYSFGVVLLEIL-TGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR  359 (429)
Q Consensus       281 ~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  359 (429)
                      .+.++|+|||||++|.+. .|+.-+..........              .....+......+....+.++++-+.+++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHhcC
Confidence            899999999999999999 4554444332111100              1111111112223345668999999999999


Q ss_pred             CCCCCCCHhHHHH
Q 014202          360 DPKSRPSMDEVVK  372 (429)
Q Consensus       360 dP~~Rpt~~eil~  372 (429)
                      ++.-||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998887743

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=1.5e-09  Score=94.78  Aligned_cols=97  Identities=21%  Similarity=0.227  Sum_probs=64.6

Q ss_pred             HHHHHHHHhcCCCc--ceeeEEeEEEeCCeEEEEEEecC--CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HhCCC
Q 014202          146 WVAEVDFLGQLHHP--NLVKLIGYCIEDDQRLLVYEFMT--RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF-LHGGS  220 (429)
Q Consensus       146 ~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~--gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~-lH~~~  220 (429)
                      ..+|++.|.++..-  ++.+++++.    .-+|||||++  |..+..+. ...  ++......++.+++..+.. +|  .
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~--~  125 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLH--K  125 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHH--C
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHH--h
Confidence            56899999999855  566676542    2379999998  55554433 221  1134455677777775554 58  8


Q ss_pred             CCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       221 ~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .||+|+||.+.|||++++ .+.|+|||.+...
T Consensus       126 ~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  126 AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             cCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            999999999999999887 9999999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=2.7e-09  Score=98.69  Aligned_cols=123  Identities=16%  Similarity=0.112  Sum_probs=89.3

Q ss_pred             CcEEEEEEeCCCCchh-h----------HHHHHHHHHHhcCCCcce--eeEEeEEEe-----CCeEEEEEEecCCC-ChH
Q 014202          127 GITVAVKSLKPDGLQG-H----------REWVAEVDFLGQLHHPNL--VKLIGYCIE-----DDQRLLVYEFMTRG-SLE  187 (429)
Q Consensus       127 g~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~hpnI--v~~~~~~~~-----~~~~~lv~e~~~gg-~L~  187 (429)
                      |+.|.||......... .          ..+.+|+..+.+|..-+|  +.++.+++.     ....+||||++++. +|.
T Consensus        45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~  124 (268)
T PRK15123         45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE  124 (268)
T ss_pred             CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence            4479999774433110 1          136789998888853333  334444433     23568999999876 798


Q ss_pred             HHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-------CCCEEEccccCccc
Q 014202          188 NHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-------EYNAKLSDFGLAKA  251 (429)
Q Consensus       188 ~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-------~~~~kl~DFg~a~~  251 (429)
                      +++... ..+.+......++.+++..+.-||  ..||+|+||++.|||++.       ++.+.|+||+.+..
T Consensus       125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        125 DYCADWATNPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            887532 234566777889999999999999  999999999999999975       46799999998864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.95  E-value=4.8e-09  Score=94.29  Aligned_cols=136  Identities=18%  Similarity=0.119  Sum_probs=97.2

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch----------------------hhHHHHHHHH
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ----------------------GHREWVAEVD  151 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~  151 (429)
                      -+.++..||.|--+.||.|.+..          |.++|||.-......                      .+....+|.+
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~----------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~  161 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPK----------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE  161 (304)
T ss_pred             HHhhccccccCccceEEEEECCC----------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence            46778999999999999998763          558999986443111                      0123468999


Q ss_pred             HHhcCCCc--ceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 014202          152 FLGQLHHP--NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFK  229 (429)
Q Consensus       152 ~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlk  229 (429)
                      +|.+|.-.  .|.+.+++    +.-.+|||+++|-.|...-.      .....-.++..|+.-+.-+-  ..||||+|+.
T Consensus       162 ~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~--~~GiVHGDlS  229 (304)
T COG0478         162 ALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAY--RRGIVHGDLS  229 (304)
T ss_pred             HHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHH--HcCccccCCc
Confidence            99999754  67777764    33479999999977765321      12233334444444444444  5789999999


Q ss_pred             CCCeEEcCCCCEEEccccCccc
Q 014202          230 TSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       230 p~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +-||+++++|.+.++||--+..
T Consensus       230 efNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         230 EFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             hheEEEecCCCEEEEeCccccc
Confidence            9999999999999999976654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=3.3e-08  Score=88.38  Aligned_cols=105  Identities=22%  Similarity=0.184  Sum_probs=82.4

Q ss_pred             HHHHHHHHHHhcCCC--cceeeEEeEEEeC----CeEEEEEEecCCC-ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 014202          144 REWVAEVDFLGQLHH--PNLVKLIGYCIED----DQRLLVYEFMTRG-SLENHLFRRTIPLPWSNRIKIALGAAKGLAFL  216 (429)
Q Consensus       144 ~~~~~E~~~l~~l~h--pnIv~~~~~~~~~----~~~~lv~e~~~gg-~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l  216 (429)
                      ....+|...+.+|..  =.+.+.+++.+..    ...+||+|+++|. +|.+++..... .+......++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            456788888887753  2344555555442    2458999999884 79988865332 56677788999999999999


Q ss_pred             hCCCCCeeeCCCCCCCeEEcCCC---CEEEccccCccc
Q 014202          217 HGGSEPVIYRDFKTSNILLDSEY---NAKLSDFGLAKA  251 (429)
Q Consensus       217 H~~~~~ivHrDlkp~Nill~~~~---~~kl~DFg~a~~  251 (429)
                      |  ..||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       135 H--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 H--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             H--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9  99999999999999998887   799999998775

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.76  E-value=1.5e-07  Score=82.78  Aligned_cols=138  Identities=19%  Similarity=0.103  Sum_probs=99.4

Q ss_pred             ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC---C---chhhHHHHHHHHHHhcCCCc--ceeeEEeEEEe--
Q 014202          101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD---G---LQGHREWVAEVDFLGQLHHP--NLVKLIGYCIE--  170 (429)
Q Consensus       101 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~--  170 (429)
                      -|+||.+-|++....           |..+-+|.-...   .   ......|.+|+..|.+|..-  .+.++......  
T Consensus        26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~   94 (216)
T PRK09902         26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKI   94 (216)
T ss_pred             cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeecc
Confidence            467999999986543           225777775411   0   23457899999999998632  24444422111  


Q ss_pred             C--CeEEEEEEecCC-CChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC--EEEc
Q 014202          171 D--DQRLLVYEFMTR-GSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN--AKLS  244 (429)
Q Consensus       171 ~--~~~~lv~e~~~g-g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~kl~  244 (429)
                      .  -..+||+|-+.| -+|.+++.+.. .+.+......++.+++..+.-||  ..|+.|+|+.+.|||++.+|.  +.++
T Consensus        95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v~lI  172 (216)
T PRK09902         95 EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEAGFL  172 (216)
T ss_pred             CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeEEEE
Confidence            1  235799997754 48888875532 24577777899999999999999  999999999999999987777  9999


Q ss_pred             cccCccc
Q 014202          245 DFGLAKA  251 (429)
Q Consensus       245 DFg~a~~  251 (429)
                      ||--++.
T Consensus       173 DlEk~r~  179 (216)
T PRK09902        173 DLEKSRR  179 (216)
T ss_pred             Ehhccch
Confidence            9976654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.70  E-value=1.1e-07  Score=95.18  Aligned_cols=142  Identities=17%  Similarity=0.185  Sum_probs=94.7

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh------------------------------H----
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH------------------------------R----  144 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~------------------------------~----  144 (429)
                      +.|+.++-|.||+|+...          |+.||||+..+.-....                              .    
T Consensus       131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            679999999999999875          55999999876522110                              0    


Q ss_pred             ------HHHHHHHHHhcCC-----CcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 014202          145 ------EWVAEVDFLGQLH-----HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL  213 (429)
Q Consensus       145 ------~~~~E~~~l~~l~-----hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l  213 (429)
                            ++.+|+.-+.+++     .|+|.--.=+++..+...|+|||++|-.+.+...-....++...+.....++.-- 
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~-  279 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLR-  279 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHH-
Confidence                  1345555555552     3443332333344556689999999998888743332345544444333332221 


Q ss_pred             HHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       214 ~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                       .+-  ..|++|.|..|.||+++.+|++.+.|||+......
T Consensus       280 -q~~--~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         280 -QLL--RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -HHH--hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             111  35899999999999999999999999999986544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.64  E-value=2.2e-09  Score=106.16  Aligned_cols=187  Identities=18%  Similarity=0.136  Sum_probs=136.0

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc-eeeEEeEEEeCCe
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN-LVKLIGYCIEDDQ  173 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~  173 (429)
                      |....-+++|++++++|.+...+.          ....+.+...     ....-++++|.+++||| .+..++-+..++.
T Consensus       244 s~~fh~fvK~altknpKkRptaek----------lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~  308 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEK----------LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY  308 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhh----------heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence            344456899999999998765443          2335554432     34456899999999999 7777888888888


Q ss_pred             EEEEEEecCCC-ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          174 RLLVYEFMTRG-SLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       174 ~~lv~e~~~gg-~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .+++|+++.++ +-..........+...+...+.+.-.++++++|  +..=+|+|    ||+..+ +..+++||+....+
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~--~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH--SSYKVHRD----NILGSE-EEVKLLDFAVPPQL  381 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc--cccccCcc----cccccc-cccccccccCCccc
Confidence            99999999877 332222111222344445556667788999999  54458888    777654 67999999998876


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDK  306 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  306 (429)
                      ....   ......+++.++|||+...+.+....|+|++|+-..+|.-|.+|-..
T Consensus       382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            5543   23347899999999999999999999999999988888878777543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.60  E-value=6.6e-07  Score=79.05  Aligned_cols=139  Identities=12%  Similarity=0.111  Sum_probs=90.7

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHH---------HHHHHHHHhcCC---
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---------WVAEVDFLGQLH---  157 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---  157 (429)
                      ...++|.+.+++-......|.+....           |..+++|..........+.         ..+++..+.++.   
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-----------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g   96 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-----------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG   96 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-----------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence            44578888888888777777665432           4489999887553322221         233444444442   


Q ss_pred             CcceeeEEeEE-----EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 014202          158 HPNLVKLIGYC-----IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN  232 (429)
Q Consensus       158 hpnIv~~~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~N  232 (429)
                      --.++.++-+.     .-....+|||||++|..|.+...     +++    .+...+++++.-||  ..|++|+|..|.|
T Consensus        97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH--~~G~~HGD~hpgN  165 (229)
T PF06176_consen   97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH--KHGFYHGDPHPGN  165 (229)
T ss_pred             ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH--HcCCccCCCCcCc
Confidence            22233333222     22344568999999988876531     222    24456777899999  8999999999999


Q ss_pred             eEEcCCCCEEEccccCccc
Q 014202          233 ILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       233 ill~~~~~~kl~DFg~a~~  251 (429)
                      ++++++ .++++||+..+.
T Consensus       166 Flv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  166 FLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             EEEECC-cEEEEECccccc
Confidence            999865 499999976653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.58  E-value=9.1e-07  Score=80.13  Aligned_cols=137  Identities=15%  Similarity=0.152  Sum_probs=85.4

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc--eeeEEeEEEeCCeEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN--LVKLIGYCIEDDQRLL  176 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~l  176 (429)
                      ..||.|..+.||+..             |..+++|......  ....+.+|.++++.+..-.  +.+.+++....+...+
T Consensus         7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL   71 (226)
T ss_pred             eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence            568999999999731             2257889886533  3345789999999986433  4677887777778889


Q ss_pred             EEEecCCCC-hHHH--------------Hhc-----CCC---CCCHHHHHH-HHH----------HHHH-HHHHH--hCC
Q 014202          177 VYEFMTRGS-LENH--------------LFR-----RTI---PLPWSNRIK-IAL----------GAAK-GLAFL--HGG  219 (429)
Q Consensus       177 v~e~~~gg~-L~~~--------------l~~-----~~~---~~~~~~~~~-~~~----------qi~~-~l~~l--H~~  219 (429)
                      |||+++|.+ +...              +.+     +..   ......... +..          .+.. ...+|  +..
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999999863 1111              100     000   111111110 000          0011 11122  222


Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++|+|+.|.||++++++ +.|+||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            44678999999999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.48  E-value=2e-06  Score=79.00  Aligned_cols=137  Identities=18%  Similarity=0.094  Sum_probs=83.9

Q ss_pred             ccccCc-eeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCCeEEEEE
Q 014202          101 LGEGGF-GYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLLVY  178 (429)
Q Consensus       101 lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~  178 (429)
                      |-.|.. +.||++....           ..+.+|+.....   ...+.+|+.+++.+. +--+.+++++...++..++||
T Consensus         6 ~~~g~~~~~v~~~~~~~-----------~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   71 (244)
T cd05150           6 VTEGQSGATVYRLDGKN-----------PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT   71 (244)
T ss_pred             cCCCCCcCeEEEEcCCC-----------CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence            444555 7899886432           268888876443   345678999988885 445667888777767789999


Q ss_pred             EecCCCChHHHHh-------------------cC---CCCCCHH--HHHHHHH--------------------HHHHHHH
Q 014202          179 EFMTRGSLENHLF-------------------RR---TIPLPWS--NRIKIAL--------------------GAAKGLA  214 (429)
Q Consensus       179 e~~~gg~L~~~l~-------------------~~---~~~~~~~--~~~~~~~--------------------qi~~~l~  214 (429)
                      |+++|.+|.....                   ..   ..++...  .......                    .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            9999987764320                   00   0011100  0000000                    0111122


Q ss_pred             HHh-----CCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          215 FLH-----GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       215 ~lH-----~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      .|-     .....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            221     0134689999999999999877788999987754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.41  E-value=3.2e-06  Score=75.55  Aligned_cols=154  Identities=19%  Similarity=0.164  Sum_probs=101.5

Q ss_pred             cccHHHHHhhcCCCCCCCccc---ccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh---------------
Q 014202           82 QFTFQELKSATGNFRPDSILG---EGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH---------------  143 (429)
Q Consensus        82 ~~~~~~~~~~~~~y~~~~~lg---~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---------------  143 (429)
                      ..+...+.....+..+....|   .|--+.||+|....          +..+|||++........               
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~----------~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~  103 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGD----------GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNS  103 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC----------CceEEEEEEehhhhhhhhHHHHHhcChhhhcC
Confidence            455566666666776665554   56666799986532          45899999865422110               


Q ss_pred             ----HH-----HHHHHHHHhcCC--CcceeeEEeEEEeCCeEEEEEEecCCCChH-HHHhcCCCCCCHHHHHHHHHHHHH
Q 014202          144 ----RE-----WVAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPLPWSNRIKIALGAAK  211 (429)
Q Consensus       144 ----~~-----~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~-~~l~~~~~~~~~~~~~~~~~qi~~  211 (429)
                          +.     ..+|+.-|.++.  +-.+.+.+.+..    ..|||||+....+. -.|..  .++...+...+..++++
T Consensus       104 ~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~  177 (268)
T COG1718         104 RSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVE  177 (268)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHH
Confidence                11     257888888874  445556666543    26999999543111 11111  12333366777788888


Q ss_pred             HHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCC
Q 014202          212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP  253 (429)
Q Consensus       212 ~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~  253 (429)
                      .+.-|-. ..++||+||+.-|||+. ++.+.|+|||-|....
T Consensus       178 ~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         178 YMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHH-hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            8887761 48999999999999999 7899999999887643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=2e-06  Score=72.75  Aligned_cols=129  Identities=18%  Similarity=0.158  Sum_probs=89.8

Q ss_pred             CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcce-eeEEeEEEeCCeE
Q 014202           96 RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNL-VKLIGYCIEDDQR  174 (429)
Q Consensus        96 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~  174 (429)
                      ++.+.||+|.+|.||++.+.           |..+|+|+-..+.  ....+..|+++|..+.-.++ .++|.+..+    
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----   87 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----   87 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-----------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----
Confidence            45678999999999999876           3489999877664  34678899999999986555 345554333    


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC-CCCeEEcCCCCEEEccccCccc
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFK-TSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlk-p~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ++.|||+.|-.|.+.....    +-.    -+..+++.---|-  ..||-|..|. |..++|-.++.+.|+||..|+.
T Consensus        88 ~i~me~i~G~~L~~~~~~~----~rk----~l~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          88 FIRMEYIDGRPLGKLEIGG----DRK----HLLRVLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhhcCcchhhhhhcc----cHH----HHHHHHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            4669999998887754321    112    2234455544444  6789999887 4444444455999999998874

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.39  E-value=2.2e-06  Score=77.83  Aligned_cols=140  Identities=19%  Similarity=0.170  Sum_probs=82.9

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCc--ceeeEEeEEEe---CCe
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP--NLVKLIGYCIE---DDQ  173 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~---~~~  173 (429)
                      +.|+.|..+.||++....           ..+++|.....  .....+..|..+++.|...  .+.+++.....   ...
T Consensus         3 ~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             ccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            578999999999998754           27999997654  4456778899998888532  35566654332   335


Q ss_pred             EEEEEEecCCCChHH----------------HH---hcC---CCCCCHHHH---------HHH------------HHHHH
Q 014202          174 RLLVYEFMTRGSLEN----------------HL---FRR---TIPLPWSNR---------IKI------------ALGAA  210 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~----------------~l---~~~---~~~~~~~~~---------~~~------------~~qi~  210 (429)
                      .+++|++++|..+..                .+   ...   ..++.....         ...            ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            689999999988777                11   011   011111100         000            01122


Q ss_pred             H-HHHHHh-----CCCCCeeeCCCCCCCeEEc-CCCCEEEccccCccc
Q 014202          211 K-GLAFLH-----GGSEPVIYRDFKTSNILLD-SEYNAKLSDFGLAKA  251 (429)
Q Consensus       211 ~-~l~~lH-----~~~~~ivHrDlkp~Nill~-~~~~~kl~DFg~a~~  251 (429)
                      . .+..++     .....++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2 233332     1256799999999999999 666678999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.34  E-value=1.4e-05  Score=70.38  Aligned_cols=128  Identities=19%  Similarity=0.270  Sum_probs=89.3

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC----------------chhhHHHHHHHHHHhcCC----
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG----------------LQGHREWVAEVDFLGQLH----  157 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~----  157 (429)
                      ...||+|+.=.||.  |..+.          ...||+.....                ....++..+|+.....+.    
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp----------~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~   73 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDP----------NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG   73 (199)
T ss_pred             CcccccCCCceEEE--CCCCC----------CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence            45799999999995  33322          47889987765                112345566666555554    


Q ss_pred             --CcceeeEEeEEEeCCeEEEEEEecCC------CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 014202          158 --HPNLVKLIGYCIEDDQRLLVYEFMTR------GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFK  229 (429)
Q Consensus       158 --hpnIv~~~~~~~~~~~~~lv~e~~~g------g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlk  229 (429)
                        +.+|.+++|+.+.+...-+|+|.+.+      -+|.+++.+..  ++. .....+.+   -..||-  ..+|+.+||+
T Consensus        74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~---f~~~l~--~~~Iv~~dl~  145 (199)
T PF10707_consen   74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDE---FKRYLL--DHHIVIRDLN  145 (199)
T ss_pred             CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHH---HHHHHH--HcCCeecCCC
Confidence              88999999999999999999998642      37888885443  444 44444433   345555  6679999999


Q ss_pred             CCCeEEcCC--C--CEEEcc
Q 014202          230 TSNILLDSE--Y--NAKLSD  245 (429)
Q Consensus       230 p~Nill~~~--~--~~kl~D  245 (429)
                      |.||++...  +  .+.|+|
T Consensus       146 ~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  146 PHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cccEEEEecCCCceEEEEEe
Confidence            999999432  2  477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.26  E-value=6.6e-06  Score=82.41  Aligned_cols=140  Identities=16%  Similarity=0.136  Sum_probs=89.5

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh-------------------------------H---
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-------------------------------R---  144 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-------------------------------~---  144 (429)
                      +.||.-+.|.||+|+...          |..||||+-++.-....                               +   
T Consensus       167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~  236 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP  236 (538)
T ss_pred             chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence            679999999999999875          44899999766421110                               0   


Q ss_pred             ---HHHHHHHHHh----cCCCcc------eeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHH
Q 014202          145 ---EWVAEVDFLG----QLHHPN------LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK  211 (429)
Q Consensus       145 ---~~~~E~~~l~----~l~hpn------Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~  211 (429)
                         +|.+|++-..    .+.|-+      |.++|.  .......|+|||++|..+.|.-.-....++...+...+.++..
T Consensus       237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL  314 (538)
T ss_pred             hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH
Confidence               1234444322    234555      444443  2334568999999998776543222223555555444443332


Q ss_pred             HHHHHhCCCCCeeeCCCCCCCeEEcC----CCCEEEccccCcccCCC
Q 014202          212 GLAFLHGGSEPVIYRDFKTSNILLDS----EYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       212 ~l~~lH~~~~~ivHrDlkp~Nill~~----~~~~kl~DFg~a~~~~~  254 (429)
                      -+-+    ..|++|.|=.|.||++..    ++.+.+.|||+......
T Consensus       315 ~qIf----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQIF----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHH----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2222    357999999999999983    67799999999986543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.22  E-value=1.8e-05  Score=85.33  Aligned_cols=81  Identities=19%  Similarity=0.261  Sum_probs=57.1

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCC-Ccce--eeEEeEEEeC--
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLH-HPNL--VKLIGYCIED--  171 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~--  171 (429)
                      .+.|+.|.++.+|+......+.       ...+++|+..... ......+.+|+.+|+.|. |++|  .+++.++.+.  
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~-------~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v  115 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGS-------VKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV  115 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCc-------ceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence            4678999999999986543211       1267888765432 223356789999999996 6665  7777777654  


Q ss_pred             -CeEEEEEEecCCCC
Q 014202          172 -DQRLLVYEFMTRGS  185 (429)
Q Consensus       172 -~~~~lv~e~~~gg~  185 (429)
                       +..|+||||++|..
T Consensus       116 ~G~~flVME~v~G~~  130 (822)
T PLN02876        116 IGTAFYIMEYLEGRI  130 (822)
T ss_pred             CCCceEEEEecCCcc
Confidence             45789999998864

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.18  E-value=3.8e-05  Score=67.21  Aligned_cols=125  Identities=30%  Similarity=0.417  Sum_probs=87.3

Q ss_pred             CCCCCCCcccccCc-eeEEEEEEccCCCCCCCCCCCcEEEEEEeCC---CCc-------h-----------hhHHHHHHH
Q 014202           93 GNFRPDSILGEGGF-GYVFKGWIEENGTAPAKPGSGITVAVKSLKP---DGL-------Q-----------GHREWVAEV  150 (429)
Q Consensus        93 ~~y~~~~~lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~---~~~-------~-----------~~~~~~~E~  150 (429)
                      .+++.++.||.|.- |.||++...           |..||+|+...   ...       .           ...-|..|.
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC  105 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC  105 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence            67888999999999 999999875           55899999321   111       0           012356777


Q ss_pred             HHHhcCC---Ccce--eeEEeEEEeCC------------------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHH
Q 014202          151 DFLGQLH---HPNL--VKLIGYCIEDD------------------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL  207 (429)
Q Consensus       151 ~~l~~l~---hpnI--v~~~~~~~~~~------------------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~  207 (429)
                      +...+|+   +.++  |+++||..-..                  ...||.||.+...          .+.    ..-+.
T Consensus       106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~  171 (207)
T PF13095_consen  106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIP  171 (207)
T ss_pred             HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHH
Confidence            7766664   5566  99999874331                  1246777765433          122    23345


Q ss_pred             HHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       208 qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +|.+-|..+|  ..||+-+|+++.|..     .=+|+|||.+
T Consensus       172 ~~~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  172 QMLRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence            6777888899  999999999999986     3488999865

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=4.6e-05  Score=66.80  Aligned_cols=100  Identities=27%  Similarity=0.328  Sum_probs=78.9

Q ss_pred             HHHHHHhcCCC-cceeeEEeEEEeCCeEEEEEEecCCCChHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCe
Q 014202          148 AEVDFLGQLHH-PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPV  223 (429)
Q Consensus       148 ~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l--~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i  223 (429)
                      .|.-+|+.+++ +++++++|+|-.    ++|.||...+++...-  ..+-...+|..+.+++.++++.+.+++... ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58889999985 699999999832    6799999876664210  011124689999999999999999998322 347


Q ss_pred             eeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          224 IYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       224 vHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      .-.|++++|+-++++|++|++|...+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            7889999999999999999999987754

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.12  E-value=1.9e-05  Score=72.09  Aligned_cols=73  Identities=14%  Similarity=0.110  Sum_probs=46.1

Q ss_pred             CcccccCce-eEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCc---ceeeEEeEEEeCC--
Q 014202           99 SILGEGGFG-YVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP---NLVKLIGYCIEDD--  172 (429)
Q Consensus        99 ~~lg~G~fg-~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~--  172 (429)
                      +.|+.|+.. .||+..              ..+++|.....  .....+.+|+.+|..|...   -+.++++.....+  
T Consensus         3 ~~~~~gG~~n~vy~~~--------------~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~   66 (235)
T cd05155           3 EPVDSGGTDNATFRLG--------------DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY   66 (235)
T ss_pred             eeccCCCcccceEEcC--------------CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence            467777776 588751              14778876542  2334788999999887531   3444454433322  


Q ss_pred             -eEEEEEEecCCCChH
Q 014202          173 -QRLLVYEFMTRGSLE  187 (429)
Q Consensus       173 -~~~lv~e~~~gg~L~  187 (429)
                       ..++||++++|.++.
T Consensus        67 ~~~~~l~~~i~G~~l~   82 (235)
T cd05155          67 PWPWSVYRWLEGETAT   82 (235)
T ss_pred             CcceEEEEeecCCCCC
Confidence             348899999987664

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.96  E-value=0.00011  Score=67.09  Aligned_cols=140  Identities=19%  Similarity=0.144  Sum_probs=79.5

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCC-cceeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH-PNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv  177 (429)
                      +.|..|-...+|++.....        .+..|++|+...... ..-...+|+.+++.+.. .-.+++++.+.  +  .+|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l   70 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLI   70 (235)
T ss_pred             EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEE
Confidence            4577788889999864420        023789997754321 11233478888888853 33444544332  2  489


Q ss_pred             EEecCCCChHHH----------H-------hcCCCC----------CC-HHHHHHHH-----------------------
Q 014202          178 YEFMTRGSLENH----------L-------FRRTIP----------LP-WSNRIKIA-----------------------  206 (429)
Q Consensus       178 ~e~~~gg~L~~~----------l-------~~~~~~----------~~-~~~~~~~~-----------------------  206 (429)
                      |||++|.++...          +       +.....          .. +..+..+.                       
T Consensus        71 ~e~i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (235)
T cd05157          71 YEFIPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFE  150 (235)
T ss_pred             EEeeCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHH
Confidence            999998765321          1       111111          11 11111111                       


Q ss_pred             --HHHHHHHH-HHhC--CCCCeeeCCCCCCCeEEcC-CCCEEEccccCccc
Q 014202          207 --LGAAKGLA-FLHG--GSEPVIYRDFKTSNILLDS-EYNAKLSDFGLAKA  251 (429)
Q Consensus       207 --~qi~~~l~-~lH~--~~~~ivHrDlkp~Nill~~-~~~~kl~DFg~a~~  251 (429)
                        .+.+..|. .+..  ....++|+|+.+.|||++. ++.+.|+||..|..
T Consensus       151 ~l~~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         151 QLRDEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence              11111111 1111  1357999999999999997 57899999987764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.91  E-value=5e-05  Score=71.89  Aligned_cols=140  Identities=16%  Similarity=0.100  Sum_probs=82.7

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCc--ceeeEEe------EEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP--NLVKLIG------YCI  169 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~------~~~  169 (429)
                      .+.|..|....+|+.....           ..+++|+...   .....+..|+.++..|.+-  .+.+++.      +..
T Consensus        19 i~~i~~G~~n~~y~v~~~~-----------~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~   84 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-----------GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE   84 (296)
T ss_pred             eecccCccccceEEEEeCC-----------CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence            4567778878999875421           2689998764   2234566788888877532  2444443      223


Q ss_pred             eCCeEEEEEEecCCCChHH----HH----------hcC--C--C------CCCHHHHH----------HHHHHHHHHHHH
Q 014202          170 EDDQRLLVYEFMTRGSLEN----HL----------FRR--T--I------PLPWSNRI----------KIALGAAKGLAF  215 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~----~l----------~~~--~--~------~~~~~~~~----------~~~~qi~~~l~~  215 (429)
                      .++..++|+++++|..+..    .+          +..  .  .      ...+....          .....+..++.+
T Consensus        85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  164 (296)
T cd05153          85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR  164 (296)
T ss_pred             eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence            3456789999999876531    00          100  0  0      00111100          011112233344


Q ss_pred             HhC-----CCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          216 LHG-----GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       216 lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..     ...+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            331     135799999999999999877778999988764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.91  E-value=4.2e-05  Score=81.42  Aligned_cols=195  Identities=22%  Similarity=0.239  Sum_probs=134.3

Q ss_pred             HHHHHHHHhcCCCcceeeEEeEEEeCCeEE----EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCC
Q 014202          146 WVAEVDFLGQLHHPNLVKLIGYCIEDDQRL----LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE  221 (429)
Q Consensus       146 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~----lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~  221 (429)
                      ...|+..+..+.|+|++.++.|.......-    +..++|...++...+..- ...+....+.+..++.+||.|+|  ..
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h--~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLH--SL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHH--Hh
Confidence            446777788889999999999877654433    345788888888877444 46788899999999999999999  55


Q ss_pred             CeeeCCCCCC---CeEEcCCCCEEEc--cccCcccCCCCCccceeeeccccccccChhhhhcCCCCC--ccchhhhHHHH
Q 014202          222 PVIYRDFKTS---NILLDSEYNAKLS--DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS--KSDVYSFGVVL  294 (429)
Q Consensus       222 ~ivHrDlkp~---Nill~~~~~~kl~--DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwSlG~il  294 (429)
                      ...|.-|..+   +.-.+..+.+.+.  ||+.+..+.......   ...-+..|.++|......+..  ..|+|.+|..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            5555544444   4444566667777  998888755433221   133456678888776655544  47999999999


Q ss_pred             HHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          295 LEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       295 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..+..|..+-.....                   ....++..        ......+++.+|+..++++|+++.+++..
T Consensus       383 ~~~~~~~~i~~~~~~-------------------~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV-------------------PVSLLDVL--------STSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhhhhcCcccccccc-------------------hhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            999988655321110                   00111100        00156788899999999999999999874

>PRK10593 hypothetical protein; Provisional

Probab=97.87  E-value=0.00025  Score=67.04  Aligned_cols=76  Identities=12%  Similarity=0.045  Sum_probs=54.5

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCC---cceeeEEeEEEe---C
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH---PNLVKLIGYCIE---D  171 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~---~  171 (429)
                      .+.||.|..+.||+.....          + .+.+|..+..  .....+..|+..|+.|.-   -.+.++++++..   .
T Consensus        19 ~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~   85 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ----------G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP   85 (297)
T ss_pred             eeecCCccceeEEEEEcCC----------C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence            4679999999999875432          1 4677775421  123467899999988852   367888877654   3


Q ss_pred             CeEEEEEEecCCCCh
Q 014202          172 DQRLLVYEFMTRGSL  186 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L  186 (429)
                      +..+||||+++|+++
T Consensus        86 g~~~LVmE~i~G~~~  100 (297)
T PRK10593         86 GPDVLLLERLRGVSV  100 (297)
T ss_pred             CCeEEEEeccCCEec
Confidence            668999999998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.85  E-value=0.00013  Score=67.57  Aligned_cols=136  Identities=18%  Similarity=0.129  Sum_probs=76.7

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcce-eeEEeEEEeCCeEEEEE
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNL-VKLIGYCIEDDQRLLVY  178 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~  178 (429)
                      .+..|-.+.+|+....           |..+++|........-.-...+|..+|+.+....+ .+++...  .  -++||
T Consensus         3 ~~~~G~tn~~y~~~~~-----------~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~   67 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHP-----------GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV   67 (256)
T ss_pred             cCCCcCcCCeEEEEeC-----------CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence            3556888899987621           33788987654322211134678999988864333 3444432  2  36899


Q ss_pred             EecCCCChHHH----------H-------hcC---CCCCCHHHH-HHHHHHH---------HHHHHHHhC------CCCC
Q 014202          179 EFMTRGSLENH----------L-------FRR---TIPLPWSNR-IKIALGA---------AKGLAFLHG------GSEP  222 (429)
Q Consensus       179 e~~~gg~L~~~----------l-------~~~---~~~~~~~~~-~~~~~qi---------~~~l~~lH~------~~~~  222 (429)
                      ||++|..+...          +       +..   ..+++.... ..+..++         ...+..+-.      ....
T Consensus        68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (256)
T TIGR02721        68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA  147 (256)
T ss_pred             EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence            99998765321          1       111   111222111 1111111         111221210      1236


Q ss_pred             eeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          223 VIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       223 ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ++|+|+.|.||++++++ +.|+||..+..
T Consensus       148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            89999999999998876 78999998865

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.81  E-value=0.00064  Score=65.06  Aligned_cols=32  Identities=25%  Similarity=0.320  Sum_probs=27.1

Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||+|+.|.|||++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45899999999999998665558999998864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.74  E-value=4.9e-06  Score=90.21  Aligned_cols=156  Identities=14%  Similarity=0.015  Sum_probs=113.7

Q ss_pred             HHHHHHHhcCCCcceeeEEeEEEe--CCeEEEEEEecCCCChHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHhC---
Q 014202          147 VAEVDFLGQLHHPNLVKLIGYCIE--DDQRLLVYEFMTRGSLENHLFRRTIP---LPWSNRIKIALGAAKGLAFLHG---  218 (429)
Q Consensus       147 ~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~---  218 (429)
                      +.|..-++...|+++...+.-...  ....|.+++|+.+|.+.+.+.+....   +...-+.....+.+.+..-+|.   
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            455555666789998887764433  33568999999999999999765322   2333333333333556666553   


Q ss_pred             CCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHH
Q 014202          219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL  298 (429)
Q Consensus       219 ~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  298 (429)
                      ...-.+|++||+-|.+|..+.+++++++|+.+...  ..........+++.|++|++.+.-.++.++|+|..|+.+|+..
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            12347899999999999999999999999998321  1222233467889999999988888998999999999999999


Q ss_pred             hCCCCC
Q 014202          299 TGRRSM  304 (429)
Q Consensus       299 ~g~~pf  304 (429)
                      .|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887776

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.70  E-value=0.00034  Score=66.58  Aligned_cols=141  Identities=16%  Similarity=0.100  Sum_probs=80.6

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCc--ceeeEEeE------EE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP--NLVKLIGY------CI  169 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~------~~  169 (429)
                      ++.++.|.-..+|++... +         | .+++|+.....  ....+..|+.++..|...  .+.+++..      ..
T Consensus        27 i~~~~~G~~n~~y~v~t~-~---------~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~   93 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-V---------G-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST   93 (307)
T ss_pred             ccccCCccccceEEEEeC-C---------C-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence            456777777899987532 1         2 57889875432  223455677777776421  23444331      12


Q ss_pred             eCCeEEEEEEecCCCChH----H-------H---HhcCCCCC-----------CHHHHH------------HHHHHHHHH
Q 014202          170 EDDQRLLVYEFMTRGSLE----N-------H---LFRRTIPL-----------PWSNRI------------KIALGAAKG  212 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~----~-------~---l~~~~~~~-----------~~~~~~------------~~~~qi~~~  212 (429)
                      .++..+++++|++|..+.    .       .   ++.....+           .|....            .....+...
T Consensus        94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~  173 (307)
T TIGR00938        94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE  173 (307)
T ss_pred             cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence            345678999999885432    0       0   11100000           000000            001112334


Q ss_pred             HHHHh-----CCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          213 LAFLH-----GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       213 l~~lH-----~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ++++.     ....+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            44443     1247899999999999999887678999998864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.68  E-value=2.2e-05  Score=72.73  Aligned_cols=136  Identities=16%  Similarity=0.103  Sum_probs=91.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--h--------------------hHHHHHHH
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--G--------------------HREWVAEV  150 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~--------------------~~~~~~E~  150 (429)
                      .-+.+++.||-|.-+-||.+-+..          |.+.++|.-......  .                    +-...+|+
T Consensus        92 ~v~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEf  161 (465)
T KOG2268|consen   92 SVESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEF  161 (465)
T ss_pred             hhhhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHH
Confidence            357889999999999999998764          557888875432110  0                    01235789


Q ss_pred             HHHhcCC-C-cceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 014202          151 DFLGQLH-H-PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDF  228 (429)
Q Consensus       151 ~~l~~l~-h-pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDl  228 (429)
                      ..|+.|. | --|.+.+++    +.-++|||++.|..|...-.-.    +...+..   .+..-+--|-  .+|+||+|.
T Consensus       162 afmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~----d~~~ly~---~lm~~Iv~la--~~GlIHgDF  228 (465)
T KOG2268|consen  162 AFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE----DPPTLYD---DLMGLIVRLA--NHGLIHGDF  228 (465)
T ss_pred             HHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC----ChHHHHH---HHHHHHHHHH--HcCceeccc
Confidence            9998886 3 234555554    3347899999998886533211    2233332   2233333444  689999999


Q ss_pred             CCCCeEEcCCCCEEEccccCccc
Q 014202          229 KTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       229 kp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      .-=||++++++.++++||--...
T Consensus       229 NEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  229 NEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             chheeEEecCCCEEEeechHhhc
Confidence            99999999999999999975543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.67  E-value=0.00038  Score=66.07  Aligned_cols=145  Identities=22%  Similarity=0.200  Sum_probs=82.9

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc-eeeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN-LVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv  177 (429)
                      +.|..|-...||++......   .....+..+++|+..... .......+|+.++..+...+ ..+++.++..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            34566777799988754321   022234589999976543 22234568888888885322 3455555432    368


Q ss_pred             EEecCCCChHHHH-----------------hcCCCC--------CC--HHHHHH--------------------------
Q 014202          178 YEFMTRGSLENHL-----------------FRRTIP--------LP--WSNRIK--------------------------  204 (429)
Q Consensus       178 ~e~~~gg~L~~~l-----------------~~~~~~--------~~--~~~~~~--------------------------  204 (429)
                      +||++|..+....                 ++....        .+  +.....                          
T Consensus        76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (302)
T cd05156          76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL  155 (302)
T ss_pred             hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence            9999887664310                 111111        00  000000                          


Q ss_pred             HHHHHHHHHHHHhC-------CCCCeeeCCCCCCCeEEcCC----CCEEEccccCccc
Q 014202          205 IALGAAKGLAFLHG-------GSEPVIYRDFKTSNILLDSE----YNAKLSDFGLAKA  251 (429)
Q Consensus       205 ~~~qi~~~l~~lH~-------~~~~ivHrDlkp~Nill~~~----~~~kl~DFg~a~~  251 (429)
                      +...+...+..+-.       ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            01112222333321       24679999999999999874    8899999988864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.004  Score=60.98  Aligned_cols=75  Identities=21%  Similarity=0.220  Sum_probs=52.5

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC------C-chhhHHHHHHHHHHhcCC---CcceeeEEeEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD------G-LQGHREWVAEVDFLGQLH---HPNLVKLIGYC  168 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~  168 (429)
                      +.||.|.+..||++.....+         +.|+||.-...      . .........|.+.|..+.   -.++.+++.+ 
T Consensus        32 ~elggGn~N~VyrV~~~~g~---------~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-  101 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGG---------KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-  101 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCC---------eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence            57899999999999875321         37999985421      1 123456677888888763   3467778776 


Q ss_pred             EeCCeEEEEEEecCCC
Q 014202          169 IEDDQRLLVYEFMTRG  184 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg  184 (429)
                       +.+..++||||+++.
T Consensus       102 -D~~~~~lVME~L~~~  116 (401)
T PRK09550        102 -DEELAVTVMEDLSDH  116 (401)
T ss_pred             -CCCCCEEEEecCCCc
Confidence             445678999999764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.34  E-value=0.0027  Score=59.37  Aligned_cols=31  Identities=26%  Similarity=0.400  Sum_probs=26.2

Q ss_pred             CCeeeCCCCCCCeEEcCCCC-EEEccccCccc
Q 014202          221 EPVIYRDFKTSNILLDSEYN-AKLSDFGLAKA  251 (429)
Q Consensus       221 ~~ivHrDlkp~Nill~~~~~-~kl~DFg~a~~  251 (429)
                      ..++|+|+.|.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999987566 46999998875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.27  E-value=0.0014  Score=62.16  Aligned_cols=142  Identities=15%  Similarity=0.112  Sum_probs=92.4

Q ss_pred             CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hh--------------------h---H-HHHHH
Q 014202           96 RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QG--------------------H---R-EWVAE  149 (429)
Q Consensus        96 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~--------------------~---~-~~~~E  149 (429)
                      .+...|..|--+-||.|....          |..+|||+++-.-.  .+                    +   + -...|
T Consensus       147 ~inGCiSTGKEANVYHat~~d----------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE  216 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEED----------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE  216 (520)
T ss_pred             ecccccccCccceeEeeecCC----------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence            345678889999999986543          55799999753210  00                    0   1 12568


Q ss_pred             HHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 014202          150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFK  229 (429)
Q Consensus       150 ~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlk  229 (429)
                      ++-|.+|+.-.|.-.--+...  .-.|||+|+. ++=.-.=.-....++...+..+-.|++.-+.-|.. ..++||.||.
T Consensus       217 ~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLS  292 (520)
T KOG2270|consen  217 MRNLKRLNNAGIPCPEPILLK--NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLS  292 (520)
T ss_pred             HHHHHHHHhcCCCCCCceeee--cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccchh
Confidence            888888865443322221111  2269999994 32211111122346677788888888888887753 6789999999


Q ss_pred             CCCeEEcCCCCEEEccccCcccC
Q 014202          230 TSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       230 p~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      --|+|+. +|.+.|+|-+-+...
T Consensus       293 EfN~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  293 EFNLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             hhhheEE-CCEEEEEEccccccC
Confidence            9999995 568999998877653

>PLN02236 choline kinase

Probab=97.17  E-value=0.0048  Score=59.68  Aligned_cols=143  Identities=16%  Similarity=0.127  Sum_probs=80.6

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcce-eeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNL-VKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv  177 (429)
                      +.|-.|-...+|++.......     ..+..|++|+......... .-.+|..+++.+..-++ .++++.+...    .|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~-----~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v  111 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEG-----NLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RV  111 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCC-----CCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence            345558888999986533211     1234799998866532222 22578888888864333 3455555332    58


Q ss_pred             EEecCCCChHHH-----------------HhcCCC-----CCCHHHHHHHHHHH-----------------HHHHHH---
Q 014202          178 YEFMTRGSLENH-----------------LFRRTI-----PLPWSNRIKIALGA-----------------AKGLAF---  215 (429)
Q Consensus       178 ~e~~~gg~L~~~-----------------l~~~~~-----~~~~~~~~~~~~qi-----------------~~~l~~---  215 (429)
                      .+|++|.+|...                 ++....     ...+..+..+..++                 ...+..   
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            999987666421                 011110     11122222222111                 111111   


Q ss_pred             -Hh--CCCCCeeeCCCCCCCeEEcC-CCCEEEccccCccc
Q 014202          216 -LH--GGSEPVIYRDFKTSNILLDS-EYNAKLSDFGLAKA  251 (429)
Q Consensus       216 -lH--~~~~~ivHrDlkp~Nill~~-~~~~kl~DFg~a~~  251 (429)
                       +.  .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11  11457899999999999976 46799999988864

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.07  E-value=0.0096  Score=57.18  Aligned_cols=73  Identities=18%  Similarity=0.220  Sum_probs=46.9

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC------C-chhhHHHHHHHHHHhcCC--Cc-ceeeEEeEEE
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD------G-LQGHREWVAEVDFLGQLH--HP-NLVKLIGYCI  169 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~  169 (429)
                      .||.|....||++.....         ++.|+||.-..-      . .-...+...|...|+...  .| .+.++|.+  
T Consensus         2 EigdGnlN~VfrV~~~~g---------~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEG---------DRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--   70 (370)
T ss_pred             cCCCCceEEEEEEEcCCC---------CeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--
Confidence            579999999999986421         137999884321      1 222345567888887764  34 45555543  


Q ss_pred             eCCeEEEEEEecCC
Q 014202          170 EDDQRLLVYEFMTR  183 (429)
Q Consensus       170 ~~~~~~lv~e~~~g  183 (429)
                      +++...+|||+++.
T Consensus        71 D~e~~~~vMEdL~~   84 (370)
T TIGR01767        71 DTEMAVTVMEDLSH   84 (370)
T ss_pred             ccccceehHhhCcc
Confidence            55566799999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.01  E-value=0.001  Score=65.58  Aligned_cols=165  Identities=24%  Similarity=0.322  Sum_probs=91.4

Q ss_pred             HHHHHHHHHHhcCCCcceeeEEeEEEeCC-eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC
Q 014202          144 REWVAEVDFLGQLHHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP  222 (429)
Q Consensus       144 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~  222 (429)
                      ..++-...+++.+.|+|...++++-.... ...+|||++ +.+|++++..+..  -...          ++  -|    +
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l--~~~s----------~~--~~----~   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL--KDES----------LL--AH----G   87 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc--chhh----------hc--cc----c
Confidence            45667788999999999999999876543 457899998 6799998865531  1111          00  12    2


Q ss_pred             eeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCC
Q 014202          223 VIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR  302 (429)
Q Consensus       223 ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  302 (429)
                      +.|-     |       .++.+| -++..                  |  |     ...++|+||||+|.++.++.-|..
T Consensus        88 ~~~~-----~-------~~~~td-~~~t~------------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   88 VLHL-----N-------IIYITD-HFLTK------------------Y--P-----SPIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             ccee-----h-------hhhccc-ccccc------------------C--C-----CCCCcchhhhhHHHHHHHHHHhhH
Confidence            2221     1       223333 11110                  0  0     011249999999999999999876


Q ss_pred             CCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHH
Q 014202          303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV  371 (429)
Q Consensus       303 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil  371 (429)
                      .|.....   .+....+..+..............   .+...+...+.++..+|+-..|..||...++.
T Consensus       130 l~~~~~~---s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  130 LEAELTE---SEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHH---HHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            6543211   111111111111100000000000   11223456678899999999999998665553

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.00  E-value=0.0093  Score=56.40  Aligned_cols=33  Identities=21%  Similarity=0.458  Sum_probs=29.4

Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ...++|+|+.+.||+++.++-+=|.||+++...
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            346899999999999999888999999999874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.86  E-value=0.012  Score=56.10  Aligned_cols=31  Identities=23%  Similarity=0.308  Sum_probs=26.8

Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            468999999999999987 6789999987754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.84  E-value=0.0071  Score=53.46  Aligned_cols=103  Identities=15%  Similarity=0.134  Sum_probs=68.6

Q ss_pred             EEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHH
Q 014202          129 TVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL  207 (429)
Q Consensus       129 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~  207 (429)
                      +..+|++..-... ...-+..+..++.+++  .|+++..-  +.-.+-+++|.|..-..              ....++.
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------------~~~N~i~  148 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------------NFSNFIT  148 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------------chhHHHH
Confidence            4566666543333 3345677888888765  57777732  33345689998843111              0112222


Q ss_pred             HHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       208 qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .=+.+|.-.|+...+.+|+|..|+||+-|..|.+||.|=+..
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            225677888976789999999999999999999999996644

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.81  E-value=0.011  Score=56.71  Aligned_cols=142  Identities=18%  Similarity=0.254  Sum_probs=78.2

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcce-eeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNL-VKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv  177 (429)
                      +.|..|-...+|++.......      .+..|++|+....... .-.-.+|..+++.+..-++ .++++++. .+   +|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~------~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i   88 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENG------NEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MI   88 (330)
T ss_pred             EEeCCcccceEEEEEecCCCC------CCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Ee
Confidence            345457778899886532211      1237899988654321 1122478888888865444 35555553 22   58


Q ss_pred             EEecCCCChHHH----------H-------hcCCCC----C-CHHHHHHHHHHH-------------------------H
Q 014202          178 YEFMTRGSLENH----------L-------FRRTIP----L-PWSNRIKIALGA-------------------------A  210 (429)
Q Consensus       178 ~e~~~gg~L~~~----------l-------~~~~~~----~-~~~~~~~~~~qi-------------------------~  210 (429)
                      .+|++|..|...          +       +....+    . .+..+..+..++                         +
T Consensus        89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  168 (330)
T PLN02421         89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI  168 (330)
T ss_pred             ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence            899877655210          1       111100    1 122222222111                         1


Q ss_pred             HHHH-HHh--CCCCCeeeCCCCCCCeEEcC-CCCEEEccccCccc
Q 014202          211 KGLA-FLH--GGSEPVIYRDFKTSNILLDS-EYNAKLSDFGLAKA  251 (429)
Q Consensus       211 ~~l~-~lH--~~~~~ivHrDlkp~Nill~~-~~~~kl~DFg~a~~  251 (429)
                      ..+. ++.  ....-++|.||.+.|||+++ ++.++++||..|..
T Consensus       169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1111 121  11234799999999999974 57899999998865

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.79  E-value=0.0071  Score=57.39  Aligned_cols=73  Identities=21%  Similarity=0.188  Sum_probs=56.7

Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      .+.|++|++- |++|.. +.    ...+.++..++.+.+..+.-+.. ...+-|||+...||||+ +|+|.|+||-+++.
T Consensus       299 ~y~yl~~kdh-gt~is~-ik----~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-IK----ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceeee-ee----cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3457788864 556642 21    23578888999988887777763 56889999999999999 99999999999986


Q ss_pred             C
Q 014202          252 G  252 (429)
Q Consensus       252 ~  252 (429)
                      .
T Consensus       371 ~  371 (488)
T COG5072         371 S  371 (488)
T ss_pred             c
Confidence            3

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.79  E-value=0.019  Score=54.74  Aligned_cols=32  Identities=16%  Similarity=0.187  Sum_probs=29.0

Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..+++|+|+.++|||++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999999999999988875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.46  E-value=0.0049  Score=55.15  Aligned_cols=31  Identities=29%  Similarity=0.351  Sum_probs=22.1

Q ss_pred             CCeeeCCCCCCCeEE-cCCCCEEEccccCccc
Q 014202          221 EPVIYRDFKTSNILL-DSEYNAKLSDFGLAKA  251 (429)
Q Consensus       221 ~~ivHrDlkp~Nill-~~~~~~kl~DFg~a~~  251 (429)
                      ..++|.||.|.|||+ +.++.++|+||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            568999999999999 8889999999988764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.28  E-value=0.027  Score=54.86  Aligned_cols=75  Identities=24%  Similarity=0.321  Sum_probs=48.9

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-----C-chhhHHHHHHHHHHhcCC--Cc-ceeeEEeEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-----G-LQGHREWVAEVDFLGQLH--HP-NLVKLIGYC  168 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~  168 (429)
                      .+.||.|.-..||++.+...+         ..|+||.-..-     . .-...+..-|...|+.+.  .| .+.++|.+ 
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~---------~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-  103 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKN---------ISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-  103 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCC---------ceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence            457899999999999874211         26888874321     1 123355667888888764  34 45556653 


Q ss_pred             EeCCeEEEEEEecCC
Q 014202          169 IEDDQRLLVYEFMTR  183 (429)
Q Consensus       169 ~~~~~~~lv~e~~~g  183 (429)
                       +++...+|||+++.
T Consensus       104 -D~e~~~~vMEdL~~  117 (409)
T PRK12396        104 -DSVMNCCVMEDLSD  117 (409)
T ss_pred             -CcHHhhHHHHhCcc
Confidence             45566789998853

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.07  E-value=0.11  Score=50.85  Aligned_cols=73  Identities=11%  Similarity=0.097  Sum_probs=49.1

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-------hhhHHHHHHHHHHhcCC---CcceeeEEeE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-------QGHREWVAEVDFLGQLH---HPNLVKLIGY  167 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpnIv~~~~~  167 (429)
                      .+.||.|....||+.....           ..|+||.-.....       -...+...|+..|+.+.   ..++.+++.+
T Consensus        37 ~~eiggGn~N~VyrV~~~~-----------~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~  105 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS-----------GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF  105 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC-----------ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence            4678999999999987631           2588998652111       12334455677776654   2478888887


Q ss_pred             EEeCCeEEEEEEecCC
Q 014202          168 CIEDDQRLLVYEFMTR  183 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~g  183 (429)
                      +.  +..+++||++++
T Consensus       106 de--d~~vlvME~L~~  119 (418)
T PLN02756        106 DR--TMALIGMRYLEP  119 (418)
T ss_pred             CC--CCCEEEEeecCC
Confidence            66  456789999976

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.97  E-value=0.15  Score=45.58  Aligned_cols=56  Identities=27%  Similarity=0.323  Sum_probs=41.2

Q ss_pred             EEEEEEeCCCCchhhHHHHHHHHHHhcCC---CcceeeEEeEEEeCCeEEEEEEecCCCChH
Q 014202          129 TVAVKSLKPDGLQGHREWVAEVDFLGQLH---HPNLVKLIGYCIEDDQRLLVYEFMTRGSLE  187 (429)
Q Consensus       129 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~  187 (429)
                      ++-||.-..   +....+..|+.-|..|.   .-++.+++.+....++.|+||||++-+.+.
T Consensus        41 ~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          41 PFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            688886432   23345667777666664   466888999999999999999999876554

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.89  E-value=0.047  Score=51.21  Aligned_cols=73  Identities=22%  Similarity=0.259  Sum_probs=46.4

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC---CcceeeEEeEEEeCCeE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH---HPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~  174 (429)
                      .+.|+.|....+|+..  .+         +..+.||+-..   .....+..|+.-|+.|.   --.+.+++.+...++..
T Consensus        22 ~~~v~GG~i~~a~~~~--~~---------~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~   87 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TD---------GGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA   87 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TT---------S-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred             eEecCCCChhheEEEE--CC---------CccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence            4568889999999876  22         34899998762   23345678888888773   45678899988888888


Q ss_pred             EEEEEecCCC
Q 014202          175 LLVYEFMTRG  184 (429)
Q Consensus       175 ~lv~e~~~gg  184 (429)
                      ||||||++.+
T Consensus        88 fLlle~l~~~   97 (288)
T PF03881_consen   88 FLLLEFLEMG   97 (288)
T ss_dssp             EEEEE-----
T ss_pred             eEEEEeecCC
Confidence            9999998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=95.87  E-value=0.16  Score=56.20  Aligned_cols=32  Identities=38%  Similarity=0.442  Sum_probs=27.3

Q ss_pred             CCCeeeCCCCCCCeEEcCCC--CEE-EccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSEY--NAK-LSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~--~~k-l~DFg~a~~  251 (429)
                      ..++||.|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            46799999999999998775  565 999998865

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.66  E-value=0.039  Score=53.31  Aligned_cols=60  Identities=17%  Similarity=0.126  Sum_probs=41.8

Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      ..|+=+|..|-++..++....  .++.....++.-.+.|+--+-. -.+++|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEE
Confidence            346667888889988886554  3555555666655666554432 45799999999999993

>PTZ00384 choline kinase; Provisional

Probab=95.44  E-value=0.15  Score=49.99  Aligned_cols=81  Identities=12%  Similarity=0.110  Sum_probs=45.5

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcce-eeEEeEEEeCCeEEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNL-VKLIGYCIEDDQRLLV  177 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv  177 (429)
                      +.|..|-...+|++.......   .....+.|.+.......... -+-.+|+.+++.|...++ .++++.+..    ++|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~---~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDK---DRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCC---CccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence            455558888999987543211   00001135555432221111 122478999999975444 556665542    699


Q ss_pred             EEecCCCChH
Q 014202          178 YEFMTRGSLE  187 (429)
Q Consensus       178 ~e~~~gg~L~  187 (429)
                      .||++|..|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999987664

>PTZ00296 choline kinase; Provisional

Probab=95.37  E-value=0.2  Score=50.14  Aligned_cols=83  Identities=12%  Similarity=0.065  Sum_probs=47.7

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCccee-eEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLV-KLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~l  176 (429)
                      ++.|..|-...+|++....... ...+..+..|.+++.......-. .-..|..+++.+..-+|- ++++.+.    -+.
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~-~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~  183 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETA-NNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR  183 (442)
T ss_pred             EEEecCcccCceEEEEecCCCC-ccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence            4556667778899987543211 11112245899998865432211 224677777777543433 4555442    246


Q ss_pred             EEEecCCCCh
Q 014202          177 VYEFMTRGSL  186 (429)
Q Consensus       177 v~e~~~gg~L  186 (429)
                      |.||++|..|
T Consensus       184 I~efi~g~~l  193 (442)
T PTZ00296        184 IEEWLYGDPL  193 (442)
T ss_pred             EEEeeCCccC
Confidence            7899988744

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.27  E-value=0.36  Score=46.25  Aligned_cols=30  Identities=20%  Similarity=0.227  Sum_probs=25.4

Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||+|+.+.|||++ + .+.|+||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            45789999999999995 3 578999998864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	429
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-56
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-55
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-51
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-47
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-47
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-46
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-44
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-25
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-25
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-25
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-23
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-23
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-23
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-23
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-23
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-23
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-23
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-23
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-23
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-23
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-23
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-23
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-22
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-22
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-21
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-21
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-19
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-19
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-19
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-19
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-19
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-19
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-19
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-19
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-19
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-19
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-19
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-18
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-18
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-18
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-18
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-17
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-17
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-17
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-17
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-17
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-17
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-17
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-17
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-17
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-17
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-17
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-16
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-16
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-15
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-15
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-15
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-15
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-15
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-15
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-15
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-15
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-15
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-07
3soa_A	444	Full-Length Human Camkii Length = 444		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  215 bits (547), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 130/314 (41%), Positives = 187/314 (59%), Gaps = 20/314 (6%)
Query: 69  PAPTD-EKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSG 127
           PA  D E    QL +F+ +EL+ A+ NF   +ILG GGFG V+KG          +   G
Sbjct: 13  PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKG----------RLADG 62
Query: 128 ITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSL 186
             VAVK LK +  QG   ++  EV+ +    H NL++L G+C+   +RLLVY +M  GS+
Sbjct: 63  TLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
Query: 187 ENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEP-VIYRDFKTSNILLDSEYNAK 242
            + L  R     PL W  R +IALG+A+GLA+LH   +P +I+RD K +NILLD E+ A 
Sbjct: 123 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 182
Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
           + DFGLAK     D  HV   V GT G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R
Sbjct: 183 VGDFGLAKLMDYKD-XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 241
Query: 303 SMDKKRPSGEQN--LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD 360
           + D  R + + +  L+ W +  L +K KL  +VD  L+ NY  + V+++ Q+A  C    
Sbjct: 242 AFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 300
Query: 361 PKSRPSMDEVVKVL 374
           P  RP M EVV++L
Sbjct: 301 PMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 129/314 (41%), Positives = 186/314 (59%), Gaps = 20/314 (6%)
Query: 69  PAPTD-EKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSG 127
           PA  D E    QL +F+ +EL+ A+ NF   +ILG GGFG V+KG          +   G
Sbjct: 5   PAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKG----------RLADG 54
Query: 128 ITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSL 186
             VAVK LK +  QG   ++  EV+ +    H NL++L G+C+   +RLLVY +M  GS+
Sbjct: 55  XLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 187 ENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEP-VIYRDFKTSNILLDSEYNAK 242
            + L  R     PL W  R +IALG+A+GLA+LH   +P +I+RD K +NILLD E+ A 
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
           + DFGLAK     D  HV   V G  G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R
Sbjct: 175 VGDFGLAKLMDYKD-XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 303 SMDKKRPSGEQN--LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD 360
           + D  R + + +  L+ W +  L +K KL  +VD  L+ NY  + V+++ Q+A  C    
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292
Query: 361 PKSRPSMDEVVKVL 374
           P  RP M EVV++L
Sbjct: 293 PMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 114/298 (38%), Positives = 173/298 (58%), Gaps = 16/298 (5%)
Query: 77  PCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK 136
           P +  +    +L+ AT NF    ++G G FG V+KG + +          G  VA+K   
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRT 72
Query: 137 PDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP 196
           P+  QG  E+  E++ L    HP+LV LIG+C E ++ +L+Y++M  G+L+ HL+   +P
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 197 ---LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP 253
              + W  R++I +GAA+GL +LH  +  +I+RD K+ NILLD  +  K++DFG++K G 
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190
Query: 254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
           + D+TH+   V GT GY  PEY + G LT KSDVYSFGVVL E+L  R ++ +  P    
Sbjct: 191 ELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
Query: 314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           NL  WA +   +  +L QIVDP L      + ++K    A  CL+   + RPSM +V+
Sbjct: 251 NLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  200 bits (508), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 113/298 (37%), Positives = 172/298 (57%), Gaps = 16/298 (5%)
Query: 77  PCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK 136
           P +  +    +L+ AT NF    ++G G FG V+KG + +          G  VA+K   
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRT 72
Query: 137 PDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP 196
           P+  QG  E+  E++ L    HP+LV LIG+C E ++ +L+Y++M  G+L+ HL+   +P
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 197 ---LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP 253
              + W  R++I +GAA+GL +LH  +  +I+RD K+ NILLD  +  K++DFG++K G 
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190
Query: 254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
           +  +TH+   V GT GY  PEY + G LT KSDVYSFGVVL E+L  R ++ +  P    
Sbjct: 191 ELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
Query: 314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           NL  WA +   +  +L QIVDP L      + ++K    A  CL+   + RPSM +V+
Sbjct: 251 NLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 175/312 (56%), Gaps = 21/312 (6%)
Query: 74  EKSPCQLLQFTFQELKSATGNF--RPDSI----LGEGGFGYVFKGWIEENGTAPAKPGSG 127
           E S  +   F+F ELK+ T NF  RP S+    +GEGGFG V+KG++     A  K  + 
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAM 65
Query: 128 ITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLE 187
           + +  + LK       +++  E+  + +  H NLV+L+G+  + D   LVY +M  GSL 
Sbjct: 66  VDITTEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 188 NHL--FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD 245
           + L     T PL W  R KIA GAA G+ FLH      I+RD K++NILLD  + AK+SD
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISD 176
Query: 246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD 305
           FGLA+A  +  +T + +R+VGT  Y APE  + G +T KSD+YSFGVVLLEI+TG  ++D
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 306 KKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
           + R    Q L+    +   +++ +   +D ++  +     V+ +  +A  CL      RP
Sbjct: 236 EHREP--QLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 366 SMDEVVKVLTPL 377
            + +V ++L  +
Sbjct: 293 DIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 174/312 (55%), Gaps = 21/312 (6%)
Query: 74  EKSPCQLLQFTFQELKSATGNF--RPDSI----LGEGGFGYVFKGWIEENGTAPAKPGSG 127
           E S  +   F+F ELK+ T NF  RP S+    +GEGGFG V+KG++     A  K  + 
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAM 65
Query: 128 ITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLE 187
           + +  + LK       +++  E+  + +  H NLV+L+G+  + D   LVY +M  GSL 
Sbjct: 66  VDITTEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 188 NHL--FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD 245
           + L     T PL W  R KIA GAA G+ FLH      I+RD K++NILLD  + AK+SD
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISD 176
Query: 246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD 305
           FGLA+A  +  +T +  R+VGT  Y APE  + G +T KSD+YSFGVVLLEI+TG  ++D
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 306 KKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
           + R    Q L+    +   +++ +   +D ++  +     V+ +  +A  CL      RP
Sbjct: 236 EHREP--QLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 366 SMDEVVKVLTPL 377
            + +V ++L  +
Sbjct: 293 DIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 111/303 (36%), Positives = 170/303 (56%), Gaps = 21/303 (6%)
Query: 83  FTFQELKSATGNF--RPDSI----LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK 136
           F+F ELK+ T NF  RP S+    +GEGGFG V+KG++     A  K  + + +  + LK
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 137 PDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRT 194
                  +++  E+  + +  H NLV+L+G+  + D   LVY +M  GSL + L     T
Sbjct: 69  -------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 121
Query: 195 IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
            PL W  R KIA GAA G+ FLH      I+RD K++NILLD  + AK+SDFGLA+A  +
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEK 179
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN 314
             +  +  R+VGT  Y APE  + G +T KSD+YSFGVVLLEI+TG  ++D+ R    Q 
Sbjct: 180 FAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QL 236
Query: 315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L+    +   +++ +   +D ++  +     V+ +  +A  CL      RP + +V ++L
Sbjct: 237 LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295
Query: 375 TPL 377
             +
Sbjct: 296 QEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 110/300 (36%), Positives = 164/300 (54%), Gaps = 21/300 (7%)
Query: 83  FTFQELKSATGNF--RPDSI----LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK 136
           F+F ELK+ T NF  RP S+     GEGGFG V+KG++     A  K  + + +  + LK
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 137 PDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRT 194
                  +++  E+    +  H NLV+L+G+  + D   LVY +   GSL + L     T
Sbjct: 66  -------QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT 118
Query: 195 IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
            PL W  R KIA GAA G+ FLH      I+RD K++NILLD  + AK+SDFGLA+A  +
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEK 176
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN 314
             +    +R+VGT  Y APE  + G +T KSD+YSFGVVLLEI+TG  ++D+ R    Q 
Sbjct: 177 FAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QL 233
Query: 315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L+    +   +++ +   +D +   +     V+    +A  CL      RP + +V ++L
Sbjct: 234 LLDIKEEIEDEEKTIEDYIDKKXN-DADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 132/282 (46%), Gaps = 35/282 (12%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHR--EWVAEVDFLGQLH 157
           +G G FG V +  W             G  VAVK L        R  E++ EV  + +L 
Sbjct: 45  IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIALGAAKGLAF 215
           HPN+V  +G   +     +V E+++RGSL   L +      L    R+ +A   AKG+ +
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           LH  + P+++RD K+ N+L+D +Y  K+ DFGL++   +      S    GT  + APE 
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEV 210
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +       KSDVYSFGV+L E+ T ++      P+     V +  +              
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-------------- 256
Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           RLE+  +L    +V+ +   C + +P  RPS   ++ +L PL
Sbjct: 257 RLEIPRNLN--PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 142/283 (50%), Gaps = 15/283 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           LGEG FG V           P   G+G  VAVK+LK D    HR  W  E+D L  L+H 
Sbjct: 22  LGEGHFGKV-----SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 160 NLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +++K  G C +  ++   LV E++  GSL ++L R +I L  +  +  A    +G+A+LH
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH-VSTRVVGTYGYAAPEYV 276
             S+  I+R+    N+LLD++   K+ DFGLAKA P+G + + V         + APE +
Sbjct: 135 --SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
                   SDV+SFGV L E+LT   S  +  P+    L+  A+  +   R L ++++  
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMTVLR-LTELLERG 250
Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
             L    K   +V  L  NC   +   RP+ + ++ +L  + +
Sbjct: 251 ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 142/284 (50%), Gaps = 17/284 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           LGEG FG V     +     P   G+G  VAVK+LK D    HR  W  E+D L  L+H 
Sbjct: 39  LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 160 NLVKLIGYCIEDD---QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
           +++K  G C ED       LV E++  GSL ++L R +I L  +  +  A    +G+A+L
Sbjct: 94  HIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYL 150
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH-VSTRVVGTYGYAAPEY 275
           H  ++  I+RD    N+LLD++   K+ DFGLAKA P+G + + V         + APE 
Sbjct: 151 H--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +        SDV+SFGV L E+LT   S  +  P+    L+  A+  +   R L ++++ 
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMTVLR-LTELLER 266
Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
              L    K   +V  L  NC   +   RP+ + ++ +L  + +
Sbjct: 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 35/282 (12%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHR--EWVAEVDFLGQLH 157
           +G G FG V +  W             G  VAVK L        R  E++ EV  + +L 
Sbjct: 45  IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIALGAAKGLAF 215
           HPN+V  +G   +     +V E+++RGSL   L +      L    R+ +A   AKG+ +
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           LH  + P+++R+ K+ N+L+D +Y  K+ DFGL++   +      S    GT  + APE 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEV 210
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +       KSDVYSFGV+L E+ T ++      P+     V +  +              
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-------------- 256
Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           RLE+  +L    +V+ +   C + +P  RPS   ++ +L PL
Sbjct: 257 RLEIPRNLN--PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/283 (31%), Positives = 142/283 (50%), Gaps = 15/283 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           LGEG FG V           P   G+G  VAVK+LK D    HR  W  E+D L  L+H 
Sbjct: 22  LGEGHFGKV-----SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 160 NLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +++K  G C +  ++   LV E++  GSL ++L R +I L  +  +  A    +G+A+LH
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH-VSTRVVGTYGYAAPEYV 276
             ++  I+R+    N+LLD++   K+ DFGLAKA P+G + + V         + APE +
Sbjct: 135 --AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
                   SDV+SFGV L E+LT   S  +  P+    L+  A+  +   R L ++++  
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMTVLR-LTELLERG 250
Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
             L    K   +V  L  NC   +   RP+ + ++ +L  + +
Sbjct: 251 ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 44/291 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-------KPDGLQGHREWVAEVDFL 153
           +G+GGFG V KG + ++ +          VA+KSL       + + ++  +E+  EV  +
Sbjct: 27  IGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
             L+HPN+VKL  Y +  +   +V EF+  G L + L  +  P+ WS ++++ L  A G+
Sbjct: 78  SNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDS-----EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            ++   + P+++RD ++ NI L S        AK++DFGL++        H  + ++G +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNF 190
Query: 269 GYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
            + APE +       T K+D YSF ++L  ILTG    D+    G+   +   R+    +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREE-GLR 248
Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
             + +   PRL         + V +L   C S DPK RP    +VK L+ L
Sbjct: 249 PTIPEDCPPRL---------RNVIEL---CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 143/291 (49%), Gaps = 44/291 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-------KPDGLQGHREWVAEVDFL 153
           +G+GGFG V KG + ++ +          VA+KSL       + + ++  +E+  EV  +
Sbjct: 27  IGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
             L+HPN+VKL  Y +  +   +V EF+  G L + L  +  P+ WS ++++ L  A G+
Sbjct: 78  SNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDS-----EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            ++   + P+++RD ++ NI L S        AK++DF L++        H  + ++G +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNF 190
Query: 269 GYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
            + APE +       T K+D YSF ++L  ILTG    D+    G+   +   R+    +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREE-GLR 248
Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
             + +   PRL         + V +L   C S DPK RP    +VK L+ L
Sbjct: 249 PTIPEDCPPRL---------RNVIEL---CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 143/291 (49%), Gaps = 44/291 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-------KPDGLQGHREWVAEVDFL 153
           +G+GGFG V KG + ++ +          VA+KSL       + + ++  +E+  EV  +
Sbjct: 27  IGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
             L+HPN+VKL  Y +  +   +V EF+  G L + L  +  P+ WS ++++ L  A G+
Sbjct: 78  SNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDS-----EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            ++   + P+++RD ++ NI L S        AK++DFG ++        H  + ++G +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNF 190
Query: 269 GYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
            + APE +       T K+D YSF ++L  ILTG    D+    G+   +   R+    +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREE-GLR 248
Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
             + +   PRL         + V +L   C S DPK RP    +VK L+ L
Sbjct: 249 PTIPEDCPPRL---------RNVIEL---CWSGDPKKRPHFSYIVKELSEL 287

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 145/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGLA
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLA 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 23  PHTYEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 74
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 75  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 134
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 135 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLS 192
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 193 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 247
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 248 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 296
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 297 QIVSILDKL 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTYEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGFVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTYEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 144/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL 
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 144/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGAVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/205 (37%), Positives = 108/205 (52%), Gaps = 15/205 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLHHP 159
           LGEG FG V     E     P    +G  VAVKSLKP+    H  +   E++ L  L+H 
Sbjct: 29  LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 160 NLVKLIGYCIED--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           N+VK  G C ED  +   L+ EF+  GSL+ +L +    +    ++K A+   KG+ +L 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST---RVVGTYGYAAPE 274
            GS   ++RD    N+L++SE+  K+ DFGL KA  + DK   +    R    + Y APE
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEXXTVKDDRDSPVFWY-APE 199
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +M       SDV+SFGV L E+LT
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 144/309 (46%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G ++     P+K    I+V
Sbjct: 25  PHTYEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISV 76
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + +PE +     TS SDV+S+G+VL E+++       +R
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GER 249
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E +            + + + VD    L   +     + QL  +C  +D  +RP  +
Sbjct: 250 PYWEMS-----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 369 EVVKVLTPL 377
           ++V +L  L
Sbjct: 299 QIVSILDKL 307

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/205 (37%), Positives = 108/205 (52%), Gaps = 15/205 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLHHP 159
           LGEG FG V     E     P    +G  VAVKSLKP+    H  +   E++ L  L+H 
Sbjct: 17  LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 160 NLVKLIGYCIED--DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           N+VK  G C ED  +   L+ EF+  GSL+ +L +    +    ++K A+   KG+ +L 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 130
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST---RVVGTYGYAAPE 274
            GS   ++RD    N+L++SE+  K+ DFGL KA  + DK   +    R    + Y APE
Sbjct: 131 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEXXTVKDDRDSPVFWY-APE 187
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +M       SDV+SFGV L E+LT
Sbjct: 188 CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 26/286 (9%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           N   D ++G G FG V  G ++     P+K    I+VA+K+LK    +  R +++ E   
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           +GQ  HPN+++L G   +    ++V E+M  GSL++ L +          + +  G A G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT-YGYA 271
           + +L       ++RD    NIL++S    K+SDFGL++      +   +TR       + 
Sbjct: 131 MKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           +PE +     TS SDV+S+G+VL E+++       +RP  E +            + + +
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS-----------NQDVIK 232
Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            VD    L   +     + QL  +C  +D  +RP  +++V +L  L
Sbjct: 233 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 144/286 (50%), Gaps = 43/286 (15%)
Query: 98  DSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V K  W  ++            VA+K ++ +  +  + ++ E+  L ++
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELRQLSRV 59
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPW---SNRIKIALGAAKGL 213
           +HPN+VKL G C+  +   LV E+   GSL N +     PLP+   ++ +   L  ++G+
Sbjct: 60  NHPNIVKLYGACL--NPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 214 AFLHGGS-EPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           A+LH    + +I+RD K  N+LL +     K+ DFG A       +TH+ T   G+  + 
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGSAAWM 171
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE     + + K DV+S+G++L E++T R+  D+    G    + WA         ++ 
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWA---------VHN 220
Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
              P L  N      + +  L   C S+DP  RPSM+E+VK++T L
Sbjct: 221 GTRPPLIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 142/316 (44%), Gaps = 63/316 (19%)
Query: 80  LLQFTFQELKSATGNFRPDSILGEGGFGYVFKG-WIEENGTAPAK---PGSGITVAVKSL 135
           LL+  F EL         + I+G GGFG V++  WI +     A    P   I+  ++++
Sbjct: 1   LLEIDFAELTL-------EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV 53
Query: 136 KPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI 195
           +            E      L HPN++ L G C+++    LV EF   G L   L  + I
Sbjct: 54  R-----------QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI 102
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYN--------AKLSDF 246
           P      +  A+  A+G+ +LH  +  P+I+RD K+SNIL+  +           K++DF
Sbjct: 103 PP--DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160
Query: 247 GLAKAGPQGDKTHVSTRV--VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR--- 301
           GLA+      + H +T++   G Y + APE +     +  SDV+S+GV+L E+LTG    
Sbjct: 161 GLAR------EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 302 RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDP 361
           R +D    +                   Y +   +L L       +  ++L  +C + DP
Sbjct: 215 RGIDGLAVA-------------------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDP 255
Query: 362 KSRPSMDEVVKVLTPL 377
            SRPS   ++  LT +
Sbjct: 256 HSRPSFTNILDQLTTI 271

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 26/286 (9%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           N   D ++G G FG V  G ++     P+K    I+VA+K+LK    +  R +++ E   
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           +GQ  HPN+++L G   +    ++V E+M  GSL++ L +          + +  G A G
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT-YGYA 271
           + +L       ++RD    NIL++S    K+SDFGL++      +   +TR       + 
Sbjct: 148 MKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           +PE +     TS SDV+S+G+VL E+++       +RP  E +            + + +
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS-----------NQDVIK 249
Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            VD    L   +     + QL  +C  +D  +RP  +++V +L  L
Sbjct: 250 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 144/287 (50%), Gaps = 43/287 (14%)
Query: 98  DSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V K  W  ++            VA+K ++ +  +  + ++ E+  L ++
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELRQLSRV 58
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPW---SNRIKIALGAAKGL 213
           +HPN+VKL G C+  +   LV E+   GSL N +     PLP+   ++ +   L  ++G+
Sbjct: 59  NHPNIVKLYGACL--NPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 214 AFLHGGS-EPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           A+LH    + +I+RD K  N+LL +     K+ DFG A       +TH+ T   G+  + 
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGSAAWM 170
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE     + + K DV+S+G++L E++T R+  D+    G    + WA         ++ 
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWA---------VHN 219
Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
              P L  N      + +  L   C S+DP  RPSM+E+VK++T L 
Sbjct: 220 GTRPPLIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           N   D ++G G FG V  G ++     P+K    I+VA+K+LK    +  R +++ E   
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           +GQ  HPN+++L G   +    ++V E M  GSL++ L +          + +  G A G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT-YGYA 271
           + +L       ++RD    NIL++S    K+SDFGL++      +   +TR       + 
Sbjct: 131 MKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           +PE +     TS SDV+S+G+VL E+++       +RP  E +            + + +
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS-----------NQDVIK 232
Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            VD    L   +     + QL  +C  +D  +RP  +++V +L  L
Sbjct: 233 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 133/293 (45%), Gaps = 39/293 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E    +P K    + VAVK+LK   L   +++  E + L  L H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP----------------LPWSNRIK 204
           +VK  G C + D  ++V+E+M  G L N   R   P                L  S  + 
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           IA   A G+ +L   S+  ++RD  T N L+ +    K+ DFG+++     D   V    
Sbjct: 138 IASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           +    +  PE +M    T++SDV+SFGV+L EI T           G+Q    W +  L+
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT----------YGKQ---PWFQ--LS 240
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           +   +  I   R+ L       ++V  +   C  R+P+ R ++ E+ K+L  L
Sbjct: 241 NTEVIECITQGRV-LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 32/278 (11%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V  G W+ ++            VA+K+++ +G     +++ E + + +L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L   
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           S  VI+RD    N L+      K+SDFG+ +     D+   ST       +A+PE     
Sbjct: 123 S--VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
             +SKSDV+SFGV++ E+ +  +   + R + E          + D    +++  PRL  
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 230
Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            +       V Q+  +C    P+ RP+   +++ L  +
Sbjct: 231 TH-------VYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 36/290 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E     P +    I VAVK+LK       +++  E + L  L H +
Sbjct: 21  LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP-------------LPWSNRIKIAL 207
           +VK  G C+E D  ++V+E+M  G L N   R   P             L  S  + IA 
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A G+ +L   S+  ++RD  T N L+      K+ DFG+++     D   V    +  
Sbjct: 136 QIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             +  PE +M    T++SDV+S GVVL EI T           G+Q    W +  L++  
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT----------YGKQ---PWYQ--LSNNE 238
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            +  I   R+ L       Q+V +L   C  R+P  R ++  +  +L  L
Sbjct: 239 VIECITQGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 130/280 (46%), Gaps = 32/280 (11%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V  G W+ ++            VA+K+++ +G     +++ E + + +L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L   
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
              VI+RD    N L+      K+SDFG+ +     D+   ST       +A+PE     
Sbjct: 123 C--VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
             +SKSDV+SFGV++ E+ +  +   + R + E          + D    +++  PRL  
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 230
Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
            +       V Q+  +C    P+ RP+   +++ L  + +
Sbjct: 231 TH-------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 130/280 (46%), Gaps = 32/280 (11%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V  G W+ ++            VA+K+++ +G     +++ E + + +L HP
Sbjct: 13  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 60
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L   
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
              VI+RD    N L+      K+SDFG+ +     D+   ST       +A+PE     
Sbjct: 121 C--VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
             +SKSDV+SFGV++ E+ +  +   + R + E          + D    +++  PRL  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 228
Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
            +       V Q+  +C    P+ RP+   +++ L  + +
Sbjct: 229 TH-------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 130/280 (46%), Gaps = 32/280 (11%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V  G W+ ++            VA+K+++ +G     +++ E + + +L HP
Sbjct: 18  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 65
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L   
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
              VI+RD    N L+      K+SDFG+ +     D+   ST       +A+PE     
Sbjct: 126 C--VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
             +SKSDV+SFGV++ E+ +  +   + R + E          + D    +++  PRL  
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 233
Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
            +       V Q+  +C    P+ RP+   +++ L  + +
Sbjct: 234 TH-------VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 130/280 (46%), Gaps = 32/280 (11%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V  G W+ ++            VA+K++K +G     +++ E + + +L HP
Sbjct: 35  IGSGQFGLVHLGYWLNKD-----------KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHP 82
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L   
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
              VI+RD    N L+      K+SDFG+ +     D+   ST       +A+PE     
Sbjct: 143 C--VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
             +SKSDV+SFGV++ E+ +  +   + R + E          + D    +++  PRL  
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 250
Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
            +       V Q+  +C    P+ RP+   +++ L  + +
Sbjct: 251 TH-------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 136/283 (48%), Gaps = 15/283 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHP 159
           LGEG FG V     +     P   G+G  VAVK+LK   G Q    W  E++ L  L+H 
Sbjct: 17  LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 71
Query: 160 NLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           ++VK  G C +  ++   LV E++  GSL ++L R  + L  +  +  A    +G+A+LH
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLH 129
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH-VSTRVVGTYGYAAPEYV 276
             ++  I+R     N+LLD++   K+ DFGLAKA P+G + + V         + APE +
Sbjct: 130 --AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
                   SDV+SFGV L E+LT   S   + P  +   +    Q      +L ++++  
Sbjct: 188 KECKFYYASDVWSFGVTLYELLTYCDS--NQSPHTKFTELIGHTQGQMTVLRLTELLERG 245
Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
             L    +   ++  L  NC   +   RP+   +V +L   Q+
Sbjct: 246 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 288

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 136/283 (48%), Gaps = 15/283 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHP 159
           LGEG FG V     +     P   G+G  VAVK+LK   G Q    W  E++ L  L+H 
Sbjct: 16  LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 70
Query: 160 NLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           ++VK  G C +  ++   LV E++  GSL ++L R  + L  +  +  A    +G+A+LH
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLH 128
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH-VSTRVVGTYGYAAPEYV 276
             ++  I+R     N+LLD++   K+ DFGLAKA P+G + + V         + APE +
Sbjct: 129 --AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
                   SDV+SFGV L E+LT   S   + P  +   +    Q      +L ++++  
Sbjct: 187 KECKFYYASDVWSFGVTLYELLTYCDS--NQSPHTKFTELIGHTQGQMTVLRLTELLERG 244
Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
             L    +   ++  L  NC   +   RP+   +V +L   Q+
Sbjct: 245 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 287

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 21  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ EF+  GSL  +L +    +     ++      KG+ +L  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 192
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 129/280 (46%), Gaps = 32/280 (11%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V  G W+ ++            VA+K+++ +G     +++ E + + +L HP
Sbjct: 16  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
            LV+L G C+E     LV EFM  G L ++L  +         + + L   +G+A+L   
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
              VI+RD    N L+      K+SDFG+ +     D+   ST       +A+PE     
Sbjct: 124 C--VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL 339
             +SKSDV+SFGV++ E+ +  +   + R + E          + D    +++  PRL  
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 231
Query: 340 NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
            +       V Q+  +C    P+ RP+   +++ L  + +
Sbjct: 232 TH-------VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 17  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 188
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 18  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 189
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 18  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESL 189
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 16  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 128
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 187
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 21  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 192
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 23  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 135
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 194
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 18  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 189
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 24  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 136
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 195
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 22  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 134
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 193
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 25  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 137
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 196
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT 219

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 34  TSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATG 93
           TSL   A +E  Y   +N          LS+ NP+          Q +Q       S   
Sbjct: 45  TSLYKKAGSENLYFQGANTV-----HIDLSALNPELV--------QAVQHVVIGPSSLIV 91
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDF 152
           +F  + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   
Sbjct: 92  HF--NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 153 LGQLHHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           +    HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AK
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYG 269
           G+ FL   S+  ++RD    N +LD ++  K++DFGLA+     + D  H  T       
Sbjct: 204 GMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           + A E + T   T+KSDV+SFGV+L E++T
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 49  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 220
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 36  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 207
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 36  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 207
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 107/229 (46%), Gaps = 31/229 (13%)
Query: 95  FRPD-----SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAE 149
           FRP       +LG+G FG   K    E G           + +K L     +  R ++ E
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEV---------MVMKELIRFDEETQRTFLKE 57
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
           V  +  L HPN++K IG   +D +   + E++  G+L   +       PWS R+  A   
Sbjct: 58  VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA------KAGPQG-------D 256
           A G+A+LH  S  +I+RD  + N L+    N  ++DFGLA      K  P+G       D
Sbjct: 118 ASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD 305
           +    T VVG   + APE +       K DV+SFG+VL EI+ GR + D
Sbjct: 176 RKKRYT-VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 19  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +L  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 131
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+R+  T NIL+++E   K+ DFGL K  PQ DK +   +  G     + APE +
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESL 190
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 191 TESKFSVASDVWSFGVVLYELFT 213

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 140/309 (45%), Gaps = 28/309 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +E++++      + ++G G FG V  G ++  G         + V
Sbjct: 2   PHTYEDPNQAVHEFAKEIEASCITI--ERVIGAGEFGEVCSGRLKLPGK------RELPV 53
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN++ L G   +    ++V E+M  GSL+  
Sbjct: 54  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTF 113
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G + G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 114 LKKNDGQFTVIQLVGMLRGISAGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLS 171
Query: 250 KAGPQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
           +      +   +TR       + APE +     TS SDV+S+G+V+ E+++       +R
Sbjct: 172 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSY-----GER 226
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           P  E              + + + V+    L   +     + QL  +C  ++  SRP  D
Sbjct: 227 PYWEMT-----------NQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFD 275
Query: 369 EVVKVLTPL 377
           E+V +L  L
Sbjct: 276 EIVNMLDKL 284

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V     E     P +  +G  VAVK L+    +  R++  E++ L  L H N
Sbjct: 21  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 161 LVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           +VK  G C    +R   L+ E++  GSL ++L      +     ++      KG+ +L  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL-- 133
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPEYV 276
           G++  I+RD  T NIL+++E   K+ DFGL K  PQ DK     +  G     + APE +
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 192
Query: 277 MTGHLTSKSDVYSFGVVLLEILT 299
                +  SDV+SFGVVL E+ T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 36  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ F
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 149
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     + D  H  T       + A 
Sbjct: 150 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 33  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ F
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 146
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     + D  H  T       + A 
Sbjct: 147 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ F
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 148
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     + D  H  T       + A 
Sbjct: 149 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 36  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ F
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 149
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     + D  H  T       + A 
Sbjct: 150 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 133/305 (43%), Gaps = 37/305 (12%)
Query: 83  FTFQELKSATGNF---------RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK 133
           FTF++   A   F         + + ++G G FG V  G ++  G         I VA+K
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIK 67
Query: 134 SLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR 192
           +LK    +  R ++++E   +GQ  HPN++ L G   +    +++ EFM  GSL++ L +
Sbjct: 68  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 127
Query: 193 RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG 252
                     + +  G A G+ +L       ++RD    NIL++S    K+SDFGL++  
Sbjct: 128 NDGQFTVIQLVGMLRGIAAGMKYL--ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 253 PQGDKTHVSTRVVG---TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP 309
                    T  +G      + APE +     TS SDV+S+G+V+ E+++       +RP
Sbjct: 186 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY-----GERP 240
Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
             +              + +   ++    L   +     + QL  +C  +D   RP   +
Sbjct: 241 YWDMT-----------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 289
Query: 370 VVKVL 374
           +V  L
Sbjct: 290 IVNTL 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 40  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 93
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ F
Sbjct: 94  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 153
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     + D  H  T       + A 
Sbjct: 154 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ F
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 148
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     + D  H  T       + A 
Sbjct: 149 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 29/282 (10%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHH 158
           ++G G FG V+KG ++ +      P     VA+K+LK    +  R +++ E   +GQ  H
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
            N+++L G   +    +++ E+M  G+L+  L  +         + +  G A G+ +L  
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVSTRVVGTYGYAAPEY 275
            +   ++RD    NIL++S    K+SDFGL++     P+   T    ++     + APE 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEA 221
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +     TS SDV+SFG+V+ E++T       +RP  E +             ++ + ++ 
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT-----YGERPYWELS-----------NHEVMKAIND 265
Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
              L   +     + QL   C  ++   RP   ++V +L  L
Sbjct: 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 28/281 (9%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQL 156
           + ++G G FG V +G ++    AP K  S   VA+K+LK    +  R E+++E   +GQ 
Sbjct: 21  EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HPN+++L G        +++ EFM  G+L++ L            + +  G A G+ +L
Sbjct: 75  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 134
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG---TYGYAAP 273
              S   ++RD    NIL++S    K+SDFGL++   +       T  +G      + AP
Sbjct: 135 AEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     TS SD +S+G+V+ E+++           GE+     + Q + +  +    +
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMS----------FGERPYWDMSNQDVINAIEQDYRL 242
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
            P  +   SL       QL  +C  +D  +RP   +VV  L
Sbjct: 243 PPPPDCPTSLH------QLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 131/285 (45%), Gaps = 36/285 (12%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQL 156
           + ++G G FG V +G ++    AP K  S   VA+K+LK    +  R E+++E   +GQ 
Sbjct: 19  EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HPN+++L G        +++ EFM  G+L++ L            + +  G A G+ +L
Sbjct: 73  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 132
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG---TYGYAAP 273
              S   ++RD    NIL++S    K+SDFGL++   +       T  +G      + AP
Sbjct: 133 AEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     TS SD +S+G+V+ E+++       +RP  + +                Q V
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSF-----GERPYWDMS---------------NQDV 230
Query: 334 DPRLELNYSL----KGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
              +E +Y L         + QL  +C  +D  +RP   +VV  L
Sbjct: 231 INAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 89  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 207 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 30  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 148 SCTYQLARGMEYL--ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 19  LGGGQFGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L+G C  +    ++ EFMT G+L ++L R       S  + + +      A  +   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD    N L+   +  K++DFGL++    GD             + APE +    
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            + KSDV++FGV+L EI T   S     P               D  ++Y++++    + 
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDPSQVYELLEKDYRME 230
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                 +KV +L   C   +P  RPS  E+
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 35  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 153 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 32  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 150 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E +   P +    + VAVK+LK       +++  E + L  L H +
Sbjct: 26  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--------------PLPWSNRIKIA 206
           +V+  G C E    L+V+E+M  G L   L                   PL     + +A
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
              A G+ +L G     ++RD  T N L+      K+ DFG+++     D   V  R + 
Sbjct: 142 SQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
              +  PE ++    T++SDV+SFGVVL EI T           G+Q    W +  L++ 
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT----------YGKQ---PWYQ--LSNT 244
Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
             +  I   R EL        +V  +   C  R+P+ R S+ +V
Sbjct: 245 EAIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E +   P +    + VAVK+LK       +++  E + L  L H +
Sbjct: 20  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--------------PLPWSNRIKIA 206
           +V+  G C E    L+V+E+M  G L   L                   PL     + +A
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
              A G+ +L G     ++RD  T N L+      K+ DFG+++     D   V  R + 
Sbjct: 136 SQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
              +  PE ++    T++SDV+SFGVVL EI T           G+Q    W +  L++ 
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT----------YGKQ---PWYQ--LSNT 238
Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
             +  I   R EL        +V  +   C  R+P+ R S+ +V
Sbjct: 239 EAIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      +++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+G FG V +G       AP+  G  ++VAVK LKPD L   +   +++ EV+ +  L 
Sbjct: 20  LGDGSFGVVRRG----EWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H NL++L G  +    ++ V E    GSL + L +           + A+  A+G+ +L 
Sbjct: 74  HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV--STRVVGTYGYAAPEY 275
             S+  I+RD    N+LL +    K+ DFGL +A PQ D  +V    R V  + + APE 
Sbjct: 133 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 189
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           + T   +  SD + FGV L E+ T
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V+KG W   +G    K      + V +  P  LQ  +    EV  L +  H 
Sbjct: 20  IGSGSFGTVYKGKW---HGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHV 68
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  
Sbjct: 69  NILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 127
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-- 277
           S  +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +   
Sbjct: 128 S--IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 278 -TGHLTSKSDVYSFGVVLLEILTGR 301
            +   + +SDVY+FG+VL E++TG+
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 140/310 (45%), Gaps = 30/310 (9%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P + +    +EL ++    + + ++G G FG V  G ++  G         + V
Sbjct: 23  PETYEDPNRAVHQFAKELDASC--IKIERVIGAGEFGEVCSGRLKLPGK------RDVAV 74
Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+V L G        ++V EFM  G+L+  
Sbjct: 75  AIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF 134
Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL+
Sbjct: 135 LRKHDGQFTVIQLVGMLRGIAAGMRYL--ADMGYVHRDLAARNILVNSNLVCKVSDFGLS 192
Query: 250 KAGPQGDKTHVSTRVVGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKK 307
           +   + D   V T   G     + APE +     TS SDV+S+G+V+ E+++       +
Sbjct: 193 RV-IEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY-----GE 246
Query: 308 RPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM 367
           RP  + +            + + + ++    L   +     + QL  +C  ++   RP  
Sbjct: 247 RPYWDMS-----------NQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKF 295
Query: 368 DEVVKVLTPL 377
           +++V +L  +
Sbjct: 296 EQIVGILDKM 305

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E +   P +    + VAVK+LK       +++  E + L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--------------PLPWSNRIKIA 206
           +V+  G C E    L+V+E+M  G L   L                   PL     + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
              A G+ +L G     ++RD  T N L+      K+ DFG+++     D   V  R + 
Sbjct: 165 SQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
              +  PE ++    T++SDV+SFGVVL EI T       K+P        W +  L++ 
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT-----YGKQP--------WYQ--LSNT 267
Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
             +  I   R EL        +V  +   C  R+P+ R S+ +V
Sbjct: 268 EAIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 29  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 77
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 78  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 137 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYG 193
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 194 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 241
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 242 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 272

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 52/279 (18%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           LG G FG V+ G W   NG           VA+K+LKP G      ++ E   + +L H 
Sbjct: 17  LGNGQFGEVWMGTW---NGNT--------KVAIKTLKP-GTMSPESFLEEAQIMKKLKHD 64
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFL 216
            LV+L    + ++   +V E+M +GSL + L     R + LP  N + +A   A G+A++
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAYI 121
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVSTRVVGTYG 269
              +   I+RD +++NIL+ +    K++DFGLA+          QG K  +         
Sbjct: 122 ERMN--YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK-------- 171
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           + APE  + G  T KSDV+SFG++L E++T  R      P    N     R+ L    + 
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV-----PYPGMN----NREVLEQVERG 222
Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           Y++  P+ +   SL       +L  +C  +DP+ RP+ +
Sbjct: 223 YRMPCPQ-DCPISL------HELMIHCWKKDPEERPTFE 254

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 19  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L+G C  +    ++ EFMT G+L ++L R       S  + + +      A  +   
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD    N L+   +  K++DFGL++    GD             + APE +    
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            + KSDV++FGV+L EI T   S     P               D  ++Y++++    + 
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDPSQVYELLEKDYRME 230
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                 +KV +L   C   +P  RPS  E+
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+G FG V +G       AP+  G  ++VAVK LKPD L   +   +++ EV+ +  L 
Sbjct: 20  LGDGSFGVVRRG----EWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H NL++L G  +    ++ V E    GSL + L +           + A+  A+G+ +L 
Sbjct: 74  HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV--STRVVGTYGYAAPEY 275
             S+  I+RD    N+LL +    K+ DFGL +A PQ D  +V    R V  + + APE 
Sbjct: 133 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 189
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           + T   +  SD + FGV L E+ T
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+G FG V +G       AP+  G  ++VAVK LKPD L   +   +++ EV+ +  L 
Sbjct: 16  LGDGSFGVVRRG----EWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H NL++L G  +    ++ V E    GSL + L +           + A+  A+G+ +L 
Sbjct: 70  HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV--STRVVGTYGYAAPEY 275
             S+  I+RD    N+LL +    K+ DFGL +A PQ D  +V    R V  + + APE 
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 185
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           + T   +  SD + FGV L E+ T
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+G FG V +G       AP+  G  ++VAVK LKPD L   +   +++ EV+ +  L 
Sbjct: 26  LGDGSFGVVRRG----EWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H NL++L G  +    ++ V E    GSL + L +           + A+  A+G+ +L 
Sbjct: 80  HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV--STRVVGTYGYAAPEY 275
             S+  I+RD    N+LL +    K+ DFGL +A PQ D  +V    R V  + + APE 
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 195
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           + T   +  SD + FGV L E+ T
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V+KG W   +G    K      + V +  P  LQ  +    EV  L +  H 
Sbjct: 32  IGSGSFGTVYKGKW---HGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHV 80
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  
Sbjct: 81  NILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-- 277
           S  +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +   
Sbjct: 140 S--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 278 -TGHLTSKSDVYSFGVVLLEILTGR 301
            +   + +SDVY+FG+VL E++TG+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 138/306 (45%), Gaps = 35/306 (11%)
Query: 83  FTFQELKSATGNF---------RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK 133
           FTF++   A   F         + + ++G G FG V  G ++     P K    I VA+K
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLK----VPGK--REICVAIK 63
Query: 134 SLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR 192
           +LK     +  R++++E   +GQ  HPN++ L G   +    +++ E+M  GSL+  L +
Sbjct: 64  TLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK 123
Query: 193 RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG 252
                     + +  G   G+ +L   S   ++RD    NIL++S    K+SDFG+++  
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYLSDMS--AVHRDLAARNILVNSNLVCKVSDFGMSRVL 181
Query: 253 PQGDKTHVSTRVVGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG 311
               +   +TR       + APE +     TS SDV+S+G+V+ E+++           G
Sbjct: 182 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YG 231
Query: 312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           E+     + Q +    +    + P ++   +L       QL  +C  ++   RP   ++V
Sbjct: 232 ERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALH------QLMLDCWQKERSDRPKFGQIV 285
Query: 372 KVLTPL 377
            +L  L
Sbjct: 286 NMLDKL 291

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 34  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 147
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 148 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL 205
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+G FG V +G       AP+  G  ++VAVK LKPD L   +   +++ EV+ +  L 
Sbjct: 16  LGDGSFGVVRRG----EWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H NL++L G  +    ++ V E    GSL + L +           + A+  A+G+ +L 
Sbjct: 70  HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV--STRVVGTYGYAAPEY 275
             S+  I+RD    N+LL +    K+ DFGL +A PQ D  +V    R V  + + APE 
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 185
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           + T   +  SD + FGV L E+ T
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 30/284 (10%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQL 156
           + I+G G  G V  G +   G         + VA+K+LK    +  R ++++E   +GQ 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HPN+++L G        ++V E+M  GSL+  L            + +  G   G+ +L
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVSTRVVGTYGYAAP 273
                  ++RD    N+L+DS    K+SDFGL++     P    T    ++     + AP
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAP 223
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     +S SDV+SFGVV+ E+L        +RP            +    R +   V
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA-----YGERP-----------YWNMTNRDVISSV 267
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           +    L   +     + QL  +C  +D   RP   ++V VL  L
Sbjct: 268 EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 26/282 (9%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQL 156
           + I+G G  G V  G +   G         + VA+K+LK    +  R ++++E   +GQ 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HPN+++L G        ++V E+M  GSL+  L            + +  G   G+ +L
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG-DKTHVSTRVVGTYGYAAPEY 275
                  ++RD    N+L+DS    K+SDFGL++      D  + +T       + APE 
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +     +S SDV+SFGVV+ E+L        +RP                 R +   V+ 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA-----YGERPYWNMT-----------NRDVISSVEE 269
Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
              L   +     + QL  +C  +D   RP   ++V VL  L
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 27  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 75
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 135 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYG 191
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 239
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 240 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VAVK +K +G     E+  E   + +L HP 
Sbjct: 16  LGSGQFGVVKLG----------KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LVK  G C ++    +V E+++ G L N+L      L  S  +++     +G+AFL   S
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE--S 122
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEYVM 277
              I+RD    N L+D +   K+SDFG+ +     D  +VS+  VGT     ++APE   
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSS--VGTKFPVKWSAPEVFH 178
Query: 278 TGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
               +SKSDV++FG+++ E+ + G+   D    S    +V    Q      +LY+   P 
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKVSQ----GHRLYR---PH 228
Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
           L           + Q+ Y+C    P+ RP+  +++  + PL++
Sbjct: 229 L-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 30  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 78
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 79  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 137
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 138 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYG 194
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 195 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 242
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 243 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 129 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYG 185
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 233
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 31  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 79
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 80  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 138
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 139 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 195
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 196 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 243
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 244 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 274

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 41/291 (14%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAE 149
            NFR +  +G G F  V++          A    G+ VA+K ++   L   +   + + E
Sbjct: 32  ANFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKE 82
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLE---NHLFRRTIPLPWSNRIKIA 206
           +D L QL+HPN++K     IED++  +V E    G L     H  ++   +P     K  
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           +     L  +H  S  V++RD K +N+ + +    KL D GL +      KT  +  +VG
Sbjct: 143 VQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 198
Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
           T  Y +PE +       KSD++S G +L E                  + A    +  DK
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDK 240
Query: 327 RKLYQIVDPRLELNY----SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV 373
             LY +     + +Y    S    +++ QL   C++ DP+ RP +  V  V
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 135/297 (45%), Gaps = 40/297 (13%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR--EWVAEVDFLGQLH 157
           ILGEG FG V +G +++      + G+ + VAVK++K D        E+++E   +    
Sbjct: 41  ILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 158 HPNLVKLIGYCIEDDQR-----LLVYEFMTRGSLENHLFRRTIP-----LPWSNRIKIAL 207
           HPN+++L+G CIE   +     +++  FM  G L  +L    +      +P    +K  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A G+ +L   +   ++RD    N +L  +    ++DFGL+K    GD           
Sbjct: 155 DIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             + A E +     TSKSDV++FGV + EI T  R M      G QN   +   YL    
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPY--PGVQNHEMY--DYLLHGH 266
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD----EVVKVLTPLQDL 380
           +L Q  D           + ++ ++ Y+C   DP  RP+      ++ K+L  L D+
Sbjct: 267 RLKQPED----------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV 313

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 23  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 71
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 72  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 131 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYG 187
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 188 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 235
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 236 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 266

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +G G FG V+KG W   +G    K      + V +  P  LQ  +    EV  L +  H 
Sbjct: 32  IGSGSFGTVYKGKW---HGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHV 80
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N++  +GY     Q  +V ++    SL +HL            I IA   A+G+ +LH  
Sbjct: 81  NILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-- 277
           S  +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +   
Sbjct: 140 S--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 278 -TGHLTSKSDVYSFGVVLLEILTGR 301
            +   + +SDVY+FG+VL E++TG+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 26  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 74
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 75  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 133
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 134 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 190
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 191 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 238
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 239 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 269

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 22  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 132 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAP 182
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 226
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 227 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 27  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 75
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 135 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 191
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 239
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 240 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 22  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 71  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 129
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 130 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYG 186
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 187 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 234
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 235 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 265

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 129 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYG 185
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 233
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/205 (34%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
           S LG+G FG V     E     P    +G  VAVK L+  G    R++  E+  L  LH 
Sbjct: 29  SQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 83
Query: 159 PNLVKL--IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
             +VK   + Y        LV E++  G L + L R    L  S  +  +    KG+ +L
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPE 274
             GS   ++RD    NIL++SE + K++DFGLAK  P  DK +   R  G     + APE
Sbjct: 144 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPE 200
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +     + +SDV+SFGVVL E+ T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++  + ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/205 (34%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
           S LG+G FG V     E     P    +G  VAVK L+  G    R++  E+  L  LH 
Sbjct: 16  SQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 70
Query: 159 PNLVKL--IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
             +VK   + Y        LV E++  G L + L R    L  S  +  +    KG+ +L
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 130
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPE 274
             GS   ++RD    NIL++SE + K++DFGLAK  P  DK +   R  G     + APE
Sbjct: 131 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPE 187
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +     + +SDV+SFGVVL E+ T
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 136 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 186
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 230
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 231 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 136 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAP 186
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 230
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 231 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/205 (34%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
           S LG+G FG V     E     P    +G  VAVK L+  G    R++  E+  L  LH 
Sbjct: 17  SQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 71
Query: 159 PNLVKL--IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
             +VK   + Y        LV E++  G L + L R    L  S  +  +    KG+ +L
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 131
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPE 274
             GS   ++RD    NIL++SE + K++DFGLAK  P  DK +   R  G     + APE
Sbjct: 132 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPE 188
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +     + +SDV+SFGVVL E+ T
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 136 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 186
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 230
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 231 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L+G C  +    ++ EFMT G+L ++L R       S  + + +      A  +   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD    N L+   +  K++DFGL++    GD             + APE +    
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            + KSDV++FGV+L EI T   S     P               D  ++Y++++    + 
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELLEKDYRME 232
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                 +KV +L   C   +P  RPS  E+
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L+G C  +    ++ EFMT G+L ++L R       S  + + +      A  +   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD    N L+   +  K++DFGL++    GD             + APE +    
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            + KSDV++FGV+L EI T   S     P               D  ++Y++++    + 
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELLEKDYRME 232
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                 +KV +L   C   +P  RPS  E+
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+G FG V +G       AP+  G  ++VAVK LKPD L   +   +++ EV+ +  L 
Sbjct: 26  LGDGSFGVVRRG----EWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H NL++L G  +    ++ V E    GSL + L +           + A+  A+G+ +L 
Sbjct: 80  HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV--STRVVGTYGYAAPEY 275
             S+  I+RD    N+LL +    K+ DFGL +A PQ D   V    R V  + + APE 
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPES 195
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           + T   +  SD + FGV L E+ T
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L+G C  +    ++ EFMT G+L ++L R       S  + + +      A  +   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD    N L+   +  K++DFGL++    GD             + APE +    
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            + KSDV++FGV+L EI T   S     P               D  ++Y++++    + 
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELLEKDYRME 232
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                 +KV +L   C   +P  RPS  E+
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLH 157
           LG+G FG V +G       AP+  G  ++VAVK LKPD L   +   +++ EV+ +  L 
Sbjct: 16  LGDGSFGVVRRG----EWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H NL++L G  +    ++ V E    GSL + L +           + A+  A+G+ +L 
Sbjct: 70  HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV--STRVVGTYGYAAPEY 275
             S+  I+RD    N+LL +    K+ DFGL +A PQ D   V    R V  + + APE 
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPES 185
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           + T   +  SD + FGV L E+ T
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L+G C  +    ++ EFMT G+L ++L R       S  + + +      A  +   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD    N L+   +  K++DFGL++    GD             + APE +    
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            + KSDV++FGV+L EI T   S     P               D  ++Y++++    + 
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELLEKDYRME 237
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                 +KV +L   C   +P  RPS  E+
Sbjct: 238 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 19  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L+G C  +    ++ EFMT G+L ++L R       S  + + +      A  +   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD    N L+   +  K++DFGL++    GD             + APE +    
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNK 186
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            + KSDV++FGV+L EI T   S     P               D  ++Y++++    + 
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDPSQVYELLEKDYRME 230
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                 +KV +L   C   +P  RPS  E+
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 129 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 185
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 233
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 148
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 149 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 25  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 74
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 134
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 135 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 185
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 229
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 16  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 64
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 65  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 121
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
               I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 180
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 181 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 228
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 229 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 259

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/205 (34%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
           S LG+G FG V     E     P    +G  VAVK L+  G    R++  E+  L  LH 
Sbjct: 13  SQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 67
Query: 159 PNLVKL--IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
             +VK   + Y     +  LV E++  G L + L R    L  S  +  +    KG+ +L
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 127
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT--YGYAAPE 274
             GS   ++RD    NIL++SE + K++DFGLAK  P  DK     R  G     + APE
Sbjct: 128 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDXXVVREPGQSPIFWYAPE 184
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +     + +SDV+SFGVVL E+ T
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 54  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 107
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 108 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 167
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 168 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 225
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L+G C  +    ++ EFMT G+L ++L R       S  + + +      A  +   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD    N L+   +  K++DFGL++    GD             + APE +    
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            + KSDV++FGV+L EI T   S     P               D  ++Y++++    + 
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELLEKDYRME 232
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
                 +KV +L   C   +P  RPS  E+
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 148
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 149 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 131 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 181
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 225
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 136 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 186
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 230
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 231 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 22  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 132 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAP 182
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 226
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 227 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 21  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 139 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 32  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 145
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 146 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 133 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 183
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 227
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 27  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 80
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 81  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 140
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 141 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 34  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 147
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 148 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 133 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAP 183
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 227
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 133 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 183
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 227
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 30  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 144 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 131 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 181
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 225
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 53  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 106
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 107 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 166
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 167 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP   +TVAVK LK D  +    + V+E++ +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++  + ++G+L  +L  R  P               + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 A+G+ +L   S+  I+RD    N+L+      K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV++ EI T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 25  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 143 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V++G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 34  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 83
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    ++ EFMT G+L ++L           + L  + +I  A+   +  
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 143
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 144 NFIH--------RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 194
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y+++
Sbjct: 195 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYELL 238
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           +    +       +KV +L   C   +P  RPS  E+
Sbjct: 239 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 29  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 147 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQL 156
           + ++G G FG V+ G + +N       G  I  AVKSL +   +    +++ E   +   
Sbjct: 33  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 157 HHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
            HPN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 146
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD--KTHVSTRVVGTYGYAAP 273
           L   S+  ++RD    N +LD ++  K++DFGLA+     +    H  T       + A 
Sbjct: 147 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 48/274 (17%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG V  G              G  VAVK +K D     + ++AE   + QL H N
Sbjct: 20  IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 66
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN-RIKIALGAAKGLAFLHG 218
           LV+L+G  +E+   L +V E+M +GSL ++L  R   +   +  +K +L   + + +L G
Sbjct: 67  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYVM 277
            +   ++RD    N+L+  +  AK+SDFGL K A    D   +  +      + APE + 
Sbjct: 127 NN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 178
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               ++KSDV+SFG++L EI +  R             V + R  L D       V PR+
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD-------VVPRV 218
Query: 338 ELNYSLKGVQ----KVSQLAYNCLSRDPKSRPSM 367
           E  Y +         V ++  NC   D   RPS 
Sbjct: 219 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 252

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 48/274 (17%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG V  G              G  VAVK +K D     + ++AE   + QL H N
Sbjct: 14  IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 60
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN-RIKIALGAAKGLAFLHG 218
           LV+L+G  +E+   L +V E+M +GSL ++L  R   +   +  +K +L   + + +L G
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYVM 277
            +   ++RD    N+L+  +  AK+SDFGL K A    D   +  +      + APE + 
Sbjct: 121 NN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 172
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               ++KSDV+SFG++L EI +  R             V + R  L D       V PR+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD-------VVPRV 212
Query: 338 ELNYSLKGVQ----KVSQLAYNCLSRDPKSRPSM 367
           E  Y +         V ++  NC   D   RPS 
Sbjct: 213 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 246

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 48/274 (17%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG V  G              G  VAVK +K D     + ++AE   + QL H N
Sbjct: 29  IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 75
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN-RIKIALGAAKGLAFLHG 218
           LV+L+G  +E+   L +V E+M +GSL ++L  R   +   +  +K +L   + + +L G
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYVM 277
            +   ++RD    N+L+  +  AK+SDFGL K A    D   +  +      + APE + 
Sbjct: 136 NN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 187
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               ++KSDV+SFG++L EI +  R             V + R  L D       V PR+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD-------VVPRV 227
Query: 338 ELNYSLKGVQ----KVSQLAYNCLSRDPKSRPSM 367
           E  Y +         V ++  NC   D   RPS 
Sbjct: 228 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 261

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 43  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 92
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 93  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 151
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 152 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 281 ---LTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 124/281 (44%), Gaps = 28/281 (9%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQL 156
           + ++G G FG V  G ++  G         I VA+K+LK    +  R ++++E   +GQ 
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKRE------IFVAIKTLKSGYTEKQRRDFLSEASIMGQF 65
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HPN++ L G   +    +++ EFM  GSL++ L +          + +  G A G+ +L
Sbjct: 66  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG---TYGYAAP 273
                  ++R     NIL++S    K+SDFGL++           T  +G      + AP
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     TS SDV+S+G+V+ E+++       +RP  +              + +   +
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSY-----GERPYWDMT-----------NQDVINAI 227
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           +    L   +     + QL  +C  +D   RP   ++V  L
Sbjct: 228 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 28  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 146 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 21  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 71  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-- 278
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 279 -GHLTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 44  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 93
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 94  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 281 ---LTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 18  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 67
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 68  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 126
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-- 278
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 127 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 279 -GHLTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 21  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 71  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 281 ---LTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 36  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 85
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 86  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 144
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 145 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 281 ---LTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 124/274 (45%), Gaps = 48/274 (17%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG V  G              G  VAVK +K D     + ++AE   + QL H N
Sbjct: 201 IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 247
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHG 218
           LV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L   + + +L G
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYVM 277
            +   ++RD    N+L+  +  AK+SDFGL K A    D   +  +      + APE + 
Sbjct: 308 NN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 359
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               ++KSDV+SFG++L EI +  R             V + R  L D       V PR+
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD-------VVPRV 399
Query: 338 ELNYSLKGVQKVSQLAY----NCLSRDPKSRPSM 367
           E  Y +          Y    NC   D  +RP+ 
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTF 433

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 65
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 66  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-- 278
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 279 -GHLTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/216 (35%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV- 147
           K+   +F    +LG+G FG VF            +P SG   A+K LK   L+  R+ V 
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLV------RKVTRPDSGHLYAMKVLKKATLKV-RDRVR 76
Query: 148 --AEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
              E D L  ++HP +VKL  Y  + + +L L+ +F+  G L   L +  +      +  
Sbjct: 77  TKMERDILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY 135
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           +A   A GL  LH  S  +IYRD K  NILLD E + KL+DFGL+K     +K   S   
Sbjct: 136 LA-ELALGLDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--F 190
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            GT  Y APE V     +  +D +S+GV++ E+LTG
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 65
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 66  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-- 278
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 279 -GHLTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 44  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 93
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY  +  Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 94  ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 281 ---LTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V+KG  + +G    K      + V +  P  LQ  +    EV  L +  H N
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVK-----MLNVTAPTPQQLQAFKN---EVGVLRKTRHVN 65
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           ++  +GY     Q  +V ++    SL +HL            I IA   A+G+ +LH  S
Sbjct: 66  ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-- 278
             +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE +    
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 279 -GHLTSKSDVYSFGVVLLEILTGR 301
               + +SDVY+FG+VL E++TG+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 17  LGAGQFGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 65
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 66  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 122
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
               I+R+ + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 181
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 182 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 229
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 230 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 260

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 26/285 (9%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFL 153
            + + ++G G FG V  G ++     P K    I VA+K+LK     +  R++++E   +
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLK----VPGK--REICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           GQ  HPN++ L G   +    +++ E+M  GSL+  L +          + +  G   G+
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 129
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT-YGYAA 272
            +L   S   ++RD    NIL++S    K+SDFG+++      +   +TR       + A
Sbjct: 130 KYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 187
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
           PE +     TS SDV+S+G+V+ E+++           GE+     + Q +    +    
Sbjct: 188 PEAIAYRKFTSASDVWSYGIVMWEVMS----------YGERPYWDMSNQDVIKAIEEGYR 237
Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           + P ++   +L       QL  +C  ++   RP   ++V +L  L
Sbjct: 238 LPPPMDCPIALH------QLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 134/303 (44%), Gaps = 30/303 (9%)
Query: 69  PAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSG 127
           PAP   K     +   + + +    +      LG G +G V++G W + +          
Sbjct: 196 PAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---------- 245
Query: 128 ITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLE 187
           +TVAVK+LK D ++   E++ E   + ++ HPNLV+L+G C  +    ++ EFMT G+L 
Sbjct: 246 LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 188 NHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG 247
           ++L R       S  + + +      A  +   +  I+R+    N L+   +  K++DFG
Sbjct: 305 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKK 307
           L++    GD             + APE +     + KSDV++FGV+L EI T   S    
Sbjct: 364 LSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---P 419
Query: 308 RPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM 367
            P               D  ++Y++++    +       +KV +L   C   +P  RPS 
Sbjct: 420 YPG-------------IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF 466
Query: 368 DEV 370
            E+
Sbjct: 467 AEI 469

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 135/310 (43%), Gaps = 44/310 (14%)
Query: 69  PAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSG 127
           PAP   K     +   + + +    +      LG G +G V++G W + +          
Sbjct: 235 PAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---------- 284
Query: 128 ITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLE 187
           +TVAVK+LK D ++   E++ E   + ++ HPNLV+L+G C  +    ++ EFMT G+L 
Sbjct: 285 LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 188 NHL-------FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN 240
           ++L           + L  + +I  A+   +   F+H        R+    N L+   + 
Sbjct: 344 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH--------RNLAARNCLVGENHL 395
Query: 241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            K++DFGL++    GD             + APE +     + KSDV++FGV+L EI T 
Sbjct: 396 VKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 454
Query: 301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD 360
             S     P               D  ++Y++++    +       +KV +L   C   +
Sbjct: 455 GMS---PYPG-------------IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 498
Query: 361 PKSRPSMDEV 370
           P  RPS  E+
Sbjct: 499 PSDRPSFAEI 508

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 26/285 (9%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFL 153
            + + ++G G FG V  G ++     P K    I VA+K+LK     +  R++++E   +
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLK----VPGK--REICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           GQ  HPN++ L G   +    +++ E+M  GSL+  L +          + +  G   G+
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 123
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT-YGYAA 272
            +L   S   ++RD    NIL++S    K+SDFG+++      +   +TR       + A
Sbjct: 124 KYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
           PE +     TS SDV+S+G+V+ E+++           GE+     + Q +    +    
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVMS----------YGERPYWDMSNQDVIKAIEEGYR 231
Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           + P ++   +L       QL  +C  ++   RP   ++V +L  L
Sbjct: 232 LPPPMDCPIALH------QLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 30/205 (14%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V   W+       A       VAVK++KP G      ++AE + +  L H  
Sbjct: 190 LGAGQFGEV---WM-------ATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDK 238
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLH 217
           LVKL    +  +   ++ EFM +GSL + L        PLP    I  +   A+G+AF+ 
Sbjct: 239 LVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE 295
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
             +   I+RD + +NIL+ +    K++DFGLA+ G +               + APE + 
Sbjct: 296 QRN--YIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAIN 342
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRR 302
            G  T KSDV+SFG++L+EI+T  R
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRI 203
            N++ L+G C +D    ++ E+ ++G+L  +L  R  P               L   + +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 195 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 + APE +     T +SDV+SFGV+L EI T
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL 156
           + ILGEG FG V++G            G  I VAVK+ K D  L    ++++E   +  L
Sbjct: 13  NRILGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HP++VKLIG  IE++   ++ E    G L ++L R    L     +  +L   K +A+L
Sbjct: 67  DHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS-TRVVGTYGYAAPEY 275
              S   ++RD    NIL+ S    KL DFGL++     D    S TR+     + +PE 
Sbjct: 126 E--SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPES 181
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     T+ SDV+ F V + EIL+
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILS 205

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G  G V+ G+   NG           VAVKSLK  G      ++AE + + QL H  
Sbjct: 21  LGAGQAGEVWMGYY--NGHT--------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGG 219
           LV+L    +  +   ++ E+M  GSL + L   + I L  +  + +A   A+G+AF+   
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +   I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G
Sbjct: 129 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYG 185
Query: 280 HLTSKSDVYSFGVVLLEILTGRR--SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
             T KSDV+SFG++L EI+T  R        P   QNL            + Y++V P  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD- 233
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                    +++ QL   C    P+ RP+ D +  VL
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL 156
           + ILGEG FG V++G            G  I VAVK+ K D  L    ++++E   +  L
Sbjct: 29  NRILGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HP++VKLIG  IE++   ++ E    G L ++L R    L     +  +L   K +A+L
Sbjct: 83  DHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS-TRVVGTYGYAAPEY 275
              S   ++RD    NIL+ S    KL DFGL++     D    S TR+     + +PE 
Sbjct: 142 E--SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPES 197
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     T+ SDV+ F V + EIL+
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILS 221

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL 156
           + ILGEG FG V++G            G  I VAVK+ K D  L    ++++E   +  L
Sbjct: 17  NRILGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            HP++VKLIG  IE++   ++ E    G L ++L R    L     +  +L   K +A+L
Sbjct: 71  DHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS-TRVVGTYGYAAPEY 275
              S   ++RD    NIL+ S    KL DFGL++     D    S TR+     + +PE 
Sbjct: 130 E--SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPES 185
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     T+ SDV+ F V + EIL+
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 113/252 (44%), Gaps = 24/252 (9%)
Query: 64  SDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAK 123
           S +PD  P DE   C+ L +   + +      +    LG G FG V    IE +     K
Sbjct: 2   SMDPDELPLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDK 55
Query: 124 PGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EF 180
             +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF
Sbjct: 56  TATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 115
Query: 181 MTRGSLENHL-FRRTIPLPW------------SNRIKIALGAAKGLAFLHGGSEPVIYRD 227
              G+L  +L  +R   +P+             + I  +   AKG+ FL   S   I+RD
Sbjct: 116 CKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRD 173
Query: 228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDV 287
               NILL  +   K+ DFGLA+   +               + APE +     T +SDV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 288 YSFGVVLLEILT 299
           +SFGV+L EI +
Sbjct: 234 WSFGVLLWEIFS 245

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 28/268 (10%)
Query: 45  RYLNASNRELCAPNEAHLSS-DNPDPAPTDEKSPCQLLQFTF---QELKSATGNFRPDSI 100
           R ++  N +   P  A ++S D P P P D      + +  F   +ELK      + D++
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKPRPMPMD----TSVFESPFSDPEELKDKKLFLKRDNL 337
Query: 101 L------GEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFL 153
           L      G G FG V +G               I VA+K LK    +    E + E   +
Sbjct: 338 LIADIELGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIM 390
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
            QL +P +V+LIG C + +  +LV E    G L   L  +   +P SN  ++    + G+
Sbjct: 391 HQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYA 271
            +L    +  ++R+    N+LL + + AK+SDFGL+KA    D ++ + R  G +   + 
Sbjct: 450 KYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWY 506
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           APE +     +S+SDV+S+GV + E L+
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 42/288 (14%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-----PDGLQGHREWVAEVDFLG 154
           +G G FG V+KG W  +             VAVK LK     P+  Q  R    EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKILKVVDPTPEQFQAFRN---EVAVLR 87
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           +  H N++  +GY  +D+   +V ++    SL  HL  +         I IA   A+G+ 
Sbjct: 88  KTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMD 146
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LH  ++ +I+RD K++NI L      K+ DFGLA    +   +    +  G+  + APE
Sbjct: 147 YLH--AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE 204
Query: 275 YVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA-DKRKLY 330
            +        + +SDVYS+G+VL E++TG         + +Q +    R Y + D  KLY
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-NRDQIIFMVGRGYASPDLSKLY 263
Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
           +               + + +L  +C+ +  + RP   +++  +  LQ
Sbjct: 264 K------------NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 32/292 (10%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N +    LG G FG V    +E       K  + + VAVK LK       +E  ++E+  
Sbjct: 39  NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------PLPWSNR 202
           +  L  H N+V L+G C      L++ E+   G L N L R+           PL   + 
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +  +   A+G+AFL   S+  I+RD    N+LL + + AK+ DFGLA+         V  
Sbjct: 155 LHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 212
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE +     T +SDV+S+G++L EI     S+      G           
Sbjct: 213 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLNPYPG----------- 257
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           +    K Y++V    ++       + +  +   C + +P  RP+  ++   L
Sbjct: 258 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 18  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 131
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 132 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 189
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 190 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 234
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 235 LRFVMEGGL-LDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 124 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK- 180
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 181 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 224
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 225 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V   W+       A       VAVK++KP G      ++AE + +  L H  
Sbjct: 23  LGAGQFGEV---WM-------ATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDK 71
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLH 217
           LVKL    +  +   ++ EFM +GSL + L        PLP    I  +   A+G+AF+ 
Sbjct: 72  LVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE 128
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
             +   I+RD + +NIL+ +    K++DFGLA+     + T           + APE + 
Sbjct: 129 QRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAIN 185
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRR 302
            G  T KSDV+SFG++L+EI+T  R
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 124 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 181 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 224
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 225 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 32/292 (10%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N +    LG G FG V    +E       K  + + VAVK LK       +E  ++E+  
Sbjct: 47  NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------PLPWSNR 202
           +  L  H N+V L+G C      L++ E+   G L N L R+           PL   + 
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +  +   A+G+AFL   S+  I+RD    N+LL + + AK+ DFGLA+         V  
Sbjct: 163 LHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 220
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE +     T +SDV+S+G++L EI     S+      G           
Sbjct: 221 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLNPYPG----------- 265
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           +    K Y++V    ++       + +  +   C + +P  RP+  ++   L
Sbjct: 266 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 317

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 124 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 181 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 224
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 225 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 10  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 57
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 58  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 114
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 115 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 171
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 172 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 215
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 216 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 254

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 112/252 (44%), Gaps = 26/252 (10%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +      +    LG G FG V    IE +     K  
Sbjct: 2   DPDELPLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDKTA 55
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 183 RGSLENHL-FRRTIPLPW--------------SNRIKIALGAAKGLAFLHGGSEPVIYRD 227
            G+L  +L  +R   +P+               + I  +   AKG+ FL   S   I+RD
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRD 173
Query: 228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDV 287
               NILL  +   K+ DFGLA+   +               + APE +     T +SDV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 288 YSFGVVLLEILT 299
           +SFGV+L EI +
Sbjct: 234 WSFGVLLWEIFS 245

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 8   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 55
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 56  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 112
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 113 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 169
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 170 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVN-----REV 213
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 214 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 252

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 27  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 141 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 198
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 243
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 244 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/216 (35%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV- 147
           K+    F    +LG+G FG VF   +++   + A+       A+K LK   L+  R+ V 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVF--LVKKISGSDARQ----LYAMKVLKKATLKV-RDRVR 72
Query: 148 --AEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
              E D L +++HP +VKL  Y  + + +L L+ +F+  G L   L +  +       +K
Sbjct: 73  TKMERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT--EEDVK 129
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
             L A   LA  H  S  +IYRD K  NILLD E + KL+DFGL+K     +K   S   
Sbjct: 130 FYL-AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--F 186
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            GT  Y APE V     T  +D +SFGV++ E+LTG
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V   W+       A       VAVK++KP G      ++AE + +  L H  
Sbjct: 196 LGAGQFGEV---WM-------ATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDK 244
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLH 217
           LVKL    +  +   ++ EFM +GSL + L        PLP    I  +   A+G+AF+ 
Sbjct: 245 LVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE 301
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   I+RD + +NIL+ +    K++DFGLA+     + T    R    +   + APE 
Sbjct: 302 QRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT---AREGAKFPIKWTAPEA 356
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRR 302
           +  G  T KSDV+SFG++L+EI+T  R
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 124 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 181 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 224
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 225 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/216 (35%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV- 147
           K+    F    +LG+G FG VF   +++   + A+       A+K LK   L+  R+ V 
Sbjct: 21  KADPSQFELLKVLGQGSFGKVF--LVKKISGSDARQ----LYAMKVLKKATLKV-RDRVR 73
Query: 148 --AEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
              E D L +++HP +VKL  Y  + + +L L+ +F+  G L   L +  +       +K
Sbjct: 74  TKMERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT--EEDVK 130
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
             L A   LA  H  S  +IYRD K  NILLD E + KL+DFGL+K     +K   S   
Sbjct: 131 FYL-AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--F 187
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            GT  Y APE V     T  +D +SFGV++ E+LTG
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/216 (35%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV- 147
           K+    F    +LG+G FG VF   +++   + A+       A+K LK   L+  R+ V 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVF--LVKKISGSDARQ----LYAMKVLKKATLKV-RDRVR 72
Query: 148 --AEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
              E D L +++HP +VKL  Y  + + +L L+ +F+  G L   L +  +       +K
Sbjct: 73  TKMERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT--EEDVK 129
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
             L A   LA  H  S  +IYRD K  NILLD E + KL+DFGL+K     +K   S   
Sbjct: 130 FYL-AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--F 186
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            GT  Y APE V     T  +D +SFGV++ E+LTG
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 36/220 (16%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 9   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 56
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L   T   + LP    + +A   
Sbjct: 57  MKKLRHEKLVQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQI 113
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 114 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK- 170
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
                  + APE  + G  T KSDV+SFG++L E+ T  R
Sbjct: 171 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 36/220 (16%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 232
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L   T   + LP    + +A   
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQI 289
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 290 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 346
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
                  + APE  + G  T KSDV+SFG++L E+ T  R
Sbjct: 347 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 36/220 (16%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 232
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L   T   + LP    + +A   
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQI 289
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 290 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 346
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
                  + APE  + G  T KSDV+SFG++L E+ T  R
Sbjct: 347 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 36/220 (16%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 12  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 59
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L   T   + LP    + +A   
Sbjct: 60  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQI 116
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 117 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 173
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
                  + APE  + G  T KSDV+SFG++L E+ T  R
Sbjct: 174 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 112/252 (44%), Gaps = 26/252 (10%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +      +    LG G FG V    IE +     K  
Sbjct: 2   DPDELPLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDKTA 55
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 183 RGSLENHL-FRRTIPLPW--------------SNRIKIALGAAKGLAFLHGGSEPVIYRD 227
            G+L  +L  +R   +P+               + I  +   AKG+ FL   S   I+RD
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRD 173
Query: 228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDV 287
               NILL  +   K+ DFGLA+   +               + APE +     T +SDV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 288 YSFGVVLLEILT 299
           +SFGV+L EI +
Sbjct: 234 WSFGVLLWEIFS 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 111/251 (44%), Gaps = 25/251 (9%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +           LG G FG V    IE +     K  
Sbjct: 3   DPDELPLDEH--CERLPYDASKWEFPRDRLNLGKPLGRGAFGQV----IEADAFGIDKTA 56
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 57  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 116
Query: 183 RGSLENHL-FRRTIPLPW-------------SNRIKIALGAAKGLAFLHGGSEPVIYRDF 228
            G+L  +L  +R   +P+              + I  +   AKG+ FL   S   I+RD 
Sbjct: 117 FGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDL 174
Query: 229 KTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVY 288
              NILL  +   K+ DFGLA+   +               + APE +     T +SDV+
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 289 SFGVVLLEILT 299
           SFGV+L EI +
Sbjct: 235 SFGVLLWEIFS 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 111/248 (44%), Gaps = 22/248 (8%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +           LG G FG V    IE +     K  
Sbjct: 2   DPDELPLDEH--CERLPYDASKWEFPRDRLNLGKPLGRGAFGQV----IEADAFGIDKTA 55
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 183 RGSLENHL-FRRTIPLPWSNR----------IKIALGAAKGLAFLHGGSEPVIYRDFKTS 231
            G+L  +L  +R   +P+ +           I  +   AKG+ FL   S   I+RD    
Sbjct: 116 FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAAR 173
Query: 232 NILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFG 291
           NILL  +   K+ DFGLA+   +               + APE +     T +SDV+SFG
Sbjct: 174 NILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 233
Query: 292 VVLLEILT 299
           V+L EI +
Sbjct: 234 VLLWEIFS 241

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 111/248 (44%), Gaps = 22/248 (8%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +           LG G FG V    IE +     K  
Sbjct: 2   DPDELPLDEH--CERLPYDASKWEFPRDRLNLGKPLGRGAFGQV----IEADAFGIDKTA 55
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 183 RGSLENHL-FRRTIPLPWSNRIK----------IALGAAKGLAFLHGGSEPVIYRDFKTS 231
            G+L  +L  +R   +P+ +  K           +   AKG+ FL   S   I+RD    
Sbjct: 116 FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKXIHRDLAAR 173
Query: 232 NILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFG 291
           NILL  +   K+ DFGLA+   +               + APE +     T +SDV+SFG
Sbjct: 174 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 233
Query: 292 VVLLEILT 299
           V+L EI +
Sbjct: 234 VLLWEIFS 241

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG +G V+K   +E G           VA+K +  +     +E + E+  + Q   P+
Sbjct: 37  LGEGSYGSVYKAIHKETGQ---------IVAIKQVPVES--DLQEIIKEISIMQQCDSPH 85
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +VK  G   ++    +V E+   GS+ + +  R   L       I     KGL +LH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  I+RD K  NILL++E +AKL+DFG+  AG   D       V+GT  + APE +    
Sbjct: 146 K--IHRDIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 281 LTSKSDVYSFGVVLLEILTGR 301
               +D++S G+  +E+  G+
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 36/220 (16%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 315
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L   T   + LP    + +A   
Sbjct: 316 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQI 372
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 373 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 429
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
                  + APE  + G  T KSDV+SFG++L E+ T  R
Sbjct: 430 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD   +NIL+      K++DFGLA+          QG K  +  
Sbjct: 124 ASGMAYVERMN--YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 181 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 224
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 225 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 22  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++           P      I++A  
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 136 IADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 238
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +PK RP+  E+V +L
Sbjct: 239 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 112/252 (44%), Gaps = 26/252 (10%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +      +    LG G FG V    IE +     K  
Sbjct: 2   DPDELPLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDKTA 55
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 183 RGSLENHL-FRRTIPLPW--------------SNRIKIALGAAKGLAFLHGGSEPVIYRD 227
            G+L  +L  +R   +P+               + I  +   AKG+ FL   S   I+RD
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRD 173
Query: 228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDV 287
               NILL  +   K+ DFGLA+   +               + APE +     T +SDV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 288 YSFGVVLLEILT 299
           +SFGV+L EI +
Sbjct: 234 WSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 112/252 (44%), Gaps = 26/252 (10%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +      +    LG G FG V    IE +     K  
Sbjct: 4   DPDELPLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDKTA 57
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 58  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 117
Query: 183 RGSLENHL-FRRTIPLPW--------------SNRIKIALGAAKGLAFLHGGSEPVIYRD 227
            G+L  +L  +R   +P+               + I  +   AKG+ FL   S   I+RD
Sbjct: 118 FGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRD 175
Query: 228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDV 287
               NILL  +   K+ DFGLA+   +               + APE +     T +SDV
Sbjct: 176 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 235
Query: 288 YSFGVVLLEILT 299
           +SFGV+L EI +
Sbjct: 236 WSFGVLLWEIFS 247

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + ++ H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 67  MKKIRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 124 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 181 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 224
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 225 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-HH 158
           LG G FG V    +E       K  + +TVAVK LKP      RE  ++E+  L  L +H
Sbjct: 47  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN----------------- 201
            N+V L+G C      L++ E+   G L N L R+      S                  
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            +  +   AKG+AFL   S+  I+RD    NILL      K+ DFGLA+         V 
Sbjct: 163 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
                   + APE +     T +SDV+S+G+ L E+ +   S     P            
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------- 271
Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                 K Y+++     +        ++  +   C   DP  RP+  ++V+++
Sbjct: 272 ------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 318

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++G L + L     + + LP    + +A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 124 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 181 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 224
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 225 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-HH 158
           LG G FG V    +E       K  + +TVAVK LKP      RE  ++E+  L  L +H
Sbjct: 31  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN----------------- 201
            N+V L+G C      L++ E+   G L N L R+      S                  
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            +  +   AKG+AFL   S+  I+RD    NILL      K+ DFGLA+         V 
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
                   + APE +     T +SDV+S+G+ L E+ +   S     P            
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------- 255
Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                 K Y+++     +        ++  +   C   DP  RP+  ++V+++
Sbjct: 256 ------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-HH 158
           LG G FG V    +E       K  + +TVAVK LKP      RE  ++E+  L  L +H
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN----------------- 201
            N+V L+G C      L++ E+   G L N L R+      S                  
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            +  +   AKG+AFL   S+  I+RD    NILL      K+ DFGLA+         V 
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
                   + APE +     T +SDV+S+G+ L E+ +   S     P            
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------- 278
Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                 K Y+++     +        ++  +   C   DP  RP+  ++V+++
Sbjct: 279 ------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+            +   VAVK+LKP G    + ++ E + +  L H  
Sbjct: 21  LGAGQFGEVWMGYY----------NNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 69
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGAAKGLAFLH 217
           LV+L      ++   ++ E+M +GSL + L       + LP    I  +   A+G+A++ 
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE 127
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
             +   I+RD + +N+L+      K++DFGLA+     + T           + APE + 
Sbjct: 128 RKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAIN 184
Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
            G  T KSDV+SFG++L EI+T
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVT 206

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 36/220 (16%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 232
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L   T   + LP    + +A   
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQI 289
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 290 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 346
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
                  + APE  + G  T KSDV+SFG++L E+ T  R
Sbjct: 347 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++           P      I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 139 IADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 241
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +PK RP+  E+V +L
Sbjct: 242 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-HH 158
           LG G FG V    +E       K  + +TVAVK LKP      RE  ++E+  L  L +H
Sbjct: 49  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN----------------- 201
            N+V L+G C      L++ E+   G L N L R+      S                  
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            +  +   AKG+AFL   S+  I+RD    NILL      K+ DFGLA+         V 
Sbjct: 165 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
                   + APE +     T +SDV+S+G+ L E+ +   S     P            
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------- 273
Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                 K Y+++     +        ++  +   C   DP  RP+  ++V+++
Sbjct: 274 ------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 320

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 112/252 (44%), Gaps = 26/252 (10%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +      +    LG G FG V    IE +     K  
Sbjct: 39  DPDELPLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDKTA 92
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 93  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 152
Query: 183 RGSLENHL-FRRTIPLPW--------------SNRIKIALGAAKGLAFLHGGSEPVIYRD 227
            G+L  +L  +R   +P+               + I  +   AKG+ FL   S   I+RD
Sbjct: 153 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRD 210
Query: 228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDV 287
               NILL  +   K+ DFGLA+   +               + APE +     T +SDV
Sbjct: 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270
Query: 288 YSFGVVLLEILT 299
           +SFGV+L EI +
Sbjct: 271 WSFGVLLWEIFS 282

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQL-HH 158
           LG G FG V    +E       K  + +TVAVK LKP      RE  ++E+  L  L +H
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN----------------- 201
            N+V L+G C      L++ E+   G L N L R+      S                  
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            +  +   AKG+AFL   S+  I+RD    NILL      K+ DFGLA+         V 
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
                   + APE +     T +SDV+S+G+ L E+ +   S     P            
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------- 278
Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                 K Y+++     +        ++  +   C   DP  RP+  ++V+++
Sbjct: 279 ------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 20  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 134 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 236
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 237 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 113 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 112 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 132/281 (46%), Gaps = 32/281 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 33  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTI-------PLPWSNRIKIALGAA 210
           ++V+L+G   +    L++ E MTRG L+++L   R  +       P   S  I++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +    +
Sbjct: 149 DGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ L 
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLR 251
Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
            +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 252 FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 113 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 27  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 141 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 198
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 243
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 244 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 112 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 33  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 146
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 147 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 249
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 250 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 8   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 56
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 57  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 117 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 170
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++G L + L     + + LP    + +A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 124 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R        G  N     R+ 
Sbjct: 181 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVN-----REV 224
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 225 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 132/281 (46%), Gaps = 32/281 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 23  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTI-------PLPWSNRIKIALGAA 210
           ++V+L+G   +    L++ E MTRG L+++L   R  +       P   S  I++A   A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +    +
Sbjct: 139 DGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 196
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ L 
Sbjct: 197 MSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLR 241
Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
            +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 242 FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V+ G+            +   VAVK+LKP G    + ++ E + +  L H  
Sbjct: 20  LGAGQFGEVWMGYY----------NNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 68
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGAAKGLAFLH 217
           LV+L     +++   ++ EFM +GSL + L       + LP    I  +   A+G+A++ 
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE 126
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
              +  I+RD + +N+L+      K++DFGLA+     + T    R    +   + APE 
Sbjct: 127 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT---AREGAKFPIKWTAPEA 181
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +  G  T KS+V+SFG++L EI+T
Sbjct: 182 INFGCFTIKSNVWSFGILLYEIVT 205

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 26  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 140 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 242
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 243 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 113 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 11  NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 119
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 120 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 173
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 5   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 114 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 167
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 24  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 137
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 138 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 196 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 240
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 241 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 26  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 140 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 242
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 243 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 11  NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 119
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 120 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 173
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 63
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M +GSL + L   T   + LP    + ++   
Sbjct: 64  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQI 120
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 121 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK- 177
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
                  + APE  + G  T KSDV+SFG++L E+ T  R
Sbjct: 178 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GTMSPEAFLQEAQV 63
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M +GSL + L   T   + LP    + ++   
Sbjct: 64  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQI 120
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGLA+          QG K  +  
Sbjct: 121 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 177
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
                  + APE  + G  T KSDV+SFG++L E+ T  R
Sbjct: 178 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQLH 157
           +LG G FG V+KG W+ E  T        I VA+K L +  G + + E++ E   +  + 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETV------KIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HP+LV+L+G C+    +L V + M  G L  ++      +     +   +  AKG+ +L 
Sbjct: 99  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                +++RD    N+L+ S  + K++DFGLA+     +K + +        + A E + 
Sbjct: 158 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
               T +SDV+S+GV + E++T
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQLH 157
           +LG G FG V+KG W+ E  T        I VA+K L +  G + + E++ E   +  + 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETV------KIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HP+LV+L+G C+    +L V + M  G L  ++      +     +   +  AKG+ +L 
Sbjct: 76  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                +++RD    N+L+ S  + K++DFGLA+     +K + +        + A E + 
Sbjct: 135 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
               T +SDV+S+GV + E++T
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMT 214

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 55  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 168
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 169 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 226
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 227 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 271
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 272 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHH 158
           LGE  FG V+KG +   G AP +      VA+K+LK D  +G    E+  E     +L H
Sbjct: 34  LGEDRFGKVYKGHL--FGPAPGEQTQA--VAIKTLK-DKAEGPLREEFRHEAMLRARLQH 88
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRI 203
           PN+V L+G   +D    +++ + + G L   L  R+                 L   + +
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +    A G+ +L   S  V+++D  T N+L+  + N K+SD GL +     D   +   
Sbjct: 149 HLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +    + APE +M G  +  SD++S+GVVL E+ +
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 31/272 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG VFKG   +N T        I +     + + +Q       E+  L Q   P 
Sbjct: 30  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPY 81
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH  S
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH--S 137
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           E  I+RD K +N+LL      KL+DFG+  AG   D        VGT  + APE +    
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
             SK+D++S G+  +E+  G     +  P     L+                  P LE N
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGN 242
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           YS    + + +    CL+++P  RP+  E++K
Sbjct: 243 YS----KPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 36/221 (16%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYE--------FMTRGSLENHLFRRTIPLPWSN 201
           +  L +L+HPN+VKL+     +++  LV+E        FM   +L        IPLP   
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTG------IPLPLIK 105
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
                L   +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      
Sbjct: 106 SYLFQL--LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTY 159
Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           T  V T  Y APE ++   + ++  D++S G +  E++T R
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQL 156
           D  LG G FG V +G               I VA+K LK    +    E + E   + QL
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            +P +V+LIG C + +  +LV E    G L   L  +   +P SN  ++    + G+ +L
Sbjct: 68  DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPE 274
               +  ++RD    N+LL + + AK+SDFGL+KA    D ++ + R  G +   + APE
Sbjct: 127 E--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAPE 183
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +     +S+SDV+S+GV + E L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GL+F H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T
Sbjct: 113 --LQGLSFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           +GEG FG VF+      G  P +P +   VAVK LK +       ++  E   + +  +P
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI------------------------ 195
           N+VKL+G C       L++E+M  G L    F R++                        
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNE--FLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 196 -PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
            PL  + ++ IA   A G+A+L       ++RD  T N L+      K++DFGL++    
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            D             +  PE +     T++SDV+++GVVL EI +
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 112/216 (51%), Gaps = 26/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 6   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 54
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIA 206
           +  L +L+HPN+VKL+     +++  LV+EF++   L++ +       IPLP        
Sbjct: 55  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQ 113
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           L   +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A     +T+    V  
Sbjct: 114 L--LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           T  Y APE ++   + ++  D++S G +  E++T R
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 24  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++           P      I++A  
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 138 IADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 240
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +PK RP+  E+V +L
Sbjct: 241 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 31/272 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG VFKG   +N T        I +     + + +Q       E+  L Q   P 
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPY 66
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH  S
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH--S 122
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           E  I+RD K +N+LL      KL+DFG+  AG   D        VGT  + APE +    
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
             SK+D++S G+  +E+  G     +  P     L+                  P LE N
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGN 227
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           YS    + + +    CL+++P  RP+  E++K
Sbjct: 228 YS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 31/272 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG VFKG   +N T        I +     + + +Q       E+  L Q   P 
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPY 66
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH  S
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH--S 122
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           E  I+RD K +N+LL      KL+DFG+  AG   D        VGT  + APE +    
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
             SK+D++S G+  +E+  G     +  P     L+                  P LE N
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGN 227
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           YS    + + +    CL+++P  RP+  E++K
Sbjct: 228 YS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 30/218 (13%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 5   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-----IPLPWSNRIK 204
           +  L +L+HPN+VKL+     +++  LV+EF+   S++   F        IPLP      
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYL 110
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
             L   +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A     +T+    V
Sbjct: 111 FQL--LQGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 265 VGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             T  Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 30/218 (13%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 7   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 55
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-----IPLPWSNRIK 204
           +  L +L+HPN+VKL+     +++  LV+EF+   S++   F        IPLP      
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYL 112
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
             L   +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         
Sbjct: 113 FQL--LQGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHE 166
Query: 265 VGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           V T  Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           NF+    +GEG +G V+K   +  G   A     +    + +    ++       E+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 56
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIALGAAK 211
            +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L   +
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQ 114
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T  Y 
Sbjct: 115 GLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYR 170
Query: 272 APEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           APE ++   + ++  D++S G +  E++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           NF+    +GEG +G V+K   +  G   A     +    + +    ++       E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 55
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIALGAAK 211
            +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L   +
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQ 113
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      T  V T  Y 
Sbjct: 114 GLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYR 169
Query: 272 APEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           APE ++   + ++  D++S G +  E++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 7   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 55
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIA 206
           +  L +L+HPN+VKL+     +++  LV+EF++   L++ +       IPLP        
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQ 114
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           L   +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V 
Sbjct: 115 L--LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV 168
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           T  Y APE ++   + ++  D++S G +  E++T R
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 122/296 (41%), Gaps = 36/296 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N +    LG G FG V    +E       K  + + VAVK LK       +E  ++E+  
Sbjct: 47  NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG--- 208
           +  L  H N+V L+G C      L++ E+   G L N L R++  L       IA     
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 209 ----------AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT 258
                      A+G+AFL   S+  I+RD    N+LL + + AK+ DFGLA+        
Sbjct: 163 TRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 259 HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW 318
            V         + APE +     T +SDV+S+G++L EI     S+      G       
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLNPYPG------- 269
Query: 319 ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
               +    K Y++V    ++       + +  +   C + +P  RP+  ++   L
Sbjct: 270 ----ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++           P      I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 139 IADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 241
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +PK RP+  E+V +L
Sbjct: 242 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           + R +  LG+G FG V+ G W   NGT          VA+K+LKP G      ++ E   
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLKP-GNMSPEAFLQEAQV 233
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIALGA 209
           + +L H  LV+L    + ++   +V E+M++GSL + L     + + LP    + +A   
Sbjct: 234 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 290
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-------AGPQGDKTHVST 262
           A G+A++   +   ++RD + +NIL+      K++DFGL +          QG K  +  
Sbjct: 291 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK- 347
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE  + G  T KSDV+SFG++L E+ T  R      P G  N     R+ 
Sbjct: 348 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYP-GMVN-----REV 391
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
           L    + Y++  P        +  + +  L   C  +DP+ RP+ +
Sbjct: 392 LDQVERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERPTFE 430

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQLHH 158
           LGE  FG V+KG +   G AP +      VA+K+LK D  +G    E+  E     +L H
Sbjct: 17  LGEDRFGKVYKGHL--FGPAPGEQTQA--VAIKTLK-DKAEGPLREEFRHEAMLRARLQH 71
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRI 203
           PN+V L+G   +D    +++ + + G L   L  R+                 L   + +
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +    A G+ +L   S  V+++D  T N+L+  + N K+SD GL +     D   +   
Sbjct: 132 HLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +    + APE +M G  +  SD++S+GVVL E+ +
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++           P      I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++RD    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 139 IADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 241
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +P  RP+  E+V +L
Sbjct: 242 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 122/296 (41%), Gaps = 36/296 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N +    LG G FG V    +E       K  + + VAVK LK       +E  ++E+  
Sbjct: 47  NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG--- 208
           +  L  H N+V L+G C      L++ E+   G L N L R++  L       IA     
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 209 ----------AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT 258
                      A+G+AFL   S+  I+RD    N+LL + + AK+ DFGLA+        
Sbjct: 163 TRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 259 HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW 318
            V         + APE +     T +SDV+S+G++L EI     S+      G       
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLNPYPG------- 269
Query: 319 ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
               +    K Y++V    ++       + +  +   C + +P  RP+  ++   L
Sbjct: 270 ----ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 37/287 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEVD 151
            F    +LG+G FG V +  +++      + GS + VAVK LK D +      E++ E  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQ------EDGSFVKVAVKMLKADIIASSDIEEFLREAA 77
Query: 152 FLGQLHHPNLVKLIGYCIEDDQR------LLVYEFMTRGSLENHLFRRTI-----PLPWS 200
            + +  HP++ KL+G  +    +      +++  FM  G L   L    I      LP  
Sbjct: 78  CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
             ++  +  A G+ +L   S   I+RD    N +L  +    ++DFGL++    GD    
Sbjct: 138 TLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
                    + A E +     T  SDV++FGV + EI+T  ++      +G +N  A   
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT----PYAGIEN--AEIY 249
Query: 321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM 367
            YL    +L Q            + +++V  L Y C S DPK RPS 
Sbjct: 250 NYLIGGNRLKQ----------PPECMEEVYDLMYQCWSADPKQRPSF 286

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIA 206
           +  L +L+HPN+VKL+     +++  LV+EF+ +  L++ +       IPLP        
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           L   +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V 
Sbjct: 112 L--LQGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV 165
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
           T  Y APE ++   + ++  D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 36/283 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHP 159
           LG+G FG V++G     G    +P +   VA+K++        R E++ E   + + +  
Sbjct: 20  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L++ E MTRG L+++L  R++           P   S  I++A  
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+      ++RD    N  +  ++  K+ DFG+ +   + D      + +   
Sbjct: 134 IADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + +PE +  G  T+ SDV+SFGVVL EI T               L     Q L++++ 
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQV 236
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L  +++  L L+        + +L   C   +PK RPS  E++
Sbjct: 237 LRFVMEGGL-LDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAEVDFLGQL 156
           +GEG +G V+K          AK   G  VA+K ++ D    G+      + E+  L +L
Sbjct: 29  VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL-GAAKGLAF 215
           HHPN+V LI     +    LV+EFM +  L+  L      L   ++IKI L    +G+A 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ-DSQIKIYLYQLLRGVAH 134
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H     +++RD K  N+L++S+   KL+DFGLA+A   G      T  V T  Y AP+ 
Sbjct: 135 CH--QHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDV 190
Query: 276 VMTGHLTSKS-DVYSFGVVLLEILTGR 301
           +M     S S D++S G +  E++TG+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAEVDFLGQL 156
           +GEG +G V+K          AK   G  VA+K ++ D    G+      + E+  L +L
Sbjct: 29  VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL-GAAKGLAF 215
           HHPN+V LI     +    LV+EFM +  L+  L      L   ++IKI L    +G+A 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ-DSQIKIYLYQLLRGVAH 134
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H     +++RD K  N+L++S+   KL+DFGLA+A   G      T  V T  Y AP+ 
Sbjct: 135 CH--QHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDV 190
Query: 276 VMTGHLTSKS-DVYSFGVVLLEILTGR 301
           +M     S S D++S G +  E++TG+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 38/298 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N +    LG G FG V    +E       K  + + VAVK LK       +E  ++E+  
Sbjct: 47  NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP--------------- 196
           +  L  H N+V L+G C      L++ E+   G L N L R+  P               
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           L   + +  +   A+G+AFL   S+  I+RD    N+LL + + AK+ DFGLA+      
Sbjct: 163 LSSRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
              V         + APE +     T +SDV+S+G++L EI     S+      G     
Sbjct: 221 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLNPYPG----- 271
Query: 317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                 +    K Y++V    ++       + +  +   C + +P  RP+  ++   L
Sbjct: 272 ------ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 7   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 55
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +   +  +      IPLP        L
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQL 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 116 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 169
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 120/272 (44%), Gaps = 31/272 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG VFKG   +N T        I +     + + +Q       E+  L Q   P 
Sbjct: 35  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPY 86
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH  S
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH--S 142
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           E  I+RD K +N+LL      KL+DFG+  AG   D        VGT  + APE +    
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 200
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
             SK+D++S G+  +E+  G     +  P            +L  K        P LE N
Sbjct: 201 YDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKNN-----PPTLEGN 247
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           YS    + + +    CL+++P  RP+  E++K
Sbjct: 248 YS----KPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 113 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 113 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 113 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 112 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 165
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 5   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 114 --LQGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 167
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 112 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 165
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 113 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 5   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 114 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 167
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 6   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 54
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 55  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 115 --LQGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 168
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 7   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 55
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 116 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 169
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 6   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 54
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 55  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 115 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 168
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 6   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 54
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 55  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 115 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 168
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           LG GGFGYV + WI ++        +G  VA+K  + +    +RE W  E+  + +L+HP
Sbjct: 23  LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 160 NLVKL------IGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRIKIALGAAK 211
           N+V        +     +D  LL  E+   G L  +L  F     L       +    + 
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLD---SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            L +LH     +I+RD K  NI+L         K+ D G AK   QG+   + T  VGT 
Sbjct: 134 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTL 188
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
            Y APE +     T   D +SFG +  E +TG R
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           LG GGFGYV + WI ++        +G  VA+K  + +    +RE W  E+  + +L+HP
Sbjct: 22  LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 160 NLVKL------IGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRIKIALGAAK 211
           N+V        +     +D  LL  E+   G L  +L  F     L       +    + 
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLD---SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            L +LH     +I+RD K  NI+L         K+ D G AK   QG+   + T  VGT 
Sbjct: 133 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTL 187
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
            Y APE +     T   D +SFG +  E +TG R
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 5   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 114 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 167
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 8   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 56
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 57  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 117 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 170
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 7   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 55
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG--SLENHLFRRTIPLPWSNRIKIAL 207
           +  L +L+HPN+VKL+     +++  LV+EF+ +      +      IPLP        L
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
              +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G         V T
Sbjct: 116 --LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 169
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE ++   + ++  D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK---PDGLQGHREWVAEVDFLGQLH 157
           +G G FG VF G +  + T          VAVKS +   P  L+   +++ E   L Q  
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKA--KFLQEARILKQYS 170
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN+V+LIG C +     +V E +  G     L      L     +++   AA G+ +L 
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
             S+  I+RD    N L+  +   K+SDFG+++    G              + APE + 
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
            G  +S+SDV+SFG++L E  +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLH 157
           +G G FG V+      N            VA+K +   G Q + +W   + EV FL +L 
Sbjct: 62  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN ++  G  + +    LV E+   GS  + L     PL       +  GA +GLA+LH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
             S  +I+RD K  NILL      KL DFG A      +        VGT  + APE ++
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVIL 223
Query: 278 T---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
               G    K DV+S G+  +E+       ++K P    N ++           LY I  
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMS----------ALYHIAQ 267
Query: 335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                  S    +       +CL + P+ RP+ + ++K
Sbjct: 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLH 157
           +G G FG V+      N            VA+K +   G Q + +W   + EV FL +L 
Sbjct: 23  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN ++  G  + +    LV E+   GS  + L     PL       +  GA +GLA+LH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
             S  +I+RD K  NILL      KL DFG A      +        VGT  + APE ++
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVIL 184
Query: 278 T---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
               G    K DV+S G+  +E+       ++K P    N ++           LY I  
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMS----------ALYHIAQ 228
Query: 335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                  S    +       +CL + P+ RP+ + ++K
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK---PDGLQGHREWVAEVDFLGQLH 157
           +G G FG VF G +  + T          VAVKS +   P  L+   +++ E   L Q  
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKA--KFLQEARILKQYS 170
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN+V+LIG C +     +V E +  G     L      L     +++   AA G+ +L 
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
             S+  I+RD    N L+  +   K+SDFG+++    G              + APE + 
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 278 TGHLTSKSDVYSFGVVLLEILT 299
            G  +S+SDV+SFG++L E  +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 21/219 (9%)
Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVA 148
           S++  F+    LG G +  V+KG    N T      +G+ VA+K +K D  +G     + 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGL---NKT------TGVYVALKEVKLDSEEGTPSTAIR 52
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---PLPWS-NRIK 204
           E+  + +L H N+V+L      +++  LV+EFM    L+ ++  RT+   P     N +K
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 205 -IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                  +GLAF H     +++RD K  N+L++     KL DFGLA+A   G   +  + 
Sbjct: 112 YFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSS 167
Query: 264 VVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
            V T  Y AP+ +M     S S D++S G +L E++TG+
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE-- 128
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           S+  ++RD    N+L+ S    KL DFGL++          S   +    + APE +   
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI-KWMAPESINFR 187
Query: 280 HLTSKSDVYSFGVVLLEIL 298
             TS SDV+ FGV + EIL
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 123/305 (40%), Gaps = 45/305 (14%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N +    LG G FG V    +E       K  + + VAVK LK       +E  ++E+  
Sbjct: 32  NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------- 195
           +  L  H N+V L+G C      L++ E+   G L N L R+                  
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 196 ------PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
                 PL   + +  +   A+G+AFL   S+  I+RD    N+LL + + AK+ DFGLA
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 205
Query: 250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP 309
           +         V         + APE +     T +SDV+S+G++L EI     S+     
Sbjct: 206 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLNPY 261
Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
            G           +    K Y++V    ++       + +  +   C + +P  RP+  +
Sbjct: 262 PG-----------ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 310
Query: 370 VVKVL 374
           +   L
Sbjct: 311 ICSFL 315

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 123/307 (40%), Gaps = 49/307 (15%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTA--PAKPGSGITVAVKSLKPDGLQGHRE-WVAEV 150
           N     +LG G FG V       N TA   +K G  I VAVK LK       RE  ++E+
Sbjct: 46  NLEFGKVLGSGAFGKVM------NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL 99
Query: 151 DFLGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP------------- 196
             + QL  H N+V L+G C       L++E+   G L N+L  +                
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 197 ---------LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG 247
                    L + + +  A   AKG+ FL   S   ++RD    N+L+      K+ DFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFG 217
Query: 248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKK 307
           LA+         V         + APE +  G  T KSDV+S+G++L EI     S+   
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF----SLGVN 273
Query: 308 RPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM 367
              G           +      Y+++    +++      +++  +  +C + D + RPS 
Sbjct: 274 PYPG-----------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 322
Query: 368 DEVVKVL 374
             +   L
Sbjct: 323 PNLTSFL 329

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD----GLQGHREWVAE 149
           NF+    +GEG +G V+K              +G  VA+K ++ D    G+      + E
Sbjct: 7   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTA--IRE 55
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYE--------FMTRGSLENHLFRRTIPLPWSN 201
           +  L +L+HPN+VKL+     +++  LV+E        FM   +L        IPLP   
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTG------IPLPLIK 109
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
                L   +GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A   G      
Sbjct: 110 SYLFQL--LQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTY 163
Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              V T  Y APE ++   + ++  D++S G +  E++T R
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE-- 508
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ S    KL DFGL++     D T+  +++      + APE +  
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 566
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 72  HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 128
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ S    KL DFGL++     D T+  +++      + APE +  
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 186
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 15  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 69  HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ S    KL DFGL++     D T+  +++      + APE +  
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 183
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 20  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 74  HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 130
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ S    KL DFGL++     D T+  +++      + APE +  
Sbjct: 131 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 188
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 34/281 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+  ++LG+G F  V++              +G+ VA+K +    +   G  + V  EV
Sbjct: 12  DFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
               QL HP++++L  Y  + +   LV E    G +  +L  R  P   +          
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            G+ +LH  S  +++RD   SN+LL    N K++DFGLA       + H +  + GT  Y
Sbjct: 123 TGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            +PE         +SDV+S G +   +L GR   D        N V  A           
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----------- 227
Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
              D  +    S++    + QL    L R+P  R S+  V+
Sbjct: 228 ---DYEMPSFLSIEAKDLIHQL----LRRNPADRLSLSSVL 261

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 72  HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 128
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ S    KL DFGL++     D T+  +++      + APE +  
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 186
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 21  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 75  HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 131
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ S    KL DFGL++     D T+  +++      + APE +  
Sbjct: 132 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 189
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 23  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 77  HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 133
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ S    KL DFGL++     D T+  +++      + APE +  
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 191
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 46  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 100 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 156
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ S    KL DFGL++     D T+  +++      + APE +  
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 214
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 85  FQELKS---ATGNFRPDSI------LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL 135
           FQ +K     T +  P+        LG+G FG V+K   +E         + +  A K +
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVI 70
Query: 136 KPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI 195
                +   +++ E+D L    HPN+VKL+     ++   ++ EF   G+++  +     
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER 130
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
           PL  S    +       L +LH     +I+RD K  NIL   + + KL+DFG++    + 
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 188
Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEI 297
            +   S   +GT  + APE VM           K+DV+S G+ L+E+
Sbjct: 189 IQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HH 158
           LG G FG V    IE +     K  +  TVAVK LK       HR  ++E+  L  + HH
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 159 PNLVKLIGYCIEDDQRLLVY-EFMTRGSLENHL-FRRTIPLPW--------------SNR 202
            N+V L+G C +    L+V  EF   G+L  +L  +R   +P+               + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I  +   AKG+ FL   S   I+RD    NILL  +   K+ DFGLA+   +        
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                  + APE +     T +SDV+SFGV+L EI +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 85  FQELKS---ATGNFRPDSI------LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL 135
           FQ +K     T +  P+        LG+G FG V+K   +E         + +  A K +
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVI 70
Query: 136 KPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI 195
                +   +++ E+D L    HPN+VKL+     ++   ++ EF   G+++  +     
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER 130
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
           PL  S    +       L +LH     +I+RD K  NIL   + + KL+DFG++    + 
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRX 188
Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEI 297
            +   S   +GT  + APE VM           K+DV+S G+ L+E+
Sbjct: 189 IQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HH 158
           LG G FG V    IE +     K  +  TVAVK LK       HR  ++E+  L  + HH
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 159 PNLVKLIGYCIEDDQRLLVY-EFMTRGSLENHL-FRRTIPLPW--------------SNR 202
            N+V L+G C +    L+V  EF   G+L  +L  +R   +P+               + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I  +   AKG+ FL   S   I+RD    NILL  +   K+ DFGLA+   +        
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                  + APE +     T +SDV+SFGV+L EI +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 106/225 (47%), Gaps = 34/225 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSG--ITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           LGEG FG V K       TA    G     TVAVK LK +      R+ ++E + L Q++
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIP------------------- 196
           HP+++KL G C +D   LL+ E+   GSL   L   R+  P                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 197 --LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
             L   + I  A   ++G+ +L   S  +++RD    NIL+      K+SDFGL++   +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            D     ++      + A E +     T++SDV+SFGV+L EI+T
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++           P      I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++RD    N ++  ++  K+ DFG+ +   +        + +   
Sbjct: 139 IADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV 196
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 241
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +PK RP+  E+V +L
Sbjct: 242 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 72  HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE-- 128
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ +    KL DFGL++     D T+  +++      + APE +  
Sbjct: 129 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 186
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLHHP 159
           +GEG FG V +G       +P  P   + VA+K+ K       RE ++ E   + Q  HP
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           ++VKLIG  I ++   ++ E  T G L + L  R   L  ++ I  A   +  LA+L   
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE-- 508
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYGYAAPEYVMT 278
           S+  ++RD    N+L+ +    KL DFGL++     D T+  +++      + APE +  
Sbjct: 509 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINF 566
Query: 279 GHLTSKSDVYSFGVVLLEIL 298
              TS SDV+ FGV + EIL
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDF 152
           + +   ++GEG FG V K  I+++G         +  A+K +K    +  HR++  E++ 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEV 78
Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------P 196
           L +L HHPN++ L+G C       L  E+   G+L + L +  +                
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           L     +  A   A+G+ +L    +  I+RD    NIL+   Y AK++DFGL++    G 
Sbjct: 139 LSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQ 192
Query: 257 KTHVSTRVVGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           + +V  + +G     + A E +     T+ SDV+S+GV+L EI++
Sbjct: 193 EVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 32  DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 86
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 87  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 144
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 145 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 201
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 32  DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 86
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 87  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 144
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 145 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 201
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HH 158
           LG G FG V    IE +     K  +  TVAVK LK       HR  ++E+  L  + HH
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 159 PNLVKLIGYCIEDDQRLLVY-EFMTRGSLENHL-FRRTIPLPW--------------SNR 202
            N+V L+G C +    L+V  EF   G+L  +L  +R   +P+               + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I  +   AKG+ FL   S   I+RD    NILL  +   K+ DFGLA+   +        
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                  + APE +     T +SDV+SFGV+L EI +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 13/232 (5%)
Query: 79  QLLQFTFQELKSATGN-FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP 137
           + LQ+ + E +  T N FR   +LG+GGFG V    +   G   A         ++  + 
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA------CKKLEKKRI 222
Query: 138 DGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-TIP 196
              +G    + E   L +++   +V L       D   LV   M  G L+ H++      
Sbjct: 223 KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
            P +  +  A     GL  LH   E ++YRD K  NILLD   + ++SD GLA   P+G 
Sbjct: 283 FPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
              +  R VGT GY APE V     T   D ++ G +L E++ G+    +++
Sbjct: 341 T--IKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 85  FQELKS---ATGNFRPDSI------LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL 135
           FQ +K     T +  P+        LG+G FG V+K   +E         + +  A K +
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVI 70
Query: 136 KPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI 195
                +   +++ E+D L    HPN+VKL+     ++   ++ EF   G+++  +     
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER 130
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
           PL  S    +       L +LH     +I+RD K  NIL   + + KL+DFG++    + 
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR- 187
Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEI 297
                    +GT  + APE VM           K+DV+S G+ L+E+
Sbjct: 188 -XIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-H 157
           ++GEG FG V K  I+++G         +  A+K +K    +  HR++  E++ L +L H
Sbjct: 22  VIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------PLPWSNR 202
           HPN++ L+G C       L  E+   G+L + L +  +                L     
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +  A   A+G+ +L    +  I+RD    NIL+   Y AK++DFGL++    G + +V  
Sbjct: 135 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 187
Query: 263 RVVGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           + +G     + A E +     T+ SDV+S+GV+L EI++
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSG--ITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           LGEG FG V K       TA    G     TVAVK LK +      R+ ++E + L Q++
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIP------------------- 196
           HP+++KL G C +D   LL+ E+   GSL   L   R+  P                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 197 --LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
             L   + I  A   ++G+ +L      +++RD    NIL+      K+SDFGL++   +
Sbjct: 145 RALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            D     ++      + A E +     T++SDV+SFGV+L EI+T
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HH 158
           LG G FG V    IE +     K  +  TVAVK LK       HR  ++E+  L  + HH
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 159 PNLVKLIGYCIEDDQRLLVY-EFMTRGSLENHL-FRRTIPLPW--------------SNR 202
            N+V L+G C +    L+V  EF   G+L  +L  +R   +P+               + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I  +   AKG+ FL   S   I+RD    NILL  +   K+ DFGLA+   +        
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                  + APE +     T +SDV+SFGV+L EI +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 42/276 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G +G V+ G               +TVAVK+LK D ++   E++ E   + ++ HPN
Sbjct: 40  LGGGQYGEVYVG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 89
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAAKGL 213
           LV+L+G C  +    +V E+M  G+L ++L           + L  + +I  A+   +  
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK 149
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            F+H        RD    N L+   +  K++DFGL++    GD             + AP
Sbjct: 150 NFIH--------RDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 200
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +     + KSDV++FGV+L EI T   S     P               D  ++Y ++
Sbjct: 201 ESLAYNTFSIKSDVWAFGVLLWEIATYGMS---PYPG-------------IDLSQVYDLL 244
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
           +    +        KV +L   C    P  RPS  E
Sbjct: 245 EKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 30  DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 84
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 85  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 142
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 143 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 199
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 22  DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 76
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 77  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 135 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 191
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++           P      I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++R+    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 139 IADGMAYLN--AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 241
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +P  RP+  E+V +L
Sbjct: 242 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 13/232 (5%)
Query: 79  QLLQFTFQELKSATGN-FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP 137
           + LQ+ + E +  T N FR   +LG+GGFG V    +   G   A         ++  + 
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA------CKKLEKKRI 222
Query: 138 DGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-TIP 196
              +G    + E   L +++   +V L       D   LV   M  G L+ H++      
Sbjct: 223 KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
            P +  +  A     GL  LH   E ++YRD K  NILLD   + ++SD GLA   P+G 
Sbjct: 283 FPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
              +  R VGT GY APE V     T   D ++ G +L E++ G+    +++
Sbjct: 341 T--IKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHP 159
           LG+G FG V++G    N     K  +   VAVK++     L+   E++ E   +      
Sbjct: 26  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-----------PLPWSNRIKIALG 208
           ++V+L+G   +    L+V E M  G L+++L  R++           P      I++A  
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            A G+A+L+  ++  ++R+    N ++  ++  K+ DFG+ +   + D      + +   
Sbjct: 140 IADGMAYLN--AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +  G  T+ SD++SFGVVL EI +               L     Q L++++ 
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 242
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           L  ++D    L+      ++V+ L   C   +P  RP+  E+V +L
Sbjct: 243 LKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 16  DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 70
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 71  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 128
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 129 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 185
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 374 DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 428
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 429 NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 486
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 487 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 543
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSG--ITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           LGEG FG V K       TA    G     TVAVK LK +      R+ ++E + L Q++
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIP------------------- 196
           HP+++KL G C +D   LL+ E+   GSL   L   R+  P                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 197 --LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
             L   + I  A   ++G+ +L      +++RD    NIL+      K+SDFGL++   +
Sbjct: 145 RALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            D     ++      + A E +     T++SDV+SFGV+L EI+T
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 10  DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 64
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 65  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 122
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 123 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 179
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 375 DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 429
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 430 NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 487
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 488 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 544
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 12  DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 66
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 67  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 124
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+ +   +  G +   + APE 
Sbjct: 125 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPEC 181
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
             R   +LG G FG V KG WI E  +        I V +K ++   G Q  +     + 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESI------KIPVCIKVIEDKSGRQSFQAVTDHML 85
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +G L H ++V+L+G C     +L V +++  GSL +H+ +    L     +   +  AK
Sbjct: 86  AIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 144
Query: 212 GLAFL--HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           G+ +L  HG    +++R+    N+LL S    +++DFG+A   P  DK  + +       
Sbjct: 145 GMYYLEEHG----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 200
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           + A E +  G  T +SDV+S+GV + E++T
Sbjct: 201 WMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
             R   +LG G FG V KG WI E  +        I V +K ++   G Q  +     + 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESI------KIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +G L H ++V+L+G C     +L V +++  GSL +H+ +    L     +   +  AK
Sbjct: 68  AIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 212 GLAFL--HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           G+ +L  HG    +++R+    N+LL S    +++DFG+A   P  DK  + +       
Sbjct: 127 GMYYLEEHG----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           + A E +  G  T +SDV+S+GV + E++T
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + +L+H
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKLNH 93
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 153 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           D  LG G FG V KG+ +            + +         L+   E +AE + + QL 
Sbjct: 16  DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLD 70
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ +L 
Sbjct: 71  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE 128
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY--GYAAPEY 275
             +   ++RD    N+LL +++ AK+SDFGL+KA  + D+     +  G +   + APE 
Sbjct: 129 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENXYKAQTHGKWPVKWYAPEC 185
Query: 276 VMTGHLTSKSDVYSFGVVLLEILT 299
           +     +SKSDV+SFGV++ E  +
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-H 157
           ++GEG FG V K  I+++G         +  A+K +K    +  HR++  E++ L +L H
Sbjct: 29  VIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------PLPWSNR 202
           HPN++ L+G C       L  E+   G+L + L +  +                L     
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +  A   A+G+ +L    +  I+R+    NIL+   Y AK++DFGL++    G + +V  
Sbjct: 142 LHFAADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK- 194
Query: 263 RVVGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           + +G     + A E +     T+ SDV+S+GV+L EI++
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V+K   +E G            A K ++    +   +++ E++ L    HP 
Sbjct: 27  LGDGAFGKVYKAKNKETGA---------LAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +VKL+G    D +  ++ EF   G+++  +      L       +     + L FLH  S
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--S 135
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           + +I+RD K  N+L+  E + +L+DFG++    +  +   S   +GT  + APE VM   
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 193
Query: 281 LTS-----KSDVYSFGVVLLEI 297
           +       K+D++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEM 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 123/279 (44%), Gaps = 30/279 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VA+K +K +G     E++ E   +  L H  
Sbjct: 32  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L   S
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--S 138
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           +  ++RD    N L++ +   K+SDFGL++     ++T  S        ++ PE +M   
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMYSK 197
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
            +SKSD+++FGV++ EI +  +   ++  + E        +++A   +LY+   P L   
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL--- 245
Query: 341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
                 +KV  + Y+C       RP+   ++  +  + D
Sbjct: 246 ----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 36/284 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VA+K +K +G     E++ E   +  L H  
Sbjct: 17  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L   S
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--S 123
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEYVM 277
           +  ++RD    N L++ +   K+SDFGL++     D  + S+  VG+     ++ PE +M
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLM 179
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               +SKSD+++FGV++ EI +  +   ++  + E        +++A   +LY+   P L
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL 230
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN 381
                    +KV  + Y+C       RP+   ++  +  + D N
Sbjct: 231 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEN 267

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + +L+H
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKLNH 107
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 108 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 167 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G FG V+K   +E G            A K ++    +   +++ E++ L    HP 
Sbjct: 19  LGDGAFGKVYKAKNKETGA---------LAAAKVIETKSEEELEDYIVEIEILATCDHPY 69
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +VKL+G    D +  ++ EF   G+++  +      L       +     + L FLH  S
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--S 127
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           + +I+RD K  N+L+  E + +L+DFG++    +  +   S   +GT  + APE VM   
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 185
Query: 281 LTS-----KSDVYSFGVVLLEI 297
           +       K+D++S G+ L+E+
Sbjct: 186 MKDTPYDYKADIWSLGITLIEM 207

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 119
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 120 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 178
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 179 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 236
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 36/282 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VA+K +K +G     E++ E   +  L H  
Sbjct: 17  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L   S
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--S 123
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEYVM 277
           +  ++RD    N L++ +   K+SDFGL++     D  + S+R  G+     ++ PE +M
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSR--GSKFPVRWSPPEVLM 179
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               +SKSD+++FGV++ EI +  +   ++  + E        +++A   +LY+   P L
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL 230
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
                    +KV  + Y+C       RP+   ++  +  + D
Sbjct: 231 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 109
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 110 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 168
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 169 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 226
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 36/282 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VA+K +K +G     E++ E   +  L H  
Sbjct: 16  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 64
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L   S
Sbjct: 65  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--S 122
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEYVM 277
           +  ++RD    N L++ +   K+SDFGL++     D  + S+  VG+     ++ PE +M
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLM 178
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               +SKSD+++FGV++ EI +  +   ++  + E        +++A   +LY+   P L
Sbjct: 179 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL 229
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
                    +KV  + Y+C       RP+   ++  +  + D
Sbjct: 230 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 264

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 92
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 152 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 36/282 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VA+K +K +G     E++ E   +  L H  
Sbjct: 12  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 60
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L   S
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--S 118
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEYVM 277
           +  ++RD    N L++ +   K+SDFGL++     D  + S+  VG+     ++ PE +M
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLM 174
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               +SKSD+++FGV++ EI +  +   ++  + E        +++A   +LY+   P L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL 225
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
                    +KV  + Y+C       RP+   ++  +  + D
Sbjct: 226 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 260

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 92
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 93  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 152 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 18/219 (8%)
Query: 87  ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW 146
           ++K    +F    +LG+G FG VF    ++              A+K+LK D +    + 
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQ---------FFAIKALKKDVVLMDDDV 62
Query: 147 ---VAEVDFLG-QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR 202
              + E   L     HP L  +       +    V E++  G L  H+ +       S  
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRA 121
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
              A     GL FLH  S+ ++YRD K  NILLD + + K++DFG+ K    GD    + 
Sbjct: 122 TFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TN 177
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
              GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 178 EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 93
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 153 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 157 HHPNLVKLIGYCIEDDQRLL-VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           +HP LV L   C + + RL  V E++  G L  H+ +R   LP  +    +   +  L +
Sbjct: 79  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNY 136
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRVVGTYGYAAPE 274
           LH     +IYRD K  N+LLDSE + KL+D+G+ K G + GD T   +   GT  Y APE
Sbjct: 137 LH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPE 191
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG--EQNLVAWARQYLADKRKLYQI 332
            +         D ++ GV++ E++ GR   D    S   +QN   +  Q + +K    QI
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----QI 247
Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             PR   + S+K    +       L++DPK R
Sbjct: 248 RIPR---SMSVKAASVLKSF----LNKDPKER 272

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 99
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 100 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 158
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 159 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 216
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 157 HHPNLVKLIGYCIEDDQRLL-VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           +HP LV L   C + + RL  V E++  G L  H+ +R   LP  +    +   +  L +
Sbjct: 111 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNY 168
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRVVGTYGYAAPE 274
           LH     +IYRD K  N+LLDSE + KL+D+G+ K G + GD T   +   GT  Y APE
Sbjct: 169 LH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPE 223
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG--EQNLVAWARQYLADKRKLYQI 332
            +         D ++ GV++ E++ GR   D    S   +QN   +  Q + +K    QI
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----QI 279
Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             PR   + S+K    +       L++DPK R
Sbjct: 280 RIPR---SLSVKAASVLKSF----LNKDPKER 304

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 36/282 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VA+K +K +G     E++ E   +  L H  
Sbjct: 32  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L   S
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--S 138
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEYVM 277
           +  ++RD    N L++ +   K+SDFGL++     D  + S+  VG+     ++ PE +M
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLM 194
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               +SKSD+++FGV++ EI +  +   ++  + E        +++A   +LY+   P L
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL 245
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
                    +KV  + Y+C       RP+   ++  +  + D
Sbjct: 246 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 19/233 (8%)
Query: 73  DEKSPCQLLQFTFQELKSAT---GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGIT 129
           DE+   +L  F  Q+ K       +F   S LG G  G VFK           KP SG+ 
Sbjct: 45  DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLV 95
Query: 130 VAVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN 188
           +A K +  +     R + + E+  L + + P +V   G    D +  +  E M  GSL +
Sbjct: 96  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-D 154
Query: 189 HLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL 248
            + ++   +P     K+++   KGL +L    + +++RD K SNIL++S    KL DFG+
Sbjct: 155 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV 213
Query: 249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           +  G   D   ++   VGT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 214 S--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 36/282 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V  G          K      VA+K +K +G     E++ E   +  L H  
Sbjct: 23  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 71
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L   S
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--S 129
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEYVM 277
           +  ++RD    N L++ +   K+SDFGL++     D  + S+  VG+     ++ PE +M
Sbjct: 130 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLM 185
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               +SKSD+++FGV++ EI +  +   ++  + E        +++A   +LY+   P L
Sbjct: 186 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL 236
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
                    +KV  + Y+C       RP+   ++  +  + D
Sbjct: 237 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           +F   S LG G  G VFK           KP SG+ +A K +  +     R + + E+  
Sbjct: 10  DFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQV 60
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L + + P +V   G    D +  +  E M  GSL + + ++   +P     K+++   KG
Sbjct: 61  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKG 119
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +L      +++RD K SNIL++S    KL DFG++  G   D+  ++   VGT  Y +
Sbjct: 120 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANEFVGTRSYMS 174
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE +   H + +SD++S G+ L+E+  GR
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 93
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 153 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPV 210
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 107
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 108 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 167 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 84
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 85  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 143
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 144 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 201
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 11/208 (5%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVD 151
             R   +LG G FG V+KG WI      P      I VA+K L+ +   + ++E + E  
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  +  P + +L+G C+    +L V + M  G L +H+      L   + +   +  AK
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAK 130
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+++L      +++RD    N+L+ S  + K++DFGLA+     +  + +        + 
Sbjct: 131 GMSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 188
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           A E ++    T +SDV+S+GV + E++T
Sbjct: 189 ALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 110
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 111 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 169
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 170 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 227
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 228 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 157 HHPNLVKLIGYCIEDDQRLL-VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           +HP LV L   C + + RL  V E++  G L  H+ +R   LP  +    +   +  L +
Sbjct: 64  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNY 121
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRVVGTYGYAAPE 274
           LH     +IYRD K  N+LLDSE + KL+D+G+ K G + GD T   +   GT  Y APE
Sbjct: 122 LH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPE 176
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG--EQNLVAWARQYLADKRKLYQI 332
            +         D ++ GV++ E++ GR   D    S   +QN   +  Q + +K    QI
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----QI 232
Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             PR     SL    K + +  + L++DPK R
Sbjct: 233 RIPR-----SLS--VKAASVLKSFLNKDPKER 257

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 37/275 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG V+KG   +N T        I +     + + +Q       E+  L Q   P 
Sbjct: 27  IGKGSFGEVYKGI--DNHTKEVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPY 78
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           + +  G  ++  +  ++ E++  GS  + L  +  PL  +    I     KGL +LH  S
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH--S 134
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           E  I+RD K +N+LL  + + KL+DFG+  AG   D        VGT  + APE +    
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 192
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PRL 337
              K+D++S G+  +E+  G      + P+ +          L   R L+ I     P L
Sbjct: 193 YDFKADIWSLGITAIELAKG------EPPNSD----------LHPMRVLFLIPKNSPPTL 236
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           E  +S    +   +    CL++DP+ RP+  E++K
Sbjct: 237 EGQHS----KPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 19/233 (8%)
Query: 73  DEKSPCQLLQFTFQELKSAT---GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGIT 129
           DE+   +L  F  Q+ K       +F   S LG G  G VFK           KP SG+ 
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLV 60
Query: 130 VAVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN 188
           +A K +  +     R + + E+  L + + P +V   G    D +  +  E M  GSL +
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-D 119
Query: 189 HLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL 248
            + ++   +P     K+++   KGL +L    + +++RD K SNIL++S    KL DFG+
Sbjct: 120 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           +  G   D   ++   VGT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 179 S--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 133
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 193 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 157 HHPNLVKLIGYCIEDDQRLL-VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           +HP LV L   C + + RL  V E++  G L  H+ +R   LP  +    +   +  L +
Sbjct: 68  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNY 125
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRVVGTYGYAAPE 274
           LH     +IYRD K  N+LLDSE + KL+D+G+ K G + GD T   +   GT  Y APE
Sbjct: 126 LH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPE 180
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG--EQNLVAWARQYLADKRKLYQI 332
            +         D ++ GV++ E++ GR   D    S   +QN   +  Q + +K    QI
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----QI 236
Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             PR     SL    K + +  + L++DPK R
Sbjct: 237 RIPR-----SLS--VKAASVLKSFLNKDPKER 261

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHH 158
           LG G FG V++G +      P    S + VAVK+L P+    Q   +++ E   + + +H
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTL-PEVYSEQDELDFLMEALIISKFNH 107
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIKIALGAAK 211
            N+V+ IG  ++   R ++ E M  G L++ L R T P P         + + +A   A 
Sbjct: 108 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           G  +L       I+RD    N LL        AK+ DFG+A+   +          +   
Sbjct: 167 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +  PE  M G  TSK+D +SFGV+L EI +
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           +F   S LG G  G VFK           KP SG+ +A K +  +     R + + E+  
Sbjct: 26  DFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQV 76
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L + + P +V   G    D +  +  E M  GSL + + ++   +P     K+++   KG
Sbjct: 77  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKG 135
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +L      +++RD K SNIL++S    KL DFG++  G   D   ++   VGT  Y +
Sbjct: 136 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMS 190
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE +   H + +SD++S G+ L+E+  GR
Sbjct: 191 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 73
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 133 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 189
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 18/219 (8%)
Query: 87  ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW 146
           ++K    +F    +LG+G FG VF    ++              A+K+LK D +    + 
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQ---------FFAIKALKKDVVLMDDDV 61
Query: 147 ---VAEVDFLG-QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR 202
              + E   L     HP L  +       +    V E++  G L  H+ +       S  
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRA 120
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
              A     GL FLH  S+ ++YRD K  NILLD + + K++DFG+ K    GD    + 
Sbjct: 121 TFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TN 176
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
              GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 177 XFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 70
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+ +L      +++RD    N+L+ +  + K++DFGLAK     +K + +        + 
Sbjct: 130 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           A E ++    T +SDV+S+GV + E++T
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 79
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 138
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 139 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 195
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 69
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 129 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 185
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 72
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 132 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 188
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 71
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+ +L      +++RD    N+L+ +  + K++DFGLAK     +K + +        + 
Sbjct: 131 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           A E ++    T +SDV+S+GV + E++T
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 70
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 130 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 186
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 38/283 (13%)
Query: 98  DSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQ 155
           D ++G+G FG V+ G +I++         + I  A+KSL +   +Q    ++ E   +  
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQ-------NRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 156 LHHPNLVKLIGYCIEDD---QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L+HPN++ LIG  +  +     LL Y  M  G L   +          + I   L  A+G
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD----KTHVSTRVVGTY 268
           + +L    +  ++RD    N +LD  +  K++DFGLA+     +    + H   R+    
Sbjct: 137 MEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PV 192
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + A E + T   T+KSDV+SFGV+L E+LT  R     R     +L      +LA  R+
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLT--RGAPPYRHIDPFDLT----HFLAQGRR 246
Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           L Q         Y    + +V Q    C   DP  RP+   +V
Sbjct: 247 LPQP-------EYCPDSLYQVMQ---QCWEADPAVRPTFRVLV 279

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           +F   S LG G  G VFK           KP SG+ +A K +  +     R + + E+  
Sbjct: 7   DFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L + + P +V   G    D +  +  E M  GSL + + ++   +P     K+++   KG
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +L    + +++RD K SNIL++S    KL DFG++  G   D   ++   VGT  Y +
Sbjct: 117 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMS 171
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE +   H + +SD++S G+ L+E+  GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           +F   S LG G  G VFK           KP SG+ +A K +  +     R + + E+  
Sbjct: 7   DFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L + + P +V   G    D +  +  E M  GSL + + ++   +P     K+++   KG
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +L    + +++RD K SNIL++S    KL DFG++  G   D   ++   VGT  Y +
Sbjct: 117 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMS 171
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE +   H + +SD++S G+ L+E+  GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           +F   S LG G  G VFK           KP SG+ +A K +  +     R + + E+  
Sbjct: 7   DFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L + + P +V   G    D +  +  E M  GSL + + ++   +P     K+++   KG
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +L    + +++RD K SNIL++S    KL DFG++  G   D   ++   VGT  Y +
Sbjct: 117 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMS 171
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE +   H + +SD++S G+ L+E+  GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 75
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 134
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 135 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 191
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK-PDGLQG-HREWVA 148
           AT  + P + +G G +G V+K            P SG  VA+KS++ P+G +G     V 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 149 EVDFLGQLH---HPNLVKLIGYCI--EDDQRL---LVYEFMTRGSLENHLFRRTIP-LPW 199
           EV  L +L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +   P LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
                +     +GL FLH     +++RD K  NIL+ S    KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQM 166
Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
               VV T  Y APE ++     +  D++S G +  E+ 
Sbjct: 167 ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 72
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 132 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 188
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 76
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 136 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 192
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           +F   S LG G  G VFK           KP SG+ +A K +  +     R + + E+  
Sbjct: 7   DFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L + + P +V   G    D +  +  E M  GSL + + ++   +P     K+++   KG
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +L      +++RD K SNIL++S    KL DFG++  G   D   ++   VGT  Y +
Sbjct: 117 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMS 171
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE +   H + +SD++S G+ L+E+  GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
           +F   S LG G  G VFK           KP SG+ +A K +  +     R + + E+  
Sbjct: 7   DFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L + + P +V   G    D +  +  E M  GSL + + ++   +P     K+++   KG
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           L +L      +++RD K SNIL++S    KL DFG++  G   D   ++   VGT  Y +
Sbjct: 117 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMS 171
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE +   H + +SD++S G+ L+E+  GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 10/177 (5%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV    QL H N+V +I    EDD   LV E++   +L  ++     PL     I     
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQ 119
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
              G+   H     +++RD K  NIL+DS    K+ DFG+AKA  +   T  +  V+GT 
Sbjct: 120 ILDGIK--HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTV 176
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
            Y +PE          +D+YS G+VL E+L G      + P   +  V+ A +++ D
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVG------EPPFNGETAVSIAIKHIQD 227

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 94
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 154 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 210
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 72
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+ +L      +++RD    N+L+ +  + K++DFGLAK     +K + +        + 
Sbjct: 132 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           A E ++    T +SDV+S+GV + E++T
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 69
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 129 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 185
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA 148
           K +  +F+    LG G FG V       NG   A       + V+  + +     R  ++
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
            V       HP ++++ G   +  Q  ++ +++  G L + L R++   P  N +     
Sbjct: 62  IVT------HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFP--NPVAKFYA 112
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
           A   LA  +  S+ +IYRD K  NILLD   + K++DFG AK  P      V+  + GT 
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTP 167
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE V T       D +SFG+++ E+L G
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG+GG+G VF+  + +   A       + V  K++     +      AE + L ++ HP
Sbjct: 24  VLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP-----WSNRIKIALGAAKGL 213
            +V LI Y  +   +L L+ E+++ G L   L R  I +      +   I +ALG     
Sbjct: 82  FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG----- 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ-GDKTHVSTRVVGTYGYAA 272
              H   + +IYRD K  NI+L+ + + KL+DFGL K     G  TH      GT  Y A
Sbjct: 136 ---HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCGTIEYMA 189
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           PE +M        D +S G ++ ++LTG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 72
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 132 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 188
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 71
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 131 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 187
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 69
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+ +L      +++RD    N+L+ +  + K++DFGLAK     +K + +        + 
Sbjct: 129 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           A E ++    T +SDV+S+GV + E++T
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK-PDGLQG-HREWVA 148
           AT  + P + +G G +G V+K            P SG  VA+KS++ P+G +G     V 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 149 EVDFLGQLH---HPNLVKLIGYCI--EDDQRL---LVYEFMTRGSLENHLFRRTIP-LPW 199
           EV  L +L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +   P LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
                +     +GL FLH     +++RD K  NIL+ S    KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQM 166
Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
               VV T  Y APE ++     +  D++S G +  E+ 
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 63
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 123 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 179
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 69
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 129 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 185
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG+GG+G VF+  + +   A       + V  K++     +      AE + L ++ HP
Sbjct: 24  VLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP-----WSNRIKIALGAAKGL 213
            +V LI Y  +   +L L+ E+++ G L   L R  I +      +   I +ALG     
Sbjct: 82  FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG----- 135
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
              H   + +IYRD K  NI+L+ + + KL+DFGL K     D T V+    GT  Y AP
Sbjct: 136 ---HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGT-VTHXFCGTIEYMAP 190
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTG 300
           E +M        D +S G ++ ++LTG
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVD 151
            GN++    LGEG FG V   +    G   A       +  K L    +QG  E   E+ 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK----IINKKVLAKSDMQGRIE--REIS 65
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           +L  L HP+++KL       D+ ++V E+      +  + R  +    + R    + +A 
Sbjct: 66  YLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 125
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
                H     +++RD K  N+LLD   N K++DFGL+     G+    S    G+  YA
Sbjct: 126 EYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 178
Query: 272 APEYVMTGHLTS--KSDVYSFGVVLLEILTGRRSMD 305
           APE V++G L +  + DV+S GV+L  +L  R   D
Sbjct: 179 APE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 80  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVD 151
            GN++    LGEG FG V   +    G   A       +  K L    +QG  E   E+ 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK----IINKKVLAKSDMQGRIE--REIS 66
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           +L  L HP+++KL       D+ ++V E+      +  + R  +    + R    + +A 
Sbjct: 67  YLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 126
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
                H     +++RD K  N+LLD   N K++DFGL+     G+    S    G+  YA
Sbjct: 127 EYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 179
Query: 272 APEYVMTGHLTS--KSDVYSFGVVLLEILTGRRSMD 305
           APE V++G L +  + DV+S GV+L  +L  R   D
Sbjct: 180 APE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 80  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVD 151
            GN++    LGEG FG V   +    G   A       +  K L    +QG  E   E+ 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK----IINKKVLAKSDMQGRIE--REIS 56
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           +L  L HP+++KL       D+ ++V E+      +  + R  +    + R    + +A 
Sbjct: 57  YLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 116
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
                H     +++RD K  N+LLD   N K++DFGL+     G+    S    G+  YA
Sbjct: 117 EYCHRHK----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 169
Query: 272 APEYVMTGHLTS--KSDVYSFGVVLLEILTGRRSMD 305
           APE V++G L +  + DV+S GV+L  +L  R   D
Sbjct: 170 APE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 81
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 82  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 37  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 87
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 88  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 142
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 143 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 80  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-------FRRTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E M    L  HL         +T  L   +         
Sbjct: 100 HENIIG-----INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 154
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK-PDGLQG-HREWVA 148
           AT  + P + +G G +G V+K            P SG  VA+KS++ P+G +G     V 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 149 EVDFLGQLH---HPNLVKLIGYCI--EDDQRL---LVYEFMTRGSLENHLFRRTIP-LPW 199
           EV  L +L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +   P LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
                +     +GL FLH     +++RD K  NIL+ S    KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQM 166
Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
               VV T  Y APE ++     +  D++S G +  E+ 
Sbjct: 167 ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 80  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 33/292 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDF 152
           ++    ++G G    V   +      AP K      VA+K +  +  Q    E + E+  
Sbjct: 16  DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 66
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN---HLF----RRTIPLPWSNRIKI 205
           + Q HHPN+V      +  D+  LV + ++ GS+ +   H+      ++  L  S    I
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTR- 263
                +GL +LH   +  I+RD K  NILL  + + +++DFG+ A     GD T    R 
Sbjct: 127 LREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 264 -VVGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
             VGT  + APE +  + G+   K+D++SFG+  +E+ TG     K  P     ++    
Sbjct: 185 TFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPP---MKVLMLTL 240
Query: 321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           Q   D   L   V  +  L    K  +K+  L   CL +DP+ RP+  E+++
Sbjct: 241 Q--NDPPSLETGVQDKEMLKKYGKSFRKMISL---CLQKDPEKRPTAAELLR 287

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 24/256 (9%)
Query: 130 VAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN 188
           VA+K +  +  Q    E + E+  + Q HHPN+V      +  D+  LV + ++ GS+ +
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 189 ---HLF----RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA 241
              H+      ++  L  S    I     +GL +LH   +  I+RD K  NILL  + + 
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSV 155
Query: 242 KLSDFGL-AKAGPQGDKTHVSTR--VVGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLE 296
           +++DFG+ A     GD T    R   VGT  + APE +  + G+   K+D++SFG+  +E
Sbjct: 156 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIE 214
Query: 297 ILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNC 356
           + TG     K  P     ++    Q   D   L   V  +  L    K  +K+  L   C
Sbjct: 215 LATGAAPYHKYPP---MKVLMLTLQ--NDPPSLETGVQDKEMLKKYGKSFRKMISL---C 266
Query: 357 LSRDPKSRPSMDEVVK 372
           L +DP+ RP+  E+++
Sbjct: 267 LQKDPEKRPTAAELLR 282

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 84  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVD 151
            GN++    LGEG FG V   +    G   A       +  K L    +QG  E   E+ 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK----IINKKVLAKSDMQGRIE--REIS 60
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           +L  L HP+++KL       D+ ++V E+      +  + R  +    + R    + +A 
Sbjct: 61  YLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
                H     +++RD K  N+LLD   N K++DFGL+     G+    S    G+  YA
Sbjct: 121 EYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 173
Query: 272 APEYVMTGHLTS--KSDVYSFGVVLLEILTGRRSMD 305
           APE V++G L +  + DV+S GV+L  +L  R   D
Sbjct: 174 APE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYXQRTLREIKILLRFR 83
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 84  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 54  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 114 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 27  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 78  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 132
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 34  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 85  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 139
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 35  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 85
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 86  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 140
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 141 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 26  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 76
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 77  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 131
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 132 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 84  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 55  EICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 115 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 27  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 78  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 132
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 100 HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 154
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 80  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 54  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 114 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 114 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 53  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 112
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 113 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 115 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 114 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 82  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 55  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 115 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+  RG +   L ++              
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYIT 120
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 217
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 218 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLA 214
           L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
            +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLA 214
           L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
            +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 114 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 115 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 115 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 115 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLA 214
           L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
            +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLA 214
           L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
            +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 82  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLA 214
           L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
            +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQE 216

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLA 214
           L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
            +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLA 214
           L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
            +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 112/235 (47%), Gaps = 18/235 (7%)
Query: 68  DPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGS 126
           +P     ++P Q L    +E       F+   +LG G FG V+KG WI E          
Sbjct: 29  EPLTPSGEAPNQALLRILKE-----TEFKKIKVLGSGAFGTVYKGLWIPEGEKV------ 77
Query: 127 GITVAVKSLK-PDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGS 185
            I VA+  L+     + ++E + E   +  + +P++ +L+G C+    +L+  + M  G 
Sbjct: 78  KIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGC 136
Query: 186 LENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD 245
           L +++      +     +   +  AKG+ +L      +++RD    N+L+ +  + K++D
Sbjct: 137 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITD 194
Query: 246 FGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           FGLAK  G +  + H     V    + A E ++    T +SDV+S+GV + E++T
Sbjct: 195 FGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 66
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  A+
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 126 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 182
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIAL 207
           E+     L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A  G+ +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT
Sbjct: 114 MA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
             Y APE +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 73
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFG AK  G +  + H     V    +
Sbjct: 133 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KW 189
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +L  G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 76
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 136 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 192
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA++ + P   Q + +  + E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIRKISPFEHQTYCQRTLREIKILLRFR 83
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 84  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 71
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+ +L      +++RD    N+L+ +  + K++DFG AK     +K + +        + 
Sbjct: 131 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           A E ++    T +SDV+S+GV + E++T
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLA 214
           L+H N+VK  G+  E + + L  E+ + G L + +     +P P + R    L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LHG    + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
            +      ++  DV+S G+VL  +L G    D+   S ++
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 145 EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
           + + E+  L + + P +V   G    D +  +  E M  GSL + + +    +P     K
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 118
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           +++   +GLA+L    + +++RD K SNIL++S    KL DFG++  G   D   ++   
Sbjct: 119 VSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 173
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           VGT  Y APE +   H + +SD++S G+ L+E+  GR
Sbjct: 174 VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +L  G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 69
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 129 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 185
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 11/208 (5%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 71
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+ +L      +++RD    N+L+ +  + K++DFG AK     +K + +        + 
Sbjct: 131 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           A E ++    T +SDV+S+GV + E++T
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 71
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L++ + M  G L +++      +     +   +  AK
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFG AK  G +  + H     V    +
Sbjct: 131 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KW 187
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +L  G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 76
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFGLAK  G +  + H     V    +
Sbjct: 136 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KW 192
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFRRTIPLPWSNR--IKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++       SN           
Sbjct: 84  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQIL 138
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 76
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFG AK  G +  + H     V    +
Sbjct: 136 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KW 192
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 94  NFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREWVAEVD 151
            F+   +LG G FG V+KG WI E           I VA+K L+     + ++E + E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV------KIPVAIKELREATSPKANKEILDEAY 69
Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            +  + +P++ +L+G C+    +L+  + M  G L +++      +     +   +  AK
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGY 270
           G+ +L      +++RD    N+L+ +  + K++DFG AK  G +  + H     V    +
Sbjct: 129 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KW 185
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            A E ++    T +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG------LQGHREWVAEVDFLG 154
           +GEG +G VFK    +NG        G  VA+K ++         L   RE VA +  L 
Sbjct: 19  IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLE 69
Query: 155 QLHHPNLVKLIGYCI-----EDDQRLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALG 208
              HPN+V+L   C       + +  LV+E + +  L  +L +   P +P      +   
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
             +GL FLH  S  V++RD K  NIL+ S    KL+DFGLA+           T VV T 
Sbjct: 129 LLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTL 183
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
            Y APE ++     +  D++S G +  E+ 
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 37/275 (13%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G FG VFKG   +N T        I +     + + +Q       E+  L Q     
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSSY 82
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           + K  G  ++  +  ++ E++  GS  + L  R  P        +     KGL +LH  S
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLH--S 138
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH 280
           E  I+RD K +N+LL  + + KL+DFG+  AG   D        VGT  + APE +    
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 196
Query: 281 LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PRL 337
             SK+D++S G+  +E+  G        P                 R L+ I     P L
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPM----------------RVLFLIPKNNPPTL 240
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             +++    +   +    CL++DP  RP+  E++K
Sbjct: 241 VGDFT----KSFKEFIDACLNKDPSFRPTAKELLK 271

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 84  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T      V T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLH 157
           S +GEG +G V   +   N          + VA+K + P   Q + +  + E+  L +  
Sbjct: 34  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 158 HPNLVKLIGYCIEDDQRLLVYE-----FMTRGSLENHLFR--RTIPLPWSNRIKIALGAA 210
           H N++      I D  R    E     ++ +  +E  L++  +T  L   +         
Sbjct: 85  HENIIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 139
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYG 269
           +GL ++H  +  V++RD K SN+LL++  + K+ DFGLA+ A P  D T      V T  
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE ++     +KS D++S G +L E+L+ R
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEV 150
           NF    +LG+G FG V    ++E G            AVK LK D +    +    + E 
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGD---------LYAVKVLKKDVILQDDDVECTMTEK 74
Query: 151 DFLGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
             L    +HP L +L       D+   V EF+  G L  H+ +++     +     A   
Sbjct: 75  RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEI 133
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
              L FLH   + +IYRD K  N+LLD E + KL+DFG+ K G     T  +    GT  
Sbjct: 134 ISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPD 189
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           Y APE +         D ++ GV+L E+L G
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 116
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +T +S    GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GT 170
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 213
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 214 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 10/213 (4%)
Query: 87  ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW 146
           ++KS    +     LGEG F  V+K    +  T        I +  +S   DG+  +R  
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGI--NRTA 59
Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
           + E+  L +L HPN++ L+          LV++FM    LE  +   ++ L  S+     
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           L   +GL +LH     +++RD K +N+LLD     KL+DFGLAK+   G         V 
Sbjct: 119 LMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXHQVV 174
Query: 267 TYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEIL 298
           T  Y APE +    +     D+++ G +L E+L
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGT 169
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 212
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 213 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 73
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 132
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 133 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 186
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 229
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 230 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 141
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 142 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 195
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 238
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 239 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG------LQGHREWVAEVDFLG 154
           +GEG +G VFK    +NG        G  VA+K ++         L   RE VA +  L 
Sbjct: 19  IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLE 69
Query: 155 QLHHPNLVKLIGYCI-----EDDQRLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALG 208
              HPN+V+L   C       + +  LV+E + +  L  +L +   P +P      +   
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
             +GL FLH  S  V++RD K  NIL+ S    KL+DFGLA+           T VV T 
Sbjct: 129 LLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTL 183
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
            Y APE ++     +  D++S G +  E+ 
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 120
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 217
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 218 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+  RG +   L ++              
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYIT 120
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +  +     GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX----GT 174
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 217
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 218 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 132/320 (41%), Gaps = 52/320 (16%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLHHP 159
           +GEG +G V   +     T          VA+K + P   Q + +  + E+  L +  H 
Sbjct: 51  IGEGAYGMVSSAYDHVRKT---------RVAIKKISPFEHQTYCQRTLREIQILLRFRHE 101
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR--IKIALGAAKGLAFLH 217
           N++ +           +   ++ +  +E  L++       SN           +GL ++H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYV 276
             +  V++RD K SN+L+++  + K+ DFGLA+ A P+ D T   T  V T  Y APE +
Sbjct: 162 SAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 277 MTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKR--------------PSGE--------- 312
           +     +KS D++S G +L E+L+ R     K               PS E         
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMK 279
Query: 313 -----QNL-----VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR--D 360
                Q+L     VAWA+ +     K   ++D  L  N + K +     LA+  L +  D
Sbjct: 280 ARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPN-KRITVEEALAHPYLEQYYD 338
Query: 361 PKSRPSMDEVVKVLTPLQDL 380
           P   P  +E       L DL
Sbjct: 339 PTDEPVAEEPFTFAMELDDL 358

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQL 156
           +LG+G FG V             + G+    A+K LK D +    +    + E   L  L
Sbjct: 26  VLGKGSFGKVMLA---------DRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL-----FRRTIPLPWSNRIKIALGAA 210
             P  +  +  C +   RL  V E++  G L  H+     F+    + ++  I I     
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI----- 131
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR-VVGTYG 269
            GL FLH     +IYRD K  N++LDSE + K++DFG+ K   +     V+TR   GT  
Sbjct: 132 -GLFFLH--KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPD 185
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD 305
           Y APE +         D +++GV+L E+L G+   D
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV+ L +L HPN++KL     +     +V E  T G L + + +R       +  +I   
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQ 129
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
              G+ ++H  +  +++RD K  NILL+S   + + K+ DFGL+    Q   T +  R +
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDR-I 184
Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 106/250 (42%), Gaps = 23/250 (9%)
Query: 60  AHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPD-SILGEGGFGYVFKGWIEENG 118
           AHL    P     D K   + LQ+ + E +    ++  D  +LG GGFG VF   ++  G
Sbjct: 152 AHLGQ-APFQEFLDSKYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATG 210
Query: 119 TAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LV 177
              A          +  K  G QG    + E   L ++H   +V L  Y  E    L LV
Sbjct: 211 KLYA---CKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFIVSL-AYAFETKTDLCLV 263
Query: 178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---GLAFLHGGSEPVIYRDFKTSNIL 234
              M  G +  H++      P     +     A+   GL  LH     +IYRD K  N+L
Sbjct: 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVL 321
Query: 235 LDSEYNAKLSDFGLA---KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFG 291
           LD + N ++SD GLA   KAG    K +      GT G+ APE ++        D ++ G
Sbjct: 322 LDDDGNVRISDLGLAVELKAGQTKTKGY-----AGTPGFMAPELLLGEEYDFSVDYFALG 376
Query: 292 VVLLEILTGR 301
           V L E++  R
Sbjct: 377 VTLYEMIAAR 386

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 120
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 217
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 218 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK-PDGLQGHREW--- 146
           AT  + P + +G G +G V+K            P SG  VA+KS++ P+G  G       
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGGGGGGGLPIS 57
Query: 147 -VAEVDFLGQLH---HPNLVKLIGYCI--EDDQRL---LVYEFMTRGSLENHLFRRTIP- 196
            V EV  L +L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +   P 
Sbjct: 58  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG 116
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           LP      +     +GL FLH     +++RD K  NIL+ S    KL+DFGLA+      
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI---YS 171
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
                T VV T  Y APE ++     +  D++S G +  E+ 
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG------LQGHREWVAEVDFLG 154
           +GEG +G VFK    +NG        G  VA+K ++         L   RE VA +  L 
Sbjct: 19  IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLE 69
Query: 155 QLHHPNLVKLIGYCI-----EDDQRLLVYEFMTRGSLENHLFRRTIP-LPWSNRIKIALG 208
              HPN+V+L   C       + +  LV+E + +  L  +L +   P +P      +   
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
             +GL FLH  S  V++RD K  NIL+ S    KL+DFGLA+           T VV T 
Sbjct: 129 LLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTL 183
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
            Y APE ++     +  D++S G +  E+ 
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 116
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +T     + GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGT 170
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 213
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 214 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 118
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 172
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 215
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 216 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV+ L +L HPN++KL     +     +V E  T G L + + +R       +  +I   
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQ 129
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
              G+ ++H  +  +++RD K  NILL+S   + + K+ DFGL+    Q   T +  R +
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDR-I 184
Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 169
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 212
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 213 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +T     + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGT 169
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 212
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 213 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 120
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +T     + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGT 174
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 217
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 218 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV+ L +L HPN++KL     +     +V E  T G L + + +R       +  +I   
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQ 129
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
              G+ ++H  +  +++RD K  NILL+S   + + K+ DFGL+    Q   T +  R +
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDR-I 184
Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +T     + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGT 169
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 212
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 213 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDF 152
           +F P   LG GGFG VF+                   A+K ++    +  RE V  EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 153 LGQLHHPNLVKLIGYCIEDD--QRLLVYEFMTRGSLENHLFRRTIPLPWSNR-------- 202
           L +L HP +V+     +E +  ++L          ++  L R+     W N         
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 203 ----IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT 258
               + I L  A+ + FLH  S+ +++RD K SNI    +   K+ DFGL  A  Q ++ 
Sbjct: 117 RSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 259 HV----------STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
                        T  VGT  Y +PE +     + K D++S G++L E+L
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGT 169
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 212
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 213 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 55
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 115 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 168
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 211
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 212 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 118
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 172
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 215
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 216 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 34/231 (14%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSL-------ENHLFRRTIPLPWSN 201
           EV  L  + HPN+V+      E+    +V ++   G L       +  LF+    L W  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
           +I +AL         H     +++RD K+ NI L  +   +L DFG+A+         ++
Sbjct: 133 QICLALK--------HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELA 182
Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
              +GT  Y +PE        +KSD+++ G VL E+ T + + +       +NLV     
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVL---- 235
Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                 K+     P + L+YS      VSQL      R+P+ RPS++ +++
Sbjct: 236 ------KIISGSFPPVSLHYSYDLRSLVSQL----FKRNPRDRPSVNSILE 276

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 60
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 119
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT
Sbjct: 120 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 173
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 216
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 217 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG GGFG VF   ++  G   A          +  K  G QG    + E   L ++H  
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYA---CKKLNKKRLKKRKGYQGA---MVEKKILAKVHSR 245
Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---GLAF 215
            +V L  Y  E    L LV   M  G +  H++      P     +     A+   GL  
Sbjct: 246 FIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA---KAGPQGDKTHVSTRVVGTYGYAA 272
           LH     +IYRD K  N+LLD + N ++SD GLA   KAG    K +      GT G+ A
Sbjct: 305 LH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGTPGFMA 357
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE ++        D ++ GV L E++  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG GGFG VF   ++  G   A          +  K  G QG    + E   L ++H  
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYA---CKKLNKKRLKKRKGYQGA---MVEKKILAKVHSR 245
Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---GLAF 215
            +V L  Y  E    L LV   M  G +  H++      P     +     A+   GL  
Sbjct: 246 FIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA---KAGPQGDKTHVSTRVVGTYGYAA 272
           LH     +IYRD K  N+LLD + N ++SD GLA   KAG    K +      GT G+ A
Sbjct: 305 LH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGTPGFMA 357
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE ++        D ++ GV L E++  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG GGFG VF   ++  G   A          +  K  G QG    + E   L ++H  
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYA---CKKLNKKRLKKRKGYQGA---MVEKKILAKVHSR 245
Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---GLAF 215
            +V L  Y  E    L LV   M  G +  H++      P     +     A+   GL  
Sbjct: 246 FIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA---KAGPQGDKTHVSTRVVGTYGYAA 272
           LH     +IYRD K  N+LLD + N ++SD GLA   KAG    K +      GT G+ A
Sbjct: 305 LH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGTPGFMA 357
Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           PE ++        D ++ GV L E++  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 111/280 (39%), Gaps = 37/280 (13%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           K    +F    +LG+G FG V    + E  T       G   A+K L+ + +    E   
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 54
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            V E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 55  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 113
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
            A      L +LH  S  V+YRD K  N++LD + + K++DFGL K G     T  +   
Sbjct: 114 GA-EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--F 168
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y APE +         D +  GVV+ E++ GR                    Y  
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQ 211
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           D  +L++++    E+ +      +   L    L +DPK R
Sbjct: 212 DHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ILG G FG V K   EE  T       G+ +A K +K  G++   E   E+  + QL H 
Sbjct: 96  ILGGGRFGQVHK--CEETAT-------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           NL++L       +  +LV E++  G L + +   +  L   + I       +G+  +H  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH-- 204
Query: 220 SEPVIYRDFKTSNILLDSE--YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
              +++ D K  NIL  +      K+ DFGLA+     +K  V+    GT  + APE V 
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLAPEVVN 261
Query: 278 TGHLTSKSDVYSFGVVLLEILTG 300
              ++  +D++S GV+   +L+G
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 128 ITVAVKSLKPDGLQGHREWVA-EVDFLGQLH-HPNLVKLIGYCIEDDQRLLVYEFMTRGS 185
           + V  + L P+ L+  RE    E   L Q+  HP+++ LI          LV++ M +G 
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 186 LENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD 245
           L ++L  + + L       I     + ++FLH  +  +++RD K  NILLD     +LSD
Sbjct: 187 LFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSD 243
Query: 246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS------KSDVYSFGVVLLEILT 299
           FG +     G+K      + GT GY APE +      +      + D+++ GV+L  +L 
Sbjct: 244 FGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 300 G 300
           G
Sbjct: 301 G 301

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLHH 158
           +G+G FG V++G              G  VAVK       +  R W  E +      L H
Sbjct: 11  IGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 159 PNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
            N++  I    +D+    Q  LV ++   GSL ++L R T+ +     IK+AL  A GLA
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKLALSTASGLA 114
Query: 215 FLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVS-TRVVG 266
            LH       G   + +RD K+ NIL+       ++D GLA +     D   ++    VG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 267 TYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEI 297
           T  Y APE     +   H  S  ++D+Y+ G+V  EI
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLHH 158
           +G+G FG V++G              G  VAVK       +  R W  E +      L H
Sbjct: 12  IGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 57
Query: 159 PNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
            N++  I    +D+    Q  LV ++   GSL ++L R T+ +     IK+AL  A GLA
Sbjct: 58  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKLALSTASGLA 115
Query: 215 FLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVS-TRVVG 266
            LH       G   + +RD K+ NIL+       ++D GLA +     D   ++    VG
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 175
Query: 267 TYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEI 297
           T  Y APE     +   H  S  ++D+Y+ G+V  EI
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 110/280 (39%), Gaps = 37/280 (13%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           K    +F    +LG+G FG V    + E  T       G   A+K L+ + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            V E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
            A      L +LH  S  V+YRD K  N++LD + + K++DFGL K G     T      
Sbjct: 111 GA-EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y APE +         D +  GVV+ E++ GR                    Y  
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQ 208
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           D  +L++++    E+ +      +   L    L +DPK R
Sbjct: 209 DHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 111/280 (39%), Gaps = 37/280 (13%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           K    +F    +LG+G FG V    + E  T       G   A+K L+ + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            V E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
            A      L +LH  S  V+YRD K  N++LD + + K++DFGL K G     T  +   
Sbjct: 111 GA-EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--F 165
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y APE +         D +  GVV+ E++ GR                    Y  
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQ 208
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           D  +L++++    E+ +      +   L    L +DPK R
Sbjct: 209 DHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 44/279 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V    +           SG  VAVK +     Q       EV  +    H N
Sbjct: 159 IGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLH 217
           +V++    +  D+  +V EF+  G+L + +    +     N  +IA   L   + L+ LH
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIAAVCLAVLQALSVLH 264
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFG----LAKAGPQGDKTHVSTRVVGTYGYAAP 273
             ++ VI+RD K+ +ILL  +   KLSDFG    ++K  P+         +VGT  + AP
Sbjct: 265 --AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAP 316
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +       + D++S G++++E++ G      + P     ++   R  L  + K    V
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKV 373
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            P      SLKG           L RDP  R +  E++K
Sbjct: 374 SP------SLKG------FLDRLLVRDPAQRATAAELLK 400

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 58
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 117
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K+++FG +   P   +    T + GT
Sbjct: 118 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGT 171
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 214
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 215 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 111/280 (39%), Gaps = 37/280 (13%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           K    +F    +LG+G FG V    + E  T       G   A+K L+ + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            V E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
            A      L +LH  S  V+YRD K  N++LD + + K++DFGL K G     T  +   
Sbjct: 111 GA-EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--F 165
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y APE +         D +  GVV+ E++ GR                    Y  
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQ 208
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           D  +L++++    E+ +      +   L    L +DPK R
Sbjct: 209 DHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           +LG+G FG V             + G+    AVK LK D +    +    + E   L   
Sbjct: 348 VLGKGSFGKVM---------LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
             P  +  +  C +   RL  V E++  G L  H+ ++       + +  A   A GL F
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           L   S+ +IYRD K  N++LDSE + K++DFG+ K       T  +    GT  Y APE 
Sbjct: 458 LQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEI 513
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGR 301
           +         D ++FGV+L E+L G+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 38  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 88
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +C +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 89  DVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 146
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 147 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 199
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 200 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLHH 158
           +G+G FG V++G              G  VAVK       +  R W  E +      L H
Sbjct: 17  IGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 62
Query: 159 PNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
            N++  I    +D+    Q  LV ++   GSL ++L R T+ +     IK+AL  A GLA
Sbjct: 63  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKLALSTASGLA 120
Query: 215 FLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVS-TRVVG 266
            LH       G   + +RD K+ NIL+       ++D GLA +     D   ++    VG
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 180
Query: 267 TYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEI 297
           T  Y APE     +   H  S  ++D+Y+ G+V  EI
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 110/280 (39%), Gaps = 37/280 (13%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           K    +F    +LG+G FG V    + E  T       G   A+K L+ + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            V E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
            A      L +LH  S  V+YRD K  N++LD + + K++DFGL K G     T      
Sbjct: 111 GA-EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y APE +         D +  GVV+ E++ GR                    Y  
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQ 208
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           D  +L++++    E+ +      +   L    L +DPK R
Sbjct: 209 DHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLHH 158
           +G+G FG V++G              G  VAVK       +  R W  E +      L H
Sbjct: 37  IGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 82
Query: 159 PNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
            N++  I    +D+    Q  LV ++   GSL ++L R T+ +     IK+AL  A GLA
Sbjct: 83  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKLALSTASGLA 140
Query: 215 FLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVS-TRVVG 266
            LH       G   + +RD K+ NIL+       ++D GLA +     D   ++    VG
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 200
Query: 267 TYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEI 297
           T  Y APE     +   H  S  ++D+Y+ G+V  EI
Sbjct: 201 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPA-KPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           ++   +LG+G FG V     +  G   A K  S   V  K+ K   L+       EV  L
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-------EVQLL 80
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
            QL HPN++KL  +  +     LV E  T G L + +  R       +  +I      G+
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGI 139
Query: 214 AFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            ++H     +++RD K  N+LL+S   + N ++ DFGL+       K       +GT  Y
Sbjct: 140 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYY 194
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V+ G    K DV+S GV+L  +L+G
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 115/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA---------REKNSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 116 ELANALSYCH--SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGT 169
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 212
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 213 DTYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 58
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 117
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 118 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 171
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 214
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 215 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 110/280 (39%), Gaps = 37/280 (13%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           K    +F    +LG+G FG V    + E  T       G   A+K L+ + +    E   
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 56
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            V E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 57  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 115
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
            A      L +LH  S  V+YRD K  N++LD + + K++DFGL K G     T      
Sbjct: 116 GA-EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 170
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y APE +         D +  GVV+ E++ GR                    Y  
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQ 213
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           D  +L++++    E+ +      +   L    L +DPK R
Sbjct: 214 DHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLHH 158
           +G+G FG V++G              G  VAVK       +  R W  E +      L H
Sbjct: 14  IGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 59
Query: 159 PNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
            N++  I    +D+    Q  LV ++   GSL ++L R T+ +     IK+AL  A GLA
Sbjct: 60  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKLALSTASGLA 117
Query: 215 FLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVS-TRVVG 266
            LH       G   + +RD K+ NIL+       ++D GLA +     D   ++    VG
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 177
Query: 267 TYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEI 297
           T  Y APE     +   H  S  ++D+Y+ G+V  EI
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLHH 158
           +G+G FG V++G              G  VAVK       +  R W  E +      L H
Sbjct: 50  IGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 95
Query: 159 PNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
            N++  I    +D+    Q  LV ++   GSL ++L R T+ +     IK+AL  A GLA
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKLALSTASGLA 153
Query: 215 FLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVS-TRVVG 266
            LH       G   + +RD K+ NIL+       ++D GLA +     D   ++    VG
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 267 TYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEI 297
           T  Y APE     +   H  S  ++D+Y+ G+V  EI
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 113/239 (47%), Gaps = 48/239 (20%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           G+ +   I   G FG V+K  +  +            VAVK      LQ  + W +E + 
Sbjct: 15  GSLQLLEIKARGRFGCVWKAQLMND-----------FVAVKIFP---LQDKQSWQSEREI 60
Query: 153 LGQ--LHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
                + H NL++ I     G  +E  +  L+  F  +GSL ++L    I   W+    +
Sbjct: 61  FSTPGMKHENLLQFIAAEKRGSNLEV-ELWLITAFHDKGSLTDYLKGNIIT--WNELCHV 117
Query: 206 ALGAAKGLAFLHG--------GSEPVI-YRDFKTSNILLDSEYNAKLSDFGLA----KAG 252
           A   ++GL++LH         G +P I +RDFK+ N+LL S+  A L+DFGLA       
Sbjct: 118 AETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGK 177
Query: 253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS------DVYSFGVVLLEILTGRRSMD 305
           P GD TH     VGT  Y APE V+ G +  +       D+Y+ G+VL E+++  ++ D
Sbjct: 178 PPGD-THGQ---VGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 141
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 142 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGT 195
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 238
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 239 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 116
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGT 170
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 213
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 214 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 118
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGT 172
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 215
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 216 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 110/280 (39%), Gaps = 37/280 (13%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           K    +F    +LG+G FG V    + E  T       G   A+K L+ + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            V E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
            A      L +LH  S  V+YRD K  N++LD + + K++DFGL K G     T      
Sbjct: 111 GA-EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  Y APE +         D +  GVV+ E++ GR                    Y  
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQ 208
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
           D  +L++++    E+ +      +   L    L +DPK R
Sbjct: 209 DHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPA-KPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           ++   +LG+G FG V     +  G   A K  S   V  K+ K   L+       EV  L
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-------EVQLL 103
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
            QL HPN++KL  +  +     LV E  T G L + +  R       +  +I      G+
Sbjct: 104 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGI 162
Query: 214 AFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            ++H     +++RD K  N+LL+S   + N ++ DFGL+       K       +GT  Y
Sbjct: 163 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYY 217
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V+ G    K DV+S GV+L  +L+G
Sbjct: 218 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPA-KPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           ++   +LG+G FG V     +  G   A K  S   V  K+ K   L+       EV  L
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-------EVQLL 86
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
            QL HPN++KL  +  +     LV E  T G L + +  R       +  +I      G+
Sbjct: 87  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGI 145
Query: 214 AFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            ++H     +++RD K  N+LL+S   + N ++ DFGL+       K       +GT  Y
Sbjct: 146 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYY 200
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V+ G    K DV+S GV+L  +L+G
Sbjct: 201 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 118
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K+++FG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGT 172
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 215
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 216 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V             +  +G  VAVK +     Q       EV  +   HH N
Sbjct: 53  IGEGSTGIV---------CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLH 217
           +V +    +  D+  +V EF+  G+L + +    +     N  +IA   L   + L++LH
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIATVCLSVLRALSYLH 158
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
             ++ VI+RD K+ +ILL S+   KLSDFG  A+   +  K      +VGT  + APE +
Sbjct: 159 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKXLVGTPYWMAPEVI 213
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
                 ++ D++S G++++E++ G
Sbjct: 214 SRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPA-KPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           ++   +LG+G FG V     +  G   A K  S   V  K+ K   L+       EV  L
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-------EVQLL 104
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
            QL HPN++KL  +  +     LV E  T G L + +  R       +  +I      G+
Sbjct: 105 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGI 163
Query: 214 AFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            ++H     +++RD K  N+LL+S   + N ++ DFGL+       K       +GT  Y
Sbjct: 164 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYY 218
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V+ G    K DV+S GV+L  +L+G
Sbjct: 219 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHH 158
            LG+GGF   F+  I +  T     G  +  ++  LKP      RE ++ E+     L H
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSL-LLKPH----QREKMSMEISIHRSLAH 98
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRI--KIALGAAKGLAF 215
            ++V   G+  ++D   +V E   R SL E H  R+ +  P +     +I LG      +
Sbjct: 99  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----Y 154
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPE 274
           LH     VI+RD K  N+ L+ +   K+ DFGLA K    G++  V   + GT  Y APE
Sbjct: 155 LHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPE 209
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
            +     + + DV+S G ++  +L G       +P  E +       YL  K+  Y I  
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETS--CLKETYLRIKKNEYSIP- 259
Query: 335 PRLELNYSLKGVQKV-SQLAYNCLSRDPKSRPSMDEVV 371
                    K +  V + L    L  DP +RP+++E++
Sbjct: 260 ---------KHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 132/318 (41%), Gaps = 58/318 (18%)
Query: 76  SPCQLL-QFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKS 134
           SP + L +     L+   G F    ++G G +G V+KG             +G   A+K 
Sbjct: 6   SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKV 56
Query: 135 LKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIE------DDQRLLVYEFMTRGSLE 187
           +   G +   E   E++ L +  HH N+    G  I+      DDQ  LV EF   GS+ 
Sbjct: 57  MDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 188 NHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS 244
           + +      T+   W   I       +GL+ LH     VI+RD K  N+LL      KL 
Sbjct: 116 DLIKNTKGNTLKEEWIAYI--CREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLV 171
Query: 245 DFGLAKAGPQGDKTHVSTR--VVGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEI 297
           DFG++    Q D+T V  R   +GT  + APE +            KSD++S G+  +E+
Sbjct: 172 DFGVS---AQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
Query: 298 LTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PRLELNYSLKGVQKVSQLAY 354
             G   +    P                 R L+ I     PRL+   S K  +K      
Sbjct: 228 AEGAPPLCDMHPM----------------RALFLIPRNPAPRLK---SKKWSKKFQSFIE 268
Query: 355 NCLSRDPKSRPSMDEVVK 372
           +CL ++   RP+ ++++K
Sbjct: 269 SCLVKNHSQRPATEQLMK 286

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 67/126 (53%), Gaps = 4/126 (3%)
Query: 176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL 235
           +V E++   +L + +     P+     I++   A + L F H     +I+RD K +NIL+
Sbjct: 93  IVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANILI 149
Query: 236 DSEYNAKLSDFGLAKA-GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 294
            +    K+ DFG+A+A    G+    +  V+GT  Y +PE      + ++SDVYS G VL
Sbjct: 150 SATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 295 LEILTG 300
            E+LTG
Sbjct: 210 YEVLTG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 15/181 (8%)
Query: 130 VAVKSLKPDGLQG---HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQR------LLVYEF 180
           VAVK L+ D  +    +  +  E      L+HP +V +  Y   + +        +V E+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEY 97
Query: 181 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN 240
           +   +L + +     P+     I++   A + L F H     +I+RD K +NI++ +   
Sbjct: 98  VDGVTLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNA 154
Query: 241 AKLSDFGLAKA-GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            K+ DFG+A+A    G+    +  V+GT  Y +PE      + ++SDVYS G VL E+LT
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 300 G 300
           G
Sbjct: 215 G 215

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHH 158
            LG+GGF   F+  I +  T     G  +  ++  LKP      RE ++ E+     L H
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSL-LLKPH----QREKMSMEISIHRSLAH 100
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRI--KIALGAAKGLAF 215
            ++V   G+  ++D   +V E   R SL E H  R+ +  P +     +I LG      +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----Y 156
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPE 274
           LH     VI+RD K  N+ L+ +   K+ DFGLA K    G++  V   + GT  Y APE
Sbjct: 157 LHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPE 211
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
            +     + + DV+S G ++  +L G       +P  E +       YL  K+  Y I  
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETS--CLKETYLRIKKNEYSIP- 261
Query: 335 PRLELNYSLKGVQKV-SQLAYNCLSRDPKSRPSMDEVV 371
                    K +  V + L    L  DP +RP+++E++
Sbjct: 262 ---------KHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 121/301 (40%), Gaps = 61/301 (20%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           +F+   ++G GGFG VFK               G T  +K +K +  +  RE    V  L
Sbjct: 12  DFKEIELIGSGGFGQVFKA---------KHRIDGKTYVIKRVKYNNEKAERE----VKAL 58
Query: 154 GQLHHPNLVKLIG------YCIEDDQR----------LLVYEFMTRGSLENHLF-RRTIP 196
            +L H N+V   G      Y  E   +           +  EF  +G+LE  +  RR   
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           L     +++     KG+ ++H  S+ +I RD K SNI L      K+ DFGL  +     
Sbjct: 119 LDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
           K     R  GT  Y +PE + +     + D+Y+ G++L E+L               +  
Sbjct: 177 K---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------CDTA 221
Query: 317 AWARQYLADKRK--LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
               ++  D R   +  I D            +K   L    LS+ P+ RP+  E+++ L
Sbjct: 222 FETSKFFTDLRDGIISDIFD------------KKEKTLLQKLLSKKPEDRPNTSEILRTL 269
Query: 375 T 375
           T
Sbjct: 270 T 270

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 33/283 (11%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKS-LKPDGLQGHREWVAE 149
           A  +F     LG+G FG V+    ++     A     + V  K+ L+  G++   +   E
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILA-----LKVLFKAQLEKAGVE--HQLRRE 55
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
           V+    L HPN+++L GY  +  +  L+ E+   G++   L ++                
Sbjct: 56  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITEL 114
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT  
Sbjct: 115 ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 168
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           Y  PE +       K D++S GV+  E L G       +P  E N            ++ 
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN----------TYQET 211
Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 212 YKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGT 169
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 212
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 213 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA 148
           +   G++     LG G FG V  G  E  G           VAVK L       +R+ + 
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVGKHELTGHK---------VAVKIL-------NRQKIR 55
Query: 149 EVDFLGQLH----------HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP 198
            +D +G++           HP+++KL           +V E+++ G L +++ +    L 
Sbjct: 56  SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLD 114
Query: 199 WSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT 258
                ++      G+ + H     V++RD K  N+LLD+  NAK++DFGL+     G+  
Sbjct: 115 EKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172
Query: 259 HVSTRVVGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEILTGRRSMD 305
             S    G+  YAAPE V++G L +  + D++S GV+L  +L G    D
Sbjct: 173 RXSC---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G  G V+               +G  VA++ +           + E+  + +  +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V  +   +  D+  +V E++  GSL + +      +       +     + L FLH  S
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH--S 134
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
             VI+RD K+ NILL  + + KL+DFG  A+  P+  K    + +VGT  + APE V   
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTRK 191
Query: 280 HLTSKSDVYSFGVVLLEILTGR 301
               K D++S G++ +E++ G 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 44/279 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V    +           SG  VAVK +     Q       EV  +    H N
Sbjct: 37  IGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 87
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLH 217
           +V++    +  D+  +V EF+  G+L + +    +     N  +IA   L   + L+ LH
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIAAVCLAVLQALSVLH 142
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFG----LAKAGPQGDKTHVSTRVVGTYGYAAP 273
             ++ VI+RD K+ +ILL  +   KLSDFG    ++K  P+         +VGT  + AP
Sbjct: 143 --AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAP 194
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +       + D++S G++++E++ G      + P     ++   R  L  + K    V
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKV 251
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            P      SLKG           L RDP  R +  E++K
Sbjct: 252 SP------SLKG------FLDRLLVRDPAQRATAAELLK 278

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQL 156
           +LG+G FG V             + G+    AVK LK D +    +    + E   L   
Sbjct: 27  VLGKGSFGKV---------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
             P  +  +  C +   RL  V E++  G L  H+ ++       + +  A   A GL F
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           L   S+ +IYRD K  N++LDSE + K++DFG+ K       T  +    GT  Y APE 
Sbjct: 137 LQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEI 192
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGR 301
           +         D ++FGV+L E+L G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G  G V+               +G  VA++ +           + E+  + +  +PN
Sbjct: 29  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V  +   +  D+  +V E++  GSL + +      +       +     + L FLH  S
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH--S 135
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
             VI+RD K+ NILL  + + KL+DFG  A+  P+  K    + +VGT  + APE V   
Sbjct: 136 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRK 192
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV---DPR 336
               K D++S G++ +E++ G      + P                 R LY I     P 
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALYLIATNGTPE 236
Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV-----KVLTPLQDLNDL 383
           L+    L  + +       CL  D + R S  E++     K+  PL  L  L
Sbjct: 237 LQNPEKLSAIFR--DFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPL 286

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 44/279 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V    +           SG  VAVK +     Q       EV  +    H N
Sbjct: 39  IGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 89
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLH 217
           +V++    +  D+  +V EF+  G+L + +    +     N  +IA   L   + L+ LH
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIAAVCLAVLQALSVLH 144
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFG----LAKAGPQGDKTHVSTRVVGTYGYAAP 273
             ++ VI+RD K+ +ILL  +   KLSDFG    ++K  P+         +VGT  + AP
Sbjct: 145 --AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAP 196
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +       + D++S G++++E++ G      + P     ++   R  L  + K    V
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKV 253
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            P      SLKG           L RDP  R +  E++K
Sbjct: 254 SP------SLKG------FLDRLLVRDPAQRATAAELLK 280

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 118
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 172
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 215
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 216 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 169
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 212
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 213 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 44/279 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V    +           SG  VAVK +     Q       EV  +    H N
Sbjct: 82  IGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 132
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLH 217
           +V++    +  D+  +V EF+  G+L + +    +     N  +IA   L   + L+ LH
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIAAVCLAVLQALSVLH 187
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFG----LAKAGPQGDKTHVSTRVVGTYGYAAP 273
             ++ VI+RD K+ +ILL  +   KLSDFG    ++K  P+         +VGT  + AP
Sbjct: 188 --AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAP 239
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +       + D++S G++++E++ G      + P     ++   R  L  + K    V
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKV 296
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            P      SLKG           L RDP  R +  E++K
Sbjct: 297 SP------SLKG------FLDRLLVRDPAQRATAAELLK 323

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHH 158
            LG+GGF   F+  I +  T     G  +  ++  LKP      RE ++ E+     L H
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSL-LLKPH----QREKMSMEISIHRSLAH 74
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRI--KIALGAAKGLAF 215
            ++V   G+  ++D   +V E   R SL E H  R+ +  P +     +I LG      +
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----Y 130
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPE 274
           LH     VI+RD K  N+ L+ +   K+ DFGLA K    G++  V   + GT  Y APE
Sbjct: 131 LHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPE 185
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
            +     + + DV+S G ++  +L G       +P  E +       YL  K+  Y I  
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETS--CLKETYLRIKKNEYSIP- 235
Query: 335 PRLELNYSLKGVQKV-SQLAYNCLSRDPKSRPSMDEVV 371
                    K +  V + L    L  DP +RP+++E++
Sbjct: 236 ---------KHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 32/191 (16%)
Query: 130 VAVKSLKPDGLQGHREWVAEVDF--LGQLHHPNLVKLIGY----CIEDDQRLLVYEFMTR 183
           VAVK      +Q  + W  E +   L  + H N+++ IG        D    L+  F  +
Sbjct: 50  VAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106
Query: 184 GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH-------GGSEPVI-YRDFKTSNILL 235
           GSL +  F +   + W+    IA   A+GLA+LH        G +P I +RD K+ N+LL
Sbjct: 107 GSLSD--FLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 236 DSEYNAKLSDFGLA---KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS------D 286
            +   A ++DFGLA   +AG     TH     VGT  Y APE V+ G +  +       D
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQ---VGTRRYMAPE-VLEGAINFQRDAFLRID 220
Query: 287 VYSFGVVLLEI 297
           +Y+ G+VL E+
Sbjct: 221 MYAMGLVLWEL 231

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLL--VYEF---------MTRGSLENHLFRRTI 195
           V+EV+ L +L HPN+V+     I+     L  V E+         +T+G+ E        
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
            L    ++ +AL      +    G   V++RD K +N+ LD + N KL DFGLA+     
Sbjct: 113 VLRVMTQLTLALKECHRRS---DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LN 167
Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEI 297
             T  +   VGT  Y +PE +       KSD++S G +L E+
Sbjct: 168 HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G  G V+               +G  VA++ +           + E+  + +  +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V  +   +  D+  +V E++  GSL + +      +       +     + L FLH  S
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH--S 134
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
             VI+RD K+ NILL  + + KL+DFG  A+  P+  K    + +VGT  + APE V   
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRK 191
Query: 280 HLTSKSDVYSFGVVLLEILTGR 301
               K D++S G++ +E++ G 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G  G V+               +G  VA++ +           + E+  + +  +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V  +   +  D+  +V E++  GSL + +      +       +     + L FLH  S
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH--S 134
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
             VI+RD K+ NILL  + + KL+DFG  A+  P+  K    + +VGT  + APE V   
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRK 191
Query: 280 HLTSKSDVYSFGVVLLEILTGR 301
               K D++S G++ +E++ G 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 147 VAEVDFLGQLHHPNLVKLIGYCIE--DDQRLLVYEF---------MTRGSLENHLFRRTI 195
           V+EV+ L +L HPN+V+     I+  +    +V E+         +T+G+ E        
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
            L    ++ +AL      +    G   V++RD K +N+ LD + N KL DFGLA+     
Sbjct: 113 VLRVMTQLTLALKECHRRS---DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LN 167
Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEI 297
             T  +   VGT  Y +PE +       KSD++S G +L E+
Sbjct: 168 HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 4/126 (3%)
Query: 176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL 235
           +V E++   +L + +     P+     I++   A + L F H     +I+RD K +NI++
Sbjct: 93  IVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI 149
Query: 236 DSEYNAKLSDFGLAKA-GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 294
            +    K+ DFG+A+A    G+    +  V+GT  Y +PE      + ++SDVYS G VL
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 295 LEILTG 300
            E+LTG
Sbjct: 210 YEVLTG 215

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 33/274 (12%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
            LG+GGF   ++  I +  T     G  +  ++  LKP       +   E+     L +P
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSM-LLKP---HQKEKMSTEIAIHKSLDNP 102
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           ++V   G+  +DD   +V E   R SL E H  R+ +  P +          +G+ +LH 
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHN 160
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
               VI+RD K  N+ L+ + + K+ DFGLA K    G++      + GT  Y APE + 
Sbjct: 161 NR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAPEVLC 215
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               + + D++S G +L  +L G       +P  E +       Y+  K+  Y +  PR 
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVG-------KPPFETS--CLKETYIRIKKNEYSV--PR- 263
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
            +N         S L    L  DP  RPS+ E++
Sbjct: 264 HIN------PVASALIRRMLHADPTLRPSVAELL 291

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWV 147
           A  +F     LG+G FG V+            +  S   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV+    L HPN+++L GY  +  +  L+ E+   G++   L ++              
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 118
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGT 172
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             Y  PE +       K D++S GV+  E L G       +P  E N            +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTY----------Q 215
Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           + Y+ +  R+E  +     +    L    L  +P  RP + EV++
Sbjct: 216 ETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 33/274 (12%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
            LG+GGF   ++  I +  T     G  +  ++  LKP       +   E+     L +P
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSM-LLKP---HQKEKMSTEIAIHKSLDNP 102
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           ++V   G+  +DD   +V E   R SL E H  R+ +  P +          +G+ +LH 
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHN 160
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
               VI+RD K  N+ L+ + + K+ DFGLA K    G++      + GT  Y APE + 
Sbjct: 161 NR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT---LCGTPNYIAPEVLC 215
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               + + D++S G +L  +L G       +P  E +       Y+  K+  Y +  PR 
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVG-------KPPFETS--CLKETYIRIKKNEYSV--PR- 263
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
            +N         S L    L  DP  RPS+ E++
Sbjct: 264 HIN------PVASALIRRMLHADPTLRPSVAELL 291

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 44/279 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V    +           SG  VAVK +     Q       EV  +    H N
Sbjct: 28  IGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLH 217
           +V++    +  D+  +V EF+  G+L + +    +     N  +IA   L   + L+ LH
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIAAVCLAVLQALSVLH 133
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFG----LAKAGPQGDKTHVSTRVVGTYGYAAP 273
             ++ VI+RD K+ +ILL  +   KLSDFG    ++K  P+         +VGT  + AP
Sbjct: 134 --AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAP 185
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +       + D++S G++++E++ G      + P     ++   R  L  + K    V
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKV 242
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            P      SLKG           L RDP  R +  E++K
Sbjct: 243 SP------SLKGFLD------RLLVRDPAQRATAAELLK 269

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-GPQ 254
           P+     I++   A + L F H     +I+RD K +NI++ +    K+ DFG+A+A    
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           G+    +  V+GT  Y +PE      + ++SDVYS G VL E+LTG
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-GPQ 254
           P+     I++   A + L F H     +I+RD K +NI++ +    K+ DFG+A+A    
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           G+    +  V+GT  Y +PE      + ++SDVYS G VL E+LTG
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 44/279 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V    +           SG  VAVK +     Q       EV  +    H N
Sbjct: 32  IGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 82
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA---LGAAKGLAFLH 217
           +V++    +  D+  +V EF+  G+L + +    +     N  +IA   L   + L+ LH
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM-----NEEQIAAVCLAVLQALSVLH 137
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFG----LAKAGPQGDKTHVSTRVVGTYGYAAP 273
             ++ VI+RD K+ +ILL  +   KLSDFG    ++K  P+         +VGT  + AP
Sbjct: 138 --AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAP 189
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +       + D++S G++++E++ G      + P     ++   R  L  + K    V
Sbjct: 190 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKV 246
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            P      SLKG           L RDP  R +  E++K
Sbjct: 247 SP------SLKGFLD------RLLVRDPAQRATAAELLK 273

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP-DGLQGHREWVA 148
           + + +F+  S+LGEG +G V         +A  KP +G  VA+K ++P D        + 
Sbjct: 8   NISSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLR 58
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIA 206
           E+  L    H N++ +      D        ++ +  ++  L R   T  L   +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK---------AGPQGDK 257
               + +  LHG +  VI+RD K SN+L++S  + K+ DFGLA+         + P G +
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           + + T  V T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 177 SGM-TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGHREWV 147
           GN+R    +G+G F  V                +G  VAVK      L P  LQ   +  
Sbjct: 15  GNYRLQKTIGKGNFAKV---------KLARHVLTGREVAVKIIDKTQLNPTSLQ---KLF 62
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            EV  +  L+HPN+VKL      +    LV E+ + G + ++L           R K   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 121
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
                + + H   + +++RD K  N+LLD + N K++DFG +     G+K        G+
Sbjct: 122 QIVSAVQYCH--QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGS 176
Query: 268 YGYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
             YAAPE          + DV+S GV+L  +++G    D
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 33/274 (12%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
            LG+GGF   ++  I +  T     G  +  ++  LKP       +   E+     L +P
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSM-LLKP---HQKEKMSTEIAIHKSLDNP 102
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           ++V   G+  +DD   +V E   R SL E H  R+ +  P +          +G+ +LH 
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHN 160
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
               VI+RD K  N+ L+ + + K+ DFGLA K    G++      + GT  Y APE + 
Sbjct: 161 NR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLC 215
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               + + D++S G +L  +L G       +P  E +       Y+  K+  Y +  PR 
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVG-------KPPFETS--CLKETYIRIKKNEYSV--PR- 263
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
            +N         S L    L  DP  RPS+ E++
Sbjct: 264 HIN------PVASALIRRMLHADPTLRPSVAELL 291

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEGGF YV                 G   A+K +     Q   E   E D     +HPN
Sbjct: 37  LGEGGFSYV---------DLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPN 87
Query: 161 LVKLIGYCIED----DQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGL 213
           +++L+ YC+ +     +  L+  F  RG+L N + R   +   L     + + LG  +GL
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG---LAKAGPQGDKTHVSTRVVG---- 266
             +H  ++   +RD K +NILL  E    L D G    A    +G +  ++ +       
Sbjct: 148 EAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 267 TYGYAAPE-YVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
           T  Y APE + +  H  +  ++DV+S G VL  ++ G    D     G+   +A      
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA------ 259
Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
                    V  +L +  S +    + QL  + ++ DP  RP +  ++  L  LQ
Sbjct: 260 ---------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 33/274 (12%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
            LG+GGF   ++  I +  T     G  +  ++  LKP       +   E+     L +P
Sbjct: 33  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSM-LLKP---HQKEKMSTEIAIHKSLDNP 86
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           ++V   G+  +DD   +V E   R SL E H  R+ +  P +          +G+ +LH 
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHN 144
Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
               VI+RD K  N+ L+ + + K+ DFGLA K    G++      + GT  Y APE + 
Sbjct: 145 NR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLC 199
Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRL 337
               + + D++S G +L  +L G       +P  E +       Y+  K+  Y +  PR 
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVG-------KPPFETS--CLKETYIRIKKNEYSV--PR- 247
Query: 338 ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
            +N         S L    L  DP  RPS+ E++
Sbjct: 248 HIN------PVASALIRRMLHADPTLRPSVAELL 275

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP-DGLQGHREWVA 148
           + + +F+  S+LGEG +G V         +A  KP +G  VA+K ++P D        + 
Sbjct: 8   NISSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLR 58
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIA 206
           E+  L    H N++ +      D        ++ +  ++  L R   T  L   +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK---------AGPQGDK 257
               + +  LHG +  VI+RD K SN+L++S  + K+ DFGLA+         + P G +
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           + + T  V T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 177 SGM-TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 114/282 (40%), Gaps = 40/282 (14%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           +     F    +LG+G FG V    ++E  T       G   A+K LK + +    E   
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 194
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            + E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +   +S    
Sbjct: 195 TLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRA 250
Query: 205 IALGA--AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
              GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T  + 
Sbjct: 251 RFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
              GT  Y APE +         D +  GVV+ E++ GR                    Y
Sbjct: 309 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------Y 350
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             D  KL++++    E+ +      +   L    L +DPK R
Sbjct: 351 NQDHEKLFELILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-GPQ 254
           P+     I++   A + L F H     +I+RD K +NI++ +    K+ DFG+A+A    
Sbjct: 129 PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADS 186
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           G+    +  V+GT  Y +PE      + ++SDVYS G VL E+LTG
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 40/271 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQL 156
           +LG+G FG V    ++E  T       G   A+K LK + +    E    + E   L   
Sbjct: 158 LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA--AKGL 213
            HP L  L  Y  +   RL  V E+   G L  HL R  +   +S       GA     L
Sbjct: 209 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 264
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH   + V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y AP
Sbjct: 265 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 321
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +         D +  GVV+ E++ GR                    Y  D  KL++++
Sbjct: 322 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFELI 364
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
               E+ +      +   L    L +DPK R
Sbjct: 365 LME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLL--VYEF---------MTRGSLENHLFRRTI 195
           V+EV+ L +L HPN+V+     I+     L  V E+         +T+G+ E        
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
            L    ++ +AL      +    G   V++RD K +N+ LD + N KL DFGLA+     
Sbjct: 113 VLRVMTQLTLALKECHRRS---DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169
Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEI 297
           +    +   VGT  Y +PE +       KSD++S G +L E+
Sbjct: 170 ED--FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPA-KPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           ++   +LG+G FG V     +  G   A K  S   V  K+ K   L+       EV  L
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-------EVQLL 80
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
            QL HPN+ KL  +  +     LV E  T G L + +  R       +  +I      G+
Sbjct: 81  KQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGI 139
Query: 214 AFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            + H     +++RD K  N+LL+S   + N ++ DFGL+       K       +GT  Y
Sbjct: 140 TYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTAYY 194
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V+ G    K DV+S GV+L  +L+G
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHH 158
            LG+GGF   F+  I +  T     G  +  ++  LKP      RE ++ E+     L H
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSL-LLKPH----QREKMSMEISIHRSLAH 80
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRI--KIALGAAKGLAF 215
            ++V   G+  ++D   +V E   R SL E H  R+ +  P +     +I LG      +
Sbjct: 81  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----Y 136
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPE 274
           LH     VI+RD K  N+ L+ +   K+ DFGLA K    G++      + GT  Y APE
Sbjct: 137 LHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPE 191
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
            +     + + DV+S G ++  +L G       +P  E +       YL  K+  Y I  
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETS--CLKETYLRIKKNEYSIP- 241
Query: 335 PRLELNYSLKGVQKV-SQLAYNCLSRDPKSRPSMDEVV 371
                    K +  V + L    L  DP +RP+++E++
Sbjct: 242 ---------KHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHH 158
            LG+GGF   F+  I +  T     G  +  ++  LKP      RE ++ E+     L H
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSL-LLKPH----QREKMSMEISIHRSLAH 76
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRI--KIALGAAKGLAF 215
            ++V   G+  ++D   +V E   R SL E H  R+ +  P +     +I LG      +
Sbjct: 77  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----Y 132
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPE 274
           LH     VI+RD K  N+ L+ +   K+ DFGLA K    G++      + GT  Y APE
Sbjct: 133 LHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPE 187
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
            +     + + DV+S G ++  +L G       +P  E +       YL  K+  Y I  
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETS--CLKETYLRIKKNEYSIP- 237
Query: 335 PRLELNYSLKGVQKV-SQLAYNCLSRDPKSRPSMDEVV 371
                    K +  V + L    L  DP +RP+++E++
Sbjct: 238 ---------KHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 111/271 (40%), Gaps = 40/271 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQL 156
           +LG+G FG V    ++E  T       G   A+K LK + +    E    + E   L   
Sbjct: 17  LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA--AKGL 213
            HP L  L  Y  +   RL  V E+   G L  HL R  +   +S       GA     L
Sbjct: 68  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 123
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH   + V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y AP
Sbjct: 124 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAP 180
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +         D +  GVV+ E++ GR                    Y  D  KL++++
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFELI 223
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
               E+ +      +   L    L +DPK R
Sbjct: 224 LME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 124/314 (39%), Gaps = 74/314 (23%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           +F+   ++G GGFG VFK               G T  ++ +K +  +  RE    V  L
Sbjct: 13  DFKEIELIGSGGFGQVFKA---------KHRIDGKTYVIRRVKYNNEKAERE----VKAL 59
Query: 154 GQLHHPNLVKLIG--------------------YCIEDDQR---------LLVYEFMTRG 184
            +L H N+V   G                    Y  E+ +           +  EF  +G
Sbjct: 60  AKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKG 119
Query: 185 SLENHLF-RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL 243
           +LE  +  RR   L     +++     KG+ ++H  S+ +I+RD K SNI L      K+
Sbjct: 120 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLIHRDLKPSNIFLVDTKQVKI 177
Query: 244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS 303
            DFGL  +     K    TR  GT  Y +PE + +     + D+Y+ G++L E+L     
Sbjct: 178 GDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV--- 231
Query: 304 MDKKRPSGEQNLVAWARQYLADKRK--LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDP 361
                     +      ++  D R   +  I D            +K   L    LS+ P
Sbjct: 232 ---------CDTAFETSKFFTDLRDGIISDIFD------------KKEKTLLQKLLSKKP 270
Query: 362 KSRPSMDEVVKVLT 375
           + RP+  E+++ LT
Sbjct: 271 EDRPNTSEILRTLT 284

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHH 158
            LG+GGF   F+  I +  T     G  +  ++  LKP      RE ++ E+     L H
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSL-LLKPH----QREKMSMEISIHRSLAH 76
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRI--KIALGAAKGLAF 215
            ++V   G+  ++D   +V E   R SL E H  R+ +  P +     +I LG      +
Sbjct: 77  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----Y 132
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPE 274
           LH     VI+RD K  N+ L+ +   K+ DFGLA K    G++      + GT  Y APE
Sbjct: 133 LHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPE 187
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
            +     + + DV+S G ++  +L G       +P  E +       YL  K+  Y I  
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETS--CLKETYLRIKKNEYSIP- 237
Query: 335 PRLELNYSLKGVQKV-SQLAYNCLSRDPKSRPSMDEVV 371
                    K +  V + L    L  DP +RP+++E++
Sbjct: 238 ---------KHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 111/271 (40%), Gaps = 40/271 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQL 156
           +LG+G FG V    ++E  T       G   A+K LK + +    E    + E   L   
Sbjct: 16  LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA--AKGL 213
            HP L  L  Y  +   RL  V E+   G L  HL R  +   +S       GA     L
Sbjct: 67  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 122
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH   + V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y AP
Sbjct: 123 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAP 179
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +         D +  GVV+ E++ GR                    Y  D  KL++++
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFELI 222
Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
               E+ +      +   L    L +DPK R
Sbjct: 223 LME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 113/282 (40%), Gaps = 40/282 (14%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW-- 146
           +     F    +LG+G FG V    ++E  T       G   A+K LK + +    E   
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 54
Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            + E   L    HP L  L  Y  +   RL  V E+   G L  HL R  +   +S    
Sbjct: 55  TLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRA 110
Query: 205 IALGA--AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
              GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T    
Sbjct: 111 RFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MK 167
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
              GT  Y APE +         D +  GVV+ E++ GR                    Y
Sbjct: 168 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------Y 210
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             D  KL++++    E+ +      +   L    L +DPK R
Sbjct: 211 NQDHEKLFELILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G  G V+               +G  VA++ +           + E+  + +  +PN
Sbjct: 29  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V  +   +  D+  +V E++  GSL + +      +       +     + L FLH  S
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH--S 135
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
             VI+R+ K+ NILL  + + KL+DFG  A+  P+  K    + +VGT  + APE V   
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRK 192
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV---DPR 336
               K D++S G++ +E++ G      + P                 R LY I     P 
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALYLIATNGTPE 236
Query: 337 LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV-----KVLTPLQDLNDL 383
           L+    L  + +       CL  D + R S  E++     K+  PL  L  L
Sbjct: 237 LQNPEKLSAIFR--DFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPL 286

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV-AEVDFLGQLHHP 159
           LG G FG V    +EE         SG+   +K++  D  Q   E + AE++ L  L HP
Sbjct: 30  LGSGAFGDV--HLVEERS-------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFL 216
           N++K+     +     +V E    G L   +     R   L      ++       LA+ 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 217 HGGSEPVIYRDFKTSNILL-DSEYNA--KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
           H  S+ V+++D K  NIL  D+  ++  K+ DFGLA+     +    ST   GT  Y AP
Sbjct: 141 H--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAP 195
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTG 300
           E V    +T K D++S GVV+  +LTG
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL--KPDGLQGHREWVAEVDFLGQLH 157
           ++GEG +G V K              +G  VA+K      D     +  + E+  L QL 
Sbjct: 32  LVGEGSYGMVMKC---------RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN-HLFRRTIPLPWSNRIKIALGAAKGLAFL 216
           H NLV L+  C +  +  LV+EF+    L++  LF     L +    K       G+ F 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFC 140
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAPE 274
           H  S  +I+RD K  NIL+      KL DFG A+  A P      V    V T  Y APE
Sbjct: 141 H--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP----GEVYDDEVATRWYRAPE 194
Query: 275 YVMTGHLTSKS-DVYSFGVVLLEILTG 300
            ++      K+ DV++ G ++ E+  G
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 73/161 (45%), Gaps = 10/161 (6%)
Query: 143 HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR 202
           H E   E+  L  L HPN++KL     +     LV EF   G L   +  R       + 
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDA 148
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTH 259
             I      G+ +LH     +++RD K  NILL+++    N K+ DFGL+    +  K  
Sbjct: 149 ANIMKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
                +GT  Y APE V+      K DV+S GV++  +L G
Sbjct: 207 DR---LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEV 150
           +F    ++G+G FG V                  +  AVK L+   +   +E    ++E 
Sbjct: 39  DFHFLKVIGKGSFGKVLLA---------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSER 89
Query: 151 D-FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
           +  L  + HP LV L       D+   V +++  G L  HL R    L    R   A   
Sbjct: 90  NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEI 148
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           A  L +LH  S  ++YRD K  NILLDS+ +  L+DFGL K   + + T  ++   GT  
Sbjct: 149 ASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           Y APE +         D +  G VL E+L G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP-DGLQGHREWVA 148
           + + +F+  S+LGEG +G V         +A  KP +G  VA+K ++P D        + 
Sbjct: 8   NISSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLR 58
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIA 206
           E+  L    H N++ +      D        ++ +  ++  L R   T  L   +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK---------AGPQGDK 257
               + +  LHG +  VI+RD K SN+L++S  + K+ DFGLA+         + P G +
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           + +    V T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 177 SGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 86  QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGH 143
           Q  K    +F+   ILGEG F  V             +  +    A+K L+   +  +  
Sbjct: 2   QPRKKRPEDFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENK 52
Query: 144 REWVA-EVDFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIP 196
             +V  E D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T  
Sbjct: 53  VPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT 111
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
             ++  I         L +LHG    +I+RD K  NILL+ + + +++DFG AK      
Sbjct: 112 RFYTAEI------VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 163
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           K   +   VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 164 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 86  QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGH 143
           Q  K    +F+   ILGEG F  V             +  +    A+K L+   +  +  
Sbjct: 3   QPRKKRPEDFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENK 53
Query: 144 REWVA-EVDFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIP 196
             +V  E D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T  
Sbjct: 54  VPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT 112
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
             ++  I         L +LHG    +I+RD K  NILL+ + + +++DFG AK      
Sbjct: 113 RFYTAEI------VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 164
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           K   +   VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 165 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 86  QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGH 143
           Q  K    +F+   ILGEG F  V             +  +    A+K L+   +  +  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENK 51
Query: 144 REWVA-EVDFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIP 196
             +V  E D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T  
Sbjct: 52  VPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT 110
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
             ++  I         L +LHG    +I+RD K  NILL+ + + +++DFG AK      
Sbjct: 111 RFYTAEI------VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           K   +   VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 163 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 90  SATGNF-RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA 148
           S  G F + D  +G G F  V+KG   E     A       +  + L     Q  +E   
Sbjct: 22  SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVA----WCELQDRKLTKSERQRFKE--- 74
Query: 149 EVDFLGQLHHPNLVKLIG---------YCIEDDQRLLVYEFMTRGSLENHLFRRTIP--- 196
           E + L  L HPN+V+             CI     +LV E  T G+L+ +L R  +    
Sbjct: 75  EAEXLKGLQHPNIVRFYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIK 129
Query: 197 --LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDFGLAKAGP 253
               W  +I       KGL FLH  + P+I+RD K  NI +     + K+ D GLA    
Sbjct: 130 VLRSWCRQI------LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-- 181
Query: 254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
              +   +  V+GT  + APE     +  S  DVY+FG   LE  T
Sbjct: 182 --KRASFAKAVIGTPEFXAPEXYEEKYDES-VDVYAFGXCXLEXAT 224

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 89  KSATGNFRPDSILGEGGFGYVF---KGWIEENGTAPA-KPGSGITVAVKSLKPDGLQGHR 144
           K    NF    +LG G +G VF   K    + G   A K     T+  K+   +  +  R
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 145 ---EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWS 200
              E + +  FL  LH         Y  + + +L L+ +++  G L  HL +R       
Sbjct: 110 QVLEHIRQSPFLVTLH---------YAFQTETKLHLILDYINGGELFTHLSQR--ERFTE 158
Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
           + ++I +G    LA  H     +IYRD K  NILLDS  +  L+DFGL+K     D+T  
Sbjct: 159 HEVQIYVGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETER 216
Query: 261 STRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG 300
           +    GT  Y AP+ V    +GH     D +S GV++ E+LTG
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 8   DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 58
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 59  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 116
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 117 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 170 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWVAEVDFLGQLH 157
           LG+G FG V+            +  S   +A+K L    L+      +   EV+    L 
Sbjct: 20  LGKGKFGNVYLA---------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL---GAAKGLA 214
           HPN+++L GY  +  +  L+ E+   G++    +R    L   +  + A      A  L+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALS 126
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           + H  S+ VI+RD K  N+LL S    K++DFG +   P   +    T + GT  Y  PE
Sbjct: 127 YCH--SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 180
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTG 300
            +       K D++S GV+  E L G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI- 141
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 142 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +     +  SD+++ G ++ +++ G
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH---REWVAEVDFLGQLH 157
           LG+G FG V+            +  S   VA+K L    ++      +   E++    LH
Sbjct: 31  LGKGKFGNVYLA---------REKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN+++L  Y  +  +  L+ E+  RG L   L +++          I    A  L + H
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH 140
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
           G    VI+RD K  N+LL  +   K++DFG +   P   +      + GT  Y  PE + 
Sbjct: 141 GKK--VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTMCGTLDYLPPEMIE 194
Query: 278 TGHLTSKSDVYSFGVVLLEILTG 300
                 K D++  GV+  E+L G
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 139
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 140 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 139
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 140 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEV 150
           GN+R    +G+G F  V                +G  VAVK +    L     ++   EV
Sbjct: 14  GNYRLLKTIGKGNFAKV---------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
             +  L+HPN+VKL    IE ++ L LV E+ + G + ++L           R K     
Sbjct: 65  RIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QI 122
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
              + + H   + +++RD K  N+LLD++ N K++DFG +     G+K        G+  
Sbjct: 123 VSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPP 177
Query: 270 YAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
           YAAPE          + DV+S GV+L  +++G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEV 150
           GN+R    +G+G F  V                +G  VAVK +    L     ++   EV
Sbjct: 14  GNYRLLKTIGKGNFAKV---------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
             +  L+HPN+VKL    IE ++ L LV E+ + G + ++L           R K     
Sbjct: 65  RIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QI 122
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
              + + H   + +++RD K  N+LLD++ N K++DFG +     G+K        G+  
Sbjct: 123 VSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPP 177
Query: 270 YAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
           YAAPE          + DV+S GV+L  +++G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 15  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 65
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 66  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 123
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 124 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 177 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 141
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 142 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 20/218 (9%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAE 149
            GN+R    +G+G F  V                +G  VAVK +    L     ++   E
Sbjct: 6   IGNYRLLKTIGKGNFAKV---------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE 56
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           V  +  L+HPN+VKL    IE ++ L LV E+ + G + ++L           R K    
Sbjct: 57  VRIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-Q 114
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
               + + H   + +++RD K  N+LLD++ N K++DFG +     G+K        G+ 
Sbjct: 115 IVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSP 169
Query: 269 GYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
            YAAPE          + DV+S GV+L  +++G    D
Sbjct: 170 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 141
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 142 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N+ P  ILG G    V +   +      A     +T    S   + +Q  RE  + EVD 
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGG-GSFSAEEVQELREATLKEVDI 63
Query: 153 LGQLH-HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L ++  HPN+++L      +    LV++ M +G L ++L  + + L      KI     +
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLE 122
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
            +  LH  +  +++RD K  NILLD + N KL+DFG +     G+K      V GT  Y 
Sbjct: 123 VICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYL 177
Query: 272 APEYVMTGH------LTSKSDVYSFGVVLLEILTG 300
           APE +             + D++S GV++  +L G
Sbjct: 178 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 139
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 140 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N+ P  ILG G    V +   +      A     +T    S   + +Q  RE  + EVD 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGG-GSFSAEEVQELREATLKEVDI 76
Query: 153 LGQLH-HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L ++  HPN+++L      +    LV++ M +G L ++L  + + L      KI     +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLE 135
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
            +  LH  +  +++RD K  NILLD + N KL+DFG +     G+K      V GT  Y 
Sbjct: 136 VICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYL 190
Query: 272 APEYVMTGH------LTSKSDVYSFGVVLLEILTG 300
           APE +             + D++S GV++  +L G
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 30  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 81  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 138
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 139 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 34  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 85  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 142
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 143 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 141
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 142 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 30  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 81  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 138
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 139 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNR 202
           E D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I         L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   + 
Sbjct: 139 I------VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
             VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 45/229 (19%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL------KPDGLQGHREWVAEVDFLG 154
           LG+G +G V+K              +G  VAVK +        D  +  RE +   +  G
Sbjct: 17  LGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 155 QLHHPNLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
              H N+V L+     D+ R   LV+++M     + H   R   L   ++  +     K 
Sbjct: 68  ---HENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVYQLIKV 121
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ------------------ 254
           + +LH G   +++RD K SNILL++E + K++DFGL+++                     
Sbjct: 122 IKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 255 -GDKTHVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             D   + T  V T  Y APE ++ +   T   D++S G +L EIL G+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVA-EV 150
           +F+   ILGEG F  V             +  +    A+K L+   +  +    +V  E 
Sbjct: 34  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNRIK 204
           D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  I 
Sbjct: 85  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI- 142
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
                   L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   +   
Sbjct: 143 -----VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 149 EVDFLGQLHHPNLVKLIGYC-IEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN----R 202
           E D +   + P +V+L  +C  +DD+ L +V E+M  G L N +    +P  W+      
Sbjct: 125 ERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAE 182
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           + +AL A   +  +H        RD K  N+LLD   + KL+DFG      +    H  T
Sbjct: 183 VVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT 234
Query: 263 RVVGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEILTG 300
             VGT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 235 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG 154
           F+ + + G+G FG V  G          +  +G++VA+K +  D    +RE     D L 
Sbjct: 25  FQVERMAGQGTFGTVQLG---------KEKSTGMSVAIKKVIQDPRFRNRELQIMQD-LA 74
Query: 155 QLHHPNLVKLIGYCI---EDDQRLL----VYEFM---TRGSLENHLFRRTIPLPWSNRIK 204
            LHHPN+V+L  Y     E D+R +    V E++         N+  R+  P P   ++ 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV- 133
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILL-DSEYNAKLSDFGLAK--AGPQGDKTHVS 261
                 + +  LH  S  V +RD K  N+L+ +++   KL DFG AK  +  + +  ++ 
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTG 300
           +R      Y APE +    H T+  D++S G +  E++ G
Sbjct: 194 SRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 40/225 (17%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ--LH 157
           +G+G +G V++G W             G +VAVK       +  + W  E +      L 
Sbjct: 16  VGKGRYGEVWRGLW------------HGESVAVKIFSS---RDEQSWFRETEIYNTVLLR 60
Query: 158 HPNLVKLIGYCI----EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           H N++  I   +       Q  L+  +   GSL + L R+T+    +  +++A+ AA GL
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA--LRLAVSAACGL 118
Query: 214 AFLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG-DKTHVSTRV-V 265
           A LH       G   + +RDFK+ N+L+ S     ++D GLA    QG D   +     V
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV 178
Query: 266 GTYGYAAPEY----VMTGHLTSK--SDVYSFGVVLLEILTGRRSM 304
           GT  Y APE     + T    S   +D+++FG+VL EI   RR++
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNR 202
           E D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  
Sbjct: 82  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I         L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   + 
Sbjct: 141 I------VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
             VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNR 202
           E D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  
Sbjct: 82  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I         L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   + 
Sbjct: 141 I------VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
             VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 193 XFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN----RI 203
           E D +   + P +V+L  Y  +DD+ L +V E+M  G L N +    +P  W+      +
Sbjct: 119 ERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 177
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +AL A   + F+H        RD K  N+LLD   + KL+DFG      +       T 
Sbjct: 178 VLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT- 228
Query: 264 VVGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEILTG 300
            VGT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAE 149
            GN+R    +G+G F  V                +G  VAVK +    L     ++   E
Sbjct: 13  IGNYRLLKTIGKGNFAKV---------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE 63
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           V  +  L+HPN+VKL    IE ++ L LV E+ + G + ++L           R K    
Sbjct: 64  VRIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 121
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
               + + H   + +++RD K  N+LLD++ N K++DFG +     G+K        G  
Sbjct: 122 IVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAP 176
Query: 269 GYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
            YAAPE          + DV+S GV+L  +++G    D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N+ P  ILG G    V +   +      A     +T    S   + +Q  RE  + EVD 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGG-GSFSAEEVQELREATLKEVDI 76
Query: 153 LGQLH-HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L ++  HPN+++L      +    LV++ M +G L ++L  + + L      KI     +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLE 135
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
            +  LH  +  +++RD K  NILLD + N KL+DFG +     G+K      V GT  Y 
Sbjct: 136 VICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTPSYL 190
Query: 272 APEYVMTGH------LTSKSDVYSFGVVLLEILTG 300
           APE +             + D++S GV++  +L G
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHL-----FRRTIPLPWSNR 202
           E D + +L HP  VKL  +  +DD++L     +   G L  ++     F  T    ++  
Sbjct: 85  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 143
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           I         L +LHG    +I+RD K  NILL+ + + +++DFG AK      K   + 
Sbjct: 144 I------VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 195
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
             VGT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEV 150
           +F    I+G GGFG V+            K  +G   A+K L    +   QG    + E 
Sbjct: 189 DFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 239
Query: 151 DFLGQLHHPN--LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
             L  +   +   +  + Y      +L  + + M  G L  HL +  +   +S       
Sbjct: 240 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFY 296
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A   L   H  +  V+YRD K +NILLD   + ++SD GLA       K H S   VGT
Sbjct: 297 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGT 352
Query: 268 YGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTG 300
           +GY APE +  G    S +D +S G +L ++L G
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN----RI 203
           E D +   + P +V+L  Y  +DD+ L +V E+M  G L N +    +P  W+      +
Sbjct: 124 ERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 182
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +AL A   + F+H        RD K  N+LLD   + KL+DFG      +       T 
Sbjct: 183 VLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT- 233
Query: 264 VVGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEILTG 300
            VGT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEV 150
           +F    I+G GGFG V+            K  +G   A+K L    +   QG    + E 
Sbjct: 190 DFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 151 DFLGQLHHPN--LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
             L  +   +   +  + Y      +L  + + M  G L  HL +  +   +S       
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFY 297
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
            A   L   H  +  V+YRD K +NILLD   + ++SD GLA       K H S   VGT
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGT 353
Query: 268 YGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTG 300
           +GY APE +  G    S +D +S G +L ++L G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWV 147
              +F    I+G GGFG V+            K  +G   A+K L    +   QG    +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 148 AEVDFLGQLHHPN--LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            E   L  +   +   +  + Y      +L  + + M  G L  HL +  +   +S    
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADM 294
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
               A   L   H  +  V+YRD K +NILLD   + ++SD GLA       K H S   
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS--- 350
Query: 265 VGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTG 300
           VGT+GY APE +  G    S +D +S G +L ++L G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWV 147
              +F    I+G GGFG V+            K  +G   A+K L    +   QG    +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 148 AEVDFLGQLHHPN--LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
            E   L  +   +   +  + Y      +L  + + M  G L  HL +  +   +S    
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADM 294
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
               A   L   H  +  V+YRD K +NILLD   + ++SD GLA       K H S   
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS--- 350
Query: 265 VGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTG 300
           VGT+GY APE +  G    S +D +S G +L ++L G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN----RI 203
           E D +   + P +V+L  Y  +DD+ L +V E+M  G L N +    +P  W+      +
Sbjct: 124 ERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 182
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +AL A   + F+H        RD K  N+LLD   + KL+DFG      +       T 
Sbjct: 183 VLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT- 233
Query: 264 VVGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEILTG 300
            VGT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW----VAEVDFLGQL 156
           LG+G F  +FKG   E G       + + + V        + HR +          + +L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD------KAHRNYSESFFEAASMMSKL 69
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRIKIALGAAKGLA 214
            H +LV   G C+  D+ +LV EF+  GSL+ +L   +  I + W  ++++A   A  + 
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMH 127
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV--GTYGYAA 272
           FL   +  +I+ +    NILL  E + K  +    K    G    V  + +      +  
Sbjct: 128 FLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 273 PEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           PE +    +L   +D +SFG  L EI +G          G++ L A     L  +RKL Q
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSG----------GDKPLSA-----LDSQRKL-Q 229
Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
             + R +L        +++ L  NC+  +P  RPS   +++ L  L
Sbjct: 230 FYEDRHQL--PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 20/218 (9%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAE 149
            GN+R    +G+G F  V                +G  VAV+ +    L     ++   E
Sbjct: 13  IGNYRLLKTIGKGNFAKV---------KLARHILTGKEVAVRIIDKTQLNSSSLQKLFRE 63
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           V  +  L+HPN+VKL    IE ++ L LV E+ + G + ++L           R K    
Sbjct: 64  VRIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 121
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
               + + H   + +++RD K  N+LLD++ N K++DFG +     G+K        G+ 
Sbjct: 122 IVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSP 176
Query: 269 GYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
            YAAPE          + DV+S GV+L  +++G    D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGHREW 146
            GN+R    +G+G F  V                +G  VA+K      L P  LQ   + 
Sbjct: 14  IGNYRLLKTIGKGNFAKV---------KLARHILTGREVAIKIIDKTQLNPTSLQ---KL 61
Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
             EV  +  L+HPN+VKL      +    L+ E+ + G + ++L           R K  
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
                 + + H   + +++RD K  N+LLD++ N K++DFG +     G K        G
Sbjct: 122 -QIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCG 175
Query: 267 TYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
              YAAPE          + DV+S GV+L  +++G    D
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 24/220 (10%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGHREW 146
            GN+R    +G+G F  V                +G  VA+K      L P  LQ   + 
Sbjct: 11  IGNYRLLKTIGKGNFAKV---------KLARHILTGREVAIKIIDKTQLNPTSLQ---KL 58
Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
             EV  +  L+HPN+VKL      +    L+ E+ + G + ++L           R K  
Sbjct: 59  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 118
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
                 + + H   + +++RD K  N+LLD++ N K++DFG +     G K        G
Sbjct: 119 -QIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCG 172
Query: 267 TYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
           +  YAAPE          + DV+S GV+L  +++G    D
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 39/231 (16%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA 148
           +   G++     LG G FG V  G  E   T       G  VAVK L        R+ + 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIG--EHQLT-------GHKVAVKILN-------RQKIR 50
Query: 149 EVDFLGQL----------HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR--RTIP 196
            +D +G++           HP+++KL           +V E+++ G L +++ +  R   
Sbjct: 51  SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE 110
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           +      +  L A     + H     V++RD K  N+LLD+  NAK++DFGL+     G+
Sbjct: 111 MEARRLFQQILSAVD---YCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEILTGRRSMD 305
               S    G+  YAAPE V++G L +  + D++S GV+L  +L G    D
Sbjct: 166 FLRTSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEV 150
           GN+R    +G+G F  V                +G  VAV+ +    L     ++   EV
Sbjct: 14  GNYRLLKTIGKGNFAKV---------KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREV 64
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
             +  L+HPN+VKL    IE ++ L LV E+ + G + ++L           R K     
Sbjct: 65  RIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QI 122
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
              + + H   + +++RD K  N+LLD++ N K++DFG +     G+K        G+  
Sbjct: 123 VSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPP 177
Query: 270 YAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
           YAAPE          + DV+S GV+L  +++G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HRE 145
           K   G +     LGEG FG V                +   VA+K +    L+    H  
Sbjct: 5   KRHIGPYIIRETLGEGSFGKV---------KLATHYKTQQKVALKFISRQLLKKSDMHMR 55
Query: 146 WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
              E+ +L  L HP+++KL          ++V E+   G L +++  +        R + 
Sbjct: 56  VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RF 113
Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
                  + + H     +++RD K  N+LLD   N K++DFGL+     G+    S    
Sbjct: 114 FQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--- 168
Query: 266 GTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEILTGRRSMD 305
           G+  YAAPE V+ G L +  + DV+S G+VL  +L GR   D
Sbjct: 169 GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWVAEVDFLGQLH 157
           LG+G FG V+            +  S   +A+K L    L+      +   EV+    L 
Sbjct: 20  LGKGKFGNVYLA---------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL---GAAKGLA 214
           HPN+++L GY  +  +  L+ E+   G++    +R    L   +  + A      A  L+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALS 126
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           + H  S+ VI+RD K  N+LL S    K++DFG +   P   +      + GT  Y  PE
Sbjct: 127 YCH--SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPE 180
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTG 300
            +       K D++S GV+  E L G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 18/216 (8%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEV 150
           GN+R    +G+G F  V                +G  VAVK +    L     ++   EV
Sbjct: 14  GNYRLLKTIGKGNFAKV---------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
                L+HPN+VKL      +    LV E+ + G + ++L           R K      
Sbjct: 65  RIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIV 123
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             + + H   + +++RD K  N+LLD++ N K++DFG +     G+K        G   Y
Sbjct: 124 SAVQYCH--QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPY 178
Query: 271 AAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMD 305
           AAPE          + DV+S GV+L  +++G    D
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 39/231 (16%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA 148
           +   G++     LG G FG V  G  E   T       G  VAVK L        R+ + 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIG--EHQLT-------GHKVAVKILN-------RQKIR 50
Query: 149 EVDFLGQL----------HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR--RTIP 196
            +D +G++           HP+++KL           +V E+++ G L +++ +  R   
Sbjct: 51  SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE 110
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           +      +  L A     + H     V++RD K  N+LLD+  NAK++DFGL+     G+
Sbjct: 111 MEARRLFQQILSAVD---YCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEILTGRRSMD 305
               S    G+  YAAPE V++G L +  + D++S GV+L  +L G    D
Sbjct: 166 FLRDSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 37/286 (12%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW----VAEVDFLGQL 156
           LG+G F  +FKG   E G       + + + V        + HR +          + +L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD------KAHRNYSESFFEAASMMSKL 69
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRIKIALGAAKGLA 214
            H +LV   G C   D+ +LV EF+  GSL+ +L   +  I + W  ++++A   A  + 
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMH 127
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV--GTYGYAA 272
           FL   +  +I+ +    NILL  E + K  +    K    G    V  + +      +  
Sbjct: 128 FLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 273 PEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           PE +    +L   +D +SFG  L EI +G          G++ L A     L  +RKL Q
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSG----------GDKPLSA-----LDSQRKL-Q 229
Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
             + R +L        +++ L  NC+  +P  RPS   +++ L  L
Sbjct: 230 FYEDRHQL--PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 20/187 (10%)
Query: 126 SGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHH-PNLVKLIGYCIEDDQRLLVYEFMTR 183
           +G  +AVK ++  G  + ++  + ++D + + H  P +V+  G  I +    +  E M  
Sbjct: 49  TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-- 106
Query: 184 GSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFL---HGGSEPVIYRDFKTSNILLDSEY 239
           G+    L +R   P+P     K+ +   K L +L   HG    VI+RD K SNILLD   
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERG 162
Query: 240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS-----KSDVYSFGVVL 294
             KL DFG+  +G   D      R  G   Y APE +     T      ++DV+S G+ L
Sbjct: 163 QIKLCDFGI--SGRLVD-DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 295 LEILTGR 301
           +E+ TG+
Sbjct: 220 VELATGQ 226

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 53/273 (19%)
Query: 125 GSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD--QRLLVYEFMT 182
           G+ I V V  ++    +  R++  E   L    HPN++ ++G C         L+  +M 
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 183 RGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRD-FKTSNILLDSEYN 240
            GSL N L   T   +  S  +K AL  A+G+AFLH   EP+I R    + ++++D +  
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMT 151
Query: 241 AKLS--DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSK---SDVYSFGVVLL 295
           A++S  D   +   P         R+     + APE +      +    +D++SF V+L 
Sbjct: 152 ARISMADVKFSFQSP--------GRMYAP-AWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 296 EILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQ-------- 347
           E++T      ++ P              AD   +       + +  +L+G++        
Sbjct: 203 ELVT------REVP-------------FADLSNM------EIGMKVALEGLRPTIPPGIS 237
Query: 348 -KVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
             VS+L   C++ DP  RP  D +V +L  +QD
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 19/177 (10%)
Query: 83  FTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG 142
           F  Q ++      R   +L EGGF +V++             GSG   A+K L  +  + 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEA---------QDVGSGREYALKRLLSNEEEK 68
Query: 143 HREWVAEVDFLGQLH-HPNLVKL-----IGYCIED--DQRLLVYEFMTRGSLENHLFRRT 194
           +R  + EV F+ +L  HPN+V+      IG    D      L+   + +G L   L +  
Sbjct: 69  NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME 128
Query: 195 I--PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
              PL     +KI     + +  +H    P+I+RD K  N+LL ++   KL DFG A
Sbjct: 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-----WVAEVDFLGQ 155
           LGEG +  V+KG             S +T  + +LK   L+ H E      + EV  L  
Sbjct: 10  LGEGTYATVYKG------------KSKLTDNLVALKEIRLE-HEEGAPCTAIREVSLLKD 56
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L H N+V L      +    LV+E++ +  L+ +L      +   N         +GLA+
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H   + V++RD K  N+L++     KL+DFGLA+A     KT+ +  V  T  Y  P+ 
Sbjct: 116 CH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDI 171
Query: 276 VM-TGHLTSKSDVYSFGVVLLEILTGR 301
           ++ +   +++ D++  G +  E+ TGR
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V             +  SG  VAVK +     Q       EV  +    H N
Sbjct: 53  IGEGSTGIV---------CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           +V++    +  ++  ++ EF+  G+L +      + L       +     + LA+LH  +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAYLH--A 159
Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFG----LAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           + VI+RD K+ +ILL  +   KLSDFG    ++K  P+         +VGT  + APE +
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKXLVGTPYWMAPEVI 213
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
                 ++ D++S G++++E++ G
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G V+K          A+   G T A+K ++   L+   E +      E+  L +
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L H N+VKL        + +LV+E + +  L+  L      L         L    G+A+
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H     V++RD K  N+L++ E   K++DFGLA+A   G      T  V T  Y AP+ 
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDV 171
Query: 276 VM-TGHLTSKSDVYSFGVVLLEILTG 300
           +M +   ++  D++S G +  E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G V+K          A+   G T A+K ++   L+   E +      E+  L +
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L H N+VKL        + +LV+E + +  L+  L      L         L    G+A+
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H     V++RD K  N+L++ E   K++DFGLA+A   G      T  V T  Y AP+ 
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDV 171
Query: 276 VM-TGHLTSKSDVYSFGVVLLEILTG 300
           +M +   ++  D++S G +  E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G V+K          A+   G T A+K ++   L+   E +      E+  L +
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L H N+VKL        + +LV+E + +  L+  L      L         L    G+A+
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H     V++RD K  N+L++ E   K++DFGLA+A   G      T  + T  Y AP+ 
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDV 171
Query: 276 VM-TGHLTSKSDVYSFGVVLLEILTG 300
           +M +   ++  D++S G +  E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
           P+   + I  +   A+G+ FL   S   I+RD    NILL      K+ DFGLA+   + 
Sbjct: 195 PITMEDLISYSFQVARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL 315
                         + APE +     ++KSDV+S+GV+L EI     S+      G    
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIF----SLGGSPYPG---- 304
Query: 316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           V     + +  R+  ++  P     YS     ++ Q+  +C  RDPK RP   E+V+ L 
Sbjct: 305 VQMDEDFCSRLREGMRMRAP----EYS---TPEIYQIMLDCWHRDPKERPRFAELVEKLG 357
Query: 376 PL 377
            L
Sbjct: 358 DL 359

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G VFK    E            T  + +LK   L    E V      E+  L +
Sbjct: 10  IGEGTYGTVFKAKNRE------------THEIVALKRVRLDDDDEGVPSSALREICLLKE 57
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L H N+V+L      D +  LV+EF  +  L+ +       L             KGL F
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H  S  V++RD K  N+L++     KL+DFGLA+A   G      +  V T  Y  P+ 
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDV 172
Query: 276 VMTGHLTSKS-DVYSFGVVLLEILTGRRSM 304
           +    L S S D++S G +  E+    R +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFL 153
           F     LG G F  V     EE  T       G   AVK +    L+G    +  E+  L
Sbjct: 24  FEFKETLGTGAFSEVVLA--EEKAT-------GKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP--WSNRIKIALGAAK 211
            ++ H N+V L       +   LV + ++ G L + +  +        S  I+  L A  
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA-- 132
Query: 212 GLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + +LH     +++RD K  N+L    D E    +SDFGL+K   +GD   V +   GT 
Sbjct: 133 -VYYLHRMG--IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTP 186
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           GY APE +     +   D +S GV+   +L G
Sbjct: 187 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 15/218 (6%)
Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKS-LKPDGLQGHREWV 147
           K    +F     LG+G FG V+    ++N    A     + V  KS L+ +G++   +  
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMA-----LKVLFKSQLEKEGVE--HQLR 63
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            E++    L HPN++++  Y  +  +  L+ EF  RG L   L ++              
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFME 122
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L + H     VI+RD K  N+L+  +   K++DFG +   P   +      + GT
Sbjct: 123 ELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGT 176
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD 305
             Y  PE +       K D++  GV+  E L G    D
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
           + EV  L  L HPN++KL  +  +     LV E    G L + +  R +     +   I 
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVII 142
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNA--KLSDFGLAKAGPQGDKTHVSTR 263
                G+ +LH     +++RD K  N+LL+S E +A  K+ DFGL+       K      
Sbjct: 143 KQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KE 197
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            +GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 7/154 (4%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           E+  + QLHHP L+ L     +  + +L+ EF++ G L + +      +  +  I     
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEY--NAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           A +GL  +H  S  +++ D K  NI+ +++   + K+ DFGLA      +   V+T    
Sbjct: 158 ACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---A 212
Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           T  +AAPE V    +   +D+++ GV+   +L+G
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKS-LKPDGLQGHREWVAEVDFLGQLHHP 159
           LG+G FG V+    ++N    A     + V  KS L+ +G++   +   E++    L HP
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMA-----LKVLFKSQLEKEGVE--HQLRREIEIQSHLRHP 74
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N++++  Y  +  +  L+ EF  RG L   L ++                A  L + H  
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH-- 131
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
              VI+RD K  N+L+  +   K++DFG +   P   +      + GT  Y  PE +   
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGTLDYLPPEMIEGK 187
Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMD 305
               K D++  GV+  E L G    D
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 127/309 (41%), Gaps = 47/309 (15%)
Query: 76  SPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL 135
           SP Q   FT ++LK           +G G +G V K           KP SG  +AVK +
Sbjct: 12  SPEQHWDFTAEDLKDLGE-------IGRGAYGSVNK--------MVHKP-SGQIMAVKRI 55
Query: 136 KPD-GLQGHREWVAEVDFLGQLHH-PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR 193
           +     +  ++ + ++D + +    P +V+  G    +    +  E M+    + + +  
Sbjct: 56  RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVY 115
Query: 194 TI---PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
           ++    +P     KI L   K L  L    + +I+RD K SNILLD   N KL DFG++ 
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISG 174
Query: 251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEILTGRRSMDK 306
              Q   +   TR  G   Y APE +           +SDV+S G+ L E+ TGR    K
Sbjct: 175 ---QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 307 KRPSGEQNLVAWARQYLADKRKLYQIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKS 363
                      W   +     +L Q+V    P+L  +   +           CL++D   
Sbjct: 232 -----------WNSVF----DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESK 276
Query: 364 RPSMDEVVK 372
           RP   E++K
Sbjct: 277 RPKYKELLK 285

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV  L QL HPN++KL  +  +     LV E    G L + +  R       +   I   
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ-KFSEVDAAVIMKQ 112
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRVV 265
              G  +LH     +++RD K  N+LL+S+      K+ DFGL+     G K       +
Sbjct: 113 VLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERL 167
Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 168 GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV  L QL HPN++KL  +  +     LV E    G L + +  R       +   I   
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ-KFSEVDAAVIMKQ 129
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRVV 265
              G  +LH     +++RD K  N+LL+S+      K+ DFGL+     G K       +
Sbjct: 130 VLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERL 184
Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 185 GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 128/313 (40%), Gaps = 54/313 (17%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL--KPDGLQGHREWVAEVDFLGQLHH 158
           +GEG +G VFK    + G           VA+K      D     +  + E+  L QL H
Sbjct: 11  IGEGSYGVVFKCRNRDTGQ---------IVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSL-ENHLFRRTIPLPWSNRIK-IALGAAKGLAFL 216
           PNLV L+       +  LV+E+     L E   ++R +P    + +K I     + + F 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVP---EHLVKSITWQTLQAVNFC 118
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAPE 274
           H  +   I+RD K  NIL+      KL DFG A+   GP    +      V T  Y +PE
Sbjct: 119 HKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP----SDYYDDEVATRWYRSPE 172
Query: 275 YVM-TGHLTSKSDVYSFGVVLLEILTG----------------RRSMDKKRPSGEQNLVA 317
            ++         DV++ G V  E+L+G                R+++    P  +Q  V 
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ--VF 230
Query: 318 WARQYLADKRKLYQIVDPR----LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK- 372
              QY +  +    I DP     LEL +       +  L   CL  DP  R + ++++  
Sbjct: 231 STNQYFSGVK----IPDPEDMEPLELKFPNISYPALGLLK-GCLHMDPTERLTCEQLLHH 285
Query: 373 -VLTPLQDLNDLA 384
                ++++ DLA
Sbjct: 286 PYFENIREIEDLA 298

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 144 REWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNR 202
           R    E+  +  L HP LV L  Y  +D++ + +V + +  G L  HL ++ +       
Sbjct: 60  RNVFKELQIMQGLEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETV 117
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
                     L +L   ++ +I+RD K  NILLD   +  ++DF +A   P+  +T ++T
Sbjct: 118 KLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT 173
Query: 263 RVVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV--- 316
            + GT  Y APE   +      +   D +S GV   E+L GRR    +  +  + +V   
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232
Query: 317 ---------AWARQYLADKRKLYQ 331
                    AW+++ ++  +KL +
Sbjct: 233 ETTVVTYPSAWSQEMVSLLKKLLE 256

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 112/300 (37%), Gaps = 72/300 (24%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +      +    LG G FG V    IE +     K  
Sbjct: 2   DPDELPLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDKTA 55
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 183 RGSLENHL----------------FRR------TIPLPWSNRI----------KIALGAA 210
            G+L  +L                FR+       IP+    R+                 
Sbjct: 116 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 175
Query: 211 KGLAFLHGGSEPV-IYRDFKT------------------------------SNILLDSEY 239
           K L+ +     P  +Y+DF T                               NILL  + 
Sbjct: 176 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 235
Query: 240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
             K+ DFGLA+   +               + APE +     T +SDV+SFGV+L EI +
Sbjct: 236 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 16/202 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V +  + E  T       G   A K +             E+  +  L HP 
Sbjct: 59  LGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV L     +D++ +++YEFM+ G L   +      +     ++      KGL  +H  +
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 221 EPVIYRDFKTSNILLDSEYN--AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT 278
              ++ D K  NI+  ++ +   KL DFGL           V+T   GT  +AAPE    
Sbjct: 170 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEG 224
Query: 279 GHLTSKSDVYSFGVVLLEILTG 300
             +   +D++S GV+   +L+G
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSG 246

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 45/233 (19%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF- 152
           N +   ++G G +G V+KG ++E      +P     VAVK          + ++ E +  
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDE------RP-----VAVKVF---SFANRQNFINEKNIY 59
Query: 153 -LGQLHHPNLVKLI--GYCIEDDQR---LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
            +  + H N+ + I     +  D R   LLV E+   GSL  +L   T    W +  ++A
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD--WVSSCRLA 117
Query: 207 LGAAKGLAFLH------GGSEPVI-YRDFKTSNILLDSEYNAKLSDFGLA------KAGP 253
               +GLA+LH         +P I +RD  + N+L+ ++    +SDFGL+      +   
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS--------DVYSFGVVLLEIL 298
            G++ + +   VGT  Y APE V+ G +  +         D+Y+ G++  EI 
Sbjct: 178 PGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 112/300 (37%), Gaps = 72/300 (24%)
Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +PD  P DE   C+ L +   + +      +    LG G FG V    IE +     K  
Sbjct: 4   DPDELPLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDKTA 57
Query: 126 SGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLV-YEFMT 182
           +  TVAVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF  
Sbjct: 58  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 117
Query: 183 RGSLENHL----------------FRR------TIPLPWSNRI----------KIALGAA 210
            G+L  +L                FR+       IP+    R+                 
Sbjct: 118 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 177
Query: 211 KGLAFLHGGSEPV-IYRDFKT------------------------------SNILLDSEY 239
           K L+ +     P  +Y+DF T                               NILL  + 
Sbjct: 178 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 237
Query: 240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
             K+ DFGLA+   +               + APE +     T +SDV+SFGV+L EI +
Sbjct: 238 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 16/202 (7%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V +  + E  T       G   A K +             E+  +  L HP 
Sbjct: 165 LGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS 220
           LV L     +D++ +++YEFM+ G L   +      +     ++      KGL  +H  +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 221 EPVIYRDFKTSNILLDSEYN--AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT 278
              ++ D K  NI+  ++ +   KL DFGL           V+T   GT  +AAPE    
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEG 330
Query: 279 GHLTSKSDVYSFGVVLLEILTG 300
             +   +D++S GV+   +L+G
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSG 352

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +GEG +G VFK    E            T  + +LK   L    E V      E+  L +
Sbjct: 10  IGEGTYGTVFKAKNRE------------THEIVALKRVRLDDDDEGVPSSALREICLLKE 57
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L H N+V+L      D +  LV+EF  +  L+ +       L             KGL F
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
            H  S  V++RD K  N+L++     KL++FGLA+A   G      +  V T  Y  P+ 
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDV 172
Query: 276 VMTGHLTSKS-DVYSFGVVLLEILTGRRSM 304
           +    L S S D++S G +  E+    R +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 24/226 (10%)
Query: 82  QFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ 141
           +F        + N+     LG+G F  V +              +G+  A K +    L 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLS 68
Query: 142 GH--REWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PL 197
               ++   E     +L HPN+V+L     E+    LV++ +T G L   +  R      
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 198 PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQ 254
             S+ I+  L   + +A+ H  S  +++R+ K  N+LL S+      KL+DFGLA     
Sbjct: 129 DASHCIQQIL---ESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            +  H      GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 184 SEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 63  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 109
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 167
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK--THVSTRVVG 266
            + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+   +++ +R   
Sbjct: 168 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 223
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              Y APE +      TS  DV+S G VL E+L G+
Sbjct: 224 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 65  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 111
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 169
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK--THVSTRVVG 266
            + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+   +++ +R   
Sbjct: 170 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 225
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              Y APE +      TS  DV+S G VL E+L G+
Sbjct: 226 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 55  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 101
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 159
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK--THVSTRVVG 266
            + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+   +++ +R   
Sbjct: 160 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 215
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              Y APE +      TS  DV+S G VL E+L G+
Sbjct: 216 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 61  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 165
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK--THVSTRVVG 266
            + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+   +++ +R   
Sbjct: 166 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              Y APE +      TS  DV+S G VL E+L G+
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 61  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 165
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 166 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 220
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 79/354 (22%), Positives = 127/354 (35%), Gaps = 110/354 (31%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDF 152
           +F P   +G GGFG VF+                   A+K ++    +  RE V  EV  
Sbjct: 7   DFEPIQCMGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 57
Query: 153 LGQLHHPNLVKLIGYCI---------EDDQRLLVYE------------------------ 179
           L +L HP +V+     +         E D+  L  E                        
Sbjct: 58  LAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDP 117
Query: 180 FMTRGS--------------LENHLFRRTIPLPWSNR------------IKIALGAAKGL 213
           F T+ +              ++  L R+     W NR            + I +  A+ +
Sbjct: 118 FSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK------------THVS 261
            FLH  S+ +++RD K SNI    +   K+ DFGL  A  Q ++            TH  
Sbjct: 178 EFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXG 235
Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
              VGT  Y +PE +   + + K D++S G++L E+L                       
Sbjct: 236 Q--VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS--------------------- 272
Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQ---LAYNCLSRDPKSRPSMDEVVK 372
           +     ++  I D R  L + L   QK  Q   +  + LS  P  RP   ++++
Sbjct: 273 FSTQMERVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 160 NLVKLIGYCIED-DQRLLVYEFMTRGSLENHLFR---------RTIPLPWSNRIKIALGA 209
           N+V+L  +     +++ +VY  +    +   ++R         +T+P+ +       L  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 131
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 132 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L KP
Sbjct: 23  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSKP 70
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 71  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 128
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 186
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDF 152
           +FR   +LG G F  V     E+  T          VA+K +  + L+G    +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQK-------LVAIKCIAKEALEGKEGSMENEIAV 69
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L ++ HPN+V L           L+ + ++ G L + +  +       +  ++       
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDA 128
Query: 213 LAFLHGGSEPVIYRDFKTSNIL---LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           + +LH     +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT G
Sbjct: 129 VKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 183
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           Y APE +     +   D +S GV+   +L G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 192 RRTIPLPWSNRIKIAL-GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
            + +     + ++  +    +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+
Sbjct: 119 XQKLT---DDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR 173
Query: 251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                   +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 174 HTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 106 VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 152
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 210
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK--THVSTRVVG 266
            + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+   +++ +R   
Sbjct: 211 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 266
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              Y APE +      TS  DV+S G VL E+L G+
Sbjct: 267 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 82/335 (24%), Positives = 136/335 (40%), Gaps = 47/335 (14%)
Query: 51  NRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVF 110
           N  L  P EA          P D  S    +    Q  +    +  P   LG G +G V 
Sbjct: 10  NPGLKIPKEAFEQPQTSSTPPRDLDSKA-CISIGNQNFEVKADDLEPIMELGRGAYGVV- 67
Query: 111 KGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDF-LGQLHHPNLVKLIGYC 168
               E+    P    SG  +AVK ++     Q  +  + ++D  +  +  P  V   G  
Sbjct: 68  ----EKMRHVP----SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 119
Query: 169 IEDDQRLLVYEFM--TRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYR 226
             +    +  E M  +       +  +   +P     KIA+   K L  LH     VI+R
Sbjct: 120 FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHR 178
Query: 227 DFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV-----MTGHL 281
           D K SN+L+++    K+ DFG+  +G   D     T   G   Y APE +       G+ 
Sbjct: 179 DVKPSNVLINALGQVKMCDFGI--SGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGY- 234
Query: 282 TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PRLE 338
           + KSD++S G+ ++E+   R   D           +W   +    ++L Q+V+   P+L 
Sbjct: 235 SVKSDIWSLGITMIELAILRFPYD-----------SWGTPF----QQLKQVVEEPSPQLP 279
Query: 339 LN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            + +S + V   SQ    CL ++ K RP+  E+++
Sbjct: 280 ADKFSAEFVDFTSQ----CLKKNSKERPTYPELMQ 310

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDF 152
           +FR   +LG G F  V     E+  T          VA+K +  + L+G    +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQK-------LVAIKCIAKEALEGKEGSMENEIAV 69
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L ++ HPN+V L           L+ + ++ G L + +  +       +  ++       
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDA 128
Query: 213 LAFLHGGSEPVIYRDFKTSNIL---LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           + +LH     +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT G
Sbjct: 129 VKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 183
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           Y APE +     +   D +S GV+   +L G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 46  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 92
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 150
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 151 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 205
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 35  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 81
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 139
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 140 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 194
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 39  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 143
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 144 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 198
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 16  QELNKTIWEVPERYQNLSP---IGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 63
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 121
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH 179
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 180 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 192 RRTIPLPWSNRIKIAL-GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
            + +     + ++  +    +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+
Sbjct: 119 XQKLT---DDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                   +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 174 HTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 40  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 86
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 144
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 145 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSR 199
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 200 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 32  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 78
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 136
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK--THVSTRVVG 266
            + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+   +++ +R   
Sbjct: 137 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 192
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              Y APE +      TS  DV+S G VL E+L G+
Sbjct: 193 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 18  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 65
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 123
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 182 TADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDF 152
           +FR   +LG G F  V     E+  T          VA+K +  + L+G    +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQK-------LVAIKCIAKEALEGKEGSMENEIAV 69
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR--IKIALGAA 210
           L ++ HPN+V L           L+ + ++ G L + +  +     ++ R   ++     
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 126
Query: 211 KGLAFLHGGSEPVIYRDFKTSNIL---LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             + +LH     +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT
Sbjct: 127 DAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGT 181
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 39  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 143
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 144 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 198
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 18  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 65
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 123
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 182 TADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 18  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 65
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 123
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 182 TADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 16  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 63
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 121
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH 179
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 180 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 22  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 69
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 70  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 127
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 128 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDXELKILDFGLARH 185
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 17  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 64
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 122
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 180
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 181 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 38/232 (16%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
            +F   ++LG+G FG V K                   A+K ++    +     ++EV  
Sbjct: 6   SDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTE-EKLSTILSEVML 55
Query: 153 LGQLHHP-------------NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPW 199
           L  L+H              N VK +    +     +  E+   G+L + +    +    
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG---- 255
               ++     + L+++H  S+ +I+RD K  NI +D   N K+ DFGLAK   +     
Sbjct: 116 DEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 256 --DKTHVS------TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEIL 298
             D  ++       T  +GT  Y A E +  TGH   K D+YS G++  E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQG      E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQL-- 131
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 132 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 17  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 64
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 122
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDSELKILDFGLARH 180
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 181 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 22  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 69
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 70  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 127
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 128 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 185
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 103/242 (42%), Gaps = 32/242 (13%)
Query: 71  PTDEKSPC---QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSG 127
           P  ++ P    Q L  T  E+     N  P   +G G +G V          A     +G
Sbjct: 2   PMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTG 49
Query: 128 ITVAVKSL-KP-DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEF 180
           + VAVK L +P   +   +    E+  L  + H N++ L+        +E+   + +   
Sbjct: 50  LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 109
Query: 181 MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN 240
           +    L N    +   L   +   +     +GL ++H     +I+RD K SN+ ++ +  
Sbjct: 110 LMGADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCE 165
Query: 241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILT 299
            K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ E+LT
Sbjct: 166 LKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 300 GR 301
           GR
Sbjct: 221 GR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 18  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 65
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 123
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 182 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 16  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 63
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 121
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 179
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 180 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 23  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 70
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 71  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 128
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 186
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 10  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 57
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 58  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 115
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 116 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 173
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 174 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 23  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 70
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 71  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 128
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 186
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 13  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 60
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 61  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 118
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 176
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 177 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 16  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 63
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 121
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 179
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 180 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 17  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 64
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 122
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 180
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 181 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAE 149
           + N+     LG+G F  V +              +G+  A K +    L     ++   E
Sbjct: 5   SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIAL 207
                +L HPN+V+L     E+    LV++ +T G L   +  R        S+ I+  L
Sbjct: 56  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 115
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRV 264
              + +A+ H  S  +++R+ K  N+LL S+      KL+DFGLA      +  H     
Sbjct: 116 ---ESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GF 167
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 13  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 60
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 61  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 118
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 176
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 177 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 28  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 74
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 132
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 133 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 187
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 34  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 81
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 82  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 139
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 140 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 197
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 TDDEMXGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 34  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 81
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 82  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 139
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 140 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 197
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAE 149
           + N+     LG+G F  V +              +G+  A K +    L     ++   E
Sbjct: 4   SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 54
Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIAL 207
                +L HPN+V+L     E+    LV++ +T G L   +  R        S+ I+  L
Sbjct: 55  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 114
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRV 264
              + +A+ H  S  +++R+ K  N+LL S+      KL+DFGLA      +  H     
Sbjct: 115 ---ESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GF 166
Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 131
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 132 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 131
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 132 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 107/254 (42%), Gaps = 36/254 (14%)
Query: 56  APNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIE 115
            P  +H+S + P           Q L  T  E+     N  P   +G G +G V      
Sbjct: 15  VPRGSHMSQERP-------TFYRQELNKTIWEVPERYQNLSP---VGSGAYGSV------ 58
Query: 116 ENGTAPAKPGSGITVAVKSL-KP-DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYC 168
               A     +G+ VAVK L +P   +   +    E+  L  + H N++ L+        
Sbjct: 59  ---CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 115
Query: 169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDF 228
           +E+   + +   +    L N    +   L   +   +     +GL ++H  S  +I+RD 
Sbjct: 116 LEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDL 171
Query: 229 KTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDV 287
           K SN+ ++ +   K+ DFGLA+        +V+TR      Y APE ++   H     D+
Sbjct: 172 KPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDI 226
Query: 288 YSFGVVLLEILTGR 301
           +S G ++ E+LTGR
Sbjct: 227 WSVGCIMAELLTGR 240

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 8   QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 55
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 56  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 113
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 114 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 171
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 172 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 31  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 77
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 135
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 136 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 190
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 191 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 13  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 60
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 61  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 118
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDSELKILDFGLARH 176
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 177 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 45/286 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G GG   VF+   E+      K      V ++      L  +R  +A ++ L Q H   
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDK 117
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPL-PWSNR--IKIALGAAKGLAFL 216
           +++L  Y I D     +Y  M  G+++ N   ++   + PW  +   K  L A   +   
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQ 173
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           HG    +++ D K +N L+  +   KL DFG+A        + V    VGT  Y  PE +
Sbjct: 174 HG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 277 -----------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
                          ++ KSDV+S G +L  +  G+                  +Q +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQ 273
Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
             KL+ I+DP  E+ +     + +  +   CL RDPK R S+ E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQ  R    E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 131
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+    +   + + 
Sbjct: 132 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSR 186
Query: 269 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            Y APE +      TS  DV+S G VL E+L G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 7   QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 54
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 55  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 112
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 171 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 107/254 (42%), Gaps = 36/254 (14%)
Query: 56  APNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIE 115
            P  +H+S + P           Q L  T  E+     N  P   +G G +G V      
Sbjct: 14  VPRGSHMSQERP-------TFYRQELNKTIWEVPERYQNLSP---VGSGAYGSV------ 57
Query: 116 ENGTAPAKPGSGITVAVKSL-KP-DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYC 168
               A     +G+ VAVK L +P   +   +    E+  L  + H N++ L+        
Sbjct: 58  ---CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 114
Query: 169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDF 228
           +E+   + +   +    L N    +   L   +   +     +GL ++H  S  +I+RD 
Sbjct: 115 LEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDL 170
Query: 229 KTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDV 287
           K SN+ ++ +   K+ DFGLA+        +V+TR      Y APE ++   H     D+
Sbjct: 171 KPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDI 225
Query: 288 YSFGVVLLEILTGR 301
           +S G ++ E+LTGR
Sbjct: 226 WSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 8   QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 55
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 56  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 113
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 114 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 171
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 172 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 86  QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE 145
           +E+  AT   R    LG G FG V +  +E+  T       G   AVK ++ +  +    
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 134
Query: 146 WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
              E+     L  P +V L G   E     +  E +  GSL   L +    LP  +R   
Sbjct: 135 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLP-EDRALY 189
Query: 206 ALGAA-KGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAKA-GPQGDKTHVST 262
            LG A +GL +LH  S  +++ D K  N+LL S+  +A L DFG A    P G    + T
Sbjct: 190 YLGQALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLT 247
Query: 263 --RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
              + GT  + APE V+     +K DV+S   ++L +L G
Sbjct: 248 GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDF 152
           +FR   +LG G F  V     E+  T          VA+K +    L+G    +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQK-------LVAIKCIAKKALEGKEGSMENEIAV 69
Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR--IKIALGAA 210
           L ++ HPN+V L           L+ + ++ G L + +  +     ++ R   ++     
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 126
Query: 211 KGLAFLHGGSEPVIYRDFKTSNIL---LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             + +LH     +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT
Sbjct: 127 DAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGT 181
Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 9   QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 56
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 57  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 114
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 115 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 172
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 173 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 86  QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE 145
           +E+  AT   R    LG G FG V +  +E+  T       G   AVK ++ +  +    
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 115
Query: 146 WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
              E+     L  P +V L G   E     +  E +  GSL   L +    LP  +R   
Sbjct: 116 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLP-EDRALY 170
Query: 206 ALGAA-KGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAKA-GPQGDKTHVST 262
            LG A +GL +LH  S  +++ D K  N+LL S+  +A L DFG A    P G    + T
Sbjct: 171 YLGQALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLT 228
Query: 263 --RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
              + GT  + APE V+     +K DV+S   ++L +L G
Sbjct: 229 GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQG      E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 131
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK--THVSTRVVG 266
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+   +++ +R   
Sbjct: 132 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              Y APE +      TS  DV+S G VL E+L G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG V++  + +         SG  VA+K +    LQG      E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 160 NLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGA 209
           N+V+L  +     ++        +L Y   T   +  H  R  +T+P+ +       L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 131
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK--THVSTRVVG 266
            + LA++H     + +RD K  N+LLD +    KL DFG AK   +G+   +++ +R   
Sbjct: 132 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 267 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
              Y APE +      TS  DV+S G VL E+L G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIALGAAKG 212
           +L HPN+V+L     E+    LV++ +T G L   +  R        S+ I+  L   + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ES 117
Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           +A+ H  S  +++R+ K  N+LL S+      KL+DFGLA      +  H      GT G
Sbjct: 118 IAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPG 172
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           Y +PE +     +   D+++ GV+L  +L G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G G FG VF+  + E+            VA+K +    LQ  R    E+  +  + HP
Sbjct: 47  VIGNGSFGVVFQAKLVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHP 92
Query: 160 NLVKLIGYCIED----DQRLL------VYEFMTRGSLENHLFRRTIPLPWSNRIKIAL-G 208
           N+V L  +   +    D+  L      V E + R S      ++T+P+     IK+ +  
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL---IKLYMYQ 149
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTHVSTRVVGT 267
             + LA++H  S  + +RD K  N+LLD      KL DFG AK    G+    +   + +
Sbjct: 150 LLRSLAYIH--SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXICS 204
Query: 268 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
             Y APE +    + T+  D++S G V+ E++ G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 45/286 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G GG   VF+   E+      K      V ++      L  +R  +A ++ L Q H   
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDK 117
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPL-PWSNR--IKIALGAAKGLAFL 216
           +++L  Y I D     +Y  M  G+++ N   ++   + PW  +   K  L A   +   
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQ 173
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           HG    +++ D K +N L+  +   KL DFG+A        + V    VGT  Y  PE +
Sbjct: 174 HG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 277 -----------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
                          ++ KSDV+S G +L  +  G+                  +Q +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQ 273
Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
             KL+ I+DP  E+ +     + +  +   CL RDPK R S+ E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLH 157
           +G+G +G V++G W  EN            VAVK       +  + W  E +      L 
Sbjct: 45  VGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETELYNTVMLR 89
Query: 158 HPNLVKLIGYCI----EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           H N++  I   +       Q  L+  +   GSL ++L   T+     + ++I L  A GL
Sbjct: 90  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRIVLSIASGL 147
Query: 214 AFLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG-DKTHVSTR-VV 265
           A LH       G   + +RD K+ NIL+       ++D GLA    Q  ++  V     V
Sbjct: 148 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 207
Query: 266 GTYGYAAPEY------VMTGHLTSKSDVYSFGVVLLEILTGRRSM------DKKRPSGEQ 313
           GT  Y APE       V       + D+++FG+VL E+   RR +      D K P  + 
Sbjct: 208 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYD- 264
Query: 314 NLVAWARQYLADKRKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
             V        D RK+  +   R  +    +S   +  +++L   C  ++P +R +   +
Sbjct: 265 --VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 322
Query: 371 VKVLTPL 377
            K LT +
Sbjct: 323 KKTLTKI 329

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 146 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            ++  L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGL + 
Sbjct: 117 VKSQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDSELKILDFGLCRH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 156 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 15/101 (14%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG------DKTHVS--- 261
           + L+++H  S+ +I+RD K  NI +D   N K+ DFGLAK   +       D  ++    
Sbjct: 127 EALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 262 ---TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEIL 298
              T  +GT  Y A E +  TGH   K D+YS G++  E++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 155 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 67/147 (45%), Gaps = 4/147 (2%)
Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           G+L  P++V +  +  E D +L V   +  G       RR  PL       +A+    G 
Sbjct: 89  GRLQEPHVVPIHDFG-EIDGQLYVDXRLINGVDLAAXLRRQGPLAPPR--AVAIVRQIGS 145
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
           A     +    +RD K  NIL+ ++  A L DFG+A A      T +    VGT  Y AP
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYXAP 204
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTG 300
           E     H T ++D+Y+   VL E LTG
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTG 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 132 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 132 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 130 VAVKSL-KP-DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMT 182
           VAVK L +P   L   R    E+  L  L H N++ L+        IED   + +   + 
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 183 RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK 242
              L N    ++  L   +   +     +GL ++H     +I+RD K SN+ ++ +   +
Sbjct: 116 GADLNN--IVKSQALSDEHVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDSELR 171
Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
           + DFGLA+   +    +V+TR      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 172 ILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLH 157
           +G+G +G V++G W  EN            VAVK       +  + W  E +      L 
Sbjct: 16  VGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 158 HPNLVKLIGYCI----EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           H N++  I   +       Q  L+  +   GSL ++L   T+     + ++I L  A GL
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRIVLSIASGL 118
Query: 214 AFLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG-DKTHVSTR-VV 265
           A LH       G   + +RD K+ NIL+       ++D GLA    Q  ++  V     V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 266 GTYGYAAPEY------VMTGHLTSKSDVYSFGVVLLEILTGRRSM------DKKRPSGEQ 313
           GT  Y APE       V       + D+++FG+VL E+   RR +      D K P  + 
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYD- 235
Query: 314 NLVAWARQYLADKRKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
             V        D RK+  +   R  +    +S   +  +++L   C  ++P +R +   +
Sbjct: 236 --VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 371 VKVLTPL 377
            K LT +
Sbjct: 294 KKTLTKI 300

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG--QLH 157
           +G+G +G V++G W  EN            VAVK       +  + W  E +      L 
Sbjct: 16  VGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 158 HPNLVKLIGYCI----EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           H N++  I   +       Q  L+  +   GSL ++L   T+     + ++I L  A GL
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRIVLSIASGL 118
Query: 214 AFLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG-DKTHVSTR-VV 265
           A LH       G   + +RD K+ NIL+       ++D GLA    Q  ++  V     V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 266 GTYGYAAPEY------VMTGHLTSKSDVYSFGVVLLEILTGRRSM------DKKRPSGEQ 313
           GT  Y APE       V       + D+++FG+VL E+   RR +      D K P  + 
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYD- 235
Query: 314 NLVAWARQYLADKRKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
             V        D RK+  +   R  +    +S   +  +++L   C  ++P +R +   +
Sbjct: 236 --VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 371 VKVLTPL 377
            K LT +
Sbjct: 294 KKTLTKI 300

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+        +V+TR      Y
Sbjct: 165 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 217
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                   V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGXVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 45/286 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G GG   VF+   E+      K      V ++      L  +R  +A ++ L Q H   
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDK 70
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPL-PWSNR--IKIALGAAKGLAFL 216
           +++L  Y I D     +Y  M  G+++ N   ++   + PW  +   K  L A   +   
Sbjct: 71  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQ 126
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           HG    +++ D K +N L+  +   KL DFG+A        + V    VGT  Y  PE +
Sbjct: 127 HG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 277 -----------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
                          ++ KSDV+S G +L  +  G+                  +Q +  
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQ 226
Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
             KL+ I+DP  E+ +     + +  +   CL RDPK R S+ E++
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ D+GLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 25/229 (10%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD 138
           Q L  T  E+       RP   +G G +G V   +        A+    + V   S    
Sbjct: 9   QELNKTVWEVPQRLQGLRP---VGSGAYGSVCSAY-------DARLRQKVAVKKLSRPFQ 58
Query: 139 GLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLFRR 193
            L   R    E+  L  L H N++ L+        IED   + +   +    L N    +
Sbjct: 59  SLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNN--IVK 116
Query: 194 TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGP 253
              L   +   +     +GL ++H     +I+RD K SN+ ++ +   ++ DFGLA+   
Sbjct: 117 CQALSDEHVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQAD 174
Query: 254 QGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
           +    +V+TR      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 175 EEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 45/286 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G GG   VF+   E+      K      V ++      L  +R  +A ++ L Q H   
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDK 73
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPL-PWSNR--IKIALGAAKGLAFL 216
           +++L  Y I D     +Y  M  G+++ N   ++   + PW  +   K  L A   +   
Sbjct: 74  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQ 129
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           HG    +++ D K +N L+  +   KL DFG+A        + V    VGT  Y  PE +
Sbjct: 130 HG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 277 -----------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
                          ++ KSDV+S G +L  +  G+                  +Q +  
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQ 229
Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
             KL+ I+DP  E+ +     + +  +   CL RDPK R S+ E++
Sbjct: 230 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 17/180 (9%)
Query: 130 VAVKSL-KP-DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMT 182
           VAVK L +P   L   R    E+  L  L H N++ L+        IED   + +   + 
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 183 RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK 242
              L N    +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   +
Sbjct: 116 GADLNN--IVKCQALSDEHVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDSELR 171
Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
           + DFGLA+   +    +V+TR      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 172 ILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN-RIK-IA 206
           E+  L  + H N++ L+            Y+F           ++ + L +S  +I+ + 
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV 132
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
               KGL ++H     V++RD K  N+ ++ +   K+ DFGLA+        +V TR   
Sbjct: 133 YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 187
Query: 267 TYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
              Y APE +++  H     D++S G ++ E+LTG+
Sbjct: 188 --WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 45/286 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G GG   VF+   E+      K      V ++      L  +R  +A ++ L Q H   
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDK 89
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPL-PWSNR--IKIALGAAKGLAFL 216
           +++L  Y I D     +Y  M  G+++ N   ++   + PW  +   K  L A   +   
Sbjct: 90  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQ 145
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           HG    +++ D K +N L+  +   KL DFG+A        + V    VGT  Y  PE +
Sbjct: 146 HG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 277 -----------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
                          ++ KSDV+S G +L  +  G+                  +Q +  
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQ 245
Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
             KL+ I+DP  E+ +     + +  +   CL RDPK R S+ E++
Sbjct: 246 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 45/286 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G GG   VF+   E+      K      V ++      L  +R  +A ++ L Q H   
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDK 69
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPL-PWSNR--IKIALGAAKGLAFL 216
           +++L  Y I D     +Y  M  G+++ N   ++   + PW  +   K  L A   +   
Sbjct: 70  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQ 125
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           HG    +++ D K +N L+  +   KL DFG+A        + V    VGT  Y  PE +
Sbjct: 126 HG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 277 -----------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
                          ++ KSDV+S G +L  +  G+                  +Q +  
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQ 225
Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
             KL+ I+DP  E+ +     + +  +   CL RDPK R S+ E++
Sbjct: 226 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E+M  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   K++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWV 147
           S T  ++    +G+G F  V +           K  +G   A K +    L    H++  
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRC---------VKLCTGHEYAAKIINTKKLSARDHQKLE 51
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            E      L H N+V+L     E+    LV++ +T G L    F   +   + +    + 
Sbjct: 52  REARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASH 107
Query: 208 GAAKGL-AFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTR 263
              + L A LH     V++RD K  N+LL S+      KL+DFGLA    QGD+      
Sbjct: 108 CIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQ-QAWFG 165
Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
             GT GY +PE +         D+++ GV+L  +L G
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V +  +++  T       G   AVK ++ +  +     V E+     L  P 
Sbjct: 80  LGRGSFGEVHR--MKDKQT-------GFQCAVKKVRLEVFR-----VEELVACAGLSSPR 125
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA-KGLAFLHGG 219
           +V L G   E     +  E +  GSL   L ++   LP  +R    LG A +GL +LH  
Sbjct: 126 IVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLP-EDRALYYLGQALEGLEYLH-- 181
Query: 220 SEPVIYRDFKTSNILLDSEYN-AKLSDFGLAKA-GPQGDKTHVST--RVVGTYGYAAPEY 275
           +  +++ D K  N+LL S+ + A L DFG A    P G    + T   + GT  + APE 
Sbjct: 182 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTG 300
           VM     +K D++S   ++L +L G
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E+M  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   K++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 105/249 (42%), Gaps = 43/249 (17%)
Query: 85  FQELKSA--TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP--DGL 140
           FQ +K+     N+    ++G G +GYV+  +            +   VA+K +    + L
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAY---------DKNTEKNVAIKKVNRMFEDL 66
Query: 141 QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIP 196
              +  + E+  L +L    +++L    I DD      L +   +    L+  LF+  I 
Sbjct: 67  IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK-LFKTPIF 125
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA----- 251
           L   +   I      G  F+H     +I+RD K +N LL+ + + K+ DFGLA+      
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 252 --------------GPQGD--KTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVL 294
                         GP     K  +++ VV T  Y APE ++     +KS D++S G + 
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 295 LEILTGRRS 303
            E+L   +S
Sbjct: 243 AELLNMLQS 251

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 14/207 (6%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ++G+G F  V +    E G   A     I    K     GL    +   E      L HP
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFA---VKIVDVAKFTSSPGLST-EDLKREASICHMLKHP 86
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRI--KIALGAAKGLAFL 216
           ++V+L+     D    +V+EFM    L   + +R      +S  +         + L + 
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNA---KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
           H  +  +I+RD K  N+LL S+ N+   KL DFG+A     G+   V+   VGT  + AP
Sbjct: 147 HDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTG 300
           E V         DV+  GV+L  +L+G
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+         V+TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H     +I+RD K SN+ ++ +   K+ DFGLA+         V+TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+         V+TR      Y
Sbjct: 156 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WY 208
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+         V+TR      Y
Sbjct: 132 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 184
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           + G+G   A K +K   L   R  V+      EV+ L 
Sbjct: 13  LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E ++ G L + L  +   L      +       G+ 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 122
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S+ + + D K  NI LLD        KL DFG+A     G++      + GT  +
Sbjct: 123 YLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 177
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVGTY 268
           +GL ++H     VI+RD K SN+L++     K+ DFG+A+       +  +  T  V T 
Sbjct: 170 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 269 GYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRR 302
            Y APE +++ H  T   D++S G +  E+L  R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G F  V +             G      + + K    + H++   E      L HPN
Sbjct: 30  LGKGAFSVVRR-------CVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 82
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL-AFLHGG 219
           +V+L     E+    L+++ +T G     LF   +   + +    +    + L A LH  
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 220 SEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
              V++RD K  N+LL S+      KL+DFGLA    +G++        GT GY +PE +
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ-QAWFGFAGTPGYLSPEVL 196
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
                    D+++ GV+L  +L G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN-RIK-IA 206
           E+  L  + H N++ L+            Y+F           ++ + + +S  +I+ + 
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
               KGL ++H     V++RD K  N+ ++ +   K+ DFGLA+        +V TR   
Sbjct: 151 YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 205
Query: 267 TYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
              Y APE +++  H     D++S G ++ E+LTG+
Sbjct: 206 --WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 23/206 (11%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG G F  VF            +  +G   A+K +K            E+  L ++ H 
Sbjct: 16  VLGSGAFSEVF---------LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP--WSNRIKIALGAAKGLAFLH 217
           N+V L           LV + ++ G L + +  R +      S  I+  L A K   +LH
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK---YLH 123
Query: 218 GGSEPVIYRDFKTSNIL-LDSEYNAKL--SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
                +++RD K  N+L L  E N+K+  +DFGL+K    G    + +   GT GY APE
Sbjct: 124 ENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPE 177
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTG 300
            +     +   D +S GV+   +L G
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 117/286 (40%), Gaps = 45/286 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G GG   VF+   E+      K      V ++      L  +R  +A ++ L Q H   
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDK 89
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPL-PWSNR--IKIALGAAKGLAFL 216
           +++L  Y I D     +Y  M  G+++ N   ++   + PW  +   K  L A   +   
Sbjct: 90  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQ 145
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           HG    +++ D K +N L+  +   KL DFG+A          V    VGT  Y  PE +
Sbjct: 146 HG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200
Query: 277 -----------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
                          ++ KSDV+S G +L  +  G+                  +Q +  
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQ 245
Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
             KL+ I+DP  E+ +     + +  +   CL RDPK R S+ E++
Sbjct: 246 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           + G+G   A K +K   L   R  V+      EV+ L 
Sbjct: 20  LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E ++ G L + L  +   L      +       G+ 
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 129
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S+ + + D K  NI LLD        KL DFG+A     G++      + GT  +
Sbjct: 130 YLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 184
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 117/286 (40%), Gaps = 45/286 (15%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G GG   VF+   E+      K      V ++      L  +R  +A ++ L Q H   
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDK 117
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLE-NHLFRRTIPL-PWSNR--IKIALGAAKGLAFL 216
           +++L  Y I D     +Y  M  G+++ N   ++   + PW  +   K  L A   +   
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQ 173
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           HG    +++ D K +N L+  +   KL DFG+A        + V    VG   Y  PE +
Sbjct: 174 HG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 277 -----------MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
                          ++ KSDV+S G +L  +  G+                  +Q +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQ 273
Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
             KL+ I+DP  E+ +     + +  +   CL RDPK R S+ E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIE--DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
           E+  L +L HPN+VKL+    +  +D   +V+E + +G +         PL         
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLKPLSEDQARFYF 143
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
               KG+ +LH   + +I+RD K SN+L+  + + K++DFG++      D    +T  VG
Sbjct: 144 QDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT--VG 199
Query: 267 TYGYAAPEYVMTGH--LTSKS-DVYSFGVVLLEILTGR 301
           T  + APE +       + K+ DV++ GV L   + G+
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V +  +++  T       G   AVK ++ +  +     V E+     L  P 
Sbjct: 66  VGRGSFGEVHR--MKDKQT-------GFQCAVKKVRLEVFR-----VEELVACAGLSSPR 111
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA-KGLAFLHGG 219
           +V L G   E     +  E +  GSL   L ++   LP  +R    LG A +GL +LH  
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLP-EDRALYYLGQALEGLEYLH-- 167
Query: 220 SEPVIYRDFKTSNILLDSEYN-AKLSDFGLAKA-GPQGDKTHVST--RVVGTYGYAAPEY 275
           +  +++ D K  N+LL S+ + A L DFG A    P G    + T   + GT  + APE 
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTG 300
           VM     +K D++S   ++L +L G
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG+G +G V+ G    N          + +A+K +     +  +    E+     L H 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---GLAFL 216
           N+V+ +G   E+    +  E +  GSL   L  +  PL   N   I     +   GL +L
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK-DNEQTIGFYTKQILEGLKYL 138
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           H     +++RD K  N+L+++     K+SDFG +K  AG        +    GT  Y AP
Sbjct: 139 HDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG----INPCTETFTGTLQYMAP 192
Query: 274 EYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
           E +  G       +D++S G  ++E+ TG+
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           + G+G   A K +K   L   R  V+      EV+ L 
Sbjct: 34  LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILR 84
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E ++ G L + L  +   L      +       G+ 
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 143
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S+ + + D K  NI LLD        KL DFG+A     G++      + GT  +
Sbjct: 144 YLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 198
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 199 VAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVGTY 268
           +GL ++H     VI+RD K SN+L++     K+ DFG+A+       +  +  T  V T 
Sbjct: 169 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 269 GYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRR 302
            Y APE +++ H  T   D++S G +  E+L  R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 109/295 (36%), Gaps = 72/295 (24%)
Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P DE   C+ L +   + +      +    LG G FG V    IE +     K  +  TV
Sbjct: 2   PLDEH--CERLPYDASKWEFPRDRLKLGKPLGRGAFGQV----IEADAFGIDKTATCRTV 55
Query: 131 AVKSLKPDGLQG-HREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVY-EFMTRGSLE 187
           AVK LK       HR  ++E+  L  + HH N+V L+G C +    L+V  EF   G+L 
Sbjct: 56  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 115
Query: 188 NHL----------------FRR------TIPLPWSNRI----------KIALGAAKGLAF 215
            +L                FR+       IP+    R+                 K L+ 
Sbjct: 116 TYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175
Query: 216 LHGGSEPV-IYRDFKT------------------------------SNILLDSEYNAKLS 244
           +     P  +Y+DF T                               NILL  +   K+ 
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           DFGLA+   +               + APE +     T +SDV+SFGV+L EI +
Sbjct: 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 88  LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREW 146
           ++    +  P   LG G +G V     E+    P    SG  +AVK ++     Q  +  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVV-----EKMRHVP----SGQIMAVKRIRATVNSQEQKRL 52
Query: 147 VAEVDF-LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI----PLPWSN 201
           + ++D  +  +  P  V   G    +    +  E M      +  +++ I     +P   
Sbjct: 53  LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSL--DKFYKQVIDKGQTIPEDI 110
Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
             KIA+   K L  LH     VI+RD K SN+L+++    K+ DFG++          + 
Sbjct: 111 LGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169
Query: 262 TRVVGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
               G   Y APE +       G+ + KSD++S G+ ++E+   R   D           
Sbjct: 170 A---GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD----------- 214
Query: 317 AWARQYLADKRKLYQIVD---PRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           +W   +    ++L Q+V+   P+L  + +S + V   SQ    CL ++ K RP+  E+++
Sbjct: 215 SWGTPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPELMQ 266

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 25/259 (9%)
Query: 125 GSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD--QRLLVYEFMT 182
           G+ I V V  ++    +  R++  E   L    HPN++ ++G C         L+  +  
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 183 RGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRD-FKTSNILLDSEYN 240
            GSL N L   T   +  S  +K AL  A+G AFLH   EP+I R    + ++ +D +  
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXT 151
Query: 241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           A++S   +  +     + +    V        PE          +D +SF V+L E++T 
Sbjct: 152 ARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTN----RRSADXWSFAVLLWELVT- 206
Query: 301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD 360
                      E      +   +  K  L + + P +    S      VS+L   C + D
Sbjct: 207 ----------REVPFADLSNXEIGXKVAL-EGLRPTIPPGIS----PHVSKLXKICXNED 251
Query: 361 PKSRPSMDEVVKVLTPLQD 379
           P  RP  D +V +L   QD
Sbjct: 252 PAKRPKFDXIVPILEKXQD 270

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 31/271 (11%)
Query: 31  IPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKS 90
           +PR S + +AA   +    S +E      A    D      T  ++  QL QF    +K+
Sbjct: 15  VPRGSHMGNAAAAKK---GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQF--DRIKT 69
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEV 150
                     LG G FG V     +E+G   A         VK  + +     +  +  V
Sbjct: 70  ----------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
           +F      P LVKL  +  +D+  L +V E++  G + +HL RR       +    A   
Sbjct: 120 NF------PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQI 171
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
                +LH  S  +IYRD K  N+L+D +   +++DFG AK       T     + GT  
Sbjct: 172 VLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPE 224
Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           Y APE +++       D ++ GV++ E+  G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G FG V +  +++  T       G   AVK ++ +  +     V E+     L  P 
Sbjct: 82  VGRGSFGEVHR--MKDKQT-------GFQCAVKKVRLEVFR-----VEELVACAGLSSPR 127
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA-KGLAFLHGG 219
           +V L G   E     +  E +  GSL   L ++   LP  +R    LG A +GL +LH  
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLP-EDRALYYLGQALEGLEYLH-- 183
Query: 220 SEPVIYRDFKTSNILLDSEYN-AKLSDFGLAKA-GPQGDKTHVST--RVVGTYGYAAPEY 275
           +  +++ D K  N+LL S+ + A L DFG A    P G    + T   + GT  + APE 
Sbjct: 184 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 276 VMTGHLTSKSDVYSFGVVLLEILTG 300
           VM     +K D++S   ++L +L G
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+  FGLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILGFGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 38/213 (17%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA-- 206
           E++ L +L+HP ++K+  +   +D   +V E M  G     LF + +    + R+K A  
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVV---GNKRLKEATC 122
Query: 207 ----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTH 259
                     + +LH     +I+RD K  N+LL S+      K++DFG +K    G+ + 
Sbjct: 123 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 178
Query: 260 VSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG---------RRSMDKK 307
           + T + GT  Y APE ++   T       D +S GV+L   L+G         + S+  +
Sbjct: 179 MRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 237
Query: 308 RPSGEQNLV--AWAR--QYLADKRKLYQIVDPR 336
             SG+ N +   WA   +   D  K   +VDP+
Sbjct: 238 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 270

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 23/218 (10%)
Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWV 147
           S T  ++    LG+G F  V +           K  +G   A K +    L    H++  
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLE 51
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKI 205
            E      L HPN+V+L     E+    LV++ +T G L   +  R        S+ I+ 
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQ 111
Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVST 262
            L +       H     +++RD K  N+LL S+      KL+DFGLA    QGD+     
Sbjct: 112 ILESVN-----HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWF 164
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
              GT GY +PE +         D+++ GV+L  +L G
Sbjct: 165 GFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA-- 206
           E++ L +L+HP ++K+  +   +D   +V E M  G     LF + +    + R+K A  
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVV---GNKRLKEATC 115
Query: 207 ----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTH 259
                     + +LH     +I+RD K  N+LL S+      K++DFG +K   +   T 
Sbjct: 116 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 170
Query: 260 VSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG---------RRSMDKK 307
           +   + GT  Y APE ++   T       D +S GV+L   L+G         + S+  +
Sbjct: 171 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 230
Query: 308 RPSGEQNLV--AWAR--QYLADKRKLYQIVDPR 336
             SG+ N +   WA   +   D  K   +VDP+
Sbjct: 231 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 263

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA-- 206
           E++ L +L+HP ++K+  +   +D   +V E M  G     LF + +    + R+K A  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVV---GNKRLKEATC 116
Query: 207 ----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTH 259
                     + +LH     +I+RD K  N+LL S+      K++DFG +K   +   T 
Sbjct: 117 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 171
Query: 260 VSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG---------RRSMDKK 307
           +   + GT  Y APE ++   T       D +S GV+L   L+G         + S+  +
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 308 RPSGEQNLV--AWAR--QYLADKRKLYQIVDPR 336
             SG+ N +   WA   +   D  K   +VDP+
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA-- 206
           E++ L +L+HP ++K+  +   +D   +V E M  G     LF + +    + R+K A  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVV---GNKRLKEATC 116
Query: 207 ----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTH 259
                     + +LH     +I+RD K  N+LL S+      K++DFG +K   +   T 
Sbjct: 117 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 171
Query: 260 VSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG---------RRSMDKK 307
           +   + GT  Y APE ++   T       D +S GV+L   L+G         + S+  +
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 308 RPSGEQNLV--AWAR--QYLADKRKLYQIVDPR 336
             SG+ N +   WA   +   D  K   +VDP+
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA-- 206
           E++ L +L+HP ++K+  +   +D   +V E M  G     LF + +    + R+K A  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVG---NKRLKEATC 116
Query: 207 ----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTH 259
                     + +LH     +I+RD K  N+LL S+      K++DFG +K   +   T 
Sbjct: 117 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 171
Query: 260 VSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG---------RRSMDKK 307
           +   + GT  Y APE ++   T       D +S GV+L   L+G         + S+  +
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 308 RPSGEQNLV--AWAR--QYLADKRKLYQIVDPR 336
             SG+ N +   WA   +   D  K   +VDP+
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  Y  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  Y  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  Y  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ D GLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 23/218 (10%)
Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWV 147
           S T  ++    LG+G F  V +           K  +G   A K +    L    H++  
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLE 51
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKI 205
            E      L HPN+V+L     E+    LV++ +T G L   +  R        S+ I+ 
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQ 111
Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVST 262
            L +       H     +++RD K  N+LL S+      KL+DFGLA    QGD+     
Sbjct: 112 ILESVN-----HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWF 164
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
              GT GY +PE +         D+++ GV+L  +L G
Sbjct: 165 GFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   K++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H     +I+RD K SN+ ++ +   K+ D GLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA- 206
            E++ L +L+HP ++K+  +   +D   +V E M  G     LF + +    + R+K A 
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVG---NKRLKEAT 240
Query: 207 -----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKT 258
                      + +LH     +I+RD K  N+LL S+      K++DFG +K   +   T
Sbjct: 241 CKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 295
Query: 259 HVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG---------RRSMDK 306
            +   + GT  Y APE ++   T       D +S GV+L   L+G         + S+  
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355
Query: 307 KRPSGEQNLV--AWAR--QYLADKRKLYQIVDPR 336
           +  SG+ N +   WA   +   D  K   +VDP+
Sbjct: 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 99/265 (37%), Gaps = 70/265 (26%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQL-HH 158
           LG G FG V    IE +     K  +  TVAVK LK       HR  ++E+  L  + HH
Sbjct: 28  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 83
Query: 159 PNLVKLIGYCIEDDQRLLVY-EFMTRGSLENHL----------------FRR------TI 195
            N+V L+G C +    L+V  EF   G+L  +L                FR+       I
Sbjct: 84  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 143
Query: 196 PLPWSNRI----------KIALGAAKGLAFLHGGSEPV-IYRDFKT-------------- 230
           P+    R+                 K L+ +     P  +Y+DF T              
Sbjct: 144 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 203
Query: 231 ----------------SNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
                            NILL  +   K+ DFGLA+   +               + APE
Sbjct: 204 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 263
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT 299
            +     T +SDV+SFGV+L EI +
Sbjct: 264 TIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   K++DFGLAK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLAGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA- 206
            E++ L +L+HP ++K+  +   +D   +V E M  G     LF + +    + R+K A 
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVG---NKRLKEAT 254
Query: 207 -----LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKT 258
                      + +LH     +I+RD K  N+LL S+      K++DFG +K   +   T
Sbjct: 255 CKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 309
Query: 259 HVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTG---------RRSMDK 306
            +   + GT  Y APE ++   T       D +S GV+L   L+G         + S+  
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 369
Query: 307 KRPSGEQNLV--AWAR--QYLADKRKLYQIVDPR 336
           +  SG+ N +   WA   +   D  K   +VDP+
Sbjct: 370 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 403

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 42/240 (17%)
Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP--DGLQGHREWVAEVD 151
           N+    ++G G +GYV+  + ++N            VA+K +    + L   +  + E+ 
Sbjct: 29  NYEIKHLIGRGSYGYVYLAY-DKNANK--------NVAIKKVNRMFEDLIDCKRILREIT 79
Query: 152 FLGQLHHPNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
            L +L    +++L    I +D      L +   +    L+  LF+  I L   +   I  
Sbjct: 80  ILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKK-LFKTPIFLTEQHVKTILY 138
Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS------ 261
               G  F+H     +I+RD K +N LL+ + + K+ DFGLA+        H+       
Sbjct: 139 NLLLGEKFIHESG--IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEK 196
Query: 262 -----------------TRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRS 303
                            T  V T  Y APE ++   + T+  D++S G +  E+L   +S
Sbjct: 197 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG+G F  V +             G      + + K    + H++   E      L HPN
Sbjct: 19  LGKGAFSVVRR-------CVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL-AFLHGG 219
           +V+L     E+    L+++ +T G     LF   +   + +    +    + L A LH  
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 220 SEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
              V++R+ K  N+LL S+      KL+DFGLA    +G++        GT GY +PE +
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ-QAWFGFAGTPGYLSPEVL 185
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
                    D+++ GV+L  +L G
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVG 209

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFAEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 79  QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP 137
           Q L  T  E+     N  P   +G G +G V          A     +G+ VAVK L +P
Sbjct: 11  QELNKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP 58
Query: 138 -DGLQGHREWVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRLLVYEFMTRGSLENHLF 191
              +   +    E+  L  + H N++ L+        +E+   + +   +    L N   
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--I 116
Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
            +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ D GLA+ 
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDGGLARH 174
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                  +V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 175 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 159
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +GL ++H     +I+RD K SN+ ++ +   K+ DF LA+        +V+TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WY 188
Query: 271 AAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 60/311 (19%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-----WVAEVDFLGQ 155
           +G+G FG VFK    + G   A            LK   ++  +E      + E+  L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVA------------LKKVLMENEKEGFPITALREIKILQL 73
Query: 156 LHHPNLVKLIGYCIED--------DQRLLVYEFMTR---GSLENHLFRRTIPLPWSNRIK 204
           L H N+V LI  C               LV++F      G L N L + T+    S   +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVS 261
           +      GL ++H     +++RD K +N+L+  +   KL+DFGLA+A             
Sbjct: 130 VMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
            RVV T  Y  PE ++         D++  G ++ E+ T    M   + + EQ+ +A   
Sbjct: 188 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM---QGNTEQHQLALIS 243
Query: 321 QYL----------ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           Q             D  +LY+    +LEL   +KG ++  +       RDP +   +D++
Sbjct: 244 QLCGSITPEVWPNVDNYELYE----KLEL---VKGQKRKVKDRLKAYVRDPYALDLIDKL 296
Query: 371 VKVLTPLQDLN 381
           + VL P Q ++
Sbjct: 297 L-VLDPAQRID 306

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 22/224 (9%)
Query: 85  FQELKSAT---GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ 141
           FQ + + T    +++    LG+G F  V +            P       + + K    +
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRR-------CVKKTPTQEYAAKIINTKKLSAR 72
Query: 142 GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPW 199
            H++   E      L HPN+V+L     E+    LV++ +T G L   +  R        
Sbjct: 73  DHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADA 132
Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGD 256
           S+ I   L +       H     +++RD K  N+LL S+      KL+DFGLA    QG+
Sbjct: 133 SHCIHQILESVN-----HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGE 186
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           +        GT GY +PE +         D+++ GV+L  +L G
Sbjct: 187 Q-QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 114/274 (41%), Gaps = 37/274 (13%)
Query: 31  IPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKS 90
           +PR S + +AA   +    S +E      A    D      T  ++  QL QF    +K+
Sbjct: 15  VPRGSHMGNAAAAKK---GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQF--DRIKT 69
Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEV 150
                     LG G FG V     +E+G   A         VK  + +     +  +  V
Sbjct: 70  ----------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
           +F      P LVKL  +  +D+  L +V E++  G + +HL RR       +    A   
Sbjct: 120 NF------PFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQI 171
Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVG 266
                +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + G
Sbjct: 172 VLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 221
Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG+G +G V+ G    N          + +A+K +     +  +    E+     L H 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---GLAFL 216
           N+V+ +G   E+    +  E +  GSL   L  +  PL   N   I     +   GL +L
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK-DNEQTIGFYTKQILEGLKYL 124
Query: 217 HGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAP 273
           H     +++RD K  N+L+++     K+SDFG +K  AG        +    GT  Y AP
Sbjct: 125 HDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG----INPCTETFTGTLQYMAP 178
Query: 274 EYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
           E +  G       +D++S G  ++E+ TG+
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLXGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 97
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 98  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLH-- 153
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 205
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 206 LSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 89
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 90  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 145
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 197
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 198 LSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 15/101 (14%)
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG------DKTHVS--- 261
           + L+++H  S+ +I+R+ K  NI +D   N K+ DFGLAK   +       D  ++    
Sbjct: 127 EALSYIH--SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 262 ---TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEIL 298
              T  +GT  Y A E +  TGH   K D YS G++  E +
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 134/314 (42%), Gaps = 50/314 (15%)
Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ--LH 157
           +G+G +G V+ G W             G  VAVK            W  E +      + 
Sbjct: 45  IGKGRYGEVWMGKW------------RGEKVAVKVF---FTTEEASWFRETEIYQTVLMR 89
Query: 158 HPNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           H N++  I   I+      Q  L+ ++   GSL ++L  ++  L   + +K+A  +  GL
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGL 147
Query: 214 AFLHG------GSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHV--STRV 264
             LH       G   + +RD K+ NIL+       ++D GLA K     ++  +  +TR 
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR- 206
Query: 265 VGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEILTGRRSMDKKRPSGEQ----N 314
           VGT  Y  PE     +   H  S   +D+YSFG++L E+   RR +        Q    +
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHD 264
Query: 315 LVAWARQYLADKRKLYQI--VDPRLELNYSL-KGVQKVSQLAYNCLSRDPKSRPSMDEVV 371
           LV     Y  D R++  I  + P     +S  + ++++ +L   C + +P SR +   V 
Sbjct: 265 LVPSDPSY-EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 372 KVLTPLQDLNDLAI 385
           K L  + +  D+ +
Sbjct: 324 KTLAKMSESQDIKL 337

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
              +LH  S  +IYRD K  N+L+D +   +++DFG AK       T     + GT  Y 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYL 206
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE +++       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG 154
           F     LG G FG V     +E G   A         VK  + +     +  +  V+F  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-- 101
Query: 155 QLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
               P LVKL  +  +D+  L +V E++  G + +HL RR       +    A       
Sbjct: 102 ----PFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTF 155
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGY 270
            +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y
Sbjct: 156 EYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 205
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE +++       D ++ GV++ E+  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 203
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 203
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 17/182 (9%)
Query: 127 GITVAVKSL-KPDGLQGH-REWVAEVDFLGQLHHPNLVKLIGY-----CIEDDQRL-LVY 178
           GI VAVK L +P   Q H +    E+  L  ++H N++ L+        +E+ Q + LV 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 179 EFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE 238
           E M      N      + L       +      G+  LH     +I+RD K SNI++ S+
Sbjct: 109 ELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 162
Query: 239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
              K+ DFGLA+         + T  V T  Y APE ++     +  D++S G ++ E++
Sbjct: 163 CTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV 219
Query: 299 TG 300
            G
Sbjct: 220 KG 221

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E G   A         VK  + +     +  +  V+F      P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 95
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 151
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 203
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 16/149 (10%)
Query: 156 LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ P LVKL  +  +D+  L +V E+   G + +HL RR       +    A        
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVLEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFE 156
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYA 271
           +LH  S  +IYRD K  N+L+D +   K++DFG AK         V  R   + GT  Y 
Sbjct: 157 YLH--SLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYL 206
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE +++       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 60/311 (19%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-----WVAEVDFLGQ 155
           +G+G FG VFK    + G   A            LK   ++  +E      + E+  L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVA------------LKKVLMENEKEGFPITALREIKILQL 73
Query: 156 LHHPNLVKLIGYCIEDDQ--------RLLVYEFMTR---GSLENHLFRRTIPLPWSNRIK 204
           L H N+V LI  C               LV++F      G L N L + T+    S   +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVS 261
           +      GL ++H     +++RD K +N+L+  +   KL+DFGLA+A             
Sbjct: 130 VMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
            RVV T  Y  PE ++         D++  G ++ E+ T    M   + + EQ+ +A   
Sbjct: 188 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM---QGNTEQHQLALIS 243
Query: 321 QYL----------ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           Q             D  +LY+    +LEL   +KG ++  +       RDP +   +D++
Sbjct: 244 QLCGSITPEVWPNVDNYELYE----KLEL---VKGQKRKVKDRLKAYVRDPYALDLIDKL 296
Query: 371 VKVLTPLQDLN 381
           + VL P Q ++
Sbjct: 297 L-VLDPAQRID 306

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 203
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 116 LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 173
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 174 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 223
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 60/311 (19%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-----WVAEVDFLGQ 155
           +G+G FG VFK    + G   A            LK   ++  +E      + E+  L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVA------------LKKVLMENEKEGFPITALREIKILQL 73
Query: 156 LHHPNLVKLIGYCIED--------DQRLLVYEFMTR---GSLENHLFRRTIPLPWSNRIK 204
           L H N+V LI  C               LV++F      G L N L + T+    S   +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVS 261
           +      GL ++H     +++RD K +N+L+  +   KL+DFGLA+A             
Sbjct: 130 VMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
            RVV T  Y  PE ++         D++  G ++ E+ T    M   + + EQ+ +A   
Sbjct: 188 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM---QGNTEQHQLALIS 243
Query: 321 QYL----------ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           Q             D  +LY+    +LEL   +KG ++  +       RDP +   +D++
Sbjct: 244 QLCGSITPEVWPNVDNYELYE----KLEL---VKGQKRKVKDRLKAYVRDPYALDLIDKL 296
Query: 371 VKVLTPLQDLN 381
           + VL P Q ++
Sbjct: 297 L-VLDPAQRID 306

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E G   A         VK  + +     +  +  V+F      P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 95
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLH-- 151
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 203
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 60/311 (19%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-----WVAEVDFLGQ 155
           +G+G FG VFK    + G   A            LK   ++  +E      + E+  L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVA------------LKKVLMENEKEGFPITALREIKILQL 72
Query: 156 LHHPNLVKLIGYCIED--------DQRLLVYEFMTR---GSLENHLFRRTIPLPWSNRIK 204
           L H N+V LI  C               LV++F      G L N L + T+    S   +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 128
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVS 261
           +      GL ++H     +++RD K +N+L+  +   KL+DFGLA+A             
Sbjct: 129 VMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
            RVV T  Y  PE ++         D++  G ++ E+ T    M   + + EQ+ +A   
Sbjct: 187 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM---QGNTEQHQLALIS 242
Query: 321 QYL----------ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
           Q             D  +LY+    +LEL   +KG ++  +       RDP +   +D++
Sbjct: 243 QLCGSITPEVWPNVDNYELYE----KLEL---VKGQKRKVKDRLKAYVRDPYALDLIDKL 295
Query: 371 VKVLTPLQDLN 381
           + VL P Q ++
Sbjct: 296 L-VLDPAQRID 305

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   K++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   K++DFG AK         V  R   + GT 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTP 203
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 81  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 138
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
              +LH  S  +IYRD K  N+L+D +   +++DFG AK       T     + GT  Y 
Sbjct: 139 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYL 191
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE +++       D ++ GV++ E+  G
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+++D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 ISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 203
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   +++DFGLAK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   K++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 39/231 (16%)
Query: 84  TFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KP--DGL 140
           T  E+++   + +P   +G G +G V          +     +G  VA+K L +P    L
Sbjct: 19  TAWEVRAVYRDLQP---VGSGAYGAV---------CSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 141 QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD------QRLLVYEFM--TRGSLENHLFR 192
              R +  E+  L  + H N++ L+     D+         LV  FM    G L  H   
Sbjct: 67  FAKRAY-RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--- 122
Query: 193 RTIPLPWSNRIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
                   +RI+ +     KGL ++H     +I+RD K  N+ ++ +   K+ DFGLA+ 
Sbjct: 123 ---EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGR 301
                   V TR      Y APE ++     T   D++S G ++ E++TG+
Sbjct: 178 ADSEMXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E++  G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ ++  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 127 GITVAVKSL-KPDGLQGH-REWVAEVDFLGQLHHPNLVKLIGY-----CIEDDQRL-LVY 178
           GI VAVK L +P   Q H +    E+  L  ++H N++ L+        +E+ Q + LV 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 179 EFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE 238
           E M      N      + L       +      G+  LH     +I+RD K SNI++ S+
Sbjct: 107 ELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 160
Query: 239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
              K+ DFGLA+         + T  V T  Y APE ++        D++S G ++ E++
Sbjct: 161 CTLKILDFGLART---ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217
Query: 299 TG 300
            G
Sbjct: 218 KG 219

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V       EV  L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           Q+ HPN++ L          +L+ E ++ G L + L ++   L              G+ 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  ++ + + D K  NI LLD      + KL DFGLA     G +      + GT  +
Sbjct: 130 YLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPAF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 193
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           ++ +G G +G V             + G+ I  A K +    ++    +  E++ +  L 
Sbjct: 14  ENTIGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN+++L     ++    LV E  T G L   +  + +    S+  +I       +A+ H
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH 123
Query: 218 GGSEPVIYRDFKTSNILL--DS-EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
             +  V +RD K  N L   DS +   KL DFGLA     G         VGT  Y +P+
Sbjct: 124 KLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ 178
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTG 300
            V+ G    + D +S GV++  +L G
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR-----I 203
           E+  L +L HPN++KL        +  LV E +T G L + +  +     +S R     +
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAV 154
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHV 260
           K  L A   +A+LH     +++RD K  N+L  +   +   K++DFGL+K     +   +
Sbjct: 155 KQILEA---VAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVL 206
Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
              V GT GY APE +       + D++S G++   +L G
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           ++ +G G +G V             + G+ I  A K +    ++    +  E++ +  L 
Sbjct: 31  ENTIGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 81
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN+++L     ++    LV E  T G L   +  + +    S+  +I       +A+ H
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH 140
Query: 218 GGSEPVIYRDFKTSNILL--DS-EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
             +  V +RD K  N L   DS +   KL DFGLA     G         VGT  Y +P+
Sbjct: 141 KLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ 195
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTG 300
            V+ G    + D +S GV++  +L G
Sbjct: 196 -VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 18/148 (12%)
Query: 152 FLGQLHHPNLVKLIGYCIEDDQR-----LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
           FL ++ HP++V++  +    D+       +V E++   SL+    ++   LP +  I   
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYL 188
Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           L     L++LH  S  ++Y D K  NI+L +E   KL D G         + +    + G
Sbjct: 189 LEILPALSYLH--SIGLVYNDLKPENIML-TEEQLKLIDLGAVS------RINSFGYLYG 239
Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVL 294
           T G+ APE V TG  T  +D+Y+ G  L
Sbjct: 240 TPGFQAPEIVRTGP-TVATDIYTVGRTL 266

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-H 158
           +LGEG +  V      +NG            AVK ++            EV+ L Q   +
Sbjct: 20  LLGEGAYAKVQGAVSLQNGK---------EYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 159 PNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
            N+++LI +  EDD R  LV+E +  GS+  H+ ++          ++    A  L FLH
Sbjct: 71  KNILELIEF-FEDDTRFYLVFEKLQGGSILAHI-QKQKHFNEREASRVVRDVAAALDFLH 128
Query: 218 GGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDK-----THVSTRVVGTYG 269
             ++ + +RD K  NIL +S       K+ DF L       +      T   T   G+  
Sbjct: 129 --TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 270 YAAPEY--VMTGHLT---SKSDVYSFGVVLLEILTG 300
           Y APE   V T   T    + D++S GVVL  +L+G
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    +   VV  Y Y 
Sbjct: 140 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVVTRY-YR 194
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTG 300
           APE ++        D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 48/293 (16%)
Query: 94  NFRPDSILGEGGFG-YVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           +F P  +LG G  G  V++G  +              VAVK + P+          EV  
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRD-----------VAVKRILPECFSFADR---EVQL 70
Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEF-MTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
           L +   HPN+++   +C E D++       +   +L+ ++ ++         I +     
Sbjct: 71  LRESDEHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTT 128
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLD-----SEYNAKLSDFGLAKAGPQGDKTHVSTR-- 263
            GLA LH  S  +++RD K  NIL+       +  A +SDFGL K    G   H  +R  
Sbjct: 129 SGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG--RHSFSRRS 184
Query: 264 -VVGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
            V GT G+ APE +      + T   D++S G V   +++       K    + N++  A
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                   + ++ V  R              +L    ++ DP+ RPS   V+K
Sbjct: 245 CSLDCLHPEKHEDVIAR--------------ELIEKMIAMDPQKRPSAKHVLK 283

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P LVKL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 95  LQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 152
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLH--SLDLIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT  Y AP  +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPAII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 185
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 303
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 304 SVDDALQ 310

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P L KL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   K++DFG AK         V  R   + GT 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTP 203
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P L KL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   K++DFG AK         V  R   + GT 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTP 203
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 65/147 (44%), Gaps = 8/147 (5%)
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           HPN+VKL     +     LV E +  G L   + ++      +    I       ++ +H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 218 GGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
                V++RD K  N+L   E +    K+ DFG A+  P  D   + T    T  YAAPE
Sbjct: 124 DVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAAPE 179
Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGR 301
            +         D++S GV+L  +L+G+
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 230
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEIL------TGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E++       GR  +D+     EQ           L
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 348
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 349 SVDDALQ 355

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    +   VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT------GRRSMDKKRPSGEQ 313
           APE ++        D++S G ++ E++       GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 153 LGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           L  ++ P L KL  +  +D+  L +V E+   G + +HL RR       +    A     
Sbjct: 96  LQAVNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARFYAAQIVL 153
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTY 268
              +LH  S  +IYRD K  N+++D +   K++DFG AK         V  R   + GT 
Sbjct: 154 TFEYLH--SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTP 203
Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            Y APE +++       D ++ GV++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 186
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 246
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 247 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 304
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 305 SVDDALQ 311

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 230
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEIL------TGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E++       GR  +D+     EQ           L
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 348
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 349 SVDDALQ 355

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 185
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 303
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 304 SVDDALQ 310

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 310
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 311 SVDDALQ 317

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 186
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 246
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 247 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 304
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 305 SVDDALQ 311

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 193
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 253
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 254 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 311
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 312 SVDDALQ 318

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 193
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 253
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 254 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 311
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 312 SVDDALQ 318

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 310
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 311 SVDDALQ 317

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 137 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 191
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEIL------TGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E++       GR  +D+     EQ           L
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 251
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 252 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 309
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 310 SVDDALQ 316

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEIL------TGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E++       GR  +D+     EQ           L
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 310
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 311 SVDDALQ 317

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLE------ILTGRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E      +  GR  +D+     EQ           L
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 310
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 311 SVDDALQ 317

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT------GRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E++       GR  +D+     EQ           L
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 310
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 311 SVDDALQ 317

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT------GRRSMDKKRPSGEQ----------NL 315
           APE ++        D++S G ++ E++       GR  +D+     EQ           L
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 316 VAWARQYLADKRKLYQIVDPRL----------ELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
               R Y+ ++ K   +  P+L          E N  LK  Q    L+   L  DP  R 
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN-KLKASQARDLLS-KMLVIDPAKRI 310
Query: 366 SMDEVVK 372
           S+D+ ++
Sbjct: 311 SVDDALQ 317

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LG G FG V     +E+G   A         VK  + +     +  +  V+F      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 161 LVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           LVKL  +  +D+  L +V E++  G + +HL RR       +    A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR---VVGTYGYAAPEYV 276
           S  +IYRD K  N+L+D +   +++DFG AK         V  R   + GT    APE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEALAPEII 210
Query: 277 MTGHLTSKSDVYSFGVVLLEILTG 300
           ++       D ++ GV++ E+  G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGKFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 18  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 127
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 128 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 182
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 18  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 127
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 128 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 182
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 107/267 (40%), Gaps = 38/267 (14%)
Query: 39  DAATETRYLNASN----RELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGN 94
           D  TE  Y  + +    R +    EA  +  +P     D   P    Q +FQ L      
Sbjct: 12  DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPG---YDPSRPESFFQQSFQRL------ 62
Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP-DGLQGHREWVAEV--- 150
               S LG G +G VFK   +E+G         +    +S+ P  G +     +AEV   
Sbjct: 63  ----SRLGHGSYGEVFKVRSKEDGR--------LYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
           + +GQ  HP  V+L     E+   L +   +   SL+ H       LP +          
Sbjct: 111 EKVGQ--HPCCVRL-EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             LA LH  S+ +++ D K +NI L      KL DFGL           V     G   Y
Sbjct: 168 LALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRY 222
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEI 297
            APE ++ G   + +DV+S G+ +LE+
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEV 248

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 16/185 (8%)
Query: 126 SGITVAVKSLKPDGLQGHREWVA------EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYE 179
           +G+  A K +K    +  R  V+      EV  L ++ HPN++ L          +L+ E
Sbjct: 35  TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94
Query: 180 FMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNI-LLDSE 238
            +  G L + L  +   L      +       G+ +LH  S  + + D K  NI LLD  
Sbjct: 95  LVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRN 151
Query: 239 Y---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 295
                 K+ DFGLA     G++      + GT  + APE V    L  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 296 EILTG 300
            +L+G
Sbjct: 209 ILLSG 213

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 33/176 (18%)
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
           KIA+   K L  LH     VI+RD K SN+L+++    K  DFG++          +   
Sbjct: 140 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA- 197
Query: 264 VVGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW 318
             G   Y APE +       G+ + KSD++S G+  +E+   R   D           +W
Sbjct: 198 --GCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILRFPYD-----------SW 243
Query: 319 ARQYLADKRKLYQIVD---PRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEV 370
              +    ++L Q+V+   P+L  + +S + V   SQ    CL ++ K RP+  E+
Sbjct: 244 GTPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPEL 291

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 90  SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK----PDGLQGHRE 145
           ++   +R  + LGEG +G V+K              +  TVA+K ++     +G+ G   
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKA---------IDTVTNETVAIKRIRLEHEEEGVPGTA- 80
Query: 146 WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLP-WSNRI- 203
            + EV  L +L H N+++L      + +  L++E+      EN L +     P  S R+ 
Sbjct: 81  -IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVI 134
Query: 204 -KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD----SEYNA-KLSDFGLAKAGPQGDK 257
                    G+ F H  S   ++RD K  N+LL     SE    K+ DFGLA+A   G  
Sbjct: 135 KSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIP 190
Query: 258 THVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEIL 298
               T  + T  Y  PE ++ + H ++  D++S   +  E+L
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    +   VV  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRY-YR 192
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT------GRRSMDKKRPSGEQ 313
           APE ++        D++S G ++ E++       GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 186
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT------GRRSMDKKRPSGEQ 313
           APE ++        D++S G ++ E++       GR  +D+     EQ
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+  LH     +I+RD K SNI++ S+   K+ DFGLA+    G    ++  VV  Y Y 
Sbjct: 143 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 197
Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT------GRRSMDKKRPSGEQ 313
           APE ++        D++S G ++ E++       GR  +D+     EQ
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 16/186 (8%)
Query: 125 GSGITVAVKSLKPDGLQGHREWVA------EVDFLGQLHHPNLVKLIGYCIEDDQRLLVY 178
            +G+  A K +K    +  R  V+      EV  L ++ HPN++ L          +L+ 
Sbjct: 34  STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93
Query: 179 EFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNI-LLDS 237
           E +  G L + L  +   L      +       G+ +LH  S  + + D K  NI LLD 
Sbjct: 94  ELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDR 150
Query: 238 EY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 294
                  K+ DFGLA     G++      + GT  + APE V    L  ++D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 295 LEILTG 300
             +L+G
Sbjct: 208 YILLSG 213

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 76/314 (24%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA---- 148
             +R   +LG+GGFG VF G          +    + VA+K +  + + G   W      
Sbjct: 31  AEYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLG---WSPLSDS 78
Query: 149 -----EVDFLGQLH----HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPW 199
                EV  L ++     HP +++L+ +    +  +LV E   R      LF        
Sbjct: 79  VTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYI----- 130
Query: 200 SNRIKIALGAAKGL------AFLHGGSEPVIYRDFKTSNILLDSEYN-AKLSDFGLAKAG 252
           + +  +  G ++        A  H  S  V++RD K  NIL+D     AKL DFG     
Sbjct: 131 TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG----- 185
Query: 253 PQGDKTHVS--TRVVGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMDKKRP 309
             G   H    T   GT  Y+ PE++      +  + V+S G++L +++ G    ++   
Sbjct: 186 -SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER--- 241
Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
             +Q ++                     EL++          L   CL+  P SRPS++E
Sbjct: 242 --DQEIL-------------------EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEE 280
Query: 370 VVK---VLTPLQDL 380
           ++    + TP +D+
Sbjct: 281 ILLDPWMQTPAEDV 294

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRI--KI 205
           E      L HP++V+L+     D    +V+EFM    L   + +R      +S  +    
Sbjct: 78  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 137
Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA---KLSDFGLAKAGPQGDKTHVST 262
                + L + H  +  +I+RD K   +LL S+ N+   KL  FG+A     G+   V+ 
Sbjct: 138 MRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAG 193
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
             VGT  + APE V         DV+  GV+L  +L+G
Sbjct: 194 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 87  ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW 146
           +L S   + +P   LG GG G VF                   VA+K +     Q  +  
Sbjct: 8   DLGSRYMDLKP---LGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHA 55
Query: 147 VAEVDFLGQLHHPNLVKL--------------IGYCIEDDQRLLVYEFMTRGSLENHLFR 192
           + E+  + +L H N+VK+              +G   E +   +V E+M    L N L +
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ 114
Query: 193 RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAK- 250
              PL   +         +GL ++H  +  V++RD K +N+ +++E    K+ DFGLA+ 
Sbjct: 115 G--PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 251 AGPQ-GDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR 301
             P    K H+S  +V T  Y +P  +++  + T   D+++ G +  E+LTG+
Sbjct: 171 MDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 23/169 (13%)
Query: 149 EVDFLGQLH-HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK--- 204
           EV+ L Q   H N+++LI +  E+D+  LV+E M  GS+ +H+ +R       N ++   
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASV 115
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKA-GPQGDKTHV 260
           +    A  L FLH  ++ + +RD K  NIL +        K+ DFGL       GD + +
Sbjct: 116 VVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPI 173
Query: 261 ST----RVVGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEILTG 300
           ST       G+  Y APE V            + D++S GV+L  +L+G
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 83/173 (47%), Gaps = 30/173 (17%)
Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY---NAKLSDFGLAKAGPQGDKTH 259
           I++     +G+ +LH  +  +++ D K  NILL S Y   + K+ DFG+++      +  
Sbjct: 134 IRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR 191
Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
               ++GT  Y APE +    +T+ +D+++ G++   +LT           GE       
Sbjct: 192 ---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF-----VGE------- 236
Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMD 368
                D ++ Y  +  ++ ++YS +    VSQLA +     L ++P+ RP+ +
Sbjct: 237 -----DNQETYLNIS-QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 144 REWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR 202
           R+   E++ L +   HPN++ L     +     +V E M  G L + + R+     +S R
Sbjct: 60  RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSER 116
Query: 203 --IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NAKLSDFGLAKAGPQGD 256
               +     K + +LH  ++ V++RD K SNIL   E     + ++ DFG AK     +
Sbjct: 117 EASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
              ++     T  + APE +      +  D++S GV+L  +LTG
Sbjct: 175 GLLMTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRI--KI 205
           E      L HP++V+L+     D    +V+EFM    L   + +R      +S  +    
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA---KLSDFGLAKAGPQGDKTHVST 262
                + L + H  +  +I+RD K   +LL S+ N+   KL  FG+A     G+   V+ 
Sbjct: 136 MRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAG 191
Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
             VGT  + APE V         DV+  GV+L  +L+G
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           ++ HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S  + + D K  NI LLD        K+ DFGLA     G++      + GT  +
Sbjct: 129 YLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 162 VKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP------WSNRIKIALGAAKGLA 214
           +  + Y  +DD  L LV ++   G L   L +    LP      +   + IA+ +   L 
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           ++H        RD K  NIL+D   + +L+DFG +      D T  S+  VGT  Y +PE
Sbjct: 196 YVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 275 YVMT-----GHLTSKSDVYSFGVVLLEILTGR 301
            +       G    + D +S GV + E+L G 
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 23/169 (13%)
Query: 149 EVDFLGQLHHPNLVKL--IGYCIEDDQRLLVYEF----------MTRGSLENHLFRRTIP 196
           E+  L +L HPN++ L  +     D +  L++++            R S  N   ++ + 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQ 124
Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NAKLSDFGLAKAG 252
           LP      +      G+ +LH     V++RD K +NIL+  E       K++D G A+  
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 253 PQGDKTHVSTR-VVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILT 299
               K       VV T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/300 (21%), Positives = 123/300 (41%), Gaps = 51/300 (17%)
Query: 99  SILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
            ++G+G FG V+ G W  E           + + +  ++ D     + +  EV    Q  
Sbjct: 39  ELIGKGRFGQVYHGRWHGE-----------VAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H N+V  +G C+      ++       +L + +    I L  +   +IA    KG+ +LH
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGL------AKAGPQGDKTHVSTRVVGTYGYA 271
             ++ ++++D K+ N+  D+     ++DFGL       +AG + DK  +     G   + 
Sbjct: 148 --AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN---GWLCHL 201
Query: 272 APEYVMTGH---------LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
           APE +              +  SDV++ G +  E L  R    K +P+     + W    
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQPA---EAIIWQ--- 254
Query: 323 LADKRKLYQIVDPRLELNYSLKGVQK-VSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN 381
                     +   ++ N S  G+ K +S +   C + + + RP+  +++ +L  L   N
Sbjct: 255 ----------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 56/304 (18%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-H 158
           ++ E   GY   G +   G+   +P     VAVK +  D        + E+  L +   H
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRP-----VAVKRMLIDFCDIA---LMEIKLLTESDDH 68
Query: 159 PNLVKLIGYCIEDDQRLLVYEF-MTRGSLENHLFRRTIP------LPWSNRIKIALGAAK 211
           PN+++   YC E   R L     +   +L++ +  + +           N I +    A 
Sbjct: 69  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLD--SEYNAK-----------LSDFGLAK---AGPQG 255
           G+A LH  S  +I+RD K  NIL+   S + A            +SDFGL K   +G   
Sbjct: 127 GVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGH-------LTSKSDVYSFGVVLLEILTGRRSMDKKR 308
            +T+++    GT G+ APE +   +       LT   D++S G V   IL+  +     +
Sbjct: 185 FRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
            S E N++          R ++ + + +   + SL  + + + L    +  DP  RP+  
Sbjct: 244 YSRESNII----------RGIFSLDEMKCLHDRSL--IAEATDLISQMIDHDPLKRPTAM 291
Query: 369 EVVK 372
           +V++
Sbjct: 292 KVLR 295

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 45/230 (19%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---- 211
           L HPN+V+     +      +V E+ + G     LF R       N  + +   A+    
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERI-----CNAGRFSEDEARFFFQ 122
Query: 212 ----GLAFLHGGSEPVIYRDFKTSNILLDSE--YNAKLSDFGLAKAGPQGDKTHVSTRVV 265
               G+++ H     V +RD K  N LLD       K++DFG +KA     +       V
Sbjct: 123 QLISGVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---PKSAV 177
Query: 266 GTYGYAAPEYVMTGHLTSK-SDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           GT  Y APE ++      K +DV+S GV L  +L G    +   P   +N          
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED--PEEPKNF--------- 226
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR----DPKSRPSMDEV 370
            ++ +++I    L + Y++     +S    + +SR    DP  R S+ E+
Sbjct: 227 -RKTIHRI----LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 63/132 (47%), Gaps = 14/132 (10%)
Query: 172 DQRLLVYEFMTRGSL---ENHLF----RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVI 224
           D+  ++YE+M   S+   + + F      T  +P      I        +++H   + + 
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNIC 174
Query: 225 YRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM--TGHLT 282
           +RD K SNIL+D     KLSDFG  ++    DK    +R  GTY +  PE+    + +  
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFG--ESEYMVDKKIKGSR--GTYEFMPPEFFSNESSYNG 230
Query: 283 SKSDVYSFGVVL 294
           +K D++S G+ L
Sbjct: 231 AKVDIWSLGICL 242

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 50/299 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-H 158
           ++ E   GY   G +   G+   +P     VAVK +  D        + E+  L +   H
Sbjct: 35  VVSEKILGYGSSGTVVFQGSFQGRP-----VAVKRMLIDFCDIA---LMEIKLLTESDDH 86
Query: 159 PNLVKLIGYCIEDDQRLLVYEF-MTRGSLENHLFRRTIP------LPWSNRIKIALGAAK 211
           PN+++   YC E   R L     +   +L++ +  + +           N I +    A 
Sbjct: 87  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLD--SEYNAK-----------LSDFGLAKAGPQGDKT 258
           G+A LH  S  +I+RD K  NIL+   S + A            +SDFGL K    G   
Sbjct: 145 GVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 259 HVST--RVVGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
                    GT G+ APE +       LT   D++S G V   IL+  +     + S E 
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           N++          R ++ + + +   + SL  + + + L    +  DP  RP+  +V++
Sbjct: 263 NII----------RGIFSLDEMKCLHDRSL--IAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 50/299 (16%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-H 158
           ++ E   GY   G +   G+   +P     VAVK +  D        + E+  L +   H
Sbjct: 35  VVSEKILGYGSSGTVVFQGSFQGRP-----VAVKRMLIDFCDIA---LMEIKLLTESDDH 86
Query: 159 PNLVKLIGYCIEDDQRLLVYEF-MTRGSLENHLFRRTIP------LPWSNRIKIALGAAK 211
           PN+++   YC E   R L     +   +L++ +  + +           N I +    A 
Sbjct: 87  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLD--SEYNAK-----------LSDFGLAKAGPQGDKT 258
           G+A LH  S  +I+RD K  NIL+   S + A            +SDFGL K    G   
Sbjct: 145 GVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 259 HVST--RVVGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ 313
                    GT G+ APE +       LT   D++S G V   IL+  +     + S E 
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           N++          R ++ + + +   + SL  + + + L    +  DP  RP+  +V++
Sbjct: 263 NII----------RGIFSLDEMKCLHDRSL--IAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 47/231 (20%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---- 211
           L HPN+V+     +      ++ E+ + G L   +          N  + +   A+    
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI---------CNAGRFSEDEARFFFQ 123
Query: 212 ----GLAFLHGGSEPVIYRDFKTSNILLDSE--YNAKLSDFGLAKAGPQGDKTHVSTRVV 265
               G+++ H  S  + +RD K  N LLD       K+ DFG +K+     +   +   V
Sbjct: 124 QLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---V 178
Query: 266 GTYGYAAPEYVMTGHLTSK-SDVYSFGVVLLEILTGRRSM-DKKRPSGEQNLVAWARQYL 323
           GT  Y APE ++      K +DV+S GV L  +L G     D + P              
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR------------- 225
Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR----DPKSRPSMDEV 370
            D RK  Q +   L + YS+    ++S    + +SR    DP +R S+ E+
Sbjct: 226 -DYRKTIQRI---LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 97/232 (41%), Gaps = 44/232 (18%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP--DGLQGHREWVAEVDFLGQLH 157
           ++G G +G+V + + +              VA+K +    + L   +  + E+  L +L+
Sbjct: 60  LIGTGSYGHVCEAYDKLEKR---------VVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 158 HPNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
           H ++VK++   I  D      L V   +     +  LFR  + L   +   +      G+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKK-LFRTPVYLTELHIKTLLYNLLVGV 169
Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-------------GPQGDKTHV 260
            ++H     +++RD K +N L++ + + K+ DFGLA+               P+ D  ++
Sbjct: 170 KYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 261 STRV------------VGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEILT 299
            T              V T  Y APE + +  + T   DV+S G +  E+L 
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           Q+ H N++ L          +L+ E ++ G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  ++ + + D K  NI LLD      + KL DFGLA     G +      + GT  +
Sbjct: 130 YLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           Q+ H N++ L          +L+ E ++ G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  ++ + + D K  NI LLD      + KL DFGLA     G +      + GT  +
Sbjct: 130 YLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           Q+ H N++ L          +L+ E ++ G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  ++ + + D K  NI LLD      + KL DFGLA     G +      + GT  +
Sbjct: 130 YLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           Q+ H N++ L          +L+ E ++ G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  ++ + + D K  NI LLD      + KL DFGLA     G +      + GT  +
Sbjct: 130 YLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK--IALGAAKGLA 214
            HPN++ L     +     LV E M  G L + + R+     +S R    +     K + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF---FSEREASFVLHTIGKTVE 135
Query: 215 FLHGGSEPVIYRDFKTSNIL-LDSEYNA---KLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S+ V++RD K SNIL +D   N    ++ DFG AK   + +   + T    T  +
Sbjct: 136 YLH--SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTPCY-TANF 191
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE +         D++S G++L  +L G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 65/157 (41%), Gaps = 14/157 (8%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQ-----RLLVYEFMTRGSLENHLFRRTIPLPWSNRI 203
           E+  L   HHPN++ L    +  ++       LV E M R  L   +  + I +   +  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQ 137
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVST 262
                   GL  LH     V++RD    NILL    +  + DF LA+      +KTH  T
Sbjct: 138 YFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 263 RVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEIL 298
                  Y APE VM     T   D++S G V+ E+ 
Sbjct: 196 H----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 65/157 (41%), Gaps = 14/157 (8%)
Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQ-----RLLVYEFMTRGSLENHLFRRTIPLPWSNRI 203
           E+  L   HHPN++ L    +  ++       LV E M R  L   +  + I +   +  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQ 137
Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVST 262
                   GL  LH     V++RD    NILL    +  + DF LA+      +KTH  T
Sbjct: 138 YFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 263 RVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEIL 298
                  Y APE VM     T   D++S G V+ E+ 
Sbjct: 196 H----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 45/230 (19%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---- 211
           L HPN+V+     +      +V E+ + G     LF R       N  + +   A+    
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERI-----CNAGRFSEDEARFFFQ 122
Query: 212 ----GLAFLHGGSEPVIYRDFKTSNILLDSE--YNAKLSDFGLAKAGPQGDKTHVSTRVV 265
               G+++ H     V +RD K  N LLD       K+ DFG +K+     +       V
Sbjct: 123 QLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTV 177
Query: 266 GTYGYAAPEYVMTGHLTSK-SDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           GT  Y APE ++      K +DV+S GV L  +L G    +   P   +N          
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED--PEEPKNF--------- 226
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR----DPKSRPSMDEV 370
            ++ +++I    L + Y++     +S    + +SR    DP  R S+ E+
Sbjct: 227 -RKTIHRI----LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 23/169 (13%)
Query: 149 EVDFLGQLH-HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK--- 204
           EV+ L Q   H N+++LI +  E+D+  LV+E M  GS+ +H+ +R       N ++   
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASV 115
Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKA-GPQGDKTHV 260
           +    A  L FLH  ++ + +RD K  NIL +        K+ DF L       GD + +
Sbjct: 116 VVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 261 ST----RVVGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEILTG 300
           ST       G+  Y APE V            + D++S GV+L  +L+G
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK--IALGAAKGLA 214
            HPN++ L     +     LV E M  G L + + R+     +S R    +     K + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF---FSEREASFVLHTIGKTVE 135
Query: 215 FLHGGSEPVIYRDFKTSNIL-LDSEYNA---KLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  S+ V++RD K SNIL +D   N    ++ DFG AK   + +   + T    T  +
Sbjct: 136 YLH--SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTPCY-TANF 191
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE +         D++S G++L  +L G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 122/303 (40%), Gaps = 54/303 (17%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-H 158
           ++ E   GY   G +   G+   +P     VAVK +  D        + E+  L +   H
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRP-----VAVKRMLIDFCDIA---LMEIKLLTESDDH 68
Query: 159 PNLVKLIGYCIEDDQRLLVYEF-MTRGSLENHLFRRTIP------LPWSNRIKIALGAAK 211
           PN+++   YC E   R L     +   +L++ +  + +           N I +    A 
Sbjct: 69  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 212 GLAFLHGGSEPVIYRDFKTSNILLD--SEYNAK-----------LSDFGLAKAGPQGDKT 258
           G+A LH  S  +I+RD K  NIL+   S + A            +SDFGL K    G   
Sbjct: 127 GVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 259 HVST--RVVGTYGYAAPEYVMTGH-------LTSKSDVYSFGVVLLEILTGRRSMDKKRP 309
                    GT G+ APE +   +       LT   D++S G V   IL+  +     + 
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
           S E N++          R ++ + + +   + SL  + + + L    +  DP  RP+  +
Sbjct: 245 SRESNII----------RGIFSLDEMKCLHDRSL--IAEATDLISQMIDHDPLKRPTAMK 292
Query: 370 VVK 372
           V++
Sbjct: 293 VLR 295

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 45/230 (19%)
Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK---- 211
           L HPN+V+     +      +V E+ + G     LF R       N  + +   A+    
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERI-----CNAGRFSEDEARFFFQ 121
Query: 212 ----GLAFLHGGSEPVIYRDFKTSNILLDSE--YNAKLSDFGLAKAGPQGDKTHVSTRVV 265
               G+++ H     V +RD K  N LLD       K+ DFG +K+     +       V
Sbjct: 122 QLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTV 176
Query: 266 GTYGYAAPEYVMTGHLTSK-SDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           GT  Y APE ++      K +DV+S GV L  +L G    +   P   +N          
Sbjct: 177 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED--PEEPKNF--------- 225
Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR----DPKSRPSMDEV 370
            ++ +++I    L + Y++     +S    + +SR    DP  R S+ E+
Sbjct: 226 -RKTIHRI----LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 270

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K           +  +G+  A K +K    +  R  V+      EV  L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           Q+ H N++ L          +L+ E ++ G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 215 FLHGGSEPVIYRDFKTSNI-LLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +LH  ++ + + D K  NI LLD      + KL DFGLA     G +      + GT  +
Sbjct: 130 YLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
            APE V    L  ++D++S GV+   +L+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ILG+G    VF+G  ++ G   A     +   +  L+P  +Q     + E + L +L+H 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQ-----MREFEVLKKLNHK 67
Query: 160 NLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGAAKGL 213
           N+VKL  + IE++     ++L+ EF   GSL   L        LP S  + +      G+
Sbjct: 68  NIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 214 AFLHGGSEPVIYRDFKTSNILL----DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             L      +++R+ K  NI+     D +   KL+DFG A+   + D+  VS  + GT  
Sbjct: 126 NHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVS--LYGTEE 180
Query: 270 YAAPEYVMTGHLT--------SKSDVYSFGVVLLEILTG 300
           Y  P+      L         +  D++S GV      TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 162 VKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP------WSNRIKIALGAAKGLA 214
           +  + Y  +D+  L LV ++   G L   L +    LP      +   + +A+ +   L 
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           ++H        RD K  N+LLD   + +L+DFG +      D T  S+  VGT  Y +PE
Sbjct: 212 YVH--------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPE 262
Query: 275 YVMT-----GHLTSKSDVYSFGVVLLEILTGR 301
            +       G    + D +S GV + E+L G 
Sbjct: 263 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 162 VKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP------WSNRIKIALGAAKGLA 214
           +  + Y  +D+  L LV ++   G L   L +    LP      +   + +A+ +   L 
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           ++H        RD K  N+LLD   + +L+DFG +      D T  S+  VGT  Y +PE
Sbjct: 196 YVH--------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPE 246
Query: 275 YVMT-----GHLTSKSDVYSFGVVLLEILTGR 301
            +       G    + D +S GV + E+L G 
Sbjct: 247 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 144 REWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR 202
           R+   E++ L +   HPN++ L     +     +V E    G L + + R+     +S R
Sbjct: 60  RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF---FSER 116
Query: 203 --IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NAKLSDFGLAKAGPQGD 256
               +     K + +LH  ++ V++RD K SNIL   E     + ++ DFG AK   + +
Sbjct: 117 EASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAE 173
Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG 300
              + T    T  + APE +      +  D++S GV+L   LTG
Sbjct: 174 NGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
           G +    +LGEG +G V +  + ++ T   +    +        P+G    ++   E+  
Sbjct: 5   GKYLMGDLLGEGSYGKVKE--VLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQL 59
Query: 153 LGQLHHPNLVKLIG--YCIEDDQRLLVYEFMTRGSLE--NHLFRRTIPLPWSNRIKIALG 208
           L +L H N+++L+   Y  E  +  +V E+   G  E  + +  +  P+  ++     L 
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL- 118
Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
              GL +LH  S+ ++++D K  N+LL +    K+S  G+A+A              G+ 
Sbjct: 119 -IDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 269 GYAAPEYVMTGHLT---SKSDVYSFGVVLLEILTG 300
            +  PE +  G  T    K D++S GV L  I TG
Sbjct: 176 AFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           ILG+G    VF+G  ++ G   A     +   +  L+P  +Q     + E + L +L+H 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQ-----MREFEVLKKLNHK 67
Query: 160 NLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGAAKGL 213
           N+VKL  + IE++     ++L+ EF   GSL   L        LP S  + +      G+
Sbjct: 68  NIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 214 AFLHGGSEPVIYRDFKTSNILL----DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             L      +++R+ K  NI+     D +   KL+DFG A+   + D+  V   + GT  
Sbjct: 126 NHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVX--LYGTEE 180
Query: 270 YAAPEYVMTGHLT--------SKSDVYSFGVVLLEILTG 300
           Y  P+      L         +  D++S GV      TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 52
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 53  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 112
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 113 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 159
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 160 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 215
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 216 GILLYDMVCG 225

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 65
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 66  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 126 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 172
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 173 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 228
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 229 GILLYDMVCG 238

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 53
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 54  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 113
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 114 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 160
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 161 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 216
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 217 GILLYDMVCG 226

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 52
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 53  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 112
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 113 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 159
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 160 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 215
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 216 GILLYDMVCG 225

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 66
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 67  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 127 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 173
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 174 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 229
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 230 GILLYDMVCG 239

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 53
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 54  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 113
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 114 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 160
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 161 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 216
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 217 GILLYDMVCG 226

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 65
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 66  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 126 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 172
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 173 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 228
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 229 GILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 66
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 67  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 127 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 173
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 174 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 229
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 230 GILLYDMVCG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 64/294 (21%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 66
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 67  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 127 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 173
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 174 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 229
Query: 291 GVVLLEILTGRRSMD------------KKRPSGE-QNLVAWARQYLADKRKLYQ 331
           G++L +++ G    +            ++R S E Q+L+ W        R  ++
Sbjct: 230 GILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFE 283

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 30  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 80
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 81  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 140
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 141 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 187
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 188 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 243
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 244 GILLYDMVCG 253

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 53
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 54  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 113
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 114 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 160
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 161 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 216
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 217 GILLYDMVCG 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 35  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 85
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 86  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 145
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 146 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 192
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 193 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 248
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 249 GILLYDMVCG 258

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 30  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 80
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 81  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 140
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 141 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 187
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 188 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 243
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 244 GILLYDMVCG 253

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 64/294 (21%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 65
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 66  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 126 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 172
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 173 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 228
Query: 291 GVVLLEILTGRRSMD------------KKRPSGE-QNLVAWARQYLADKRKLYQ 331
           G++L +++ G    +            ++R S E Q+L+ W        R  ++
Sbjct: 229 GILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFE 282

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 66
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 67  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 127 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 173
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 174 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 229
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 230 GILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 65
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 66  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 126 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 172
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 173 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 228
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 229 GILLYDMVCG 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 76  SPCQLLQFT----FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVA 131
           +PC  L  T     +E +     ++   +LG GGFG V+ G          +    + VA
Sbjct: 22  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVA 72
Query: 132 VKSLKPDGLQGHREW------VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV------ 177
           +K ++ D +    E         EV  L ++      +++L+ +    D  +L+      
Sbjct: 73  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 132
Query: 178 ----YEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
               ++F+T RG+L+  L R      W       L A +     H  +  V++RD K  N
Sbjct: 133 VQDLFDFITERGALQEELARSFF---WQ-----VLEAVR-----HCHNCGVLHRDIKDEN 179
Query: 233 ILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSF 290
           IL+D +    KL DFG         K  V T   GT  Y+ PE++       +S  V+S 
Sbjct: 180 ILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235
Query: 291 GVVLLEILTG 300
           G++L +++ G
Sbjct: 236 GILLYDMVCG 245
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	429
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-156
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-90
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-70
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-67
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-66
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-65
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-63
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-63
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-63
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-62
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-60
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-60
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-58
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-47
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-47
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-46
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-43
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-42
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-38
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-04
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-23
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  530 bits (1367), Expect = 0.0
 Identities = 113/318 (35%), Positives = 172/318 (54%), Gaps = 29/318 (9%)

Query: 74  EKSPCQLLQFTFQELKSATGNFRP------DSILGEGGFGYVFKGWIEENGTAPAKPGSG 127
           E S  +   F+F ELK+ T NF         + +GEGGFG V+KG++             
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------N 54

Query: 128 ITVAVKSLK----PDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTR 183
            TVAVK L         +  +++  E+  + +  H NLV+L+G+  + D   LVY +M  
Sbjct: 55  TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114

Query: 184 GSLENHLFRR--TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA 241
           GSL + L     T PL W  R KIA GAA G+ FLH      I+RD K++NILLD  + A
Sbjct: 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTA 172

Query: 242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           K+SDFGLA+A  +  +T +++R+VGT  Y APE  + G +T KSD+YSFGVVLLEI+TG 
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGL 231

Query: 302 RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDP 361
            ++D+ R    Q L+    +   +++ +   +D ++  +     V+ +  +A  CL    
Sbjct: 232 PAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKK 288

Query: 362 KSRPSMDEVVKVLTPLQD 379
             RP + +V ++L  +  
Sbjct: 289 NKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  515 bits (1329), Expect = 0.0
 Identities = 120/326 (36%), Positives = 183/326 (56%), Gaps = 16/326 (4%)

Query: 63  SSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPA 122
           ++   D   +    P +  +    +L+ AT NF    ++G G FG V+KG + +      
Sbjct: 9   TNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD------ 62

Query: 123 KPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMT 182
               G  VA+K   P+  QG  E+  E++ L    HP+LV LIG+C E ++ +L+Y++M 
Sbjct: 63  ----GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118

Query: 183 RGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY 239
            G+L+ HL+     T+ + W  R++I +GAA+GL +LH  +  +I+RD K+ NILLD  +
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENF 176

Query: 240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
             K++DFG++K G + D+TH+ST V GT GY  PEY + G LT KSDVYSFGVVL E+L 
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236

Query: 300 GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR 359
            R ++ +  P    NL  WA +   +  +L QIVDP L      + ++K    A  CL+ 
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295

Query: 360 DPKSRPSMDEVVKVLTPLQDLNDLAI 385
             + RPSM +V+  L     L +  I
Sbjct: 296 SSEDRPSMGDVLWKLEYALRLQESVI 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  442 bits (1140), Expect = e-156
 Identities = 131/315 (41%), Positives = 191/315 (60%), Gaps = 20/315 (6%)

Query: 69  PAPTDEK-SPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSG 127
           PA  D +    QL +F+ +EL+ A+ NF   +ILG GGFG V+KG +  +GT        
Sbjct: 5   PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT-------- 55

Query: 128 ITVAVKSLKPDGLQGH-REWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSL 186
             VAVK LK +  QG   ++  EV+ +    H NL++L G+C+   +RLLVY +M  GS+
Sbjct: 56  -LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114

Query: 187 ENHLFRRT---IPLPWSNRIKIALGAAKGLAFLHGGSEP-VIYRDFKTSNILLDSEYNAK 242
            + L  R     PL W  R +IALG+A+GLA+LH   +P +I+RD K +NILLD E+ A 
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174

Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
           + DFGLAK     D THV+T V GT G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R
Sbjct: 175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233

Query: 303 SMDKKRPSGEQ--NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRD 360
           + D  R + +    L+ W +  L +K+ L  +VD  L+ NY  + V+++ Q+A  C    
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292

Query: 361 PKSRPSMDEVVKVLT 375
           P  RP M EVV++L 
Sbjct: 293 PMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  275 bits (706), Expect = 2e-90
 Identities = 76/327 (23%), Positives = 130/327 (39%), Gaps = 40/327 (12%)

Query: 81  LQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL 140
           +    + L   +   +   +   G FG V+K  +               VAVK       
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPI--- 57

Query: 141 QGHREWVAEVD--FLGQLHHPNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRT 194
           Q  + W  E +   L  + H N+++ IG             L+  F  +GSL + L    
Sbjct: 58  QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117

Query: 195 IPLPWSNRIKIALGAAKGLAFLH-------GGSEP-VIYRDFKTSNILLDSEYNAKLSDF 246
             + W+    IA   A+GLA+LH        G +P + +RD K+ N+LL +   A ++DF
Sbjct: 118 --VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175

Query: 247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS-----KSDVYSFGVVLLEILTGR 301
           GLA     G     +   VGT  Y APE +            + D+Y+ G+VL E+ +  
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235

Query: 302 RSMDKKRPSGEQNLVAWARQY--LADKRKL--YQIVDPRLELNY-SLKGVQKVSQLAYNC 356
            + D               Q+  L D +++  ++   P L   +    G+  + +    C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295

Query: 357 LSRDPKSRPSMDEVVKVLTPLQDLNDL 383
              D ++R S   V + +T +Q L ++
Sbjct: 296 WDHDAEARLSAGCVGERITQMQRLTNI 322

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  222 bits (568), Expect = 3e-70
 Identities = 81/293 (27%), Positives = 135/293 (46%), Gaps = 46/293 (15%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-------REWVAEVDF 152
            +G+GGFG V KG + ++ +          VA+KSL     +G        +E+  EV  
Sbjct: 26  QIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEKFQEFQREVFI 76

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           +  L+HPN+VKL G         +V EF+  G L + L  +  P+ WS ++++ L  A G
Sbjct: 77  MSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDS-----EYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
           + ++   + P+++RD ++ NI L S        AK++DFGL++        H  + ++G 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGN 189

Query: 268 YGYAAPEYVMTG---HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           + + APE  +       T K+D YSF ++L  ILTG      + P  E +        + 
Sbjct: 190 FQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTG------EGPFDEYSYGKIKFINMI 242

Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            +  L      R  +        ++  +   C S DPK RP    +VK L+ L
Sbjct: 243 REEGL------RPTIPEDCP--PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  222 bits (566), Expect = 2e-69
 Identities = 63/338 (18%), Positives = 123/338 (36%), Gaps = 53/338 (15%)

Query: 81  LQFTFQELKSATGNFRPDSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDG 139
           ++    E      N +   ++G G +G V+KG                  VAVK      
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL------------DERPVAVKVFSF-- 46

Query: 140 LQGHREWVAEVD--FLGQLHHPNLVKLIGYCIEDD-----QRLLVYEFMTRGSLENHLFR 192
               + ++ E +   +  + H N+ + I            + LLV E+   GSL  +L  
Sbjct: 47  -ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL 105

Query: 193 RTIPLPWSNRIKIALGAAKGLAFLH-------GGSEPVIYRDFKTSNILLDSEYNAKLSD 245
            T    W +  ++A    +GLA+LH            + +RD  + N+L+ ++    +SD
Sbjct: 106 HT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 246 FGLAK------AGPQGDKTHVSTRVVGTYGYAAPEYVM-------TGHLTSKSDVYSFGV 292
           FGL+           G++ + +   VGT  Y APE +              + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 293 VLLEILTGRRSMDKKRPSGEQNL----VAWARQYLADKRKL--YQIVDPRLELNYSL--K 344
           +  EI      +       E  +             D + L   +   P+    +     
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283

Query: 345 GVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLND 382
            V+ + +   +C  +D ++R +     + +  L  + +
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  215 bits (549), Expect = 5e-67
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 35/283 (12%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEVDFLGQLH 157
           +G G FG V +  W             G  VAVK L           E++ EV  + +L 
Sbjct: 45  IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIALGAAKGLAF 215
           HPN+V  +G   +     +V E+++RGSL   L +      L    R+ +A   AKG+ +
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEY 275
           LH  + P+++R+ K+ N+L+D +Y  K+ DFGL++       +  S    GT  + APE 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEV 210

Query: 276 VMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP 335
           +       KSDVYSFGV+L E+ T       ++P G  N            +        
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATL------QQPWGNLNPAQVV--AAVGFKCK------ 256

Query: 336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
           RLE+  +L    +V+ +   C + +P  RPS   ++ +L PL 
Sbjct: 257 RLEIPRNLN--PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  213 bits (545), Expect = 1e-66
 Identities = 79/284 (27%), Positives = 131/284 (46%), Gaps = 41/284 (14%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
           ++G G FG V K  W                VA+K ++ +  +  + ++ E+  L +++H
Sbjct: 15  VVGRGAFGVVCKAKW------------RAKDVAIKQIESESER--KAFIVELRQLSRVNH 60

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLEN--HLFRRTIPLPWSNRIKIALGAAKGLAFL 216
           PN+VKL G C+      LV E+   GSL N  H          ++ +   L  ++G+A+L
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 217 HGGS-EPVIYRDFKTSNILLDSEYN-AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           H    + +I+RD K  N+LL +     K+ DFG A      D     T   G+  + APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPE 173

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
                + + K DV+S+G++L E++T       ++P  E    A+   +            
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITR------RKPFDEIGGPAFRIMWAVHNGT------ 221

Query: 335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
            R  L  +L   + +  L   C S+DP  RPSM+E+VK++T L 
Sbjct: 222 -RPPLIKNLP--KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  211 bits (538), Expect = 2e-65
 Identities = 73/303 (24%), Positives = 114/303 (37%), Gaps = 47/303 (15%)

Query: 95  FRPDSI-----LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA 148
           FRP  +     LG+G FG   K               +G  + +K L     +  R ++ 
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTFLK 56

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV  +  L HPN++K IG   +D +   + E++  G+L   +       PWS R+  A  
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK------------AGPQGD 256
            A G+A+LH  S  +I+RD  + N L+    N  ++DFGLA+               +  
Sbjct: 117 IASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
                  VVG   + APE +       K DV+SFG+VL EI+    +     P      +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234

Query: 317 AWARQYLADKRKLYQIVDPRLELNYSLKGV-QKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
                                               +   C   DP+ RPS  ++   L 
Sbjct: 235 NVRGFL-------------DRYCP---PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

Query: 376 PLQ 378
            L+
Sbjct: 279 TLR 281

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  204 bits (521), Expect = 2e-63
 Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 46/290 (15%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEVDFLGQL 156
            L E   G ++KG W             G  + VK LK         R++  E   L   
Sbjct: 17  KLNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 157 HHPNLVKLIGYCIEDDQRLL--VYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGL 213
            HPN++ ++G C          +  +M  GSL N L   T   +  S  +K AL  A+G+
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
           AFLH     +      + ++++D +  A++S   +         +  S   +    + AP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAP 177

Query: 274 EYVMTG----HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           E  +           +D++SF V+L E++T       + P  + + +    +   +    
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELVTR------EVPFADLSNMEIGMKVALEGL-- 228

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
                 R  +   +     VS+L   C++ DP  RP  D +V +L  +QD
Sbjct: 229 ------RPTIPPGI--SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  204 bits (521), Expect = 2e-63
 Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 48/292 (16%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----EVDFLG 154
           I+G GGFG V++  W    G           VAVK+ + D  +   + +     E     
Sbjct: 14  IIGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
            L HPN++ L G C+++    LV EF   G L   L  +   +P    +  A+  A+G+ 
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMN 119

Query: 215 FLHG-GSEPVIYRDFKTSNILLDSEY--------NAKLSDFGLAKAGPQGDKTHVSTRVV 265
           +LH     P+I+RD K+SNIL+  +           K++DFGLA+   +  K        
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS----AA 175

Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
           G Y + APE +     +  SDV+S+GV+L E+LTG      + P    + +A A     +
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG------EVPFRGIDGLAVAYGVAMN 229

Query: 326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           K          L +  +    +  ++L  +C + DP SRPS   ++  LT +
Sbjct: 230 KL--------ALPIPSTCP--EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  204 bits (522), Expect = 3e-63
 Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 42/288 (14%)

Query: 101 LGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEVDFLGQLH 157
           +G G FG V+KG W   +G           VAVK L          + +  EV  L +  
Sbjct: 32  IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H N++  +GY     Q  +V ++    SL +HL            I IA   A+G+ +LH
Sbjct: 79  HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE--- 274
             ++ +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  + APE   
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGR---RSMDKKRPSGEQNLVAWARQYL-ADKRKLY 330
              +   + +SDVY+FG+VL E++TG+    +++    + +Q +    R  L  D  K+ 
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIEMVGRGSLSPDLSKVR 251

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
                R+             +L   CL +    RPS   ++  +  L 
Sbjct: 252 SNCPKRM------------KRLMAECLKKKRDERPSFPRILAEIEELA 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  204 bits (520), Expect = 1e-62
 Identities = 55/297 (18%), Positives = 111/297 (37%), Gaps = 47/297 (15%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEVDFLGQL 156
           ++G+G FG V+ G W   +G           VA++ +  +       + +  EV    Q 
Sbjct: 40  LIGKGRFGQVYHGRW---HGE----------VAIRLIDIERDNEDQLKAFKREVMAYRQT 86

Query: 157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFL 216
            H N+V  +G C+      ++       +L + +    I L  +   +IA    KG+ +L
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK---AGPQGDKTHVSTRVVGTYGYAAP 273
           H  ++ ++++D K+ N+  D      ++DFGL         G +        G   + AP
Sbjct: 147 H--AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 274 EYVMTG---------HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           E +              +  SDV++ G +  E+         + P   Q   A   Q   
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR------EWPFKTQPAEAIIWQMGT 257

Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN 381
             +        ++ +   +        +   C + + + RP+  +++ +L  L   N
Sbjct: 258 GMKPN----LSQIGMGKEIS------DILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  197 bits (503), Expect = 6e-60
 Identities = 71/317 (22%), Positives = 116/317 (36%), Gaps = 54/317 (17%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF--LGQL 156
            +G+G +G V+ G W             G  VAVK            W  E +      +
Sbjct: 44  QIGKGRYGEVWMGKW------------RGEKVAVKVFFT---TEEASWFRETEIYQTVLM 88

Query: 157 HHPNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
            H N++  I   I+      Q  L+ ++   GSL ++L   T  L   + +K+A  +  G
Sbjct: 89  RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSG 146

Query: 213 LAFLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH--VSTRV 264
           L  LH       G   + +RD K+ NIL+       ++D GLA                 
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206

Query: 265 VGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEILTGRRSMDKKRP-------- 309
           VGT  Y  PE V+   L          +D+YSFG++L E+     S              
Sbjct: 207 VGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGV-QKVSQLAYNCLSRDPKSRPSMD 368
                     R+ +  K+       P     +S     +++ +L   C + +P SR +  
Sbjct: 266 VPSDPSYEDMREIVCIKKL-----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320

Query: 369 EVVKVLTPLQDLNDLAI 385
            V K L  + +  D+ +
Sbjct: 321 RVKKTLAKMSESQDIKL 337

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  192 bits (490), Expect = 2e-58
 Identities = 69/311 (22%), Positives = 119/311 (38%), Gaps = 58/311 (18%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF--LGQL 156
            +G+G +G V++G W             G  VAVK       +  + W  E +      L
Sbjct: 15  CVGKGRYGEVWRGSW------------QGENVAVKIFSS---RDEKSWFRETELYNTVML 59

Query: 157 HHPNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
            H N++  I   +       Q  L+  +   GSL ++L  +   L   + ++I L  A G
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASG 117

Query: 213 LAFLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV--STRV 264
           LA LH       G   + +RD K+ NIL+       ++D GLA    Q        +   
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177

Query: 265 VGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEILTGRRSMDKKRP-------- 309
           VGT  Y APE V+   +         + D+++FG+VL E+     S              
Sbjct: 178 VGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPS 366
                     R+ +   ++       R  +    +S   +  +++L   C  ++P +R +
Sbjct: 237 VPNDPSFEDMRKVVCVDQQ-------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289

Query: 367 MDEVVKVLTPL 377
              + K LT +
Sbjct: 290 ALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  193 bits (491), Expect = 4e-58
 Identities = 74/313 (23%), Positives = 124/313 (39%), Gaps = 46/313 (14%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF--LGQL 156
            +G+G FG V++G W             G  VAVK       +  R W  E +      L
Sbjct: 49  SIGKGRFGEVWRGKW------------RGEEVAVKIFSS---REERSWFREAEIYQTVML 93

Query: 157 HHPNLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
            H N++  I    +D+    Q  LV ++   GSL ++L R T  +     IK+AL  A G
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASG 151

Query: 213 LAFLH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH--VSTRV 264
           LA LH       G   + +RD K+ NIL+       ++D GLA        T        
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211

Query: 265 VGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
           VGT  Y APE V+   +         ++D+Y+ G+V  EI   R S+       +     
Sbjct: 212 VGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYD 269

Query: 318 WARQYLADKRKLYQIVDPRL-----ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                 + +     + + +L         S + ++ ++++   C   +  +R +   + K
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

Query: 373 VLTPLQDLNDLAI 385
            L+ L     + +
Sbjct: 330 TLSQLSQQEGIKM 342

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  163 bits (414), Expect = 3e-47
 Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 29/293 (9%)

Query: 99  SILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
             LG+G FG V    +       P +  +G  VAVK L+    +  R++  E++ L  L 
Sbjct: 16  QQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 158 HPNLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           H N+VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG-----Y 270
           L   ++  I+RD  T NIL+++E   K+ DFGL K  PQ  +           G     +
Sbjct: 130 LG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFW 183

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            APE +     +  SDV+SFGVVL E+ T      K  P+    ++   +Q       L 
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

Query: 331 QIVDPRLELNYSLKG----VQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
           +     L+ N  L        ++  +   C + +   RPS  ++   +  ++D
Sbjct: 243 E----LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  163 bits (414), Expect = 7e-47
 Identities = 82/292 (28%), Positives = 121/292 (41%), Gaps = 32/292 (10%)

Query: 99  SILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
           S LG+G FG V    +       P    +G  VAVK L+  G    R++  E+  L  LH
Sbjct: 29  SQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 158 HPNLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
              +VK  G      ++   LV E++  G L + L R    L  S  +  +    KG+ +
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG-----Y 270
           L   S   ++RD    NIL++SE + K++DFGLAK  P     +V        G     +
Sbjct: 143 LG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFW 196

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
            APE +     + +SDV+SFGVVL E+ T   +S                   L+   +L
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256

Query: 330 YQIVDPRLELNYSLKG----VQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
                  LE    L        +V +L   C +  P+ RPS   +   L  L
Sbjct: 257 -------LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  162 bits (413), Expect = 9e-47
 Identities = 76/293 (25%), Positives = 129/293 (44%), Gaps = 29/293 (9%)

Query: 99  SILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH 157
             LG+G FG V    +       P +  +G  VAVK L+    +  R++  E++ L  L 
Sbjct: 47  QQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 158 HPNLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           H N+VK  G C    +R   L+ E++  GSL ++L +    +     ++      KG+ +
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG-----Y 270
           L   ++  I+RD  T NIL+++E   K+ DFGL K  PQ  + +         G     +
Sbjct: 161 LG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFW 214

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            APE +     +  SDV+SFGVVL E+ T      K  P+    ++   +Q       L 
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273

Query: 331 QIVDPRLELNYSLKG----VQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
           +     L+ N  L        ++  +   C + +   RPS  ++   +  ++D
Sbjct: 274 E----LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  161 bits (409), Expect = 3e-46
 Identities = 90/294 (30%), Positives = 135/294 (45%), Gaps = 33/294 (11%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLH 157
             LGEG FG V     +     P   G+G  VAVK+LK D G Q    W  E+D L  L+
Sbjct: 37  RDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91

Query: 158 HPNLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           H +++K  G C +       LV E++  GSL ++L R +I L     +  A    +G+A+
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA--QLLLFAQQICEGMAY 149

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG-----Y 270
           LH  ++  I+RD    N+LLD++   K+ DFGLAKA P+G + +     V   G     +
Sbjct: 150 LH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFW 203

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
            APE +        SDV+SFGV L E+LT    S        E   +A  +  +    +L
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263

Query: 330 YQIVDPRLELNYSLKG----VQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
                  LE    L        +V  L  NC   +   RP+ + ++ +L  + +
Sbjct: 264 -------LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  162 bits (411), Expect = 6e-46
 Identities = 72/284 (25%), Positives = 115/284 (40%), Gaps = 38/284 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHP 159
           +G G FG VF G +  + T          VAVKS +         +++ E   L Q  HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG 219
           N+V+LIG C +     +V E +  G     L      L     +++   AA G+ +L   
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           S+  I+RD    N L+  +   K+SDFG+++    G              + APE +  G
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290

Query: 280 HLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLE 338
             +S+SDV+SFG++L E  + G        P            Y        Q  +  +E
Sbjct: 291 RYSSESDVWSFGILLWETFSLGA------SP------------Y--PNLSNQQTRE-FVE 329

Query: 339 LNYSL---KGV-QKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
               L   +     V +L   C + +P  RPS   + + L  ++
Sbjct: 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  158 bits (401), Expect = 3e-45
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 31/292 (10%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLH 157
             LGEG FG V     +     P    +G  VAVKSLKP+ G     +   E++ L  L+
Sbjct: 27  RDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81

Query: 158 HPNLVKLIGYCIEDDQR--LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           H N+VK  G C ED      L+ EF+  GSL+ +L +    +    ++K A+   KG+ +
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG-----Y 270
           L   S   ++RD    N+L++SE+  K+ DFGL KA     + +               +
Sbjct: 142 LG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFW 195

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
            APE +M       SDV+SFGV L E+LT             +       +  +      
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255

Query: 330 YQIVDPRLELNYSLKG----VQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
                  L+    L        +V QL   C    P +R S   +++    L
Sbjct: 256 -------LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  153 bits (389), Expect = 3e-43
 Identities = 69/288 (23%), Positives = 122/288 (42%), Gaps = 47/288 (16%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLH 157
           +LG G FG V+KG WI E           I VA+K L+     + ++E + E   +  + 
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVK------IPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P++ +L+G C+      L+ + M  G L +++      +     +   +  AKG+ +L 
Sbjct: 76  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG-----YAA 272
                +++RD    N+L+ +  + K++DFGLAK     +K + +       G     + A
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMA 187

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
            E ++    T +SDV+S+GV + E++T G       +P            Y  D     +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGS------KP------------Y--DGIPASE 227

Query: 332 IVDPRLELNYSLKGVQ----KVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
           I    LE    L         V  +   C   D  SRP   E++   +
Sbjct: 228 ISS-ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  150 bits (380), Expect = 2e-42
 Identities = 68/314 (21%), Positives = 113/314 (35%), Gaps = 63/314 (20%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            LG+G F  +FKG                  V +K L          +      + +L H
Sbjct: 15  SLGQGTFTKIFKGVR---REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
            +LV   G C+  D+ +LV EF+  GSL+ +L +    +    ++++A   A  + FL  
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE- 130

Query: 219 GSEPVIYRDFKTSNILLDSEYN--------AKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
               +I+ +    NILL  E +         KLSD G++               V     
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITVLPKDI 176

Query: 271 -------AAPEYVMTG-HLTSKSDVYSFGVVLLEILT-GRRSMDKKRP----SGEQNLVA 317
                    PE +    +L   +D +SFG  L EI + G       +P      ++    
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD------KPLSALDSQR---- 226

Query: 318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
              Q+  D+ +L       L              L  NC+  +P  RPS   +++ L  L
Sbjct: 227 -KLQFYEDRHQLPAPKAAEL---A---------NLINNCMDYEPDHRPSFRAIIRDLNSL 273

Query: 378 QDLNDLAILSYHSR 391
              + +   S+H  
Sbjct: 274 FTPDLVPRGSHHHH 287

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  148 bits (375), Expect = 1e-41
 Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 50/295 (16%)

Query: 89  KSATGNF-RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK--SLKPDGLQGHRE 145
            S  G F + D  +G G F  V+KG   E         + + VA      +       + 
Sbjct: 21  MSNDGRFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQR 71

Query: 146 WVAEVDFLGQLHHPNLVKLIGYCI---EDDQRLLVY-EFMTRGSLENHLFRRTIPLPWSN 201
           +  E + L  L HPN+V+         +  + +++  E MT G+L+ +L +R   +    
Sbjct: 72  FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKV 130

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDFGLAKAGPQGDKTHV 260
                    KGL FLH  + P+I+RD K  NI +     + K+ D GLA        +  
Sbjct: 131 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFA 187

Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWA 319
              V+GT  + APE     +     DVY+FG+ +LE+ T       + P S  QN     
Sbjct: 188 KA-VIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATS------EYPYSECQNAAQ-- 237

Query: 320 RQYLADKRKLYQIVD-----PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
                    +Y+ V         +     +  + +      C+ ++   R S+ +
Sbjct: 238 ---------IYRRVTSGVKPASFDKVAIPEVKEIIEG----CIRQNKDERYSIKD 279

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  147 bits (372), Expect = 3e-41
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 25/214 (11%)

Query: 98  DSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQ 155
           D  LG G FG V +G +              I VA+K LK         E + E   + Q
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQ--------IDVAIKVLKQGTEKADTEEMMREAQIMHQ 66

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L +P +V+LIG C + +  +LV E    G L   L  +   +P SN  ++    + G+ +
Sbjct: 67  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG------ 269
           L    +  ++RD    N+LL + + AK+SDFGL+KA    D  + +              
Sbjct: 126 L--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLK 178

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
           + APE +     +S+SDV+S+GV + E L+ G++
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (383), Expect = 5e-41
 Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 48/285 (16%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            LG G +G V++G W              +TVAVK+LK D ++   E++ E   + ++ H
Sbjct: 227 KLGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKH 275

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFLH 217
           PNLV+L+G C  +    ++ EFMT G+L ++L       +     + +A   +  + +L 
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
              +  I+R+    N L+   +  K++DFGL++    GD             + APE + 
Sbjct: 336 --KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 392

Query: 278 TGHLTSKSDVYSFGVVLLEILT-GRR---SMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
               + KSDV++FGV+L EI T G      +D  +                        V
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------------------V 428

Query: 334 DPRLELNYSLKG----VQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
              LE +Y ++      +KV +L   C   +P  RPS  E+ +  
Sbjct: 429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  147 bits (373), Expect = 6e-41
 Identities = 66/250 (26%), Positives = 114/250 (45%), Gaps = 24/250 (9%)

Query: 62  LSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKG-WIEENGTA 120
            +++N          P Q +     E+  +        ++G G FG V+KG     +G  
Sbjct: 15  PTTENLYFQGAMGSDPNQAVLKFTTEIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKK 72

Query: 121 PAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYE 179
                  + VA+K+LK    +  R +++ E   +GQ  H N+++L G   +    +++ E
Sbjct: 73  E------VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126

Query: 180 FMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY 239
           +M  G+L+  L  +         + +  G A G+ +L   +   ++RD    NIL++S  
Sbjct: 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNL 184

Query: 240 NAKLSDFGLAKAGPQGDKTHVSTRVVG------TYGYAAPEYVMTGHLTSKSDVYSFGVV 293
             K+SDFGL++   + D     T   G      T    APE +     TS SDV+SFG+V
Sbjct: 185 VCKVSDFGLSRV-LEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIV 239

Query: 294 LLEILT-GRR 302
           + E++T G R
Sbjct: 240 MWEVMTYGER 249

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  146 bits (370), Expect = 6e-41
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 20/211 (9%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQ 155
            LG+G FG V +G W   +G         ++VAVK LKPD L   +   +++ EV+ +  
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L H NL++L G  +      +V E    GSL + L +           + A+  A+G+ +
Sbjct: 78  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAA 272
           L   S+  I+RD    N+LL +    K+ DFGL +A PQ D  +V          + + A
Sbjct: 137 LE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
           PE + T   +  SD + FGV L E+ T G+ 
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (372), Expect = 6e-41
 Identities = 71/307 (23%), Positives = 129/307 (42%), Gaps = 48/307 (15%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLH 157
           +LG G FG V+KG WI E           I VA+K L+     + ++E + E   +  + 
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVK------IPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           +P++ +L+G C+      L+ + M  G L +++      +     +   +  AKG+ +L 
Sbjct: 76  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG-----YAA 272
                +++RD    N+L+ +  + K++DFGLAK     +K + +       G     + A
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMA 187

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
            E ++    T +SDV+S+GV + E++T G       +P            Y  D     +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGS------KP------------Y--DGIPASE 227

Query: 332 IVDPRLELNYSLKG----VQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL-QDLNDLAIL 386
           I    LE    L         V  +   C   D  SRP   E++   + + +D     ++
Sbjct: 228 ISS-ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286

Query: 387 SYHSRLS 393
               R+ 
Sbjct: 287 QGDERMH 293

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  146 bits (370), Expect = 7e-41
 Identities = 75/293 (25%), Positives = 119/293 (40%), Gaps = 56/293 (19%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHH 158
           ++G G FG V+ G      T     G  I  AVKSL     +    +++ E   +    H
Sbjct: 32  VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85

Query: 159 PNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           PN++ L+G C+  +   L+V  +M  G L N +   T      + I   L  AKG+ +L 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG------TYGYA 271
             S+  ++RD    N +LD ++  K++DFGLA+     +   V  +              
Sbjct: 146 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM---- 199

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
           A E + T   T+KSDV+SFGV+L E++T G        P                    Y
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRG------APP--------------------Y 233

Query: 331 QIVDPRLELNYSLKGV---------QKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
             V+      Y L+G            + ++   C     + RPS  E+V  +
Sbjct: 234 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  146 bits (371), Expect = 1e-40
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 23/240 (9%)

Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P +  +   +E++++      + I+G G  G V  G               + V
Sbjct: 29  PHTYEEPGRAGRSFTREIEAS--RIHIEKIIGSGDSGEVCYG------RLRVPGQRDVPV 80

Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R ++++E   +GQ  HPN+++L G        ++V E+M  GSL+  
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140

Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L            + +  G   G+ +L       ++RD    N+L+DS    K+SDFGL+
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198

Query: 250 KAGPQGDKTHVSTRVVG------TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
           +   + D     T   G      T    APE +     +S SDV+SFGVV+ E+L  G R
Sbjct: 199 RV-LEDDPDAAYTTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  146 bits (370), Expect = 1e-40
 Identities = 76/342 (22%), Positives = 115/342 (33%), Gaps = 49/342 (14%)

Query: 35  SLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGN 94
           S   D  TE  Y  + ++    P       +  +   +    P +   F  Q        
Sbjct: 8   SSGVDLGTENLYFQSMHQ--LQPRRVSFRGEASETLQSPGYDPSRPESFFQQS------- 58

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDF 152
           F+  S LG G +G VFK               G   AVK       G +     +AEV  
Sbjct: 59  FQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109

Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
             ++  HP  V+L     E     L  E     SL+ H       LP +           
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
            LA LH  S+ +++ D K +NI L      KL DFGL           V     G   Y 
Sbjct: 169 ALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYM 223

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE +   +  + +DV+S G+ +LE+         + P                 ++L Q
Sbjct: 224 APELLQGSY-GTAADVFSLGLTILEVACN-----MELPH-----------GGEGWQQLRQ 266

Query: 332 -IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             + P      S +    +       L  DPK R + + ++ 
Sbjct: 267 GYLPPEFTAGLSSELRSVLVM----MLEPDPKLRATAEALLA 304

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  145 bits (367), Expect = 2e-40
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 27/215 (12%)

Query: 98  DSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHR--EWVAEVDFLG 154
           D  LG G FG V KG +  +            TVAVK LK +        E +AE + + 
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVV--------KTVAVKILKNEANDPALKDELLAEANVMQ 73

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           QL +P +V++IG C E +  +LV E    G L  +L ++   +   N I++    + G+ 
Sbjct: 74  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMK 131

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG----- 269
           +L       ++RD    N+LL +++ AK+SDFGL+KA    +  + +             
Sbjct: 132 YL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPV 184

Query: 270 -YAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
            + APE +     +SKSDV+SFGV++ E  + G++
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  145 bits (369), Expect = 2e-40
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 22/211 (10%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLH 157
           +LG G FG V KG WI E  +        I V +K ++   G Q  +     +  +G L 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIK------IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           H ++V+L+G C       LV +++  GSL +H+ +    L     +   +  AKG+ +L 
Sbjct: 74  HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG-----YAA 272
                +++R+    N+LL S    +++DFG+A   P  DK  + +            + A
Sbjct: 133 --EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMA 185

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
            E +  G  T +SDV+S+GV + E++T G  
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  146 bits (370), Expect = 3e-40
 Identities = 87/383 (22%), Positives = 139/383 (36%), Gaps = 66/383 (17%)

Query: 15  VRGSCKSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDE 74
                +  AS  +   +PR S   D       L+ S  +       +    N        
Sbjct: 11  HHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSA 70

Query: 75  KSPCQLLQFTFQELKSATGNFRPDSI-----LGEGGFGYVFKGWIEENGTAPAKPGSGIT 129
            +P        Q ++          +     +G G FG V+ G      T     G  I 
Sbjct: 71  LNP-----ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG------TLLDNDGKKIH 119

Query: 130 VAVKSLKPD-GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD-QRLLVYEFMTRGSLE 187
            AVKSL     +    +++ E   +    HPN++ L+G C+  +   L+V  +M  G L 
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 188 NHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG 247
           N +   T      + I   L  AKG+ FL   S+  ++RD    N +LD ++  K++DFG
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFG 237

Query: 248 LAKAGPQGDKTHVSTRVVG------TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-G 300
           LA+     +   V  +              A E + T   T+KSDV+SFGV+L E++T G
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRG 293

Query: 301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGV---------QKVSQ 351
                   P                    Y  V+      Y L+G            + +
Sbjct: 294 A------PP--------------------YPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327

Query: 352 LAYNCLSRDPKSRPSMDEVVKVL 374
           +   C     + RPS  E+V  +
Sbjct: 328 VMLKCWHPKAEMRPSFSELVSRI 350

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  142 bits (361), Expect = 3e-39
 Identities = 76/328 (23%), Positives = 133/328 (40%), Gaps = 78/328 (23%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHH 158
            LG+G FG V++G     G    +P     VA+K++     ++   E++ E   + + + 
Sbjct: 32  ELGQGSFGMVYEG--VAKGVVKDEPE--TRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR---------TIPLPWSNRIKIALGA 209
            ++V+L+G   +    L++ E MTRG L+++L              P   S  I++A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           A G+A+L+  +   ++RD    N ++  ++  K+ DFG+              R +    
Sbjct: 148 ADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMT-------------RDIYETD 192

Query: 270 YA-------------APEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRP----SG 311
           Y              +PE +  G  T+ SDV+SFGVVL EI T         +P    S 
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE------QPYQGLSN 246

Query: 312 EQNLVAWARQYLADK-----RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
           EQ L       L DK       L++++                      C   +PK RPS
Sbjct: 247 EQVLRFVMEGGLLDKPDNCPDMLFELM--------------------RMCWQYNPKMRPS 286

Query: 367 MDEVVKVLTPLQDLNDLAILSYHSRLSQ 394
             E++  +    +     +  Y+S  ++
Sbjct: 287 FLEIISSIKEEMEPGFREVSFYYSEENK 314

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  143 bits (363), Expect = 3e-39
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 17/237 (7%)

Query: 71  PTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
           P   + P Q +    +EL +   N   D ++G G FG V  G               I+V
Sbjct: 25  PHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSG------RLKLPSKKEISV 76

Query: 131 AVKSLKPDGLQGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH 189
           A+K+LK    +  R +++ E   +GQ  HPN+++L G   +    ++V E+M  GSL++ 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136

Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           L +          + +  G A G+ +L       ++RD    NIL++S    K+SDFGL 
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLG 194

Query: 250 KAGPQGDKTHVSTRVVGT---YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
           +      +   +TR  G      + +PE +     TS SDV+S+G+VL E+++ G R
Sbjct: 195 RVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  141 bits (358), Expect = 4e-39
 Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 56/293 (19%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHH 158
           ++G+G FG V+ G          +  + I  A+KSL     +Q    ++ E   +  L+H
Sbjct: 28  VIGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81

Query: 159 PNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLH 217
           PN++ LIG  +  +    ++  +M  G L   +          + I   L  A+G+ +L 
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG------TYGYA 271
              +  ++RD    N +LD  +  K++DFGLA+     +   V            T    
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT---- 195

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
           A E + T   T+KSDV+SFGV+L E+LT G        P                    Y
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGA------PP--------------------Y 229

Query: 331 QIVDPRLELNYSLKGV---------QKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           + +DP    ++  +G            + Q+   C   DP  RP+   +V  +
Sbjct: 230 RHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  147 bits (373), Expect = 4e-39
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 19/211 (9%)

Query: 98  DSILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQ 155
           D  LG G FG V +G +              I VA+K LK         E + E   + Q
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQ--------IDVAIKVLKQGTEKADTEEMMREAQIMHQ 392

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L +P +V+LIG C + +  +LV E    G L   L  +   +P SN  ++    + G+ +
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 451

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAA 272
           L    +  ++R+    N+LL + + AK+SDFGL+KA    D  + +           + A
Sbjct: 452 L--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYA 507

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
           PE +     +S+SDV+S+GV + E L+ G++
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  144 bits (365), Expect = 7e-39
 Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 56/286 (19%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            +G+G FG V  G +             G  VAVK +K D     + ++AE   + QL H
Sbjct: 200 TIGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 245

Query: 159 PNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFL 216
            NLV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L   + + +L
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
                  ++RD    N+L+  +  AK+SDFGL K   +   T  + ++     + APE +
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEAL 358

Query: 277 MTGHLTSKSDVYSFGVVLLEILT-GRR---SMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
                ++KSDV+SFG++L EI + GR     +  K                         
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------------------ 394

Query: 333 VDPRLELNYSLKGVQ----KVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           V PR+E  Y +         V  +  NC   D  +RP+  ++ + L
Sbjct: 395 VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  140 bits (354), Expect = 1e-38
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 36/217 (16%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHH 158
           ILGEG FG V++G            G  I VAVK+ K D    ++ ++++E   +  L H
Sbjct: 19  ILGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           P++VKLIG   E+    ++ E    G L ++L R    L     +  +L   K +A+L  
Sbjct: 73  PHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 130

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY-------- 270
            S   ++RD    NIL+ S    KL DFGL+             R +    Y        
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRL 176

Query: 271 ----AAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
                +PE +     T+ SDV+ F V + EIL+ G++
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  141 bits (357), Expect = 1e-38
 Identities = 80/305 (26%), Positives = 123/305 (40%), Gaps = 54/305 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E +   P +    + VAVK+LK       +++  E + L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR--------------TIPLPWSNRIKIA 206
           +V+  G C E    L+V+E+M  G L   L                   PL     + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--- 263
              A G+ +L       ++RD  T N L+      K+ DFG+++     D   V  R   
Sbjct: 165 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 264 -VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRP----SGEQNLVA 317
            +        PE ++    T++SDV+SFGVVL EI T G      K+P    S  + +  
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYG------KQPWYQLSNTEAI-- 270

Query: 318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
                +   R+L +      E+ Y          +   C  R+P+ R S+ +V   L  L
Sbjct: 271 ---DCITQGRELERPRACPPEV-Y---------AIMRGCWQREPQQRHSIKDVHARLQAL 317

Query: 378 QDLND 382
                
Sbjct: 318 AQAPP 322

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  139 bits (353), Expect = 1e-38
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            +G G FG V  G W                VA+K+++  G     +++ E + + +L H
Sbjct: 15  EIGSGQFGLVHLGYW---LNKDK--------VAIKTIRE-GAMSEEDFIEEAEVMMKLSH 62

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           P LV+L G C+E     LV EFM  G L ++L  +         + + L   +G+A+L  
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-- 120

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEY 275
               VI+RD    N L+      K+SDFG+ +           T   GT     +A+PE 
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEV 176

Query: 276 VMTGHLTSKSDVYSFGVVLLEILT-GRR 302
                 +SKSDV+SFGV++ E+ + G+ 
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  140 bits (354), Expect = 1e-38
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 41/218 (18%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            LG G +G V++G W              +TVAVK+LK D ++   E++ E   + ++ H
Sbjct: 20  KLGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKH 68

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFLH 217
           PNLV+L+G C  +    ++ EFMT G+L ++L       +     + +A   +  + +L 
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL- 127

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA------ 271
              +  I+RD    N L+   +  K++DFGL+             R++    Y       
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAK 173

Query: 272 ------APEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
                 APE +     + KSDV++FGV+L EI T G  
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  139 bits (352), Expect = 1e-38
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            LG G FG V  G W    G           VAVK +K  G     E+  E   + +L H
Sbjct: 15  ELGSGQFGVVKLGKW---KGQ--------YDVAVKMIKE-GSMSEDEFFQEAQTMMKLSH 62

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           P LVK  G C ++    +V E+++ G L N+L      L  S  +++     +G+AFL  
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL-- 120

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEY 275
            S   I+RD    N L+D +   K+SDFG+ +              VGT     ++APE 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEV 176

Query: 276 VMTGHLTSKSDVYSFGVVLLEILT-GRR 302
                 +SKSDV++FG+++ E+ + G+ 
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKM 204

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  140 bits (354), Expect = 2e-38
 Identities = 76/320 (23%), Positives = 126/320 (39%), Gaps = 83/320 (25%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLH 157
           ILGEG FG V +G          + G+ + VAVK++K D    +   E+++E   +    
Sbjct: 41  ILGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94

Query: 158 HPNLVKLIGYCIEDDQR-----LLVYEFMTRGSLENHLFRR-----TIPLPWSNRIKIAL 207
           HPN+++L+G CIE   +     +++  FM  G L  +L           +P    +K  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A G+ +L   +   ++RD    N +L  +    ++DFGL+             + + +
Sbjct: 155 DIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYS 199

Query: 268 YGY-------------AAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ 313
             Y              A E +     TSKSDV++FGV + EI T G        P    
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM------TP---- 249

Query: 314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGV---------QKVSQLAYNCLSRDPKSR 364
                           Y  V      +Y L G           ++ ++ Y+C   DP  R
Sbjct: 250 ----------------YPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293

Query: 365 PSMDEVVKVLTP-LQDLNDL 383
           P+   +   L   L+ L D+
Sbjct: 294 PTFSVLRLQLEKLLESLPDV 313

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  139 bits (352), Expect = 2e-38
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 36/217 (16%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDFLGQLHH 158
            +GEG FG V +G         +     + VA+K+ K       R +++ E   + Q  H
Sbjct: 22  CIGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           P++VKLIG   E+    ++ E  T G L + L  R   L  ++ I  A   +  LA+L  
Sbjct: 76  PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE- 133

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY-------- 270
            S+  ++RD    N+L+ S    KL DFGL+             R +    Y        
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKGKL 179

Query: 271 ----AAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
                APE +     TS SDV+ FGV + EIL  G +
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  143 bits (362), Expect = 2e-38
 Identities = 78/320 (24%), Positives = 133/320 (41%), Gaps = 47/320 (14%)

Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSI-----LGEGGFGYVFKG-WIEENGT 119
           + D       + C   +   Q L         +S+     LG+G FG V+ G W   NGT
Sbjct: 152 HADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW---NGT 208

Query: 120 APAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYE 179
                     VA+K+LKP  +     ++ E   + +L H  LV+L     E+    +V E
Sbjct: 209 TR--------VAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTE 258

Query: 180 FMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE 238
           +M++GSL + L       L     + +A   A G+A++       ++RD + +NIL+   
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGEN 316

Query: 239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEIL 298
              K++DFGLA+   + ++            + APE  + G  T KSDV+SFG++L E+ 
Sbjct: 317 LVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

Query: 299 TGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSL---KGV-QKVSQLAY 354
           T  R       + E                    V  ++E  Y +       + +  L  
Sbjct: 376 TKGRVPYPGMVNRE--------------------VLDQVERGYRMPCPPECPESLHDLMC 415

Query: 355 NCLSRDPKSRPSMDEVVKVL 374
            C  ++P+ RP+ + +   L
Sbjct: 416 QCWRKEPEERPTFEYLQAFL 435

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  139 bits (352), Expect = 2e-38
 Identities = 86/315 (27%), Positives = 131/315 (41%), Gaps = 79/315 (25%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           LGEG FG VF    E    +P K    + VAVK+LK   L   +++  E + L  L H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTKDK--MLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNRIKI 205
           +VK  G C + D  ++V+E+M  G L   L                     L  S  + I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
           A   A G+ +L   S+  ++RD  T N L+ +    K+ DFG++             R V
Sbjct: 139 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMS-------------RDV 183

Query: 266 GTYGY-------------AAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRP-- 309
            +  Y               PE +M    T++SDV+SFGV+L EI T G      K+P  
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG------KQPWF 237

Query: 310 --SGEQNLVAWARQYLADKRKLYQIVDPRL---ELNYSLKGVQKVSQLAYNCLSRDPKSR 364
             S  +       + +   R L +   PR+   E+ Y          +   C  R+P+ R
Sbjct: 238 QLSNTE-----VIECITQGRVLER---PRVCPKEV-Y---------DVMLGCWQREPQQR 279

Query: 365 PSMDEVVKVLTPLQD 379
            ++ E+ K+L  L  
Sbjct: 280 LNIKEIYKILHALGK 294

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (350), Expect = 4e-38
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            LG G FG V  G W    G           VA+K +K  G     E++ E   +  L H
Sbjct: 31  ELGTGQFGVVKYGKW---RGQ--------YDVAIKMIKE-GSMSEDEFIEEAKVMMNLSH 78

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
             LV+L G C +     ++ E+M  G L N+L            +++     + + +L  
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-- 136

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPEY 275
            S+  ++RD    N L++ +   K+SDFGL++     +     T  VG+     ++ PE 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 192

Query: 276 VMTGHLTSKSDVYSFGVVLLEILT-GRR 302
           +M    +SKSD+++FGV++ EI + G+ 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKM 220

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  137 bits (347), Expect = 9e-38
 Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 25/207 (12%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            +G+G FG V  G +             G  VAVK +K D     + ++AE   + QL H
Sbjct: 28  TIGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 73

Query: 159 PNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFL 216
            NLV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L   + + +L
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
                  ++RD    N+L+  +  AK+SDFGL K   +   T  + ++     + APE +
Sbjct: 134 E--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEAL 186

Query: 277 MTGHLTSKSDVYSFGVVLLEILT-GRR 302
                ++KSDV+SFG++L EI + GR 
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRV 213

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  138 bits (349), Expect = 1e-37
 Identities = 74/303 (24%), Positives = 116/303 (38%), Gaps = 45/303 (14%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKP-GSGITVAVKSLKPDGLQGHREWVAEVDF 152
           ++     LGEGGF YV             +    G   A+K +     Q   E   E D 
Sbjct: 30  HYLFIQKLGEGGFSYVDL----------VEGLHDGHFYALKRILCHEQQDREEAQREADM 79

Query: 153 LGQLHHPNLVKLIGYCIEDDQR----LLVYEFMTRGSLENHLFRRTI---PLPWSNRIKI 205
               +HPN+++L+ YC+ +        L+  F  RG+L N + R       L     + +
Sbjct: 80  HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
            LG  +GL  +H  ++   +RD K +NILL  E    L D G         +       +
Sbjct: 140 LLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 266 -------GTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL 315
                   T  Y APE         +  ++DV+S G VL  ++ G    D     G+   
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-- 255

Query: 316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
                  LA + +L     PR    +S      + QL  + ++ DP  RP +  ++  L 
Sbjct: 256 -----VALAVQNQLSIPQSPR----HS----SALWQLLNSMMTVDPHQRPHIPLLLSQLE 302

Query: 376 PLQ 378
            LQ
Sbjct: 303 ALQ 305

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  138 bits (349), Expect = 1e-37
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 47/226 (20%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLH 157
           +LG+G FG V +           + GS + VAVK LK D +      E++ E   + +  
Sbjct: 30  MLGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83

Query: 158 HPNLVKLIGYCIEDDQR------LLVYEFMTRGSLENHLFRRTIP-----LPWSNRIKIA 206
           HP++ KL+G  +    +      +++  FM  G L   L    I      LP    ++  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           +  A G+ +L   S   I+RD    N +L  +    ++DFGL+             R + 
Sbjct: 144 VDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLS-------------RKIY 188

Query: 267 TYGYA-------------APEYVMTGHLTSKSDVYSFGVVLLEILT 299
           +  Y              A E +     T  SDV++FGV + EI+T
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  136 bits (344), Expect = 3e-37
 Identities = 70/296 (23%), Positives = 113/296 (38%), Gaps = 57/296 (19%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           +F+   ++G GGFG VFK     +G          T  +K +K +  +  RE    V  L
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIKRVKYNNEKAERE----VKAL 58

Query: 154 GQLHHPNLVKLIGYCIEDDQRL----------------LVYEFMTRGSLENHL-FRRTIP 196
            +L H N+V   G     D                   +  EF  +G+LE  +  RR   
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           L     +++     KG+ ++H  S+ +I RD K SNI L      K+ DFGL        
Sbjct: 119 LDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLK 173

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
                TR  GT  Y +PE + +     + D+Y+ G++L E+L                  
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-----CDTAFETSKF- 227

Query: 317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                          + D  +   +     +K   L    LS+ P+ RP+  E+++
Sbjct: 228 ------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILR 267

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  143 bits (361), Expect = 3e-37
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 21/285 (7%)

Query: 24  SNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPA-PTDEKSPCQLLQ 82
           +  + + I R     + A  +    A+N +    +     S+  D A   DE+    +  
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381

Query: 83  FTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQ 141
               E++           +GEG FG V +G         +     + VA+K+ K      
Sbjct: 382 TRDYEIQRE--RIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDS 433

Query: 142 GHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN 201
              +++ E   + Q  HP++VKLIG   E+    ++ E  T G L + L  R   L  ++
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLAS 492

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
            I  A   +  LA+L   S+  ++RD    N+L+ S    KL DFGL++          S
Sbjct: 493 LILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550

Query: 262 TR---VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
                +       APE +     TS SDV+ FGV + EIL  G +
Sbjct: 551 KGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVK 591

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  136 bits (345), Expect = 6e-37
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 52/274 (18%)

Query: 56  APNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIE 115
           + +  H  S +P  A   E    +  ++ F               LGEG FG V     E
Sbjct: 3   SSHHHHHHSQDPMLAGVSEYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMA--E 55

Query: 116 ENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQ 173
             G    KP   +TVAVK LK D   +   + V+E++ +  +  H N++ L+G C +D  
Sbjct: 56  AVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115

Query: 174 RLLVYEFMTRGSLENHLFRR---------------TIPLPWSNRIKIALGAAKGLAFLHG 218
             ++ E+ ++G+L  +L  R                  + + + +      A+G+ +L  
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-- 173

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY-------- 270
            S+  I+RD    N+L+      K++DFGLA             R +    Y        
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------------RDINNIDYYKKTTNGR 220

Query: 271 -----AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 APE +     T +SDV+SFGV++ EI T
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  135 bits (342), Expect = 7e-37
 Identities = 71/318 (22%), Positives = 116/318 (36%), Gaps = 84/318 (26%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHP 159
           LGE  FG V+KG     G AP +      VA+K+LK         E+  E     +L HP
Sbjct: 17  LGEDRFGKVYKG--HLFGPAPGEQT--QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNRIK 204
           N+V L+G   +D    +++ + + G L   L  R                  L   + + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           +    A G+ +L   S  V+++D  T N+L+  + N K+SD GL              R 
Sbjct: 133 LVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLF-------------RE 177

Query: 265 VGTYGYA-------------APEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRP- 309
           V    Y              APE +M G  +  SD++S+GVVL E+ + G       +P 
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL------QPY 231

Query: 310 ---SGEQNLVAWARQYLADK-----RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDP 361
              S +  +     + +          +Y ++                      C +  P
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCPDDCPAWVYALM--------------------IECWNEFP 271

Query: 362 KSRPSMDEVVKVLTPLQD 379
             RP   ++   L    +
Sbjct: 272 SRRPRFKDIHSRLRAWGN 289

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (354), Expect = 8e-37
 Identities = 79/322 (24%), Positives = 134/322 (41%), Gaps = 47/322 (14%)

Query: 64  SDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSI-----LGEGGFGYVFKG-WIEEN 117
           S + D       + C   +   Q L         +S+     LG+G FG V+ G W   N
Sbjct: 233 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW---N 289

Query: 118 GTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV 177
           GT          VA+K+LKP  +     ++ E   + +L H  LV+L     E+    +V
Sbjct: 290 GTTR--------VAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIV 339

Query: 178 YEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD 236
            E+M++GSL + L       L     + +A   A G+A++       ++RD + +NIL+ 
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVG 397

Query: 237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 296
                K++DFGLA+   + ++            + APE  + G  T KSDV+SFG++L E
Sbjct: 398 ENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 456

Query: 297 ILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSL---KGV-QKVSQL 352
           + T  R       + E                    V  ++E  Y +       + +  L
Sbjct: 457 LTTKGRVPYPGMVNRE--------------------VLDQVERGYRMPCPPECPESLHDL 496

Query: 353 AYNCLSRDPKSRPSMDEVVKVL 374
              C  ++P+ RP+ + +   L
Sbjct: 497 MCQCWRKEPEERPTFEYLQAFL 518

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  135 bits (341), Expect = 1e-36
 Identities = 64/307 (20%), Positives = 112/307 (36%), Gaps = 58/307 (18%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           +F   ++LG+G FG V K                   A+K ++    +     ++EV  L
Sbjct: 7   DFEEIAVLGQGAFGQVVKA--RNALD-------SRYYAIKKIRHTEEK-LSTILSEVMLL 56

Query: 154 GQLHHPNLVKLIGYCIEDDQRL-------------LVYEFMTRGSLENHLFRRTIPLPWS 200
             L+H  +V+     +E    +             +  E+   G+L + +    +     
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
              ++     + L+++H  S+ +I+RD K  NI +D   N K+ DFGLAK   +      
Sbjct: 117 EYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 261 S------------TRVVGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEILTGRRSMDK 306
                        T  +GT  Y A E V+  TGH   K D+YS G++  E++        
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP------ 227

Query: 307 KRPSGEQNLVAWARQYLADK-RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
              S         R  +  K R +     P  + N      + +       +  DP  RP
Sbjct: 228 --FSTGME-----RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL----LIDHDPNKRP 276

Query: 366 SMDEVVK 372
               ++ 
Sbjct: 277 GARTLLN 283

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  134 bits (340), Expect = 2e-36
 Identities = 78/325 (24%), Positives = 129/325 (39%), Gaps = 53/325 (16%)

Query: 63  SSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPA 122
                 P P  +          +  L     NFR +  +G G F  V++     +G    
Sbjct: 6   QGMQGPPVPQFQPQKALRPDMGYNTLA----NFRIEKKIGRGQFSEVYRAACLLDGV--- 58

Query: 123 KPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYE 179
                  VA+K ++   L   +     + E+D L QL+HPN++K     IED++  +V E
Sbjct: 59  ------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112

Query: 180 FMTRGSLENHL---FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD 236
               G L   +    ++   +P     K  +     L  +H  S  V++RD K +N+ + 
Sbjct: 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFIT 170

Query: 237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 296
           +    KL D GL +      KT  +  +VGT  Y +PE +       KSD++S G +L E
Sbjct: 171 ATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228

Query: 297 ILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV--------DPRLELNYSLKGVQK 348
           +         + P            +  DK  LY +          P    +YS    ++
Sbjct: 229 MAAL------QSP------------FYGDKMNLYSLCKKIEQCDYPPLPSDHYS----EE 266

Query: 349 VSQLAYNCLSRDPKSRPSMDEVVKV 373
           + QL   C++ DP+ RP +  V  V
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDV 291

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (338), Expect = 2e-36
 Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 25/209 (11%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            LG G FG V+ G +   NG           VAVKSLK   +     ++AE + + QL H
Sbjct: 20  RLGAGQFGEVWMGYY---NGH--------TKVAVKSLKQGSMS-PDAFLAEANLMKQLQH 67

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAAKGLAFLH 217
             LV+L     ++    ++ E+M  GSL + L     I L  +  + +A   A+G+AF+ 
Sbjct: 68  QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI- 125

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT---YGYAAPE 274
                 I+RD + +NIL+    + K++DFGLA+     +     T   G      + APE
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPE 180

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILT-GRR 302
            +  G  T KSDV+SFG++L EI+T GR 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI 209

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  135 bits (341), Expect = 3e-36
 Identities = 70/354 (19%), Positives = 128/354 (36%), Gaps = 55/354 (15%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH--REWVAEVD 151
            +     +GEG FG        E+G             +K +    +      E   EV 
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGR---------QYVIKEINISRMSSKEREESRREVA 75

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTIPLPWSNRIKIALGAA 210
            L  + HPN+V+      E+    +V ++   G L   +  ++ +       +   +   
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             L  +H     +++RD K+ NI L  +   +L DFG+A+         ++   +GT  Y
Sbjct: 136 LALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYY 191

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            +PE        +KSD+++ G VL E+ T       K      ++       L  K    
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTL------KHAFEAGSMKN-----LVLK---- 236

Query: 331 QIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV----------KVLTPL 377
            I+    P + L+YS      +  L      R+P+ RPS++ ++          K L+P 
Sbjct: 237 -IISGSFPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ 291

Query: 378 QDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASA------HSKSIRDSPLNTGK 425
               +  + ++    SQ    K+   G   ++           +    PL   K
Sbjct: 292 LIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKK 345

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  133 bits (337), Expect = 7e-36
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 41/223 (18%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-H 157
           ++GEG FG V K  I+       K G  +  A+K +K       HR++  E++ L +L H
Sbjct: 32  VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNR 202
           HPN++ L+G C       L  E+   G+L + L +                   L     
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS- 261
           +  A   A+G+ +L    +  I+RD    NIL+   Y AK++DFGL++      K  +  
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202

Query: 262 -----TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                          A E +     T+ SDV+S+GV+L EI++
Sbjct: 203 LPVRWM---------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (343), Expect = 1e-35
 Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 52/286 (18%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
            LG G FG V+   +   N            VAVK++KP  +     ++AE + +  L H
Sbjct: 195 KLGAGQFGEVWMATY---NKH--------TKVAVKTMKPGSMS-VEAFLAEANVMKTLQH 242

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF-RRTIPLPWSNRIKIALGAAKGLAFLH 217
             LVKL     ++    ++ EFM +GSL + L        P    I  +   A+G+AF+ 
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI- 300

Query: 218 GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM 277
                 I+RD + +NIL+ +    K++DFGLA+   + ++            + APE + 
Sbjct: 301 -EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAIN 358

Query: 278 TGHLTSKSDVYSFGVVLLEILT-GRR---SMDKKRPSGEQNLVAWARQYLADK-----RK 328
            G  T KSDV+SFG++L+EI+T GR     M     S  + + A  R Y   +      +
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALERGYRMPRPENCPEE 413

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           LY I+                      C    P+ RP+ + +  VL
Sbjct: 414 LYNIM--------------------MRCWKNRPEERPTFEYIQSVL 439

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (333), Expect = 2e-35
 Identities = 69/304 (22%), Positives = 114/304 (37%), Gaps = 55/304 (18%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDF 152
           +F P   LG GGFG VF+                   A+K ++    +  RE V  EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVKA 56

Query: 153 LGQLHHPNLVKLIGYCIEDD---------QRLLVY---EFMTRGSLENHLFRR--TIPLP 198
           L +L HP +V+     +E +          ++ +Y   +   + +L++ +  R       
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 199 WSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA------- 251
            S  + I L  A+ + FLH  S+ +++RD K SNI    +   K+ DFGL  A       
Sbjct: 117 RSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 252 ---GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR 308
                        T  VGT  Y +PE +     + K D++S G++L E+L          
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------P 226

Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD 368
            S +       R       +  +   P L              +  + LS  P  RP   
Sbjct: 227 FSTQME-----RVRTLTDVRNLKF--PPLFTQKY----PCEYVMVQDMLSPSPMERPEAI 275

Query: 369 EVVK 372
            +++
Sbjct: 276 NIIE 279

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  131 bits (332), Expect = 3e-35
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 26/215 (12%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHH 158
            LG G FG V++G  + +G         + VAVK+L      Q   +++ E   + + +H
Sbjct: 37  GLGHGAFGEVYEG--QVSGMPNDPSP--LQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR------TIPLPWSNRIKIALGAAKG 212
            N+V+ IG  ++   R ++ E M  G L++ L            L   + + +A   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             +L       I+RD    N LL        AK+ DFG+A+   +           G   
Sbjct: 153 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCA 205

Query: 270 Y-----AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                   PE  M G  TSK+D +SFGV+L EI +
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  132 bits (334), Expect = 5e-35
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 47/230 (20%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-H 157
            LGEG FG V     E  G    KP   +TVAVK LK D   +   + V+E++ +  +  
Sbjct: 88  PLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNR 202
           H N++ L+G C +D    ++ E+ ++G+L  +L  R                  + + + 
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +      A+G+ +L   S+  I+RD    N+L+      K++DFGLA             
Sbjct: 206 VSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLA------------- 250

Query: 263 RVVGTYGY-------------AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           R +    Y              APE +     T +SDV+SFGV++ EI T
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  131 bits (332), Expect = 9e-35
 Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 47/229 (20%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-HH 158
           LGEG FG V     E  G    KP     VAVK LK D   +   + ++E++ +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL-FRRTIPLPWSNR--------------I 203
            N++ L+G C +D    ++ E+ ++G+L  +L  RR   L +S                +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
             A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA             R
Sbjct: 195 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------------R 239

Query: 264 VVGTYGY-------------AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
            +    Y              APE +     T +SDV+SFGV+L EI T
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  131 bits (331), Expect = 1e-34
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 26/215 (12%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHH 158
            LG G FG V++G  + +G         + VAVK+L      Q   +++ E   + + +H
Sbjct: 78  GLGHGAFGEVYEG--QVSGMPNDPSP--LQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR------TIPLPWSNRIKIALGAAKG 212
            N+V+ IG  ++   R ++ E M  G L++ L            L   + + +A   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             +L       I+RD    N LL        AK+ DFG+A+   +           G   
Sbjct: 194 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCA 246

Query: 270 Y-----AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                   PE  M G  TSK+D +SFGV+L EI +
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (325), Expect = 4e-34
 Identities = 74/332 (22%), Positives = 123/332 (37%), Gaps = 48/332 (14%)

Query: 48  NASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFG 107
            AS  +  +   A L    P+    +     + L+    E +           +G G FG
Sbjct: 13  LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFG 72

Query: 108 YVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGY 167
            V +   ++ G            AVK ++   L+  R    E+     L  P +V L G 
Sbjct: 73  EVHRMKDKQTGF---------QCAVKKVR---LEVFRV--EELVACAGLSSPRIVPLYGA 118

Query: 168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRD 227
             E     +  E +  GSL   L ++   LP    +     A +GL +LH  +  +++ D
Sbjct: 119 VREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH--TRRILHGD 175

Query: 228 FKTSNILLDSE-YNAKLSDFGLAK--AGPQGDKTHVSTR-VVGTYGYAAPEYVM-TGHLT 282
            K  N+LL S+   A L DFG A         K+ ++   + GT  + APE VM      
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-D 234

Query: 283 SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PRLEL 339
           +K D++S   ++L +L G        P        W +          +I     P  E+
Sbjct: 235 AKVDIWSSCCMMLHMLNG------CHP--------WTQ--YFRGPLCLKIASEPPPIREI 278

Query: 340 --NYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
             + +    Q + +     L ++P  R S  E
Sbjct: 279 PPSCAPLTAQAIQE----GLRKEPVHRASAME 306

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (321), Expect = 4e-34
 Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 44/298 (14%)

Query: 88  LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHRE 145
           + S   ++     +G G +G   K   + +G           +  K L    +     + 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGK---------ILVWKELDYGSMTEAEKQM 51

Query: 146 WVAEVDFLGQLHHPNLVKLIG-YCIEDDQRL-LVYEFMTRGSLENHL---FRRTIPLPWS 200
            V+EV+ L +L HPN+V+         +  L +V E+   G L + +    +    L   
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111

Query: 201 NRIKIALGAAKGLAFLH---GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK 257
             +++       L   H    G   V++RD K +N+ LD + N KL DFGLA+       
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHD 169

Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
           T  +   VGT  Y +PE +       KSD++S G +L E+           P    +   
Sbjct: 170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL------MPPFTAFSQKE 223

Query: 318 WARQYLADKRKLYQIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                LA K     I +    R+   YS     +++++    L+     RPS++E+++
Sbjct: 224 -----LAGK-----IREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (323), Expect = 5e-34
 Identities = 69/334 (20%), Positives = 116/334 (34%), Gaps = 69/334 (20%)

Query: 61  HLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTA 120
           H    +        ++        FQ +      +     +G GG   VF+  + E    
Sbjct: 2   HHHHHHSSGVDLGTENL------YFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQ- 53

Query: 121 PAKPGSGITVAVK-----SLKPDGLQGHREWVAEVDFLGQLHHPNL--VKLIGYCIEDDQ 173
                     A+K           L  +R    E+ +L +L   +   ++L  Y    DQ
Sbjct: 54  --------IYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDKIIRLYDY-EITDQ 101

Query: 174 RL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN 232
            + +V E      L + L ++   +    R        + +  +H     +++ D K +N
Sbjct: 102 YIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPAN 157

Query: 233 ILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-----------TGHL 281
            L+      KL DFG+A        + V    VGT  Y  PE +               +
Sbjct: 158 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216

Query: 282 TSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADKRKLYQIVDPRLELN 340
           + KSDV+S G +L  +  G      K P     N ++          KL+ I+DP  E+ 
Sbjct: 217 SPKSDVWSLGCILYYMTYG------KTPFQQIINQIS----------KLHAIIDPNHEIE 260

Query: 341 YSLKGVQKVSQLA----YNCLSRDPKSRPSMDEV 370
           +         +        CL RDPK R S+ E+
Sbjct: 261 FP----DIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 6e-34
 Identities = 63/331 (19%), Positives = 111/331 (33%), Gaps = 46/331 (13%)

Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WV 147
            ++   +    ILG+G    VF+G      T       G   A+K           +  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRG--RHKKT-------GDLFAIKVFNNISFLRPVDVQM 55

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVY---EFMTRGSLENHLFR--RTIPLPWSNR 202
            E + L +L+H N+VKL     E+          EF   GSL   L        LP S  
Sbjct: 56  REFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL----DSEYNAKLSDFGLAKAGPQGDKT 258
           + +      G+  L      +++R+ K  NI+     D +   KL+DFG A+     ++ 
Sbjct: 115 LIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172

Query: 259 HVSTRVVGTYGYAAPEYVMTGHL--------TSKSDVYSFGVVLLEILTGR--------- 301
                + GT  Y  P+      L         +  D++S GV      TG          
Sbjct: 173 VS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 302 ---RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLS 358
              + +  K  +G+ +      Q   +    +    P    + S      ++ +  N L 
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILE 288

Query: 359 RDPKSRPSMDEVVKVLTPLQDLNDLAILSYH 389
            D +     D+     + +    +     +H
Sbjct: 289 ADQEKCWGFDQFFAETSDILHRGNSHHHHHH 319

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  130 bits (329), Expect = 6e-34
 Identities = 68/312 (21%), Positives = 115/312 (36%), Gaps = 57/312 (18%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           +F P  +LG G  G +                    VAVK + P+          EV  L
Sbjct: 25  SFCPKDVLGHGAEGTIVY----------RGMFDNRDVAVKRILPECFSFADR---EVQLL 71

Query: 154 GQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
            +   HPN+++      +   + +  E     +L+ ++ ++         I +      G
Sbjct: 72  RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG 130

Query: 213 LAFLHGGSEPVIYRDFKTSNILL-----DSEYNAKLSDFGLAKAGPQGDKT-HVSTRVVG 266
           LA LH  S  +++RD K  NIL+       +  A +SDFGL K    G  +    + V G
Sbjct: 131 LAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 267 TYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
           T G+ APE +      + T   D++S G V   +++         P G+           
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE-----GSHPFGKSL--------- 234

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEV--------- 370
             ++    +    L+    L   +    +A       ++ DP+ RPS   V         
Sbjct: 235 -QRQANILLGACSLD---CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

Query: 371 VKVLTPLQDLND 382
            K L   QD++D
Sbjct: 291 EKQLQFFQDVSD 302

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (324), Expect = 7e-34
 Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 56/236 (23%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHP 159
           +GEG FG VF+      G  P +P     VAVK LK +       ++  E   + +  +P
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPF--TMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-----------------------TIP 196
           N+VKL+G C       L++E+M  G L   L                            P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           L  + ++ IA   A G+A+L       ++RD  T N L+      K++DFGL+       
Sbjct: 171 LSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLS------- 221

Query: 257 KTHVSTRVVGTYGY-------------AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                 R + +  Y               PE +     T++SDV+++GVVL EI +
Sbjct: 222 ------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (320), Expect = 1e-33
 Identities = 65/232 (28%), Positives = 94/232 (40%), Gaps = 51/232 (21%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-H 157
            LG G FG V +           K  + +TVAVK LKP   L      ++E+  L  L +
Sbjct: 30  TLGAGAFGKVVEATAYG----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-----------------TIPLPWS 200
           H N+V L+G C      L++ E+   G L N L R+                  + L   
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
           + +  +   AKG+AFL   S+  I+RD    NILL      K+ DFGLA           
Sbjct: 146 DLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLA----------- 192

Query: 261 STRVVGTYGY-------------AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
             R +                   APE +     T +SDV+S+G+ L E+ +
Sbjct: 193 --RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (322), Expect = 3e-33
 Identities = 64/329 (19%), Positives = 111/329 (33%), Gaps = 46/329 (13%)

Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WV 147
            ++   +    ILG+G    VF+G      T       G   A+K           +  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRG--RHKKT-------GDLFAIKVFNNISFLRPVDVQM 55

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVY---EFMTRGSLENHLFR--RTIPLPWSNR 202
            E + L +L+H N+VKL     E+          EF   GSL   L        LP S  
Sbjct: 56  REFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL----DSEYNAKLSDFGLAKAGPQGDKT 258
           + +      G+  L      +++R+ K  NI+     D +   KL+DFG A+     D  
Sbjct: 115 LIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDE 170

Query: 259 HVSTRVVGTYGYAAPEYVMTGHL--------TSKSDVYSFGVVLLEILTGR--------- 301
              + + GT  Y  P+      L         +  D++S GV      TG          
Sbjct: 171 QFVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 302 ---RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLS 358
              + +  K  +G+ +      Q   +    +    P    + S      ++ +  N L 
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILE 288

Query: 359 RDPKSRPSMDEVVKVLTPLQDLNDLAILS 387
            D +     D+     + +     + + S
Sbjct: 289 ADQEKCWGFDQFFAETSDILHRMVIHVFS 317

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (317), Expect = 3e-33
 Identities = 63/251 (25%), Positives = 92/251 (36%), Gaps = 26/251 (10%)

Query: 56  APNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIE 115
             +  H S   P  +  D  +        F       G +R   ++G GG G V++    
Sbjct: 5   HHHHHHSSGLVPRGSHMDG-TAESREGTQF-------GPYRLRRLVGRGGMGDVYEAE-- 54

Query: 116 ENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----EVDFLGQLHHPNLVKLIGYCIED 171
                         VA+K +    L     +      E    G+L  P++V +  +   D
Sbjct: 55  -------DTVRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106

Query: 172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTS 231
            Q  +    +    L   L RR  PL     + I       L   H       +RD K  
Sbjct: 107 GQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPE 163

Query: 232 NILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFG 291
           NIL+ ++  A L DFG+A A      T +    VGT  Y APE     H T ++D+Y+  
Sbjct: 164 NILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATYRADIYALT 222

Query: 292 VVLLEILTGRR 302
            VL E LTG  
Sbjct: 223 CVLYECLTGSP 233

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (315), Expect = 5e-33
 Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 38/296 (12%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA---- 148
             ++    LG GG   V+                   VA+K++     +   E +     
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNI---------KVAIKAIFIP-PREKEETLKRFER 60

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV    QL H N+V +I    EDD   LV E++   +L  ++     PL     I     
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQ 119

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
              G+   H     +++RD K  NIL+DS    K+ DFG+AKA  +   T  +  V+GT 
Sbjct: 120 ILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTV 176

Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADKR 327
            Y +PE          +D+YS G+VL E+L G        P +GE   V+ A +++ D  
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQD-- 227

Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVKVLTPLQ 378
               + +   ++   +   Q +S +      +D  +R        D++  VL   +
Sbjct: 228 ---SVPNVTTDVRKDIP--QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (316), Expect = 5e-33
 Identities = 74/266 (27%), Positives = 107/266 (40%), Gaps = 54/266 (20%)

Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKG-WIEENGTAPAKP 124
           +PD  P DE   C+ L +   + +      +    LG G FG V +      + TA    
Sbjct: 2   DPDELPLDE--HCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATC-- 57

Query: 125 GSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQ-RLLVYEFM 181
               TVAVK LK       HR  ++E+  L  + HH N+V L+G C +     +++ EF 
Sbjct: 58  ---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 114

Query: 182 TRGSLENHLFRR---------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYR 226
             G+L  +L  +                  L   + I  +   AKG+ FL   S   I+R
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHR 172

Query: 227 DFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY-------------AAP 273
           D    NILL  +   K+ DFGLA             R +                   AP
Sbjct: 173 DLAARNILLSEKNVVKICDFGLA-------------RDIYKDPDYVRKGDARLPLKWMAP 219

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILT 299
           E +     T +SDV+SFGV+L EI +
Sbjct: 220 ETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  125 bits (316), Expect = 6e-33
 Identities = 67/238 (28%), Positives = 97/238 (40%), Gaps = 58/238 (24%)

Query: 100 ILGEGGFGYVFKG-WIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLH 157
            LGEG FG V K       G A        TVAVK LK +      R+ ++E + L Q++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGY-----TTVAVKMLKENASPSELRDLLSEFNVLKQVN 84

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-----------------------T 194
           HP+++KL G C +D   LL+ E+   GSL   L                           
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144

Query: 195 IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
             L   + I  A   ++G+ +L      +++RD    NIL+      K+SDFGL+     
Sbjct: 145 RALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLS----- 197

Query: 255 GDKTHVSTRVVGTYGY-------------AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                   R V                   A E +     T++SDV+SFGV+L EI+T
Sbjct: 198 --------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (317), Expect = 7e-33
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 31/220 (14%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-H 157
            LG G FG V +      G    K  + + VAVK LK           ++E+  +  L  
Sbjct: 53  TLGAGAFGKVVEATAFGLG----KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-------------TIPLPWSNRIK 204
           H N+V L+G C      L++ E+   G L N L R+                    + + 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
            +   A+G+AFL   S+  I+RD    N+LL + + AK+ DFGLA+     D  + S  +
Sbjct: 169 FSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYI 221

Query: 265 VGTYG-----YAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           V         + APE +     T +SDV+S+G++L EI +
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  124 bits (314), Expect = 7e-33
 Identities = 60/280 (21%), Positives = 114/280 (40%), Gaps = 43/280 (15%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG+G +G V+ G    N            +A+K +     +  +    E+     L H 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQV---------RIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI--KIALGAAKGLAFLH 217
           N+V+ +G   E+    +  E +  GSL   L  +  PL  + +          +GL +LH
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139

Query: 218 GGSEPVIYRDFKTSNILLDSEY-NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
                +++RD K  N+L+++     K+SDFG +K     +    +    GT  Y APE +
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195

Query: 277 ---MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI- 332
                G+    +D++S G  ++E+ TG      K P        +  +    +  ++++ 
Sbjct: 196 DKGPRGY-GKAADIWSLGCTIIEMATG------KPP--------FY-ELGEPQAAMFKVG 239

Query: 333 ---VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
              V P +  + S +    + +    C   DP  R   ++
Sbjct: 240 MFKVHPEIPESMSAEAKAFILK----CFEPDPDKRACAND 275

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  126 bits (317), Expect = 1e-32
 Identities = 78/416 (18%), Positives = 135/416 (32%), Gaps = 79/416 (18%)

Query: 42  TETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSIL 101
           +  +   A+  E    +   L +D+ D A +       +    +  LK           +
Sbjct: 15  SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILK----------QI 64

Query: 102 GEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGHREWVAEVDFLGQL 156
           G GG   VF+  + E              A+K           L  +R    E+ +L +L
Sbjct: 65  GSGGSSKVFQV-LNEKKQ---------IYAIKYVNLEEADNQTLDSYRN---EIAYLNKL 111

Query: 157 HHPNL--VKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
              +   ++L  Y    DQ + +V E      L + L ++   +    R        + +
Sbjct: 112 QQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAV 168

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
             +H     +++ D K +N L+      KL DFG+A        + V    VG   Y  P
Sbjct: 169 HTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

Query: 274 EYVM-----------TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQ 321
           E +               ++ KSDV+S G +L  +  G      K P     N ++    
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG------KTPFQQIINQIS---- 275

Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLA----YNCLSRDPKSRPSMDE------VV 371
                 KL+ I+DP  E+ +         +        CL RDPK R S+ E      V 
Sbjct: 276 ------KLHAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

Query: 372 KVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLNTGKQR 427
               P+  +           L Q           +   + +         N+   +
Sbjct: 326 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSK 381

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  124 bits (314), Expect = 2e-32
 Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 63/294 (21%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGHREWVAEVDFLGQ 155
           +G GG   VF+  + E              A+K           L  +R    E+ +L +
Sbjct: 17  IGSGGSSKVFQV-LNEKKQ---------IYAIKYVNLEEADNQTLDSYRN---EIAYLNK 63

Query: 156 LHHPNL--VKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           L   +   ++L  Y    DQ + +V E      L + L ++   +    R        + 
Sbjct: 64  LQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 120

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           +  +H     +++ D K +N L+      KL DFG+A        + V    VGT  Y  
Sbjct: 121 VHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 273 PEYVM-----------TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWAR 320
           PE +               ++ KSDV+S G +L  +  G      K P     N ++   
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG------KTPFQQIINQIS--- 228

Query: 321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLA----YNCLSRDPKSRPSMDEV 370
                  KL+ I+DP  E+ +         +        CL RDPK R S+ E+
Sbjct: 229 -------KLHAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  126 bits (318), Expect = 1e-31
 Identities = 82/363 (22%), Positives = 131/363 (36%), Gaps = 51/363 (14%)

Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEV 150
            G +     LG GGFGYV + WI ++        +G  VA+K  + +    +RE W  E+
Sbjct: 13  CGPWEMKERLGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEI 63

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFR--RTIPLPWS 200
             + +L+HPN+V      + D  +        LL  E+   G L  +L +      L   
Sbjct: 64  QIMKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA---KLSDFGLAKAGPQGDK 257
               +    +  L +LH     +I+RD K  NI+L         K+ D G AK   QG+ 
Sbjct: 122 PIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179

Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
                  VGT  Y APE +     T   D +SFG +  E +TG       RP        
Sbjct: 180 CTEF---VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF------RPFLPNWQPV 230

Query: 318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNC------------LSRDPKSRP 365
                + +K   + +V   L        V                      L    + R 
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290

Query: 366 SMDEV--VKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLNT 423
           +  +   V     L  +  L +LS  + +S +          + L +  S   +D+ +  
Sbjct: 291 TDPQNPNVGCFQALDSILSLKLLSVMNMVSGR-VHTYPVTENENLQNLKSWLQQDTGIPE 349

Query: 424 GKQ 426
            +Q
Sbjct: 350 EEQ 352

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (308), Expect = 1e-31
 Identities = 62/237 (26%), Positives = 93/237 (39%), Gaps = 56/237 (23%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-H 157
           +LG G FG V            +K G  I VAVK LK           ++E+  + QL  
Sbjct: 52  VLGSGAFGKVMNATA----YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR----------------------TI 195
           H N+V L+G C       L++E+   G L N+L  +                        
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
            L + + +  A   AKG+ FL    +  ++RD    N+L+      K+ DFGLA      
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219

Query: 256 DKTHVSTRVVGTYGY-------------AAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
                  R + +                 APE +  G  T KSDV+S+G++L EI +
Sbjct: 220 -------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (304), Expect = 3e-31
 Identities = 72/327 (22%), Positives = 117/327 (35%), Gaps = 55/327 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKP-GSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HH 158
           L EGGF +V++          A+  GSG   A+K L  +  + +R  + EV F+ +L  H
Sbjct: 36  LAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85

Query: 159 PNLVKLIGYCIEDDQR-------LLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIALGA 209
           PN+V+         +         L+   + +G L   L +     PL     +KI    
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA---GPQGDKTHVSTRVV- 265
            + +  +H    P+I+RD K  N+LL ++   KL DFG A      P    +     +V 
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 266 ------GTYGYAAPEYV-MTGHL--TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
                  T  Y  PE + +  +     K D+++ G +L  +         + P  +    
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR------QHPFEDGAK- 258

Query: 317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP 376
                 L      Y I                   L    L  +P+ R S+ EVV  L  
Sbjct: 259 ------LRIVNGKYSIPPH---DTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305

Query: 377 LQDLNDLAILS-YHSRLSQQGRRKKKQ 402
           +    ++   S     L Q G      
Sbjct: 306 IAAARNVNPKSPITELLEQNGGYGSAT 332

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (301), Expect = 5e-31
 Identities = 83/320 (25%), Positives = 129/320 (40%), Gaps = 56/320 (17%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV-AEVDFL 153
           F     +G+G FG VFKG                 VA+K +  +  +   E +  E+  L
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQK---------VVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL---GAA 210
            Q   P + K  G  ++D +  ++ E++  GS  + L    +         IA       
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREIL 129

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTY 268
           KGL +LH  SE  I+RD K +N+LL      KL+DFG+A    Q   T    R   VGT 
Sbjct: 130 KGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDT-QIKRNTFVGTP 183

Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            + APE +      SK+D++S G+  +E+  G     +  P                 + 
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----------------KV 227

Query: 329 LYQIVD---PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE------VVKVLTPLQD 379
           L+ I     P LE NYS    + V      CL+++P  RP+  E      +++       
Sbjct: 228 LFLIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

Query: 380 LNDLAILSYHSRLSQQGRRK 399
           L +L I  Y    ++Q    
Sbjct: 284 LTEL-IDRYKRWKAEQSHDD 302

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (293), Expect = 6e-30
 Identities = 59/306 (19%), Positives = 104/306 (33%), Gaps = 65/306 (21%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK--SLKPDGLQGHREWVAEVD 151
            F     +G G FG VFK           K   G   A+K       G    +  + EV 
Sbjct: 12  EFHELEKIGSGEFGSVFKCV---------KRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62

Query: 152 FLGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHL---FRRTIPLPWSNRIKIAL 207
               L  H ++V+      EDD  L+  E+   GSL + +   +R       +    + L
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLD-------------------SEYNAKLSDFGL 248
              +GL ++H  S  +++ D K SNI +                    ++   K+ D G 
Sbjct: 123 QVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEILTGRRSMDK 306
                +     V     G   + A E +     HL  K+D+++  + ++           
Sbjct: 181 VT---RISSPQV---EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGA------ 227

Query: 307 KRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
           +      +             ++ Q   PR+    S +  + +       +  DP+ RPS
Sbjct: 228 EPLPRNGDQW----------HEIRQGRLPRIPQVLSQEFTELLKV----MIHPDPERRPS 273

Query: 367 MDEVVK 372
              +VK
Sbjct: 274 AMALVK 279

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (296), Expect = 6e-30
 Identities = 40/351 (11%), Positives = 71/351 (20%), Gaps = 61/351 (17%)

Query: 58  NEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEEN 117
            EA         A T    P          L       +    L  G    VF     E 
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86

Query: 118 GTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLHHPNLVKLIGYC------ 168
                        A+K           E            +L   +  +           
Sbjct: 87  LE---------DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137

Query: 169 --------------------IEDDQRLLVYEFM-----TRGSLENHLFRRTIPLPWSNRI 203
                                     LL+            S  + ++            
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALH 197

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
            +     +  A L   S+ +++  F   N+ +  +    L D                  
Sbjct: 198 ILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA----- 250

Query: 264 VVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
                 YA  E++       T   + +  G+ +  +           P G         +
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF------LPFGLVTP---GIK 301

Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
               +  L       L           V  L    L+ D + R    E ++
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  116 bits (292), Expect = 1e-29
 Identities = 77/327 (23%), Positives = 133/327 (40%), Gaps = 54/327 (16%)

Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVD 151
              F     LGEG +G V+K       T       G  VA+K +  +     +E + E+ 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKA--IHKET-------GQIVAIKQVPVE--SDLQEIIKEIS 76

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            + Q   P++VK  G   ++    +V E+   GS+ + +  R   L       I     K
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYG 269
           GL +LH      I+RD K  NILL++E +AKL+DFG+A    Q   T ++ R  V+GT  
Sbjct: 137 GLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDT-MAKRNTVIGTPF 190

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           + APE +        +D++S G+  +E+  G+       P                 R +
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----------------RAI 234

Query: 330 YQIVD---PRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEV-----VKVLTPL 377
           + I     P        +  +  S    +    CL + P+ R +  ++     V+    +
Sbjct: 235 FMIPTNPPPT------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288

Query: 378 QDLNDLAILSYHSRLSQQGRRKKKQDG 404
             L DL I        ++   +++++G
Sbjct: 289 SILRDL-INEAMDVKLKRQESQQREEG 314

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (303), Expect = 1e-29
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 27/216 (12%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVD 151
           G +     +  GG G+++               +G  V +K L   G    +   +AE  
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQ 131

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRL-----LVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
           FL ++ HP++V++  +    D+       +V E++   SL+    +    LP +  I   
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYL 188

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           L     L++LH  S  ++Y D K  NI+L  E   KL D G                + G
Sbjct: 189 LEILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYG 239

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR 302
           T G+ APE ++    T  +D+Y+ G  L  +     
Sbjct: 240 TPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (291), Expect = 1e-29
 Identities = 73/298 (24%), Positives = 121/298 (40%), Gaps = 55/298 (18%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G+G  G V+               +G  VA++ +           + E+  + +  +PN
Sbjct: 28  IGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI-KIALGAAKGLAFLHGG 219
           +V  +   +  D+  +V E++  GSL + +    +       I  +     + L FLH  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLH-- 133

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYGYAAPEYVM 277
           S  VI+RD K+ NILL  + + KL+DFG      Q      S R  +VGT  + APE V 
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPE-QSKRSTMVGTPYWMAPEVVT 189

Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD--- 334
                 K D++S G++ +E++ G      + P                 R LY I     
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALYLIATNGT 233

Query: 335 PRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEV-----VKVLTPLQDLNDL 383
           P       L+  +K+S +  +    CL  D + R S  E+     +K+  PL  L  L
Sbjct: 234 PE------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  115 bits (289), Expect = 3e-29
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 43/301 (14%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA---- 148
             +    ILG GG   V       +            VAVK L+ D L     +      
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHR---------DVAVKVLRAD-LARDPSFYLRFRR 61

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL----LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
           E      L+HP +V +      +        +V E++   +L + +     P+     I+
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIE 120

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST-R 263
           +   A + L F H     +I+RD K +NI++ +    K+ DFG+A+A      +   T  
Sbjct: 121 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQY 322
           V+GT  Y +PE      + ++SDVYS G VL E+LTG        P +G+ + V+ A Q+
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SPVSVAYQH 231

Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVKVLTPL 377
           + +       + P    +  L     +  +    L+++P++R         ++V+V    
Sbjct: 232 VRE-----DPIPPS-ARHEGLS--ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283

Query: 378 Q 378
            
Sbjct: 284 P 284

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (291), Expect = 4e-29
 Identities = 46/376 (12%), Positives = 95/376 (25%), Gaps = 95/376 (25%)

Query: 43  ETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILG 102
           +      S     A +    +S      P   +S          EL          ++LG
Sbjct: 33  QANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES----------ELGERPRTLVRGTVLG 82

Query: 103 EGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK-------------------------- 136
           +       +   +E G          +  V                              
Sbjct: 83  QEDPYAYLEATDQETGE---------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 137 --PDGLQGHREWVAEVDFLGQLHHPNLVKLIGYC--IEDDQRLLVYEFM-----TRGSLE 187
                 + H  ++   D +       ++++      +    R  +Y  M     T G + 
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 188 NHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG 247
                    L    R+++ L   + LA LH     +++   +  +I+LD      L+ F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLE 296
                    +         + G+  PE                 +T   D ++ G+V+  
Sbjct: 252 HLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 297 ILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNC 356
           I           P  +   +  +       + +     P           Q V  L    
Sbjct: 306 IWCADL------PITKDAALGGSEWIFRSCKNI-----P-----------QPVRALLEGF 343

Query: 357 LSRDPKSRPSMDEVVK 372
           L    + R    + ++
Sbjct: 344 LRYPKEDRLLPLQAME 359

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  114 bits (286), Expect = 9e-29
 Identities = 71/298 (23%), Positives = 123/298 (41%), Gaps = 55/298 (18%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +GEG  G V      E  +       G  VAVK +     Q       EV  +    H N
Sbjct: 53  IGEGSTGIVCLA--REKHS-------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI-KIALGAAKGLAFLHGG 219
           +V++    +  ++  ++ EF+  G+L + + +  +       I  +     + LA+LH  
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ---IATVCEAVLQALAYLH-- 158

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYGYAAPEYVM 277
           ++ VI+RD K+ +ILL  +   KLSDFG      Q  K  V  R  +VGT  + APE + 
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKD-VPKRKSLVGTPYWMAPEVIS 214

Query: 278 TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD--- 334
                ++ D++S G++++E++ G        P                 + + ++ D   
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----------------QAMKRLRDSPP 258

Query: 335 PRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEV-----VKVLTPLQDLNDL 383
           P+      LK   KVS +  +     L RDP+ R +  E+     +      + L  L
Sbjct: 259 PK------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPL 310

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (287), Expect = 1e-28
 Identities = 56/317 (17%), Positives = 106/317 (33%), Gaps = 62/317 (19%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA---- 148
            ++R    L +G F  +     E++             A+K  +   L+  R++      
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNK---------FYALKKYEKSLLEKKRDFTKSNND 79

Query: 149 -------------EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL---- 190
                        E+  +  + +   +   G  I +   + ++YE+M   S+        
Sbjct: 80  KISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFF 138

Query: 191 ---FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG 247
                 T  +P      I        +++H   + + +RD K SNIL+D     KLSDFG
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFG 197

Query: 248 LAKAGPQGD-KTHVSTRVVGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEILTGRRS 303
            ++       K        GTY +  PE   +   +   +K D++S G+ L  +      
Sbjct: 198 ESEYMVDKKIKG-----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV-- 249

Query: 304 MDKKRP-SGEQNLVAWARQYLADKRKL---YQIVDPRLELNYSLKGVQKVSQLAYNCLSR 359
                P S + +LV           +           L    S      +S    + L  
Sbjct: 250 ----VPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL 305

Query: 360 ----DPKSRPSMDEVVK 372
               +P  R + ++ +K
Sbjct: 306 FLRKNPAERITSEDALK 322

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (286), Expect = 1e-28
 Identities = 74/295 (25%), Positives = 117/295 (39%), Gaps = 54/295 (18%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDF 152
           + +    +G G +G V K   +          SG  +AVK ++     +  ++ + ++D 
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDV 73

Query: 153 -LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI------KI 205
            +     P +V+  G    +    +  E M+  S +     + +     + I      KI
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKI 130

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
            L   K L  L    + +I+RD K SNILLD   N KL DFG++    Q   +   TR  
Sbjct: 131 TLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDA 186

Query: 266 GTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ 321
           G   Y APE +           +SDV+S G+ L E+ TGR    K     +Q        
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------- 238

Query: 322 YLADKRKLYQIVD---PRL----ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
                  L Q+V    P+L    E  +S   +  V+     CL++D   RP   E
Sbjct: 239 -------LTQVVKGDPPQLSNSEEREFSPSFINFVNL----CLTKDESKRPKYKE 282

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  116 bits (293), Expect = 2e-28
 Identities = 74/249 (29%), Positives = 105/249 (42%), Gaps = 31/249 (12%)

Query: 64  SDNPDPAPTDEKSPCQLLQFTFQELKSATGN-FRPDSILGEGGFGYVFKGWIEENGTAPA 122
           S  P     D     + LQ+ + E +  T N FR   +LG+GGFG V          A  
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC---------ACQ 204

Query: 123 KPGSGITVAVKSLKPDGL--QGHREWV-AEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVY 178
              +G   A K L+   +  +        E   L +++   +V L  Y  E    L LV 
Sbjct: 205 VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVL 263

Query: 179 EFMTRGSLENHLFRRTIPLPWSNRIK-----IALGAAKGLAFLHGGSEPVIYRDFKTSNI 233
             M  G L+ H++          R       I  G    L  LH   E ++YRD K  NI
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLH--RERIVYRDLKPENI 317

Query: 234 LLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGV 292
           LLD   + ++SD GLA   P+G       R VGT GY APE V+     + S D ++ G 
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQTIK--GR-VGTVGYMAPE-VVKNERYTFSPDWWALGC 373

Query: 293 VLLEILTGR 301
           +L E++ G+
Sbjct: 374 LLYEMIAGQ 382

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (284), Expect = 3e-28
 Identities = 40/230 (17%), Positives = 74/230 (32%), Gaps = 21/230 (9%)

Query: 87  ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW 146
           E +  +       +LGEG F  V++    +     AK  +     +K  KP         
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEA--TQGDLNDAK--NKQKFVLKVQKPANPWEFYIG 114

Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI----PLPWSNR 202
              ++ L        +K     +  +  +LV E  + G+L N +          +P    
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-----------KLSDFGLAKA 251
           I  A+     +  +H     +I+ D K  N +L + +              L D G +  
Sbjct: 175 ISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
                K  + T    T G+   E +       + D +     +  +L G 
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  112 bits (281), Expect = 5e-28
 Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 45/281 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLH-H 158
           +G G  G V+K    +         +G  +AVK ++  G  + ++  + ++D + + H  
Sbjct: 33  MGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83

Query: 159 PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           P +V+  G  I +    +  E M     E    R   P+P     K+ +   K L +L  
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 219 GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT 278
               VI+RD K SNILLD     KL DFG++    +        R  G   Y APE +  
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDP 198

Query: 279 GHL-----TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
                     ++DV+S G+ L+E+ TG+      +   E                L +++
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV---------------LTKVL 243

Query: 334 D---PRL--ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
               P L   + +S      V      CL++D + RP  ++
Sbjct: 244 QEEPPLLPGHMGFSGDFQSFVKD----CLTKDHRKRPKYNK 280

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (282), Expect = 6e-28
 Identities = 80/331 (24%), Positives = 139/331 (41%), Gaps = 53/331 (16%)

Query: 73  DEKSPCQLLQFTFQELKSATGN---FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGIT 129
           DE+   +L  F  Q+ K        F   S LG G  G VFK   +          SG+ 
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP---------SGLV 60

Query: 130 VAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN 188
           +A K +  +       + + E+  L + + P +V   G    D +  +  E M  GSL+ 
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 189 HLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL 248
            + ++   +P     K+++   KGL +L    + +++RD K SNIL++S    KL DFG+
Sbjct: 121 -VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR------- 301
           +    Q   +  ++  VGT  Y +PE +   H + +SD++S G+ L+E+  GR       
Sbjct: 179 SG---QLIDSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234

Query: 302 ------------RSMDKKRPSGEQNLVAWARQYLADKRK-------LYQIVD---PRL-E 338
                            + P   +       ++  D R        L  IV+   P+L  
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294

Query: 339 LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
             +SL+    V++    CL ++P  R  + +
Sbjct: 295 GVFSLEFQDFVNK----CLIKNPAERADLKQ 321

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (287), Expect = 6e-28
 Identities = 87/342 (25%), Positives = 140/342 (40%), Gaps = 67/342 (19%)

Query: 88  LKSATGNFRPD----SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH 143
           ++ +T  F        +LG+G FG V     ++  T       G   AVK +    ++  
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILC--KDKIT-------GQECAVKVISKRQVKQK 67

Query: 144 REWVA---EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPW 199
            +  +   EV  L QL HPN++KL  +  ED     LV E  T G L + +  R     +
Sbjct: 68  TDKESLLREVQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RF 123

Query: 200 SNR-----IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKA 251
           S       I+  L     + ++H     +++RD K  N+LL+S   + N ++ DFGL+  
Sbjct: 124 SEVDAARIIRQVLSG---ITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178

Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG 311
                K       +GT  Y APE V+ G    K DV+S GV+L  +L+G        P  
Sbjct: 179 FEASKKMK---DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC------PPFN 228

Query: 312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLA----YNCLSRDPKSRPSM 367
             N          +   L ++   + +  + L   +KVS+ A       L+  P  R S 
Sbjct: 229 GAN----------EYDILKKVE--KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 276

Query: 368 DEV-----VKVLTPLQDLNDLAIL-SYHSRLSQ-QGRRKKKQ 402
            +      ++  T  Q   D+  L +    + Q QG +K  Q
Sbjct: 277 RDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQ 318

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  114 bits (288), Expect = 7e-28
 Identities = 79/305 (25%), Positives = 114/305 (37%), Gaps = 58/305 (19%)

Query: 79  QLLQFTFQELKSATGN-FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP 137
           + LQ+ + E +    + F    +LG GGFG VF         A     +G   A K L  
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNK 220

Query: 138 DGL--QGHREWV-AEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRR 193
             L  +   +    E   L ++H   +V L  Y  E    L LV   M  G +  H++  
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNV 279

Query: 194 TIPLPW--SNRIK-----IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF 246
               P     R       I  G    L  LH     +IYRD K  N+LLD + N ++SD 
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSG----LEHLH--QRNIIYRDLKPENVLLDDDGNVRISDL 333

Query: 247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR---R 302
           GLA     G          GT G+ APE ++ G     S D ++ GV L E++  R   R
Sbjct: 334 GLAVELKAGQTK-TKGY-AGTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

Query: 303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIV---DPRLELNYSLKGVQKVSQLAYNCLSR 359
           +  +K                 + ++L Q V          +S         L    L +
Sbjct: 391 ARGEK----------------VENKELKQRVLEQAVTYPDKFSPASKDFCEAL----LQK 430

Query: 360 DPKSR 364
           DP+ R
Sbjct: 431 DPEKR 435

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (278), Expect = 8e-28
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 58/309 (18%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG 154
           +     LG+G FG V+K   +E G            A K ++    +   +++ E++ L 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGA---------LAAAKVIETKSEEELEDYIVEIEILA 71

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL---GAAK 211
              HP +VKL+G    D +  ++ EF   G+++  +      L      +I +      +
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVVCRQMLE 128

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYG 269
            L FLH  S+ +I+RD K  N+L+  E + +L+DFG++    +  KT +  R   +GT  
Sbjct: 129 ALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKT-LQKRDSFIGTPY 182

Query: 270 YAAPEYVMTGHLT-----SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
           + APE VM   +       K+D++S G+ L+E+        +  P               
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------- 228

Query: 325 DKRKLYQIVD---PRLEL--NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV-----VKVL 374
             R L +I     P L     +S++    +       L ++P++RPS  ++     V  +
Sbjct: 229 --RVLLKIAKSDPPTLLTPSKWSVEFRDFLKI----ALDKNPETRPSAAQLLEHPFVSSI 282

Query: 375 TPLQDLNDL 383
           T  + L +L
Sbjct: 283 TSNKALREL 291

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (286), Expect = 8e-28
 Identities = 73/302 (24%), Positives = 116/302 (38%), Gaps = 59/302 (19%)

Query: 88  LKSATGNFRPD----SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG- 142
           + S  G+          LG G +G V      +  T        +  A+K ++   +   
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLC--RDKVT-------HVERAIKIIRKTSVSTS 78

Query: 143 HREWVA-EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWS 200
               +  EV  L  L HPN++KL  +  ED +   LV E    G L + +  R     ++
Sbjct: 79  SNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFN 134

Query: 201 NR-----IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAG 252
                  IK  L     + +LH     +++RD K  N+LL+S   +   K+ DFGL+   
Sbjct: 135 EVDAAVIIKQVLSG---VTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189

Query: 253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE 312
               K       +GT  Y APE V+      K DV+S GV+L  +L G        P G 
Sbjct: 190 ENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------PPFGG 239

Query: 313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLA----YNCLSRDPKSRPSMD 368
           Q           D+  L ++   + +  +     + VS+ A       L  D + R S  
Sbjct: 240 QT----------DQEILRKVE--KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287

Query: 369 EV 370
           + 
Sbjct: 288 QA 289

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (283), Expect = 1e-27
 Identities = 75/333 (22%), Positives = 111/333 (33%), Gaps = 80/333 (24%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG 154
              + ILG G  G V      +          G  VAVK +  D          E+  L 
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQ----------GRPVAVKRMLIDFCDIALM---EIKLLT 63

Query: 155 QL-HHPNLVKLIGYCIEDDQRL--LVYEFMTRGSLE------NHLFRRTIPLPWSNRIKI 205
           +   HPN+++   YC E   R   +  E     +L+      N            N I +
Sbjct: 64  ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-------------YNAKLSDFGLAKAG 252
               A G+A LH  S  +I+RD K  NIL+ +                  +SDFGL K  
Sbjct: 121 LRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 253 PQGDKTHVSTR--VVGTYGYAAPE-------YVMTGHLTSKSDVYSFGVVLLEILTGRRS 303
             G  +  +      GT G+ APE             LT   D++S G V   IL+    
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK--- 235

Query: 304 MDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLEL-NYSLKGVQKVSQLAYN----CLS 358
              K P G++              +   I+     L        + +   A +     + 
Sbjct: 236 --GKHPFGDKY------------SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID 281

Query: 359 RDPKSRPSMDEV---------VKVLTPLQDLND 382
            DP  RP+  +V          K L  L  ++D
Sbjct: 282 HDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSD 314

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  111 bits (279), Expect = 1e-27
 Identities = 91/377 (24%), Positives = 140/377 (37%), Gaps = 68/377 (18%)

Query: 49  ASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSA---TGNFRPDSILGEGG 105
             +       E        DP P   ++   L      EL         F     +G G 
Sbjct: 8   HHHDYDIPTTENLYFQGAMDPMPAGGRAG-SLKDPDVAELFFKDDPEKLFSDLREIGHGS 66

Query: 106 FGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLHHPNLV 162
           FG V+      N            VA+K +   G Q + +W   + EV FL +L HPN +
Sbjct: 67  FGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117

Query: 163 KLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL---GAAKGLAFLHGG 219
           +  G  + +    LV E+   GS  + L     PL     ++IA    GA +GLA+LH  
Sbjct: 118 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPL---QEVEIAAVTHGALQGLAYLH-- 171

Query: 220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR--VVGTYGYAAPEYVM 277
           S  +I+RD K  NILL      KL DFG A        + ++     VGT  + APE ++
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVIL 223

Query: 278 T---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
               G    K DV+S G+  +E+   +  +                        LY I  
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQ 267

Query: 335 ---PRLEL-NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEV-----VKVLTPLQDLNDLAI 385
              P L+  ++S      V      CL + P+ RP+ + +     V    P   + DL I
Sbjct: 268 NESPALQSGHWSEYFRNFVDS----CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL-I 322

Query: 386 LSYHSRLSQQGRRKKKQ 402
                 + +    + ++
Sbjct: 323 QRTKDAVRELDNLQYRK 339

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (276), Expect = 1e-27
 Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 46/288 (15%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDF- 152
             P   LG G +G V K              SG  +AVK ++     Q  +  + ++D  
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDIS 59

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLEN---HLFRRTIPLPWSNRIKIALGA 209
           +  +  P  V   G    +    +  E M   SL+     +  +   +P     KIA+  
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
            K L  LH     VI+RD K SN+L+++    K+ DFG++                G   
Sbjct: 119 VKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKP 174

Query: 270 YAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
           Y APE +         + KSD++S G+ ++E+   R   D                +   
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS---------------WGTP 219

Query: 326 KRKLYQIVD---PRL-ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
            ++L Q+V+   P+L    +S + V   SQ    CL ++ K RP+  E
Sbjct: 220 FQQLKQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPE 263

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (276), Expect = 2e-27
 Identities = 77/338 (22%), Positives = 126/338 (37%), Gaps = 77/338 (22%)

Query: 60  AHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGT 119
           +  SS  P     D         +  QE+            +G G    V   +      
Sbjct: 2   SEDSSALPWSINRD--------DYELQEV------------IGSGATAVVQAAYCAPKKE 41

Query: 120 APAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHHPNLVKLIGYCIEDDQRLLVY 178
                     VA+K +  +  Q   + +  E+  + Q HHPN+V      +  D+  LV 
Sbjct: 42  ---------KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92

Query: 179 EFMTRGSLENHLFRRTIPLPWSNRIK-----IAL---GAAKGLAFLHGGSEPVIYRDFKT 230
           + ++ GS+   + +  +              IA       +GL +LH      I+RD K 
Sbjct: 93  KLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKA 149

Query: 231 SNILLDSEYNAKLSDFGL-AKAGPQGDKTHVSTR--VVGTYGYAAPEYVMTGHL-TSKSD 286
            NILL  + + +++DFG+ A     GD T    R   VGT  + APE +        K+D
Sbjct: 150 GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209

Query: 287 VYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PRLELNYSL 343
           ++SFG+  +E+ TG     K  P                 + L   +    P LE     
Sbjct: 210 IWSFGITAIELATGAAPYHKYPPM----------------KVLMLTLQNDPPSLETGVQD 253

Query: 344 KGVQK---------VSQLAYNCLSRDPKSRPSMDEVVK 372
           K + K         +S     CL +DP+ RP+  E+++
Sbjct: 254 KEMLKKYGKSFRKMISL----CLQKDPEKRPTAAELLR 287

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (274), Expect = 2e-27
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 25/215 (11%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAK-PGSGITVAVKSLKPDGLQGHR--EWV-A 148
            +F     LG+G FG V+           A+   S   +A+K L    L+       +  
Sbjct: 9   EDFEIGRPLGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRR 58

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
           EV+    L HPN+++L GY   D  R+ L+ E+   G++   L ++              
Sbjct: 59  EVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 116

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG-DKTHVSTRVVG 266
             A  L++ H  S+ VI+RD K  N+LL S    K++DFG +   P           + G
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCG 169

Query: 267 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (283), Expect = 3e-27
 Identities = 77/344 (22%), Positives = 122/344 (35%), Gaps = 87/344 (25%)

Query: 66  NPDPAPTDEKSPCQLLQFTFQE-LKSATGNFRPD----SILGEGGFGYVFKGWIEENGTA 120
           +   +   E    Q +       ++   G           LG G +G V     +E    
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC--KEKNG- 60

Query: 121 PAKPGSGITVAVKSLK------------PDGLQGHREWVA-EVDFLGQLHHPNLVKLIGY 167
                     A+K +K               ++   E +  E+  L  L HPN++KL   
Sbjct: 61  ------HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114

Query: 168 CIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG------AAK-------GL 213
             ED +   LV EF   G     LF          +I I         AA        G+
Sbjct: 115 F-EDKKYFYLVTEFYEGGE----LF---------EQI-INRHKFDECDAANIMKQILSGI 159

Query: 214 AFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            +LH     +++RD K  NILL++     N K+ DFGL+    +  K       +GT  Y
Sbjct: 160 CYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYY 214

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            APE V+      K DV+S GV++  +L G        P G QN          D+  + 
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIMYILLCGY------PPFGGQN----------DQDIIK 257

Query: 331 QIVDPRLELNYSLKGVQKVSQLA----YNCLSRDPKSRPSMDEV 370
           ++   + +  +     + +S  A       L+ D   R + +E 
Sbjct: 258 KVE--KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  108 bits (272), Expect = 4e-27
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAK-PGSGITVAVK-----SLKPDGLQGHREW 146
            +F+  ++LG+G F  V++          A+   +G+ VA+K     ++   G+    + 
Sbjct: 11  EDFKVGNLLGKGSFAGVYR----------AESIHTGLEVAIKMIDKKAMYKAGMVQRVQ- 59

Query: 147 VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
             EV    QL HP++++L  Y  ED   + LV E    G +  +L  R  P   +     
Sbjct: 60  -NEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRV 264
                 G+ +LH  S  +++RD   SN+LL    N K++DFGLA +     +K +  T +
Sbjct: 118 MHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--T-L 172

Query: 265 VGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            GT  Y +PE    + H   +SDV+S G +   +L GR
Sbjct: 173 CGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  108 bits (272), Expect = 6e-27
 Identities = 72/288 (25%), Positives = 115/288 (39%), Gaps = 45/288 (15%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVA-E 149
             +     LG+GGF   F+    +  T           A K +    L     RE ++ E
Sbjct: 15  RRYVRGRFLGKGGFAKCFEI--SDADT-------KEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRR-TIPLPWSNRIKIAL 207
           +     L H ++V   G+  ED+  + +V E   R SL     RR  +  P +      +
Sbjct: 66  ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVG 266
               G  +LH     VI+RD K  N+ L+ +   K+ DFGLA K    G++  V     G
Sbjct: 125 --VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CG 177

Query: 267 TYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
           T  Y APE V++    S + DV+S G ++  +L G      K P     L          
Sbjct: 178 TPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVG------KPPFETSCL---------- 220

Query: 326 KRKLYQ-IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            ++ Y  I      +   +      + L    L  DP +RP+++E++ 
Sbjct: 221 -KETYLRIKKNEYSIPKHIN--PVAASLIQKMLQTDPTARPTINELLN 265

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  108 bits (272), Expect = 9e-27
 Identities = 53/306 (17%), Positives = 101/306 (33%), Gaps = 35/306 (11%)

Query: 81  LQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL 140
           L       +      +  + L   G    F  W+E       +    I +  +S      
Sbjct: 41  LPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS 100

Query: 141 QGHREWVA--EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR--TIP 196
                     ++  +      N V  +          +  +   + +L++ + RR     
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA----- 251
                 + I +  A+ + FLH  S+ +++RD K SNI    +   K+ DFGL  A     
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

Query: 252 -----GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDK 306
                          T  VGT  Y +PE +   + + K D++S G++L E+L        
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS------ 272

Query: 307 KRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
                E+  +            +  +  P L          +   +  + LS  P  RP 
Sbjct: 273 FSTQMERVRII---------TDVRNLKFPLLFTQKY----PQEHMMVQDMLSPSPTERPE 319

Query: 367 MDEVVK 372
             ++++
Sbjct: 320 ATDIIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 22/81 (27%), Positives = 33/81 (40%), Gaps = 10/81 (12%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDF 152
           +F P   +G GGFG VF+                   A+K ++    +  RE V  EV  
Sbjct: 7   DFEPIQCMGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVKA 57

Query: 153 LGQLHHPNLVKLIGYCIEDDQ 173
           L +L HP +V+     +E   
Sbjct: 58  LAKLEHPGIVRYFNAWLETPP 78

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (274), Expect = 1e-26
 Identities = 62/365 (16%), Positives = 108/365 (29%), Gaps = 69/365 (18%)

Query: 102 GEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHP 159
           G      V     +  G           V V+ +  +            E+      +HP
Sbjct: 36  GFEDLMTVNLARYKPTGE---------YVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL---GAAKGLAFL 216
           N+V      I D++  +V  FM  GS +  L         +    IA    G  K L ++
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMNELA-IAYILQGVLKALDYI 144

Query: 217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFG-LAKAGPQGDKTHV----STRVVGTYGYA 271
           H      ++R  K S+IL+  +    LS           G +  V        V    + 
Sbjct: 145 H--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 272 APEYVMTGHL---TSKSDVYSFGV-------------------VLLEILTGRRSMDKKRP 309
           +PE V+  +L    +KSD+YS G+                   +LLE L G         
Sbjct: 203 SPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261

Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAY---------NCLSRD 360
           +     +  +         L   +        +           +          CL R+
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321

Query: 361 PKSRPSMDEVVK----------VLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLAS 410
           P +RPS   ++               L +L    +       + +G + +   G   L +
Sbjct: 322 PDARPSASTLLNHSFFKQIKRRASEALPEL----LRPVTPITNFEGSQSQDHSGIFGLVT 377

Query: 411 AHSKS 415
              + 
Sbjct: 378 NLEEL 382

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  109 bits (275), Expect = 2e-26
 Identities = 74/286 (25%), Positives = 117/286 (40%), Gaps = 55/286 (19%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVA-EVDFLGQLH 157
           +LG+G FG V K   ++  T           AVK +     +      +  EV+ L +L 
Sbjct: 29  MLGKGSFGEVLKC--KDRIT-------QQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNR-----IKIALGAAK 211
           HPN++KL     ED     +V E  T G L + + +R     +S       IK       
Sbjct: 80  HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSG-- 133

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDS-EYNA--KLSDFGLAKAGPQGDKTHVSTRVVGTY 268
            + ++H     +++RD K  NILL+S E +   K+ DFGL+    Q  K       +GT 
Sbjct: 134 -ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187

Query: 269 GYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
            Y APE V+ G    K DV+S GV+L  +L+G        P   +N          +   
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------PPFYGKN----------EYDI 230

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLA----YNCLSRDPKSRPSMDEV 370
           L ++     +  + L   + +S  A       L+  P  R +  + 
Sbjct: 231 LKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (272), Expect = 3e-26
 Identities = 43/373 (11%), Positives = 91/373 (24%), Gaps = 84/373 (22%)

Query: 45  RYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEG 104
             L     +      +       D   +              EL          ++LG+ 
Sbjct: 30  EELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQE 89

Query: 105 GFGYVFKGWIEENGTAPAKPGSGITVAVKSLK---------------------------- 136
                 +   +E G          +  V                                
Sbjct: 90  DPYAYLEATDQETGE---------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 137 PDGLQGHREWVAEVDFLGQLHHPNLVKLI--GYCIEDDQRLLVYEFM-----TRGSLENH 189
               + H  ++   D +       ++++      +    R  +Y  M     T G +   
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 190 LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
                  L    R+++ L   + LA LH     +++   +  +I+LD      L+ F   
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 250 KAGPQGDKTHVSTRVVGTYGYAAPEYVM----------TGHLTSKSDVYSFGVVLLEILT 299
                G             G+A PE                +T   D ++ G+ +  I  
Sbjct: 259 V--RDGASAVSPI----GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 300 GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR 359
                    P+ +   +  +       + +     P+            V  L    L  
Sbjct: 313 ADL------PNTDDAALGGSEWIFRSCKNI-----PQP-----------VRALLEGFLRY 350

Query: 360 DPKSRPSMDEVVK 372
             + R    + ++
Sbjct: 351 PKEDRLLPLQAME 363

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (266), Expect = 3e-26
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 23/214 (10%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAK-PGSGITVAVKSLKPDGLQGHR--EWVA- 148
            +F     LG+G FG V+           A+   +   +A+K L    L+       +  
Sbjct: 14  DDFDIGRPLGKGKFGNVYL----------AREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
           E++    L HPN++++  Y   D +R+ L+ EF  RG L   L ++              
Sbjct: 64  EIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFME 121

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             A  L + H     VI+RD K  N+L+  +   K++DFG +   P   +        GT
Sbjct: 122 ELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTM---CGT 175

Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
             Y  PE +       K D++  GV+  E L G 
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 4e-26
 Identities = 82/323 (25%), Positives = 126/323 (39%), Gaps = 65/323 (20%)

Query: 74  EKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK 133
           +     L +     L+   G F    ++G G +G V+KG   + G            A+K
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQ---------LAAIK 55

Query: 134 SLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIG------YCIEDDQRLLVYEFMTRGSL 186
            +   G     E   E++ L +  HH N+    G          DDQ  LV EF   GS+
Sbjct: 56  VMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV 114

Query: 187 E---NHLFRRTIPLPWSNRIKIAL---GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN 240
                +    T+   W     IA       +GL+ LH     VI+RD K  N+LL     
Sbjct: 115 TDLIKNTKGNTLKEEW-----IAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAE 167

Query: 241 AKLSDFGLAKAGPQGDKTHVSTR--VVGTYGYAAPEYVMTGHLT-----SKSDVYSFGVV 293
            KL DFG++    Q D+T V  R   +GT  + APE +            KSD++S G+ 
Sbjct: 168 VKLVDFGVSA---QLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223

Query: 294 LLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD---PRLE-LNYSLKGVQKV 349
            +E+  G   +    P                 R L+ I     PRL+   +S K    +
Sbjct: 224 AIEMAEGAPPLCDMHPM----------------RALFLIPRNPAPRLKSKKWSKKFQSFI 267

Query: 350 SQLAYNCLSRDPKSRPSMDEVVK 372
                 CL ++   RP+ ++++K
Sbjct: 268 ES----CLVKNHSQRPATEQLMK 286

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  106 bits (267), Expect = 4e-26
 Identities = 76/325 (23%), Positives = 124/325 (38%), Gaps = 49/325 (15%)

Query: 57  PNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEE 116
           P +A +       AP       ++ +        +   +     LG+GGF   F+    +
Sbjct: 7   PGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEI--SD 62

Query: 117 NGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVA-EVDFLGQLHHPNLVKLIGYCIEDDQ 173
             T           A K +    L     RE ++ E+     L H ++V   G+  ED+ 
Sbjct: 63  ADT-------KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-FEDND 114

Query: 174 RL-LVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTS 231
            + +V E   R SL     RR  +  P +      +    G  +LH     VI+RD K  
Sbjct: 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH--RNRVIHRDLKLG 170

Query: 232 NILLDSEYNAKLSDFGLA-KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS-KSDVYS 289
           N+ L+ +   K+ DFGLA K    G++  V     GT  Y APE V++    S + DV+S
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIAPE-VLSKKGHSFEVDVWS 226

Query: 290 FGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ-IVDPRLEL-NYSLKGVQ 347
            G ++  +L G      K P     L           ++ Y  I      +  +      
Sbjct: 227 IGCIMYTLLVG------KPPFETSCL-----------KETYLRIKKNEYSIPKHINPVAA 269

Query: 348 KVSQLAYNCLSRDPKSRPSMDEVVK 372
               L    L  DP +RP+++E++ 
Sbjct: 270 S---LIQKMLQTDPTARPTINELLN 291

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  108 bits (270), Expect = 2e-25
 Identities = 64/222 (28%), Positives = 93/222 (41%), Gaps = 37/222 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEV 150
           +F    I+G GGFG V+            K  +G   A+K L    +   QG    + E 
Sbjct: 190 DFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 151 DFLGQLH---HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRIK- 204
             L  +     P +V +  Y      +L  + + M  G L  HL +           ++ 
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRF 296

Query: 205 ----IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
               I LG    L  +H  +  V+YRD K +NILLD   + ++SD GLA       K H 
Sbjct: 297 YAAEIILG----LEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH- 348

Query: 261 STRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
               VGT+GY APE +  G     S D +S G +L ++L G 
Sbjct: 349 -AS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (264), Expect = 2e-25
 Identities = 65/245 (26%), Positives = 102/245 (41%), Gaps = 43/245 (17%)

Query: 69  PAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGI 128
           P   DE        F    L+           +G+G FG V    +++N T         
Sbjct: 3   PPVFDENEDVNFDHFEI--LR----------AIGKGSFGKVCI--VQKNDT-------KK 41

Query: 129 TVAVKSLKPDGL--QGHREWV-AEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRG 184
             A+K +       +     V  E+  +  L HP LV L  Y  +D++ + +V + +  G
Sbjct: 42  MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGG 100

Query: 185 SLENHLFR-RTIPLPWSNRIKIA-LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK 242
            L  HL +          ++ I  L  A  L +L   ++ +I+RD K  NILLD   +  
Sbjct: 101 DLRYHLQQNVHFKEETV-KLFICELVMA--LDYLQ--NQRIIHRDMKPDNILLDEHGHVH 155

Query: 243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM----TGHLTSKS-DVYSFGVVLLEI 297
           ++DF +A   P+  +    T + GT  Y APE        G+  S + D +S GV   E+
Sbjct: 156 ITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGY--SFAVDWWSLGVTAYEL 210

Query: 298 LTGRR 302
           L GRR
Sbjct: 211 LRGRR 215

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (261), Expect = 3e-25
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 29/217 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----- 148
            +     +GEG +G VFK    + G           VA+K             +      
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQ---------IVAIKKFL---ESEDDPVIKKIALR 51

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           E+  L QL HPNLV L+       +  LV+E+    ++ + L R    +P      I   
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTH-VSTRVV 265
             + + F H      I+RD K  NIL+      KL DFG A+   GP       V+TR  
Sbjct: 111 TLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-- 166

Query: 266 GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
               Y +PE ++         DV++ G V  E+L+G 
Sbjct: 167 ---WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  104 bits (261), Expect = 6e-25
 Identities = 76/380 (20%), Positives = 138/380 (36%), Gaps = 69/380 (18%)

Query: 63  SSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRP----DSILGEGGFGYVFKGWIEENG 118
             D P     D+       ++  Q ++   G+          LG G FG V +    E  
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC--VEKA 74

Query: 119 TAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LV 177
           T       G     K +             E+  + QLHHP L+ L     ED   + L+
Sbjct: 75  T-------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-FEDKYEMVLI 126

Query: 178 YEFMTRGSL------ENHLF--RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFK 229
            EF++ G L      E++       I       ++ A     GL  +H     +++ D K
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACE---GLKHMH--EHSIVHLDIK 176

Query: 230 TSNILLDSEYNA--KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDV 287
             NI+ +++  +  K+ DFGLA    + +   +      T  +AAPE V    +   +D+
Sbjct: 177 PENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDM 233

Query: 288 YSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGV 346
           ++ GV+   +L+G        P +GE            D  +  Q V      ++     
Sbjct: 234 WAIGVLGYVLLSG------LSPFAGE------------DDLETLQNV---KRCDWEFDED 272

Query: 347 --QKVSQLA----YNCLSRDPKSRPSMDEVVK---VLTPLQDLNDLAILSYHSRLSQQGR 397
               VS  A     N L ++P+ R ++ + ++   +     +L      S ++++ Q+ +
Sbjct: 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 332

Query: 398 RKKKQDGTQQLASAHSKSIR 417
            K       Q A     +  
Sbjct: 333 EKYADWPAPQPAIGRIANFS 352

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  103 bits (258), Expect = 2e-24
 Identities = 73/301 (24%), Positives = 117/301 (38%), Gaps = 48/301 (15%)

Query: 25  NHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQ-- 82
           +HS+     T  +Y  + +      S        E   ++D  +  P   K    L    
Sbjct: 7   HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66

Query: 83  ------FTFQELKSATGNFR------PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITV 130
                 F  + + +  G            ILG G FG V K   EE  T       G+ +
Sbjct: 67  PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC--EETAT-------GLKL 117

Query: 131 AVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSL--- 186
           A K +K  G++   E   E+  + QL H NL++L     E    + LV E++  G L   
Sbjct: 118 AAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDR 176

Query: 187 ---ENHLF--RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA 241
              E++      TI       +K       G+  +H     +++ D K  NIL  +    
Sbjct: 177 IIDESYNLTELDTILF-----MKQICE---GIRHMH--QMYILHLDLKPENILCVNRDAK 226

Query: 242 --KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
             K+ DFGLA+     +K  V     GT  + APE V    ++  +D++S GV+   +L+
Sbjct: 227 QIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283

Query: 300 G 300
           G
Sbjct: 284 G 284

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  100 bits (251), Expect = 4e-24
 Identities = 74/290 (25%), Positives = 115/290 (39%), Gaps = 63/290 (21%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHHP 159
           LG G FG V     EE  +       G+   +K++  D  Q   E +  E++ L  L HP
Sbjct: 30  LGSGAFGDVHLV--EERSS-------GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNR----------IKIALG 208
           N++K+     ED   + +V E    G  E  L  R +      +          +K  + 
Sbjct: 81  NIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMMN 135

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
           A   LA+ H  S+ V+++D K  NIL          K+ DFGLA+     + +   T   
Sbjct: 136 A---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAA 187

Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD 325
           GT  Y APE V    +T K D++S GVV+  +LTG        P                
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------LP-------FTGT----S 229

Query: 326 KRKLYQIVDPRLELNYSLKGV-QKVSQLA----YNCLSRDPKSRPSMDEV 370
             ++ Q          +     + ++  A       L++DP+ RPS  +V
Sbjct: 230 LEEVQQKA---TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (252), Expect = 4e-24
 Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 31/248 (12%)

Query: 65  DNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKP 124
           D     P       Q  Q   Q  K    +F+   ILGEG F  V      E  T     
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVL--ARELAT----- 54

Query: 125 GSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEF 180
                 A+K L+   +    +      E D + +L HP  VKL  +  +DD++L     +
Sbjct: 55  --SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSY 111

Query: 181 MTRGSLENHLFR-RTIPLPWSNRIK-----IALGAAKGLAFLHGGSEPVIYRDFKTSNIL 234
              G L  ++ +  +         +     I       L +LH   + +I+RD K  NIL
Sbjct: 112 AKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLH--GKGIIHRDLKPENIL 162

Query: 235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVV 293
           L+ + + +++DFG AK      K   +   VGT  Y +PE ++T     KS D+++ G +
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCI 221

Query: 294 LLEILTGR 301
           + +++ G 
Sbjct: 222 IYQLVAGL 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  100 bits (251), Expect = 7e-24
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 29/217 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----- 148
            +    ++GEG +G V K   ++ G           VA+K           + V      
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGR---------IVAIKKFL---ESDDDKMVKKIAMR 73

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           E+  L QL H NLV L+  C +  +  LV+EF+   ++ + L      L +    K    
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTH-VSTRVV 265
              G+ F H  S  +I+RD K  NIL+      KL DFG A+    P       V+TR  
Sbjct: 133 IINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-- 188

Query: 266 GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
               Y APE ++      K+ DV++ G ++ E+  G 
Sbjct: 189 ---WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =   99 bits (250), Expect = 1e-23
 Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 25/216 (11%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW--VAEVD 151
            F    +LG+G FG VF   +++         +    A+K LK   L+         E D
Sbjct: 25  QFELLKVLGQGSFGKVFL--VKKISG----SDARQLYAMKVLKKATLKVRDRVRTKMERD 78

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRI---KIA 206
            L +++HP +VKL  Y  + + +L L+ +F+  G L   L +          +    ++A
Sbjct: 79  ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELA 136

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG 266
           L     L  LH  S  +IYRD K  NILLD E + KL+DFGL+K     +K   +    G
Sbjct: 137 LA----LDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 188

Query: 267 TYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           T  Y APE V+     ++S D +SFGV++ E+LTG 
Sbjct: 189 TVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =   99 bits (250), Expect = 1e-23
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 29/219 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV----AE 149
            F    +LG+GG+G VF+  + +         +G   A+K LK   +  + +      AE
Sbjct: 18  CFELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTI-PLPWSNRI---K 204
            + L ++ HP +V LI Y  +   +L L+ E+++ G L   L R  I     +      +
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYLAE 129

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVSTR 263
           I++     L  LH   + +IYRD K  NI+L+ + + KL+DFGL K     G  TH  T 
Sbjct: 130 ISMA----LGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--T- 180

Query: 264 VVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
             GT  Y APE ++     +++ D +S G ++ ++LTG 
Sbjct: 181 FCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 68/265 (25%), Positives = 106/265 (40%), Gaps = 36/265 (13%)

Query: 56  APNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDS-----ILGEGGFGYVF 110
             +    +  + D     E+      +     L         ++     +LG G +G VF
Sbjct: 12  GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71

Query: 111 KGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV----AEVDFLGQL-HHPNLVKLI 165
              + +         +G   A+K LK   +    +       E   L  +   P LV L 
Sbjct: 72  L--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125

Query: 166 GYCIEDDQRL-LVYEFMTRGSLENHLFRRTI-PLPWSNRI---KIALGAAKGLAFLHGGS 220
            Y  + + +L L+ +++  G L  HL +R         +I   +I L     L  LH   
Sbjct: 126 -YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVGEIVLA----LEHLH--K 177

Query: 221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM--- 277
             +IYRD K  NILLDS  +  L+DFGL+K     +         GT  Y AP+ V    
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRGGD 236

Query: 278 TGHLTSKS-DVYSFGVVLLEILTGR 301
           +GH   K+ D +S GV++ E+LTG 
Sbjct: 237 SGH--DKAVDWWSLGVLMYELLTGA 259

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  100 bits (251), Expect = 2e-23
 Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 30/218 (13%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
           +G G +G+V+K   ++              A+K ++  G+        E+  L +L HPN
Sbjct: 29  VGRGTYGHVYKAKRKDGKD-------DKDYALKQIEGTGI--SMSACREIALLRELKHPN 79

Query: 161 LVKLIGYCIED-DQRL-LVYEFMT---RGSLENH----LFRRTIPLPWSNRIKIALGAAK 211
           ++ L    +   D+++ L++++        ++ H      ++ + LP      +      
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNA----KLSDFGLAKA--GPQGDKTHVSTRVV 265
           G+ +LH  +  V++RD K +NIL+  E       K++D G A+    P      +   VV
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 266 GTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
            T+ Y APE ++ G  H T   D+++ G +  E+LT  
Sbjct: 198 -TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (253), Expect = 2e-23
 Identities = 70/384 (18%), Positives = 125/384 (32%), Gaps = 66/384 (17%)

Query: 57  PNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRP----DSILGEGGFGYVFKG 112
                +       +  D        Q+  Q ++    +          LG G FG V + 
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176

Query: 113 WIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD 172
              E  T       G   A K +             E+  +  L HP LV L     +D+
Sbjct: 177 --TERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 173 QRLLVYEFMTRGSLENHLFRRTIPLPWS-------NRIKIALGAAKGLAFLHGGSEPVIY 225
           + +++YEFM+ G  E  LF +                ++      KGL  +H      ++
Sbjct: 228 EMVMIYEFMSGG--E--LFEKVADEHNKMSEDEAVEYMRQVC---KGLCHMH--ENNYVH 278

Query: 226 RDFKTSNILLDS--EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS 283
            D K  NI+  +      KL DFGL           V     GT  +AAPE      +  
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGY 335

Query: 284 KSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADKRKLYQIVDPRLELNYS 342
            +D++S GV+   +L+G        P  GE            +  +  + V      +++
Sbjct: 336 YTDMWSVGVLSYILLSGL------SPFGGE------------NDDETLRNV---KSCDWN 374

Query: 343 LKGV--QKVSQLA----YNCLSRDPKSRPSMDEVVK---VLTPLQDLNDLAI-LSYHSRL 392
           +       +S+         L  DP +R ++ + ++   +        D  I  S ++++
Sbjct: 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434

Query: 393 SQQGRRKKKQDGTQQLASAHSKSI 416
               + K               + 
Sbjct: 435 RDSIKTKYDAWPEPLPPLGRISNY 458

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 30/217 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-----REWVA 148
            +     LGEG +  V+KG  +              VA+K ++ +  +G      RE   
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDN---------LVALKEIRLEHEEGAPCTAIRE--- 50

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
            V  L  L H N+V L      +    LV+E++ +  L+ +L      +   N       
Sbjct: 51  -VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVG 266
             +GLA+ H   + V++RD K  N+L++     KL+DFGLA+A   P     +    VV 
Sbjct: 109 LLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV- 162

Query: 267 TYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
           T  Y  P+ ++ G    +++ D++  G +  E+ TGR
Sbjct: 163 TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  100 bits (250), Expect = 3e-23
 Identities = 72/253 (28%), Positives = 105/253 (41%), Gaps = 25/253 (9%)

Query: 57  PNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSAT-GNFRPDSILGEGGFGYVFKGWIE 115
             +A    D    +P+D     ++     +     T   F    +LG+G FG V    ++
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVIL--VK 168

Query: 116 ENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQLHHPNLVKLIGYCIEDD 172
           E  T       G   A+K LK + +    E    + E   L    HP L  L  Y  +  
Sbjct: 169 EKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTH 220

Query: 173 QRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKT 230
            RL  V E+   G L  HL R R      + R   A      L +LH     V+YRD K 
Sbjct: 221 DRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYGA-EIVSALDYLHSEKN-VVYRDLKL 277

Query: 231 SNILLDSEYNAKLSDFGLAKAG-PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVY 288
            N++LD + + K++DFGL K G   G          GT  Y APE V+  +   ++ D +
Sbjct: 278 ENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPE-VLEDNDYGRAVDWW 333

Query: 289 SFGVVLLEILTGR 301
             GVV+ E++ GR
Sbjct: 334 GLGVVMYEMMCGR 346

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 97.2 bits (243), Expect = 5e-23
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 29/218 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----- 148
            +     +GEG +G VFK    E             VA+K ++   L    E V      
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVR---LDDDDEGVPSSALR 50

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           E+  L +L H N+V+L      D +  LV+EF  +  L+ +       L           
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVG 266
             KGL F H  S  V++RD K  N+L++     KL++FGLA+A   P    +     VV 
Sbjct: 110 LLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV- 163

Query: 267 TYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGRR 302
           T  Y  P+ V+ G    ++  D++S G +  E+    R
Sbjct: 164 TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 31/218 (14%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEV 150
           +F    +LG+G FG V    + E  T       G   A+K L+ + +    E    V E 
Sbjct: 6   DFDYLKLLGKGTFGKVIL--VREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTES 56

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRI---KI 205
             L    HP L  L  Y  +   RL  V E+   G L  HL R R      + R    +I
Sbjct: 57  RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGAEI 114

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVSTRV 264
                  L +LH  S  V+YRD K  N++LD + + K++DFGL K G   G      T  
Sbjct: 115 VSA----LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-F 165

Query: 265 VGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
            GT  Y APE V+  +   ++ D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 97.3 bits (243), Expect = 8e-23
 Identities = 60/256 (23%), Positives = 103/256 (40%), Gaps = 37/256 (14%)

Query: 62  LSSDNPDPAPTDEKSPCQLLQFTFQELKSATG--NFRPDSILGEGGFGYVFKGWIEENGT 119
           ++  +     T E         +     SAT    +R  + LGEG +G V+K        
Sbjct: 1   MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60

Query: 120 APAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQLHHPNLVKLIGYCIEDDQR 174
                    TVA+K ++   L+   E V      EV  L +L H N+++L      + + 
Sbjct: 61  ---------TVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108

Query: 175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL 234
            L++E+     L+ ++  +   +              G+ F H  S   ++RD K  N+L
Sbjct: 109 HLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLL 164

Query: 235 LDSEYNA-----KLSDFGLAKA--GPQGDKTHVSTRVVGTYGYAAPEYVMTG--HLTSKS 285
           L     +     K+ DFGLA+A   P    TH    ++ T  Y  PE ++ G  H ++  
Sbjct: 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPE-ILLGSRHYSTSV 219

Query: 286 DVYSFGVVLLEILTGR 301
           D++S   +  E+L   
Sbjct: 220 DIWSIACIWAEMLMKT 235

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.4 bits (241), Expect = 1e-22
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----- 148
            +     +GEG +G V+K          A+   G T A+K ++   L+   E +      
Sbjct: 3   KYHGLEKIGEGTYGVVYK----------AQNNYGETFALKKIR---LEKEDEGIPSTTIR 49

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           E+  L +L H N+VKL        + +LV+E + +  L+  L      L         L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVG 266
              G+A+ H     V++RD K  N+L++ E   K++DFGLA+A   P    TH    +V 
Sbjct: 109 LLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV- 162

Query: 267 TYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
           T  Y AP+ V+ G    ++  D++S G +  E++ G 
Sbjct: 163 TLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 47/212 (22%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
           +LG G F  VF    ++  T       G   A+K +K            E+  L ++ H 
Sbjct: 16  VLGSGAFSEVFLV--KQRLT-------GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66

Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG------AAK- 211
           N+V L     E      LV + ++ G  E  LF         +RI +  G      A+  
Sbjct: 67  NIVTLEDI-YESTTHYYLVMQLVSGG--E--LF---------DRI-LERGVYTEKDASLV 111

Query: 212 ------GLAFLHGGSEPVIYRDFKTSNILLDS-EYNA--KLSDFGLAKAGPQGDKTHVST 262
                  + +LH     +++RD K  N+L  + E N+   ++DFGL+K    G    + +
Sbjct: 112 IQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMS 165

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 294
              GT GY APE +     +   D +S GV+ 
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 73/317 (23%), Positives = 114/317 (35%), Gaps = 62/317 (19%)

Query: 89  KSATGNFR-----PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH 143
            S +G F       + +LGEG    V         T           AVK ++       
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTC--INLIT-------SQEYAVKIIEKQPGHIR 54

Query: 144 REWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN 201
                EV+ L Q   H N+++LI +  E++ R  LV+E M  GS+ +H+ +R     ++ 
Sbjct: 55  SRVFREVEMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNE 110

Query: 202 R-----IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA---KLSDFGLAKAGP 253
                 ++    A   L FLH  ++ + +RD K  NIL +        K+ DF L     
Sbjct: 111 LEASVVVQDVASA---LDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165

Query: 254 QGDKTHVSTR-----VVGTYGYAAPEYVMTGHLTSKS-----DVYSFGVVLLEILTGRRS 303
                   +        G+  Y APE V      +       D++S GV+L  +L+G   
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-- 223

Query: 304 MDKKRP----SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGV--QKVSQLA---- 353
                P     G            A +  L++ +    E  Y         +S  A    
Sbjct: 224 ----PPFVGRCGSDCGWDRGEACPACQNMLFESI---QEGKYEFPDKDWAHISCAAKDLI 276

Query: 354 YNCLSRDPKSRPSMDEV 370
              L RD K R S  +V
Sbjct: 277 SKLLVRDAKQRLSAAQV 293

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 79/349 (22%), Positives = 127/349 (36%), Gaps = 69/349 (19%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLG 154
           ++G+G F  V +       T       G   AVK +                  E     
Sbjct: 31  VIGKGPFSVVRRC--INRET-------GQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81

Query: 155 QLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPW------SNRIKIAL 207
            L HP++V+L+      D  L +V+EFM    L   + +R            S+ ++  L
Sbjct: 82  MLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA---KLSDFGLAKAGPQGDKTHVSTRV 264
            A   L + H     +I+RD K   +LL S+ N+   KL  FG+A    +     V+   
Sbjct: 141 EA---LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGR 193

Query: 265 VGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
           VGT  + APE V+      K  DV+  GV+L  +L+G        P            + 
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC------LP------------FY 234

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCLSRDPKSRPSMDEV-----VK 372
             K +L++ +   ++  Y +   Q   +S+ A       L  DP  R ++ E      +K
Sbjct: 235 GTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

Query: 373 VLTPLQDLNDLAILSYHSRLSQ-QGRRKKKQDGTQQLASAHSKSIRDSP 420
                     L       +L +   RRK K      ++S    S    P
Sbjct: 292 ERDRYAYKIHLPETV--EQLRKFNARRKLKGAVLAAVSSHKFNSFYGDP 338

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 30/217 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----- 148
            ++    +GEG +G V+K          AK   G  VA+K ++   L    E +      
Sbjct: 22  KYQKLEKVGEGTYGVVYK----------AKDSQGRIVALKRIR---LDAEDEGIPSTAIR 68

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           E+  L +LHHPN+V LI     +    LV+EFM +  L+  L      L  S        
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVG 266
             +G+A  H     +++RD K  N+L++S+   KL+DFGLA+A   P    TH    VV 
Sbjct: 128 LLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV- 181

Query: 267 TYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
           T  Y AP+ V+ G    ++  D++S G +  E++TG+
Sbjct: 182 TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 71/333 (21%), Positives = 119/333 (35%), Gaps = 96/333 (28%)

Query: 83  FTFQELKSATGNFRPDSI---------LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK 133
           F F +L     +  P ++         LG G  G V      E  T          VA++
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA--FERKT-------CKKVAIR 166

Query: 134 SLKPDGLQGHREWVA--------EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGS 185
            +            A        E++ L +L+HP ++K+  +  + +   +V E M  G 
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG- 224

Query: 186 LENHLFRRTIPLPWSNRIKIALG------AAK-------GLAFLHGGSEPVIYRDFKTSN 232
            E  LF         +++ +                    + +LH     +I+RD K  N
Sbjct: 225 -E--LF---------DKV-VGNKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPEN 269

Query: 233 ILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL----TSKS 285
           +LL S   +   K++DFG +K    G+ + + T + GT  Y APE V+            
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYLAPE-VLVSVGTAGYNRAV 325

Query: 286 DVYSFGVVLLEILTGRRSMDKKRP--SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSL 343
           D +S GV+L   L+G        P  S  +            +  L   +       Y+ 
Sbjct: 326 DCWSLGVILFICLSG-------YPPFSEHRT-----------QVSLKDQI---TSGKYNF 364

Query: 344 KGVQ--KVSQLA----YNCLSRDPKSRPSMDEV 370
                 +VS+ A       L  DPK+R + +E 
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 78/297 (26%), Positives = 118/297 (39%), Gaps = 77/297 (25%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL-KPDGLQGHREWV-AEVDFLGQLH 157
           +LG+G FG V K   ++  T           AVK + K          +  EV+ L +L 
Sbjct: 29  MLGKGSFGEVLKC--KDRIT-------QQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG------AA 210
           HPN++KL     ED     +V E  T G  E  LF         + I I         AA
Sbjct: 80  HPNIMKLFEIL-EDSSSFYIVGELYTGG--E--LF---------DEI-IKRKRFSEHDAA 124

Query: 211 K-------GLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHV 260
           +       G+ ++H     +++RD K  NILL+S   + + K+ DFGL+    Q  K   
Sbjct: 125 RIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180

Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWA 319
               +GT  Y APE V+ G    K DV+S GV+L  +L+G        P  G+       
Sbjct: 181 -KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------PPFYGK------- 225

Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCLSRDPKSRPSMDEV 370
                ++  + + V       Y+    Q   +S  A       L+  P  R +  + 
Sbjct: 226 -----NEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 33/224 (14%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA---- 148
           G +    +LGEG +G V +    E              AVK LK   L+      A    
Sbjct: 5   GKYLMGDLLGEGSYGKVKEVLDSETLC---------RRAVKILKKKKLRRIPNGEANVKK 55

Query: 149 EVDFLGQLHHPNLVKLIG-YCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIA 206
           E+  L +L H N+++L+     E+ Q++ +V E+   G  E  +           R  + 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP----EKRFPVC 109

Query: 207 LGAAK------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
                      GL +LH  S+ ++++D K  N+LL +    K+S  G+A+A         
Sbjct: 110 QAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167

Query: 261 STRVVGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEILTGR 301
                G+  +  PE +  G  T    K D++S GV L  I TG 
Sbjct: 168 CRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 28/225 (12%)

Query: 87  ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW 146
           ++KS    +     LGEG F  V+K   +              VA+K +K       ++ 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQ---------IVAIKKIKLGHRSEAKDG 54

Query: 147 VA-----EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSN 201
           +      E+  L +L HPN++ L+          LV++FM    LE  +   ++ L  S+
Sbjct: 55  INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSH 113

Query: 202 RIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKT 258
            IK   L   +GL +LH     +++RD K +N+LLD     KL+DFGLAK+   P    T
Sbjct: 114 -IKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170

Query: 259 HVSTRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
           H   +VV T  Y APE ++ G        D+++ G +L E+L   
Sbjct: 171 H---QVV-TRWYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 68/287 (23%), Positives = 108/287 (37%), Gaps = 59/287 (20%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP 159
            +G G +G V      + GT        I  A K +    ++    +  E++ +  L HP
Sbjct: 16  TIGRGSWGEVKIA--VQKGT-------RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66

Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPW------SNRIKIALGAAKG 212
           N+++L     ED+  + LV E  T G  E  LF R +          +  +K  L A   
Sbjct: 67  NIIRLYET-FEDNTDIYLVMELCTGG--E--LFERVVHKRVFRESDAARIMKDVLSA--- 118

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           +A+ H     V +RD K  N L  +   +   KL DFGLA     G         VGT  
Sbjct: 119 VAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPY 173

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           Y +P+ V+ G    + D +S GV++  +L G        P         A        ++
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY------PP-------FSAP----TDSEV 215

Query: 330 YQIVDPRLELNYSLKGVQ--KVSQLA----YNCLSRDPKSRPSMDEV 370
              +    E  ++        VS  A       L++ PK R +  + 
Sbjct: 216 MLKI---REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-----REWVAEVDFLGQ 155
           LG G +  V+KG  +  G           VA+K +K D  +G      RE    +  + +
Sbjct: 13  LGNGTYATVYKGLNKTTGV---------YVALKEVKLDSEEGTPSTAIRE----ISLMKE 59

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMT---RGSLENHLFRRT-IPLPWSNRIKIALGAAK 211
           L H N+V+L      +++  LV+EFM    +  +++     T   L  +          +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA--GPQGDKTHVSTRVVGTYG 269
           GLAF H     +++RD K  N+L++     KL DFGLA+A   P    +     VV T  
Sbjct: 120 GLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173

Query: 270 YAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
           Y AP+ V+ G    ++  D++S G +L E++TG+
Sbjct: 174 YRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 81/285 (28%), Positives = 127/285 (44%), Gaps = 47/285 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWV-AEV 150
           +F    ++G G +  V    +    T           A+K +K + +      +WV  E 
Sbjct: 10  DFDLLRVIGRGSYAKVLL--VRLKKT-------DRIYAMKVVKKELVNDDEDIDWVQTEK 60

Query: 151 DFLGQ-LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRI---K 204
               Q  +HP LV L   C + + RL  V E++  G L  H+ R R +P   + R    +
Sbjct: 61  HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAE 118

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVSTR 263
           I+L     L +LH     +IYRD K  N+LLDSE + KL+D+G+ K G   GD T   T 
Sbjct: 119 ISLA----LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T- 169

Query: 264 VVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
             GT  Y APE ++ G     S D ++ GV++ E++ GR        S    + +     
Sbjct: 170 FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR--------SPFDIVGSSDNPD 220

Query: 323 LADKRKLYQ-IV--DPRLELNYSLKGVQKVSQLAYNCLSRDPKSR 364
              +  L+Q I+    R+  + S+K    +       L++DPK R
Sbjct: 221 QNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF----LNKDPKER 261

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 30/230 (13%)

Query: 86  QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE 145
           +E++    +F    ++G G F  V    ++   T       G   A+K +    +    E
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAV--VKMKQT-------GQVYAMKIMNKWDMLKRGE 104

Query: 146 ---WVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR--RTIPLPW 199
              +  E D L       + +L  +  +D+  L LV E+   G L   L +    IP   
Sbjct: 105 VSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM 163

Query: 200 SNRIKIA-LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT 258
           + R  +A +  A  +  +H      ++RD K  NILLD   + +L+DFG           
Sbjct: 164 A-RFYLAEIVMA--IDSVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 259 HVSTRVVGTYGYAAPEYVMTGHLTSKSDVY-------SFGVVLLEILTGR 301
                 VGT  Y +PE +        +  Y       + GV   E+  G+
Sbjct: 219 RSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 74/261 (28%), Positives = 111/261 (42%), Gaps = 45/261 (17%)

Query: 57  PNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPD-----SILGEGGFGYVFK 111
           P E  L + NP P P   +              S+  + +P       ++G+G FG V  
Sbjct: 5   PQEPELMNANPAPPPAPSQQ--------INLGPSSNPHAKPSDFHFLKVIGKGSFGKVLL 56

Query: 112 GWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWV-AEVDFLGQ-LHHPNLVKLIGY 167
                           +  AVK L+   +  +   + + +E + L + + HP LV L  +
Sbjct: 57  --ARHKAE-------EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-F 106

Query: 168 CIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRI---KIALGAAKGLAFLHGGSEP 222
             +   +L  V +++  G L  HL R R    P + R    +IA      L +LH  S  
Sbjct: 107 SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASA----LGYLH--SLN 159

Query: 223 VIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVSTRVVGTYGYAAPEYVMTGHL 281
           ++YRD K  NILLDS+ +  L+DFGL K        T  ST   GT  Y APE V+    
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAPE-VLHKQP 215

Query: 282 TSKS-DVYSFGVVLLEILTGR 301
             ++ D +  G VL E+L G 
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGL 236

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 96.4 bits (240), Expect = 6e-22
 Identities = 54/228 (23%), Positives = 88/228 (38%), Gaps = 28/228 (12%)

Query: 86  QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE 145
           ++++    +F    ++G G FG V    ++               A+K L    +    E
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAV--VKLKNA-------DKVFAMKILNKWEMLKRAE 117

Query: 146 ---WVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHL--FRRTIPLPW 199
              +  E D L       +  L  Y  +DD  L LV ++   G L   L  F   +P   
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM 176

Query: 200 SNRIKIA-LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT 258
           + R  +A +  A  +  +H      ++RD K  NIL+D   + +L+DFG      +    
Sbjct: 177 A-RFYLAEMVIA--IDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 259 HVSTRVVGTYGYAAPEYVMTGHLTSKS-----DVYSFGVVLLEILTGR 301
             S   VGT  Y +PE +              D +S GV + E+L G 
Sbjct: 232 QSSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 95.9 bits (239), Expect = 6e-22
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 39/222 (17%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG 154
           +    ++G G FG VF+  + E+            VA+K +  D    +R    E+  + 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD----------EVAIKKVLQDKRFKNR----ELQIMR 87

Query: 155 QLHHPNLVKLIGYCI------EDDQRL-LVYEFM--TRGSLENHLFRRTIPLPWSNRIKI 205
            + HPN+V L           +D+  L LV E++  T      H  +    +P    IK+
Sbjct: 88  IVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP-MLLIKL 145

Query: 206 AL-GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKA-GPQGDKTH-VS 261
            +    + LA++H  S  + +RD K  N+LLD      KL DFG AK           + 
Sbjct: 146 YMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203

Query: 262 TRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
           +R    Y Y APE ++ G  + T+  D++S G V+ E++ G+
Sbjct: 204 SR----Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 58/314 (18%), Positives = 115/314 (36%), Gaps = 51/314 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVDFLGQLHHP 159
           LG G FG V +    E  +         T   K +K  G    +  V  E+  L    H 
Sbjct: 13  LGRGEFGIVHRC--VETSS-------KKTYMAKFVKVKGTD--QVLVKKEISILNIARHR 61

Query: 160 NLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG 218
           N++ L     E  + L +++EF++   +   +      L     +       + L FLH 
Sbjct: 62  NILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH- 119

Query: 219 GSEPVIYRDFKTSNILLDSEYNA--KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
            S  + + D +  NI+  +  ++  K+ +FG A+    GD   +   +     Y APE  
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175

Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADKRKLYQIVDP 335
               +++ +D++S G ++  +L+G        P   E              +++ + +  
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI------NPFLAE------------TNQQIIENI-- 215

Query: 336 RLELNYSLKGV--QKVSQLA----YNCLSRDPKSRPSMDEVVKV--LTPLQDLNDLAILS 387
            +   Y+      +++S  A       L ++ KSR +  E ++   L    +     ++ 
Sbjct: 216 -MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274

Query: 388 YHSRLSQQGRRKKK 401
                       KK
Sbjct: 275 TLKHRRYYHTLIKK 288

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 95.5 bits (238), Expect = 8e-22
 Identities = 84/323 (26%), Positives = 138/323 (42%), Gaps = 48/323 (14%)

Query: 57  PNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSAT-GNFRPDSILGEGGFGYVFKGWIE 115
           P   +L       +  +E+      + + +   S    +F    ++G G +  V    + 
Sbjct: 15  PTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL--VR 72

Query: 116 ENGTAPAKPGSGITVAVKSLKPDGL--QGHREWV-AEVDFLGQ-LHHPNLVKLIGYCIED 171
              T           A++ +K + +      +WV  E     Q  +HP LV L   C + 
Sbjct: 73  LKKT-------DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQT 124

Query: 172 DQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRI---KIALGAAKGLAFLHGGSEPVIYR 226
           + RL  V E++  G L  H+ R R +P   + R    +I+L     L +LH     +IYR
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLA----LNYLH--ERGIIYR 177

Query: 227 DFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS 285
           D K  N+LLDSE + KL+D+G+ K G   GD T   T   GT  Y APE ++ G     S
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNYIAPE-ILRGEDYGFS 233

Query: 286 -DVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ-IV--DPRLELNY 341
            D ++ GV++ E++ GR        S    + +        +  L+Q I+    R+  + 
Sbjct: 234 VDWWALGVLMFEMMAGR--------SPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285

Query: 342 SLKGVQKVSQLAYNCLSRDPKSR 364
           S+K    +       L++DPK R
Sbjct: 286 SVKAASVLKSF----LNKDPKER 304

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 38/223 (17%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           ++    ++G G FG V++  + ++G           VA+K +  D    +RE    +  +
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGE---------LVAIKKVLQDKRFKNRE----LQIM 101

Query: 154 GQLHHPNLVKLIGYCI------EDDQRL-LVYEFM--TRGSLENHLFRRTIPLPWSNRIK 204
            +L H N+V+L  Y        +D+  L LV +++  T   +  H  R    LP    +K
Sbjct: 102 RKLDHCNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVK 159

Query: 205 IAL-GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDK-TH-V 260
           + +    + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+     +
Sbjct: 160 LYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 261 STRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
            +R    Y Y APE ++ G    TS  DV+S G VL E+L G+
Sbjct: 218 CSR----Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.1 bits (237), Expect = 9e-22
 Identities = 71/337 (21%), Positives = 123/337 (36%), Gaps = 88/337 (26%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K    E  T       G+  A K +K    +  R  V       EV  L 
Sbjct: 20  LGSGQFAIVKKC--REKST-------GLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 155 QLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSL------ENHL-------FRRTIPLPWS 200
           Q+ HPN++ L     E+   + L+ E ++ G L      +  L       F + I     
Sbjct: 71  QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----- 124

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE----YNAKLSDFGLAKAGPQGD 256
                      G+ +LH  ++ + + D K  NI+L  +     + KL DFGLA     G 
Sbjct: 125 ---------LDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP--SGEQN 314
           +      + GT  + APE V    L  ++D++S GV+   +L+G            G+  
Sbjct: 174 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------ASPFLGD-- 221

Query: 315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGV--QKVSQLA----YNCLSRDPKSRPSMD 368
                      K++    +     ++Y        + S+LA       L ++ + R ++ 
Sbjct: 222 ----------TKQETLANI---TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQ 268

Query: 369 EV-----VKVLTPLQDLNDLAILSYHSRLSQQGRRKK 400
           E      +  +   Q +     +       +Q  R++
Sbjct: 269 EALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRR 305

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 66/309 (21%), Positives = 111/309 (35%), Gaps = 65/309 (21%)

Query: 20  KSSASNHSANTIPRTSLVYDAATETRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQ 79
           +   +      +P  +     A      +  ++      EA    ++  P  T+      
Sbjct: 18  ERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAK-KLNDAQPKGTENLYFQS 76

Query: 80  LLQFTFQELKSATGNFR----PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKS- 134
           +         +A   F     P  ++G G    V +       T       G   AVK  
Sbjct: 77  MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC--VHRAT-------GHEFAVKIM 127

Query: 135 ------LKPDGLQGHREWVA-EVDFLGQLH-HPNLVKLIGYCIEDDQRL-LVYEFMTRGS 185
                 L P+ L+  RE    E   L Q+  HP+++ LI    E    + LV++ M +G 
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG- 185

Query: 186 LENHLFRRTIPLPWSNRIKIALG------AAK-------GLAFLHGGSEPVIYRDFKTSN 232
            E  LF         + +                      ++FLH  +  +++RD K  N
Sbjct: 186 -E--LF---------DYL-TEKVALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPEN 230

Query: 233 ILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS-------KS 285
           ILLD     +LSDFG +     G+K      + GT GY APE ++   +         + 
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPE-ILKCSMDETHPGYGKEV 286

Query: 286 DVYSFGVVL 294
           D+++ GV+L
Sbjct: 287 DLWACGVIL 295

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 32/223 (14%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
            F+ + + G+G FG V  G  +  G          +VA+K +  D    +RE +  +  L
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGM---------SVAIKKVIQDPRFRNRE-LQIMQDL 73

Query: 154 GQLHHPNLVKLI------GYCIEDDQRL-LVYEFM--TRGSLENHLFRRTIPLPWSNRIK 204
             LHHPN+V+L       G     D  L +V E++  T      + +RR +  P    IK
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP-PILIK 132

Query: 205 IAL-GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKA-GPQGDKTH-V 260
           + L    + +  LH  S  V +RD K  N+L++      KL DFG AK   P       +
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192

Query: 261 STRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGR 301
            +R    Y Y APE ++ G  H T+  D++S G +  E++ G 
Sbjct: 193 CSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 72/313 (23%), Positives = 112/313 (35%), Gaps = 85/313 (27%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK--------PDGLQGHRE 145
           N+ P  ILG G    V +       T           AVK +          + +Q  RE
Sbjct: 18  NYEPKEILGRGVSSVVRRC--IHKPT-------CKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 146 WVA-EVDFLGQL-HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNR 202
               EVD L ++  HPN+++L     E +    LV++ M +G  E  LF         + 
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LF---------DY 114

Query: 203 IKIALG------AAK-------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
           +             K        +  LH     +++RD K  NILLD + N KL+DFG +
Sbjct: 115 L-TEKVTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

Query: 250 KAGPQGDKTHVSTRVVGTYGYAAPE------YVMTGHLTSKSDVYSFGVVLLEILTGRRS 303
                G+K      V GT  Y APE               + D++S GV++  +L G   
Sbjct: 172 CQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-- 226

Query: 304 MDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCL 357
                P        W R     +  + +++   +  NY     +    S          L
Sbjct: 227 ----PP-------FWHR----KQMLMLRMI---MSGNYQFGSPEWDDYSDTVKDLVSRFL 268

Query: 358 SRDPKSRPSMDEV 370
              P+ R + +E 
Sbjct: 269 VVQPQKRYTAEEA 281

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 64/297 (21%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQG-HREW 146
           GN+R    +G+G F  V        G           VA+K      L P  LQ   RE 
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGR---------EVAIKIIDKTQLNPTSLQKLFRE- 64

Query: 147 VAEVDFLGQLHHPNLVKLIGY-CIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
              V  +  L+HPN+VKL  +  IE ++ L L+ E+ + G + ++L           R+K
Sbjct: 65  ---VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAH-------GRMK 112

Query: 205 IALGAAK------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT 258
                +K       + + H   + +++RD K  N+LLD++ N K++DFG +     G K 
Sbjct: 113 EKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170

Query: 259 HVSTRVVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
                  G   YAAPE +  G      + DV+S GV+L  +++G    D       QNL 
Sbjct: 171 DAF---CGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNL- 219

Query: 317 AWARQYLADKRKLYQ-IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                     ++L + ++  +  + + +        L    L  +P  R ++++++K
Sbjct: 220 ----------KELRERVLRGKYRIPFYMS--TDCENLLKRFLVLNPIKRGTLEQIMK 264

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 69/327 (21%), Positives = 109/327 (33%), Gaps = 89/327 (27%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ----GHREWVA-EVDFLGQ 155
           +G+G +G V      EN T           A+K +  + ++       E +  EV  + +
Sbjct: 34  IGQGSYGVVRVA--IENQT-------RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 156 LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG------ 208
           LHHPN+ +L     ED+Q + LV E    G L + L            + +         
Sbjct: 85  LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 209 --------------------------AAK-------GLAFLHGGSEPVIYRDFKTSNILL 235
                                      +         L +LH  ++ + +RD K  N L 
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRDIKPENFLF 201

Query: 236 DSEYNA--KLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS---KSDVY 288
            +  +   KL DFGL+K        + +  T   GT  + APE V+     S   K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAW 260

Query: 289 SFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQ 347
           S GV+L  +L G        P  G             +       V    +L +      
Sbjct: 261 SAGVLLHLLLMG------AVPFPGV------------NDADTISQVL-NKKLCFENPNYN 301

Query: 348 KVSQLAY----NCLSRDPKSRPSMDEV 370
            +S LA     N L+R+   R      
Sbjct: 302 VLSPLARDLLSNLLNRNVDERFDAMRA 328

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 54/240 (22%), Positives = 88/240 (36%), Gaps = 58/240 (24%)

Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA 148
           K+    +     LG G  G V      E  T          VA+K +            A
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLA--FERKT-------CKKVAIKIISKRKFAIGSAREA 56

Query: 149 --------EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWS 200
                   E++ L +L+HP ++K+  +  + +   +V E M  G  E  LF         
Sbjct: 57  DPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LF--------- 102

Query: 201 NRIKIALG------AAK-------GLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLS 244
           +++ +                    + +LH     +I+RD K  N+LL S   +   K++
Sbjct: 103 DKV-VGNKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKIT 159

Query: 245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTG 300
           DFG +K   +         + GT  Y APE V+            D +S GV+L   L+G
Sbjct: 160 DFGHSKILGETSLM---RTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 34/221 (15%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVD 151
            ++     LGEG +G V          A         VAVK +         E +  E+ 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEA---------VAVKIVDMKRAVDCPENIKKEIC 57

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
               L+H N+VK  G    +     L  E+ + G L + +            I +    A
Sbjct: 58  INKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDA 107

Query: 211 K--------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +        G+ +LH     + +RD K  N+LLD   N K+SDFGLA      ++  +  
Sbjct: 108 QRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165

Query: 263 RVVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGR 301
           ++ GT  Y APE ++          DV+S G+VL  +L G 
Sbjct: 166 KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 72/334 (21%), Positives = 124/334 (37%), Gaps = 75/334 (22%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFL 153
            LG G F  V K    E  T       G+  A K +K    +  R  V+      EV  L
Sbjct: 19  ELGSGQFAIVKKC--REKST-------GLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 154 GQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSL------ENHLFRRTIPLPWSNRIKIA 206
            Q+ H N++ L     E+   + L+ E ++ G L      +  L         ++ IK  
Sbjct: 70  RQVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQI 124

Query: 207 LGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE----YNAKLSDFGLAKAGPQGDKTHVST 262
           L    G+ +LH  ++ + + D K  NI+L  +     + KL DFGLA     G +     
Sbjct: 125 LD---GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP--SGEQNLVAWAR 320
            + GT  + APE V    L  ++D++S GV+   +L+G            G+        
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------ASPFLGD-------- 221

Query: 321 QYLADKRKLYQIVDPRLELNYSLKGV--QKVSQLA----YNCLSRDPKSRPSMDEV---- 370
                K++    +     ++Y          S+LA       L ++ + R ++ E     
Sbjct: 222 ----TKQETLANI---TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 371 -VKVLTPLQDLNDLAILSYHSRLSQ-QGRRKKKQ 402
            +  +   Q +     +       +   RR+ K 
Sbjct: 275 WITPVDNQQAMVRRESVVNLENFRKQYVRRRWKL 308

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 25/211 (11%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEVDFLGQL 156
           ++G G FG V    +    T           A+K L    +    +   +  E D +   
Sbjct: 76  VIGRGAFGEVQL--VRHKST-------RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126

Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIA-LGAAKGLA 214
           + P +V+L  Y  +DD+ L +V E+M  G L N +    +P  W+ R   A +  A  L 
Sbjct: 127 NSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLA--LD 182

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
            +H  S   I+RD K  N+LLD   + KL+DFG      +       T  VGT  Y +PE
Sbjct: 183 AIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPE 239

Query: 275 YVMT----GHLTSKSDVYSFGVVLLEILTGR 301
            + +    G+   + D +S GV L E+L G 
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 43/228 (18%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA---- 148
             +   S LG G FG+V+    +E             V VK +K + +     W+     
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNK---------EVVVKFIKKEKVLEDC-WIEDPKL 73

Query: 149 -----EVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGS-LENHLFRRTIPLPWSN 201
                E+  L ++ H N++K++    E+     LV E    G  L   + R         
Sbjct: 74  GKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP------- 125

Query: 202 RIKIALGAAK------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
           R+   L +         + +L    + +I+RD K  NI++  ++  KL DFG A    +G
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183

Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGR 301
              +      GT  Y APE V+ G+     + +++S GV L  ++   
Sbjct: 184 KLFYTF---CGTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 91.5 bits (228), Expect = 5e-21
 Identities = 70/309 (22%), Positives = 116/309 (37%), Gaps = 80/309 (25%)

Query: 92  TGNFR----PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HRE 145
           +  F         LG+G F  V +       T       G+  A K +    L     ++
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRC--VHKTT-------GLEFAAKIINTKKLSARDFQK 51

Query: 146 WVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
              E     +L HPN+V+L    I+++    LV++ +T G  E  LF           I 
Sbjct: 52  LEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGG--E--LF---------EDI- 96

Query: 205 IALG------AAK-------GLAFLHGGSEPVIYRDFKTSNILLDSEYNA---KLSDFGL 248
           +A        A+         +A+ H  S  +++R+ K  N+LL S+      KL+DFGL
Sbjct: 97  VAREFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154

Query: 249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKK 307
           A      +         GT GY +PE V+     +   D+++ GV+L  +L G       
Sbjct: 155 AIEVNDSEAW---HGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF--- 207

Query: 308 RPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCLSRDP 361
                     W      D+ +LY  +       Y     +   V+  A     + L+ +P
Sbjct: 208 ----------WDE----DQHRLYAQI---KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 250

Query: 362 KSRPSMDEV 370
           K R + D+ 
Sbjct: 251 KKRITADQA 259

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 70/221 (31%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEV 150
           +F    +LG+G FG VF    E   T           A+K+LK D +    +    + E 
Sbjct: 18  DFILHKMLGKGSFGKVFL--AEFKKT-------NQFFAIKALKKDVVLMDDDVECTMVEK 68

Query: 151 DFLGQ-LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRIK--- 204
             L     HP L  +     +  + L  V E++  G L  H+       L    R     
Sbjct: 69  RVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYA 124

Query: 205 --IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG-PQGDKTHVS 261
             I LG    L FLH  S+ ++YRD K  NILLD + + K++DFG+ K       KT  +
Sbjct: 125 AEIILG----LQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--N 176

Query: 262 TRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
           T   GT  Y APE ++ G   + S D +SFGV+L E+L G+
Sbjct: 177 T-FCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.1 bits (227), Expect = 7e-21
 Identities = 73/301 (24%), Positives = 116/301 (38%), Gaps = 81/301 (26%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K    + GT       G   A K +K   L   R  V+      EV+ L 
Sbjct: 13  LGSGQFAIVRKC--RQKGT-------GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 155 QLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSL------ENHL-------FRRTIPLPWS 200
           ++ HPN++ L     E+   + L+ E ++ G L      +  L       F + I     
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----- 117

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA----KLSDFGLAKAGPQGD 256
                      G+ +LH  S+ + + D K  NI+L  +       KL DFG+A     G+
Sbjct: 118 ---------LDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNL 315
           +      + GT  + APE V    L  ++D++S GV+   +L+G        P  GE   
Sbjct: 167 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGE--- 214

Query: 316 VAWARQYLADKRKLYQIVDPRLELNYSLKGV--QKVSQLA----YNCLSRDPKSRPSMDE 369
                     K++    +     +NY          S+LA       L +DPK R ++ +
Sbjct: 215 ---------TKQETLTNI---SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262

Query: 370 V 370
            
Sbjct: 263 S 263

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 92.3 bits (230), Expect = 7e-21
 Identities = 75/250 (30%), Positives = 106/250 (42%), Gaps = 44/250 (17%)

Query: 63  SSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPA 122
           ++          +   +L  F F  L           +LG+G FG V     E  GT   
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNF--LM----------VLGKGSFGKVML--SERKGT--- 44

Query: 123 KPGSGITVAVKSLKPDGL--QGHREWV-AEVDFLGQ-LHHPNLVKLIGYCIEDDQRL-LV 177
                   AVK LK D +      E    E   L      P L +L   C +   RL  V
Sbjct: 45  ----DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFV 99

Query: 178 YEFMTRGSLENHLFRRTI-PLPWSNRI---KIALGAAKGLAFLHGGSEPVIYRDFKTSNI 233
            E++  G L  H+ +      P +      +IA+G    L FL   S+ +IYRD K  N+
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPHA-VFYAAEIAIG----LFFLQ--SKGIIYRDLKLDNV 152

Query: 234 LLDSEYNAKLSDFGLAKAG-PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFG 291
           +LDSE + K++DFG+ K     G  T   T   GT  Y APE ++      KS D ++FG
Sbjct: 153 MLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDYIAPE-IIAYQPYGKSVDWWAFG 208

Query: 292 VVLLEILTGR 301
           V+L E+L G+
Sbjct: 209 VLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 91.9 bits (229), Expect = 9e-21
 Identities = 75/250 (30%), Positives = 106/250 (42%), Gaps = 44/250 (17%)

Query: 63  SSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPA 122
           SS   +    +  +   +  F F  ++          +LG+G FG V         T   
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEF--IR----------VLGKGSFGKVML--ARVKET--- 47

Query: 123 KPGSGITVAVKSLKPDGL--QGHREWV-AEVDFLGQ-LHHPNLVKLIGYCIEDDQRL-LV 177
               G   AVK LK D +      E    E   L    +HP L +L   C +   RL  V
Sbjct: 48  ----GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFV 102

Query: 178 YEFMTRGSLENHLFR-RTIPLPWSNRI---KIALGAAKGLAFLHGGSEPVIYRDFKTSNI 233
            EF+  G L  H+ + R      + R    +I       L FLH   + +IYRD K  N+
Sbjct: 103 MEFVNGGDLMFHIQKSRRFDEARA-RFYAAEIISA----LMFLH--DKGIIYRDLKLDNV 155

Query: 234 LLDSEYNAKLSDFGLAKAG-PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFG 291
           LLD E + KL+DFG+ K G   G  T  +T   GT  Y APE ++   L   + D ++ G
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPDYIAPE-ILQEMLYGPAVDWWAMG 211

Query: 292 VVLLEILTGR 301
           V+L E+L G 
Sbjct: 212 VLLYEMLCGH 221

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.5 bits (228), Expect = 9e-21
 Identities = 78/339 (23%), Positives = 125/339 (36%), Gaps = 82/339 (24%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLG 154
           LG G F  V K    E  T       G+  A K +K    +  R  V+      EV  L 
Sbjct: 19  LGSGQFAVVKKC--REKST-------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 155 QLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSL------ENHL-------FRRTIPLPWS 200
           ++ HPN++ L     E+   + L+ E +  G L      +  L       F + I     
Sbjct: 70  EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----- 123

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA----KLSDFGLAKAGPQGD 256
                      G+ +LH  S  + + D K  NI+L          K+ DFGLA     G+
Sbjct: 124 ---------LNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNL 315
           +      + GT  + APE V    L  ++D++S GV+   +L+G        P  G+   
Sbjct: 173 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGD--- 220

Query: 316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLA----YNCLSRDPKSRPSMDEV- 370
                     K++    V   +   +  +     S LA       L +DPK R ++ +  
Sbjct: 221 ---------TKQETLANVS-AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

Query: 371 ----VKVLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGT 405
               +K     Q L+  A      +  +   RKK  +G+
Sbjct: 271 QHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGS 309

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 34/221 (15%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVD 151
            ++     LGEG +G V          A         VAVK +         E +  E+ 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEA---------VAVKIVDMKRAVDCPENIKKEIC 57

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
               L+H N+VK  G    +     L  E+ + G L + +            I +    A
Sbjct: 58  INKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDA 107

Query: 211 K--------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVST 262
           +        G+ +LH     + +RD K  N+LLD   N K+SDFGLA      ++  +  
Sbjct: 108 QRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165

Query: 263 RVVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGR 301
           ++ GT  Y APE ++          DV+S G+VL  +L G 
Sbjct: 166 KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 70/312 (22%), Positives = 118/312 (37%), Gaps = 78/312 (25%)

Query: 88  LKSATGNFR----PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG- 142
           + +A+  F         LG+G F  V +       T       G+  A K +    L   
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRC--VHKTT-------GLEFAAKIINTKKLSAR 70

Query: 143 -HREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWS 200
             ++   E     +L HPN+V+L    I+++    LV++ +T G  E  LF         
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGG--E--LF--------- 116

Query: 201 NRIKIALG------AAK-------GLAFLHGGSEPVIYRDFKTSNILLDSEYNA---KLS 244
             I +A        A+         +A+ H  S  +++R+ K  N+LL S+      KL+
Sbjct: 117 EDI-VAREFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLA 173

Query: 245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSM 304
           DFGLA      +         GT GY +PE +     +   D+++ GV+L  +L G    
Sbjct: 174 DFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

Query: 305 DKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCLS 358
                        W      D+ +LY  +       Y     +   V+  A     + L+
Sbjct: 231 -------------WDE----DQHRLYAQI---KAGAYDYPSPEWDTVTPEAKSLIDSMLT 270

Query: 359 RDPKSRPSMDEV 370
            +PK R + D+ 
Sbjct: 271 VNPKKRITADQA 282

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.8 bits (230), Expect = 2e-20
 Identities = 73/258 (28%), Positives = 104/258 (40%), Gaps = 24/258 (9%)

Query: 51  NRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVF 110
           N EL    E                +            +    +F    +LG+G FG V 
Sbjct: 299 NEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVM 358

Query: 111 KGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVDFLGQ-LHHPNLVKLIG 166
               E  GT           AVK LK D +    +    + E   L      P L +L  
Sbjct: 359 L--SERKGT-------DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH- 408

Query: 167 YCIEDDQRL-LVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVI 224
            C +   RL  V E++  G L  H+ +      P +     A   A GL FL   S+ +I
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-VFYAA-EIAIGLFFLQ--SKGII 464

Query: 225 YRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSK 284
           YRD K  N++LDSE + K++DFG+ K       T  +    GT  Y APE ++      K
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPE-IIAYQPYGK 521

Query: 285 S-DVYSFGVVLLEILTGR 301
           S D ++FGV+L E+L G+
Sbjct: 522 SVDWWAFGVLLYEMLAGQ 539

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 40/214 (18%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV----AEVDFLGQL 156
           LG G FG V    I            G   A+K LK + +   ++ V     E   L  +
Sbjct: 14  LGTGSFGRVHL--IRSRHN-------GRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIV 63

Query: 157 HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRIK-----IALGA 209
            HP ++++     +D Q++ ++ +++  G L + L + +  P P     K     + L  
Sbjct: 64  THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCLA- 118

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
              L +LH  S+ +IYRD K  NILLD   + K++DFG AK  P    T     + GT  
Sbjct: 119 ---LEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPD 168

Query: 270 YAAPEYVMT-GHLTSKS-DVYSFGVVLLEILTGR 301
           Y APE V T  +  +KS D +SFG+++ E+L G 
Sbjct: 169 YIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 73/355 (20%), Positives = 121/355 (34%), Gaps = 83/355 (23%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVA-EVDFLGQLH 157
            LG+G F  V +    +          G   A   +    L     + +  E      L 
Sbjct: 18  ELGKGAFSVVRRC--VKVLA-------GQEYAAMIINTKKLSARDHQKLEREARICRLLK 68

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG------AA 210
           HPN+V+L    I ++    L+++ +T G  E  LF           I +A        A+
Sbjct: 69  HPNIVRLHDS-ISEEGHHYLIFDLVTGG--E--LF---------EDI-VAREYYSEADAS 113

Query: 211 K-------GLAFLHGGSEPVIYRDFKTSNILLDSEYNA---KLSDFGLAKAGPQGDKTHV 260
                    +   H     V++R+ K  N+LL S+      KL+DFGLA       +   
Sbjct: 114 HCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW- 170

Query: 261 STRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
                GT GY +PE V+         D+++ GV+L  +L G        P        W 
Sbjct: 171 -FGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGY------PP-------FWD 215

Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCLSRDPKSRPSMDEV--- 370
                D+ +LYQ +       Y     +   V+  A       L+ +P  R +  E    
Sbjct: 216 E----DQHRLYQQI---KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268

Query: 371 --VKVLTPLQDLNDLAILSYHSRLSQ-QGRRKKKQDGTQQLASAHSKSIRDSPLN 422
             +   + +              L +   RRK K      + +  + S+R   + 
Sbjct: 269 PWISHRSTVASCMHRQETV--DCLKKFNARRKLKGAILTVMLATRNFSVRKQEII 321

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 68/292 (23%), Positives = 113/292 (38%), Gaps = 65/292 (22%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVA-EVDFLGQL-H 157
           LG G F  V +       T       G   A K LK     Q  R  +  E+  L     
Sbjct: 37  LGRGKFAVVRQC--ISKST-------GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 158 HPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPW--------SNRIKIALG 208
            P ++ L     E+   + L+ E+   G  E  +F   +P              IK  L 
Sbjct: 88  CPRVINLHEV-YENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEY---NAKLSDFGLAKAGPQGDKTHVSTRVV 265
              G+ +LH     +++ D K  NILL S Y   + K+ DFG+++      +      ++
Sbjct: 143 ---GVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IM 194

Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLA 324
           GT  Y APE +    +T+ +D+++ G++   +LT         P  GE            
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH------TSPFVGE------------ 236

Query: 325 DKRKLYQIVDPRLELNYSLKGV--QKVSQLA----YNCLSRDPKSRPSMDEV 370
           D ++ Y  +    ++N          VSQLA     + L ++P+ RP+ +  
Sbjct: 237 DNQETYLNI---SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 34/218 (15%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEV 150
            F     LG G FG V    ++   +       G   A+K L    +   ++    + E 
Sbjct: 42  QFDRIKTLGTGSFGRVML--VKHKES-------GNHYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFR-RTIPLPWSNRI---KI 205
             L  ++ P LVKL  +  +D+  L +V E++  G + +HL R      P + R    +I
Sbjct: 93  RILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQI 150

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
            L       +LH  S  +IYRD K  N+L+D +   +++DFG AK       T     + 
Sbjct: 151 VLT----FEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LC 199

Query: 266 GTYGYAAPEYVMT-GHLTSKS-DVYSFGVVLLEILTGR 301
           GT    APE +++ G+  +K+ D ++ GV++ E+  G 
Sbjct: 200 GTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGY 235

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.4 bits (220), Expect = 8e-20
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 31/228 (13%)

Query: 89  KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA 148
             AT  + P + +G G +G V+K     +G           VA+KS++     G    + 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGH---------FVALKSVRVPNGGGGGGGLP 55

Query: 149 -----EVDFLGQLH---HPNLVKLI----GYCIEDDQRL-LVYEFMTRGSLENHLFRRTI 195
                EV  L +L    HPN+V+L+        + + ++ LV+E + +  L  +L +   
Sbjct: 56  ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP 114

Query: 196 PLPWSNRIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-GP 253
           P   +  IK +     +GL FLH  +  +++RD K  NIL+ S    KL+DFGLA+    
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY 172

Query: 254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           Q   T     VV T  Y APE ++     +  D++S G +  E+   +
Sbjct: 173 QMALTP---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 65/292 (22%), Positives = 109/292 (37%), Gaps = 58/292 (19%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HH 158
            LGEG F    K       +           AVK +        ++   E+  L     H
Sbjct: 18  PLGEGSFSICRKC--VHKKS-------NQAFAVKIISKRMEANTQK---EITALKLCEGH 65

Query: 159 PNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNR-----IKIALGAAKG 212
           PN+VKL      D     LV E +  G L   + ++     +S       ++  + A   
Sbjct: 66  PNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSA--- 118

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEY-NA--KLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           ++ +H     V++RD K  N+L   E  N   K+ DFG A+  P  ++         T  
Sbjct: 119 VSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLH 174

Query: 270 YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRP--SGEQNLVAWARQYLADK 326
           YAAPE ++  +   +S D++S GV+L  +L+G       +                    
Sbjct: 175 YAAPE-LLNQNGYDESCDLWSLGVILYTMLSG-------QVPFQSHDR-----SLTCTSA 221

Query: 327 RKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCLSRDPKSRPSMDEVVK 372
            ++ + +    + ++S +G     VSQ A       L+ DP  R  M  +  
Sbjct: 222 VEIMKKI---KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 45/226 (19%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGH--RE 145
           G++     LG G FG V  G  +  G           VAVK      ++   + G   RE
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGH---------KVAVKILNRQKIRSLDVVGKIKRE 61

Query: 146 WVAEVDFLGQLHHPNLVKLIGY-CIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRI 203
               +  L    HP+++KL  Y  I       +V E+++ G L +++ +         R+
Sbjct: 62  ----IQNLKLFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKH-------GRV 108

Query: 204 KIALGAAK------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK 257
           +              + + H     V++RD K  N+LLD+  NAK++DFGL+     G+ 
Sbjct: 109 EEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

Query: 258 THVSTRVVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGR 301
              S    G+  YAAPE V++G L    + D++S GV+L  +L G 
Sbjct: 167 LRTS---CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 71/368 (19%), Positives = 123/368 (33%), Gaps = 78/368 (21%)

Query: 85  FQELKSATGNFR----PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL 140
            Q+L   +  F         +G G +    +       T        +  AVK +     
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRC--IHKAT-------NMEFAVKIIDKSKR 60

Query: 141 QGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLP 198
               E    ++ L +   HPN++ L     +D + + +V E M  G L + + R+     
Sbjct: 61  DPTEE----IEILLRYGQHPNIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQK---F 112

Query: 199 WSNR-----IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA----KLSDFGLA 249
           +S R     +         + +LH  ++ V++RD K SNIL   E       ++ DFG A
Sbjct: 113 FSEREASAVLFTITKT---VEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167

Query: 250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKR 308
           K     +   +      T  + APE V+       + D++S GV+L  +LTG        
Sbjct: 168 KQLRAENG--LLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGY------- 217

Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCLSRDPK 362
                    +A        ++   +       +SL G     VS  A       L  DP 
Sbjct: 218 -------TPFANGPDDTPEEILARI---GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267

Query: 363 SRPSMDEVVKVLTPLQD--LNDLAILSYHSRLSQQGRRKKKQDGTQQLASAHS------K 414
            R +   V      L+   +     L  +    Q      K       ++ +       +
Sbjct: 268 QRLTAALV------LRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLE 321

Query: 415 SIRDSPLN 422
            +  S L 
Sbjct: 322 PVGRSTLA 329

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 79/364 (21%), Positives = 133/364 (36%), Gaps = 81/364 (22%)

Query: 81  LQFTFQELKSATGNFRPD-----SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL 135
           L+  FQ  +        D      +LG G  G V +       T       G   A+K L
Sbjct: 12  LEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLEC--FHRRT-------GQKCALKLL 62

Query: 136 --KPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIEDDQR-----LLVYEFMTRGSLE 187
              P   Q       EVD   Q    P++V ++    E+        L++ E M  G L 
Sbjct: 63  YDSPKARQ-------EVDHHWQASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELF 114

Query: 188 NHLFRRTIPLPWSNR-----IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NA 241
           + +  R     ++ R     ++    A   + FLH  S  + +RD K  N+L  S+  +A
Sbjct: 115 SRIQERG-DQAFTEREAAEIMRDIGTA---IQFLH--SHNIAHRDVKPENLLYTSKEKDA 168

Query: 242 --KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
             KL+DFG AK   Q     + T    T  Y APE +         D++S GV++  +L 
Sbjct: 169 VLKLTDFGFAKETTQNA---LQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 224

Query: 300 GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA---- 353
           G        P        ++    A    + + +       Y     +  +VS+ A    
Sbjct: 225 GF------PP-------FYSNTGQAISPGMKRRI---RLGQYGFPNPEWSEVSEDAKQLI 268

Query: 354 YNCLSRDPKSRPSMDEVVK-------VLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQ 406
              L  DP  R ++ + +        ++ P   L+   +L    +  +    + K++ T 
Sbjct: 269 RLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVL----QEDKDHWDEVKEEMTS 324

Query: 407 QLAS 410
            LA+
Sbjct: 325 ALAT 328

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 61/331 (18%), Positives = 114/331 (34%), Gaps = 56/331 (16%)

Query: 56  APNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSAT-GNFRPDSILGEGGFGYVFKGWI 114
             +  H S   P  +     +     +    + K      ++   +LG GGFG V+ G  
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG-- 62

Query: 115 EENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------EVDFLGQLHH--PNLVKLIG 166
                   +    + VA+K ++ D +    E         EV  L ++      +++L+ 
Sbjct: 63  -------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115

Query: 167 YCIEDDQRL-LVYEFMT-RGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVI 224
           +  E      L+ E       L + +  R   L             + +   H  +  V+
Sbjct: 116 W-FERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH--NCGVL 171

Query: 225 YRDFKTSNILLDSEY-NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-- 281
           +RD K  NIL+D      KL DFG   A  +           GT  Y+ PE++   H   
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF---DGTRVYSPPEWIR-YHRYH 226

Query: 282 TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNY 341
              + V+S G++L +++ G    +                      +   I+  ++    
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFE-------------------HDEE---IIRGQVFFRQ 264

Query: 342 SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            +    +   L   CL+  P  RP+ +E+  
Sbjct: 265 RVS--SECQHLIRWCLALRPSDRPTFEEIQN 293

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 37/225 (16%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA----- 148
            +   + +GEG +G VFK   +           G  VA+K ++   +Q   E +      
Sbjct: 12  QYECVAEIGEGAYGKVFKA-RDLKNG-------GRFVALKRVR---VQTGEEGMPLSTIR 60

Query: 149 EVDFLGQLH---HPNLVKLI----GYCIEDDQRL-LVYEFMT---RGSLENHLFRRTIPL 197
           EV  L  L    HPN+V+L         + + +L LV+E +       L+         +
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGV 117

Query: 198 PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-GPQGD 256
           P      +     +GL FLH  S  V++RD K  NIL+ S    KL+DFGLA+    Q  
Sbjct: 118 PTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
            T     VV T  Y APE ++     +  D++S G +  E+   +
Sbjct: 176 LTS---VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.5 bits (215), Expect = 7e-19
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 39/221 (17%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQ 155
           +G+G FG VFK    + G           VA+K +    ++  +E        E+  L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQ---------KVALKKVL---MENEKEGFPITALREIKILQL 72

Query: 156 LHHPNLVKLIGYCIEDDQRL--------LVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
           L H N+V LI  C               LV++F     L   L    +    S   ++  
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 131

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA------GPQGDKTHVS 261
               GL ++H     +++RD K +N+L+  +   KL+DFGLA+A            T+  
Sbjct: 132 MLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN-- 187

Query: 262 TRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGR 301
            RVV T  Y  PE ++         D++  G ++ E+ T  
Sbjct: 188 -RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 83/376 (22%), Positives = 130/376 (34%), Gaps = 91/376 (24%)

Query: 62  LSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFR----PDSILGEGGFGYVFKGWIEEN 117
           L   +              L   +    S           +S LG G    V++   ++ 
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRC--KQK 75

Query: 118 GTAPAKPGSGITVAVKSL-KPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRL- 175
           GT           A+K L K    +  R    E+  L +L HPN++KL     E    + 
Sbjct: 76  GT-------QKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEIF-ETPTEIS 124

Query: 176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG------AAK-------GLAFLHGGSEP 222
           LV E +T G     LF         +RI +  G      AA         +A+LH     
Sbjct: 125 LVLELVTGGE----LF---------DRI-VEKGYYSERDAADAVKQILEAVAYLH--ENG 168

Query: 223 VIYRDFKTSNILLDS-EYNA--KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG 279
           +++RD K  N+L  +   +A  K++DFGL+K             V GT GY APE +   
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGC 225

Query: 280 HLTSKSDVYSFGVVLLEILTGRRSMDKKRP-SGEQNLVAWARQYLADKRKLYQIVDPRLE 338
               + D++S G++   +L G        P   E+             + +++ +   L 
Sbjct: 226 AYGPEVDMWSVGIITYILLCGF------EPFYDERG-----------DQFMFRRI---LN 265

Query: 339 LNYSLKGVQ--KVSQLA----YNCLSRDPKSRPSMDEV-----VKVLTPLQDLNDLAILS 387
             Y        +VS  A       +  DPK R +  +      V          D A   
Sbjct: 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQ-- 323

Query: 388 YHSRLSQ-QGRRKKKQ 402
              +L +   RRK K 
Sbjct: 324 --KKLQEFNARRKLKA 337

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 63/294 (21%), Positives = 108/294 (36%), Gaps = 55/294 (18%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGHREWV 147
             +R   +LG+GGFG VF G          +    + VA+K      +            
Sbjct: 31  AEYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81

Query: 148 A-EVDFLGQLH----HPNLVKLIGYCIEDDQRL-LVYEFMTRGS-LENHLFRRTIPLPWS 200
             EV  L ++     HP +++L+ +  E  +   LV E       L +++  +  PL   
Sbjct: 82  PLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG-PLGEG 139

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAGPQGDKTH 259
                       +   H  S  V++RD K  NIL+D      KL DFG   A    +   
Sbjct: 140 PSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196

Query: 260 VSTRVVGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW 318
                 GT  Y+ PE++         + V+S G++L +++ G    +             
Sbjct: 197 DF---DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE------------- 240

Query: 319 ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                   ++   I++  L     +        L   CL+  P SRPS++E++ 
Sbjct: 241 ------RDQE---ILEAELHFPAHVS--PDCCALIRRCLAPKPSSRPSLEEILL 283

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 45/226 (19%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGH--RE 145
           G++     LG G FG V  G  +   T       G  VAVK      ++   + G   RE
Sbjct: 16  GHYILGDTLGVGTFGKVKVG--KHELT-------GHKVAVKILNRQKIRSLDVVGKIRRE 66

Query: 146 WVAEVDFLGQLHHPNLVKLIGY-CIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRI 203
               +  L    HP+++KL  Y  I     + +V E+++ G L +++ +         R+
Sbjct: 67  ----IQNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKN-------GRL 113

Query: 204 KIALGAAK------GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK 257
                         G+ + H     V++RD K  N+LLD+  NAK++DFGL+     G+ 
Sbjct: 114 DEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171

Query: 258 THVSTRVVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGR 301
              S    G+  YAAPE V++G L    + D++S GV+L  +L G 
Sbjct: 172 LRTS---CGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 68/297 (22%), Positives = 106/297 (35%), Gaps = 59/297 (19%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EVD 151
             +     +G G FG       +              VAVK ++          V  E+ 
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKE---------LVAVKYIERGAAIDEN--VQREII 68

Query: 152 FLGQLHHPNLVKLIGY-CIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
               L HPN+V+      I     L ++ E+ + G L   +           R       
Sbjct: 69  NHRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNA-------GRFSEDEAR 119

Query: 210 AK------GLAFLHGGSEPVIYRDFKTSNILLDSEY--NAKLSDFGLAKAGPQGDKTHVS 261
                   G+++ H  S  + +RD K  N LLD       K+ DFG +K+     +   +
Sbjct: 120 FFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177

Query: 262 TRVVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
              VGT  Y APE V+         +DV+S GV L  +L G        P  +       
Sbjct: 178 ---VGTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA------YPFEDPEEP--- 224

Query: 320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR----DPKSRPSMDEVVK 372
                D RK  Q +   L + YS+    ++S    + +SR    DP +R S+ E+  
Sbjct: 225 ----RDYRKTIQRI---LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 52/248 (20%), Positives = 101/248 (40%), Gaps = 65/248 (26%)

Query: 149 EVDFLGQLHHPNLVKLIGYCI----EDDQRLLVYEFMTRGSL----------EN---HLF 191
           E+  L +L HPN+VKL    +     +D   +V+E + +G +          E+     F
Sbjct: 86  EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF 143

Query: 192 RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA 251
           +  I               KG+ +LH   + +I+RD K SN+L+  + + K++DFG++  
Sbjct: 144 QDLI---------------KGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVS-N 185

Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEILTGRRSMDKKR 308
             +G    +S   VGT  + APE +            DV++ GV L   + G+       
Sbjct: 186 EFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC------ 238

Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR----DPKSR 364
           P  ++ ++            L+  +               +++   + ++R    +P+SR
Sbjct: 239 PFMDERIMC-----------LHSKI---KSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284

Query: 365 PSMDEVVK 372
             + E+  
Sbjct: 285 IVVPEIKL 292

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 62/233 (26%), Positives = 94/233 (40%), Gaps = 60/233 (25%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK-----SLKPDGLQGH--RE 145
           G +     LGEG FG V         T          VA+K      LK   +     RE
Sbjct: 9   GPYIIRETLGEGSFGKVKLA--THYKT-------QQKVALKFISRQLLKKSDMHMRVERE 59

Query: 146 WVAEVDFLGQLHHPNLVKLIGY-CIEDDQRL-LVYEF---------MTRGSLEN----HL 190
               + +L  L HP+++KL  Y  I     + +V E+         + +  +        
Sbjct: 60  ----ISYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF 113

Query: 191 FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
           F++ I                 + + H     +++RD K  N+LLD   N K++DFGL+ 
Sbjct: 114 FQQII---------------CAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSN 156

Query: 251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEILTGR 301
               G+    S    G+  YAAPE V+ G L    + DV+S G+VL  +L GR
Sbjct: 157 IMTDGNFLKTS---CGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 59/254 (23%), Positives = 99/254 (38%), Gaps = 68/254 (26%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
            +     LG G FG V + +  E+G            A+K +  D    +RE    +D +
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGK---------RFALKKVLQDPRYKNRE----LDIM 54

Query: 154 GQLHHPNLVKLIGY-------------------------------------CIEDDQRL- 175
             L H N++KL+ Y                                         ++ L 
Sbjct: 55  KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 176 LVYEFM--TRGSLENHLFRRTIPLPWSNRIKIAL-GAAKGLAFLHGGSEPVIYRDFKTSN 232
           ++ E++  T   +     R    +P  N I I +    + + F+H  S  + +RD K  N
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIH--SLGICHRDIKPQN 171

Query: 233 ILLDSEYNA-KLSDFGLAKAGPQGDK-TH-VSTRVVGTYGYAAPEYVMTG--HLTSKSDV 287
           +L++S+ N  KL DFG AK     +     + +R    + Y APE +M G    T   D+
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTPSIDL 225

Query: 288 YSFGVVLLEILTGR 301
           +S G V  E++ G+
Sbjct: 226 WSIGCVFGELILGK 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 34/211 (16%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHP 159
           LG G +  VF+     N            V VK LKP      ++   E+  L  L   P
Sbjct: 44  LGRGKYSEVFEAINITNNE---------KVVVKILKPVK---KKKIKREIKILENLRGGP 91

Query: 160 NLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKI----ALGAAKGLAF 215
           N++ L     +   R     F     + N  F++         I+      L   K L +
Sbjct: 92  NIITLADIVKDPVSRTPALVFE---HVNNTDFKQLYQTLTDYDIRFYMYEIL---KALDY 145

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNA-KLSDFGLAKAG-PQGDKTH-VSTRVVGTYGYAA 272
            H  S  +++RD K  N+++D E+   +L D+GLA+   P  +    V++R      +  
Sbjct: 146 CH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKG 198

Query: 273 PEYVMTGHLTSKS-DVYSFGVVLLEILTGRR 302
           PE ++   +   S D++S G +L  ++  + 
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 76/342 (22%), Positives = 125/342 (36%), Gaps = 66/342 (19%)

Query: 57  PNEAHLSSDNPDPAPTDEKSPCQLLQFTFQE-LKSATGNFRPD-----SILGEGGFGYVF 110
           P +    +    PA      P Q  QF  +  L+        D      +LG G  G V 
Sbjct: 20  PPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79

Query: 111 KGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCI 169
           +  I    T           A+K L+ D  +  RE    V+   +    P++V+++    
Sbjct: 80  Q--IFNKRT-------QEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDVY- 124

Query: 170 EDDQR-----LLVYEFMTRGSLENHLFRRTIPLPWSNR-----IKIALGAAKGLAFLHGG 219
           E+        L+V E +  G L + +  R     ++ R     +K    A   + +LH  
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEA---IQYLH-- 178

Query: 220 SEPVIYRDFKTSNILLDSEY-NA--KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV 276
           S  + +RD K  N+L  S+  NA  KL+DFG AK     +     T    T  Y APE +
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVL 235

Query: 277 MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPR 336
                    D++S GV++  +L G        P        ++   LA    +   +   
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGY------PP-------FYSNHGLAISPGMKTRI--- 279

Query: 337 LELNYSLKGVQ--KVSQLA----YNCLSRDPKSRPSMDEVVK 372
               Y     +  +VS+       N L  +P  R ++ E + 
Sbjct: 280 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 55/230 (23%), Positives = 83/230 (36%), Gaps = 45/230 (19%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------ 148
           +     +  G +G V                 GI VA+K +      G    +       
Sbjct: 24  YTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 149 -----EVDFLGQLHHPNLVKL----IGYCIEDDQRL-LVYEFMTRGSLENHLFR--RTIP 196
                E+  L   HHPN++ L    + +      +L LV E M        L +      
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQR 128

Query: 197 LPWSN-RIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA-KAGP 253
           +  S   I+        GL  LH     V++RD    NILL    +  + DF LA +   
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA 186

Query: 254 QGDKT-HVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR 301
             +KT +V+ R      Y APE VM     T   D++S G V+ E+   +
Sbjct: 187 DANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 38/288 (13%), Positives = 83/288 (28%), Gaps = 58/288 (20%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAE 149
           G +R     G       ++                  VA+  + P G+      +E ++ 
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDR---------QVALTFVDPQGVLPDDVLQETLSR 81

Query: 150 VDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
              L ++  P + +++         L+V E++  GSL+      T P P    I+     
Sbjct: 82  TLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVG-AIRAMQSL 138

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           A      H     V       S + +  + +  L+                         
Sbjct: 139 AAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA---------------------- 174

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
                         + D+   G  L  +L  R  +          L        A++   
Sbjct: 175 TMPDA-------NPQDDIRGIGASLYALLVNRWPLP--EAGVRSGLAP------AERDTA 219

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
            Q ++P  +++  +     +S +A   +  D   R +   ++ ++   
Sbjct: 220 GQPIEPA-DIDRDIPFQ--ISAVAARSVQGDGGIRSA-STLLNLMQQA 263

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 61/250 (24%), Positives = 109/250 (43%), Gaps = 37/250 (14%)

Query: 66  NPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPG 125
           +         +  ++++    ++      +   S +GEG +G V   +   N        
Sbjct: 3   HHHHMAAAAAAGPEMVRGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKV------ 53

Query: 126 SGITVAVKSLKP-----DGLQGHREWVAEVDFLGQLHHPNLVKLIG----YCIEDDQRL- 175
               VA+K + P        +  RE    +  L +  H N++ +        IE  + + 
Sbjct: 54  ---RVAIKKISPFEHQTYCQRTLRE----IKILLRFRHENIIGINDIIRAPTIEQMKDVY 106

Query: 176 LVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNI 233
           +V + M     E  L++  +T  L   +         +GL ++H  +  V++RD K SN+
Sbjct: 107 IVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNL 159

Query: 234 LLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFG 291
           LL++  + K+ DFGLA+ A P  D T   T  V T  Y APE ++     +KS D++S G
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219

Query: 292 VVLLEILTGR 301
            +L E+L+ R
Sbjct: 220 CILAEMLSNR 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 66/312 (21%), Positives = 121/312 (38%), Gaps = 60/312 (19%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL------KPDGLQGHREWVA 148
           ++    +G G  G V   +                VA+K L      +    + +RE   
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDR---------NVAIKKLSRPFQNQTHAKRAYRE--- 111

Query: 149 EVDFLGQLHHPNLVKLI-----GYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNR 202
            +  +  ++H N++ L+        +E+ Q + LV E M   +    + +  +      R
Sbjct: 112 -LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL---DHER 165

Query: 203 IKIAL-GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
           +   L     G+  LH     +I+RD K SNI++ S+   K+ DFGLA+       + + 
Sbjct: 166 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 220

Query: 262 TRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT------GRRSMDKKR------- 308
           T  V T  Y APE ++        D++S G ++ E++       GR  +D+         
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280

Query: 309 -PSGE--QNLVAWARQYLAD----KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR-- 359
            P  E  + L    R Y+ +        +  + P        +  +  +  A + LS+  
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340

Query: 360 --DPKSRPSMDE 369
             DP  R S+D+
Sbjct: 341 VIDPAKRISVDD 352

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 66/314 (21%), Positives = 122/314 (38%), Gaps = 64/314 (20%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL------KPDGLQGHREWVA 148
           ++    +G G  G V   +                VA+K L      +    + +RE   
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRE--- 74

Query: 149 EVDFLGQLHHPNLVKLI-----GYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN- 201
            +  +  ++H N++ L+        +E+ Q + +V E M     + +L  + I +   + 
Sbjct: 75  -LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANL-CQVIQMELDHE 127

Query: 202 RIKIAL-GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
           R+   L     G+  LH     +I+RD K SNI++ S+   K+ DFGLA+       + +
Sbjct: 128 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFM 182

Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR------RSMDKKR------ 308
            T  V T  Y APE ++        D++S G ++ E++ G         +D+        
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242

Query: 309 --PSGE--QNLVAWARQYLA-----DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSR 359
             P  E  + L    R Y+            ++  P +      +  +  +  A + LS+
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF-PDVLFPADSEHNKLKASQARDLLSK 301

Query: 360 ----DPKSRPSMDE 369
               D   R S+DE
Sbjct: 302 MLVIDASKRISVDE 315

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 43/224 (19%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL------KPDGLQGHREWV 147
            +   + +G G +G V     + +G           VA+K L      +    + +RE  
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGE---------KVAIKKLSRPFQSEIFAKRAYRE-- 73

Query: 148 AEVDFLGQLHHPNLVKLI-----GYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSN 201
             +  L  + H N++ L+        + +     LV  FM     +  L ++ + L +S 
Sbjct: 74  --LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDL-QKIMGLKFSE 125

Query: 202 -RIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
            +I+ +     KGL ++H  S  V++RD K  N+ ++ +   K+ DFGLA+     + T 
Sbjct: 126 EKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG 182

Query: 260 -VSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR 301
            V TR    + Y APE +++  H     D++S G ++ E+LTG+
Sbjct: 183 YVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 51/231 (22%), Positives = 93/231 (40%), Gaps = 45/231 (19%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL----KPDGLQGHREWVAEV 150
           +     LG GG G VF     +             VA+K +            RE    +
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDK---------RVAIKKIVLTDPQSVKHALRE----I 59

Query: 151 DFLGQLHHPNLVKLI-------------GYCIEDDQRL-LVYEFMTRGSLENHLFR--RT 194
             + +L H N+VK+                 + +   + +V E+M     E  L      
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQ 114

Query: 195 IPLPWSNRIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAK-A 251
            PL      +       +GL ++H  S  V++RD K +N+ +++E    K+ DFGLA+  
Sbjct: 115 GPLL-EEHARLFMYQLLRGLKYIH--SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
            P        +  + T  Y +P  +++ +  +K+ D+++ G +  E+LTG+
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 49/232 (21%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP-----DGLQGHREWVAE 149
           F+  S+LGEG +G V     +  G           VA+K ++P       L+  RE    
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGE---------IVAIKKIEPFDKPLFALRTLRE---- 59

Query: 150 VDFLGQLHHPNLVKLI----GYCIEDDQRL-LVYEFMTRGSLENHLFR--RTIPLPWSNR 202
           +  L    H N++ +         E+   + ++ E M     +  L R   T  L   + 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDH 113

Query: 203 IKI----ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA--------K 250
           I+      L   + +  LHG +  VI+RD K SN+L++S  + K+ DFGLA         
Sbjct: 114 IQYFIYQTL---RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
                 +       V T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 42/223 (18%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP------DGLQGHREWVA 148
           ++  S +G G +G V   +  +         +G+ VAVK L           + +RE   
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE--- 78

Query: 149 EVDFLGQLHHPNLVKLI-----GYCIEDDQRL-LVYEFMTRGSLENHLFR--RTIPLPWS 200
            +  L  + H N++ L+        +E+   + LV   M        L    +   L   
Sbjct: 79  -LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLT-D 131

Query: 201 NRIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTH 259
           + ++ +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+        +
Sbjct: 132 DHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189

Query: 260 VSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR 301
           V+TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 36/113 (31%), Positives = 50/113 (44%), Gaps = 2/113 (1%)

Query: 187 ENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF 246
           E         L   + I  +   AKG+ FL   S   I+RD    NILL  +   K+ DF
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDF 237

Query: 247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT 299
           GLA+   +               + APE +     T +SDV+SFGV+L EI +
Sbjct: 238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 7/99 (7%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL 156
              LG G FG V +           K  +  TVAVK LK       HR  ++E+  L  +
Sbjct: 27  GKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82

Query: 157 -HHPNLVKLIGYCIEDDQRLLV-YEFMTRGSLENHLFRR 193
            HH N+V L+G C +    L+V  EF   G+L  +L  +
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 40/225 (17%)

Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL------KPDGLQGHRE 145
              +R    +G G +G V        G           VA+K L      +    + +RE
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGA---------KVAIKKLYRPFQSELFAKRAYRE 74

Query: 146 WVAEVDFLGQLHHPNLVKLI-----GYCIEDDQRL-LVYEFMTRGSLENHLFR--RTIPL 197
               +  L  + H N++ L+        ++D     LV  FM        L +  +   L
Sbjct: 75  ----LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKL 125

Query: 198 PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK 257
                  +     KGL ++H  +  +I+RD K  N+ ++ +   K+ DFGLA+       
Sbjct: 126 GEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183

Query: 258 THVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGR 301
            +V TR      Y APE ++     T   D++S G ++ E++TG+
Sbjct: 184 GYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 54/303 (17%), Positives = 105/303 (34%), Gaps = 57/303 (18%)

Query: 49  ASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFTFQELKSA---TGNFRPDSILGEGG 105
           A+  +       H  S +       ++        +     S       +    ++G G 
Sbjct: 6   AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGS 65

Query: 106 FGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-----EVDFLGQLHHPN 160
           +G+V + + +              VA+K  K   +             E+  L +L+H +
Sbjct: 66  YGHVCEAYDKLEKR---------VVAIK--KILRVFED-LIDCKRILREIAILNRLNHDH 113

Query: 161 LVKL----IGYCIEDDQRL-LVYEFMTRGSLENHLFRRTIPLPWSNRIK-IALGAAKGLA 214
           +VK+    I   +E    L +V E     S    LFR  + L     IK +      G+ 
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLT-ELHIKTLLYNLLVGVK 170

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG----- 269
           ++H  S  +++RD K +N L++ + + K+ DFGLA+     +  +    +          
Sbjct: 171 YVH--SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

Query: 270 --------------------YAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKR 308
                               Y APE ++     +++ DV+S G +  E+L   +      
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288

Query: 309 PSG 311
              
Sbjct: 289 ADR 291

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 54/243 (22%), Positives = 91/243 (37%), Gaps = 51/243 (20%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP------DGLQGHREWV 147
           N+    ++G G +GYV+  + +              VA+K +        D  +  RE  
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEK---------NVAIKKVNRMFEDLIDCKRILRE-- 75

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRL-----LVYEFMTRGSLENHLFRRTIPLPWSNR 202
             +  L +L    +++L    I DD        +V E     S    LF+  I L     
Sbjct: 76  --ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLT-EEH 130

Query: 203 IK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS 261
           IK I      G  F+H     +I+RD K +N LL+ + + K+ DFGLA+       T++ 
Sbjct: 131 IKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 262 TRVVGTYGYAAP---------EYVMT------------GHLTSKSDVYSFGVVLLEILTG 300
             +                   +V+T             + T   D++S G +  E+L  
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

Query: 301 RRS 303
            +S
Sbjct: 249 LQS 251

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 70/341 (20%), Positives = 121/341 (35%), Gaps = 98/341 (28%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HH 158
           +LG G  G V +       T           A+K L+ D  +  RE    V+   +    
Sbjct: 25  VLGLGINGKVLQI--FNKRT-------QEKFALKMLQ-DCPKARRE----VELHWRASQC 70

Query: 159 PNLVKLIGYCIEDDQR-----LLVYEFMTRGSLENHLFRRTI---PLPWSNR-----IKI 205
           P++V+++    E+        L+V E +  G  E  LF R        ++ R     +K 
Sbjct: 71  PHIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSRIQDRGDQAFTEREASEIMKS 125

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NA--KLSDFGLAKAGPQGDKTHVST 262
              A   + +LH  S  + +RD K  N+L  S+  NA  KL+DFG AK          + 
Sbjct: 126 IGEA---IQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------ETTG 172

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                Y  +              D++S GV++  +L G        P        ++   
Sbjct: 173 E---KYDKSC-------------DMWSLGVIMYILLCGY------PP-------FYSNHG 203

Query: 323 LADKRKLYQIVDPRLELNYSLKGVQ--KVSQLA----YNCLSRDPKSRPSMDEVVK---- 372
           LA    +   +       Y     +  +VS+       N L  +P  R ++ E +     
Sbjct: 204 LAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

Query: 373 ---VLTPLQDLNDLAILSYHSRLSQQGRRKKKQDGTQQLAS 410
                 P   L+   +L    +  ++     K++ T  LA+
Sbjct: 261 MQSTKVPQTPLHTSRVL----KEDKERWEDVKEEMTSALAT 297

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 53/239 (22%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSL------KPDGLQGHREWVA 148
           +     LG+G +G V+K      G           VAVK +        D  +  RE   
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGE---------VVAVKKIFDAFQNSTDAQRTFRE--- 58

Query: 149 EVDFLGQLH-HPNLVKLIGYCI-EDDQRL-LVYEFMTRGSLENHLFR--RTIPLPWSNRI 203
            +  L +L  H N+V L+     ++D+ + LV+++M     E  L    R   L      
Sbjct: 59  -IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHK 111

Query: 204 K-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA------------- 249
           + +     K + +LH G   +++RD K SNILL++E + K++DFGL+             
Sbjct: 112 QYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 250 ------KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGR 301
                       D   + T  V T  Y APE ++     +K  D++S G +L EIL G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 52/225 (23%), Positives = 81/225 (36%), Gaps = 37/225 (16%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
             +R    +G G FG ++ G     G           VA+K         H +   E   
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKI 57

Query: 153 LGQLHH-PNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALG 208
              +     +  +     E D  ++V E +   SLE  LF    R   L     + +A  
Sbjct: 58  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSL--KTVLLLADQ 113

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK---LSDFGLAKA-GPQGDKTHVSTR- 263
               + ++H  S+  I+RD K  N L+          + DFGLAK         H+  R 
Sbjct: 114 MISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171

Query: 264 ---VVGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGR 301
              + GT  YA+    +  HL    + + D+ S G VL+    G 
Sbjct: 172 NKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 49/232 (21%), Positives = 81/232 (34%), Gaps = 49/232 (21%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK--SLKPDGLQGHREWVAEV 150
            +++    +GEG FG +F+G    N            VA+K    + D  Q   E+    
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQ---------QVAIKFEPRRSDAPQLRDEYRTYK 60

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNR-------I 203
              G    P    +  +  E    +LV + +   SLE  L           R        
Sbjct: 61  LLAGCTGIP---NVYYFGQEGLHNVLVIDLLGP-SLE-DLLD------LCGRKFSVKTVA 109

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK-----LSDFGLAKA-GPQGDK 257
             A      +  +H   + ++YRD K  N L+    +       + DFG+ K       K
Sbjct: 110 MAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

Query: 258 THVSTR----VVGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGR 301
            H+  R    + GT  Y +    +  HL    + + D+ + G V +  L G 
Sbjct: 168 QHIPYREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 53/226 (23%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-- 156
           S++G+G FG V K +                VA+K +K +      +   EV  L  +  
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQE---------WVAIKIIK-NKKAFLNQAQIEVRLLELMNK 109

Query: 157 ------HHPNLVKLIGY-------CI--EDDQRLL---VYEFMTRGSLENHLFRRTIPLP 198
                 ++  +V L  +       C+  E    +L   +Y+      L N  FR    + 
Sbjct: 110 HDTEMKYY--IVHLKRHFMFRNHLCLVFE----MLSYNLYDL-----LRNTNFR---GVS 155

Query: 199 WSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA--KLSDFGLAKAGPQGD 256
            +   K A      L FL      +I+ D K  NILL +   +  K+ DFG +    Q  
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGR 301
             ++ +R      Y +PE V+ G       D++S G +L+E+ TG 
Sbjct: 216 YQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 55/228 (24%), Positives = 84/228 (36%), Gaps = 41/228 (17%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK--SLKPDGLQGHREWVAEV 150
            NFR    +G G FG +  G                 VA+K   +K    Q H E+    
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNE---------YVAIKLEPMKSRAPQLHLEYRFYK 59

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIAL 207
                   P   ++  +        +V E +   SLE  LF    RT  L     + IA+
Sbjct: 60  QLGSGDGIP---QVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSL--KTVLMIAI 112

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK-----LSDFGLAKA-GPQGDKTHVS 261
                + ++H  S+ +IYRD K  N L+    N       + DF LAK       K H+ 
Sbjct: 113 QLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170

Query: 262 TR----VVGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGR 301
            R    + GT  Y +    +  HL    + + D+ + G + +  L G 
Sbjct: 171 YREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 49/224 (21%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL- 156
             ++G+G FG V K +  +             VA+K ++ +  + HR+   E+  L  L 
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQ---------HVALKMVR-NEKRFHRQAAEEIRILEHLR 151

Query: 157 -----HHPNLVKLIGY-------CI--EDDQRLL---VYEFMTRGSLENHLFRRTIPLPW 199
                +  N++ ++         C+  E    LL   +YE + +       F+       
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNK-----FQ---GFSL 199

Query: 200 SNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA--KLSDFGLAKAGPQGDK 257
               K A    + L  LH     +I+ D K  NILL  +  +  K+ DFG +    Q   
Sbjct: 200 PLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257

Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           T++ +R      Y APE ++        D++S G +L E+LTG 
Sbjct: 258 TYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 37/225 (16%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
             FR    +G G FG ++ G   +     A       + ++++K    Q   E       
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA-------IKLENVKTKHPQLLYES----KI 55

Query: 153 LGQLH-HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALG 208
              L     +  +  + +E D  +LV + +   SLE  LF    R + L     + +A  
Sbjct: 56  YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSL--KTVLMLADQ 111

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK---LSDFGLAKA-GPQGDKTHVSTR- 263
               + F+H  S+  ++RD K  N L+     A    + DFGLAK         H+  R 
Sbjct: 112 MINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169

Query: 264 ---VVGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGR 301
              + GT  YA+    +  HL    + + D+ S G VL+  L G 
Sbjct: 170 NKNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 47/233 (20%), Positives = 85/233 (36%), Gaps = 55/233 (23%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
             LG G F  V+      N T          VA+K ++ D          E+  L +++ 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74

Query: 159 PNLVKLIG----YCIEDDQRLLVYEFMTRGSLENHL-------------------FRRTI 195
            +  K       + +    +LL + F  +G    H+                    R  I
Sbjct: 75  ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-I 128

Query: 196 PLPWSNRIK-IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE------YNAKLSDFGL 248
           PL     +K I+     GL ++H     +I+ D K  N+L++           K++D G 
Sbjct: 129 PLI---YVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184

Query: 249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR 301
           A    +     + TR      Y +PE ++       +D++S   ++ E++TG 
Sbjct: 185 ACWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 41/238 (17%), Positives = 86/238 (36%), Gaps = 43/238 (18%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE------- 145
             ++    +G+GGFG ++   +  +       GS     VK    D      E       
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90

Query: 146 ----WVAEVDFLGQLHHPNLVKLIGYCIEDDQ----RLLVYEFMTRGSLENHLFR---RT 194
                + +     +L +  + K  G  + D      R ++ +      L+  ++    + 
Sbjct: 91  AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANAKR 148

Query: 195 IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK--LSDFGLAKA- 251
                   ++++L     L ++H      ++ D K SN+LL+ +   +  L D+GLA   
Sbjct: 149 FSR--KTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

Query: 252 GPQGDKTHVSTR----VVGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGR 301
            P+G     +        GT  + +    +  H     + + D+   G  +++ LTG 
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 40/237 (16%), Positives = 81/237 (34%), Gaps = 41/237 (17%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW------ 146
             ++  S       G +++     +             ++K L     +   E       
Sbjct: 42  RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRA 99

Query: 147 --VAEVDFLGQLHHPNLV---KLIGY-CIEDDQRLLVYEFMTRGSLENHLF----RRTIP 196
               +V+   +L+   L+     +G+   +D  R LV   + R SL+        +  + 
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHVLS 157

Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK--LSDFGLAKAGPQ 254
               + +++A      L FLH      ++ +    NI +D E  ++  L+ +G A     
Sbjct: 158 E--RSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213

Query: 255 GDKTHVSTR------VVGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGR 301
               HV+          G   + +    M  H     + +SD+ S G  +L+ L G 
Sbjct: 214 -SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.3 bits (127), Expect = 6e-08
 Identities = 52/335 (15%), Positives = 86/335 (25%), Gaps = 83/335 (24%)

Query: 83  FTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG 142
             F      T   +    +GEG FG VF+   +              VA+K +  +G   
Sbjct: 11  VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIAD-----------HTPVAIKIIAIEGPDL 58

Query: 143 H--------REWVAEVDFLGQLH---------HPNLVKLIGYCI---------------- 169
                     E + E+    +L              + L                     
Sbjct: 59  VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118

Query: 170 --------------EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
                         +DDQ  +V EF   G     +  +      +    I       LA 
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAV 176

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG---------PQGDKTHVSTRVVG 266
                    +RD    N+LL      KL      K+             D T       G
Sbjct: 177 AEASLR-FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235

Query: 267 TYGYA---APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
              +      E + TG    + D+Y         L  + + ++       + V W   YL
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQFDIYR--------LMKKENNNRWGEYHPYSNVLWLH-YL 286

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLS 358
            DK         +       +  +K+ +     L+
Sbjct: 287 TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 53/315 (16%), Positives = 96/315 (30%), Gaps = 109/315 (34%)

Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA-EV 150
            G +     LG G F  V+  W  +             VA+K +K    + + E    E+
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKK---------FVAMKVVKSA--EHYTETALDEI 84

Query: 151 DFLGQL-----HHPN---LVKLIGY-----------CIEDDQRLLVYEFMTRGSLENHLF 191
             L  +     + PN   +V+L+             C       +V+E +    L   + 
Sbjct: 85  RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWII 136

Query: 192 R---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---------- 238
           +   + +PLP   +I       +GL +LH     +I+ D K  NILL             
Sbjct: 137 KSNYQGLPLPCVKKI--IQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAE 193

Query: 239 ---------------------------------------YNAKLSDFGLAKAGPQGDKTH 259
                                                     K++D G A    +     
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED 253

Query: 260 VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA 319
           + TR      Y + E ++     + +D++S   +  E+ TG    +              
Sbjct: 254 IQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE-------- 300

Query: 320 RQYLADKRKLYQIVD 334
             Y  D+  +  I++
Sbjct: 301 --YTRDEDHIALIIE 313

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 39/239 (16%), Positives = 81/239 (33%), Gaps = 48/239 (20%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
             +     +G GGFG ++  +                 A   +K +  Q +    +E+ F
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPE---------KDARHVVKVEY-QENGPLFSELKF 86

Query: 153 LGQLHHPNLV---------------KLIGY----CIEDDQRLLVYEFMTRGSLENHLFRR 193
             ++   + +                  G           R +V E +    L+  +  +
Sbjct: 87  YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ-KISGQ 144

Query: 194 TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK--LSDFGLAKA 251
                 S  +++ +     L ++H      ++ D K +N+LL  +   +  L+D+GL+  
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

Query: 252 -GPQGDKTHVSTRV----VGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEILTGR 301
             P G+             GT  + +    +  H     + +SDV   G  +L  L G+
Sbjct: 203 YCPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 7e-06
 Identities = 58/371 (15%), Positives = 117/371 (31%), Gaps = 130/371 (35%)

Query: 44  TRYLNASNRELCAPNEAHLSSDNPDPAPTDEKSPCQLLQFT---FQELKSATGNFRPDSI 100
           TR+   ++  L A    H+S D+     T ++    LL++     Q+L            
Sbjct: 272 TRFKQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR---------- 320

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN 160
                         E   T P +    +++  +S+        R+ +A  D    ++   
Sbjct: 321 --------------EVLTTNPRR----LSIIAESI--------RDGLATWDNWKHVNCDK 354

Query: 161 LVKLIGYCIE----DDQRLLVYEFMTRGSLENHLFRRTIPLP-------WSNRIK----- 204
           L  +I   +      + R + ++ ++       +F  +  +P       W + IK     
Sbjct: 355 LTTIIESSLNVLEPAEYRKM-FDRLS-------VFPPSAHIPTILLSLIWFDVIKSDVMV 406

Query: 205 ----------IALGAAKGLAFLHGGSEPVIYRDFKTS--------NILLDSEYNAKLSDF 246
                     +     +    +       IY + K            ++D  YN   +  
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPS-----IYLELKVKLENEYALHRSIVDH-YNIPKTFD 460

Query: 247 GLAKAGPQGDK---THVSTRVVGTYGYAAPEYVMTGHLTSKS---DVYSFGVVLLEILTG 300
                 P  D+   +H+        G+         HL +      +  F +V L+    
Sbjct: 461 SDDLIPPYLDQYFYSHI--------GH---------HLKNIEHPERMTLFRMVFLDF--- 500

Query: 301 RRSMDKK-RPSGEQNLVAW-ARQYLAD---KRKLYQ--IVD--PRLE--LNYSLKGVQKV 349
            R +++K R        AW A   + +   + K Y+  I D  P+ E  +N  L  + K+
Sbjct: 501 -RFLEQKIRHDS----TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKI 555

Query: 350 SQLAYNCLSRD 360
            +        D
Sbjct: 556 EENLICSKYTD 566

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 55/245 (22%), Positives = 85/245 (34%), Gaps = 73/245 (29%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-- 156
             +G+G FG V      +N             AVK ++ +  +  R    E D L ++  
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKK---------YYAVKVVR-NIKKYTRSAKIEADILKKIQN 90

Query: 157 ---HHPNLVKLIGY-------CI--EDDQRLL---VYEFMTRGSLENHLFRRTIPLPWSN 201
              ++ N+VK  G        C+  E     L   +YE      +  + +         +
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN---GFHIED 138

Query: 202 RIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL-DSEYNA------------------- 241
                +   K L +L      + + D K  NILL D  +                     
Sbjct: 139 IKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 242 -----KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLL 295
                KL DFG A        + ++TR      Y APE V+        SD++SFG VL 
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCVLA 250

Query: 296 EILTG 300
           E+ TG
Sbjct: 251 ELYTG 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 56/242 (23%), Positives = 86/242 (35%), Gaps = 71/242 (29%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-- 156
             LGEG FG V +      G           VA+K ++ +  +       E++ L ++  
Sbjct: 25  GNLGEGTFGKVVECLDHARG--------KSQVALKIIR-NVGKYREAARLEINVLKKIKE 75

Query: 157 ------HHPNLVKLIGY-------CI--EDDQRLL---VYEFMTRGSLENHLFRRTIPLP 198
                      V +  +       CI  E    LL    +EF     L+ + F+   P P
Sbjct: 76  KDKENKFL--CVLMSDWFNFHGHMCIAFE----LLGKNTFEF-----LKENNFQ---PYP 121

Query: 199 WSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL-DSEYNA---------------- 241
             +   +A      L FLH     + + D K  NIL  +SE+                  
Sbjct: 122 LPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179

Query: 242 --KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEIL 298
             +++DFG A    +   T V+TR      Y  PE V+         DV+S G +L E  
Sbjct: 180 SIRVADFGSATFDHEHHTTIVATRH-----YRPPE-VILELGWAQPCDVWSIGCILFEYY 233

Query: 299 TG 300
            G
Sbjct: 234 RG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 63/240 (26%), Positives = 92/240 (38%), Gaps = 67/240 (27%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH 158
             LGEG FG V +    + G        G  VAVK +K +  +      +E+  L  L+ 
Sbjct: 20  DTLGEGAFGKVVECIDHKAG--------GRHVAVKIVK-NVDRYCEAARSEIQVLEHLNT 70

Query: 159 P------NLVKLIGY-------CI--EDDQRLL---VYEFMTRGSLENHLFRRTIPLPWS 200
                    V+++ +       CI  E    LL    Y+F     ++ + F    P    
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-----IKENGFL---PFRLD 118

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL-DSEYNA------------------ 241
           +  K+A    K + FLH  S  + + D K  NIL   S+Y                    
Sbjct: 119 HIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTG 300
           K+ DFG A    +   T VSTR      Y APE V+     +   DV+S G +L+E   G
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALGWSQPCDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	429
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.65
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.65
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.43
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.41
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.92
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.72
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.63
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.59
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.44
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.4
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.38
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.27
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.19
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.96
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.95
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.12
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.7
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.62
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.53
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.13

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.5e-61  Score=460.25  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=212.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ..|++++.||+|+||+||+|++..+++         .||||++........+.+.+|+.+|++|+|||||+++++|.+++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~---------~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCC---------EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            569999999999999999999988765         99999997665556677899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .+|||||||+||+|.+++.+.  .+++..+..++.||+.||+|||  +++||||||||+||||+.+|.+||+|||+|+..
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  220 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  220 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecCcCceec
Confidence            999999999999999988653  5899999999999999999999  899999999999999999999999999999875


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ....  ......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+...      .+....       +...
T Consensus       221 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~-------i~~~  285 (346)
T 4fih_A          221 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKM-------IRDN  285 (346)
T ss_dssp             CSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-------HHHS
T ss_pred             CCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHH-------HHcC
Confidence            4322  223457999999999999999999999999999999999999999976432      111111       1111


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..  .........++++.+||.+||+.||++|||+.|+++
T Consensus       286 ~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 LP--PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SC--CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC--CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11  112223455688999999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-61  Score=456.10  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=211.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||+||+|++..+++         .||||++.+..   ....+.+.+|+.+|++|+|||||+++++|+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~---------~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  102 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSR---------EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ  102 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCC---------EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            469999999999999999999988765         99999997542   233467899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||  +++|+||||||+|||++.+|.+||+|||+|
T Consensus       103 ~~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~DFGla  179 (311)
T 4aw0_A          103 DDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTA  179 (311)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence            9999999999999999999997654 6999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +..............+||+.|||||++.+..|+.++|||||||++|||++|.+||.+...      .+.......     
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~-----  248 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIK-----  248 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-----
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc-----
Confidence            976544444445567999999999999999999999999999999999999999975431      111111111     


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV  371 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil  371 (429)
                           ..  ..++...++++.+||.+||+.||++|||++|++
T Consensus       249 -----~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          249 -----LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -----TC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -----CC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                 11  122334567899999999999999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-61  Score=454.13  Aligned_cols=264  Identities=30%  Similarity=0.454  Sum_probs=216.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|.+.+.||+|+||+||+|++.....    ..+|..||||+++.......++|.+|+.+|++|+|||||++++++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCP----EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCccc----CCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            568889999999999999998764211    1236689999998776666788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          173 QRLLVYEFMTRGSLENHLFRR------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      ..|||||||+||+|.++|...            ...+++..+..++.||+.||.|||  +++||||||||+|||++.++.
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECCCCc
Confidence            999999999999999999654            246999999999999999999999  899999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  319 (429)
                      +||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...   ..+.   
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~---  240 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVI---  240 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH---
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH---
Confidence            99999999986544333333334579999999999999999999999999999999998 8999976432   1111   


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ....       .    ......+..+++++.+|+.+||+.||++|||+.+|+..|+.+..
T Consensus       241 ~~i~-------~----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          241 ECIT-------Q----GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHH-------H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHH-------c----CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111       0    11122344566889999999999999999999999998876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.3e-61  Score=457.78  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=205.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++++.||+|+||+||+|++..+++         .||||++.....  ...+.+.+|+.+|++|+|||||++++++.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   94 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGR---------QYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE   94 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCC---------EEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCC---------EEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence            589999999999999999999988755         999999976543  335678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++.+|||||||+||+|.++|..+ ...+++..++.++.||+.||.|||  ++|||||||||+||||+.+|.+||+|||+|
T Consensus        95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla  172 (350)
T 4b9d_A           95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIA  172 (350)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence            99999999999999999999755 445799999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +.....  .......+||+.|||||++.+..|+.++|||||||+||||++|..||.+...      .+.......     
T Consensus       173 ~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-----  239 (350)
T 4b9d_A          173 RVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIIS-----  239 (350)
T ss_dssp             SCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-----
T ss_pred             eeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHc-----
Confidence            875321  1223347899999999999999999999999999999999999999976431      111111111     


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                           ...+ ..+...+.++.+||.+||+.||++|||+.|+++
T Consensus       240 -----~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          240 -----GSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -----TCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 1111 123345678999999999999999999999987

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-60  Score=446.47  Aligned_cols=261  Identities=26%  Similarity=0.426  Sum_probs=207.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||+|+||+||+|++..            .||||+++...  ....+.|.+|+.+|++|+|||||++++++.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~  102 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT  102 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4578889999999999999998642            69999987543  344577999999999999999999999875


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                       ++.+|||||||+||+|.++|......+++..+..++.||+.||+|||  +.+||||||||+||||+.++.+||+|||+|
T Consensus       103 -~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          103 -KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             -SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             -CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence             45789999999999999999877778999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +..............+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.......   .   ....... 
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~---~~~~~~~-  252 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---Q---IIFMVGR-  252 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---H---HHHHHHT-
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---H---HHHHHhc-
Confidence            87654333334455789999999999974   358999999999999999999999997543211   1   1100100 


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                          ....+.+ ...+..+++.+.+|+.+||+.||++|||+.||++.|+.++.
T Consensus       253 ----~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          253 ----GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ----TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ----CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                0111111 12334566889999999999999999999999998876643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.7e-60  Score=462.29  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=213.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ..|++++.||+|+||.||+|++..+++         .||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~---------~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCC---------EEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence            569999999999999999999988765         99999998776666778999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .+|||||||+||+|.+++...  .+++..+..++.||+.||+|||  ++|||||||||+||||+.+|.+||+|||+|+..
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence            999999999999999988654  4899999999999999999999  899999999999999999999999999999875


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ....  ......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+..+      .+....       +...
T Consensus       298 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~-------i~~~  362 (423)
T 4fie_A          298 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKM-------IRDN  362 (423)
T ss_dssp             CSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-------HHHS
T ss_pred             CCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHH-------HHcC
Confidence            4332  223457999999999999999999999999999999999999999975432      111111       1111


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..+  ........++++.+||.+||+.||++|||+.|+++
T Consensus       363 ~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          363 LPP--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCC--CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC--CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111  12223345688999999999999999999999987

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.8e-60  Score=453.13  Aligned_cols=264  Identities=28%  Similarity=0.425  Sum_probs=210.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|.+.++||+|+||+||+|++....    ...++..||||+++.......++|.+|+.+|++|+|||||++++++.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLL----PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSC----C---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcc----cCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            45778899999999999999876421    11235689999998776667788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT--------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE  238 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~  238 (429)
                      .+|||||||++|+|.+++....              .++++.+++.++.||+.||+|||  +.+||||||||+||||+.+
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEECCC
Confidence            9999999999999999996542              35899999999999999999999  8999999999999999999


Q ss_pred             CCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHH
Q 014202          239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~  317 (429)
                      +.+||+|||+++..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.....   ..+  
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~--  269 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEA--  269 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHH--
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHH--
Confidence            9999999999987655444444455789999999999999999999999999999999999 8999975431   111  


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                       ....       ..    ..+...+..+++++.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       270 -~~~i-------~~----g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          270 -IDCI-------TQ----GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             -HHHH-------HH----TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -HHHH-------Hc----CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence             1111       11    11223344566889999999999999999999999999877654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.9e-60  Score=445.97  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=214.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++++.+.||+|+||+||+|.+.....    ..+++.||||+++.... ...++|.+|+.+|++|+|||||++++++.+++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~----~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAP----GEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCcc----CCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            46778899999999999998753211    12356899999975532 34578999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      .++||||||++|+|.++|..+.               ..+++..+..++.||+.||+|||  +.+||||||||+||||++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECG
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCccccceEECC
Confidence            9999999999999999996532               35899999999999999999999  899999999999999999


Q ss_pred             CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHH
Q 014202          238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~  316 (429)
                      ++.+||+|||+++.....+........+||+.|||||++.++.|+.++|||||||+||||+| |..||.+...   ..+.
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~  257 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV  257 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence            99999999999986544333333445689999999999999999999999999999999998 8999976432   1111


Q ss_pred             HHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      .              .+......+.+..++..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       258 ~--------------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          258 E--------------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             H--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             H--------------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            1              111111223445667889999999999999999999999999987644

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.4e-59  Score=444.29  Aligned_cols=252  Identities=24%  Similarity=0.262  Sum_probs=207.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +.|++.+.||+|+||.||+|++..++.         .||||+++.....     .+|+.+|++|+|||||++++++.+++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~---------~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGF---------QCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCC---------EEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            468888999999999999999988755         9999999765332     47999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFg~a~~  251 (429)
                      .+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||  +++||||||||+||||+.+| .+||+|||+|+.
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence            9999999999999999997654 6999999999999999999999  89999999999999999887 599999999987


Q ss_pred             CCCCCcc---ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          252 GPQGDKT---HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       252 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      .......   ......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.........      ....   
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~---  271 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IASE---  271 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH------HHHS---
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------HHcC---
Confidence            6443211   112336899999999999999999999999999999999999999986544321111      0111   


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                            +......+..+++.+.+||.+||+.||++|||+.|+++.|..
T Consensus       272 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          272 ------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             ------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                  111112334566889999999999999999999999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.4e-59  Score=435.51  Aligned_cols=248  Identities=26%  Similarity=0.413  Sum_probs=200.9

Q ss_pred             CCC-CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNF-RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y-~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++| ++.++||+|+||+||+|++..++.         .||+|++....  ....+.+.+|+.+|++|+|||||+++++|.
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   95 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTV---------EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCe---------EEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            344 677889999999999999987755         99999996543  233467899999999999999999999987


Q ss_pred             e----CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeEEc-CCCCEE
Q 014202          170 E----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP--VIYRDFKTSNILLD-SEYNAK  242 (429)
Q Consensus       170 ~----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~--ivHrDlkp~Nill~-~~~~~k  242 (429)
                      .    +..+|||||||+||+|.+++.+.. .+++..+..++.||+.||+|||  +++  ||||||||+||||+ .+|.+|
T Consensus        96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH--~~~~~IiHRDlKp~NILl~~~~g~vK  172 (290)
T 3fpq_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             EEETTEEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred             eccCCCcEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCCCEEecccChhheeEECCCCCEE
Confidence            5    346899999999999999997654 6899999999999999999999  666  99999999999997 479999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |+|||+|+....    ......+||+.|||||++.+ .|+.++|||||||++|||+||..||.....     ....... 
T Consensus       173 l~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~-  241 (290)
T 3fpq_A          173 IGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRR-  241 (290)
T ss_dssp             ECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHH-
T ss_pred             EEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHH-
Confidence            999999986432    22345789999999998864 699999999999999999999999975332     1111111 


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                               +.....+...+...++++.+||.+||+.||++|||+.|+++
T Consensus       242 ---------i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          242 ---------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---------HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     11111111222234468999999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.1e-59  Score=432.00  Aligned_cols=246  Identities=25%  Similarity=0.395  Sum_probs=194.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||+||+|++..+++         .||||++.+...   .....+.+|+.+|++++|||||++++++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQ---------KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCC---------EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            689999999999999999999887755         999999976532   23457899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++.+||||||| +|+|.+++.+++ .+++..+..++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+|
T Consensus        84 ~~~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~DFGla  159 (275)
T 3hyh_A           84 SKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLS  159 (275)
T ss_dssp             CSSEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred             ECCEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEeecCCC
Confidence            999999999999 679999987654 6999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +......   .....+||+.|||||++.+..| +.++|||||||++|+|++|..||.+..      ..........    
T Consensus       160 ~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~----  226 (275)
T 3hyh_A          160 NIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISN----  226 (275)
T ss_dssp             ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH----
T ss_pred             eecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc----
Confidence            8654322   2334789999999999998876 579999999999999999999997532      1111111111    


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ..  ...+...++++.+||.+||+.||++|||++|+++
T Consensus       227 ------~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          227 ------GV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------TC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  11  1122345578999999999999999999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-59  Score=440.11  Aligned_cols=251  Identities=29%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++++.||+|+||+||+|++..++.      +++.||||++.....  .....+.+|+.+|++|+|||||++++++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSD------ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTT------TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCC------CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            469999999999999999999865432      356999999976532  233467899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||  ++||+||||||+|||++.+|.+||+|||+|+
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence            999999999999999999997654 6999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ......  ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+...      .+.....        
T Consensus       175 ~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i--------  238 (304)
T 3ubd_A          175 ESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMI--------  238 (304)
T ss_dssp             C-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH--------
T ss_pred             eccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHH--------
Confidence            643322  223347899999999999999999999999999999999999999976432      1111111        


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH-----hHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM-----DEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~eil~  372 (429)
                        ....  ...+...++++.+||.+||+.||++|||+     +|+++
T Consensus       239 --~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          239 --LKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --HcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              1111  12233456889999999999999999984     67765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.3e-59  Score=446.55  Aligned_cols=275  Identities=27%  Similarity=0.385  Sum_probs=224.2

Q ss_pred             ccccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCC-
Q 014202           81 LQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHH-  158 (429)
Q Consensus        81 ~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-  158 (429)
                      ..+...+++...++|++++.||+|+||+||+|.+..++...    .++.||||.+...... ..+.+.+|+.+|.++.| 
T Consensus        52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~----~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hh  127 (353)
T 4ase_A           52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH  127 (353)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTT----CEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC
T ss_pred             CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCccc----CCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCC
Confidence            34455667777789999999999999999999987654322    3458999999866443 35678999999999965 


Q ss_pred             cceeeEEeEEEeC-CeEEEEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCC
Q 014202          159 PNLVKLIGYCIED-DQRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNRIKIALGAAKGLAFLHGGSEP  222 (429)
Q Consensus       159 pnIv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~  222 (429)
                      ||||+++++|..+ +.+|||||||++|+|.++|...               ...+++..+..++.||+.||+|||  +++
T Consensus       128 pnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--~~~  205 (353)
T 4ase_A          128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRK  205 (353)
T ss_dssp             TTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             CcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--hCC
Confidence            9999999998765 5689999999999999999653               234899999999999999999999  899


Q ss_pred             eeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CC
Q 014202          223 VIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GR  301 (429)
Q Consensus       223 ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~  301 (429)
                      ||||||||+|||++.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |.
T Consensus       206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~  285 (353)
T 4ase_A          206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  285 (353)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence            99999999999999999999999999987655444444455789999999999999999999999999999999998 99


Q ss_pred             CCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          302 RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       302 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .||.+.....  .+.    ..+.          .......+..+++++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       286 ~Pf~~~~~~~--~~~----~~i~----------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          286 SPYPGVKIDE--EFC----RRLK----------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CSSTTCCCSH--HHH----HHHH----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHH--HHH----HHHH----------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            9997654221  111    1111          1112233345568899999999999999999999999988655

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.7e-56  Score=419.66  Aligned_cols=250  Identities=26%  Similarity=0.405  Sum_probs=190.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++++.||+|+||+||+|++..++.         .||||++...... ..+.+.+|+.+|++|+|||||+++++|.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   75 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDC---------NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK   75 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCC---------EEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCC---------EEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence            358999999999999999999987755         9999999765433 346789999999999999999999998765


Q ss_pred             C------------eEEEEEEecCCCChHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          172 D------------QRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       172 ~------------~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      +            .+|||||||+||+|.+++.....  ..++..++.++.||+.||+|||  +++||||||||+|||++.
T Consensus        76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl~~  153 (299)
T 4g31_A           76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTM  153 (299)
T ss_dssp             C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECT
T ss_pred             CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEECC
Confidence            4            36999999999999999976532  2456678899999999999999  899999999999999999


Q ss_pred             CCCEEEccccCcccCCCCCcc----------ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 014202          238 EYNAKLSDFGLAKAGPQGDKT----------HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKK  307 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  307 (429)
                      +|.+||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||...
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            999999999999875443211          11234689999999999999999999999999999999996   77431


Q ss_pred             CCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          308 RPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                           .+....          +....+...+ +.....++.+.+||.+||+.||++|||+.|+++
T Consensus       231 -----~~~~~~----------~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          231 -----MERVRT----------LTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -----HHHHHH----------HHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----cHHHHH----------HHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 111110          1111111111 011233456789999999999999999999997

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.7e-56  Score=422.29  Aligned_cols=268  Identities=26%  Similarity=0.333  Sum_probs=199.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .+|.+.+.||+|+||+||+|++.           |+.||||++...... ......|+..+.+++|||||++++++..++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            35788899999999999999873           448999999654221 122345666777899999999999998764


Q ss_pred             ----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCCeEEcCCCCEE
Q 014202          173 ----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG------SEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       173 ----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~------~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                          .+|||||||+||+|.+++...  ++++..+..++.|++.||+|||..      ..+||||||||+||||+.++.+|
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence                579999999999999999765  489999999999999999999932      23999999999999999999999


Q ss_pred             EccccCcccCCCCCcc--ceeeeccccccccChhhhhcC------CCCCccchhhhHHHHHHHHhCCCCCCCCCCCc---
Q 014202          243 LSDFGLAKAGPQGDKT--HVSTRVVGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG---  311 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---  311 (429)
                      |+|||+|+........  ......+||+.|||||++.+.      .++.++|||||||+||||+||.+||.......   
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            9999999865433221  122346899999999999764      36779999999999999999988875432211   


Q ss_pred             ------cccHHHHHHHHHHhhhhhhhhcCCccccC-CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          312 ------EQNLVAWARQYLADKRKLYQIVDPRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       312 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                            ....... ....     ......+.++.. .....+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       229 ~~~~~~~~~~~~~-~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          229 YDLVPSDPSVEEM-RKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTSCSSCCHHHH-HHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhcccccchHHHH-HHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                  0111111 1100     111122222211 1234567899999999999999999999999998766543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-55  Score=425.76  Aligned_cols=271  Identities=22%  Similarity=0.300  Sum_probs=207.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++++.||+|+||+||+|++..+++         .||||++.....  ...+.+.+|+.+|+.|+|||||++++++.
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~---------~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  123 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQ---------QVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR  123 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCC---------EEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence            4689999999999999999999988765         999999976532  33467889999999999999999999876


Q ss_pred             e------CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          170 E------DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       170 ~------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      .      .+.+|||||||. |+|.+++.+. ..+++..+..++.||+.||.|||  ++|||||||||+|||++.+|.+||
T Consensus       124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~~~~Ki  199 (398)
T 4b99_A          124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCELKI  199 (398)
T ss_dssp             CSSCTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred             cccccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCCCCEEE
Confidence            4      357899999995 6899988654 47999999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCC--ccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          244 SDFGLAKAGPQGD--KTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       244 ~DFg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      +|||+|+......  ........+||+.|||||++.+. .|+.++|||||||++|||++|.+||.+.....   ....+.
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~  276 (398)
T 4b99_A          200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIM  276 (398)
T ss_dssp             CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHH
T ss_pred             eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHH
Confidence            9999998754321  12233457999999999998875 56999999999999999999999998653211   111111


Q ss_pred             HHHHhh-h------------hhhhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCc
Q 014202          321 QYLADK-R------------KLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQ  378 (429)
Q Consensus       321 ~~~~~~-~------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~  378 (429)
                      ...... .            .....+....+..   .....++++.+||.+||+.||++|||+.|+|+  +|....
T Consensus       277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            110000 0            0000000000000   01123578899999999999999999999998  555544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.6e-54  Score=414.06  Aligned_cols=268  Identities=23%  Similarity=0.297  Sum_probs=202.6

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeE
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGY  167 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~  167 (429)
                      ....++|++.+.||+|+||+||+|+++.+..      +++.||||.+....  ....+.+|+.+|+.+ +|||||+++++
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~------~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~   88 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVG------PEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYC   88 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTS------CEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCC------CCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence            3456789999999999999999998764211      35589999987653  335678999999998 59999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CCEEEccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDF  246 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~DF  246 (429)
                      |.+++.+|||||||+||+|.+++.    .+++.++..++.||+.||+|||  ++||+||||||+|||++.+ +.+||+||
T Consensus        89 ~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           89 FRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             EEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            999999999999999999999883    4899999999999999999999  8999999999999999876 79999999


Q ss_pred             cCcccCCCCCc--------------------------cceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHh
Q 014202          247 GLAKAGPQGDK--------------------------THVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILT  299 (429)
Q Consensus       247 g~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~  299 (429)
                      |+|+.......                          .......+||+.|+|||++.+. .|+.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99975433211                          0112335899999999999875 58999999999999999999


Q ss_pred             CCCCCCCCCCCccccHHHHHHHHHHhhh------------------------hhhhh---cC---C---------ccccC
Q 014202          300 GRRSMDKKRPSGEQNLVAWARQYLADKR------------------------KLYQI---VD---P---------RLELN  340 (429)
Q Consensus       300 g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~---~~---~---------~~~~~  340 (429)
                      |+.||......  ......+...+....                        .+.+.   .+   +         .....
T Consensus       243 G~~Pf~~~~~~--~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  320 (361)
T 4f9c_A          243 GRYPFYKASDD--LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE  320 (361)
T ss_dssp             TCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred             CCCCCCCCCCH--HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence            99999654321  111111111100000                        00000   00   0         00001


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          341 YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       341 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .....++++.+||.+||+.||++|||++|+++
T Consensus       321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11234578899999999999999999999997

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1e-53  Score=437.47  Aligned_cols=257  Identities=23%  Similarity=0.316  Sum_probs=216.5

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++++.||+|+||.||+|++..++.         .||+|++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~---------~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  226 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGN---------NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD  226 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCC---------EEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3689999999999999999999988765         9999999877666677889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC--CCEEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE--YNAKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~kl~DFg~a  249 (429)
                      +.+|||||||+||+|.++|......+++..+..++.||+.||.|||  +++|+||||||+|||++.+  +.+||+|||+|
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a  304 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT  304 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred             CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEeeccce
Confidence            9999999999999999999777667999999999999999999999  8999999999999999754  89999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +......   .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+...      .+.......     
T Consensus       305 ~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~-----  370 (573)
T 3uto_A          305 AHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKS-----  370 (573)
T ss_dssp             EECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHT-----
T ss_pred             eEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHh-----
Confidence            9864432   23456899999999999999999999999999999999999999976432      111111110     


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTP  376 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~  376 (429)
                         .+..+........++++.+||.+||+.||.+|||+.|+++  +|..
T Consensus       371 ---~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          371 ---CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             ---TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ---CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence               1111111222334578999999999999999999999998  4443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3e-53  Score=432.37  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hh---HHHHHHHHHHhcCCCcceeeEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GH---REWVAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~---~~~~~E~~~l~~l~hpnIv~~~~  166 (429)
                      ++|+++++||+|+||+||+|++..++.         .||||++.+....   ..   .....++.+++.++|||||++++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~---------~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~  259 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY  259 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCC---------EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence            679999999999999999999988765         9999999654211   11   22344577788889999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      +|.+++.+|||||||+||+|.++|.+.+ .+++..+..++.||+.||+|||  ++|||||||||+||||+.+|.+||+||
T Consensus       260 ~f~~~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vKL~DF  336 (689)
T 3v5w_A          260 AFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDL  336 (689)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEECCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEEeccc
Confidence            9999999999999999999999997654 6999999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      |+|+......    ....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+......   .......   
T Consensus       337 GlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i---  406 (689)
T 3v5w_A          337 GLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMT---  406 (689)
T ss_dssp             TTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHH---
T ss_pred             ceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhh---
Confidence            9998754332    234699999999999974 5799999999999999999999999975433221   1111111   


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~  372 (429)
                             ...  ...++...++++.+||.+||+.||.+|++     ++||++
T Consensus       407 -------~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          407 -------LTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -------HHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -------cCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                   111  11233345688999999999999999998     688875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.1e-51  Score=389.62  Aligned_cols=281  Identities=41%  Similarity=0.738  Sum_probs=237.5

Q ss_pred             HHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeE
Q 014202           85 FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        85 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      +.++....++|++.+.||+|+||.||+|.+. +         |..||||.+..........+.+|+.+|+.++||||+++
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~  100 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-D---------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL  100 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-T---------CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEEC-C---------CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            3344556789999999999999999999864 2         34899999987766677889999999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      ++++..++..++||||+++|+|.+++....   ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+
T Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~  178 (321)
T 2qkw_B          101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVP  178 (321)
T ss_dssp             EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTTCCE
T ss_pred             EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCCCCE
Confidence            999999999999999999999999986543   35899999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||+|||++................||+.|+|||++.+..++.++|||||||++|||++|..||....+........|...
T Consensus       179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  258 (321)
T 2qkw_B          179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE  258 (321)
T ss_dssp             EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred             EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence            99999999865433333333446799999999999999999999999999999999999999988777666666665443


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      . .....+...+++..........+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       259 ~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          259 S-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             H-HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c-cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            2 2233344555666666667788899999999999999999999999999887554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-49  Score=375.14  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=211.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++..........+.+|+.+|++++||||+++++++..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQ---------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCC---------EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCc---------EEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            3689999999999999999999877655         9999999766555567789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..|+||||++||+|.+++...  .+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++..
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence            9999999999999999999765  4899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+..      ....       +..
T Consensus       166 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~-------~~~  230 (297)
T 3fxz_A          166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYL-------IAT  230 (297)
T ss_dssp             CCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-------HHH
T ss_pred             cCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-------HHh
Confidence            543322  2234689999999999999999999999999999999999999997543211      0000       000


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .  .......+...+..+.+||.+||+.||++|||+.|+++
T Consensus       231 ~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          231 N--GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             H--CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C--CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0  11112223445678999999999999999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.6e-50  Score=379.39  Aligned_cols=261  Identities=28%  Similarity=0.414  Sum_probs=216.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|.+.+.||+|+||.||+|.+..++.         .||+|.+........+.+.+|+.+|++++||||+++++++.+++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~---------~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   80 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGE---------VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK   80 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCC---------EEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCc---------EEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence            579999999999999999999987655         99999997766667788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+++|+|.+++......+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            999999999999999999887778999999999999999999999  899999999999999999999999999999865


Q ss_pred             CCCCccc------------eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          253 PQGDKTH------------VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       253 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      .......            ......||+.|+|||++.+..++.++|||||||++|||++|..||....+......... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~  237 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-R  237 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-H
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-h
Confidence            4322211            01135799999999999999999999999999999999999999976543221110000 0


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      .      ....        ..+..++..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       238 ~------~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          238 G------FLDR--------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             H------HHHH--------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c------cccc--------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0      0000        1112334678999999999999999999999999987764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.7e-49  Score=387.02  Aligned_cols=266  Identities=26%  Similarity=0.427  Sum_probs=216.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++++.||+|+||.||+|.+...+.  .....+..||||++..... .....+.+|+.+|+++ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            3679999999999999999999864332  1223456899999976643 3346789999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      .++.+|+||||++||+|.+++....               ..+++..++.++.||+.||.|||  +.+|+||||||+|||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVL  235 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchhhEE
Confidence            9999999999999999999997643               24789999999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---  312 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  312 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999986544332222233567889999999999999999999999999999999 99999764321   


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .+..              .+........+..++..+.+||.+||+.||.+||++.|+++.|+.+.
T Consensus       313 ~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          313 ELFK--------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             GHHH--------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111              11111112233445678999999999999999999999999887654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.7e-49  Score=378.93  Aligned_cols=286  Identities=44%  Similarity=0.755  Sum_probs=232.7

Q ss_pred             ccccccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCC
Q 014202           79 QLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLH  157 (429)
Q Consensus        79 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~  157 (429)
                      +...+++.++....++|++.+.||+|+||.||+|.+..          |..||||++...... ....+.+|+.+|+.++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~   85 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD----------GTLVAVKRLKEERTQGGELQFQTEVEMISMAV   85 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS----------SCCEEEEECCC-----CCCHHHHHHHGGGTCC
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC----------CCEEEEEEeccccCchHHHHHHHHHHHHHhcc
Confidence            45678899999999999999999999999999997432          348999999765432 2346889999999999


Q ss_pred             CcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhCCCC---CeeeCCCCCC
Q 014202          158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT---IPLPWSNRIKIALGAAKGLAFLHGGSE---PVIYRDFKTS  231 (429)
Q Consensus       158 hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~---~ivHrDlkp~  231 (429)
                      ||||+++++++...+..++||||+.+|+|.+++....   ..+++..+..++.|++.||.|||  +.   +|+||||||+
T Consensus        86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~ivH~Dlkp~  163 (326)
T 3uim_A           86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--DHCDPKIIHRDVKAA  163 (326)
T ss_dssp             CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH--HSSSSCEECCCCSGG
T ss_pred             CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCchh
Confidence            9999999999999999999999999999999997643   34899999999999999999999  77   9999999999


Q ss_pred             CeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCC--C
Q 014202          232 NILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR--P  309 (429)
Q Consensus       232 Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~  309 (429)
                      |||++.++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....  .
T Consensus       164 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (326)
T 3uim_A          164 NILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN  242 (326)
T ss_dssp             GEEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred             hEEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence            9999999999999999998754332 223344679999999999999899999999999999999999999996221  1


Q ss_pred             CccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ........|..... ....+....+...........+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          243 DDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TSCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             ccchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            12222333322211 122334445555556677788899999999999999999999999999997643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=380.07  Aligned_cols=263  Identities=27%  Similarity=0.459  Sum_probs=215.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..++.      .+..||||++.... ....+.+.+|+.+|++++||||+++++++.+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            3679999999999999999999986654      24479999998653 3345678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|+||||++||+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            99999999999999999999777677999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          251 AGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......   ..             
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~-------------  263 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV-------------  263 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH-------------
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH-------------
Confidence            76443221 12223456889999999999999999999999999999999 99999654311   11             


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                       ...+........+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       264 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          264 -ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             11111112222334556889999999999999999999999999877643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.7e-49  Score=379.20  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=209.1

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++....  ....+.+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   83 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGR---------EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI   83 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34689999999999999999999987755         99999997543  23456788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..++..|+||||++||+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           84 ETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             EECCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence            99999999999999999999986654 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +........   ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+...      .........   
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~---  228 (328)
T 3fe3_A          161 SNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLR---  228 (328)
T ss_dssp             CGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH---
T ss_pred             ceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh---
Confidence            986543322   2346899999999999988775 799999999999999999999976431      111111111   


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                             ..  ...+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       229 -------~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          229 -------GK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -------CC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -------CC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   11  11222345789999999999999999999999973

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-48  Score=378.90  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=208.4

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch------hhHHHHHHHHHHhcCCCcceeeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ------GHREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      ..++|++++.||+|+||.||+|.+..++.         .||+|++......      ....+.+|+.+|++++||||+++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---------~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l   80 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGL---------EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL   80 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCC---------EEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence            34679999999999999999999987655         9999999765432      24678999999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----C
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----N  240 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~  240 (429)
                      ++++.+.+..|+||||++||+|.+++... ..+++..+..++.||+.||.|||  +.||+||||||+|||++.++    .
T Consensus        81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~~~  157 (361)
T 2yab_A           81 HDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPH  157 (361)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSCC
T ss_pred             EEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCCCccC
Confidence            99999999999999999999999999654 46999999999999999999999  89999999999999998777    7


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      +||+|||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...      .....
T Consensus       158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~  228 (361)
T 2yab_A          158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLA  228 (361)
T ss_dssp             EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHH
T ss_pred             EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            99999999987544321   2346899999999999999999999999999999999999999976431      11111


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .....        ............+..+.+||.+||..||.+|||+.|+++
T Consensus       229 ~i~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          229 NITAV--------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHTT--------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhc--------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11100        000111111233578999999999999999999999997

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-49  Score=374.93  Aligned_cols=253  Identities=18%  Similarity=0.243  Sum_probs=210.5

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||+|.+.... .....+.+|+.+|+.++||||+++++++.+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   72 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKK---------TYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCc---------EEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec
Confidence            34789999999999999999999887654         99999997553 445668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC--CCCEEEccccC
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS--EYNAKLSDFGL  248 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~--~~~~kl~DFg~  248 (429)
                      .+..++||||++||+|.+++......+++..++.++.|++.||.|||  +.||+||||||+|||++.  ++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~  150 (321)
T 1tki_A           73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence            99999999999999999999777667999999999999999999999  899999999999999987  78999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ...........  
T Consensus       151 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~--  219 (321)
T 1tki_A          151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAE--  219 (321)
T ss_dssp             CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC--
T ss_pred             CeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCC--
Confidence            98764432   23346899999999999988899999999999999999999999975431      11111111110  


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ...........+.++.+||.+||..||.+|||+.|+++
T Consensus       220 ------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          220 ------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  00000001123578999999999999999999999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.9e-48  Score=367.77  Aligned_cols=265  Identities=26%  Similarity=0.341  Sum_probs=211.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||+|.+.....   ...+.+.+|+.++++++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   79 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNI---------KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV   79 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCS---------EEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCC---------eEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence            35789999999999999999999887655         999999865432   334678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +..++..|+||||++|++|.+++.... ++++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           80 DEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             eeeCCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999999999999996654 6899999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||......      .......    
T Consensus       157 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~----  225 (294)
T 4eqm_A          157 IAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHI----  225 (294)
T ss_dssp             SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHH----
T ss_pred             Cccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHh----
Confidence            9987543221 2223467999999999999999999999999999999999999999764321      1000000    


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-CHhHHHHHhcCCcCcc
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-SMDEVVKVLTPLQDLN  381 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~eil~~l~~~~~~~  381 (429)
                         ....+..........++.+.++|.+||+.||.+|| +++++.+.|..+....
T Consensus       226 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          226 ---QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             ---SSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             ---hccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence               00111111122334557899999999999999998 8999999888775543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.2e-49  Score=375.26  Aligned_cols=255  Identities=26%  Similarity=0.359  Sum_probs=207.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..+++         .||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   76 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEE---------AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE   76 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCc---------EEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3689999999999999999999987655         999999865533 234568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|+||||++||+|.+++... ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++.
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~  153 (323)
T 3tki_A           77 GNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLAT  153 (323)
T ss_dssp             SSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEEeeccc
Confidence            99999999999999999988544 45899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ...............||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+           
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~-----------  221 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-----------  221 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH-----------
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH-----------
Confidence            6543333333345689999999999987765 7789999999999999999999976543211 11110           


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         .............+..+.+||.+||+.||.+|||+.|+++.
T Consensus       222 ---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          222 ---KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---hcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               01111111123345788999999999999999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7e-49  Score=373.41  Aligned_cols=259  Identities=29%  Similarity=0.476  Sum_probs=203.9

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+.           |..||||++.....  .....+.+|+.+|++++||||+++++++
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3467999999999999999999763           34899999976643  3346788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeEEcCCCCEEEc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIALGAAKGLAFLHGGSEP--VIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ...+..++||||+++|+|.+++.....  .+++..++.++.|++.||+|||  +.+  |+||||||+|||++.++.+||+
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence            999999999999999999999976532  3899999999999999999999  788  9999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ...   ..   
T Consensus       182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~---~~---  250 (309)
T 3p86_A          182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVV---AA---  250 (309)
T ss_dssp             CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHH---HH---
T ss_pred             CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HH---
Confidence            999997643321  1223467999999999999999999999999999999999999999754321   110   00   


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                             ..........+...+..+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       251 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          251 -------VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                   0001111223344557899999999999999999999999998776543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-48  Score=375.87  Aligned_cols=248  Identities=27%  Similarity=0.365  Sum_probs=207.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||.||+|++..++.         .||+|++....   ......+.+|+.+|+.++||||+++++++.
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~   75 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGR---------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence            579999999999999999999887655         99999997542   223456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ..+..|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||  +.||+||||||+|||++.+|.+||+|||++
T Consensus        76 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DFG~a  152 (337)
T 1o6l_A           76 THDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEeeccch
Confidence            9999999999999999999886543 5899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .........     
T Consensus       153 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~-----  219 (337)
T 1o6l_A          153 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILM-----  219 (337)
T ss_dssp             BCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-----
T ss_pred             hhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHc-----
Confidence            8643222  123346899999999999999999999999999999999999999975321      111111111     


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                           ..  ..++...+.++.+||.+||+.||.+||     ++.++++
T Consensus       220 -----~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          220 -----EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                 11  112234557899999999999999999     8999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3e-49  Score=378.19  Aligned_cols=272  Identities=26%  Similarity=0.327  Sum_probs=208.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|++.           +..||||++.... ........|+.+|++++||||+++++++...
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            357999999999999999999875           3489999997543 2334456799999999999999999999875


Q ss_pred             C----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCC----------CeeeCCCCCCCeEEcC
Q 014202          172 D----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE----------PVIYRDFKTSNILLDS  237 (429)
Q Consensus       172 ~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~----------~ivHrDlkp~Nill~~  237 (429)
                      .    .+++||||+++|+|.+++...  .+++..++.++.|++.||.|||  +.          +|+||||||+|||++.
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhEEECC
Confidence            4    369999999999999999664  4899999999999999999999  77          9999999999999999


Q ss_pred             CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcc
Q 014202          238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE  312 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  312 (429)
                      ++.+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|..||.+......
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~  246 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM  246 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred             CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence            999999999999765443332223336799999999999863     455688999999999999999999986544322


Q ss_pred             ccHHHHHHHHHHhhhhhh-----hhcCCcccc-CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          313 QNLVAWARQYLADKRKLY-----QIVDPRLEL-NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                      .......... .....+.     ....+.+.. ......+..+.+||.+||+.||++|||+.++++.|+.++..
T Consensus       247 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          247 LPFEEEIGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CTTHHHHCSS-CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhhhhccC-CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            2111100000 0000000     111111111 11234567799999999999999999999999998877543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.2e-49  Score=383.33  Aligned_cols=280  Identities=28%  Similarity=0.397  Sum_probs=223.3

Q ss_pred             cccccccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC
Q 014202           78 CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL  156 (429)
Q Consensus        78 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l  156 (429)
                      +....+....+....++|++.+.||+|+||.||+|++.....    ..+++.||||++..... ...+.+.+|+.+|.++
T Consensus         7 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   82 (359)
T 3vhe_A            7 CERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHI   82 (359)
T ss_dssp             GGGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCCCcccccccccceeeceeecCCCCceEEEEEeccccc----cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhh
Confidence            334455666777778899999999999999999999654221    22456999999986543 3346789999999999


Q ss_pred             -CCcceeeEEeEEEeCCe-EEEEEEecCCCChHHHHhcCCC---------------------------------------
Q 014202          157 -HHPNLVKLIGYCIEDDQ-RLLVYEFMTRGSLENHLFRRTI---------------------------------------  195 (429)
Q Consensus       157 -~hpnIv~~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~---------------------------------------  195 (429)
                       +||||+++++++...+. .++||||++||+|.+++.....                                       
T Consensus        83 ~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (359)
T 3vhe_A           83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSS  162 (359)
T ss_dssp             CCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------
T ss_pred             cCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccc
Confidence             79999999999987654 8999999999999999976432                                       


Q ss_pred             --------------------------CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          196 --------------------------PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       196 --------------------------~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                                                .+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  240 (359)
T 3vhe_A          163 ASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLA  240 (359)
T ss_dssp             ---------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred             cccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccce
Confidence                                      1889999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ................||+.|+|||++.+..++.++|||||||++|||++ |..||.......  ....    .+.    
T Consensus       241 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~----  310 (359)
T 3vhe_A          241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLK----  310 (359)
T ss_dssp             SCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHH----
T ss_pred             eeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHH----
Confidence            87644443334445678999999999999999999999999999999998 999997654321  1110    011    


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                        .    ......+...++++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       311 --~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          311 --E----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             --H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --c----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence              0    11112223345789999999999999999999999999876643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.2e-49  Score=376.36  Aligned_cols=262  Identities=24%  Similarity=0.405  Sum_probs=208.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|++..++...+     ..||+|.+.... ....+.+.+|+.+|++++||||+++++++..+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-----IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CC-----EEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEE-----EEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            579999999999999999999887655322     257999886543 24457789999999999999999999999875


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      . .++|+||+.+|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            4 78999999999999999887778999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............||+.|+|||++.+..++.++|||||||++|||++ |..||.......   ..              
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~--------------  229 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS--------------  229 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH--------------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH--------------
Confidence            544433333334567889999999999999999999999999999999 999997654221   11              


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ..+........+...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111111222333455789999999999999999999999998876654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.9e-49  Score=387.79  Aligned_cols=260  Identities=27%  Similarity=0.413  Sum_probs=213.2

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..++|.+.+.||+|+||.||+|.+..++.         .||||.+..... .....+.+|+.+|++++||||+++++++.
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCe---------EEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34679999999999999999999986654         899999875532 23456889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..|+||||+++|+|.+++......+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s  260 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMS  260 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence            999999999999999999999876667899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +...............+++.|+|||++.+..++.++|||||||++|||++ |..||......   ...            
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~------------  325 (377)
T 3cbl_A          261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTR------------  325 (377)
T ss_dssp             EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHH------------
T ss_pred             eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH------------
Confidence            86433211111112345778999999999999999999999999999998 99999754311   111            


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        ..+........+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       326 --~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          326 --EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence              111111122333445678999999999999999999999999887654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-48  Score=377.97  Aligned_cols=254  Identities=20%  Similarity=0.311  Sum_probs=212.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|++..........+.+|+.+|+.++||||+++++++.++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  120 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGR---------VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK  120 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCC---------EEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence            3579999999999999999999987655         9999999876655566789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC--CCCEEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS--EYNAKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~--~~~~kl~DFg~a  249 (429)
                      ...++||||+.||+|.+++......+++..++.++.||+.||.|||  +.+|+||||||+|||++.  ++.+||+|||++
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLA  198 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEEecccc
Confidence            9999999999999999999777667999999999999999999999  899999999999999974  577999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .........     
T Consensus       199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~-----  264 (387)
T 1kob_A          199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKR-----  264 (387)
T ss_dssp             EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHH-----
T ss_pred             eecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHh-----
Confidence            8754432   22345799999999999999999999999999999999999999975431      111111100     


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         .............+.++.+||.+||+.||.+|||+.++++.
T Consensus       265 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          265 ---CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ---CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               01111112223445789999999999999999999999984

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.4e-48  Score=382.91  Aligned_cols=255  Identities=22%  Similarity=0.278  Sum_probs=208.1

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||+|++......  ....+.+|+.+|++++||||+++++++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~---------~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~   79 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQ---------EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI   79 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTE---------EEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCc---------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence            34579999999999999999999887654         9999999766432  345688999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCCEEEcc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD---SEYNAKLSD  245 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~D  245 (429)
                      .+++..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||  +.||+||||||+|||++   .++.+||+|
T Consensus        80 ~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           80 SEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             ECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             EECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCcEEEcc
Confidence            99999999999999999999987664 5899999999999999999999  89999999999999997   567899999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ..........
T Consensus       157 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~  228 (444)
T 3soa_A          157 FGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAG  228 (444)
T ss_dssp             CSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT
T ss_pred             CceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhC
Confidence            999987543322  22346899999999999998999999999999999999999999975331      1111111110


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                              ............++.+.+||.+||+.||.+|||+.|+++.
T Consensus       229 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          229 --------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             --------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                    0111111122445789999999999999999999999984

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-48  Score=374.39  Aligned_cols=262  Identities=25%  Similarity=0.395  Sum_probs=211.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++...+     ..||+|.+.... ......+.+|+.++++++||||+++++++. +
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~-----~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIK-----IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCC-----EEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEE-----EEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            579999999999999999999987765322     258999886543 233456778999999999999999999886 5


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+.+|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            6789999999999999999876667899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   ...             
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~-------------  228 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD-------------  228 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH-------------
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH-------------
Confidence            655444434445678889999999999999999999999999999999 999998654321   111             


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                       .+........+...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          229 -LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -HHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -HHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             010111112222344578899999999999999999999999877654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=378.59  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEEeE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLIGY  167 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~  167 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++....   ......+.+|..+|..+ +||||++++++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~   92 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGD---------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC   92 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCC---------EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence            4689999999999999999999987655         99999997542   12335678999999988 69999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +.+.+.+||||||++||+|.+++.+.. .+++..+..++.||+.||.|||  +.+|+||||||+|||++.+|.+||+|||
T Consensus        93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           93 FQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEEEcccc
Confidence            999999999999999999999986654 5899999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .......     
T Consensus       170 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i-----  236 (353)
T 3txo_A          170 MCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAI-----  236 (353)
T ss_dssp             TCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-----
T ss_pred             ceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHH-----
Confidence            998643222  223346899999999999998999999999999999999999999975432      1111111     


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH------hHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM------DEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~eil~  372 (429)
                           ....  ..++...+..+.+||.+||+.||.+||++      .++++
T Consensus       237 -----~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          237 -----LNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -----HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -----HcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                 1111  11223345789999999999999999998      77776

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-47  Score=366.28  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=208.0

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeE
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  174 (429)
                      |...+.||+|+||.||+|++..++.         .||||++........+.+.+|+.+|++++||||+++++++...+..
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~---------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGR---------QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCc---------EEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            6777899999999999999876654         9999999877666667889999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCC
Q 014202          175 LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ  254 (429)
Q Consensus       175 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~  254 (429)
                      ++||||++|++|.+++...  .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       118 ~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             EEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence            9999999999999988543  5899999999999999999999  89999999999999999999999999999987543


Q ss_pred             CCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ......       +.....
T Consensus       194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~-------~~~~~~  258 (321)
T 2c30_A          194 DVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKR-------LRDSPP  258 (321)
T ss_dssp             SSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-------HHHSSC
T ss_pred             Ccc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-------HhcCCC
Confidence            221  22346899999999999999999999999999999999999999975432      111111       111111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      +.  .......+..+.+||.+||+.||++|||+.++++.
T Consensus       259 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          259 PK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             CC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11  11223345789999999999999999999999984

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=380.15  Aligned_cols=268  Identities=26%  Similarity=0.403  Sum_probs=218.4

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      ..++|.+.+.||+|+||.||+|.+..++.  .....+..||||++..... .....+.+|+.+|+++ +||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            34689999999999999999999875443  1223456899999976543 3346788999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNI  233 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Ni  233 (429)
                      ..++..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||  +.+|+||||||+||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNV  222 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCcceE
Confidence            99999999999999999999997653               35899999999999999999999  89999999999999


Q ss_pred             EEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcc
Q 014202          234 LLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGE  312 (429)
Q Consensus       234 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  312 (429)
                      |++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.....   
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---  299 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  299 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999987654333233334567899999999999999999999999999999999 9999975431   


Q ss_pred             ccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          313 QNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                         ....           ..+........+...+.++.+||.+||+.||++|||+.++++.|+.+..
T Consensus       300 ---~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          300 ---EELF-----------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             ---HHHH-----------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHH-----------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               1111           1111111122233455789999999999999999999999998877654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-48  Score=369.25  Aligned_cols=252  Identities=24%  Similarity=0.335  Sum_probs=207.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch------hhHHHHHHHHHHhcCCCcceeeEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ------GHREWVAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~  166 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|++......      ....+.+|+.+|++++||||+++++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   81 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGL---------QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE   81 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCC---------EEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCc---------EEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            469999999999999999999987655         9999999765332      3567899999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----CEE
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NAK  242 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~~k  242 (429)
                      ++..++..++||||++|++|.+++... ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.++    .+|
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCCCCCEE
Confidence            999999999999999999999998654 46899999999999999999999  89999999999999998887    799


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....      ......
T Consensus       159 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~  229 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANV  229 (326)
T ss_dssp             ECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHH
T ss_pred             EEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHH
Confidence            999999987543221   23357999999999999899999999999999999999999999754311      111110


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..        .............+..+.+||.+||+.||++|||+.++++.
T Consensus       230 ~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          230 SA--------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HH--------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             Hh--------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00        01111111111234679999999999999999999999984

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.4e-48  Score=360.74  Aligned_cols=259  Identities=27%  Similarity=0.422  Sum_probs=213.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..          +..||+|++..... ...++.+|+.+|.+++||||+++++++..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE   75 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            4679999999999999999997763          33799999976543 346789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++..
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            9999999999999999999877667999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||......      .....       +.
T Consensus       154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~-------~~  219 (268)
T 3sxs_A          154 VLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLK-------VS  219 (268)
T ss_dssp             CCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH-------HH
T ss_pred             cchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHH-------HH
Confidence            544322 22223456778999999999899999999999999999999 99999754311      10000       01


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                      .    ......+...++.+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       220 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          220 Q----GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             T----TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             c----CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            1    1111122234578999999999999999999999999998887643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-48  Score=379.39  Aligned_cols=262  Identities=28%  Similarity=0.490  Sum_probs=203.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|.+.+.||+|+||.||+|++...+.      .+..||||.+..... ...+.+.+|+.+|++++||||+++++++...
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSK------KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTS------CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCC------CceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            579999999999999999998764322      245799999976532 3456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++|+|.+++......+++..++.++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999999999877777999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          252 GPQGDKTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       252 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....   ...              
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~--------------  259 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDV--------------  259 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHH--------------
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHH--------------
Confidence            54322111 1112345788999999999999999999999999999998 9999965431   111              


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ...+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       260 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             HHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            11111112222333456789999999999999999999999998877643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=371.80  Aligned_cols=264  Identities=24%  Similarity=0.396  Sum_probs=209.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..++...+     ..||+|.+.... ......+.+|+.+|++++||||+++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~-----~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-----IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCC-----EEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEE-----EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            3679999999999999999999987765332     257889886543 3445778999999999999999999999987


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +. .++|+||+.+|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            65 78999999999999999887778999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......   ..             
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~-------------  229 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS-------------  229 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH-------------
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH-------------
Confidence            7644333333334567889999999999999999999999999999999 999997654321   11             


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                       ..+........+...+..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus       230 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          230 -SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence             11111112223334557899999999999999999999999998877543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.7e-48  Score=379.46  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=205.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      ++|+++++||+|+||.||+|++..++.         .||+|++.+...   .....+..|..+|.++ +||||+++++++
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~---------~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDR---------IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            579999999999999999999987654         899999975422   2335678999999887 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..++.+||||||++||+|..++.+.. .+++..+..++.||+.||.|||  +.+|+||||||+|||++.+|.+||+|||+
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEEEeecce
Confidence            99999999999999999999987654 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc--cHHHHHHHHHHhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ--NLVAWARQYLADK  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~  326 (429)
                      ++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........  ........     
T Consensus       200 a~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~-----  272 (396)
T 4dc2_A          200 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-----  272 (396)
T ss_dssp             CBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH-----
T ss_pred             eeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH-----
Confidence            98633222  2234478999999999999999999999999999999999999999754322111  11111111     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH------hHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM------DEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~eil~  372 (429)
                          .+....  ..++...+.++.+||.+||+.||.+||++      .++++
T Consensus       273 ----~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          273 ----VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ----HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ----HHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                011111  12233455789999999999999999985      67776

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-47  Score=373.35  Aligned_cols=254  Identities=24%  Similarity=0.338  Sum_probs=207.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||+|++.....  .....+.+|+.+|++++||||+++++++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~   97 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGL---------EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   97 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCC---------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34579999999999999999999987655         999999976543  3346788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CCEEEcc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSD  245 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~D  245 (429)
                      .+++..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||++.+   +.+||+|
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A           98 QEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEee
Confidence            99999999999999999999886554 6899999999999999999999  8999999999999999765   4599999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ..........
T Consensus       175 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~  245 (362)
T 2bdw_A          175 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAG  245 (362)
T ss_dssp             CTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT
T ss_pred             cCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhC
Confidence            999987543321   2346899999999999998999999999999999999999999975421      1111111110


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                              ....+.......+..+.+||.+||+.||++||++.++++.
T Consensus       246 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          246 --------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             --------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    0011111112345789999999999999999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-48  Score=387.13  Aligned_cols=269  Identities=20%  Similarity=0.248  Sum_probs=215.1

Q ss_pred             cHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcc
Q 014202           84 TFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPN  160 (429)
Q Consensus        84 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpn  160 (429)
                      .+.++....++|++.++||+|+||+||+|++..+++         .||+|++.....   .....+.+|+.+|..++|||
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---------~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~  135 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK---------VFAMKILNKWEMLKRAETACFREERDVLVNGDSKW  135 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTT
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCc---------EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCC
Confidence            345556667899999999999999999999987654         899999965321   12234789999999999999


Q ss_pred             eeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       161 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      |+++++++.+++.+||||||++||+|.+++.+....+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.
T Consensus       136 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             BCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSC
T ss_pred             EEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcCCCC
Confidence            999999999999999999999999999999876667999999999999999999999  899999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      +||+|||+++...... .......+||+.|+|||++.     +..++.++|||||||++|||++|..||.....      
T Consensus       214 vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------  286 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------  286 (437)
T ss_dssp             EEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------
T ss_pred             EEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------
Confidence            9999999997654322 22233468999999999987     45789999999999999999999999975432      


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCC--CCCHhHHHH--HhcCC
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKS--RPSMDEVVK--VLTPL  377 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~eil~--~l~~~  377 (429)
                      .+.....+.....   ...+.    .....++++.+||.+||..+|++  ||+++|+++  ++..+
T Consensus       287 ~~~~~~i~~~~~~---~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          287 VETYGKIMNHKER---FQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             HHHHHHHHTHHHH---CCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             hHHHHhhhhcccc---ccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            1111111111100   00010    11224578999999999998888  999999997  44443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-47  Score=360.56  Aligned_cols=254  Identities=31%  Similarity=0.549  Sum_probs=207.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-------hHHHHHHHHHHhcCCCcceeeE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-------HREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||+|++.......       .+.+.+|+.++++++||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL   88 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCC---------EEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hccceehhccccCCceeEEEEEEcCCce---------EEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence            3679999999999999999999987655         89999987653322       1578899999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeEEcCCCC--
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP--VIYRDFKTSNILLDSEYN--  240 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~--  240 (429)
                      ++++.+..  ++||||+++|+|.+++......+++..++.++.|++.||.|||  +.+  |+||||||+|||++.++.  
T Consensus        89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred             heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEEEeccCCCC
Confidence            99986655  7999999999999999887778999999999999999999999  788  999999999999988776  


Q ss_pred             ---EEEccccCcccCCCCCccceeeeccccccccChhhhh--cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          241 ---AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       241 ---~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                         +||+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|+|++|..||........   
T Consensus       165 ~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---  236 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI---  236 (287)
T ss_dssp             SCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH---
T ss_pred             ceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH---
Confidence               99999999985332     233468999999999984  45678899999999999999999999976543211   


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                       ....          ...........+...++.+.+||.+||+.||.+|||+.++++.|+.+
T Consensus       237 -~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          237 -KFIN----------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -HHHH----------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -HHHH----------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence             1000          00111122223344567899999999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-48  Score=367.47  Aligned_cols=276  Identities=25%  Similarity=0.357  Sum_probs=211.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|++....     ..+|..||||++........+.+.+|+.+|++++||||+++++++...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQ-----DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTC-----SSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEeccc-----CCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            357999999999999999999854211     123569999999877666667899999999999999999999998654


Q ss_pred             --CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 --DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                        ...++||||+++|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence              5689999999999999999877667999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH---HHh
Q 014202          250 KAGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY---LAD  325 (429)
Q Consensus       250 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~  325 (429)
                      ......... .......|++.|+|||++.+..++.++||||||+++|+|++|..||......    ........   ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMI  237 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchh
Confidence            875433211 1222346788899999999999999999999999999999999998642110    00000000   000


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ...+...+........+..++.++.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            00111111122223334456688999999999999999999999999887654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.3e-48  Score=369.02  Aligned_cols=265  Identities=20%  Similarity=0.207  Sum_probs=213.5

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++.....  ...+.+|+.+|++| +||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   76 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNE---------YVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC   76 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTE---------EEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCc---------EEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence            4689999999999999999999877654         999999875532  34678999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC-----EEEcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN-----AKLSD  245 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-----~kl~D  245 (429)
                      ++..++||||+ +++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.     +||+|
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~~kl~D  153 (330)
T 2izr_A           77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIID  153 (330)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred             CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCceEEEEE
Confidence            99999999999 99999999876667999999999999999999999  899999999999999998887     99999


Q ss_pred             ccCcccCCCCCccc-----eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          246 FGLAKAGPQGDKTH-----VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       246 Fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|..||..............+ 
T Consensus       154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i-  232 (330)
T 2izr_A          154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI-  232 (330)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH-
T ss_pred             cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH-
Confidence            99998654332211     123468999999999999999999999999999999999999999876433322222111 


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                        .......     +  ........+ ++.+|+..||+.||.+||++++|++.|+.+....
T Consensus       233 --~~~~~~~-----~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          233 --GDTKRAT-----P--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             --HHHHHHS-----C--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             --HhhhccC-----C--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence              1110000     0  000011123 8999999999999999999999999887665443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.1e-47  Score=358.51  Aligned_cols=283  Identities=38%  Similarity=0.639  Sum_probs=227.6

Q ss_pred             ccccccHHHHHhhcCCCCCC------CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC----chhhHHHHH
Q 014202           79 QLLQFTFQELKSATGNFRPD------SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG----LQGHREWVA  148 (429)
Q Consensus        79 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~  148 (429)
                      ....|++.++...+++|...      +.||+|+||.||+|.+.           +..||||++....    ....+.+.+
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~   79 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQ   79 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHH
Confidence            34568888999998888776      89999999999999863           3389999987542    233567889


Q ss_pred             HHHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 014202          149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR--TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYR  226 (429)
Q Consensus       149 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHr  226 (429)
                      |+.+|++++||||+++++++...+..++||||+++++|.+++...  ...+++..++.++.|++.||.|||  +.+|+||
T Consensus        80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~  157 (307)
T 2nru_A           80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHR  157 (307)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECS
T ss_pred             HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecC
Confidence            999999999999999999999999999999999999999998643  346899999999999999999999  8999999


Q ss_pred             CCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 014202          227 DFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDK  306 (429)
Q Consensus       227 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  306 (429)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999999987544333333334679999999998764 588999999999999999999999986


Q ss_pred             CCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          307 KRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .......  ..+..........+...++... .......+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       237 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          237 HREPQLL--LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TBSSSBT--THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             CcchHHH--HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            5443221  1122222222222333344333 2345667789999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-48  Score=361.13  Aligned_cols=255  Identities=26%  Similarity=0.459  Sum_probs=211.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||+|.+..          +..||+|++..... ..+.+.+|+.+|++++||||+++++++.+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             hhceeeheecCCCccEEEEEEecC----------CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            579999999999999999999863          23799999986543 3467899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++...
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence            999999999999999999877777999999999999999999999  899999999999999999999999999999864


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      .... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||......      .....       +..
T Consensus       157 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~-------~~~  222 (269)
T 4hcu_A          157 LDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVED-------IST  222 (269)
T ss_dssp             CCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH-------HHT
T ss_pred             cccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHH-------Hhc
Confidence            3321 112223467888999999999999999999999999999999 99999754321      11110       111


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                          ......+...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          223 ----GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence                1111222334578999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=372.80  Aligned_cols=247  Identities=26%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  177 (429)
                      .+.||+|+||.||+|.+..++.         .||+|++..........+.+|+.+|++++||||+++++++...+..+||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~---------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGL---------KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             EEECC-----CEEEEEETTTCC---------EEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCc---------EEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            5789999999999999887655         9999999877666677899999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--cCCCCEEEccccCcccCCCC
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL--DSEYNAKLSDFGLAKAGPQG  255 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~~~kl~DFg~a~~~~~~  255 (429)
                      |||+++++|.+++......+++..++.++.||+.||.|||  +.+|+||||||+|||+  +.++.+||+|||+++.....
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            9999999999999777667999999999999999999999  8999999999999999  66788999999999876443


Q ss_pred             CccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCC
Q 014202          256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDP  335 (429)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (429)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|..||.+...      ...........        .
T Consensus       243 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~--------~  305 (373)
T 2x4f_A          243 EK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACR--------W  305 (373)
T ss_dssp             CB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC--------C
T ss_pred             cc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcc--------C
Confidence            22   2235799999999999988999999999999999999999999975432      11111111110        0


Q ss_pred             ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          336 RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..........+.++.+||.+||+.||.+|||+.|+++
T Consensus       306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0111111234578999999999999999999999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-48  Score=364.48  Aligned_cols=261  Identities=26%  Similarity=0.389  Sum_probs=202.2

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..++|++.+.||+|+||.||+|.+..++.      .+..||+|.+..... ...+.+.+|+.+|++++||||+++++++ 
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-   85 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence            34679999999999999999999876543      245799999876533 3346788999999999999999999987 


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..|+||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           86 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEEECccccc
Confidence            456789999999999999999877767999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||......   .....          
T Consensus       164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~----------  229 (281)
T 1mp8_A          164 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----------  229 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----------
T ss_pred             cccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH----------
Confidence            87543221 11223467889999999999999999999999999999996 99999764321   11111          


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      +..    ......+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       230 i~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          230 IEN----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             HHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHc----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            000    0111223345678999999999999999999999999887654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-48  Score=366.92  Aligned_cols=245  Identities=27%  Similarity=0.399  Sum_probs=206.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||+|++.....   .....+.+|+.+|+.++||||+++++++.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   76 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGR---------YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   76 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence            569999999999999999999987655         999999975421   23456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +.+..|+||||++||+|.+++.... .+++..+..++.||+.||.|||  +.||+||||||+|||++.+|.+||+|||++
T Consensus        77 ~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a  153 (318)
T 1fot_A           77 DAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFA  153 (318)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEeecCcc
Confidence            9999999999999999999997654 6899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .......       
T Consensus       154 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i-------  215 (318)
T 1fot_A          154 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKI-------  215 (318)
T ss_dssp             EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHH-------
T ss_pred             eecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHH-------
Confidence            874332     2236899999999999999999999999999999999999999975321      1111111       


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                         .....  .++...+.++.+||.+||+.||.+||     +++++++
T Consensus       216 ---~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          216 ---LNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---HHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---HhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               11111  12233457899999999999999999     8999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=381.05  Aligned_cols=266  Identities=26%  Similarity=0.374  Sum_probs=211.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+.....    ..++..||||++.... ......+.+|+.+|++++||||+++++++..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPN----DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCC----CCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3579999999999999999999654211    1235689999997543 3344578899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---CE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY---NA  241 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~  241 (429)
                      +...|+||||++||+|.+++....      ..+++..++.++.||+.||.|||  +.+|+||||||+|||++.++   .+
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCCCCceE
Confidence            999999999999999999997543      35899999999999999999999  89999999999999998555   49


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....   ...     
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~-----  295 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEV-----  295 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH-----
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH-----
Confidence            9999999974322121222233578999999999999999999999999999999998 9999975431   111     


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                               ...+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       296 ---------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          296 ---------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             ---------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                     111111111222334557899999999999999999999999998766543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=374.67  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=207.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|++....   ......+.+|+.+|+.++||||+++++++.
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~---------~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   85 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKK---------MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ   85 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            579999999999999999999987755         99999986542   223467889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +.+..|+||||+.||+|.+++... ..+++..+..++.||+.||.|||  +.||+||||||+|||++.+|.+||+|||++
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DFG~a  162 (384)
T 4fr4_A           86 DEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIA  162 (384)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEEEecccee
Confidence            999999999999999999998654 46999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .......   .....+||+.|+|||++.+   ..++.++|||||||++|||++|..||...............   .   
T Consensus       163 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~---  233 (384)
T 4fr4_A          163 AMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---E---  233 (384)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---H---
T ss_pred             eeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h---
Confidence            8754332   2334689999999999863   45899999999999999999999999765433222221110   0   


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-HhHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-MDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~eil~  372 (429)
                           ..    ...++...+..+.+||.+||+.||.+||+ ++++++
T Consensus       234 -----~~----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          234 -----TT----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----HC----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----hc----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 00    11223345578999999999999999998 777765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.9e-47  Score=358.89  Aligned_cols=265  Identities=17%  Similarity=0.196  Sum_probs=214.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++....  ....+.+|+.++..+ +|+||+++++++.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQ---------QVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTE---------EEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCc---------EEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            45789999999999999999999876644         99999986543  335678999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC-----EEEc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN-----AKLS  244 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-----~kl~  244 (429)
                      .+...++||||+ +++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.     +||+
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~  153 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVV  153 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence            999999999999 99999999877767999999999999999999999  899999999999999987776     9999


Q ss_pred             cccCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          245 DFGLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       245 DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      |||++.........     .......||+.|+|||++.+..++.++|||||||++|||++|..||..............+
T Consensus       154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (298)
T 1csn_A          154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  233 (298)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence            99999865443221     1223467999999999999999999999999999999999999999875543332222211


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ..   .....     +  ........+..+.+|+.+||+.||++||++.+|++.|+.+..
T Consensus       234 ~~---~~~~~-----~--~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          234 GE---KKQST-----P--LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HH---HHHHS-----C--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             Hh---hccCc-----c--HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            11   00000     0  000111234789999999999999999999999998876654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-47  Score=364.74  Aligned_cols=264  Identities=27%  Similarity=0.346  Sum_probs=204.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|++..          |..||+|++......  ....+.+|+.+|++++||||+++++++
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   88 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ----------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI   88 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT----------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC----------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            34689999999999999999998743          348999999755322  246788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+++..++||||+++ +|.+.+......+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  165 (311)
T 3niz_A           89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGL  165 (311)
T ss_dssp             CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEEEccCcC
Confidence            999999999999975 888888777777999999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +.......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......   ...+...+....
T Consensus       166 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~  240 (311)
T 3niz_A          166 ARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPN  240 (311)
T ss_dssp             CEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCC
T ss_pred             ceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCC
Confidence            98754322  12233578999999999876 5689999999999999999999999986544322   111111110000


Q ss_pred             --------hhhh-------hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 --------KLYQ-------IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 --------~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                              .+..       ..............+.++.+||.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                    0000       00000000011223468899999999999999999999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.1e-48  Score=373.02  Aligned_cols=252  Identities=23%  Similarity=0.300  Sum_probs=204.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-----chhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-----LQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||++....     ......+.+|+.+|+.++||||++++++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   94 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQ---------QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET   94 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCC---------EEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            469999999999999999999987655         99999985431     1235678999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC---E
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---A  241 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~  241 (429)
                      +..++..|+||||++|++|.+++...   ...+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.   +
T Consensus        95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A           95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTTCCE
T ss_pred             EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCCCcE
Confidence            99999999999999999999887543   345899999999999999999999  899999999999999976655   9


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||+|||++.......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....    .   .....
T Consensus       173 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~~~~~  243 (351)
T 3c0i_A          173 KLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E---RLFEG  243 (351)
T ss_dssp             EECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H---HHHHH
T ss_pred             EEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H---HHHHH
Confidence            999999998754422  12234689999999999999999999999999999999999999997531    1   11111


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .....      ..  .........+..+.+||.+||+.||++|||+.++++
T Consensus       244 i~~~~------~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          244 IIKGK------YK--MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHTC------CC--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHcCC------CC--CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11100      00  000000123478999999999999999999999997

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.3e-48  Score=370.86  Aligned_cols=265  Identities=26%  Similarity=0.445  Sum_probs=197.4

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ...++|++.+.||+|+||.||+|++..++.      ....||||++...  .....+.+.+|+.+|++++||||++++++
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   93 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV   93 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence            345689999999999999999999876543      1237999999765  33445778999999999999999999999


Q ss_pred             EEeCCeE------EEEEEecCCCChHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          168 CIEDDQR------LLVYEFMTRGSLENHLFRR-----TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       168 ~~~~~~~------~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      +......      ++||||+.+|+|.+++...     ...+++..++.++.|++.||.|||  +.||+||||||+|||++
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NIli~  171 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLA  171 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEC
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceEEEc
Confidence            9887665      9999999999999998543     225899999999999999999999  89999999999999999


Q ss_pred             CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccH
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNL  315 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  315 (429)
                      .++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......   .
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~  248 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I  248 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H
Confidence            999999999999987544433333334567889999999999999999999999999999999 999997644221   1


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ...             +. .......+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       249 ~~~-------------~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          249 YNY-------------LI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHH-------------HH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH-------------Hh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            110             00 011112233455789999999999999999999999998877654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-48  Score=373.66  Aligned_cols=270  Identities=26%  Similarity=0.387  Sum_probs=216.7

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEe
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~  166 (429)
                      +....++|++.+.||+|+||.||+|++.....    ..++..||||++..... .....+.+|+.+|++++||||+++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~  117 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG  117 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCC----CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            34456789999999999999999999874321    11345899999986543 33467899999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRT-----------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPV  223 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i  223 (429)
                      ++..++..|+||||+++|+|.+++....                       ..+++..++.++.||+.||.|||  +.+|
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~i  195 (343)
T 1luf_A          118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKF  195 (343)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            9999999999999999999999997642                       56899999999999999999999  8999


Q ss_pred             eeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCC
Q 014202          224 IYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRR  302 (429)
Q Consensus       224 vHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~  302 (429)
                      +||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999976433222222334578999999999999999999999999999999999 999


Q ss_pred             CCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       303 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                      ||.....      ......          +.+.. ....+..++..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       276 p~~~~~~------~~~~~~----------~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          276 PYYGMAH------EEVIYY----------VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTTTSCH------HHHHHH----------HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             cCCCCCh------HHHHHH----------HhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            9975431      111110          01111 1122334557899999999999999999999999999877653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=362.26  Aligned_cols=268  Identities=22%  Similarity=0.283  Sum_probs=212.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD---------LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCc---------EEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            3679999999999999999999987655         999999975432 334667899999999999999999999987


Q ss_pred             CC--eEEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCCEE
Q 014202          171 DD--QRLLVYEFMTRGSLENHLFRRT--IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL----DSEYNAK  242 (429)
Q Consensus       171 ~~--~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~k  242 (429)
                      ..  ..++||||+++++|.+++....  ..+++..++.++.|++.||.|||  +.+|+||||||+|||+    +.++.+|
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~k  156 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYK  156 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCceEE
Confidence            65  7799999999999999997643  33899999999999999999999  8999999999999999    7788899


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhh--------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM--------TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN  314 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  314 (429)
                      |+|||+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|..||......... 
T Consensus       157 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-  232 (319)
T 4euu_A          157 LTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-  232 (319)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC-
T ss_pred             EccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh-
Confidence            999999987544322   22357999999999986        467899999999999999999999999754432221 


Q ss_pred             HHHHHHHHHHhhh-hh----hhhc--------CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          315 LVAWARQYLADKR-KL----YQIV--------DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       315 ~~~~~~~~~~~~~-~~----~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                       .......+.... ..    ....        ............+..+.+||.+||+.||++|||++|+++...
T Consensus       233 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          233 -KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             -HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             -HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence             111111111110 00    0000        011122345677889999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-48  Score=367.08  Aligned_cols=263  Identities=29%  Similarity=0.423  Sum_probs=214.5

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|.+.+.||+|+||.||+|.+...+.    ...+..||||++..... ...+.+.+|+.+|++++||||+++++++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKG----RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGG----CSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCc----ccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            4679999999999999999999854321    11345899999976532 345678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT-----------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRD  227 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrD  227 (429)
                      ++..++||||+++++|.+++....                       ..+++..++.++.|++.||.|||  +.+|+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~d  175 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRD  175 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HTTEECCC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HCCCcccc
Confidence            999999999999999999997643                       23789999999999999999999  89999999


Q ss_pred             CCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 014202          228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDK  306 (429)
Q Consensus       228 lkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~  306 (429)
                      |||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987644333222333567889999999999999999999999999999999 9999976


Q ss_pred             CCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          307 KRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .....   ...              .+........+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus       256 ~~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          256 IPPER---LFN--------------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CCGGG---HHH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHH---HHH--------------HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            54311   111              1111111222334557899999999999999999999999988755

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.9e-48  Score=373.29  Aligned_cols=251  Identities=27%  Similarity=0.412  Sum_probs=206.1

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLI  165 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~  165 (429)
                      ...++|.+.+.||+|+||.||+|++..+++         .||||++....   ......+..|..+|..+ +||||++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~   84 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQ---------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF   84 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence            345789999999999999999999987654         99999997542   12345677899999876 899999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          166 GYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      +++.+.+..|+||||++||+|.+++.... .+++..+..++.||+.||.|||  +.||+||||||+|||++.+|.+||+|
T Consensus        85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~D  161 (345)
T 1xjd_A           85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIAD  161 (345)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECCCCCEEEeE
Confidence            99999999999999999999999986643 5899999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......... 
T Consensus       162 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~-  232 (345)
T 1xjd_A          162 FGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRM-  232 (345)
T ss_dssp             CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-
T ss_pred             ChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHh-
Confidence            999986433221  23347899999999999999999999999999999999999999975431      111111110 


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHh-HHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD-EVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-eil~  372 (429)
                             ...    .++...+.++.+||.+||+.||.+||++. ++++
T Consensus       233 -------~~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          233 -------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -------CCC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                   011    12233457899999999999999999997 7764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-47  Score=371.12  Aligned_cols=253  Identities=22%  Similarity=0.304  Sum_probs=197.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++..... ....+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKE---------LVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCC---------EEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCc---------EEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            3679999999999999999999987755         999999976532 335688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC--EEEccccCc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN--AKLSDFGLA  249 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~kl~DFg~a  249 (429)
                      +..|+||||+.||+|.+++.... .+++..+..++.|++.||.|||  +.||+||||||+|||++.++.  +||+|||++
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYS  165 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence            99999999999999999986544 5899999999999999999999  899999999999999987765  999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSK-SDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +......   ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||........  ......        
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~--------  232 (361)
T 3uc3_A          166 KSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQ--------  232 (361)
T ss_dssp             ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHH--------
T ss_pred             ccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHH--------
Confidence            7532221   2233679999999999988887655 8999999999999999999976543222  111111        


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                        .+.......+.....+..+.+||.+||+.||.+|||+.|+++
T Consensus       233 --~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          233 --RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             --HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             --HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence              111111222222234578999999999999999999999997

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.4e-47  Score=359.73  Aligned_cols=264  Identities=25%  Similarity=0.303  Sum_probs=204.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||++.....  .....+.+|+.+|++++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCc---------eEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence            579999999999999999999987655         999999976533  234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..++||||+.+ +|.+.+......+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++.
T Consensus        73 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  149 (292)
T 3o0g_A           73 DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            9999999999975 777777666667999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh--h
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK--R  327 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~  327 (429)
                      ......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....  .......+.......  .
T Consensus       150 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~  225 (292)
T 3o0g_A          150 AFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             ECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTT
T ss_pred             ecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChh
Confidence            754322  1223457899999999998765 89999999999999999998888643321  111111111110000  0


Q ss_pred             h---hhhhcC---------CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 K---LYQIVD---------PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~---~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .   .....+         ...........+..+.+||.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0   000000         00001112235578999999999999999999999997

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-48  Score=380.84  Aligned_cols=259  Identities=23%  Similarity=0.279  Sum_probs=209.6

Q ss_pred             HHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCccee
Q 014202           86 QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLV  162 (429)
Q Consensus        86 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv  162 (429)
                      .++....++|++.+.||+|+||.||+|++..++.         .||+|++.....   .....+.+|+.+|..++||||+
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---------~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv  132 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK---------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV  132 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBC
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCc---------EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence            3444556889999999999999999999987655         999999865321   1224578999999999999999


Q ss_pred             eEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          163 KLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ++++++.+++.+||||||++||+|.+++...  .+++..+..++.||+.||.|||  +.+|+||||||+|||++.+|.+|
T Consensus       133 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ik  208 (410)
T 3v8s_A          133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLK  208 (410)
T ss_dssp             CEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEE
T ss_pred             eEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCCCEE
Confidence            9999999999999999999999999998654  4899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAW  318 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  318 (429)
                      |+|||+++...... .......+||+.|+|||++.+..    ++.++|||||||++|||++|..||.....      ...
T Consensus       209 L~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~  281 (410)
T 3v8s_A          209 LADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGT  281 (410)
T ss_dssp             ECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH
T ss_pred             EeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhH
Confidence            99999998754322 12233478999999999998665    78999999999999999999999975432      111


Q ss_pred             HHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCC--CCCHhHHHH
Q 014202          319 ARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKS--RPSMDEVVK  372 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~eil~  372 (429)
                      ....+.....        +..+.....+.++.+||.+||+.+|.+  ||+++||++
T Consensus       282 ~~~i~~~~~~--------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          282 YSKIMNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHTHHHH--------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHhcccc--------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            1111111100        111111234578999999999999988  999999997

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=362.55  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=198.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--------------------------hhHH
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--------------------------GHRE  145 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------------------~~~~  145 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++......                          ..+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNT---------YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ   82 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTE---------EEEEEEEECC-------------------------------CH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCc---------EEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence            3689999999999999999999887654         9999998755321                          1356


Q ss_pred             HHHHHHHHhcCCCcceeeEEeEEEe--CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Q 014202          146 WVAEVDFLGQLHHPNLVKLIGYCIE--DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPV  223 (429)
Q Consensus       146 ~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i  223 (429)
                      +.+|+.+|++++||||+++++++.+  ++..|+||||+++++|.+++.  ...+++..+..++.|++.||.|||  +.+|
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH--~~~i  158 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLH--YQKI  158 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            8899999999999999999999987  568899999999999988653  346899999999999999999999  8999


Q ss_pred             eeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCC---CCCccchhhhHHHHHHHHhC
Q 014202          224 IYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEILTG  300 (429)
Q Consensus       224 vHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g  300 (429)
                      +||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..   ++.++|||||||++|+|++|
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            999999999999999999999999998754322  1233468999999999987655   37789999999999999999


Q ss_pred             CCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       301 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..||.....      ........          ............+..+.+||.+||+.||++|||+.|+++
T Consensus       237 ~~pf~~~~~------~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          237 QCPFMDERI------MCLHSKIK----------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCSSCCSSH------HHHHHHHH----------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCccH------HHHHHHHh----------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            999975321      11111110          011111112234578999999999999999999999976

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-47  Score=370.72  Aligned_cols=245  Identities=24%  Similarity=0.339  Sum_probs=206.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||.||+|++..++.         .||||++.....   .....+.+|+.+|+.++||||+++++++.
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  111 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGN---------HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCC---------EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            579999999999999999999987655         999999865422   23456789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||  +.||+||||||+|||++.+|.+||+|||++
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFg~a  188 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEcccccc
Confidence            9999999999999999999997654 5899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.....      ........      
T Consensus       189 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~------  251 (350)
T 1rdq_E          189 KRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV------  251 (350)
T ss_dssp             EECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH------
T ss_pred             eeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHH------
Confidence            875332     2236899999999999999999999999999999999999999975431      11111111      


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~  372 (429)
                          ...  ..++...+..+.+||.+||+.||.+||+     +.+|++
T Consensus       252 ----~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          252 ----SGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----HCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----cCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                111  1122345578999999999999999998     888876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-48  Score=373.38  Aligned_cols=267  Identities=26%  Similarity=0.420  Sum_probs=214.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+.....    ...+..||||++.... ......+.+|+.+|.++ +||||+++++++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeeecCCCCceeEEeeeecccc----CCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34689999999999999999999753211    1235689999997543 23446789999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTI----------------------PLPWSNRIKIALGAAKGLAFLHGGSEPVIYR  226 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~----------------------~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHr  226 (429)
                      ...+..++||||+++|+|.+++.....                      .+++..++.++.||+.||.|||  +.||+||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~  196 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHR  196 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEET
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCcccC
Confidence            999999999999999999999976542                      3789999999999999999999  8999999


Q ss_pred             CCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCC
Q 014202          227 DFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMD  305 (429)
Q Consensus       227 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~  305 (429)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986544333333344568899999999999999999999999999999998 999997


Q ss_pred             CCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          306 KKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ......  ...              ..+........+...+..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       277 ~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          277 GIPVDA--NFY--------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TCCCSH--HHH--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCCcHH--HHH--------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            654321  111              1111111122233445789999999999999999999999999876654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3e-47  Score=367.51  Aligned_cols=255  Identities=25%  Similarity=0.397  Sum_probs=205.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||+|++.....   .....+.+|+.+|.++ +||||+++++++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   79 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDR---------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF   79 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence            469999999999999999999987654         999999976532   3345678999999988 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+++..|+||||++||+|.+++.+.. .+++..++.++.||+.||.|||  +.+|+||||||+|||++.+|.+||+|||+
T Consensus        80 ~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           80 QTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999999999999986644 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc--cHHHHHHHHHHhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ--NLVAWARQYLADK  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~  326 (429)
                      ++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........  ........     
T Consensus       157 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----  229 (345)
T 3a8x_A          157 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-----  229 (345)
T ss_dssp             CBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-----
T ss_pred             cccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-----
Confidence            98633222  1233468999999999999999999999999999999999999999753221111  00011110     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH------hHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM------DEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~eil~  372 (429)
                          .+....  ...+...+..+.+||.+||+.||.+||++      .++++
T Consensus       230 ----~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          230 ----VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             ----HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             ----HHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                011111  11233455789999999999999999995      67765

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.2e-48  Score=371.08  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=205.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++.....   .....+.+|+.+|+.++||||+++++++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   78 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQ---------KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI   78 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4789999999999999999999987655         999999864321   2235688999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ...+..++||||+ +|+|.+++.... .+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~DFG~  154 (336)
T 3h4j_B           79 TTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGL  154 (336)
T ss_dssp             ECSSEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred             EeCCEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEEEEecc
Confidence            9999999999999 789999886654 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......                
T Consensus       155 s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------  215 (336)
T 3h4j_B          155 SNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------  215 (336)
T ss_dssp             TBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------
T ss_pred             ceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------
Confidence            987544322   233689999999999988776 789999999999999999999997543211                


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       +...+.. .....+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       216 -~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          216 -LFKKVNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -CBCCCCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -HHHHHHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             1111111 111223345678999999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.2e-48  Score=389.01  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=218.3

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ....+|++.+.||+|+||.||+|.+..++.         .||||.+.... ...+++.+|+.+|++++||||+++++++.
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---------~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~  286 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT  286 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTE---------EEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCe---------EEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            344678999999999999999999987644         89999997654 34578899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .++..||||||+++|+|.+++... ...+++..++.++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus       287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeeccc
Confidence            999999999999999999999764 346899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ++...... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....   .+.           
T Consensus       365 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~-----------  429 (495)
T 1opk_A          365 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY-----------  429 (495)
T ss_dssp             EECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH-----------
T ss_pred             ceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHH-----------
Confidence            98754322 112223456789999999999999999999999999999999 99999764321   111           


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                         ..+........+..++..+.+||.+||+.||++|||+.+|++.|+.+....
T Consensus       430 ---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          430 ---ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             ---HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence               111112223334456688999999999999999999999999999886544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-48  Score=380.43  Aligned_cols=263  Identities=20%  Similarity=0.221  Sum_probs=210.6

Q ss_pred             cHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcc
Q 014202           84 TFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPN  160 (429)
Q Consensus        84 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpn  160 (429)
                      .+.+.....++|++.+.||+|+||.||+|++..+++         .||||++.+...   .....+.+|..+|..++|||
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~---------~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~  122 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ---------VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW  122 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTT
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCC
Confidence            344555667899999999999999999999987655         999999975322   22345789999999999999


Q ss_pred             eeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       161 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      |+++++++.+++.+||||||++||+|.+++.+.+..+++..+..++.||+.||.|||  +.+|+||||||+|||++.+|.
T Consensus       123 Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSC
T ss_pred             eeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecCCCC
Confidence            999999999999999999999999999999876667999999999999999999999  899999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhh-------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-------TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ  313 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  313 (429)
                      +||+|||+++....... ......+||+.|+|||++.       +..++.++|||||||++|||++|..||.....    
T Consensus       201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----  275 (412)
T 2vd5_A          201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----  275 (412)
T ss_dssp             EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----
T ss_pred             EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----
Confidence            99999999987543222 1223468999999999987       35689999999999999999999999975432    


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCC---CCHhHHHH
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR---PSMDEVVK  372 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~eil~  372 (429)
                        .+.....+.....   ...+.    .....+.++.+||.+||. +|.+|   |+++|+++
T Consensus       276 --~~~~~~i~~~~~~---~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          276 --AETYGKIVHYKEH---LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             --HHHHHHHHTHHHH---CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             --HHHHHHHHhcccC---cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence              1111111111000   00011    112345789999999998 99998   69999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.8e-48  Score=363.39  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=207.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..          +..||+|++..... ...++.+|+.+|.+++||||+++++++.++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcC----------CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            4579999999999999999998763          33799999986543 346789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++..
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            9999999999999999999775667999999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||......      ....       .+.
T Consensus       170 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~-------~~~  235 (283)
T 3gen_A          170 VLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAE-------HIA  235 (283)
T ss_dssp             BCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHH-------HHH
T ss_pred             ccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHH-------HHh
Confidence            43321 111222457788999999999999999999999999999998 99999754321      1000       111


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..    .....+...++.+.+|+.+||+.||.+|||+.++++.|..+.
T Consensus       236 ~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          236 QG----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             TT----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cc----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            11    111222334578999999999999999999999999887654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.9e-47  Score=357.84  Aligned_cols=261  Identities=27%  Similarity=0.471  Sum_probs=198.3

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..            .||+|++.....  ...+.+.+|+.+|++++||||++++++.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS   89 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence            35789999999999999999998643            699999976533  3346789999999999999999999964


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                       .....++||||+.+++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus        90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             -CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             -cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCCEEEcccee
Confidence             566789999999999999999777778999999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      +................||+.|+|||++.   +..++.++||||||+++|+|++|..||.......  ....    ....
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~  240 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MVGR  240 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HHHH
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----Hhcc
Confidence            98654333333334467999999999986   5678889999999999999999999997543211  1111    0100


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                           ....+. .......++..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       241 -----~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          241 -----GSLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             -----TSCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----cccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                 001111 11122345578999999999999999999999999987664

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-47  Score=370.27  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=206.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcC-CCcceeeEEeE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQL-HHPNLVKLIGY  167 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~  167 (429)
                      .++|++++.||+|+||.||+|++..++.         .||||++.....   .....+..|..+|..+ +||||++++++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   89 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDE---------LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC   89 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEE---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence            4689999999999999999999987644         899999975421   2345678999999988 79999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +...+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||  +.||+||||||+|||++.+|.+||+|||
T Consensus        90 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           90 FQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            999999999999999999999997654 5899999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .......+    
T Consensus       167 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~----  234 (353)
T 2i0e_A          167 MCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM----  234 (353)
T ss_dssp             TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH----
T ss_pred             cccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHH----
Confidence            998643222  123346899999999999999999999999999999999999999975421      11111111    


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~  372 (429)
                            ...  ..++...+.++.+||.+||+.||.+||+     +.++++
T Consensus       235 ------~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          235 ------EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ------HCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ------hCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  111  1123345578999999999999999995     577775

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.9e-48  Score=367.11  Aligned_cols=266  Identities=27%  Similarity=0.406  Sum_probs=215.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+....    ...++..||||++..... .....+.+|+.+|+++ +||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLI----KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeecc----ccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            3467999999999999999999864321    112356899999986643 3456788999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTI-----------------PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTS  231 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~-----------------~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~  231 (429)
                      ..++..++||||+++|+|.+++.....                 .+++..++.++.|++.||.|||  +.+|+||||||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~  174 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAAR  174 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGG
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccc
Confidence            999999999999999999999976542                 4899999999999999999999  899999999999


Q ss_pred             CeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCC
Q 014202          232 NILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPS  310 (429)
Q Consensus       232 Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  310 (429)
                      |||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987655443333344568889999999999999999999999999999999 99999765422


Q ss_pred             ccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          311 GEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .  ....    ...      ..    .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       255 ~--~~~~----~~~------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          255 S--KFYK----MIK------EG----FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             H--HHHH----HHH------HT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             h--HHHH----Hhc------cC----CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            1  1111    000      11    111122334578999999999999999999999999886543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.7e-47  Score=368.44  Aligned_cols=274  Identities=26%  Similarity=0.345  Sum_probs=213.0

Q ss_pred             cccccccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC
Q 014202           78 CQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH  157 (429)
Q Consensus        78 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  157 (429)
                      .....+++.+.....++|++.+.||+|+||.||+|++..++.         .||||++... ......+..|+.+|+.+.
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~-~~~~~~~~~e~~~l~~l~   89 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNI-KKYTRSAKIEADILKKIQ   89 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECSC-HHHHHHHHHHHHHHHHTC
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCe---------EEEEEEeccc-hhhhhhhHHHHHHHHHhc
Confidence            344556667777778999999999999999999999987654         9999999743 233456778999999986


Q ss_pred             -----CcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 014202          158 -----HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTS  231 (429)
Q Consensus       158 -----hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~  231 (429)
                           ||||+++++++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||  +.+|+||||||+
T Consensus        90 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~  166 (360)
T 3llt_A           90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPE  166 (360)
T ss_dssp             CCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGG
T ss_pred             ccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCcc
Confidence                 999999999999999999999999 999999997654 35899999999999999999999  899999999999


Q ss_pred             CeEEcC-------------------------CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccc
Q 014202          232 NILLDS-------------------------EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSD  286 (429)
Q Consensus       232 Nill~~-------------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  286 (429)
                      |||++.                         ++.+||+|||++.......     ....||+.|+|||++.+..++.++|
T Consensus       167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~D  241 (360)
T 3llt_A          167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSD  241 (360)
T ss_dssp             GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred             cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccc
Confidence            999975                         7889999999998643322     2367999999999999999999999


Q ss_pred             hhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh--hhhh--------hhcC-CccccCCC-------------
Q 014202          287 VYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK--RKLY--------QIVD-PRLELNYS-------------  342 (429)
Q Consensus       287 iwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~-~~~~~~~~-------------  342 (429)
                      ||||||++|+|++|..||......   .....+.......  ..+.        ...+ .......+             
T Consensus       242 iwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  318 (360)
T 3llt_A          242 MWSFGCVLAELYTGSLLFRTHEHM---EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK  318 (360)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHCCCCCCCCcHH---HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhh
Confidence            999999999999999999764321   1111111100000  0000        0000 00000000             


Q ss_pred             -------HHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          343 -------LKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       343 -------~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             ....+.+.+||.+||+.||.+|||+.|+++
T Consensus       319 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             TCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                   001256889999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5e-47  Score=356.87  Aligned_cols=263  Identities=23%  Similarity=0.322  Sum_probs=201.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+ .+         |..||+|++......  ....+.+|+.+|++++||||+++++++..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~---------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NY---------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TT---------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CC---------CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            5799999999999999999987 33         348999999765432  23668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..++||||+.+ +|.+++......+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++.
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (288)
T 1ob3_A           72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR  148 (288)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred             CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence            9999999999975 999998777677999999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh-h-
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK-R-  327 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-  327 (429)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......   .....+....... . 
T Consensus       149 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~  223 (288)
T 1ob3_A          149 AFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSK  223 (288)
T ss_dssp             HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred             ccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChh
Confidence            643221  122335789999999998764 5899999999999999999999999754321   1111111100000 0 


Q ss_pred             ---hhh--hhcCCccc-------cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 ---KLY--QIVDPRLE-------LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 ---~~~--~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         ...  ...++...       .......+..+.+||.+||+.||++|||+.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               000  00000000       01112345789999999999999999999999873

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-47  Score=363.20  Aligned_cols=263  Identities=23%  Similarity=0.333  Sum_probs=198.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-hHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||++....... ...+.+|+.+|++++||||+++++++..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDN---------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   72 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCc---------EEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence            579999999999999999999987655         99999997553222 22456799999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+. |+|.+++......+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++..
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  149 (324)
T 3mtl_A           73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARA  149 (324)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred             CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccCccccc
Confidence            99999999997 5999999887777999999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh--hh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK--RK  328 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~  328 (429)
                      .....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....   .....+...+...  ..
T Consensus       150 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~  224 (324)
T 3mtl_A          150 KSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEET  224 (324)
T ss_dssp             C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTT
T ss_pred             ccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHh
Confidence            43221  22233578999999999876 56899999999999999999999999764321   1111111111000  00


Q ss_pred             hh---------hhcCCccc----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LY---------QIVDPRLE----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~---------~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..         ....+...    .......+..+.+||.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00         00000000    0011223577899999999999999999999997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.4e-48  Score=366.93  Aligned_cols=277  Identities=27%  Similarity=0.387  Sum_probs=220.7

Q ss_pred             cccccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-C
Q 014202           80 LLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-H  157 (429)
Q Consensus        80 ~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~  157 (429)
                      ...+....+....++|++.+.||+|+||.||+|.+.....    ..+++.||||++..... .....+.+|+.+|.++ +
T Consensus        14 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~   89 (316)
T 2xir_A           14 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH   89 (316)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC
T ss_pred             hccccccceecchhheeeeeEEcCCCceeEEEEEEecCCc----cccceEEEEEecccCCCcHHHHHHHHHHHHHHhccc
Confidence            3345556666677899999999999999999998754211    22456999999986543 3346788999999999 6


Q ss_pred             CcceeeEEeEEEeCC-eEEEEEEecCCCChHHHHhcCCCC---------------CCHHHHHHHHHHHHHHHHHHhCCCC
Q 014202          158 HPNLVKLIGYCIEDD-QRLLVYEFMTRGSLENHLFRRTIP---------------LPWSNRIKIALGAAKGLAFLHGGSE  221 (429)
Q Consensus       158 hpnIv~~~~~~~~~~-~~~lv~e~~~gg~L~~~l~~~~~~---------------~~~~~~~~~~~qi~~~l~~lH~~~~  221 (429)
                      ||||+++++++...+ ..++||||+++|+|.+++......               +++..++.++.|++.||.|||  +.
T Consensus        90 hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~  167 (316)
T 2xir_A           90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SR  167 (316)
T ss_dssp             CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hC
Confidence            999999999988765 489999999999999999765432               789999999999999999999  89


Q ss_pred             CeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-C
Q 014202          222 PVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-G  300 (429)
Q Consensus       222 ~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g  300 (429)
                      +|+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus       168 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g  247 (316)
T 2xir_A          168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG  247 (316)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999987654433333344678999999999999999999999999999999998 9


Q ss_pred             CCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       301 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..||.......  ....    .+.      ...    ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       248 ~~p~~~~~~~~--~~~~----~~~------~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          248 ASPYPGVKIDE--EFCR----RLK------EGT----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSSTTCCCSH--HHHH----HHH------HTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcccchhH--HHHH----Hhc------cCc----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            99997644221  1111    011      000    11122234578999999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=367.91  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=192.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..++|++.+.||+|+||.||+|++..++.         .||||++....  ..+.+.+|+.+|++++||||+++++++..
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~  119 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQK---------PYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET  119 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCc---------EEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence            45689999999999999999999987654         89999997553  34567899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCCEEEcccc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAKLSDFG  247 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~DFg  247 (429)
                      .+..++||||++||+|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||++.   ++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            999999999999999999986554 5899999999999999999999  899999999999999975   8899999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|||++|..||.......  ..   .......  
T Consensus       197 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~---~~~i~~~--  266 (349)
T 2w4o_A          197 LSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM---FRRILNC--  266 (349)
T ss_dssp             -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH---HHHHHTT--
T ss_pred             cccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH---HHHHHhC--
Confidence            998653321   2234679999999999999999999999999999999999999997543210  00   1111000  


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                            ............+..+.+||.+||+.||++|||+.++++.
T Consensus       267 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          267 ------EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0011111223455789999999999999999999999983

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-47  Score=361.07  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=217.0

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ...++|++.+.||+|+||.||+|.+..++.         .||+|.+.... ...+.+.+|+.+|++++||||+++++++.
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   79 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT   79 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTE---------EEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCE---------EEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            345679999999999999999999987654         89999997653 34577889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .++..++||||++|++|.+++... ...+++..++.++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||+
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence            999999999999999999999764 345899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.......   ...          
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----------  223 (288)
T 3kfa_A          158 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----------  223 (288)
T ss_dssp             GGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----------
T ss_pred             ceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----------
Confidence            98754332 222333567889999999999999999999999999999999 999997643211   111          


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                          .+........+...+..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus       224 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          224 ----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                111111222334455789999999999999999999999999876654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.3e-47  Score=363.32  Aligned_cols=267  Identities=27%  Similarity=0.451  Sum_probs=202.7

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeE
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      ++....++|.+.+.||+|+||.||+|.+...+.      ++..||+|.+.....  .....+.+|+.+|++++||||+++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~  101 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG------TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL  101 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS------CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCC------ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence            334455789999999999999999998875432      355899999976532  334678899999999999999999


Q ss_pred             EeEEEeCCe-----EEEEEEecCCCChHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          165 IGYCIEDDQ-----RLLVYEFMTRGSLENHLFR-----RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       165 ~~~~~~~~~-----~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      ++++...+.     .++||||+++|+|.+++..     ....+++..++.++.|++.||.|||  +.+|+||||||+|||
T Consensus       102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIl  179 (313)
T 3brb_A          102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCM  179 (313)
T ss_dssp             CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEE
T ss_pred             eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEE
Confidence            999887653     4999999999999999843     2356899999999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......   
T Consensus       180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---  256 (313)
T 3brb_A          180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---  256 (313)
T ss_dssp             ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred             EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---
Confidence            99999999999999987544332223334567889999999999999999999999999999999 89999764321   


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .....          +..    ......+...+..+.+||.+||..||.+|||+.++++.|+.+.
T Consensus       257 ~~~~~----------~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          257 EMYDY----------LLH----GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             GHHHH----------HHT----TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHH----------HHc----CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11110          000    0111222344578999999999999999999999999887654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.7e-47  Score=361.09  Aligned_cols=264  Identities=25%  Similarity=0.366  Sum_probs=191.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++++.||+|+||.||+|.+..++.         .||+|++..... .....+.+|+.+|++++||||+++++++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   74 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGV---------YVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT   74 (317)
T ss_dssp             ---------------CEEEEEECSSSCC---------EEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCc---------EEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence            3579999999999999999999877654         999999976532 234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT-----IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      ++..|+||||++ |+|.+++....     ..+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECc
Confidence            999999999997 59999886532     35899999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      ||++........  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....   .....+...+.
T Consensus       152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~  226 (317)
T 2pmi_A          152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMG  226 (317)
T ss_dssp             CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred             CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Confidence            999987533211  1233578999999999976 46899999999999999999999999764321   11111111110


Q ss_pred             hh-hhhhhh------cCCcc------------ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 DK-RKLYQI------VDPRL------------ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ~~-~~~~~~------~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .. ......      ..+..            ........+..+.+||.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00 000000      00000            00011123468999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.3e-47  Score=353.81  Aligned_cols=251  Identities=31%  Similarity=0.522  Sum_probs=196.5

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch----hhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ----GHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .++|++.+.||+|+||.||+|.+.           |..||||++......    ..+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV   74 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            367999999999999999999874           338999998765322    24678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC---eeeCCCCCCCeEEcC-------
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP---VIYRDFKTSNILLDS-------  237 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~---ivHrDlkp~Nill~~-------  237 (429)
                      +..++..++||||++|++|.+++..  ..+++..++.++.|++.||.|||  +.+   |+||||||+|||++.       
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~~~~i~H~dikp~Nil~~~~~~~~~~  150 (271)
T 3dtc_A           75 CLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLH--DEAIVPIIHRDLKSSNILILQKVENGDL  150 (271)
T ss_dssp             ECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH--HSSSSCCCCSCCSGGGEEESSCCSSSCC
T ss_pred             EecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCchHHEEEecccccccc
Confidence            9999999999999999999998853  36899999999999999999999  777   999999999999986       


Q ss_pred             -CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH
Q 014202          238 -EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       238 -~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  316 (429)
                       ++.+||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||......      
T Consensus       151 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------  220 (271)
T 3dtc_A          151 SNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------  220 (271)
T ss_dssp             SSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------
T ss_pred             cCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence             6789999999998643322    22357999999999999999999999999999999999999999754311      


Q ss_pred             HHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .          ..............+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       221 ~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          221 A----------VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             H----------HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             H----------HHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            0          01111112222233445567899999999999999999999999998753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-47  Score=366.29  Aligned_cols=271  Identities=25%  Similarity=0.387  Sum_probs=215.1

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEE
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLI  165 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~  165 (429)
                      ++....++|++.+.||+|+||.||+|.+.....    ..++..||||.+..... .....+.+|+.+|+.++||||++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVK----DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEET----TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccC----CCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344556789999999999999999998763110    01245899999976533 3345688999999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          166 GYCIEDDQRLLVYEFMTRGSLENHLFRRT---------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      +++...+..++||||+++|+|.+++....         ..+++..++.++.|++.||.|||  +.||+||||||+|||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEEC
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEEEc
Confidence            99999999999999999999999986531         45789999999999999999999  89999999999999999


Q ss_pred             CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccH
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNL  315 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  315 (429)
                      .++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....      
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  246 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------  246 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------
Confidence            999999999999986433222222223467899999999999999999999999999999999 8999975421      


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                      ...... .         .... ....+...+..+.+||.+||+.||.+|||+.++++.|+.....
T Consensus       247 ~~~~~~-~---------~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          247 EQVLRF-V---------MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHHHHH-H---------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHHH-H---------HcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            111110 0         0100 1112234557899999999999999999999999999877553

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.2e-47  Score=365.87  Aligned_cols=267  Identities=26%  Similarity=0.412  Sum_probs=214.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|.+...+.  .....+..||||++..... .....+.+|+.+|+++ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            3679999999999999999999864332  1223466899999976543 3456788999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      .++..|+||||+++|+|.+++....               ..+++..++.++.||+.||.|||  +.+|+||||||+|||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCccceEE
Confidence            9999999999999999999997653               23889999999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....    
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----  265 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  265 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence            99999999999999987554332222333567889999999999899999999999999999999 9999975431    


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                        .+....       +....    ....+..++..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       266 --~~~~~~-------~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          266 --EELFKL-------LKEGH----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             --HHHHHH-------HHHTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHH-------HhcCC----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              111110       01111    112223445789999999999999999999999998877643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.2e-47  Score=363.40  Aligned_cols=251  Identities=28%  Similarity=0.381  Sum_probs=197.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ++|++.+.||+|+||.||+|++.....      +|..||+|++.....    .....+.+|+.+|+.++||||+++++++
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGAN------TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTT------TTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCC------CCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            579999999999999999999863211      356999999976532    2335578899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..++..|+||||++|++|.+++.... .+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            99999999999999999999986554 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .........    
T Consensus       168 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~----  235 (327)
T 3a62_A          168 CKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILK----  235 (327)
T ss_dssp             C------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH----
T ss_pred             ccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh----
Confidence            97543221  122346899999999999999999999999999999999999999975431      111111111    


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                            ..  ...+...+..+.+||.+||+.||.+||     ++.++++
T Consensus       236 ------~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          236 ------CK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ------TC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ------CC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                  11  112233457899999999999999999     7889887

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-46  Score=358.72  Aligned_cols=268  Identities=26%  Similarity=0.285  Sum_probs=201.9

Q ss_pred             cCCCCCC-CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPD-SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++. +.||+|+||.||+|++..++.         .||||++..........+.+|+.+|.++ +||||+++++++.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~   81 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQ---------EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE   81 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCC---------EEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCc---------EEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            3578885 789999999999999877654         9999999876555567889999999985 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC---EEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl~DF  246 (429)
                      +++..|+||||++||+|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.   +||+||
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           82 EEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            9999999999999999999997653 5899999999999999999999  899999999999999988776   999999


Q ss_pred             cCcccCCCCCc-----cceeeeccccccccChhhhhc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH
Q 014202          247 GLAKAGPQGDK-----THVSTRVVGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       247 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  316 (429)
                      |++........     .......+||+.|+|||++.+     ..++.++|||||||++|+|++|..||............
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            99976432211     111223569999999999875     56889999999999999999999999865433211100


Q ss_pred             HHHHHHHHhhhhh-hhhcCCccccC--CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          317 AWARQYLADKRKL-YQIVDPRLELN--YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ....  ......+ ..+........  .....+..+.+||.+||+.||.+|||+.|+++.
T Consensus       239 ~~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          239 GEAC--PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             --CC--HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccc--hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000  0000000 00001111100  001234789999999999999999999999983

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-47  Score=371.07  Aligned_cols=268  Identities=19%  Similarity=0.261  Sum_probs=205.1

Q ss_pred             cCCCCCCCccccc--CceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           92 TGNFRPDSILGEG--GFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        92 ~~~y~~~~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .++|++.+.||+|  +||.||+|++..++.         .||||++....  ......+.+|+.+|++++|||||+++++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGE---------YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCC---------EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCC---------EEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            3579999999999  999999999987655         99999997553  2334667889999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      +..++..|+||||+++|+|.+++... ...+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCG
T ss_pred             EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEccc
Confidence            99999999999999999999998765 346899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCcc-----ceeeeccccccccChhhhhc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          247 GLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       247 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      |++.........     .......||+.|+|||++.+  ..++.++|||||||++|||++|..||.........  ....
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~  250 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL  250 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHh
Confidence            998653221110     11122478999999999987  57899999999999999999999999764432211  0000


Q ss_pred             HHHHH---h-----h-------------hhhhhhc---------CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhH
Q 014202          320 RQYLA---D-----K-------------RKLYQIV---------DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE  369 (429)
Q Consensus       320 ~~~~~---~-----~-------------~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  369 (429)
                      .....   .     .             ..+....         ............+..+.+||.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            00000   0     0             0000000         000001122334578999999999999999999999


Q ss_pred             HHH
Q 014202          370 VVK  372 (429)
Q Consensus       370 il~  372 (429)
                      +++
T Consensus       331 ll~  333 (389)
T 3gni_B          331 LLN  333 (389)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.7e-47  Score=379.25  Aligned_cols=274  Identities=20%  Similarity=0.301  Sum_probs=191.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++++.||+|+||.||+|++..++.         .||||++....  ....+.+.+|+.+|++++||||+++++++.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  122 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKR---------VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI  122 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--C---------EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCc---------EEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            3689999999999999999999987655         99999996542  234567889999999999999999999985


Q ss_pred             eC-----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          170 ED-----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       170 ~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ..     ..+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||  +.+|+||||||+||||+.++.+||+
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             CSCTTTCCCEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCcccCceEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCCCEeec
Confidence            43     5689999998 57999988654 46999999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCcc-------------------------ceeeeccccccccChhhh-hcCCCCCccchhhhHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKT-------------------------HVSTRVVGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEIL  298 (429)
Q Consensus       245 DFg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell  298 (429)
                      |||+++........                         ......+||+.|+|||++ .+..|+.++|||||||++|||+
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            99999875422110                         123346899999999986 4667999999999999999999


Q ss_pred             h-----------CCCCCCCCCCCcc-----------------ccHHHHHHHHHHhh-------------hhhhhhcCCcc
Q 014202          299 T-----------GRRSMDKKRPSGE-----------------QNLVAWARQYLADK-------------RKLYQIVDPRL  337 (429)
Q Consensus       299 ~-----------g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~-------------~~~~~~~~~~~  337 (429)
                      +           |.++|.+......                 .+....+...+...             ......+....
T Consensus       279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  358 (458)
T 3rp9_A          279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE  358 (458)
T ss_dssp             TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred             HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence            9           6666655432100                 00000000000000             00000000000


Q ss_pred             c---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCc
Q 014202          338 E---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQ  378 (429)
Q Consensus       338 ~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~  378 (429)
                      .   .......+.++.+||.+||..||++|||++|+++  ++..+.
T Consensus       359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            0   0111233578999999999999999999999998  555543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.8e-47  Score=361.74  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=197.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||++..... ...+.+.+|+.+|++++||||+++++++.+.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   76 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDC---------NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET   76 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCC---------EEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCc---------EEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence            569999999999999999999987655         999999975433 3456789999999999999999999998665


Q ss_pred             C---------------------------------------------------------eEEEEEEecCCCChHHHHhcCC
Q 014202          172 D---------------------------------------------------------QRLLVYEFMTRGSLENHLFRRT  194 (429)
Q Consensus       172 ~---------------------------------------------------------~~~lv~e~~~gg~L~~~l~~~~  194 (429)
                      .                                                         ..++||||++|++|.+++....
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  156 (332)
T 3qd2_B           77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC  156 (332)
T ss_dssp             CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred             ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence            4                                                         3799999999999999997653


Q ss_pred             C--CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCcc----------ceee
Q 014202          195 I--PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT----------HVST  262 (429)
Q Consensus       195 ~--~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~----------~~~~  262 (429)
                      .  ..++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.........          ....
T Consensus       157 ~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T 3qd2_B          157 SLEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT  234 (332)
T ss_dssp             SGGGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred             CccchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence            2  3456678999999999999999  899999999999999999999999999999876543211          1123


Q ss_pred             eccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCC
Q 014202          263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYS  342 (429)
Q Consensus       263 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..|+..        ....          .........+ ...
T Consensus       235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~----------~~~~~~~~~~-~~~  295 (332)
T 3qd2_B          235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRI----------ITDVRNLKFP-LLF  295 (332)
T ss_dssp             SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHH----------HHHHHTTCCC-HHH
T ss_pred             ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHH----------HHHhhccCCC-ccc
Confidence            35799999999999999999999999999999999998665421        0000          0011111111 111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          343 LKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       343 ~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ...++.+.+||.+||+.||.+|||+.|+++.
T Consensus       296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          296 TQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            2344678999999999999999999999973

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.5e-47  Score=371.99  Aligned_cols=251  Identities=22%  Similarity=0.264  Sum_probs=195.2

Q ss_pred             CCCCCC-CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHh-cCCCcceeeEEeEEEe
Q 014202           93 GNFRPD-SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLG-QLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~  170 (429)
                      ++|.+. ++||+|+||+||+|++..++.         .||||++...     ..+.+|+.++. .++||||+++++++..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~---------~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQE---------KFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCC---------EEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            467766 789999999999999987755         9999998632     45678888874 4579999999999876


Q ss_pred             ----CCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCCEE
Q 014202          171 ----DDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAK  242 (429)
Q Consensus       171 ----~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~k  242 (429)
                          ...+||||||++||+|.+++.... ..+++..+..++.||+.||.|||  +.+|+||||||+|||++.   ++.+|
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCCccEE
Confidence                567899999999999999997653 46899999999999999999999  899999999999999987   78899


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc-cHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ-NLVAWARQ  321 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~  321 (429)
                      |+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|||++|..||......... .....+  
T Consensus       205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i--  279 (400)
T 1nxk_A          205 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--  279 (400)
T ss_dssp             ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH--
T ss_pred             EEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH--
Confidence            99999998654322   223468999999999999999999999999999999999999999765443211 111100  


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       ..        .............+.++.+||.+||+.||++|||+.++++.
T Consensus       280 -~~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          280 -RM--------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -HH--------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -Hc--------CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             00        00111111112345789999999999999999999999983

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.1e-47  Score=352.36  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=205.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|++.           |..||||++.....  ...+.+.+|+.+|++++||||+++++++..
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS   78 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence            57999999999999999999984           33899999986542  334678999999999999999999999988


Q ss_pred             C--CeEEEEEEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeEEcCCCCEEEcc
Q 014202          171 D--DQRLLVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEP--VIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       171 ~--~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      .  ...++||||+++|+|.+++..... .+++..++.++.|++.||.|||  +.+  |+||||||+|||++.++.++|+|
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             TTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             CCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCcceeEEe
Confidence            7  788999999999999999976543 5899999999999999999999  778  99999999999999999999999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCC---ccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTS---KSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      ||++......       ...||+.|+|||++.+..++.   ++|||||||++|||++|..||.....      .....  
T Consensus       157 ~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~--  221 (271)
T 3kmu_A          157 ADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGM--  221 (271)
T ss_dssp             GGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHH--
T ss_pred             ccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHH--
Confidence            9887653221       247899999999998765554   79999999999999999999975431      11101  


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                              ...........+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       222 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          222 --------KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --------HHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                    1111111222333456789999999999999999999999999876643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-47  Score=355.96  Aligned_cols=260  Identities=27%  Similarity=0.406  Sum_probs=210.6

Q ss_pred             CCCCCCC-cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDS-ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|.+.+ .||+|+||.||+|.+...+.       +..||||++..... ...+.+.+|+.+|++++||||+++++++ .
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~   80 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q   80 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---C-------CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCC-------cceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence            4677776 99999999999998764432       55899999987533 3456789999999999999999999999 5


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      .+..++||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEECccccee
Confidence            56789999999999999999777777999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          251 AGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||......   .....    +     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i-----  226 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----I-----  226 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----H-----
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----H-----
Confidence            76433221 11222457899999999998899999999999999999998 99999764321   11110    0     


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                       ..    ......+...+..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus       227 -~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          227 -EQ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             -HT----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hc----CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             00    11112333456889999999999999999999999999877654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-47  Score=362.79  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=197.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++......   ....+.+|+.++.+++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHR---------DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCc---------eEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            4689999999999999999999877654         9999999765332   235688999999999999999999998


Q ss_pred             EeCCe----EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          169 IEDDQ----RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       169 ~~~~~----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      .....    .|+||||++|++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTSCEEEC
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCCCEEEe
Confidence            76653    499999999999999986554 6899999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......      .......
T Consensus       159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~  232 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHV  232 (311)
T ss_dssp             CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH
T ss_pred             eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHh
Confidence            99999865432211 2223367999999999999999999999999999999999999999754321      1111111


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..        ............+.++.+||.+||+.||.+||+..+++.
T Consensus       233 ~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          233 RE--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HC--------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             cC--------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            10        000011111224578999999999999999998777665

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-47  Score=361.31  Aligned_cols=263  Identities=25%  Similarity=0.345  Sum_probs=209.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|.+.+.||+|+||.||+|.+..++.....  .+..||+|++........+.+.+|+.+|++++||||+++++++..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQL--HETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCE--EEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccc--cchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            35799999999999999999998876531110  1247999999776656667899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC--------EEE
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN--------AKL  243 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--------~kl  243 (429)
                      +..++||||++||+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.        +||
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999999877666999999999999999999999  899999999999999988887        999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      +|||++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.....     ..... ..
T Consensus       163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~-~~  230 (289)
T 4fvq_A          163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRKL-QF  230 (289)
T ss_dssp             CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHH-HH
T ss_pred             ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHHH-HH
Confidence            999999764221      22568999999999987 6789999999999999999996554432211     10000 00


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCccc
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLND  382 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~~  382 (429)
                      ...        ....    +...+..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus       231 ~~~--------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          231 YED--------RHQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HHT--------TCCC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             hhc--------cCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            000        0111    11223568899999999999999999999999998876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.8e-47  Score=359.20  Aligned_cols=266  Identities=26%  Similarity=0.385  Sum_probs=203.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||++....   ......+.+|+.+|++++||||+++++++.
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  102 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGV---------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI  102 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCC---------EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCc---------eEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            579999999999999999999877654         99999997542   234567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      .++..++||||+++++|.+++..   ....+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+||
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCCEEEEec
Confidence            99999999999999999998864   3556899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |++.......  .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+...    +.......     
T Consensus       181 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-----  249 (310)
T 2wqm_A          181 GLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-----  249 (310)
T ss_dssp             --------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHH-----
T ss_pred             cceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHH-----
Confidence            9998653322  122335799999999999999999999999999999999999999975432    11111111     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCccchhh
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLAI  385 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~~~~~  385 (429)
                        +..   ...........+..+.+||.+||..||.+|||+.++++.|+.+......++
T Consensus       250 --~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          250 --IEQ---CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             --HHT---TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             --hhc---ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence              101   111111112345789999999999999999999999999988876655443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.2e-47  Score=367.40  Aligned_cols=277  Identities=16%  Similarity=0.207  Sum_probs=211.7

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhh-----------HHHHHHHHHHhcCCCc
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-----------REWVAEVDFLGQLHHP  159 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hp  159 (429)
                      ..++|++.+.||+|+||.||+|.+..++..    ..+..||||++........           ..+..|+..+..++||
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~  108 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESV----GSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL  108 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCC----CTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCcccc----ccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence            346899999999999999999998765421    1245899999876642211           2245677788889999


Q ss_pred             ceeeEEeEEEeC----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          160 NLVKLIGYCIED----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       160 nIv~~~~~~~~~----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      ||+++++++...    ...||||||+ |++|.+++......+++..++.++.||+.||.|||  +.+|+||||||+|||+
T Consensus       109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH--~~~iiHrDlkp~Nill  185 (364)
T 3op5_A          109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLL  185 (364)
T ss_dssp             CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEE
T ss_pred             CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeEEecCCHHHEEE
Confidence            999999998775    4589999999 99999999887678999999999999999999999  8999999999999999


Q ss_pred             c--CCCCEEEccccCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014202          236 D--SEYNAKLSDFGLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR  308 (429)
Q Consensus       236 ~--~~~~~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  308 (429)
                      +  .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8  8899999999999765332111     11123569999999999999999999999999999999999999997533


Q ss_pred             CCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                      ..  ...........  ...+...++..+.   ....+.++.+|+..||+.||.+||++.+|++.|+.+....
T Consensus       266 ~~--~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          266 KD--PKYVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             TC--HHHHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cC--HHHHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            21  11111111111  1112222221111   1123478999999999999999999999999887765433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=362.42  Aligned_cols=244  Identities=23%  Similarity=0.326  Sum_probs=204.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--------hhHHHHHHHHHHhcCCCccee
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--------GHREWVAEVDFLGQLHHPNLV  162 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv  162 (429)
                      ..++|++.+.||+|+||.||+|++..++.         .||||++......        ....+.+|+.+|++++||||+
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv   92 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNK---------EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII   92 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTE---------EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCc---------EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence            34679999999999999999999887654         9999999765321        234567899999999999999


Q ss_pred             eEEeEEEeCCeEEEEEEecCCC-ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          163 KLIGYCIEDDQRLLVYEFMTRG-SLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~gg-~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      ++++++.+.+..++||||+.+| +|.+++... ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~  169 (335)
T 3dls_A           93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTI  169 (335)
T ss_dssp             CEEEEEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCE
T ss_pred             eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEcCCCcE
Confidence            9999999999999999999766 999988654 36999999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....           
T Consensus       170 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------  235 (335)
T 3dls_A          170 KLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------  235 (335)
T ss_dssp             EECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------
T ss_pred             EEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------
Confidence            9999999987544322   233679999999999988776 7899999999999999999999964210           


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                 ......  ..+...+..+.+||.+||+.||++|||+.++++.
T Consensus       236 -----------~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 -----------TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       111111  1112245789999999999999999999999984

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.6e-47  Score=380.86  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC---CchhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD---GLQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++...   .......+.+|+.+|+.++||||++++++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~  216 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGR---------YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS  216 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCC---------EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence            34679999999999999999999987655         9999998753   22334567889999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      +...+.+||||||++||+|.+++.... .+++..+..++.||+.||+|||  + .||+||||||+|||++.++.+||+||
T Consensus       217 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~giiHrDlkp~NIll~~~~~~kl~DF  293 (446)
T 4ejn_A          217 FQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDF  293 (446)
T ss_dssp             EEETTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCCCGGGEEECSSSCEEECCC
T ss_pred             EeeCCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh--hcCCEEECCCCHHHEEECCCCCEEEccC
Confidence            999999999999999999999886654 6899999999999999999999  7 89999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .........  
T Consensus       294 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~--  363 (446)
T 4ejn_A          294 GLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILM--  363 (446)
T ss_dssp             CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH--
T ss_pred             CCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHh--
Confidence            9998643322  223347899999999999999999999999999999999999999975431      111111111  


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                              ..  ..++...++.+.+||.+||+.||.+||     ++.|+++
T Consensus       364 --------~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          364 --------EE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --------CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------CC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                    11  112233457899999999999999999     9999987

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=364.46  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=199.5

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCC--cceeeEEeE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHH--PNLVKLIGY  167 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--pnIv~~~~~  167 (429)
                      .++|++.+.||+|+||.||+|.+..          +..||||++.....  .....+.+|+.+|.+++|  |||++++++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   77 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK----------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   77 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT----------SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC----------CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence            4679999999999999999998742          34899999875533  334678899999999986  999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +..++..|+||| +.+++|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++ ++.+||+|||
T Consensus        78 ~~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           78 EITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             EeeCCEEEEEEe-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEEEeecc
Confidence            999999999999 55889999997654 6899999999999999999999  89999999999999997 5789999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHH
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV  316 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  316 (429)
                      +++..............+||+.|+|||++.+           ..++.++|||||||++|||++|..||.....     ..
T Consensus       153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~  227 (343)
T 3dbq_A          153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QI  227 (343)
T ss_dssp             SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HH
T ss_pred             cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HH
Confidence            9987654433333345689999999999875           6788999999999999999999999965321     11


Q ss_pred             HHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                ..+...+++......+...+..+.+||.+||+.||.+|||+.++++.
T Consensus       228 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 ----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                      11222233333333344445789999999999999999999999973

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=353.73  Aligned_cols=270  Identities=24%  Similarity=0.314  Sum_probs=203.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||++......  ..+.+.+|+.+|++++||||+++++++..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQ---------IVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR   73 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCc---------EEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence            679999999999999999999987655         9999998665432  24567899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..++||||+++++|.+++... ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++.
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  150 (311)
T 4agu_A           74 KRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFAR  150 (311)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCeEEEEEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence            99999999999999998877544 46899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH-----
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA-----  324 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----  324 (429)
                      ......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......   ......+.     
T Consensus       151 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~  225 (311)
T 4agu_A          151 LLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPR  225 (311)
T ss_dssp             ECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHH
T ss_pred             hccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhcccccc
Confidence            754322  12234579999999999976 67899999999999999999999999765432111   11111000     


Q ss_pred             ------hhhhhhhhcCCccccC-----CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCcC
Q 014202          325 ------DKRKLYQIVDPRLELN-----YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQD  379 (429)
Q Consensus       325 ------~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~~  379 (429)
                            ..........+.....     .....+..+.+||.+||+.||.+|||+.++++  +++.+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                  0000000000000000     00234567999999999999999999999997  4444443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.3e-47  Score=377.42  Aligned_cols=252  Identities=29%  Similarity=0.442  Sum_probs=209.0

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ...++|++.+.||+|+||.||+|.+.           |..||||+++...  ..+.+.+|+.+|++++||||+++++++.
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~  256 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV  256 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence            34567999999999999999999874           3489999998654  4567899999999999999999999987


Q ss_pred             eCC-eEEEEEEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          170 EDD-QRLLVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       170 ~~~-~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      ..+ ..|+||||+++|+|.+++..... .+++..++.++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||
T Consensus       257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG  334 (450)
T 1k9a_A          257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFG  334 (450)
T ss_dssp             CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence            765 78999999999999999976543 3799999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +++......     ....+++.|+|||++.+..++.++|||||||++|||++ |..||.......   ...         
T Consensus       335 ~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~---------  397 (450)
T 1k9a_A          335 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP---------  397 (450)
T ss_dssp             TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH---------
T ss_pred             Ccccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---------
Confidence            998643211     12367889999999999999999999999999999998 999997654321   111         


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                           .+........+..++..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       398 -----~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          398 -----RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                 01111222334456688999999999999999999999999887654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-47  Score=367.12  Aligned_cols=267  Identities=25%  Similarity=0.400  Sum_probs=215.2

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~  167 (429)
                      ...++|++.+.||+|+||.||+|.+..++...    .+..||+|.+..... .....+.+|+.+|+++ +||||++++++
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKED----AVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSC----CCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCccc----chhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34578999999999999999999987765421    234899999976543 3456788999999999 89999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRR-------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      +..++..++||||+++|+|.+++...             ...+++..++.++.|++.||.|||  +.+|+||||||+|||
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVL  196 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGCE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcccceEE
Confidence            99999999999999999999998653             345799999999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......  
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  274 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--  274 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence            99999999999999986543333223334567889999999999999999999999999999998 999997643221  


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ....    ....          ......+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       275 ~~~~----~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          275 KFYK----LVKD----------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHH----HHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH----HHhc----------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            1111    1110          1111122233578999999999999999999999999886553

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-46  Score=368.55  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=199.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCC--CcceeeEEeEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLH--HPNLVKLIGYC  168 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~~~~~~  168 (429)
                      .+|++.+.||+|+||.||+|.+..          |..||||++.....  .....+.+|+.+|++|+  ||||+++++++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~  125 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK----------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE  125 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT----------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC----------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence            469999999999999999998753          34899999976532  34567899999999996  59999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..++.+||||| +.+++|.+++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||++ ++.+||+|||+
T Consensus       126 ~~~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~DFG~  200 (390)
T 2zmd_A          126 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGI  200 (390)
T ss_dssp             ECSSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred             ecCCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEEecCc
Confidence            99999999999 56889999997654 6899999999999999999999  89999999999999995 57999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      ++..............+||+.|+|||++.+           ..++.++|||||||++|||++|..||.....     ...
T Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~  275 (390)
T 2zmd_A          201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QIS  275 (390)
T ss_dssp             SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHH
T ss_pred             cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHH
Confidence            987644333223345689999999999875           3688999999999999999999999975321     111


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                                .+..++++......+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       276 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          276 ----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                      112222332233333333578999999999999999999999997

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-47  Score=366.83  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=203.5

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++.....    ...+|+.+|.++ +||||+++++++.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~   86 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNM---------EFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD   86 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            34579999999999999999999987654         999999976542    234688888887 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC----CCEEEcc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE----YNAKLSD  245 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~~~kl~D  245 (429)
                      +++..|+||||++||+|.+++.... .+++..+..++.||+.||.|||  +.||+||||||+|||+.++    +.+||+|
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           87 DGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence            9999999999999999999986654 6899999999999999999999  8999999999999998433    3499999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ||++........  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+.   ......
T Consensus       164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~i~~~  238 (342)
T 2qr7_A          164 FGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---ARIGSG  238 (342)
T ss_dssp             CTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH---HHHHHC
T ss_pred             CCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH---HHHccC
Confidence            999987543322  223468999999999998888999999999999999999999999754322211111   111110


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                              ............+..+.+||.+||..||++||++.++++
T Consensus       239 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          239 --------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    111111222345678999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.4e-47  Score=359.34  Aligned_cols=268  Identities=31%  Similarity=0.432  Sum_probs=210.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+|++.+.||+|+||.||+|++...+.     .+|..||||++..... .....+.+|+.+|++++||||+++++++..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGD-----NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSS-----SCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccC-----ccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            458999999999999999998532211     2366999999975532 3346788999999999999999999999877


Q ss_pred             --CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 --DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                        ...++||||+++|+|.+++......+++..++.++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCCEEECccccc
Confidence              6689999999999999999776667999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------CCccccHHHHHH
Q 014202          250 KAGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR--------PSGEQNLVAWAR  320 (429)
Q Consensus       250 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~  320 (429)
                      ......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+....        +.......    
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  249 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV----  249 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH----
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH----
Confidence            876443221 22334578889999999999999999999999999999999998864321        00000000    


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                            ..+...+........+...++.+.+||.+||+.||.+|||+.++++.|+.+
T Consensus       250 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          250 ------TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             ------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence                  111111112222233445568899999999999999999999999988754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.4e-47  Score=356.58  Aligned_cols=261  Identities=28%  Similarity=0.379  Sum_probs=209.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+.....      .+..||+|.+.... ....+.+.+|+.+|++++||||+++++++.+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKG------EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTC------CEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCC------CcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            3579999999999999999999765432      24479999998663 3345678999999999999999999999765


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                       +..|+||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence             4568999999999999999877667999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......   ......          
T Consensus       162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~----------  227 (281)
T 3cc6_A          162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVL----------  227 (281)
T ss_dssp             CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHH----------
T ss_pred             ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHH----------
Confidence            7543221 11223567889999999999999999999999999999998 99999754321   111110          


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ...    .....+...++.+.+|+.+||..||++||++.++++.|+.+..
T Consensus       228 ~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          228 EKG----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             HHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcC----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            000    0111223345789999999999999999999999999877644

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-47  Score=381.94  Aligned_cols=261  Identities=27%  Similarity=0.452  Sum_probs=212.6

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      +....++|++.+.||+|+||.||+|.+..          +..||||++.... ...+.+.+|+.+|++++||||++++++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~  251 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV  251 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            34445689999999999999999998853          3479999998654 446789999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      +. ++..|+||||+.+|+|.+++... ...+++..++.++.||+.||+|||  +.+|+||||||+|||++.++.+||+||
T Consensus       252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEECST
T ss_pred             Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEeeC
Confidence            86 66789999999999999999754 235889999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      |+++...... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+...   ....   ..    
T Consensus       329 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~---~~----  397 (454)
T 1qcf_A          329 GLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVI---RA----  397 (454)
T ss_dssp             TGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH---HH----
T ss_pred             CCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHH---HH----
Confidence            9998753321 111122456789999999999999999999999999999999 9999975431   1111   11    


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                         +..    ......+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       398 ---i~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          398 ---LER----GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ---HHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ---HHc----CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence               111    112223344568899999999999999999999999999888653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=388.75  Aligned_cols=258  Identities=27%  Similarity=0.408  Sum_probs=206.6

Q ss_pred             CCCCCCC-cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDS-ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +++.+.+ .||+|+||.||+|.+...+.       +..||||+++.... ...+++.+|+.+|++++|||||++++++..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSC-------EEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCC-------cEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            4455555 79999999999998875432       45799999986532 345789999999999999999999999876


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                       +..+|||||+.+|+|.+++......+++..++.++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+++
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence             5689999999999999999877777999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          251 AGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||......   .+..           
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~-----------  550 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA-----------  550 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHH-----------
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHH-----------
Confidence            75433211 11122346789999999999999999999999999999998 99999764421   1111           


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                         .+........+..++..+.+||.+||+.||++||++.+|++.|+.+
T Consensus       551 ---~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          551 ---FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ---HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               1111112233445668899999999999999999999999988655

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.5e-47  Score=365.25  Aligned_cols=247  Identities=29%  Similarity=0.412  Sum_probs=203.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..|.+.+.||+|+||.||+|++..++.         .||||++......   ..+.+.+|+.+|++++||||+++++++.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  124 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL  124 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCe---------EEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            458999999999999999999877654         9999999765332   2356889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .++..++||||+. |+|.+++......+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus       125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  201 (348)
T 1u5q_A          125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSA  201 (348)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEeeccCc
Confidence            9999999999997 5888888766667999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ......      ....||+.|+|||++.   +..++.++|||||||++|||++|..||.....      .......    
T Consensus       202 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~----  265 (348)
T 1u5q_A          202 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHI----  265 (348)
T ss_dssp             BSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHH----
T ss_pred             eecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHH----
Confidence            865322      2357999999999985   56789999999999999999999999965431      1111111    


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         .....   +.......+..+.+||.+||+.||++|||+.++++.
T Consensus       266 ---~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          266 ---AQNES---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ---HHSCC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ---HhcCC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               11111   111122345789999999999999999999999974

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=362.02  Aligned_cols=264  Identities=25%  Similarity=0.456  Sum_probs=207.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..+|.+.+.||+|+||.||+|.+..++..     .+..||||.+..... .....+.+|+.+|++++||||+++++++..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---C-----CEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCC-----ccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            36788899999999999999998765321     234699999976533 334578899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      .+..++||||+++|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            99999999999999999999877778999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          251 AGPQGDKTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       251 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....   ....   .        
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~---~--------  261 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVM---K--------  261 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH---H--------
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHH---H--------
Confidence            754322111 1222456889999999999999999999999999999999 9999965431   1111   0        


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                         .+........+...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       262 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          262 ---AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ---HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               010111122233456789999999999999999999999998876643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-46  Score=376.59  Aligned_cols=248  Identities=27%  Similarity=0.400  Sum_probs=207.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|.+++.||+|+||.||+|++..++.         .||||++.....   .....+.+|+.+|+.++||||+++++++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~---------~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGH---------KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCC---------EEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4689999999999999999999987655         999999965422   2245688999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ...+..|+||||++||+|.+++.+. ..+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~DFG~  162 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGL  162 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEEeccc
Confidence            9999999999999999999998654 46999999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +.......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......   ..   ...      
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~---~~~------  227 (476)
T 2y94_A          163 SNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TL---FKK------  227 (476)
T ss_dssp             CEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HH---HHH------
T ss_pred             hhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HH---HHH------
Confidence            98754432   2234689999999999988765 68999999999999999999999754321   11   111      


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          +.+...  ..+...+..+.+||.+||+.||.+|||+.++++
T Consensus       228 ----i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          228 ----ICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----HHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                111111  112234578999999999999999999999997

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-46  Score=358.18  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=207.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch------hhHHHHHHHHHHhcCCCcceeeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ------GHREWVAEVDFLGQLHHPNLVKLI  165 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~  165 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||+|++......      ....+.+|+.+|++++||||++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   81 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGL---------EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH   81 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCe---------EEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence            3569999999999999999999987655         9999999765322      346789999999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----CE
Q 014202          166 GYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NA  241 (429)
Q Consensus       166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~~  241 (429)
                      +++...+..++||||++|++|.+++... ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.++    .+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~~~~~~  158 (321)
T 2a2a_A           82 DVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHI  158 (321)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             EEEecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCCCcCCE
Confidence            9999999999999999999999998654 46899999999999999999999  89999999999999999887    79


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ......
T Consensus       159 kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~  229 (321)
T 2a2a_A          159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLAN  229 (321)
T ss_dssp             EECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHH
T ss_pred             EEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHH
Confidence            9999999987544321   2335799999999999999999999999999999999999999975421      111111


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ...        .............+..+.+||.+||+.||++|||+.++++.
T Consensus       230 i~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          230 ITS--------VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHT--------TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             HHh--------cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            100        00001101111234679999999999999999999999983

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=354.51  Aligned_cols=246  Identities=26%  Similarity=0.289  Sum_probs=196.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      ++|++.++||+|+||+||+|++..++.         .||||++.....  ........|+..+.++ +||||+++++++.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGR---------LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSC---------EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCe---------EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            479999999999999999999987655         999999865432  2333455666666555 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|+||||+ +++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEccceee
Confidence            999999999999 77999998877778999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....     .              .
T Consensus       205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~--------------~  261 (311)
T 3p1a_A          205 VELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G--------------W  261 (311)
T ss_dssp             EECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H--------------H
T ss_pred             eecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H--------------H
Confidence            8754322   2233579999999998875 78999999999999999999977664311     0              0


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..+.............+..+.+||.+||+.||++|||+.|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          262 QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            01111111111112345789999999999999999999999973

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.1e-46  Score=349.55  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=207.2

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||+|++....  ......+.+|+.++++++||||+++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGL---------EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   74 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCc---------eEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            35789999999999999999999987655         99999986543  23346788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC---EEEcc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSD  245 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl~D  245 (429)
                      ..++..++||||+.|++|.+.+.... .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.   +||+|
T Consensus        75 ~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~kl~D  151 (284)
T 3kk8_A           75 QEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLAD  151 (284)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EcCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcEEEee
Confidence            99999999999999999999886654 5899999999999999999999  899999999999999976655   99999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....      ..........
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~  222 (284)
T 3kk8_A          152 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAG  222 (284)
T ss_dssp             CTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT
T ss_pred             ceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhc
Confidence            999976543222   2336799999999999999999999999999999999999999965321      1111111000


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                              ............++.+.+||.+||+.||++|||+.++++
T Consensus       223 --------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          223 --------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             --------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    011111112234578999999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.7e-47  Score=363.60  Aligned_cols=276  Identities=28%  Similarity=0.378  Sum_probs=216.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE--e
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI--E  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~  170 (429)
                      ++|++.+.||+|+||.||+|++...+.     .+|..||||++........+.+.+|+.+|++++||||+++++++.  +
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGD-----NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSS-----SCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCC-----CcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            579999999999999999998543211     235699999998877666778999999999999999999999887  4


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ....++||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence            56689999999999999999775557999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH--HHHHHhhh
Q 014202          251 AGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA--RQYLADKR  327 (429)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~  327 (429)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||......    .....  ........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPALS  251 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhcccccccccHH
Confidence            76443221 1222356888999999999999999999999999999999999998642110    00000  00000001


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      .+...+........+...++.+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1122222222333445566889999999999999999999999999887754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.4e-47  Score=370.52  Aligned_cols=273  Identities=24%  Similarity=0.335  Sum_probs=197.7

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCC-CcceeeEEe
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLH-HPNLVKLIG  166 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~  166 (429)
                      ...++|++.+.||+|+||.||+|.+..++.         .||||++...  .......+.+|+.+|..+. ||||+++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~   76 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGE---------VVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN   76 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCC---------EEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCC---------EEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence            345789999999999999999999987755         9999998654  2344567789999999997 999999999


Q ss_pred             EEEeCC--eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          167 YCIEDD--QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       167 ~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ++..++  .+|+||||+. ++|.+++...  .+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           77 VLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             EEECTTSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEecCCCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCCEEec
Confidence            998654  6899999997 5899988654  5899999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCC-------------------ccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCC
Q 014202          245 DFGLAKAGPQGD-------------------KTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSM  304 (429)
Q Consensus       245 DFg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf  304 (429)
                      |||+++......                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            999997643211                   1112334689999999999986 67899999999999999999999999


Q ss_pred             CCCCCCccccHHHHHHHHHHhh--hhhh---------------hhc---CCccc------------cCCCHHHHHHHHHH
Q 014202          305 DKKRPSGEQNLVAWARQYLADK--RKLY---------------QIV---DPRLE------------LNYSLKGVQKVSQL  352 (429)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~--~~~~---------------~~~---~~~~~------------~~~~~~~~~~l~~l  352 (429)
                      .+.....   ....+...+...  ..+.               ...   .....            .......++.+.+|
T Consensus       232 ~~~~~~~---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  308 (388)
T 3oz6_A          232 PGSSTMN---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL  308 (388)
T ss_dssp             CCSSHHH---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred             CCCCHHH---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence            7653211   111110000000  0000               000   00000            00011234679999


Q ss_pred             HHHcccCCCCCCCCHhHHHHH--hcCCcC
Q 014202          353 AYNCLSRDPKSRPSMDEVVKV--LTPLQD  379 (429)
Q Consensus       353 i~~~l~~dP~~Rpt~~eil~~--l~~~~~  379 (429)
                      |.+||+.||++|||+.|++++  +..+.+
T Consensus       309 l~~~L~~dP~~R~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          309 LDKLLQFNPNKRISANDALKHPFVSIFHN  337 (388)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred             HHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence            999999999999999999984  544443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.8e-46  Score=351.64  Aligned_cols=268  Identities=18%  Similarity=0.210  Sum_probs=209.5

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeE-EE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGY-CI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-~~  169 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++....  ....+.+|+.+++.++|++++..+.. +.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCc---------eEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence            45789999999999999999999877654         99999876543  22457899999999998776666654 46


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~DF  246 (429)
                      ..+..++||||+ +++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||+   +.++.+||+||
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Df  152 (296)
T 4hgt_A           76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred             CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeEEEecC
Confidence            777889999999 99999999876667999999999999999999999  8999999999999999   78899999999


Q ss_pred             cCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          247 GLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       247 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus       153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 4hgt_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence            999875443221     112346799999999999999999999999999999999999999987655444333322111


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCccc
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLND  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~~  382 (429)
                      ....  ....        ......+..+.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus       233 ~~~~--~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          233 KKMS--TPIE--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHH--SCHH--------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cccc--chhh--------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            1000  0000        0011234789999999999999999999999999887765443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-46  Score=352.85  Aligned_cols=247  Identities=26%  Similarity=0.423  Sum_probs=203.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|++.....   .....+.+|+.++++++||||+++++++.
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKF---------ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCc---------EEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            579999999999999999999987655         899999864322   22356889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||  +.||+||||||+|||++.++.++|+|||++
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~  156 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWS  156 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEEecccc
Confidence            9999999999999999999986653 5899999999999999999999  899999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....      ......       +
T Consensus       157 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~-------~  219 (279)
T 3fdn_A          157 VHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKR-------I  219 (279)
T ss_dssp             SCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH-------H
T ss_pred             ccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHH-------H
Confidence            6543321    2346799999999999999999999999999999999999999975431      111110       0


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .. .    ....+...+..+.+||.+||+.||.+|||+.|+++.
T Consensus       220 ~~-~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          220 SR-V----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HH-T----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             Hh-C----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00 1    111223345789999999999999999999999983

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.8e-47  Score=370.12  Aligned_cols=244  Identities=26%  Similarity=0.369  Sum_probs=194.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHH-HhcCCCcceeeEEeEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDF-LGQLHHPNLVKLIGYC  168 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~~~~~~  168 (429)
                      ++|++++.||+|+||.||+|++..++.         .||||++.....   .....+..|..+ ++.++||||+++++++
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~  108 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEV---------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF  108 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCC---------EEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCC---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence            579999999999999999999987655         899999976532   223456677776 5778999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+.+.+|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||  +.||+||||||+|||++.+|.+||+|||+
T Consensus       109 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          109 QTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEeeCcc
Confidence            99999999999999999999986644 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .+.....      
T Consensus       186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i------  251 (373)
T 2r5t_A          186 CKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNI------  251 (373)
T ss_dssp             CGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHH------
T ss_pred             ccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHH------
Confidence            98632221  123346899999999999999999999999999999999999999975321      1111111      


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHh
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD  368 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  368 (429)
                          +....  .++...+..+.+||.+||+.||.+||++.
T Consensus       252 ----~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          252 ----LNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             ----HHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             ----Hhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence                11111  12223457899999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-46  Score=355.92  Aligned_cols=262  Identities=27%  Similarity=0.429  Sum_probs=206.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEE-e
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCI-E  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~  170 (429)
                      .+|++.+.||+|+||.||+|.+..++.      .+..||+|.+..... .....+.+|+.+|++++||||+++++++. .
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence            568999999999999999999765432      234689999976533 34567889999999999999999999854 5


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..++||||+.+|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCEEECcccccc
Confidence            56789999999999999999877777899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCc--cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          251 AGPQGDK--THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       251 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .......  ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.......   ....         
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---------  244 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---------  244 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---------
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---------
Confidence            6543221  112233568889999999999999999999999999999999 566665443221   1110         


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                       +...    .....+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       245 -~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          245 -LLQG----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -HHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HhcC----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             0000    0111122345789999999999999999999999998876543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.5e-46  Score=349.91  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=206.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|++..........+.+|+.+|++++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRI---------RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN   78 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCc---------EEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4579999999999999999999887654         8999999776556667889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCCEEEccccC
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSDFGL  248 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~DFg~  248 (429)
                      +..++||||+++++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||+   +.++.++|+|||+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            99999999999999999886654 5899999999999999999999  8999999999999999   7889999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......      .........   
T Consensus       156 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~---  222 (277)
T 3f3z_A          156 AARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREG---  222 (277)
T ss_dssp             CEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC---
T ss_pred             ceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC---
Confidence            98754332   2233579999999998765 4899999999999999999999999754311      111111000   


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                           ............++.+.+||.+||+.||.+|||+.++++
T Consensus       223 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          223 -----TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -----CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000000000123478999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=355.32  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=208.7

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      .|.+.+.||+|+||.||+|.+..++.      .+..||+|.+..... ...+.+.+|+.+|++++||||+++++++...+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   95 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE   95 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             EEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence            46677999999999999999876543      234799999976543 34567889999999999999999999998776


Q ss_pred             eE-EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QR-LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~-~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      .. ++||||+.+|+|.+++......+++..++.++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            65 9999999999999999877777999999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCc--cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          252 GPQGDK--THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       252 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ......  ........|++.|+|||.+.+..++.++||||||+++|+|++|..|+......  .....            
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~------------  239 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTH------------  239 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHH------------
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHH------------
Confidence            533221  11222357889999999999999999999999999999999965554332211  11111            


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        .+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       240 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          240 --FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              11111112223344578999999999999999999999999887654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=353.44  Aligned_cols=266  Identities=26%  Similarity=0.341  Sum_probs=200.6

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-----hhhHHHHHHHHHHhcCC---Ccce
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-----QGHREWVAEVDFLGQLH---HPNL  161 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---hpnI  161 (429)
                      ...++|++.+.||+|+||.||+|++..+++         .||||++.....     .....+.+|+.++++++   ||||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni   76 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGH---------FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV   76 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCC---------EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCc---------EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence            345789999999999999999999877655         999999864321     12245667888777765   9999


Q ss_pred             eeEEeEEEeCC-----eEEEEEEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          162 VKLIGYCIEDD-----QRLLVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       162 v~~~~~~~~~~-----~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      +++++++....     ..++||||+. ++|.+++..... .+++..+..++.|++.||+|||  +.+|+||||||+|||+
T Consensus        77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~  153 (308)
T 3g33_A           77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILV  153 (308)
T ss_dssp             CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTTEEE
T ss_pred             EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEE
Confidence            99999998765     5799999996 599999876543 4899999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      +.++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......   ..
T Consensus       154 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~  227 (308)
T 3g33_A          154 TSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQ  227 (308)
T ss_dssp             CTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HH
T ss_pred             cCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HH
Confidence            9999999999999986543222   23468999999999999999999999999999999999999999764321   11


Q ss_pred             HHHHHHHHHhh--hhhhhh-------cCC---ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          316 VAWARQYLADK--RKLYQI-------VDP---RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       316 ~~~~~~~~~~~--~~~~~~-------~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ...+.......  ......       ...   ..........+..+.+||.+||+.||++|||+.|+++.
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            11111100000  000000       000   00000112345789999999999999999999999973

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-46  Score=362.46  Aligned_cols=259  Identities=23%  Similarity=0.248  Sum_probs=201.6

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-----CchhhHHHHHHHHHHhcCCCcceee
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-----GLQGHREWVAEVDFLGQLHHPNLVK  163 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~  163 (429)
                      ....++|++.+.||+|+||.||+|.+..++.         .||+|++...     .......+.+|+.+|++++||||++
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~   92 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRA---------IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR   92 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCc---------eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3445689999999999999999999887655         8999998643     2234567899999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcC---------------------------------------CCCCCHHHHHH
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRR---------------------------------------TIPLPWSNRIK  204 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---------------------------------------~~~~~~~~~~~  204 (429)
                      +++++.+.+..++||||++||+|.+++...                                       ...+++..++.
T Consensus        93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (345)
T 3hko_A           93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN  172 (345)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred             eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence            999999999999999999999999988421                                       11235677889


Q ss_pred             HHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC--CEEEccccCcccCCCCCc--cceeeeccccccccChhhhhc--
Q 014202          205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY--NAKLSDFGLAKAGPQGDK--THVSTRVVGTYGYAAPEYVMT--  278 (429)
Q Consensus       205 ~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--~~kl~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--  278 (429)
                      ++.|++.||.|||  +.+|+||||||+|||++.++  .+||+|||++........  ........||+.|+|||++.+  
T Consensus       173 i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          173 IMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            9999999999999  89999999999999998776  899999999975432111  112334679999999999975  


Q ss_pred             CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHccc
Q 014202          279 GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLS  358 (429)
Q Consensus       279 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  358 (429)
                      ..++.++|||||||++|||++|..||......      ..........        ...........+..+.+||.+||+
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKK--------LCFENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC--------CCTTSGGGGGSCHHHHHHHHHHSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcc--------cccCCcccccCCHHHHHHHHHHcC
Confidence            67899999999999999999999999754321      1111111110        001111112345789999999999


Q ss_pred             CCCCCCCCHhHHHH
Q 014202          359 RDPKSRPSMDEVVK  372 (429)
Q Consensus       359 ~dP~~Rpt~~eil~  372 (429)
                      .||.+||++.++++
T Consensus       317 ~~p~~Rps~~~~l~  330 (345)
T 3hko_A          317 RNVDERFDAMRALQ  330 (345)
T ss_dssp             SCTTTSCCHHHHHH
T ss_pred             CChhHCCCHHHHhc
Confidence            99999999999998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.8e-47  Score=351.56  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=211.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..          +..||+|++..... ..+.+.+|+.++++++||||+++++++..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3579999999999999999999863          33799999986643 346789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+||+++.++.+||+|||++..
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  153 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRF  153 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEcccccccc
Confidence            9999999999999999999877677999999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..... ........|++.|+|||++.+..++.++||||||+++|+|++ |..||.....      ......       +.
T Consensus       154 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~-------i~  219 (267)
T 3t9t_A          154 VLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVED-------IS  219 (267)
T ss_dssp             BCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH-------HH
T ss_pred             ccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHH-------Hh
Confidence            43211 111223467889999999999999999999999999999999 8999975431      111111       11


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..    .....+...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       220 ~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          220 TG----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             TT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC----CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11    111122234578999999999999999999999999887654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5e-46  Score=352.76  Aligned_cols=251  Identities=21%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|.+.+.||+|+||.||+|++..++.         .||+|++..........+.+|+.+|++++||||+++++++...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGK---------LFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST   78 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCC---------EEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence            3579999999999999999999887654         9999999876544556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCCEEEccccC
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSDFGL  248 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~DFg~  248 (429)
                      +..|+||||++|++|.+++.... .+++..+..++.|++.||.|||  +.+|+||||||+|||+   +.++.+||+|||+
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           79 THYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             CEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            99999999999999999886554 5899999999999999999999  8999999999999999   7889999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +.......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .   .........   
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~---~~~~~i~~~---  222 (304)
T 2jam_A          156 SKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---S---KLFEKIKEG---  222 (304)
T ss_dssp             TCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHHHC---
T ss_pred             ceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H---HHHHHHHcC---
Confidence            97643221    2235799999999999998999999999999999999999999975431   1   111111000   


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                           ............+..+.+||.+||..||++|||+.++++
T Consensus       223 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          223 -----YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             -----CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             -----CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 001111222344578999999999999999999999997

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=351.91  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=187.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||++.....   .....+.+|+.++++++||||+++++++.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGL---------EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE   81 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCc---------eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence            579999999999999999999876654         999999864421   22366889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +.+..++||||+++++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~  159 (278)
T 3cok_A           82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLA  159 (278)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred             cCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEEeecce
Confidence            999999999999999999999877678999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||........                +
T Consensus       160 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~  221 (278)
T 3cok_A          160 TQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------L  221 (278)
T ss_dssp             EECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------
T ss_pred             eeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------H
Confidence            87543221  12235799999999999988999999999999999999999999976432211                0


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .......  ...+...+..+.+||.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          222 NKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            0111111  1122334578999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=370.42  Aligned_cols=260  Identities=28%  Similarity=0.443  Sum_probs=200.1

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEe-C
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE-D  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~  171 (429)
                      .|.+.+.||+|+||.||+|.+..++.      .+..||+|.+.... ......+.+|+.+|++++||||+++++++.. +
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  163 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE  163 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            47788999999999999999865432      13468999987543 3455778999999999999999999998654 5


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEEeecccccc
Confidence            6789999999999999999877777899999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCcc--ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          252 GPQGDKT--HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       252 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      .......  .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.......   ....    ...   
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~---  311 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQ---  311 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHT---
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHc---
Confidence            5332211  11233567889999999999999999999999999999999 777886544322   1111    000   


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                         .    .....+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       312 ---~----~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          312 ---G----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             ---T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---C----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               0    011122334578999999999999999999999999887654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-46  Score=380.99  Aligned_cols=254  Identities=30%  Similarity=0.445  Sum_probs=209.9

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ..++|++.+.||+|+||.||+|++..++.         .||||++.....   .....+.+|+.+|+.++||||++++++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~---------~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~  252 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA  252 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            34679999999999999999999987655         999999965422   233567899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      +.+.+.+|+||||++||+|.+++.... ..+++..++.++.||+.||.|||  +.||+||||||+|||++.+|.+||+||
T Consensus       253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEEEec
Confidence            999999999999999999999987653 35899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |+++......   .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+  ....    
T Consensus       331 Gla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~~i----  401 (576)
T 2acx_A          331 GLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERLV----  401 (576)
T ss_dssp             TTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HHHH----
T ss_pred             ccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HHHh----
Confidence            9998754432   223468999999999999989999999999999999999999999865432211111  1100    


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                          ...    ...++...+.++.+||.+||+.||.+||     ++.|+++
T Consensus       402 ----~~~----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          402 ----KEV----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----HHC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----hcc----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                001    1122334557899999999999999999     7899986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-46  Score=360.08  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=181.9

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  176 (429)
                      .+.||+|+||.||+|.+..++.         .||||++...   ....+.+|+.+|+.+. ||||+++++++.++...|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQ---------AFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCC---------EEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCC---------EEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            4789999999999999987655         9999999643   3456779999999997 9999999999999999999


Q ss_pred             EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---CEEEccccCcccCC
Q 014202          177 VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY---NAKLSDFGLAKAGP  253 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~kl~DFg~a~~~~  253 (429)
                      ||||++||+|.+++... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++   .+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            99999999999999765 46999999999999999999999  89999999999999997765   79999999998654


Q ss_pred             CCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcc-ccHHHHHHHHHHhhhhhhhh
Q 014202          254 QGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE-QNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  332 (429)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....+...          .+
T Consensus       161 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----------~i  228 (325)
T 3kn6_A          161 PDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK----------KI  228 (325)
T ss_dssp             C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH----------HH
T ss_pred             CCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH----------HH
Confidence            322  222346789999999999999999999999999999999999999976543211 11111111          11


Q ss_pred             cCCccccC--CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELN--YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ........  .....++++.+||.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            11111111  11234578999999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.3e-46  Score=349.73  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=207.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||++.... ......+.+|+.+++.++||||+++++++.++
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEE---------AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCc---------EEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence            579999999999999999999887655         89999986543 23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..|+||||+++++|.+++... ..+++..++.++.|++.||.|||  +.+|+||||||+||+++.++.+||+|||++..
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           78 NIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            9999999999999999988543 46899999999999999999999  89999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+            
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~------------  221 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW------------  221 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH------------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh------------
Confidence            543322222334679999999999987665 7789999999999999999999976543211 11110            


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        .............+..+.+||.+||+.||.+|||+.++++.
T Consensus       222 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          222 --KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --hhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence              00000111112345789999999999999999999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-45  Score=348.62  Aligned_cols=267  Identities=18%  Similarity=0.209  Sum_probs=212.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeE-EE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGY-CI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-~~  169 (429)
                      ..++|++.+.||+|+||.||+|++..++.         .||||++.....  ...+.+|+.+++.++|++++..+.+ +.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCc---------EEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC
Confidence            35789999999999999999999877654         999999876532  3468899999999998876665554 46


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~DF  246 (429)
                      .++..++||||+ +++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||+   +.++.+||+||
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence            677889999999 99999999866667999999999999999999999  8999999999999999   48889999999


Q ss_pred             cCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          247 GLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       247 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            999875443221     112346799999999999999999999999999999999999999987654443333322111


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                      .....  ...        ......+..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus       233 ~~~~~--~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          233 KKMST--PIE--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHS--CHH--------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccCC--chH--------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            10000  000        001123478999999999999999999999999988765443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=360.39  Aligned_cols=271  Identities=17%  Similarity=0.197  Sum_probs=202.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-----------hHHHHHHHHHHhcCCCcc
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-----------HREWVAEVDFLGQLHHPN  160 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpn  160 (429)
                      .++|++.+.||+|+||.||+|.+..++.      .+..||||++.......           ...+.+|+.+++.++|||
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            4689999999999999999999986322      23489999997664321           134668899999999999


Q ss_pred             eeeEEeEEEe----CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          161 LVKLIGYCIE----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       161 Iv~~~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      |+++++++..    ....|+||||+ |++|.+++.... .+++..++.++.||+.||.|||  +.+|+||||||+|||++
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLG  185 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEE
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCcCHHHEEEc
Confidence            9999999988    67899999999 999999986655 7899999999999999999999  89999999999999998


Q ss_pred             CCC--CEEEccccCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 014202          237 SEY--NAKLSDFGLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP  309 (429)
Q Consensus       237 ~~~--~~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  309 (429)
                      .++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            877  9999999999765322111     111335799999999999999999999999999999999999999964221


Q ss_pred             CccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ... ...........   .+......   .......+.++.+||.+||..||++||++.+|++.|+.+..
T Consensus       266 ~~~-~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          266 DPV-AVQTAKTNLLD---ELPQSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             CHH-HHHHHHHHHHH---TTTHHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             ccH-HHHHHHHhhcc---cccHHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            111 11111111110   01100000   00011344689999999999999999999999999987653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=358.25  Aligned_cols=263  Identities=27%  Similarity=0.375  Sum_probs=207.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe-
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE-  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  170 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++..........+.+|+.+++.++||||+++++++.. 
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGH---------FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCC---------EEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCc---------EEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            4679999999999999999999877654         999999877666667788999999999999999999999873 


Q ss_pred             ---CCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          171 ---DDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       171 ---~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                         ....++||||+.+|+|.+++..   ....+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A           99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCCEEEE
Confidence               3478999999999999998865   3567999999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCccc-------eeeeccccccccChhhhhcCC---CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 014202          245 DFGLAKAGPQGDKTH-------VSTRVVGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN  314 (429)
Q Consensus       245 DFg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  314 (429)
                      |||++..........       ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||........ .
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~  255 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-S  255 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-C
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-h
Confidence            999987643211000       011245799999999987554   68999999999999999999999953110000 0


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                                    +................+..+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       256 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          256 --------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             --------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             --------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence                          0000111111222234457899999999999999999999999999877653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.8e-46  Score=352.64  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=200.7

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhc--CCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ--LHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|++.           |..||||++...   ....+..|.+++..  ++||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            3468999999999999999999873           348999998643   33455667776666  7899999999986


Q ss_pred             EeC----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCCeEEcCC
Q 014202          169 IED----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG------SEPVIYRDFKTSNILLDSE  238 (429)
Q Consensus       169 ~~~----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~------~~~ivHrDlkp~Nill~~~  238 (429)
                      ...    ...++||||+++|+|.+++..  ..+++..++.++.|++.||.|||..      +.+|+||||||+|||++.+
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN  149 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence            543    457999999999999999954  3589999999999999999999932      5799999999999999999


Q ss_pred             CCEEEccccCcccCCCCCccc--eeeeccccccccChhhhhcC------CCCCccchhhhHHHHHHHHhC----------
Q 014202          239 YNAKLSDFGLAKAGPQGDKTH--VSTRVVGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEILTG----------  300 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g----------  300 (429)
                      +.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            999999999997643322211  12234799999999999876      345789999999999999999          


Q ss_pred             CCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccc-cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          301 RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLE-LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       301 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      ..||....+..... .. ......     .....+..+ .......+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       230 ~~pf~~~~~~~~~~-~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          230 KPPFYDVVPNDPSF-ED-MRKVVC-----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCTTTTTSCSSCCH-HH-HHHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccCCCCcch-hh-hhHHHh-----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            88886544332211 11 010000     001111111 112345678899999999999999999999999988654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-46  Score=359.38  Aligned_cols=258  Identities=28%  Similarity=0.474  Sum_probs=206.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|++..++.       ...||+|.+.... ......+.+|+.+|+++ +||||+++++++..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTE-------EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCc-------ccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            469999999999999999999887654       1134999987542 23456788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      .+..|+||||+++|+|.+++....               ..+++..++.++.||+.||.|||  +.+|+||||||+|||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILV  175 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCccceEEE
Confidence            999999999999999999996643               46899999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQN  314 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  314 (429)
                      +.++.+||+|||++......   .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....     
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----  247 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----  247 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----
T ss_pred             cCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----
Confidence            99999999999999753221   11223467889999999998889999999999999999998 9999975431     


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                       ...           ...+........+...+..+.+||.+||+.||.+|||+.++++.|..+..
T Consensus       248 -~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          248 -AEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             -HHH-----------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHH-----------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             111           11111111122233455789999999999999999999999998866543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.5e-46  Score=374.82  Aligned_cols=261  Identities=22%  Similarity=0.265  Sum_probs=197.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++++.||+|+||.||+|++..++.         .||||++...  .....+.+.+|+.+|+.++||||+++++++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  130 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDR---------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF  130 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTE---------EEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCC---------EEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            35789999999999999999999987655         8999999754  223456788999999999999999999999


Q ss_pred             EeC------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IED------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~~------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ...      ...||||||+.+ +|.+.+..   .+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+|
T Consensus       131 ~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          131 TPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             CSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEE
T ss_pred             ccCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCCCCEE
Confidence            755      357999999976 56666643   3899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |+|||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.....   ....+...
T Consensus       205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~  278 (464)
T 3ttj_A          205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQ  278 (464)
T ss_dssp             ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH
T ss_pred             EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHh
Confidence            99999998754321   2334689999999999999999999999999999999999999997653211   11100000


Q ss_pred             HHhh---------hhhhhhcCCcc-------ccC-----------CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADK---------RKLYQIVDPRL-------ELN-----------YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~---------~~~~~~~~~~~-------~~~-----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      +...         ......+....       +..           .....+.++.+||.+||+.||++|||++|+++
T Consensus       279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000         00000000000       000           00112578999999999999999999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-46  Score=360.42  Aligned_cols=264  Identities=25%  Similarity=0.304  Sum_probs=200.7

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-----hHHHHHHHHHHhcCCCcceeeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-----HREWVAEVDFLGQLHHPNLVKL  164 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~  164 (429)
                      ...++|++.+.||+|+||.||+|.+..++.         .||||++.......     ...+.+|+.+|++++||||+++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   77 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQ---------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL   77 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCS---------EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCc---------EEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence            345789999999999999999999877654         99999997543221     2467899999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ++++...+..++||||+++ +|.+++......+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+
T Consensus        78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~kl~  154 (346)
T 1ua2_A           78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLA  154 (346)
T ss_dssp             EEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCCCEEEE
Confidence            9999999999999999976 899988777777999999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||++.......  .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....      .......
T Consensus       155 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~------~~~~~i~  226 (346)
T 1ua2_A          155 DFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL------DQLTRIF  226 (346)
T ss_dssp             CCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH
T ss_pred             ecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH
Confidence            999998754322  122346799999999998764 5889999999999999999999999764321      1111111


Q ss_pred             Hhhhhh-----hh------hcCCccccC-----CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          324 ADKRKL-----YQ------IVDPRLELN-----YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       324 ~~~~~~-----~~------~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ......     ..      .........     .....+..+.+||.+||+.||.+|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            110000     00      000000000     012335789999999999999999999999983

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.7e-46  Score=353.68  Aligned_cols=260  Identities=28%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             cCCCCCCC-cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDS-ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|.+.+ .||+|+||.||+|.+.....       +..||||++.....  ...+.+.+|+.+++.++||||+++++++
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSS-------EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCc-------eeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            35788888 99999999999997654322       45899999976532  2356789999999999999999999998


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                       ..+..++||||+++++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence             6677899999999999999997653 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          249 AKAGPQGDKTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       249 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +.......... ......|++.|+|||++.+..++.++||||||+++|+|++ |..||......   ....         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---------  231 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA---------  231 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH---------
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---------
Confidence            98754433221 1222456789999999998889999999999999999999 99999754321   1110         


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                           .+........+...+..+.++|.+||+.||.+||++.++++.|+.+..
T Consensus       232 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          232 -----MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 010111112233456789999999999999999999999999877644

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.4e-46  Score=356.96  Aligned_cols=259  Identities=20%  Similarity=0.281  Sum_probs=207.2

Q ss_pred             HHHHhhcCCCCCC-CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCC-Ccce
Q 014202           86 QELKSATGNFRPD-SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLH-HPNL  161 (429)
Q Consensus        86 ~~~~~~~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnI  161 (429)
                      +......++|.+. +.||+|+||.||+|.+..++.         .||+|++....  ......+.+|+.+|..+. ||||
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i   91 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQ---------EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV   91 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCC---------EEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE
Confidence            3344556678887 899999999999999987655         99999987543  233567889999999995 7999


Q ss_pred             eeEEeEEEeCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---
Q 014202          162 VKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---  237 (429)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---  237 (429)
                      +++++++...+..++||||+.||+|.+++... ...+++..++.++.|++.||.|||  ..||+||||||+|||++.   
T Consensus        92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~NIl~~~~~~  169 (327)
T 3lm5_A           92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYP  169 (327)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESCBTT
T ss_pred             EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChHHEEEecCCC
Confidence            99999999999999999999999999988654 456899999999999999999999  899999999999999987   


Q ss_pred             CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      ++.+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......      .
T Consensus       170 ~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~  240 (327)
T 3lm5_A          170 LGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------E  240 (327)
T ss_dssp             BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred             CCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------H
Confidence            7899999999998754322   123367999999999999999999999999999999999999999754311      1


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ....       +. ..............+..+.+||.+||+.||.+|||+.++++
T Consensus       241 ~~~~-------i~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          241 TYLN-------IS-QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHH-------HH-HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHH-------HH-hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            0000       00 01111122222345578999999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=350.47  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=204.2

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||.+....  ....+.+|+.+|++++||||+++++++..
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   95 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQ---------IVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK   95 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCC---------EEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCC---------EEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            34689999999999999999999887654         99999997653  34678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|+||||+++++|.+++......+++..++.++.|++.||.|||  ..||+|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence            99999999999999999999766667999999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||......      ....       .+.
T Consensus       174 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-------~~~  238 (314)
T 3com_A          174 QLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIF-------MIP  238 (314)
T ss_dssp             ECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-------HHH
T ss_pred             hhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHH-------HHh
Confidence            653321  1223457999999999999989999999999999999999999999754311      1000       000


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .  ........+...+..+.+||.+||..||.+|||+.++++
T Consensus       239 ~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          239 T--NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             H--SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             c--CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1  111111223334578999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-46  Score=376.45  Aligned_cols=259  Identities=26%  Similarity=0.414  Sum_probs=207.5

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ...++|++.+.||+|+||.||+|.+..+          ..||||++.... ...+.+.+|+.+|++++||||+++++++.
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~----------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  249 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGT----------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS  249 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT----------EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCC----------ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            4456799999999999999999998642          379999998654 33567899999999999999999999986


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      . +..|+||||+++|+|.+++... ...+++..++.++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus       250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence            6 6789999999999999999653 345899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...      .+...       
T Consensus       327 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~-------  392 (452)
T 1fmk_A          327 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLD-------  392 (452)
T ss_dssp             TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHH-------
T ss_pred             ceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHH-------
Confidence            987543221 12223457889999999999999999999999999999999 9999975431      11111       


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                          .+........+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       393 ----~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          393 ----QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ----HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ----HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                1111112233345568899999999999999999999999999887654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-46  Score=348.49  Aligned_cols=250  Identities=26%  Similarity=0.350  Sum_probs=199.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|.+.+.||+|+||.||+|.+..++.         .||+|++.... ......+.+|+.+|++++||||+++++++.+.
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGL---------ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY   92 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hheeecceeccCCCeEEEEEEEccCCc---------eEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence            469999999999999999999887654         89999987653 23457788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCCEEEcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSD  245 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D  245 (429)
                      +..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||  +.+|+||||||+|||+   +.++.+||+|
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence            9999999999999999988543   457999999999999999999999  8999999999999999   4567899999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....      ......    
T Consensus       171 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~----  236 (285)
T 3is5_A          171 FGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQK----  236 (285)
T ss_dssp             CCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH----
T ss_pred             eecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhh----
Confidence            99998654322   223467999999999875 5789999999999999999999999975431      111000    


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          .......... .....++.+.+||.+||+.||.+|||+.|+++
T Consensus       237 ----~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          237 ----ATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----HHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----hccCCccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0001111110 01113478999999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-46  Score=359.82  Aligned_cols=274  Identities=31%  Similarity=0.445  Sum_probs=211.7

Q ss_pred             CC-CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           94 NF-RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        94 ~y-~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +| ++++.||+|+||.||++.+....     ..+|+.||||++..... .....+.+|+.+|++++||||+++++++.+.
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTN-----DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC-------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCC-----CCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            45 99999999999999998764322     12467999999986643 3456789999999999999999999999884


Q ss_pred             --CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 --DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                        ...++||||+++|+|.+++....  +++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEEECCcccc
Confidence              67899999999999999996654  899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....+.. .......
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~-~~~~~~~  259 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQ-GQMTVLR  259 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCC-HHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccc-cchhHHH
Confidence            876543321 12334568889999999999899999999999999999999999986421100 00000000 0000111


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      +...+........+..++..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            22222222233344456688999999999999999999999999887664

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.8e-45  Score=369.29  Aligned_cols=269  Identities=19%  Similarity=0.243  Sum_probs=214.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCC-cceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH-PNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~  169 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++.....  ...+..|+.+++.|+| ++|..+..++.
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---------~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~   73 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV   73 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCC---------EEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCc---------EEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            34789999999999999999999887655         999999875532  2457899999999986 66667777778


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~DF  246 (429)
                      ..+..+|||||+ +++|.+++......+++..++.++.||+.||.|||  ..+|+||||||+||||   +.++.+||+||
T Consensus        74 ~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEEEEeC
Confidence            888999999999 99999999876678999999999999999999999  8999999999999999   68899999999


Q ss_pred             cCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          247 GLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       247 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |+++........     .......||+.|+|||++.+..++.++|||||||+||||++|..||..............+..
T Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence            999875443221     112246899999999999999999999999999999999999999987654333322221111


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCccch
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDL  383 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~~~  383 (429)
                      .... ..+..         ....++.++.+||..||+.||++||++.+|++.|+.+......
T Consensus       231 ~~~~-~~~~~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~  282 (483)
T 3sv0_A          231 KKVA-TSIEA---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF  282 (483)
T ss_dssp             HHHH-SCHHH---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cccc-ccHHH---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence            0000 00000         0012347899999999999999999999999988877654443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-46  Score=359.99  Aligned_cols=266  Identities=25%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+....    ...++..||||.+.... ......+.+|+.+|++++||||+++++++..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            357999999999999999999854321    11235589999997543 3445678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCCE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRT------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNA  241 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~  241 (429)
                      .+..|+||||++|++|.+++....      ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.   +..+
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEEecCCCcceE
Confidence            999999999999999999997653      34889999999999999999999  899999999999999984   4469


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....   .....   
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~---  256 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLE---  256 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH---
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHH---
Confidence            9999999875433222222233578999999999999999999999999999999998 9999975431   11111   


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                      . .      .    .......+...+..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus       257 ~-~------~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          257 F-V------T----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             H-H------H----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             H-H------h----cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            0 0      0    0111122234457899999999999999999999999988766543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-45  Score=351.54  Aligned_cols=261  Identities=22%  Similarity=0.269  Sum_probs=201.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|++.....   .....+.+|+.++++++||||+++++++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  103 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRER---------IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG  103 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCe---------EEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence            3689999999999999999999877654         899999875532   2246788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ..++..|+||||++|++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~  180 (309)
T 2h34_A          104 EIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGI  180 (309)
T ss_dssp             EETTEEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred             eeCCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEEcCCCCEEEecCcc
Confidence            99999999999999999999987653 6899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +........ .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....       ......+.    
T Consensus       181 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~----  248 (309)
T 2h34_A          181 ASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHIN----  248 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHH----
T ss_pred             Ccccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhc----
Confidence            976543221 122345799999999999998999999999999999999999999975321       01111111    


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-CHhHHHHHhcCCcCc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-SMDEVVKVLTPLQDL  380 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~eil~~l~~~~~~  380 (429)
                        ...  ..........+..+.+||.+||+.||++|| +++++++.|+.....
T Consensus       249 --~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          249 --QAI--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             --SCC--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             --cCC--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence              000  011122234457899999999999999999 999999988766543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.1e-46  Score=376.34  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=208.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|.+.+.||+|+||.||+|++..+++         .||+|++.....   .....+.+|+.+|++++||||+++++++.
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~---------~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  255 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGK---------LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE  255 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCc---------EEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            679999999999999999999987655         999999965422   23356789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      ..+.+|+||||++||+|.+++...   ...+++..++.++.||+.||.|||  +.||+||||||+|||++.+|.+||+||
T Consensus       256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEEeec
Confidence            999999999999999999998654   346899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||........  .........   
T Consensus       334 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~---  406 (543)
T 3c4z_A          334 GLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVL---  406 (543)
T ss_dssp             TTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHH---
T ss_pred             ceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHh---
Confidence            99987544322  12336899999999999999999999999999999999999999986543221  111111111   


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH-----hHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM-----DEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~eil~  372 (429)
                             ...  ..++...+..+.+||.+||+.||.+||++     .+|++
T Consensus       407 -------~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          407 -------EQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -------HCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -------hcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                   111  12233455789999999999999999975     66664

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=353.39  Aligned_cols=270  Identities=25%  Similarity=0.384  Sum_probs=204.5

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC--CCcceeeEE
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL--HHPNLVKLI  165 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~  165 (429)
                      .....++|++.+.||+|+||.||+|.+.           |..||||++...   ....+..|.+++..+  +||||++++
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~   97 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFI   97 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEE
Confidence            3445568999999999999999999874           348999998643   223445566666554  899999999


Q ss_pred             eEEEeC----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCC--------CeeeCCCCCCCe
Q 014202          166 GYCIED----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE--------PVIYRDFKTSNI  233 (429)
Q Consensus       166 ~~~~~~----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--------~ivHrDlkp~Ni  233 (429)
                      +++...    ...|+||||+++|+|.+++...  .+++..++.++.|++.||.|||  ..        +|+||||||+||
T Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~~~~ivH~Dikp~Ni  173 (337)
T 3mdy_A           98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH--TEIFSTQGKPAIAHRDLKSKNI  173 (337)
T ss_dssp             EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH--SCBCSTTCBCCEECSCCCGGGE
T ss_pred             EEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH--HhhhhhccCCCEEecccchHHE
Confidence            999887    7899999999999999999654  5899999999999999999999  66        999999999999


Q ss_pred             EEcCCCCEEEccccCcccCCCCCccc--eeeeccccccccChhhhhcCCCCCc------cchhhhHHHHHHHHhC-----
Q 014202          234 LLDSEYNAKLSDFGLAKAGPQGDKTH--VSTRVVGTYGYAAPEYVMTGHLTSK------SDVYSFGVVLLEILTG-----  300 (429)
Q Consensus       234 ll~~~~~~kl~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~ell~g-----  300 (429)
                      |++.++.+||+|||++..........  ......||+.|+|||++.+..++..      +|||||||++|||++|     
T Consensus       174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~  253 (337)
T 3mdy_A          174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG  253 (337)
T ss_dssp             EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence            99999999999999997654322211  1123579999999999988776665      9999999999999999     


Q ss_pred             -----CCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccC-CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHh
Q 014202          301 -----RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL  374 (429)
Q Consensus       301 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l  374 (429)
                           ..||....+.... .... ....     ......+..+.. ....++..+.+|+.+||+.||.+|||+.++++.|
T Consensus       254 ~~~~~~~p~~~~~~~~~~-~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          254 IVEEYQLPYHDLVPSDPS-YEDM-REIV-----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             BCCCCCCTTTTTSCSSCC-HHHH-HHHH-----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             ccccccccHhhhcCCCCc-hhhh-HHHH-----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence                 6666544332211 1110 0000     011111111111 1236778899999999999999999999999999


Q ss_pred             cCCcCccc
Q 014202          375 TPLQDLND  382 (429)
Q Consensus       375 ~~~~~~~~  382 (429)
                      +.+.....
T Consensus       327 ~~l~~~~~  334 (337)
T 3mdy_A          327 AKMSESQD  334 (337)
T ss_dssp             HHHHHTTT
T ss_pred             HHHHhhcc
Confidence            87765443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-45  Score=366.96  Aligned_cols=275  Identities=23%  Similarity=0.323  Sum_probs=201.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC--CchhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD--GLQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++...  .....+.+.+|+.+|++++||||+++++++.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~   95 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEK---------NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII   95 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCc---------EEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence            4689999999999999999999987654         9999999754  2234567899999999999999999999998


Q ss_pred             eC-----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          170 ED-----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       170 ~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ..     ...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A           96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             CSCTTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHeEECCCCCEEEc
Confidence            76     57899999985 5999988654 46999999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCcc--------------------ceeeeccccccccChhhh-hcCCCCCccchhhhHHHHHHHHhCCCC
Q 014202          245 DFGLAKAGPQGDKT--------------------HVSTRVVGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEILTGRRS  303 (429)
Q Consensus       245 DFg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~p  303 (429)
                      |||+++........                    ......+||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            99999875432211                    123457899999999986 456799999999999999999986555


Q ss_pred             CC-----------CCCCCcc-----------ccHHHHHHHH---HHh----------hhhhh---hhcCCccccC---CC
Q 014202          304 MD-----------KKRPSGE-----------QNLVAWARQY---LAD----------KRKLY---QIVDPRLELN---YS  342 (429)
Q Consensus       304 f~-----------~~~~~~~-----------~~~~~~~~~~---~~~----------~~~~~---~~~~~~~~~~---~~  342 (429)
                      |.           +......           ..........   +..          .....   ..........   ..
T Consensus       252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (432)
T 3n9x_A          252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY  331 (432)
T ss_dssp             TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred             cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence            43           2221000           0000000000   000          00000   0000000000   01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCcC
Q 014202          343 LKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQD  379 (429)
Q Consensus       343 ~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~~  379 (429)
                      ...++.+.+||.+||+.||.+|||+.|+++  ++..+..
T Consensus       332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            124578999999999999999999999998  5555543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-45  Score=356.96  Aligned_cols=265  Identities=23%  Similarity=0.335  Sum_probs=202.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||++......  ....+.+|+.+|+.++||||+++++++..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   87 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQ---------KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   87 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCC---------EEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCC---------EEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence            579999999999999999999987655         9999998655332  24567899999999999999999999887


Q ss_pred             --------CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          171 --------DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       171 --------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                              .+..|+||||+.+ +|.+.+......+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~k  164 (351)
T 3mi9_A           88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLK  164 (351)
T ss_dssp             C--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEE
T ss_pred             cccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCCEE
Confidence                    4468999999975 888888777677999999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCc--cceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          243 LSDFGLAKAGPQGDK--THVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       243 l~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      |+|||++........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....   .....+
T Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i  241 (351)
T 3mi9_A          165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALI  241 (351)
T ss_dssp             ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH
T ss_pred             EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHH
Confidence            999999986543221  122234678999999999876 45899999999999999999999999764321   111111


Q ss_pred             HHHHHhh-hhh---------hhhcCCccccCCCH-------HHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          320 RQYLADK-RKL---------YQIVDPRLELNYSL-------KGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       320 ~~~~~~~-~~~---------~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ....... ...         ..............       ..++.+.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1110000 000         00000000000000       01356889999999999999999999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.4e-46  Score=346.95  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=203.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch------hhHHHHHHHHHHhcCCCcceeeEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ------GHREWVAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~  166 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||+|++......      ....+.+|+.+|++++||||+++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGK---------EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD   75 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCC---------eeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence            469999999999999999999987655         9999998765322      3567899999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----CEE
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NAK  242 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~~k  242 (429)
                      ++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++    .+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           76 IFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred             eecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCCCCceE
Confidence            999999999999999999999998654 36899999999999999999999  89999999999999998877    799


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |+|||++.......   ......|++.|+|||++.+..++.++||||||+++|+|++|..||.....      .......
T Consensus       153 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~  223 (283)
T 3bhy_A          153 LIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNI  223 (283)
T ss_dssp             ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHH
T ss_pred             EEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHh
Confidence            99999998754322   12335799999999999989999999999999999999999999975431      1111100


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .        ..............+..+.+|+.+||..||++||++.++++
T Consensus       224 ~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          224 S--------AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             H--------TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             H--------hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            0        00011111111123467999999999999999999999997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.3e-46  Score=375.32  Aligned_cols=251  Identities=26%  Similarity=0.376  Sum_probs=206.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++....   ......+.+|+.+|++++||||+++++++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   95 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQ---------ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF   95 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCC---------EEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3579999999999999999999987655         99999986553   23456789999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCCEEEcc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSD  245 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D  245 (429)
                      ...+..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||+   +.++.+||+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           96 EDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            99999999999999999999886654 6899999999999999999999  8999999999999999   5678999999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      ||++........   ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....      ........ 
T Consensus       173 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~-  241 (484)
T 3nyv_A          173 FGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEK-  241 (484)
T ss_dssp             TTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-
T ss_pred             eeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc-
Confidence            999986543322   233579999999998876 6999999999999999999999999764321      11111100 


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             .......+.....++.+.+||.+||+.||.+|||+.++++
T Consensus       242 -------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 -------GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -------CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                   0011111122345678999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-46  Score=351.61  Aligned_cols=258  Identities=29%  Similarity=0.447  Sum_probs=208.3

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ....++|++.+.||+|+||.||+|.+..          +..||||.+.... .....+.+|+.+|++++||||+++++++
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~   77 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV   77 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcC----------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence            3445689999999999999999998653          3479999997654 3456789999999999999999999987


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      . ++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||  +.||+||||||+|||++.++.+||+|||
T Consensus        78 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             c-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence            6 456899999999999999986542 25899999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......      .....     
T Consensus       155 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~-----  222 (279)
T 1qpc_A          155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQN-----  222 (279)
T ss_dssp             TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-----
T ss_pred             ccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHH-----
Confidence            9987543221 11223457889999999998899999999999999999999 99999754311      11111     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        +..    ......+...+..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus       223 --~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          223 --LER----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             --HHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --Hhc----ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence              001    1111223344578999999999999999999999999887654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=356.91  Aligned_cols=263  Identities=27%  Similarity=0.390  Sum_probs=203.6

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEE
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLI  165 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~  165 (429)
                      ++....++|++.+.||+|+||.||+|++..++.         .||||++.... .....+.+|+.+|+++ +||||++++
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~   87 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQ---------LAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYY   87 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCC---------eEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeee
Confidence            334456789999999999999999999977654         99999987553 3346788999999999 799999999


Q ss_pred             eEEEe------CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 014202          166 GYCIE------DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE  238 (429)
Q Consensus       166 ~~~~~------~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~  238 (429)
                      +++..      .+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||  ..||+||||||+|||++.+
T Consensus        88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~  165 (326)
T 2x7f_A           88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTEN  165 (326)
T ss_dssp             EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTT
T ss_pred             eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcHHHEEEcCC
Confidence            99987      46889999999999999999764 346899999999999999999999  8999999999999999999


Q ss_pred             CCEEEccccCcccCCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 014202          239 YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ  313 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  313 (429)
                      +.+||+|||++.......  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||......   
T Consensus       166 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---  240 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---  240 (326)
T ss_dssp             CCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---
T ss_pred             CCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---
Confidence            999999999998653321  1223357999999999986     567899999999999999999999999654311   


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCcC
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQD  379 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~~  379 (429)
                         .....       +.....   ........+..+.+||.+||..||.+||++.++++  ++.....
T Consensus       241 ---~~~~~-------~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          241 ---RALFL-------IPRNPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             ---HHHHH-------HHHSCC---CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ---HHHHH-------hhcCcc---ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence               10000       011111   11112234578999999999999999999999998  5554433

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.3e-46  Score=373.98  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=203.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||++....  ......+.+|+.+|++++||||+++++++..
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQ---------EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCC---------EEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCC---------EEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            579999999999999999999987655         99999986431  2335678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCCEEEcccc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD---SEYNAKLSDFG  247 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~DFg  247 (429)
                      ....|+||||+.||+|.+++.... .+++..+..++.||+.||.|||  +.||+||||||+|||++   .++.+||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            999999999999999999886654 5899999999999999999999  89999999999999994   45679999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ++.......   .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...      ..........  
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~--  237 (486)
T 3mwu_A          170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETG--  237 (486)
T ss_dssp             CTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT--
T ss_pred             cCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC--
Confidence            998654322   2234679999999998875 589999999999999999999999976432      1111111100  


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ......+.....++.+.+||.+||+.||.+|||+.++++
T Consensus       238 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          238 ------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ------CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  011111122344578999999999999999999999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.6e-45  Score=345.36  Aligned_cols=249  Identities=25%  Similarity=0.384  Sum_probs=200.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..|++.+.||+|+||.||+|.+..++.         .||+|.+....  ......+.+|+.+|++++||||+++++++..
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---------~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTV---------EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCce---------EEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            458889999999999999999887655         89999987543  2345678899999999999999999999876


Q ss_pred             ----CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeEEc-CCCCEEE
Q 014202          171 ----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP--VIYRDFKTSNILLD-SEYNAKL  243 (429)
Q Consensus       171 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~--ivHrDlkp~Nill~-~~~~~kl  243 (429)
                          ....++||||+++++|.+++... ..+++..++.++.|++.||.|||  +.+  |+||||||+|||++ .++.+||
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH--cCCCCEEECCCCHHHEEEECCCCCEEE
Confidence                35689999999999999999664 35899999999999999999999  777  99999999999997 7899999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      +|||++......    ......||+.|+|||++. +.++.++|||||||++|+|++|..||.....     .......  
T Consensus       174 ~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~--  241 (290)
T 1t4h_A          174 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRR--  241 (290)
T ss_dssp             CCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHH--
T ss_pred             eeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHH--
Confidence            999999764332    223467999999999876 4589999999999999999999999975332     1111111  


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                              ..........+...++.+.+||.+||+.||.+|||+.++++.
T Consensus       242 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          242 --------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --------HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    111111111222234679999999999999999999999973

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.2e-46  Score=352.63  Aligned_cols=253  Identities=24%  Similarity=0.393  Sum_probs=202.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|++..........+.+|+.+|+.++||||+++++++..+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGA---------LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD   88 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCC---------EEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCc---------EEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence            4679999999999999999999987654         8999999877666677889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++++|.+++......+++..+..++.|++.||.|||  ..||+||||||+|||++.++.+||+|||++..
T Consensus        89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999999999998776667999999999999999999999  89999999999999999999999999998753


Q ss_pred             CCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ...  .........||+.|+|||++.     +..++.++||||||+++|+|++|..||.....      ........   
T Consensus       167 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~---  235 (302)
T 2j7t_A          167 NLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA---  235 (302)
T ss_dssp             HHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH---
T ss_pred             ccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHh---
Confidence            211  111122357999999999984     56789999999999999999999999975432      11111100   


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          ..  .......+...+..+.+||.+||+.||.+|||+.++++
T Consensus       236 ----~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          236 ----KS--DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----HS--CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----cc--CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                00  01111223344578999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-46  Score=353.60  Aligned_cols=262  Identities=27%  Similarity=0.411  Sum_probs=202.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+.....      .+..||||++....   ....+.+.+|+.++++++||||+++++++.
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCC------ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            579999999999999999998754322      13369999987652   244567889999999999999999999988


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .+. .++||||+.+++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCCCCEEEcccccc
Confidence            765 88999999999999999876667899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          250 KAGPQGDKTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       250 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....      .....       
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~-------  235 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILH-------  235 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH-------
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHH-------
Confidence            8764433221 2223567889999999998889999999999999999999 9999975431      11111       


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                         .+.........+...+..+.+++.+||..||.+|||+.++++.|..++.
T Consensus       236 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          236 ---KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ---HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ---HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence               1111111222233456789999999999999999999999998876654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.3e-45  Score=352.04  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=207.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|.+.+.||+|+||.||+|.+..++.         .||+|++....   ......+.+|+.+++.++||||+++++++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  110 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKE---------VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF  110 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3679999999999999999999987655         89999986542   23456788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+.+..|+||||+.+++|.+++... ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          111 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence            9999999999999999999988654 36899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....      ..........   
T Consensus       188 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~---  256 (335)
T 2owb_A          188 ATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKN---  256 (335)
T ss_dssp             CEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHT---
T ss_pred             ceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcC---
Confidence            987543221  22336799999999999998999999999999999999999999975321      1111110000   


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                           .    ...+...+..+.+||.+||+.||++||++.++++
T Consensus       257 -----~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          257 -----E----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -----C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -----C----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0    1122234478999999999999999999999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=353.23  Aligned_cols=249  Identities=30%  Similarity=0.496  Sum_probs=196.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||+|.+.           +..||||.+...  ...+.+.+|+.+|++++||||+++++++.  +
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~   72 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N   72 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence            46999999999999999999874           348999999754  34567899999999999999999999876  4


Q ss_pred             eEEEEEEecCCCChHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhCCC---CCeeeCCCCCCCeEEcCCCC-EEEccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTI--PLPWSNRIKIALGAAKGLAFLHGGS---EPVIYRDFKTSNILLDSEYN-AKLSDF  246 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---~~ivHrDlkp~Nill~~~~~-~kl~DF  246 (429)
                      ..++||||++||+|.+++.....  .+++..++.++.|++.||.|||  .   .+|+||||||+|||++.++. +||+||
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH--SMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH--TCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH--hCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence            47999999999999999976542  4788999999999999999999  6   79999999999999988887 799999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||.......    ......     
T Consensus       151 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~-----  216 (307)
T 2eva_A          151 GTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWA-----  216 (307)
T ss_dssp             CC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHH-----
T ss_pred             ccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHH-----
Confidence            999764321     123469999999999999999999999999999999999999997543211    110000     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        ......+    ......+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       217 --~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          217 --VHNGTRP----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             --HHTTCCC----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             --HhcCCCC----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence              0011111    122234578999999999999999999999999887654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-45  Score=373.47  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=199.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++++.||+|+||.||+|++..++.         .||+|++....  ......+.+|+.+|+.++||||+++++++.+
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  107 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHV---------ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED  107 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCC---------EEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCc---------EEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            469999999999999999999987655         89999997653  2335678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CCEEEcccc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLSDFG  247 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~DFg  247 (429)
                      ....|+|||||.||+|.+++.... .+++..+..++.||+.||.|||  +.||+||||||+|||++..   +.+||+|||
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            999999999999999999886654 5899999999999999999999  8999999999999999764   459999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ++.......   .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+...      ..........  
T Consensus       185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~--  252 (494)
T 3lij_A          185 LSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKG--  252 (494)
T ss_dssp             TCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT--
T ss_pred             CCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC--
Confidence            998754322   223467999999999876 5699999999999999999999999976432      1111111100  


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ............+..+.+||.+||+.||.+|||+.++++
T Consensus       253 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          253 ------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                  000111111234578999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.1e-46  Score=356.28  Aligned_cols=263  Identities=22%  Similarity=0.271  Sum_probs=194.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++......  ....+.+|+.+|++++||||+++++++.
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNE---------TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH  103 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCc---------eEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence            3579999999999999999999887654         9999999765432  2355779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-----CCCCEEEc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-----SEYNAKLS  244 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~-----~~~~~kl~  244 (429)
                      .++..++||||+.| +|.+++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||++     .++.+||+
T Consensus       104 ~~~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          104 HNHRLHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             cCCEEEEEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence            99999999999975 9999986654 5899999999999999999999  89999999999999994     45569999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||++.......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......   .........+
T Consensus       180 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~  254 (329)
T 3gbz_A          180 DFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVL  254 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH
T ss_pred             cCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHh
Confidence            999997643221  122335789999999999874 5899999999999999999999999764321   1111000000


Q ss_pred             Hhh-hh-------hhhhc-------CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADK-RK-------LYQIV-------DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~-~~-------~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ... ..       .....       ...+........+.++.+||.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000 00       00000       000000001113478899999999999999999999997

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.5e-46  Score=348.43  Aligned_cols=246  Identities=25%  Similarity=0.385  Sum_probs=205.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||+|++.....   .....+.+|+.++++++||||+++++++.
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKF---------IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCc---------EEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            579999999999999999999877644         899999864321   22356889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..++||||+++++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  161 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWS  161 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEeccccc
Confidence            9999999999999999999987654 5899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .......    .....|++.|+|||++.+..++.++||||||+++|+|++|..||.....      .....         
T Consensus       162 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~---------  222 (284)
T 2vgo_A          162 VHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHR---------  222 (284)
T ss_dssp             EECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH---------
T ss_pred             ccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHH---------
Confidence            7643322    2235799999999999999999999999999999999999999975321      11111         


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       .+....  ...+...+..+.+||.+||+.||.+||++.++++
T Consensus       223 -~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          223 -RIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -HHHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence             111111  1122334578999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=367.10  Aligned_cols=273  Identities=22%  Similarity=0.273  Sum_probs=213.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD---------LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCc---------EEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            4579999999999999999999987655         999999975432 334667899999999999999999999987


Q ss_pred             CC--eEEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCCEE
Q 014202          171 DD--QRLLVYEFMTRGSLENHLFRRT--IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL----DSEYNAK  242 (429)
Q Consensus       171 ~~--~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~k  242 (429)
                      .+  ..++||||++||+|.+++....  ..+++..++.++.|++.||.|||  +.+|+||||||+|||+    +.++.+|
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~k  156 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYK  156 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCceeEE
Confidence            65  7799999999999999986543  33899999999999999999999  8999999999999999    7778899


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhc--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT--------GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN  314 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  314 (429)
                      |+|||+++......   ......||+.|+|||++.+        ..++.++|||||||++|||++|..||......... 
T Consensus       157 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-  232 (396)
T 4eut_A          157 LTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-  232 (396)
T ss_dssp             ECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-
T ss_pred             EecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-
Confidence            99999998754322   1223679999999999875        56778999999999999999999999754432221 


Q ss_pred             HHHHHHHHHHhhh-hhh----hhc--------CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          315 LVAWARQYLADKR-KLY----QIV--------DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       315 ~~~~~~~~~~~~~-~~~----~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                       .+.....+.... ...    ...        ............+..+.+++.+||+.||++||++.++++.+..+...
T Consensus       233 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          233 -KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             -HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             -HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence             111111111110 000    000        01112234467788999999999999999999999999877666543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-45  Score=373.03  Aligned_cols=252  Identities=25%  Similarity=0.347  Sum_probs=202.5

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-------------hhhHHHHHHHHHHhcCC
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-------------QGHREWVAEVDFLGQLH  157 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~  157 (429)
                      ..++|++++.||+|+||.||+|.+..++.         .||||++.....             .....+.+|+.+|++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHS---------EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCC---------EEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCc---------EEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            45689999999999999999999987655         999999976432             22467889999999999


Q ss_pred             CcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       158 hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      ||||+++++++.+....|+|||||+||+|.+++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||++.
T Consensus       105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~  181 (504)
T 3q5i_A          105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLEN  181 (504)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESS
T ss_pred             CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHHEEEec
Confidence            9999999999999999999999999999999886654 5899999999999999999999  899999999999999987


Q ss_pred             CC---CEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 014202          238 EY---NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN  314 (429)
Q Consensus       238 ~~---~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  314 (429)
                      ++   .+||+|||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+....    
T Consensus       182 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----  253 (504)
T 3q5i_A          182 KNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----  253 (504)
T ss_dssp             TTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred             CCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence            76   69999999998754432   223467999999999876 56899999999999999999999999764321    


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                        .........        ............+..+.+||.+||+.||.+|||+.|+++
T Consensus       254 --~~~~~i~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          254 --DIIKKVEKG--------KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             --HHHHHHHHC--------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHHHHcC--------CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              111111100        000000001123578999999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.6e-46  Score=363.24  Aligned_cols=265  Identities=25%  Similarity=0.343  Sum_probs=205.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|++..... .....+.+|+.+|++++||||+++++++..
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGL---------VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS  102 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCc---------EEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence            3679999999999999999999987655         999999976533 334678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++..++||||++|++|.+++.... .+++..+..++.|++.||.|||  +. +|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence            999999999999999999996654 5899999999999999999999  65 8999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH------------
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA------------  317 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~------------  317 (429)
                      .....    .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............            
T Consensus       180 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3eqc_A          180 GQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  255 (360)
T ss_dssp             HHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred             ccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence            65321    12233689999999999999999999999999999999999999997543211000000            


Q ss_pred             -------HHHHHHH---h----hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 -------WARQYLA---D----KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 -------~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             ....+..   .    ...+................+.++.+||.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                   0000000   0    00000011111111112234578999999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=356.47  Aligned_cols=275  Identities=25%  Similarity=0.356  Sum_probs=213.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||.||+|++....     ..+|..||||++........+.+.+|+.+|++++||||+++++++...+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQ-----DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTS-----SSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             HHceeeeeeccCCCeEEEEEEecccc-----CCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            56999999999999999999853211     1236699999998876666778999999999999999999999987654


Q ss_pred             --eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          173 --QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       173 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                        ..++||||+++++|.+++......+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence              689999999999999999887667999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH---HHhh
Q 014202          251 AGPQGDKTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY---LADK  326 (429)
Q Consensus       251 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~~  326 (429)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++|..||.....    .........   ....
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhH
Confidence            764432211 12234577889999999998899999999999999999999998853210    000000000   0000


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..+...+........+..++..+.+||.+||+.||++|||+.++++.|+.+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0111111111122233455688999999999999999999999999887653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.3e-46  Score=355.98  Aligned_cols=264  Identities=26%  Similarity=0.389  Sum_probs=201.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||++......  ..+.+.+|+.+|++++||||+++++++..
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGR---------IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCC---------EEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCc---------eEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            479999999999999999999987655         9999998655332  24557899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      .+..++||||+++++|.+++... ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFAR  172 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             CCEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence            99999999999998888876443 46899999999999999999999  8999999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH---------
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR---------  320 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------  320 (429)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||........  ......         
T Consensus       173 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~  248 (331)
T 4aaa_A          173 TLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRH  248 (331)
T ss_dssp             -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHH
T ss_pred             eecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhh
Confidence            643322  122345799999999999875 789999999999999999999999976432111  100000         


Q ss_pred             -HHHHhhhhhhhhcCCccccC-----CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          321 -QYLADKRKLYQIVDPRLELN-----YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       321 -~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       ..............+.....     .....++.+.+||.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             00000000000001111100     11234578999999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.8e-46  Score=364.09  Aligned_cols=265  Identities=20%  Similarity=0.253  Sum_probs=206.1

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC--------Cccee
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH--------HPNLV  162 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv  162 (429)
                      ..++|++.+.||+|+||.||+|++..++.         .||||++... ......+.+|+.+|+.++        |+||+
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKK---------FVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCe---------EEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            35789999999999999999999887654         9999999754 234567889999999985        78899


Q ss_pred             eEEeEEE----eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCeEEc
Q 014202          163 KLIGYCI----EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNILLD  236 (429)
Q Consensus       163 ~~~~~~~----~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~ivHrDlkp~Nill~  236 (429)
                      ++++++.    .....|+||||+ +++|.+.+... ...+++..++.++.||+.||.|||  +. ||+||||||+|||++
T Consensus       105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~givHrDikp~NIll~  181 (397)
T 1wak_A          105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLS  181 (397)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECCCCSGGGEEEC
T ss_pred             eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCCHHHeeEe
Confidence            9999988    556789999999 56776666554 356999999999999999999999  77 999999999999998


Q ss_pred             CCC-------------------------------------------------CEEEccccCcccCCCCCccceeeecccc
Q 014202          237 SEY-------------------------------------------------NAKLSDFGLAKAGPQGDKTHVSTRVVGT  267 (429)
Q Consensus       237 ~~~-------------------------------------------------~~kl~DFg~a~~~~~~~~~~~~~~~~gt  267 (429)
                      .++                                                 .+||+|||++......     .....||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt  256 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT  256 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence            775                                                 7999999999875332     2235799


Q ss_pred             ccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh-----------hhcCCc
Q 014202          268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY-----------QIVDPR  336 (429)
Q Consensus       268 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~  336 (429)
                      +.|+|||++.+..++.++|||||||++|||++|..||..........................           ......
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            999999999999999999999999999999999999986654332222111111111000000           000000


Q ss_pred             -------------------cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          337 -------------------LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       337 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                                         .....+...+..+.+||.+||+.||++|||+.|+++.
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                               0112345667889999999999999999999999973

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.5e-46  Score=368.12  Aligned_cols=255  Identities=22%  Similarity=0.315  Sum_probs=195.1

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--------hhhHHHHHHHHHHhcCCCcce
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--------QGHREWVAEVDFLGQLHHPNL  161 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnI  161 (429)
                      ...++|.+.+.||+|+||.||+|++..++.         .||||++.....        .....+.+|+.+|++++||||
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  202 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCK---------KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI  202 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCc---------EEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence            445789999999999999999999987755         999999865421        122357899999999999999


Q ss_pred             eeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC--
Q 014202          162 VKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY--  239 (429)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--  239 (429)
                      +++++++. .+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++  
T Consensus       203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~  278 (419)
T 3i6u_A          203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEED  278 (419)
T ss_dssp             CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSSS
T ss_pred             eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCCCc
Confidence            99999975 45689999999999999988654 46899999999999999999999  89999999999999996544  


Q ss_pred             -CEEEccccCcccCCCCCccceeeeccccccccChhhhhc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          240 -NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       240 -~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                       .+||+|||+++.....   ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......  ..
T Consensus       279 ~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~  353 (419)
T 3i6u_A          279 CLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SL  353 (419)
T ss_dssp             CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CH
T ss_pred             ceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HH
Confidence             5999999999875432   22334689999999999853   567889999999999999999999997643321  11


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      .....    .      . ............+..+.+||.+||+.||.+|||+.++++.
T Consensus       354 ~~~i~----~------~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          354 KDQIT----S------G-KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHHH----T------T-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHh----c------C-CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11100    0      0 0000000011234789999999999999999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-45  Score=345.67  Aligned_cols=249  Identities=29%  Similarity=0.418  Sum_probs=205.4

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||+|.+....    ..+.+|+.+|++++||||+++++++..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG   75 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCC---------EEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCe---------EEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence            34579999999999999999999887654         99999997553    356789999999999999999998865


Q ss_pred             ----------------CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 014202          171 ----------------DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNI  233 (429)
Q Consensus       171 ----------------~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Ni  233 (429)
                                      ....++||||+++++|.+++... ...+++..++.++.|++.||.|||  +.+|+||||||+||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Ni  153 (284)
T 2a19_B           76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNI  153 (284)
T ss_dssp             EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGE
T ss_pred             cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHE
Confidence                            44579999999999999999654 356899999999999999999999  89999999999999


Q ss_pred             EEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 014202          234 LLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ  313 (429)
Q Consensus       234 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  313 (429)
                      |++.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...      
T Consensus       154 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------  224 (284)
T 2a19_B          154 FLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------  224 (284)
T ss_dssp             EEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------
T ss_pred             EEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------
Confidence            999999999999999987544321   22357999999999999999999999999999999999998886310      


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                        ....          ........    +...+..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       225 --~~~~----------~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          225 --SKFF----------TDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             --HHHH----------HHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             --HHHH----------HHhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence              0000          01111111    12234678999999999999999999999998876654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=361.18  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=190.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEE-
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCI-  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~-  169 (429)
                      ..+|++.+.||+|+||.||+|.+..++.         .||||++..........+.+|+.+|.++. ||||+++++++. 
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGR---------EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCC---------EEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCc---------EEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            4579999999999999999999887655         99999997666666678899999999996 999999999984 


Q ss_pred             -------eCCeEEEEEEecCCCChHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeEEcCC
Q 014202          170 -------EDDQRLLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALGAAKGLAFLHGGSEP--VIYRDFKTSNILLDSE  238 (429)
Q Consensus       170 -------~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~--ivHrDlkp~Nill~~~  238 (429)
                             .....++||||+. |+|.+++..  ....+++..++.++.||+.||.|||  ..+  |+||||||+|||++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCCCCCGGGCEECTT
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEEccCCcccEEECCC
Confidence                   3345799999995 699998864  3456999999999999999999999  778  9999999999999999


Q ss_pred             CCEEEccccCcccCCCCCccc----------eeeeccccccccChhhh---hcCCCCCccchhhhHHHHHHHHhCCCCCC
Q 014202          239 YNAKLSDFGLAKAGPQGDKTH----------VSTRVVGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEILTGRRSMD  305 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~  305 (429)
                      +.+||+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            999999999998754322111          11135699999999998   56678899999999999999999999996


Q ss_pred             CCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          306 KKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ......                    ..............+..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       255 ~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          255 DGAKLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            432110                    011111111122233568899999999999999999999998876654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.4e-46  Score=386.60  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=208.3

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcC-CCcceeeEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQL-HHPNLVKLIG  166 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~  166 (429)
                      ..++|++++.||+|+||.||+|++..+++         .||||++....   ......+..|..+|..+ +||||+++++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~---------~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~  409 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDE---------LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS  409 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCC---------EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCc---------EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            34789999999999999999999987755         89999987542   22345678899999988 6999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      ++.+.+.+||||||++||+|.+++.... .+++..++.++.||+.||+|||  +.+|+||||||+||||+.+|.+||+||
T Consensus       410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ikL~DF  486 (674)
T 3pfq_A          410 CFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADF  486 (674)
T ss_dssp             ECBCSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEEECCC
T ss_pred             EEEeCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEEEeec
Confidence            9999999999999999999999997654 5899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+...      .+...      
T Consensus       487 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~------  552 (674)
T 3pfq_A          487 GMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQ------  552 (674)
T ss_dssp             TTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH------
T ss_pred             ceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHH------
Confidence            99986433221  23447899999999999999999999999999999999999999976431      11111      


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCH-----hHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM-----DEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~eil~  372 (429)
                          .++...+  .++...+.++.+||.+||+.||.+||++     ++|++
T Consensus       553 ----~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          553 ----SIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----HHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----HHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                1122211  2333456889999999999999999997     77775

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-45  Score=358.28  Aligned_cols=266  Identities=22%  Similarity=0.288  Sum_probs=201.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++.....  ...+.+.+|+.+|+.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   94 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGA---------KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   94 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCC---------EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCC---------EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence            4689999999999999999999987655         999999965422  33467889999999999999999999998


Q ss_pred             eCC------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          170 EDD------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       170 ~~~------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      ...      .+|+||||+ +++|.+++...  .+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl  169 (367)
T 1cm8_A           95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKI  169 (367)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             cCCccccCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCCCCEEE
Confidence            763      469999999 88999988663  5899999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      +|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.....   ....+...
T Consensus       170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~  241 (367)
T 1cm8_A          170 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKV  241 (367)
T ss_dssp             CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH
T ss_pred             Eeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHh
Confidence            999999875332     233689999999999887 679999999999999999999999997643211   11111100


Q ss_pred             HHh-hh------------hhhhhcCC---ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCcC
Q 014202          323 LAD-KR------------KLYQIVDP---RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQD  379 (429)
Q Consensus       323 ~~~-~~------------~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~~  379 (429)
                      ... ..            .....+..   ..-.......++.+.+||.+||+.||.+|||+.++++  ++..+..
T Consensus       242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            000 00            00000000   0000112234578999999999999999999999998  5555543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4e-46  Score=348.74  Aligned_cols=250  Identities=29%  Similarity=0.448  Sum_probs=199.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+.           |..||||++....  ..+.+.+|+.++++++||||+++++++...
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            357999999999999999999864           3489999997553  456788999999999999999999987654


Q ss_pred             -CeEEEEEEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          172 -DQRLLVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       172 -~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                       +..++||||+++++|.+++..... .+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeecccc
Confidence             478999999999999999966532 3789999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      .......     ....+++.|+|||++.+..++.++||||||+++|+|++ |..||......   ...            
T Consensus       165 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~------------  224 (278)
T 1byg_A          165 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV------------  224 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH------------
T ss_pred             ccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH------------
Confidence            8643321     22467899999999999999999999999999999998 99999754321   111            


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        ..+........+...+..+.++|.+||+.||.+||++.++++.|+.+.
T Consensus       225 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          225 --PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             --HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence              111111122233445678999999999999999999999999887664

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-45  Score=347.87  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=206.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|.+.+.||+|+||.||+|.+..++.         .||+|++....   ......+.+|+.+++.++||||+++++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKE---------VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF   84 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCc---------eEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            3579999999999999999999987655         89999986542   23446788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+++..++||||+++++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  161 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGL  161 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCCCCEEEEeccC
Confidence            99999999999999999999886543 6899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      +........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....      .+...        
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~--------  225 (294)
T 2rku_A          162 ATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYL--------  225 (294)
T ss_dssp             CEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH--------
T ss_pred             ceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH--------
Confidence            987543221  22336799999999999988899999999999999999999999975431      11111        


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                        .+....  ...+...+..+.+|+.+||+.||++|||+.++++
T Consensus       226 --~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          226 --RIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             --HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --HHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence              011111  1122234578999999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.4e-46  Score=350.19  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=206.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|.+.....  ...+.+.+|+.+|++++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGK---------ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII   75 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCc---------EEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            3579999999999999999999987654         999999976532  34467889999999999999999999875


Q ss_pred             e--CCeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCC-----eeeCCCCCCCeEEcCCC
Q 014202          170 E--DDQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEP-----VIYRDFKTSNILLDSEY  239 (429)
Q Consensus       170 ~--~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~-----ivHrDlkp~Nill~~~~  239 (429)
                      .  +...|+||||+++++|.+++...   ...+++..++.++.|++.||.|||  ..+     |+||||||+|||++.++
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~ivH~dl~p~NIl~~~~~  153 (279)
T 2w5a_A           76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQ  153 (279)
T ss_dssp             EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHC------CCCCCSGGGEEECSSS
T ss_pred             cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--cccCCCCeeEEeccchhhEEEcCCC
Confidence            4  56889999999999999998653   345899999999999999999999  777     99999999999999999


Q ss_pred             CEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       240 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      .+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....   ....   
T Consensus       154 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---  225 (279)
T 2w5a_A          154 NVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA---  225 (279)
T ss_dssp             CEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---
T ss_pred             CEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHH---
Confidence            999999999987543221  12235799999999999998999999999999999999999999975431   1111   


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..       +......    ..+...+..+.+||.+||+.||.+||++.++++.+....
T Consensus       226 ~~-------i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          226 GK-------IREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             HH-------HHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             HH-------Hhhcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            11       1111111    122344578999999999999999999999998765443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=344.61  Aligned_cols=252  Identities=22%  Similarity=0.341  Sum_probs=201.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +.|....+||+|+||.||+|.+..++.         .||||.+........+.+.+|+.+++.++||||+++++++...+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   92 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQV---------RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG   92 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCC---------EEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCe---------EEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence            345666799999999999999887654         99999998776566678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCCEEEccccCc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRT--IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNAKLSDFGLA  249 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFg~a  249 (429)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.||.|||  +.+|+|+||||+|||++. ++.+||+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence            9999999999999999997653  34678889999999999999999  899999999999999987 899999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ........  ......||+.|+|||++.+..  ++.++||||||+++|+|++|..||.......   . .....      
T Consensus       171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~-~~~~~------  238 (295)
T 2clq_A          171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---A-AMFKV------  238 (295)
T ss_dssp             EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---H-HHHHH------
T ss_pred             cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---H-HHHhh------
Confidence            87543221  123457999999999997654  8899999999999999999999996432110   0 00000      


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      . .....+    ..+...+..+.+||.+||+.||++||++.++++
T Consensus       239 ~-~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          239 G-MFKVHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             H-HHCCCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             c-cccccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0 001111    223344578999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-45  Score=347.80  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=206.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +.|++.+.||+|+||.||+|.+..++.         .||||++..... .....+.+|+.+|++++||||+++++++..+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   92 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQK---------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   92 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCc---------EEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            469999999999999999999877654         999999976542 3457789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+++++|.+++..  ..+++..+..++.|++.||.|||  ..||+||||||+|||++.++.+||+|||++..
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ  168 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEeeccccee
Confidence            999999999999999998854  35899999999999999999999  89999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      .....  .......||+.|+|||++.+..++.++||||||+++|+|++|..||......      .....       +..
T Consensus       169 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-------~~~  233 (303)
T 3a7i_A          169 LTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFL-------IPK  233 (303)
T ss_dssp             CBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-------HHH
T ss_pred             cCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHH-------hhc
Confidence            54322  1223467999999999999999999999999999999999999999754311      11000       111


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ...+    ......+..+.+||.+||..||.+|||+.++++.
T Consensus       234 ~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          234 NNPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SCCC----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCC----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1111    1222344779999999999999999999999873

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=357.44  Aligned_cols=259  Identities=18%  Similarity=0.183  Sum_probs=205.4

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC---CcceeeEEe
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH---HPNLVKLIG  166 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~  166 (429)
                      ...++|.+.+.||+|+||.||+|++..+..    ...++.||||++....   ..++..|+.++.+++   |+||+++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLND----AKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcc----cccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            345789999999999999999996433211    1235589999997653   346677888888876   999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-----
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFR----RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-----  237 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-----  237 (429)
                      ++..++..||||||++||+|.+++..    ....+++..++.++.||+.||+|||  +.+|+||||||+|||++.     
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGGTCC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEecccccCc
Confidence            99999999999999999999999964    3456999999999999999999999  899999999999999988     


Q ss_pred             ------CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 014202          238 ------EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG  311 (429)
Q Consensus       238 ------~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  311 (429)
                            ++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999975433233334455789999999999999999999999999999999999999995432110


Q ss_pred             cccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCC-CCHhHHHHHhcCCcC
Q 014202          312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR-PSMDEVVKVLTPLQD  379 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-pt~~eil~~l~~~~~  379 (429)
                                     ..+    ......   ....+.+.+++..||+.+|.+| |++.++.+.|+.+..
T Consensus       293 ---------------~~~----~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 ---------------CKP----EGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             ---------------EEE----CSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---------------eee----chhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                           000    011110   0124678899999999999999 678888777665543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.1e-45  Score=355.50  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=206.5

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--------hhHHHHHHHHHHhcC-C
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--------GHREWVAEVDFLGQL-H  157 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~  157 (429)
                      ......++|++.+.||+|+||.||+|++..++.         .||||++......        ..+.+.+|+.+|+++ +
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  158 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH---------EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG  158 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCc---------EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            344555789999999999999999999976654         9999998765311        134578999999999 7


Q ss_pred             CcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          158 HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       158 hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      ||||+++++++......|+||||++|++|.+++... ..+++..+..++.||+.||.|||  +.||+||||||+|||++.
T Consensus       159 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NIl~~~  235 (365)
T 2y7j_A          159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENILLDD  235 (365)
T ss_dssp             CTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECT
T ss_pred             CCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECC
Confidence            999999999999999999999999999999998654 35899999999999999999999  899999999999999999


Q ss_pred             CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC------CCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 014202          238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG  311 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  311 (429)
                      ++.+||+|||++........   .....||+.|+|||++.+.      .++.++|||||||++|+|++|..||.....  
T Consensus       236 ~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--  310 (365)
T 2y7j_A          236 NMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--  310 (365)
T ss_dssp             TCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred             CCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--
Confidence            99999999999987544322   2346899999999998643      588899999999999999999999975321  


Q ss_pred             cccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                          ..........      ...  .........+..+.+||.+||+.||++|||+.++++.
T Consensus       311 ----~~~~~~i~~~------~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          311 ----ILMLRMIMEG------QYQ--FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             ----HHHHHHHHHT------CCC--CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----HHHHHHHHhC------CCC--CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                1111111000      000  0000001234679999999999999999999999983

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-45  Score=345.31  Aligned_cols=245  Identities=22%  Similarity=0.269  Sum_probs=200.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++....  ......+.+|+..+..+ +||||+++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~   80 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGC---------IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW   80 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCc---------eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            3579999999999999999999987655         99999997642  33456788999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-------
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRR---TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-------  238 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-------  238 (429)
                      .+++..++||||++|++|.+++...   ...+++..++.++.||+.||.|||  +.+|+||||||+|||++.+       
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC---------
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCcccc
Confidence            9999999999999999999999654   256899999999999999999999  8999999999999999844       


Q ss_pred             ------------CCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCC
Q 014202          239 ------------YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMD  305 (429)
Q Consensus       239 ------------~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~  305 (429)
                                  ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++.
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             cccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                        479999999998754322      24699999999999865 56689999999999999999987764


Q ss_pred             CCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          306 KKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ...      ...          .+.....+    ..+...+..+.+||.+||+.||++|||+.++++.
T Consensus       233 ~~~------~~~----------~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          233 NGD------QWH----------EIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             SSH------HHH----------HHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             chh------HHH----------HHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            321      000          01111111    1222345789999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=358.12  Aligned_cols=257  Identities=28%  Similarity=0.361  Sum_probs=204.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----hhhHHHHHHHHHHhcC-CCcceeeEEeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGHREWVAEVDFLGQL-HHPNLVKLIGY  167 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~  167 (429)
                      ++|++.+.||+|+||.||+|++.....      +|..||||++.....    .....+.+|+.+|.++ +||||++++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHD------TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTT------TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCC------CCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            579999999999999999999854211      356999999875421    2335567899999999 69999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +..++..+|||||+++|+|.+++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence            999999999999999999999997654 5899999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      +++...... .......+||+.|+|||++.+  ..++.++|||||||++|||++|..||.........  ......... 
T Consensus       205 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~-  280 (355)
T 1vzo_A          205 LSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK-  280 (355)
T ss_dssp             EEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHH-
T ss_pred             CCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhc-
Confidence            998653322 222334689999999999985  34789999999999999999999999754432221  111111110 


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVKV  373 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~~  373 (429)
                             ..    ...+...+..+.+||.+||..||.+||     ++.++++.
T Consensus       281 -------~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          281 -------SE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -------CC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -------cC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                   01    112234457899999999999999999     99999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.1e-46  Score=379.25  Aligned_cols=261  Identities=26%  Similarity=0.413  Sum_probs=212.5

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ....++|++.+.||+|+||.||+|.+..+          ..||||++.... ...+++.+|+.+|++|+||||+++++++
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~----------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGT----------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTT----------EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCC----------ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34456799999999999999999998642          379999998654 3356789999999999999999999998


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      .. +..||||||+.+|+|.+++... ...+++..++.++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||
T Consensus       332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            66 6789999999999999999753 345899999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+...      .+...      
T Consensus       409 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~------  475 (535)
T 2h8h_A          409 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLD------  475 (535)
T ss_dssp             STTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHH------
T ss_pred             cceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH------
Confidence            998754321 111222457789999999999999999999999999999999 9999975431      11111      


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                           .+........+..++..+.+||.+||+.||++|||+.+|++.|+.+....
T Consensus       476 -----~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          476 -----QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             -----HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                 11111122233455678999999999999999999999999998886543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.1e-46  Score=351.42  Aligned_cols=264  Identities=24%  Similarity=0.383  Sum_probs=188.4

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ...++|++.+.||+|+||.||+|.+..++.         .||||.+..... ....++.+|+.+|++++||||+++++++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKE---------KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----C---------EEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCc---------EEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            445789999999999999999999876654         899999875532 3346788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFR-------RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      ..++..++||||++|++|.+++..       ....+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~  160 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSV  160 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCChhhEEEcCCCCE
Confidence            999999999999999999999864       2446899999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCc---cceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          242 KLSDFGLAKAGPQGDK---THVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      ||+|||++........   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......   ...
T Consensus       161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~  237 (303)
T 2vwi_A          161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLM  237 (303)
T ss_dssp             EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH
T ss_pred             EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHH
Confidence            9999999876543211   112233579999999999875 578999999999999999999999997654321   100


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         .....  ..................+..+.+||.+||+.||.+||++.++++
T Consensus       238 ---~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          238 ---LTLQN--DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             ---HHHTS--SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHhcc--CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence               00000  000000000001112234578999999999999999999999997

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=345.28  Aligned_cols=251  Identities=24%  Similarity=0.296  Sum_probs=200.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC----chhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG----LQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||+|++....    ......+.+|+.+|++++||||++++++
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLC---------RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV   74 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCC---------EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCc---------EEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            4789999999999999999999877654         99999997542    2334678899999999999999999999


Q ss_pred             EE--eCCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          168 CI--EDDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       168 ~~--~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      +.  +....|+||||+.++ |.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+
T Consensus        75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~~kl~  151 (305)
T 2wtk_C           75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKIS  151 (305)
T ss_dssp             EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCcEEee
Confidence            84  455789999999876 76666543 456899999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |||++................||+.|+|||++.+..  ++.++||||||+++|+|++|..||.....      .......
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i  225 (305)
T 2wtk_C          152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENI  225 (305)
T ss_dssp             CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHH
T ss_pred             ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHH
Confidence            999998764433333334467999999999987644  37799999999999999999999975321      1111111


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .       .   ..  ...+...+..+.+||.+||+.||.+|||+.++++
T Consensus       226 ~-------~---~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          226 G-------K---GS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             H-------H---CC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             h-------c---CC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0       0   00  1122234578999999999999999999999997

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.5e-45  Score=345.20  Aligned_cols=251  Identities=25%  Similarity=0.328  Sum_probs=188.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hh-HHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GH-REWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++...... .. ..+..+...++.++||||+++++++.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   76 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQ---------IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF   76 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCe---------EEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence            4679999999999999999999977654         9999999765332 22 33445555688899999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      .++..++||||++| +|.+++..   ....+++..++.++.|++.||.|||  +. ||+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~D  153 (290)
T 3fme_A           77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCD  153 (290)
T ss_dssp             CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHSCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred             ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999975 88777643   4567999999999999999999999  77 999999999999999999999999


Q ss_pred             ccCcccCCCCCccceeeeccccccccChhhh----hcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          246 FGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       246 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||++.......   ......||+.|+|||++    .+..++.++|||||||++|+|++|..||......    . .... 
T Consensus       154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~-~~~~-  224 (290)
T 3fme_A          154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----F-QQLK-  224 (290)
T ss_dssp             C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----H-HHHH-
T ss_pred             cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----H-HHHH-
Confidence            99998654322   12234799999999996    4567899999999999999999999999753221    1 1011 


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                               ...............+..+.+|+.+||+.||++|||+.++++
T Consensus       225 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          225 ---------QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---------HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                     111111111112234578999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.1e-46  Score=366.24  Aligned_cols=241  Identities=17%  Similarity=0.172  Sum_probs=190.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC---CchhhHHHHHHH---HHHhcCCCcceeeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD---GLQGHREWVAEV---DFLGQLHHPNLVKLI  165 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~~~  165 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++...   .....+.+.+|+   .+|++++|||||+++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~  142 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGE---------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  142 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCC---------EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCc---------EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence            4679999999999999999999876654         9999999743   334457788999   555566899999998


Q ss_pred             -------eEEEeCCe-----------------EEEEEEecCCCChHHHHhcCCC------CCCHHHHHHHHHHHHHHHHH
Q 014202          166 -------GYCIEDDQ-----------------RLLVYEFMTRGSLENHLFRRTI------PLPWSNRIKIALGAAKGLAF  215 (429)
Q Consensus       166 -------~~~~~~~~-----------------~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~  215 (429)
                             +++...+.                 .||||||+ +|+|.+++.....      .+++..++.++.||+.||+|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence                   66665542                 78999999 6799999975421      12347888899999999999


Q ss_pred             HhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC-----------CCCCc
Q 014202          216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-----------HLTSK  284 (429)
Q Consensus       216 lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~  284 (429)
                      ||  +.+|+||||||+|||++.++.+||+|||+++....     .....+| +.|+|||++.+.           .++.+
T Consensus       222 LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  293 (377)
T 3byv_A          222 LH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS  293 (377)
T ss_dssp             HH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred             HH--hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence            99  89999999999999999999999999999986322     2334678 999999999887           89999


Q ss_pred             cchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCC
Q 014202          285 SDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSR  364 (429)
Q Consensus       285 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  364 (429)
                      +|||||||++|||++|..||........                ...+...      ....+..+.+||.+||+.||++|
T Consensus       294 ~DvwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~R  351 (377)
T 3byv_A          294 FDAWALGLVIYWIWCADLPITKDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDR  351 (377)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC------CC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGC
T ss_pred             hhHHHHHHHHHHHHHCCCCCcccccccc----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhC
Confidence            9999999999999999999965432111                1111110      12334789999999999999999


Q ss_pred             CCHhHHHH
Q 014202          365 PSMDEVVK  372 (429)
Q Consensus       365 pt~~eil~  372 (429)
                      ||+.++++
T Consensus       352 pt~~e~l~  359 (377)
T 3byv_A          352 LLPLQAME  359 (377)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=354.91  Aligned_cols=265  Identities=21%  Similarity=0.334  Sum_probs=205.0

Q ss_pred             HHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceee
Q 014202           86 QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVK  163 (429)
Q Consensus        86 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~  163 (429)
                      .++....++|++.+.||+|+||.||+|.+..            .||+|++.....  ...+.+.+|+.++++++||||++
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   93 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL   93 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeE
Confidence            3444456789999999999999999998753            489999875432  23356778999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      +++++...+..++||||++|++|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++ ++.+||
T Consensus        94 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~~~~l  170 (319)
T 2y4i_B           94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVI  170 (319)
T ss_dssp             CCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---CCEE
T ss_pred             EEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CCCEEE
Confidence            999999999999999999999999999877767999999999999999999999  89999999999999998 679999


Q ss_pred             ccccCcccCCCCC---ccceeeeccccccccChhhhhc---------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 014202          244 SDFGLAKAGPQGD---KTHVSTRVVGTYGYAAPEYVMT---------GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG  311 (429)
Q Consensus       244 ~DFg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  311 (429)
                      +|||++.......   .........||+.|+|||++.+         ..++.++|||||||++|||++|..||...... 
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-  249 (319)
T 2y4i_B          171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-  249 (319)
T ss_dssp             CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-
T ss_pred             eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence            9999987542211   1112223569999999999864         35788999999999999999999999754311 


Q ss_pred             cccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                           .....       +.....+..   .....+..+.+|+.+||..||.+|||+.++++.|+.+....
T Consensus       250 -----~~~~~-------~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          250 -----AIIWQ-------MGTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -----HHHHH-------HHTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -----HHHHH-------hccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                 11110       111111111   11123467999999999999999999999999999887654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-45  Score=382.05  Aligned_cols=251  Identities=29%  Similarity=0.418  Sum_probs=200.3

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  176 (429)
                      +.||+|+||.||+|.+.....       +..||||+++....  ...+++.+|+.+|++++|||||++++++.. +..+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSC-------EEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCc-------ceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            479999999999997654332       45899999976432  335779999999999999999999999864 56889


Q ss_pred             EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCC
Q 014202          177 VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~  256 (429)
                      ||||+++|+|.+++... ..+++..++.++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       447 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            99999999999999654 46899999999999999999999  8999999999999999999999999999998754432


Q ss_pred             c-cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          257 K-THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       257 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      . ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....   .              +...+.
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~--------------~~~~i~  586 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E--------------VTAMLE  586 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H--------------HHHHHH
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H--------------HHHHHH
Confidence            2 122233467889999999999999999999999999999998 99999764321   1              111111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .......+..++.++.+||.+||+.||++||++.+|++.|+.+
T Consensus       587 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          587 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1122233445668899999999999999999999999988754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.1e-45  Score=356.63  Aligned_cols=262  Identities=22%  Similarity=0.310  Sum_probs=197.8

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ....++|++.+.||+|+||.||+|++..++.         .||||++..+..    ...+|+.+|+.++||||+++++++
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~---------~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~   69 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGK---------RFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYF   69 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCC---------EEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCC---------EEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhhee
Confidence            3456789999999999999999999987755         999999865432    224799999999999999999998


Q ss_pred             Ee--------------------------------------CCeEEEEEEecCCCChHHHHh---cCCCCCCHHHHHHHHH
Q 014202          169 IE--------------------------------------DDQRLLVYEFMTRGSLENHLF---RRTIPLPWSNRIKIAL  207 (429)
Q Consensus       169 ~~--------------------------------------~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~~  207 (429)
                      ..                                      ....++||||+++ +|.+.+.   .....+++..+..++.
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~  148 (383)
T 3eb0_A           70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIY  148 (383)
T ss_dssp             EEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence            54                                      3348899999974 8777664   3456799999999999


Q ss_pred             HHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCcc
Q 014202          208 GAAKGLAFLHGGSEPVIYRDFKTSNILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKS  285 (429)
Q Consensus       208 qi~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  285 (429)
                      ||+.||.|||  +.||+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++
T Consensus       149 qi~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          149 QLFRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence            9999999999  89999999999999997 688999999999987543322   2235789999999998865 489999


Q ss_pred             chhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh--hhhhhh------------hcCCccccCCCHHHHHHHHH
Q 014202          286 DVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD--KRKLYQ------------IVDPRLELNYSLKGVQKVSQ  351 (429)
Q Consensus       286 DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~------------~~~~~~~~~~~~~~~~~l~~  351 (429)
                      |||||||++|||++|..||.+.....   ....+...+..  ...+..            ..........+...+..+.+
T Consensus       224 DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence            99999999999999999997643211   11111110000  000000            00001111122334578999


Q ss_pred             HHHHcccCCCCCCCCHhHHHH
Q 014202          352 LAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       352 li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ||.+||+.||.+|||+.|+++
T Consensus       301 li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhhCCCHHHHhc
Confidence            999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-46  Score=359.31  Aligned_cols=273  Identities=16%  Similarity=0.209  Sum_probs=206.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceee--------
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVK--------  163 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------  163 (429)
                      .++|++.+.||+|+||.||+|.+..++... ....+..||||++...     ..+.+|+.+|++++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~-~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCD-SGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCcccc-ccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            368999999999999999999998742210 0012458999998754     46789999999999999988        


Q ss_pred             -------EEeEEEe-CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          164 -------LIGYCIE-DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       164 -------~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                             +++++.. +...|+||||+ +++|.+++... ...+++..++.++.||+.||.|||  +.+|+||||||+|||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCGGGEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEE
Confidence                   6777776 67889999999 99999999765 356999999999999999999999  899999999999999


Q ss_pred             EcCCC--CEEEccccCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 014202          235 LDSEY--NAKLSDFGLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKK  307 (429)
Q Consensus       235 l~~~~--~~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  307 (429)
                      ++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999765432111     1112357999999999999989999999999999999999999999764


Q ss_pred             CCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCc
Q 014202          308 RPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDL  380 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~  380 (429)
                      .... .........+...   ........   ......+..+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       272 ~~~~-~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          272 LPNT-EDIMKQKQKFVDK---PGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TTCH-HHHHHHHHHHHHS---CCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcCH-HHHHHHHHhccCC---hhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            3211 1111111111110   00011100   00112347899999999999999999999999998766543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.6e-45  Score=348.88  Aligned_cols=256  Identities=21%  Similarity=0.307  Sum_probs=201.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEe-
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIE-  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~-  170 (429)
                      ++|++.+.||+|+||.||+|++..++.         .||||++....   .+.+.+|+.+|++++ ||||+++++++.. 
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCc---------EEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            579999999999999999999887655         99999997443   467889999999997 9999999999988 


Q ss_pred             -CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CEEEccccC
Q 014202          171 -DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDFGL  248 (429)
Q Consensus       171 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFg~  248 (429)
                       ....++||||+.+++|.+++.    .+++..+..++.|++.||.|||  +.||+||||||+|||++.++ .+||+|||+
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence             667899999999999999874    3789999999999999999999  89999999999999999776 899999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +........   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  .........+.. .
T Consensus       178 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~-~  251 (330)
T 3nsz_A          178 AEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGT-E  251 (330)
T ss_dssp             CEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCH-H
T ss_pred             ceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCC-c
Confidence            986544322   223579999999999887 678999999999999999999999996433211  111111111100 0


Q ss_pred             hhhhhc-------CC----------------ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIV-------DP----------------RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~-------~~----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .+...+       ++                ..........+..+.+||.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000       00                0001111224578999999999999999999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-44  Score=341.46  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=205.7

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---------hhhHHHHHHHHHHhcCC-Ccc
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---------QGHREWVAEVDFLGQLH-HPN  160 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpn  160 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++.....         .....+.+|+.+|+++. |||
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~   85 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCK---------EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN   85 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCc---------eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            34689999999999999999999987654         999999976531         12356789999999996 999


Q ss_pred             eeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC
Q 014202          161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       161 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~  240 (429)
                      |+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.
T Consensus        86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~  162 (298)
T 1phk_A           86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMN  162 (298)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCC
T ss_pred             EeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEcCCCc
Confidence            999999999999999999999999999998664 36899999999999999999999  899999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhh------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM------TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN  314 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  314 (429)
                      +||+|||++........   .....|++.|+|||++.      ...++.++||||||+++|+|++|..||.....     
T Consensus       163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----  234 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----  234 (298)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred             EEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----
Confidence            99999999987543322   23357999999999985      45688999999999999999999999965321     


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       ..........        ............+..+.+||.+||+.||.+|||+.++++
T Consensus       235 -~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 -MLMLRMIMSG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -HHHHHHHHHT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHHHHHhcC--------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             1111111110        011111112345578999999999999999999999987

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-44  Score=353.49  Aligned_cols=257  Identities=22%  Similarity=0.274  Sum_probs=193.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++....  ......+.+|+.+|+.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   94 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILER---------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   94 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCc---------eEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence            4689999999999999999999887654         89999997542  233466889999999999999999999998


Q ss_pred             eCC------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          170 EDD------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       170 ~~~------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      ..+      ..|+||||+.+ +|.+.+..   .+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A           95 PQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccccccccceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEE
Confidence            765      78999999965 78887742   4889999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....      ......
T Consensus       169 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~  239 (371)
T 2xrw_A          169 LDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID------QWNKVI  239 (371)
T ss_dssp             CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred             EEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence            999999864322   12234689999999999999999999999999999999999999997643211      000000


Q ss_pred             Hhh------------hhhhhhc--CC------------ccccC----CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADK------------RKLYQIV--DP------------RLELN----YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~------------~~~~~~~--~~------------~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...            ..+....  .+            ....+    .....+..+.+||.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            000            0000000  00            00000    01223678999999999999999999999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.5e-45  Score=354.14  Aligned_cols=276  Identities=22%  Similarity=0.286  Sum_probs=203.8

Q ss_pred             ccHHHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-----------hhHHHHHHHH
Q 014202           83 FTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-----------GHREWVAEVD  151 (429)
Q Consensus        83 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~  151 (429)
                      ..+.++....++|++.+.||+|+||.||+|.+..          |..||||++......           ..+.+.+|+.
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   81 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE----------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR   81 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT----------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC----------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHH
Confidence            3456788889999999999999999999998753          348999998653221           1267889999


Q ss_pred             HHhcCCCcceeeEEeEEEeC-----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 014202          152 FLGQLHHPNLVKLIGYCIED-----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYR  226 (429)
Q Consensus       152 ~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHr  226 (429)
                      +|++++||||+++++++...     ...|+||||+. |+|.+++......+++..+..++.||+.||.|||  +.+|+||
T Consensus        82 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~  158 (362)
T 3pg1_A           82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH--EAGVVHR  158 (362)
T ss_dssp             HHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCC
T ss_pred             HHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCEec
Confidence            99999999999999998543     36799999997 6898888877778999999999999999999999  8999999


Q ss_pred             CCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCC
Q 014202          227 DFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMD  305 (429)
Q Consensus       227 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~  305 (429)
                      ||||+|||++.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus       159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  235 (362)
T 3pg1_A          159 DLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR  235 (362)
T ss_dssp             CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence            999999999999999999999997543322   2234679999999999887 678999999999999999999999997


Q ss_pred             CCCCCccccHHHHHHHHHHh----------hhhhhhhcCCcc-------ccCCCHHHHHHHHHHHHHcccCCCCCCCCHh
Q 014202          306 KKRPSGEQNLVAWARQYLAD----------KRKLYQIVDPRL-------ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD  368 (429)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  368 (429)
                      +.....   ....+......          ............       ........++.+.+||.+||+.||.+|||+.
T Consensus       236 ~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  312 (362)
T 3pg1_A          236 GSTFYN---QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE  312 (362)
T ss_dssp             CSSHHH---HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCHHH---HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence            643211   11111000000          000000000000       0011122356799999999999999999999


Q ss_pred             HHHH--HhcCC
Q 014202          369 EVVK--VLTPL  377 (429)
Q Consensus       369 eil~--~l~~~  377 (429)
                      ++++  +++.+
T Consensus       313 ell~hp~f~~~  323 (362)
T 3pg1_A          313 QALRHPYFESL  323 (362)
T ss_dssp             HHHTSGGGTTT
T ss_pred             HHHcCchhhhc
Confidence            9997  44444

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-45  Score=360.18  Aligned_cols=253  Identities=13%  Similarity=0.044  Sum_probs=186.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHH---HHHhcCCCcceeeEE-
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEV---DFLGQLHHPNLVKLI-  165 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpnIv~~~-  165 (429)
                      .+|++.+.||+|+||.||+|.+..++.         .||||++.....   .....+.+|+   .+|+. +||||++++ 
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~  131 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLE---------DFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR  131 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCc---------eeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence            358999999999999999999887654         999999987643   2335567775   45555 799988865 


Q ss_pred             ------eEEEeC-----------------CeEEEEEEecCCCChHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHH
Q 014202          166 ------GYCIED-----------------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNR------IKIALGAAKGLAFL  216 (429)
Q Consensus       166 ------~~~~~~-----------------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~------~~~~~qi~~~l~~l  216 (429)
                            +++...                 ...||||||++ |+|.+++......+.+..+      ..++.||+.||+||
T Consensus       132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L  210 (371)
T 3q60_A          132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL  210 (371)
T ss_dssp             CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence                  455443                 33799999998 8999999765444565666      77889999999999


Q ss_pred             hCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhc--CCCCCccchhhhHHHH
Q 014202          217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVL  294 (429)
Q Consensus       217 H~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il  294 (429)
                      |  +.+|+||||||+|||++.++.+||+|||+++....     ......||+.|+|||++.+  ..++.++|||||||++
T Consensus       211 H--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il  283 (371)
T 3q60_A          211 Q--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI  283 (371)
T ss_dssp             H--HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred             H--HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence            9  89999999999999999999999999999986432     1113567799999999987  6799999999999999


Q ss_pred             HHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          295 LEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       295 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      |||++|..||....+......         .....................+..+.+||.+||+.||++|||+.++++
T Consensus       284 ~elltg~~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          284 YRVWCLFLPFGLVTPGIKGSW---------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHSSCSTTBCCTTCTTCC---------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHhCCCCCCCcCcccccch---------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999999986643211100         000001111112222222345688999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.5e-45  Score=349.88  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=198.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--------hhhHHHHHHHHHHhcCCCcceee
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--------QGHREWVAEVDFLGQLHHPNLVK  163 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~  163 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++.....        .....+.+|+.+|++++||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   79 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCK---------KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK   79 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCc---------EEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence            4579999999999999999999987654         999999875432        12245789999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC---
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---  240 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---  240 (429)
                      +++++..+. .|+||||+++++|.+++... ..+++..++.++.||+.||.|||  +.+|+||||||+|||++.++.   
T Consensus        80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~  155 (322)
T 2ycf_A           80 IKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCL  155 (322)
T ss_dssp             EEEEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSSSCC
T ss_pred             EeeEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecCCCCCe
Confidence            999987655 89999999999999988654 46899999999999999999999  899999999999999987665   


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA  317 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  317 (429)
                      +||+|||++.......   ......||+.|+|||++.   +..++.++|||||||++|+|++|..||........  +..
T Consensus       156 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~  230 (322)
T 2ycf_A          156 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD  230 (322)
T ss_dssp             EEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH
T ss_pred             EEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH
Confidence            9999999998754321   122357999999999975   46789999999999999999999999976543221  111


Q ss_pred             HHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ...   ...      ..  .........+..+.+||.+||+.||++||++.++++.
T Consensus       231 ~~~---~~~------~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          231 QIT---SGK------YN--FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHH---HTC------CC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHH---hCc------cc--cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            110   000      00  0000011234789999999999999999999999973

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-44  Score=359.50  Aligned_cols=200  Identities=23%  Similarity=0.330  Sum_probs=174.1

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC------CCcceeeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL------HHPNLVKL  164 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~  164 (429)
                      ...+|++.+.||+|+||.||+|.+..++.         .||||++.... .....+.+|+.+|+.+      .|+||+++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~---------~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~  164 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHM  164 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTE---------EEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCc---------EEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence            45689999999999999999999887654         99999997542 3345677888888776      57899999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC--E
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN--A  241 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~  241 (429)
                      ++++...+..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.  +
T Consensus       165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTTSCCE
T ss_pred             EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCCCcce
Confidence            999999999999999995 69999887654 45899999999999999999999  899999999999999999887  9


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR  308 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  308 (429)
                      ||+|||++......     ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+..
T Consensus       242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999764322     223589999999999999999999999999999999999999997653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.1e-45  Score=340.70  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=197.7

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++.....   .....+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGH---------KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV   79 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCc---------eEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            34789999999999999999999887654         999999865421   234578899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +...+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||  +.+|+|+||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg  156 (276)
T 2h6d_A           80 ISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFG  156 (276)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EecCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEEeecc
Confidence            999999999999999999999986654 5899999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ++.......   ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.....      .......    
T Consensus       157 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~----  223 (276)
T 2h6d_A          157 LSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKI----  223 (276)
T ss_dssp             GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH----
T ss_pred             cccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHh----
Confidence            998754322   1223579999999999987765 6899999999999999999999975321      1111110    


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         ... .    ...+...+..+.++|.+||+.||.+|||+.++++
T Consensus       224 ---~~~-~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          224 ---RGG-V----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ---HHC-C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---hcC-c----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence               000 0    0112234478999999999999999999999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.8e-45  Score=354.37  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=203.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   96 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKV---------RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   96 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCe---------EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence            4689999999999999999999887654         899999975433 334678899999999999999999999876


Q ss_pred             C-----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcc
Q 014202          171 D-----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSD  245 (429)
Q Consensus       171 ~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D  245 (429)
                      .     ...|+||||+. |+|.+++...  .+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A           97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             SSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCCCEEEEe
Confidence            5     36899999996 5999988654  4899999999999999999999  89999999999999999999999999


Q ss_pred             ccCcccCCCCCc-cceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          246 FGLAKAGPQGDK-THVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       246 Fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      ||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......   ..+...+
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~  248 (364)
T 3qyz_A          172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGIL  248 (364)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHH
T ss_pred             CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHh
Confidence            999986543211 111234589999999998764 55899999999999999999999999765432211   1111110


Q ss_pred             Hhh--h-----------hhhhhcCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          324 ADK--R-----------KLYQIVDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       324 ~~~--~-----------~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...  .           ...........   .......+..+.+||.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000  0           00000000000   0011223477999999999999999999999997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-44  Score=347.34  Aligned_cols=271  Identities=26%  Similarity=0.382  Sum_probs=209.1

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhc--CCCcceeeEE
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ--LHHPNLVKLI  165 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~  165 (429)
                      .....++|++.+.||+|+||.||+|.+.           |+.||||++...   ....+.+|++++..  ++||||++++
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~  102 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFI  102 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence            3455578999999999999999999873           348999999643   34567788888887  7899999999


Q ss_pred             eEEEeCC----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCCeEE
Q 014202          166 GYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG------SEPVIYRDFKTSNILL  235 (429)
Q Consensus       166 ~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~------~~~ivHrDlkp~Nill  235 (429)
                      +++....    ..++||||+++|+|.+++.+.  .+++..++.++.|++.||.|||..      +.+|+||||||+|||+
T Consensus       103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  180 (342)
T ss_dssp             EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred             eeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence            9998876    789999999999999999664  589999999999999999999942      4789999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccc--eeeeccccccccChhhhhcCC------CCCccchhhhHHHHHHHHhC-------
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTH--VSTRVVGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEILTG-------  300 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~ell~g-------  300 (429)
                      +.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            999999999999997654332211  123357999999999987653      33689999999999999999       


Q ss_pred             ---CCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccC-CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          301 ---RRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELN-YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       301 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                         ..||....+... ....+....      ......+.+... .....+..+.+|+.+||+.||++|||+.++++.|+.
T Consensus       261 ~~~~~p~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDP-SVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCCCTTTTTSCSSC-CHHHHHHHH------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccCccccCcCcc-cHHHHHHHH------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence               778865433221 111111110      011111111111 123567789999999999999999999999999887


Q ss_pred             CcCcc
Q 014202          377 LQDLN  381 (429)
Q Consensus       377 ~~~~~  381 (429)
                      +....
T Consensus       334 i~~~~  338 (342)
T 1b6c_B          334 LSQQE  338 (342)
T ss_dssp             HHHTT
T ss_pred             HHHHh
Confidence            65433

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.3e-45  Score=357.35  Aligned_cols=266  Identities=23%  Similarity=0.331  Sum_probs=189.0

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++....  ......+.+|+.+|+.++||||+++++++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   97 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGL---------RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   97 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTE---------EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCC---------EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34789999999999999999999887654         99999997542  23456788999999999999999999998


Q ss_pred             EeC------CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IED------DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~~------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ...      ...|+|||++ +++|.+++..  ..+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~k  172 (367)
T 2fst_X           98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELK  172 (367)
T ss_dssp             CSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECCCCCEE
Confidence            754      5679999999 7899998855  45899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....   .....+..
T Consensus       173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~  244 (367)
T 2fst_X          173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILR  244 (367)
T ss_dssp             ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHH
Confidence            9999999864321     234689999999999887 67899999999999999999999999764321   11111111


Q ss_pred             HHHhh-------------hhhhhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCc
Q 014202          322 YLADK-------------RKLYQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQ  378 (429)
Q Consensus       322 ~~~~~-------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~  378 (429)
                      .+...             ....+.+.......   .....+..+.+||.+||+.||.+|||+.++++  ++..+.
T Consensus       245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence            11000             00000000000000   01123467899999999999999999999997  444443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.8e-45  Score=379.81  Aligned_cols=263  Identities=26%  Similarity=0.386  Sum_probs=210.7

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ....++|++.+.||+|+||.||+|.+..++.      .+..||||.+..... ...+.+.+|+.+|++++||||++++++
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3445779999999999999999999876543      245899999876533 334678999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +. ++..|+||||+++|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||
T Consensus       460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          460 IT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCEEEEecC
Confidence            84 56789999999999999999877777999999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....   ....   .     
T Consensus       537 ~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~---~-----  604 (656)
T 2j0j_A          537 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---R-----  604 (656)
T ss_dssp             CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-----
T ss_pred             CCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---H-----
Confidence            9987543322 12223567889999999999999999999999999999997 99999754321   1111   1     


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                        +...    .....+..++..+.+||.+||..||.+|||+.++++.|+.+.
T Consensus       605 --i~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          605 --IENG----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             --HHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHcC----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              0010    111223345578999999999999999999999999887654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=350.76  Aligned_cols=264  Identities=23%  Similarity=0.377  Sum_probs=194.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHH--HhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF--LGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|++.           |..||||++....   ...+..|..+  +..++||||+++++.+.
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~   77 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE   77 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC-----------CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence            368999999999999999999763           3489999996432   2334444444  55589999999998654


Q ss_pred             e-----CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCC---------CeeeCCCCCCCeEE
Q 014202          170 E-----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE---------PVIYRDFKTSNILL  235 (429)
Q Consensus       170 ~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---------~ivHrDlkp~Nill  235 (429)
                      .     ...+++||||+++|+|.+++....  .++..++.++.|++.||.|||  +.         +|+||||||+|||+
T Consensus        78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH--~~~~~~~~~~~~ivH~Dikp~Nill  153 (336)
T 3g2f_A           78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH--TELPRGDHYKPAISHRDLNSRNVLV  153 (336)
T ss_dssp             EECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH--CCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred             ccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH--hhhccccccccceeecccccceEEE
Confidence            3     235689999999999999996654  588999999999999999999  77         99999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCc------cceeeeccccccccChhhhhc-------CCCCCccchhhhHHHHHHHHhCCC
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDK------THVSTRVVGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEILTGRR  302 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~  302 (429)
                      +.++.+||+|||++........      ........||+.|+|||++.+       ..++.++|||||||++|||++|..
T Consensus       154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            9999999999999986543211      112223579999999999976       356678999999999999999977


Q ss_pred             CCCCCCCCcccc-HH----------HHHHHHHHhhhhhhhhcCCccc--cCCCHHHHHHHHHHHHHcccCCCCCCCCHhH
Q 014202          303 SMDKKRPSGEQN-LV----------AWARQYLADKRKLYQIVDPRLE--LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE  369 (429)
Q Consensus       303 pf~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  369 (429)
                      ||.......... ..          ........     .....+.++  .......+..+.+||.+||+.||++|||+.|
T Consensus       234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (336)
T 3g2f_A          234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS-----REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX  308 (336)
T ss_dssp             GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHT-----TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cCCCccchhHHHHhhhcccCCCchHHHHHhhhc-----ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence            765433221110 00          00000000     000111111  1122346678999999999999999999999


Q ss_pred             HHHHhcCCc
Q 014202          370 VVKVLTPLQ  378 (429)
Q Consensus       370 il~~l~~~~  378 (429)
                      +++.|+.+.
T Consensus       309 ~l~~L~~ll  317 (336)
T 3g2f_A          309 AEERMAELM  317 (336)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999887664

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-44  Score=342.53  Aligned_cols=254  Identities=23%  Similarity=0.389  Sum_probs=197.0

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe-
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE-  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  170 (429)
                      .++|++.+.||+|+||.||+|++..++.         .||||++... ......+.+|+.+|++++||||+++++++.+ 
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   74 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSR---------YYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLER   74 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCe---------EEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence            3579999999999999999999877654         9999999643 2345678899999999999999999998865 


Q ss_pred             ------------CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 014202          171 ------------DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE  238 (429)
Q Consensus       171 ------------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~  238 (429)
                                  ....|+||||+++|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.+
T Consensus        75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Nil~~~~  152 (303)
T 1zy4_A           75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDES  152 (303)
T ss_dssp             CCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTT
T ss_pred             cchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhEEEcCC
Confidence                        35679999999999999999877667889999999999999999999  8999999999999999999


Q ss_pred             CCEEEccccCcccCCCCCc------------cceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCC
Q 014202          239 YNAKLSDFGLAKAGPQGDK------------THVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMD  305 (429)
Q Consensus       239 ~~~kl~DFg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~  305 (429)
                      +.+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            9999999999986542210            1122345799999999999864 68999999999999999998   443


Q ss_pred             CCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          306 KKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..     .........       + .......+.......+..+.+||.+||+.||.+|||+.++++.
T Consensus       230 ~~-----~~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          230 TG-----MERVNILKK-------L-RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             SH-----HHHHHHHHH-------H-HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Cc-----hhHHHHHHh-------c-cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            21     111111111       0 1111122223344455779999999999999999999999984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-44  Score=357.47  Aligned_cols=263  Identities=25%  Similarity=0.348  Sum_probs=197.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC-
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED-  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  171 (429)
                      .+|++.+.||+|+||.||+|++..++.         .||||++....    ....+|+.+|++++||||+++++++... 
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~---------~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGE---------LVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCc---------EEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccC
Confidence            469999999999999999999987655         99999986543    2234799999999999999999988542 


Q ss_pred             -----CeEEEEEEecCCCChHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CCEE
Q 014202          172 -----DQRLLVYEFMTRGSLENHLF---RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAK  242 (429)
Q Consensus       172 -----~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k  242 (429)
                           ..+++||||+++ +|.+.+.   .....+++..+..++.||+.||.|||  +.+|+||||||+|||++.+ +.+|
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~k  197 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLK  197 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeEE
Confidence                 236799999976 6666553   34567999999999999999999999  8999999999999999865 5689


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+....  ..+...+..
T Consensus       198 l~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~  272 (420)
T 1j1b_A          198 LCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKV  272 (420)
T ss_dssp             ECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH
T ss_pred             eccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHH
Confidence            999999987543322   2236799999999998765 7899999999999999999999999764321  111111110


Q ss_pred             HHHh-hhhhhhhcCCcc-----c--------cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCC
Q 014202          322 YLAD-KRKLYQIVDPRL-----E--------LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPL  377 (429)
Q Consensus       322 ~~~~-~~~~~~~~~~~~-----~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~  377 (429)
                      .-.. ...+.. .++..     +        ..+....+.++.+||.+||..||.+||++.|+++  ++..+
T Consensus       273 lg~p~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          273 LGTPTREQIRE-MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HCSCCHHHHHH-HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hCCCCHHHHHh-hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            0000 000100 01100     0        0012234578999999999999999999999997  44443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.9e-44  Score=349.07  Aligned_cols=206  Identities=24%  Similarity=0.286  Sum_probs=175.8

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-Cc-----c
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HP-----N  160 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----n  160 (429)
                      ......++|++.+.||+|+||.||+|++..++.         .||||++.... .....+..|+.++..++ |+     +
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~  117 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYY  117 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGG
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCc---------EEEEEEEeccH-HHHHHHHHHHHHHHHHHhccccccee
Confidence            334456799999999999999999999887654         89999997542 33456778888888875 54     4


Q ss_pred             eeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc--C
Q 014202          161 LVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD--S  237 (429)
Q Consensus       161 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~--~  237 (429)
                      |+++++++...+..||||||+. ++|.+++.... ..+++..+..++.|++.||.|||.+..+|+||||||+|||++  .
T Consensus       118 iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          118 IVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             BCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred             EEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence            9999999999999999999995 59999987654 468999999999999999999996567999999999999994  5


Q ss_pred             CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014202          238 EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR  308 (429)
Q Consensus       238 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  308 (429)
                      ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus       197 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            778999999999875332     223689999999999999999999999999999999999999998643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.1e-44  Score=346.34  Aligned_cols=269  Identities=25%  Similarity=0.332  Sum_probs=192.3

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .....++|++.+.||+|+||.||+|++..++.         .||||++.... .......+|+..+..++||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~   87 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGM---------SVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSY   87 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCC---------EEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHh
Confidence            34556789999999999999999999987655         99999986543 233456788888999999999999999


Q ss_pred             EEeCCe-------EEEEEEecCCCChHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          168 CIEDDQ-------RLLVYEFMTRGSLENHLF---RRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       168 ~~~~~~-------~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      +...+.       .++||||+.+ +|.+.+.   .....+++..+..++.|++.||.|||.++.+|+||||||+|||++.
T Consensus        88 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             EEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET
T ss_pred             hhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC
Confidence            876443       7899999976 5554443   3455689999999999999999999977789999999999999986


Q ss_pred             -CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          238 -EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       238 -~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                       ++.+||+|||++........   .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......  .+
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~  241 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QL  241 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH
T ss_pred             CCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HH
Confidence             89999999999987544322   23367899999999987654 8999999999999999999999997643211  11


Q ss_pred             HHHHHHHHHhhhhhhhhcCCcc----------------ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          316 VAWARQYLADKRKLYQIVDPRL----------------ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..................++..                ........+..+.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111100000000101010000                00111224678999999999999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.2e-44  Score=343.91  Aligned_cols=263  Identities=23%  Similarity=0.324  Sum_probs=204.6

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc------eee
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN------LVK  163 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~  163 (429)
                      ...++|++.+.||+|+||.||+|.+...        .|..||||++.... .....+.+|+.+++.++|++      |++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~   81 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKA--------GGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQ   81 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCC--------CCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence            3457899999999999999999988432        24489999997542 34467789999999887654      999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-----
Q 014202          164 LIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-----  237 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-----  237 (429)
                      +++++...+..++||||+ +++|.+++.... .++++..+..++.|++.||+|||  +.+|+||||||+|||++.     
T Consensus        82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCCEEE
T ss_pred             eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEecccccc
Confidence            999999999999999999 889999987654 36899999999999999999999  899999999999999987     


Q ss_pred             --------------CCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCC
Q 014202          238 --------------EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRS  303 (429)
Q Consensus       238 --------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p  303 (429)
                                    ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                          668999999999864332     1235799999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccHHHHHHHHHHhh-hhh---------------------------hhhcCCcc-ccCCCHHHHHHHHHHHH
Q 014202          304 MDKKRPSGEQNLVAWARQYLADK-RKL---------------------------YQIVDPRL-ELNYSLKGVQKVSQLAY  354 (429)
Q Consensus       304 f~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~-~~~~~~~~~~~l~~li~  354 (429)
                      |.......   ............ ..+                           .....+.. ........++.+.+||.
T Consensus       234 f~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          234 FPTHDSKE---HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             CCCSCHHH---HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCChHH---HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence            97643211   111111111000 000                           00000000 01123345688999999


Q ss_pred             HcccCCCCCCCCHhHHHH
Q 014202          355 NCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       355 ~~l~~dP~~Rpt~~eil~  372 (429)
                      +||+.||.+|||+.|+++
T Consensus       311 ~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          311 KMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHhCcCcccccCHHHHhc
Confidence            999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=353.77  Aligned_cols=269  Identities=22%  Similarity=0.323  Sum_probs=185.4

Q ss_pred             cCCCCC-CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRP-DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~-~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .+.|.+ +++||+|+||.||+|++..+..       +..||||++.....  ...+.+|+.+|++|+||||+++++++..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~-------~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKD-------DKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLS   89 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSC-------CCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCC-------CeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence            345776 5689999999999999774322       45899999976533  3467899999999999999999999955


Q ss_pred             --CCeEEEEEEecCCCChHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----c
Q 014202          171 --DDQRLLVYEFMTRGSLENHLFRR--------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL----D  236 (429)
Q Consensus       171 --~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill----~  236 (429)
                        +...|+||||+. ++|.+++...        ...+++..++.++.||+.||.|||  +.+|+||||||+|||+    +
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGP  166 (405)
T ss_dssp             TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSST
T ss_pred             CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCCC
Confidence              678999999996 4888877422        224899999999999999999999  8999999999999999    6


Q ss_pred             CCCCEEEccccCcccCCCCCc-cceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcc--
Q 014202          237 SEYNAKLSDFGLAKAGPQGDK-THVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE--  312 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--  312 (429)
                      .++.+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||........  
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            788999999999987543211 1223346899999999999874 589999999999999999999999976543110  


Q ss_pred             ----ccHHHHHHHHHHhh--------------hhhhhhcCC-cccc--------CCCHHHHHHHHHHHHHcccCCCCCCC
Q 014202          313 ----QNLVAWARQYLADK--------------RKLYQIVDP-RLEL--------NYSLKGVQKVSQLAYNCLSRDPKSRP  365 (429)
Q Consensus       313 ----~~~~~~~~~~~~~~--------------~~~~~~~~~-~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rp  365 (429)
                          ......+...+...              ..+...... ....        ......+..+.+||.+||+.||.+||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                01111111100000              000000000 0000        00001145788999999999999999


Q ss_pred             CHhHHHH
Q 014202          366 SMDEVVK  372 (429)
Q Consensus       366 t~~eil~  372 (429)
                      |+.|+++
T Consensus       327 ta~e~L~  333 (405)
T 3rgf_A          327 TSEQAMQ  333 (405)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-44  Score=345.19  Aligned_cols=256  Identities=24%  Similarity=0.367  Sum_probs=199.2

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCC--Cccee
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLH--HPNLV  162 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hpnIv  162 (429)
                      .+....++|++.+.||+|+||.||+|.+..          |..||||++....  ......+.+|+.+|.+++  ||||+
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv   91 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEK----------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII   91 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTT----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCC----------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence            334455779999999999999999998743          3489999997543  234567889999999997  59999


Q ss_pred             eEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          163 KLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ++++++..++..|+||| +.+++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||+++ +.+|
T Consensus        92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A           92 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             CEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEET-TEEE
T ss_pred             EEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEEEC-CeEE
Confidence            99999999999999999 56889999997654 6899999999999999999999  899999999999999964 8999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG  311 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  311 (429)
                      |+|||++................||+.|+|||++.+           ..++.++|||||||++|+|++|..||.....  
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  244 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--  244 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--
Confidence            999999987544333222334679999999999875           4688899999999999999999999965321  


Q ss_pred             cccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         ...          .+....+.......+...+..+.+||.+||+.||.+||++.++++
T Consensus       245 ---~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          245 ---QIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ---HHH----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHH----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence               111          111222222222333334578999999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.1e-44  Score=349.98  Aligned_cols=263  Identities=19%  Similarity=0.259  Sum_probs=201.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-----------Ccc
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-----------HPN  160 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpn  160 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++.... .....+.+|+.+|++++           |||
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCc---------EEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            3689999999999999999999877654         99999997542 33466789999999886           899


Q ss_pred             eeeEEeEEEeCC----eEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCeE
Q 014202          161 LVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNIL  234 (429)
Q Consensus       161 Iv~~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~ivHrDlkp~Nil  234 (429)
                      |+++++++...+    ..++||||+ +++|.+++... ...+++..+..++.||+.||.|||  +. ||+||||||+|||
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~~ivH~Dikp~NIl  164 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVL  164 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChHHeE
Confidence            999999988654    789999999 88999998764 345899999999999999999999  77 9999999999999


Q ss_pred             Ec------CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014202          235 LD------SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKR  308 (429)
Q Consensus       235 l~------~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  308 (429)
                      ++      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            94      4457999999999875332     223579999999999999999999999999999999999999998654


Q ss_pred             CCccccHHHHHHHHHHhhhhhh-----------hhcCC-------------------ccccCCCHHHHHHHHHHHHHccc
Q 014202          309 PSGEQNLVAWARQYLADKRKLY-----------QIVDP-------------------RLELNYSLKGVQKVSQLAYNCLS  358 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~-------------------~~~~~~~~~~~~~l~~li~~~l~  358 (429)
                      ....................+.           ...+.                   ......+...+..+.+||.+||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  319 (373)
T 1q8y_A          240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ  319 (373)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred             ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence            3221111111111111000000           00000                   00112445678899999999999


Q ss_pred             CCCCCCCCHhHHHH
Q 014202          359 RDPKSRPSMDEVVK  372 (429)
Q Consensus       359 ~dP~~Rpt~~eil~  372 (429)
                      .||++|||+.|+++
T Consensus       320 ~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          320 LDPRKRADAGGLVN  333 (373)
T ss_dssp             SSTTTCBCHHHHHT
T ss_pred             cCccccCCHHHHhh
Confidence            99999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5e-44  Score=336.18  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=203.6

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ...++|++.+.||+|+||.||+|.+..++.         .||||++....  ......+.+|+.+|++++||||++++++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   89 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQ---------EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI   89 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCc---------EEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEE
Confidence            334689999999999999999999877654         89999986542  2345678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CCEEEc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE---YNAKLS  244 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~  244 (429)
                      +...+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||  ..+|+||||||+|||++.+   +.+||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~~~~kL~  166 (287)
T 2wei_A           90 LEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKII  166 (287)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCcccEEEe
Confidence            999999999999999999999886554 5899999999999999999999  8999999999999999654   469999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....      .........
T Consensus       167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~  236 (287)
T 2wei_A          167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVET  236 (287)
T ss_dssp             STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH
T ss_pred             ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc
Confidence            9999986543221   223568999999998865 489999999999999999999999975431      111111110


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .        ............+..+.+||.+||+.||.+|||+.++++
T Consensus       237 ~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          237 G--------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             C--------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C--------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0        000111111234578999999999999999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=342.43  Aligned_cols=262  Identities=22%  Similarity=0.307  Sum_probs=196.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEE-
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCI-  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-  169 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||.+........+.+.+|+.+|++++||||+++++++. 
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   79 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDK---------RVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGP   79 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTE---------EEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECT
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCe---------EEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccc
Confidence            34789999999999999999999987654         99999998776666778899999999999999999999873 


Q ss_pred             -------------eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          170 -------------EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       170 -------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                                   .....|+||||+. |+|.+++..  ..+++..++.++.|++.||+|||  +.||+||||||+|||++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANLFIN  154 (320)
T ss_dssp             TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEE
T ss_pred             cccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEc
Confidence                         3467899999997 599998854  35899999999999999999999  89999999999999997


Q ss_pred             -CCCCEEEccccCcccCCCCCc-cceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 014202          237 -SEYNAKLSDFGLAKAGPQGDK-THVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ  313 (429)
Q Consensus       237 -~~~~~kl~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  313 (429)
                       .++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.......  
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--  232 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--  232 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence             567899999999987533211 111223567999999998875 678999999999999999999999997653211  


Q ss_pred             cHHHHHHHHHHhh--------hhhhh--------hc-CCccc-cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          314 NLVAWARQYLADK--------RKLYQ--------IV-DPRLE-LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       314 ~~~~~~~~~~~~~--------~~~~~--------~~-~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       .   ........        ..+..        .. .+... .......+..+.+||.+||+.||.+|||+.++++
T Consensus       233 -~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          233 -Q---MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             -H---HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -H---HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence             1   11111000        00000        00 00000 0011234578999999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.9e-44  Score=346.89  Aligned_cols=259  Identities=22%  Similarity=0.300  Sum_probs=198.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|.+.+.||+|+||.||+|.+..++.         .||||++.....  .....+.+|+.+|+.++||||+++++++
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  110 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGE---------KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF  110 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCC---------EEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence            34789999999999999999999887654         999999976532  2346788999999999999999999999


Q ss_pred             EeCCeE------EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          169 IEDDQR------LLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       169 ~~~~~~------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                      ...+..      |+||||+. ++|.+++.   ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~k  184 (371)
T 4exu_A          111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELK  184 (371)
T ss_dssp             CSCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEE
T ss_pred             eccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECCCCCEE
Confidence            887765      99999996 58888763   24899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....   ....+..
T Consensus       185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~  256 (371)
T 4exu_A          185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILK  256 (371)
T ss_dssp             ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred             EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHH
Confidence            9999999864322     233678999999999987 688999999999999999999999997643211   1111100


Q ss_pred             HHHh-h------------hhhhhhcCCcccc---CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLAD-K------------RKLYQIVDPRLEL---NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~-~------------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .... .            ......+......   ......+..+.+||.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            0000 0            0000000000000   011223578999999999999999999999997

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.3e-44  Score=349.48  Aligned_cols=260  Identities=19%  Similarity=0.250  Sum_probs=203.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-----------------hHHHHHHHHHH
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-----------------HREWVAEVDFL  153 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l  153 (429)
                      ..++|++.+.||+|+||.||+|.+  +         |..||||.+.......                 ...+.+|+.+|
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   97 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--D---------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII   97 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--T---------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHH
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--C---------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHH
Confidence            347899999999999999999998  3         3489999986442111                 16789999999


Q ss_pred             hcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeee
Q 014202          154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENH------LFRR-TIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIY  225 (429)
Q Consensus       154 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~------l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivH  225 (429)
                      ++++||||+++++++.+.+..|+||||+++|+|.++      +... ...+++..++.++.|++.||.|||  + .||+|
T Consensus        98 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H  175 (348)
T 2pml_X           98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICH  175 (348)
T ss_dssp             TTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTSCEEC
T ss_pred             HhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh--ccCCEee
Confidence            999999999999999999999999999999999998      5442 557999999999999999999999  7 99999


Q ss_pred             CCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcC-CCCC-ccchhhhHHHHHHHHhCCCC
Q 014202          226 RDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTS-KSDVYSFGVVLLEILTGRRS  303 (429)
Q Consensus       226 rDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~ell~g~~p  303 (429)
                      |||||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999875332    23346799999999999877 6666 99999999999999999999


Q ss_pred             CCCCCCCccccHHHHHHHHHHhhhhhhhhcC-------CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          304 MDKKRPSGEQNLVAWARQYLADKRKLYQIVD-------PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       304 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      |......  ....   ...............       ...........+..+.+||.+||+.||.+|||+.++++
T Consensus       252 f~~~~~~--~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          252 FSLKISL--VELF---NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCCSSCS--HHHH---HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCcH--HHHH---HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9765431  1111   110000000000000       00000001334578999999999999999999999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.9e-44  Score=351.37  Aligned_cols=266  Identities=23%  Similarity=0.331  Sum_probs=197.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ..+|++.+.||+|+||.||+|++..++          .||+|++.....    ...+|+.+|+.++||||+++++++...
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~----------~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESD----------EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTE----------EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCC----------eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence            357999999999999999999987543          588888764432    223799999999999999999998654


Q ss_pred             Ce------EEEEEEecCCCChHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCCEE
Q 014202          172 DQ------RLLVYEFMTRGSLENHL--FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-SEYNAK  242 (429)
Q Consensus       172 ~~------~~lv~e~~~gg~L~~~l--~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~k  242 (429)
                      +.      .++||||+.++.+....  ......+++..+..++.||+.||.|||  +.||+||||||+|||++ .++.+|
T Consensus       105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEE
T ss_pred             CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcCCCCcEE
Confidence            43      78999999775443322  223557899999999999999999999  89999999999999998 799999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.....  .+..... 
T Consensus       183 L~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~-  256 (394)
T 4e7w_A          183 LIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK-  256 (394)
T ss_dssp             ECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-
T ss_pred             EeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-
Confidence            999999987543322   2236789999999998765 58999999999999999999999997643211  1111111 


Q ss_pred             HHHh-h-hhhh----hhcCCc--------cccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCcC
Q 014202          322 YLAD-K-RKLY----QIVDPR--------LELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQD  379 (429)
Q Consensus       322 ~~~~-~-~~~~----~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~~  379 (429)
                      .+.. . ..+.    ......        ....+....+.++.+||.+||+.||.+|||+.|+++  ++..+..
T Consensus       257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            0000 0 0000    000000        011112234578999999999999999999999997  4555543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.5e-44  Score=341.74  Aligned_cols=254  Identities=26%  Similarity=0.362  Sum_probs=181.7

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHH-HHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVD-FLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++.+.||+|+||.||+|.+..++.         .||||++..... .....+..|+. +++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQ---------IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTE---------EEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCC---------EEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            3689999999999999999999877654         999999976533 23345566666 778889999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCeEEcCCCCEEEc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFR----RTIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      .++..++||||+.+ +|.+++..    ....+++..+..++.|++.||.|||  .. +|+||||||+|||++.++.+||+
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~NIll~~~~~~kl~  168 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLC  168 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--HHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--ccCCEeECCCCHHHEEEcCCCCEEEc
Confidence            99999999999975 88777653    2456899999999999999999999  77 99999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhh----hcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      |||++.......   ......||+.|+|||++    .+..++.++|||||||++|+|++|..||........        
T Consensus       169 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------  237 (327)
T 3aln_A          169 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------  237 (327)
T ss_dssp             CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------
T ss_pred             cCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------
Confidence            999998654322   12234799999999998    456789999999999999999999999975432100        


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          ....+.....+.+........+..+.+||.+||+.||.+||++.++++
T Consensus       238 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          238 ----QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                000011111111111122234578999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-43  Score=343.68  Aligned_cols=271  Identities=23%  Similarity=0.308  Sum_probs=203.4

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..++|++.+.||+|+||.||+|.+..++.         .||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   79 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGE---------IVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQR   79 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCc---------EEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence            34689999999999999999999887654         999999975433 33456789999999999999999999877


Q ss_pred             eC-----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          170 ED-----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       170 ~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      .+     ...|+||||+. ++|.+++...  .+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~~kl~  154 (353)
T 2b9h_A           80 PDSFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDLKVC  154 (353)
T ss_dssp             CSCSTTCCCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred             ccccCccceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCcEEEE
Confidence            64     67899999996 5999988663  5899999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCccc--------eeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          245 DFGLAKAGPQGDKTH--------VSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       245 DFg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      |||++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....   .
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~  231 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---Q  231 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---H
Confidence            999998754321110        1123578999999998865 678999999999999999999999997643211   0


Q ss_pred             HHHHHHHHHhh--------------hhhhhhcCC---ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcC
Q 014202          316 VAWARQYLADK--------------RKLYQIVDP---RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTP  376 (429)
Q Consensus       316 ~~~~~~~~~~~--------------~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~  376 (429)
                      ...+.......              ......+..   ..........+..+.+||.+||+.||++|||+.++++  ++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            00000000000              000000000   0000011234578999999999999999999999997  4444


Q ss_pred             Cc
Q 014202          377 LQ  378 (429)
Q Consensus       377 ~~  378 (429)
                      ..
T Consensus       312 ~~  313 (353)
T 2b9h_A          312 YH  313 (353)
T ss_dssp             TC
T ss_pred             cC
Confidence            33

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-43  Score=338.50  Aligned_cols=265  Identities=26%  Similarity=0.345  Sum_probs=200.8

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcC---CCcceeeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQL---HHPNLVKLI  165 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~  165 (429)
                      ..++|++.+.||+|+||.||+|++...        .|..||+|++.....  .....+.+|+.+++.+   +||||++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC--------CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            346899999999999999999998532        144899999864322  1223566788777766   899999999


Q ss_pred             eEEE-----eCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 014202          166 GYCI-----EDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY  239 (429)
Q Consensus       166 ~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~  239 (429)
                      +++.     .....++||||+. |+|.+++.... ..+++..++.++.|++.||.|||  +.||+||||||+|||++.++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nili~~~~  157 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG  157 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTC
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeEEcCCC
Confidence            9987     5567899999997 69999987653 34899999999999999999999  89999999999999999999


Q ss_pred             CEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          240 NAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       240 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      .+||+|||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   .....+
T Consensus       158 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i  231 (326)
T 1blx_A          158 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKI  231 (326)
T ss_dssp             CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH
T ss_pred             CEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH
Confidence            9999999999865322   1223467999999999999999999999999999999999999999764321   111111


Q ss_pred             HHHHHh--hhhhhhh-------c---CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          320 RQYLAD--KRKLYQI-------V---DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       320 ~~~~~~--~~~~~~~-------~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ......  .......       .   ............+..+.+||.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100000  0000000       0   000001122334578999999999999999999999996

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.7e-44  Score=344.14  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=175.1

Q ss_pred             cCCCCCCC-cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDS-ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|.+.+ +||+|+||.||+|++..++.         .||||++....    .........++.+.||||+++++++..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQ---------KCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCC---------EEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence            45799855 69999999999999987655         99999996531    112223334566789999999999876


Q ss_pred             ----CCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCCEE
Q 014202          171 ----DDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAK  242 (429)
Q Consensus       171 ----~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~k  242 (429)
                          +...++||||++||+|.+++.... ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.   ++.+|
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~~~~~~~~k  171 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLK  171 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEecCCCceEE
Confidence                455899999999999999997654 46999999999999999999999  899999999999999976   45599


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |+|||++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||............   .  
T Consensus       172 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~--  242 (336)
T 3fhr_A          172 LTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---K--  242 (336)
T ss_dssp             ECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             Eeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---H--
Confidence            9999999864332    123357899999999998888999999999999999999999999754322110000   0  


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                           ..................+..+.+||.+||+.||.+|||+.++++
T Consensus       243 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          243 -----RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 000000111111112345578999999999999999999999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.1e-43  Score=340.19  Aligned_cols=262  Identities=21%  Similarity=0.293  Sum_probs=203.3

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc------eeeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN------LVKL  164 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~  164 (429)
                      ..++|++.+.||+|+||.||+|.+..++        +..||+|++.... .....+.+|+.+|++++|++      |+.+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARG--------KSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTT--------TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCC--------ceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            4578999999999999999999987654        2489999997542 34466788999999997766      9999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--------
Q 014202          165 IGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL--------  235 (429)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill--------  235 (429)
                      ++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||  +.+|+||||||+|||+        
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCCEEEE
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeccccccc
Confidence            99999999999999999 667777776553 56999999999999999999999  8999999999999999        


Q ss_pred             -----------cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCC
Q 014202          236 -----------DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSM  304 (429)
Q Consensus       236 -----------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf  304 (429)
                                 +.++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence                       567899999999998643322     2357999999999999999999999999999999999999999


Q ss_pred             CCCCCCccccHHHHHHHHHHhh-hhh---------------------------hhhcCC-ccccCCCHHHHHHHHHHHHH
Q 014202          305 DKKRPSGEQNLVAWARQYLADK-RKL---------------------------YQIVDP-RLELNYSLKGVQKVSQLAYN  355 (429)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~-~~~~~~~~~~~~~l~~li~~  355 (429)
                      ......   ............. ..+                           .....+ ..........+..+.+||.+
T Consensus       240 ~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  316 (355)
T 2eu9_A          240 QTHENR---EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR  316 (355)
T ss_dssp             CCSSHH---HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCHH---HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence            754321   1111111111000 000                           000000 00011223446789999999


Q ss_pred             cccCCCCCCCCHhHHHH
Q 014202          356 CLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       356 ~l~~dP~~Rpt~~eil~  372 (429)
                      ||+.||++|||+.|+++
T Consensus       317 ~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          317 MLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HhcCChhhCcCHHHHhc
Confidence            99999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=342.31  Aligned_cols=258  Identities=22%  Similarity=0.299  Sum_probs=198.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|.+.+.||+|+||.||+|++..++.         .||||++.....  .....+.+|+.+|+.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGE---------KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCC---------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            4689999999999999999999887654         999999976532  23467889999999999999999999998


Q ss_pred             eCCe------EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          170 EDDQ------RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       170 ~~~~------~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      ....      .|+||||+. ++|.+++..   .+++..+..++.||+.||.|||  +.||+||||||+|||++.++.+||
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~~~~kl  167 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKI  167 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTCCEEE
T ss_pred             cccccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCCCcEEE
Confidence            7654      499999996 588877632   4899999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      +|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....   .....+...
T Consensus       168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~  239 (353)
T 3coi_A          168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKV  239 (353)
T ss_dssp             CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHH
T ss_pred             eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence            999999864321     223578999999999886 67899999999999999999999999764321   111111000


Q ss_pred             HHh-h------------hhhhhhcCCccc---cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LAD-K------------RKLYQIVDPRLE---LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~-~------------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ... .            ......+.....   .......+..+.+||.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000 0            000000000000   1112345678999999999999999999999997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=337.36  Aligned_cols=245  Identities=26%  Similarity=0.422  Sum_probs=194.4

Q ss_pred             HhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch------hhHHHHHHHHHHhcC----CC
Q 014202           89 KSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ------GHREWVAEVDFLGQL----HH  158 (429)
Q Consensus        89 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h  158 (429)
                      ....++|++.+.||+|+||.||+|.+..++.         .||||++......      ....+.+|+.++.++    +|
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h   97 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRL---------QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH   97 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCC---------EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCC
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCe---------EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCC
Confidence            4456789999999999999999999877654         9999999765432      223456799999888    89


Q ss_pred             cceeeEEeEEEeCCeEEEEEEe-cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-
Q 014202          159 PNLVKLIGYCIEDDQRLLVYEF-MTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-  236 (429)
Q Consensus       159 pnIv~~~~~~~~~~~~~lv~e~-~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~-  236 (429)
                      |||+++++++...+..++|||+ +.+++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||++ 
T Consensus        98 ~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~  174 (312)
T 2iwi_A           98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDL  174 (312)
T ss_dssp             SSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGGEEEET
T ss_pred             CCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhhEEEeC
Confidence            9999999999999999999999 78999999997654 5899999999999999999999  89999999999999998 


Q ss_pred             CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      .++.+||+|||++.......    .....||+.|+|||++.+..+. .++|||||||++|+|++|..||....       
T Consensus       175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------  243 (312)
T 2iwi_A          175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------  243 (312)
T ss_dssp             TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------
Confidence            88999999999998754322    2335799999999999877664 58999999999999999999996421       


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                           ....          .  ....+...+..+.+||.+||+.||++|||+.++++.
T Consensus       244 -----~~~~----------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 -----EILE----------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -----HHHH----------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----HHhh----------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000          0  011223345789999999999999999999999984

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.4e-44  Score=340.43  Aligned_cols=246  Identities=22%  Similarity=0.367  Sum_probs=201.6

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch------hhHHHHHHHHHHhcCC--C
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ------GHREWVAEVDFLGQLH--H  158 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h  158 (429)
                      +.....++|++.+.||+|+||.||+|.+..++.         .||||++......      ....+.+|+.+|++++  |
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  107 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL---------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF  107 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTE---------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSS
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCc---------EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCC
Confidence            334556789999999999999999999887654         9999998755322      2245678999999996  5


Q ss_pred             cceeeEEeEEEeCCeEEEEEEecCC-CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-
Q 014202          159 PNLVKLIGYCIEDDQRLLVYEFMTR-GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-  236 (429)
Q Consensus       159 pnIv~~~~~~~~~~~~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~-  236 (429)
                      |||+++++++..++..++|||++.+ ++|.+++.... .+++..++.++.|++.||.|||  +.+|+||||||+|||++ 
T Consensus       108 ~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDL  184 (320)
T ss_dssp             CSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEET
T ss_pred             CCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHEEEeC
Confidence            9999999999999999999999976 89999986643 6899999999999999999999  89999999999999998 


Q ss_pred             CCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      .++.+||+|||++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++|..||....       
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------  253 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------  253 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------
Confidence            78899999999998754322    223579999999999987765 688999999999999999999996421       


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                           ....      ..      .......+..+.+||.+||+.||++|||+.++++
T Consensus       254 -----~~~~------~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 -----EIIR------GQ------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -----HHHH------CC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----hhhc------cc------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0000      00      0111233478999999999999999999999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=334.94  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=183.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-h-HHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-H-REWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||++....... . +.+..+..+++.++||||+++++++..
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGH---------VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCC---------EEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCe---------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            579999999999999999999987654         99999997654322 2 334455567888899999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSE-PVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++..++||||+ ++.+..+.......+++..++.++.|++.||.|||  .. +|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--hhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence            99999999999 55666666554567999999999999999999999  74 9999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      .......   ......||+.|+|||++.     +..++.++|||||||++|+|++|..||......     .........
T Consensus       173 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~  244 (318)
T 2dyl_A          173 GRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQ  244 (318)
T ss_dssp             -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHH
T ss_pred             hhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhc
Confidence            7653322   122357999999999984     556889999999999999999999999753221     111111111


Q ss_pred             hhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             ...+.  .......+..+.+||.+||+.||.+||++.++++
T Consensus       245 -------~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          245 -------EEPPL--LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -------SCCCC--CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------cCCCC--CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                   11111  1111234578999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=345.54  Aligned_cols=249  Identities=26%  Similarity=0.342  Sum_probs=188.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  171 (429)
                      .+|.+.++||+|+||+||... ..+         |+.||||++.....   ..+.+|+.+|+.+ +|||||++++++.+.
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~-~~~---------~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~   90 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRG-MFD---------NRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDR   90 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEE-ESS---------SSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred             EEEecCCeeecCcCEEEEEEE-EeC---------CeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            468999999999999966432 223         44899999975433   2356899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-----CCCEEEccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-----EYNAKLSDF  246 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~kl~DF  246 (429)
                      ...||||||+. |+|.+++......+.+..++.++.||+.||.|||  +.+|+||||||+|||++.     ...+||+||
T Consensus        91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            99999999996 5999999877666677778899999999999999  899999999999999943     235889999


Q ss_pred             cCcccCCCCCc-cceeeeccccccccChhhhh---cCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHH
Q 014202          247 GLAKAGPQGDK-THVSTRVVGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       247 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      |+++....... ........||+.|+|||++.   +..++.++|||||||++|||++ |..||......    ...    
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~----  239 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QAN----  239 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHH----
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHH----
Confidence            99987543321 12233467999999999987   4567889999999999999999 99999543210    000    


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            .+..... ..........+..+.+||.+||+.||.+|||+.++++
T Consensus       240 ------~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 ------ILLGACS-LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ------HHTTCCC-CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------HHhccCC-ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                  0000000 0011122345567899999999999999999999996

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.2e-42  Score=342.66  Aligned_cols=250  Identities=26%  Similarity=0.347  Sum_probs=186.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcC-CCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  171 (429)
                      +.|.+.+.||+|+||+||.+.. .+         |+.||||++..+   ....+.+|+.+|.++ +||||+++++++.++
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~---------g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQ---------GRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SS---------SSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             heeeccCeEeeCCCeEEEEEEE-EC---------CeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            4566778999999999986533 23         459999998643   234578999999876 899999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-------
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIP------LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-------  238 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~-------  238 (429)
                      +..||||||+. |+|.+++......      ..+..++.++.||+.||.|||  +.+|+||||||+|||++.+       
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCccccccc
Confidence            99999999995 5999999765321      123345789999999999999  8999999999999999654       


Q ss_pred             ------CCEEEccccCcccCCCCCccc--eeeeccccccccChhhhhc-------CCCCCccchhhhHHHHHHHHh-CCC
Q 014202          239 ------YNAKLSDFGLAKAGPQGDKTH--VSTRVVGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEILT-GRR  302 (429)
Q Consensus       239 ------~~~kl~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~-g~~  302 (429)
                            +.+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |..
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence                  479999999998765432211  1234689999999999975       568999999999999999999 999


Q ss_pred             CCCCCCCCccccHHHHHHHHHHhhhhhhhhcC-CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVD-PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       303 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ||.......    ..    .+.      .... +..........+.++.+||.+||+.||.+|||+.++++
T Consensus       239 Pf~~~~~~~----~~----i~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          239 PFGDKYSRE----SN----IIR------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TTCSTTTHH----HH----HHH------TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCchhhH----HH----Hhc------CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            996532210    00    011      1111 11122224466789999999999999999999999997

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.6e-43  Score=358.30  Aligned_cols=260  Identities=27%  Similarity=0.375  Sum_probs=199.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcCCCcceeeEEeEEEe-
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQLHHPNLVKLIGYCIE-  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  170 (429)
                      ++|++.+.||+|+||.||+|.+..++.         .||||++.... ......+.+|+.+|++++||||+++++++.. 
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~---------~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~   84 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGE---------QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL   84 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTC---------CEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCc---------EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence            689999999999999999998876654         89999987653 3345678899999999999999999998765 


Q ss_pred             -----CCeEEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCC---
Q 014202          171 -----DDQRLLVYEFMTRGSLENHLFRRT--IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYN---  240 (429)
Q Consensus       171 -----~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---  240 (429)
                           ++..|+||||++||+|.+++....  ..+++..++.++.|++.||.|||  +.||+||||||+|||++.++.   
T Consensus        85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEECCSSSCE
T ss_pred             ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeecCCCcee
Confidence                 677899999999999999997643  35899999999999999999999  899999999999999987765   


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      +||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...|..
T Consensus       163 vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~  234 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHG  234 (676)
T ss_dssp             EEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSST
T ss_pred             EEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhh
Confidence            99999999987544322   2346899999999999999999999999999999999999999965321     000000


Q ss_pred             HHHH---hhhhhhhhcCC--------ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHH
Q 014202          321 QYLA---DKRKLYQIVDP--------RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVV  371 (429)
Q Consensus       321 ~~~~---~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil  371 (429)
                      ....   ...........        ..+.......+..+.+||.+||..||++|||+.+++
T Consensus       235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0000   00000000000        111223455788999999999999999999998853

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.5e-42  Score=323.50  Aligned_cols=232  Identities=14%  Similarity=0.123  Sum_probs=186.7

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ..++|++.+.||+|+||.||+|++..++.         .||||++.....   .....+.+|+.++.+++||||++++++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   99 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDR---------QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV   99 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTE---------EEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCc---------eEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence            34789999999999999999999977654         999999986643   234678999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +..++..|+||||++|++|.+++...   ....++..++.|++.||.|||  +.||+||||||+|||++.+|.+||+++|
T Consensus       100 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          100 VHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCEEEEecc
Confidence            99999999999999999999998432   355678899999999999999  8999999999999999999999998543


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                                            |++       .++.++|||||||++|||++|..||.+........             
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------------  212 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------------  212 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-------------
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-------------
Confidence                                  333       36889999999999999999999998654322110             


Q ss_pred             hhhhhcCCcc--ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          328 KLYQIVDPRL--ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       328 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      ..........  ........+..+.+||.+||+.||++| |+.++++.|..+..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            0000000000  001122345789999999999999999 99999998876543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-41  Score=356.61  Aligned_cols=241  Identities=27%  Similarity=0.423  Sum_probs=193.0

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ...++|++.+.||+|+||.||+|++...        +|+.||||++..... .....+.+|+.+|.+++||||+++++++
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  148 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFV  148 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence            3457899999999999999999998752        134899999875433 3445788999999999999999999999


Q ss_pred             EeCCe-----EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          169 IEDDQ-----RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       169 ~~~~~-----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      ...+.     .||||||++|++|.+++..   .+++..++.++.||+.||.|||  +.||+||||||+|||++.+ .+||
T Consensus       149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             EEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-CEEE
T ss_pred             eecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-cEEE
Confidence            88765     7999999999999987644   6899999999999999999999  8999999999999999875 8999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      +|||+++.....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........           
T Consensus       223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------  284 (681)
T 2pzi_A          223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------  284 (681)
T ss_dssp             CCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------
T ss_pred             EecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------
Confidence            999999875432      2357999999999987654 8899999999999999999988864221100           


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-HhHHHHHhc
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-MDEVVKVLT  375 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~eil~~l~  375 (429)
                                   .........+..+.+||.+||+.||.+||+ ++++...|.
T Consensus       285 -------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 -------------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             -------------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -------------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                         000011123467899999999999999996 455555443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.3e-41  Score=318.95  Aligned_cols=225  Identities=22%  Similarity=0.318  Sum_probs=180.1

Q ss_pred             CCCCCC-CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHH-hcCCCcceeeEEeEEEe
Q 014202           93 GNFRPD-SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL-GQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~  170 (429)
                      ++|.+. +.||+|+||.||+|.+..++.         .||+|++...     ..+.+|+.++ +.++||||+++++++..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQE---------KFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCc---------EEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            467776 789999999999999987655         9999998642     4567889888 55689999999999987


Q ss_pred             ----CCeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCCEE
Q 014202          171 ----DDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNAK  242 (429)
Q Consensus       171 ----~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~k  242 (429)
                          +...++||||++||+|.+++.... ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.   ++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCCCcEE
Confidence                677899999999999999997653 46999999999999999999999  899999999999999988   78899


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |+|||++....                        +..++.++|||||||++|+|++|..||.........         
T Consensus       161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------  207 (299)
T 3m2w_A          161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------  207 (299)
T ss_dssp             ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------
T ss_pred             Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------
Confidence            99999986532                        234678899999999999999999999754321100         


Q ss_pred             HHhhhhhhh-hcCCccccCCC----HHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADKRKLYQ-IVDPRLELNYS----LKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~~~~~~-~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          ..+.. .....  ...+    ...+..+.+||.+||+.||.+|||+.|+++
T Consensus       208 ----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          208 ----PGMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ----CCSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                00000 00000  1111    234578999999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-41  Score=334.30  Aligned_cols=240  Identities=18%  Similarity=0.166  Sum_probs=181.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCC-cce-------
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHH-PNL-------  161 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnI-------  161 (429)
                      ..|+..+.||+|+||.||+|++..+++         .||||++.....   ...+.+.+|+.+++.++| .|+       
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~---------~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~  148 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGE---------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL  148 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCC---------ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence            457888999999999999999987755         999999884432   235678899999999987 221       


Q ss_pred             --------------eeEEeEEEe-----CCeEEEEEEecCCCChHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHH
Q 014202          162 --------------VKLIGYCIE-----DDQRLLVYEFMTRGSLENHLF------RRTIPLPWSNRIKIALGAAKGLAFL  216 (429)
Q Consensus       162 --------------v~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~------~~~~~~~~~~~~~~~~qi~~~l~~l  216 (429)
                                    ..+..++..     ...++++|+++ +++|.+++.      .....+++..++.++.|++.||+||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  227 (413)
T 3dzo_A          149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL  227 (413)
T ss_dssp             CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence                          111111222     22457777766 679999883      2244577889999999999999999


Q ss_pred             hCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhh----------hcCCCCCccc
Q 014202          217 HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYV----------MTGHLTSKSD  286 (429)
Q Consensus       217 H~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D  286 (429)
                      |  +.+|+||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++|
T Consensus       228 H--~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D  299 (413)
T 3dzo_A          228 H--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD  299 (413)
T ss_dssp             H--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred             H--hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence            9  899999999999999999999999999998864321     334678 999999999          4445788999


Q ss_pred             hhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014202          287 VYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS  366 (429)
Q Consensus       287 iwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  366 (429)
                      ||||||++|||++|+.||........                ...++..      ....++.+.+||.+||+.||++||+
T Consensus       300 vwSlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt  357 (413)
T 3dzo_A          300 TWTLGLAIYWIWCADLPNTDDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLL  357 (413)
T ss_dssp             HHHHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcC
Confidence            99999999999999999975432111                1111111      1123478999999999999999999


Q ss_pred             HhHHHH
Q 014202          367 MDEVVK  372 (429)
Q Consensus       367 ~~eil~  372 (429)
                      +.++++
T Consensus       358 ~~~~l~  363 (413)
T 3dzo_A          358 PLQAME  363 (413)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            999976

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.5e-41  Score=324.10  Aligned_cols=242  Identities=19%  Similarity=0.195  Sum_probs=184.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--------hhhHHHHHHHHHHhcCC------
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--------QGHREWVAEVDFLGQLH------  157 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------  157 (429)
                      .++|++.+.||+|+||.||+|++  +         |+.||||++.....        ...+.+.+|+.+|+.++      
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~   87 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--D---------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV   87 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--T---------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred             cccchheeeecccCceEEEEEEe--C---------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence            35799999999999999999987  2         34899999976532        22367889999988886      


Q ss_pred             ---CcceeeEEeEEE-----------------e-------------CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHH
Q 014202          158 ---HPNLVKLIGYCI-----------------E-------------DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK  204 (429)
Q Consensus       158 ---hpnIv~~~~~~~-----------------~-------------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~  204 (429)
                         ||||+++.+++.                 .             ++..||||||+++|++.+.+.+  ..+++..+..
T Consensus        88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~  165 (336)
T 2vuw_A           88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKS  165 (336)
T ss_dssp             SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHH
T ss_pred             cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHH
Confidence               777777766543                 2             6789999999999987776644  4589999999


Q ss_pred             HHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC--------------------CEEEccccCcccCCCCCccceeeec
Q 014202          205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY--------------------NAKLSDFGLAKAGPQGDKTHVSTRV  264 (429)
Q Consensus       205 ~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~DFg~a~~~~~~~~~~~~~~~  264 (429)
                      ++.||+.||.|||. +.+|+||||||+|||++.++                    .+||+|||+++.....       ..
T Consensus       166 i~~qi~~aL~~lH~-~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~  237 (336)
T 2vuw_A          166 ILHQLTASLAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IV  237 (336)
T ss_dssp             HHHHHHHHHHHHHH-HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EE
T ss_pred             HHHHHHHHHHHHHH-hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cE
Confidence            99999999999992 37899999999999999887                    8999999999864321       24


Q ss_pred             cccccccChhhhhcCCCCCccchhhhHHH-HHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh--cCCccccCC
Q 014202          265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVV-LLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI--VDPRLELNY  341 (429)
Q Consensus       265 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  341 (429)
                      +||+.|+|||++.+.. +.++||||||++ .+++++|..||..         ..|.....   ..+...  .........
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~~  304 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLT---DKMLKQMTFKTKCNTPA  304 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHH---HHHHHTCCCSSCCCSHH
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHH---HhhhhhhccCcccchhh
Confidence            8999999999998766 889999998777 7788889888832         11111111   111111  111111122


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHhHHH-H
Q 014202          342 SLKGVQKVSQLAYNCLSRDPKSRPSMDEVV-K  372 (429)
Q Consensus       342 ~~~~~~~l~~li~~~l~~dP~~Rpt~~eil-~  372 (429)
                      ....++++.+||.+||+.|     |+.|++ +
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~  331 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQ  331 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHH
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhc
Confidence            3457789999999999977     999998 5

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.9e-35  Score=298.15  Aligned_cols=187  Identities=18%  Similarity=0.073  Sum_probs=131.4

Q ss_pred             cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----------hhhHHHHHHHHHHhcC-CCcceeeEEeEE
Q 014202          100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----------QGHREWVAEVDFLGQL-HHPNLVKLIGYC  168 (429)
Q Consensus       100 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  168 (429)
                      .++.|++|.+..++....         |..||+|.+.....          ...+++.+|+++|+++ .|+||+++++++
T Consensus       241 ~~~~~~~~~h~~~rr~~f---------g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~  311 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFF---------GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG  311 (569)
T ss_dssp             C-C--------CCEEEEE---------CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE
T ss_pred             ccccCCcccccccccccc---------cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence            356666666666555554         44899999976532          2235689999999999 599999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      ++++..||||||++|++|.++|.+.+ +++..   .|+.||+.||+|+|  ++|||||||||+|||++.+|.+||+|||+
T Consensus       312 ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGl  385 (569)
T 4azs_A          312 ENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGS  385 (569)
T ss_dssp             ECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTT
T ss_pred             EECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeeccc
Confidence            99999999999999999999996654 56654   47899999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCC
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSM  304 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf  304 (429)
                      |+......  ......+||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus       386 Ar~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          386 IVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             EESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            98754322  22334789999999998875 4677899999999988877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=3.2e-30  Score=262.17  Aligned_cols=185  Identities=17%  Similarity=0.227  Sum_probs=143.9

Q ss_pred             CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--------hhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           96 RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--------GHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        96 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      ...+.||+|+||.||+|...           +..+++|........        ..+.+.+|+.+|++++||||+++..+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~  407 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF  407 (540)
T ss_dssp             ---------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence            44678999999999999433           348999987543221        12457899999999999999966666


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +...+..||||||++|++|.+++..         +..++.|++.||.|||  +.+|+||||||+|||++.  .+||+|||
T Consensus       408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL~DFG  474 (540)
T 3en9_A          408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYIIDFG  474 (540)
T ss_dssp             EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEECCCT
T ss_pred             EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEEEECc
Confidence            6677888999999999999999865         5689999999999999  899999999999999998  99999999


Q ss_pred             CcccCCCCCccc-----eeeeccccccccChhhhhc--CCCCCccchhhhHHHHHHHHhCCCCC
Q 014202          248 LAKAGPQGDKTH-----VSTRVVGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEILTGRRSM  304 (429)
Q Consensus       248 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf  304 (429)
                      +++.........     ......||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            999864422111     1234789999999999986  56888899999999888888776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.8e-26  Score=215.70  Aligned_cols=163  Identities=17%  Similarity=0.087  Sum_probs=126.3

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc------------------hhhHHHHH
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL------------------QGHREWVA  148 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~  148 (429)
                      .+......|.+++.||+|+||.||+|.+ .+         |..||||.+.....                  .....+.+
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~---------g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~  153 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EK---------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN  153 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TT---------TEEEEEEEECC------CCCC-------CHHHHHHHHHHH
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CC---------CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHH
Confidence            3344456677889999999999999998 54         44899999965422                  12456889


Q ss_pred             HHHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 014202          149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDF  228 (429)
Q Consensus       149 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDl  228 (429)
                      |+.+|++++|   +++.+++.. +..|+||||++|++|.+ +..       .....++.|++.||.|||  +.||+||||
T Consensus       154 E~~~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH--~~giiHrDl  219 (282)
T 1zar_A          154 EFRALQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY--HRGIVHGDL  219 (282)
T ss_dssp             HHHHHHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH--HTTEECSCC
T ss_pred             HHHHHHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH--HCCCEeCCC
Confidence            9999999994   555555443 45699999999999988 421       234579999999999999  899999999


Q ss_pred             CCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhc----------CCCCCccchhh
Q 014202          229 KTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT----------GHLTSKSDVYS  289 (429)
Q Consensus       229 kp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DiwS  289 (429)
                      ||+|||++ ++.+||+|||+++.               +..++|||++.+          ..|+..+|+|.
T Consensus       220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99999999 99999999999964               345789998753          34556666664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=2.8e-22  Score=184.88  Aligned_cols=139  Identities=17%  Similarity=0.078  Sum_probs=106.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcE--EEEEEeCCCCch------------------------hhHHHH
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGIT--VAVKSLKPDGLQ------------------------GHREWV  147 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~--vavK~~~~~~~~------------------------~~~~~~  147 (429)
                      -|.+.+.||+|+||.||+|.+..++         ..  ||||++......                        ....+.
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g---------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  118 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDG---------KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE  118 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETT---------EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCC---------cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence            3678899999999999999985543         38  999997543211                        012578


Q ss_pred             HHHHHHhcCCCcce--eeEEeEEEeCCeEEEEEEecCC-C----ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC
Q 014202          148 AEVDFLGQLHHPNL--VKLIGYCIEDDQRLLVYEFMTR-G----SLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS  220 (429)
Q Consensus       148 ~E~~~l~~l~hpnI--v~~~~~~~~~~~~~lv~e~~~g-g----~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  220 (429)
                      +|+.+|.++.|++|  +.+++.    +..+|||||+.+ |    +|.+....    .++..+..++.|++.+|.|||. .
T Consensus       119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~-~  189 (258)
T 1zth_A          119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ-E  189 (258)
T ss_dssp             HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH-H
Confidence            99999999988754  444432    356899999942 3    67665432    2345678899999999999993 4


Q ss_pred             CCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          221 EPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       221 ~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .||+||||||+|||++.  .++|+|||+|...
T Consensus       190 ~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          190 AELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            79999999999999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=2.6e-19  Score=171.97  Aligned_cols=142  Identities=13%  Similarity=0.100  Sum_probs=100.6

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-----h---------hhHH--------HH
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-----Q---------GHRE--------WV  147 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~---------~~~~--------~~  147 (429)
                      ....-|.++..||.|+||.||+|.+..          |+.||||+++....     .         ....        ..
T Consensus        92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~----------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~  161 (397)
T 4gyi_A           92 ARKDVYSVGSRIGVGKESDIMIVADEK----------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAI  161 (397)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEECTT----------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHH
T ss_pred             HCCCEEEecCEeeeCCceEEEEEECCC----------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHH
Confidence            333459999999999999999998642          55899999764311     0         0011        23


Q ss_pred             HHHHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 014202          148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRD  227 (429)
Q Consensus       148 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrD  227 (429)
                      +|...|.+|.+.++.-..-+...  ..+|||||++|++|.++..     .  .....++.|++.+|.+||  ..||||||
T Consensus       162 kE~~nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH--~~gIVHrD  230 (397)
T 4gyi_A          162 KEFAFMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLA--KHGLIHGD  230 (397)
T ss_dssp             HHHHHHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHH--HTTEECSC
T ss_pred             HHHHHHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHH--HCCCcCCC
Confidence            56777777754443222111112  2379999999988865431     1  234568899999999999  89999999


Q ss_pred             CCCCCeEEcCCC----------CEEEccccCcccC
Q 014202          228 FKTSNILLDSEY----------NAKLSDFGLAKAG  252 (429)
Q Consensus       228 lkp~Nill~~~~----------~~kl~DFg~a~~~  252 (429)
                      |||.|||++++|          .+.|+||+-+...
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999999998776          3899999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=8.4e-14  Score=128.13  Aligned_cols=145  Identities=14%  Similarity=-0.005  Sum_probs=112.6

Q ss_pred             hhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEE
Q 014202           90 SATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYC  168 (429)
Q Consensus        90 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  168 (429)
                      ...+.|++...++.|+++.||++...           |..+++|............+.+|+.+|+.|. +..+.++++++
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~   79 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            34467999999999999999998643           2389999987532223346889999999985 77888999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG-----------------------------  219 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------------------------  219 (429)
                      ...+..|+||||++|.+|.+.+.      +......++.+++.+|..||..                             
T Consensus        80 ~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T 3tm0_A           80 RHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             ecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence            99999999999999999987632      1122346778899999999940                             


Q ss_pred             ----------------------------CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 ----------------------------SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ----------------------------~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                                                  ...++|+|++|.|||+++++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                        04589999999999998765567999987753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=2.5e-12  Score=117.76  Aligned_cols=137  Identities=15%  Similarity=0.013  Sum_probs=98.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc--eeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN--LVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~  170 (429)
                      ..|.+..+.+.|..+.||++... +         |..+++|.....   ....+..|+.+|+.+.+.+  +.+++++...
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~-~---------g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~   86 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ-G---------RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE   86 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT-T---------SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecC-C---------CCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence            34555444456667999998642 2         337999997654   2245778999999886444  5668888888


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC------------------------------
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS------------------------------  220 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~------------------------------  220 (429)
                      ++..++||||++|.+|.  ...    ..   ...++.+++..|..||...                              
T Consensus        87 ~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           87 AGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             SSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             CCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            88899999999998884  211    11   2256677888888888321                              


Q ss_pred             --------------------------CCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          221 --------------------------EPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       221 --------------------------~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                                                ..++|+|++|.|||+++++.+.|+|||.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                      1299999999999998776667999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=2.4e-11  Score=116.99  Aligned_cols=141  Identities=14%  Similarity=0.181  Sum_probs=105.3

Q ss_pred             CCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeC--CCC-chhhHHHHHHHHHHhcCC--CcceeeEEeEEEeC
Q 014202           97 PDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLK--PDG-LQGHREWVAEVDFLGQLH--HPNLVKLIGYCIED  171 (429)
Q Consensus        97 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~  171 (429)
                      ..+.|+.|.++.||++....           ..+++|+..  ... ......+.+|+.+|+.|.  +..+++++.++.+.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-----------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-----------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-----------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             eEEEcCCcccceEEEEEECC-----------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            35678999999999987532           278999876  332 122356788999999997  45688899888776


Q ss_pred             ---CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 014202          172 ---DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG-----------------------------  219 (429)
Q Consensus       172 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------------------------  219 (429)
                         +..|+||||++|..+.+..   ...++......++.+++..|..||..                             
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK  187 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence               4479999999998875422   12367788888999999999999941                             


Q ss_pred             ---------------------------CCCeeeCCCCCCCeEEcCCCC--EEEccccCccc
Q 014202          220 ---------------------------SEPVIYRDFKTSNILLDSEYN--AKLSDFGLAKA  251 (429)
Q Consensus       220 ---------------------------~~~ivHrDlkp~Nill~~~~~--~kl~DFg~a~~  251 (429)
                                                 ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                       257999999999999987754  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=4.8e-11  Score=112.16  Aligned_cols=182  Identities=20%  Similarity=0.220  Sum_probs=119.6

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-Ccc--eeeEEeEEEeCC--
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPN--LVKLIGYCIEDD--  172 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~~~~~~~~~~--  172 (429)
                      .+.++.|....||++.              ..+++|+....  .....+.+|+.+|+.+. +..  +.+++......+  
T Consensus        25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~   88 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY   88 (304)
T ss_dssp             CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred             eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence            4568999999999852              15899986532  34467889999998874 333  445555443333  


Q ss_pred             -eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 014202          173 -QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG--------------------------------  219 (429)
Q Consensus       173 -~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------------------------------  219 (429)
                       ..|+||++++|.+|.+....   .++..+...++.+++..|..||..                                
T Consensus        89 ~~~~~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (304)
T 3sg8_A           89 QMSFAGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL  165 (304)
T ss_dssp             SCSCEEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred             CcceEEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence             34899999999888754322   356667777777788777777731                                


Q ss_pred             ------------------------CCCeeeCCCCCCCeEEcC--CCCEEEccccCcccCCCCCccceeeeccccccc---
Q 014202          220 ------------------------SEPVIYRDFKTSNILLDS--EYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY---  270 (429)
Q Consensus       220 ------------------------~~~ivHrDlkp~Nill~~--~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y---  270 (429)
                                              ...++|+|++|.||++++  ++.+.|+||+.+........      ......+   
T Consensus       166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~  239 (304)
T 3sg8_A          166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEE  239 (304)
T ss_dssp             CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTS
T ss_pred             CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccc
Confidence                                    135799999999999988  45678999999875322100      0111111   


Q ss_pred             cChhhhhc-----CCC---------CCccchhhhHHHHHHHHhCCCCC
Q 014202          271 AAPEYVMT-----GHL---------TSKSDVYSFGVVLLEILTGRRSM  304 (429)
Q Consensus       271 ~aPE~~~~-----~~~---------~~~~DiwSlG~il~ell~g~~pf  304 (429)
                      ..|+....     +..         ....+.|++|.++|.+.+|..+|
T Consensus       240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            23332210     000         11258999999999999998775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.65  E-value=1.8e-07  Score=85.92  Aligned_cols=135  Identities=18%  Similarity=0.066  Sum_probs=92.3

Q ss_pred             cccccCce-eEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCCeEEEE
Q 014202          100 ILGEGGFG-YVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       100 ~lg~G~fg-~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv  177 (429)
                      .+..|..| .||+......+         ..+++|+-..   .....+.+|+.+|+.|. +--+.+++.++.+++..|+|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~---------~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNA---------PELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTC---------CCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             EccCCCcCCeEEEEEecCCC---------eEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            34445555 68987655433         3789998653   23456788999998885 44477888999999999999


Q ss_pred             EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 014202          178 YEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG--------------------------------------  219 (429)
Q Consensus       178 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------------------------------------  219 (429)
                      ||+++|.++.+.....     ......+..+++..|..||..                                      
T Consensus        99 me~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG  173 (272)
T ss_dssp             EECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred             EEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence            9999998877654321     111223344444444444410                                      


Q ss_pred             ------------------CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 ------------------SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ------------------~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                                        ...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              11378999999999999877677999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.65  E-value=1.8e-07  Score=87.72  Aligned_cols=135  Identities=21%  Similarity=0.183  Sum_probs=91.0

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCc---ceeeEEeEEE-eCCe
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP---NLVKLIGYCI-EDDQ  173 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~-~~~~  173 (429)
                      .+.++.|....||+.     +.         .+++|+...  ......+.+|+.+|+.|.+.   .|.+++.+.. ..+.
T Consensus        24 v~~l~~G~~n~v~~v-----g~---------~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~   87 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NG---------DWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN   87 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TT---------TEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred             eeecCCCcceeEEEE-----CC---------EEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence            456888998999987     11         688998532  23346788999999999742   3566666664 4456


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 014202          174 RLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG-----------------------------------  218 (429)
Q Consensus       174 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-----------------------------------  218 (429)
                      .|+|||+++|..|......   .++......++.++...|..||.                                   
T Consensus        88 ~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           88 PFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             EEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             eEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            7899999999888763211   12333333444444444444441                                   


Q ss_pred             -----------------------CCCCeeeCCCCCCCeEEcC---CCCE-EEccccCccc
Q 014202          219 -----------------------GSEPVIYRDFKTSNILLDS---EYNA-KLSDFGLAKA  251 (429)
Q Consensus       219 -----------------------~~~~ivHrDlkp~Nill~~---~~~~-kl~DFg~a~~  251 (429)
                                             ....++|+|+.|.|||++.   ++.+ .|+||+.+..
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                   1345799999999999987   4564 8999998865

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.43  E-value=3.7e-07  Score=87.37  Aligned_cols=87  Identities=2%  Similarity=-0.093  Sum_probs=55.2

Q ss_pred             CCcc-cccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCC-C--cceeeEEeEEEe
Q 014202           98 DSIL-GEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLH-H--PNLVKLIGYCIE  170 (429)
Q Consensus        98 ~~~l-g~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~  170 (429)
                      .+.| +.|..+.+|+.........   ...|..+++|+.....   ......+.+|+.+|+.|. +  -.+.+++.+..+
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~---~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDG---RSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETT---EEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             EEECCCCCccceEEEEEEecccCC---CCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3567 8888999998865310000   0002378999865432   111245778999998885 3  356778887665


Q ss_pred             C---CeEEEEEEecCCCChH
Q 014202          171 D---DQRLLVYEFMTRGSLE  187 (429)
Q Consensus       171 ~---~~~~lv~e~~~gg~L~  187 (429)
                      .   +..|+|||+++|..+.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            5   3568999999887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.41  E-value=8.4e-07  Score=86.27  Aligned_cols=76  Identities=17%  Similarity=0.187  Sum_probs=49.7

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-------hhhHHHHHHHHHHhcCCC--c-ceeeEEeE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-------QGHREWVAEVDFLGQLHH--P-NLVKLIGY  167 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-nIv~~~~~  167 (429)
                      .+.||.|.++.||++.....         +..|+||.......       .....+..|+.+|+.+..  | .+.+++.+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~---------~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEH---------DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEECCCCceEEEEEEEECCC---------CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence            45789999999999975433         23899998653211       123456789999887742  3 34456643


Q ss_pred             EEeCCeEEEEEEecCCC
Q 014202          168 CIEDDQRLLVYEFMTRG  184 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg  184 (429)
                        +.+..++|||+++|.
T Consensus       106 --d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 --DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --ETTTTEEEECCCTTS
T ss_pred             --cCCccEEEEEeCCCc
Confidence              445568999999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=3.4e-06  Score=79.94  Aligned_cols=32  Identities=22%  Similarity=0.230  Sum_probs=28.7

Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            57899999999999998888999999997754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.92  E-value=4.2e-05  Score=71.56  Aligned_cols=135  Identities=16%  Similarity=0.102  Sum_probs=89.3

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC---CcceeeEEeEEEeCCeE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH---HPNLVKLIGYCIEDDQR  174 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~  174 (429)
                      .+.|+.|....+|+....           +..+++|+....   ....+..|+..|+.|.   ...+.+++.+....+..
T Consensus        41 ~~~l~gG~~n~~y~v~~~-----------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~  106 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-----------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS  106 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-----------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred             eEEeCCccceeeeEEEEC-----------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence            456899999999998642           237899987532   3456788999998884   36688899888888889


Q ss_pred             EEEEEecCCCChH--------H---HHhcCCC--C-------------------CCHHHHH---HHH-------------
Q 014202          175 LLVYEFMTRGSLE--------N---HLFRRTI--P-------------------LPWSNRI---KIA-------------  206 (429)
Q Consensus       175 ~lv~e~~~gg~L~--------~---~l~~~~~--~-------------------~~~~~~~---~~~-------------  206 (429)
                      ++||||++|..+.        .   .|.....  .                   -+|....   ++.             
T Consensus       107 ~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~  186 (312)
T 3jr1_A          107 FLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIF  186 (312)
T ss_dssp             EEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCC
T ss_pred             EEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCCh
Confidence            9999999987642        1   1122111  0                   1232221   011             


Q ss_pred             ---HHHHHHH-HHHh--CCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          207 ---LGAAKGL-AFLH--GGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       207 ---~qi~~~l-~~lH--~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                         ..++..+ ..|.  .....++|+|+.+.|++++.++ +.|+||+
T Consensus       187 ~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          187 GNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             SCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence               1122222 2342  2246799999999999999887 8899984

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.83  E-value=6.9e-05  Score=65.18  Aligned_cols=101  Identities=14%  Similarity=0.046  Sum_probs=67.2

Q ss_pred             CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeee
Q 014202          184 GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR  263 (429)
Q Consensus       184 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~  263 (429)
                      -+|.++|...+.++++.++|.++.|.+.+|.-+-. ...-..+=+-|..|++..+|.|-+.+ +.+.             
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            37999999999999999999999999999877610 11111333457999999999988764 1111             


Q ss_pred             ccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCC
Q 014202          264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR  301 (429)
Q Consensus       264 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~  301 (429)
                       .....+.|||... ...+.+.=|||||+++|..+--.
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence             1122466888653 33456778999999999998743

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.73  E-value=0.00013  Score=71.30  Aligned_cols=77  Identities=14%  Similarity=0.186  Sum_probs=47.1

Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccc--cccccChhhhhcCC---CCCccchhhhHHHH
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVG--TYGYAAPEYVMTGH---LTSKSDVYSFGVVL  294 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DiwSlG~il  294 (429)
                      ...++|+|++|.|||++.++ +.|+||+.+........  . ....+  ...|++|+......   -....++..+...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--l-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--I-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--H-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--H-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            67899999999999998776 99999999875321100  0 00111  13455655443111   11224455777788


Q ss_pred             HHHHhC
Q 014202          295 LEILTG  300 (429)
Q Consensus       295 ~ell~g  300 (429)
                      |+.+.+
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.72  E-value=5.1e-05  Score=71.16  Aligned_cols=155  Identities=15%  Similarity=0.123  Sum_probs=83.4

Q ss_pred             cHHHHHhhcCCCCCC-----CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-
Q 014202           84 TFQELKSATGNFRPD-----SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-  157 (429)
Q Consensus        84 ~~~~~~~~~~~y~~~-----~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-  157 (429)
                      +..++...-..|.+.     +.|+.|....+|++....          | .+++|+....  .....+..|+.++..|. 
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~   74 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK----------D-PLILTLYEKR--VEKNDLPFFLGLMQHLAA   74 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC----------c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHH
Confidence            344455444556552     346678888999986532          2 5889998753  12234567777777664 


Q ss_pred             ----CcceeeEE-e--EEEeCCeEEEEEEecCCCChHH--------------HHhcC--C--CC----CC---HHHHHH-
Q 014202          158 ----HPNLVKLI-G--YCIEDDQRLLVYEFMTRGSLEN--------------HLFRR--T--IP----LP---WSNRIK-  204 (429)
Q Consensus       158 ----hpnIv~~~-~--~~~~~~~~~lv~e~~~gg~L~~--------------~l~~~--~--~~----~~---~~~~~~-  204 (429)
                          -|.++... +  +....+..++||+|++|..+..              .++..  .  .+    ..   |..... 
T Consensus        75 ~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~  154 (322)
T 2ppq_A           75 KGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDK  154 (322)
T ss_dssp             TTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHH
T ss_pred             CCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHH
Confidence                23333211 1  1223466789999998865321              01111  1  00    01   111000 


Q ss_pred             -----------HHHHHHHHHHHHhC-----CCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          205 -----------IALGAAKGLAFLHG-----GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       205 -----------~~~qi~~~l~~lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                                 +...+...+..+..     ...+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          155 SEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                       00113334444431     135799999999999998775568999987753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.67  E-value=5.1e-05  Score=70.62  Aligned_cols=135  Identities=11%  Similarity=0.050  Sum_probs=75.7

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcce-eeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNL-VKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~l  176 (429)
                      .+.|+.|....+|++      .         .+++|+....... .....+|+.+++.+...++ .+++.+  +.+.-++
T Consensus        23 i~~l~gG~tN~~~~~------~---------~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~   84 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------G---------DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM   84 (301)
T ss_dssp             CEEEESCSSEEEEEE------T---------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred             eeEcCCcccccccee------e---------eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence            677888999999998      1         5899988653211 1223468887777752222 455543  3444578


Q ss_pred             EEEec-CCCChHHH------------------HhcCCCCC----CHH-HHHHH-----------------HHHHHHHH-H
Q 014202          177 VYEFM-TRGSLENH------------------LFRRTIPL----PWS-NRIKI-----------------ALGAAKGL-A  214 (429)
Q Consensus       177 v~e~~-~gg~L~~~------------------l~~~~~~~----~~~-~~~~~-----------------~~qi~~~l-~  214 (429)
                      |+||+ +|.+|...                  ++.....+    ... ....+                 +...+..+ .
T Consensus        85 v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  164 (301)
T 3dxq_A           85 VTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS  164 (301)
T ss_dssp             EEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred             EEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence            99999 66554310                  01111111    111 11111                 11111111 1


Q ss_pred             HH--hCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          215 FL--HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       215 ~l--H~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      .+  +.....++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            11  112446899999999999 5667899999988865

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.63  E-value=0.00039  Score=64.10  Aligned_cols=80  Identities=18%  Similarity=0.145  Sum_probs=55.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-C--cceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-H--PNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~  169 (429)
                      ....-.+.+|.|..+.||++...+          |+.|++|+...........+..|+..|+.|. .  --+.+++++. 
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~D----------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELAD----------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETT----------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-
T ss_pred             CCeEEEEecCCCCCeEEEEEEECC----------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-
Confidence            345556789999999999987643          4589999876554444456788999998884 2  2345555542 


Q ss_pred             eCCeEEEEEEecCCCCh
Q 014202          170 EDDQRLLVYEFMTRGSL  186 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L  186 (429)
                         ..++||||++++..
T Consensus        84 ---~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 ---DRTLAMEWVDERPP   97 (288)
T ss_dssp             ---TTEEEEECCCCCCC
T ss_pred             ---CceEEEEeecccCC
Confidence               23789999987643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.59  E-value=0.00021  Score=68.56  Aligned_cols=147  Identities=17%  Similarity=0.108  Sum_probs=82.9

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  176 (429)
                      .+.|..|-...+|++.......  .....+..|++|+.... ......+.+|+.+++.|. +.-..++++.+.+    .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            3567778889999987642100  01112458999986432 223455678999998885 3334566666543    29


Q ss_pred             EEEecCCCChHHH--------------H---hcC----CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 014202          177 VYEFMTRGSLENH--------------L---FRR----TIPLP--WSNRIKIALGAAK-------------------GLA  214 (429)
Q Consensus       177 v~e~~~gg~L~~~--------------l---~~~----~~~~~--~~~~~~~~~qi~~-------------------~l~  214 (429)
                      ||||++|..|...              |   +..    .....  +..+..+..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999988655311              1   111    11112  2344444433321                   122


Q ss_pred             H----Hh--CCCCCeeeCCCCCCCeEEcCC----CCEEEccccCccc
Q 014202          215 F----LH--GGSEPVIYRDFKTSNILLDSE----YNAKLSDFGLAKA  251 (429)
Q Consensus       215 ~----lH--~~~~~ivHrDlkp~Nill~~~----~~~kl~DFg~a~~  251 (429)
                      .    |.  .....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    22  123579999999999999876    7899999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.44  E-value=0.00033  Score=68.61  Aligned_cols=81  Identities=17%  Similarity=0.062  Sum_probs=50.6

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc-eeeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN-LVKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~l  176 (429)
                      .+.|+.|....||++.......  .....+..+++|+.....  ....+..|+.+++.|...+ ..++++.+.  +  .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            4567888889999997643211  001123589999984321  1245668999998885333 356776543  2  38


Q ss_pred             EEEecCCCCh
Q 014202          177 VYEFMTRGSL  186 (429)
Q Consensus       177 v~e~~~gg~L  186 (429)
                      ||||++|.+|
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            9999987443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.40  E-value=0.00083  Score=66.19  Aligned_cols=75  Identities=16%  Similarity=0.071  Sum_probs=46.9

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcce-eeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNL-VKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~l  176 (429)
                      .+.|+.|-...+|++.....         +..+++|+..... ...-+-.+|+.+|..|...++ .++++.+.  +  .+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~---------~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~  178 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSK---------QAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GR  178 (458)
T ss_dssp             EEEECC--CEEEEEEEETTT---------TEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred             EEEcCCCeEeEEEEEEECCC---------CceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence            35677788899999876431         2378999875432 111112579999988874444 56777662  2  35


Q ss_pred             EEEecCCCCh
Q 014202          177 VYEFMTRGSL  186 (429)
Q Consensus       177 v~e~~~gg~L  186 (429)
                      ||||++|..|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.38  E-value=0.00073  Score=63.36  Aligned_cols=139  Identities=14%  Similarity=0.110  Sum_probs=78.9

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCc--ceeeEEeE-----EEeC
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHP--NLVKLIGY-----CIED  171 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~-----~~~~  171 (429)
                      ..|+ |....||++....          |..+++|...... .....+..|..++..|...  .+++++..     ...+
T Consensus        32 ~~l~-g~~n~~y~v~~~~----------g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~   99 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDED----------RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ   99 (328)
T ss_dssp             EEEC-CSSSEEEEECCTT----------CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred             Eeec-CcccceEEEEcCC----------CCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence            3466 8888999875421          3369999986432 1334566788888777421  23444432     2335


Q ss_pred             CeEEEEEEecCCCChH-----H------H---Hhc--CC------CCCCHHHH----------------------HHHHH
Q 014202          172 DQRLLVYEFMTRGSLE-----N------H---LFR--RT------IPLPWSNR----------------------IKIAL  207 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~-----~------~---l~~--~~------~~~~~~~~----------------------~~~~~  207 (429)
                      +..++||++++|..+.     .      .   ++.  ..      ...+....                      ...+.
T Consensus       100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  179 (328)
T 1zyl_A          100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD  179 (328)
T ss_dssp             TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred             CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence            5678899999875432     0      0   110  00      01111110                      11111


Q ss_pred             HHHHHHHHHhC--CCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          208 GAAKGLAFLHG--GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       208 qi~~~l~~lH~--~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      .++..+.-+-.  ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            22222222210  145789999999999998 4 899999988764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.27  E-value=0.0016  Score=61.19  Aligned_cols=32  Identities=31%  Similarity=0.351  Sum_probs=28.1

Q ss_pred             CCCeeeCCCCCCCeEEcCC----CCEEEccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSE----YNAKLSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~----~~~kl~DFg~a~~  251 (429)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            5689999999999999874    6799999998875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.19  E-value=0.0011  Score=63.24  Aligned_cols=83  Identities=10%  Similarity=0.036  Sum_probs=45.5

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc-eeeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN-LVKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~l  176 (429)
                      .+.|+.|....+|++.....+. ...+..+..+++|+..... ........|+.+|+.|...+ +.++++.+  .  -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            3467778888999987643100 0001112478999875432 11123457888888875323 44666544  2  268


Q ss_pred             EEEecCCCCh
Q 014202          177 VYEFMTRGSL  186 (429)
Q Consensus       177 v~e~~~gg~L  186 (429)
                      ||||++|..+
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999988543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.95  E-value=0.0039  Score=58.82  Aligned_cols=32  Identities=16%  Similarity=0.190  Sum_probs=28.1

Q ss_pred             CCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          220 SEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       220 ~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35799999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.12  E-value=0.016  Score=56.24  Aligned_cols=82  Identities=12%  Similarity=-0.009  Sum_probs=48.8

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  176 (429)
                      .+.|..|-...+|++........  .+..+..|++++..... ...-+..+|..+++.|. +.-..++++.+  .  -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence            35577788889999886532110  11114589999875432 22223357888888875 33345566533  2  278


Q ss_pred             EEEecCCCCh
Q 014202          177 VYEFMTRGSL  186 (429)
Q Consensus       177 v~e~~~gg~L  186 (429)
                      ||||++|..|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.70  E-value=0.13  Score=49.42  Aligned_cols=30  Identities=27%  Similarity=0.305  Sum_probs=25.2

Q ss_pred             CeeeCCCCCCCeEE------cCCCCEEEccccCccc
Q 014202          222 PVIYRDFKTSNILL------DSEYNAKLSDFGLAKA  251 (429)
Q Consensus       222 ~ivHrDlkp~Nill------~~~~~~kl~DFg~a~~  251 (429)
                      .++|+|+.+.|||+      +++..+.++||-+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4466799999988764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.62  E-value=0.049  Score=53.58  Aligned_cols=63  Identities=13%  Similarity=0.118  Sum_probs=18.5

Q ss_pred             CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEE------EEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeE
Q 014202           96 RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAV------KSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGY  167 (429)
Q Consensus        96 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~  167 (429)
                      .+.+.||   ||.||+|.......         +||+      |.......  +....+.+|..+++.++|||+++.+++
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~---------~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f  212 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHM---------PVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF  212 (463)
T ss_dssp             CSTTTSS---BCCC---------C---------CBGGGC-----------------------------------CBCCCE
T ss_pred             cccccCC---chhhhcccccccCC---------chhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence            4566776   99999998865322         6777      66544322  233467889999999999999999887


Q ss_pred             EEe
Q 014202          168 CIE  170 (429)
Q Consensus       168 ~~~  170 (429)
                      ...
T Consensus       213 ~~~  215 (463)
T 3cxl_A          213 KVH  215 (463)
T ss_dssp             EEE
T ss_pred             EEe
Confidence            653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.53  E-value=1.6  Score=37.88  Aligned_cols=115  Identities=11%  Similarity=0.100  Sum_probs=76.2

Q ss_pred             CCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHhCCCCCeeeCCCCCCCeEE
Q 014202          157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA-FLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       157 ~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~-~lH~~~~~ivHrDlkp~Nill  235 (429)
                      .||++  -..+-.+++.+.+.++.-+++.=...+.    .++....++++.+|+.... +++    .-+|--|.|+||++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGEEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceEEE
Confidence            57887  4444577788888787654443333342    3678899999988887655 444    46778899999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCC
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD  305 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  305 (429)
                      +.++.++|.-.|+-....+              .=+.+|-+          +-.+=|++..++.++..|.
T Consensus       118 ~~~~~p~i~hRGi~~~lpP--------------~e~~ee~f----------l~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          118 NRALEPFFLHVGVKESLPP--------------DEWDDERL----------LREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CTTCCEEESCCEETTTBSS--------------CSCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred             eCCCcEEEEEcCCcccCCC--------------CCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            9999999987776543211              11222322          2246678888888877763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.13  E-value=1.7  Score=37.52  Aligned_cols=122  Identities=9%  Similarity=0.105  Sum_probs=80.5

Q ss_pred             HHHHHhcCCCcceeeEEeEEEeCCeEEEEEEecCCC-ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 014202          149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRG-SLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRD  227 (429)
Q Consensus       149 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg-~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrD  227 (429)
                      |+.+| ...||+++.. .+-..++.+.+.++.-+.+ ++.. +.    .++....++++.+|+....+++    .=+|--
T Consensus        36 el~LL-~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~----~r~tf~  104 (215)
T 4ann_A           36 LMYLL-EQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR----TRYTFV  104 (215)
T ss_dssp             GGGGG-GSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG----SSEECC
T ss_pred             HHHHH-hccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc----CceEEE
Confidence            44444 2368888877 5666777777777654422 3333 32    3578899999999988775555    247788


Q ss_pred             CCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCC
Q 014202          228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMD  305 (429)
Q Consensus       228 lkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  305 (429)
                      |.|+||+++.++.+++.--|+-....+.              =+.+|-+          +-.+=|++..+++++..|.
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik~~l~P~--------------~~~ee~f----------L~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQNVVDPL--------------PVSEAEF----------LTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEETTTBSCC--------------CCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred             EecceEEEcCCCCEEEEEccCccCCCCC--------------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            9999999999999999877764432111              0112222          2356688888999888774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	429
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-77
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-72
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-68
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-68
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-68
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-67
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-67
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-67
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-65
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-65
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-65
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-65
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-64
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-63
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-63
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-62
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-60
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-59
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-58
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-56
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-55
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-54
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-50
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-50
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-49
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-48
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-48
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-43
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-42
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-40
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-35
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 3e-77
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 32/291 (10%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEV 150
           G       +G G FG V+KG                 VAVK L       Q  + +  EV
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEV 55

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
             L +  H N++  +GY     Q  +V ++    SL +HL            I IA   A
Sbjct: 56  GVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           +G+ +LH  ++ +I+RD K++NI L  +   K+ DFGLA    +   +H   ++ G+  +
Sbjct: 115 QGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 271 AAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
            APE +        + +SDVY+FG+VL E++TG+          +   +        D  
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232

Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
           K+       ++            +L   CL +    RP   +++  +  L 
Sbjct: 233 KVRSNCPKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  227 bits (580), Expect = 2e-72
 Identities = 77/315 (24%), Positives = 138/315 (43%), Gaps = 38/315 (12%)

Query: 83  FTFQELKSATGNF---------RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVK 133
           FTF++   A   F         + + ++G G FG V  G ++  G         I VA+K
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60

Query: 134 SLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR 192
           +LK     +  R++++E   +GQ  HPN++ L G   +    +++ EFM  GSL++ L +
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120

Query: 193 RTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG 252
                     + +  G A G+ +L       ++RD    NIL++S    K+SDFGL++  
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 253 PQGDKTHVSTRVVG---TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP 309
                    T  +G      + APE +     TS SDV+S+G+V+ E+++       +RP
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERP 233

Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
             +              + +   ++    L   +     + QL  +C  +D   RP   +
Sbjct: 234 YWDMT-----------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 370 VVKVLTP-LQDLNDL 383
           +V  L   +++ N L
Sbjct: 283 IVNTLDKMIRNPNSL 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 3e-69
 Identities = 85/320 (26%), Positives = 138/320 (43%), Gaps = 38/320 (11%)

Query: 62  LSSDNPDPAPTDEKSPCQLLQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAP 121
           LS+ NP+          Q +Q       S   +F  + ++G G FG V+ G + +N    
Sbjct: 6   LSALNPELV--------QAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDND--- 52

Query: 122 AKPGSGITVAVKSLKPDGLQGH-REWVAEVDFLGQLHHPNLVKLIGYCIEDDQR-LLVYE 179
              G  I  AVKSL      G   +++ E   +    HPN++ L+G C+  +   L+V  
Sbjct: 53  ---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109

Query: 180 FMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY 239
           +M  G L N +   T      + I   L  AKG+ FL   S+  ++RD    N +LD ++
Sbjct: 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKF 167

Query: 240 NAKLSDFGLAK--AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEI 297
             K++DFGLA+     + D  H  T       + A E + T   T+KSDV+SFGV+L E+
Sbjct: 168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227

Query: 298 LTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCL 357
           +T         P  + N        L  +R    ++ P             + ++   C 
Sbjct: 228 MTRGA-----PPYPDVNTFDITVYLLQGRR----LLQPEYC-------PDPLYEVMLKCW 271

Query: 358 SRDPKSRPSMDEVVKVLTPL 377
               + RPS  E+V  ++ +
Sbjct: 272 HPKAEMRPSFSELVSRISAI 291

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 2e-68
 Identities = 71/286 (24%), Positives = 125/286 (43%), Gaps = 30/286 (10%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
                  +G G FG V  G+            +   VA+K+++        +++ E + +
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
            +L HP LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
           A+L      VI+RD    N L+      K+SDFG+ +     D+   ST       +A+P
Sbjct: 115 AYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASP 171

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E       +SKSDV+SFGV++ E+ +  +   + R + E          + D    +++ 
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLY 222

Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
            PRL           V Q+  +C    P+ RP+   +++ L  + +
Sbjct: 223 KPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 3e-68
 Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 30/281 (10%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           +      LG G FG V  G                 VA+K +K        E++ E   +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKVM 53

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
             L H  LV+L G C +     ++ E+M  G L N+L            +++     + +
Sbjct: 54  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +L   S+  ++RD    N L++ +   K+SDFGL++     D+   S        ++ P
Sbjct: 114 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPP 170

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E +M    +SKSD+++FGV++ EI +  +   ++  + E                  + +
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHI 214

Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
              L L       +KV  + Y+C       RP+   ++  +
Sbjct: 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 4e-68
 Identities = 68/291 (23%), Positives = 128/291 (43%), Gaps = 25/291 (8%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
                 ++G G FG V+KG ++ +      P     VA+K+LK    +  R +++ E   
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           +GQ  H N+++L G   +    +++ E+M  G+L+  L  +         + +  G A G
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGTYGYA 271
           + +L   +   ++RD    NIL++S    K+SDFGL++      + T+ ++       + 
Sbjct: 123 MKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE +     TS SDV+SFG+V+ E++T       +  + E                + +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMK 224

Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLND 382
            ++    L   +     + QL   C  ++   RP   ++V +L  L    D
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 7e-68
 Identities = 73/305 (23%), Positives = 118/305 (38%), Gaps = 45/305 (14%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
           N     +LG G FG V             K G  I VAVK LK       RE  ++E+  
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR------------------ 193
           + QL  H N+V L+G C       L++E+   G L N+L  +                  
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 194 ----TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA 249
                  L + + +  A   AKG+ FL    +  ++RD    N+L+      K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRP 309
           +         V         + APE +  G  T KSDV+S+G++L EI +   +     P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 310 SGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
                               Y+++    +++      +++  +  +C + D + RPS   
Sbjct: 272 VDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316

Query: 370 VVKVL 374
           +   L
Sbjct: 317 LTSFL 321

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 5e-67
 Identities = 72/313 (23%), Positives = 125/313 (39%), Gaps = 44/313 (14%)

Query: 87  ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE- 145
           ELK    +F   S LG G  G VFK   + +G           +A K +  +     R  
Sbjct: 2   ELK--DDDFEKISELGAGNGGVVFKVSHKPSGL---------VMARKLIHLEIKPAIRNQ 50

Query: 146 WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKI 205
            + E+  L + + P +V   G    D +  +  E M  GSL+  L +    +P     K+
Sbjct: 51  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKV 109

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVV 265
           ++   KGL +L      +++RD K SNIL++S    KL DFG++          ++   V
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164

Query: 266 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR-------------------SMDK 306
           GT  Y +PE +   H + +SD++S G+ L+E+  GR                        
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224

Query: 307 KRPSGEQNLVAWARQYLADKR---KLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSR 359
           + P   +        Y  D R    +++++D  +            S    +    CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284

Query: 360 DPKSRPSMDEVVK 372
           +P  R  + +++ 
Sbjct: 285 NPAERADLKQLMV 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 5e-67
 Identities = 75/300 (25%), Positives = 119/300 (39%), Gaps = 40/300 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV-AEVDF 152
                  LG G FG V +           K  + +TVAVK LKP      RE + +E+  
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLI----KSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRR-----------------T 194
           L  L +H N+V L+G C      L++ E+   G L N L R+                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 195 IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQ 254
           + L   + +  +   AKG+AFL   S+  I+RD    NILL      K+ DFGLA+    
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 255 GDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQN 314
                V         + APE +     T +SDV+S+G+ L E+ +   S     P   + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256

Query: 315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
                          Y+++     +        ++  +   C   DP  RP+  ++V+++
Sbjct: 257 --------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 8e-67
 Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 32/282 (11%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
             +    LG G FG V+ G+                VAVKSLK         ++AE + +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKG 212
            QL H  LV+L       +   ++ E+M  GSL + L   + I L  +  + +A   A+G
Sbjct: 63  KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           +AF+       I+RD + +NIL+    + K++DFGLA+     ++            + A
Sbjct: 122 MAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 178

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
           PE +  G  T KSDV+SFG++L EI+T  R       + E                + Q 
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VIQN 222

Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
           ++    +       +++ QL   C    P+ RP+ D +  VL
Sbjct: 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  211 bits (539), Expect = 2e-66
 Identities = 71/292 (24%), Positives = 128/292 (43%), Gaps = 30/292 (10%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           +      LG G +G V++G               +TVAVK+LK D ++   E++ E   +
Sbjct: 18  DITMKHKLGGGQYGEVYEGV---------WKKYSLTVAVKTLKEDTMEV-EEFLKEAAVM 67

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKG 212
            ++ HPNLV+L+G C  +    ++ EFMT G+L ++L       +     + +A   +  
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           + +L    +  I+RD    N L+   +  K++DFGL++    GD             + A
Sbjct: 128 MEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 184

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
           PE +     + KSDV++FGV+L EI T   S                     D  ++Y++
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYEL 228

Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDLA 384
           ++    +       +KV +L   C   +P  RPS  E+ +    +   + ++
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 8e-66
 Identities = 73/309 (23%), Positives = 123/309 (39%), Gaps = 40/309 (12%)

Query: 101 LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDFLGQLHHP 159
           +G+G FG V++G              G  VAVK       +   RE  AE+     L H 
Sbjct: 11  IGKGRFGEVWRGKW-----------RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHE 57

Query: 160 NLVKLIGYCIEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           N++  I    +D+    Q  LV ++   GSL ++L R    +     IK+AL  A GLA 
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 115

Query: 216 LH------GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKT--HVSTRVVGT 267
           LH       G   + +RD K+ NIL+       ++D GLA        T        VGT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 268 YGYAAPEYVMT------GHLTSKSDVYSFGVVLLEILTGRR----SMDKKRPSGEQNLVA 317
             Y APE +             ++D+Y+ G+V  EI           D + P  +     
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 318 WARQYLADKRKLYQIVDPRLELNY-SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP 376
            + + +       Q + P +   + S + ++ ++++   C   +  +R +   + K L+ 
Sbjct: 236 PSVEEMRKVV-CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

Query: 377 LQDLNDLAI 385
           L     + +
Sbjct: 295 LSQQEGIKM 303

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 1e-65
 Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 29/292 (9%)

Query: 86  QELKSATGNFRPDSI-LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR 144
           ++L     N     I LG G FG V +G               I VA+K LK    +   
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADT 53

Query: 145 E-WVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI 203
           E  + E   + QL +P +V+LIG C + +  +LV E    G L   L  +   +P SN  
Sbjct: 54  EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 112

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-GPQGDKTHVST 262
           ++    + G+ +L    +  ++RD    N+LL + + AK+SDFGL+KA G         +
Sbjct: 113 ELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
                  + APE +     +S+SDV+S+GV + E L+  +     +P  +          
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFI 225

Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
              KR                    ++  L  +C     + RP    V + +
Sbjct: 226 EQGKR-------MECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  210 bits (534), Expect = 2e-65
 Identities = 73/318 (22%), Positives = 118/318 (37%), Gaps = 46/318 (14%)

Query: 81  LQFTFQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL 140
           L      L+    N      +GEG FG VF+                  VAVK LK +  
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEAS 56

Query: 141 QGHR-EWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRT----- 194
              + ++  E   + +  +PN+VKL+G C       L++E+M  G L   L   +     
Sbjct: 57  ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116

Query: 195 ------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD 236
                              PL  + ++ IA   A G+A+L       ++RD  T N L+ 
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVG 174

Query: 237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 296
                K++DFGL++     D             +  PE +     T++SDV+++GVVL E
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234

Query: 297 ILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNC 356
           I +            E                +Y + D  + L        ++  L   C
Sbjct: 235 IFSYGLQPYYGMAHEEV---------------IYYVRDGNI-LACPENCPLELYNLMRLC 278

Query: 357 LSRDPKSRPSMDEVVKVL 374
            S+ P  RPS   + ++L
Sbjct: 279 WSKLPADRPSFCSIHRIL 296

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 3e-65
 Identities = 63/284 (22%), Positives = 121/284 (42%), Gaps = 25/284 (8%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFL 153
           F+   +LG G FG V+KG     G         I VA+K L+     + ++E + E   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVK-----IPVAIKELREATSPKANKEILDEAYVM 65

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
             + +P++ +L+G C+    +L + + M  G L +++      +     +   +  AKG+
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +L      +++RD    N+L+ +  + K++DFGLAK     +K + +        + A 
Sbjct: 125 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 274 EYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV 333
           E ++    T +SDV+S+GV + E++T         P+ E                +  I+
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSIL 226

Query: 334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           +    L         V  +   C   D  SRP   E++   + +
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 5e-65
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 38/287 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
             +    +G+G FG V  G              G  VAVK +K D     + ++AE   +
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASVM 54

Query: 154 GQLHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAK 211
            QL H NLV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L   +
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
            + +L       ++RD    N+L+  +  AK+SDFGL K     + +           + 
Sbjct: 115 AMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWT 167

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE +     ++KSDV+SFG++L EI +  R      P     L     +     +    
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYK---- 218

Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
                            V ++  NC   D   RPS  ++ + L  ++
Sbjct: 219 ---MDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 9e-65
 Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 28/289 (9%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEV 150
           + R    LG+G FG V +G  +         G  ++VAVK LKPD L   +   +++ EV
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREV 62

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
           + +  L H NL++L G  +    ++ V E    GSL + L +           + A+  A
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV-STRVVGTYG 269
           +G+ +L   S+  I+RD    N+LL +    K+ DFGL +A PQ D  +V        + 
Sbjct: 122 EGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           + APE + T   +  SD + FGV L E+ T  +      P    N              L
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQI----------L 224

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
           ++I      L       Q +  +   C +  P+ RP+   +   L   Q
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-64
 Identities = 66/282 (23%), Positives = 117/282 (41%), Gaps = 29/282 (10%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV-AEVD 151
            ++     LGEG +G V                +   VAVK +         E +  E+ 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEIC 55

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
               L+H N+VK  G+  E + + L  E+ + G L + +      +P  +  +       
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 114

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y 
Sbjct: 115 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 272 APEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
           APE +          DV+S G+VL  +L G    D+   S          Q  +D ++  
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---------CQEYSDWKEKK 223

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             ++P  +++ +         L +  L  +P +R ++ ++ K
Sbjct: 224 TYLNPWKKIDSAPL------ALLHKILVENPSARITIPDIKK 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 5e-64
 Identities = 74/282 (26%), Positives = 119/282 (42%), Gaps = 30/282 (10%)

Query: 98  DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEVDFLGQ 155
           D  LG G FG V KG+ +             TVAVK LK +        E +AE + + Q
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64

Query: 156 LHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAF 215
           L +P +V++IG C E +  +LV E    G L  +L +    +   N I++    + G+ +
Sbjct: 65  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKY 122

Query: 216 LHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA-GPQGDKTHVSTRVVGTYGYAAPE 274
           L       ++RD    N+LL +++ AK+SDFGL+KA     +     T       + APE
Sbjct: 123 LE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 275 YVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD 334
            +     +SKSDV+SFGV++ E  +  +     +P                +R       
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGER------- 228

Query: 335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP 376
                       +++  L   C + D ++RP    V   L  
Sbjct: 229 MGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-63
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 45/301 (14%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDF 152
           + +   ++GEG FG V K  I+++G         +  A+K +K       HR++  E++ 
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEV 63

Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI---------------P 196
           L +L HHPN++ L+G C       L  E+   G+L + L +  +                
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           L     +  A   A+G+ +L    +  I+RD    NIL+   Y AK++DFGL++      
Sbjct: 124 LSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
           K    T       + A E +     T+ SDV+S+GV+L EI++   +     P       
Sbjct: 182 KK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCA 233

Query: 317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP 376
               +     R           LN       +V  L   C    P  RPS  +++  L  
Sbjct: 234 ELYEKLPQGYR-------LEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNR 282

Query: 377 L 377
           +
Sbjct: 283 M 283

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-63
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 33/284 (11%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
            +     LG+G FG V+K              + +  A K +     +   +++ E+D L
Sbjct: 13  FWEIIGELGDGAFGKVYKAQ---------NKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
               HPN+VKL+     ++   ++ EF   G+++  +     PL  S    +       L
Sbjct: 64  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP 273
            +LH     +I+RD K  NIL   + + KL+DFG++    +  +       +GT  + AP
Sbjct: 124 NYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAP 179

Query: 274 EYVMT-----GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
           E VM           K+DV+S G+ L+E+           P  E N +    +    +  
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEPP 233

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                       +S             CL ++  +R +  ++++
Sbjct: 234 TLAQPS-----RWS----SNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 2e-62
 Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 37/285 (12%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDF 152
            + D  +G G F  V+KG             + + VA   L+   L     + +  E + 
Sbjct: 11  LKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEAEM 61

Query: 153 LGQLHHPNLVKLIGYCIE----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           L  L HPN+V+               +LV E MT G+L+ +L R    +           
Sbjct: 62  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQ 120

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
             KGL FLH  + P+I+RD K  NI +     + K+ D GLA       +   +  V+GT
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGT 176

Query: 268 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR 327
             + APE +         DVY+FG+ +LE+ T         P  E    A   +      
Sbjct: 177 PEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYR------ 223

Query: 328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
              ++       ++    + +V ++   C+ ++   R S+ +++ 
Sbjct: 224 ---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-62
 Identities = 71/287 (24%), Positives = 115/287 (40%), Gaps = 27/287 (9%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEVDF 152
                  +GEG FG V +G               + VA+K+ K       RE ++ E   
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           + Q  HP++VKLIG    ++   ++ E  T G L + L  R   L  ++ I  A   +  
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           LA+L   S+  ++RD    N+L+ S    KL DFGL++        + +++      + A
Sbjct: 121 LAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMA 177

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
           PE +     TS SDV+ FGV + EIL         +P           +    +R     
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGER----- 227

Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD 379
               +  N        +  L   C + DP  RP   E+   L+ + +
Sbjct: 228 --LPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 3e-61
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 32/285 (11%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           + R +  LG+G FG V+ G                 VA+K+LKP        ++ E   +
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTI-PLPWSNRIKIALGAAKG 212
            +L H  LV+L      ++   +V E+M++GSL + L   T   L     + +A   A G
Sbjct: 67  KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAA 272
           +A++       ++RD + +NIL+      K++DFGLA+     ++            + A
Sbjct: 126 MAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 182

Query: 273 PEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI 332
           PE  + G  T KSDV+SFG++L E+ T  R       + E                +   
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQ 226

Query: 333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL 377
           V+    +    +  + +  L   C  ++P+ RP+ + +   L   
Sbjct: 227 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (504), Expect = 6e-61
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 40/284 (14%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEVD 151
           F     +G G FG V+      N            VA+K +   G Q + +W   + EV 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
           FL +L HPN ++  G  + +    LV E+    + +     +  PL       +  GA +
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQ 126

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           GLA+LH  S  +I+RD K  NILL      KL DFG A           +   VGT  + 
Sbjct: 127 GLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWM 178

Query: 272 APEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK 328
           APE ++    G    K DV+S G+  +E+   +  +                        
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSA 222

Query: 329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           LY I         S    +       +CL + P+ RP+ + ++K
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-61
 Identities = 65/282 (23%), Positives = 108/282 (38%), Gaps = 37/282 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEV 150
           +F     LG+G FG V+    +++            +A+K L    L       +   EV
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKF---------ILALKVLFKAQLEKAGVEHQLRREV 57

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
           +    L HPN+++L GY  +  +  L+ E+   G++   L ++                A
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELA 116

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             L++ H  S+ VI+RD K  N+LL S    K++DFG +   P   +T +     GT  Y
Sbjct: 117 NALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDY 170

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
             PE +       K D++S GV+  E L G+       P          ++    +    
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFP 224

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             V                  L    L  +P  RP + EV++
Sbjct: 225 DFVTEGAR------------DLISRLLKHNPSQRPMLREVLE 254

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-60
 Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 38/289 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVD 151
           ++     +G G +G   K   + +G           +  K L    +     +  V+EV+
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGK---------ILVWKELDYGSMTEAEKQMLVSEVN 55

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLL--VYEFMTRGSLENHLFRRTI---PLPWSNRIKIA 206
            L +L HPN+V+     I+     L  V E+   G L + + + T     L     +++ 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 207 LGAAKGLAFLH---GGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 L   H    G   V++RD K +N+ LD + N KL DFGLA+       T  +  
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
            VGT  Y +PE +       KSD++S G +L E+           P    +    A +  
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             K         R+   YS     +++++    L+     RPS++E+++
Sbjct: 228 EGKF-------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-59
 Identities = 72/307 (23%), Positives = 134/307 (43%), Gaps = 32/307 (10%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR-EWVAEVDF 152
                  LG+G FG V++G  +       K      VA+K++        R E++ E   
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLF---------RRTIPLPWSNRI 203
           + + +  ++V+L+G   +    L++ E MTRG L+++L              P   S  I
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
           ++A   A G+A+L+  +   ++RD    N ++  ++  K+ DFG+ +   + D      +
Sbjct: 137 QMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
            +    + +PE +  G  T+ SDV+SFGVVL EI T                     Q L
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGL 239

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLNDL 383
           ++++ L  +++  L L+        + +L   C   +PK RPS  E++  +    +    
Sbjct: 240 SNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298

Query: 384 AILSYHS 390
            +  Y+S
Sbjct: 299 EVSFYYS 305

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 2e-59
 Identities = 70/315 (22%), Positives = 122/315 (38%), Gaps = 49/315 (15%)

Query: 84  TFQELKSA------TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP 137
             ++L+S          +     +G+G  G V+       G           VA++ +  
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQ---------EVAIRQMNL 55

Query: 138 DGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPL 197
                    + E+  + +  +PN+V  +   +  D+  +V E++  GSL + +      +
Sbjct: 56  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CM 113

Query: 198 PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDK 257
                  +     + L FLH  S  VI+RD K+ NILL  + + KL+DFG          
Sbjct: 114 DEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 258 THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
               + +VGT  + APE V       K D++S G++ +E++ G      + P        
Sbjct: 172 KR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------- 221

Query: 318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEV--- 370
                    R LY I          L+  +K+S +  +    CL  D + R S  E+   
Sbjct: 222 --------LRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270

Query: 371 --VKVLTPLQDLNDL 383
             +K+  PL  L  L
Sbjct: 271 QFLKIAKPLSSLTPL 285

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 5e-58
 Identities = 76/304 (25%), Positives = 129/304 (42%), Gaps = 37/304 (12%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH-REWVAEVDF 152
                  LGEG FG V     E  G    KP     VAVK LK D  +    + ++E++ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 153 LGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIP--------------- 196
           +  +  H N++ L+G C +D    ++ E+ ++G+L  +L  R  P               
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 197 LPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD 256
           L   + +  A   A+G+ +L   S+  I+RD    N+L+  +   K++DFGLA+     D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV 316
               +T       + APE +     T +SDV+SFGV+L EI T   S     P  E    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245

Query: 317 AWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP 376
                       L++++     ++       ++  +  +C    P  RP+  ++V+ L  
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

Query: 377 LQDL 380
           +  L
Sbjct: 294 IVAL 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 81/306 (26%), Positives = 120/306 (39%), Gaps = 39/306 (12%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-HREWVAEVDF 152
             +    LG G FG V +           K  +  TVAVK LK       HR  ++E+  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 153 LGQ-LHHPNLVKLIGYCIEDDQRL-LVYEFMTRGSLENHLFRR---------------TI 195
           L    HH N+V L+G C +    L ++ EF   G+L  +L  +                 
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 196 PLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG 255
            L   + I  +   AKG+ FL   S   I+RD    NILL  +   K+ DFGLA+   + 
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 256 DKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL 315
                         + APE +     T +SDV+SFGV+L EI +   S     P     +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKI 242

Query: 316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT 375
                      R+L +    R     +     ++ Q   +C   +P  RP+  E+V+ L 
Sbjct: 243 DEEFC------RRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

Query: 376 PLQDLN 381
            L   N
Sbjct: 293 NLLQAN 298

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 9e-56
 Identities = 57/288 (19%), Positives = 101/288 (35%), Gaps = 33/288 (11%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEV 150
           +F+   ILGEG F  V                     A+K L+   +           E 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSR---------EYAIKILEKRHIIKENKVPYVTRER 59

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
           D + +L HP  VKL     +D++      +   G L  ++ +       +          
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIV 118

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             L +LH   + +I+RD K  NILL+ + + +++DFG AK      K   +   VGT  Y
Sbjct: 119 SALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            +PE +        SD+++ G ++ +++ G        P    N     ++ +  +    
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEYDFP 230

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ 378
           +   P+               L    L  D   R   +E+        
Sbjct: 231 EKFFPKAR------------DLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  183 bits (466), Expect = 7e-55
 Identities = 66/333 (19%), Positives = 114/333 (34%), Gaps = 32/333 (9%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           ++     LG G FG V +      G            A K +             E+  +
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGN---------NFAAKFVMTPHESDKETVRKEIQTM 77

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
             L HP LV L     +D++ +++YEFM+ G L   +      +     ++      KGL
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYN--AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
             +H      ++ D K  NI+  ++ +   KL DFGL       D         GT  +A
Sbjct: 138 CHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFA 192

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE      +   +D++S GV+   +L+G        P G +N     R   +    +  
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMDD 246

Query: 332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQDLNDLAILSYH 389
                +         +         L  DP +R ++ + ++   LTP       + +   
Sbjct: 247 SAFSGIS--------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 298

Query: 390 SRLSQQGRRKKKQDGTQQLASAHSKSIRDSPLN 422
                +   K K D   +      +    S L 
Sbjct: 299 RYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLR 331

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  181 bits (461), Expect = 4e-54
 Identities = 63/333 (18%), Positives = 124/333 (37%), Gaps = 41/333 (12%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
             +     LG G FG V +   +  G              K +             E+  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGR---------VFVAKFINTPYPLDKYTVKNEISI 79

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
           + QLHHP L+ L     +  + +L+ EF++ G L + +      +  +  I     A +G
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYNA--KLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
           L  +H     +++ D K  NI+ +++  +  K+ DFGLA      +          T  +
Sbjct: 140 LKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
           AAPE V    +   +D+++ GV+   +L+G        P   ++          D   L 
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGED----------DLETLQ 238

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVK---VLTPLQDLNDL 383
            +   R +  +       VS  A +     L ++P+ R ++ + ++   +     +L   
Sbjct: 239 NVK--RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296

Query: 384 AILSYHSRLSQQGRRKKKQDGTQQLASAHSKSI 416
              S ++++ Q+ + K       Q A     + 
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANF 329

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  170 bits (432), Expect = 1e-50
 Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 45/295 (15%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---------QGHR 144
           N+ P  ILG G    V +   +               AVK +   G          +   
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCK---------EYAVKIIDVTGGGSFSAEEVQELRE 54

Query: 145 EWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI 203
             + EVD L ++  HPN+++L      +    LV++ M +G L ++L    + L      
Sbjct: 55  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR 113

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTR 263
           KI     + +  LH     +++RD K  NILLD + N KL+DFG +     G+K      
Sbjct: 114 KIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---RE 168

Query: 264 VVGTYGYAAPEYVMTGHL------TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA 317
           V GT  Y APE +             + D++S GV++  +L G        P   +  + 
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQML 222

Query: 318 WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
             R  ++     YQ   P  + +YS      V  L    L   P+ R + +E + 
Sbjct: 223 MLRMIMSGN---YQFGSPEWD-DYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (430), Expect = 2e-50
 Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 35/297 (11%)

Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---HREWVA 148
           +  +    ILG GG   V                    VAVK L+ D  +    +  +  
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHR---------DVAVKVLRADLARDPSFYLRFRR 56

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRL----LVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
           E      L+HP +V +      +        +V E++   +L + +     P+     I+
Sbjct: 57  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIE 115

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTR 263
           +   A + L F H     +I+RD K +NI++ +    K+ DFG+A+     G+    +  
Sbjct: 116 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 264 VVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL 323
           V+GT  Y +PE      + ++SDVYS G VL E+LTG        P    + V+ A Q++
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHV 227

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-SMDEVVKVLTPLQD 379
            +           L           +  +    L+++P++R  +  E+   L  + +
Sbjct: 228 REDPIPPSARHEGLS--------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (431), Expect = 4e-50
 Identities = 56/292 (19%), Positives = 110/292 (37%), Gaps = 33/292 (11%)

Query: 85  FQELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHR 144
           +++ +     +    +LG G F  V     +              VA+K +    L+G  
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQK---------LVAIKCIAKKALEGKE 51

Query: 145 EWV-AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRI 203
             +  E+  L ++ HPN+V L           L+ + ++ G L + +  +       +  
Sbjct: 52  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDAS 110

Query: 204 KIALGAAKGLAFLHGGSEPVIYRDFKTSNILL---DSEYNAKLSDFGLAKAGPQGDKTHV 260
           ++       + +LH     +++RD K  N+L    D +    +SDFGL+K     D   V
Sbjct: 111 RLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSV 165

Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
            +   GT GY APE +     +   D +S GV+   +L G        P  ++N      
Sbjct: 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFE 219

Query: 321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           Q L  + +        +                 + + +DP+ R + ++ ++
Sbjct: 220 QILKAEYEFDSPYWDDIS--------DSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-50
 Identities = 51/285 (17%), Positives = 109/285 (38%), Gaps = 39/285 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
            +     LG G FG V +           +  S  T   K +K  G         E+  L
Sbjct: 6   KYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55

Query: 154 GQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGL 213
               H N++ L       ++ ++++EF++   +   +      L     +       + L
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYNA--KLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
            FLH  S  + + D +  NI+  +  ++  K+ +FG A+    GD   +   +     Y 
Sbjct: 116 QFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYY 170

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ 331
           APE      +++ +D++S G ++  +L+G      +                  ++ +  
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----------------QQIIEN 214

Query: 332 IVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVK 372
           I++   E  +  +  +++S  A +     L ++ KSR +  E ++
Sbjct: 215 IMNA--EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-49
 Identities = 71/332 (21%), Positives = 129/332 (38%), Gaps = 31/332 (9%)

Query: 92  TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE-WVAEV 150
              +   S +GEG +G V   +   N            VA+K + P   Q + +  + E+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKV---------RVAIKKISPFEHQTYCQRTLREI 57

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFR--RTIPLPWSNRIKIALG 208
             L +  H N++ +           +   ++    +   L++  +T  L   +       
Sbjct: 58  KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK-AGPQGDKTHVSTRVVGT 267
             +GL ++H  S  V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T  V T
Sbjct: 118 ILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 268 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA------- 319
             Y APE ++     +KS D++S G +L E+L+ R     K    + N +          
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 320 --RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVK- 372
                +  K + Y +  P        +        A +     L+ +P  R  +++ +  
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295

Query: 373 -VLTPLQDLNDLAILSYHSRLSQQGRRKKKQD 403
             L    D +D  I     +   +     K+ 
Sbjct: 296 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEK 327

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 8e-49
 Identities = 69/283 (24%), Positives = 108/283 (38%), Gaps = 36/283 (12%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEV 150
           +F    +LG+G FG VF    ++              A+K+LK D +    +    + E 
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQ---------FFAIKALKKDVVLMDDDVECTMVEK 53

Query: 151 DFLG-QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGA 209
             L     HP L  +       +    V E++  G L  H+         S     A   
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEI 112

Query: 210 AKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
             GL FLH  S+ ++YRD K  NILLD + + K++DFG+ K    GD         GT  
Sbjct: 113 ILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPD 168

Query: 270 YAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL 329
           Y APE ++        D +SFGV+L E+L G+       P   Q+          D    
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFY 222

Query: 330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
            + ++   +             L      R+P+ R  +   ++
Sbjct: 223 PRWLEKEAK------------DLLVKLFVREPEKRLGVRGDIR 253

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 3e-48
 Identities = 70/301 (23%), Positives = 113/301 (37%), Gaps = 32/301 (10%)

Query: 91  ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---- 146
           A   +   + +GEG +G VFK    +NG        G  VA+K ++    +         
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56

Query: 147 -VAEVDFLGQLHHPNLVKLIGYCIEDDQR-----LLVYEFMTRGSLENHLFRRTIPLPWS 200
            VA +  L    HPN+V+L   C            LV+E + +             +P  
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116

Query: 201 NRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHV 260
               +     +GL FLH  S  V++RD K  NIL+ S    KL+DFGLA+          
Sbjct: 117 TIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMA 171

Query: 261 STRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR 320
            T VV T  Y APE ++     +  D++S G +  E+   +          +   +    
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231

Query: 321 QYLADKRKLYQIVDPRLELNYS-----LKGVQKVSQLAYN----CLSRDPKSRPSMDEVV 371
               ++     +  PR   +        K V  + +L  +    CL+ +P  R S    +
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

Query: 372 K 372
            
Sbjct: 292 S 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  166 bits (422), Expect = 3e-48
 Identities = 66/281 (23%), Positives = 103/281 (36%), Gaps = 38/281 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGH------REWV 147
           +F    I+G GGFG V+            K  +G   A+K L    ++            
Sbjct: 5   DFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNER 55

Query: 148 AEVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIAL 207
             +  +     P +V +       D+   + + M  G L  HL +       ++    A 
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAA 114

Query: 208 GAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGT 267
               GL  +H  +  V+YRD K +NILLD   + ++SD GLA    +          VGT
Sbjct: 115 EIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGT 168

Query: 268 YGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
           +GY APE +  G    S +D +S G +L ++L G     + +   +  +    R  L   
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTMA 225

Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM 367
            +L     P L              L    L RD   R   
Sbjct: 226 VELPDSFSPELR------------SLLEGLLQRDVNRRLGC 254

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (413), Expect = 9e-48
 Identities = 50/290 (17%), Positives = 91/290 (31%), Gaps = 31/290 (10%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
             +R    +G G FG ++ G     G           VA+K         H +   E   
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKI 55

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
              +     +  I +C  +    ++   +   SLE+     +        + +A      
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115

Query: 213 LAFLHGGSEPVIYRDFKTSNIL---LDSEYNAKLSDFGLAKA-----GPQGDKTHVSTRV 264
           + ++H  S+  I+RD K  N L           + DFGLAK        Q      +  +
Sbjct: 116 IEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  YA+    +    + + D+ S G VL+    G       + +         ++Y  
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA------TKRQKYER 227

Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVL 374
              K        L   Y      + +     C S     +P    + ++ 
Sbjct: 228 ISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-47
 Identities = 66/289 (22%), Positives = 114/289 (39%), Gaps = 30/289 (10%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-----HREWVAEVDFLG 154
            LGEG F  V+K   +              VA+K +K           +R  + E+  L 
Sbjct: 5   FLGEGQFATVYKARDKNTNQ---------IVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 155 QLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLA 214
           +L HPN++ L+          LV++FM    LE  +   ++ L  S+     L   +GL 
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114

Query: 215 FLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPE 274
           +LH     +++RD K +N+LLD     KL+DFGLAK+    ++ +  T  V T  Y APE
Sbjct: 115 YLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPE 170

Query: 275 YVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLV-----AWARQYLADKRK 328
            +    +     D+++ G +L E+L     +       +   +         +   D   
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 329 LYQIVDPRLELNYSLKGV-QKVSQLAYN----CLSRDPKSRPSMDEVVK 372
           L   V  +      L  +         +        +P +R +  + +K
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 4e-47
 Identities = 64/292 (21%), Positives = 105/292 (35%), Gaps = 47/292 (16%)

Query: 95  FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVA------ 148
           +     LG G F  V K   +  G            A K +K    +  R  V+      
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGL---------QYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 149 EVDFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
           EV  L ++ HPN++ L          +L+ E +  G L + L  +   L      +    
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 121

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSE----YNAKLSDFGLAKAGPQGDKTHVSTRV 264
              G+ +LH  S  + + D K  NI+L          K+ DFGLA     G++      +
Sbjct: 122 ILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNI 176

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA 324
            GT  + APE V    L  ++D++S GV+   +L+G                        
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------------- 221

Query: 325 DKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVK 372
            +  L  +     E           S LA +     L +DPK R ++ + ++
Sbjct: 222 -QETLANVSAVNYEFEDEY--FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 8e-47
 Identities = 70/295 (23%), Positives = 121/295 (41%), Gaps = 31/295 (10%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVD 151
           NF+    +GEG +G V+K   +  G           VA+K ++ D          + E+ 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGE---------VVALKKIRLDTETEGVPSTAIREIS 53

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            L +L+HPN+VKL+     +++  LV+EF+ +   +         +P            +
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           GLAF H  S  V++RD K  N+L+++E   KL+DFGLA+A     +T+ +  VV  +  A
Sbjct: 114 GLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRA 170

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS----------GEQNLVAWARQ 321
               +   + ++  D++S G +  E++T R                   G  + V W   
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230

Query: 322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVK 372
                   Y+   P+       K V  + +   +     L  DP  R S    + 
Sbjct: 231 T---SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  159 bits (403), Expect = 5e-46
 Identities = 68/276 (24%), Positives = 110/276 (39%), Gaps = 38/276 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE---WVAEV 150
           +F+    LG G FG V       NG            A+K LK + +   ++      E 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGR---------YYAMKVLKKEIVVRLKQVEHTNDER 55

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
             L  + HP ++++ G   +  Q  ++ +++  G     L R++   P       A    
Sbjct: 56  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVC 114

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             L +LH  S+ +IYRD K  NILLD   + K++DFG AK  P    T     + GT  Y
Sbjct: 115 LALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDY 167

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            APE V T       D +SFG+++ E+L G        P  + N +    + L  + +  
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELRFP 221

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS 366
              +  ++             L    ++RD   R  
Sbjct: 222 PFFNEDVK------------DLLSRLITRDLSQRLG 245

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  155 bits (392), Expect = 9e-45
 Identities = 47/300 (15%), Positives = 96/300 (32%), Gaps = 34/300 (11%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
            +++    +GEG FG +F+G    N            VA+K           +   E   
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQ---------QVAIKFEPRR--SDAPQLRDEYRT 53

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKG 212
              L     +  + Y  ++    ++   +   SLE+ L               A      
Sbjct: 54  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 113

Query: 213 LAFLHGGSEPVIYRDFKTSNILLDSEYN-----AKLSDFGLAK-----AGPQGDKTHVST 262
           +  +H   + ++YRD K  N L+    +       + DFG+ K        Q        
Sbjct: 114 VQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

Query: 263 RVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
            + GT  Y +    +    + + D+ + G V +  L G       + +  +         
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------ 225

Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT-PLQDLN 381
             ++    +   P  EL       ++  +  +   +    + P  D +  + +  L+ LN
Sbjct: 226 --ERIGEKKQSTPLRELCAGFP--EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  154 bits (389), Expect = 2e-44
 Identities = 64/292 (21%), Positives = 112/292 (38%), Gaps = 27/292 (9%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVD 151
            +     +GEG +G V+K          A+   G T A+K ++ +          + E+ 
Sbjct: 3   KYHGLEKIGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            L +L H N+VKL        + +LV+E +    L+  L      L         L    
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           G+A+ H     V++RD K  N+L++ E   K++DFGLA+A     + +    +V  +  A
Sbjct: 112 GIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRA 168

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS----------GEQNLVAWARQ 321
               + +   ++  D++S G +  E++ G         +          G  N   W   
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228

Query: 322 YLADKRKLYQIVDPRLELNYSLKGV-QKVSQLAYNCLSRDPKSRPSMDEVVK 372
               K      V   L     LKG+ +    L    L  DP  R +  + ++
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-44
 Identities = 59/290 (20%), Positives = 102/290 (35%), Gaps = 49/290 (16%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHRE------W 146
             ++   +LG GGFG V+ G    +            VA+K ++ D +    E       
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNL---------PVAIKHVEKDRISDWGELPNGTRV 54

Query: 147 VAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
             EV  L ++      +++L+ +    D  +L+ E                 L       
Sbjct: 55  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLD-SEYNAKLSDFGLAKAGPQGDKTHVSTR 263
                 + +   H  +  V++RD K  NIL+D +    KL DFG         K  V T 
Sbjct: 115 FFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTD 168

Query: 264 VVGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY 322
             GT  Y+ PE++       +S  V+S G++L +++ G        P           + 
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------PFEHDE------EI 216

Query: 323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
           +  +    Q V    +             L   CL+  P  RP+ +E+  
Sbjct: 217 IRGQVFFRQRVSSECQ------------HLIRWCLALRPSDRPTFEEIQN 254

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-43
 Identities = 63/299 (21%), Positives = 108/299 (36%), Gaps = 37/299 (12%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           ++    ++G G FG V++  + ++G           VA+K +  D    +RE    +  +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGE---------LVAIKKVLQDKRFKNRE----LQIM 67

Query: 154 GQLHHPNLVKLIGYCIEDDQR------LLVYEFMTRGSLEN--HLFRRTIPLPWSNRIKI 205
            +L H N+V+L  +     ++       LV +++         H  R    LP       
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 206 ALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAKAGPQGDKTHVSTRV 264
                + LA++H  S  + +RD K  N+LLD +    KL DFG AK   +G+     + +
Sbjct: 128 MYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYI 183

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA------- 317
              Y  A          TS  DV+S G VL E+L G+          +   +        
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 318 ----WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK 372
                       + K  QI        +  +   +   L    L   P +R +  E   
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 6e-43
 Identities = 70/279 (25%), Positives = 101/279 (36%), Gaps = 35/279 (12%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEV 150
           +F    +LG+G FG V     +  G            A+K L+ + +    E    V E 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGR---------YYAMKILRKEVIIAKDEVAHTVTES 56

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
             L    HP L  L       D+   V E+   G L  HL  R                 
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIV 115

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
             L +LH  S  V+YRD K  N++LD + + K++DFGL K G     T       GT  Y
Sbjct: 116 SALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEY 171

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            APE +         D +  GVV+ E++ GR       P   Q+        L ++ +  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFP 225

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDE 369
           + + P  +             L    L +DPK R     
Sbjct: 226 RTLSPEAK------------SLLAGLLKKDPKQRLGGGP 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 4e-42
 Identities = 63/329 (19%), Positives = 118/329 (35%), Gaps = 41/329 (12%)

Query: 100 ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQL-HH 158
           +LG G  G V + + +               A+K L+        +   EV+   +    
Sbjct: 19  VLGLGINGKVLQIFNKRTQE---------KFALKMLQD-----CPKARREVELHWRASQC 64

Query: 159 PNLVKLIGYC----IEDDQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGL 213
           P++V+++             L+V E +  G L + +  R           +I     + +
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 214 AFLHGGSEPVIYRDFKTSNILLDSEYN---AKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
            +LH  S  + +RD K  N+L  S+      KL+DFG AK     +          T  Y
Sbjct: 125 QYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYY 179

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            APE +         D++S GV++  +L G              L          +   Y
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQY 234

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP-LQDLNDLAILSYH 389
           +  +P      S    ++V  L  N L  +P  R ++ E +    P +     +     H
Sbjct: 235 EFPNPEWS-EVS----EEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTKVPQTPLH 287

Query: 390 SRLSQQGRRKKKQDGTQQLASAHSKSIRD 418
           +    +  +++ +D  +++ SA +    D
Sbjct: 288 TSRVLKEDKERWEDVKEEMTSALATMRVD 316

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 6e-42
 Identities = 60/307 (19%), Positives = 107/307 (34%), Gaps = 39/307 (12%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG--HREWVAEV 150
             +   + +G+G FG VFK    + G           VA+K +  +  +       + E+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQ---------KVALKKVLMENEKEGFPITALREI 60

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQR--------LLVYEFMTRGSLENHLFRRTIPLPWSNR 202
             L  L H N+V LI  C               LV++F                   S  
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEI 119

Query: 203 IKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVS- 261
            ++      GL ++H     +++RD K +N+L+  +   KL+DFGLA+A      +  + 
Sbjct: 120 KRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 262 -TRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA-- 317
            T  V T  Y  PE ++         D++  G ++ E+ T    M       +  L++  
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 318 --------WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRP 365
                   W      +  +  ++V  +                A +     L  DP  R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 366 SMDEVVK 372
             D+ + 
Sbjct: 298 DSDDALN 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-41
 Identities = 65/315 (20%), Positives = 113/315 (35%), Gaps = 43/315 (13%)

Query: 83  FTFQELKSAT----GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD 138
           F  QE+          +R    +G G +G V        G           VA+K L   
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGA---------KVAIKKLYRP 54

Query: 139 GL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQR------LLVYEFMTRGSLENHL 190
                  +    E+  L  + H N++ L+     D+         LV  FM  G+    L
Sbjct: 55  FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL 112

Query: 191 FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
            +    L       +     KGL ++H  +  +I+RD K  N+ ++ +   K+ DFGLA+
Sbjct: 113 MKHE-KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169

Query: 251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPS 310
                    ++  VV  +  A    +     T   D++S G ++ E++TG+         
Sbjct: 170 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225

Query: 311 GEQNLVA---------WARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CL 357
            +   +          + ++  +D+ K Y    P LE       +   S LA N     L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285

Query: 358 SRDPKSRPSMDEVVK 372
             D + R +  E + 
Sbjct: 286 VLDAEQRVTAGEALA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-40
 Identities = 61/293 (20%), Positives = 105/293 (35%), Gaps = 27/293 (9%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVD 151
            +     +GEG +G VFK    E             VA+K ++ D          + E+ 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVRLDDDDEGVPSSALREIC 53

Query: 152 FLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAK 211
            L +L H N+V+L      D +  LV+EF  +   +                       K
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLK 112

Query: 212 GLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYA 271
           GL F H  S  V++RD K  N+L++     KL++FGLA+A     + + S  VV  +   
Sbjct: 113 GLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRP 169

Query: 272 APEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL-------- 323
                     ++  D++S G +  E+    R +       +Q    +             
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

Query: 324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMDEVVK 372
             K   Y+           +  V K++    +     L  +P  R S +E ++
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  133 bits (336), Expect = 2e-36
 Identities = 59/304 (19%), Positives = 109/304 (35%), Gaps = 46/304 (15%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFL 153
           +++    LG G +  VF+     N            V VK LKP   +   +   E+  L
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILKPVKKK---KIKREIKIL 83

Query: 154 GQL-HHPNLVKLIGYCIEDDQRL--LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
             L   PN++ L     +   R   LV+E +     +         L   +         
Sbjct: 84  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEIL 139

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAKAGPQGDKTHVSTRVVGTYG 269
           K L + H  S  +++RD K  N+++D E    +L D+GLA+    G +       V +  
Sbjct: 140 KALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRY 194

Query: 270 YAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQ-----------NLVA 317
           +  PE ++         D++S G +L  ++  +        + +Q           +L  
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 318 WARQYLADKRKLY-----QIVDPRLELNYSLKGVQKVSQLAYN----CLSRDPKSRPSMD 368
           +  +Y  +    +     +    R E     +    VS  A +     L  D +SR +  
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

Query: 369 EVVK 372
           E ++
Sbjct: 315 EAME 318

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (335), Expect = 6e-36
 Identities = 61/275 (22%), Positives = 101/275 (36%), Gaps = 38/275 (13%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREW---VAEV 150
            F     LG G FG V     +E+G            A+K L    +   ++    + E 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGN---------HYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 151 DFLGQLHHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAA 210
             L  ++ P LVKL     ++    +V E++  G + +HL R        +    A    
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIV 151

Query: 211 KGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGY 270
               +LH  S  +IYRD K  N+L+D +   +++DFG AK       T     + GT   
Sbjct: 152 LTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEA 204

Query: 271 AAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY 330
            APE +++       D ++ GV++ E+  G        P      +    + ++ K +  
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFP 258

Query: 331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP 365
                 L+             L  N L  D   R 
Sbjct: 259 SHFSSDLK------------DLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-35
 Identities = 71/281 (25%), Positives = 104/281 (37%), Gaps = 31/281 (11%)

Query: 94  NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGHREWVAE 149
           NF    +LG G +G VF               +G   A+K LK   +    +       E
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78

Query: 150 VDFLGQL-HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALG 208
              L  +   P LV L      + +  L+ +++  G L  HL +R               
Sbjct: 79  RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGE 137

Query: 209 AAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTY 268
               L  LH     +IYRD K  NILLDS  +  L+DFGL+K     D+T  +    GT 
Sbjct: 138 IVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTI 194

Query: 269 GYAAPEYVMTGH--LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK 326
            Y AP+ V  G        D +S GV++ E+LTG           + +    +R+ L  +
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSE 252

Query: 327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSM 367
               Q +    +             L    L +DPK R   
Sbjct: 253 PPYPQEMSALAK------------DLIQRLLMKDPKKRLGC 281

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 60/312 (19%), Positives = 107/312 (34%), Gaps = 50/312 (16%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEV 150
             ++    +G G  G V   +                VA+K L          +    E+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDR---------NVAIKKLSRPFQNQTHAKRAYREL 67

Query: 151 DFLGQLHHPNLVKLIGYCI------EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
             +  ++H N++ L+          E     LV E M     +                 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSY 123

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRV 264
           +      G+  LH  S  +I+RD K SNI++ S+   K+ DFGLA+           T  
Sbjct: 124 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPY 178

Query: 265 VGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR----------------RSMDKKR 308
           V T  Y APE ++        D++S G ++ E++  +                  +    
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 309 PSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQ--------LAYNCLSRD 360
           P   + L    R Y+ ++ K   +  P+L  +       + ++        L    L  D
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 361 PKSRPSMDEVVK 372
           P  R S+D+ ++
Sbjct: 299 PAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 4e-33
 Identities = 61/315 (19%), Positives = 114/315 (36%), Gaps = 41/315 (13%)

Query: 82  QFTFQELKSA----TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKP 137
            F  QEL          ++  S +G G +G V   +  + G           VAVK L  
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL---------RVAVKKLSR 53

Query: 138 DGL--QGHREWVAEVDFLGQLHHPNLVKLIGYC-----IEDDQRLLVYEFMTRGSLENHL 190
                   +    E+  L  + H N++ L+        +E+   + +   +    L N +
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 113

Query: 191 FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
             +   L   +   +     +GL ++H  S  +I+RD K SN+ ++ +   K+ DFGLA+
Sbjct: 114 KCQ--KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

Query: 251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR--------- 301
                   +V+TR    +  A    +   H     D++S G ++ E+LTGR         
Sbjct: 170 HTDDEMTGYVATR----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225

Query: 302 ---RSMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQ-LAYNCL 357
              + + +   +    L+       A          P++       G   ++  L    L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285

Query: 358 SRDPKSRPSMDEVVK 372
             D   R +  + + 
Sbjct: 286 VLDSDKRITAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (282), Expect = 2e-28
 Identities = 53/326 (16%), Positives = 101/326 (30%), Gaps = 57/326 (17%)

Query: 93  GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDF 152
             +     LG G F  V+      N T          VA+K ++ D +        E+  
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-TEAAEDEIKL 62

Query: 153 LGQLHHPNLVKLIGYCIEDDQRLLVY---------------EFMTRGSLENHLFRRTIPL 197
           L +++  +  K          +LL +               E +    L          +
Sbjct: 63  LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122

Query: 198 PWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE-YNAKLSDFGLAKAGPQGD 256
           P     +I+     GL ++H     +I+ D K  N+L++       L    +A  G    
Sbjct: 123 PLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181

Query: 257 KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRR-------------- 302
                T  + T  Y +PE ++       +D++S   ++ E++TG                
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241

Query: 303 -------SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLE-----LNYSLKGVQKVS 350
                   +  + PS       + R +   +  L  I   +       L    K  +  +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301

Query: 351 QLAYN----CLSRDPKSRPSMDEVVK 372
           +   +     L  DP+ R     +V 
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.3 bits (179), Expect = 9e-16
 Identities = 23/166 (13%), Positives = 44/166 (26%), Gaps = 35/166 (21%)

Query: 99  SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----------QGHREWVA 148
            ++GEG    VF                     VK  K               G   +  
Sbjct: 6   KLMGEGKESAVFN----------CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 55

Query: 149 EVDFLGQLHHPNLVKLIGYCIED----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIK 204
                 +     L KL G  +      +   ++ E +    L              N  +
Sbjct: 56  LAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDE 107

Query: 205 IALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK 250
           +     + +A  +     +++ D    N+L+  E    + DF  + 
Sbjct: 108 VLDMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	429
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.79
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.01
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.93
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.4
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.13
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.12

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-59  Score=433.11  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=208.0

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++++.||+|+||+||+|++..+++         .||||++..... ...+.+.+|+.+|++++|||||++++++.++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~   75 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEE---------AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   75 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            579999999999999999999988755         999999976543 3346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..|||||||+||+|.+++... ..+++..+..++.||+.||+|||  +.||+||||||+|||++.++.+||+|||+|+.
T Consensus        76 ~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~  152 (271)
T d1nvra_          76 NIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATV  152 (271)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence            9999999999999999988544 46999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .............+||+.|||||++.+..+ +.++|||||||++|||++|.+||......... ..              
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~--------------  217 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--------------  217 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH--------------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH--------------
Confidence            654443334455789999999999988776 57899999999999999999999764432111 00              


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...............++++.+||.+||+.||++|||++|+++
T Consensus       218 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            001111111112334578999999999999999999999987

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-58  Score=431.09  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=211.9

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++.+.||+|+||+||+|++..+++         .||||++........+.+.+|+.+|++++|||||++++++.+++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~---------~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQ---------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCC---------EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCC---------EEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            479999999999999999999887755         99999997665556678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .+|||||||+||+|.+++.+.  .+++..+..++.||+.||.|||  +.||+||||||+|||++.+|.+||+|||+++..
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccchhheee
Confidence            999999999999999987654  5899999999999999999999  899999999999999999999999999999876


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQI  332 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .....  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....      ........        
T Consensus       167 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~--------  230 (293)
T d1yhwa1         167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIAT--------  230 (293)
T ss_dssp             CSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH--------
T ss_pred             ccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHh--------
Confidence            43322  233468999999999999999999999999999999999999999754321      11111000        


Q ss_pred             cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          333 VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       ........+...++.+.+||.+||+.||++|||+.|+++
T Consensus       231 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         231 -NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             011112233455688999999999999999999999987

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=426.03  Aligned_cols=246  Identities=26%  Similarity=0.409  Sum_probs=208.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||+||+|++..++.         .||+|++....   ......+.+|+.+|++++|||||++++++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   76 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKF---------ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   76 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCc---------EEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence            469999999999999999999987755         99999986432   223466889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++..|||||||+||+|.+++.+.. .+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||+|
T Consensus        77 ~~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~DFG~a  153 (263)
T d2j4za1          77 DATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWS  153 (263)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred             ECCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeeccccee
Confidence            9999999999999999999986654 5899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +......    .....||+.|||||++.+..|+.++|||||||++|||++|..||.+...      .+....        
T Consensus       154 ~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~--------  215 (263)
T d2j4za1         154 VHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKR--------  215 (263)
T ss_dssp             SCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH--------
T ss_pred             eecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHH--------
Confidence            8754322    2346899999999999999999999999999999999999999975431      111111        


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                        +....  ...+...++++.+||.+||+.||++|||++|+++
T Consensus       216 --i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         216 --ISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --HHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              11111  1223345678999999999999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=427.91  Aligned_cols=261  Identities=26%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      ..++|++.+.||+|+||.||+|++..            .||||++....  ....+.+.+|+.+|++++|||||++++++
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~   73 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS   73 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence            35789999999999999999997532            69999987553  34457889999999999999999999986


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      . ++.++||||||+||+|.+++......+++..+..++.||+.||+|||  +.+||||||||+|||++.++.+||+|||+
T Consensus        74 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH--~~~ivHrDlKp~NiLl~~~~~~Kl~DFGl  150 (276)
T d1uwha_          74 T-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGL  150 (276)
T ss_dssp             C-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred             e-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh--cCCEeccccCHHHEEEcCCCCEEEccccc
Confidence            5 45689999999999999999877778999999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      |+...............||+.|||||++.+   ..|+.++|||||||++|||+||..||.+......  +    ..... 
T Consensus       151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~----~~~~~-  223 (276)
T d1uwha_         151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----IFMVG-  223 (276)
T ss_dssp             SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HHHHH-
T ss_pred             eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--H----HHHHh-
Confidence            987654443334455789999999999864   3588999999999999999999999976433111  0    00011 


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                           ...........+..+++.+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       224 -----~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         224 -----RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             -----HTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----cCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 111111111233445688999999999999999999999999887554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=429.99  Aligned_cols=252  Identities=23%  Similarity=0.393  Sum_probs=212.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +.|++++.||+|+||.||+|++..++.         .||||++........+.+.+|+.+|++++|||||++++++.+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSV---------LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCe---------EEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            469999999999999999999987755         99999998776677788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..|||||||+||+|.+++.+....+++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence            999999999999999998776667999999999999999999999  899999999999999999999999999999763


Q ss_pred             CCCCccceeeeccccccccChhhhh-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ...  .......+||+.|+|||++.     +..|+.++|||||||++|||++|..||.+..+..   ...   ....   
T Consensus       161 ~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~---  229 (288)
T d2jfla1         161 TRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAK---  229 (288)
T ss_dssp             HHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHH---
T ss_pred             CCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHc---
Confidence            221  11223468999999999984     4568999999999999999999999997654321   111   1010   


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ........+...++++.+||.+||+.||++|||+.|+++
T Consensus       230 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         230 ------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ------SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  011112233455688999999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.4e-57  Score=434.13  Aligned_cols=253  Identities=21%  Similarity=0.310  Sum_probs=215.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++++.||+|+||.||+|++..++.         .||||++..........+.+|+.+|++|+|||||+++++|.+++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~---------~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGR---------VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            579999999999999999999987755         99999998776666677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc--CCCCEEEccccCcc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD--SEYNAKLSDFGLAK  250 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~DFg~a~  250 (429)
                      .+|||||||+||+|.+++.....++++.+++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||+|.
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeecccce
Confidence            999999999999999988777778999999999999999999999  89999999999999997  67899999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|||++|..||.+...      .+......       
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~-------  241 (352)
T d1koba_         178 KLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVK-------  241 (352)
T ss_dssp             ECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHH-------
T ss_pred             ecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-------
Confidence            765432   23446899999999999999999999999999999999999999975432      11111111       


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                       ..+...+.......++++.+||.+||+.||.+|||+.|++++
T Consensus       242 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         242 -RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             111122222334456889999999999999999999999983

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-58  Score=429.06  Aligned_cols=261  Identities=26%  Similarity=0.405  Sum_probs=217.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||+||+|++..++.         .||||++..+. ...+++.+|+.+|++++|||||++++++.++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTE---------EEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCe---------EEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            4579999999999999999999987654         89999997654 3456799999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..|||||||++|+|.+++... ...+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||+|+
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEcccccee
Confidence            9999999999999999998654 457899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ...... ........|++.|+|||++.+..|+.++|||||||++|||++|..||.....     ..           .+.
T Consensus       164 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~-----------~~~  226 (287)
T d1opja_         164 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS-----------QVY  226 (287)
T ss_dssp             TCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HH-----------HHH
T ss_pred             ecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HH-----------HHH
Confidence            754432 2233335689999999999999999999999999999999997776643221     11           111


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                      +.+........+...++++.+||.+||+.||++|||+.+|++.|+.+....
T Consensus       227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            122222233444556688999999999999999999999999988776544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-57  Score=426.65  Aligned_cols=254  Identities=21%  Similarity=0.339  Sum_probs=195.3

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ..+.|++.+.||+|+||+||+|++..++.         .||||++...... ....+.+|+.+|++++|||||++++++.
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   77 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQK---------LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE   77 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCC---------EEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCC---------EEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            34679999999999999999999987755         9999999765433 2355779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCCEEEccc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD---SEYNAKLSDF  246 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~DF  246 (429)
                      +++.+|||||||+||+|.+++.+. ..+++..+..++.||+.||.|||  +.+|+||||||+|||+.   +++.+||+||
T Consensus        78 ~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          78 SGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             ECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEEEecc
Confidence            999999999999999999999654 46999999999999999999999  89999999999999994   5789999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK  326 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  326 (429)
                      |+++......   .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+...      .+.......  
T Consensus       155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~--  223 (307)
T d1a06a_         155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILK--  223 (307)
T ss_dssp             ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHT--
T ss_pred             ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhc--
Confidence            9998653322   23346899999999999999999999999999999999999999975431      111111111  


Q ss_pred             hhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          327 RKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                            .............++++.+||.+||+.||++|||+.|+++.
T Consensus       224 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         224 ------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                  11112222334556889999999999999999999999983

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-58  Score=428.78  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=206.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||+||+|++..+++         .||||++....   ......+.+|+.+|++++|||||++++++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~   78 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSR---------EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ   78 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence            469999999999999999999987755         99999986542   123456889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++.+|||||||+||+|.+++...+ .+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||+|
T Consensus        79 ~~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~DFG~a  155 (288)
T d1uu3a_          79 DDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTA  155 (288)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ECCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEecccccc
Confidence            9999999999999999999886554 6999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +..............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+...      .....         
T Consensus       156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~---------  220 (288)
T d1uu3a_         156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQ---------  220 (288)
T ss_dssp             EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH---------
T ss_pred             eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHH---------
Confidence            876544433344457899999999999999999999999999999999999999975431      11111         


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       .+....  ..++...++++.+||.+||+.||++|||++|+++
T Consensus       221 -~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         221 -KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -HHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             111111  1223345678999999999999999999999754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-57  Score=426.74  Aligned_cols=260  Identities=27%  Similarity=0.475  Sum_probs=204.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      ++|++.++||+|+||+||+|++..++..      ...||||.+..... ...+++.+|+.+|++++|||||++++++..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKR------EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---C------CEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCE------EEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            5688899999999999999998876541      23689999876533 3456799999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..|+|||||+||+|.+++......+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEECCcccceE
Confidence            9999999999999999999877778999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccc---eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          252 GPQGDKTH---VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       252 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ........   ......||+.|||||++.+..++.++|||||||++|||+| |..||.....   ..+..          
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~----------  244 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVIN----------  244 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----------
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHH----------
Confidence            54432211   1222468999999999999999999999999999999998 8999975432   11111          


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                          .+......+.+..++..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus       245 ----~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         245 ----AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                1111122233445668899999999999999999999999988754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-58  Score=423.03  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=196.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++.+.||+|+||+||+|++..+++         .||||.+.....  ...+.+.+|+.+|++++|||||++++++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGK---------ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCC---------EEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            579999999999999999999988765         999999976643  234568899999999999999999999865


Q ss_pred             --CCeEEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCC-----eeeCCCCCCCeEEcCCCC
Q 014202          171 --DDQRLLVYEFMTRGSLENHLFR---RTIPLPWSNRIKIALGAAKGLAFLHGGSEP-----VIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       171 --~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~-----ivHrDlkp~Nill~~~~~  240 (429)
                        ++.+|||||||+||+|.+++.+   ....+++..++.++.||+.||.|||  +.+     |+||||||+|||++.++.
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~~~~~~IiHrDiKp~NIll~~~~~  152 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQN  152 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HHCC---------CCGGGEEECTTSC
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HhcCCCCCEEeCcCchhhcCcCCCCc
Confidence              4568999999999999998864   2457999999999999999999999  544     999999999999999999


Q ss_pred             EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          241 AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      +||+|||+++......  ......+||+.|||||++.+..|+.++|||||||++|||++|..||.....      .+...
T Consensus       153 vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~  224 (269)
T d2java1         153 VKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAG  224 (269)
T ss_dssp             EEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHH
T ss_pred             EEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHH
Confidence            9999999998754322  223347899999999999999999999999999999999999999975431      11111


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ..       ..   ... ...+...++++.+||.+||+.||++|||+.|+++.
T Consensus       225 ~i-------~~---~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         225 KI-------RE---GKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HH-------HH---TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH-------Hc---CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            11       11   111 11233455789999999999999999999999863

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-56  Score=430.41  Aligned_cols=253  Identities=22%  Similarity=0.297  Sum_probs=213.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++++.||+|+||.||+|++..++.         .||||++........+.+.+|+.+|++|+|||||++++++.+++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~---------~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGN---------NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN   96 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            579999999999999999999987654         99999998776666778899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc--CCCCEEEccccCcc
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD--SEYNAKLSDFGLAK  250 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~DFg~a~  250 (429)
                      .+|||||||+||+|.+++.+....+++..+..++.||+.||.|||  +.|||||||||+|||++  .++.+||+|||+++
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            999999999999999999777667999999999999999999999  89999999999999995  46789999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ......   ......||+.|||||++.+..|+.++|||||||++|||++|..||.+...      .+........     
T Consensus       175 ~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~-----  240 (350)
T d1koaa2         175 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSC-----  240 (350)
T ss_dssp             ECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT-----
T ss_pred             eccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-----
Confidence            754332   23447899999999999999999999999999999999999999975431      1111111111     


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                         ............++++.+||.+||+.||++|||+.|++++
T Consensus       241 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         241 ---DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               1111112223445789999999999999999999999984

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=413.87  Aligned_cols=248  Identities=26%  Similarity=0.414  Sum_probs=200.0

Q ss_pred             CCC-CCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNF-RPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y-~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++| ++.+.||+|+||+||+|++..++.         .||+|.+....  ....+.+.+|+++|++++|||||++++++.
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~---------~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   78 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTV---------EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   78 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCe---------EEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence            445 677789999999999999987755         89999987543  233467889999999999999999999987


Q ss_pred             e----CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeEEc-CCCCEE
Q 014202          170 E----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEP--VIYRDFKTSNILLD-SEYNAK  242 (429)
Q Consensus       170 ~----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~--ivHrDlkp~Nill~-~~~~~k  242 (429)
                      .    +..+|||||||+||+|.+++.+.. .+++..+..++.||+.||+|||  +++  |+||||||+|||++ +++.+|
T Consensus        79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH--~~~~~IiHrDiKp~NILl~~~~~~~K  155 (270)
T d1t4ha_          79 STVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVK  155 (270)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred             eccccCCEEEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH--HCCCCEEeCCcChhhceeeCCCCCEE
Confidence            5    346799999999999999996654 6899999999999999999999  666  99999999999996 578999


Q ss_pred             EccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          243 LSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      |+|||+++.....    .....+||+.|||||++.+ .++.++|||||||++|||++|..||.....     ....... 
T Consensus       156 l~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~-  224 (270)
T d1t4ha_         156 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRR-  224 (270)
T ss_dssp             ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHH-
T ss_pred             EeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHH-
Confidence            9999999864322    2335789999999998865 699999999999999999999999975332     1111111 


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                               +.....+...+...++++.+||.+||+.||++|||+.|+++
T Consensus       225 ---------i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         225 ---------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---------HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------HHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                     11111111222234467999999999999999999999987

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=432.54  Aligned_cols=265  Identities=26%  Similarity=0.354  Sum_probs=207.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++++.||+|+||+||+|++..++.         .||+|++..... .....+.+|+.+|++++|||||+++++|.+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGL---------VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTE---------EEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCc---------EEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            4679999999999999999999987654         999999976532 334678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGS-EPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      ++.+||||||++||+|.+++.+.+ .+++..+..++.|++.||.|||  + .+|+||||||+|||++.+|.+||+|||+|
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH--~~~~IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH--HhCCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence            999999999999999999997654 5899999999999999999999  6 48999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH------------
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA------------  317 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~------------  317 (429)
                      +....    ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...........            
T Consensus       153 ~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         153 GQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             HHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             cccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence            86422    12234689999999999999999999999999999999999999997644321100000            


Q ss_pred             ---HH----HHHHHh-------hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          318 ---WA----RQYLAD-------KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       318 ---~~----~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         +.    ......       ...+........+.......+.++.+||.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence               00    000000       00000001111111111123578999999999999999999999997

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-57  Score=417.72  Aligned_cols=255  Identities=26%  Similarity=0.437  Sum_probs=201.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++++.||+|+||.||+|.+..          +..||||++.... ...+++.+|+.+|++++|||||++++++..++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   73 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence            578999999999999999998763          2379999997654 34578999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      ..++||||+++|+|.+++......+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccchheec
Confidence            999999999999999999887778999999999999999999999  899999999999999999999999999999875


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG-RRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ...... ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||....      ..+.....       ..
T Consensus       152 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i-------~~  217 (263)
T d1sm2a_         152 LDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDI-------ST  217 (263)
T ss_dssp             --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHH-------HH
T ss_pred             cCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHH-------Hh
Confidence            443222 22346799999999999999999999999999999999995 55554321      11111111       11


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                          ......+..+++++.+|+.+||+.||++|||+++|++.|+.+.
T Consensus       218 ----~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         218 ----GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                1112223344578999999999999999999999999987653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-57  Score=429.39  Aligned_cols=262  Identities=27%  Similarity=0.448  Sum_probs=213.8

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC-chhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG-LQGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++++.||+|+||+||+|++..++..    ..+..||+|.+.... ......+.+|+.+|.++ +|||||++++++.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKT----GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSS----SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcc----cceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            35799999999999999999998765431    123479999987543 33446788999999998 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT----------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRD  227 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~----------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrD  227 (429)
                      +.+..|||||||+||+|.++|....                      ..+++..++.++.||+.||+|||  +.+|||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~IiHRD  189 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRD  189 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETT
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecc
Confidence            9999999999999999999996543                      24789999999999999999999  89999999


Q ss_pred             CCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 014202          228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDK  306 (429)
Q Consensus       228 lkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~  306 (429)
                      |||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |..||.+
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987554444334445678999999999999999999999999999999998 8999976


Q ss_pred             CCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhc
Q 014202          307 KRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLT  375 (429)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~  375 (429)
                      .....  .              +.+++......+.+..+++++.+||.+||+.||++|||++||++.|.
T Consensus       270 ~~~~~--~--------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVDA--N--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCSH--H--------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHH--H--------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            44321  1              11112222233344556688999999999999999999999999873

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=417.94  Aligned_cols=257  Identities=28%  Similarity=0.427  Sum_probs=209.8

Q ss_pred             CCCCCCCc-ccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSI-LGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~-lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|.+.+. ||+|+||.||+|.+..++.       +..||||+++.... ...+++.+|+.+|++++|||||++++++..
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~-------~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~   80 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   80 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---C-------CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCC-------cEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            45677774 9999999999998865543       45799999976543 345778999999999999999999999865


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                       +..|||||||+||+|.+++......+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||+++
T Consensus        81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceeeccchhhh
Confidence             5689999999999999998777778999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCcc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          251 AGPQGDKT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||......   .+...          
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----------  224 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----------  224 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----------
T ss_pred             cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----------
Confidence            76543322 22233578999999999999999999999999999999998 99999764321   11111          


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                          +........+..+++++.+||.+||+.||++|||+.+|++.|+.
T Consensus       225 ----i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         225 ----IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ----HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                11111223344566889999999999999999999999988754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-56  Score=407.22  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=213.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++++.||+|+||+||+|+++ +         +..||||+++.... ..+++.+|+.++++++|||||++++++.+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~---------~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~   72 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-G---------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   72 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-T---------TEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-C---------CCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence            57999999999999999999985 2         34899999987643 4568999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .+++||||+++|+|.+++......+++..++.++.|++.||.|||  +.||+||||||+|||++.++.+||+|||+++..
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchhheec
Confidence            999999999999999998777777999999999999999999999  899999999999999999999999999999865


Q ss_pred             CCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....      +....       +..
T Consensus       151 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~-------i~~  216 (258)
T d1k2pa_         151 LDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEH-------IAQ  216 (258)
T ss_dssp             SSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHH-------HHT
T ss_pred             cCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHH-------HHh
Confidence            443222 2334679999999999999999999999999999999998 89999754311      11111       111


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                          ......+...+.++.+||.+||+.||++|||+++|++.|..
T Consensus       217 ----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 ----GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                11223334455789999999999999999999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-56  Score=420.44  Aligned_cols=245  Identities=28%  Similarity=0.416  Sum_probs=204.0

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .|++++.||+|+||+||+|++..++.         .||||++......   ..+.+.+|+.+|++|+|||||++++++.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCc---------EEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            49999999999999999999987755         8999999766433   33568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|||||||.||+|..++... .++++..+..++.||+.||.|||  ++|||||||||+|||++.++.+||+|||+|.
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~  163 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             CCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEeeccccc
Confidence            99999999999999997666444 46999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .....      ...+||+.|||||++.+   +.|+.++|||||||++|||++|..||.+...      .....       
T Consensus       164 ~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~-------  224 (309)
T d1u5ra_         164 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALY-------  224 (309)
T ss_dssp             SSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH-------
T ss_pred             ccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHH-------
Confidence            64332      23689999999999864   4589999999999999999999999975431      11111       


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                         .+.........+...++.+.+||.+||+.||++|||++|+++
T Consensus       225 ---~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         225 ---HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---HHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               111111111122344578999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-56  Score=410.92  Aligned_cols=250  Identities=29%  Similarity=0.426  Sum_probs=201.4

Q ss_pred             CcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC--chhhHHHHHHHHHHhcCCCcceeeEEeEEEeCCeEEE
Q 014202           99 SILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG--LQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        99 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  176 (429)
                      ++||+|+||+||+|.+...+.       ++.||||+++...  ....+++.+|+.+|++++|||||++++++.. +..+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSS-------EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred             CCcccCCCeEEEEEEEccCCc-------CeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence            479999999999998765432       4589999997543  2334678999999999999999999999865 56789


Q ss_pred             EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCCC
Q 014202          177 VYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGD  256 (429)
Q Consensus       177 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~  256 (429)
                      |||||++|+|.+++.+.. .+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        85 vmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             EEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            999999999999986554 6999999999999999999999  8999999999999999999999999999998765433


Q ss_pred             cc-ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhcC
Q 014202          257 KT-HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIVD  334 (429)
Q Consensus       257 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      .. .......||+.|||||++.+..++.++|||||||++|||++ |..||.+...   ..+..              .+.
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~--------------~i~  224 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTA--------------MLE  224 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH--------------HHH
T ss_pred             cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHH--------------HHH
Confidence            22 22234579999999999999999999999999999999998 8999976431   11111              111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          335 PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                      .......+..++.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus       225 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         225 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             cCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            112223344566889999999999999999999999887754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-56  Score=413.76  Aligned_cols=263  Identities=24%  Similarity=0.432  Sum_probs=206.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      +.|++.++||+|+||.||+|.+..++..     ....||||++...... ...++.+|+.+|++++|||||++++++.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---C-----CEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCE-----EEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            4688899999999999999998765431     1237999999765433 345689999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      +..++||||+.+++|.+++......+++..+..++.|++.||+|||  +.+|+||||||+||||+.++.+||+|||+++.
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEEEcccchhhc
Confidence            9999999999999999998888778999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCc-cceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDK-THVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ...... ........||+.|||||++.+..++.++|||||||++|||++|..||......  ..+              .
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~--------------~  223 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV--------------M  223 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH--------------H
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHH--------------H
Confidence            544322 22233457899999999999999999999999999999999976665432211  111              1


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..+........+..++..+.+||.+||+.||++|||+.||++.|+.+.
T Consensus       224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            111122223344456688999999999999999999999999887654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=415.53  Aligned_cols=255  Identities=29%  Similarity=0.425  Sum_probs=206.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .++|++.+.||+|+||.||+|.+..          +..||||++.... ...+.+.+|+.+|++++|||||++++++. +
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~   79 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q   79 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECC----------CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence            4579999999999999999999753          3379999997654 34567999999999999999999999875 4


Q ss_pred             CeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +..||||||+++|+|.+++... ...+++..+..++.||+.||.|||  +.+|+||||||+||||+.++.+||+|||+|+
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeeccccceE
Confidence            5679999999999999977544 335899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||+||..|+.....     ..+...          
T Consensus       158 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~~~~----------  221 (272)
T d1qpca_         158 LIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQ----------  221 (272)
T ss_dssp             ECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHH----------
T ss_pred             EccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHHHHH----------
Confidence            7644322 223345789999999999999999999999999999999996555433221     111111          


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                       .+........+...++++.+|+.+||+.||++|||+++|++.|+++
T Consensus       222 -~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         222 -NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence             1111112223344567899999999999999999999999988754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=413.13  Aligned_cols=252  Identities=24%  Similarity=0.335  Sum_probs=208.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc------hhhHHHHHHHHHHhcCCCcceeeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL------QGHREWVAEVDFLGQLHHPNLVKLI  165 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~  165 (429)
                      .++|++++.||+|+||+||+|++..++.         .||||++.+...      ...+.+.+|+.+|++|+|||||+++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~---------~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~   79 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGL---------QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH   79 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCC---------EEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3679999999999999999999987655         999999865432      2246789999999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----CE
Q 014202          166 GYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY----NA  241 (429)
Q Consensus       166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~~  241 (429)
                      +++.+++.+|||||||+||+|.+++.... .+++..+..++.|++.||+|||  +.+|+||||||+|||++.++    .+
T Consensus        80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~~~~v  156 (293)
T d1jksa_          80 EVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRI  156 (293)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSSSCCE
T ss_pred             EEEEECCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCcccce
Confidence            99999999999999999999999986654 6999999999999999999999  89999999999999998776    49


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||+|||++........   .....||+.|+|||++.+..++.++|||||||++|||++|..||.+...      .+....
T Consensus       157 kl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~  227 (293)
T d1jksa_         157 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLAN  227 (293)
T ss_dssp             EECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred             EecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHH
Confidence            9999999987644322   2346899999999999999999999999999999999999999975431      111111


Q ss_pred             HHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ...        .............+..+.+||.+||+.||++|||++|+++
T Consensus       228 i~~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         228 VSA--------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHT--------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHh--------cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110        0111111111234578999999999999999999999997

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=419.31  Aligned_cols=248  Identities=27%  Similarity=0.360  Sum_probs=209.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||.||+|++..++.         .||||++.+..   ......+.+|+.+|++++||||+++++++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~---------~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   75 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGR---------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence            579999999999999999999988755         99999997542   223466889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++.+|+|||||+||+|.+++.+.. .+++..+..++.||+.||+|||  ++||+||||||+|||++.+|.+||+|||+|
T Consensus        76 ~~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~DFG~a  152 (337)
T d1o6la_          76 THDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEeecccc
Confidence            9999999999999999999986654 5899999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+...      .+.....       
T Consensus       153 ~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i-------  217 (337)
T d1o6la_         153 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELI-------  217 (337)
T ss_dssp             BCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-------
T ss_pred             cccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHH-------
Confidence            86543222  23447899999999999999999999999999999999999999976432      1111111       


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~  372 (429)
                         ....  ..++...++++.+||.+||+.||.+|++     ++|+++
T Consensus       218 ---~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         218 ---LMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---hcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               1111  1223345678999999999999999994     888887

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-56  Score=411.02  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=203.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|++++.||+|+||.||+|++..++.      .+..||||.+...... ..+.+.+|+.+|++++|||||++++++. 
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   78 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4579999999999999999999876543      2457999998755433 3467899999999999999999999985 


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..|+||||+++|+|.+++......+++..++.++.||+.||.|||  +.+|+||||||+||+++.++.+||+|||+++
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEEEccchhhe
Confidence            56789999999999999998887778999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||......   .+...           
T Consensus       157 ~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~-----------  221 (273)
T d1mp8a_         157 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR-----------  221 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH-----------
T ss_pred             eccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH-----------
Confidence            7543222 22334678999999999999999999999999999999998 89999765432   11111           


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                        +. .....+.+..+++.+.+||.+||+.||++|||+.||++.|+.+
T Consensus       222 --i~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         222 --IE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             --HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              01 1111223445668899999999999999999999999988654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=412.01  Aligned_cols=253  Identities=18%  Similarity=0.243  Sum_probs=210.6

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ..++|++++.||+|+||+||+|.+..++.         .||||++.... .....+.+|+.+|++++|||||++++++.+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~---------~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   72 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKK---------TYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCc---------EEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            34789999999999999999999988755         89999998764 334567899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC--CCEEEccccC
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSE--YNAKLSDFGL  248 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~kl~DFg~  248 (429)
                      ++.+|||||||+||+|.+++...+..+++.++..++.||+.||+|||  +.||+||||||+|||++.+  +.+||+|||+
T Consensus        73 ~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEcccch
Confidence            99999999999999999999877778999999999999999999999  8999999999999999754  5799999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ++......   ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||.....      .......+...  
T Consensus       151 ~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~--  219 (321)
T d1tkia_         151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAE--  219 (321)
T ss_dssp             CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC--
T ss_pred             hhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC--
Confidence            98754332   23446899999999999999999999999999999999999999976432      11111111110  


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                            ..+........++++.+||.+||..||++|||++|+++
T Consensus       220 ------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         220 ------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  01111111124578999999999999999999999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=416.57  Aligned_cols=261  Identities=25%  Similarity=0.411  Sum_probs=209.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  171 (429)
                      .+|+++++||+|+||+||+|.+..+++..     ...||+|.+... .....+++.+|+.+|++++|||||++++++.++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKV-----KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----C-----CEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEE-----EEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            46999999999999999999998776532     236999998754 334467899999999999999999999999764


Q ss_pred             CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                       ..+++||++.+|+|.+++......+++..++.++.||+.||+|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence             567889999999999999888888999999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKLY  330 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ..............||+.|+|||++.++.|+.++|||||||++|||+| |.+||.+....   .+..             
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~-------------  224 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS-------------  224 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHH-------------
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHH-------------
Confidence            655444444444679999999999999999999999999999999998 78898764321   1111             


Q ss_pred             hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          331 QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                       .+........+..++..+.+|+.+||+.||++|||+.+|++.|..+.
T Consensus       225 -~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         225 -ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             -HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence             11111122333455688999999999999999999999999876553

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.4e-55  Score=411.81  Aligned_cols=245  Identities=28%  Similarity=0.405  Sum_probs=206.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||+||+|++..++.         .||||++....   ....+.+.+|+.+|++++|||||++++++.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~---------~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   74 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGR---------YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   74 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCC---------EEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence            469999999999999999999987755         99999986542   233467889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      +++.+|+|||||.||+|..++.... .+++..+..++.||+.||+|||  ++||+||||||+|||++.+|.+||+|||+|
T Consensus        75 ~~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DFG~a  151 (316)
T d1fota_          75 DAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFA  151 (316)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eCCeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecCccc
Confidence            9999999999999999999886554 5889999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +.....     ....+||+.|||||++.+..|+.++|||||||++|||++|..||.+...      .+......      
T Consensus       152 ~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~------  214 (316)
T d1fota_         152 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKIL------  214 (316)
T ss_dssp             EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH------
T ss_pred             eEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHH------
Confidence            875432     2246899999999999999999999999999999999999999975431      11111111      


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                          ...  ...+...++++.++|.+||+.||.+|+     |++++++
T Consensus       215 ----~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         215 ----NAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----HCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----cCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                111  122334457899999999999999996     8999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.8e-54  Score=403.13  Aligned_cols=260  Identities=26%  Similarity=0.369  Sum_probs=204.4

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc---hhhHHHHHHHHHHhcCCCcceeeEEeEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL---QGHREWVAEVDFLGQLHHPNLVKLIGYC  168 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~  168 (429)
                      .++|++.+.||+|+||.||+|++..+++         .||||++.....   .....+.+|+.+|+.++|||||++++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~   76 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHR---------DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCC---------EEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence            4689999999999999999999987655         999999976543   2345688999999999999999999998


Q ss_pred             EeCC----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          169 IEDD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       169 ~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ..++    ..||||||++|++|.+++...+ .+++.++..++.||+.||+|||  +.||+||||||+|||++.++.++|+
T Consensus        77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             EEECSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCEEEC
T ss_pred             eeccCCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccceee
Confidence            8764    3789999999999999886654 6899999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCC-ccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGD-KTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||++....... ........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+..+      .+.....+
T Consensus       154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~  227 (277)
T d1o6ya_         154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHV  227 (277)
T ss_dssp             CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHH
T ss_pred             hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHH
Confidence            999987653322 22233446899999999999999999999999999999999999999975432      11111111


Q ss_pred             HhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-CHhHHHHHhcCC
Q 014202          324 ADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-SMDEVVKVLTPL  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~eil~~l~~~  377 (429)
                      ..        ++..........++++.+||.+||+.||++|| |+++++..|..+
T Consensus       228 ~~--------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         228 RE--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HC--------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             hc--------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            11        11111222234557899999999999999999 899998877654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-55  Score=411.55  Aligned_cols=271  Identities=27%  Similarity=0.378  Sum_probs=206.5

Q ss_pred             HHHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceee
Q 014202           86 QELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVK  163 (429)
Q Consensus        86 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~  163 (429)
                      .+++...++|++++.||+|+||.||+|.+...+.    ..+++.||||++..... ...+.+.+|..++.++ +|+||+.
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~   81 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   81 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTS----SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence            4444555789999999999999999999876543    22356899999976543 3346678888888777 6899999


Q ss_pred             EEeEEEeC-CeEEEEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 014202          164 LIGYCIED-DQRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRD  227 (429)
Q Consensus       164 ~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrD  227 (429)
                      +++++..+ ..+++|||||++|+|.+++...               ...+++..+..++.||+.||.|||  +++|||||
T Consensus        82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrD  159 (299)
T d1ywna1          82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRD  159 (299)
T ss_dssp             EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSC
T ss_pred             eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCc
Confidence            99987765 4689999999999999999653               234889999999999999999999  89999999


Q ss_pred             CCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhC-CCCCCC
Q 014202          228 FKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTG-RRSMDK  306 (429)
Q Consensus       228 lkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~  306 (429)
                      |||+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999875544433334456899999999999999999999999999999999986 457765


Q ss_pred             CCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          307 KRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      .....  .+.    ..+..          ......+...++++.+||.+||+.||++|||+.||+++|+.+.
T Consensus       240 ~~~~~--~~~----~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         240 VKIDE--EFC----RRLKE----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             CCCSH--HHH----HHHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHH--HHH----HHHhc----------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            43211  111    11111          1112233445678999999999999999999999999987653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-54  Score=408.28  Aligned_cols=268  Identities=26%  Similarity=0.376  Sum_probs=214.9

Q ss_pred             HHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch-hhHHHHHHHHHHhcCCCcceeeEEe
Q 014202           88 LKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ-GHREWVAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        88 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~  166 (429)
                      ++..+++|++++.||+|+||+||+|++.....    ..++..||||++...... ..+++.+|+.+|++++||||+++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCcc----CCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence            34445689999999999999999999864211    123558999999765443 3567899999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRT-----------------------IPLPWSNRIKIALGAAKGLAFLHGGSEPV  223 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i  223 (429)
                      ++...+..++||||+.+|+|.+++....                       ..+++..++.++.|++.||+|||  +.+|
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~i  161 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKF  161 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCCe
Confidence            9999999999999999999999986432                       24788999999999999999999  8999


Q ss_pred             eeCCCCCCCeEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCC-C
Q 014202          224 IYRDFKTSNILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR-R  302 (429)
Q Consensus       224 vHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~-~  302 (429)
                      |||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999998654433333444568999999999999999999999999999999999986 5


Q ss_pred             CCCCCCCCccccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          303 SMDKKRPSGEQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       303 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ||.....      .+....          +.+.. ....+...++++.+||.+||+.||++|||+.||++.|+.+.
T Consensus       242 p~~~~~~------~e~~~~----------v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         242 PYYGMAH------EEVIYY----------VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTTSCH------HHHHHH----------HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCH------HHHHHH----------HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            6754321      111111          11111 12233445678999999999999999999999999987653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-55  Score=404.57  Aligned_cols=259  Identities=27%  Similarity=0.412  Sum_probs=202.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++.+.||+|+||.||+|++..+..      ....||||++....   ....+++.+|+.+|++++|||||++++++.
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~------~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~   81 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   81 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCC------cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            569999999999999999998765432      23479999987653   233467899999999999999999999996


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      + ...++||||+++|+|.+++..+...+++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+|||++
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccceeeccchhh
Confidence            5 5678999999999999988877777999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccc-eeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhh
Q 014202          250 KAGPQGDKTH-VSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKR  327 (429)
Q Consensus       250 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      +......... ......|++.|+|||++.+..++.++|||||||++|||++ |..||.+...      .+..        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~--------  224 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQIL--------  224 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHH--------
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHH--------
Confidence            9765443322 2233568889999999999999999999999999999998 8999975431      1111        


Q ss_pred             hhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcC
Q 014202          328 KLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTP  376 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~  376 (429)
                        ..+.......+.+...+..+.+||.+||..||++|||+.+|++.|..
T Consensus       225 --~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         225 --HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             --HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence              11112222233344556889999999999999999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-54  Score=413.87  Aligned_cols=245  Identities=24%  Similarity=0.344  Sum_probs=207.2

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      ++|++++.||+|+||.||+|++..+++         .||||++....   ....+.+.+|+.+|+.++|||||++++++.
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~---------~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGN---------HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCC---------EEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            469999999999999999999987755         99999986532   223456889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLA  249 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a  249 (429)
                      .....++||||+.||+|..++.+.+ .+++..+..++.||+.||.|||  +++||||||||+|||++.+|.+||+|||+|
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~DFG~a  188 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEeeeceee
Confidence            9999999999999999999987654 5999999999999999999999  899999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          250 KAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      +.....     .....||+.|||||++.+..|+.++|||||||++|||++|..||.+...      .......       
T Consensus       189 ~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i-------  250 (350)
T d1rdqe_         189 KRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKI-------  250 (350)
T ss_dssp             EECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-------
T ss_pred             eecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHH-------
Confidence            875432     2236899999999999999999999999999999999999999975431      1111111       


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                         ....  ...+...++++.+||.+||+.||.+|+     |++++++
T Consensus       251 ---~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         251 ---VSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---HHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---hcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               1111  112234557899999999999999994     8999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.8e-54  Score=412.41  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=203.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch---hhHHH---HHHHHHHhcCCCcceeeEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ---GHREW---VAEVDFLGQLHHPNLVKLIG  166 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~---~~E~~~l~~l~hpnIv~~~~  166 (429)
                      ++|+++++||+|+||.||+|++..++.         .||||++......   ....+   ..|+.+|+.++|||||++++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~---------~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~   74 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY   74 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCC---------EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence            579999999999999999999988755         9999998643221   11223   34577888889999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          167 YCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      ++.+++.+|||||||+||+|.+++.+.. .+++..+..++.||+.||.|||  +.+||||||||+|||++.+|.+||+||
T Consensus        75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iKl~DF  151 (364)
T d1omwa3          75 AFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDL  151 (364)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEECCEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEEEeee
Confidence            9999999999999999999999996654 5899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          247 GLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       247 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      |+|+......    ....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||..........+.         
T Consensus       152 Gla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---------  218 (364)
T d1omwa3         152 GLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------  218 (364)
T ss_dssp             TTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---------
T ss_pred             ceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------
Confidence            9998754432    233689999999999974 56899999999999999999999999765432211110         


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCC-----HhHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPS-----MDEVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~eil~  372 (429)
                          .....  .....+...++++.+||.+||+.||++|||     ++|+++
T Consensus       219 ----~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         219 ----RMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ----HHSSS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ----Hhccc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                01111  112223345678999999999999999999     688886

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-53  Score=396.66  Aligned_cols=252  Identities=26%  Similarity=0.370  Sum_probs=207.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh---------hHHHHHHHHHHhcCC-Ccce
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG---------HREWVAEVDFLGQLH-HPNL  161 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-hpnI  161 (429)
                      .++|++.+.||+|+||+||+|++..+++         .||||++.......         ...+.+|+.+|++|+ ||||
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~---------~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI   72 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCK---------EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   72 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCC---------EEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence            3689999999999999999999887654         99999997653221         235789999999997 9999


Q ss_pred             eeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          162 VKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      |++++++.+++..|||||||+||+|.+++..++ ++++..+..++.||+.||+|||  +.||+||||||+|||++.++.+
T Consensus        73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~~  149 (277)
T d1phka_          73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNI  149 (277)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeecccCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCCCCe
Confidence            999999999999999999999999999997654 6999999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhc------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNL  315 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  315 (429)
                      ||+|||+++.......   ....+||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+...      
T Consensus       150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------  220 (277)
T d1phka_         150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------  220 (277)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred             EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------
Confidence            9999999987644322   234689999999999863      3468899999999999999999999976432      


Q ss_pred             HHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          316 VAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ..........        ............++++.+||.+||+.||++|||++|+++
T Consensus       221 ~~~~~~i~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         221 MLMLRMIMSG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHHHHT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhC--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111111111        111122223356688999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=403.85  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=203.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      ++|++++.||+|+||.||+|++..+          ..||||++.... ...+.+.+|+.+|++++|||||++++++. ++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~----------~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~   84 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT----------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE   84 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT----------EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC----------CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence            5799999999999999999998653          379999997654 44578999999999999999999999985 45


Q ss_pred             eEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          173 QRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      ..++||||+++|+|..++... ...+++..++.++.||+.||+|||  +.+|+||||||+||||+.++.+||+|||+++.
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccchhhh
Confidence            689999999999999988654 345899999999999999999999  89999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhh
Q 014202          252 GPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQ  331 (429)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ...... .......||+.|+|||++.++.++.++|||||||++|||++|..||.....     ..+...           
T Consensus       163 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~~-----------  225 (285)
T d1fmka3         163 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLD-----------  225 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHH-----------
T ss_pred             ccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHHH-----------
Confidence            543322 223346799999999999999999999999999999999997666543221     111111           


Q ss_pred             hcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          332 IVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      .+......+.+..+++++.+||.+||+.||++||++++|+++|+....
T Consensus       226 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            111112223344566889999999999999999999999998877653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=404.63  Aligned_cols=265  Identities=26%  Similarity=0.428  Sum_probs=211.6

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++++.||+|+||.||+|++..+++.  ....+..||||++..+.. ....++.+|+..+.++ +|||||++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            35799999999999999999998766532  122355899999987654 3346788999999888 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT---------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNIL  234 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nil  234 (429)
                      +++..++||||+++|+|.+++..+.               ..+++..++.++.||+.||+|||  +.+||||||||+|||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeeccccee
Confidence            9999999999999999999996543               35899999999999999999999  899999999999999


Q ss_pred             EcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccc
Q 014202          235 LDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQ  313 (429)
Q Consensus       235 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  313 (429)
                      ++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||......   
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---  244 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---  244 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence            99999999999999987655444334445689999999999999999999999999999999998 78888653321   


Q ss_pred             cHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          314 NLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .+              ...+........+...++.+.+||.+||+.||.+|||+.||++.|+.+
T Consensus       245 ~~--------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         245 EL--------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HH--------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH--------------HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            11              111111222233344567899999999999999999999999988655

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=407.36  Aligned_cols=250  Identities=23%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             cCCCCCCC-cccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhc-CCCcceeeEEeEEE
Q 014202           92 TGNFRPDS-ILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQ-LHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~  169 (429)
                      .++|.+.. +||+|+||+||+|++..+++         .||||++...     ..+.+|+.++.+ ++|||||+++++|.
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQE---------KFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCC---------EEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            35798874 69999999999999987755         9999998643     456789998765 58999999999987


Q ss_pred             e----CCeEEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCCE
Q 014202          170 E----DDQRLLVYEFMTRGSLENHLFRR-TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS---EYNA  241 (429)
Q Consensus       170 ~----~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~  241 (429)
                      +    +..+|||||||+||+|.+++.+. ...+++.++..++.||+.||+|||  +.||+||||||+|||++.   .+.+
T Consensus        76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTTCCE
T ss_pred             ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH--HcCCccccccccccccccccccccc
Confidence            6    46789999999999999999765 356999999999999999999999  899999999999999975   5679


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||+|||+++.......   ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+..........     
T Consensus       154 Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-----  225 (335)
T d2ozaa1         154 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-----  225 (335)
T ss_dssp             EECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------
T ss_pred             cccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-----
Confidence            9999999987544332   23468999999999999999999999999999999999999999765432211100     


Q ss_pred             HHHhhhhhhhhcCCccccC--CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLADKRKLYQIVDPRLELN--YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             ...+.......+  .....++++.+||.+||+.||++|||+.|+++
T Consensus       226 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         226 -------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ---------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   001111111111  12345678999999999999999999999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-54  Score=405.55  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=204.6

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCC---chhhHHHHHHHHHHh-cCCCcceeeEEeEE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDG---LQGHREWVAEVDFLG-QLHHPNLVKLIGYC  168 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~  168 (429)
                      ++|++++.||+|+||+||+|++..+++         .||||++.+..   ......+..|..++. .++|||||++++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~---------~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~   72 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQ---------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   72 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCC---------EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence            579999999999999999999987755         99999997542   123345667777665 68999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccC
Q 014202          169 IEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGL  248 (429)
Q Consensus       169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~  248 (429)
                      .+++.+||||||++||+|.+++.... .+++..+..++.||+.||+|||  +++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl~DFG~  149 (320)
T d1xjda_          73 QTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGM  149 (320)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ccCCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceeccccch
Confidence            99999999999999999999986554 5899999999999999999999  89999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK  328 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ++......  .......||+.|+|||++.+..|+.++|||||||++|||++|..||.+....      .......     
T Consensus       150 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~-----  216 (320)
T d1xjda_         150 CKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIR-----  216 (320)
T ss_dssp             CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----
T ss_pred             hhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHH-----
Confidence            98654322  2233468999999999999999999999999999999999999999764321      1111110     


Q ss_pred             hhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHh-HHHH
Q 014202          329 LYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMD-EVVK  372 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-eil~  372 (429)
                         ...+    .++...+.++.+||.+||+.||++||++. ++++
T Consensus       217 ---~~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         217 ---MDNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---HCCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---cCCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               0111    12233457899999999999999999995 7765

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=394.96  Aligned_cols=248  Identities=29%  Similarity=0.450  Sum_probs=199.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEe-C
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE-D  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~  171 (429)
                      ++|++++.||+|+||.||+|.+.           |..||||+++.+.  ..+.+.+|+.+|++++|||||++++++.+ +
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   73 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence            46888999999999999999874           3489999997653  44678999999999999999999999865 4


Q ss_pred             CeEEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          172 DQRLLVYEFMTRGSLENHLFRRT-IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       172 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      +.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||+++
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeecccccce
Confidence            56899999999999999996543 35899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHHhhhhh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSGEQNLVAWARQYLADKRKL  329 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .....     .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||.....   .++..            
T Consensus       152 ~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~------------  211 (262)
T d1byga_         152 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP------------  211 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHH------------
T ss_pred             ecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHH------------
Confidence            64332     223578999999999999999999999999999999998 7888865432   12211            


Q ss_pred             hhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          330 YQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                        .+......+.+...++++.+||.+||..||++|||+.++++.|+.+
T Consensus       212 --~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         212 --RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             --HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence              1111222334445568899999999999999999999999988765

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-53  Score=395.58  Aligned_cols=269  Identities=26%  Similarity=0.355  Sum_probs=203.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++++.||+|+||+||+|++..+++         .||||++.....  .....+.+|+.+|++++|||||++++++.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGE---------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCC---------EEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            579999999999999999999988755         999999976532  234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++.+|+||||+.++.+..........+++..+..++.|++.||.|||  +.|||||||||+|||++.++.+||+|||+|+
T Consensus        73 ~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~  150 (298)
T d1gz8a_          73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR  150 (298)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred             ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCCcce
Confidence            99999999999765454444455667999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh-hh
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK-RK  328 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~  328 (429)
                      .......  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+....   ............. ..
T Consensus       151 ~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~  225 (298)
T d1gz8a_         151 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEV  225 (298)
T ss_dssp             HHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred             eccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchh
Confidence            6543222  223358999999999887665 578999999999999999999999754321   1111000000000 00


Q ss_pred             ----hhhhcC--Cccc-c------CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH--hcCC
Q 014202          329 ----LYQIVD--PRLE-L------NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV--LTPL  377 (429)
Q Consensus       329 ----~~~~~~--~~~~-~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~--l~~~  377 (429)
                          .....+  .... .      ......+.++.+||.+||+.||++|||++|+++.  |..+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence                000000  0000 0      0011234688999999999999999999999983  4444

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=400.55  Aligned_cols=264  Identities=27%  Similarity=0.436  Sum_probs=215.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcC-CCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQL-HHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  169 (429)
                      .++|++++.||+|+||.||+|++.....    ...++.||||+++.... .....+.+|+.++.++ +|||||++++++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIK----SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEecccc----CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            4679999999999999999998754211    12466999999986543 3445788999999999 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRT-----------------IPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSN  232 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~N  232 (429)
                      +++..++|||||++|+|.+++....                 ..+++..+..++.||+.||+|||  +++||||||||+|
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDLKp~N  175 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARN  175 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccccccc
Confidence            9999999999999999999986542                 25889999999999999999999  8999999999999


Q ss_pred             eEEcCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCc
Q 014202          233 ILLDSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILT-GRRSMDKKRPSG  311 (429)
Q Consensus       233 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  311 (429)
                      ||++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+| |.+||.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999998765544444555789999999999999999999999999999999999 555554433211


Q ss_pred             cccHHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCC
Q 014202          312 EQNLVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPL  377 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~  377 (429)
                      .                +.+++........+...+..+.+||.+||+.||++|||+.+|++.|++.
T Consensus       256 ~----------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         256 K----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             H----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1                1111111122223334557899999999999999999999999988653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=400.05  Aligned_cols=257  Identities=28%  Similarity=0.472  Sum_probs=206.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcC-CCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQL-HHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  170 (429)
                      ++|++.++||+|+||.||+|++..++.       ...||||.+... .....+.+.+|+.+|.++ +|||||++++++.+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTE-------EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCe-------EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            468899999999999999999987654       225788887544 233456789999999999 69999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRR---------------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILL  235 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill  235 (429)
                      ++..|+||||++||+|.+++...               ...+++..+..++.||+.||.|||  +.+|+||||||+|||+
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~NIL~  160 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILV  160 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccceEEE
Confidence            99999999999999999998643               356899999999999999999999  8999999999999999


Q ss_pred             cCCCCEEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCC-CCCCCCCCCcccc
Q 014202          236 DSEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR-RSMDKKRPSGEQN  314 (429)
Q Consensus       236 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~  314 (429)
                      +.++.+||+|||+++.......   .....||..|+|||.+.+..++.++|||||||++|||++|. +||....      
T Consensus       161 ~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------  231 (309)
T d1fvra_         161 GENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------  231 (309)
T ss_dssp             CGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------
T ss_pred             cCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------
Confidence            9999999999999986433221   22357999999999999999999999999999999999976 4665432      


Q ss_pred             HHHHHHHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          315 LVAWARQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..+           +...+........+...++++.+||.+||+.||++|||+.||++.|+.+.
T Consensus       232 ~~~-----------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         232 CAE-----------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             HHH-----------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH-----------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111           11111111222334456689999999999999999999999999876553

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-53  Score=395.77  Aligned_cols=258  Identities=24%  Similarity=0.303  Sum_probs=196.3

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchh-----hHHHHHHHHHHhcCCCcceeeEEeEEEeCC
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQG-----HREWVAEVDFLGQLHHPNLVKLIGYCIEDD  172 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  172 (429)
                      +++||+|+||+||+|++..+++         .||||++.......     .+.+.+|+.+|++++|||||++++++..++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~   73 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQ---------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   73 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCS---------EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             ceEeccCcCeEEEEEEECCCCc---------EEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence            5789999999999999887655         99999997653221     246889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccC
Q 014202          173 QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAG  252 (429)
Q Consensus       173 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~  252 (429)
                      .+||||||+.|+++..++ .....+++..+..++.||+.||+|||  +.||+||||||+|||++.++.+||+|||+++..
T Consensus        74 ~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          74 NISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             CCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             ceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCcccccc
Confidence            999999999887766554 45557899999999999999999999  899999999999999999999999999999875


Q ss_pred             CCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh--hhh
Q 014202          253 PQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK--RKL  329 (429)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  329 (429)
                      .....  .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+....   +....+...+...  ...
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~  225 (299)
T d1ua2a_         151 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQW  225 (299)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTS
T ss_pred             CCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhc
Confidence            44322  2234689999999999875 46799999999999999999999999764321   1111111111000  000


Q ss_pred             hhhcC-------Cccc----cCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          330 YQIVD-------PRLE----LNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       330 ~~~~~-------~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      .....       ....    .......++++.+||.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000       0000    0001123578999999999999999999999997

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=393.87  Aligned_cols=257  Identities=28%  Similarity=0.429  Sum_probs=205.7

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC-CchhhHHHHHHHHHHhcCCCcceeeEEeEEEe-CCeEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD-GLQGHREWVAEVDFLGQLHHPNLVKLIGYCIE-DDQRL  175 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~  175 (429)
                      .++||+|+||+||+|++..++.      +...||||.++.. .....+++.+|+++|++++|||||++++++.. +...+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            5689999999999999876542      1346999999754 33455789999999999999999999999775 46889


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcccCCCC
Q 014202          176 LVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKAGPQG  255 (429)
Q Consensus       176 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~~~~~  255 (429)
                      +|||||++|+|.+++......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            999999999999999888777889999999999999999999  899999999999999999999999999999875443


Q ss_pred             Ccc--ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhhhhhhc
Q 014202          256 DKT--HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRKLYQIV  333 (429)
Q Consensus       256 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (429)
                      ...  .......||+.|+|||.+.+..++.++||||||+++|||++|..||.......  ...   ...       ... 
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~---~~i-------~~g-  250 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DIT---VYL-------LQG-  250 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH---HHH-------HTT-
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHH---HHH-------HcC-
Confidence            221  12233578999999999999999999999999999999999888876432111  111   110       110 


Q ss_pred             CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          334 DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                         .....+..+++++.+||.+||+.||++||++.||++.|+.+.
T Consensus       251 ---~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         251 ---RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               111222344578999999999999999999999999887664

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-53  Score=398.07  Aligned_cols=267  Identities=24%  Similarity=0.372  Sum_probs=214.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .++|.+++.||+|+||.||+|.+.....    ...+..||||++..... .....+.+|+.+|++++|||||++++++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVK----DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEET----TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCccc----CCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3578999999999999999998864311    11234899999976533 334568999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRR---------TIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      ++..++||||+.+|+|.+++...         ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecCCceE
Confidence            99999999999999999988542         234788999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCC-CCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGR-RSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||.+..      ..+...
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~  246 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLR  246 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHH
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHH
Confidence            999999998654433333334457999999999999999999999999999999999985 6665432      111111


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcCcc
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQDLN  381 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~~~  381 (429)
                      .          +.+. .....+...+..+.+||.+||+.||++|||+.+|++.|+...+..
T Consensus       247 ~----------i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         247 F----------VMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             H----------HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             H----------HHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            1          1111 112233345578999999999999999999999999987765533

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=391.42  Aligned_cols=241  Identities=23%  Similarity=0.377  Sum_probs=199.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch------hhHHHHHHHHHHhcCC--Ccceee
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ------GHREWVAEVDFLGQLH--HPNLVK  163 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~  163 (429)
                      .++|++.+.||+|+||+||+|++..++.         .||||++......      ....+.+|+.+|++++  |||||+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~   73 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNL---------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR   73 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCC---------EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence            4689999999999999999999987755         9999998754221      1234678999999987  899999


Q ss_pred             EEeEEEeCCeEEEEEEecCC-CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCCE
Q 014202          164 LIGYCIEDDQRLLVYEFMTR-GSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-EYNA  241 (429)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~  241 (429)
                      +++++.+++..|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||  +.+|+||||||+|||++. ++.+
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~~~~~v  150 (273)
T d1xwsa_          74 LLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGEL  150 (273)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEE
T ss_pred             EEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEecCCCeE
Confidence            99999999999999999976 5777777554 46999999999999999999999  899999999999999985 4789


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWAR  320 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  320 (429)
                      ||+|||+|+.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|..||....     .      
T Consensus       151 kl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~------  215 (273)
T d1xwsa_         151 KLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E------  215 (273)
T ss_dssp             EECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------
T ss_pred             EECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H------
Confidence            99999999874332    2234689999999999987765 577999999999999999999996421     0      


Q ss_pred             HHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          321 QYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                       ....            ....+...++++.+||.+||+.||++|||++|+++
T Consensus       216 -i~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 -IIRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -HHHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -Hhhc------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             0000            01122234578999999999999999999999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=394.12  Aligned_cols=265  Identities=25%  Similarity=0.321  Sum_probs=202.2

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcC---CCcceeeEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQL---HHPNLVKLIG  166 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~  166 (429)
                      .++|++++.||+|+||+||+|++..++        ++.||||++.....  .....+.+|+.+|+.|   +||||+++++
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~   77 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD   77 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTT--------TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCC--------CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence            368999999999999999999986553        23799999865422  2234566788877666   7999999999


Q ss_pred             EEEe-----CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCE
Q 014202          167 YCIE-----DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNA  241 (429)
Q Consensus       167 ~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~  241 (429)
                      +|..     ....+++|||+.++.+..........+++..+..++.|++.||+|||  +++|+||||||+|||++.++.+
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi~~~~~~  155 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQI  155 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCE
T ss_pred             eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEEcCCCCe
Confidence            9863     34679999999988777666666667999999999999999999999  8999999999999999999999


Q ss_pred             EEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH
Q 014202          242 KLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ  321 (429)
Q Consensus       242 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  321 (429)
                      ||+|||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|.+||.+..+.   .....+..
T Consensus       156 kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~  229 (305)
T d1blxa_         156 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILD  229 (305)
T ss_dssp             EECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             eecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHH
Confidence            99999999864322   2334478999999999999999999999999999999999999999764321   11111111


Q ss_pred             HHHhhh--hhh----------hhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          322 YLADKR--KLY----------QIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       322 ~~~~~~--~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                      ......  ...          ...............++.+.+||.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            110000  000          000000011122334578999999999999999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=388.50  Aligned_cols=266  Identities=27%  Similarity=0.366  Sum_probs=199.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHH--HHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWV--AEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      .+|.+.+.||+|+||.||+|++.           |+.||||++....   ...+.  .|+..+.+++|||||++++++..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~   68 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence            35778899999999999999863           4589999996442   23333  45556667899999999999987


Q ss_pred             CC----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCCeEEcCCCC
Q 014202          171 DD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGG------SEPVIYRDFKTSNILLDSEYN  240 (429)
Q Consensus       171 ~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~------~~~ivHrDlkp~Nill~~~~~  240 (429)
                      ++    .+|+||||+++|+|.+++.+.  .+++..++.++.|++.||+|||..      .++||||||||+||||+.++.
T Consensus        69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~  146 (303)
T d1vjya_          69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             CCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence            64    579999999999999999765  489999999999999999999942      369999999999999999999


Q ss_pred             EEEccccCcccCCCCCcc--ceeeeccccccccChhhhhcCC------CCCccchhhhHHHHHHHHhCCCCCCCCCCCcc
Q 014202          241 AKLSDFGLAKAGPQGDKT--HVSTRVVGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGE  312 (429)
Q Consensus       241 ~kl~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  312 (429)
                      +||+|||+++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||........
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            999999999875443221  1233468999999999987543      56789999999999999999988754332111


Q ss_pred             c--------cHHHHHHHHHHhhhhhhhhcCCccccCC-CHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCcC
Q 014202          313 Q--------NLVAWARQYLADKRKLYQIVDPRLELNY-SLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQD  379 (429)
Q Consensus       313 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~~  379 (429)
                      .        ..........     ......+.++... .......+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhcccccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0        0111111110     1111222222111 23455679999999999999999999999999876654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.2e-51  Score=381.52  Aligned_cols=262  Identities=23%  Similarity=0.296  Sum_probs=199.5

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch--hhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ--GHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++++.||+|+||+||+|++. +         |+.||||++......  ..+.+.+|+.+|++++|||||++++++.+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~---------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-Y---------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-T---------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeC-C---------CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            58999999999999999999885 3         348999999765432  24678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ++..+++||++.++.+..+. .....+++..+..++.||+.||+|||  +.+||||||||+|||++.++.+||+|||++.
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~  148 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR  148 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred             CCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccccce
Confidence            99999999999776665554 55567999999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh----
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD----  325 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  325 (429)
                      .......  ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......   +........+..    
T Consensus       149 ~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~  223 (286)
T d1ob3a_         149 AFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSK  223 (286)
T ss_dssp             HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred             ecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChh
Confidence            6533221  22335799999999998754 5689999999999999999999999754321   111111000000    


Q ss_pred             ----hhhhhhh------cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          326 ----KRKLYQI------VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       326 ----~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                          .......      ..+..........++.+.+||.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0000000      0000001112234578999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-50  Score=379.86  Aligned_cols=264  Identities=16%  Similarity=0.180  Sum_probs=211.9

Q ss_pred             hcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCC-cceeeEEeEEE
Q 014202           91 ATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHH-PNLVKLIGYCI  169 (429)
Q Consensus        91 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~  169 (429)
                      ..++|++++.||+|+||+||+|++..+++         .||||++....  ....+.+|++++..|.| +||+.+++++.
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~---------~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~   71 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQ---------QVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ   71 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTE---------EEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee
Confidence            35789999999999999999999987654         99999986543  23457789999999975 99999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-----CCCEEEc
Q 014202          170 EDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS-----EYNAKLS  244 (429)
Q Consensus       170 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~kl~  244 (429)
                      .+...++||||+ +++|.+++......+++..+..++.|++.||+|||  +.||+||||||+|||++.     ++.+||+
T Consensus        72 ~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          72 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             cCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceEEc
Confidence            999999999999 78999999887778999999999999999999999  999999999999999964     5789999


Q ss_pred             cccCcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          245 DFGLAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       245 DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      |||+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|..||.+............+
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            99999875432211     1223468999999999999999999999999999999999999999866544333222211


Q ss_pred             HHHHHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          320 RQYLADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                      ..... .....+         .....++++.+++..|+..+|++||+++.+.+.|+.+.
T Consensus       229 ~~~~~-~~~~~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         229 GEKKQ-STPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHH-HSCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HhccC-CCChHH---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11000 000000         11123467999999999999999999999988776543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-50  Score=376.30  Aligned_cols=263  Identities=19%  Similarity=0.225  Sum_probs=203.9

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcc-eeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPN-LVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~  170 (429)
                      .++|++.+.||+|+||.||+|++..+++         .||||++....  ...++..|+++++.++|+| |+.+.+++..
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~---------~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~   74 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE   74 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCC---------EEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence            4689999999999999999999887654         99999987653  2346789999999998665 5556667788


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCCEEEcccc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD---SEYNAKLSDFG  247 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~DFg  247 (429)
                      ++..++||||+ +++|.+.+......+++..+..++.|++.||+|||  ++||+||||||+|||++   .+..+||+|||
T Consensus        75 ~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          75 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             CCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeeeeccC
Confidence            88899999999 66888877777778999999999999999999999  89999999999999985   35579999999


Q ss_pred             CcccCCCCCcc-----ceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          248 LAKAGPQGDKT-----HVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       248 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      +|+........     .......||+.|||||++.+..++.++|||||||++|||++|..||..................
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            99876443221     1223468999999999999999999999999999999999999999765543322221111000


Q ss_pred             HHhhhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHHhcCCc
Q 014202          323 LADKRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKVLTPLQ  378 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~l~~~~  378 (429)
                           ...   .+ . ......+++++.+|+.+||+.||++||++.++.+.|+.+.
T Consensus       232 -----~~~---~~-~-~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         232 -----KMS---TP-I-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             -----HHH---SC-H-HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             -----cCC---CC-h-hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                 000   00 0 0011133478999999999999999999999988776553

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=385.17  Aligned_cols=265  Identities=22%  Similarity=0.295  Sum_probs=199.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++++.||+|+||+||+|++..+++         .||||++.....  ...+.+.+|+.+|++++|||||+++++|.
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~   87 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGA---------KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   87 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCC---------EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence            4689999999999999999999987755         999999976532  23467889999999999999999999998


Q ss_pred             eCC------eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEE
Q 014202          170 EDD------QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKL  243 (429)
Q Consensus       170 ~~~------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl  243 (429)
                      ..+      .+|+||||+ +.+|..++...  .+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             cCccccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhccccccccc
Confidence            665      569999999 66787766443  5899999999999999999999  899999999999999999999999


Q ss_pred             ccccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHH
Q 014202          244 SDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQY  322 (429)
Q Consensus       244 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  322 (429)
                      +|||+++.....     .+...||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+......   .......
T Consensus       163 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~---~~~~~~~  234 (346)
T d1cm8a_         163 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKV  234 (346)
T ss_dssp             CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHH
T ss_pred             ccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH---HHHHHhc
Confidence            999999875432     2346899999999998764 568999999999999999999999976532111   0000000


Q ss_pred             HHh-------------hhhhhhhc---CCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCc
Q 014202          323 LAD-------------KRKLYQIV---DPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQ  378 (429)
Q Consensus       323 ~~~-------------~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~  378 (429)
                      ...             ........   ............++.+.+||.+||..||.+|||+.|+|+  +|+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             cCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            000             00000000   000001112234578899999999999999999999998  455554

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-50  Score=383.92  Aligned_cols=272  Identities=22%  Similarity=0.318  Sum_probs=201.3

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc-hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL-QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      +.+|++++.||+|+||+||+|++..+++         .||||++..... ...+.+.+|+.+|++|+||||+++++++..
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~   77 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKV---------RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   77 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCS---------EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCc---------EEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence            4679999999999999999999887755         999999976543 335678899999999999999999999876


Q ss_pred             CC----eEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccc
Q 014202          171 DD----QRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDF  246 (429)
Q Consensus       171 ~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF  246 (429)
                      +.    ..+++++++.||+|.+++...  .+++..+..++.|++.||+|||  ++|||||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          78 PTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             SSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEEEccc
Confidence            54    234455566799999999654  5899999999999999999999  899999999999999999999999999


Q ss_pred             cCcccCCCCCcc-ceeeeccccccccChhhhh-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHH
Q 014202          247 GLAKAGPQGDKT-HVSTRVVGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLA  324 (429)
Q Consensus       247 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  324 (429)
                      |+++........ ......+||+.|+|||++. +..++.++||||+||++|+|++|..||.........   ........
T Consensus       154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~  230 (345)
T d1pmea_         154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILG  230 (345)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred             CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhcc
Confidence            999865432211 1223467999999999985 556789999999999999999999999765421111   10000000


Q ss_pred             hh-------------hhhhhhcCCcccc---CCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH--hcCCcC
Q 014202          325 DK-------------RKLYQIVDPRLEL---NYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV--LTPLQD  379 (429)
Q Consensus       325 ~~-------------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~--l~~~~~  379 (429)
                      ..             .............   ......+.++.+||.+||+.||.+|||+.|+++.  |+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            00             0000000000000   0111234678999999999999999999999983  554443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=380.79  Aligned_cols=265  Identities=24%  Similarity=0.316  Sum_probs=197.4

Q ss_pred             CCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcceeeEEeEEEeC--
Q 014202           94 NFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNLVKLIGYCIED--  171 (429)
Q Consensus        94 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  171 (429)
                      +|+.+++||+|+||+||+|++..+++         .||||++.....    ...+|+.+|++++||||++++++|...  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGE---------LVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCC---------EEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            48889999999999999999987755         999999976532    224799999999999999999998643  


Q ss_pred             ----CeEEEEEEecCCCChHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CEEEc
Q 014202          172 ----DQRLLVYEFMTRGSLENHL--FRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLS  244 (429)
Q Consensus       172 ----~~~~lv~e~~~gg~L~~~l--~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~  244 (429)
                          .++|||||||+++.+..+.  ......+++..+..++.||+.||+|||  ++||+||||||+|||++.++ .+||+
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEEEC
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCceeEe
Confidence                3578999999766443332  234557999999999999999999999  89999999999999998775 89999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHH--
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQ--  321 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--  321 (429)
                      |||+++.......   ....+||+.|+|||.+.+ ..++.++|||||||++|||++|..||........  +......  
T Consensus       166 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g  240 (350)
T d1q5ka_         166 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLG  240 (350)
T ss_dssp             CCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHC
T ss_pred             cccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhC
Confidence            9999987544322   233689999999998875 5689999999999999999999999975432111  1110000  


Q ss_pred             -----HHHhh-hhhhhh-----cCCccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCc
Q 014202          322 -----YLADK-RKLYQI-----VDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQ  378 (429)
Q Consensus       322 -----~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~  378 (429)
                           .+... ......     .............++++.+||.+||+.||++|||+.|+++  +|+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                 00000 000000     0000011112234578999999999999999999999997  454443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-49  Score=373.53  Aligned_cols=266  Identities=23%  Similarity=0.312  Sum_probs=197.1

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++++.||+|+||+||+|++..+++         .||||++.....  .....+.+|+.+|++++||||+++++++..
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~   80 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQ---------KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   80 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence            689999999999999999999987655         999999865532  234678899999999999999999998755


Q ss_pred             --------CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEE
Q 014202          171 --------DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAK  242 (429)
Q Consensus       171 --------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k  242 (429)
                              ++..|+||||+.++.+.. +......+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+|
T Consensus        81 ~~~~~~~~~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~~~~~~k  157 (318)
T d3blha1          81 KASPYNRCKGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLK  157 (318)
T ss_dssp             ----------CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEE
T ss_pred             ccccccccCceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeecCCCcEE
Confidence                    346899999997766554 4455567899999999999999999999  89999999999999999999999


Q ss_pred             EccccCcccCCCCCcc--ceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 014202          243 LSDFGLAKAGPQGDKT--HVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWA  319 (429)
Q Consensus       243 l~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  319 (429)
                      |+|||+++........  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...   ......+
T Consensus       158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i  234 (318)
T d3blha1         158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALI  234 (318)
T ss_dssp             ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH
T ss_pred             eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHH
Confidence            9999999765432211  122335799999999998765 689999999999999999999999975432   1111111


Q ss_pred             HHHHHhh-hhhhhhc---------CCccccCCC-------HHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          320 RQYLADK-RKLYQIV---------DPRLELNYS-------LKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       320 ~~~~~~~-~~~~~~~---------~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                      ....... .......         .........       ...++.+.+||.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            1111000 0000000         000000000       0113567899999999999999999999983

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=378.93  Aligned_cols=256  Identities=28%  Similarity=0.375  Sum_probs=205.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc----hhhHHHHHHHHHHhcCCC-cceeeEEeE
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL----QGHREWVAEVDFLGQLHH-PNLVKLIGY  167 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-pnIv~~~~~  167 (429)
                      ++|++++.||+|+||+||+|++.....      +|+.||||++.....    ...+.+.+|+.+|++++| |||++++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHD------TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTT------TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCC------CCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            469999999999999999999865422      466999999875422    234567899999999976 899999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEcccc
Q 014202          168 CIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFG  247 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg  247 (429)
                      +.+....++||||+.||+|.+++.... .+++..+..++.||+.||.|||  +.+|+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEEeecc
Confidence            999999999999999999999986654 5788999999999999999999  8999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccccccccChhhhhcC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHh
Q 014202          248 LAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLAD  325 (429)
Q Consensus       248 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  325 (429)
                      +++....... .......|++.|+|||.+.+.  .++.++|||||||+||||++|..||...........+.  ...   
T Consensus       175 ~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~---  248 (322)
T d1vzoa_         175 LSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRI---  248 (322)
T ss_dssp             EEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHH---
T ss_pred             chhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhc---
Confidence            9987543322 223346899999999999754  46889999999999999999999998765433222111  000   


Q ss_pred             hhhhhhhcCCccccCCCHHHHHHHHHHHHHcccCCCCCCC-----CHhHHHH
Q 014202          326 KRKLYQIVDPRLELNYSLKGVQKVSQLAYNCLSRDPKSRP-----SMDEVVK  372 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~eil~  372 (429)
                             ...  ....+...++++.+||.+||+.||++||     |++|+++
T Consensus       249 -------~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 -------LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -------HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------ccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                   000  1122334568899999999999999999     4788886

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=366.86  Aligned_cols=261  Identities=24%  Similarity=0.280  Sum_probs=205.8

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|++++.||+|+||+||+|++..++.         .||||+++....  .....+.+|+.+|+.++||||+++++++.+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCc---------EEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence            579999999999999999999987755         999999865533  335678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEccccCcc
Q 014202          171 DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAK  250 (429)
Q Consensus       171 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~  250 (429)
                      ....++||+++.|++|..++. ....+++..+..++.|++.||+|||  ..+|+||||||+|||++.++.+||+|||.++
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~  149 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ccceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecchhh
Confidence            999999999999988887664 4457899999999999999999999  8999999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccccccccChhhhhcCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhhhh-
Q 014202          251 AGPQGDKTHVSTRVVGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADKRK-  328 (429)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  328 (429)
                      .......  ......+++.|+|||++.+.. ++.++|||||||++|||++|..||.....     ..+........... 
T Consensus       150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~~~~  222 (292)
T d1unla_         150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTP  222 (292)
T ss_dssp             ECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHHHCCC
T ss_pred             cccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-----HHHHHHHHHhhcCCC
Confidence            7644332  222356789999999987654 68999999999999999999999754322     11111111110000 


Q ss_pred             -------hhhhcC---------CccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          329 -------LYQIVD---------PRLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       329 -------~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                             .....+         ...........++.+.+||.+||+.||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   000000         00011122334578999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.2e-49  Score=374.14  Aligned_cols=257  Identities=21%  Similarity=0.277  Sum_probs=199.3

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeC
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIED  171 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  171 (429)
                      ++|+++++||+|+||+||+|++..+++         .||||+++...   .+.+.+|+.+|+.++ ||||++++++|...
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~---------~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            579999999999999999999987655         99999997543   457889999999996 99999999999854


Q ss_pred             --CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-CEEEccccC
Q 014202          172 --DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEY-NAKLSDFGL  248 (429)
Q Consensus       172 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFg~  248 (429)
                        ...++|||||.+++|..+.    ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++ .+||+|||+
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeeeccccc
Confidence              5689999999999997653    35899999999999999999999  89999999999999998655 599999999


Q ss_pred             cccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHHhh-
Q 014202          249 AKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYLADK-  326 (429)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  326 (429)
                      |+.......   ....+||+.|+|||.+.+. .++.++|||||||++|||++|..||..........  ..+...+... 
T Consensus       177 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~--~~i~~~~g~~~  251 (328)
T d3bqca1         177 AEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTED  251 (328)
T ss_dssp             CEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHH
T ss_pred             ceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH--HHHHHHHCCch
Confidence            987544322   2346899999999998765 57999999999999999999999997654322111  1111111000 


Q ss_pred             -------------hhhhhhcCC--------ccccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH
Q 014202          327 -------------RKLYQIVDP--------RLELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK  372 (429)
Q Consensus       327 -------------~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~  372 (429)
                                   .........        ..........++++.+||.+||..||++|||++|+|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                         000000000        0001111234578999999999999999999999997

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=375.41  Aligned_cols=263  Identities=22%  Similarity=0.301  Sum_probs=191.4

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEEe
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCIE  170 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  170 (429)
                      ++|+++++||+|+||+||+|++..++.         .||||++.....  .....+.+|+.+|++++|||||+++++|..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~---------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~   87 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDR---------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTE---------EEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCC---------EEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence            689999999999999999999987655         999999976532  334568899999999999999999999964


Q ss_pred             ------CCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          171 ------DDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       171 ------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                            ...+|+|||||.++ +.+.+.   ..+++..++.++.||+.||.|||  +.||+||||||+|||++.++.++++
T Consensus        88 ~~~~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          88 QKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             CCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             ccccccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCccccccccccceeee
Confidence                  36789999999765 444443   34899999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHH-------
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVA-------  317 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~-------  317 (429)
                      |||+++......   .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+.       
T Consensus       162 df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         162 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_dssp             CCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             chhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence            999988654322   2334689999999999999999999999999999999999999997543211100000       


Q ss_pred             --H-------HHHHHHhhh-----hhhhhcCCcc---ccCCCHHHHHHHHHHHHHcccCCCCCCCCHhHHHHH
Q 014202          318 --W-------ARQYLADKR-----KLYQIVDPRL---ELNYSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVKV  373 (429)
Q Consensus       318 --~-------~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~~  373 (429)
                        +       .........     ..........   ........+.++.+||.+||..||++|||++|+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              0       000000000     0000000000   001122356789999999999999999999999973

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=373.16  Aligned_cols=267  Identities=22%  Similarity=0.312  Sum_probs=200.1

Q ss_pred             cCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCc--hhhHHHHHHHHHHhcCCCcceeeEEeEEE
Q 014202           92 TGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGL--QGHREWVAEVDFLGQLHHPNLVKLIGYCI  169 (429)
Q Consensus        92 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  169 (429)
                      .++|++++.||+|+||+||+|++..+++         .||||++.....  ...+.+.+|+.+|++|+|||||++++++.
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGL---------RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTE---------EEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4689999999999999999999987655         999999976533  33457889999999999999999999986


Q ss_pred             eC-----CeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCCEEEc
Q 014202          170 ED-----DQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDSEYNAKLS  244 (429)
Q Consensus       170 ~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~  244 (429)
                      ..     ...++||+++.||+|.+++..+  .+++..+..++.||+.||+|||  ++||+||||||+|||++.++.+|++
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eccccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCcccccccccccccc
Confidence            43     3346677778899999988543  5999999999999999999999  8999999999999999999999999


Q ss_pred             cccCcccCCCCCccceeeeccccccccChhhhhcC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH
Q 014202          245 DFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEILTGRRSMDKKRPSGEQNLVAWARQYL  323 (429)
Q Consensus       245 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  323 (429)
                      |||++......     .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.......   ..+....
T Consensus       164 dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~---~~i~~~~  235 (348)
T d2gfsa1         164 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLV  235 (348)
T ss_dssp             CC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH
T ss_pred             ccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhc
Confidence            99999764321     2336799999999987765 4688999999999999999999999764321111   1110000


Q ss_pred             Hh-hhhh------------hhhcCCccccC---CCHHHHHHHHHHHHHcccCCCCCCCCHhHHHH--HhcCCcC
Q 014202          324 AD-KRKL------------YQIVDPRLELN---YSLKGVQKVSQLAYNCLSRDPKSRPSMDEVVK--VLTPLQD  379 (429)
Q Consensus       324 ~~-~~~~------------~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~eil~--~l~~~~~  379 (429)
                      .. ....            ...........   .....++.+.+||.+||+.||.+|||+.|+++  +|..+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence            00 0000            00000000000   01123577899999999999999999999998  5655543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-43  Score=342.65  Aligned_cols=264  Identities=19%  Similarity=0.215  Sum_probs=192.7

Q ss_pred             CCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-----------Ccce
Q 014202           93 GNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-----------HPNL  161 (429)
Q Consensus        93 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnI  161 (429)
                      ++|+++++||+|+||+||+|++..+++         .||||+++.+.. ..+.+.+|+.+|+.++           |+||
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~---------~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            569999999999999999999987755         999999986532 3356778999888875           5789


Q ss_pred             eeEEeEEEe--CCeEEEEEEecCCCChHHH--HhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 014202          162 VKLIGYCIE--DDQRLLVYEFMTRGSLENH--LFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLDS  237 (429)
Q Consensus       162 v~~~~~~~~--~~~~~lv~e~~~gg~L~~~--l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~~  237 (429)
                      +++++++..  ....+++|+++..+.....  .......+++..+..++.||+.||+|||. ..||+||||||+|||++.
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeec
Confidence            999988764  3566777777655543332  23345568999999999999999999993 389999999999999976


Q ss_pred             CCC------EEEccccCcccCCCCCccceeeeccccccccChhhhhcCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 014202          238 EYN------AKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEILTGRRSMDKKRPSG  311 (429)
Q Consensus       238 ~~~------~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  311 (429)
                      ++.      ++|+|||.+......     ....+||+.|+|||++.+..++.++|||||||++++|++|+.||.......
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence            653      999999999864322     233689999999999999999999999999999999999999997654332


Q ss_pred             cccHHHHHHHHHHhh-----------hhhhhhcC---------C----------ccccCCCHHHHHHHHHHHHHcccCCC
Q 014202          312 EQNLVAWARQYLADK-----------RKLYQIVD---------P----------RLELNYSLKGVQKVSQLAYNCLSRDP  361 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~-----------~~~~~~~~---------~----------~~~~~~~~~~~~~l~~li~~~l~~dP  361 (429)
                      ...........+...           .......+         .          ..........+..+.+||.+||..||
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence            222111111111000           00000000         0          00112345667889999999999999


Q ss_pred             CCCCCHhHHHH
Q 014202          362 KSRPSMDEVVK  372 (429)
Q Consensus       362 ~~Rpt~~eil~  372 (429)
                      .+|||++|+|+
T Consensus       317 ~~Rpta~e~L~  327 (362)
T d1q8ya_         317 RKRADAGGLVN  327 (362)
T ss_dssp             TTCBCHHHHHT
T ss_pred             hHCcCHHHHhc
Confidence            99999999997

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.8e-26  Score=201.06  Aligned_cols=164  Identities=16%  Similarity=0.092  Sum_probs=119.9

Q ss_pred             CCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCch------------------hhHHHHHHHHHHhcC
Q 014202           95 FRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQ------------------GHREWVAEVDFLGQL  156 (429)
Q Consensus        95 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l  156 (429)
                      +.+++.||+|+||.||+|++..          |+.||||++......                  .......|+..|.++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~----------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   71 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK----------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL   71 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             chhCCEeeeCcceEEEEEECCC----------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence            4567899999999999998742          448999987542110                  012345788999999


Q ss_pred             CCcceeeEEeEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 014202          157 HHPNLVKLIGYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHGGSEPVIYRDFKTSNILLD  236 (429)
Q Consensus       157 ~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ivHrDlkp~Nill~  236 (429)
                      .|++++..+++..    .+++|||+++..+.+        ++......++.|++.+|.|||  ..||+||||||+|||++
T Consensus        72 ~~~~v~~~~~~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NILv~  137 (191)
T d1zara2          72 QGLAVPKVYAWEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLVS  137 (191)
T ss_dssp             TTSSSCCEEEEET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEEE
T ss_pred             cCCCcceEEEecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhheeee
Confidence            9999999887532    379999998866543        334455688999999999999  89999999999999998


Q ss_pred             CCCCEEEccccCcccCCCCCccceeeeccccccccCh------hhhhcCCCCCccchhhhHHHH
Q 014202          237 SEYNAKLSDFGLAKAGPQGDKTHVSTRVVGTYGYAAP------EYVMTGHLTSKSDVYSFGVVL  294 (429)
Q Consensus       237 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwSlG~il  294 (429)
                      ++ .++|+|||.|+........          .|...      + +....|+.++|+||+.--+
T Consensus       138 ~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         138 EE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             CC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence            65 4999999999765332211          11111      1 1245688999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.79  E-value=2e-08  Score=89.69  Aligned_cols=148  Identities=16%  Similarity=0.038  Sum_probs=98.9

Q ss_pred             HHHhhcCCCCCCCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEE
Q 014202           87 ELKSATGNFRPDSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLI  165 (429)
Q Consensus        87 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~  165 (429)
                      +++.....|++.+..+.++.+.||+....           +..+++|+...........+.+|...|..|. +--+.+++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-----------~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl   76 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL   76 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-----------CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence            55666678887777665666789987532           2378899887554444456778998888775 44467788


Q ss_pred             eEEEeCCeEEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhC---------------------------
Q 014202          166 GYCIEDDQRLLVYEFMTRGSLENHLFRRTIPLPWSNRIKIALGAAKGLAFLHG---------------------------  218 (429)
Q Consensus       166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---------------------------  218 (429)
                      .+...++..++||++++|.++.+......   .   ...++.+++..+..||.                           
T Consensus        77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~~---~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T d1j7la_          77 HFERHDGWSNLLMSEADGVLCSEEYEDEQ---S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             EEEEETTEEEEEEECCSSEEHHHHTTTCS---C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             EEEecCCceEEEEEecccccccccccccc---c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence            88888899999999999988765432111   1   11122333333333331                           


Q ss_pred             ------------------------------CCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          219 ------------------------------GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       219 ------------------------------~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                                                    ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                          012378999999999998776667999987753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.01  E-value=1.4e-05  Score=75.23  Aligned_cols=78  Identities=17%  Similarity=0.181  Sum_probs=49.6

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCC------C-chhhHHHHHHHHHHhcCC-C--cceeeEEeE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPD------G-LQGHREWVAEVDFLGQLH-H--PNLVKLIGY  167 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~  167 (429)
                      .+.||.|....||++.....+         +.|+||.-...      . .....+...|+..|+.+. +  ..+.+++.+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~---------~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~  101 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHD---------RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  101 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEEeCCCceEeEEEEEeCCCC---------eEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence            356899999999999865543         37999974321      1 112344567888887663 2  346666654


Q ss_pred             EEeCCeEEEEEEecCCCCh
Q 014202          168 CIEDDQRLLVYEFMTRGSL  186 (429)
Q Consensus       168 ~~~~~~~~lv~e~~~gg~L  186 (429)
                        +++..++|||++.+..+
T Consensus       102 --d~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         102 --DTEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             --ETTTTEEEECCCTTSEE
T ss_pred             --cCCCCEEEEeccCCccc
Confidence              45566899999976543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.93  E-value=3.8e-05  Score=67.20  Aligned_cols=74  Identities=16%  Similarity=0.035  Sum_probs=50.6

Q ss_pred             ccccCc-eeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC--CcceeeEEeEEEeCCeEEEE
Q 014202          101 LGEGGF-GYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH--HPNLVKLIGYCIEDDQRLLV  177 (429)
Q Consensus       101 lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv  177 (429)
                      +..|.. +.||+.....          |..+++|......   ...+..|+..|+.|.  .-.+.+++.+..+++..++|
T Consensus        18 ~~~G~s~~~v~r~~~~~----------~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQG----------RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             CSCTTSSCEEEEEECTT----------SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             cCCcccCCeEEEEEeCC----------CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            344443 6789876432          3368889876443   234667888887774  23367788888888889999


Q ss_pred             EEecCCCChH
Q 014202          178 YEFMTRGSLE  187 (429)
Q Consensus       178 ~e~~~gg~L~  187 (429)
                      |++++|.++.
T Consensus        85 ~~~i~G~~~~   94 (255)
T d1nd4a_          85 LGEVPGQDLL   94 (255)
T ss_dssp             EECCSSEETT
T ss_pred             EEeeeccccc
Confidence            9999886653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.40  E-value=0.00027  Score=66.11  Aligned_cols=81  Identities=17%  Similarity=0.041  Sum_probs=53.6

Q ss_pred             CCcccccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC-CcceeeEEeEEEeCCeEEE
Q 014202           98 DSILGEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH-HPNLVKLIGYCIEDDQRLL  176 (429)
Q Consensus        98 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  176 (429)
                      ++.|+.|-.-.+|++.......  .....+..|.+++.....  ......+|..+++.+. +.-..++++++.+    .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            3568889999999998765422  222234578888876322  2234568999998886 4444577777643    68


Q ss_pred             EEEecCCCCh
Q 014202          177 VYEFMTRGSL  186 (429)
Q Consensus       177 v~e~~~gg~L  186 (429)
                      ||||++|..|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.13  E-value=0.00086  Score=60.31  Aligned_cols=156  Identities=14%  Similarity=0.034  Sum_probs=84.7

Q ss_pred             ccHHHHHhhcCCCCCCCcc-----cccCceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCC
Q 014202           83 FTFQELKSATGNFRPDSIL-----GEGGFGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLH  157 (429)
Q Consensus        83 ~~~~~~~~~~~~y~~~~~l-----g~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  157 (429)
                      .+..++.....+|.+++..     ..|---+.|+.....          | .+++|+....  ....++..|+.+|..|.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~----------g-~yVLri~~~~--~~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK----------D-PLILTLYEKR--VEKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC----------C-cEEEEEcCCC--CCHHHHHHHHHHHHhhh
Confidence            3456677777788886554     355567889886543          1 5899998643  23345566777777764


Q ss_pred             C-----cceeeEEe---EEEeCCeEEEEEEecCCCChHH--------------HHhc--CC------CCC----------
Q 014202          158 H-----PNLVKLIG---YCIEDDQRLLVYEFMTRGSLEN--------------HLFR--RT------IPL----------  197 (429)
Q Consensus       158 h-----pnIv~~~~---~~~~~~~~~lv~e~~~gg~L~~--------------~l~~--~~------~~~----------  197 (429)
                      .     |..+...+   +.........++.++.|.....              .+..  ..      ...          
T Consensus        70 ~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (316)
T d2ppqa1          70 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD  149 (316)
T ss_dssp             HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred             hccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhh
Confidence            2     22222211   2233455566777665532210              0000  00      000          


Q ss_pred             --------CHHHHHHHHHHHHHHHHHHhC--CCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          198 --------PWSNRIKIALGAAKGLAFLHG--GSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       198 --------~~~~~~~~~~qi~~~l~~lH~--~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                              ........+..+...+...+.  ...|+||+|+.++||+++.+...-|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         150 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence                    001111222233333333331  246899999999999999887778999998853

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.12  E-value=0.00069  Score=61.38  Aligned_cols=133  Identities=15%  Similarity=0.093  Sum_probs=75.9

Q ss_pred             ceeEEEEEEccCCCCCCCCCCCcEEEEEEeCCCCchhhHHHHHHHHHHhcCCCcce-----eeEE--eEEEeCCeEEEEE
Q 014202          106 FGYVFKGWIEENGTAPAKPGSGITVAVKSLKPDGLQGHREWVAEVDFLGQLHHPNL-----VKLI--GYCIEDDQRLLVY  178 (429)
Q Consensus       106 fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~--~~~~~~~~~~lv~  178 (429)
                      -..||++...+          |..|++|+..... ....++..|...|..|...+|     +..-  ..+..++..+.++
T Consensus        35 EN~vy~v~~~d----------g~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~  103 (325)
T d1zyla1          35 ENRVYQFQDED----------RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  103 (325)
T ss_dssp             SSEEEEECCTT----------CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             cceeEEEEcCC----------CCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence            46899987542          4479999986543 344667788888877742221     1111  1345567788999


Q ss_pred             EecCCCChH-----H------HH---hc----C----CCCCCH----------------------HHHHHHHHHHHHHHH
Q 014202          179 EFMTRGSLE-----N------HL---FR----R----TIPLPW----------------------SNRIKIALGAAKGLA  214 (429)
Q Consensus       179 e~~~gg~L~-----~------~l---~~----~----~~~~~~----------------------~~~~~~~~qi~~~l~  214 (429)
                      +++.|..+.     .      .+   ..    .    ....+.                      ......+.++...+.
T Consensus       104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  183 (325)
T d1zyla1         104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT  183 (325)
T ss_dssp             ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred             eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence            998764321     0      00   00    0    001111                      111222333333333


Q ss_pred             HH--hCCCCCeeeCCCCCCCeEEcCCCCEEEccccCccc
Q 014202          215 FL--HGGSEPVIYRDFKTSNILLDSEYNAKLSDFGLAKA  251 (429)
Q Consensus       215 ~l--H~~~~~ivHrDlkp~Nill~~~~~~kl~DFg~a~~  251 (429)
                      -+  .....++||+|+.+.|||++++  ..++||+-+..
T Consensus       184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         184 AHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            22  1124579999999999999743  45899998864